PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fuller, C; Michie, S; Savage, J; McAteer, J; Besser, S; Charlett, A; Hayward, A; Cookson, BD; Cooper, BS; Duckworth, G; Jeanes, A; Roberts, J; Teare, L; Stone, S				Fuller, Christopher; Michie, Susan; Savage, Joanne; McAteer, John; Besser, Sarah; Charlett, Andre; Hayward, Andrew; Cookson, Barry D.; Cooper, Ben S.; Duckworth, Georgia; Jeanes, Annette; Roberts, Jenny; Teare, Louise; Stone, Sheldon			The Feedback Intervention Trial (FIT)-Improving Hand-Hygiene Compliance in UK Healthcare Workers: A Stepped Wedge Cluster Randomised Controlled Trial	PLOS ONE			English	Article							BEHAVIOR; STAFF; RISK	Introduction: Achieving a sustained improvement in hand-hygiene compliance is the WHO's first global patient safety challenge. There is no RCT evidence showing how to do this. Systematic reviews suggest feedback is most effective and call for long term well designed RCTs, applying behavioural theory to intervention design to optimise effectiveness. Methods: Three year stepped wedge cluster RCT of a feedback intervention testing hypothesis that the intervention was more effective than routine practice in 16 English/Welsh Hospitals (16 Intensive Therapy Units [ITU]; 44 Acute Care of the Elderly [ACE] wards) routinely implementing a national cleanyourhands campaign). Intervention-based on Goal & Control theories. Repeating 4 week cycle (20 mins/week) of observation, feedback and personalised action planning, recorded on forms. Computer-generated stepwise entry of all hospitals to intervention. Hospitals aware only of own allocation. Primary outcome: direct blinded hand hygiene compliance (%). Results: All 16 trusts (60 wards) randomised, 33 wards implemented intervention (11 ITU, 22 ACE). Mixed effects regression analysis (all wards) accounting for confounders, temporal trends, ward type and fidelity to intervention (forms/month used). Intention to Treat Analysis: Estimated odds ratio (OR) for hand hygiene compliance rose post randomisation (1.44; 95% CI 1.18, 1.76; p<0.001) in ITUs but not ACE wards, equivalent to 7-9% absolute increase in compliance. Per-Protocol Analysis for Implementing Wards: OR for compliance rose for both ACE (1.67 [1.28-2.22]; p<0.001) & ITUs (2.09 [1.55-2.81]; p<0.001) equating to absolute increases of 10-13% and 13-18% respectively. Fidelity to intervention closely related to compliance on ITUs (OR 1.12 [1.04, 1.20];p = 0.003 per completed form) but not ACE wards. Conclusion: Despite difficulties in implementation, intention-to-treat, per-protocol and fidelity to intervention, analyses showed an intervention coupling feedback to personalised action planning produced moderate but significant sustained improvements in hand-hygiene compliance, in wards implementing a national hand-hygiene campaign. Further implementation studies are needed to maximise the intervention's effect in different settings.	[Fuller, Christopher; Savage, Joanne; Besser, Sarah; Hayward, Andrew; Stone, Sheldon] UCL, Sch Med, London, England; [Charlett, Andre; Cookson, Barry D.; Cooper, Ben S.; Duckworth, Georgia] Hlth Protect Agcy, London, England; [Jeanes, Annette] Univ Coll London Hosp, London, England; [Roberts, Jenny] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Teare, Louise] Mid Essex NHS Trust, Chelmsford, Essex, England	University of London; University College London; UCL Medical School; Health Protection Agency; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Stone, S (corresponding author), UCL, Sch Med, Royal Free Campus, London, England.	s.stone@medsch.ucl.ac.uk	Cooper, Ben/HGC-7082-2022; Jeanes, Annette/L-6927-2019; Hayward, Andrew C/C-3268-2013; Michie, Susan/A-1745-2010	Hayward, Andrew C/0000-0002-3549-6232; Besser, Sarah Jane/0000-0003-3252-9665; Cooper, Ben/0000-0002-9445-7217; Michie, Susan/0000-0003-0063-6378	Patient Safety Research Programme [PS/029]; Trustees of the Royal Free; GOJO industries	Patient Safety Research Programme; Trustees of the Royal Free; GOJO industries	This work was supported by the Patient Safety Research Programme (PS/029), http://www.publichealth.bham.ac.uk/psrp; Trustees of the Royal Free, http://royalfreecharity.org; and GOJO industries, www.gojo.com (who provided an educational grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Carver CS, 2000, HDB SELF REGULATION; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; DUBBERT PM, 1990, INFECT CONT HOSP EP, V11, P191; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Feiveson AH, 2002, STATA J, V2, P107, DOI 10.1177/1536867X0200200201; Fuller C, 2010, AM J INFECT CONTROL, V38, P332, DOI 10.1016/j.ajic.2009.10.005; Gardner B, 2010, SOC SCI MED, V70, P1618, DOI 10.1016/j.socscimed.2010.01.039; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Gould DJ, 2008, J HOSP INFECT, V68, P193, DOI 10.1016/j.jhin.2007.11.013; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Hugonnet S, 2002, ARCH INTERN MED, V162, P1037, DOI 10.1001/archinte.162.9.1037; Hussain M, 1996, J HOSP INFECT, V32, P117, DOI 10.1016/S0195-6701(96)90053-5; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Magiorakos AP, 2010, EUROSURVEILLANCE, V15; MAYER JA, 1986, INFECT CONT HOSP EP, V7, P259, DOI 10.1017/S0195941700064171; McAteer J, 2008, J HOSP INFECT, V68, P222, DOI 10.1016/j.jhin.2007.12.009; MCATEER J, 2006, J HOSP INFECT S1, V64, pS53; McAteer J, 2010, THESIS U COLL LONDON; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Naikoba S, 2001, J HOSP INFECT, V47, P173, DOI 10.1053/jhin.2000.0882; National Patient Safety Agency, 2004, ACH OUR AIMS EV RES; National Patient Safety Agency, 2004, READ STEAD GO FULL G; Nosocomial Infection National Surveillance Service, 2002, SURV HOSP ACQ BACT E; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pratt R. J., 2001, Journal of Hospital Infection, V47, pS1; RAJU TNK, 1991, AM J MED SCI, V302, P355, DOI 10.1097/00000441-199112000-00006; Salemi C, 2002, INFECT CONT HOSP EP, V23, P32, DOI 10.1086/501965; Skinner B. F., 1953, SCI HUMAN BEHAV; Stone S, 2001, LANCET, V357, P479, DOI 10.1016/S0140-6736(05)71288-5; Stone S, 2012, REPORT PATIENT SAFET; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; The Joint commission, 2009, MEAS HAND HYG ADH OV; Tibballs J, 1996, MED J AUSTRALIA, V164, P395, DOI 10.5694/j.1326-5377.1996.tb122084.x; van de Mortel T, 2000, Aust Crit Care, V13, P91, DOI 10.1016/S1036-7314(00)70630-8; WHO, 2009, PAT SAF WORLD ALL SA; World Health Organisation, 2010, INCR ACH	41	106	110	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e41617	10.1371/journal.pone.0041617	http://dx.doi.org/10.1371/journal.pone.0041617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110040	Green Published, gold			2022-12-27	WOS:000310193600001
J	Stritih, N; Cokl, A				Stritih, Natasa; Cokl, Andrej			Mating Behaviour and Vibratory Signalling in Non-Hearing Cave Crickets Reflect Primitive Communication of Ensifera	PLOS ONE			English	Article							COMPLEX TIBIAL ORGAN; TROGLOPHILUS-NEGLECTUS; EVOLUTIONARY ORIGIN; FEMALE PREFERENCE; NEZARA-VIRIDULA; COURTSHIP SONG; ORTHOPTERA; NEUROANATOMY; PHYSIOLOGY; GRYLLACRIDIDAE	In Ensifera, the lack of well-supported phylogeny and the focus on acoustic communication of the terminal taxa hinders understanding of the evolutionary history of their signalling behaviour and the related sensory structures. For Rhaphidophoridae, the most relic of ensiferans following morphology-based phylogenies, the signalling modes are still unknown. Together with a detailed description of their mating process, we provide evidence on vibratory signalling for the sympatric European species Troglophilus neglectus and T. cavicola. Despite their temporal shift in reproduction, the species' behaviours differ significantly. Signalling by abdominal vibration constitutes an obligatory part of courtship in T. neglectus, while it is absent in T. cavicola. Whole-body vibration is expressed after copulation in both species. While courtship signalling appears to stimulate females for mating, the function of post-copulation signals remains unclear. Mating and signalling of both species were found to take place in most cases on bark, and less frequently on other available substrates, like moss and rock. The signals' frequency spectra were substrate dependent, but with the dominant peak always expressed below 120 Hz. On rock, the intensity of T. neglectus courtship signals was below the species' physiological detection range, presumably constraining the evolution of such signalling in caves. The species' behavioural divergence appears to reflect their divergent mating habitats, in and outside caves. We propose that short-range tremulation signalling in courtship, such as is expressed by T. neglectus, represents the primitive mode and context of mechanical signalling in Ensifera. The absence of high-frequency components in the signals may be related to the absence of the crista acoustica homologue (CAH) in the vibratory tibial organ of Rhaphidophoridae. This indirectly supports the hypothesis proposing that the CAH, as an evolutionary precursor of the ear, evolved in Ensifera along the (more) complex vibratory communication, also associated with signals of higher carrier frequency.	[Stritih, Natasa; Cokl, Andrej] Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia	National Institute of Biology - Slovenia	Stritih, N (corresponding author), Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia.	natasa.stritih@nib.si	Peljhan, Natasa Stritih/M-5369-2019		Slovenian Research Agency [J1-0823-0105, P1-0255-0105]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The work was funded by the Slovenian Research Agency (project J1-0823-0105 and program P1-0255-0105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RD, 1967, U MICHIGAN MISCELLAN; Bailey W.J., 1991, ACOUSTIC BEHAV INSEC; Ball E.E., 1989, P391; BARTH RH, 1968, ADV REPROD PHYSIOL, V3, P167; BELL PD, 1980, CAN J ZOOL, V58, P1861, DOI 10.1139/z80-254; Boldyrev B., 1912, REV RUSSE ENTOMOLOGI, V12, P552; Boldyrev B. T., 1913, Revue Russe d'Entomologie, V13; Chopard L., 1932, Archives de Zoologie Experimentale et Generale Paris, V74, P263; CHOPARD L, 1938, BIOL ORTHOPTERES; Cocroft RB, 2010, BIOL J LINN SOC, V99, P60, DOI 10.1111/j.1095-8312.2009.01345.x; Cokl A, 2005, J EXP BIOL, V208, P1481, DOI 10.1242/jeb.01557; Cokl A, 2007, BEHAV PROCESS, V75, P40, DOI 10.1016/j.beproc.2007.01.003; Cooley JR, 2001, MOL ECOL, V10, P661, DOI 10.1046/j.1365-294x.2001.01210.x; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; Dambach M, 1989, CRICKET BEHAV NEUROB, P179, DOI 10.1016/S0003-3472(05)80655-4; De Luca PA, 1998, BEHAVIOUR, V135, P777, DOI 10.1163/156853998792640422; Desutter-Grandcolas L, 2003, ZOOL SCR, V32, P525, DOI 10.1046/j.1463-6409.2003.00142.x; EADES D. C., 1964, TRANS AMER ENTOMOL SOC, V90, P73; Elias DO, 2004, J EXP BIOL, V207, P4105, DOI 10.1242/jeb.01261; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Ewing AW, 1989, ARTHROPOD BIOACUSTIC; Field Laurence H., 2001, P271, DOI 10.1079/9780851994086.0271; Field Laurence H., 2001, P429, DOI 10.1079/9780851994086.0429; Field LH, 1997, J NAT HIST, V31, P1127, DOI 10.1080/00222939700770591; Gerhardt HC, 1999, DESIGN OF ANIMAL COMMUNICATION, P515; Gogala M, 1964, THESIS U LJUBLJANA; Greenfield MD, 2002, SIGNALLERS RECEIVERS; Gwynne Darryl T., 1997, P110, DOI 10.1017/CBO9780511721946.007; Gwynne Darryl T., 1995, Journal of Orthoptera Research, V4, P203; Gwynne TD, 2001, KATYDIDS BUSH CRICKE; Heidelbach J, 1997, ETHOLOGY, V103, P827; Hill PSM, 2001, AM ZOOL, V41, P1200, DOI 10.1668/0003-1569(2001)041[1200:TBSSVS]2.0.CO;2; Hubbel TH, 1978, U MICHIGAN MISCELLAN; JERAM S, 1995, J MORPHOL, V223, P109, DOI 10.1002/jmor.1052230110; Jost MC, 2006, MOL PHYLOGENET EVOL, V38, P510, DOI 10.1016/j.ympev.2005.10.004; Karaman I, 2011, ZOOL J LINN SOC-LOND, V163, P1035, DOI 10.1111/j.1096-3642.2011.00738.x; KASTBERGER G, 1984, PHYSIOL ENTOMOL, V9, P297, DOI 10.1111/j.1365-3032.1984.tb00712.x; Kastberger G., 1989, Mitteilungen des Naturwissenschaftlichen Vereines fuer Steiermark, V119, P129; KASTBERGER G, 1985, PHYSIOL ENTOMOL, V10, P407, DOI 10.1111/j.1365-3032.1985.tb00062.x; Kastberger Gerald, 1993, Mitteilungen des Naturwissenschaftlichen Vereines fuer Steiermark, V123, P207; Kastberger Gerald, 1991, Mitteilungen des Naturwissenschaftlichen Vereines fuer Steiermark, V121, P219; Keuper A., 1985, P135; Kevan D.K.McE., 1982, P352; Kevan DK, 1955, COLLOQUE ACOUSTIQUE, P103; Lakes R, 1990, TETTIGONIIDAE BIOL S, P167; Legendre F, 2010, SYST ENTOMOL, V35, P475, DOI 10.1111/j.1365-3113.2009.00519.x; LEROY YVELINE, 1967, ANN SPELEOL, V22, P659; Loher W., 1989, P43; Magal C, 2000, J ACOUST SOC AM, V108, P2412, DOI 10.1121/1.1286098; Markl H., 1983, P332; Mason J.B., 1961, EOS, V37, P505; McVean A, 1996, J ZOOL, V239, P101, DOI 10.1111/j.1469-7998.1996.tb05440.x; MEIER T, 1990, J NEUROBIOL, V21, P592, DOI 10.1002/neu.480210407; MORRIS GK, 1980, ANIM BEHAV, V28, P42, DOI 10.1016/S0003-3472(80)80006-6; MORRIS GK, 1994, J ZOOL, V233, P129, DOI 10.1111/j.1469-7998.1994.tb05266.x; Novak T, 1983, MEM BIOSPEOL, V10, P183; Novak T, 1982, MEM BIOSPEOL, V8, P27; Otte D., 1977, ANIMALS COMMUNICATE, P334; Pehani Spela, 1997, Entomologist, V116, P224; Remy P., 1931, Annales des Sciences Naturelles (Zoologie) Paris, V(10), P263; Richards A. M., 1961, Transactions of the Royal Society of New Zealand Zoology, V1, P121; Robinson DJ, 2002, ADV INSECT PHYSIOL, V29, P151, DOI 10.1016/S0065-2806(02)29003-7; Rossler W, 2006, CONT T ENT, P35; Seliskar A., 1923, Zoologischer Anzeiger Leipzig, V57, P253; SIMON D, 1977, Z TIERPSYCHOL, V44, P80; SISMONDO E, 1980, J INSECT PHYSIOL, V26, P209, DOI 10.1016/0022-1910(80)90082-7; Strauss J, 2008, J COMP NEUROL, V511, P81, DOI 10.1002/cne.21836; Strauss J, 2008, BRAIN BEHAV EVOLUT, V71, P167, DOI 10.1159/000114405; Strauss J, 2010, J COMP NEUROL, V518, P4567, DOI 10.1002/cne.22478; Stritih N, 2009, J COMP NEUROL, V516, P519, DOI 10.1002/cne.22138; Stritih N, 2009, ZOOLOGY, V112, P48, DOI 10.1016/j.zool.2008.04.005; TINKHAM ER, 1969, PAN-PAC ENTOMOL, V45, P4; Tregenza T, 2006, ANIM BEHAV, V72, P809, DOI 10.1016/j.anbehav.2006.01.019; Turner C. L., 1916, Annals of the Entomological Society of America, V9; Vahed Karim, 1996, Journal of Orthoptera Research, V5, P199; Weissman David B., 2001, P351, DOI 10.1079/9780851994086.0351; Weissmann Michael Jay, 1997, Journal of Orthoptera Research, V6, P33; Zuk M, 2008, ANIM BEHAV, V76, P1065, DOI 10.1016/j.anbehav.2008.02.018	78	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47646	10.1371/journal.pone.0047646	http://dx.doi.org/10.1371/journal.pone.0047646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094071	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200037
J	Han, DP; Zhang, M; Ma, J; Hong, JS; Chen, C; Zhang, BR; Huang, LQ; Lv, WL; Yin, LJ; Zhang, A; Zhang, HS; Zhang, ZH; Vidyasagar, S; Okunieff, P; Zhang, LR				Han, Deping; Zhang, Mei; Ma, Jun; Hong, Jingshen; Chen, Chun; Zhang, Bingrong; Huang, Luqiang; Lv, Wenlong; Yin, Liangjie; Zhang, Amy; Zhang, Hengshan; Zhang, Zhenhuan; Vidyasagar, Sadasivan; Okunieff, Paul; Zhang, Lurong			Transition Pattern and Mechanism of B-lymphocyte Precursors in Regenerated Mouse Bone Marrow after Subtotal Body Irradiation	PLOS ONE			English	Article							CELL-DEVELOPMENT; STEM-CELLS; LIGHT-CHAIN; MICE; PROGENITORS; RECEPTOR; DIFFERENTIATION; RECOMBINATION; SYK	Little is known about the effects of ionizing radiation on the transition and the related signal transduction of progenitor B cells in the bone marrow. Thus, using an NIH Swiss mouse model, we explored the impact of ionizing radiation on the early stage of B-cell development via an examination of the transition of CLP to pro-B to pre-B cells within bone marrow as a function of radiation doses and times. Our results showed that while the total number of bone marrow lymphoid cells at different stages were greatly reduced by subtotal body irradiation (sub-TBI), the surviving cells continued to transition from common lymphoid progenitors to pro-B and then to pre-B in a reproducible temporal pattern. The rearrangement of the immunoglobulin heavy chain increased significantly 1-2 weeks after irradiation, but no change occurred after 3-4 weeks. The rearrangement of the immunoglobulin light chain decreased significantly 1-2 weeks after sub-TBI but increased dramatically after 3-4 weeks. In addition, several key transcription factors and signaling pathways were involved in B-precursor transitions after sub-TBI. The data indicate that week 2 after irradiation is a critical time for the transition from proB cells to pre-B cells, reflecting that the functional processes for different B-cell stages are well preserved even after high-dose irradiation.	[Han, Deping; Hong, Jingshen; Chen, Chun; Lv, Wenlong; Zhang, Hengshan] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China; [Zhang, Mei; Zhang, Bingrong; Huang, Luqiang; Yin, Liangjie; Zhang, Amy; Zhang, Zhenhuan; Vidyasagar, Sadasivan; Okunieff, Paul; Zhang, Lurong] UF Shands Canc Ctr, Dept Radiat Oncol, Gainesville, FL USA; [Ma, Jun] Zhengzhou Univ, Inst Digest Dis, Zhengzhou, Henan, Peoples R China	Fujian Medical University; State University System of Florida; University of Florida; Zhengzhou University	Han, DP (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China.	hdp20012004@163.com; lurongzhang@ufl.edu		Zhang, Hengshan/0000-0002-2226-4774; Ma, Jun/0000-0002-5510-6895	National Institutes of Health [NIAID: RC2-AI-087580, 1RC1AI078519, RC1-AI081274]; Shands Cancer Center startup funds (University of Florida); BARDA (Biomedical Advanced Research and Development Authority, Department of Health and Human Services) [HHSO100201000003C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI078519, RC1AI081274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shands Cancer Center startup funds (University of Florida); BARDA (Biomedical Advanced Research and Development Authority, Department of Health and Human Services); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported in part by grant supports from National Institutes of Health (NIAID: RC2-AI-087580, 1RC1AI078519, and RC1-AI081274), Shands Cancer Center startup funds (University of Florida) and BARDA (Biomedical Advanced Research and Development Authority, Department of Health and Human Services) under contract number HHSO100201000003C. The authors have no commercial affiliations and conflicts of interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RE, 1977, J IMMUNOL, V118, P1191; ANKLESARIA P, 1989, BLOOD, V74, P1144; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Cornall RJ, 2000, P NATL ACAD SCI USA, V97, P1713, DOI 10.1073/pnas.97.4.1713; Greenberger JS, 2009, SEMIN RADIAT ONCOL, V19, P133, DOI 10.1016/j.semradonc.2008.11.006; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; LEBOUTEILLER PP, 1981, IMMUNOLOGY, V42, P267; MAISIN JR, 1988, RADIAT RES, V113, P300, DOI 10.2307/3577205; Malin S, 2010, CURR OPIN IMMUNOL, V22, P168, DOI 10.1016/j.coi.2010.02.004; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Mandal M, 2009, NAT IMMUNOL, V10, P1110, DOI 10.1038/ni.1785; Martensson IL, 2010, FEBS LETT, V584, P2572, DOI 10.1016/j.febslet.2010.04.057; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Nadri S, 2007, INT J DEV BIOL, V51, P723, DOI 10.1387/ijdb.072352ns; Nishii K, 1998, CELL DEATH DIFFER, V5, P77, DOI 10.1038/sj.cdd.4400317; NOSSAL GJV, 1973, IMMUNOLOGY, V25, P33; Otero DC, 2003, J IMMUNOL, V171, P5921, DOI 10.4049/jimmunol.171.11.5921; Quesenberry PJ, 2005, EXP HEMATOL, V33, P9, DOI 10.1016/j.exphem.2004.10.012; Rolink AG, 1999, IMMUNOL LETT, V68, P89, DOI 10.1016/S0165-2478(99)00035-8; SCARANTINO CW, 1984, RADIOTHER ONCOL, V2, P215, DOI 10.1016/S0167-8140(84)80062-6; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; SCHWARTZ GN, 1988, EXP HEMATOL, V16, P752; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46560	10.1371/journal.pone.0046560	http://dx.doi.org/10.1371/journal.pone.0046560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082125	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900020
J	Kashima, S; Matsumoto, M; Ogawa, T; Eboshida, A; Takeuchi, K				Kashima, Saori; Matsumoto, Masatoshi; Ogawa, Takahiko; Eboshida, Akira; Takeuchi, Keisuke			The Impact of Travel Time on Geographic Distribution of Dialysis Patients	PLOS ONE			English	Article							STAGE RENAL-DISEASE; QUALITY-OF-LIFE; PRACTICE PATTERNS; MORTALITY; OUTCOMES; CARE	Backgrounds: The geographic disparity of prevalence rates among dialysis patients is unclear. We evaluate the association between travel time to dialysis facilities and prevalence rates of dialysis patients living in 1,867 census areas of Hiroshima, Japan. Furthermore, we study the effects of geographic features (mainland or island) on the prevalence rates and assess if these effects modify the association between travel time and prevalence. Methods: The study subjects were all 7,374 people that were certified as the "renal disabled'' by local governments in 2011. The travel time from each patient to the nearest available dialysis facility was calculated by incorporating both travel time and the capacity of all 98 facilities. The effect of travel time on the age-and sex-adjusted standard prevalence rate (SPR) and 95% confidence intervals (CIs) at each census area was evaluated in two-level Poisson regression models with 1,867 census areas (level 1) nested within 35 towns or cities (level 2). The results were adjusted for area-based parameters of socioeconomic status, urbanity, and land type. Furthermore, the SPR of dialysis patients was calculated in each specific subgroup of population for travel time, land type, and combination of land type and travel time. Results: In the regression analysis, SPR decreased by 5.2% (95% CI: -27.9-22.3) per 10-min increase in travel time even after adjusting for potential confounders. The effect of travel time on prevalence was different in the mainland and island groups. There was no travel time-dependent SPR disparity on the islands. The SPR among remote residents (>30 min from facilities) in the mainland was lower (0.77, 95% CI: 0.71-0.85) than that of closer residents (<= 30 min; 0.95, 95% CI: 0.92-0.97). Conclusions: The prevalence of dialysis patients was lower among remote residents. Geographic difficulties for commuting seem to decrease the prevalence rate.	[Kashima, Saori; Eboshida, Akira] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Matsumoto, Masatoshi; Takeuchi, Keisuke] Hiroshima Univ, Fac Med, Dept Community Based Med Syst, Hiroshima, Japan; [Ogawa, Takahiko] Hiroshima Prefectural Hosp, Ctr Kidney Dis, Hiroshima, Japan	Hiroshima University; Hiroshima University	Kashima, S (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan.	saori_ksm@ybb.ne.jp	Kashima, Saori/B-4524-2010	Kashima, Saori/0000-0002-3401-8191; Matsumoto, Masatoshi/0000-0002-8341-9303	Hiroshima Dialysis Association; Hiroshima Association of Kidney Patients; Higher Education Grant Program of ESRI Japan Corp.	Hiroshima Dialysis Association; Hiroshima Association of Kidney Patients; Higher Education Grant Program of ESRI Japan Corp.	The authors thank the Hiroshima Dialysis Association and the Hiroshima Association of Kidney Patients, for their support of this study. The software used in this study was supported by the Higher Education Grant Program of ESRI Japan Corp.	[Anonymous], 2011, OV REG DIAL TREATM J; [Anonymous], 2007, MIN INT AFF COMM JAP; Disability and Welfare Section Hiroshima City, 2004, PHYS GUID DIS CERT; Fukuhara Shunichi, 2007, Int J Health Care Finance Econ, V7, P217, DOI 10.1007/s10754-007-9017-8; Greenland S, 2008, MODERN EPIDEMIOLOGY, P258; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Imasawa T, 2010, JAPANESE J NEPHROLOG, V52, P1015; Japanese Society for Dialysis Therapy, 2012, OV REG DIAL TREATM J; Judge A, 2011, NEPHROL DIAL TRANSPL; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Lawson A, 2003, DIS MAPPING WINBUGS, Vxiii; Lawson A.B., 2006, STAT METHODS SPATIAL, P41; Maheswaran R, 2003, J EPIDEMIOL COMMUN H, V57, P523, DOI 10.1136/jech.57.7.523; Matsumoto M, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-28; Matsumoto M, 2010, HEALTH PLACE, V16, P164, DOI 10.1016/j.healthplace.2009.07.005; Moist LM, 2008, AM J KIDNEY DIS, V51, P641, DOI 10.1053/j.ajkd.2007.12.021; Nakai S, 2012, NIHON TOSEKI IGAKKAI, V45, P1; OECD, 2011, HLTH GLANC 2011 OECD; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rasbash J, 2010, MLWIN VERSION  2 22; Roderick P, 1999, J Health Serv Res Policy, V4, P139; Rucker D, 2011, KIDNEY INT, V79, P210, DOI 10.1038/ki.2010.376; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sugisawa H, 2010, J JAPANESE ASS DIAL, V25, P135; Tonelli M, 2007, CAN MED ASSOC J, V177, P1039, DOI 10.1503/cmaj.070343; Udayaraj UP, 2010, J EPIDEMIOL COMMUN H, V64, P535, DOI 10.1136/jech.2009.093518; Untas A, 2011, CLIN J AM SOC NEPHRO, V6, P142, DOI 10.2215/CJN.02340310; White P, 2006, QJM-INT J MED, V99, P445, DOI 10.1093/qjmed/hcl054; WHITTLE JC, 1991, ARCH INTERN MED, V151, P1359, DOI 10.1001/archinte.151.7.1359	29	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47753	10.1371/journal.pone.0047753	http://dx.doi.org/10.1371/journal.pone.0047753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082209	Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900106
J	Naoi, N; Watanabe, S; Maekawa, K; Hibiya, J				Naoi, Nozomi; Watanabe, Shigeru; Maekawa, Kikuo; Hibiya, Junko			Prosody Discrimination by Songbirds (Padda oryzivora)	PLOS ONE			English	Article							BUDGERIGARS MELOPSITTACUS-UNDULATUS; FREQUENCY-RANGE DISCRIMINATIONS; FINCHES TAENIOPYGIA-GUTTATA; LANGUAGE DISCRIMINATION; SPEECH-PERCEPTION; JAVA SPARROWS; JAPANESE-QUAIL; ABSOLUTE PITCH; YOUNG INFANTS; HOMO-SAPIENS	In human verbal communication, not only lexical information, but also paralinguistic information plays an important role in transmitting the speakers' mental state. Paralinguistic information is conveyed mainly through acoustic features like pitch, rhythm, tempo and so on. These acoustic features are generally known as prosody. It is known that some species of birds can discriminate certain aspects of human speech. However, there have not been any studies on the discrimination of prosody in human language which convey different paralinguistic meanings by birds. In the present study, we have shown that the Java sparrow (Padda oryzivora) can discriminate different prosodic patterns of Japanese sentences. These birds could generalize prosodic discrimination to novel sentences, but could not generalize sentence discrimination to those with novel prosody. Moreover, unlike Japanese speakers, Java sparrows used the first part of the utterance as the discrimination cue.	[Naoi, Nozomi; Watanabe, Shigeru] Keio Univ, Dept Psychol, Tokyo, Japan; [Maekawa, Kikuo] Natl Inst Japanese Language & Linguist NINJAL, Tokyo, Japan; [Hibiya, Junko] Int Christian Univ, Coll Liberal Arts, Tokyo, Japan	Keio University; International Christian University	Naoi, N (corresponding author), Japan Agcy Sci & Technol, ERATO, Okanoya Emot Informat Project, Saitama, Japan.	nnaoi@educ.kyoto-u.ac.jp			Global COE Program "Centre for Advanced Research on Logic and Sensibility"	Global COE Program "Centre for Advanced Research on Logic and Sensibility"	This research was supported by Global COE Program "Centre for Advanced Research on Logic and Sensibility". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN BP, 1983, J EXP CHILD PSYCHOL, V35, P487, DOI 10.1016/0022-0965(83)90023-1; BALL GF, 1994, BRAIN BEHAV EVOLUT, V44, P234, DOI 10.1159/000113579; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Boersma P., 2020, PRAAT DOING PHONETIC; Carew T.J., 2000, BEHAV NEUROBIOLOGY C; CUTLER A, 1993, J PHONETICS, V21, P103, DOI 10.1016/S0095-4470(19)31323-3; Dent ML, 2000, J ACOUST SOC AM, V107, P2657, DOI 10.1121/1.428651; Dent ML, 1997, J ACOUST SOC AM, V102, P1891, DOI 10.1121/1.420111; DOOLING RJ, 1989, PERCEPT PSYCHOPHYS, V46, P65, DOI 10.3758/BF03208075; DOOLING RJ, 1995, J ACOUST SOC AM, V97, P1839, DOI 10.1121/1.412058; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; FERNALD A, 1993, CHILD DEV, V64, P657, DOI 10.2307/1131209; FERNALD A, 1991, DEV PSYCHOL, V27, P209, DOI 10.1037/0012-1649.27.2.209; GOSY M, 1994, J PHONETICS, V22, P269; Grossmann T, 2005, NEUROREPORT, V16, P1825, DOI 10.1097/01.wnr.0000185964.34336.b1; HIRSHPASEK K, 1987, COGNITION, V26, P269, DOI 10.1016/S0010-0277(87)80002-1; Jusczyk PW, 1999, TRENDS COGN SCI, V3, P323, DOI 10.1016/S1364-6613(99)01363-7; JUSCZYK PW, 1992, COGNITIVE PSYCHOL, V24, P252, DOI 10.1016/0010-0285(92)90009-Q; JUSCZYK PW, 1993, J PHONETICS, V21, P3, DOI 10.1016/S0095-4470(19)31319-1; Kawakami Shin, 1963, KOKUGOKENKYUU, V16, P25; Kluender KR, 1998, J ACOUST SOC AM, V104, P3568, DOI 10.1121/1.423939; KLUENDER KR, 1987, SCIENCE, V237, P1195, DOI 10.1126/science.3629235; KOJIMA S, 1989, INT J PRIMATOL, V10, P199, DOI 10.1007/BF02735200; KUHL PK, 1978, J ACOUST SOC AM, V63, P905, DOI 10.1121/1.381770; LADD DR, 1985, J ACOUST SOC AM, V78, P435, DOI 10.1121/1.392466; Ladd RobertD., 1996, INTONATIONAL PHONOLO; Lee TTY, 2006, J COMP PSYCHOL, V120, P217, DOI 10.1037/0735-7036.120.3.217; LIEBERMAN P, 1962, J ACOUST SOC AM, V34, P922, DOI 10.1121/1.1918222; Lotto AJ, 1997, J ACOUST SOC AM, V102, P1134, DOI 10.1121/1.419865; MacDougallShackleton SA, 1996, J COMP PSYCHOL, V110, P139, DOI 10.1037/0735-7036.110.2.139; Maekawa K., 1998, P 5 INT C SPOK LANG, V2, P635; Maekawa K, 2004, P SPEECH PROS 2004, P367; Makarova V, 2001, J PHONETICS, V29, P137, DOI 10.1006/jpho.2001.0137; MARGOLIASH D, 1994, BRAIN BEHAV EVOLUT, V44, P247, DOI 10.1159/000113580; MEHRABIAN A, 1967, J PERS SOC PSYCHOL, V6, P109, DOI 10.1037/h0024532; Metzner W, 1996, J COMP NEUROL, V368, P252; MORGAN JL, 1994, INFANT BEHAV DEV, V17, P389, DOI 10.1016/0163-6383(94)90031-0; MORGAN JL, 1981, J VERB LEARN VERB BE, V20, P67, DOI 10.1016/S0022-5371(81)90312-1; MORSE PA, 1975, PERCEPT PSYCHOPHYS, V17, P9, DOI 10.3758/BF03203991; Nachtigall PE, 2003, J ACOUST SOC AM, V113, P3425, DOI 10.1121/1.1570438; Nazzi T, 2003, SPEECH COMMUN, V41, P233, DOI 10.1016/S0167-6393(02)00106-1; NJEGOVAN M, 1995, J EXP PSYCHOL ANIM B, V21, P33, DOI 10.1037/0097-7403.21.1.33; Oshinsky J.S., 1977, MOTIV EMOTION, V1, P331, DOI [10.1007/BF00992539, DOI 10.1007/BF00992539, 10.1007/BF009 92539]; Peters A. M., 1985, CROSSLINGUISTIC STUD, V2, P1029; PISACRETA R, 1986, J EXP ANAL BEHAV, V45, P269, DOI 10.1901/jeab.1986.45-269; Poole JH, 2005, NATURE, V434, P455, DOI 10.1038/434455a; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; SCHERER KR, 1991, MOTIV EMOTION, V15, P123, DOI 10.1007/BF00995674; SINNOTT JM, 1987, J COMP PSYCHOL, V101, P355, DOI 10.1037/0735-7036.101.4.355; Soderstrom M, 2003, J MEM LANG, V49, P249, DOI 10.1016/S0749-596X(03)00024-X; Thompson WF, 2006, SEMIOTICA, V158, P407, DOI 10.1515/SEM.2006.017; Thorsen N, 1980, J ACOUST SOC AM, V67, P1015; Tincoff R, 2005, DEVELOPMENTAL SCI, V8, P26, DOI 10.1111/j.1467-7687.2005.00390.x; Toro JM, 2005, COGNITION, V97, pB25, DOI 10.1016/j.cognition.2005.01.006; Toro JM, 2005, J EXP PSYCHOL-ANIM B, V31, P95, DOI 10.1037/0097-7403.31.1.95; Toro JM, 2003, ANIM COGN, V6, P131, DOI 10.1007/s10071-003-0172-0; VICARIO DS, 1994, BRAIN BEHAV EVOLUT, V44, P265, DOI 10.1159/000113581; Watanabe S, 2005, BEHAV PROCESS, V70, P203, DOI 10.1016/j.beproc.2005.06.001; Watanabe S, 1999, BEHAV PROCESS, V47, P53, DOI 10.1016/S0376-6357(99)00049-2; Watanabe S, 2006, BEHAV PROCESS, V73, P114, DOI 10.1016/j.beproc.2006.01.013; Weisman R, 1998, J COMP PSYCHOL, V112, P244, DOI 10.1037/0735-7036.112.3.244; Weisman RG, 2010, BEHAV PROCESS, V84, P421, DOI 10.1016/j.beproc.2010.01.010	62	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47446	10.1371/journal.pone.0047446	http://dx.doi.org/10.1371/journal.pone.0047446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082167	Green Submitted, gold, Green Published			2022-12-27	WOS:000311146900063
J	Haraoka, T; Ojima, T; Murata, C; Hayasaka, S				Haraoka, Tomoko; Ojima, Toshiyuki; Murata, Chiyoe; Hayasaka, Shinya			Factors Influencing Collaborative Activities between Non-Professional Disaster Volunteers and Victims of Earthquake Disasters	PLOS ONE			English	Article								Background: Assistance from non-professional disaster volunteers (hereinafter, volunteers) is essential for disaster victims to recover physically and rebuild their lives; however, disaster victims in some areas are reluctant to accept assistance from volunteers. This study explored factors that may influence collaborative activities between volunteers and victims of earthquake disasters. Methods: From July to September 2008, a self-reporting questionnaire survey was conducted with all 302 leaders of neighborhood associations in a city within Niigata Prefecture at the time of the Niigataken Chuetsu-oki Earthquake in 2007. Each factor was determined based on the Health Belief Model. Multiple regression analysis was conducted, using collaborative activities as the objective variable. Results: From 261 valid responses received (response rate 86.4%), 41.3% of leaders collaborated with volunteers, and 60.2% of associations had residents who collaborated with volunteers. Collaboration with volunteers was significantly and positively related to perceived severity of an earthquake disaster (standardized partial regression coefficient beta = 0.224, p<0.001) and neighborhood association activities during the earthquake disaster (beta = 0.539, p<0.001). A positive and marginally significant relation was found between such collaboration and sense of coherence within a community (beta = 0.137, p = 0.06), social capital (beta = 0.119, p = 0.08), and perceived benefits (beta = 0.116, p = 0.09). Conclusion: Collaboration between disaster victims and volunteers during the response to an earthquake may require the preemptive estimation of damage by residents during normal times and the enhancement of neighborhood association activities during a disaster. For residents to have such estimation abilities, public institutions should provide information related to anticipated disaster damage and appropriate disaster prevention training and education. In addition, residents should create a disaster prevention map with other residents. Lastly, promoting neighborhood association activities may require the participation of many residents in disaster drills and education as well as a preemptive discussion of neighborhood activities during a disaster.	[Haraoka, Tomoko] Hamamatsu Univ Sch Med, Dept Reg Med Management, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan; [Haraoka, Tomoko; Ojima, Toshiyuki; Hayasaka, Shinya] Hamamatsu Univ Sch Med, Dept Community Hlth & Prevent Med, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan; [Murata, Chiyoe] NCGG, CGSS, Dept Social Sci, Sect Social Participat & Support, Aichi, Japan; [Hayasaka, Shinya] Daito Bunka Univ, Dept Sports & Hlth Sci, Saitama, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Haraoka, T (corresponding author), Hamamatsu Univ Sch Med, Dept Reg Med Management, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan.	tomohara@hama-med.ac.jp			Ministry of Health, Labor and Welfare, Japan (Research on Health Security Control) [H19-kenki-ippan-007]	Ministry of Health, Labor and Welfare, Japan (Research on Health Security Control)	The present study was conducted as part of research related to volunteer aid preparedness in a community based critical health management project (Critical Community Health Management Research Project) funded by a Grant-in-Aid from Ministry of Health, Labor and Welfare, Japan (Research on Health Security Control: H19-kenki-ippan-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antonovsky A., 1987, UNRAVELING MYSTERY H; ARONSON E, 1992, SOCIAL ANIMAL; BECKER MH, 1974, AM J PUBLIC HEALTH, V64, P205, DOI 10.2105/AJPH.64.3.205; Britton R.N., 1991, NONPROFIT VOLUNTARY, V20, P395, DOI DOI 10.1177/089976409102000404; Cabinet Office Government of Japan, 2006, GREAT HANSH AW EARTH; Cabinet Office Government of Japan, 2002, PUBL OP RES DIS PREV; City Kashiwazaki, 2006, KASH CIT NEIGHB ASS; Glanz K., 2008, HLTH BEHAV HLTH ED T; Green G., 2008, ASSET BUILDING COMMU, V(2nd); Hayashi H, 2005, REGIONAL POLICY RES, V33, P16; Hirao T, 2005, COMMUNITY ENV WELFAR, V18, P75; Japan National Council of Social Welfare, 2011, DIS AR AID DIS VOL I; Kanagawa K, 2010, EUR GROUP PUBL ADM E, P8; Kondo K, 2008, VERIFICATION SOCIAL; Munakata T, 1992, HLTH ILLNESS BASED B; Murosaki Y, 2005, REGIONAL POLICY RES, V33, P7; Nakamura Y, 2009, INTRO STAT MED SCI; National Cancer Institute, 2005, THEOR GLANC GUID HLT; Ojima T., 2008, Journal of the National Institute of Public Health, V57, P245; Ojima T, 2010, SUPPORT SYSTEM VOLUN; Osborne Stephen, 2003, VOLUNTARY NONPROFIT; Pekkanen R., 2006, JAPANS DUAL CIVIL SO; Public Relations Office Government of Japan, 2011, CAB OFF ONL NEWSL; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Simo G, 2007, PUBLIC ADMIN REV, V67, P125, DOI 10.1111/j.1540-6210.2007.00821.x; Sugama S, 2008, INTRO DISASTER VOLUN; Suzuki I., 2006, BETTER INTEGRATED MA, V1st ed., P153; Takahashi K, 2007, J TOKYO KASEI GAKUIM, V47, P95; Togari T, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.056697; Tsukuba T, 2005, J ARCHITECTURAL I JA, V48, P55; Yanai H, 2007, STAT DATA ANAL SPSS	31	15	15	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47203	10.1371/journal.pone.0047203	http://dx.doi.org/10.1371/journal.pone.0047203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23094037	Green Submitted, gold, Green Published			2022-12-27	WOS:000310135800032
J	Kim, KA; Gu, W; Lee, IA; Joh, EH; Kim, DH				Kim, Kyung-Ah; Gu, Wan; Lee, In-Ah; Joh, Eun-Ha; Kim, Dong-Hyun			High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; ADIPOSE-TISSUE; INFILTRATION; ACTIVATION; RESISTANCE; ECOLOGY; SYSTEM; MODEL	Background & Aims: While it is widely accepted that obesity is associated with low-grade systemic inflammation, the molecular origin of the inflammation remains unknown. Here, we investigated the effect of endotoxin-induced inflammation via TLR4 signaling pathway at both systemic and intestinal levels in response to a high-fat diet. Methods: C57BL/6J and TLR4-deficient C57BL/10ScNJ mice were maintained on a low-fat (10 kcal % fat) diet (LFD) or a high-fat (60 kcal % fat) diet (HFD) for 8 weeks. Results: HFD induced macrophage infiltration and inflammation in the adipose tissue, as well as an increase in the circulating proinflammatory cytokines. HFD increased both plasma and fecal endotoxin levels and resulted in dysregulation of the gut microbiota by increasing the Firmicutes to Bacteriodetes ratio. HFD induced the growth of Enterobecteriaceae and the production of endotoxin in vitro. Furthermore, HFD induced colonic inflammation, including the increased expression of proinflammatory cytokines, the induction of Toll-like receptor 4 (TLR4), iNOS, COX-2, and the activation of NF-kappa B in the colon. HFD reduced the expression of tight junction-associated proteins claudin-1 and occludin in the colon. HFD mice demonstrated higher levels of Akt and FOXO3 phosphorylation in the colon compared to the LFD mice. While the body weight of HFD-fed mice was significantly increased in both TLR4-deficient and wild type mice, the epididymal fat weight and plasma endotoxin level of HFD-fed TLR4-deficient mice were 69% and 18% of HFD-fed wild type mice, respectively. Furthermore, HFD did not increase the proinflammatory cytokine levels in TLR4-deficient mice. Conclusions: HFD induces inflammation by increasing endotoxin levels in the intestinal lumen as well as in the plasma by altering the gut microbiota composition and increasing its intestinal permeability through the induction of TLR4, thereby accelerating obesity.	[Kim, Kyung-Ah; Gu, Wan; Lee, In-Ah; Joh, Eun-Ha; Kim, Dong-Hyun] Kyung Hee Univ, Coll Pharm, Dept Life & Nanopharmaceut Sci, Seoul, South Korea	Kyung Hee University	Kim, DH (corresponding author), Kyung Hee Univ, Coll Pharm, Dept Life & Nanopharmaceut Sci, Seoul, South Korea.	dhkim@khu.ac.kr			World Class University through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R33-2008-000-10018-0]	World Class University through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant from World Class University Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R33-2008-000-10018-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chakraborty S, 2010, ANN NY ACAD SCI, V1207, pE94, DOI 10.1111/j.1749-6632.2010.05752.x; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; Clark DA, 2008, AM J REPROD IMMUNOL, V60, P529, DOI 10.1111/j.1600-0897.2008.00652.x; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Ding SL, 2011, CURR OPIN CLIN NUTR, V14, P328, DOI 10.1097/MCO.0b013e3283478727; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Faulds MH, 2012, CURR OPIN ONCOL, V24, P58, DOI 10.1097/CCO.0b013e32834e0582; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Hollenbach E, 2005, J BIOL CHEM, V280, P14981, DOI 10.1074/jbc.M500966200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Joh EH, 2011, BRIT J PHARMACOL, V162, P1731, DOI 10.1111/j.1476-5381.2010.01195.x; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim DH, 2008, BIOGERONTOLOGY, V9, P33, DOI 10.1007/s10522-007-9114-6; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; Neuman MG, 2007, TRANSL RES, V149, P173, DOI 10.1016/j.trsl.2006.11.009; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	34	775	801	9	192	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47713	10.1371/journal.pone.0047713	http://dx.doi.org/10.1371/journal.pone.0047713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091640	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800066
J	Seal, S; Chatterjee, P; Bhattacharya, S; Pal, D; Dasgupta, S; Kundu, R; Mukherjee, S; Bhattacharya, S; Bhuyan, M; Bhattacharyya, PR; Baishya, G; Barua, NC; Baruah, PK; Rao, PG; Bhattacharya, S				Seal, Soma; Chatterjee, Priyajit; Bhattacharya, Sushmita; Pal, Durba; Dasgupta, Suman; Kundu, Rakesh; Mukherjee, Sandip; Bhattacharya, Shelley; Bhuyan, Mantu; Bhattacharyya, Pranab R.; Baishya, Gakul; Barua, Nabin C.; Baruah, Pranab K.; Rao, Paruchuri G.; Bhattacharya, Samir			Vapor of Volatile Oils from Litsea cubeba Seed Induces Apoptosis and Causes Cell Cycle Arrest in Lung Cancer Cells	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; AKT PHOSPHORYLATION; KINASE-B; ACTIVATION; BAD; PACLITAXEL; SURVIVAL; P53; OVEREXPRESSION; INVOLVEMENT	Non-small cell lung carcinoma (NSCLC) is a major killer in cancer related human death. Its therapeutic intervention requires superior efficient molecule(s) as it often becomes resistant to present chemotherapy options. Here we report that vapor of volatile oil compounds obtained from Litsea cubeba seeds killed human NSCLC cells, A549, through the induction of apoptosis and cell cycle arrest. Vapor generated from the combined oils (VCO) deactivated Akt, a key player in cancer cell survival and proliferation. Interestingly VCO dephosphorylated Akt at both Ser(473) and Thr(308); through the suppression of mTOR and pPDK1 respectively. As a consequence of this, diminished phosphorylation of Bad occurred along with the decreased Bcl-xL expression. This subsequently enhanced Bax levels permitting the release of mitochondrial cytochrome c into the cytosol which concomitantly activated caspase 9 and caspase 3 resulting apoptotic cell death. Impairment of Akt activation by VCO also deactivated Mdm2 that effected overexpression of p53 which in turn upregulated p21 expression. This causes enhanced p21 binding to cyclin D1 that halted G1 to S phase progression. Taken together, VCO produces two prong effects on lung cancer cells, it induces apoptosis and blocked cancer cell proliferation, both occurred due to the deactivation of Akt. In addition, it has another crucial advantage: VCO could be directly delivered to lung cancer tissue through inhalation.	[Seal, Soma; Chatterjee, Priyajit; Bhattacharya, Sushmita; Pal, Durba; Dasgupta, Suman; Kundu, Rakesh; Mukherjee, Sandip; Bhattacharya, Shelley; Bhattacharya, Samir] Visva Bharati Univ, Sch Life Sci, Ctr Adv Studies Zool, Santini Ketan, W Bengal, India; [Dasgupta, Suman; Bhuyan, Mantu; Bhattacharyya, Pranab R.; Baishya, Gakul; Barua, Nabin C.; Baruah, Pranab K.; Rao, Paruchuri G.; Bhattacharya, Samir] CSIR, N E Inst Sci & Technol, Jorhat, Assam, India	Visva Bharati University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - North East Institute of Science & Technology (NEIST)	Bhattacharya, S (corresponding author), Visva Bharati Univ, Sch Life Sci, Ctr Adv Studies Zool, Santini Ketan, W Bengal, India.	bhattacharyasa@gmail.com	Kundu, Rakesh/AAG-2582-2021; Kundu, Rakesh/ABE-3083-2021; Rao, Paruchuri/C-3050-2009; Kundu, Rakesh Kundu/AAC-3543-2019; Dasgupta, Suman/B-8808-2013	Rao, Paruchuri/0000-0002-1058-9248; Kundu, Rakesh Kundu/0000-0001-8871-0565; Dasgupta, Suman/0000-0003-2599-2299; CHATTERJEE, PRIYAJIT/0000-0001-6728-0981	CSIR-NEEP [HCP-005]; Council of Scientific and Industrial Research (CSIR), New Delhi	CSIR-NEEP; Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This research work was financially supported by the grant from CSIR-NEEP Project (HCP-005). The authors SS and PC are thankful to the Department of Science & Technology, Govt. of India, New Delhi; Sushmita Bhattacharya, DP and RK are indebted to Council of Scientific and Industrial Research (CSIR), New Delhi, for the award of Research Fellowships. SD is thankful to UGC for Dr. D. S. Kothari PDF & CSIR-NEIST for QHF; and Samir Bhattacharya to the Indian National Science Academy for his INSA Senior Scientist position. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, CLIN LUNG CANCER, V7, P17, DOI 10.1016/S1525-7304(11)70385-0; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; Brognard J, 2001, CANCER RES, V61, P3986; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elrod HA, 2007, MOL CANCER THER, V6, P2029, DOI 10.1158/1535-7163.MCT-07-0004; Franke TF, 1997, NATURE, V390, P116, DOI 10.1038/36442; Han JW, 2001, J BIOL CHEM, V276, P42084, DOI 10.1074/jbc.M106688200; Hu LM, 2002, CANCER RES, V62, P1087; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KROPP PJ, 1995, J ORG CHEM, V60, P4146, DOI 10.1021/jo00118a035; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maira SM, 2009, FUTURE MED CHEM, V1, P137, DOI 10.4155/FMC.09.5; Massion PP, 2004, AM J RESP CRIT CARE, V170, P1088, DOI 10.1164/rccm.200404-487OC; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mishina T, 1999, BRIT J CANCER, V80, P1289, DOI 10.1038/sj.bjc.6690500; Nacht M, 2001, P NATL ACAD SCI USA, V98, P15203, DOI 10.1073/pnas.261414598; Nadkar A, 2006, EXPERT OPIN DRUG MET, V2, P753, DOI 10.1517/17425255.2.5.753; Namsa ND, 2011, J ETHNOBIOL ETHNOMED, V31, P1; Nimako K, 2012, MEDICINE, V40, P202; Ottilie S, 1997, J BIOL CHEM, V272, P30866, DOI 10.1074/jbc.272.49.30866; PHAN SH, 1985, J CLIN INVEST, V76, P241, DOI 10.1172/JCI111953; Rowinsky EK, 1999, CLIN CANCER RES, V5, P767; Salvesen GS, 2007, ADV EXP MED BIOL, V615; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schuurbiers OCJ, 2009, J THORAC ONCOL, V4, P761, DOI 10.1097/JTO.0b013e3181a1084f; Scripture CD, 2006, CURR NEUROPHARMACOL, V4, P165, DOI 10.2174/157015906776359568; Sinha S, 2006, PROSTATE, V66, P1257, DOI 10.1002/pros.20415; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Srivastava RC, 2009, INDIAN J TRADIT KNOW, V8, P146; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	43	41	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47014	10.1371/journal.pone.0047014	http://dx.doi.org/10.1371/journal.pone.0047014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091605	Green Submitted, gold, Green Published			2022-12-27	WOS:000310135800020
J	Chountala, M; Vakaloglou, KM; Zervas, CG				Chountala, Maria; Vakaloglou, Katerina M.; Zervas, Christos G.			Parvin Overexpression Uncovers Tissue-Specific Genetic Pathways and Disrupts F-Actin to Induce Apoptosis in the Developing Epithelia in Drosophila	PLOS ONE			English	Article							JNK SIGNALING PATHWAY; INTEGRIN ADHESION; CELL MORPHOLOGY; IMAGINAL DISCS; LONG LIVE; PROTEIN; KINASE; EXPRESSION; SURVIVAL; MORPHOGENESIS	Parvin is a putative F-actin binding protein important for integrin-mediated cell adhesion. Here we used overexpression of Drosophila Parvin to uncover its functions in different tissues in vivo. Parvin overexpression caused major defects reminiscent of metastatic cancer cells in developing epithelia, including apoptosis, alterations in cell shape, basal extrusion and invasion. These defects were closely correlated with abnormalities in the organization of F-actin at the basal epithelial surface and of integrin-matrix adhesion sites. In wing epithelium, overexpressed Parvin triggered increased Rho1 protein levels, predominantly at the basal side, whereas in the developing eye it caused a rough eye phenotype and severely disrupted F-actin filaments at the retina floor of pigment cells. We identified genes that suppressed these Parvin-induced dominant effects, depending on the cell type. Co-expression of both ILK and the apoptosis inhibitor DIAP1 blocked Parvin-induced lethality and apoptosis and partially ameliorated cell delamination in epithelia, but did not rescue the elevated Rho1 levels, the abnormal organization of F-actin in the wing and the assembly of integrin-matrix adhesion sites. The rough eye phenotype was suppressed by coexpression of either PTEN or Wech, or by knock-down of Xrp1. Two main conclusions can be drawn from our studies: (1), high levels of cytoplasmic Parvin are toxic in epithelial cells; (2) Parvin in a dose dependent manner affects the organization of actin cytoskeleton in both wing and eye epithelia, independently of its role as a structural component of the ILK-PINCH-Parvin complex that mediates the integrin-actin link. Thus, distinct genetic interactions of Parvin occur in different cell types and second site modifier screens are required to uncover such genetic circuits.	[Chountala, Maria; Vakaloglou, Katerina M.; Zervas, Christos G.] BRFAA, Div Genet, Athens, Greece		Zervas, CG (corresponding author), BRFAA, Div Genet, Athens, Greece.	czervas@bioacademy.gr		Zervas, Christos/0000-0003-0531-9515	Greek Secretariat for Research and Technology [PENED-03ED777]; Association Francaise contre les Myopathies (AFM) [12641]; BRFAA	Greek Secretariat for Research and Technology(Greek Ministry of Development-GSRT); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); BRFAA	This research was supported by Greek Secretariat for Research and Technology (PENED-03ED777), Association Francaise contre les Myopathies (AFM;12641) and BRFAA intramural funds to CGZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Agnes F, 1999, DEVELOPMENT, V126, P5453; Akdemir F, 2007, ONCOGENE, V26, P5184, DOI 10.1038/sj.onc.1210328; Becam I, 2011, DEVELOPMENT, V138, P3781, DOI 10.1242/dev.064774; Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; BRAND AH, 1993, DEVELOPMENT, V118, P401; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Cagan R, 2009, CURR TOP DEV BIOL, V89, P115, DOI 10.1016/S0070-2153(09)89005-4; Chen GC, 2005, MOL CELL BIOL, V25, P979, DOI 10.1128/MCB.25.3.979-987.2005; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dominguez-Gimenez P, 2007, J CELL SCI, V120, P1061, DOI 10.1242/jcs.03404; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Fan Y, 2010, CELL DEATH DIFFER, V17, P534, DOI 10.1038/cdd.2009.185; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Fukuda T, 2003, J CELL BIOL, V160, P1001, DOI 10.1083/jcb.200212113; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Grzeschik NA, 2005, DEVELOPMENT, V132, P2035, DOI 10.1242/dev.01800; GUTZEIT HO, 1991, J CELL SCI, V100, P781; Huang H, 1999, DEVELOPMENT, V126, P5365; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Janody F, 2006, DEVELOPMENT, V133, P3349, DOI 10.1242/dev.02511; Johnstone CN, 2008, MOL CELL BIOL, V28, P687, DOI 10.1128/MCB.01617-06; Kimura M, 2010, J CELL SCI, V123, P747, DOI 10.1242/jcs.052498; Kramer Jamie M, 2003, Genet Mol Res, V2, P43; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Loer B, 2008, NAT CELL BIOL, V10, P422, DOI 10.1038/ncb1704; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; MartinBermudo MD, 1997, EMBO J, V16, P4184, DOI 10.1093/emboj/16.14.4184; Mishima W, 2004, GENES CELLS, V9, P193, DOI 10.1111/j.1356-9597.2004.00717.x; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Neisch AL, 2010, J CELL BIOL, V189, P311, DOI 10.1083/jcb.200912010; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Staveley BE, 1998, CURR BIOL, V8, P599, DOI 10.1016/S0960-9822(98)70231-3; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; Vakaloglou KM, 2012, J CELL SCI, V125, P3221, DOI 10.1242/jcs.102384; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Widmann TJ, 2009, J CELL SCI, V122, P1362, DOI 10.1242/jcs.044271; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200	51	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47355	10.1371/journal.pone.0047355	http://dx.doi.org/10.1371/journal.pone.0047355			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077599	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100098
J	Cox, WA; Thompson, FR; Root, B; Faaborg, J				Cox, W. Andrew; Thompson, Frank R., III; Root, Brian; Faaborg, John			Declining Brown-Headed Cowbird (Molothrus ater) Populations Are Associated with Landscape-Specific Reductions in Brood Parasitism and Increases in Songbird Productivity	PLOS ONE			English	Article							NEST PREDATION; BIOTIC INTERACTIONS; PATTERNS; SUCCESS; CLIMATE; FRAGMENTATION; ABUNDANCE; HABITAT; MODELS; IMPACT	Many songbird species have experienced significant population declines, partly because of brood parasitism by the Brown-headed Cowbird (Molothrus ater), which is positively associated with increasing landscape forest cover in the midwestern United States. However, cowbirds are also experiencing long-term population declines, which should reduce parasitism pressure and thus increase productivity of host species. We used 20 years of nest monitoring data from five sites in Missouri across a gradient of landscape forest cover to assess temporal trends in the rate and intensity of brood parasitism for Acadian Flycatchers (Empidonax virescens), Indigo Buntings (Passerina cyanea), and Northern Cardinals (Cardinalis cardinalis). We evaluated whether there were concomitant changes in fledging brood size, nest survival, a combination of the two metrics (i.e., host young produced per nest attempt), and whether such changes were more substantial with decreasing landscape forest cover. Parasitism rates and intensities declined substantially during 1991-2010. Fledging brood size and nest survival rates were positively associated with landscape forest cover, confirming the fragmentation hypothesis for Midwest forest birds. Declining parasitism rates were associated with increased fledging brood sizes, with more pronounced increases as landscape forest cover decreased. Nest survival increased insubstantially across time during laying and incubation, but not during the nestling stage. The best predictor of nest survival was parasitism status, with parasitized nests surviving at lower rates than unparasitized nests. Overall, productivity increased during 1991-2010, with more pronounced increases associated with lower levels of landscape forest cover. The negative effects of cowbirds on nest survival in addition to fledging brood size in less forested landscapes suggest that cowbirds may be a primary cause of forest fragmentation effects on songbird productivity in the Midwest. Our results underscore the dynamic nature of demographic parameters, which should be accounted for in predictive models of wildlife responses to future environmental conditions.	[Cox, W. Andrew] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65211 USA; [Thompson, Frank R., III] Univ Missouri, USDA, US Forest Serv, No Res Stn, Columbia, MO USA; [Root, Brian] Missouri Dept Conservat, Columbia, MO USA; [Faaborg, John] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Cox, WA (corresponding author), Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65211 USA.	wac253@mail.missouri.edu		Cox, William/0000-0002-1205-5979	U.S.D.A. Forest Service; Missouri Department of Conservation; U.S. Fish and Wildlife Service	U.S.D.A. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Missouri Department of Conservation; U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	Funding for this project was provided by the U.S.D.A. Forest Service. Funding sources for the original field studies included the U.S.D.A. Forest Service, Missouri Department of Conservation, and U.S. Fish and Wildlife Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders AD, 2006, J ANIM ECOL, V75, P221, DOI 10.1111/j.1365-2656.2006.01034.x; Annand EM, 1997, J WILDLIFE MANAGE, V61, P159, DOI 10.2307/3802425; Benson TJ, 2010, J ANIM ECOL, V79, P225, DOI 10.1111/j.1365-2656.2009.01604.x; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chace Jameson F., 2005, Ornithological Monographs, V57, P45; Cox WA, 2012, LANDSCAPE ECOL, V27, P659, DOI 10.1007/s10980-012-9711-x; Cox WA, 2012, AUK, V129, P147, DOI 10.1525/auk.2012.11169; De Marsico MC, 2010, CONDOR, V112, P407, DOI 10.1525/cond.2010.090118; Dearborn DC, 1999, AUK, V116, P448, DOI 10.2307/4089378; Dearborn DC, 1998, CONDOR, V100, P326, DOI 10.2307/1370273; Dearborn DC, 1996, CONDOR, V98, P645, DOI 10.2307/1369581; Donovan TM, 2001, ECOL APPL, V11, P871; Donovan TM, 2000, ECOLOGY AND MANAGEMENT OF COWBIRDS AND THEIR HOSTS, P255; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; ESRI , 2008, ARCGIS 9 3; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; Friedmann H., 1929, COWBIRDS STUDY BIOL; Goguen CB, 2000, CONSERV BIOL, V14, P1862, DOI 10.1046/j.1523-1739.2000.99313.x; HALKIN S. L., 1999, BIRDS N AM ONLINE; HOOVER JP, 1993, WILSON BULL, V105, P228; Lloyd P, 2005, ECOL APPL, V15, P1504, DOI 10.1890/04-1243; Lorenzana JC, 1999, STUD AVIAN BIOL, P241; Manolis JC, 2000, AUK, V117, P615, DOI 10.1642/0004-8038(2000)117[0615:UNFISS]2.0.CO;2; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1993, J FIELD ORNITHOL, V64, P507; MARVIL RE, 1989, AUK, V106, P476; MAYFIELD HAROLD, 1965, LIVING BIRD, V4, P13; McDonald TL, 2010, J WILDLIFE MANAGE, V74, P514, DOI 10.2193/2009-270; McLaren CM, 2006, CONDOR, V108, P238, DOI 10.1650/0010-5422(2006)108[0238:CTCITF]2.0.CO;2; Payne R. B., 2006, BIRDS N AM ONLINE; Peterjohn BG, 2000, ECOLOGY AND MANAGEMENT OF COWBIRDS AND THEIR HOSTS, P21; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Reidy JL, 2012, STUD AVIAN BIOL, P135; Rivers JW, 2010, AUK, V127, P263, DOI 10.1525/auk.2009.09053; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Rodewald AD, 2011, CONDOR, V113, P899, DOI 10.1525/cond.2011.100132; Rotella J. J., 2004, Animal Biodiversity and Conservation, V27, P187; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; SAUER JR, 2011, N AM BREEDING BIRD S; Schmidt KA, 2008, ECOLOGY, V89, P635, DOI 10.1890/07-0199.1; Shaffer Terry L., 2007, Studies in Avian Biology, V34, P84; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Sherry Thomas W., 1995, P85; Shifley S. R., 2000, P 2 MISS OZ FOR EC P; SMITH JNM, 1981, CONDOR, V83, P152, DOI 10.2307/1367420; Stumpf KJ, 2012, J WILDLIFE MANAGE, V76, P269, DOI 10.1002/jwmg.246; Thompson FR, 2000, ECOLOGY AND MANAGEMENT OF COWBIRDS AND THEIR HOSTS, P271; THOMPSON FR, 1994, AUK, V111, P979, DOI 10.2307/4088830; Thompson FR, 2003, J WILDLIFE MANAGE, V67, P408, DOI 10.2307/3802781; Trine CL, 2000, ECOLOGY AND MANAGEMENT OF COWBIRDS AND THEIR HOSTS, P135; U.S. Department of Agriculture, 2012, NAT AGR STAT SERV WE; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; VanHorn MA, 1995, AUK, V112, P98; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; ZIMMERMAN JL, 1983, WILSON BULL, V95, P7	58	10	10	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47591	10.1371/journal.pone.0047591	http://dx.doi.org/10.1371/journal.pone.0047591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077647	gold, Green Published			2022-12-27	WOS:000309995100142
J	Manzano-Marin, A; Lamelas, A; Moya, A; Latorre, A				Manzano-Marin, Alejandro; Lamelas, Araceli; Moya, Andres; Latorre, Amparo			Comparative Genomics of Serratia spp.: Two Paths towards Endosymbiotic Life	PLOS ONE			English	Article							HORIZONTAL TRANSFER; FACULTATIVE SYMBIONTS; BACTERIAL ENDOSYMBIONTS; ACYRTHOSIPHON-PISUM; OPEN SOFTWARE; EVOLUTION; BUCHNERA; APHID; OBLIGATE; SEQUENCE	Symbiosis is a widespread phenomenon in nature, in which insects show a great number of these associations. Buchnera aphidicola, the obligate endosymbiont of aphids, coexists in some species with another intracellular bacterium, Serratia symbiotica. Of particular interest is the case of the cedar aphid Cinara cedri, where B. aphidicola BCc and S. symbiotica SCc need each other to fulfil their symbiotic role with the insect. Moreover, various features seem to indicate that S. symbiotica SCc is closer to an obligate endosymbiont than to other facultative S. symbiotica, such as the one described for the aphid Acirthosyphon pisum (S. symbiotica SAp). This work is based on the comparative genomics of five strains of Serratia, three free-living and two endosymbiotic ones (one facultative and one obligate) which should allow us to dissect the genome reduction taking place in the adaptive process to an intracellular life-style. Using a pan-genome approach, we have identified shared and strain-specific genes from both endosymbiotic strains and gained insight into the different genetic reduction both S. symbiotica have undergone. We have identified both retained and reduced functional categories in S. symbiotica compared to the Free-Living Serratia (FLS) that seem to be related with its endosymbiotic role in their specific host-symbiont systems. By means of a phylogenomic reconstruction we have solved the position of both endosymbionts with confidence, established the probable insect-pathogen origin of the symbiotic clade as well as the high amino-acid substitution rate in S. symbiotica SCc. Finally, we were able to quantify the minimal number of rearrangements suffered in the endosymbiotic lineages and reconstruct a minimal rearrangement phylogeny. All these findings provide important evidence for the existence of at least two distinctive S. symbiotica lineages that are characterized by different rearrangements, gene content, genome size and branch lengths.	[Manzano-Marin, Alejandro; Lamelas, Araceli; Moya, Andres; Latorre, Amparo] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain; [Lamelas, Araceli; Moya, Andres; Latorre, Amparo] Ctr Super Invest Salud Publ Generalitat Valencian, Unidad Mixta Invest Genom & Salud, Valencia, Spain	University of Valencia	Latorre, A (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain.	amparo.latorre@uv.es	Cabello, Araceli Lamelas/AAC-6066-2019; Lamelas Cabello, Araceli/B-6129-2015; Cabello, Araceli Lamelas/Q-6726-2018; Marín, Alejandro Manzano/J-9922-2015; Latorre, Amparo/E-4997-2015; Moya, Andrés/A-8190-2008	Cabello, Araceli Lamelas/0000-0002-1939-5642; Cabello, Araceli Lamelas/0000-0002-1939-5642; Marín, Alejandro Manzano/0000-0002-0707-9052; Latorre, Amparo/0000-0002-9146-7284; Moya, Andrés/0000-0002-2867-1119	Ministerio de Ciencia e Innovacion (Spain) [BFU2009-12895-CO2-01]; EU [SYMBIOMICS 264774]; Generalitat Valenciana (Spain) [Prometeo 92/2009]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EU(European Commission); Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF))	This work has been funded by grants BFU2009-12895-CO2-01 from Ministerio de Ciencia e Innovacion (Spain), SYMBIOMICS 264774 from Marie Curie FP7-PEOPLE-2010-ITN (EU), Prometeo 92/2009 from Generalitat Valenciana (Spain). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz LD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-332; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Belda E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-449; Burke G, 2010, ISME J, V4, P242, DOI 10.1038/ismej.2009.114; Burke GR, 2011, GENOME BIOL EVOL, V3, P195, DOI 10.1093/gbe/evr002; Burke GR, 2009, APPL ENVIRON MICROB, V75, P5328, DOI 10.1128/AEM.00717-09; Caspi-Fluger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021096; Charles H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029096; Chen DQ, 2000, ENTOMOL EXP APPL, V95, P315, DOI 10.1023/A:1004083324807; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Degnan PH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002252; Degnan PH, 2010, ENVIRON MICROBIOL, V12, P2060, DOI 10.1111/j.1462-2920.2009.02085.x; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Degnan PH, 2004, SYST BIOL, V53, P95, DOI 10.1080/10635150490264842; Dramsi S, 2002, J CELL BIOL, V156, P943, DOI 10.1083/jcb.200202121; Faltin F, 2004, CAN J MICROBIOL, V50, P811, DOI 10.1139/W04-063; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; FLYG C, 1980, J GEN MICROBIOL, V120, P173; Gil R, 2002, P NATL ACAD SCI USA, V99, P4454, DOI 10.1073/pnas.062067299; Gil R, 2008, INT MICROBIOL, V11, P41, DOI 10.2436/20.1501.01.43; Gillespie JJ, 2012, J BACTERIOL, V194, P376, DOI 10.1128/JB.06244-11; Gonzalez V, 2010, APPL ENVIRON MICROB, V76, P1604, DOI 10.1128/AEM.02039-09; GRIFFITHS BB, 1988, J BASIC MICROB, V28, P427, DOI 10.1002/jobm.3620280703; Grimont F, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P219, DOI 10.1007/0-387-30746-x_11; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lamelas A, 2008, APPL ENVIRON MICROB, V74, P4236, DOI 10.1128/AEM.00022-08; Lamelas A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002357; Lamelas A, 2011, APPL ENVIRON MICROB, V77, P4446, DOI 10.1128/AEM.00141-11; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Lin CH, 2010, BIOINFORMATICS, V26, P408, DOI 10.1093/bioinformatics/btp689; MacDonald SJ, 2011, MOL ECOL, V20, P2073, DOI 10.1111/j.1365-294X.2011.05031.x; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2005, J BACTERIOL, V187, P4229, DOI 10.1128/JB.187.12.4229-4237.2005; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Perotti MA, 2006, FASEB J, V20, P2372, DOI 10.1096/fj.06-5870fje; Plague GR, 2008, J BACTERIOL, V190, P777, DOI 10.1128/JB.01082-07; Read TD, 2006, CURR OPIN MICROBIOL, V9, P496, DOI 10.1016/j.mib.2006.08.010; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Russell JA, 2005, APPL ENVIRON MICROB, V71, P7987, DOI 10.1128/AEM.71.12.7987-7994.2005; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEPHENS JM, 1963, J INSECT PATHOL, V5, P61; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; WARNES GR, 2010, GPLOTS VARIOUS R PRO; Worning P, 2006, ENVIRON MICROBIOL, V8, P353, DOI 10.1111/j.1462-2920.2005.00917.x	65	22	22	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47274	10.1371/journal.pone.0047274	http://dx.doi.org/10.1371/journal.pone.0047274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077583	Green Published, gold			2022-12-27	WOS:000309995100085
J	Miyazaki, S; Tashiro, F; Fujikura, J; Yamato, E; Miyazaki, J				Miyazaki, Satsuki; Tashiro, Fumi; Fujikura, Junji; Yamato, Eiji; Miyazaki, Jun-ichi			Acinar-to-Ductal Metaplasia Induced by Adenovirus-Mediated Pancreatic Expression of Isl1	PLOS ONE			English	Article							INSULIN GENE-TRANSCRIPTION; BETA-CELLS; TUBULAR COMPLEXES; PROGENITOR CELLS; ENDOCRINE PANCREAS; SIGNAL TRANSDUCER; TRANSGENIC MICE; ADULT EXOCRINE; MOUSE PANCREAS; RAT PANCREAS	Tubular complexes (TCs) are aggregates of duct-like monolayered cells in the developing and regenerating pancreas. Recent studies showed that TCs have regenerative potential, including islet neogenesis. We previously delivered adenovirus vector (AdV) into exocrine cells of the pancreas by intra-common bile ductal (ICBD) injection, and found that AdV expressing Pdx1, a pancreas-specific transcription factor, causes TC formation and islet neogenesis. We also established RTF-Pdx1-EGFP mice, which ubiquitously express Pdx1 when tetracycline is removed from the drinking water. However, exogenous Pdx1 expression in adult RTF-Pdx1-EGFP mice did not cause any pathological changes in the pancreas during three weeks of observation after tetracycline withdrawal. To examine whether the host immune response induced by AdV was involved in TC formation, we delivered AdVs expressing pancreas-related transcription factors or an irrelevant protein into the pancreas of RTF-Pdx1-EGFP mice. Histological analyses showed that both AdV injection and Pdx1 expression are required for TC formation. We also analyzed the effects of these ICBD-injected AdVs. AdV expressing Isl1, a proendocrine transcription factor, effectively induced TC formation through acinar-to-ductal metaplasia, and exogenous Pdx1 expression facilitated this process. Considering the regenerative potential of TCs, a strategy that efficiently induces TC formation may lead to novel therapies for diabetes.	[Miyazaki, Satsuki; Tashiro, Fumi; Fujikura, Junji; Yamato, Eiji; Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka, Japan	Osaka University	Miyazaki, J (corresponding author), Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka, Japan.	jimiyaza@nutri.med.osaka-u.ac.jp	Fujikura, Junji/AAR-2684-2020; Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X; Yamato, Eiji/0000-0002-9075-6869; Miyazaki, Satsuki/0000-0003-1781-1590	Japanese Society for the Promotion of Science [05J09752]; NICHD	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a Grant-in-Aid (No. 05J09752) from the Japanese Society for the Promotion of Science(http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Masaomi Ashida for technical assistance. Rat anti-cytokeratin 19 monoclonal antibody (TROMA III) and mouse anti-Isl1 monoclonal antibodies 40.2D6 and 39.4D5, developed by Thomas M. Jessell, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; BOCKMAN DE, 1982, AM J SURG, V144, P243, DOI 10.1016/0002-9610(82)90518-9; Bockman DE, 2003, LAB INVEST, V83, P853, DOI 10.1097/01.LAB.0000074918.31303.5A; Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; DELAPORTE PL, 1991, PANCREAS, V6, P298, DOI 10.1097/00006676-199105000-00007; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Greten FR, 2002, GASTROENTEROLOGY, V123, P2052, DOI 10.1053/gast.2002.37075; GU DL, 1993, DEVELOPMENT, V118, P33; GUZ Y, 1995, DEVELOPMENT, V121, P11; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hao AJ, 2005, MOL BIOL CELL, V16, P1569, DOI 10.1091/mbc.e04-08-0664; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kataoka K, 2004, J MOL ENDOCRINOL, V32, P9, DOI 10.1677/jme.0.0320009; Krizik MR, 1999, J ENDOCRINOL, V163, P523, DOI 10.1677/joe.0.1630523; Lardon J, 2004, VIRCHOWS ARCH, V444, P61, DOI 10.1007/s00428-003-0930-z; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Miyazaki S, 2004, DIABETES, V53, P1030, DOI 10.2337/diabetes.53.4.1030; Miyazaki S, 2005, BIOCHEM BIOPH RES CO, V338, P1083, DOI 10.1016/j.bbrc.2005.10.054; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Rosenberg L, 1998, MICROSC RES TECHNIQ, V43, P337, DOI 10.1002/(SICI)1097-0029(19981115)43:4<337::AID-JEMT8>3.0.CO;2-U; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507; Taniguchi H, 2003, GENE THER, V10, P15, DOI 10.1038/sj.gt.3301846; Tashiro F, 1999, HUM GENE THER, V10, P1845, DOI 10.1089/10430349950017527; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Tokoro T, 2003, PANCREATOLOGY, V3, P487, DOI 10.1159/000075580; Trucco M, 2005, J CLIN INVEST, V115, P5, DOI 10.1172/JCI200523935; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wagner M, 1998, GASTROENTEROLOGY, V115, P1254, DOI 10.1016/S0016-5085(98)70098-8; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; Wang GS, 2005, LAB INVEST, V85, P675, DOI 10.1038/labinvest.3700259; Watada H, 1996, DIABETES, V45, P1826, DOI 10.2337/diabetes.45.12.1826; WILLEMER S, 1989, DIGEST DIS SCI, V34, P46, DOI 10.1007/BF01536153; Worgall S, 2005, PEDIATR NEPHROL, V20, P118, DOI 10.1007/s00467-004-1680-0; Yamamoto T, 2006, DIABETOLOGIA, V49, P2359, DOI 10.1007/s00125-006-0372-7; Yamato E, 2012, J DIABETES INVEST, V3, P41, DOI 10.1111/j.2040-1124.2011.00136.x; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	50	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47536	10.1371/journal.pone.0047536	http://dx.doi.org/10.1371/journal.pone.0047536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077629	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100125
J	Schulz, E; Gottschling, M; Ulrich, RG; Richter, D; Stockfleth, E; Nindl, I				Schulz, Eric; Gottschling, Marc; Ulrich, Rainer G.; Richter, Dania; Stockfleth, Eggert; Nindl, Ingo			Isolation of Three Novel Rat and Mouse Papillomaviruses and Their Genomic Characterization	PLOS ONE			English	Article							MASTOMYS-NATALENSIS PAPILLOMAVIRUS; NUCLEOTIDE-SEQUENCE; MICROMYS-MINUTUS; E6 PROTEINS; CLONING; LESIONS; SKIN; BETAPAPILLOMAVIRUS; ORGANIZATION; INFECTION	Despite a growing knowledge about the biological diversity of papillomaviruses (PV), only little is known about non-human PV in general and about PV mice models in particular. We cloned and sequenced the complete genomes of two novel PV types from the Norway rat (Rattus norvegicus; RnPV2) and the wood mouse (Apodemus sylvaticus; AsPV1) as well as a novel variant of the recently described MmuPV1 (originally designated as MusPV) from a house mouse (Mus musculus; MmuPV1 variant). In addition, we conducted phylogenetic analyses using a systematically representative set of 79 PV types, including the novel sequences. As inferred from concatenated amino acid sequences of six proteins, MmuPV1 variant and AsPV1 nested within the Beta+Xi-PV super taxon as members of the Pi-PV. RnPV2 is a member of the Iota-PV that has a distant phylogenetic position from Pi-PV. The phylogenetic results support a complex scenario of PV diversification driven by different evolutionary forces including co-divergence with hosts and adaptive radiations to new environments. PV types particularly isolated from mice and rats are the basis for new animal models, which are valuable to study PV induced tumors and new treatment options.	[Schulz, Eric; Stockfleth, Eggert; Nindl, Ingo] Univ Hosp, Dept Dermatol Venereol & Allergy, DKFZ Charite Cooperat, Viral Skin Carcinogenesis Grp,Charite, Berlin, Germany; [Gottschling, Marc] Univ Munich, Dept Biol Systemat Bot & Mycol, GeoBio Ctr, Munich, Germany; [Ulrich, Rainer G.] Inst Novel & Emerging Infect Dis, Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany; [Richter, Dania] Univ Hosp, Dept Parasitol, Inst Pathol, Charite, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; Friedrich Loeffler Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Nindl, I (corresponding author), Univ Hosp, Dept Dermatol Venereol & Allergy, DKFZ Charite Cooperat, Viral Skin Carcinogenesis Grp,Charite, Berlin, Germany.	ingo.nindl@charite.de	Ulrich, Rainer/A-4411-2013; Gottschling, Marc/K-2186-2014	Ehrke-Schulz, Eric/0000-0001-8154-9860	European Skin Cancer Foundation (ESCF); Deutsche Krebshilfe [109125-Ni]; Wilhelm Sander-Stiftung	European Skin Cancer Foundation (ESCF); Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm Sander-Stiftung	The work of Eric Schulz was supported by the European Skin Cancer Foundation (ESCF). The Nindl laboratory is supported by grants of the Deutsche Krebshilfe (109125-Ni) and the Wilhelm Sander-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2002, J VIROL, V76, P12537, DOI 10.1128/JVI.76.24.12537-12542.2002; Bernard H U, 1990, FEMS Microbiol Immunol, V2, P201; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; CHONG T, 1990, NUCLEIC ACIDS RES, V18, P465, DOI 10.1093/nar/18.3.465; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; ENSSER A, 1990, NUCLEIC ACIDS RES, V18, P3919, DOI 10.1093/nar/18.13.3919; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Garcia-Vallve S, 2005, TRENDS MICROBIOL, V13, P514, DOI 10.1016/j.tim.2005.09.003; Gasteiger E, 2005, PROTEOMIC PROTOCOLS; Giampieri S, 2004, BRIT J CANCER, V90, P2203, DOI 10.1038/sj.bjc.6601829; GLOSS B, 1990, J VIROL, V64, P5577, DOI 10.1128/JVI.64.11.5577-5584.1990; Gottschling M, 2008, VIRUS GENES, V36, P281, DOI 10.1007/s11262-008-0200-x; Gottschling M, 2007, MOL BIOL EVOL, V24, P1242, DOI 10.1093/molbev/msm039; Gottschling M, 2011, MOL BIOL EVOL, V28, P2101, DOI 10.1093/molbev/msr030; Iftner T, 2002, EMBO J, V21, P4741, DOI 10.1093/emboj/cdf443; Iftner Thomas, 2003, J Natl Cancer Inst Monogr, P80; Ingle A, 2011, VET PATHOL, V48, P500, DOI 10.1177/0300985810377186; Iwasaki T, 1997, J GEN VIROL, V78, P1087, DOI 10.1099/0022-1317-78-5-1087; Jackson AP, 2005, SYST BIOL, V54, P127, DOI 10.1080/10635150590905911; Jackson S, 2000, ONCOGENE, V19, P592, DOI 10.1038/sj.onc.1203339; Joh J, 2011, J GEN VIROL, V92, P692, DOI 10.1099/vir.0.026138-0; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kohler A, 2010, VIROLOGY, V399, P129, DOI 10.1016/j.virol.2009.12.023; MULLER H, 1978, J GEN VIROL, V41, P315, DOI 10.1099/0022-1317-41-2-315; Muschik D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027655; Nafz J, 2008, VIROLOGY, V374, P186, DOI 10.1016/j.virol.2007.12.012; Nafz J, 2007, J GEN VIROL, V88, P2670, DOI 10.1099/vir.0.82955-0; Narechania A, 2005, J VIROL, V79, P15503, DOI 10.1128/JVI.79.24.15503-15510.2005; Nindl I, 2007, DIS MARKERS, V23, P247, DOI 10.1155/2007/942650; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; OBANION MK, 1988, J VIROL, V62, P226, DOI 10.1128/JVI.62.1.226-233.1988; OCONNOR M, 1995, VIROLOGY, V207, P77, DOI 10.1006/viro.1995.1053; Rector A, 2005, VIROLOGY, V331, P449, DOI 10.1016/j.virol.2004.10.033; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; Rowe KC, 2008, MOL PHYLOGENET EVOL, V47, P84, DOI 10.1016/j.ympev.2008.01.001; Schulz E, 2009, J GEN VIROL, V90, P626, DOI 10.1099/vir.0.008011-0; Schulz E, 2009, J GEN VIROL, V90, P2609, DOI 10.1099/vir.0.012583-0; TAN CH, 1994, VIROLOGY, V198, P534, DOI 10.1006/viro.1994.1064; Tomaic V, 2009, ONCOGENE, V28, P1, DOI 10.1038/onc.2008.365; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Van Doorslaer K, 2007, J GEN VIROL, V88, P1484, DOI 10.1099/vir.0.82615-0; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	43	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47164	10.1371/journal.pone.0047164	http://dx.doi.org/10.1371/journal.pone.0047164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077564	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100070
J	Huang, SF; Dai, W; Sun, S; Zhang, XJ; Zhang, LP				Huang, Shifeng; Dai, Wei; Sun, Shan; Zhang, Xiaojiao; Zhang, Liping			Prevalence of Plasmid-Mediated Quinolone Resistance and Aminoglycoside Resistance Determinants among Carbapeneme Non-Susceptible Enterobacter cloacae	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; KLEBSIELLA-PNEUMONIAE; QNR PREVALENCE; EMERGENCE; ARMA	Background: Simultaneous resistance to aminoglycosides and fluoroquinolones in carbapeneme non-susceptible (CNS) isolates will inevitably create problems. The present study was performed to characterize the prevalence of the plasmid-mediated quinolone resistance determinants (QRDs) and aminoglycoside resistance determinants (ARDs) among the CNS Enterobacter cloacae (E. cloacae) isolates in a Chinese teaching hospital, and to acquire their molecular epidemiological characteristics. Methods: The beta-lactamases genes (including class A carbapenemase genes bla(KPC) and bla(SME), metallo-beta-lactamase genes (MBLs) bla(IMP), bla(VIM) and bla(NDM), and extended spectrum beta-lactamases (ESBLs), bla(CTX-M), bla(TEM) and bla(SHV)), QRDs (including qnrA, qnrB, qnrS and aac(6')-Ib-cr) and ARDs (including aac(6')-Ib, armA and rmtB) of these 35 isolates were determined by PCR and sequenced bidirectionally. The clonal relatedness was investigated by pulsed-field gel electrophoresis (PFGE). Results: Of the 35 isolates, 9 (25.7%) harbored a carbapenemase gene; 23 (65.7%) carried ESBLs; 24 (68.6%) were QRD positive; and 27 (77.1%) were ARD positive. Among the 5 bla(IMP-8) positive strains, 4 (80%) contained both ESBL and QRD genes, and all the 5 (100%) harbored ARD genes. Of the 23 ESBLs positive isolates, 6 (26.1%) were carbapenemase positive, 14 (60.9%) were QRD positive, and 18 (78.3%) were ARD positive. PFGE revealed genetic diversity among the 35 isolates, indicating that the high prevalence of CNS E. cloacae isolates was not caused by clonal dissemination. Conclusion: QRD and ARD genes were highly prevalent among the CNS E. cloacae isolates. Multiple resistant genes were co-expressed in the same isolates. The CNS E. cloacae isolate co-expressing bla(NDM-1), bla(IMP-26), qnrA1 and qnrS1 was first reported.	[Huang, Shifeng; Dai, Wei; Sun, Shan; Zhang, Xiaojiao; Zhang, Liping] Chongqing Med Univ, Affiliated Hosp 1, Dept Lab Med, Chongqing, Peoples R China	Chongqing Medical University	Zhang, LP (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Lab Med, Chongqing, Peoples R China.	liuzhangcq@yahoo.com		Huang, Shifeng/0000-0001-7641-8823	National Science Foundation of China [81071621, 30973378]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Science Foundation of China (Grant No. 81071621 and No. 30973378; http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Chmelnitsky I, 2008, ANTIMICROB AGENTS CH, V52, P2962, DOI 10.1128/AAC.01341-07; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Folster JP, 2009, ANTIMICROB AGENTS CH, V53, P4563, DOI 10.1128/AAC.00656-09; Kim HK, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.066; Liu Y, 2009, ANTIMICROB AGENTS CH, V53, P1642, DOI 10.1128/AAC.01325-08; Livermore DM, 2011, J ANTIMICROB CHEMOTH, V66, P48, DOI 10.1093/jac/dkq408; Ma L, 2009, ANTIMICROB AGENTS CH, V53, P104, DOI 10.1128/AAC.00852-08; Mammeri H, 2005, ANTIMICROB AGENTS CH, V49, P71, DOI 10.1128/AAC.49.1.71-76.2005; Mc Gann P, 2012, ANTIMICROB AGENTS CH, V56, P1673, DOI 10.1128/AAC.05604-11; Miriagou V, 2010, CLIN MICROBIOL INFEC, V16, P112, DOI 10.1111/j.1469-0691.2009.03116.x; Naas T, 2011, J CLIN MICROBIOL, V49, P1608, DOI 10.1128/JCM.02607-10; O'Neill A, 2008, EXPERT OPIN INV DRUG, V17, P297, DOI 10.1517/13543784.17.3.297 ; Paterson DL, 2000, CLIN MICROBIOL INFEC, V6, P460, DOI 10.1046/j.1469-0691.2000.00107.x; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2006, ANTIMICROB AGENTS CH, V50, P2872, DOI 10.1128/AAC.01647-05; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rodriguez-Martinez JM, 2007, ANTIMICROB AGENTS CH, V51, P2236, DOI 10.1128/AAC.01444-06; Strahilevitz J, 2007, ANTIMICROB AGENTS CH, V51, P3001, DOI 10.1128/aac.00256-07; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Wu JJ, 2007, ANTIMICROB AGENTS CH, V51, P1223, DOI 10.1128/AAC.01195-06; Wu Q, 2010, DIAGN MICR INFEC DIS, V66, P326, DOI 10.1016/j.diagmicrobio.2009.10.003; Yang FC, 2012, J CLIN MICROBIOL, V50, P223, DOI 10.1128/JCM.01263-11; Yang H, 2008, ANTIMICROB AGENTS CH, V52, P4268, DOI 10.1128/AAC.00830-08; Zacharczuk K, 2011, ANTIMICROB AGENTS CH, V55, P443, DOI 10.1128/AAC.00386-10	30	37	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47636	10.1371/journal.pone.0047636	http://dx.doi.org/10.1371/journal.pone.0047636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110085	Green Published, gold, Green Submitted			2022-12-27	WOS:000310193600019
J	August, SL; De Rosa, MJ				August, Suzanne L.; De Rosa, Michael J.			Evaluation of the Prevalence of Urinary Tract Infection in Rural Panamanian Women	PLOS ONE			English	Article							ASYMPTOMATIC BACTERIURIA	Objective: Urinary tract infection (UTI) is the most common non-intestinal infection worldwide. In the developed world, incidence and prevalence of UTI would be similar owing to the relatively short duration of illness experienced by women with ready access to healthcare services. We hypothesize that, in the developing world, factors limiting access to care and those which may increase the likelihood of developing UTI, result in increased morbidity. This difference is reflected in an increased prevalence of UTI in regions where women suffer the effects of UTI for extended periods of time. Methods: This study represents a cross sectional analysis of UTI prevalence in rural western Panama conducted over the course of a 3-day medical mission. All women 18-45 years of age reporting to the medical brigade clinic were tested for UTI by dipstick urinalysis and a brief history regardless of whether they themselves were presenting with a complaint. Results: UTI was diagnosed clinically by providers in 29.8% of the women tested although only 21.15% of these same women met the evidence-based study criteria. This prevalence of 21.15% is seven times greater than reported by the Panamanian Ministry of Health. When comparing the effectiveness of clinical diagnosis relative to urinalysis by dipstick, a Kappa coefficient revealed only low moderate agreement (0.42; SE 0.0955). Conclusions: The prevalence of UTI in rural western Panama is greater than would be expected based on prevalence data from either the US or Panamanian Ministry of Health and may represent an opportunity for targeted interventions, including educational programming about UTI prevention.	[August, Suzanne L.] Samuel Merritt Univ, Sch Nursing, Oakland, CA USA; [De Rosa, Michael J.] Samuel Merritt Univ, Phys Assistant Dept, Oakland, CA USA	Samuel Merritt University; Samuel Merritt University	August, SL (corresponding author), Samuel Merritt Univ, Sch Nursing, Oakland, CA USA.	saugust@samuelmerritt.edu						Akinloye O, 2006, BRIT J BIOMED SCI, V63, P109, DOI 10.1080/09674845.2006.11732734; [Anonymous], 2006, IND BAS SAL REP PAN; Awonuga DO, 2010, NIGER J MED, V19, P339; Delzell JE, 2000, AM FAM PHYSICIAN, V61, P713; Dielubanza EJ, 2011, MED CLIN N AM, V95, P27, DOI 10.1016/j.mcna.2010.08.023; Gau JT, 2009, J AM OSTEOPATH ASSOC, V109, P220; Hooton TM, 2000, NEW ENGL J MED, V343, P1037; Kovavisarach Ekachai, 2009, Journal of the Medical Association of Thailand, V92, P606; Liao YM, 2009, INT J NURS STUD, V46, P633, DOI 10.1016/j.ijnurstu.2008.12.001; Masinde A, 2009, Tanzan J Health Res, V11, P154; Medina-Bombardo D, 2003, FAM PRACT, V20, P103, DOI 10.1093/fampra/20.2.103; Mehnert-Kay SA, 2005, AM FAM PHYSICIAN, V72, P451; National Institutes of Health, 2021, UROLOGIC DIS AM; OLUSANYA O, 1992, CENT AFR J MED, V38, P297; Trestioreanu AZ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007182.pub2; Vital and Health Statistics, 2004, VITAL HLTH STAT, V13; World Health Organization (WHO), 2019, DEM KEY FACTS	17	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47752	10.1371/journal.pone.0047752	http://dx.doi.org/10.1371/journal.pone.0047752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094080	Green Submitted, gold, Green Published			2022-12-27	WOS:000310050200041
J	Cuypers, KF; Loos, RJF; Kvaloy, K; Kulle, B; Romundstad, P; Holmen, TL				Cuypers, Koenraad Frans; Loos, Ruth J. F.; Kvaloy, Kirsti; Kulle, Bettina; Romundstad, Pal; Holmen, Turid Lingaas			Obesity-Susceptibility Loci and Their Influence on Adiposity-Related Traits in Transition from Adolescence to Adulthood - The HUNT Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NORD-TRONDELAG HEALTH; BODY-MASS INDEX; PHYSICAL-ACTIVITY; FTO GENE; OVERWEIGHT; CHILDHOOD; VARIANTS; VALIDITY; RELIABILITY	Introduction: Obesity-susceptibility loci have been related to adiposity traits in adults and may affect body fat estimates in adolescence. There are indications that different sets of obesity-susceptibility loci influence level of and change in obesity-related traits from adolescence to adulthood. Objectives: To investigate whether previously reported obesity-susceptible loci in adults influence adiposity traits in adolescence and change in BMI and waist circumference (WC) from adolescence into young adulthood. We also examined whether physical activity modifies the effects of these genetic loci on adiposity-related traits. Methods: Nine obesity-susceptibility variants were genotyped in 1 643 adolescents (13-19 years old) from the HUNT study, Norway, who were followed-up into young adulthood. Lifestyle was assessed using questionnaires and anthropometric measurements were taken. The effects of genetic variants individually and combined in a genetic predisposition score (GPS) on obesity-related traits were studied cross-sectionally and longitudinally. A modifying effect of physical activity was tested. Results: The GPS was significantly associated to BMI (B: 0.046 SD/allele [0.020, 0.073], p = 0.001) in adolescence and in young adulthood (B: 0.041 SD/allele [0.015, 0.067], p = 0.002) as it was to waist circumference (WC). The GPS was not associated to change in BMI (p = 0.762) or WC (p = 0.726). We found no significant interaction effect between the GPS and physical activity. Conclusions: Our observations suggest that obesity-susceptibility loci established in adults affect BMI and WC already in adolescence. However, an association with change in adiposity-related traits from adolescence to adulthood could not be verified for these loci. Neither could an attenuating effect of physical activity on the association between the obesity-susceptibility genes and body fat estimates be revealed.	[Cuypers, Koenraad Frans; Kvaloy, Kirsti; Holmen, Turid Lingaas] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, N-7034 Trondheim, Norway; [Loos, Ruth J. F.] Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [Loos, Ruth J. F.] Mt Sinai Sch Med, Charles Bronfman Inst Personalized Med, Inst Child Hlth, Genet Obes & Related Metab Traits Program, New York, NY USA; [Kulle, Bettina] Univ Oslo, Akershus Univ Hosp, Inst Clin Med, Epi Gen, Oslo, Norway; [Kulle, Bettina] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Romundstad, Pal] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Icahn School of Medicine at Mount Sinai; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU)	Cuypers, KF (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, N-7034 Trondheim, Norway.	Koenraad.cuypers@ntnu.no	Loos, Ruth/GON-5877-2022; Loos, Ruth J F/Q-2862-2016	Loos, Ruth J F/0000-0002-8532-5087; Romundstad, Pal Richard/0000-0003-2061-4336	Norwegian Research Council; European Science Foundation [ESF- 4064]; MRC [MC_U106188470] Funding Source: UKRI; Medical Research Council [MC_U106188470] Funding Source: researchfish	Norwegian Research Council(Research Council of NorwayEuropean Commission); European Science Foundation(European Science Foundation (ESF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The present study was supported by a grant of The Norwegian Research Council. The Nord-Trondelag Health Study (HUNT) is a cooperation between the HUNT Research Center, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), the Norwegian Institute for Public Health and the Nord-Trondelag County Council. We also acknowledge the support received from the European Science Foundation (ESF- 4064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Bratberg GH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-54; Coady SA, 2002, OBES RES, V10, P675, DOI 10.1038/oby.2002.91; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; den Hoed M, 2010, DIABETES, V59, P2980, DOI 10.2337/db10-0370; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Goris A, 2006, EUR J HUM GENET, V14, P1064, DOI 10.1038/sj.ejhg.5201665; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Haworth CMA, 2008, OBESITY, V16, P1585, DOI 10.1038/oby.2008.240; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hjelmborg JVB, 2008, OBESITY, V16, P847, DOI 10.1038/oby.2007.135; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Krokstad S, 2002, SCAND J PUBLIC HEALT, V30, P113, DOI 10.1080/14034940210133753; Kurtze N, 2007, EUR J EPIDEMIOL, V22, P379, DOI 10.1007/s10654-007-9110-9; Li S, AM J CLIN NUTR, V91, P184; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Livingstone M B, 2001, Public Health Nutr, V4, P109; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Mei H, 2010, HUM GENET, V128, P589, DOI 10.1007/s00439-010-0883-7; Ortega-Alonso A, 2009, BEHAV GENET, V39, P154, DOI 10.1007/s10519-008-9245-9; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009; Patton GC, 2011, J ADOLESCENT HEALTH, V48, P275, DOI 10.1016/j.jadohealth.2010.06.019; Rangul V, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-47; Ruiz JR, ARCH PEDIAT ADOLESC, V164, P328; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Sovio U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001307; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159	37	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e46912	10.1371/journal.pone.0046912	http://dx.doi.org/10.1371/journal.pone.0046912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094032	Green Submitted, gold, Green Published			2022-12-27	WOS:000310050200014
J	Karlsgodt, KH; Rosser, T; Lutkenhoff, ES; Cannon, TD; Silva, A; Bearden, CE				Karlsgodt, Katherine H.; Rosser, Tena; Lutkenhoff, Evan S.; Cannon, Tyrone D.; Silva, Alcino; Bearden, Carrie E.			Alterations in White Matter Microstructure in Neurofibromatosis-1	PLOS ONE			English	Article							OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; APPARENT DIFFUSION-COEFFICIENT; CORPUS-CALLOSUM MORPHOLOGY; PEDIATRIC-PATIENTS; COGNITIVE FUNCTION; BRAIN; CHILDREN; TYPE-1; REGISTRATION; ROBUST	Neurofibromatosis (NF1) represents the most common single gene cause of learning disabilities. NF1 patients have impairments in frontal lobe based cognitive functions such as attention, working memory, and inhibition. Due to its well-characterized genetic etiology, investigations of NF1 may shed light on neural mechanisms underlying such difficulties in the general population or other patient groups. Prior neuroimaging findings indicate global brain volume increases, consistent with neural over-proliferation. However, little is known about alterations in white matter microstructure in NF1. We performed diffusion tensor imaging (DTI) analyses using tract-based spatial statistics (TBSS) in 14 young adult NF1 patients and 12 healthy controls. We also examined brain volumetric measures in the same subjects. Consistent with prior studies, we found significantly increased overall gray and white matter volume in NF1 patients. Relative to healthy controls, NF1 patients showed widespread reductions in white matter integrity across the entire brain as reflected by decreased fractional anisotropy (FA) and significantly increased absolute diffusion (ADC). When radial and axial diffusion were examined we found pronounced differences in radial diffusion in NF1 patients, indicative of either decreased myelination or increased space between axons. Secondary analyses revealed that FA and radial diffusion effects were of greatest magnitude in the frontal lobe. Such alterations of white matter tracts connecting frontal regions could contribute to the observed cognitive deficits. Furthermore, although the cellular basis of these white matter microstructural alterations remains to be determined, our findings of disproportionately increased radial diffusion against a background of increased white matter volume suggest the novel hypothesis that one potential alteration contributing to increased cortical white matter in NF1 may be looser packing of axons, with or without myelination changes. Further, this indicates that axial and radial diffusivity can uniquely contribute as markers of NF1-associated brain pathology in conjunction with the typically investigated measures.	[Karlsgodt, Katherine H.; Cannon, Tyrone D.; Silva, Alcino; Bearden, Carrie E.] Univ Calif Los Angeles, Semel Inst Neurosci & Behav, Los Angeles, CA 90095 USA; [Karlsgodt, Katherine H.; Cannon, Tyrone D.; Bearden, Carrie E.] Univ Calif Los Angeles, Ctr Cognit Neurosci, Los Angeles, CA USA; [Lutkenhoff, Evan S.; Cannon, Tyrone D.; Silva, Alcino; Bearden, Carrie E.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Rosser, Tena] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Silva, Alcino] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Children's Hospital Los Angeles; University of California System; University of California Los Angeles	Karlsgodt, KH (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Behav, Los Angeles, CA 90095 USA.	kkarlsgodt@nshs.edu	Silva, Alcino/ABD-7684-2021; Karlsgodt, Katherine H/H-2964-2013	Silva, Alcino/0000-0002-1587-4558; Karlsgodt, Katherine H/0000-0003-3332-4231; Bearden, Carrie/0000-0002-8516-923X	Carol Moss Spivak Foundation; National Institutes of Health [MH084315]; National Institute of Mental Health [R34 MH089299-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH089299, R01MH084315] Funding Source: NIH RePORTER	Carol Moss Spivak Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Carol Moss Spivak Foundation and National Institutes of Health grant MH084315 to AS, and the National Institute of Mental Health (R34 MH089299-01 to CEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Alkan A, 2005, EUR J RADIOL, V56, P229, DOI 10.1016/j.ejrad.2005.05.008; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bennett MR, 2008, AUST NZ J PSYCHIAT, V42, P662, DOI 10.1080/00048670802203467; Boyanapalli M, 2006, BIOCHEM BIOPH RES CO, V340, P1200, DOI 10.1016/j.bbrc.2005.12.129; Cutting LE, 2002, NEUROLOGY, V59, P1388, DOI 10.1212/01.WNL.0000032370.68306.8A; de Zeeuw P, 2012, HUM BRAIN MAPP, V33, P1941, DOI 10.1002/hbm.21335; DIPAOLO DP, 1995, RADIOLOGY, V195, P721, DOI 10.1148/radiology.195.3.7754001; Dubovsky EC, 2001, AM J NEURORADIOL, V22, P190; Eastwood JD, 2001, RADIOLOGY, V219, P354, DOI 10.1148/radiology.219.2.r01ap25354; First M. B., 1997, STRUCTURED CLIN INTE; Ford JC, 1998, JMRI-J MAGN RESON IM, V8, P775, DOI 10.1002/jmri.1880080405; Gil V, 2010, CEREB CORTEX, V20, P1769, DOI 10.1093/cercor/bhp246; GILLBERG C, 1984, J AUTISM DEV DISORD, V14, P1, DOI 10.1007/BF02408551; Golabchi FN, 2010, MAGN RESON MED, V63, P1510, DOI 10.1002/mrm.22337; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greenwood RS, 2005, ARCH NEUROL-CHICAGO, V62, P1904, DOI 10.1001/archneur.62.12.1904; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Huijbregts SCJ, 2011, BEHAV GENET, V41, P430, DOI 10.1007/s10519-010-9430-5; HUSON SM, 1989, ARCH DIS CHILD, V64, P745, DOI 10.1136/adc.64.5.745; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson MR, 2000, J NEUROL NEUROSUR PS, V68, P643, DOI 10.1136/jnnp.68.5.643; Karlsgodt KH, 2012, CURR PHARM DESIGN, V18, P422; Karlsgodt KH, 2009, BIOL PSYCHIAT, V66, P562, DOI 10.1016/j.biopsych.2009.03.013; Kayl AE, 2000, J CHILD NEUROL, V15, P90, DOI 10.1177/088307380001500206; Kweh F, 2009, MOL CARCINOGEN, V48, P1005, DOI 10.1002/mc.20552; Lee JS, 2010, HUM MOL GENET, V19, P4643, DOI 10.1093/hmg/ddq395; Margariti PN, 2007, EUR RADIOL, V17, P433, DOI 10.1007/s00330-006-0323-1; Mautner VF, 2002, DEV MED CHILD NEUROL, V44, P164, DOI 10.1017/S0012162201001876; MIKOL DD, 1993, GENOMICS, V17, P604, DOI 10.1006/geno.1993.1379; Moore BD, 2000, NEUROLOGY, V54, P914, DOI 10.1212/WNL.54.4.914; Mori S., 2005, MRI ATLAS HUMAN WHIT; Nagel BJ, 2011, J AM ACAD CHILD PSY, V50, P283, DOI 10.1016/j.jaac.2010.12.003; NORTH K, 1994, NEUROLOGY, V44, P878, DOI 10.1212/WNL.44.5.878; North K, 2000, AM J MED GENET, V97, P119, DOI 10.1002/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3; North KN, 1997, NEUROLOGY, V48, P1121, DOI 10.1212/WNL.48.4.1121; Ozonoff S, 1999, AM J MED GENET, V89, P45, DOI 10.1002/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.0.CO;2-J; Payne JM, 2010, J NEUROL NEUROSUR PS, V81, P304, DOI 10.1136/jnnp.2009.179630; Pride N, 2010, J CHILD NEUROL, V25, P834, DOI 10.1177/0883073809350723; Rowbotham I, 2009, NEUROPSYCHOLOGY, V23, P50, DOI 10.1037/a0013927; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sheikh SF, 2003, J COMPUT ASSIST TOMO, V27, P681, DOI 10.1097/00004728-200309000-00004; Shilyansky C, 2010, P NATL ACAD SCI USA, V107, P13141, DOI 10.1073/pnas.1004829107; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song AW, 2003, NEUROIMAGE; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Tamm L, 2012, PSYCHIAT RES-NEUROIM, V202, P150, DOI 10.1016/j.pscychresns.2012.04.001; Tognini G, 2005, J COMPUT ASSIST TOMO, V29, P298, DOI 10.1097/01.rct.0000162406.71300.b7; van Engelen SJPM, 2008, AM J NEURORADIOL, V29, P816, DOI 10.3174/ajnr.A0921; VISKOCHIL D, 1991, MOL CELL BIOL, V11, P906, DOI 10.1128/MCB.11.2.906; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wignall EL, 2010, AM J NEURORADIOL, V31, P856, DOI 10.3174/ajnr.A2005; Wozniak JR, 2006, NEUROSCI BIOBEHAV R, V30, P762, DOI 10.1016/j.neubiorev.2006.06.003; Zamboni SL, 2007, AM J NEURORADIOL, V28, P773; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	65	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47854	10.1371/journal.pone.0047854	http://dx.doi.org/10.1371/journal.pone.0047854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094098	gold, Green Submitted, Green Published			2022-12-27	WOS:000310050200051
J	Karn, RC; Laukaitis, CM				Karn, Robert C.; Laukaitis, Christina M.			The Roles of Gene Duplication, Gene Conversion and Positive Selection in Rodent Esp and Mup Pheromone Gene Families with Comparison to the Abp Family	PLOS ONE			English	Article							ANDROGEN-BINDING-PROTEIN; MAJOR URINARY PROTEINS; GC-CONTENT EVOLUTION; MULTIPLE SEQUENCE ALIGNMENT; SEXUAL ISOLATION; HOUSE MOUSE; COMPREHENSIVE ANALYSIS; PHYLOGENETIC ANALYSIS; ADAPTIVE EVOLUTION; SULFATED STEROIDS	Three proteinaceous pheromone families, the androgen-binding proteins (ABPs), the exocrine-gland secreting peptides (ESPs) and the major urinary proteins (MUPs) are encoded by large gene families in the genomes of Mus musculus and Rattus norvegicus. We studied the evolutionary histories of the Mup and Esp genes and compared them with what is known about the Abp genes. Apparently gene conversion has played little if any role in the expansion of the mouse Class A and Class B Mup genes and pseudogenes, and the rat Mups. By contrast, we found evidence of extensive gene conversion in many Esp genes although not in all of them. Our studies of selection identified at least two amino acid sites in beta-sheets as having evolved under positive selection in the mouse Class A and Class B MUPs and in rat MUPs. We show that selection may have acted on the ESPs by determining K-a/K-s for Exon 3 sequences with and without the converted sequence segment. While it appears that purifying selection acted on the ESP signal peptides, the secreted portions of the ESPs probably have undergone much more rapid evolution. When the inner gene converted fragment sequences were removed, eleven Esp paralogs were present in two or more pairs with K-a/K-s > 1.0 and thus we propose that positive selection is detectable by this means in at least some mouse Esp paralogs. We compare and contrast the evolutionary histories of all three mouse pheromone gene families in light of their proposed functions in mouse communication.	[Karn, Robert C.; Laukaitis, Christina M.] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85719 USA	University of Arizona	Karn, RC (corresponding author), Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85719 USA.	rkarn@butler.edu	Laukaitis, Christina M/AAL-5865-2021; Laukaitis, Christina/AAW-2510-2020; Laukaitis, Christina/ABF-1739-2021	Laukaitis, Christina M/0000-0003-1466-7941; 	National Cancer Institute at the National Institutes of Health;  [P50 CA095060];  [P30 CA023074]; NATIONAL CANCER INSTITUTE [P50CA095060, P30CA023074] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute at the National Institutes of Health CML received salary support from P50 CA095060 and laboratory support from P30 CA023074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SD, 2005, BIOCHEM J, V391, P343, DOI 10.1042/BJ20050404; Arnheim N., 1983, P38; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Bimova B, 2005, BIOL J LINN SOC, V84, P349, DOI 10.1111/j.1095-8312.2005.00439.x; Bimova BV, 2011, MOL ECOL, V20, P2403, DOI 10.1111/j.1365-294X.2011.05106.x; Bradford JR, 2001, PROTEIN DESIGN BIOPH; Callebaut I, 2000, ANN NY ACAD SCI, V923, P90; Castillo-Davis CI, 2004, GENOME RES, V14, P802, DOI 10.1101/gr.2195604; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cheetham SA, 2007, CURR BIOL, V17, P1771, DOI 10.1016/j.cub.2007.10.007; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; CLARK AJ, 1985, EMBO J, V4, P3159, DOI 10.1002/j.1460-2075.1985.tb04059.x; CLARK AJ, 1985, EMBO J, V4, P3167, DOI 10.1002/j.1460-2075.1985.tb04060.x; Clark NL, 2005, PLOS GENET, V1, P335, DOI 10.1371/journal.pgen.0010035; CLISSOLD PM, 1984, BIOCHEM GENET, V22, P379, DOI 10.1007/BF00484236; Coyne JA, 1997, GENETICS, V145, P1015; Dean MD, 2009, MOL BIOL EVOL, V26, P1733, DOI 10.1093/molbev/msp094; DLOUHY SR, 1983, BIOCHEM GENET, V21, P1057, DOI 10.1007/BF00488459; DLOUHY SR, 1987, GENETICS, V115, P535; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Emes RD, 2004, GENOME RES, V14, P1516, DOI 10.1101/gr.2540304; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; Galtier N, 2003, TRENDS GENET, V19, P65, DOI 10.1016/S0168-9525(02)00002-1; Galtier N, 2001, GENETICS, V159, P907; Galtier N, 2009, TRENDS GENET, V25, P1, DOI 10.1016/j.tig.2008.10.011; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; HAYASHIDA H, 1983, P NATL ACAD SCI-BIOL, V80, P2671, DOI 10.1073/pnas.80.9.2671; Hsu FF, 2008, BIOCHEMISTRY-US, V47, P14009, DOI 10.1021/bi801392j; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Hwang JM, 1997, J HERED, V88, P93, DOI 10.1093/oxfordjournals.jhered.a023083; Janousek V, 2012, GENOME BIOL EV UNPUB; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jensen JD, 2007, TRENDS GENET, V23, P568, DOI 10.1016/j.tig.2007.08.009; Karn RC, 1999, MOL BIOL EVOL, V16, P1192, DOI 10.1093/oxfordjournals.molbev.a026209; Karn RC, 2003, BIOCHEMISTRY-US, V42, P7162, DOI 10.1021/bi027424l; Karn RC, 2002, MOL BIOL EVOL, V19, P462, DOI 10.1093/oxfordjournals.molbev.a004102; KARN RC, 1991, J HERED, V82, P453, DOI 10.1093/oxfordjournals.jhered.a111127; Karn RC, 2008, MOL BIOL EVOL, V25, P2301, DOI 10.1093/molbev/msn182; Karn RC, 2009, GENOME BIOL EVOL, V1, P494, DOI 10.1093/gbe/evp049; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; Kudla G, 2004, MOL BIOL EVOL, V21, P1438, DOI 10.1093/molbev/msh146; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laukaitis C.M., 2012, EVOLUTION HOUSE MOUS, P150, DOI [10.1017/CBO9781139044547.009, DOI 10.1017/CBO9781139044547.009]; Laukaitis CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-46; Laukaitis CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035898; Laukaitis CM, 2003, MAMM GENOME, V14, P679, DOI 10.1007/s00335-003-2291-y; Laukaitis CM, 1997, EVOLUTION, V51, P2000, DOI [10.2307/2411020, 10.1111/j.1558-5646.1997.tb05121.x]; Lawson MJ, 2009, NUCLEIC ACIDS RES, V37, P4570, DOI 10.1093/nar/gkp421; Li W. H, 1997, MOL EVOLUTION; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Lyon JD, 1999, DEV BIOL, V214, P151, DOI 10.1006/dbio.1999.9411; McGrath CL, 2009, GENETICS, V182, P615, DOI 10.1534/genetics.109.101428; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Ohno S., 1970, P1; OHTA T, 1983, THEOR POPUL BIOL, V23, P216, DOI 10.1016/0040-5809(83)90015-1; Ohta T., 1980, EVOLUTION VARIATION, V37, DOI [10.1007/978-3-642-93138-3, DOI 10.1007/978-3-642-93138-3]; Orr HA, 2005, EVOLUTION, V59, P216; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Robertson DHL, 1996, BIOCHEM J, V316, P265, DOI 10.1042/bj3160265; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Swanson WJ, 2004, GENETICS, V168, P1457, DOI 10.1534/genetics.104.030478; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Talley HM, 2001, EVOLUTION, V55, P631, DOI 10.1554/0014-3820(2001)055[0631:FPFMSI]2.0.CO;2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thom MD, 2008, CURR BIOL, V18, P619, DOI 10.1016/j.cub.2008.03.056; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	94	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47697	10.1371/journal.pone.0047697	http://dx.doi.org/10.1371/journal.pone.0047697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094077	Green Submitted, gold, Green Published			2022-12-27	WOS:000310050200039
J	Villafuerte-Galvez, J; Sotelo-Olivera, MI; Cok, J; Piscoya-Rivera, A; Huerta-Mercado, J				Villafuerte-Galvez, Javier; Isabel Sotelo-Olivera, Maria; Cok, Jaime; Piscoya-Rivera, Alejandro; Huerta-Mercado, Jorge			Colonoscopic Findings in Peruvian Patients with Chronic Diarrhea	PLOS ONE			English	Article							GASTROINTESTINAL SYMPTOMS; MICROSCOPIC COLITIS; SINGLE-CENTER; PREVALENCE	Objective: To report the colonoscopic and pathological findings in patients with chronic diarrhea from a gastroenterology unit during approximately 3 years in a general teaching hospital located in Lima-Peru. Materials and Methods: Patients with chronic diarrhea as the motive for colonoscopy from March 2008 to December 2010 were selected from the colonoscopy report computerized database. Colonoscopic findings were registered. Biopsies taken during the procedure were prospectively reviewed. Results: 226 patients were included, of which 162 (71.7%) had a colon biopsy available. The average age of the patients was 53.6 +/- 16.36. 85.8% of patients were reported to have a normal colon. 14.8% of patients were found to have a normal colonic mucosa or mucosal edema, 35.8% of patients had lymphocytic colitis and 28.4% had paucicelular colitis. Conclusions: The majority of colonoscopies were reported with unremarkable macroscopic findings. Lymphocytic colitis was unusually frequent compared to previous reports.	[Villafuerte-Galvez, Javier; Isabel Sotelo-Olivera, Maria] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru; [Villafuerte-Galvez, Javier] Soc Cient Estudiantes Med Cayetano Heredia SOCEMC, Lima, Peru; [Cok, Jaime] Hosp Nacl Cayetano Heredia, Dept Pathol, Lima, Peru; [Cok, Jaime] Univ Peruana Cayetano Heredia, Dept Preclin Sci & Diagnost Aid, Lima, Peru; [Piscoya-Rivera, Alejandro; Huerta-Mercado, Jorge] Hosp Nacl Cayetano Heredia, Dept Med, Gastroenteol Unit, Lima, Peru; [Huerta-Mercado, Jorge] Univ Peruana Cayetano Heredia, Dept Clin Med, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Villafuerte-Galvez, J (corresponding author), Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru.	javier.villafuerte@upch.pe	Piscoya, Alejandro/C-6380-2012	Piscoya, Alejandro/0000-0002-4420-2419; Villafuerte Galvez, Javier/0000-0002-3379-5271				Arévalo F, 2008, Rev. gastroenterol. Perú, V28, P140; Carmona-Sanchez R, 2000, REV GASTROENTEROL ME, V72, P349; Coronel F, 2005, GASTROENTEROL LATINO, V16, P186; Fernandez-Banarcs F, 2009, AM J GASTROENTEROL, V104, P1189, DOI 10.1038/ajg.2009.65; Fine KD, 1999, GASTROENTEROLOGY, V116, P1464, DOI 10.1016/S0016-5085(99)70513-5; Gado AS, 2011, SAUDI J GASTROENTERO, V17, P383, DOI 10.4103/1319-3767.87178; Gopalan SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029936; Ichiyanagui C, 1997, BOL SOC PER MED INT, V10; Nyhlin N, 2006, ALIMENT PHARM THER, V23, P1525, DOI 10.1111/j.1365-2036.2006.02913.x; Pardi DS, 2011, GASTROENTEROLOGY, V140, P1155, DOI 10.1053/j.gastro.2011.02.003; Rubio-Tapia A, 2007, INT J COLORECTAL DIS, V22, P1031, DOI 10.1007/s00384-006-0258-7; TALLEY NJ, 1992, GASTROENTEROLOGY, V102, P895, DOI 10.1016/0016-5085(92)90175-X; TALLEY NJ, 1992, AM J EPIDEMIOL, V136, P165, DOI 10.1093/oxfordjournals.aje.a116483; Valle Mansilla JL, 2002, REV GASTROENTEROL PE, V22, P275	14	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e46690	10.1371/journal.pone.0046690	http://dx.doi.org/10.1371/journal.pone.0046690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094029	Green Published, gold, Green Submitted			2022-12-27	WOS:000312384500003
J	Inoue, K; Kashima, S; Ohara, C; Matsumoto, M; Akimoto, K				Inoue, Kazuo; Kashima, Saori; Ohara, Chisako; Matsumoto, Masatoshi; Akimoto, Kimihiko			Concordance of Two Diabetes Diagnostic Criteria Using Fasting Plasma Glucose and Hemoglobin A1c: The Yuport Medical Checkup Centre Study	PLOS ONE			English	Article							EXPERT COMMITTEE; MELLITUS; CLASSIFICATION	Background: We tested the concordance of the two diagnostic criteria for diabetes using fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) by the Japan Diabetes Society (JDS) and American Diabetes Association (ADA). Methods: We used data from 7,328 subjects without known diabetes who participated in a voluntary health checkup program at least twice between 1998 and 2006, at intervals <= 2 years. For repeat participants who attended the screening over two times, data from the first and second checkups were used for this study. At the first visit, diabetes was diagnosed both at FPG >= 7.0 mmol/L and HbA1c >= 6.5% using the JDS criteria. In addition, diabetes was diagnosed using two ADA criteria; ADA-FPG diabetes for persistent fasting hyperglycemia (FPG >= 7.0 mmol/L) or ADA-HbA1c diabetes for hyperglycated hemoglominemia (HbA1c >= 6.5%), both at the first and second checkups. Subsequently, the concordance of diagnosis between the JDS and the ADA criteria was evaluated. Results: At the first checkup, 153 (2.1%) persons were diagnosed with diabetes by the JDS criteria. They had higher levels of risk factors for diabetes than non-diabetic subjects. Using the first and second checkups, 174 (2.4%) and 175 (2.4%) were diagnosed with diabetes by the ADA-FPG criteria, respectively. Among 153 subjects diagnosed with diabetes by the JDS criteria, 125 (81.7%) and 129 (84.3%) had ADA-FPG and ADA-HbA1c diabetes, respectively. The kappa coefficients of the JDS criteria with ADA-FPG and ADA-HbA1c criteria were 0.759 and 0.782 (P<0.001), respectively. In the subgroup analysis stratified by sex, the concordance was well preserved at the kappa coefficients around 0.8 (between 0.725 and 0.836). Conclusion: The JDS diagnostic criteria for diabetes have a substantial and acceptable concordance with the ADA criteria. The JDS criteria may be a practical method for diagnosing diabetes that maintains compatibility with the ADA criteria.	[Inoue, Kazuo] Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan; [Kashima, Saori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Ohara, Chisako] Teikyo Univ, Grad Sch Publ Hlth, Dept Publ Hlth, Tokyo 173, Japan; [Matsumoto, Masatoshi] Hiroshima Univ, Fac Med, Dept Community Based Med Syst, Hiroshima, Japan; [Akimoto, Kimihiko] Akimoto Occupat Hlth Consultant Off, Tokyo, Japan	Teikyo University; Hiroshima University; Teikyo University; Hiroshima University	Inoue, K (corresponding author), Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan.	inouek@med.teikyo-u.ac.jp	Kashima, Saori/B-4524-2010	Kashima, Saori/0000-0002-3401-8191; Matsumoto, Masatoshi/0000-0002-8341-9303				[Anonymous], 2012, DIABETES CARE S1, V35, pS11; Avignon A, 1997, DIABETES CARE, V20, P1822, DOI 10.2337/diacare.20.12.1822; Barr RG, 2002, ANN INTERN MED, V137, P263, DOI 10.7326/0003-4819-137-4-200208200-00011; BOGARDUS C, 1984, J CLIN INVEST, V74, P1238, DOI 10.1172/JCI111533; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; DINNEEN S, 1992, NEW ENGL J MED, V327, P707, DOI 10.1056/NEJM199209033271007; Gavin JR, 1997, DIABETES CARE, V20, P1183; Inoue K, 2009, DIABETIC MED, V26, P1175, DOI 10.1111/j.1464-5491.2009.02850.x; Inoue K, 2012, DIABETIC MED, V29, P1327; Inoue K, 2008, DIABETIC MED, V25, P1157, DOI 10.1111/j.1464-5491.2008.02572.x; Kuzuya T, 2002, DIABETES RES CLIN PR, V55, P65, DOI 10.1016/S0168-8227(01)00365-5; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Ollerton RL, 1999, DIABETES CARE, V22, P394, DOI 10.2337/diacare.22.3.394; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; Viera AJ, 2005, FAM MED, V37, P360; Young TK, 2001, CAN MED ASSOC J, V164, P24	18	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47747	10.1371/journal.pone.0047747	http://dx.doi.org/10.1371/journal.pone.0047747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082207	Green Submitted, gold, Green Published			2022-12-27	WOS:000311146900104
J	Leung, YY; Chang, CQ; Hung, YS				Leung, Yuk Yee; Chang, Chun Qi; Hung, Yeung Sam			An Integrated Approach for Identifying Wrongly Labelled Samples When Performing Classification in Microarray Data	PLOS ONE			English	Article							GENE-EXPRESSION; FEATURE-SELECTION; OUTLIER DETECTION; PROSTATE-CANCER; BREAST-CANCER; GROWTH-FACTOR; LUNG-CANCER; DISCOVERY; POLYMORPHISMS; PREDICTION	Background: Using hybrid approach for gene selection and classification is common as results obtained are generally better than performing the two tasks independently. Yet, for some microarray datasets, both classification accuracy and stability of gene sets obtained still have rooms for improvement. This may be due to the presence of samples with wrong class labels (i.e. outliers). Outlier detection algorithms proposed so far are either not suitable for microarray data, or only solve the outlier detection problem on their own. Results: We tackle the outlier detection problem based on a previously proposed Multiple-Filter-Multiple-Wrapper (MFMW) model, which was demonstrated to yield promising results when compared to other hybrid approaches (Leung and Hung, 2010). To incorporate outlier detection and overcome limitations of the existing MFMW model, three new features are introduced in our proposed MFMW-outlier approach: 1) an unbiased external Leave-One-Out Cross-Validation framework is developed to replace internal cross-validation in the previous MFMW model; 2) wrongly labeled samples are identified within the MFMW-outlier model; and 3) a stable set of genes is selected using an L1-norm SVM that removes any redundant genes present. Six binary-class microarray datasets were tested. Comparing with outlier detection studies on the same datasets, MFMW-outlier could detect all the outliers found in the original paper (for which the data was provided for analysis), and the genes selected after outlier removal were proven to have biological relevance. We also compared MFMW-outlier with PRAPIV (Zhang et al., 2006) based on same synthetic datasets. MFMW-outlier gave better average precision and recall values on three different settings. Lastly, artificially flipped microarray datasets were created by removing our detected outliers and flipping some of the remaining samples' labels. Almost all the 'wrong' (artificially flipped) samples were detected, suggesting that MFMW-outlier was sufficiently powerful to detect outliers in high-dimensional microarray datasets.	[Leung, Yuk Yee; Chang, Chun Qi; Hung, Yeung Sam] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Leung, Yuk Yee] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Leung, Yuk Yee] Univ Penn, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA	University of Hong Kong; University of Pennsylvania; University of Pennsylvania	Leung, YY (corresponding author), Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China.	yyleung@eee.hku.hk	Chang, CQ/C-1845-2009	Leung, Yuk Yee/0000-0002-3047-5440; Chang, Chunqi/0000-0003-1172-6491	Research Grants Council of the Hong Kong Special Administration Region, China (GRF) [HKU 710709E, HKU 762111M]; CRCG of the University of Hong Kong; NIA [U01-AG-032984-02, RC2-AG036528-01]; NATIONAL INSTITUTE ON AGING [RC2AG036528, U01AG032984] Funding Source: NIH RePORTER	Research Grants Council of the Hong Kong Special Administration Region, China (GRF); CRCG of the University of Hong Kong; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	YYL, YSH and CQC are supported by the Research Grants Council of the Hong Kong Special Administration Region, China (GRF projects HKU 710709E and HKU 762111M) and CRCG of the University of Hong Kong for their work in this paper. YYL is also supported by NIA (U01-AG-032984-02 and RC2-AG036528-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1998, J CLIN ONCOL, V16, P1397, DOI 10.1200/JCO.1998.16.4.1397; Aggarwal CC, 2001, SIGMOD RECORD, V30, P37; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; BOISSARD C, 1986, CANCER RES, V46, P4406; Borst L, 2012, J PEDIAT HEMATOL ONC, V34, P38, DOI 10.1097/MPH.0b013e3182346cdd; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Desmond JC, 2007, LEUKEMIA, V21, P1026, DOI 10.1038/sj.leu.2404611; DiLella AG, 2001, J HISTOCHEM CYTOCHEM, V49, P669, DOI 10.1177/002215540104900517; Dowdy SC, 2003, J BIOL CHEM, V278, P44377, DOI 10.1074/jbc.M307202200; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Dunlap J, 2012, HUM PATHOL IN PRESS; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Fedele M, 2005, ONCOGENE, V24, P3427, DOI 10.1038/sj.onc.1208501; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordon GJ, 2002, CANCER RES, V62, P4963; Grate LR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-97; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jenssen TK, 2005, LANCET, V365, P634; Kadota K., 2003, CHEM BIO INFORM J, V3, P30; Knorr E. M., 1998, Proceedings of the Twenty-Fourth International Conference on Very-Large Databases, P392; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Krizek P, 2007, LECT NOTES COMPUT SC, V4673, P929; Leung Y, 2010, IEEE ACM T COMPUT BI, V7, P108, DOI 10.1109/TCBB.2008.46; Leung YY, 2009, P 8 INT C COMP SYST, P32; Li T, 2004, BIOINFORMATICS, V20, P2429, DOI 10.1093/bioinformatics/bth267; Liekens AML, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r57; Lu XS, 2004, I C CONT AUTOMAT ROB, P1331; Ma HX, 2009, CANCER LETT, V273, P172, DOI 10.1016/j.canlet.2008.08.002; Malossini A, 2006, BIOINFORMATICS, V22, P2114, DOI 10.1093/bioinformatics/btl346; Manenti G, 1997, CARCINOGENESIS, V18, P1917, DOI 10.1093/carcin/18.10.1917; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Oshiro MM, 2005, BREAST CANCER RES, V7, pR669, DOI 10.1186/bcr1273; Pal P, 2006, HUM GENET, V120, P187, DOI 10.1007/s00439-006-0204-3; Quackenbush J, 2006, METHOD INFORM MED, V45, P91; Ramaswamy S, 2000, SIGMOD REC, V29, P427, DOI 10.1145/335191.335437; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Shetzline SE, 2004, BLOOD, V104, P1833, DOI 10.1182/blood-2003-10-3577; Shieh AD, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1426; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sontrop HMJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-389; Sra S, 2006, LECT NOTES COMPUT SC, V4212, P767; Unger G, 2008, IEEE ACM T COMPUT BI, V7, P375; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Yang AJ, 2010, BIOINFORMATICS, V26, P215, DOI 10.1093/bioinformatics/btp638; Zhang WS, 2006, BIOINFORMATICS, V22, P317, DOI 10.1093/bioinformatics/bti738; Zhou Y, 2011, COMM COM INF SC, V215, P513; Zhu J, 2004, ADV NEUR IN, V16, P49	53	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46700	10.1371/journal.pone.0046700	http://dx.doi.org/10.1371/journal.pone.0046700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082127	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900022
J	Penney, D; McNeil, A; Green, DI; Bradley, RS; Jepson, JE; Withers, PJ; Preziosi, RF				Penney, David; McNeil, Andrew; Green, David I.; Bradley, Robert S.; Jepson, James E.; Withers, Philip J.; Preziosi, Richard F.			Ancient Ephemeroptera-Collembola Symbiosis Fossilized in Amber Predicts Contemporary Phoretic Associations	PLOS ONE			English	Article							MAYFLIES EPHEMEROPTERA; GLOBAL DIVERSITY; INSECTA	X-ray computed tomography is used to identify a unique example of fossilized phoresy in 16 million-year-old Miocene Dominican amber involving a springtail being transported by a mayfly. It represents the first evidence (fossil or extant) of phoresy in adult Ephemeroptera and only the second record in Collembola (the first is also preserved in amber). This is the first record of Collembola using winged insects for dispersal. This fossil predicts the occurrence of similar behaviour in living springtails and helps explain the global distribution of Collembola today.	[Penney, David; Preziosi, Richard F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [McNeil, Andrew; Bradley, Robert S.; Withers, Philip J.] Univ Manchester, Manchester Xray Imaging Facil, Sch Mat, Manchester, Lancs, England; [Green, David I.; Jepson, James E.] Amgueddfa Cymru Natl Museum Wales, Dept Geol, Cardiff, S Glam, Wales; [Jepson, James E.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Penney, D (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	david.penney@manchester.ac.uk	Preziosi, Richard F/A-8626-2010; Withers, Phil/A-6760-2009; Bradley, Robert/X-1861-2019	Preziosi, Richard F/0000-0003-0468-6655; Withers, Phil/0000-0002-1946-5647; Jepson, James/0000-0003-3184-8277	Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council [EP/I02249X/1] Funding Source: researchfish; EPSRC [EP/I02249X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The Engineering and Physical Sciences Research Council are acknowledged for funding the Manchester X-Ray Imaging Facility at the University of Manchester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arillo A, 2007, GEOL ACTA, V5, P159; Avila-Jimenez Maria Luisa, 2011, Insects, V2, P273, DOI 10.3390/insects2030273; Barber-James HM, 2008, HYDROBIOLOGIA, V595, P339, DOI 10.1007/s10750-007-9028-y; Betz V, 2007, LAPIS, V32, P22; Boucot A.J., 2010, FOSSIL BEHAV COMPEND; BRITTAIN JE, 1982, ANNU REV ENTOMOL, V27, P119, DOI 10.1146/annurev.en.27.010182.001003; CHRISTIANSEN K, 1994, ORIENT INSECTS, V28, P309; Christiansen K., 1971, University of California Publications in Entomology, V63, P45; Davis Steven R., 2006, Transactions of the Kansas Academy of Science, V109, P191, DOI 10.1660/0022-8443(2006)109[191:DWIDAC]2.0.CO;2; Deharveng L, 2008, HYDROBIOLOGIA, V595, P329, DOI 10.1007/s10750-007-9116-z; Dunger W, 2002, PEDOBIOLOGIA, V46, P316, DOI 10.1078/0031-4056-00139; Dunlop JA, 2012, BIOL LETTERS, V8, P457, DOI 10.1098/rsbl.2011.0923; EPLER JH, 1986, FLA ENTOMOL, V69, P319, DOI 10.2307/3494936; Fiera C, 2012, BIOL J LINN SOC, V105, P498, DOI 10.1111/j.1095-8312.2011.01816.x; Gordh G, 2011, DICT ENTOMOLOGY; Iturralde-Vinent MA, 2001, CARIBB J SCI, V37, P141; Knecht RJ, 2011, P NATL ACAD SCI USA, V108, P6515, DOI 10.1073/pnas.1015948108; Monaghan MT, 2005, P ROY SOC B-BIOL SCI, V272, P1829, DOI 10.1098/rspb.2005.3139; MUTT JAM, 1983, P ENTOMOL SOC WASH, V85, P575; Ohl M, 2011, NATURWISSENSCHAFTEN, V98, P453, DOI 10.1007/s00114-011-0783-2; Penney D., 2010, BIODIVERSITY FOSSILS; Penney D., 2011, FOSSILS AMBER REMARK; Penney D, 2011, ZOOTAXA, P60; Perez-Gelabert DE, 2008, ZOOTAXA, P1; Poinar G.O., 2010, FOSSIL BEHAV COMPEND, P183; Poinar G, 2010, ANN SOC ENTOMOL FR, V46, P23, DOI 10.1080/00379271.2010.10697637; Poinar George O. Jr., 1998, Acta Arachnologica, V47, P79, DOI 10.2476/asjaa.47.79; Soldan T, 2012, MAYFL EUR EPH, DOI 10.1163/9789004260887; Staniczek Arnold H., 2003, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V341, P1; von Tschirnhaus Michael, 2009, Denisia, P171; Wichard W., 2009, AQUATIC INSECTS BALT; Willkommen J, 2007, ARTHROPOD STRUCT DEV, V36, P253, DOI 10.1016/j.asd.2007.01.003	32	17	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47651	10.1371/journal.pone.0047651	http://dx.doi.org/10.1371/journal.pone.0047651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082186	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000311146900083
J	Sun, XQ; Shen, HW; Cheng, XQ; Wang, ZY				Sun, Xiao-Qian; Shen, Hua-Wei; Cheng, Xue-Qi; Wang, Zhao-Yang			Degree-Strength Correlation Reveals Anomalous Trading Behavior	PLOS ONE			English	Article							STOCK-PRICE MANIPULATION; MARKET; NETWORKS; INDEX	Manipulation is an important issue for both developed and emerging stock markets. Many efforts have been made to detect manipulation in stock markets. However, it is still an open problem to identify the fraudulent traders, especially when they collude with each other. In this paper, we focus on the problem of identifying the anomalous traders using the transaction data of eight manipulated stocks and forty-four non-manipulated stocks during a one-year period. By analyzing the trading networks of stocks, we find that the trading networks of manipulated stocks exhibit significantly higher degree-strength correlation than the trading networks of non-manipulated stocks and the randomized trading networks. We further propose a method to detect anomalous traders of manipulated stocks based on statistical significance analysis of degree-strength correlation. Experimental results demonstrate that our method is effective at distinguishing the manipulated stocks from non-manipulated ones. Our method outperforms the traditional weight-threshold method at identifying the anomalous traders in manipulated stocks. More importantly, our method is difficult to be fooled by colluded traders.	[Sun, Xiao-Qian; Shen, Hua-Wei; Cheng, Xue-Qi; Wang, Zhao-Yang] Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Computing Technology, CAS	Cheng, XQ (corresponding author), Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China.	cxq@ict.ac.cn	Cheng, Xueqi/F-1706-2010; Shen, Hua-Wei/E-8028-2010	Shen, Hua-Wei/0000-0002-1081-8119	National Natural Science Foundation of China [60933005, 61202215]; National Basic Research Program of China (973 program) [2012CB316303]; Beijing Natural Science Foundation [4122077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was funded by the National Natural Science Foundation of China under grant number 60933005, 61202215 and the National Basic Research Program of China (973 program) under grant number 2012CB316303. This work was also partly funded by the Beijing Natural Science Foundation under grant number 4122077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2006, J BUS, V79, P1915, DOI 10.1086/503652; Alber R, 2002, REV MODERN PHYS, V74; ALLEN F, 1992, REV FINANC STUD, V5, P503, DOI 10.1093/rfs/5.3.503; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bommel JV, 2004, J FINANC, V58; Chakraborty A, 2004, J ECON THEORY, V114, P132, DOI 10.1016/S0022-0531(03)00101-7; JARROW RA, 1992, J FINANC QUANT ANAL, V27, P311, DOI 10.2307/2331322; Jiang ZQ, 2010, PHYSICA A, V389, P4929, DOI 10.1016/j.physa.2010.07.024; Kucukkocao, 2008, FRONTIERS FINANCE EC, V5, P46; Li P, 2006, CHINESE SCI BULL, V51, P624, DOI 10.1007/s11434-006-0624-4; Li P, 2007, PHYSICA A, V378, P519, DOI 10.1016/j.physa.2006.10.089; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Ogut H, 2009, EXPERT SYST APPL, V36, P11944, DOI 10.1016/j.eswa.2009.03.065; Onnela JP, 2004, EUR PHYS J B, V38, P353, DOI 10.1140/epjb/e2004-00128-7; Palshikar GK, 2008, DATA MIN KNOWL DISC, V16, P135, DOI 10.1007/s10618-007-0076-8; Palshikar GK, 2000, P INT C ADV DAT COMA; Piccardi C, 2010, PHYSICA A, V389, P5247, DOI 10.1016/j.physa.2010.06.038; Qiu T, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043057; Shen HW, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056111; Shen HW, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016114; Shen HW, 2009, PHYSICA A, V388, P1706, DOI 10.1016/j.physa.2008.12.021; Sun XQ, 2011, PHYSICA A, V390, P3427, DOI 10.1016/j.physa.2011.04.006; Sun XQ, 2010, PHYSCS PROC, V3, P1699, DOI 10.1016/j.phpro.2010.07.008; Tumminello M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013041; Tumminello M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017994; Vikram SV, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016101	26	14	15	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e45598	10.1371/journal.pone.0045598	http://dx.doi.org/10.1371/journal.pone.0045598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082114	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900009
J	Firat, E; Weyerbrock, A; Gaedicke, S; Grosu, AL; Niedermann, G				Firat, Elke; Weyerbrock, Astrid; Gaedicke, Simone; Grosu, Anca-Ligia; Niedermann, Gabriele			Chloroquine or Chloroquine-PI3K/Akt Pathway Inhibitor Combinations Strongly Promote gamma-Irradiation-Induced Cell Death in Primary Stem-Like Glioma Cells	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMA; AKT INHIBITION; RADIATION; AUTOPHAGY; APOPTOSIS; RADIOSENSITIVITY; RADIORESISTANCE; RADIOTHERAPY; TEMOZOLOMIDE	We asked whether inhibitors of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, which is highly active in cancer stem cells (CSCs) and upregulated in response to genotoxic treatments, promote gamma-irradiation gamma IR)-induced cell death in highly radioresistant, patient-derived stem-like glioma cells (SLGCs). Surprisingly, in most cases the inhibitors did not promote gamma IR-induced cell death. In contrast, the strongly cytostatic Ly294002 and PI-103 even tended to reduce it. Since autophagy was induced we examined whether addition of the clinically applicable autophagy inhibitor chloroquine (CQ) would trigger cell death in SLGCs. Triple therapy with CQ at doses as low as 5 to 10 mu M indeed caused strong apoptosis. At slightly higher doses, CQ alone strongly promoted gamma IR-induced apoptosis in all SLGC lines examined. The strong apoptosis in combinations with CQ was invariably associated with strong accumulation of the autophagosomal marker LC3-II,indicating inhibition of late autophagy. Thus, autophagy-promoting effects of PI3K/Akt pathway inhibitors apparently hinder cell death induction in gamma-irradiated SLGCs. However, as we show here for the first time, the late autophagy inhibitor CQ strongly promotes gamma IR-induced cell death in highly radioresistant CSCs, and triple combinations of CQ, gamma IR and a PI3K/Akt pathway inhibitor permit reduction of the CQ dose required to trigger cell death.	[Firat, Elke; Gaedicke, Simone; Grosu, Anca-Ligia; Niedermann, Gabriele] Univ Hosp Freiburg, Dept Radiat Oncol, Freiburg, Germany; [Weyerbrock, Astrid] Univ Hosp Freiburg, Dept Neurosurg, Freiburg, Germany	University of Freiburg; University of Freiburg	Niedermann, G (corresponding author), Univ Hosp Freiburg, Dept Radiat Oncol, Freiburg, Germany.	gabriele.niedermann@uniklinik-freiburg.de	Weyerbrock, Astrid/AAI-1731-2020; Weyerbrock, Astrid/E-8493-2014	Weyerbrock, Astrid/0000-0001-9060-4462; 	Clotten Foundation	Clotten Foundation	This research was supported by a grant from the Clotten Foundation to GN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELUSI SA, 1982, J PHARM PHARMACOL, V34, P733, DOI 10.1111/j.2042-7158.1982.tb06211.x; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Briceno Eduardo, 2003, Neurosurg Focus, V14, pe3; Chautard E, 2010, NEURO-ONCOLOGY, V12, P434, DOI 10.1093/neuonc/nop059; Chen JS, 2008, MOL CANCER THER, V7, P841, DOI 10.1158/1535-7163.MCT-07-0393; Cheng CK, 2009, BRAIN PATHOL, V19, P112, DOI 10.1111/j.1750-3639.2008.00233.x; Cooper RG, 2008, INDIAN J MED RES, V127, P305; de la Pena L, 2006, MOL CANCER THER, V5, P1504, DOI 10.1158/1535-7163.MCT-06-0091; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; DJORDJEVIC B, 1992, RADIAT RES, V130, P267, DOI 10.2307/3578284; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Fan QW, 2011, CURR TOP MICROBIOL, V347, P279, DOI 10.1007/82_2010_67; Firat E, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-71; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Guillard S, 2009, CELL CYCLE, V8, P443, DOI 10.4161/cc.8.3.7643; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Janku F., 2011, NAT REV CLIN ONCOL; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim EL, 2010, NEURO-ONCOLOGY, V12, P389, DOI 10.1093/neuonc/nop046; Kim MJ, 2008, MOL CANCER RES, V6, P1872, DOI 10.1158/1541-7786.MCR-08-0084; Kogel D, 2010, ANTI-CANCER AGENT ME, V10, P438, DOI 10.2174/1871520611009060438; Lathia JD, 2011, STEM CELL REV REP, V7, P227, DOI 10.1007/s12015-010-9194-6; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lipani JD, 2008, TECHNOL CANCER RES T, V7, P249, DOI 10.1177/153303460800700311; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Maugeri-Sacca M, 2011, CLIN CANCER RES, V17, P4942, DOI 10.1158/1078-0432.CCR-10-2538; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mzayek F, 2007, PLOS CLIN TRIALS E, pe6; Paglin S, 2001, CANCER RES, V61, P439; Perry J, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/428565; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Prevo R, 2008, CANCER RES, V68, P5915, DOI 10.1158/0008-5472.CAN-08-0757; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Yang S, GENES DEV, V25, P717; Zaidi AU, 2001, J NEUROPATH EXP NEUR, V60, P937, DOI 10.1093/jnen/60.10.937; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhao H, 2005, RADIAT RES, V164, P250, DOI 10.1667/RR3436.1	48	66	72	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47357	10.1371/journal.pone.0047357	http://dx.doi.org/10.1371/journal.pone.0047357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091617	Green Submitted, gold, Green Published			2022-12-27	WOS:000310135800040
J	Parsa, S; Kondo, T; Winotai, A				Parsa, Soroush; Kondo, Takumasa; Winotai, Amporn			The Cassava Mealybug (Phenacoccus manihoti) in Asia: First Records, Potential Distribution, and an Identification Key	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; HOMOPTERA; PSEUDOCOCCIDAE; TEMPERATURE; POPULATION; PEST; PREDICTION; MANAGEMENT; HEMIPTERA; INVASIONS	Phenacoccus manihoti Matile-Ferrero (Hemiptera: Pseudococcidae), one of the most serious pests of cassava worldwide, has recently reached Asia, raising significant concern over its potential spread throughout the region. To support management decisions, this article reports recent distribution records, and estimates the climatic suitability for its regional spread using a CLIMEX distribution model. The article also presents a taxonomic key that separates P. manihoti from all other mealybug species associated with the genus Manihot. Model predictions suggest P. manihoti imposes an important, yet differential, threat to cassava production in Asia. Predicted risk is most acute in the southern end of Karnataka in India, the eastern end of the Ninh Thuan province in Vietnam, and in most of West Timor in Indonesia. The model also suggests P. manihoti is likely to be limited by cold stress across Vietnam's northern regions and in the entire Guangxi province in China, and by high rainfall across the wet tropics in Indonesia and the Philippines. Predictions should be particularly important to guide management decisions for high risk areas where P. manihoti is absent (e. g., India), or where it has established but populations remain small and localized (e. g., South Vietnam). Results from this article should help decision-makers assess site-specific risk of invasion, and develop proportional prevention and surveillance programs for early detection and rapid response.	[Parsa, Soroush] CIAT, Cali, Colombia; [Kondo, Takumasa] Corp Colombiana Invest Agr CORPOICA, Ctr Invest Palmira, Palmira, Valle, Colombia; [Winotai, Amporn] Dept Agr, Plant Protect Res & Dev Off, Entomol & Zool Grp, Bangkok, Thailand	Alliance; International Center for Tropical Agriculture - CIAT; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Ministry of Agriculture & Cooperatives - Thailand	Parsa, S (corresponding author), CIAT, Cali, Colombia.	s.parsa@cgiar.org			Roots, Tubers, and Bananas for Food Security and Income Research Program of the Consultative Group on International Agricultural Research (CGIAR)	Roots, Tubers, and Bananas for Food Security and Income Research Program of the Consultative Group on International Agricultural Research (CGIAR)	The research was funded by the Roots, Tubers, and Bananas for Food Security and Income Research Program of the Consultative Group on International Agricultural Research (CGIAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellotti AC, 1999, ANNU REV ENTOMOL, V44, P343, DOI 10.1146/annurev.ento.44.1.343; Bellotti A, 2012, TROP PLANT BIOL, V5, P39, DOI 10.1007/s12042-011-9091-4; Ben-Dov Y, 2012, SCALENET DATABASE SC; CABI-Plantwise, 2012, CASS MEAL PHEN MAN F; Calatayud P.A., 2006, CASSAVA MEALYBUG INT; CALATAYUD PA, 1994, B ENTOMOL RES, V84, P453, DOI 10.1017/S0007485300032673; COX JM, 1981, B ENTOMOL RES, V71, P247, DOI 10.1017/S0007485300008270; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Frison E. A., 1991, FAO IBPGR TECHNICAL; GUTIERREZ AP, 1988, J APPL ECOL, V25, P921, DOI 10.2307/2403755; HENNESSEY RD, 1990, TROP PEST MANAGE, V36, P103, DOI 10.1080/09670879009371451; HERREN HR, 1991, ANNU REV ENTOMOL, V36, P257, DOI 10.1146/annurev.en.36.010191.001353; Herren HR, 1983, BIOL CONTR HOST PLAN; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IHEAGWAM E U, 1981, Revue de Zoologie Africaine, V95, P959; IHEAGWAM EU, 1983, DEUT ENTOMOL Z, V30, P17; Jones PG, 2000, AGRON J, V92, P445, DOI 10.2134/agronj2000.923445x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Kriticos DJ, 2011, METHODS ECOL EVOL; LEMA KM, 1985, ENTOMOL EXP APPL, V38, P165, DOI 10.1007/BF00361928; LERU B, 1990, ACTA OECOL, V11, P741; LERU B, 1987, ACTA OECOL-OEC APPL, V8, P165; Leuschner K., 1977, P CASS PROT WORKSH C, P195; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; LOHR B, 1990, B ENTOMOL RES, V80, P417, DOI 10.1017/S0007485300050677; Malumphy Chris, 2005, Entomologist's Gazette, V56, P53; MATILEFERRERO D, 1977, ANN SOC ENTOMOL FR, V13, P145; Minko D. Obame, 2009, Tropicultura, V27, P21; Muniappan R, 2009, J AGR URBAN ENTOMOL, V26, P167, DOI 10.3954/1523-5475-26.4.167; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; NEUENSCHWANDER P, 1988, PHILOS T ROY SOC B, V318, P319, DOI 10.1098/rstb.1988.0012; Neuenschwander P, 2001, BIOL CONTROL, V21, P214, DOI 10.1006/bcon.2001.0937; NORGAARD RB, 1988, AM J AGR ECON, V70, P366, DOI 10.2307/1242077; NWANZE KF, 1982, TROP PEST MANAGE, V28, P27, DOI 10.1080/09670878209370669; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; SCHULTHESS F, 1987, INSECT SCI APPL, V8, P851, DOI 10.1017/S1742758400023055; Sutherst RW, 2007, GLOBAL CHANGE BIOL, V13, P1843, DOI 10.1111/j.1365-2486.2007.01396.x; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Sutherst RW, 2000, AGR ECOSYST ENVIRON, V82, P303, DOI 10.1016/S0167-8809(00)00234-6; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Williams D., 1992, MEALYBUGS CENTRAL S; Williams D.J., 2004, MEALYBUGS SO ASIA; Williams DJ, 1981, BIOCONTROL NEWS INF, V2, P146; Winotai W., 2010, BIOCONTROL NEWS INFO, V31, p10N; Wittenberg R, 2001, INVASIVE ALIEN SPECI; [武三安 Wu Sanan], 2011, [环境昆虫学报, Journal of Environmental Entomology], V33, P122; Yaseen M, 1982, BIOL CONTR HOST PLAN, P81; Zeddies J, 2001, AGR ECON, V24, P209, DOI 10.1111/j.1574-0862.2001.tb00024.x	56	35	39	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47675	10.1371/journal.pone.0047675	http://dx.doi.org/10.1371/journal.pone.0047675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077659	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100152
J	Adams, RA; Perrinet, LU; Friston, KJ				Adams, Rick A.; Perrinet, Laurent U.; Friston, Karl J.			Smooth Pursuit and Visual Occlusion: Active Inference and Oculomotor Control in Schizophrenia	PLOS ONE			English	Article							CORTICAL NETWORK MODEL; WORKING-MEMORY; EYE-MOVEMENTS; PREFRONTAL CORTEX; TRANSIENT DISAPPEARANCE; SENSORY CONSEQUENCES; DOPAMINE MODULATION; MOTION SIGNALS; MOTOR CONTROL; TRACKING	This paper introduces a model of oculomotor control during the smooth pursuit of occluded visual targets. This model is based upon active inference, in which subjects try to minimise their (proprioceptive) prediction error based upon posterior beliefs about the hidden causes of their (exteroceptive) sensory input. Our model appeals to a single principle - the minimisation of variational free energy - to provide Bayes optimal solutions to the smooth pursuit problem. However, it tries to accommodate the cardinal features of smooth pursuit of partially occluded targets that have been observed empirically in normal subjects and schizophrenia. Specifically, we account for the ability of normal subjects to anticipate periodic target trajectories and emit pre-emptive smooth pursuit eye movements - prior to the emergence of a target from behind an occluder. Furthermore, we show that a single deficit in the postsynaptic gain of prediction error units (encoding the precision of posterior beliefs) can account for several features of smooth pursuit in schizophrenia: namely, a reduction in motor gain and anticipatory eye movements during visual occlusion, a paradoxical improvement in tracking unpredicted deviations from target trajectories and a failure to recognise and exploit regularities in the periodic motion of visual targets. This model will form the basis of subsequent (dynamic causal) models of empirical eye tracking measurements, which we hope to validate, using psychopharmacology and studies of schizophrenia.	[Adams, Rick A.; Perrinet, Laurent U.; Friston, Karl J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Perrinet, Laurent U.] Aix Marseille Univ, Inst Neurosci Timone, CNRS, Marseille, France	University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Adams, RA (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, Queen Sq, London, England.	rick.adams@ucl.ac.uk	Friston, Karl/D-9230-2011; Adams, Rick/M-7640-2015; Perrinet, Laurent U./C-4900-2009	Friston, Karl/0000-0001-7984-8909; Adams, Rick/0000-0002-7661-8881; Perrinet, Laurent U./0000-0002-9536-010X	Wellcome Trust [088130/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Wellcome Trust (http://www.wellcome.ac.uk/) Program grant to KJF (088130/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Allen AJ, 2009, SCHIZOPHR RES, V109, P24, DOI 10.1016/j.schres.2009.01.016; Avila MT, 2006, J NEUROPHYSIOL, V95, P593, DOI 10.1152/jn.00369.2005; BALLARD DH, 1983, NATURE, V306, P21, DOI 10.1038/306021a0; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Beal Matthew James, 2003, VARIATIONAL ALGORITH; BECKER W, 1985, EXP BRAIN RES, V57, P562; Bennett SJ, 2003, J NEUROPHYSIOL, V90, P2504, DOI 10.1152/jn.01145.2002; Bialek W, 2001, NEURAL COMPUT, V13, P2409, DOI 10.1162/089976601753195969; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Calkins ME, 2008, BRAIN COGNITION, V68, P436, DOI 10.1016/j.bandc.2008.09.001; Chen Y, 1999, ARCH GEN PSYCHIAT, V56, P155, DOI 10.1001/archpsyc.56.2.155; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Corlett PR, 2010, NEUROPSYCHOPHARMACOL; DAYAN P, 1995, NEURAL COMPUT, V7, P889, DOI 10.1162/neco.1995.7.5.889; de Xivry JJO, 2006, J NEUROPHYSIOL, V95, P418, DOI 10.1152/jn.00596.2005; Durstewitz D, 1999, J NEUROSCI, V19, P2807; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; FELDMAN AG, 1995, BEHAV BRAIN SCI, V18, P723, DOI 10.1017/S0140525X0004070X; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Friston K, 2011, NEURON, V72, P488, DOI 10.1016/j.neuron.2011.10.018; Friston KJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002327; Friston KJ, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/937860; Friston KJ, 2011, BIOL CYBERN, V104, P137, DOI 10.1007/s00422-011-0424-z; Friston KJ, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/621670; Friston KJ, 2010, BIOL CYBERN, V102, P227, DOI 10.1007/s00422-010-0364-z; Friston KJ, 2009, NEURAL NETWORKS, V22, P1093, DOI 10.1016/j.neunet.2009.07.023; Friston KJ, 2009, TRENDS COGN SCI, V13, P293, DOI 10.1016/j.tics.2009.04.005; Friston KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006421; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Friston KJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000211; Friston KJ, 2005, BEHAV BRAIN SCI, V28, P764, DOI 10.1017/S0140525X05290131; Friston KJ, 2003, NEURAL NETWORKS, V16, P1325, DOI 10.1016/j.neunet.2003.06.005; Frith CD, 1992, COGNITIVE NEUROPSYCH, Vxiv; GINZBURG VL, 1955, NUOVO CIMENTO, V2, P1235; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Gray JA, 1998, SCHIZOPHRENIA BULL, V24, P249, DOI 10.1093/oxfordjournals.schbul.a033324; GRAY JA, 1991, BEHAV BRAIN SCI, V14, P1, DOI 10.1017/S0140525X00065055; GREGORY RL, 1980, PHILOS T ROY SOC B, V290, P181, DOI 10.1098/rstb.1980.0090; Grossberg S, 1997, J NEUROSCI, V17, P9706; Haken H, 1983, SYNERGETICS INTRO AD; Hong LE, 2008, BIOL PSYCHIAT, V63, P458, DOI 10.1016/j.biopsych.2007.06.004; Hong LE, 2009, BIOL PSYCHIAT, V65, P1079, DOI 10.1016/j.biopsych.2008.10.021; Hong LE, 2006, ARCH GEN PSYCHIAT, V63, P259, DOI 10.1001/archpsyc.63.3.259; Hong LE, 2005, EXP BRAIN RES, V165, P125, DOI 10.1007/s00221-005-2276-z; Hong LE, 2005, BIOL PSYCHIAT, V57, P726, DOI 10.1016/j.biopsych.2004.12.015; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Hutton S, 1998, NEUROLOGY, V50, P604, DOI 10.1212/WNL.50.3.604; Hutton SB, 1998, PSYCHOL MED, V28, P685, DOI 10.1017/S0033291798006722; Jones SH, 1997, BEHAV BRAIN RES, V88, P103, DOI 10.1016/S0166-4328(97)02312-7; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kattoulas E, 2011, EXP BRAIN RES, V215, P207, DOI 10.1007/s00221-011-2887-5; Kattoulas E, 2011, EXP BRAIN RES, V215, P219, DOI 10.1007/s00221-011-2888-4; Kiebel Stefan J, 2009, Front Neuroinform, V3, P20, DOI 10.3389/neuro.11.020.2009; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Krauzlis RJ, 1989, NEURAL COMPUT, V1, P116, DOI 10.1162/neco.1989.1.1.116; Laruelle M, 2003, ANN NY ACAD SCI, V1003, P138, DOI 10.1196/annals.1300.063; Lencer R, 2008, BRAIN COGNITION, V68, P219, DOI 10.1016/j.bandc.2008.08.013; LEVY DL, 1993, SCHIZOPHRENIA BULL, V19, P461, DOI 10.1093/schbul/19.3.461; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Maloney LT, 2010, VISION RES, V50, P2362, DOI 10.1016/j.visres.2010.09.031; Moutoussis M, 2011, COGN NEUROPSYCHIATRY, V16, P422, DOI 10.1080/13546805.2010.548678; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Nkam I, 2010, BIOL PSYCHIAT, V67, P992, DOI 10.1016/j.biopsych.2009.11.029; O'Driscoll GA, 2008, BRAIN COGNITION, V68, P359, DOI 10.1016/j.bandc.2008.08.023; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; ROBINSON DA, 1986, BIOL CYBERN, V55, P43, DOI 10.1007/BF00363977; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Schneider U, 2002, SCHIZOPHR RES, V53, P101, DOI 10.1016/S0920-9964(00)00172-9; Schnell K, 2008, BRAIN, V131, P2783, DOI 10.1093/brain/awn184; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Shibata T, 2005, NEURAL NETWORKS, V18, P213, DOI 10.1016/j.neunet.2005.01.001; Smyrnis N, 2007, EXP BRAIN RES, V179, P397, DOI 10.1007/s00221-006-0797-8; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Synofzik M, 2010, BRAIN, V133, P262, DOI 10.1093/brain/awp291; Thaker GK, 1998, ARCH GEN PSYCHIAT, V55, P830, DOI 10.1001/archpsyc.55.9.830; Thaker GK, 2003, PSYCHOPHYSIOLOGY, V40, P277, DOI 10.1111/1469-8986.00029; Thaker GK, 1999, PSYCHIAT RES, V88, P209, DOI 10.1016/S0165-1781(99)00084-0; Thakkar KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027089; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Voss M, 2010, BRAIN, V133, P3104, DOI 10.1093/brain/awq152; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Williams LE, 2010, SCHIZOPHR RES, V121, P101, DOI 10.1016/j.schres.2009.10.021; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	92	54	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47502	10.1371/journal.pone.0047502	http://dx.doi.org/10.1371/journal.pone.0047502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	026GL	23110076	gold, Green Published, Green Submitted			2022-12-27	WOS:000310262500013
J	Cho, LY; Yang, JJ; Ko, KP; Ma, SH; Shin, A; Choi, BY; Han, DS; Song, KS; Kim, YS; Chang, SH; Shin, HR; Kang, D; Yoo, KY; Park, SK				Cho, Lisa Y.; Yang, Jae Jeong; Ko, Kwang-Pil; Ma, Seung Hyun; Shin, Aesun; Choi, Bo Youl; Han, Dong Soo; Song, Kyu Sang; Kim, Yong Sung; Chang, Soung-Hoon; Shin, Hai-Rim; Kang, Daehee; Yoo, Keun-Young; Park, Sue K.			Genetic Susceptibility Factors on Genes Involved in the Steroid Hormone Biosynthesis Pathway and Progesterone Receptor for Gastric Cancer Risk	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; HUMAN BREAST-CANCER; SINGLE-NUCLEOTIDE POLYMORPHISMS; TISSUE-SPECIFIC EXPRESSION; REPRODUCTIVE FACTORS; POSTMENOPAUSAL WOMEN; PROSTATE-CANCER; AROMATASE GENE; SEX-HORMONES; QUANTITATIVE-ANALYSIS	Background: The objective of the study was to investigate the role of genes (HSD3B1, CYP17A1, CYP19A1, HSD17B2, HSD17B1) involved in the steroid hormone biosynthesis pathway and progesterone receptor (PGR) in the etiology of gastric cancer in a population-based two-phase genetic association study. Methods: In the discovery phase, 108 candidate SNPs in the steroid hormone biosynthesis pathway related genes and PGR were analyzed in 76 gastric cancer cases and 322 controls in the Korean Multi-Center Cancer Cohort. Statistically significant SNPs identified in the discovery phase were re-evaluated in an extended set of 386 cases and 348 controls. Pooled-and meta-analyses were conducted to summarize the results. Results: Of the 108 SNPs in steroid hormone biosynthesis pathway related genes and PGR analyzed in the discovery phase, 23 SNPs in PGR in the recessive model and 10 SNPs in CYP19A1 in the recessive or additive models were significantly associated with increased gastric cancer risk (p<0.05). The minor allele frequencies of the SNPs in both the discovery and extension phases were not statistically different. Pooled-and meta-analyses showed CYP19A1 rs1004982, rs16964228, and rs1902580 had an increased risk for gastric cancer (pooled OR [95% CI] = 1.22 [1.01-1.48], 1.31 [1.03-1.66], 3.03 [1.12-8.18], respectively). In contrast, all PGR SNPs were not statistically significantly associated with gastric cancer risk. Conclusions: Our findings suggest CYP19A1 that codes aromatase may play an important role in the association of gastric cancer risk and be a genetic marker for gastric cancer susceptibility.	[Cho, Lisa Y.; Yang, Jae Jeong; Ma, Seung Hyun; Kang, Daehee; Yoo, Keun-Young; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Cho, Lisa Y.; Yang, Jae Jeong; Ma, Seung Hyun; Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Ko, Kwang-Pil] Gachon Univ, Grad Sch Med, Dept Prevent Med, Inchon, South Korea; [Shin, Aesun] Natl Canc Ctr, Res Inst, Mol Epidemiol Branch, Goyang Si, South Korea; [Choi, Bo Youl] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Han, Dong Soo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea; [Song, Kyu Sang] Chungnam Natl Univ, Coll Med, Dept Pathol, Taejon, South Korea; [Kim, Yong Sung] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea; [Chang, Soung-Hoon] Konkuk Univ, Dept Prevent Med, Chungju, South Korea; [Shin, Hai-Rim] Natl Canc Ctr, Canc Epidemiol Branch, Goyang Si, South Korea; [Shin, Hai-Rim] WHO, Western Pacific Reg Off, Non Communicable Dis & Hlth Promot, Manila, Philippines; [Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Gachon University; National Cancer Center - Korea (NCC); Hanyang University; Hanyang University; Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Konkuk University; Konkuk University Medical Center; National Cancer Center - Korea (NCC); WHO Western Pacific Regional Office; World Health Organization; Seoul National University (SNU)	Park, SK (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	suepark@snu.ac.kr	Han, Dong Soo/P-1753-2015; Shin, Aesun/E-9145-2014; Han, Dong Soo/AHD-6285-2022; Park, Sue Kyung/J-2757-2012; Yoo, Keun-Young/J-5548-2012	Shin, Aesun/0000-0002-6426-1969; Han, Dong Soo/0000-0001-7103-3318; Kang, Daehee/0000-0003-4031-5878	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [0520140]; National Research Foundation of Korea; Ministry of Education, Science and Technology [NRF-2009-353-0066258, 2011-0001564]; Basic Research Laboratory (BRL) program through the National Research Foundation of Korea	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Research Laboratory (BRL) program through the National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from (1) the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (0520140); (2) the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology [NRF-2009-353-0066258]; and (3) the Basic Research Laboratory (BRL) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology [2011-0001564]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Al Sarakbi W, 2006, ANTICANCER RES, V26, P4985; Ashton KA, 2010, CANCER EPIDEMIOL, V34, P328, DOI 10.1016/j.canep.2010.03.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brodie A, 1997, J STEROID BIOCHEM, V61, P281; Bulun SE, 2003, J STEROID BIOCHEM, V86, P219, DOI 10.1016/S0960-0760(03)00359-5; Cai H, 2008, PHARMACOGENET GENOM, V18, P657, DOI 10.1097/FPC.0b013e3282fe3326; Camargo MC, 2012, CANCER EPIDEM BIOMAR, V21, P20, DOI 10.1158/1055-9965.EPI-11-0834; Canzian F, 2010, HUM MOL GENET, V19, P3873, DOI 10.1093/hmg/ddq291; Cho LY, 2009, ANN EPIDEMIOL, V19, P644, DOI 10.1016/j.annepidem.2009.04.011; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; Duell EJ, 2010, AM J EPIDEMIOL, V172, P1384, DOI 10.1093/aje/kwq321; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Ferlay J, 2010, IARC CANCERBASE, V10; Fernandez E, 2003, INT J CANCER, V105, P408, DOI 10.1002/ijc.11083; Freedman ND, 2007, GUT, V56, P1671, DOI 10.1136/gut.2007.129411; Freedman ND, 2009, CARCINOGENESIS, V30, P71, DOI 10.1093/carcin/bgn258; Frise S, 2006, ANN EPIDEMIOL, V16, P908, DOI 10.1016/j.annepidem.2006.03.001; FURUKAWA H, 1982, CANCER RES, V42, P5181; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goodman MT, 2008, ENDOCR-RELAT CANCER, V15, P1055, DOI 10.1677/ERC-08-0104; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; HARADA N, 1993, P NATL ACAD SCI USA, V90, P11312, DOI 10.1073/pnas.90.23.11312; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Heuch I, 2000, CANCER CAUSE CONTROL, V11, P869, DOI 10.1023/A:1008975817061; Heuch I, 2003, INT J CANCER, V106, P982, DOI 10.1002/ijc.11291; Ikeda S, 2008, AM J GASTROENTEROL, V103, P1476, DOI 10.1111/j.1572-0241.2008.01810.x; Inoue M, 2002, INT J CANCER, V97, P833, DOI 10.1002/ijc.10149; Irahara N, 2006, INT J CANCER, V118, P1915, DOI 10.1002/ijc.21562; Irahara N, 2006, CANCER LETT, V243, P23, DOI 10.1016/j.canlet.2005.11.010; Izawa M, 2008, GASTRIC CANCER, V11, P103, DOI 10.1007/s10120-008-0463-x; Jacobs E, 1997, EUR J CANCER, V33, P1130, DOI 10.1016/S0959-8049(97)00070-1; Justenhoven C, 2008, BREAST CANCER RES TR, V108, P137, DOI 10.1007/s10549-007-9586-8; Kaneko S, 2003, CANCER CAUSE CONTROL, V14, P53, DOI 10.1023/A:1022596104796; Karat D, 1999, BRIT J CANCER, V80, P1271, DOI 10.1038/sj.bjc.6690497; Katoh M, 2003, INT J MOL MED, V12, P3; Kim JY, 2009, ONCOL REP, V22, P487, DOI 10.3892/or_0000461; Kominea A, 2004, J CANCER RES CLIN, V130, P253, DOI 10.1007/s00432-003-0531-x; LAVECCHIA C, 1993, INT J CANCER, V53, P215, DOI 10.1002/ijc.2910530207; LAVECCHIA C, 1994, INT J CANCER, V59, P761, DOI 10.1002/ijc.2910590609; Lindblad M, 2006, BRIT J CANCER, V94, P136, DOI 10.1038/sj.bjc.6602906; Low YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001012; Ma XY, 2010, BREAST CANCER RES TR, V122, P495, DOI 10.1007/s10549-009-0693-6; MACAULAY VM, 1994, BRIT J CANCER, V69, P77, DOI 10.1038/bjc.1994.12; MAHENDROO MS, 1991, J BIOL CHEM, V266, P11276; Ohtani M, 2007, CARCINOGENESIS, V28, P2597, DOI 10.1093/carcin/bgm150; PALLI D, 1994, INT J CANCER, V56, P812, DOI 10.1002/ijc.2910560609; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Persson C, 2008, EUR J CANCER PREV, V17, P345, DOI 10.1097/CEJ.0b013e3282f521e4; Pricci M, 2001, ANTICANCER RES, V21, P3215; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Simpson E R, 1994, Int J Fertil Menopausal Stud, V39 Suppl 2, P75; Sipponen Pentti, 2002, Gastric Cancer, V5, P213, DOI 10.1007/s101200200037; Sissung TM, 2011, J CLIN ENDOCR METAB, V96, pE368, DOI 10.1210/jc.2010-2070; Sonoda T, 2010, EUR J CANCER PREV, V19, P131, DOI 10.1097/CEJ.0b013e328333fbe2; Takano N, 2002, CANCER LETT, V176, P129, DOI 10.1016/S0304-3835(01)00739-X; Tsuchiya Y, 2005, CANCER LETT, V227, P115, DOI 10.1016/j.canlet.2004.10.007; Ueyama T, 2002, ENDOCRINOLOGY, V143, P3162, DOI 10.1210/en.143.8.3162; Utsumi T, 1996, J CLIN ENDOCR METAB, V81, P2344, DOI 10.1210/jc.81.6.2344; Wang H, 2011, MOL HUM REPROD, V17, P386, DOI 10.1093/molehr/gar007; WU CW, 1992, GASTROENTEROLOGY, V102, P1639, DOI 10.1016/0016-5085(92)91724-I; WU CW, 1990, CANCER, V65, P1396, DOI 10.1002/1097-0142(19900315)65:6<1396::AID-CNCR2820650625>3.0.CO;2-2; Yang HP, 2010, CARCINOGENESIS, V31, P827, DOI 10.1093/carcin/bgp328; Yoo Keun Young, 2002, Asian Pac J Cancer Prev, V3, P85	64	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47603	10.1371/journal.pone.0047603	http://dx.doi.org/10.1371/journal.pone.0047603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110082	Green Published, gold, Green Submitted			2022-12-27	WOS:000310193600018
J	Bond, CE; Umapathy, A; Buttenshaw, RL; Wockner, L; Leggett, BA; Whitehall, VLJ				Bond, Catherine E.; Umapathy, Aarti; Buttenshaw, Ron L.; Wockner, Leesa; Leggett, Barbara A.; Whitehall, Vicki L. J.			Chromosomal Instability in BRAF Mutant, Microsatellite Stable Colorectal Cancers	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; III COLON-CANCER; TGF-BETA; AURORA-B; GENOMIC INSTABILITY; GENETIC ALTERATIONS; SERRATED ADENOMAS; PROGNOSTIC IMPACT; MUTATIONS; EXPRESSION	The BRAF oncogene is mutated in 15% of sporadic colorectal cancers. Approximately half of these BRAF mutant cancers demonstrate frequent frameshift mutations termed microsatellite instability (MSI), but are diploid and chromosomally stable. BRAF wild type cancers are typically microsatellite stable (MSS) and instead acquire chromosomal instability (CIN). In these cancers, CIN is associated with a poor outcome. BRAF mutant cancers that are MSS, typically present at an advanced stage and have a particularly poor prognosis. We have previously demonstrated clinical and molecular similarities between MSS cancers with or without a BRAF mutation, and therefore hypothesised that CIN may also be frequent in BRAF mutant/MSS cancers. BRAF mutant/MSS (n = 60), and BRAF wild type/MSS CRCs (n = 90) were investigated for CIN using loss of heterozygosity analysis over twelve loci encompassing chromosomal regions 5q, 8p, 17p and 18q. CIN was frequent in BRAF mutant/MSS cancers (41/57, 72%), which was comparable to the rate found in BRAF wild type/MSS cancers (74/90, 82%). The greatest loss in BRAF mutant/MSS cancers occurred at 8p (26/44, 59%), and the least at 5q (19/49, 39%). CIN in BRAF mutant/MSS cancers correlated with advanced stage (AJCC III/IV: 15/17, 88%; p = 0.02); showed high rates of co-occurrence with the CpG Island Methylator Phenotype (17/23, 74%); and CIN at 18q and 8p associated with worse survival (p = 0.02, p < 0.05). This study demonstrates that CIN commonly occurs in advanced BRAF mutant/MSS colorectal cancers where it may contribute to poorer survival, and further highlights molecular similarities occurring between these and BRAF wild type cancers.	[Bond, Catherine E.; Umapathy, Aarti; Buttenshaw, Ron L.; Leggett, Barbara A.; Whitehall, Vicki L. J.] Queensland Inst Med Res, Conjoint Gastroenterol Lab, Brisbane, Qld 4006, Australia; [Bond, Catherine E.; Leggett, Barbara A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Buttenshaw, Ron L.; Whitehall, Vicki L. J.] Queensland Hlth, Clin & Statewide Serv, Pathol Queensland, Brisbane, Qld, Australia; [Wockner, Leesa] Queensland Inst Med Res, Stat Unit, Brisbane, Qld 4006, Australia; [Leggett, Barbara A.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Queensland Health; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Bond, CE (corresponding author), Queensland Inst Med Res, Conjoint Gastroenterol Lab, Brisbane, Qld 4006, Australia.	Catherine.Bond@qimr.edu.au	; Whitehall, Vicki/B-6262-2013	Wockner, Leesa/0000-0002-8921-9265; Bond, Catherine/0000-0002-9615-5300; Leggett, Barbara/0000-0003-2062-7380; Whitehall, Vicki/0000-0002-8285-2391	National Health and Medical Research Council grant [NHMRC 442965]; Pathology Queensland, Clinical and Statewide Services, Queensland, Australia; Australian Postgraduate Award (APA)	National Health and Medical Research Council grant(National Health and Medical Research Council (NHMRC) of Australia); Pathology Queensland, Clinical and Statewide Services, Queensland, Australia; Australian Postgraduate Award (APA)(Australian Government)	This research was supported by a National Health and Medical Research Council grant (NHMRC 442965); Pathology Queensland, Clinical and Statewide Services, Queensland, Australia; and an Australian Postgraduate Award (APA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Joint Committee on Cancer, 2010, AJCC CANC STAGING HD, V7th; Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Andersen CL, 2011, INT J CANCER, V129, P1848, DOI 10.1002/ijc.25841; Baba Y, 2009, NEOPLASIA, V11, P418, DOI 10.1593/neo.09154; Bertagnolli MM, 2011, J CLIN ONCOL, V29, P3153, DOI 10.1200/JCO.2010.33.0092; Boland CR, 1998, CANCER RES, V58, P5248; Bond CE, 2012, INT J CANCER, V130, P1567, DOI 10.1002/ijc.26175; Bonet C, 2012, J BIOL CHEM, V287, P29887, DOI 10.1074/jbc.M112.371682; Chang SC, 2006, INT J CANCER, V118, P1721, DOI 10.1002/ijc.21563; Cheng YW, 2008, CLIN CANCER RES, V14, P6005, DOI 10.1158/1078-0432.CCR-08-0216; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; Derks S, 2009, CARCINOGENESIS, V30, P1041, DOI 10.1093/carcin/bgp073; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Diep CB, 2003, J CLIN ONCOL, V21, P820, DOI 10.1200/JCO.2003.05.190; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Goel A, 2003, CANCER RES, V63, P1608; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Halling KC, 1999, JNCI-J NATL CANCER I, V91, P1295, DOI 10.1093/jnci/91.15.1295; Hollingsworth SJ, 2005, J SURG ONCOL, V92, P317, DOI 10.1002/jso.20321; Iino H, 1999, J CLIN PATHOL, V52, P5, DOI 10.1136/jcp.52.1.5; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 1999, J CLIN PATHOL, V52, P455, DOI 10.1136/jcp.52.6.455; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kakar S, 2008, ARCH PATHOL LAB MED, V132, P958, DOI 10.1043/1543-2165(2008)132[958:CCCIMP]2.0.CO;2; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kane MF, 1997, CANCER RES, V57, P808; Katayama H, 1999, J NATL CANCER I, V91, P1160, DOI 10.1093/jnci/91.13.1160; Koinuma K, 2004, INT J CANCER, V108, P237, DOI 10.1002/ijc.11523; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kurai M, 2005, HUM PATHOL, V36, P1281, DOI 10.1016/j.humpath.2005.09.014; Lanza G, 1998, INT J CANCER, V79, P390, DOI 10.1002/(SICI)1097-0215(19980821)79:4<390::AID-IJC14>3.3.CO;2-M; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Lin ZZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-461; LOTHE RA, 1993, CANCER RES, V53, P5849; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Melcher R, 2011, CARCINOGENESIS, V32, P636, DOI 10.1093/carcin/bgr011; Nagasaka T, 2008, GASTROENTEROLOGY, V134, P1950, DOI 10.1053/j.gastro.2008.02.094; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; Ogino S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-72; Ogino S, 2012, CLIN CANCER RES, V18, P890, DOI 10.1158/1078-0432.CCR-11-2246; Ogino S, 2009, J CLIN ONCOL, V27, P4591, DOI 10.1200/JCO.2009.22.8858; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Pino MS, 2010, GASTROENTEROLOGY, V138, P1406, DOI 10.1053/j.gastro.2009.12.010; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Rosenberg DW, 2007, CANCER RES, V67, P3551, DOI 10.1158/0008-5472.CAN-07-0343; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sinicrope FA, 2006, GASTROENTEROLOGY, V131, P729, DOI 10.1053/j.gastro.2006.06.005; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Tanaka T, 2009, DIAGN MOL PATHOL, V18, P219, DOI 10.1097/PDM.0b013e3181910f17; Toyota M, 1999, CANCER RES, V59, P2307; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Vlajnic T, 2011, MODERN PATHOL, V24, P1404, DOI 10.1038/modpathol.2011.96; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Walther A, 2008, GUT, V57, P941, DOI 10.1136/gut.2007.135004; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Watanabe T, 2012, J CLIN ONCOL, V30, P2256, DOI 10.1200/JCO.2011.38.6490; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834	65	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47483	10.1371/journal.pone.0047483	http://dx.doi.org/10.1371/journal.pone.0047483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110075	Green Published, gold, Green Submitted			2022-12-27	WOS:000310193400010
J	Zhurov, V; Stead, JDH; Merali, Z; Palkovits, M; Faludi, G; Schild-Poulter, C; Anisman, H; Poulter, MO				Zhurov, Vladimir; Stead, John D. H.; Merali, Zul; Palkovits, Miklos; Faludi, Gabor; Schild-Poulter, Caroline; Anisman, Hymie; Poulter, Michael O.			Molecular Pathway Reconstruction and Analysis of Disturbed Gene Expression in Depressed Individuals Who Died by Suicide	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; CELL-DEATH; BRAIN; RECEPTORS; PROTEINS; CREB; SP1	Molecular mechanisms behind the etiology and pathophysiology of major depressive disorder and suicide remain largely unknown. Recent molecular studies of expression of serotonin, GABA and CRH receptors in various brain regions have demonstrated that molecular factors may contribute to the development of depressive disorder and suicide behaviour. Here, we used microarray analysis to examine the expression of genes in brain tissue (frontopolar cortex) of individuals who had been diagnosed with major depressive disorder and died by suicide, and those who had died suddenly without a history of depression. We analyzed the list of differentially expressed genes using pathway analysis, which is an assumption-free approach to analyze microarray data. Our analysis revealed that the differentially expressed genes formed functional networks that were implicated in cell to cell signaling related to synapse maturation, neuronal growth and neuronal complexity. We further validated these data by randomly choosing (100 times) similarly sized gene lists and subjecting these lists to the same analyses. Random gene lists did not provide highly connected gene networks like those generated by the differentially expressed list derived from our samples. We also found through correlational analysis that the gene expression of control participants was more highly coordinated than in the MDD/suicide group. These data suggest that among depressed individuals who died by suicide, wide ranging perturbations of gene expression exist that are critical for normal synaptic connectively, morphology and cell to cell communication.	[Zhurov, Vladimir; Schild-Poulter, Caroline; Poulter, Michael O.] Univ Western Ontario, Robarts Res Inst, Mol Brain Res Grp, London, ON, Canada; [Palkovits, Miklos] Hungarian Acad Sci, Neuromorphol Lab, Budapest, Hungary; [Palkovits, Miklos] Semmelweis Univ, Budapest, Hungary; [Faludi, Gabor] Semmelweis Univ Hosp, Budapest, Hungary; [Merali, Zul] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada; [Merali, Zul] Univ Ottawa, Dept Psychol Psychiat & Cellular & Mol Med, Ottawa, ON, Canada; [Stead, John D. H.; Anisman, Hymie] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada	Western University (University of Western Ontario); Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; University of Ottawa; University of Ottawa; Carleton University	Poulter, MO (corresponding author), Univ Western Ontario, Robarts Res Inst, Mol Brain Res Grp, London, ON, Canada.	mpoulter@robarts.ca	Schild-Poulter, Caroline/K-4476-2013; Poulter, Michael/K-3909-2013; Palkovits, Miklos/F-2707-2013; Stead, John/X-8500-2018	Poulter, Michael/0000-0001-7469-8462; Palkovits, Miklos/0000-0003-0578-0387; Stead, John/0000-0002-5726-6809; Zhurov, Vladimir/0000-0002-7120-4655	CIHR; NARSAD	CIHR(Canadian Institutes of Health Research (CIHR)); NARSAD(NARSAD)	This research was supported by a CIHR grant to MOP, HA and ZM. A NARSAD Independent Researcher Award also supported MOP. HA is a Tier I Canada Research Chair in Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergeron L, 1998, CURR OPIN NEUROBIOL, V8, P55, DOI 10.1016/S0959-4388(98)80008-1; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; David MD, 2008, J CELL SCI, V121, P2718, DOI 10.1242/jcs.029660; Dick O, 2010, J BIOL CHEM, V285, P19354, DOI 10.1074/jbc.M110.127654; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Fisar Z, 2010, FOLIA BIOL-PRAGUE, V56, P135; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Fukunaga K, 2009, ADV EXP MED BIOL, V665, P130; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Guy J, 2010, ANN REV CELL DEV BIO; Hayley S, 2005, NEUROSCIENCE, V135, P659, DOI 10.1016/j.neuroscience.2005.03.051; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Kang HJ, 2007, J NEUROSCI, V27, P13329, DOI 10.1523/JNEUROSCI.4083-07.2007; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Kosenko E, 2003, NEUROCHEM INT, V43, P493, DOI 10.1016/S0197-0186(03)00039-1; Kovacs-Nagy Reka, 2009, Neuropsychopharmacol Hung, V11, P89; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Maiese K, 2007, CURR NEUROVASC RES, V4, P295, DOI 10.2174/156720207782446306; Marampon F, 2008, MOL BIOL CELL, V19, P2566, DOI 10.1091/mbc.E06-12-1110; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Merali Z, 2006, BIOL PSYCHIAT, V59, P594, DOI 10.1016/j.biopsych.2005.08.008; Merali Z, 2004, J NEUROSCI, V24, P1478, DOI 10.1523/JNEUROSCI.4734-03.2004; Merz K, 2011, EUR J NEUROSCI, V33, P1078, DOI 10.1111/j.1460-9568.2011.07606.x; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mokhtar NM, 2011, CANC INVEST; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Ong PS, 2011, EUR J PHARM SCI; Poulter MO, 2010, NEUROSCIENCE, V165, P1039, DOI 10.1016/j.neuroscience.2009.11.028; Poulter M.O., 2010, FRONTIERS NEUROSCIEN, V29, P3; Poulter MO, 2008, BIOL PSYCHIAT, V64, P645, DOI 10.1016/j.biopsych.2008.05.028; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Saura CA, 2011, REV NEUROSCIENCE, V22, P153, DOI 10.1515/RNS.2011.018; Schmidt-Kastner R, 2006, SCHIZOPHR RES, V84, P253, DOI 10.1016/j.schres.2006.02.022; Schymick JC, 2007, HUM MOL GENET, V16, pR233, DOI 10.1093/hmg/ddm215; Seo J, 2006, BIOINFORMATICS, V22, P808, DOI 10.1093/bioinformatics/btk052; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Sequeira A, 2006, OMICS, V10, P444, DOI 10.1089/omi.2006.10.444; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; Tabuchi Y, 2012, INT J MOL MED, V29, P380, DOI 10.3892/ijmm.2011.862; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vande Velde C, 2005, NAT NEUROSCI, V8, P5, DOI 10.1038/nn0105-5; Yan R, 2006, CELL MOL LIFE SCI, V63, P877, DOI 10.1007/s00018-005-5338-2; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	48	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47581	10.1371/journal.pone.0047581	http://dx.doi.org/10.1371/journal.pone.0047581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110080	Green Submitted, Green Published, gold			2022-12-27	WOS:000310193400012
J	Fujita, Y; Kuchimaru, T; Kadonosono, T; Tanaka, S; Hase, Y; Tomimoto, H; Hiraoka, M; Kizaka-Kondoh, S; Ihara, M; Takahashi, R				Fujita, Youshi; Kuchimaru, Takahiro; Kadonosono, Tetsuya; Tanaka, Shotaro; Hase, Yoshiki; Tomimoto, Hidekazu; Hiraoka, Masahiro; Kizaka-Kondoh, Shinae; Ihara, Masafumi; Takahashi, Ryosuke			In Vivo Imaging of Brain Ischemia Using an Oxygen-Dependent Degradative Fusion Protein Probe	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; INDUCIBLE FACTOR-I; GENE-EXPRESSION; ACUTE STROKE; BCL-XL; HYPOXIA; RAT; PENUMBRA; INJURY; MOUSE	Within the ischemic penumbra, blood flow is sufficiently reduced that it results in hypoxia severe enough to arrest physiological function. Nevertheless, it has been shown that cells present within this region can be rescued and resuscitated by restoring perfusion and through other protective therapies. Thus, the early detection of the ischemic penumbra can be exploited to improve outcomes after focal ischemia. Hypoxia-inducible factor (HIF)-1 is a transcription factor induced by a reduction in molecular oxygen levels. Although the role of HIF-1 in the ischemic penumbra remains unknown, there is a strong correlation between areas with HIF-1 activity and the ischemic penumbra. We recently developed a near-infrared fluorescently labeled-fusion protein, POH-N, with an oxygen-dependent degradation property identical to the alpha subunit of HIF-1. Here, we conduct in vivo imaging of HIF-active regions using POH-N in ischemic brains after transient focal cerebral ischemia induced using the intraluminal middle cerebral artery occlusion technique in mice. The results demonstrate that POH-N enables the in vivo monitoring and ex vivo detection of HIF-1-active regions after ischemic brain injury and suggest its potential in imaging and drug delivery to HIF-1-active areas in ischemic brains.	[Fujita, Youshi; Hase, Yoshiki; Ihara, Masafumi; Takahashi, Ryosuke] Kyoto Univ, Dept Neurol, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Kuchimaru, Takahiro; Kadonosono, Tetsuya; Kizaka-Kondoh, Shinae] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 227, Japan; [Tomimoto, Hidekazu] Mie Univ, Sch Med, Dept Neurol, Tsu, Mie, Japan; [Tanaka, Shotaro] Tokyo Womens Med Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Hiraoka, Masahiro] Kyoto Univ, Dept Radiat Oncol & Image Appl Therapy, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Ihara, Masafumi] Inst Biomed Res & Innovat, Dept Regenerat Med & Res, Chuo Ku, Kobe, Hyogo, Japan	Kyoto University; Tokyo Institute of Technology; Mie University; Tokyo Women's Medical University; Kyoto University; Institute for Biomedical Research & Innovation (IBRI)	Ihara, M (corresponding author), Kyoto Univ, Dept Neurol, Grad Sch Med, Sakyo Ku, Kyoto, Japan.	iharama@gmail.com	Kadonosono, Tetsuya/D-4651-2019; Kondoh, Shinae/AAF-8745-2020; Kondoh, Shinae/C-6937-2015; Ihara, Masafumi/O-5020-2019; Kuchimaru, Takahiro/B-9269-2015	Kondoh, Shinae/0000-0003-3085-5782; Kondoh, Shinae/0000-0003-3085-5782; Ihara, Masafumi/0000-0002-7102-4048; Kuchimaru, Takahiro/0000-0002-5355-3165; Fujita, Youshi/0000-0002-9056-5878	Japanese Ministry of Education, Science, and Culture; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [23390233, 22112009] Funding Source: KAKEN	Japanese Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Young Scientists (B) (to YF) and for Scientific Research (B) (to MI) from the Japanese Ministry of Education, Science, and Culture and by the Global COE Program "Center for Frontier Medicine'' funded by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. This study is part of a joint research program focusing on the development of technology to establish a Center of Excellence for nanomedicine and carried out by the Kyoto City Collaboration of Regional Entities for Advancing Technology Excellence assigned by the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, the decision to publish, or manuscript preparation.	ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Cao GD, 2002, J NEUROSCI, V22, P5423; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Fisher M, 2008, CURR OPIN DRUG DISC, V11, P626; Gonzalez RG, 2006, AM J NEURORADIOL, V27, P728; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Harada H, 2002, CANCER RES, V62, P2013; Harada H, 2005, MOL IMAGING, V4, P182; Harada H, 2006, FEBS LETT, V580, P5718, DOI 10.1016/j.febslet.2006.09.025; Hase Y, 2012, EXP NEUROL, V233, P523, DOI 10.1016/j.expneurol.2011.11.038; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kilic E, 2002, ANN NEUROL, V52, P617, DOI 10.1002/ana.10356; Kilic U, 2003, STROKE, V34, P1304, DOI 10.1161/01.STR.0000066869.45310.50; Kim DW, 2005, MOL CELLS, V19, P88; KINOUCHI H, 1993, BRAIN RES, V619, P334, DOI 10.1016/0006-8993(93)91630-B; Kizaka-Kondoh S, 2009, CLIN CANCER RES, V15, P3433, DOI 10.1158/1078-0432.CCR-08-2267; Koistinaho J, 1999, STROKE, V30, P114, DOI 10.1161/01.STR.30.1.114; Kuchimaru T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015736; Kucinski T, 2005, AM J NEURORADIOL, V26, P815; Labiche Lise A, 2004, NeuroRx, V1, P46, DOI 10.1007/BF03206567; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; NEDERGAARD M, 1987, ACTA NEUROPATHOL, V73, P267, DOI 10.1007/BF00686621; Savitz SI, 2007, ANN NEUROL, V61, P396, DOI 10.1002/ana.21127; Schlaug G, 1999, NEUROLOGY, V53, P1528, DOI 10.1212/WNL.53.7.1528; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Shah Zahoor Ahmad, 2006, J Stroke Cerebrovasc Dis, V15, P133, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.002; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; YUAN F, 1994, CANCER RES, V54, P4564	34	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e48051	10.1371/journal.pone.0048051	http://dx.doi.org/10.1371/journal.pone.0048051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094105	Green Submitted, Green Published, gold			2022-12-27	WOS:000310050200057
J	Baker, JV; Hullsiek, KH; Prosser, R; Duprez, D; Grimm, R; Tracy, RP; Rhame, F; Henry, K; Neaton, JD				Baker, Jason V.; Hullsiek, Kathleen Huppler; Prosser, Rachel; Duprez, Daniel; Grimm, Richard; Tracy, Russell P.; Rhame, Frank; Henry, Keith; Neaton, James D.			Angiotensin Converting Enzyme Inhibitor and HMG-CoA Reductase Inhibitor as Adjunct Treatment for Persons with HIV Infection: A Feasibility Randomized Trial	PLOS ONE			English	Article							C-REACTIVE PROTEIN; T-CELL-ACTIVATION; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; IMMUNE ACTIVATION; RISK-FACTORS; DOUBLE-BLIND; RNA LEVELS; INDIVIDUALS; PREVENTION	Background: Treatments that reduce inflammation and cardiovascular disease (CVD) risk among individuals with HIV infection receiving effective antiretroviral therapy (ART) are needed. Design and Methods: We conducted a 2x2 factorial feasibility study of lisinopril (L) (10 mg daily) vs L-placebo in combination with pravastatin (P) (20 mg daily) vs P-placebo among participants receiving ART with undetectable HIV RNA levels, a Framingham 10 year risk score (FRS) >= 3%, and no indication for ACE-I or statin therapy. Tolerability and adherence were evaluated. Longitudinal mixed models assessed changes in blood pressure (BP), blood lipids, and inflammatory biomarkers from baseline through months 1 and 4. Results: Thirty-seven participants were randomized and 34 [lisinopril/pravastatin (n = 9), lisinopril/P-placebo (n = 8), L-placebo/pravastatin (n = 9), L-placebo/P-placebo (n = 8)] attended at least one follow-up visit. Participants were 97% male, 41% white, 67% were current smokers, and 65% were taking a protease inhibitor. Median age was 48 years, CD4 count 483 cells/mm(3), FRS 7.79%, total cholesterol 184 mg/dL, and LDL-C 95 mg/dL. There was no treatment difference for pravastatin vs P-placebo in total cholesterol, LDL-C, or any of the inflammatory biomarkers. Participants randomized to lisinopril vs. L-placebo had significant declines in diastolic BP (-3.3 mmHg, p = 0.05), hsCRP (-0.61 mg/mL, p = 0.02) and TNF-alpha (-0.17 pg/mL, p = 0.04). Participants taking lisinopril vs L-placebo were more likely to report missed doses (88 vs 35%; p = 0.001) and have adherence <90% by pill count (42 vs. 0%; p = 0.02). Few participants from either group reported side effects (n = 3 vs. n = 1). Conclusions: The modest BP changes and decreased adherence with lisinopril and absence of lipid differences with pravastatin suggest future studies of these drug classes should consider a run-in period to assess adherence and use a different statin. Our results also indicate that ACE-I therapy may have anti-inflammatory benefits for ART-treated persons with HIV infection and this should be further evaluated.	[Baker, Jason V.; Prosser, Rachel; Grimm, Richard; Henry, Keith] Hennepin Cty Med Ctr, Dept Med, Minneapolis, MN 55415 USA; [Baker, Jason V.; Duprez, Daniel; Grimm, Richard; Rhame, Frank; Henry, Keith] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Hullsiek, Kathleen Huppler; Neaton, James D.] Univ Minnesota, Dept Biostat, Minneapolis, MN USA; [Tracy, Russell P.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Rhame, Frank] Abbott NW Hosp, Dept Med, Minneapolis, MN 55407 USA	Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Vermont	Baker, JV (corresponding author), Hennepin Cty Med Ctr, Dept Med, Minneapolis, MN 55415 USA.	baker459@umn.edu			American Heart Association Clinical Research Program [CRP2230357]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER	American Heart Association Clinical Research Program(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for study provided by the American Heart Association Clinical Research Program (grant# CRP2230357). More information on AHA funding can be found on their website: www.my.americanheart.org/professional/research/research_ucm_316889_subhomepage.jsp. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baker JV, 2011, CLIN INFECT DIS, V53, P826, DOI 10.1093/cid/cir497; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Boger MS, 2009, JAIDS-J ACQ IMM DEF, V52, P480, DOI 10.1097/QAI.0b013e3181b939e5; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cruickshank J, 2001, LANCET, V358, P1994, DOI 10.1016/S0140-6736(01)06981-1; Freiberg M, 2011, 18 C RETR OPP INF BO; Ganesan A, 2011, J INFECT DIS, V203, P756, DOI 10.1093/infdis/jiq115; Grinspoon S. K., 2008, Circulation, V118, P198, DOI 10.1161/CIRCULATIONAHA.107.189622; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kaplan RC, 2012, J ACQUIRED IMMUNE DE; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MG, 2006, CURR OPIN HIV AIDS, V1, P482, DOI 10.1097/01.COH.0000247389.08485.87; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lonn E, 2010, CIRCULATION, V122, P2078, DOI 10.1161/CIRCULATIONAHA.109.873232; Montecucco F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/752406; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; NEATON JD, 1992, ARCH INTERN MED, V152, P1490, DOI 10.1001/archinte.152.7.1490; Neogi U, 2011, AIDS, V25, P1123, DOI 10.1097/QAD.0b013e328346269f; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Ormiston J, 2007, LANCET, V369, P1839, DOI 10.1016/S0140-6736(07)60829-0; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Sabin CA, 2008, CLIN INFECT DIS, V46, P1101, DOI 10.1086/528862; Stein JH, 2008, CIRCULATION, V118, pS1088; Triant VA, 2010, J ACQUIR IMMUNE DEFI; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5	37	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46894	10.1371/journal.pone.0046894	http://dx.doi.org/10.1371/journal.pone.0046894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082133	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900028
J	Fukuda, K; Ishida, W; Uchiyama, J; Rashel, M; Kato, S; Morita, T; Muraoka, A; Sumi, T; Matsuzaki, S; Daibata, M; Fukushima, A				Fukuda, Ken; Ishida, Waka; Uchiyama, Jumpei; Rashel, Mohammad; Kato, Shin-ichiro; Morita, Tamae; Muraoka, Asako; Sumi, Tamaki; Matsuzaki, Shigenobu; Daibata, Masanori; Fukushima, Atsuki			Pseudomonas aeruginosa Keratitis in Mice: Effects of Topical Bacteriophage KPP12 Administration	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; BACTERIAL-INFECTIONS; THERAPY; INFLAMMATION; ELIMINATION; RESISTANCE; LYSIN	The therapeutic effects of bacteriophage (phage) KPP12 in Pseudomonas aeruginosa keratitis were investigated in mice. Morphological analysis showed that phage KPP12 is a member of the family Myoviridae, morphotype A1, and DNA sequence analysis revealed that phage KPP12 is similar to PB1-like viruses. Analysis of the phage KPP12 genome did not identify any genes related to drug resistance, pathogenicity or lysogenicity, and so phage KPP12 may be a good candidate for therapeutic. KPP12 showed a broad host range for P. aeruginosa strains isolated from clinical ophthalmic infections. Inoculation of the scarified cornea with P. aeruginosa caused severe keratitis and eventual corneal perforation. Subsequent single-dose administration of KPP12 eye-drops significantly improved disease outcome, and preserved the structural integrity and transparency of the infected cornea. KPP12 treatment resulted in the suppression of neutrophil infiltration and greatly enhanced bacterial clearance in the infected cornea. These results indicate that bacteriophage eye-drops may be a novel adjunctive or alternative therapeutic agent for the treatment of infectious keratitis secondary to antibiotic-resistant bacteria.	[Fukuda, Ken; Ishida, Waka; Sumi, Tamaki; Fukushima, Atsuki] Kochi Med Sch, Dept Ophthalmol & Visual Sci, Kochi, Japan; [Uchiyama, Jumpei; Rashel, Mohammad; Matsuzaki, Shigenobu; Daibata, Masanori] Kochi Med Sch, Dept Microbiol & Infect, Kochi, Japan; [Kato, Shin-ichiro] Kochi Univ, Res Inst Mol Genet, Kochi 780, Japan; [Morita, Tamae] Kochi Med Sch Hosp, Kochi, Japan; [Muraoka, Asako] Kochi Gakuen Jr Coll, Kochi, Japan	Kochi University; Kochi University; Kochi University; Kochi University	Fukuda, K (corresponding author), Kochi Med Sch, Dept Ophthalmol & Visual Sci, Kochi, Japan.	k.fukuda@kochi-u.ac.jp	Uchiyama, Jumpei/GNP-6661-2022; Uchiyama, Jumpei/GWC-4189-2022; Fukuda, Ken/A-3076-2011	Uchiyama, Jumpei/0000-0003-0846-0100; Fukuda, Ken/0000-0003-4990-6308	Grants-in-Aid for Scientific Research [23591391, 24791025] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002; Carmody LA, 2010, J INFECT DIS, V201, P264, DOI 10.1086/649227; Comeau AM, 2008, MOL BIOL EVOL, V25, P1321, DOI 10.1093/molbev/msn080; d'Herelle F, 1917, CR HEBD ACAD SCI, V165, P373; Dabrowska K, 2005, J APPL MICROBIOL, V98, P7, DOI 10.1111/j.1365-2672.2004.02422.x; DUCKWORTH DH, 1976, BACTERIOL REV, V40, P793, DOI 10.1128/MMBR.40.4.793-802.1976; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Gorski A, 2009, OPHTHALMOLOGICA, V223, P162, DOI 10.1159/000193293; Hazlett LD, 2000, INVEST OPHTH VIS SCI, V41, P805; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Khosravi A. D., 2007, SMJ Singapore Medical Journal, V48, P741; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Matsuzaki S, 2003, J INFECT DIS, V187, P613, DOI 10.1086/374001; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Proskurov V A, 1970, Vestn Oftalmol, V6, P82; Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Sheehan MM, 1997, MOL MICROBIOL, V25, P717, DOI 10.1046/j.1365-2958.1997.5101880.x; SLOPEK S, 1987, ARCH IMMUNOL THER EX, V35, P569; Sulakvelidze A, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P381; Wang J, 2006, INT J MOL MED, V17, P347; Wang J, 2006, INT J MOL MED, V17, P309, DOI 10.1177/1045389X06054331; Weber-Dabrowska Beata, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P547; Willcox MDP, 2007, OPTOMETRY VISION SCI, V84, P273, DOI 10.1097/OPX.0b013e3180439c3e; Willcox MDP, 2011, CLIN EXP OPTOM, V94, P161, DOI 10.1111/j.1444-0938.2010.00536.x; WILLIAMS RN, 1982, CURR EYE RES, V2, P465, DOI 10.3109/02713688208996350; Wu MH, 2009, J IMMUNOL, V182, P1609, DOI 10.4049/jimmunol.182.3.1609	30	54	61	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47742	10.1371/journal.pone.0047742	http://dx.doi.org/10.1371/journal.pone.0047742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082205	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900102
J	Krstic, D; Rodriguez, M; Knuesel, I				Krstic, Dimitrije; Rodriguez, Myriam; Knuesel, Irene			Regulated Proteolytic Processing of Reelin through Interplay of Tissue Plasminogen Activator (tPA), ADAMTS-4, ADAMTS-5, and Their Modulators	PLOS ONE			English	Article							C-TERMINAL REGION; ALZHEIMERS-DISEASE; VLDL RECEPTOR; A-BETA; PROTEIN; AGGRECANASE-1; BINDING; EXPRESSION; MODEL; MICE	The extracellular signaling protein Reelin, indispensable for proper neuronal migration and cortical layering during development, is also expressed in the adult brain where it modulates synaptic functions. It has been shown that proteolytic processing of Reelin decreases its signaling activity and promotes Reelin aggregation in vitro, and that proteolytic processing is affected in various neurological disorders, including Alzheimer's disease (AD). However, neither the pathophysiological significance of dysregulated Reelin cleavage, nor the involved proteases and their modulators are known. Here we identified the serine protease tissue plasminogen activator (tPA) and two matrix metalloproteinases, ADAMTS-4 and ADAMTS-5, as Reelin cleaving enzymes. Moreover, we assessed the influence of several endogenous protease inhibitors, including tissue inhibitors of metalloproteinases (TIMPs), alpha-2-Macroglobulin, and multiple serpins, as well as matrix metalloproteinase 9 (MMP-9) on Reelin cleavage, and described their complex interplay in the regulation of this process. Finally, we could demonstrate that in the murine hippocampus, the expression levels and localization of Reelin proteases largely overlap with that of Reelin. While this pattern remained stable during normal aging, changes in their protein levels coincided with accelerated Reelin aggregation in a mouse model of AD.	[Krstic, Dimitrije; Rodriguez, Myriam; Knuesel, Irene] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland	University of Zurich	Knuesel, I (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.	knuesel@pharma.uzh.ch		Knuesel, Irene/0000-0003-0396-9952	Swiss National Science Foundation [310030-132629]; Gottfried und Julia Bangerter-Rhyner-Stiftung; Novartis Foundation; Alzheimer and Depression - Fonds, Swiss Academy of Medical Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gottfried und Julia Bangerter-Rhyner-Stiftung; Novartis Foundation(Novartis); Alzheimer and Depression - Fonds, Swiss Academy of Medical Sciences	This work was supported by the Swiss National Science Foundation, Grant No 310030-132629 to IK, Gottfried und Julia Bangerter-Rhyner-Stiftung to IK and DK, The Novartis Foundation, formerly Ciba-Geigy Jubilee Foundation to IK and DK, Alzheimer and Depression - Fonds, Swiss Academy of Medical Sciences to IK and DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Botella-Lopez A, 2010, NEUROBIOL DIS, V37, P682, DOI 10.1016/j.nbd.2009.12.006; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; Doehner J, 2012, EUR J NEUROSCI, V35, P1938, DOI 10.1111/j.1460-9568.2012.08154.x; Doehner J, 2010, J ALZHEIMERS DIS, V19, P1339, DOI 10.3233/JAD-2010-1333; Ducharme P, 2010, NEUROSCIENCE, V167, P633, DOI 10.1016/j.neuroscience.2010.02.039; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Duveau V, 2011, HIPPOCAMPUS, V21, P935, DOI 10.1002/hipo.20793; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Fatemi SH, 2005, MOL PSYCHIATR, V10, P251, DOI 10.1038/sj.mp.4001613; Fatemi SH, 2001, NEUROREPORT, V12, P3209, DOI 10.1097/00001756-200110290-00014; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Hatada I, 2008, J HUM GENET, V53, P185, DOI 10.1007/s10038-007-0228-0; Herring A, 2012, J ALZHEIMERS DIS, V30, P963, DOI 10.3233/JAD-2012-112069; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hibi T, 2009, FEBS LETT, V583, P1299, DOI 10.1016/j.febslet.2009.03.024; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Knuesel I, 2010, PROG NEUROBIOL, V91, P257, DOI 10.1016/j.pneurobio.2010.04.002; Knuesel I, 2009, NEUROBIOL AGING, V30, P697, DOI 10.1016/j.neurobiolaging.2007.08.011; Kocherhans S, 2010, J NEUROSCI, V30, P9228, DOI 10.1523/JNEUROSCI.0418-10.2010; Kohno S, 2009, BIOCHEM BIOPH RES CO, V380, P93, DOI 10.1016/j.bbrc.2009.01.039; Kohno T, 2009, J NEUROSCI RES, V87, P3043, DOI 10.1002/jnr.22143; Kubo K, 2002, NEUROSCI RES, V43, P381, DOI 10.1016/S0168-0102(02)00068-8; Lauer-Fields JL, 2008, ANAL BIOCHEM, V373, P43, DOI 10.1016/j.ab.2007.09.014; Lee JY, 2007, NEUROSCI LETT, V423, P82, DOI 10.1016/j.neulet.2007.06.037; Lugli Giovanni, 2003, BMC Biochem, V4, P9, DOI 10.1186/1471-2091-4-9; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; Medina MG, 2005, EMBO J, V24, P1706, DOI 10.1038/sj.emboj.7600650; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Nomura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001454; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ohkubo N, 2002, FASEB J, V16, P295, DOI 10.1096/fj.02-0434fje; PITTMAN RN, 1989, J NEUROSCI, V9, P4269; Pratta MA, 2003, ARTHRITIS RHEUM, V48, P119, DOI 10.1002/art.10726; Rogers JT, 2008, NEURON GLIA BIOL, V4, P259, DOI 10.1017/S1740925X09990184; Salles FJ, 2002, J NEUROSCI, V22, P2125, DOI 10.1523/JNEUROSCI.22-06-02125.2002; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tissir F, 2002, BRAZ J MED BIOL RES, V35, P1473, DOI 10.1590/S0100-879X2002001200007; Tortorella MD, 2008, CURR PHARM BIOTECHNO, V9, P16, DOI 10.2174/138920108783497622; Tortorella MD, 2005, ARCH BIOCHEM BIOPHYS, V444, P34, DOI 10.1016/j.abb.2005.09.018; Tortorella MD, 2004, J BIOL CHEM, V279, P17554, DOI 10.1074/jbc.M313041200; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Tsirka SE, 1997, J NEUROSCI, V17, P543; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497; Vankemmelbeke MN, 2003, EUR J BIOCHEM, V270, P2394, DOI 10.1046/j.1432-1033.2003.03607.x; Wagsater D, 2008, ATHEROSCLEROSIS, V196, P514, DOI 10.1016/j.atherosclerosis.2007.05.018; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Weaver MS, 2010, J BIOL CHEM, V285, P5868, DOI 10.1074/jbc.M109.070318; Yasui N, 2011, J BIOL CHEM, V286, P35247, DOI 10.1074/jbc.M111.242719; Yuan W, 2002, NEUROSCIENCE, V114, P1091, DOI 10.1016/S0306-4522(02)00347-0; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	63	64	64	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47793	10.1371/journal.pone.0047793	http://dx.doi.org/10.1371/journal.pone.0047793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082219	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000311146900116
J	Maia, R; Brasileiro, L; Lacava, RV; Macedo, RH				Maia, Rafael; Brasileiro, Luiza; Lacava, Roberto V.; Macedo, Regina H.			Social Environment Affects Acquisition and Color of Structural Nuptial Plumage in a Sexually Dimorphic Tropical Passerine	PLOS ONE			English	Article							BLUE-BLACK GRASSQUITS; IRIDESCENT PLUMAGE; SATIN BOWERBIRDS; BEHAVIOR; TITS; MOLT; REFLECTANCE; PARASITES; DISPLAY; STRESS	Structural colors result from the physical interaction of light with organic materials of differing refractive indexes organized at nanoscale dimensions to produce significant interference effects. Because color properties emerge from these finely organized nanostructures, the production of structural coloration could respond to environmental factors and be developmentally more plastic than expected, functioning as an indicator of individual quality. However, there are many unknown factors concerning the function and mechanisms regulating structural coloration, especially relative to social environment. We hypothesized that social environment, in the form of competitive settings, can influence the developmental pathways involving production of feather structural coloration. We experimentally assessed the impact of social environment upon body condition, molt and spectral properties of two types of structural color that compose the nuptial plumage in blue-black grassquits: black iridescent plumage and white underwing patches. We manipulated male social environment during nine months by keeping individuals in three treatments: (1) pairs; (2) all-male groups; and (3) male-female mixed groups. All morphological characters and spectral plumage measures varied significantly through time, but only acquisition of nuptial plumage coverage and nuptial plumage color were influenced by social environment. Compared with males in the paired treatment, those in treatments with multiple males molted into nuptial plumage faster and earlier, and their plumage was more UV-purple-shifted. Our results provide experimental evidence that social context strongly influences development and expression of structural plumage. These results emphasize the importance of longterm experimental studies to identify the phenotypic consequences of social dynamics relative to ornament expression.	[Brasileiro, Luiza; Lacava, Roberto V.; Macedo, Regina H.] Univ Brasilia, Dept Zool, Lab Comportamento Anim, Brasilia, DF, Brazil; [Maia, Rafael; Brasileiro, Luiza; Lacava, Roberto V.] Univ Brasilia, Programa Posgrad Ecol, Brasilia, DF, Brazil; [Maia, Rafael] Univ Akron, Integrated Biosci Program, Dept Biol, Akron, OH 44325 USA	Universidade de Brasilia; Universidade de Brasilia; University System of Ohio; University of Akron	Macedo, RH (corresponding author), Univ Brasilia, Dept Zool, Lab Comportamento Anim, Brasilia, DF, Brazil.	rhfmacedo@unb.br	Macedo, Regina/GSE-3916-2022; Macedo, Regina H. F./C-1411-2013	Macedo, Regina H. F./0000-0003-3510-9172; Maia, Rafael/0000-0002-7563-9795; Lacava, Roberto Victor/0000-0003-3734-2488	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq [302063/2007-2]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq (www.cnpq.br) [302063/2007-2 to RHM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar TM, 2008, BEHAV ECOL, V19, P292, DOI 10.1093/beheco/arm130; ALDERTON CORA C., 1963, CONDOR, V65, P154, DOI 10.2307/1365492; Almeida JB, 2001, AUK, V118, P404, DOI 10.1642/0004-8038(2001)118[0404:LLMSOT]2.0.CO;2; Andersson Malte, 1994; Badyaev AV, 2002, AUK, V119, P301, DOI 10.1642/0004-8038(2002)119[0301:PSTITC]2.0.CO;2; Bortolotti G. R., 2006, BIRD COLORATION, V2, P3, DOI DOI 10.2307/J.CTV22JNR8K.4; Brawner WR, 2000, AUK, V117, P952, DOI 10.1642/0004-8038(2000)117[0952:EOCAMI]2.0.CO;2; Carvalho CBV., 2007, Braz. J. Biol., V67, P275, DOI 10.1590/S1519-69842007000200012; Carvalho CBV, 2006, CONDOR, V108, P579, DOI 10.1650/0010-5422(2006)108[579:BSOASM]2.0.CO;2; COLLIS K, 1993, ETHOLOGY, V94, P59; Costa FJV, 2005, ANIM BEHAV, V70, P1401, DOI 10.1016/j.anbehav.2005.03.024; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; Dias Raphael I., 2009, Oecologia Brasiliensis, V13, P183; Dias RI, 2009, CONDOR, V111, P706, DOI 10.1525/cond.2009.090142; DIETZ MW, 1992, PHYSIOL ZOOL, V65, P1217, DOI 10.1086/physzool.65.6.30158276; Dijkstra PD, 2007, BEHAV ECOL SOCIOBIOL, V61, P599, DOI 10.1007/s00265-006-0289-7; Doucet SM, 2002, CONDOR, V104, P30, DOI 10.1650/0010-5422(2002)104[0030:SPCMBS]2.0.CO;2; Doucet SM, 2005, BEHAV ECOL, V16, P218, DOI 10.1093/beheco/arh154; Doucet SM, 2006, J EXP BIOL, V209, P380, DOI 10.1242/jeb.01988; Doucet SM, 2003, BEHAV ECOL, V14, P503, DOI 10.1093/beheco/arg035; Doucet SM, 2009, J R SOC INTERFACE, V6, pS115, DOI 10.1098/rsif.2008.0395.focus; Dufresne ER, 2009, SOFT MATTER, V5, P1792, DOI 10.1039/b902775k; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; FINGER E, 1994, VISION RES, V34, P1509, DOI 10.1016/0042-6989(94)90152-X; Fitze PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005111; Fitzpatrick S, 1998, ANN ZOOL FENN, V35, P67; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Galvan I, 2008, BIOL LETTERS, V4, P12, DOI 10.1098/rsbl.2007.0504; Galvan I, 2008, BEHAV ECOL SOCIOBIOL, V63, P303, DOI 10.1007/s00265-008-0662-9; Ghiradella HT, 2009, J R SOC INTERFACE, V6, pS243, DOI 10.1098/rsif.2008.0372.focus; GOSLER AG, 1994, BIRD STUDY, V41, P146, DOI 10.1080/00063659409477211; GREENEWALT CH, 1960, J OPT SOC AM, V50, P1005, DOI 10.1364/JOSA.50.001005; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; HASTIE T, 1993, J ROY STAT SOC B MET, V55, P757; Hill GE, 2005, ANIM BEHAV, V69, P387, DOI 10.1016/j.anbehav.2004.03.013; Hunt S, 1998, P ROY SOC B-BIOL SCI, V265, P451, DOI 10.1098/rspb.1998.0316; Jouventin P, 2007, WATERBIRDS, V30, P573, DOI 10.1675/1524-4695(2007)030[0573:DCSAOB]2.0.CO;2; Karubian J, 2011, ANIM BEHAV, V81, P795, DOI 10.1016/j.anbehav.2011.01.012; Keyser AJ, 1999, P ROY SOC B-BIOL SCI, V266, P771, DOI 10.1098/rspb.1999.0704; Kimball Rebecca T., 2006, P431; Kinoshita S, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/7/076401; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; Lacava RV, 2011, HORM BEHAV, V59, P51, DOI 10.1016/j.yhbeh.2010.10.003; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; Loiseau C, 2008, GEN COMP ENDOCR, V155, P101, DOI 10.1016/j.ygcen.2007.03.004; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Maia R, 2011, J ROYAL SOC INTERFAC; Maia R, 2011, J ORNITHOL, V152, P243, DOI 10.1007/s10336-010-0576-y; Maia R, 2009, J R SOC INTERFACE, V6, pS203, DOI 10.1098/rsif.2008.0460.focus; Martinez-Padilla J, 2010, J EVOLUTION BIOL, V23, P902, DOI 10.1111/j.1420-9101.2010.01956.x; McGraw KJ, 2002, J EXP BIOL, V205, P3747; Meylan S, 2007, OIKOS, V116, P650, DOI 10.1111/j.2007.0030-1299.15432.x; Montgomerie Robert, 2006, P90; Munoz A, 2008, BEHAV ECOL, V19, P404, DOI 10.1093/beheco/arm148; Osorio D, 2002, J EXP BIOL, V205, P2017; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Peters A, 2011, J EVOLUTION BIOL, V24, P976, DOI 10.1111/j.1420-9101.2011.02229.x; Peters A, 2000, BEHAV ECOL SOCIOBIOL, V47, P438, DOI 10.1007/s002650050688; Peters A, 2007, AM NAT, V169, pS122, DOI 10.1086/510139; Prum RO, 2009, J R SOC INTERFACE, V6, pS253, DOI 10.1098/rsif.2008.0466.focus; Prum RO, 2006, BIRD COLORATION, V1, P295; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasband W., 2006, IMAGEJ; Rubenstein DR, 2008, TRENDS ECOL EVOL, V23, P655, DOI 10.1016/j.tree.2008.07.010; Santos ESA, 2009, BEHAV ECOL, V20, P553, DOI 10.1093/beheco/arp031; Senar JC, 2002, BEHAV ECOL, V13, P725, DOI 10.1093/beheco/13.6.725; Shawkey MD, 2007, AM NAT, V169, pS112, DOI 10.1086/510100; Shawkey MD, 2006, J EXP BIOL, V209, P1245, DOI 10.1242/jeb.02115; Sick H, 2001, ORNITOLOGIA BRASILEI; Siefferman L, 2007, BEHAV ECOL SOCIOBIOL, V61, P1839, DOI 10.1007/s00265-007-0416-0; Stoddard MC, 2011, BEHAV ECOL, V22, P1042, DOI 10.1093/beheco/arr088; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; WEBBER T, 1985, CONDOR, V87, P543, DOI 10.2307/1367957; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	74	16	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47501	10.1371/journal.pone.0047501	http://dx.doi.org/10.1371/journal.pone.0047501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082172	Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900068
J	Zhu, JJ; Gonda, Y; Yu, LZ; Li, FQ; Yan, QL; Sun, YR				Zhu, Jiaojun; Gonda, Yutaka; Yu, Lizhong; Li, Fengqin; Yan, Qiaoling; Sun, Yirong			Regeneration of a Coastal Pine (Pinus thunbergii Parl.) Forest 11 Years after Thinning, Niigata, Japan	PLOS ONE			English	Article							GAP SIZE; SEEDLING ESTABLISHMENT; GROWTH; VEGETATION; AUSTRALIA; SURVIVAL	To examine the effects of thinning intensity on wind vulnerability and regeneration in a coastal pine (Pinus thunbergii) forest, thinning with intensities of 20%, 30% and 50% was conducted in December 1997; there was an unthinned treatment as the control (total 8 stands). We re-measured the permanent sites to assess the regeneration characteristics 11 years after thinning. In the 50% thinned stand, seedlings aged from 2 to 10 years exhibited the highest pine seedling density and growth. The age composition ranged from 1-3 years with densities of 9.9 and 5.1 seedlings m(-2) in 30% and 20% thinned stands; only 1-year-old seedlings with a density of 6.1 seedlings m(-2) in the unthinned stand. Similar trends were found for the regeneration of broadleaved species such as Robinia pseudoacacia and Prunus serrulata. We speculate that the canopy openness and moss coverage contributed to the regeneration success in the 50% thinned stand, while the higher litter depth and lack of soil moisture induced the regeneration failure in the unthinned stand. The stands thinned at 20% or 30% were less favourable for pine regeneration than the stands thinned at 50%. Therefore, thinning with less than 30% canopy openness (20% and 30% thinned stands) should be avoided, and thinning at higher than 30% canopy openness (50% thinned stand, approximately 1500 stems ha(-1) at ages 40-50 years) is suggested for increasing regeneration in the coastal pine forest. The implications of thinning-based silviculture in the coastal pine forest management are also discussed. The ongoing development of the broadleaved seedlings calls for further observations.	[Zhu, Jiaojun; Yu, Lizhong; Li, Fengqin; Yan, Qiaoling; Sun, Yirong] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Zhu, Jiaojun; Yu, Lizhong; Li, Fengqin; Yan, Qiaoling; Sun, Yirong] Chinese Acad Sci, Qingyuan Expt Stn Forest Ecol, Shenyang, Peoples R China; [Gonda, Yutaka] Niigata Univ, Fac Agr, Niigata 95021, Japan	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Niigata University	Zhu, JJ (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	jiaojunzhu@iae.ac.cn		ZHU, Jiaojun/0000-0002-2512-7900; GONDA, Yutaka/0000-0002-9266-9275	National Natural Science Foundation of China [30830085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by the National Natural Science Foundation of China (30830085). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brett RB, 1998, CAN J FOREST RES, V28, P1825, DOI 10.1139/cjfr-28-12-1825; CANHAM CD, 1989, ECOLOGY, V70, P548, DOI 10.2307/1940200; Cheng Jinhua, 2003, Yingyong Shengtai Xuebao, V14, P1825; Deal RL, 2007, BIOL CONSERV, V137, P520, DOI 10.1016/j.biocon.2007.03.014; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Fule PZ, 2005, FOREST ECOL MANAG, V218, P129, DOI 10.1016/j.foreco.2005.07.005; Gardiner B, 2008, FORESTRY, V81, P447, DOI 10.1093/forestry/cpn022; Gray AN, 1996, J ECOL, V84, P635, DOI 10.2307/2261327; Han Guang-xuan, 2009, Shengtaixue Zazhi, V28, P2171; Han GuangXuan, 2010, Scientia Silvae Sinicae, V46, P158; Ilisson T, 2007, FOREST ECOL MANAG, V250, P17, DOI 10.1016/j.foreco.2007.03.022; Iverson LR, 2008, FOREST ECOL MANAG, V255, P3035, DOI 10.1016/j.foreco.2007.09.088; Jung SC, 2009, J FOREST RES-JPN, V14, P101, DOI 10.1007/s10310-008-0109-1; Kathke S, 2010, FOREST ECOL MANAG, V259, P1597, DOI 10.1016/j.foreco.2010.01.036; Mason B, 2001, 40 FOR COMM; Mizunaga H, 2010, J FOREST RES-JPN, V15, P1, DOI 10.1007/s10310-009-0177-x; Murai H, 1992, COASTAL FOREST JAPAN; Myers GP, 2000, FOREST ECOL MANAG, V127, P119, DOI 10.1016/S0378-1127(99)00124-3; Ogasawara R., 1988, Research Bulletin of the Tottori University Forests, P37; Osem Y, 2009, FOREST ECOL MANAG, V259, P14, DOI 10.1016/j.foreco.2009.09.034; Parhizkar P, 2011, FORESTRY, V84, P177, DOI 10.1093/forestry/cpr004; Prevosto B, 2008, FOREST ECOL MANAG, V256, P2058, DOI 10.1016/j.foreco.2008.07.027; Steege H, 1994, HEMIPHOT PROGRAMME A; Taniguchi T, 2008, SOIL BIOL BIOCHEM, V40, P1235, DOI 10.1016/j.soilbio.2007.12.017; Taniguchi T, 2007, J FOREST RES-JPN, V12, P350, DOI 10.1007/s10310-007-0023-y; Van Der Meer PJ, 2007, FOREST ECOL MANAG, V244, P102, DOI 10.1016/j.foreco.2007.03.055; Van Der Meer PJ, 1999, FOREST ECOL MANAG, V117, P33, DOI 10.1016/S0378-1127(98)00471-X; Wang HeXin, 2005, Forest Research, Beijing, V18, P524; Xiong SJ, 1999, J ECOL, V87, P984, DOI 10.1046/j.1365-2745.1999.00414.x; Xu JingWei, 2003, Journal of Northeast Forestry University, V31, P4; Zhang Dan, 2011, Chinese Journal of Plant Ecology, V35, P926, DOI 10.3724/SP.J.1258.2011.00926; [张志东 ZHANG Zhidong], 2010, [生态学报, Acta Ecologica Sinica], V30, P2205; Zhu Jiao-jun, 2003, Journal of Forestry Research (Harbin), V14, P1, DOI 10.1007/BF02856755; Zhu JJ, 2003, FOREST ECOL MANAG, V182, P339, DOI 10.1016/S0378-1127(03)00094-X; Zhu JJ, 2001, J FOR RES, V6, P287	35	10	14	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47593	10.1371/journal.pone.0047593	http://dx.doi.org/10.1371/journal.pone.0047593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091632	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800056
J	Fleitas, T; Martinez-Sales, V; Vila, V; Reganon, E; Mesado, D; Martin, M; Gomez-Codina, J; Montalar, J; Reynes, G				Fleitas, Tania; Martinez-Sales, Vicenta; Vila, Virtudes; Reganon, Edelmiro; Mesado, David; Martin, Maria; Gomez-Codina, Jose; Montalar, Joaquin; Reynes, Gaspar			Circulating Endothelial Cells and Microparticles as Prognostic Markers in Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							PLATELET-DERIVED MICROPARTICLES; THROMBIN GENERATION; COAGULATION ACTIVATION; 1ST-LINE TREATMENT; MEMBRANE-VESICLES; PERIPHERAL-BLOOD; EMERGING ROLE; CHEMOTHERAPY; ASSOCIATION; ENUMERATION	Background: Circulating endothelial cells and microparticles have prognostic value in cancer, and might be predictors of response to chemotherapy and antiangiogenic treatments. We have investigated the prognostic value of circulating endothelial cells and microparticles in patients treated for advanced non-small cell lung cancer. Methodology/Principal Findings: Peripheral blood samples were obtained from 60 patients before first line, platinum-based chemotherapy +/- bevacizumab, and after the third cycle of treatment. Blood samples from 60 healthy volunteers were also obtained as controls. Circulating endothelial cells were measured by an immunomagnetic technique and immunofluorescence microscopy. Phosphatidylserine-positive microparticles were evaluated by flow cytometry. Microparticle-mediated procoagulant activity was measured by the endogen thrombin generation assay. Results: pre- and posttreatment levels of markers were higher in patients than in controls (p<0.0001). Elevated levels of microparticles were associated with longer survival. Elevated pretreatment levels of circulating endothelial cells were associated with shorter survival. Conclusions/Significance: Circulating levels of microparticles and circulating endothelial cells correlate with prognosis, and could be useful as prognostic markers in patients with advanced non-small cell lung cancer.	[Fleitas, Tania; Martin, Maria; Gomez-Codina, Jose; Montalar, Joaquin; Reynes, Gaspar] Hosp Univ & Politecn La Fe Valencia, Dept Med Oncol, Valencia, Spain; [Martinez-Sales, Vicenta; Vila, Virtudes; Reganon, Edelmiro; Mesado, David] Hosp Univ & Politecn La Fe Valencia, Res Ctr, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Fleitas, T (corresponding author), Hosp Univ & Politecn La Fe Valencia, Dept Med Oncol, Valencia, Spain.	tfleitask@gmail.com		Reynes, Gaspar/0000-0001-8636-6094; Fleitas kanonnikoff, Tania/0000-0002-2789-9082	Fundacion para la Investigacion, Hospital Universitario La Fe - Bancaja; Roche Pharma; Amgen; Lilly; MSD; Bayer	Fundacion para la Investigacion, Hospital Universitario La Fe - Bancaja; Roche Pharma; Amgen(Amgen); Lilly(Eli Lilly); MSD; Bayer(Bayer AG)	This study was supported in part by a grant of Fundacion para la Investigacion, Hospital Universitario La Fe - Bancaja. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The following industries: Roche Pharma, Amgen, Lilly, MSD, and Bayer contributed financially to the purchase of reagents and for hiring a laboratory technician, in accordance with legal procedure of the foundation of Hospital La Fe for donations, without any kind of interest in the results of the study, and they did not participated in any other aspect in the study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Ay C, 2011, J CLIN ONCOL, V29, P2099, DOI 10.1200/JCO.2010.32.8294; Beerepoot LV, 2004, ANN ONCOL, V15, P139, DOI 10.1093/annonc/mdh017; Bidot L, 2008, J THROMB HAEMOST, V6, P913, DOI 10.1111/j.1538-7836.2008.02963.x; Calleri A, 2009, CLIN CANCER RES, V15, P7652, DOI 10.1158/1078-0432.CCR-09-1493; Chou J, 2004, BLOOD, V104, P3190, DOI 10.1182/blood-2004-03-0935; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Davila M, 2008, J THROMB HAEMOST, V6, P1517, DOI 10.1111/j.1538-7836.2008.02987.x; Erdbruegger U, 2010, CURR STEM CELL RES T, V5, P294, DOI 10.2174/157488810793351721; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goon PKY, 2006, NEOPLASIA, V8, P79, DOI 10.1593/neo.05592; Guervilly C, 2011, CRIT CARE, V15, DOI 10.1186/cc9978; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Helley D, 2009, EUR UROL, V56, P479, DOI 10.1016/j.eururo.2008.06.038; Hron G, 2007, THROMB HAEMOSTASIS, V97, P119, DOI 10.1160/TH06-03-0141; Kawaishi M, 2009, J THORAC ONCOL, V4, P208, DOI 10.1097/JTO.0b013e318193030d; Kim HK, 2003, EUR J CANCER, V39, P184, DOI 10.1016/S0959-8049(02)00596-8; Lacroix R, 2010, J THROMB HAEMOST, V8, P2571, DOI 10.1111/j.1538-7836.2010.04047.x; Macey MG, 2011, CYTOM PART B-CLIN CY, V80B, P57, DOI 10.1002/cyto.b.20551; Mancuso P, 2001, BLOOD, V97, P3658, DOI 10.1182/blood.V97.11.3658; Mancuso P, 2010, MICROVASC RES, V79, P224, DOI 10.1016/j.mvr.2010.02.007; Matsusaka S, 2011, CANCER CHEMOTH PHARM, V68, P763, DOI 10.1007/s00280-010-1543-2; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Pereira J, 2006, THROMB HAEMOSTASIS, V95, P94, DOI 10.1160/TH05-05-0310; Ronzoni M, 2010, ANN ONCOL, V21, P2382, DOI 10.1093/annonc/mdq261; Rossi A, 2010, CURR MED CHEM, V17, P1030; Rowand JL, 2007, CYTOM PART A, V71A, P105, DOI 10.1002/cyto.a.20364; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Toth B, 2008, THROMB HAEMOSTASIS, V100, P663, DOI 10.1160/TH07-10-0602; Ulahannan SV, 2011, CANCER INVEST, V29, P325, DOI 10.3109/07357907.2011.554476; Woywodt A, 2006, J THROMB HAEMOST, V4, P671, DOI 10.1111/j.1538-7836.2006.01794.x; Yang C, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12533; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121; Zwicker JI, 2009, CLIN CANCER RES, V15, P6830, DOI 10.1158/1078-0432.CCR-09-0371	37	55	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47365	10.1371/journal.pone.0047365	http://dx.doi.org/10.1371/journal.pone.0047365			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077602	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100101
J	Miller, GW; Ulatowski, L; Labut, EM; Lebold, KM; Manor, D; Atkinson, J; Barton, CL; Tanguay, RL; Traber, MG				Miller, Galen W.; Ulatowski, Lynn; Labut, Edwin M.; Lebold, Katie M.; Manor, Danny; Atkinson, Jeffrey; Barton, Carrie L.; Tanguay, Robert L.; Traber, Maret G.			The alpha-Tocopherol Transfer Protein Is Essential for Vertebrate Embryogenesis	PLOS ONE			English	Article							VITAMIN-E-DEFICIENCY; MATERNAL DIETARY LOADS; ZEBRAFISH DANIO-RERIO; EMBRYONIC-DEVELOPMENT; MORPHOLINO OLIGOS; GENE; ATAXIA; LOCALIZATION; TROPHOBLAST; EXPRESSION	The hepatic alpha-tocopherol transfer protein (TTP) is required for optimal alpha-tocopherol bioavailability in humans; mutations in the human TTPA gene result in the heritable disorder ataxia with vitamin E deficiency (AVED, OMIM #277460). TTP is also expressed in mammalian uterine and placental cells and in the human embryonic yolk-sac, underscoring TTP's significance during fetal development. TTP and vitamin E are essential for productive pregnancy in rodents, but their precise physiological role in embryogenesis is unknown. We hypothesize that TTP is required to regulate delivery of alpha-tocopherol to critical target sites in the developing embryo. We tested to find if TTP is essential for proper vertebrate development, utilizing the zebrafish as a non-placental model. We verify that TTP is expressed in the adult zebrafish and its amino acid sequence is homologous to the human ortholog. We show that embryonic transcription of TTP mRNA increases >7-fold during the first 24 hours following fertilization. In situ hybridization demonstrates that Ttpa transcripts are localized in the developing brain, eyes and tail bud at 1-day post fertilization. Inhibiting TTP expression using oligonucleotide morpholinos results in severe malformations of the head and eyes in nearly all morpholino-injected embryos (88% compared with 5.6% in those injected with control morpholinos or 1.7% in non-injected embryos). We conclude that TTP is essential for early development of the vertebrate central nervous system.	[Miller, Galen W.; Labut, Edwin M.; Lebold, Katie M.; Traber, Maret G.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Miller, Galen W.; Tanguay, Robert L.; Traber, Maret G.] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA; [Lebold, Katie M.; Traber, Maret G.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Barton, Carrie L.; Tanguay, Robert L.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Tanguay, Robert L.; Traber, Maret G.] Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA; [Ulatowski, Lynn; Manor, Danny] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Manor, Danny] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Atkinson, Jeffrey] Brock Univ, Dept Chem, St Catharines, ON L2S 3A1, Canada	Oregon State University; Oregon State University; Oregon State University; Oregon State University; Oregon State University; Case Western Reserve University; Case Western Reserve University; Brock University	Traber, MG (corresponding author), Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.	maret.traber@oregonstate.edu	Traber, Maret G./ABI-2511-2020; Ulatowski, Lynn/ABI-5652-2020	Traber, Maret G./0000-0002-2892-4024; Atkinson, Jeffrey/0000-0003-3710-4893	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD062109]; Aquatic Biomedical Models Facility Core of the Environmental Health Sciences Center, Oregon State University (National Institute of Environmental Health Sciences) [P30 ES000210]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD062109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Aquatic Biomedical Models Facility Core of the Environmental Health Sciences Center, Oregon State University (National Institute of Environmental Health Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This publication was made possible, in part, by the Aquatic Biomedical Models Facility Core of the Environmental Health Sciences Center, Oregon State University (National Institute of Environmental Health Sciences, P30 ES000210) and by a grant from The Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD062109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogini P, 2011, PHYSIOL BEHAV, V104, P809, DOI 10.1016/j.physbeh.2011.07.026; AMES SR, 1979, J NUTR, V109, P2198, DOI 10.1093/jn/109.12.2198; Bedell VM, 2011, BRIEF FUNCT GENOMICS, V10, P181, DOI 10.1093/bfgp/elr021; Betti M, 2011, J NUTR BIOCHEM, V22, P60, DOI 10.1016/j.jnutbio.2009.11.014; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Evans HM, 1922, SCIENCE, V56, P650, DOI 10.1126/science.56.1458.650; Food and Nutrition Board. Institute of Medicine, 2000, ACADEMY; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Ho E, 2012, COMP BIOCHEM PHYS C, V155, P26, DOI 10.1016/j.cbpc.2011.05.002; Jauniaux E, 2004, J CLIN ENDOCR METAB, V89, P1452, DOI 10.1210/jc.2003-031332; Jishage K, 2001, J BIOL CHEM, V276, P1669, DOI 10.1074/jbc.C000676200; Kaempf-Rotzoll DE, 2003, PLACENTA, V24, P439, DOI 10.1053/plac.2002.0966; Kaempf-Rotzoll DE, 2002, BIOL REPROD, V67, P599, DOI 10.1095/biolreprod67.2.599; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LETH T, 1977, J NUTR, V107, P2236, DOI 10.1093/jn/107.12.2236; Li ZQ, 2012, J BIOL CHEM, V287, P13005, DOI 10.1074/jbc.M112.347419; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Manor D, 2007, VITAM HORM, V76, P45, DOI 10.1016/S0083-6729(07)76003-X; Mariotti C, 2004, NEUROL SCI, V25, P130, DOI 10.1007/s10072-004-0246-z; Martin E, 2012, NEUROBIOL DIS, V48, P299, DOI 10.1016/j.nbd.2012.07.003; McBurney MI, 2011, J NUTR, V141, P1920, DOI 10.3945/jn.111.147330; Meier R, 2003, J MOL BIOL, V331, P725, DOI 10.1016/S0022-2836(03)00724-1; Miller GW, 2012, J NUTR BIOCHEM, V23, P478, DOI 10.1016/j.jnutbio.2011.02.002; Min KC, 2003, P NATL ACAD SCI USA, V100, P14713, DOI 10.1073/pnas.2136684100; Min KC, 2007, VITAM HORM, V76, P23; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Morley S, 2004, BIOCHEMISTRY-US, V43, P4143, DOI 10.1021/bi0363073; Muller-Schmehl K, 2004, FREE RADICAL RES, V38, P413, DOI 10.1080/10715760310001659611; Nava P, 2006, BIOORGAN MED CHEM, V14, P3721, DOI 10.1016/j.bmc.2006.01.053; Neto A, 2012, DEVELOPMENT, V139, P301, DOI 10.1242/dev.074856; Panagabko C, 2002, PROTEIN EXPRES PURIF, V24, P395, DOI 10.1006/prep.2001.1576; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Shichiri M, 2011, FREE RADICAL BIO MED, V50, P1801, DOI 10.1016/j.freeradbiomed.2011.03.023; Tallafuss A, 2012, DEVELOPMENT, V139, P1691, DOI 10.1242/dev.072702; Terasawa Y, 2000, P NATL ACAD SCI USA, V97, P13830, DOI 10.1073/pnas.240462697; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Usuki F, 2000, J NEUROL NEUROSUR PS, V69, P254, DOI 10.1136/jnnp.69.2.254; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zhang M, 2012, DEVELOPMENT, V139, P2009, DOI 10.1242/dev.074435	39	31	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47402	10.1371/journal.pone.0047402	http://dx.doi.org/10.1371/journal.pone.0047402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077608	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100106
J	Russell, SE; Moore, AC; Fallon, PG; Walsh, PT				Russell, Shane E.; Moore, Anne C.; Fallon, Padraic G.; Walsh, Patrick T.			Soluble IL-2R alpha (sCD25) Exacerbates Autoimmunity and Enhances the Development of Th17 Responses in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; INTERLEUKIN-2 RECEPTOR-ALPHA; RHEUMATOID-ARTHRITIS; CUTTING EDGE; IL-2; DISEASE; ACTIVATION; ANTIBODY; BETA	A strong association exists between mutations at the IL2 receptor alpha chain (CD25) gene locus and susceptibility to a number of T cell driven autoimmune diseases. Interestingly, the presence of certain CD25 susceptibility alleles has been correlated with significantly increased levels of the soluble form of CD25 (sCD25) in the serum of patients. However, the functional consequences, if any, of this observation are unknown. We have demonstrated that elevated levels of sCD25 in vivo resulted in exacerbated experimental autoimmune encephalomyelitis (EAE) and enhanced antigen-specific Th17 responses in the periphery. sCD25 exerted its effects early during the Th17 developmental programme in vitro, through inhibiting signalling downstream of the IL-2R. Although, sCD25 did not interact with the T cell surface, it specifically bound to secreted IL-2 demonstrating its ability to act as a decoy receptor for IL-2 in the T cell microenvironment. These data identify the ability of sCD25 to promote autoimmune disease pathogenesis and enhance Th17 responses through its ability to sequester local IL-2.	[Russell, Shane E.; Fallon, Padraic G.; Walsh, Patrick T.] Trinity Coll Dublin, Sch Med, Dept Clin Med, Dublin, Ireland; [Russell, Shane E.; Fallon, Padraic G.; Walsh, Patrick T.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Moore, Anne C.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland	Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University College Cork	Walsh, PT (corresponding author), Trinity Coll Dublin, Sch Med, Dept Clin Med, Dublin, Ireland.	walshp10@tcd.ie	Walsh, Patrick/I-7909-2014; Fallon, Padraic/Y-2711-2019	Walsh, Patrick/0000-0002-0130-8766; Fallon, Padraic/0000-0002-8401-7293; Moore, Anne/0000-0003-3656-4230	Science Foundation Ireland [10/YI/B1827]; Marie Curie Reintegration fellowship [Pirg05-GA-2009-246738]; National Childrens Research Centre	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Marie Curie Reintegration fellowship; National Childrens Research Centre	This work was supported by funding from Science Foundation Ireland (PIYRA award 10/YI/B1827) and a Marie Curie Reintegration fellowship (Pirg05-GA-2009-246738) and the National Childrens Research Centre (PRiTI programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Chistiakov DA, 2011, SCAND J IMMUNOL, V74, P496, DOI 10.1111/j.1365-3083.2011.02608.x; Dummer R, 1996, J INTERF CYTOK RES, V16, P315, DOI 10.1089/jir.1996.16.315; Heaney ML, 1998, J LEUKOCYTE BIOL, V64, P135, DOI 10.1002/jlb.64.2.135; JACQUES Y, 1990, J BIOL CHEM, V265, P20252; Junghans RP, 1998, P NATL ACAD SCI USA, V95, P1752, DOI 10.1073/pnas.95.4.1752; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Martin R, 2012, CLIN IMMUNOL, V142, P9, DOI 10.1016/j.clim.2011.10.008; OSAWA H, 1986, EUR J IMMUNOL, V16, P467, DOI 10.1002/eji.1830160426; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rouse M, 2012, IMMUNOBIOLOGY; RUBIN L A, 1990, Cytokine, V2, P330, DOI 10.1016/1043-4666(90)90062-X; RUBIN LA, 1986, J IMMUNOL, V137, P3841; RUBIN LA, 1990, ANN INTERN MED, V113, P619, DOI 10.7326/0003-4819-113-8-619; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; Suzuki H, 1999, J EXP MED, V190, P1561, DOI 10.1084/jem.190.11.1561; SYMONS JA, 1988, J IMMUNOL, V141, P2612; Turka LA, 2008, FRONT BIOSCI-LANDMRK, V13, P1440, DOI 10.2741/2773; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Witkowska AM, 2005, MEDIAT INFLAMM, P121, DOI 10.1155/MI.2005.121; Yang ZZ, 2011, BLOOD, V118, P2809, DOI 10.1182/blood-2011-03-340885; ZORN U, 1994, CYTOKINE, V6, P358, DOI 10.1016/1043-4666(94)90058-2	34	40	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47748	10.1371/journal.pone.0047748	http://dx.doi.org/10.1371/journal.pone.0047748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077668	Green Published, gold			2022-12-27	WOS:000309995100160
J	Molano, A; Huang, ZF; Marko, MG; Azzi, A; Wu, DY; Wang, E; Kelly, SL; Merrill, AH; Bunnell, SC; Meydani, SN				Molano, Alberto; Huang, Zhaofeng; Marko, Melissa G.; Azzi, Angelo; Wu, Dayong; Wang, Elaine; Kelly, Samuel L.; Merrill, Alfred H., Jr.; Bunnell, Stephen C.; Meydani, Simin Nikbin			Age-Dependent Changes in the Sphingolipid Composition of Mouse CD4(+) T Cell Membranes and Immune Synapses Implicate Glucosylceramides in Age-Related T Cell Dysfunction	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; CYTOKINE PRODUCTION; HUMAN-LYMPHOCYTES; CERAMIDE; SPHINGOSINE; ACCUMULATION; ASSOCIATION; INHIBITION; LONGEVITY; SYNTHASE	To determine whether changes in sphingolipid composition are associated with age-related immune dysfunction, we analyzed the core sphingolipidome (i.e., all of the metabolites through the first headgroup additions) of young and aged CD4(+) T cells. Since sphingolipids influence the biophysical properties of membranes, we evaluated the compositions of immune synapse (IS) and non-IS fractions prepared by magnetic immuno-isolation. Broadly, increased amounts of sphingomyelins, dihydrosphingomyelins and ceramides were found in aged CD4(+) T cells. After normalizing for total sphingolipid content, a statistically significant decrease in the molar fraction of glucosylceramides was evident in both the non-IS and IS fractions of aged T cells. This change was balanced by less dramatic increases in the molar fractions of sphingomyelins and dihydrosphingomyelins in aged CD4(+) T cells. In vitro, the direct or enzymatic enhancement of ceramide levels decreased CD4(+) T cell proliferation without regard for the age of the responding T cells. In contrast, the in vitro inhibition of glucosylceramidase preferentially increased the proliferation of aged CD4(+) T cells. These results suggest that reductions in glucosylceramide abundance contribute to age-related impairments in CD4(+) T cell function.	[Bunnell, Stephen C.; Meydani, Simin Nikbin] Tufts Univ, Dept Pathol, Sackler Grad Sch Biomed Sci, Boston, MA 02111 USA; [Molano, Alberto; Huang, Zhaofeng; Marko, Melissa G.; Azzi, Angelo; Meydani, Simin Nikbin] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Wang, Elaine; Kelly, Samuel L.; Merrill, Alfred H., Jr.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Tufts University; Tufts University; United States Department of Agriculture (USDA); University System of Georgia; Georgia Institute of Technology	Bunnell, SC (corresponding author), Tufts Univ, Dept Pathol, Sackler Grad Sch Biomed Sci, Boston, MA 02111 USA.	stephen.bunnell@tufts.edu; simin.meydani@tufts.edu		Merrill, Alfred/0000-0002-6673-968X; Bunnell, Stephen/0000-0001-6887-0828	United States Department of Agriculture-Agricultural Research Service (USDA-ARS) [58-1950-7-707]; National Institute on Aging (NIA) [R21-AG030931, R01-AG009140-14]; LIPID MAPS Consortium [GM069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG030931, R01AG009140] Funding Source: NIH RePORTER	United States Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); LIPID MAPS Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by United States Department of Agriculture-Agricultural Research Service (USDA-ARS) contract number 58-1950-7-707, National Institute on Aging (NIA) R21-AG030931, R01-AG009140-14, and LIPID MAPS Consortium grant GM069338. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson O, 2001, J IMMUNOL, V167, P3809, DOI 10.4049/jimmunol.167.7.3809; Agarwal S, 2010, ANN ALLERG ASTHMA IM, V104, P183, DOI 10.1016/j.anai.2009.11.009; Barbat C, 2007, BIOCHEM J, V402, P471, DOI 10.1042/BJ20061061; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; Blank N, 2005, BIOCHEM PHARMACOL, V71, P126, DOI 10.1016/j.bcp.2005.10.004; Camoletto PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005310; Castillo SS, 2007, EXP CELL RES, V313, P2680, DOI 10.1016/j.yexcr.2007.04.002; Chen YF, 2010, NEUROMOL MED, V12, P306, DOI 10.1007/s12017-010-8132-8; Cowart LA, 2007, J BIOL CHEM, V282, P12330, DOI 10.1074/jbc.M700685200; Dbaibo GS, 1998, J CLIN INVEST, V102, P329, DOI 10.1172/JCI1180; DBAIBO GS, 1995, P NATL ACAD SCI USA, V92, P1347, DOI 10.1073/pnas.92.5.1347; Elson EL, 2010, ANNU REV BIOPHYS, V39, P207, DOI 10.1146/annurev.biophys.093008.131238; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Garofalo T, 2002, J BIOL CHEM, V277, P11233, DOI 10.1074/jbc.M109601200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Huang SX, 2011, P NATL ACAD SCI USA, V108, P19335, DOI 10.1073/pnas.1112969108; Ikeda K, 2008, J LIPID RES, V49, P2678, DOI 10.1194/jlr.D800038-JLR200; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jazwinski SM, 2000, ACTA BIOCHIM POL, V47, P269, DOI 10.18388/abp.2000_4007; Jiang JC, 2004, EXP GERONTOL, V39, P999, DOI 10.1016/j.exger.2004.03.026; KANFER JN, 1975, BIOCHEM BIOPH RES CO, V67, P85, DOI 10.1016/0006-291X(75)90286-7; Kaucic K, 2006, METHOD ENZYMOL, V417, P168, DOI 10.1016/S0076-6879(06)17013-5; Lee JY, 2000, EXP CELL RES, V261, P303, DOI 10.1006/excr.2000.5028; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Marko MG, 2007, J IMMUNOL, V178, P1443, DOI 10.4049/jimmunol.178.3.1443; MARSH NL, 1995, J CLIN INVEST, V95, P2903, DOI 10.1172/JCI117997; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Nakamura S, 1996, J BIOL CHEM, V271, P1255, DOI 10.1074/jbc.271.3.1255; Natoli TA, 2010, NAT MED, V16, P788, DOI 10.1038/nm.2171; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; SHAYMAN JA, 1991, J BIOL CHEM, V266, P22968; Stefanic S, 2010, J LIPID RES, V51, P2527, DOI 10.1194/jlr.M003392; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Tamir A, 2000, J IMMUNOL, V165, P1243, DOI 10.4049/jimmunol.165.3.1243; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Zhu YX, 2011, J BIOL CHEM, V286, P14787, DOI 10.1074/jbc.M111.218610; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	48	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47650	10.1371/journal.pone.0047650	http://dx.doi.org/10.1371/journal.pone.0047650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110086	Green Published, Green Submitted, gold			2022-12-27	WOS:000310262500016
J	Lahti, P; Lindstrom, M; Somervuo, P; Heikinheimo, A; Korkeala, H				Lahti, Paivi; Lindstrom, Miia; Somervuo, Panu; Heikinheimo, Annamari; Korkeala, Hannu			Comparative Genomic Hybridization Analysis Shows Different Epidemiology of Chromosomal and Plasmid-Borne cpe-Carrying Clostridium perfringens Type A	PLOS ONE			English	Article							ENTEROTOXIN GENE CPE; GROWTH; PCR; IDENTIFICATION; ORGANIZATION; PREVALENCE; SURVIVAL; SEQUENCE; STRAINS; TOXINS	Clostridium perfringens, one of the most common causes of food poisonings, can carry the enterotoxin gene, cpe, in its chromosome or on a plasmid. C. perfringens food poisonings are more frequently caused by the chromosomal cpe-carrying strains, while the plasmid-borne cpe-positive genotypes are more commonly found in the human feces and environmental samples. Different tolerance to food processing conditions by the plasmid-borne and chromosomal cpe-carrying strains has been reported, but the reservoirs and contamination routes of enterotoxin-producing C. perfringens remain unknown. A comparative genomic hybridization (CGH) analysis with a DNA microarray based on three C. perfringens type A genomes was conducted to shed light on the epidemiology of C. perfringens food poisonings caused by plasmid-borne and chromosomal cpe-carrying strains by comparing chromosomal and plasmid-borne cpe-positive and cpe-negative C. perfringens isolates from human, animal, environmental, and food samples. The chromosomal and plasmid-borne cpe-positive C. perfringens genotypes formed two distinct clusters. Variable genes were involved with myo-inositol, ethanolamine and cellobiose metabolism, suggesting a new epidemiological model for C. perfringens food poisonings. The CGH results were complemented with growth studies, which demonstrated different myo-inositol, ethanolamine, and cellobiose metabolism between the chromosomal and plasmid-borne cpe-carrying strains. These findings support a ubiquitous occurrence of the plasmid-borne cpe-positive strains and their adaptation to the mammalian intestine, whereas the chromosomal cpe-positive strains appear to have a narrow niche in environments containing degrading plant material. Thus the epidemiology of the food poisonings caused by two populations appears different, the plasmid-borne cpe-positive strains probably contaminating foods via humans and the chromosomal strains being connected to plant material.	[Lahti, Paivi; Lindstrom, Miia; Somervuo, Panu; Heikinheimo, Annamari; Korkeala, Hannu] Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland	University of Helsinki	Lahti, P (corresponding author), Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland.	paivi.lahti@helsinki.fi		Korkeala, Hannu/0000-0003-0699-1290; Heikinheimo, Annamari/0000-0002-6559-5442	Finnish Centre of Excellence in Microbial Food Safety Research of the Academy of Finland	Finnish Centre of Excellence in Microbial Food Safety Research of the Academy of Finland	This work was supported by the Finnish Centre of Excellence in Microbial Food Safety Research of the Academy of Finland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brynestad S, 1997, MICROBIOL-UK, V143, P2109, DOI 10.1099/00221287-143-7-2109; Brynestad S, 2001, INFECT IMMUN, V69, P3483, DOI 10.1128/IAI.69.5.3483-3487.2001; Carman RJ, 2008, ANAEROBE, V14, P102, DOI 10.1016/j.anaerobe.2008.01.003; CORNILLOT E, 1995, MOL MICROBIOL, V15, P639, DOI 10.1111/j.1365-2958.1995.tb02373.x; Daube G, 1996, AM J VET RES, V57, P496; Deguchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005598; Grant KA, 2008, FOODBORNE PATHOG DIS, V5, P629, DOI 10.1089/fpd.2007.0066; Heikinheimo A, 2005, LETT APPL MICROBIOL, V40, P407, DOI 10.1111/j.1472-765X.2005.01702.x; Heikinheimo A, 2006, EMERG INFECT DIS, V12, P1724, DOI 10.3201/eid1211.060478; Ho KL, 2011, BIORESOURCE TECHNOL, V102, P8547, DOI 10.1016/j.biortech.2011.04.031; Kawsar HI, 2004, FEMS MICROBIOL LETT, V235, P289, DOI 10.1016/j.femsle.2004.04.047; Keto-Timonen R, 2005, APPL ENVIRON MICROB, V71, P1148, DOI 10.1128/AEM.71.3.1148-1154.2005; KOKAIKUN JF, 1994, J CLIN MICROBIOL, V32, P2533, DOI 10.1128/JCM.32.10.2533-2539.1994; LABBE RG, 2000, MICROBIOLOGICAL SAFE, P1110; Lahti P, 2008, J CLIN MICROBIOL, V46, P371, DOI 10.1128/JCM.01650-07; Li JH, 2007, APPL ENVIRON MICROB, V73, P7218, DOI 10.1128/AEM.01075-07; Li JH, 2006, APPL ENVIRON MICROB, V72, P4561, DOI 10.1128/AEM.00177-06; Li JH, 2006, APPL ENVIRON MICROB, V72, P7620, DOI 10.1128/AEM.01911-06; Lindstrom M, 2011, FOOD MICROBIOL, V28, P192, DOI 10.1016/j.fm.2010.03.020; Miki Y, 2008, APPL ENVIRON MICROB, V74, P5366, DOI 10.1128/AEM.00783-08; Miwa N, 1997, J VET MED SCI, V59, P557, DOI 10.1292/jvms.59.557; Miyamoto K, 2006, J BACTERIOL, V188, P1585, DOI 10.1128/JB.188.4.1585-1598.2006; Miyamoto K, 2004, J CLIN MICROBIOL, V42, P1552, DOI 10.1128/JCM.42.4.1552-1558.2004; Miyamoto K, 2002, INFECT IMMUN, V70, P4261, DOI 10.1128/IAI.70.8.4261-4272.2002; Mueller-Spitz SR, 2010, APPL ENVIRON MICROB, V76, P5556, DOI 10.1128/AEM.01702-09; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; R Core Team, 2020, R LANG ENV STAT COMP; ROOF DM, 1988, J BACTERIOL, V170, P3855, DOI 10.1128/jb.170.9.3855-3863.1988; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SEBALD M, 1975, APPL MICROBIOL, V29, P1; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Smedley JG, 2005, REV PHYSIOL BIOCH P, V152, P183, DOI 10.1007/s10254-004-0036-2; Sparks SG, 2001, J CLIN MICROBIOL, V39, P883, DOI 10.1128/JCM.39.3.883-888.2001; Streit WR, 2003, APPL MICROBIOL BIOT, V61, P21, DOI 10.1007/s00253-002-1186-2; Tanaka D, 2007, JPN J INFECT DIS, V60, P68; Tsoy O, 2009, J BACTERIOL, V191, P7157, DOI 10.1128/JB.00838-09; Wen QY, 2004, APPL ENVIRON MICROB, V70, P2685, DOI 10.1128/AEM.70.5.2685-2691.2004	39	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e46162	10.1371/journal.pone.0046162	http://dx.doi.org/10.1371/journal.pone.0046162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094024	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200008
J	Lucas, R; Fraga, S; Ramos, E; Barros, H				Lucas, Raquel; Fraga, Silvia; Ramos, Elisabete; Barros, Henrique			Early Initiation of Smoking and Alcohol Drinking as a Predictor of Lower Forearm Bone Mineral Density in Late Adolescence: A Cohort Study in Girls	PLOS ONE			English	Article							BIOPSYCHOSOCIAL VARIABLES; RISK; MASS; DETERMINANTS; OSTEOPOROSIS; CONSUMPTION; FRACTURE; TOBACCO; HEALTH; WOMEN	Background: Adolescence is a critical stage for bone accrual. It is also decisive for the establishment of behaviors such as smoking and alcohol drinking. Objective: To quantify the short-and long-term associations between smoking and drinking initiation and bone mineral density in adolescent girls. Methods: We used prospective data from 731 girls identified in public and private schools in Porto, Portugal. Evaluations were conducted when participants were 13 and 17 years old. Bone mineral density (BMD) was measured at the forearm by dual-energy X-ray absorptiometry and weight, height and fat-free mass were measured. Pubertal development status was estimated using menarche age. Self-administered questionnaires were used to collect data on smoking and alcohol drinking, physical exercise and calcium and vitamin D intakes. BMD in early and late adolescence was analyzed as a continuous or dichotomous (Z-score cutoff: -1.0) variable. Associations were calculated using linear or logistic regression. Results: Over one quarter of these girls had tried smoking by 13, while 59% had drunk alcoholic beverages and 20% had experienced both behaviors by that age. Lower mean BMD at 17 years of age was observed in girls who had ever smoked by 13, as well as in those who reported drinking at that age. There were no significant cross-sectional associations between experience and frequency of smoking or drinking and BMD at 13 years of age. However, we observed significant associations between BMD z-score<-1 in late adolescence and having ever smoked by 13, after adjustment for menarche age and sports practice, (OR = 1.92; 95% CI: 1.21, 3.05) and with ever smoking and drinking in the same period (OR = 2.33; 95% CI: 1.36, 4.00). Conclusion: Our study adds prospective evidence to the role of early initiation of smoking and alcohol drinking as relevant markers of lower bone mineral density in late adolescence.	[Lucas, Raquel; Fraga, Silvia; Ramos, Elisabete; Barros, Henrique] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, P-4100 Oporto, Portugal; [Lucas, Raquel; Fraga, Silvia; Ramos, Elisabete; Barros, Henrique] Univ Porto, Inst Publ Hlth, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Lucas, R (corresponding author), Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	rlucas@med.up.pt	Ramos, Elisabete/F-3473-2013; Barros, Henrique/A-5488-2008; Barros, Henrique/Q-8609-2019	Ramos, Elisabete/0000-0001-6573-218X; Barros, Henrique/0000-0003-4699-6571; Fraga, Silvia/0000-0002-5268-7751; Lucas, Raquel/0000-0002-4408-8134	Portuguese Foundation for Science and Technology [PTDC/SAU-ESA/108407/2008, PTDC/SAU-EPI/115254/2009, SFRH/BD/40656/2007]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese Foundation for Science and Technology: Grant numbers PTDC/SAU-ESA/108407/2008, PTDC/SAU-EPI/115254/2009, and SFRH/BD/40656/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachrach LK, 2001, TRENDS ENDOCRIN MET, V12, P22, DOI 10.1016/S1043-2760(00)00336-2; Baim S, 2008, J CLIN DENSITOM, V11, P6, DOI 10.1016/j.jocd.2007.12.002; Berg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012; Botvin GJ, 2007, INT REV PSYCHIATR, V19, P607, DOI 10.1080/09540260701797753; Bouxsein ML, 2003, OSTEOPOROSIS INT, V14, pS118, DOI 10.1007/s00198-003-1489-x; Brener ND, 2003, J ADOLESCENT HEALTH, V33, P436, DOI 10.1016/S1054-139X(03)00052-1; Clark EM, 2006, PEDIATRICS, V117, pE291, DOI 10.1542/peds.2005-1404; Coleman L, 2002, J ADOLESCENCE, V25, P535, DOI 10.1006/jado.2002.0494; Crabtree NJ, 2007, CURR CLIN PRACT, P41, DOI 10.1007/978-1-59745-211-3_3; Elgan C, 2003, CONTRACEPTION, V67, P439, DOI 10.1016/S0010-7824(03)00048-9; Fraga S, 2011, J PUBLIC HEALTH-HEID, V19, pS21, DOI 10.1007/s10389-010-0376-0; Harel Z, 2007, J ADOLESCENT HEALTH, V40, P44, DOI 10.1016/j.jadohealth.2006.08.013; Harel Z, 2010, CONTRACEPTION, V82, P503, DOI 10.1016/j.contraception.2010.04.022; Hawker GA, 2002, AM J EPIDEMIOL, V156, P418, DOI 10.1093/aje/kwf061; Heaney RP, 2003, AM J CLIN NUTR, V78, P350, DOI 10.1093/ajcn/78.2.350; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Hernandez CJ, 2003, OSTEOPOROSIS INT, V14, P843, DOI 10.1007/s00198-003-1454-8; HOPPER JL, 1994, NEW ENGL J MED, V330, P387, DOI 10.1056/NEJM199402103300603; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; Jugdaohsingh R, 2006, P NUTR SOC, V65, P291, DOI 10.1079/PNS2006508; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Koo MM, 1997, ANN HUM BIOL, V24, P61, DOI 10.1080/03014469700004782; Korkor Adel B, 2009, WMJ, V108, P181; Lopes C, 2007, J AM DIET ASSOC, V107, P276, DOI 10.1016/j.jada.2006.11.008; Lorentzon M, 2007, J CLIN ENDOCR METAB, V92, P497, DOI 10.1210/jc.2006-1294; Maurel DB, 2012, OSTEOPOROSIS INT, V23, P1, DOI 10.1007/s00198-011-1787-7; Mikkola TM, 2008, J BONE MINER RES, V23, P492, DOI 10.1359/JBMR.071205; OrtegoCenteno N, 1997, CALCIFIED TISSUE INT, V60, P496, DOI 10.1007/s002239900270; Powell S, 2008, J CLIN ENDOCR METAB, V93, P521, DOI 10.1210/jc.2007-1139; Ralston SH, 2007, P NUTR SOC, V66, P158, DOI 10.1017/S002966510700540X; Ramos E, 2007, ACTA PAEDIATR, V96, P281, DOI 10.1111/j.1651-2227.2007.00107.x; Ronis Martin J J, 2011, Curr Osteoporos Rep, V9, P53, DOI 10.1007/s11914-011-0049-0; Taes Y, 2010, J BONE MINER RES, V25, P379, DOI 10.1359/jbmr.090809; Turner RT, 2000, ALCOHOL CLIN EXP RES, V24, P1693, DOI 10.1111/j.1530-0277.2000.tb01971.x; Turner RT, 2001, ALCOHOL RES HEALTH, V25, P276; VALIMAKI MJ, 1994, BMJ-BRIT MED J, V309, P230, DOI 10.1136/bmj.309.6949.230; Waugh EJ, 2009, OSTEOPOROSIS INT, V20, P1, DOI 10.1007/s00198-008-0643-x; Wong PKK, 2007, CLIN SCI, V113, P233, DOI 10.1042/CS20060173; Yan C, CURR OSTEOPOROS REP, V9, P202; Yoon V, 2012, OSTEOPOROSIS INT, V23, P2081, DOI 10.1007/s00198-012-1940-y	40	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e46940	10.1371/journal.pone.0046940	http://dx.doi.org/10.1371/journal.pone.0046940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054ZN	23094033	Green Published, gold, Green Submitted			2022-12-27	WOS:000312384500005
J	Booy, R; Lindley, RI; Dwyer, DE; Yin, JHK; Heron, LG; Moffatt, CRM; Chiu, CK; Rosewell, AE; Dean, AS; Dobbins, T; Philp, DJ; Gao, ZH; MacIntyre, CR				Booy, Robert; Lindley, Richard I.; Dwyer, Dominic E.; Yin, Jiehui K.; Heron, Leon G.; Moffatt, Cameron R. M.; Chiu, Clayton K.; Rosewell, Alexander E.; Dean, Anna S.; Dobbins, Timothy; Philp, David J.; Gao, Zhanhai; MacIntyre, C. Raina			Treating and Preventing Influenza in Aged Care Facilities: A Cluster Randomised Controlled Trial	PLOS ONE			English	Article							NEURAMINIDASE INHIBITOR OSELTAMIVIR; LABORATORY DIAGNOSIS; VIRUS-INFECTION; SURVEILLANCE; OUTBREAKS; EFFICACY; TESTS	Background: Influenza is an important cause of morbidity and mortality for frail older people. Whilst the antiviral drug oseltamivir (a neuraminidase inhibitor) is approved for treatment and prophylaxis of influenza during outbreaks, there have been no trials comparing treatment only (T) versus treatment and prophylaxis (T&P) in Aged Care Facilities (ACFs). Our objective was to compare a policy of T versus T&P for influenza outbreaks in ACFs. Methods and Findings: We performed a cluster randomised controlled trial in 16 ACFs, that followed a policy of either "T"-oseltamivir treatment (75 mg twice a day for 5 days)-or "T&P"-treatment and prophylaxis (75 mg once a day for 10 days) for influenza outbreaks over three years, in addition to enhanced surveillance. The primary outcome measure was the attack rate of influenza. Secondary outcomes measures were deaths, hospitalisation, pneumonia and adverse events. Laboratory testing was performed to identify the viral cause of influenza-like illness (ILI) outbreaks. The study period 30 June 2006 to 23 December 2008 included three southern hemisphere winters. During that time, influenza was confirmed as the cause of nine of the 23 ILI outbreaks that occurred amongst the 16 ACFs. The policy of T&P resulted in a significant reduction in the influenza attack rate amongst residents: 93/255 (36%) in residents in T facilities versus 91/397 (23%) in T&P facilities (p = 0.002). We observed a non-significant reduction in staff: 46/216 (21%) in T facilities versus 47/350 (13%) in T&P facilities (p = 0.5). There was a significant reduction in mean duration of outbreaks (T = 24 days, T&P = 11 days, p = 0.04). Deaths, hospitalisations and pneumonia were non-significantly reduced in the T&P allocated facilities. Drug adverse events were common but tolerated. Conclusion: Our trial lacked power but these results provide some support for a policy of "treatment and prophylaxis" with oseltamivir in controlling influenza outbreaks in ACFs.	[Lindley, Richard I.] Univ Sydney, Discipline Med, Sydney, NSW 2006, Australia; [Lindley, Richard I.] George Inst Global Hlth, Sydney, NSW, Australia; [Booy, Robert; Yin, Jiehui K.; Heron, Leon G.; Moffatt, Cameron R. M.; Chiu, Clayton K.; Rosewell, Alexander E.; Dean, Anna S.] Univ Sydney, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Sydney, NSW 2006, Australia; [Dwyer, Dominic E.] Univ Sydney, Ctr Infect Dis & Microbiol Lab Serv, Inst Clin Pathol & Med Res, Westmead Hosp, Sydney, NSW 2006, Australia; [Dwyer, Dominic E.] Univ Sydney, Sydney Inst Emerging Infect & Biosecur, Sydney, NSW 2006, Australia; [Dobbins, Timothy] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Gao, Zhanhai; MacIntyre, C. Raina] Univ New S Wales, Fac Med, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	University of Sydney; George Institute for Global Health; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of New South Wales Sydney	Lindley, RI (corresponding author), Univ Sydney, Discipline Med, Sydney, NSW 2006, Australia.	Richard.lindley@sydney.edu.au	Lindley, Richard/B-8148-2013; Dobbins, Timothy A/I-5819-2013; Dobbins, Timothy/AAS-1422-2020; Moffatt, Cameron R M/AAM-8740-2020	Lindley, Richard/0000-0002-0104-5679; Dobbins, Timothy A/0000-0003-1841-9056; Dobbins, Timothy/0000-0003-1841-9056; Moffatt, Cameron R M/0000-0003-1717-1853; Dean, Anna/0000-0002-9539-7164; MacIntyre, C Raina/0000-0002-3060-0555	Australian Research Council [LP0668279]; Moran Health Care Group; Roche; CSL; Sanofi; GlaxoSmithKline (GSK); Wyeth; Novartis; Sanofi Pasteur; Merck	Australian Research Council(Australian Research Council); Moran Health Care Group; Roche(Roche Holding); CSL; Sanofi; GlaxoSmithKline (GSK)(GlaxoSmithKline); Wyeth(Wyeth); Novartis(Novartis); Sanofi Pasteur; Merck(Merck & Company)	This work was funded by the Australian Research Council, Linkage Project Scheme LP0668279 with the Moran Health Care Group as partner (http://www.arc.gov.au/). Roche (http://www.roche.com/) provided the oseltamivir and additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Richard Lindley has been a paid consultant for CSL in his role of Chairman of Data Monitoring Committees for influenza vaccines. He currently holds the position of Moran Foundation for Older Australians Professor of Geriatric Medicine. The Moran Health Care group were the industrial partners for this study. Robert Booy has received funding from CSL, Roche, Sanofi, GlaxoSmithKline (GSK) and Wyeth to attend and present at scientific meetings; any funding received is directed to a research account at the Children's Hospital at Westmead. Leon Heron has performed consultancy work for Novartis for which payment was made to the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. He has had travel expenses covered by GSK and Sanofi Pasteur and has conducted sponsored research and investigator-driven research with funding from GSK, Wyeth, Merck, CSL, Roche, and Sanofi Pasteur. David J. Philp's university has received support from GSK and CSL to perform work on pneumococcal transmission and HPV transmission and vaccination and has received payment from CSL for consultancy. The trial was also supported by Roche, but this support does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ageing DoHa, 2005, GUID PREV CONTR INFL; Australian Technical Advisory Group on Immunisation (ATAGI), 2009, AUSTR IMM HDB; Barlow G, 2000, LANCET, V355, P1187, DOI 10.1016/S0140-6736(05)72268-6; Berg HF, 2003, J INFECTION, V46, P129, DOI 10.1053/jinf.2002.1104; Bush Kym A, 2004, Commun Dis Intell Q Rep, V28, P396; Communicable Diseases Network Australia, 2009, PRACT GUID ASS PREV; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gaillat J, 2009, EUR J CLIN MICROBIOL, V28, P1077, DOI 10.1007/s10096-009-0751-3; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Ludbrook J, 1998, AM STAT, V52, P127, DOI 10.2307/2685470; MacIntyre CR, 2011, INFLUENZA OTHER RESP, V5, P170, DOI 10.1111/j.1750-2659.2011.00198.x; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Owen R, 2008, COMMUN DIS INTELL, V32, P208; Playford EG, 2002, PATHOLOGY, V34, P115, DOI 10.1080/003130201201117909; Ridda I, 2008, AUSTRALAS J AGEING, V27, P61, DOI 10.1111/j.1741-6612.2008.00288.x; Rosewell A, 2010, EPIDEMIOL INFECT, V138, P1126, DOI 10.1017/S0950268809991440; Sartor C, 2002, INFECT CONT HOSP EP, V23, P615, DOI 10.1086/501981; Schilling M, 1998, VACCINE, V16, P1771, DOI 10.1016/S0264-410X(98)00141-8; Taylor J, 2009, J MED VIROL, V81, P1918, DOI 10.1002/jmv.21604; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016	28	29	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46509	10.1371/journal.pone.0046509	http://dx.doi.org/10.1371/journal.pone.0046509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082123	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900018
J	Comenge, J; Sotelo, C; Romero, F; Gallego, O; Barnadas, A; Parada, TGC; Dominguez, F; Puntes, VF				Comenge, Joan; Sotelo, Carmen; Romero, Francisco; Gallego, Oscar; Barnadas, Agusti; Garcia-Caballero Parada, Tomas; Dominguez, Fernando; Puntes, Victor F.			Detoxifying Antitumoral Drugs via Nanoconjugation: The Case of Gold Nanoparticles and Cisplatin	PLOS ONE			English	Article							TUMOR VASCULAR-PERMEABILITY; IN-VIVO; CANCER-THERAPY; OXIDE NANOPARTICLES; TARGETED DELIVERY; BIODISTRIBUTION; SIZE; THERAPEUTICS; TOXICITY; SYSTEMS	Nanoparticles (NPs) have emerged as a potential tool to improve cancer treatment. Among the proposed uses in imaging and therapy, their use as a drug delivery scaffold has been extensively highlighted. However, there are still some controversial points which need a deeper understanding before clinical application can occur. Here the use of gold nanoparticles (AuNPs) to detoxify the antitumoral agent cisplatin, linked to a nanoparticle via a pH-sensitive coordination bond for endosomal release, is presented. The NP conjugate design has important effects on pharmacokinetics, conjugate evolution and biodistribution and results in an absence of observed toxicity. Besides, AuNPs present unique opportunities as drug delivery scaffolds due to their size and surface tunability. Here we show that cisplatin-induced toxicity is clearly reduced without affecting the therapeutic benefits in mice models. The NPs not only act as carriers, but also protect the drug from deactivation by plasma proteins until conjugates are internalized in cells and cisplatin is released. Additionally, the possibility to track the drug (Pt) and vehicle (Au) separately as a function of organ and time enables a better understanding of how nanocarriers are processed by the organism.	[Sotelo, Carmen; Dominguez, Fernando] Univ Santiago de Compostela, Dept Physiol, Fac Med, Santiago De Compostela, Spain; [Comenge, Joan; Puntes, Victor F.] Univ Autonoma Barcelona, ICN, E-08193 Barcelona, Spain; [Comenge, Joan] Int Iberian Nanotechnol Lab INL, Braga, Portugal; [Romero, Francisco] Univ Valencia, Inst Mol Sci, Paterna, Spain; [Gallego, Oscar; Barnadas, Agusti] St Pau Hosp, Dept Oncol, Barcelona, Spain; [Garcia-Caballero Parada, Tomas] Univ Santiago de Compostela, Clin Hosp, Sch Med Univ, Dept Morphol Sci, Santiago De Compostela, Spain; [Puntes, Victor F.] ICREA, Barcelona, Spain	Universidade de Santiago de Compostela; Autonomous University of Barcelona; International Iberian Nanotechnology Laboratory; University of Valencia; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; ICREA	Puntes, VF (corresponding author), Univ Santiago de Compostela, Dept Physiol, Fac Med, Santiago De Compostela, Spain.	fernando.dominguez@usc.es; victor.puntes@icn.cat	Puntes, Victor/AAL-6081-2021; Puntes, Víctor F./F-8407-2013; Romero, Francisco M./M-1683-2013	Puntes, Victor/0000-0001-8996-9499; Puntes, Víctor F./0000-0001-8996-9499; Romero, Francisco M./0000-0002-1936-0781; dominguez, fernando/0000-0002-5003-4335	Spanish Government [MAT2009-14734-C02-01, MAT2009-14734-C02-02, CSD2006-00012]; Catalan Government [VALTEC09-2-0085, VALTEC09-2-0089, 2009-SGR-776]; ICREA Funding Source: Custom	Spanish Government(Spanish GovernmentEuropean Commission); Catalan Government; ICREA(ICREA)	The authors acknowledge financial support from the grants "Plan Nacional" (MAT2009-14734-C02-01 and MAT2009-14734-C02-02) and NANOBIOMED-CONSOLIDER (CSD2006-00012) from the Spanish Government. Also grants VALTEC09-2-0085, VALTEC09-2-0089, and 2009-SGR-776 from the Catalan Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhalim MAK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-133; Ajima K, 2008, ACS NANO, V2, P2057, DOI 10.1021/nn800395t; Arvizo RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024374; Bajaj G, PHARM RES, V27, P735; Bastus NG, 2008, NANOTOXICOLOGY, V2, P99, DOI 10.1080/17435390802217830; Bastus NG, 2011, LANGMUIR, V27, P11098, DOI 10.1021/la201938u; Bastus NG, 2009, ACS NANO, V3, P1335, DOI 10.1021/nn8008273; Bishop KJM, 2007, CHEMPHYSCHEM, V8, P2171, DOI 10.1002/cphc.200700349; Borm P, 2006, TOXICOL SCI, V90, P23, DOI 10.1093/toxsci/kfj084; Burger KNJ, 2002, NAT MED, V8, P81, DOI 10.1038/nm0102-81; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Chen YS, 2009, NANOSCALE RES LETT, V4, P858, DOI 10.1007/s11671-009-9334-6; Cheng K, 2009, J AM CHEM SOC, V131, P10637, DOI 10.1021/ja903300f; Cheng LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025433; Chithrani DB, RAD RES, V173, P719; Cho WS, 2009, TOXICOL APPL PHARM, V236, P16, DOI 10.1016/j.taap.2008.12.023; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Comenge J, 2010, J CONTROL RELEASE, V148, pE31, DOI 10.1016/j.jconrel.2010.07.041; Craig GE, 2012, INORG CHEM, V51, P3490, DOI 10.1021/ic202197g; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; DECONTI RC, 1973, CANCER RES, V33, P1310; Dhar S, 2011, P NATL ACAD SCI USA, V108, P1850, DOI 10.1073/pnas.1011379108; Dhar S, 2009, J AM CHEM SOC, V131, P14652, DOI 10.1021/ja9071282; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Dreher MR, 2007, JNCI-J NATL CANCER I, V99, P983, DOI 10.1093/jnci/djm042; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; El-Sayed IH, 2005, NANO LETT, V5, P829, DOI 10.1021/nl050074e; El-Sayed IH, 2006, CANCER LETT, V239, P129, DOI 10.1016/j.canlet.2005.07.035; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; Feazell RP, 2007, J AM CHEM SOC, V129, P8438, DOI 10.1021/ja073231f; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Graham MA, 2000, CLIN CANCER RES, V6, P1205; Griset AP, 2009, J AM CHEM SOC, V131, P2469, DOI 10.1021/ja807416t; Gupta AK, 2007, NANOMEDICINE-UK, V2, P23, DOI 10.2217/17435889.2.1.23; Han G, 2007, NANOMEDICINE-UK, V2, P113, DOI 10.2217/17435889.2.1.113; Heckel K, 2004, AM J PHYSIOL-LUNG C, V287, pL867, DOI 10.1152/ajplung.00078.2004; Huang XL, 2008, J MATER SCI-MATER M, V19, P2581, DOI 10.1007/s10856-007-3210-7; Jabr-Milane LS, 2008, CANCER TREAT REV, V34, P592, DOI 10.1016/j.ctrv.2008.04.003; Jain PK, 2007, NANO TODAY, V2, P18, DOI 10.1016/S1748-0132(07)70016-6; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Kato T, 2003, CELL TISSUE RES, V311, P47, DOI 10.1007/s00441-002-0647-3; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kelland LR, 2000, PLATINUM BASED DRUGS; Khlebtsov N, 2011, CHEM SOC REV, V40, P1647, DOI 10.1039/c0cs00018c; Kim B, 2010, NAT NANOTECHNOL, V5, P465, DOI [10.1038/nnano.2010.58, 10.1038/NNANO.2010.58]; Lasagna-Reeves C, 2010, BIOCHEM BIOPH RES CO, V393, P649, DOI 10.1016/j.bbrc.2010.02.046; Lipka J, 2010, BIOMATERIALS, V31, P6574, DOI 10.1016/j.biomaterials.2010.05.009; Lu HX, 2007, CANCER CHEMOTH PHARM, V59, P175, DOI 10.1007/s00280-006-0256-z; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Madaan A, 2012, ONCOLOGY, P1; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Amigo JM, 2011, ANAL CHIM ACTA, V683, P170, DOI 10.1016/j.aca.2010.10.014; McMahon SJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00018; Mehta D, 2004, AM J PHYSIOL-LUNG C, V287, pL1081, DOI 10.1152/ajplung.00268.2004; Meng H, 2011, ACS NANO, V5, P4131, DOI 10.1021/nn200809t; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Mikhail AS, 2009, J CONTROL RELEASE, V138, P214, DOI 10.1016/j.jconrel.2009.04.010; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Minelli C, 2010, SMALL, V6, P2336, DOI 10.1002/smll.201000523; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Moreno D, 2010, EUR J PHARM BIOPHARM, V74, P265, DOI 10.1016/j.ejpb.2009.10.005; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; Nam J, 2009, J AM CHEM SOC, V131, P13639, DOI 10.1021/ja902062j; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Niu JL, 2007, CARDIOVASC RES, V73, P549, DOI 10.1016/j.cardiores.2006.11.031; Ojea-Jimenez I, 2009, J AM CHEM SOC, V131, P13320, DOI 10.1021/ja902894s; Oliver TG, GENES DEV, V24, P837; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Paciotti GF, 2006, DRUG DEVELOP RES, V67, P47, DOI 10.1002/ddr.20066; Peleg-Shulman T, 2002, J INORG BIOCHEM, V91, P306, DOI 10.1016/S0162-0134(02)00362-8; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Pujals S, 2009, CHEMBIOCHEM, V10, P1025, DOI 10.1002/cbic.200800843; Reedijk J, 2003, P NATL ACAD SCI USA, V100, P3611, DOI 10.1073/pnas.0737293100; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Ren L, 2003, MAT SCI ENG C-BIO S, V23, P113, DOI 10.1016/S0928-4931(02)00247-3; Ren L, 2008, J BIOMED MATER RES A, V85A, P787, DOI 10.1002/jbm.a.31608; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; Ruenraroengsak P, J CONTROLLED RELEASE, V141, P265; Ruenraroengsak P, 2010, J CONTROL RELEASE, V141, P265, DOI 10.1016/j.jconrel.2009.10.032; Simpson CA, 2010, CHEM RES TOXICOL, V23, P1608, DOI 10.1021/tx100209t; Sinha R, 2006, MOL CANCER THER, V5, P1909, DOI 10.1158/1535-7163.MCT-06-0141; Sonavane G, 2008, COLLOID SURFACE B, V66, P274, DOI 10.1016/j.colsurfb.2008.07.004; Sperling RA, 2009, CURR DRUG METAB, V10, P895, DOI 10.2174/138920009790274577; Takakura Y, 1996, PHARMACEUT RES, V13, P820, DOI 10.1023/A:1016084508097; Thakor AS, 2011, NANO LETT, V11, P4029, DOI 10.1021/nl202559p; Tseng CL, 2009, BIOMATERIALS, V30, P3476, DOI 10.1016/j.biomaterials.2009.03.010; Varmus H, 2006, SCIENCE, V312, P1162, DOI 10.1126/science.1126758; Vasir JK, 2005, CURR NANOSCI, V1, P47, DOI 10.2174/1573413052953110; Vickers AEM, 2004, TOXICOL PATHOL, V32, P577, DOI 10.1080/01926230490508821; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Zhang GD, 2009, BIOMATERIALS, V30, P1928, DOI 10.1016/j.biomaterials.2008.12.038; Zhang XD, 2011, INT J NANOMED, V6, P2071, DOI 10.2147/IJN.S21657; Zhang XD, 2010, INT J NANOMED, V5, P771, DOI 10.2147/IJN.S8428	98	68	70	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47562	10.1371/journal.pone.0047562	http://dx.doi.org/10.1371/journal.pone.0047562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082177	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900073
J	Dai, MX; Freeman, B; Shikani, HJ; Bruno, FP; Collado, JE; Macias, R; Reznik, SE; Davies, P; Spray, DC; Tanowitz, HB; Weiss, LM; Desruisseaux, MS				Dai, Minxian; Freeman, Brandi; Shikani, Henry J.; Bruno, Fernando Pereira; Elias Collado, J.; Macias, Rolando; Reznik, Sandra E.; Davies, Peter; Spray, David Conover; Tanowitz, Herbert Bernard; Weiss, Louis Martin; Desruisseaux, Mahalia Sabrina			Altered Regulation of Akt Signaling with Murine Cerebral Malaria, Effects on Long-Term Neuro-Cognitive Function, Restoration with Lithium Treatment	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; SEVERE FALCIPARUM-MALARIA; PAIRED HELICAL FILAMENTS; N-ACETYL ASPARTATE; ALZHEIMERS-DISEASE; PLASMODIUM-FALCIPARUM; CELL-SURVIVAL; CEREBROSPINAL-FLUID; TAU PATHOLOGY; BLOOD-FLOW	Neurological and cognitive impairment persist in more than 20% of cerebral malaria (CM) patients long after successful antiparasitic treatment. We recently reported that long term memory and motor coordination deficits are also present in our experimental cerebral malaria model (ECM). We also documented, in a murine model, a lack of obvious pathology or inflammation after parasite elimination, suggesting that the long-term negative neurological outcomes result from potentially reversible biochemical and physiological changes in brains of ECM mice, subsequent to acute ischemic and inflammatory processes. Here, we demonstrate for the first time that acute ECM results in significantly reduced activation of protein kinase B (PKB or Akt) leading to decreased Akt phosphorylation and inhibition of the glycogen kinase synthase (GSK3 beta) in the brains of mice infected with Plasmodium berghei ANKA (PbA) compared to uninfected controls and to mice infected with the non-neurotrophic P. berghei NK65 (PbN). Though Akt activation improved to control levels after chloroquine treatment in PbA-infected mice, the addition of lithium chloride, a compound which inhibits GSK3 beta activity and stimulates Akt activation, induced a modest, but significant activation of Akt in the brains of infected mice when compared to uninfected controls treated with chloroquine with and without lithium. In addition, lithium significantly reversed the long-term spatial and visual memory impairment as well as the motor coordination deficits which persisted after successful anti-parasitic treatment. GSK3 beta inhibition was significantly increased after chloroquine treatment, both in lithium and non-lithium treated PbA-infected mice. These data indicate that acute ECM is associated with abnormalities in cell survival pathways that result in neuronal damage. Regulation of Akt/GSK3 beta with lithium reduces neuronal degeneration and may have neuroprotective effects in ECM. Aberrant regulation of Akt/GSK3 beta signaling likely underlies long-term neurological sequelae observed in ECM and may yield adjunctive therapeutic targets for the management of CM.	[Dai, Minxian; Freeman, Brandi; Shikani, Henry J.; Bruno, Fernando Pereira; Davies, Peter; Tanowitz, Herbert Bernard; Weiss, Louis Martin; Desruisseaux, Mahalia Sabrina] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Dai, Minxian; Reznik, Sandra E.] St Johns Univ, Coll Pharm & Allied Hlth Profess, Dept Pharmaceut Sci, Queens, NY USA; [Elias Collado, J.] Pontificia Univ Catolica Madrey Maestra, Santiago, Dominican Rep; [Macias, Rolando] Meharry Med Coll, Nashville, TN 37208 USA; [Davies, Peter; Spray, David Conover] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Davies, Peter] Feinstein Inst Med Res, Litwin Zucker Ctr Study Alzheimers Dis & Memory D, Manhasset, NY USA; [Spray, David Conover; Tanowitz, Herbert Bernard; Weiss, Louis Martin; Desruisseaux, Mahalia Sabrina] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Saint John's University; Pontificia Universidad Catolica Madre y Maestra; Meharry Medical College; Yeshiva University; Albert Einstein College of Medicine; Northwell Health; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Desruisseaux, MS (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	m.desruis@einstein.yu.edu	Bruno, Fernando P/H-1073-2015; Desruisseaux, Mahalia S/GOK-0005-2022	Bruno, Fernando P/0000-0002-4561-5290; Spray, David/0000-0001-8368-5073; Desruisseaux, Mahalia/0000-0003-2060-412X	National Institutes of Health (NIH) Training Grant in Mechanisms of Cardiovascular Diseases [T32 HL07675]; Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine; Burroughs-Wellcome Fund's Career Awards for Medical Scientists; Einstein-Montefiore Institute for Clinical and Translational Research Career Development Award; NIH Training Grant in Geographic Medicine and Emerging Infections [T32AI070117]; NIH Training Grant in Molecular Neuropathology [T32 NS007098-31]; NIH Global Infectious Disease Research Training Program [D43 TW007129, NS069577, AI076248, AI39454, NS041282]; Department of Psychiatry and Behavioral Sciences Neuroscience Fellowship, Albert Einstein College of Medicine; FOGARTY INTERNATIONAL CENTER [D43TW007129] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070117, R01AI076248, R01AI039454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007098, R01NS069577] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Training Grant in Mechanisms of Cardiovascular Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine; Burroughs-Wellcome Fund's Career Awards for Medical Scientists(Burroughs Wellcome Fund); Einstein-Montefiore Institute for Clinical and Translational Research Career Development Award; NIH Training Grant in Geographic Medicine and Emerging Infections; NIH Training Grant in Molecular Neuropathology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Global Infectious Disease Research Training Program; Department of Psychiatry and Behavioral Sciences Neuroscience Fellowship, Albert Einstein College of Medicine; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH) Training Grant in Mechanisms of Cardiovascular Diseases T32 HL07675 (MSD) (NIH.gov); Dominick P. Purpura Department of Neuroscience and Department of Psychiatry and Behavioral Sciences Neuroscience Fellowship (MSD), Albert Einstein College of Medicine; Burroughs-Wellcome Fund's Career Awards for Medical Scientists (MSD) (http://www.bwfund.org/pages/188/Career-Awards-for-Medical-Scientists/); Einstein-Montefiore Institute for Clinical and Translational Research Career Development Award (MSD) (http://www.einstein.yu.edu/ictr/home.aspx); the NIH Training Grant in Geographic Medicine and Emerging Infections T32AI070117 (BF, HBT); the NIH Training Grant in Molecular Neuropathology T32 NS007098-31 (HJS); the NIH Global Infectious Disease Research Training Program D43 TW007129 (FPB, HBT); NS069577 (MSD); AI076248 (HBT); AI39454 (LMW); NS041282 (DCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Beare NAV, 2006, J NEUROL NEUROSUR PS, V77, P1288, DOI 10.1136/jnnp.2005.083956; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Boivin MJ, 2002, J DEV BEHAV PEDIATR, V23, P353, DOI 10.1097/00004703-200210000-00010; Cabrales P, 2010, AM J PATHOL, V176, P1306, DOI 10.2353/ajpath.2010.090691; Carter JA, 2006, DEV MED CHILD NEUROL, V48, P51, DOI 10.1017/S0012162206000107; Carter JA, 2005, J NEUROL NEUROSUR PS, V76, P476, DOI 10.1136/jnnp.2004.043893; Carter JA, 2005, TROP MED INT HEALTH, V10, P3, DOI 10.1111/j.1365-3156.2004.01345.x; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cohen-Gadol AA, 2004, J NEUROSURG, V101, P613, DOI 10.3171/jns.2004.101.4.0613; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Crawley J, 2001, ARCH DIS CHILD, V84, P247, DOI 10.1136/adc.84.3.247; Dai M, 2010, MICROBES INFECT; Demougeot C, 2004, J NEUROCHEM, V90, P776, DOI 10.1111/j.1471-4159.2004.02583.x; Desruisseaux Mahalia S, 2010, J Neuroparasitology, V1, DOI 10.4303/jnp/N100803; Desruisseaux MS, 2010, AM J PATHOL, V176, P1075, DOI 10.2353/ajpath.2010.091090; Ding ZY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009910; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Falchook GS, 2003, CLIN INFECT DIS, V37, pE22, DOI 10.1086/375269; Fernando D, 2003, T ROY SOC TROP MED H, V97, P633, DOI 10.1016/S0035-9203(03)80093-7; FLAMENT S, 1990, BRAIN RES, V516, P15, DOI 10.1016/0006-8993(90)90891-E; Freude S, 2005, DIABETES, V54, P3343, DOI 10.2337/diabetes.54.12.3343; Gotz J, 2007, BRAIN PATHOL, V17, P91, DOI 10.1111/j.1750-3639.2007.00051.x; GOLDSTEIN FB, 1969, J BIOL CHEM, V244, P4257; de Barreda EG, 2010, NEUROBIOL DIS, V37, P622, DOI 10.1016/j.nbd.2009.11.017; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Holding PA, 1999, T ROY SOC TROP MED H, V93, P529, DOI 10.1016/S0035-9203(99)90368-1; Hugon J, 1999, DRUG METAB REV, V31, P635, DOI 10.1081/DMR-100101939; Hyde R, 2002, J BIOL CHEM, V277, P13628, DOI 10.1074/jbc.M108609200; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jope RS, 1999, MOL PSYCHIATR, V4, P117, DOI 10.1038/sj.mp.4000494; Kampfl A, 1997, AM J TROP MED HYG, V56, P585, DOI 10.4269/ajtmh.1997.56.585; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; Kennan RP, 2005, PARASITOL RES, V96, P302, DOI 10.1007/s00436-005-1349-z; Kihara M, 2006, TROP MED INT HEALTH, V11, P386, DOI 10.1111/j.1365-3156.2006.01579.x; Kim B, 2009, ENDOCRINOLOGY, V150, P5294, DOI 10.1210/en.2009-0695; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kuret J, 2005, MICROSC RES TECHNIQ, V67, P141, DOI 10.1002/jemt.20187; Lacerda-Queiroz N, 2011, ACTA TROP, V120, P31, DOI 10.1016/j.actatropica.2011.04.020; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; Li XH, 2002, J AFFECT DISORDERS, V69, P1, DOI 10.1016/S0165-0327(00)00361-X; Liu Y, 2009, J NEUROCHEM, V111, P242, DOI 10.1111/j.1471-4159.2009.06320.x; Machado FS, 2006, EXP BIOL MED, V231, P1176; Mandelkow EM, 1996, ANN NY ACAD SCI, V777, P96, DOI 10.1111/j.1749-6632.1996.tb34407.x; Medana IM, 2005, T ROY SOC TROP MED H, V99, P610, DOI 10.1016/j.trstmh.2004.11.017; Medana IM, 2007, J NEUROL SCI, V258, P93, DOI 10.1016/j.jns.2007.03.005; MeierRuge W, 1996, REV NEUROSCIENCE, V7, P1; Meremikwu M M, 1997, Cent Afr J Med, V43, P231; Minami M, 2011, MOL BIOL CELL; Muyllaert D, 2008, GENES BRAIN BEHAV, V7, P57, DOI 10.1111/j.1601-183X.2007.00376.x; Nagajyothi F, 2008, OBESITY, V16, P1992, DOI 10.1038/oby.2008.331; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Pan JW, 2005, ANN NEUROL, V57, P92, DOI 10.1002/ana.20317; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pardo R, 2003, J NEUROCHEM, V87, P417, DOI 10.1046/j.1471-4159.2003.02015.x; Richardson ED, 1997, APPL NEUROPSYCHOL, V4, P238, DOI 10.1207/s15324826an0404_5; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Rowe Michael K., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008385; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Salas TR, 2003, J BIOL CHEM, V278, P41338, DOI 10.1074/jbc.M302972200; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; SENANAYAKE N, 1994, J NEUROL, V241, P456, DOI 10.1007/BF00900965; Serghides L, 2009, J INFECT DIS, V199, P1536, DOI 10.1086/598222; Sorrentino G, 2007, NEUROL SCI, V28, P63, DOI 10.1007/s10072-007-0789-x; Sugiyama M, 2004, AM J TROP MED HYG, V71, P542, DOI 10.4269/ajtmh.2004.71.542; TAKAHASHI M, 1994, J NEUROCHEM, V63, P245; Trojanowski JQ, 1995, FASEB J, V9, P1570, DOI 10.1096/fasebj.9.15.8529836; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Wang YB, 2009, CELL MICROBIOL, V11, P983, DOI 10.1111/j.1462-5822.2009.01305.x; Weber SM, 2000, J IMMUNOL, V165, P1534, DOI 10.4049/jimmunol.165.3.1534; Weber SM, 2002, J IMMUNOL, V168, P5303, DOI 10.4049/jimmunol.168.10.5303; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Welsh GI, 1996, TRENDS CELL BIOL, V6, P274, DOI 10.1016/0962-8924(96)10023-4; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zakaria NA, 2010, TROP BIOMED, V27, P624	90	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e44117	10.1371/journal.pone.0044117	http://dx.doi.org/10.1371/journal.pone.0044117			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082110	gold, Green Submitted, Green Published			2022-12-27	WOS:000311146900005
J	Dozieres, A; Chapuis, JL; Thibault, S; Baudry, E				Dozieres, Anne; Chapuis, Jean-Louis; Thibault, Sophie; Baudry, Emmanuelle			Genetic Structure of the French Red Squirrel Populations: Implication for Conservation	PLOS ONE			English	Article							SCIURUS-VULGARIS L.; HABITAT FRAGMENTATION; PHYLOGEOGRAPHY; DISTANCE; GROWTH; RATES; UNITS	The decline of the red squirrel (Sciurus vulgaris) in several European countries due to the introduction of the American grey squirrel (S. carolinensis) and the predicted arrival of the grey squirrel in France in the near future has lead to the development of a preventative conservation project in this country. In this study, we conducted an extensive survey of mitochondrial DNA variation in French red squirrels using a fragment of the mitochondrial D-loop and we compared the results with previously published data from other European populations. Our main aims were: (1) to determine whether genetically differentiated populations, which could represent prioritized units for conservation purposes, were present in France and (2) to determine whether the French population, which is currently largely undisturbed, could provide information on the postglacial recolonization history of the species. We found that French D-loop haplotypes show almost no tendency to cluster by geographic origin, be it region or country, suggesting that French red squirrels have not been isolated from other populations during an evolutionarily significant period and that they do not constitute an Evolutionary Significant Unit. The French red squirrels showed strong signals of population expansion, the opposite to what is observed in most other European populations, making them of particular interest to study the postglacial expansion history of the species.	[Dozieres, Anne; Chapuis, Jean-Louis] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, UMR Conservat Especes Restaurat & Suivi Populat 7, MNHN CNRS P6, F-75231 Paris, France; [Thibault, Sophie; Baudry, Emmanuelle] Univ Paris 11, Lab Ecol Syst & Evolut, CNRS UMR 8079, Orsay, France	Museum National d'Histoire Naturelle (MNHN); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Dozieres, A (corresponding author), Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, UMR Conservat Especes Restaurat & Suivi Populat 7, MNHN CNRS P6, F-75231 Paris, France.	dozieres@mnhn.fr	Baudry, Emmanuelle/G-4005-2010		Office National des Forets (ONF); French Ministere de l'Environment	Office National des Forets (ONF); French Ministere de l'Environment	This work was funded by the Office National des Forets (ONF) and the French Ministere de l'Environment. Several members of the ONF, in particular Franck Basset and Sebastien Laguet, helped to collect samples (see Acknowledgments). The French Ministere had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, POPULATION GENETICS; Barratt EM, 1999, MOL ECOL, V8, pS55, DOI 10.1046/j.1365-294X.1999.00771.x; Bertolino S, 2008, CURR SCI INDIA, V95, P903; Bray SCE, 2013, DIVERS DISTRIB, V19, P245, DOI 10.1111/j.1472-4642.2012.00923.x; Charlesworth B, 2003, ANNU REV ECOL EVOL S, V34, P99, DOI 10.1146/annurev.ecolsys.34.011802.132359; Corbet G.B, 1978, MAMMALS PALAEARCTIC; Delin AE, 1999, LANDSCAPE ECOL, V14, P67, DOI 10.1023/A:1008040001801; Emerson BC, 2001, TRENDS ECOL EVOL, V16, P707, DOI 10.1016/S0169-5347(01)02305-9; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Finnegan LA, 2008, CONSERV GENET, V9, P1099, DOI 10.1007/s10592-007-9419-7; Fu YX, 1997, GENETICS, V147, P915; Grill A, 2009, MOL ECOL, V18, P2687, DOI 10.1111/j.1365-294X.2009.04215.x; GURNELL J, 1993, MAMMAL REV, V23, P127, DOI 10.1111/j.1365-2907.1993.tb00424.x; Gurnell J, 1987, NATURAL HIST SQUIRRE; Hale ML, 2001, SCIENCE, V293, P2246, DOI 10.1126/science.1062574; Hale ML, 2004, CONSERV GENET, V5, P167, DOI 10.1023/B:COGE.0000030001.86288.12; Hancock J.M., 1997, MICROSATELLITES EVOL, P1; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; IFN, 2010, INV FOR NAT FOR FRAN; Kuhner MK, 1998, GENETICS, V149, P429; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Lurz Peter W. W., 2005, Mammalian Species, P1; Lurz PWW, 2001, LANDSCAPE ECOL, V16, P407, DOI 10.1023/A:1017508711713; Martinoli A, 2010, HYSTRIX, V21, P127, DOI 10.4404/Hystrix-21.2-4463; Mather AS, 1999, J RURAL STUD, V15, P65, DOI 10.1016/S0743-0167(98)00023-0; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Ogden R, 2005, CONSERV GENET, V6, P511, DOI 10.1007/s10592-005-9006-8; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Shar S, 2008, IUCN 2011 IUCN RED L; Shuttleworth Craig M., 2003, Urban Ecosystems, V5, P109, DOI 10.1023/A:1022387620713; SIDOROWICZ J, 1971, Zoologischer Anzeiger, V187, P123; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trizio I, 2005, MOL ECOL, V14, P469, DOI 10.1111/j.1365-294X.2005.02428.x; Wauters L.A., 1997, CONSERVATION RED SQU, P79; WAUTERS LA, 1994, P ROY SOC B-BIOL SCI, V255, P107, DOI 10.1098/rspb.1994.0015; Wauters LA, 1999, ETHOLOGY, V105, P1053, DOI 10.1046/j.1439-0310.1999.10512488.x; Wauters LA, 2004, MAMMALIA, V68, P37, DOI 10.1515/mamm.2004.005; Wauters LA, 2011, MAMM BIOL, V76, P369, DOI 10.1016/j.mambio.2010.04.003; Wauters LA, 2010, POPUL ECOL, V52, P527, DOI 10.1007/s10144-010-0203-z	45	14	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47607	10.1371/journal.pone.0047607	http://dx.doi.org/10.1371/journal.pone.0047607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082180	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900076
J	Helikar, T; Kowal, B; Madrahimov, A; Shrestha, M; Pedersen, J; Limbu, K; Thapa, I; Rowley, T; Satalkar, R; Kochi, N; Konvalina, J; Rogers, JA				Helikar, Tomas; Kowal, Bryan; Madrahimov, Alex; Shrestha, Manish; Pedersen, Jay; Limbu, Kahani; Thapa, Ishwor; Rowley, Thaine; Satalkar, Rahul; Kochi, Naomi; Konvalina, John; Rogers, Jim A.			Bio-Logic Builder: A Non-Technical Tool for Building Dynamical, Qualitative Models	PLOS ONE			English	Article							RHO-FAMILY GTPASES; BINDING; RAC; EXCHANGE; PHOSPHORYLATION; SIMULATION; NETWORKS; PROTEIN; IDENTIFICATION; DISSOCIATION	Computational modeling of biological processes is a promising tool in biomedical research. While a large part of its potential lies in the ability to integrate it with laboratory research, modeling currently generally requires a high degree of training in mathematics and/or computer science. To help address this issue, we have developed a web-based tool, Bio-Logic Builder, that enables laboratory scientists to define mathematical representations (based on a discrete formalism) of biological regulatory mechanisms in a modular and non-technical fashion. As part of the user interface, generalized "biologic" modules have been defined to provide users with the building blocks for many biological processes. To build/modify computational models, experimentalists provide purely qualitative information about a particular regulatory mechanisms as is generally found in the laboratory. The Bio-Logic Builder subsequently converts the provided information into a mathematical representation described with Boolean expressions/rules. We used this tool to build a number of dynamical models, including a 130-protein large-scale model of signal transduction with over 800 interactions, influenza A replication cycle with 127 species and 200+ interactions, and mammalian and budding yeast cell cycles. We also show that any and all qualitative regulatory mechanisms can be built using this tool.	[Helikar, Tomas; Madrahimov, Alex; Shrestha, Manish; Rowley, Thaine; Konvalina, John; Rogers, Jim A.] Univ Nebraska, Dept Math, Omaha, NE 68182 USA; [Kowal, Bryan; Pedersen, Jay; Limbu, Kahani; Thapa, Ishwor; Satalkar, Rahul] Univ Nebraska, Coll Informat Sci & Technol, Omaha, NE 68182 USA; [Madrahimov, Alex; Rowley, Thaine; Kochi, Naomi] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA; [Rogers, Jim A.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA	University of Nebraska System; University of Nebraska System; University of Nebraska System; University of Nebraska System; University of Nebraska Medical Center	Helikar, T (corresponding author), Univ Nebraska, Dept Math, Omaha, NE 68182 USA.	thelikar@unomaha.edu		Helikar, Tomas/0000-0003-3653-1906; Thapa, Ishwor/0000-0002-3594-1631; Madrahimov, Alex/0000-0003-4724-6844	University of Nebraska at Omaha; University of Nebraska Foundation; Patrick J. Kerrigan Foundation; Donald F. Dillon Foundation; National Institutes of Health [5R01DA030962]; National Aeronautics and Space Administration Nebraska Space Grant Consortium; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030962] Funding Source: NIH RePORTER	University of Nebraska at Omaha; University of Nebraska Foundation; Patrick J. Kerrigan Foundation; Donald F. Dillon Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration Nebraska Space Grant Consortium; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported and funded by the University of Nebraska at Omaha, the University of Nebraska Foundation, Patrick J. Kerrigan and Donald F. Dillon Foundations, National Institutes of Health grant #5R01DA030962, and the National Aeronautics and Space Administration Nebraska Space Grant Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-16; Baird D, 2005, CURR BIOL, V15, P1, DOI 10.1016/j.cub.2004.12.040; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Beyer T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002121; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Buchel F, 2012, BIOINFORMATICS; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Corbett KD, 2001, TRENDS BIOCHEM SCI, V26, P710, DOI 10.1016/S0968-0004(01)01974-0; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; de Jong H, 2003, BIOINFORMATICS, V19, P336, DOI 10.1093/bioinformatics/btf851; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Eungdamrong NJ, 2004, BIOL CELL, V96, P355, DOI 10.1016/j.biolcel.2004.03.004; Faeder JR, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-68; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Helikar T, 2011, OPEN BIOINFORMATICS, V4, P16, DOI [DOI 10.1186/1687-4153-2011-797251, 10.2174/1875036201105010016, DOI 10.2174/1875036201105010016]; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Helikar T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-96; Helikar T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-58; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Irons D, 2009, J THEORETICAL BIOL; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kahlem P, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100080; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyono M, 2000, J BIOL CHEM, V275, P5441, DOI 10.1074/jbc.275.8.5441; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Naldi A, 2009, BIOSYSTEMS, V97, P134, DOI 10.1016/j.biosystems.2009.04.008; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; Rodriguez A, 2012, BIOINFORMATICS, V28, P858, DOI 10.1093/bioinformatics/bts036; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahin O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-1; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Todd R, PLOS ONE IN PRESS; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Zheng J, 2010, BIOINFORMATICS, V26, P141, DOI 10.1093/bioinformatics/btp617	43	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46417	10.1371/journal.pone.0046417	http://dx.doi.org/10.1371/journal.pone.0046417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082121	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900016
J	Song, JT; Hu, B; Qu, HY; Bi, CL; Huang, XZ; Zhang, M				Song, Jian Tao; Hu, Bo; Qu, Hai Yan; Bi, Cheng Long; Huang, Xiao Zhen; Zhang, Mei			Mechanical Stretch Modulates MicroRNA 21 Expression, Participating in Proliferation and Apoptosis in Cultured Human Aortic Smooth Muscle Cells	PLOS ONE			English	Article							TGF-BETA; FLOW; BIOMARKERS; TARGETS; MIR-21	Objectives: Stretch affects vascular smooth muscle cell proliferation and apoptosis, and several responsible genes have been proposed. We tested whether the expression of microRNA 21 (miR-21) is modulated by stretch and is involved in stretch-induced proliferation and apoptosis of human aortic smooth muscle cells (HASMCs). Methods and Results: RT-PCR revealed that elevated stretch (16% elongation, 1 Hz) increased miR-21 expression in cultured HASMCs, and moderate stretch (10% elongation, 1 Hz) decreased the expression. BrdU incorporation assay and cell counting showed miR-21 involved in the proliferation of HASMCs mediated by stretch, likely by regulating the expression of p27 and phosphorylated retinoblastoma protein (p-Rb). FACS analysis revealed that the complex of miR-21 and programmed cell death protein 4 (PDCD4) participated in regulating apoptosis with stretch. Stretch increased the expression of primary miR-21 and pre-miR-21 in HASMCs. Electrophoretic mobility shift assay (EMSA) demonstrated that stretch increased NF-kB and AP-1 activities in HASMCs, and blockade of AP-1 activity by c-jun siRNA significantly suppressed stretch-induced miR-21 expression. Conclusions: Cyclic stretch modulates miR-21 expression in cultured HASMCs, and miR-21 plays important roles in regulating proliferation and apoptosis mediated by stretch. Stretch upregulates miR-21 expression at least in part at the transcription level and AP-1 is essential for stretch-induced miR-21 expression.	[Song, Jian Tao; Hu, Bo; Qu, Hai Yan; Bi, Cheng Long; Huang, Xiao Zhen; Zhang, Mei] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Song, Jian Tao; Hu, Bo; Qu, Hai Yan; Bi, Cheng Long; Huang, Xiao Zhen; Zhang, Mei] Shandong Univ, Chinese Minist Hlth, Dept Cardiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Hu, Bo] Shandong Univ, Dept Emergency, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Qu, Hai Yan] Shandong Prov Chest Hosp, Dept Cardiol, Jinan, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Zhang, M (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	daixh@vip.sina.com			National Basic Research Program of China (973 Program) [2010CB732605, 2011CB503906]; National Nature Science Foundation of China [30728025, 30970709]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2010CB732605, 2011CB503906) and the National Nature Science Foundation of China (30728025, 30970709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boettger T, 2012, CIRC RES, V110, P1000, DOI 10.1161/CIRCRESAHA.111.247742; Chapman GB, 2000, AM J PHYSIOL-HEART C, V278, pH748, DOI 10.1152/ajpheart.2000.278.3.H748; Cheng JZ, 2007, J BIOL CHEM, V282, P34268, DOI 10.1074/jbc.M703115200; Cheng WP, 2008, CARDIOVASC RES, V77, P551, DOI 10.1093/cvr/cvm057; Cheng WP, 2012, CARDIOVASC RES, V93, P181, DOI 10.1093/cvr/cvr280; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Corsini LR, 2012, EXPERT OPIN THER TAR, V16, pS103, DOI 10.1517/14728222.2011.650632; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; D'Alessandra Y, 2012, CURR OPIN CARDIOL, V27, P228, DOI 10.1097/HCO.0b013e3283522052; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Joki N, 2000, HYPERTENS RES, V23, P91, DOI 10.1291/hypres.23.91; Kim YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028308; Kohanbash G, 2012, SEMIN CANCER BIOL, V22, P70, DOI 10.1016/j.semcancer.2011.12.010; Li CH, 2003, FASEB J, V17, P2106, DOI 10.1096/fj.03-0150fje; Liu G, 2010, HYPERTENS RES, V33, P1250, DOI 10.1038/hr.2010.187; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Papageorgiou N, 2012, CURR MED CHEM, V19, P2605, DOI 10.2174/092986712800493048; Qin XM, 2010, P NATL ACAD SCI USA, V107, P3240, DOI 10.1073/pnas.0914882107; Sacco J, 2012, CURR OPIN LIPIDOL, V23, P220, DOI 10.1097/MOL.0b013e3283534c9f; Sedding DG, 2003, CIRCULATION, V108, P616, DOI 10.1161/01.CIR.0000079102.08464.E2; Su BY, 2006, J VASC RES, V43, P229, DOI 10.1159/000091102; Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107; Wang T, 2012, INT J BIOCHEM CELL B, V44, P366, DOI 10.1016/j.biocel.2011.11.012; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Wu XQ, 2010, ARTERIOSCL THROM VAS, V30, P471, DOI 10.1161/ATVBAHA.109.184259; Yehya N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-154; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056	35	48	52	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47657	10.1371/journal.pone.0047657	http://dx.doi.org/10.1371/journal.pone.0047657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082189	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900086
J	Brull, F; Mensink, RP; Steinbusch, MF; Husche, C; Lutjohann, D; Wesseling, GJ; Plat, J				Brull, Florence; Mensink, Ronald P.; Steinbusch, Mandy F.; Husche, Constanze; Luetjohann, Dieter; Wesseling, Geert-Jan; Plat, Jogchum			Beneficial Effects of Sitostanol on the Attenuated Immune Function in Asthma Patients: Results of an In Vitro Approach	PLOS ONE			English	Article							REGULATORY T-CELLS; ALLERGIC AIRWAY INFLAMMATION; NATURAL-KILLER-CELLS; NKT CELLS; PLANT STEROLS; PERIPHERAL-BLOOD; TLR2 AGONIST; MURINE MODEL; SIMVASTATIN; STANOLS	Background: In vitro and animal studies have suggested that plant sterols and stanols increase cytokine production by T-helper-1 cells. This may be beneficial for patient groups characterized by a T-helper-2 dominant immune response, e. g. asthma patients. (1) to evaluate whether sitostanol induces a T-helper-1 shift in peripheral blood mononuclear cells (PBMCs) from asthma patients, and (2) to unravel the role of regulatory T-cells in this respect. Methodology/Principal Findings: PBMCs from 10 asthma patients and 10 healthy subjects were isolated and incubated with 1.2 mu M sitostanol, while stimulated with 5 mu g/ml PHA. Similar amounts of cholesterol were used to determine whether effects were specific for plant stanols or for sterols in general. Changes in cytokine production were measured using antibody arrays and ELISAs. Changes in regulatory T-cell population size were measured by flow cytometry, using intracellular Foxp3 staining. Sitostanol increased production of IFN gamma by 6.5% and IL-2 by 6.0% compared to cholesterol (p < 0.01). No changes in IL-4 and IL-13 were found. Interestingly, this effect was only present in PBMCs from asthma patients. The number of Foxp3+ cells tended to increase and their activity, measured by IL-10 production, increased after sitostanol treatment in PBMCs from asthma patients compared to controls by 32.3% (p = 0.077) and 13.3% (p < 0.05), respectively. Conclusions/Significance: Altogether, the sitostanol-induced Thelper-1 shift in PBMCs from asthma patients and the stimulating effects of sitostanol on Treg cell numbers and activity indicate a possible novel approach for plant stanol ester enriched functional foods in the amelioration of asthmatic symptoms. Functional effects, however, require further evaluation.	[Brull, Florence; Mensink, Ronald P.; Steinbusch, Mandy F.; Plat, Jogchum] Maastricht Univ, Med Ctr, Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands; [Husche, Constanze; Luetjohann, Dieter] Univ Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Wesseling, Geert-Jan] Maastricht Univ, Med Ctr, Dept Resp Med, Maastricht, Netherlands	Maastricht University; University of Bonn; Maastricht University	Plat, J (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands.	J.Plat@HB.unimaas.nl			Raisio Nutrition Ltd, Finland; Raisio Nutrition Ltd	Raisio Nutrition Ltd, Finland; Raisio Nutrition Ltd	Performing the study was financially supported by Raisio Nutrition Ltd, Finland. The firm had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors did receive financial support from Raisio Nutrition Ltd, but this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Akbari O, 2003, CURR OPIN IMMUNOL, V15, P627, DOI 10.1016/j.coi.2003.09.012; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Blease K, 2001, J IMMUNOL, V166, P5219, DOI 10.4049/jimmunol.166.8.5219; Bouic P J, 1999, Altern Med Rev, V4, P170; Breytenbach U, 2001, CELL BIOL INT, V25, P43, DOI 10.1006/cbir.2000.0676; Brull F, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.036343; Brull F, 2009, CLIN LIPIDOL, V4, P355, DOI 10.2217/CLP.09.26; Calpe-Berdiel L, 2007, LIFE SCI, V80, P1951, DOI 10.1016/j.lfs.2007.02.032; Cosmi L, 2011, ALLERGY, V66, P989, DOI 10.1111/j.1398-9995.2011.02576.x; Cowan DC, 2010, THORAX, V65, P891, DOI 10.1136/thx.2010.138990; Desai F, 2009, INT IMMUNOPHARMACOL, V9, P153, DOI 10.1016/j.intimp.2008.10.019; Eigenmann PA, 2008, CLIN EXP IMMUNOL, V151, P546, DOI 10.1111/j.1365-2249.2007.03582.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frossard CP, 2007, J ALLERGY CLIN IMMUN, V119, P952, DOI 10.1016/j.jaci.2006.12.615; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hamzaoui A, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/71214; Hsu CY, 2010, GENE THER, V17, P1011, DOI 10.1038/gt.2010.39; Iwamura C, 2010, CURR OPIN IMMUNOL, V22, P807, DOI 10.1016/j.coi.2010.10.008; Katan MB, 2003, MAYO CLIN PROC, V78, P965, DOI 10.4065/78.8.965; Kim KW, 2011, LUNG, V189, P417, DOI 10.1007/s00408-011-9312-5; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Lee JH, 2007, CLIN EXP IMMUNOL, V148, P53, DOI 10.1111/j.1365-2249.2007.03329.x; Leech MD, 2007, J IMMUNOL, V179, P7050, DOI 10.4049/jimmunol.179.10.7050; Mahajan SG, 2011, EUR J PHARMACOL, V650, P458, DOI 10.1016/j.ejphar.2010.09.075; Mamessier E, 2008, ALLERGY, V63, P1202, DOI 10.1111/j.1398-9995.2008.01687.x; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Menzies D, 2007, J ALLERGY CLIN IMMUN, V119, P328, DOI 10.1016/j.jaci.2006.10.014; Meyer EH, 2008, ANNU REV MED, V59, P281, DOI 10.1146/annurev.med.59.061506.154139; O'Garra A, 2003, NAT IMMUNOL, V4, P304, DOI 10.1038/ni0403-304; Ostroukhova M, 2009, ANN ALLERG ASTHMA IM, V103, P463, DOI 10.1016/S1081-1206(10)60261-X; Page K, 2009, J IMMUNOL, V183, P3400, DOI 10.4049/jimmunol.0900838; Paiva H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Pham-Thi N, 2006, J ALLERGY CLIN IMMUN, V117, P217, DOI 10.1016/j.jaci.2005.09.052; Plat J, 2001, NUTR METAB CARDIOVAS, V11, P31; Ple C, 2010, SCAND J IMMUNOL, V72, P118, DOI 10.1111/j.1365-3083.2010.02419.x; Ray A, 2010, MUCOSAL IMMUNOL, V3, P216, DOI 10.1038/mi.2010.4; Rosenkranz SK, 2010, EUR J APPL PHYSIOL, V109, P499, DOI 10.1007/s00421-010-1390-1; Scordamaglia F, 2008, J ALLERGY CLIN IMMUN, V121, P479, DOI 10.1016/j.jaci.2007.09.047; Smart JM, 2002, J ALLERGY CLIN IMMUN, V110, P450, DOI 10.1067/mai.2002.127283; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Umetsu DT, 2010, J ALLERGY CLIN IMMUN, V125, P975, DOI 10.1016/j.jaci.2010.02.006; Valerio M, 2011, INFLAMM RES, V60, P457, DOI 10.1007/s00011-010-0288-z; Wang YH, 2011, CURR ALLERGY ASTHMA; Wei HM, 2005, J ALLERGY CLIN IMMUN, V115, P841, DOI 10.1016/j.jaci.2004.11.026; Wei W, 2010, INT ARCH ALLERGY IMM, V153, P19, DOI 10.1159/000301575; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Xu YQ, 2010, J ASTHMA, V47, P367, DOI 10.3109/02770903.2010.481340; Xue KY, 2007, J HUAZHONG U SCI-MED, V27, P31, DOI 10.1007/s11596-007-0109-y; Xystrakis E, 2006, EXPERT OPIN BIOL TH, V6, P121, DOI 10.1517/14712598.6.2.121; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; Zhou G, 2010, VACCINE, V28, P1838, DOI 10.1016/j.vaccine.2009.11.081	56	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46895	10.1371/journal.pone.0046895	http://dx.doi.org/10.1371/journal.pone.0046895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091602	gold, Green Published, Green Submitted			2022-12-27	WOS:000310135800015
J	Gkantidis, N; Blumer, S; Katsaros, C; Graf, D; Chiquet, M				Gkantidis, Nikolaos; Blumer, Susan; Katsaros, Christos; Graf, Daniel; Chiquet, Matthias			Site-Specific Expression of Gelatinolytic Activity during Morphogenesis of the Secondary Palate in the Mouse Embryo	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CLEFT-PALATE; SUBSTRATE-SPECIFICITY; MOLECULAR-MECHANISMS; SKELETAL-MUSCLE; PALATOGENESIS; SHELF; INHIBITORS; BINDING; GROWTH	Morphogenesis of the secondary palate in mammalian embryos involves two major events: first, reorientation of the two vertically oriented palatal shelves into a horizontal position above the tongue, and second, fusion of the two shelves at the midline. Genetic evidence in humans and mice indicates the involvement of matrix metalloproteinases (MMPs). As MMP expression patterns might differ from sites of activity, we used a recently developed highly sensitive in situ zymography technique to map gelatinolytic MMP activity in the developing mouse palate. At embryonic day 14.5 (E14.5), we detected strong gelatinolytic activity around the lateral epithelial folds of the nasopharyngeal cavity, which is generated as a consequence of palatal shelf elevation. Activity was concentrated in the basement membrane of the epithelial fold but extended into the adjacent mesenchyme, and increased in intensity with lateral outgrowth of the cavity at E15.5. Gelatinolytic activity at this site was not the consequence of epithelial fold formation, as it was also observed in Bmp7-deficient embryos where shelf elevation is delayed. In this case, gelatinolytic activity appeared in vertical shelves at the exact position where the epithelial fold will form during elevation. Mmp2 and Mmp14 (MT1-MMP), but not Mmp9 and Mmp13, mRNAs were expressed in the mesenchyme around the epithelial folds of the elevated palatal shelves; this was confirmed by immunostaining for MMP-2 and MT1-MMP. Weak gelatinolytic activity was also found at the midline of E14.5 palatal shelves, which increased during fusion at E15.5. Whereas MMPs have been implicated in palatal fusion before, this is the first report showing that gelatinases might contribute to tissue remodeling during early stages of palatal shelf elevation and formation of the nasopharynx.	[Gkantidis, Nikolaos; Blumer, Susan; Katsaros, Christos; Chiquet, Matthias] Univ Bern, Sch Dent Med, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland; [Graf, Daniel] Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland	University of Bern; University of Zurich	Chiquet, M (corresponding author), Univ Bern, Sch Dent Med, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland.	matthias.chiquet@zmk.unibe.ch	Gkantidis, Nikolaos/ABC-4727-2020	Gkantidis, Nikolaos/0000-0002-3180-6272; Chiquet, Matthias/0000-0001-7812-4853; Graf, Daniel/0000-0003-1163-8117; Katsaros, Christos/0000-0001-5545-6740	Swiss National Science Foundation [31003A-135530]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded in part by grant 31003A-135530 from the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Blavier L, 2001, MOL BIOL CELL, V12, P1457, DOI 10.1091/mbc.12.5.1457; Briknarova K, 2001, J BIOL CHEM, V276, P27613, DOI 10.1074/jbc.M101105200; BRINKLEY LL, 1987, DEVELOPMENT, V100, P629; Brown GD, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-93; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chin JR, 1997, DEVELOPMENT, V124, P1519; Chou MJ, 2004, ANAT EMBRYOL, V208, P19, DOI 10.1007/s00429-004-0379-0; Cowell S, 1998, BIOCHEM J, V331, P453, DOI 10.1042/bj3310453; Evans Richard D., 2007, V135, P239; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; Fluck M, 2000, J CELL SCI, V113, P3583; Frederiks WM, 2004, J HISTOCHEM CYTOCHEM, V52, P711, DOI 10.1369/jhc.4R6251.2004; Gkantidis N, 2012, HISTOCHEM CELL BIOL, V138, P557, DOI 10.1007/s00418-012-0982-8; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Gritli-Linde A, 2008, CURR TOP DEV BIOL, V84, P37, DOI 10.1016/S0070-2153(08)00602-9; Hornebeck W, 2002, SEMIN CANCER BIOL, V12, P231, DOI 10.1016/S1044-579X(02)00026-3; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Iseki S, 2007, BIRTH DEFECTS RES A, V79, P688, DOI 10.1002/bdra.20400; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jin JZ, 2010, DEV DYNAM, V239, P2110, DOI 10.1002/dvdy.22339; Jugessur A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039240; Jugessur A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005385; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; KOCH M, 1995, J CELL BIOL, V130, P1005, DOI 10.1083/jcb.130.4.1005; Kouskoura Thaleia, 2011, Schweiz Monatsschr Zahnmed, V121, P636; Meng L, 2009, J DENT RES, V88, P22, DOI 10.1177/0022034508327868; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Mitchell J C, 2000, J Pediatr Health Care, V14, P13, DOI 10.1016/S0891-5245(00)70039-3; Mitchell LE, 2009, COMPREHENSIVE CLEFT; Moretti RM, 2011, INT J ONCOL, V39, P225, DOI 10.3892/ijo.2011.1030; Morris-Wiman J, 1999, J CRAN GENET DEV BIO, V19, P201; MORRISWIMAN J, 1992, ANAT RECORD, V234, P575, DOI 10.1002/ar.1092340413; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Robbins JR, 1999, DEV BIOL, V212, P255, DOI 10.1006/dbio.1999.9373; Ruta A, 2009, EXP LUNG RES, V35, P59, DOI 10.1080/01902140802406059; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Snyder-Warwick AK, 2010, P NATL ACAD SCI USA, V107, P2515, DOI 10.1073/pnas.0913985107; Stanier P, 2004, HUM MOL GENET, V13, pR73, DOI 10.1093/hmg/ddh052; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Yu K, 2011, DEV DYNAM, V240, P1737, DOI 10.1002/dvdy.22670; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983; Zouvelou V, 2009, INT J DEV BIOL, V53, P597, DOI 10.1387/ijdb.082648vz; Zouvelou V, 2009, J EXP ZOOL PART B, V312B, P361, DOI 10.1002/jez.b.21262	52	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47762	10.1371/journal.pone.0047762	http://dx.doi.org/10.1371/journal.pone.0047762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091646	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000310135800072
J	Sels, JWEM; Elsenberg, EHAM; Hoefer, IE; van Zonneveld, AJ; Kuiper, J; Jukema, JW; Pijls, NHJ; Pasterkamp, G				Sels, Jan-Willem E. M.; Elsenberg, Ellen H. A. M.; Hoefer, Imo E.; van Zonneveld, Anton Jan; Kuiper, Johan; Jukema, J. Wouter; Pijls, Nico H. J.; Pasterkamp, Gerard			Fractional Flow Reserve Is Not Associated with Inflammatory Markers in Patients with Stable Coronary Artery Disease	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; INCREMENTAL PROGNOSTIC VALUE; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; FUNCTIONAL SEVERITY; MONONUCLEAR-CELLS; UNSTABLE ANGINA; UP-REGULATION; INTERVENTION	Background: Atherosclerosis is an inflammatory condition and increased blood levels of inflammatory biomarkers have been observed in acute coronary syndromes. In addition, high expression of inflammatory markers is associated with worse prognosis of coronary artery disease. The presence and extent of inducible ischemia in patients with stable angina has previously been shown to have strong prognostic value. We hypothesized that evidence of inducible myocardial ischemia by local lesions, as measured by fractional flow reserve (FFR), is associated with increased levels of blood based inflammatory biomarkers. Methods: Whole blood samples of 89 patients with stable angina pectoris and 16 healthy controls were analyzed. The patients with stable angina pectoris underwent coronary angiography and FFR of all coronary lesions. We analyzed plasma levels of cytokines IL-6, IL-8 and TNF-alpha and membrane expression of Toll-like receptor 2 and 4, CD11b, CD62L and CD14 on monocytes and granulocytes as markers of inflammation. Furthermore, we quantified the severity of hemodynamically significant coronary artery disease by calculating Functional Syntax Score (FSS), an extension of the Syntax Score. Results: For the majority of biomarkers, we observed lower levels in the healthy control group compared with patients with stable angina who underwent coronary catheterization. We found no difference for any of the selected biomarkers between patients with a positive FFR (<= 0.75) and negative FFR (>0.80). We observed no relationship between the investigated biomarkers and FSS. Conclusion: The presence of local atherosclerotic lesions that result in inducible myocardial ischemia as measured by FFR in patients with stable coronary artery disease is not associated with increased plasma levels of IL-6, IL-8 and TNF-a or increased expression of TLR2 and TLR4, CD11b, CD62L and CD14 on circulating leukocytes.	[Sels, Jan-Willem E. M.; Pijls, Nico H. J.] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands; [Elsenberg, Ellen H. A. M.; Hoefer, Imo E.; Pasterkamp, Gerard] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Sels, Jan-Willem E. M.; Pijls, Nico H. J.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Kuiper, Johan] Leiden Univ, Div Biopharmaceut, Leiden, Netherlands; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands	Catharina Hospital; Utrecht University; Utrecht University Medical Center; Eindhoven University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sels, JWEM (corresponding author), Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands.	jan-willem.sels@cze.nl	Jukema, J. Wouter/ABD-6503-2021; van Zonneveld, Anton Jan/D-8060-2018	Jukema, J. Wouter/0000-0002-3246-8359; van Zonneveld, Anton Jan/0000-0002-1676-7738	project CIRCULATING CELLS [01C-102]; Dutch Heart Foundation; St Jude Medical Inc.; Stichting Vrienden van het Hart Zuid-Oost Brabant, The Netherlands; Astellas; Astra-Zeneca; Bayer; Biotronik; Boston Scientific; Daiichi Sankyo; Lilly; Genzyme; Medtronic; Merck-Schering-Plough; Pfizer; Orbus Neich; Novartis; Roche; Servier; Sanofi Aventis; Netherlands Heart Foundation; Interuniversity Cardiology Institute of the Netherlands; European Community; St Jude Medical; Abbott; Maquet	project CIRCULATING CELLS; Dutch Heart Foundation(Netherlands Heart Foundation); St Jude Medical Inc.(St. Jude Medical); Stichting Vrienden van het Hart Zuid-Oost Brabant, The Netherlands(Netherlands Government); Astellas(Astellas Pharmaceuticals); Astra-Zeneca(AstraZeneca); Bayer(Bayer AG); Biotronik; Boston Scientific(Boston Scientific); Daiichi Sankyo(Daiichi Sankyo Company Limited); Lilly(Eli Lilly); Genzyme(Sanofi-AventisGenzyme Corporation); Medtronic(Medtronic); Merck-Schering-Plough(Merck & CompanySchering Plough Corporation); Pfizer(Pfizer); Orbus Neich; Novartis(Novartis); Roche(Roche Holding); Servier(Servier); Sanofi Aventis(Sanofi-Aventis); Netherlands Heart Foundation(Netherlands Heart Foundation); Interuniversity Cardiology Institute of the Netherlands; European Community(European Commission); St Jude Medical(St. Jude Medical); Abbott(Abbott Laboratories); Maquet	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project CIRCULATING CELLS (grant 01C-102), and supported by the Dutch Heart Foundation, St Jude Medical Inc. and Stichting Vrienden van het Hart Zuid-Oost Brabant, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; The authors have read the journal's policy and have the following potential conflicts: GP is founder of Cavadis, a biomarker company. There is no association with the content of this paper. JJ has received research grants from and was speaker on (CME accredited) meetings sponsored by Astellas, Astra-Zeneca, Bayer, Biotronik, Boston Scientific, Daiichi Sankyo, Lilly, Genzyme, Medtronic, Merck-Schering-Plough, Pfizer, Orbus Neich, Novartis, Roche, Servier, Sanofi Aventis, the Netherlands Heart Foundation, the Interuniversity Cardiology Institute of the Netherlands and the European Community Framework KP7 Programme. NHJP has received research grants from St Jude Medical, Abbott and Maquet and is a consultant for St Jude Medical. Other authors have no potential conflicts to disclose.	Anguera I, 2002, AM HEART J, V144, P811, DOI 10.1067/mhj.2002.124831; Bruun JM, 2003, EUR J ENDOCRINOL, V148, P535, DOI 10.1530/eje.0.1480535; De Bruyne B, 2001, CIRCULATION, V104, P157, DOI 10.1161/01.CIR.104.2.157; Deliargyris EN, 2000, AM J CARDIOL, V86, P913, DOI 10.1016/S0002-9149(00)01121-8; ElMokhtari N, 2010, J THROMB THROMBOLYS, V30, P391, DOI 10.1007/s11239-010-0466-4; Elsenberg EH, 2011, CLIN SCI, V122, P527; Graff J, 2005, CLIN PHARMACOL THER, V78, P468, DOI 10.1016/j.clpt.2005.08.002; Hachamovitch R, 1997, AM J CARDIOL, V80, P426, DOI 10.1016/S0002-9149(97)00390-1; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Ikonomidis I, 2005, CIRCULATION, V112, P3272, DOI 10.1161/CIRCULATIONAHA.104.532259; Inoue T, 2008, INT J CARDIOL, V124, P319, DOI 10.1016/j.ijcard.2007.02.012; ISKANDRIAN AS, 1993, J AM COLL CARDIOL, V22, P665, DOI 10.1016/0735-1097(93)90174-Y; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li HL, 2007, J CELL MOL MED, V11, P88, DOI 10.1111/j.1582-4934.2007.00011.x; Liuzzo G, 2001, CIRCULATION, V103, P2236; Luc G, 2003, ARTERIOSCL THROM VAS, V23, P1255, DOI 10.1161/01.ATV.0000079512.66448.1D; Methe H, 2005, CIRCULATION, V111, P2654, DOI 10.1161/CIRCULATIONAHA.104.498865; Mizia-Stec K, 2003, CORONARY ARTERY DIS, V14, P431, DOI 10.1097/00019501-200309000-00003; Mizia-Stec Katarzyna, 2002, Eur J Intern Med, V13, P115, DOI 10.1016/S0953-6205(02)00004-3; Muhlestein JB, 2010, THROMB HAEMOSTASIS, V103, P71, DOI 10.1160/TH09-03-0177; Musaad S, 2007, EPIDEMIOL REV, V29, P98, DOI 10.1093/epirev/mxm005; Nam CW, 2011, J AM COLL CARDIOL, V58, P1211, DOI 10.1016/j.jacc.2011.06.020; Ortego M, 1999, ATHEROSCLEROSIS, V147, P253, DOI 10.1016/S0021-9150(99)00193-8; PIJLS NHJ, 1995, CIRCULATION, V92, P3183, DOI 10.1161/01.CIR.92.11.3183; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pijls NHJ, 2012, J AM COLL CARDIOL, V59, P1045, DOI 10.1016/j.jacc.2011.09.077; Quinn MJ, 2004, AM J CARDIOL, V93, P679, DOI 10.1016/j.amjcard.2003.11.048; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Scholtes VPW, 2011, CLIN SCI, V121, P205, DOI 10.1042/CS20100601; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Steinhubl SR, 2007, VASC MED, V12, P113, DOI 10.1177/1358863X07077462; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Tziakas DN, 2008, EUR HEART J, V29, P2713, DOI 10.1093/eurheartj/ehn382; Ueda K, 1999, AM HEART J, V138, P908, DOI 10.1016/S0002-8703(99)70016-5; Vilahur G, 2009, J THROMB HAEMOST, V7, P485, DOI 10.1111/j.1538-7836.2008.03244.x; Vink A, 2002, CIRCULATION, V106, P1985, DOI 10.1161/01.CIR.0000032146.75113.EE; Virmani Renu, 2003, J Interv Cardiol, V16, P267, DOI 10.1034/j.1600-0854.2003.8042.x; Willerson JT, 2009, TEX HEART I J, V36, P530; Yong ASC, 2011, BLOOD, V117, P11, DOI 10.1182/blood-2010-04-278812	45	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46356	10.1371/journal.pone.0046356	http://dx.doi.org/10.1371/journal.pone.0046356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091596	Green Submitted, Green Published, gold			2022-12-27	WOS:000310135800007
J	Bastani, A; Jaberzadeh, S				Bastani, Andisheh; Jaberzadeh, Shapour			A Higher Number of TMS-Elicited MEP from a Combined Hotspot Improves Intra- and Inter-Session Reliability of the Upper Limb Muscles in Healthy Individuals	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR-EVOKED-POTENTIALS; TEST-RETEST RELIABILITY; EXCITABILITY; CORTEX; BRAIN; REPRESENTATIONS; CONTRACTION; SIZE	We aimed to determine, using transcranial magnetic stimulation (TMS), the number of elicited motor evoked potentials (MEPs) that induces the highest intra- and inter-sessions reliability for the extensor carpi radialis (ECR) and first dorsal interosseus (FDI) muscles. Twelve healthy subjects participated in this study on two separate days. Single pulse magnetic stimuli were triggered with Magstim 200(2) to obtain MEPs from the muscles of interest, with the subjects in a relaxed position. Reliability of MEP responses was investigated in three blocks of 5, 10 and 15 trials. The intra- and inter-session reliability of the MEPs' amplitudes and latencies were assessed using intraclass correlation coefficients (ICCs). Repeated measures ANOVA and paired t-tests revealed no significant time effect in the MEP amplitude and latency measurements (P>0.05). The ICCs indicated high intra-session reliability in the MEPs' amplitudes for the ECR and FDI muscles (0.77 to 0.99, 0.90 to 0.99, respectively) and latency (0.80 to 1.00, 0.75 to 0.97, respectively). The MEPs' amplitudes also had high inter-session reliability (0.84 to 0.97, 0.88 to 0.93, respectively), as did their latency (0.80 to 0.90, 0.75 to 0.97, respectively). Highest intra- and inter-session reliability was achieved for blocks of 10 and 15 trials. Our data suggest that intra- and inter-session comparisons should be performed using at least 10 MEPs in "combined hotspot" stimulation technique to ensure highest reliability.	[Bastani, Andisheh; Jaberzadeh, Shapour] Monash Univ, Dept Physiotherapy, Sch Primary Hlth Care, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia	Monash University	Bastani, A (corresponding author), Monash Univ, Dept Physiotherapy, Sch Primary Hlth Care, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia.	andisheh.bastanijahromi@monash.edu		jaberzadeh, shapour/0000-0003-2957-4510				BARKER AT, 1985, LANCET, V1, P1106; BARKER AT, 1987, NEUROSURGERY, V20, P100; Cacchio A, 2009, CLIN NEUROPHYSIOL, V120, P414, DOI 10.1016/j.clinph.2008.11.019; Carroll TJ, 2001, J NEUROSCI METH, V112, P193, DOI 10.1016/S0165-0270(01)00468-X; Christie A, 2007, J NEUROSCI METH, V164, P320, DOI 10.1016/j.jneumeth.2007.05.011; Corneal SF, 2005, ARCH PHYS MED REHAB, V86, P1670, DOI 10.1016/j.apmr.2004.12.039; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Deuschl G., 1999, RECOMMENDATIONS PRAC; Devanne H, 2006, EUR J NEUROSCI, V23, P2467, DOI 10.1111/j.1460-9568.2006.04760.x; Doeltgen SH, 2009, J NEUROSCI METH, V178, P134, DOI 10.1016/j.jneumeth.2008.12.005; Fleming MK, 2012, IEEE T NEUR IN PRESS; FUHR P, 1991, ELECTROEN CLIN NEURO, V81, P81, DOI 10.1016/0168-5597(91)90001-E; Gilmore K L, 1983, Aust J Physiother, V29, P3, DOI 10.1016/S0004-9514(14)60659-0; Hallett M, 1996, ANN NEUROL, V40, P344, DOI 10.1002/ana.410400303; Hallett M., 2005, MAGNETIC STIMULATION, V2nd; Harvill L.M., 1991, EDUC MEAS-ISSUES PRA, V10, P33, DOI [DOI 10.1111/J.1745-3992.1991.TB00195.X, 10.1111/j.1745-3992.1991.tb00195.x]; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Jung NH, 2010, BRAIN STIMUL, V3, P87, DOI 10.1016/j.brs.2009.10.003; Kamen G, 2004, MED SCI SPORT EXER, V36, P1574, DOI 10.1249/01.MSS.0000139804.02576.6A; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kendall F., 2010, MUSCLES TESTING FUNC, V5th ed; Lefebvre R, 2004, J MANIP PHYSIOL THER, V27, P97, DOI 10.1016/j.jmpt.2003.12.004; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; Liepert J, 2000, CLIN NEUROPHYSIOL, V111, P1157, DOI 10.1016/S1388-2457(00)00308-4; Livingston SC, 2008, INT J NEUROSCI, V118, P239, DOI 10.1080/00207450701668020; Maeda F, 2002, CLIN NEUROPHYSIOL, V113, P376, DOI 10.1016/S1388-2457(02)00008-1; Malcolm MP, 2006, CLIN NEUROPHYSIOL, V117, P1037, DOI 10.1016/j.clinph.2006.02.005; Marconi B, 2008, J NEUROL SCI, V275, P51, DOI 10.1016/j.jns.2008.07.025; McKay DR, 2002, EXP BRAIN RES, V143, P342, DOI 10.1007/s00221-001-0995-3; Ngomo S, 2012, J NEUROSCI METH, V205, P65, DOI 10.1016/j.jneumeth.2011.12.012; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Oh S.J., 2003, CLIN ELECTROMYOGRAPH, DOI [10.1046/j.1468-1331.2003.00654.x, DOI 10.1046/J.1468-1331.2003.00654.X]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patterson CH, 1955, J EXP EDUC, V23, P247, DOI 10.1080/00220973.1955.11010510; Perotto A., 2005, ANATOMICAL GUIDE ELE; Plowman-Prine EK, 2008, CLIN NEUROPHYSIOL, V119, P2298, DOI 10.1016/j.clinph.2008.06.006; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Pourtney L, 2000, FDN CLIN RES APPL PR; RAVNBORG M, 1991, ACTA NEUROL SCAND, V84, P491, DOI 10.1111/j.1600-0404.1991.tb05001.x; Ridding MC, 2001, CLIN NEUROPHYSIOL, V112, P1461, DOI 10.1016/S1388-2457(01)00592-2; Robertson V, 2006, ELECTROTHERAPY EXPLA, V4th; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; ROTHSTEIN JM, 1985, MEASUREMENT PHYSICAL, P1; Schwartz M. S., 2003, BIOFEEDBACK PRACTITI, V3rd; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Wassermann E., 2008, OXFORD HDB TRANSCRAN; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wolf SL, 2004, CLIN NEUROPHYSIOL, V115, P1740, DOI 10.1016/j.clinph.2004.02.027; Wu L, 2002, CLIN NEUROPHYSIOL, V113, P1286, DOI 10.1016/S1388-2457(02)00160-8	50	51	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47582	10.1371/journal.pone.0047582	http://dx.doi.org/10.1371/journal.pone.0047582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077645	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100140
J	Hepp, GR; Kennamer, RA				Hepp, Gary R.; Kennamer, Robert A.			Warm Is Better: Incubation Temperature Influences Apparent Survival and Recruitment of Wood Ducks (Aix sponsa)	PLOS ONE			English	Article							EMBRYONIC TEMPERATURE; TREE SWALLOWS; EGG SIZE; DUCKLINGS; PHILOPATRY; PATTERNS; FITNESS; GROWTH; COSTS; BIRDS	Avian parents that physically incubate their eggs must balance demands of self-maintenance with providing the proper thermal environment for egg development. Low incubation temperatures can lengthen the incubation period and produce changes in neonate phenotype that may influence subsequent survival and reproduction. We artificially incubated wood duck (Aix sponsa) eggs at three temperature regimes (low, 35.0; mid, 35.9; and high, 37.3 degrees C) that are within the range of temperatures of naturally-incubated nests. We tested the effect of incubation temperature on duckling body composition, fledging success, the probability that females were recruited to the breeding population, and their subsequent reproductive success. Incubation period was inversely related to incubation temperature, and body mass and lipid mass for newly-hatched ducklings incubated at the lowest temperature were lower than for ducklings produced at higher temperatures. In 2008, ducklings (n = 412) were individually marked and broods (n = 38) containing ducklings from each temperature treatment were placed with wild foster mothers within 24 hrs of hatching. Ducklings incubated at the lowest temperature were less likely to fledge from nest sites than ducklings incubated at the higher temperatures. We recaptured female ducklings as adults when they were either prospecting for nest sites (n = 171; 2009-2011) or nesting (n = 527; 2009-2012). Female ducklings incubated at the lowest temperature were less likely to survive and be recruited to the breeding population than females incubated at higher temperatures. Reproductive success of surviving females also was greater for females that had been incubated at warmer temperatures. To our knowledge, this is the first avian study to link developmental conditions experienced by neonates during incubation with their survival and recruitment to the breeding population, and subsequent reproductive success. These results advance our understanding of incubation as an important reproductive cost in birds and support the potential significance of incubation in influencing the evolution of avian life histories.	[Hepp, Gary R.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA; [Kennamer, Robert A.] Savannah River Ecol Lab, Aiken, SC USA	Auburn University System; Auburn University; United States Department of Energy (DOE); Savannah River Ecology Laboratory	Hepp, GR (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.	heppgar@auburn.edu			National Science Foundation [IOB-0615361]; Department of Energy [DE-FC09-07SR22506]	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE))	Research was supported by National Science Foundation grant IOB-0615361 to GRH. Logistical support of research activities was also provided by the Department of Energy through Award Number DE-FC09-07SR22506 to the University of Georgia Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson CL, 2011, J WILDLIFE MANAGE, V75, P1330, DOI 10.1002/jwmg.166; Ardia DR, 2010, P ROY SOC B-BIOL SCI, V277, P1881, DOI 10.1098/rspb.2009.2138; Ardia DR, 2009, J ANIM ECOL, V78, P4, DOI 10.1111/j.1365-2656.2008.01453.x; Bellrose F.C., 1994, ECOLOGY MANAGEMENT W; BOOTH DT, 1987, PHYSIOL ZOOL, V60, P437, DOI 10.1086/physzool.60.4.30157905; Brown GP, 2004, ECOLOGY, V85, P1627, DOI 10.1890/03-0107; Deeming D.C., 1991, P147, DOI 10.1017/CBO9780511585739.011; Deeming D.C., 2002, AVIAN INCUBATION BEH; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; DuRant SE, 2011, PHYSIOL BIOCHEM ZOOL, V84, P451, DOI 10.1086/661749; DuRant SE, 2010, J EXP BIOL, V213, P45, DOI 10.1242/jeb.034488; DuRant SE, 2012, FUNCT ECOL, V26, P416, DOI 10.1111/j.1365-2435.2011.01945.x; DuRant SE, 2012, BIOL LETTERS, V8, P108, DOI 10.1098/rsbl.2011.0735; Eiby YA, 2009, J COMP PHYSIOL B, V179, P875, DOI 10.1007/s00360-009-0370-4; Hepp GR, 2006, FUNCT ECOL, V20, P307, DOI 10.1111/j.1365-2435.2006.01108.x; Hepp GR, 2011, AUK, V128, P258, DOI 10.1525/auk.2011.10189; HEPP GR, 1989, ECOLOGY, V70, P897, DOI 10.2307/1941357; HEPP GR, 1987, J WILDLIFE MANAGE, V51, P401, DOI 10.2307/3801026; Hopkins BC, 2011, J EXP ZOOL PART A, V315A, P274, DOI 10.1002/jez.673; JANZEN FJ, 1993, ECOLOGY, V74, P332, DOI 10.2307/1939296; Korschgen CE, 1996, J WILDLIFE MANAGE, V60, P120, DOI 10.2307/3802046; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Manlove CA, 2000, CONDOR, V102, P286, DOI 10.1650/0010-5422(2000)102[0286:PONAIF]2.0.CO;2; Martin TE, 2008, P NATL ACAD SCI USA, V105, P9268, DOI 10.1073/pnas.0709366105; Martin TE, 2007, EVOLUTION, V61, P2558, DOI 10.1111/j.1558-5646.2007.00204.x; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moller AP, 2004, OIKOS, V104, P299, DOI 10.1111/j.0030-1299.2004.12844.x; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Nord A, 2010, FUNCT ECOL, V24, P1031, DOI 10.1111/j.1365-2435.2010.01719.x; Olson CR, 2006, PHYSIOL BIOCHEM ZOOL, V79, P927, DOI 10.1086/506003; Pelayo JT, 2003, AUK, V120, P384, DOI 10.1642/0004-8038(2003)120[0384:COESFO]2.0.CO;2; Perez JH, 2008, BIOL LETTERS, V4, P468, DOI 10.1098/rsbl.2008.0266; Reid JM, 2000, P ROY SOC B-BIOL SCI, V267, P37, DOI 10.1098/rspb.2000.0963; Reid JM, 2002, OX ORN SER, V13, P314; SAS Institute, 2007, SAS STAT US GUID VER; Tinbergen JM, 2002, AVIAN INCUBATION BEH; Traylor JJ, 2006, AUK, V123, P67, DOI 10.1642/0004-8038(2006)123[0067:EOIAEF]2.0.CO;2; Vleck Carol M., 1996, P417; Warner DA, 2009, OECOLOGIA, V161, P209, DOI 10.1007/s00442-009-1366-1; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; ZICUS MC, 1989, J FIELD ORNITHOL, V60, P109	42	55	56	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47777	10.1371/journal.pone.0047777	http://dx.doi.org/10.1371/journal.pone.0047777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077669	Green Submitted, gold, Green Published			2022-12-27	WOS:000309995100161
J	Katz, G; Wei, H; Alimova, A; Katz, A; Morgan, DG; Gottlieb, P				Katz, Garrett; Wei, Hui; Alimova, Alexandra; Katz, Al; Morgan, David Gene; Gottlieb, Paul			Protein P7 of the Cystovirus phi 6 Is Located at the Three-Fold Axis of the Unexpanded Procapsid	PLOS ONE			English	Article							RNA BACTERIOPHAGE PHI-6; CRYOELECTRON MICROSCOPY; ELECTRON-MICROSCOPY; POLYMERASE COMPLEX; PURIFIED PROTEIN; REPLICATION; TRANSCRIPTION; PARTICLES; SEGMENT	The objective of this study was to determine the location of protein P7, the RNA packaging factor, in the procapsid of the phi 6 cystovirus. A comparison of cryo-electron microscopy high-resolution single particle reconstructions of the phi 6 complete unexpanded procapsid, the protein P2-minus procapsid (P2 is the RNA directed RNA-polymerase), and the P7-minus procapsid, show that prior to RNA packaging the P7 protein is located near the three-fold axis of symmetry. Difference maps highlight the precise position of P7 and demonstrate that in P7-minus particles the P2 proteins are less localized with reduced densities at the three-fold axes. We propose that P7 performs the mechanical function of stabilizing P2 on the inner protein P1 shell which ensures that entering viral single-stranded RNA is replicated.	[Katz, Garrett; Wei, Hui; Alimova, Alexandra; Gottlieb, Paul] CUNY City Coll, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA; [Katz, Al] CUNY City Coll, Dept Phys, New York, NY 10031 USA; [Morgan, David Gene] Indiana Univ, Dept Chem, Bloomington, IN USA	City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education; City University of New York (CUNY) System; City College of New York (CUNY); Indiana University System; Indiana University Bloomington	Gottlieb, P (corresponding author), CUNY City Coll, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA.	pgottl@med.cuny.edu	Morgan, David Gene/W-3429-2019; Katz, Garrett/S-8037-2019		National Institute of General Medical Science [SC1-GM092781]; Research Centers in Minority Institutions (NIH/NCRR/RCMI) CCNY/Grant [G12-RR03060]; New York State Foundation for Science, Technology and Innovation (NYSTAR) [C000087]; National Institutes of Health [S10 RR017291]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017291, G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM092781] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research Centers in Minority Institutions (NIH/NCRR/RCMI) CCNY/Grant; New York State Foundation for Science, Technology and Innovation (NYSTAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is support in part by the National Institute of General Medical Science - Grant SC1-GM092781 and the Research Centers in Minority Institutions (NIH/NCRR/RCMI) CCNY/Grant G12-RR03060. The electron microscopy facilities at the New York Structural Biology Center are supported by grant C000087 from the New York State Foundation for Science, Technology and Innovation (NYSTAR), and National Institutes of Health grant S10 RR017291. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butcher SJ, 1997, EMBO J, V16, P4477, DOI 10.1093/emboj/16.14.4477; de Haas F, 1999, J MOL BIOL, V294, P357, DOI 10.1006/jmbi.1999.3260; Eryilmaz E, 2008, J MOL BIOL, V382, P402, DOI 10.1016/j.jmb.2008.07.006; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; GOTTLIEB P, 1991, VIROLOGY, V181, P589, DOI 10.1016/0042-6822(91)90892-F; GOTTLIEB P, 1988, J VIROL, V62, P181, DOI 10.1128/JVI.62.1.181-187.1988; GOTTLIEB P, 1988, VIROLOGY, V163, P183, DOI 10.1016/0042-6822(88)90245-0; GOTTLIEB P, 1990, J BACTERIOL, V172, P5774, DOI 10.1128/jb.172.10.5774-5782.1990; Hu GB, 2008, VIROLOGY, V372, P1, DOI 10.1016/j.virol.2007.10.013; Huiskonen JT, 2006, STRUCTURE, V14, P1039, DOI 10.1016/j.str.2006.03.018; Juuti JT, 1997, J MOL BIOL, V266, P891, DOI 10.1006/jmbi.1996.0817; Kainov DE, 2004, NUCLEIC ACIDS RES, V32, P3515, DOI 10.1093/nar/gkh680; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mindich L, 2004, VIRUS RES, V101, P83, DOI 10.1016/j.virusres.2003.12.008; MINDICH L, 1994, VIROLOGY, V202, P258, DOI 10.1006/viro.1994.1341; Nemecek D, 2011, J MOL BIOL; Nemecek D, 2010, J STRUCT BIOL, V171, P389, DOI 10.1016/j.jsb.2010.06.005; OLKKONEN VM, 1987, J VIROL, V61, P2362, DOI 10.1128/JVI.61.8.2362-2367.1987; PAATERO AO, 1995, J VIROL, V69, P6729, DOI 10.1128/JVI.69.11.6729-6734.1995; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poranen MM, 2008, J MOL BIOL, V383, P529, DOI 10.1016/j.jmb.2008.08.082; Poranen MM, 2001, MOL CELL, V7, P845, DOI 10.1016/S1097-2765(01)00228-3; Sen A, 2008, J BIOL CHEM, V283, P12227, DOI 10.1074/jbc.M710508200; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Swanson MI, 2002, RAPID COMMUN MASS SP, V16, P2317, DOI 10.1002/rcm.866; Wei H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006850; Yan X, 2007, J STRUCT BIOL, V157, P73, DOI 10.1016/j.jsb.2006.08.007; Zhang X, 2003, NAT STRUCT BIOL, V10, P1011, DOI 10.1038/nsb1009	30	10	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47489	10.1371/journal.pone.0047489	http://dx.doi.org/10.1371/journal.pone.0047489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077625	gold, Green Published			2022-12-27	WOS:000309995100121
J	Zhang, Y; Sun, LP; Xing, CZ; Xu, Q; He, CY; Li, P; Gong, YH; Liu, YP; Yuan, Y				Zhang, Ye; Sun, Li-Ping; Xing, Cheng-Zhong; Xu, Qian; He, Cai-Yun; Li, Ping; Gong, Yue-Hua; Liu, Yun-Peng; Yuan, Yuan			Interaction between GSTP1 Val Allele and H. pylori Infection, Smoking and Alcohol Consumption and Risk of Gastric Cancer among the Chinese Population	PLOS ONE			English	Article							TRANSFERASE P1 POLYMORPHISMS; GENETIC-POLYMORPHISM; PROSTATE-CANCER; BREAST-CANCER; SUSCEPTIBILITY; ASSOCIATION; LUNG; CELLS; EXPRESSION; VARIANTS	Glutathione S-transferase P1 (GSTP1) is a critical enzyme in the phase II detoxification pathway. One of the common functional polymorphisms of GSTP1 is A -> G at nucleotide 313, which results in an amino acid substitution (Ile105Val) at the substrate binding site and reduced catalytic activity. We evaluated the interaction between GSTP1 Val allele and Helicobacter pylori infection, smoking and alcohol consumption, increasing the risk of gastric cancer among the Chinese population. Information on potential gastric cancer risk factors and blood specimens were collected from 618 incident gastric cancer cases and 1,830 non-cancer controls between March 2002 and December 2011 in Liaoning Province, China. GSTP1 Ile105Val was genotyped by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and polymerase chain reaction-restriction fragment length polymorphism. Serum levels of anti-H. pylori IgG were measured by ELISA. Odds ratio (OR) and 95% confidence interval (CI) were calculated using multivariate logistic regression, adjusted by sex and age. The risk of gastric cancer was significantly elevated in patients with the GSTP1 Val/Val genotype (adjusted OR = 3.324; 95% CI = 1.790-6.172). An elevated risk of gastric cancer was observed in patients with H. pylori infection, smoking, or alcohol consumption, and together with the GSTP1 Ile/Val + Val/Val genotype (OR = 3.696; 95% CI = 2.475-5.521; OR = 1.638; 95% CI = 1.044-2.571; OR = 1.641; 95% CI = 0.983-2.739, respectively) (p<0.05). The GSTP1 Val allele shows an interaction with smoking, alcohol consumption, and especially H. pylori infection for increasing the risk of gastric cancer. These findings could demonstrate new pathophysiological pathways for the development of gastric cancer.	[Zhang, Ye; Sun, Li-Ping; Xing, Cheng-Zhong; Xu, Qian; He, Cai-Yun; Li, Ping; Gong, Yue-Hua; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Canc Inst & Gen Surg, Shenyang, Peoples R China; [Zhang, Ye; Sun, Li-Ping; Xing, Cheng-Zhong; Xu, Qian; He, Cai-Yun; Li, Ping; Gong, Yue-Hua; Yuan, Yuan] Key Lab Canc Control Liaoning Prov, Shenyang, Peoples R China; [Liu, Yun-Peng] China Med Univ, Affiliated Hosp 1, Dept Med Oncol, Shenyang, Peoples R China	China Medical University; China Medical University	Yuan, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Canc Inst & Gen Surg, Shenyang, Peoples R China.	yyuan@mail.cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Basic Research Program of China (973 Program) [2010CB529304]; Foundation of the Key Laboratory in Liaoning Province [LS2010167]; Foundation for the Scientific Research Fund of Liaoning Provincial Education Department [L2010641]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Foundation of the Key Laboratory in Liaoning Province; Foundation for the Scientific Research Fund of Liaoning Provincial Education Department	This study was supported by grants from the National Basic Research Program of China (973 Program) (no. 2010CB529304), the Foundation of the Key Laboratory in Liaoning Province (no. LS2010167), and the Foundation for the Scientific Research Fund of Liaoning Provincial Education Department (no. L2010641). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Darazy M, 2011, GENET TEST MOL BIOMA, V15, P423, DOI 10.1089/gtmb.2010.0206; Ding WQ, 1998, ALCOHOL CLIN EXP RES, V22, P225, DOI 10.1111/j.1530-0277.1998.tb03642.x; Epplein M, 2009, CANCER EPIDEM BIOMAR, V18, P314, DOI 10.1158/1055-9965.EPI-08-0627; Ferrand J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029007; Hauptstock V, 2011, BIOCHEM BIOPH RES CO, V412, P606, DOI 10.1016/j.bbrc.2011.08.007; Hu X, 1999, CANCER RES, V59, P2358; Huang BF, 2012, INT J CANCER, V131, pE744, DOI 10.1002/ijc.27407; Ihsan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029431; Jana S, 2009, CURR DRUG METAB, V10, P595, DOI 10.2174/138920009789375379; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karen-Ng LP, 2011, ASIAN PAC J CANCER P, V12, P1161; Katoh T, 1999, PHARMACOGENETICS, V9, P165; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; Luo YP, 2011, TUMOR BIOL, V32, P215, DOI 10.1007/s13277-010-0115-8; McCullough MJ, 2008, AUST DENT J, V53, P302, DOI 10.1111/j.1834-7819.2008.00070.x; Mikko S, 2012, J GASTROEN HEPATOL, V27, P135, DOI 10.1111/j.1440-1746.2012.07017.x; Ramalhinho ACM, 2012, DNA CELL BIOL, V31, P1100, DOI 10.1089/dna.2011.1538; Moyer AM, 2007, CLIN CANCER RES, V13, P7207, DOI 10.1158/1078-0432.CCR-07-0635; Niwa T, 2010, ADV GENET, V71, P41, DOI [10.1016/S0065-2660(10)71002-6, 10.1016/B978-0-12-380864-6.00002-X]; Palli D, 2010, MUTAGENESIS, V25, P569, DOI 10.1093/mutage/geq042; Persson C, 2011, AM J EPIDEMIOL, V173, P259, DOI 10.1093/aje/kwq370; Qadri Q, 2011, GENET MOL RES, V10, P3038, DOI 10.4238/2011.December.6.4; Romero A, 2012, ANN ONCOL, V23, P1750, DOI 10.1093/annonc/mdr483; Schistosomes liver flukes and Helicobacter pylori, 1994, IARC MONOGR EVAL CAR, V61, P1; Setiawan VW, 2001, CANCER CAUSE CONTROL, V12, P673, DOI 10.1023/A:1011261602940; Song HR, 2011, GASTRIC CANCER, V14, P242, DOI 10.1007/s10120-011-0034-4; Souiden Y, 2010, CANCER EPIDEMIOL, V34, P598, DOI 10.1016/j.canep.2010.06.002; Stolte M, 2001, CAN J GASTROENTEROL, V15, P591, DOI 10.1155/2001/367832; Strange R C, 1999, IARC Sci Publ, P231; Sweeney C, 2000, CANCER RES, V60, P5621; Vaughn MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025707; Vecanova J, 2011, BRATISL MED J, V112, P67; Vural B, 2012, GENET TEST MOL BIOMA, V16, P701, DOI 10.1089/gtmb.2011.0315; Wang GH, 2009, CANCER-AM CANCER SOC, V115, P2430, DOI 10.1002/cncr.24255; Wang ZY, 2012, ASIAN PAC J CANCER P, V13, P1515, DOI 10.7314/APJCP.2012.13.4.1515; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; Yamada H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-63; Yu J, 2011, CANCER INVEST, V29, P564, DOI 10.3109/07357907.2011.605411; Zhang Y, 2009, ANTI-CANCER DRUG, V20, P208, DOI 10.1097/CAD.0b013e328322fbaa; Zhang Ye, 2007, Yichuan, V29, P293, DOI 10.1360/yc-007-0299; Zhang YJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-256	41	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47178	10.1371/journal.pone.0047178	http://dx.doi.org/10.1371/journal.pone.0047178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077566	Green Published, gold			2022-12-27	WOS:000309995100072
J	Fernandez, P; Soria, M; Blesa, D; DiRienzo, J; Moschen, S; Rivarola, M; Clavijo, BJ; Gonzalez, S; Peluffo, L; Principi, D; Dosio, G; Aguirrezabal, L; Garcia-Garcia, F; Conesa, A; Hopp, E; Dopazo, J; Heinz, RA; Paniego, N				Fernandez, Paula; Soria, Marcelo; Blesa, David; DiRienzo, Julio; Moschen, Sebastian; Rivarola, Maximo; Jose Clavijo, Bernardo; Gonzalez, Sergio; Peluffo, Lucila; Principi, Dario; Dosio, Guillermo; Aguirrezabal, Luis; Garcia-Garcia, Francisco; Conesa, Ana; Hopp, Esteban; Dopazo, Joaquin; Amelia Heinz, Ruth; Paniego, Norma			Development, Characterization and Experimental Validation of a Cultivated Sunflower (Helianthus annuus L.) Gene Expression Oligonucleotide Microarray	PLOS ONE			English	Article							CDNA MICROARRAY; FUNCTIONAL ANNOTATION; SIGNAL-TRANSDUCTION; CANDIDATE GENES; SNP DISCOVERY; GENOMICS; DATABASE; TOOL; TRANSCRIPTOME; INFORMATION	Oligonucleotide-based microarrays with accurate gene coverage represent a key strategy for transcriptional studies in orphan species such as sunflower, H. annuus L., which lacks full genome sequences. The goal of this study was the development and functional annotation of a comprehensive sunflower unigene collection and the design and validation of a custom sunflower oligonucleotide-based microarray. A large scale EST (>130,000 ESTs) curation, assembly and sequence annotation was performed using Blast2GO (www.blast2go.de). The EST assembly comprises 41,013 putative transcripts (12,924 contigs and 28,089 singletons). The resulting Sunflower Unigen Resource (SUR version 1.0) was used to design an oligonucleotide-based Agilent microarray for cultivated sunflower. This microarray includes a total of 42,326 features: 1,417 Agilent controls, 74 control probes for sunflower replicated 10 times (740 controls) and 40,169 different non-control probes. Microarray performance was validated using a model experiment examining the induction of senescence by water deficit. Pre-processing and differential expression analysis of Agilent microarrays was performed using the Bioconductor limma package. The analyses based on p-values calculated by eBayes (p<0.01) allowed the detection of 558 differentially expressed genes between water stress and control conditions; from these, ten genes were further validated by qPCR. Over-represented ontologies were identified using FatiScan in the Babelomics suite. This work generated a curated and trustable sunflower unigene collection, and a custom, validated sunflower oligonucleotide-based microarray using Agilent technology. Both the curated unigene collection and the validated oligonucleotide microarray provide key resources for sunflower genome analysis, transcriptional studies, and molecular breeding for crop improvement.	[Fernandez, Paula; Moschen, Sebastian; Jose Clavijo, Bernardo; Hopp, Esteban; Amelia Heinz, Ruth; Paniego, Norma] Inst Nacl Tecnol Agropecuaria, Ctr Invest Ciencias Agron & Vet, Inst Biotecnol, Buenos Aires, DF, Argentina; [Soria, Marcelo] Univ Buenos Aires, Fac Agron, Buenos Aires, DF, Argentina; [Blesa, David; Garcia-Garcia, Francisco; Conesa, Ana; Dopazo, Joaquin] Ctr Invest Principe Felipe, Dept Bioinformat & Genom, Valencia, Spain; [DiRienzo, Julio] Univ Nacl Cordoba, Fac Ciencias Agr, Catedra Estadist & Biometria, RA-5000 Cordoba, Argentina; [Moschen, Sebastian; Dosio, Guillermo; Aguirrezabal, Luis] Univ Nacl Mar del Plata, Unidad Integrada, Lab Fisiol Vegetal, Estn Expt Agr INTA Balcarce, Buenos Aires, DF, Argentina; [Fernandez, Paula; Rivarola, Maximo; Peluffo, Lucila; Principi, Dario; Dosio, Guillermo; Aguirrezabal, Luis; Amelia Heinz, Ruth; Paniego, Norma] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Gonzalez, Sergio] Univ Buenos Aires, Fac Ingn, Buenos Aires, DF, Argentina; [Hopp, Esteban; Amelia Heinz, Ruth] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Fernandez, Paula] Univ Nacl San Martin, Escuela Ciencia & Tecnol, Buenos Aires, DF, Argentina; [Garcia-Garcia, Francisco; Dopazo, Joaquin] Ctr Invest Principe Felipe, Natl Inst Bioinformat, Valencia, Spain	Instituto Nacional de Tecnologia Agropecuaria (INTA); University of Buenos Aires; Prince Felipe Research Center; National University of Cordoba; Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Mar del Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Prince Felipe Research Center	Paniego, N (corresponding author), Inst Nacl Tecnol Agropecuaria, Ctr Invest Ciencias Agron & Vet, Inst Biotecnol, Buenos Aires, DF, Argentina.	npaniego@cnia.inta.gov.ar	García-García, Francisco/B-1929-2014; Paniego, Norma/AAK-6140-2021; Rivarola, Maximo L/C-1261-2014; Cegarra, Ana V Conesa/A-9559-2014; Blesa, David/D-8067-2018; García-García, Francisco/N-2263-2019; Dopazo, Joaquin/A-9270-2014	García-García, Francisco/0000-0001-8354-5636; Cegarra, Ana V Conesa/0000-0001-9597-311X; Blesa, David/0000-0002-1762-7833; García-García, Francisco/0000-0001-8354-5636; Dopazo, Joaquin/0000-0003-3318-120X; Dosio, Guillermo/0000-0003-1274-5862; Paniego, Norma/0000-0003-3906-5330; Clavijo, Bernardo J./0000-0002-7597-2774; Rivarola, Maximo/0000-0003-2818-1037; Moschen, Sebastian/0000-0002-9127-7958; Hopp, H. Esteban/0000-0002-2230-641X	Instituto Nacional de Tecnologia Agropecuaria (INTA, Argentina) [PPR241001/245001, PE245711/245732]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina), Proyecto de Areas Estrategicas [PAE 2007 37100, PME 023, PID 073, PICT 15-32905]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET, Argentina), Proyectos de Investigacion Plurianuales [PIP 5788]; Universidad Nacional de Mar del Plata (UNMdP, Argentina) [AGR212/AGR260]; Agencia Espanola de Cooperacion Internacional y Desarrollo (AECID, Spain) [D/016099/08, D/024562/09, D/031348/10]; CONICET, Ing; AECID; Lic; ANPCyT fellowship	Instituto Nacional de Tecnologia Agropecuaria (INTA, Argentina); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina), Proyecto de Areas Estrategicas; Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET, Argentina), Proyectos de Investigacion Plurianuales; Universidad Nacional de Mar del Plata (UNMdP, Argentina)(National University of La Plata); Agencia Espanola de Cooperacion Internacional y Desarrollo (AECID, Spain); CONICET, Ing; AECID; Lic; ANPCyT fellowship(ANPCyT)	This work was supported by grants from Instituto Nacional de Tecnologia Agropecuaria (INTA, Argentina) PPR241001/245001, PE245711/245732; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina), Proyecto de Areas Estrategicas PAE 2007 37100, PME 023, PID 073, PICT 15-32905; Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET, Argentina), Proyectos de Investigacion Plurianuales, PIP 5788; Universidad Nacional de Mar del Plata (UNMdP, Argentina) AGR212/AGR260; Agencia Espanola de Cooperacion Internacional y Desarrollo (AECID, Spain) D/016099/08, D/024562/09, D/031348/10. Dr. LP holds a fellowship from CONICET, Ing. SG holds a fellowship from AECID and Lic. SM holds an ANPCyT fellowship. Dr. PF, Dr. RAH, Dr. NP, Dr. MR, Dr. GD and Dr. LA are career members of the CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Al-Shahrour F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-114; Alignan M, 2006, NEW PHYTOL, V170, P523, DOI 10.1111/j.1469-8137.2006.01696.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Bazin J, 2011, PLANT CELL, V23, P2196, DOI 10.1105/tpc.111.086694; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Booman M, 2011, MAR BIOTECHNOL, V13, P733, DOI 10.1007/s10126-010-9335-6; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brouillette LC, 2011, ANN BOT-LONDON, V107, P101, DOI 10.1093/aob/mcq203; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Chen YA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-191; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Clarke JD, 2006, PLANT J, V45, P630, DOI 10.1111/j.1365-313X.2006.02668.x; Close TJ, 2004, PLANT PHYSIOL, V134, P960, DOI 10.1104/pp.103.034462; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Di Rienzo J.A, 2009, FGSTATISTICS; Edwards KD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-142; Ewing R M, 2000, Pac Symp Biocomput, P430; Fenart S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-592; Fernandez P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-11; Fernandez P, 2011, PLANT CELL REP, V30, P63, DOI 10.1007/s00299-010-0944-3; Forment J, 2005, PLANT MOL BIOL, V57, P375, DOI 10.1007/s11103-004-7926-1; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hardiman G, 2004, PHARMACOGENOMICS, V5, P487, DOI 10.1517/14622416.5.5.487; Heesacker A, 2008, THEOR APPL GENET, V117, P1021, DOI 10.1007/s00122-008-0841-0; Hewezi T, 2006, PLANTA, V223, P948, DOI 10.1007/s00425-005-0151-6; Hewezi T, 2006, J EXP BOT, V57, P3109, DOI 10.1093/jxb/erl080; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; JAN CC, 2007, GENETIC RESOURCES CH, V4, P103; Kane NC, 2011, BOTANY, V89, P429, DOI [10.1139/B11-032, 10.1139/b11-032]; Lai Z, 2006, MOL ECOL, V15, P1213, DOI 10.1111/j.1365-294X.2006.02775.x; Lai Z, 2008, GENETICS, V179, P1881, DOI 10.1534/genetics.108.091041; Lai Z, 2012, AM J BOT, V99, P209, DOI 10.3732/ajb.1100313; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Li XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-60; Martinez-Godoy MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-318; Mascarell-Creus A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-467; Nazar RN, 2010, MOL BIOTECHNOL, V44, P8, DOI 10.1007/s12033-009-9212-6; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ophir R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-269; Paniego N., 2007, Oilseeds, P153; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Privat I, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-5; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rensink WA, 2005, TRENDS PLANT SCI, V10, P603, DOI 10.1016/j.tplants.2005.10.003; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roche J, 2007, PLANTA, V226, P601, DOI 10.1007/s00425-007-0508-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Seiler G, 2010, GENET GENOM BREED CR, P1, DOI 10.1201/b10192-2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trick M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-50; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Udall JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-81; Vick BA, 2010, GENET GENOM BREED CR, P313, DOI 10.1201/b10192-11; Wan YF, 2009, PLANT BIOTECHNOL J, V7, P401, DOI 10.1111/j.1467-7652.2009.00405.x; Wurmbach E, 2003, METHODS, V31, P306, DOI 10.1016/S1046-2023(03)00161-0	64	24	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e45899	10.1371/journal.pone.0045899	http://dx.doi.org/10.1371/journal.pone.0045899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110046	Green Submitted, gold, Green Published			2022-12-27	WOS:000310262500003
J	Kim, JY; Sohn, JH; Choi, JM; Lee, JH; Hong, CS; Lee, JS; Park, JW				Kim, Joo Young; Sohn, Jung Ho; Choi, Je-Min; Lee, Jae-Hyun; Hong, Chein-Soo; Lee, Joo-Shil; Park, Jung-Won			Alveolar Macrophages Play a Key Role in Cockroach-Induced Allergic Inflammation via TNF-alpha Pathway	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTOR-2; AIRWAY EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; GERMAN-COCKROACH; DUST-MITE; IL-8 EXPRESSION; LUNG-DISEASE; ASTHMA; EXPOSURE; SENSITIZATION	The activity of the serine protease in the German cockroach allergen is important to the development of allergic disease. The protease-activated receptor (PAR)-2, which is expressed in numerous cell types in lung tissue, is known to mediate the cellular events caused by inhaled serine protease. Alveolar macrophages express PAR-2 and produce considerable amounts of tumor necrosis factor (TNF)-alpha. We determined whether the serine protease in German cockroach extract (GCE) enhances TNF-alpha production by alveolar macrophages through the PAR-2 pathway and whether the TNF-alpha production affects GCE-induced pulmonary inflammation. Effects of GCE on alveolar macrophages and TNF-alpha production were evaluated using in vitro MH-S and RAW264.6 cells and in vivo GCE-induced asthma models of BALB/c mice. GCE contained a large amount of serine protease. In the MH-S and RAW264.7 cells, GCE activated PAR-2 and thereby produced TNF-alpha. In the GCE-induced asthma model, intranasal administration of GCE increased airway hyperresponsiveness (AHR), inflammatory cell infiltration, productions of serum immunoglobulin E, interleukin (IL)-5, IL-13 and TNF-alpha production in alveolar macrophages. Blockade of serine proteases prevented the development of GCE induced allergic pathologies. TNF-alpha blockade also prevented the development of such asthma-like lesions. Depletion of alveolar macrophages reduced AHR and intracellular TNF-alpha level in pulmonary cell populations in the GCE-induced asthma model. These results suggest that serine protease from GCE affects asthma through an alveolar macrophage and TNF-alpha dependent manner, reflecting the close relation of innate and adaptive immune response in allergic asthma model.	[Sohn, Jung Ho; Lee, Jae-Hyun; Hong, Chein-Soo; Park, Jung-Won] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea; [Kim, Joo Young] Ewha Womans Univ, Pharmaceut Sci Res Inst, Coll Pharm, Seoul, South Korea; [Sohn, Jung Ho; Choi, Je-Min] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Kim, Joo Young; Park, Jung-Won] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120749, South Korea; [Lee, Jae-Hyun; Hong, Chein-Soo; Park, Jung-Won] Yonsei Univ, Coll Med, Inst Allergy, Seoul 120749, South Korea; [Lee, Joo-Shil] Korea Natl Inst Hlth, Ctr Immunol & Pathol, Osong, South Korea	Yonsei University; Yonsei University Health System; Ewha Womans University; Hanyang University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology	Park, JW (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea.	parkjw@yuhs.ac	Lee, Jae-Hyun/ABE-3803-2020; Kim, Jooyoung/R-5839-2018	Lee, Jae-Hyun/0000-0002-0760-0071; Kim, Jooyoung/0000-0003-4846-6259; Park, Jung-Won/0000-0003-0249-8749; Choi, Je-Min/0000-0002-9482-710X	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092076]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by the grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A092076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizmendi NG, 2011, ALLERGY ASTHMA CL IM, V7, DOI 10.1186/1710-1492-7-22; Arizmendi NG, 2011, J IMMUNOL, V186, P3164, DOI 10.4049/jimmunol.0903812; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Berger P, 2001, J APPL PHYSIOL, V91, P1372, DOI 10.1152/jappl.2001.91.3.1372; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bhat RK, 2003, CLIN EXP ALLERGY, V33, P35, DOI 10.1046/j.1365-2222.2002.01481.x; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Chapman MD, 2007, J ALLERGY CLIN IMMUN, V119, P414, DOI 10.1016/j.jaci.2006.11.001; Cocks TM, 1999, NATURE, V398, P156, DOI 10.1038/18223; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Compton SJ, 2001, BRIT J PHARMACOL, V134, P705, DOI 10.1038/sj.bjp.0704303; Day SB, 2010, J INNATE IMMUN, V2, P495, DOI 10.1159/000317195; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Di Valentin E, 2009, AM J PHYSIOL-LUNG C, V296, pL185, DOI 10.1152/ajplung.90367.2008; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; Ebeling C, 2005, J ALLERGY CLIN IMMUN, V115, P623, DOI 10.1016/j.jaci.2004.11.042; Ebeling C, 2007, J IMMUNOL, V179, P2910, DOI 10.4049/jimmunol.179.5.2910; Feola DJ, 2010, ANTIMICROB AGENTS CH, V54, P2437, DOI 10.1128/AAC.01424-09; Fields RC, 2003, AM J PATHOL, V162, P1817, DOI 10.1016/S0002-9440(10)64316-7; Goplen N, 2009, J ALLERGY CLIN IMMUN, V123, P925, DOI 10.1016/j.jaci.2009.02.009; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gough L, 2003, CLIN EXP ALLERGY, V33, P1159, DOI 10.1046/j.1365-2222.2003.01716.x; Hong JH, 2004, J ALLERGY CLIN IMMUN, V113, P315, DOI 10.1016/j.jaci.2003.11.026; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; Huang H, 2010, J IMMUNOL, V185, P5003, DOI 10.4049/jimmunol.0903446; Jeon SK, 2008, J INVEST DERMATOL, V128, P1930, DOI 10.1038/jid.2008.13; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kauffman Henk F, 2006, Clin Mol Allergy, V4, P5, DOI 10.1186/1476-7961-4-5; Kelso EB, 2006, J PHARMACOL EXP THER, V316, P1017, DOI 10.1124/jpet.105.093807; Kelso EB, 2007, ARTHRITIS RHEUM, V56, P765, DOI 10.1002/art.22423; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kiselyov K, 2003, CELL SIGNAL, V15, P243, DOI 10.1016/S0898-6568(02)00074-8; Lee KE, 2007, CLIN EXP ALLERGY, V37, P1364, DOI 10.1111/j.1365-2222.2007.02797.x; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Page K, 2003, J ALLERGY CLIN IMMUN, V112, P1112, DOI 10.1016/j.jaci.2003.08.050; Page K, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-62; Park JW, 2004, AM J RESP CRIT CARE, V169, P726, DOI 10.1164/rccm.200307-1042OC; Peters T, 2010, J PHARMACOL EXP THER, V335, P424, DOI 10.1124/jpet.109.163253; Pomes A, 2002, AM J RESP CRIT CARE, V165, P391, DOI 10.1164/ajrccm.165.3.2104027; Roscic-Mrkic B, 2001, J VIROL, V75, P3343, DOI 10.1128/JVI.75.7.3343-3351.2001; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; THEPEN T, 1989, J EXP MED, V170, P499, DOI 10.1084/jem.170.2.499; Tu WC, 2006, J INVERTEBR PATHOL, V92, P73, DOI 10.1016/j.jip.2006.04.002; TWINING SS, 1984, ANAL BIOCHEM, V143, P30, DOI 10.1016/0003-2697(84)90553-0; Van Hove CL, 2007, AM J RESP CELL MOL, V36, P573, DOI 10.1165/rcmb.2006-0385OC; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; Vliagoftis H, 2001, J ALLERGY CLIN IMMUN, V107, P679, DOI 10.1067/mai.2001.114245; Wang Q, 2010, J IMMUNOL, V185, P834, DOI 10.4049/jimmunol.0901490; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yin L, 2001, CELL TISSUE RES, V304, P391, DOI 10.1007/s004410000245; Zhang-Hoover J, 2000, IMMUNOLOGY, V101, P501, DOI 10.1046/j.1365-2567.2000.00143.x	54	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47971	10.1371/journal.pone.0047971	http://dx.doi.org/10.1371/journal.pone.0047971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094102	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200054
J	Rohrmeier, M; Fu, QF; Dienes, Z				Rohrmeier, Martin; Fu, Qiufang; Dienes, Zoltan			Implicit Learning of Recursive Context-Free Grammars	PLOS ONE			English	Article							ARTIFICIAL GRAMMAR; NONADJACENT DEPENDENCIES; SUBJECTIVE MEASURES; NEURAL BASIS; LANGUAGE; ORDER; ACQUISITION; KNOWLEDGE; SYNTAX; LEARNABILITY	Context-free grammars are fundamental for the description of linguistic syntax. However, most artificial grammar learning experiments have explored learning of simpler finite-state grammars, while studies exploring context-free grammars have not assessed awareness and implicitness. This paper explores the implicit learning of context-free grammars employing features of hierarchical organization, recursive embedding and long-distance dependencies. The grammars also featured the distinction between left-and right-branching structures, as well as between centre-and tail-embedding, both distinctions found in natural languages. People acquired unconscious knowledge of relations between grammatical classes even for dependencies over long distances, in ways that went beyond learning simpler relations (e.g. n-grams) between individual words. The structural distinctions drawn from linguistics also proved important as performance was greater for tail-embedding than centre-embedding structures. The results suggest the plausibility of implicit learning of complex context-free structures, which model some features of natural languages. They support the relevance of artificial grammar learning for probing mechanisms of language learning and challenge existing theories and computational models of implicit learning.	[Rohrmeier, Martin] Free Univ Berlin, Berlin, Germany; [Fu, Qiufang] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Dienes, Zoltan] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Dienes, Zoltan] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	Free University of Berlin; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Sussex; University of Sussex	Rohrmeier, M (corresponding author), Free Univ Berlin, Berlin, Germany.	mrohrmeier@cantab.net	, Grace/ABB-4349-2021	Rohrmeier, Martin Alois/0000-0002-4323-7257; Dienes, Zoltan/0000-0001-7454-3161	Chinese Ministry of Science and Technology [2011CB302201]; National Natural Science Foundation of China [30900395]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported in part by grants from 973 Program of Chinese Ministry of Science and Technology (2011CB302201), the National Natural Science Foundation of China (30900395). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN GTM, 1995, J EXP PSYCHOL LEARN, V21, P899, DOI 10.1037/0278-7393.21.4.899; [Anonymous], 1992, BACKGROUND EXPT MACH; Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; Bahlmann J, 2008, NEUROIMAGE, V42, P525, DOI 10.1016/j.neuroimage.2008.04.249; Bahlmann J, 2009, BRAIN RES, V1298, P161, DOI 10.1016/j.brainres.2009.08.017; Bigand E, 1998, CAH PSYCHOL COGN, V17, P577; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; Boucher L, 2003, COGNITIVE SCI, V27, P807, DOI 10.1016/j.cogsci.2003.03.001; BRAINE MDS, 1963, PSYCHOL REV, V70, P323, DOI 10.1037/h0047696; BROOKS LR, 1991, J EXP PSYCHOL GEN, V120, P316, DOI 10.1037/0096-3445.120.3.316; CHOMSKY N, 1956, IRE T INFORM THEOR, V2, P113; Chomsky N., 1957, SYNTACTIC STRUCTURES; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Chomsky Noam, 1959, COMPUTER PROGRAMMING, V26, P118; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; Cleeremans A., 1993, MECH IMPLICIT LEARNI; Cleeremans A, 2008, CAMB HANDB PSYCHOL, P396; Creel SC, 2004, J EXP PSYCHOL LEARN, V30, P1119, DOI 10.1037/0278-7393.30.5.1119; de Vries MH, 2008, COGNITION, V107, P763, DOI 10.1016/j.cognition.2007.09.002; de Vries MH, 2011, BIOLINGUISTICS, V5, P10; Dienes Z, 2004, J CONSCIOUSNESS STUD, V11, P25; Dienes Z, 2004, COGNITIVE SCI, V28, P531, DOI 10.1016/j.cogsci.2004.03.003; DIENES Z, 1995, J EXP PSYCHOL LEARN, V21, P1322, DOI 10.1037/0278-7393.21.5.1322; Dienes Z, 1998, Q J EXP PSYCHOL-A, V51, P593, DOI 10.1080/713755772; Dienes Z., 2008, UNDERSTANDING PSYCHO; Dienes Z., 2012, STAT LEARN LANG ACQU, V1, P337; Dienes Z, 2012, LANGUAGE MU IN PRESS; Dienes Z, 2012, J EXPT PSYC IN PRESS; Dienes Z, 2008, PROG BRAIN RES, V168, P49, DOI 10.1016/S0079-6123(07)68005-4; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; DULANY DE, 1962, J PERS, V30, P102, DOI 10.1111/j.1467-6494.1962.tb02310.x; Endress AD, 2009, TRENDS COGN SCI, V13, P348, DOI 10.1016/j.tics.2009.05.005; Ferreira F, 2007, LANG LINGUIST COMPAS, V1, P71, DOI 10.1111/j.1749-818x.2007.00007.x; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Fitch WT, 2012, ARTIFICIAL GRAMMAR L; Frensch PA, 2003, CURR DIR PSYCHOL SCI, V12, P13, DOI 10.1111/1467-8721.01213; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2004, NEUROREPORT, V15, P165, DOI 10.1097/00001756-200401190-00032; Friederici AD, 2002, P NATL ACAD SCI USA, V99, P529, DOI 10.1073/pnas.012611199; Friederici AD, 1996, J EXP PSYCHOL LEARN, V22, P1219, DOI 10.1037//0278-7393.22.5.1219; Friederici AD, 2004, TRENDS COGN SCI, V8, P245, DOI 10.1016/S1364-6613(04)00116-0; Friederici AD, 2011, BIOLINGUISTICS, V5, P87; Fu QF, 2010, CONSCIOUS COGN, V19, P462, DOI 10.1016/j.concog.2009.10.001; Gebhart AL, 2009, PSYCHON B REV, V16, P486, DOI 10.3758/PBR.16.3.486; Gomez RL, 2000, TRENDS COGN SCI, V4, P178, DOI 10.1016/S1364-6613(00)01467-4; Gomez RL, 1999, COGNITION, V70, P109, DOI 10.1016/S0010-0277(99)00003-7; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Guo X, 2012, CONSCIOUSNE IN PRESS; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hawkins J, 2003, EFFICIENCY COMPLEXIT; HAWKINS JA, 1990, LINGUIST INQ, V21, P223; Hawkins JA, 1994, PERFORMANCE THEORY O; Hochmann JR, 2008, COGNITIVE SCI, V32, P1021, DOI 10.1080/03640210801897849; Hopcroft J.E., 1969, FORMAL LANGUAGES THE; Jackendoff, 2007, LANGUAGE CONSCIOUSNE; Jackendoff R, 2006, COGNITION, V100, P33, DOI 10.1016/j.cognition.2005.11.005; Jackendoff R, 2009, MUSIC PERCEPT, V26, P195, DOI 10.1525/MP.2009.26.3.195; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Jiang S, 2012, CONSCIOUS COGN, V21, P476, DOI 10.1016/j.concog.2011.12.009; Jimenez L, 2006, J EXP PSYCHOL LEARN, V32, P475, DOI 10.1037/0278-7393.32.3.475; Johnstone T, 1999, J EXP PSYCHOL LEARN, V25, P524, DOI 10.1037/0278-7393.25.2.524; Kenny BJ, 2002, SCI PSYCHOL MUSIC PE, P163; Kirby S., 1999, FUNCTION SELECTION I; KNOWLTON BJ, 1994, J EXP PSYCHOL LEARN, V20, P79, DOI 10.1037/0278-7393.20.1.79; Kuhn G, 2005, J EXP PSYCHOL LEARN, V31, P1417, DOI 10.1037/0278-7393.31.6.1417; Kuhn G, 2008, COGNITION, V106, P184, DOI 10.1016/j.cognition.2007.01.003; Lai J, 2011, COGNITION, V118, P265, DOI 10.1016/j.cognition.2010.11.011; Land M. F., 1998, VISION AND ACTION, P163, DOI DOI 10.1016/S0960-9822(01)0; LANGENDOEN DT, 1975, LINGUIST INQ, V6, P533; Lerdahl F., 1983, GENERATIVE THEORY TO; Leung J, 2007, THESIS U CAMBRIDGE U; Leung J, 2006, P ANN M COGN SCI SOC, P465; Lobina DJ, 2011, LANGUAGE COGNITIVE P; Lobina DJ, 2010, INTERLINGUISTICA; Lotz A, 2009, Q J EXP PSYCHOL, V62, P576, DOI 10.1080/17470210802103739; Loui P, 2008, MUSIC SCI, V12, P207, DOI 10.1177/102986490801200202; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P197, DOI 10.1016/0010-0285(83)90009-9; Martins MD, 2012, PHILOS T R SOC B, V367, P2055, DOI 10.1098/rstb.2012.0097; Masters RSW, 2004, REHABIL PSYCHOL, V49, P79, DOI 10.1037/0090-5550.49.1.79; Mathews R. C., 1997, IMPLICIT IS IMPLICIT, P13; MATHEWS RC, 1989, J EXP PSYCHOL LEARN, V15, P1083, DOI 10.1037/0278-7393.15.6.1083; MOESER SD, 1972, J VERB LEARN VERB BE, V11, P759, DOI 10.1016/S0022-5371(72)80010-0; Mueller JL, 2010, COGNITIVE SCI, V34, P338, DOI 10.1111/j.1551-6709.2009.01093.x; Newport EL, 2004, COGNITIVE PSYCHOL, V48, P127, DOI 10.1016/S0010-0285(03)00128-2; Opitz B, 2003, NEUROIMAGE, V19, P1730, DOI 10.1016/S1053-8119(03)00170-8; Opitz B, 2007, HUM BRAIN MAPP, V28, P585, DOI 10.1002/hbm.20287; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Perruchet P, 2005, PSYCHON B REV, V12, P307, DOI 10.3758/BF03196377; Perruchet P, 1998, J MEM LANG, V39, P246, DOI 10.1006/jmla.1998.2576; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Poletiek FH, 2011, BIOLINGUISTICS, V5, P36; Pothos EM, 2007, PSYCHOL BULL, V133, P227, DOI 10.1037/0033-2909.133.2.227; PULLUM GK, 1986, NAT LANG LINGUIST TH, V4, P409, DOI 10.1007/BF00133376; Reber A.S., 1993, IMPLICIT LEARNING TA; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; REBER AS, 1977, COGNITION, V114, P14; Rebuschat P, 2008, THESIS U CAMBRIDGE; Redington M, 1998, LANG COGNITIVE PROC, V13, P129, DOI 10.1080/016909698386500; REDINGTON M, 1993, PROCEEDINGS OF THE FIFTEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P848; Redington M, 1996, J EXP PSYCHOL GEN, V125, P123, DOI 10.1037/0096-3445.125.2.123; Reed N, 2010, CONSCIOUS COGN, V19, P63, DOI 10.1016/j.concog.2009.07.006; Reeder PA, 2009, P 31 ANN M COGN SCI; Robinson P, 2005, STUD SECOND LANG ACQ, V27, P235, DOI 10.1017/S0272263105050126; Rohrmeier M, 2010, CONSCIOUSNE IN PRESS, V20, P214; Rohrmeier M, 2010, THESIS U CAMBRIDGE C; Rohrmeier M, 2012, TOP COGN SCI, V4, P525, DOI 10.1111/j.1756-8765.2012.01223.x; Rohrmeier M, 2011, J MATH MUSIC, V5, P35, DOI 10.1080/17459737.2011.573676; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 2002, J MEM LANG, V47, P172, DOI 10.1006/jmla.2001.2839; Saffran JR, 2001, J MEM LANG, V44, P493, DOI 10.1006/jmla.2000.2759; Scott RB, 2008, J EXP PSYCHOL LEARN, V34, P1264, DOI 10.1037/a0012943; SERVANSCHREIBER E, 1990, J EXP PSYCHOL LEARN, V16, P592, DOI 10.1037/0278-7393.16.4.592; SMITH KH, 1966, J VERB LEARN VERB BE, V5, P447, DOI 10.1016/S0022-5371(66)80059-2; Steedman M, 2002, LINGUIST PHILOS, V25, P723, DOI 10.1023/A:1020820000972; STEEDMAN MJ, 1984, MUSIC PERCEPT, V2, P52; Taatgen Niels A, 2009, P 31 ANN C COGN SCI, P1347; Thiessen ED, 2007, LANG LEARN DEV, V3, P73, DOI 10.1080/15475440709337001; Thompson SP, 2007, LANG LEARN DEV, V3, P1, DOI 10.1080/15475440709336999; Tomalin M, 2007, LINGUA, V117, P1784, DOI 10.1016/j.lingua.2006.11.001; Tunney RJ, 2001, J EXP PSYCHOL LEARN, V27, P614, DOI 10.1037//0278-7393.27.3.614; Udden J, 2012, COGNITIVE SCI, V36, P1078, DOI 10.1111/j.1551-6709.2012.01235.x; VOKEY JR, 1992, J EXP PSYCHOL LEARN, V18, P328, DOI 10.1037/0278-7393.18.2.328; Wilkinson L, 2004, J EXP PSYCHOL LEARN, V30, P354, DOI 10.1037/0278-7393.30.2.354; Williams J., 2004, FORM MEANING CONNECT, P203; Williams JN, 2005, STUD SECOND LANG ACQ, V27, P269, DOI 10.1017/S0272263105050138; Williams JN, 2008, LINGUA, V118, P522, DOI 10.1016/j.lingua.2007.03.003; Williams JN, 2009, NEW HANDBOOK OF SECOND LANGUAGE ACQUISITION, 2ND EDITION, P319; Zwart JW, 2011, BIOLINGUISTICS, V5, P43	132	29	29	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e45885	10.1371/journal.pone.0045885	http://dx.doi.org/10.1371/journal.pone.0045885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	023QT	23094021	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000310050200006
J	Rufer, ES; Tran, TD; Attridge, MM; Andrzejewski, ME; Flentke, GR; Smith, SM				Rufer, Echoleah S.; Tran, Tuan D.; Attridge, Megan M.; Andrzejewski, Matthew E.; Flentke, George R.; Smith, Susan M.			Adequacy of Maternal Iron Status Protects against Behavioral, Neuroanatomical, and Growth Deficits in Fetal Alcohol Spectrum Disorders	PLOS ONE			English	Article							ETHANOL EXPOSURE; COGNITIVE DEFICITS; CEREBELLAR CORTEX; LIGHT DRINKING; UNITED-STATES; RATS; PREVALENCE; PREGNANCY; CHILDREN; RISK	Fetal alcohol spectrum disorders (FASD) are the leading non-genetic cause of neurodevelopmental disability in children. Although alcohol is clearly teratogenic, environmental factors such as gravidity and socioeconomic status significantly modify individual FASD risk despite equivalent alcohol intake. An explanation for this variability could inform FASD prevention. Here we show that the most common nutritional deficiency of pregnancy, iron deficiency without anemia (ID), is a potent and synergistic modifier of FASD risk. Using an established rat model of third trimester-equivalent binge drinking, we show that ID significantly interacts with alcohol to impair postnatal somatic growth, associative learning, and white matter formation, as compared with either insult separately. For the associative learning and myelination deficits, the ID-alcohol interaction was synergistic and the deficits persisted even after the offsprings' iron status had normalized. Importantly, the observed deficits in the ID-alcohol animals comprise key diagnostic criteria of FASD. Other neurobehaviors were normal, showing the ID-alcohol interaction was selective and did not reflect a generalized malnutrition. Importantly ID worsened FASD outcome even though the mothers lacked overt anemia; thus diagnostics that emphasize hematological markers will not identify pregnancies at-risk. This is the first direct demonstration that, as suggested by clinical studies, maternal iron status has a unique influence upon FASD outcome. While alcohol is unquestionably teratogenic, this ID-alcohol interaction likely represents a significant portion of FASD diagnoses because ID is more common in alcohol-abusing pregnancies than generally appreciated. Iron status may also underlie the associations between FASD and parity or socioeconomic status. We propose that increased attention to normalizing maternal iron status will substantially improve FASD outcome, even if maternal alcohol abuse continues. These findings offer novel insights into how alcohol damages the developing brain.	[Rufer, Echoleah S.; Smith, Susan M.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI USA; [Rufer, Echoleah S.; Attridge, Megan M.; Flentke, George R.; Smith, Susan M.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Andrzejewski, Matthew E.; Smith, Susan M.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Tran, Tuan D.] E Carolina Univ, Dept Psychol, Multidisciplinary Studies Program Neurosci, Greenville, NC 27858 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; East Carolina University	Smith, SM (corresponding author), Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI USA.	suesmith@nutrisci.wisc.edu	Mireku, Michael/D-5262-2016	Andrzejewski, Matthew/0000-0002-3557-3453; Attridge, Megan/0000-0003-1298-6826	National Institutes of Health [T32 ES07015, R37 AA11085, R21 AA17281, P30 HD03352]; Palmer Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017281, R37AA011085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Palmer Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants T32 ES07015 (E.S.R), R37 AA11085 (S.M.S), R21 AA17281 (S.M.S, T.D.T.), and P30 HD03352 (Waisman Center), and the Palmer Fund (S.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard JL, 2006, BEHAV BRAIN RES, V170, P224, DOI 10.1016/j.bbr.2006.02.024; Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739; Beard JL, 2000, AM J CLIN NUTR, V71, p1288S, DOI 10.1093/ajcn/71.5.1288s; Bichenkov E, 2001, DEV BRAIN RES, V128, P9, DOI 10.1016/S0165-3806(01)00142-0; Bodnar LM, 2002, J NUTR, V132, P2298, DOI 10.1093/jn/132.8.2298; Car BD, 2006, AM COLL LAB, P127, DOI 10.1016/B978-012074903-4/50008-X; Carter RC, 2007, PEDIATRICS, V120, P559, DOI 10.1542/peds.2007-0151; Cogswell ME, 2003, J NUTR, V133, p1974S, DOI 10.1093/jn/133.6.1974S; Coyne D, 2006, KIDNEY INT, V69, pS4, DOI 10.1038/sj.ki.5000404; DREOSTI IE, 1993, ANN NY ACAD SCI, V678, P193; *FAO WHO IRON, 2001, HUM VIT MIN REQ, P195; GOODLETT CR, 1990, ALCOHOL, V7, P107, DOI 10.1016/0741-8329(90)90070-S; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Harthoorn-Lasthuizen EJ, 2000, ACTA OBSTET GYN SCAN, V79, P660, DOI 10.1034/j.1600-0412.2000.079008660.x; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Ioannou GN, 2004, GASTROENTEROLOGY, V126, P1293, DOI 10.1053/j.gastro.2004.01.020; Jacobson SW, 2008, ALCOHOL CLIN EXP RES, V32, P365, DOI 10.1111/j.1530-0277.2007.00585.x; Jacobson SW, 2004, ALCOHOL CLIN EXP RES, V28, P1732, DOI 10.1097/01.ALC.0000145691.81233.FA; Kaharuza FM, 2001, ACTA OBSTET GYN SCAN, V80, P532, DOI 10.1034/j.1600-0412.2001.080006532.x; Keen CL, 2010, BIOFACTORS, V36, P125, DOI 10.1002/biof.89; KEEN CL, 1981, J NUTR, V111, P226, DOI 10.1093/jn/111.2.226; Kelly Y, 2009, INT J EPIDEMIOL, V38, P129, DOI 10.1093/ije/dyn230; Kelly YJ, 2012, J EPIDEMIOL COMMUN H, V66, P41, DOI 10.1136/jech.2009.103002; Klintsova AY, 1998, BRAIN RES, V800, P48, DOI 10.1016/S0006-8993(98)00495-8; Lebel C, 2008, ALCOHOL CLIN EXP RES, V32, P1732, DOI 10.1111/j.1530-0277.2008.00750.x; Lindquist DH, 2007, BRAIN RES, V1150, P155, DOI 10.1016/j.brainres.2007.03.002; Lindsley TL, 2006, BRAIN DEV NORMAL PRO, P230, DOI DOI 10.1523/JNEUROSCI.5067-07.2008; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Mattson SN, 2010, ALCOHOL CLIN EXP RES, V34, P1640, DOI 10.1111/j.1530-0277.2010.01250.x; May PA, 2005, AM J PUBLIC HEALTH, V95, P1190, DOI 10.2105/AJPH.2003.037093; May PA, 2008, ALCOHOL CLIN EXP RES, V32, P738, DOI 10.1111/j.1530-0277.2008.00634.x; May PA, 2007, DRUG ALCOHOL DEPEN, V88, P259, DOI 10.1016/j.drugalcdep.2006.11.007; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; MILLER MW, 1995, J NEUROCHEM, V65, P373; Mostofi A, 2010, J NEUROSCI, V30, P8920, DOI 10.1523/JNEUROSCI.6117-09.2010; National Institute on Alcohol Abuse and Alcoholism, 2009, NIAAA 5 YEAR STRAT P; PHILLIPS DE, 1989, EXP NEUROL, V103, P90, DOI 10.1016/0014-4886(89)90190-8; Rao R, 2007, SEMIN FETAL NEONAT M, V12, P54, DOI 10.1016/j.siny.2006.10.007; Rettmer RL, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.3.e37; Rosato-Siri MV, 2010, J NEUROSCI RES, V88, P1695, DOI 10.1002/jnr.22348; Sampson PD, 1997, TERATOLOGY, V56, P317, DOI 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.0.CO;2-U; Smith LN, 2006, PHARMACOL BIOCHEM BE, V85, P91, DOI 10.1016/j.pbb.2006.07.014; Sowell ER, 2008, J NEUROSCI, V28, P1313, DOI 10.1523/JNEUROSCI.5067-07.2008; Spohr HL, 2007, J PEDIATR-US, V150, P175, DOI 10.1016/j.jpeds.2006.11.044; Spottiswoode BS, 2011, ALCOHOL CLIN EXP RES, V35, P2174, DOI 10.1111/j.1530-0277.2011.01566.x; Stanton ME, 1998, ALCOHOL CLIN EXP RES, V22, P270, DOI 10.1111/j.1530-0277.1998.tb03649.x; Stoltzfus RJ, 2001, J NUTR, V131, p697S, DOI 10.1093/jn/131.2.697S; Stratton K., 1996, FETAL ALCOHOL SYNDRO; STREISSGUTH AP, 1983, ALCOHOL CLIN EXP RES, V7, P227, DOI 10.1111/j.1530-0277.1983.tb05447.x; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Tran TD, 2007, DEV PSYCHOBIOL, V49, P589, DOI 10.1002/dev.20226; Villarreal RP, 2005, J EXP ANAL BEHAV, V84, P631, DOI 10.1901/jeab.2005.96-04; Wozniak JR, 2009, ALCOHOL CLIN EXP RES, V33, P1825, DOI 10.1111/j.1530-0277.2009.01021.x; Zeisel SH, 2011, MOL NEUROBIOL, V44, P185, DOI 10.1007/s12035-011-8165-5	56	41	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47499	10.1371/journal.pone.0047499	http://dx.doi.org/10.1371/journal.pone.0047499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094056	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200028
J	Machado, P; Manco, L; Gomes, C; Mendes, C; Fernandes, N; Salome, G; Sitoe, L; Chibute, S; Langa, J; Ribeiro, L; Miranda, J; Cano, J; Pinto, J; Amorim, A; do Rosario, VE; Arez, AP				Machado, Patricia; Manco, Licinio; Gomes, Claudia; Mendes, Cristina; Fernandes, Natercia; Salome, Graca; Sitoe, Luis; Chibute, Sergio; Langa, Jose; Ribeiro, Leticia; Miranda, Juliana; Cano, Jorge; Pinto, Joao; Amorim, Antonio; do Rosario, Virgilio E.; Arez, Ana Paula			Pyruvate Kinase Deficiency in Sub-Saharan Africa: Identification of a Highly Frequent Missense Mutation (G829A; Glu277Lys) and Association with Malaria	PLOS ONE			English	Article							POPULATION-GENETICS; QUANTITATIVE ASSAY; PREVALENCE; RESISTANCE; PROTECTS; CHINESE; HUMANS	Background: Pyruvate kinase (PK) deficiency, causing hemolytic anemia, has been associated to malaria protection and its prevalence in sub-Saharan Africa is not known so far. This work shows the results of a study undertaken to determine PK deficiency occurrence in some sub-Saharan African countries, as well as finding a prevalent PK variant underlying this deficiency. Materials and Methods: Blood samples of individuals from four malaria endemic countries (Mozambique, Angola, Equatorial Guinea and Sao Tome and Principe) were analyzed in order to determine PK deficiency occurrence and detect any possible high frequent PK variant mutation. The association between this mutation and malaria was ascertained through association studies involving sample groups from individuals showing different malaria infection and outcome status. Results: The percentage of individuals showing a reduced PK activity in Maputo was 4.1% and the missense mutation G829A (Glu277Lys) in the PKLR gene (only identified in three individuals worldwide to date) was identified in a high frequency. Heterozygous carrier frequency was between 6.7% and 2.6%. A significant association was not detected between either PK reduced activity or allele 829A frequency and malaria infection and outcome, although the variant was more frequent among individuals with uncomplicated malaria. Conclusions: This was the first study on the occurrence of PK deficiency in several areas of Africa. A common PKLR mutation G829A (Glu277Lys) was identified. A global geographical co-distribution between malaria and high frequency of PK deficiency seems to occur suggesting that malaria may be a selective force raising the frequency of this 277Lys variant.	[Machado, Patricia; Gomes, Claudia; Mendes, Cristina; Pinto, Joao; do Rosario, Virgilio E.; Arez, Ana Paula] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais, Unidade Parasitol Med, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Manco, Licinio] Univ Coimbra, CIAS, Coimbra, Portugal; [Fernandes, Natercia; Salome, Graca; Sitoe, Luis; Chibute, Sergio] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Langa, Jose] Hosp Cent Maputo, Banco Sangue, Maputo, Mozambique; [Ribeiro, Leticia] Ctr Hosp Coimbra, Dept Hematol, Coimbra, Portugal; [Miranda, Juliana] Hosp Pediat David Bernardino, Luanda, Angola; [Cano, Jorge] Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain; [Amorim, Antonio] Univ Porto IPATIMUP, Inst Patol & Imunol Mol, Oporto, Portugal; [Amorim, Antonio] Univ Porto, Fac Ciencias, P-4100 Oporto, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Coimbra; Eduardo Mondlane University; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Universidade do Porto; Universidade do Porto	Arez, AP (corresponding author), Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais, Unidade Parasitol Med, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal.	aparez@ihmt.unl.pt	J., Pinto/H-6177-2019; Amorim, Antonio/A-7938-2008; Cano, Jorge/E-2962-2016; Manco, Licinio/M-4746-2013; Pinto, Joao/C-2208-2012; Arez, Ana Paula/I-1729-2012; Cano, Jorge/AAV-6392-2020	J., Pinto/0000-0001-8572-7708; Amorim, Antonio/0000-0002-7518-6247; Cano, Jorge/0000-0001-9864-5058; Manco, Licinio/0000-0002-2636-0288; Pinto, Joao/0000-0001-8572-7708; Arez, Ana Paula/0000-0002-0497-6532; Cano, Jorge/0000-0001-9864-5058; Gomes, Claudia/0000-0003-3746-1671; Ribeiro, Maria Leticia/0000-0002-5964-5001; Ribeiro, Maria Leticia de/0000-0002-7469-7061	FCT grant [SFRH/BD/28236/2006]; Fundacao para a Ciencia e a Tecnologia; "Fundacao para a Ciencia e Tecnologia/Ministerio da Educacao e Ciencia'', FCT/MEC, Portugal [PTDC/SAU-MET/110323/2009];  [PEst-OE/SAU/LA0018/2011];  [LA0018 2011/2012]	FCT grant(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); "Fundacao para a Ciencia e Tecnologia/Ministerio da Educacao e Ciencia'', FCT/MEC, Portugal(Portuguese Foundation for Science and Technology); ; 	This study was supported by PEst-OE/SAU/LA0018/2011 - Proj. Estrategico LA0018 2011/2012 (http://cmdt.ihmt.unl.pt/index.php/pt/) and PTDC/SAU-MET/110323/2009, "Fundacao para a Ciencia e Tecnologia/Ministerio da Educacao e Ciencia'', FCT/MEC (http://alfa.fct.mctes.pt/index.phtml.pt), Portugal. PM holds a FCT grant (SFRH/BD/28236/2006). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Education and Science, and is partially supported by Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMELHA AM, 1991, ACTA HAEMATOL-BASEL, V85, P192; Akin H, 1997, HUM HERED, V47, P42, DOI 10.1159/000154388; Allison AC, 2009, CURR OPIN IMMUNOL, V21, P499, DOI 10.1016/j.coi.2009.04.001; Alves J, 2010, BLOOD CELL MOL DIS, V44, P62, DOI 10.1016/j.bcmd.2009.09.008; [Anonymous], VERS 1 2R3PRE; Ayi K, 2008, NEW ENGL J MED, V358, P1805, DOI 10.1056/NEJMoa072464; Berghout J, 2012, GENES IMMUN, V13, P98, DOI 10.1038/gene.2011.54; Beutler E, 2000, BLOOD, V95, P3585, DOI 10.1182/blood.V95.11.3585.011k39_3585_3588; Beutler E., 1984, GLUTATHIONE RED CELL; Carey PJ, 2000, BLOOD, V96, P4005, DOI 10.1182/blood.V96.12.4005.h8004000e_4005_4006; CARMONAGARCIA S, 1979, HUM HERED, V29, P310; Durand PM, 2008, HAEMATOLOGICA, V93, P939, DOI 10.3324/haematol.12450; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FENG CS, 1993, AM J HEMATOL, V43, P271, DOI 10.1002/ajh.2830430408; FUNG RHP, 1969, ARCH DIS CHILD, V44, P373, DOI 10.1136/adc.44.235.373; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Loh W P, 1968, J Indiana State Med Assoc, V61, P1651; Machado P, 2010, BRIT J HAEMATOL, V149, P775, DOI 10.1111/j.1365-2141.2010.08165.x; Manco L, 1999, BRIT J HAEMATOL, V105, P591, DOI 10.1046/j.1365-2141.1999.01387.x; Mendes C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001192; Min-Oo G, 2003, NAT GENET, V35, P357, DOI 10.1038/ng1260; Ministerio da Saude Direccao Geral da Saude Republica de Mocambique, 2002, MOC INV NUTR RED POB; Pinto J, 2000, ACTA TROP, V76, P185, DOI 10.1016/S0001-706X(00)00100-5; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; University Medical Center, 2007, PKLR MUT DAT; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; Verra F, 2009, PARASITE IMMUNOL, V31, P234, DOI 10.1111/j.1365-3024.2009.01106.x; WHO EMRO, 2011, WHO REG OFF E MED EP; Yavarian M, 2008, BLOOD CELL MOL DIS, V40, P308, DOI 10.1016/j.bcmd.2007.08.008; Zanella A, 2007, BLOOD REV, V21, P217, DOI 10.1016/j.blre.2007.01.001	31	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47071	10.1371/journal.pone.0047071	http://dx.doi.org/10.1371/journal.pone.0047071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082140	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000311146900035
J	Maes, J; Verlooy, L; Buenafe, OE; de Witte, PAM; Esguerra, CV; Crawford, AD				Maes, Jan; Verlooy, Lien; Buenafe, Olivia E.; de Witte, Peter A. M.; Esguerra, Camila V.; Crawford, Alexander D.			Evaluation of 14 Organic Solvents and Carriers for Screening Applications in Zebrafish Embryos and Larvae	PLOS ONE			English	Article							DANIO-RERIO EMBRYOS; IN-VIVO; GENETIC APPROACH; DRUG DISCOVERY; TOXICITY; EXPOSURE; DIMETHYLFORMAMIDE; MODELS; SYSTEM; KETONE	Zebrafish are rapidly growing in popularity as an in vivo model system for chemical genetics, drug discovery, and toxicology, and more recently also for natural product discovery. Experiments involving the pharmacological evaluation of small molecules or natural product extracts in zebrafish bioassays require the effective delivery of these compounds to embryos and larvae. While most samples to be screened are first solubilized in dimethyl sulfoxide (DMSO), which is then diluted in the embryo medium, often this method is not sufficient to prevent the immediate or eventual precipitation of the sample. Certain compounds and extracts are also not highly soluble in DMSO. In such instances the use of carriers and/or other solvents might offer an alternative means to achieve the required sample concentration. Towards this end, we determined the maximum tolerated concentration (MTC) of several commonly used solvents and carriers in zebrafish embryos and larvae at various developmental stages. Solvents evaluated for this study included acetone, acetonitrile, butanone, dimethyl formamide, DMSO, ethanol, glycerol, isopropanol, methanol, polyethylene glycol (PEG-400), propylene glycol, and solketal, and carriers included albumin (BSA) and cyclodextrin (2-hydroxypropyl-beta-cyclodextrin, or HPBCD). This study resulted in the identification of polyethylene glycol (PEG400), propylene glycol, and methanol as solvents that were relatively well-tolerated over a range of developmental stages. In addition, our results showed that acetone was well-tolerated by embryos but not by larvae, and 1% cyclodextrin (HPBCD) was well-tolerated by both embryos and larvae, indicating the utility of this carrier for compound screening in zebrafish. However, given the relatively small differences (2-3 fold) between concentrations that are apparently safe and those that are clearly toxic, further studies - e.g. omics analyses - should be carried out to determine which cellular processes and signalling pathways are affected by any solvents and carriers that are used for small-molecule screens in zebrafish.	[Maes, Jan; Verlooy, Lien; Buenafe, Olivia E.; de Witte, Peter A. M.; Esguerra, Camila V.; Crawford, Alexander D.] Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium	KU Leuven	Crawford, AD (corresponding author), Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium.	alexander.crawford@pharm.kuleuven.be	Esguerra, Camila/D-7657-2014; Esguerra, Camila/N-6159-2015	Esguerra, Camila/0000-0001-7891-1427; Esguerra, Camila/0000-0002-2271-8094; de Witte, Peter/0000-0002-9989-9567; Buenafe, Olivia Erin/0000-0001-6048-4121				Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; BAUMANN M, 1984, J EXP ZOOL, V230, P363, DOI 10.1002/jez.1402300305; Berghmans S, 2007, EPILEPSY RES, V75, P18, DOI 10.1016/j.eplepsyres.2007.03.015; Blader P, 1998, DEV BIOL, V201, P185, DOI 10.1006/dbio.1998.8995; Bowman TV, 2010, ACS CHEM BIOL, V5, P159, DOI 10.1021/cb100029t; Challal S, 2012, CHIMIA, V66, P229, DOI 10.2533/chimia.2012.229; Chan J, 2002, CANCER CELL, V1, P257, DOI 10.1016/S1535-6108(02)00042-9; Chen TH, 2011, AQUAT TOXICOL, V102, P162, DOI 10.1016/j.aquatox.2011.01.010; Crawford AD, 2008, PLANTA MED, V74, P624, DOI 10.1055/s-2008-1034374; Crawford AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014694; DEACON MM, 1981, TOXICOL APPL PHARM, V59, P620, DOI 10.1016/0041-008X(81)90317-3; Eimon PM, 2009, EXPERT OPIN DRUG MET, V5, P393, DOI [10.1517/17425250902882128 , 10.1517/17425250902882128]; Feng B, 2002, EXP CELL RES, V279, P14, DOI 10.1006/excr.2002.5579; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Hagedorn M, 1996, P NATL ACAD SCI USA, V93, P7454, DOI 10.1073/pnas.93.15.7454; Hallare A, 2006, ECOTOX ENVIRON SAFE, V63, P378, DOI 10.1016/j.ecoenv.2005.07.006; Hallare AV, 2004, CHEMOSPHERE, V56, P659, DOI 10.1016/j.chemosphere.2004.04.007; Lahnsteiner F, 2008, THERIOGENOLOGY, V69, P384, DOI 10.1016/j.theriogenology.2007.10.007; Likhodii SS, 2003, ANN NEUROL, V54, P219, DOI 10.1002/ana.10634; Lin Ling, 2008, Wei Sheng Yan Jiu, V37, P278; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; Loucks E, 2004, NEUROTOXICOL TERATOL, V26, P745, DOI 10.1016/j.ntt.2004.06.017; MALLEY LA, 1994, FUND APPL TOXICOL, V23, P268, DOI 10.1006/faat.1994.1105; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; Milan DJ, 2003, CIRCULATION, V107, P1355, DOI 10.1161/01.CIR.0000061912.88753.87; Orellana-Paucar AM, 2012, EPILEPSY BEHAV, V24, P14, DOI 10.1016/j.yebeh.2012.02.020; Mottu F, 2000, PDA J PHARM SCI TECH, V54, P456; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Patlolla A, 2010, ACTA BIOMATER, V6, P90, DOI 10.1016/j.actbio.2009.07.028; Ren LF, 1996, CHEM-BIOL INTERACT, V102, P63, DOI 10.1016/0009-2797(96)03727-1; Rico EP, 2006, NEUROTOXICOL TERATOL, V28, P489, DOI 10.1016/j.ntt.2006.05.001; Saillenfait AM, 2000, TOXICOL APPL PHARM, V163, P149, DOI 10.1006/taap.1999.8839; Sakai N, 1997, MOL MAR BIOL BIOTECH, V6, P84; SCHWETZ BA, 1991, FUND APPL TOXICOL, V16, P742, DOI 10.1016/0272-0590(91)90160-6; SMYTH HF, 1950, J AM PHARM ASSOC SCI, V39, P349, DOI 10.1002/jps.3030390615; STUART GW, 1988, DEVELOPMENT, V103, P403; Turner C, 2012, ENVIRON TOXICOL CHEM, V31, P593, DOI 10.1002/etc.1718; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Yang LX, 2009, REPROD TOXICOL, V28, P245, DOI 10.1016/j.reprotox.2009.04.013; Yeh JRJ, 2003, DEV CELL, V5, P11, DOI 10.1016/S1534-5807(03)00200-4; Yuan Shiaulou, 2009, J Vis Exp, DOI 10.3791/1113; Zhang Y, 2006, CHEM BIOL, V13, P1001, DOI 10.1016/j.chembiol.2006.07.010; Zon LI, 2010, ZEBRAFISH, V7, P1, DOI 10.1089/zeb.2010.9996; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	45	143	147	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e43850	10.1371/journal.pone.0043850	http://dx.doi.org/10.1371/journal.pone.0043850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082109	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900004
J	Soberman, RJ; MacKay, CR; Vaine, CA; Ryan, GB; Cerny, AM; Thompson, MR; Nikolic, B; Primo, V; Christmas, P; Sheiffele, P; Aronov, L; Knipe, DM; Kurt-Jones, EA				Soberman, Roy J.; MacKay, Christopher R.; Vaine, Christine A.; Ryan, Glennice Bowen; Cerny, Anna M.; Thompson, Mikayla R.; Nikolic, Boris; Primo, Valeria; Christmas, Peter; Sheiffele, Paul; Aronov, Lisa; Knipe, David M.; Kurt-Jones, Evelyn A.			CD200R1 Supports HSV-1 Viral Replication and Licenses Pro-Inflammatory Signaling Functions of TLR2	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CENTRAL-NERVOUS-SYSTEM; KAPPA-B; RECEPTOR; HOST; EXPRESSION; RESPONSES; MICE; RECOGNIZES; ACTIVATION	The CD200R1:CD200 axis is traditionally considered to limit tissue inflammation by down-regulating pro-inflammatory signaling in myeloid cells bearing the receptor. We generated CD200R1(-/-) mice and employed them to explore both the role of CD200R1 in regulating macrophage signaling via TLR2 as well as the host response to an in vivo, TLR2-dependent model, herpes simplex virus 1 (HSV-1) infection. CD200R1(-/-) peritoneal macrophages demonstrated a 70-75% decrease in the generation of IL-6 and CCL5 (Rantes) in response to the TLR2 agonist Pam(2)CSK(4) and to HSV-1. CD200R1(-/-) macrophages could neither up-regulate the expression of TLR2, nor assemble a functional inflammasome in response to HSV-1. CD200R1(-/-) mice were protected from HSV-1 infection and exhibited dysfunctional TLR2 signaling. Finally, both CD200R1(-/-) mice and CD200R1(-/-) fibroblasts and macrophages showed a markedly reduced ability to support HSV-1 replication. In summary, our data demonstrate an unanticipated and novel requirement for CD200R1 in "licensing'' pro-inflammatory functions of TLR2 and in limiting viral replication that are supported by ex vivo and in vivo evidence.	[Soberman, Roy J.; Vaine, Christine A.; Nikolic, Boris; Primo, Valeria; Christmas, Peter] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Renal Unit,Dept Med, Charlestown, MA USA; [MacKay, Christopher R.; Ryan, Glennice Bowen; Cerny, Anna M.; Thompson, Mikayla R.; Kurt-Jones, Evelyn A.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Sheiffele, Paul; Aronov, Lisa] InGenious Targeting Lab Inc, Stony Brook, NY USA; [Knipe, David M.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School	Soberman, RJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Renal Unit,Dept Med, Charlestown, MA USA.	Soberman@helix.mgh.harvard.edu; evelyn.kurt-jones@umassmed.edu	Mackay, Charles R/A-9673-2008	Mackay, Charles R/0000-0002-6338-7340; Vaine, Christine/0000-0003-2645-8223	National Institutes of Health [R01AI068871, R01AI068871-S4, P01 AI083215-01]; Diabetes Endocrinology Research Center [DK32520]; UMass CFAR from the National Institutes of Health [5P30 AI-42845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083215, R01AI068871, P30AI042845, T32AI095213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; UMass CFAR from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants R01AI068871 (RJS), R01AI068871-S4 (RJS and CV), P01 AI083215-01 (EAK-J and DMK) and UMass CFAR Grant 5P30 AI-42845 (EAK-J) from the National Institutes of Health. Core resources supported by the Diabetes Endocrinology Research Center grant DK32520 were also used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudakov I, 2007, TRANSPLANTATION, V84, P251, DOI 10.1097/01.tp.0000269795.04592.cc; Burckstummer T, 2009, NAT IMMUNOL; Carr DJJ, 1999, J NEUROVIROL, V5, P449, DOI 10.3109/13550289909045373; Cook WJ, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-5; Cortez M, 2011, CELL HOST MICROBE, V9, P463, DOI 10.1016/j.chom.2011.04.014; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Davey GM, 2010, J IMMUNOL, V184, P2243, DOI 10.4049/jimmunol.0903013; Deckert M, 2006, ACTA NEUROPATHOL, V111, P548, DOI 10.1007/s00401-006-0062-z; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Eidson KM, 2002, J VIROL, V76, P2180, DOI 10.1128/JVI.76.5.2180-2191.2002; Fernandes-Alnemri T, 2009, NATURE; Fields BN, 2001, FIELDS VIROLOGY, Vxix; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Karnam G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002710; Koning N, 2009, J NEUROPATH EXP NEUR, V68, P159, DOI 10.1097/NEN.0b013e3181964113; Kurt-Jones EA, 2005, J INFECT DIS, V191, P746, DOI 10.1086/427339; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; McGinnes LW, 2011, J VIROL, V85, P366, DOI 10.1128/JVI.01861-10; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Melchjorsen J, 2003, J GEN VIROL, V84, P2491, DOI 10.1099/vir.0.19159-0; Menachery VD, 2010, J VIROL, V84, P9685, DOI 10.1128/JVI.00706-10; Mihrshahi R, 2010, J IMMUNOL, V185, P7216, DOI 10.4049/jimmunol.1002858; Mihrshahi R, 2009, J IMMUNOL, V183, P4879, DOI 10.4049/jimmunol.0901531; Mott KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-56; Mukhopadhyay S, 2010, CELL HOST MICROBE, V8, P236, DOI 10.1016/j.chom.2010.08.005; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Sheridan BS, 2009, J VIROL, V83, P2237, DOI 10.1128/JVI.01699-08; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Shrivastava K, 2012, J COMP NEUROLOGY; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; St Leger AJ, 2011, J IMMUNOL, V186, P3927, DOI 10.4049/jimmunol.1003735; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Taylor TJ, 2003, VIROLOGY, V309, P232, DOI 10.1016/S0042-6822(03)00107-7; van Lint AL, 2010, J VIROL, V84, P10802, DOI 10.1128/JVI.00063-10; Vilela MC, 2009, ANN NY ACAD SCI, V1153, P256, DOI 10.1111/j.1749-6632.2008.03959.x; Vollstedt S, 2001, J VIROL, V75, P9596, DOI 10.1128/JVI.75.20.9596-9600.2001; Wang JP, 2012, J VIROL, V86, P2273, DOI 10.1128/JVI.06010-11; WHITLEY R, 1991, NEW ENGL J MED, V324, P450, DOI 10.1056/NEJM199102143240704; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Young JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029688; Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786	52	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47740	10.1371/journal.pone.0047740	http://dx.doi.org/10.1371/journal.pone.0047740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082204	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900101
J	Ackerman, SH; Tillier, ER; Gatti, DL				Ackerman, Sharon H.; Tillier, Elisabeth R.; Gatti, Domenico L.			Accurate Simulation and Detection of Coevolution Signals in Multiple Sequence Alignments	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; INVERSE COVARIANCE ESTIMATION; MUTUAL INFORMATION; ALLOSTERIC COMMUNICATION; MOLECULAR COEVOLUTION; COEVOLVING POSITIONS; CORRELATED MUTATIONS; CONTACT PREDICTION; PROTEIN EVOLUTION; RESIDUE CONTACTS	Background: While the conserved positions of a multiple sequence alignment (MSA) are clearly of interest, non-conserved positions can also be important because, for example, destabilizing effects at one position can be compensated by stabilizing effects at another position. Different methods have been developed to recognize the evolutionary relationship between amino acid sites, and to disentangle functional/structural dependencies from historical/phylogenetic ones. Methodology/Principal Findings: We have used two complementary approaches to test the efficacy of these methods. In the first approach, we have used a new program, MSAvolve, for the in silico evolution of MSAs, which records a detailed history of all covarying positions, and builds a global coevolution matrix as the accumulated sum of individual matrices for the positions forced to co-vary, the recombinant coevolution, and the stochastic coevolution. We have simulated over 1600 MSAs for 8 protein families, which reflect sequences of different sizes and proteins with widely different functions. The calculated coevolution matrices were compared with the coevolution matrices obtained for the same evolved MSAs with different coevolution detection methods. In a second approach we have evaluated the capacity of the different methods to predict close contacts in the representative X-ray structures of an additional 150 protein families using only experimental MSAs. Conclusions/Significance: Methods based on the identification of global correlations between pairs were found to be generally superior to methods based only on local correlations in their capacity to identify coevolving residues using either simulated or experimental MSAs. However, the significant variability in the performance of different methods with different proteins suggests that the simulation of MSAs that replicate the statistical properties of the experimental MSA can be a valuable tool to identify the coevolution detection method that is most effective in each case.	[Ackerman, Sharon H.; Gatti, Domenico L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Gatti, Domenico L.] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA; [Tillier, Elisabeth R.] Univ Hlth Network, Univ Toronto, Campbell Family Inst Canc Res, Dept Med Biophys, Toronto, ON, Canada	Wayne State University; Wayne State University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gatti, DL (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	dgatti@med.wayne.edu		Tillier, Elisabeth/0000-0003-2194-9058	United States Public Health Service [GM69840, GM48157]; Wayne State University; Natural Sciences and Engineering Research Council of Canada (NSERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048157, R01GM069840] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Wayne State University; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by United States Public Health Service grants GM69840 to DLG, and GM48157 to SHA, by a Wayne State University Research Enhancement Program in Computational Biology grant to DLG, and by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant to ERT. Funding was used for the purchase and maintenance of the computational hardware and software used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Brown CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010779; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Caporaso JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-327; Codoner FM, 2008, EVOL BIOINFORM, V4, P29; Codoner FM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-106; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erdogmus D, 2004, NEURAL COMPUT, V16, P1235, DOI 10.1162/089976604773717595; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fernandes AD, 2010, BIOINFORMATICS, V26, P1135, DOI 10.1093/bioinformatics/btq111; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; FRITSCH FN, 1980, SIAM J NUMER ANAL, V17, P238, DOI 10.1137/0717021; GASSNER GT, 1995, FASEB J, V9, P1411, DOI 10.1096/fasebj.9.14.7589982; GATTI DL, 1994, SCIENCE, V266, P110, DOI 10.1126/science.7939628; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Gloor GB, 2010, MOL BIOL EVOL, V27, P1181, DOI 10.1093/molbev/msq004; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Horner DS, 2008, BRIEF BIOINFORM, V9, P46, DOI 10.1093/bib/bbm052; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; JUKES T H, 1969, P21; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Ludlam A, 2009, J BIOL CHEM, V284, P17138, DOI 10.1074/jbc.M109.002568; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Martin P, 2001, STRUCTURE, V9, P1071, DOI 10.1016/S0969-2126(01)00672-4; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Pang A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-236; Radaev S, 2000, J BIOL CHEM, V275, P9476, DOI 10.1074/jbc.275.13.9476; Reza F. M., 1994, INTRO INFORM THEORY; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sigala PA, 2008, J AM CHEM SOC, V130, P13696, DOI 10.1021/ja803928m; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sukumar N, 2001, BIOCHEMISTRY-US, V40, P9870, DOI 10.1021/bi010938k; Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Zhou TQ, 2000, EMBO J, V19, P4838, DOI 10.1093/emboj/19.17.4838	50	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47108	10.1371/journal.pone.0047108	http://dx.doi.org/10.1371/journal.pone.0047108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091608	gold, Green Published, Green Submitted			2022-12-27	WOS:000310135800024
J	Musatovova, O; Kannan, TR; Baseman, JB				Musatovova, Oxana; Kannan, T. R.; Baseman, Joel B.			Mycoplasma pneumoniae Large DNA Repetitive Elements RepMP1 Show Type Specific Organization among Strains	PLOS ONE			English	Article							TUMOR ALVEOLAR RHABDOMYOSARCOMA; TANDEM-REPEAT ANALYSIS; CHROMOSOMAL SEQUENCES; GENE; GENOME; RECOMBINATION; GENITALIUM; NUMBER; PRODUCTS; SUBTYPES	Mycoplasma pneumoniae is the smallest self-replicating bacterium with a streamlined genome of 0.81 Mb. Complete genome analysis revealed the presence of multiple copies of four large repetitive elements (designated RepMP1, RepMP2/3, RepMP4 and RepMP5) that are implicated in creating sequence variations among individual strains. Recently, we described RepMP1-associated sequence variations between reference strain M129 and clinical isolate S1 that involved three RepMP1-genes (i.e. mpn130, mpn137 and mpn138). Using PCR and sequencing we analyze 28 additional M. pneumoniae strains and demonstrate the existence of S1-like sequence variants in nine strains and M129-like variants in the remaining nineteen strains. We propose a series of recombination steps that facilitates transition from M129- to S1-like sequence variants. Next we examined the remaining RepMP1-genes and observed no other rearrangements related to the repeat element. The only other detected difference was varying numbers of the 21-nucleotide tandem repeats within mpn127, mpn137, mpn501 and mpn524. Furthermore, typing of strains through analysis of large RepMPs localized within the adhesin P1 operon revealed that sequence divergence involving RepMP1-genes mpn130, mpn137 and mpn138 is strictly type-specific. Once more our analysis confirmed existence of two highly conserved groups of M. pneumoniae strains.	[Musatovova, Oxana; Kannan, T. R.; Baseman, Joel B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Musatovova, O (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	musatovova@gmail.com			National Institutes of Health [AI U19070412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health AI U19070412. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Baseman J B, 1993, Subcell Biochem, V20, P243; Catrein I, 2004, MICROBIOL-SGM, V150, P3989, DOI 10.1099/mic.0.27506-0; Chalker V, 2011, EURO SURVEILL, V16; CRAVEN RB, 1976, J CLIN MICROBIOL, V4, P225; Degrange S, 2009, J CLIN MICROBIOL, V47, P914, DOI 10.1128/JCM.01935-08; Dorigo-Zetsma JW, 2000, J CLIN MICROBIOL, V38, P965, DOI 10.1128/JCM.38.3.965-970.2000; Dumke R, 2003, INT J MED MICROBIOL, V292, P513, DOI 10.1078/1438-4221-00231; Dumke R, 2011, J MICROBIOL METH, V86, P393, DOI 10.1016/j.mimet.2011.06.008; Forsyth MH, 1996, J BACTERIOL, V178, P917, DOI 10.1128/jb.178.3.917-921.1996; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GOULET M, 1995, J CLIN MICROBIOL, V33, P2823, DOI 10.1128/JCM.33.11.2823-2825.1995; Hasselbring BA, 2006, J BACTERIOL, V188, P6335, DOI 10.1128/JB.00698-06; HEDEN LO, 1993, J GEN MICROBIOL, V139, P2067, DOI 10.1099/00221287-139-9-2067; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; HU PC, 1977, J EXP MED, V145, P1328, DOI 10.1084/jem.145.5.1328; INAMINE JM, 1988, GENE, V64, P217, DOI 10.1016/0378-1119(88)90337-X; Iverson-Cabral SL, 2007, MOL MICROBIOL, V66, P55, DOI 10.1111/j.1365-2958.2007.05898.x; Iverson-Cabral SL, 2006, INFECT IMMUN, V74, P3715, DOI 10.1128/IAI.00239-06; Jacobs E, 1996, EUR J CLIN MICROBIOL, V15, P38, DOI 10.1007/BF01586183; Kannan TR, 2011, CLIN INFECT DIS; Kenri T, 2008, J MED MICROBIOL, V57, P469, DOI 10.1099/jmm.0.47634-0; Kenri T, 2012, J BACTERIOL, V194, P1253, DOI 10.1128/JB.06553-11; Kokotovic B, 1999, J CLIN MICROBIOL, V37, P3300, DOI 10.1128/JCM.37.10.3300-3307.1999; Krishnakumar R, 2010, APPL ENVIRON MICROB, V76, P5297, DOI 10.1128/AEM.00024-10; Ma L, 2007, MOL MICROBIOL, V66, P220, DOI 10.1111/j.1365-2958.2007.05911.x; Musatovova O, 2008, INFECT IMMUN, V76, P1639, DOI 10.1128/IAI.01621-07; Nisar N, 2007, POSTGRAD MED J, V83, P100, DOI 10.1136/pgmj.2006.049023; RULAND K, 1994, J BACTERIOL, V176, P5202, DOI 10.1128/JB.176.17.5202-5209.1994; RULAND K, 1990, NUCLEIC ACIDS RES, V18, P6311, DOI 10.1093/nar/18.21.6311; Shak JR, 2009, J BACTERIOL, V191, P6900, DOI 10.1128/JB.00706-09; Shin DH, 2006, PROTEIN SCI, V15, P921, DOI 10.1110/ps.051993506; SPERKER B, 1991, MOL MICROBIOL, V5, P299, DOI 10.1111/j.1365-2958.1991.tb02110.x; SU CJ, 1987, INFECT IMMUN, V55, P3023, DOI 10.1128/IAI.55.12.3023-3029.1987; SU CJ, 1990, J CLIN MICROBIOL, V28, P1538, DOI 10.1128/JCM.28.7.1538-1540.1990; SU CJ, 1990, INFECT IMMUN, V58, P2669, DOI 10.1128/IAI.58.8.2669-2674.1990; URSI D, 1994, J CLIN MICROBIOL, V32, P2873, DOI 10.1128/JCM.32.11.2873-2875.1994; VU AC, 1987, INFECT IMMUN, V55, P1830, DOI 10.1128/IAI.55.8.1830-1836.1987; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; WENZEL R, 1988, NUCLEIC ACIDS RES, V16, P8337, DOI 10.1093/nar/16.17.8337	40	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47625	10.1371/journal.pone.0047625	http://dx.doi.org/10.1371/journal.pone.0047625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091634	gold, Green Published, Green Submitted			2022-12-27	WOS:000310135800058
J	Sharp, H; Pickles, A; Meaney, M; Marshall, K; Tibu, F; Hill, J				Sharp, Helen; Pickles, Andrew; Meaney, Michael; Marshall, Kate; Tibu, Florin; Hill, Jonathan			Frequency of Infant Stroking Reported by Mothers Moderates the Effect of Prenatal Depression on Infant Behavioural and Physiological Outcomes	PLOS ONE			English	Article							VAGAL REGULATION; MATERNAL-CARE; STRESS; CHILDREN; STIMULATION; TEMPERAMENT; EPIGENETICS; CONFLICT; EXPOSURE	Animal studies find that prenatal stress is associated with increased physiological and emotional reactivity later in life, mediated via fetal programming of the HPA axis through decreased glucocorticoid receptor (GR) gene expression. Postnatal behaviours, notably licking and grooming in rats, cause decreased behavioural indices of fear and reduced HPA axis reactivity mediated via increased GR gene expression. Post-natal maternal behaviours may therefore be expected to modify prenatal effects, but this has not previously been examined in humans. We examined whether, according to self-report, maternal stroking over the first weeks of life modified associations between prenatal depression and physiological and behavioral outcomes in infancy, hence mimicking effects of rodent licking and grooming. From a general population sample of 1233 first time mothers recruited at 20 weeks gestation we drew a stratified random sample of 316 for assessment at 32 weeks based on reported inter-partner psychological abuse, a risk to child development. Of these 271 provided data at 5, 9 and 29 weeks post delivery. Mothers reported how often they stroked their babies at 5 and 9 weeks. At 29 weeks vagal withdrawal to a stressor, a measure of physiological adaptability, and maternal reported negative emotionality were assessed. There was a significant interaction between prenatal depression and maternal stroking in the prediction of vagal reactivity to a stressor (p = .01), and maternal reports of infant anger proneness (p = .007) and fear (p = .043). Increasing maternal depression was associated with decreasing physiological adaptability, and with increasing negative emotionality, only in the presence of low maternal stroking. These initial findings in humans indicate that maternal stroking in infancy, as reported by mothers, has effects strongly resembling the effects of observed maternal behaviours in animals, pointing to future studies of the epigenetic, physiological and behavioral effects of maternal stroking.	[Sharp, Helen] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Pickles, Andrew] Kings Coll London, Inst Psychiat, Dept Biostat, London WC2R 2LS, England; [Meaney, Michael] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Marshall, Kate; Tibu, Florin; Hill, Jonathan] Univ Manchester, Mental Hlth & Neurodegenerat Res Grp, Manchester, Lancs, England	University of Liverpool; University of London; King's College London; McGill University; University of Manchester	Sharp, H (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England.	hmsharp@liverpool.ac.uk	Pickles, Andrew/A-9625-2011; Sharp, Helen/G-5754-2016; Meaney, Michael/N-5931-2019; Tibu, Florin/O-9581-2015; Sharp, Helen/GOG-8045-2022	Pickles, Andrew/0000-0003-1283-0346; Tibu, Florin/0000-0003-0873-1097; Sharp, Helen/0000-0002-0988-8718	United Kingdom Medical Research Council [G0400577]; MRC [G0400577] Funding Source: UKRI; Medical Research Council [G0400577] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by a grant from the United Kingdom Medical Research Council (G0400577). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2008, NESTLE NUTR WORKS SE, V61, P21, DOI 10.1159/0000113163; Bullinger AF, 2011, DEVELOPMENTAL SCI, V14, P58, DOI 10.1111/j.1467-7687.2010.00952.x; Calkins SD, 2000, J ABNORM CHILD PSYCH, V28, P103, DOI 10.1023/A:1005112912906; Calkins SD, 2007, BIOL PSYCHOL, V74, P144, DOI 10.1016/j.biopsycho.2006.09.005; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Cox JL, 1996, J AFFECT DISORDERS, V39, P185, DOI 10.1016/0165-0327(96)00008-0; Davis EP, 2007, J AM ACAD CHILD PSY, V46, P737, DOI 10.1097/chi.0b013e318047b775; de Bruijn ATCE, 2009, DEV PSYCHOBIOL, V51, P553, DOI 10.1002/dev.20393; Del Cerro MCR, 2010, BEHAV BRAIN RES, V208, P593, DOI 10.1016/j.bbr.2010.01.003; El-Sheikh M, 2001, CHILD DEV, V72, P1617, DOI 10.1111/1467-8624.00369; Gagne JR, 2011, DEVELOPMENTAL SCI, V14, P112, DOI 10.1111/j.1467-7687.2010.00969.x; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Kagan J, 1999, DEV PSYCHOPATHOL, V11, P209, DOI 10.1017/S0954579499002023; Kajantie E, 2010, NEUROSCI BIOBEHAV R, V35, P23, DOI 10.1016/j.neubiorev.2009.11.013; Kappeler L, 2010, BIOESSAYS, V32, P818, DOI 10.1002/bies.201000015; Koehl M, 2001, NEUROTOX RES, V3, P65, DOI 10.1007/BF03033231; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; LEVINE S, 1994, ANN NY ACAD SCI, V746, P275, DOI 10.1111/j.1749-6632.1994.tb39245.x; Lloyd, 2004, ENGLISH INDICES DEPR; McElwain NL, 2006, J FAM PSYCHOL, V20, P247, DOI 10.1037/0893-3200.20.2.247; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Moffitt TE, 1997, PSYCHOL ASSESSMENT, V9, P47, DOI 10.1037/1040-3590.9.1.47; Moore GA, 2010, DEV PSYCHOPATHOL, V22, P23, DOI 10.1017/S095457940999023X; Moore GA, 2009, CHILD DEV, V80, P209, DOI 10.1111/j.1467-8624.2008.01255.x; MOUSSEAU TA, 1999, MATERNAL EFFECTS ADA; O'Connor TG, 2003, J CHILD PSYCHOL PSYC, V44, P1025, DOI 10.1111/1469-7610.00187; Parade SH, 2008, INFANT BEHAV DEV, V31, P637, DOI 10.1016/j.infbeh.2008.07.009; Porges S. W., 1990, PRINCIPLES PSYCHOPHY, P708; Porges S.W., 1985, U.S. Patent, Patent No. [4,510,944, 4510944, 4:510,944]; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Royston P, 2007, STATA J, V7, P445, DOI 10.1177/1536867X0700700401; SCHANBERG SM, 1987, CHILD DEV, V58, P1431, DOI 10.1111/j.1467-8624.1987.tb03856.x; SCHANBERG SM, 1984, P SOC EXP BIOL MED, V175, P135; Seckl JR, 2007, PROG BRAIN RES, V167, P17, DOI 10.1016/S0079-6123(07)67002-2; Smeekens S, 2007, J ABNORM CHILD PSYCH, V35, P347, DOI 10.1007/s10802-006-9095-y; StataCorp, 2009, STAT STAT SOFTW; TRONICK E, 1978, J AM ACAD CHILD PSY, V17, P1, DOI 10.1016/S0002-7138(09)62273-1; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Yao M, 2007, ENDOCRINOLOGY, V148, P2518, DOI 10.1210/en.2006-1413	44	87	87	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e45446	10.1371/journal.pone.0045446	http://dx.doi.org/10.1371/journal.pone.0045446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	024UX	23091594	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000310135800004
J	Lv, XX; Yu, XH; Wang, YY; Wang, FQ; Li, HM; Wang, YP; Lu, DX; Qi, RB; Wang, HD				Lv, Xiuxiu; Yu, Xiaohui; Wang, Yiyang; Wang, Faqiang; Li, Hongmei; Wang, Yanping; Lu, Daxiang; Qi, Renbin; Wang, Huadong			Berberine Inhibits Doxorubicin-Triggered Cardiomyocyte Apoptosis via Attenuating Mitochondrial Dysfunction and Increasing Bcl-2 Expression	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CONGESTIVE-HEART-FAILURE; INDUCED CARDIOTOXICITY; IN-VIVO; CELL-DEATH; MICE; P53; PATHWAY; MANAGEMENT; SECONDARY	Cardiomyocyte apoptosis is an important event in doxorubicin (DOX)-induced cardiac injury. The aim of the present study was to investigate the protection of berberine (Ber) against DOX-triggered cardiomyocyte apoptosis in neonatal rat cardiomyocytes and rats. In neonatal rat cardiomyocytes, Ber attenuated DOX-induced cellular injury and apoptosis in a dose-dependent manner. However, Ber has no significant effect on viability of MCF-7 breast cancer cells treated with DOX. Ber reduced caspase-3 and caspase-9, but not caspase-8 activity in DOX-treated cardiomyocytes. Furthermore, Ber decreased adenosine monophosphate-activated protein kinase alpha (AMPK alpha) and p53 phosphorylation at 2 h, cytosolic cytochrome c and mitochondrial Bax levels and increased Bcl-2 level at 6 h in DOX-stimulated cardiomyocytes. Pretreatment with compound C, an AMPK inhibitor, also suppressed p53 phosphorylation and apoptosis in DOX-treated cardiomyocytes. DOX stimulation for 30 min led to a loss of mitochondrial membrane potential and a rise in the AMP/ATP ratio. Ber markedly reduced DOX-induced mitochondrial membrane potential loss and an increase in the AMP/ATP ratio at 1 h and 2 h post DOX exposure. In in vivo experiments, Ber significantly improved survival, increased stroke volume and attenuated myocardial injury in DOX-challenged rats. TUNEL and Western blot assays showed that Ber not only decreased myocardial apoptosis, caspase-3 activation, AMPKa and p53 phosphorylation, but also increased Bcl-2 expression in myocardium of rats exposed to DOX for 84 h. These findings indicate that Ber attenuates DOX-induced cardiomyocyte apoptosis via protecting mitochondria, inhibiting an increase in the AMP/ATP ratio and AMPKa phosphorylation as well as elevating Bcl-2 expression, which offer a novel mechanism responsible for protection of Ber against DOX-induced cardiomyopathy.	[Lv, Xiuxiu; Yu, Xiaohui; Wang, Yiyang; Wang, Faqiang; Li, Hongmei; Wang, Yanping; Lu, Daxiang; Qi, Renbin; Wang, Huadong] Jinan Univ, Sch Med, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Lu, Daxiang; Qi, Renbin; Wang, Huadong] Jinan Univ, Sch Med, Key Lab State Adm Tradit Chinese Med Peoples Repu, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Wang, HD (corresponding author), Jinan Univ, Sch Med, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.	owanghd@jnu.edu.cn		wang, yiyang/0000-0002-0318-6715	National Natural Science Foundation of China [30670826]; Fundamental Research Funds for the Central Universities [21609405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by grants from the National Natural Science Foundation of China (grant no. 30670826), Leading Academic Discipline Program, 211 Project for Jinan University (the 3rd phase) and the Fundamental Research Funds for the Central Universities (21609405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arola OJ, 2000, CANCER RES, V60, P1789; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Childs AC, 2002, CANCER RES, V62, P4592; Christiansen S, 2011, J CARDIOVASC SURG, V52, P133; Chua CC, 2009, CARDIOVASC RES, V81, P20, DOI 10.1093/cvr/cvn257; Das J, 2011, BIOCHEM PHARMACOL, V81, P891, DOI 10.1016/j.bcp.2011.01.008; GOORMAGHTIGH E, 1987, BIOCHEMISTRY-US, V26, P1789, DOI 10.1021/bi00380a043; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hardie DG, 2004, J CLIN INVEST, V114, P465, DOI 10.1172/JCI200422683; Jang YM, 2004, FEBS LETT, V577, P483, DOI 10.1016/j.febslet.2004.10.053; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005; Lau CW, 2001, CARDIOVASC DRUG REV, V19, P234; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Ludke ARL, 2009, CAN J PHYSIOL PHARM, V87, P756, DOI 10.1139/Y09-059; Ma XA, 2010, METABOLISM, V59, P1619, DOI 10.1016/j.metabol.2010.03.009; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; MARINNETO JA, 1988, CLIN CARDIOL, V11, P253, DOI 10.1002/clc.4960110411; MIYASHITA T, 1995, CELL, V80, P293; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Pointon AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012733; Sardao VA, 2009, CANCER CHEMOTH PHARM, V64, P811, DOI 10.1007/s00280-009-0932-x; Serafim TL, 2008, CANCER CHEMOTH PHARM, V61, P1007, DOI 10.1007/s00280-007-0558-9; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Thomas L, 2004, FUND CLIN PHARMACOL, V18, P649, DOI 10.1111/j.1472-8206.2004.00282.x; Wang SB, 2012, J BIOL CHEM, V287, P8001, DOI 10.1074/jbc.M111.315812; Wang YY, 2011, SHOCK, V35, P322, DOI 10.1097/SHK.0b013e3181facf73; Wang YQ, 2009, CARDIOVASC RES, V82, P484, DOI 10.1093/cvr/cvp078; Wu YJ, 2008, J MATH MED, V21, P217; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Zeng XH, 2003, AM J CARDIOL, V92, P173, DOI 10.1016/S0002-9149(03)00533-2; Zhang C, 2011, CARDIOVASC RES, V90, P538, DOI 10.1093/cvr/cvr022; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8; Zhao X, 2011, J INT MED RES, V39, P1720, DOI 10.1177/147323001103900514; Zhou XQ, 2008, NEUROSCI LETT, V447, P31, DOI 10.1016/j.neulet.2008.09.064; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	40	93	102	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47351	10.1371/journal.pone.0047351	http://dx.doi.org/10.1371/journal.pone.0047351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077597	gold, Green Submitted, Green Published			2022-12-27	WOS:000309995100097
J	Schache, M; Baird, PN				Schache, Maria; Baird, Paul N.			Assessment of the Association of Matrix Metalloproteinases with Myopia, Refractive Error and Ocular Biometric Measures in an Australian Cohort	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; FORM-DEPRIVATION MYOPIA; GENE POLYMORPHISMS; COL1A1 GENE; SUSCEPTIBILITY; EXPRESSION; SCLERA; RECRUITMENT; JAPANESE; LUMICAN	Extracellular matrix proteins have been implicated in protein remodelling of the sclera in refractive error. The matrix metalloproteinases (MMPs) falling into the collagenase (MMP1, MMP8, MMP13), gelatinase (MMP2, MMP9) and stromelysin (MMP3, MMP10, MMP11) functional groups are particularly important. We wished to assess their association with myopia, refractive error and ocular biometric measures in an Australian cohort. A total of 543 unrelated individuals of Caucasian ethnicity were genotyped including 269 myopes (<=-1.0D) and 274 controls (>-1.0D). Tag single nucleotide polymorphisms (SNPs) (n = 53) were chosen to encompass these eight MMPs. Association tests were performed using linear and logistic regression analysis with age and gender as covariates. Spherical equivalent, myopia, axial length, anterior chamber depth and corneal curvature were the phenotypes of interest. Initial findings indicated that the best p values for each trait were 0.02 for myopia at rs2274755 (MMP9), 0.02 for SE at both rs3740938 (MMP8) and rs131451 (MMP11), 0.01 for axial length at rs11225395 (MMP8), 0.01 for anterior chamber depth at rs498186 (MMP1) and 0.02 at rs10488 (MMP1). However, following correction for multiple testing, none of these SNPs remained statistically significant. Our data suggests that the MMPs in the collagenase, gelatinase and stromelysin categories do not appear to be associated with myopia, refractive error or ocular biometric measures in this cohort.	[Schache, Maria; Baird, Paul N.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	Schache, M (corresponding author), Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia.	mschache@unimelb.edu.au		Baird, Paul/0000-0002-1305-3502	National Health and Medical Research Council (NHMRC) Canberra, Australia through the Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases [529923]; NHMRC [1028444]	National Health and Medical Research Council (NHMRC) Canberra, Australia through the Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this work came from the National Health and Medical Research Council (NHMRC) Canberra, Australia through the Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases (grant no.: 529923) and an NHMRC research fellowship to PNB (No. 1028444). The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird PN, 2010, PROGR RETINAL EYE RE, P31; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Biino G, 2005, HUM GENET, V116, P152, DOI 10.1007/s00439-004-1231-6; Chen ZTY, 2009, OPHTHALMOLOGY, V116, P1920, DOI 10.1016/j.ophtha.2009.03.023; Dirani M, 2008, OPHTHAL EPIDEMIOL, V15, P140, DOI 10.1080/09286580801939338; Garoufalis P, 2005, OPHTHAL EPIDEMIOL, V12, P383, DOI 10.1080/09286580500281222; Gauderman WJ, 2006, COMPUTER PROGRAM POW; Gentle A, 2003, J BIOL CHEM, V278, P16587, DOI 10.1074/jbc.M300970200; Guggenheim JA, 1996, INVEST OPHTH VIS SCI, V37, P1380; Hall NF, 2009, INVEST OPHTH VIS SCI, V50, P2632, DOI 10.1167/iovs.08-2427; Inamori Y, 2007, HUM GEN         0608; Leung KH, 2011, INVEST OPHTH VIS SCI, V52, P3893, DOI 10.1167/iovs.11-7286; Liang CL, 2007, J HUM GENET, V52, P374, DOI 10.1007/s10038-007-0117-6; Liang CL, 2006, AM J OPHTHALMOL, V142, P518, DOI 10.1016/j.ajo.2006.03.063; Majava M, 2006, HUM MUTAT; Metlapally R, 2009, INVEST OPHTH VIS SCI, V50, P4080, DOI 10.1167/iovs.08-3346; Metlapally R, 2009, INVEST OPHTH VIS SCI, V50, P1552, DOI 10.1167/iovs.08-2455; Meyer KJ, 2011, HUM GENET, V129, P91, DOI 10.1007/s00439-010-0904-6; Mutti DO, 2007, MOL VIS, V13, P1012; Nakanishi H, 2009, INVEST OPHTH VIS SCI, V50, P544, DOI 10.1167/iovs.08-2425; Nakanishi H, 2010, INVEST OPHTH VIS SCI, V51, P4432, DOI 10.1167/iovs.09-4871; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P2050; Rada JA, 1998, INVEST OPHTH VIS SCI, V39, P1990; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Richardson AJ, 2006, J LAB CLIN MED, V147, P290, DOI 10.1016/j.lab.2006.01.005; Schache M, 2009, MOL VIS, V15, P2599; Schippert R, 2006, EXP EYE RES, V82, P710, DOI 10.1016/j.exer.2005.09.010; Siegwart JT, 2005, INVEST OPHTH VIS SCI, V46, P3484, DOI 10.1167/iovs.05-0194; Wang IJ, 2006, MOL VIS, V12, P852; Wang J, 2012, MOL MED REP, V5, P133, DOI 10.3892/mmr.2011.626; Wang PF, 2009, INVEST OPHTH VIS SCI, V50, P1546, DOI 10.1167/iovs.08-2537; Wojciechowski R, 2010, INVEST OPHTH VIS SCI, V51, P4989, DOI 10.1167/iovs.10-5474; Yip SP, 2011, INVEST OPHTH VIS SCI, V52, P6396, DOI 10.1167/iovs.11-7639; Young TL, 2007, ARCH OPHTHALMOL-CHIC, V125, P38, DOI 10.1001/archopht.125.1.38; Young TL, 2004, MOL VIS, V10, P163; Zhang DD, 2011, MOL VIS, V17, P3379	38	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47181	10.1371/journal.pone.0047181	http://dx.doi.org/10.1371/journal.pone.0047181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077567	Green Published, gold			2022-12-27	WOS:000309995100073
J	Wang, J; Spitz, MR; Amos, CI; Wu, XF; Wetter, DW; Cinciripini, PM; Shete, S				Wang, Jian; Spitz, Margaret R.; Amos, Christopher I.; Wu, Xifeng; Wetter, David W.; Cinciripini, Paul M.; Shete, Sanjay			Method for Evaluating Multiple Mediators: Mediating Effects of Smoking and COPD on the Association between the CHRNA5-A3 Variant and Lung Cancer Risk	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; SUSCEPTIBILITY LOCUS; NICOTINE DEPENDENCE; SECONDARY PHENOTYPE; ODDS RATIOS; PREVALENCE; 15Q25; METAANALYSIS	A mediation model explores the direct and indirect effects between an independent variable and a dependent variable by including other variables (or mediators). Mediation analysis has recently been used to dissect the direct and indirect effects of genetic variants on complex diseases using case-control studies. However, bias could arise in the estimations of the genetic variant-mediator association because the presence or absence of the mediator in the study samples is not sampled following the principles of case-control study design. In this case, the mediation analysis using data from case-control studies might lead to biased estimates of coefficients and indirect effects. In this article, we investigated a multiple-mediation model involving a three-path mediating effect through two mediators using case-control study data. We propose an approach to correct bias in coefficients and provide accurate estimates of the specific indirect effects. Our approach can also be used when the original case-control study is frequency matched on one of the mediators. We employed bootstrapping to assess the significance of indirect effects. We conducted simulation studies to investigate the performance of the proposed approach, and showed that it provides more accurate estimates of the indirect effects as well as the percent mediated than standard regressions. We then applied this approach to study the mediating effects of both smoking and chronic obstructive pulmonary disease (COPD) on the association between the CHRNA5-A3 gene locus and lung cancer risk using data from a lung cancer case-control study. The results showed that the genetic variant influences lung cancer risk indirectly through all three different pathways. The percent of genetic association mediated was 18.3% through smoking alone, 30.2% through COPD alone, and 20.6% through the path including both smoking and COPD, and the total genetic variant-lung cancer association explained by the two mediators was 69.1%.	[Wang, Jian; Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Spitz, Margaret R.] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Wang, Jian; Wu, Xifeng; Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wetter, David W.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX 77030 USA; [Cinciripini, Paul M.] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shete, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA.	sshete@mdanderson.org	Cinciripini, Paul M/I-5773-2012; Wang, Jian/A-3276-2013	Cinciripini, Paul M/0000-0003-2877-9928; Wetter, David/0000-0002-6366-0108	United States National Institutes of Health (NIH) [R01CA131324]; University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment; NIH [U19CA148127, R01CA121197]; NATIONAL CANCER INSTITUTE [R01CA121197, R01CA131324, U19CA148127] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States National Institutes of Health (NIH) grant R01CA131324 (SS) and by a faculty fellowship from The University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment (JW). This study makes use of lung cancer data generated by support from NIH grants U19CA148127 and R01CA121197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWIN DF, 1975, AM SOCIOL REV, V40, P37, DOI 10.2307/2094445; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Barr RG, 2002, AM J EPIDEMIOL, V155, P965, DOI 10.1093/aje/155.10.965; Blackburn EH, 2011, CANCER PREV RES, V4, P473, DOI 10.1158/1940-6207.CAPR-11-0066; Chen LS, 2012, GENET EPIDEMIOL, V36, P340, DOI 10.1002/gepi.21627; Chen LS, 2012, AM J PSYCHIAT; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Eisner MD, 2005, CHEST, V127, P1890, DOI 10.1378/chest.127.6.1890; Fairchild AJ, 2009, BEHAV RES METHODS, V41, P486, DOI 10.3758/BRM.41.2.486; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; Hayes AF, 2012, ANAL PRIMER CO UNPUB; Hayes AF, 2011, COMMUN SER, P434; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Ishii T, 2011, J HUM GENET, V56, P41, DOI 10.1038/jhg.2010.133; Kaur-Knudsen D, 2011, J CLIN ONCOL, V29, P2875, DOI 10.1200/JCO.2010.32.9870; Keskitalo K, 2009, HUM MOL GENET, V18, P4007, DOI 10.1093/hmg/ddp322; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Li HL, 2010, GENET EPIDEMIOL, V34, P427, DOI 10.1002/gepi.20495; Lin DY, 2009, GENET EPIDEMIOL, V33, P256, DOI 10.1002/gepi.20377; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; MacKinnon DP, 2007, CLIN TRIALS, V4, P499, DOI 10.1177/1740774507083434; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605; Mathworks, 2002, MATLAB; Maurice E., 2005, Morbidity and Mortality Weekly Report, V54, P1121; Munafo MR, 2012, JNCI-J NATL CANCER I, V104, P740, DOI 10.1093/jnci/djs191; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; POWELL M. J. D., 1970, NUMERICAL METHODS NO; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Richardson DB, 2007, EPIDEMIOLOGY, V18, P441, DOI 10.1097/EDE.0b013e318060d25c; Rothman K., 1998, MODERN EPIDEMIOLOGY; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Spitz MR, 2012, J NATL CANCER I, V104, P720, DOI 10.1093/jnci/djs211; Stav D, 2007, ISR MED ASSOC J, V9, P800; Straus SE, 2002, J GEN INTERN MED, V17, P684, DOI 10.1046/j.1525-1497.2002.20102.x; Taylor AB, 2008, ORGAN RES METHODS, V11, P241, DOI 10.1177/1094428107300344; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; VanderWeele TJ, 2012, AM J EPIDEMIOL, V175, P1013, DOI 10.1093/aje/kwr467; VanderWeele TJ, 2010, AM J EPIDEMIOL, V172, P1339, DOI 10.1093/aje/kwq332; VILLENEUVE PJ, 1994, CAN J PUBLIC HEALTH, V85, P385; Wacholder S, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn380; Wang J, 2012, ANAL SECOND IN PRESS; Wang J, 2011, GENET EPIDEMIOL, V35, P739, DOI 10.1002/gepi.20611; Wang JA, 2011, GENET EPIDEMIOL, V35, P190, DOI 10.1002/gepi.20568; Wang JA, 2010, CANCER-AM CANCER SOC, V116, P3458, DOI 10.1002/cncr.25085; Young RP, 2008, EUR RESPIR J, V32, P1158, DOI 10.1183/09031936.00093908; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208; Young RP, 2011, APPL CLIN GENET, V4, P1, DOI 10.2147/TACG.S15758; Zaas D, 2004, CHEST, V125, P106, DOI 10.1378/chest.125.1.106; Zhu WS, 2009, J KOREAN STAT SOC, V38, P1, DOI 10.1016/j.jkss.2008.10.006	61	13	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47705	10.1371/journal.pone.0047705	http://dx.doi.org/10.1371/journal.pone.0047705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077662	Green Submitted, gold, Green Published			2022-12-27	WOS:000309995100154
J	Zhou, QL; Liu, KH; Wu, HY; Chen, LH; Pouranan, V; Yuan, MX; Xiao, Z; Peng, WS; Xiang, A; Tang, R; Zhang, WZ				Zhou, Qiaoling; Liu, Kanghan; Wu, Hongyu; Chen, Lihe; Pouranan, Veeraragoo; Yuan, Mingxia; Xiao, Zhou; Peng, Weisheng; Xiang, Ao; Tang, Rong; Zhang, Wenzheng			Spironolactone Rescues Dot1a-Af9-Mediated Repression of Endothelin-1 and Improves Kidney Injury in Streptozotocin-Induced Diabetic Rats	PLOS ONE			English	Article							PROTEIN-KINASE-C; DUCT-SPECIFIC KNOCKOUT; HISTONE H3; GENE-EXPRESSION; NUCLEAR-LOCALIZATION; FUSION PARTNER; RENAL INJURY; ENAC-ALPHA; ALDOSTERONE; METHYLATION	The molecular mechanism linking aldosterone and endothelin-1 in the development of diabetic nephropathy has not been completely elucidated. Here, we provide evidence showing that streptozotocin-induced diabetic rats have significantly increased aldosterone and endothelin-1 in the kidney tissue and markedly decreased expression of Dot1a and Af9. Blocking aldosterone with spironolactone significantly reduced proteinuria, glomerulosclerosis, tubulointerstitial injury and endothelin-1 expression, and significantly increased Dot1a and Af9 expression. Increasing Dot1a and Af9 expression by spironolactone or by stable transfection led to impaired endothelin-1 expression in NRK-52 cells. In contrast, downregulation of Dot1a and Af9 by aldosterone in NRK-52E cells caused upregulation of endothelin-1. Genetic inactivation of Dot1l, which encodes Dot1a, in Aqp2-expressing principal cells of mouse kidney impaired association of Dot1a and H3 dimethyl K79 with the specific subregions of endothelin-1 promoter, and upregulates endothelin-1 mRNA and protein expression. Our data suggest that Dot1a and Af9 repress endothelin-1 in vitro and in vivo. Excessive aldosterone induces kidney injury, in part possibly by downregulating Dot1a and Af9, and thus relieving Dot1a-Af9-mediated repression to increase endothelin-1 transcription. Spironolactone ameliorates kidney injury in Streptozotocin-induced diabetic rats, possibly by restoring Dot1a-Af9-mediated repression to reduce endothelin-1 expression. Therefore, Dot1a and Af9 as aldosterone-downregulated targets are negative regulators of endothelin-1 transcription in vitro and in vivo, and may be considered as new potential therapeutic targets of kidney injury in diabetes.	[Zhou, Qiaoling; Liu, Kanghan; Pouranan, Veeraragoo; Yuan, Mingxia; Xiao, Zhou; Peng, Weisheng; Xiang, Ao; Tang, Rong] Cent S Univ, Xiangya Hosp, Dept Nephropathy, Changsha, Hunan, Peoples R China; [Wu, Hongyu; Zhang, Wenzheng] Univ Texas Med Sch Houston, Dept Internal Med, Houston, TX USA; [Chen, Lihe; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX USA	Central South University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Zhou, QL (corresponding author), Cent S Univ, Xiangya Hosp, Dept Nephropathy, Changsha, Hunan, Peoples R China.	zhouqling@yahoo.com.cn; wenzheng.zhang@uth.tmc.edu	Chen, Lihe/N-3186-2018	Chen, Lihe/0000-0002-6207-6364	National Natural Science Foundation of China (NSFC) [81070552]; National Institutes of Health [R01 DK080236]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080236] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The National Natural Science Foundation of China (NSFC) grant 81070552 (to Q.Z.), and National Institutes of Health Grants R01 DK080236 (to W.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Chang MJ, 2010, CANCER RES, V70, P10234, DOI 10.1158/0008-5472.CAN-10-3294; Chen LH, 2011, J AM SOC NEPHROL, V22, P1076, DOI 10.1681/ASN.2010121270; Doi T, 2008, AM J PHYSIOL-HEART C, V295, pH1279, DOI 10.1152/ajpheart.00148.2008; EMORI T, 1991, HYPERTENSION, V18, P165, DOI 10.1161/01.HYP.18.2.165; Erfurth F, 2004, LEUKEMIA, V18, P92, DOI 10.1038/sj.leu.2403200; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Feng Y, 2010, BLOOD, V116, P4483, DOI 10.1182/blood-2010-03-276501; Feria I, 2003, KIDNEY INT, V63, P43, DOI 10.1046/j.1523-1755.2003.00707.x; Fujisawa G, 2004, KIDNEY INT, V66, P1493, DOI 10.1111/j.1523-1755.2004.00913.x; Ge YQ, 2005, AM J PHYSIOL-RENAL, V288, pF912, DOI 10.1152/ajprenal.00432.2004; Giunti Sara, 2006, J Clin Hypertens (Greenwich), V8, P108, DOI 10.1111/j.1524-6175.2005.04508.x; Gumz ML, 2003, AM J PHYSIOL-RENAL, V285, pF664, DOI 10.1152/ajprenal.00353.2002; Han KH, 2006, KIDNEY INT, V70, P111, DOI 10.1038/sj.ki.5000438; Hemenway CS, 2001, ONCOGENE, V20, P3798, DOI 10.1038/sj.onc.1204478; IIDA S, 1993, ONCOGENE, V8, P3085; Jo SY, 2011, BLOOD, V117, P4759, DOI 10.1182/blood-2010-12-327668; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kohan DE, 1997, AM J KIDNEY DIS, V29, P2, DOI 10.1016/S0272-6386(97)90004-4; Kolkhof P, 2012, MOL CELL ENDOCRINOL, V350, P310, DOI 10.1016/j.mce.2011.06.025; Li JJ, 2009, AM J PHYSIOL-RENAL, V297, pF200, DOI 10.1152/ajprenal.90649.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehdi UF, 2009, J AM SOC NEPHROL, V20, P2641, DOI 10.1681/ASN.2009070737; MORITA T, 1994, CIRC RES, V75, P630, DOI 10.1161/01.RES.75.4.630; Nakagawa T, 2005, J CELL BIOCHEM, V95, P589, DOI 10.1002/jcb.20422; Nakagawa T, 2006, J CELL BIOCHEM, V99, P1064, DOI 10.1002/jcb.20863; Nakamaki S, 2011, EXP BIOL MED, V236, P614, DOI 10.1258/ebm.2011.010218; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Nguyen AT, 2011, GENE DEV, V25, P263, DOI 10.1101/gad.2018511; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Park JY, 2003, BIOCHEM BIOPH RES CO, V303, P891, DOI 10.1016/S0006-291X(03)00436-4; Park JY, 2000, DIABETES, V49, P1239, DOI 10.2337/diabetes.49.7.1239; Reisenauer MR, 2010, AM J PHYSIOL-RENAL, V299, pF63, DOI 10.1152/ajprenal.00105.2010; Reisenauer MR, 2009, J BIOL CHEM, V284, P35659, DOI 10.1074/jbc.M109.038448; Ronzaud C, 2007, J AM SOC NEPHROL, V18, P1679, DOI 10.1681/ASN.2006090975; Salber D, 2008, J NUCL MED, V49, P995, DOI 10.2967/jnumed.108.050880; Schmieder RE, 2007, LANCET, V369, P1208, DOI 10.1016/S0140-6736(07)60242-6; Schwarz U, 1998, KIDNEY INT, V53, P1696, DOI 10.1046/j.1523-1755.1998.00951.x; Singer MS, 1998, GENETICS, V150, P613; Srinivasan RS, 2003, ONCOGENE, V22, P3395, DOI 10.1038/sj.onc.1206361; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Stow LR, 2009, J BIOL CHEM, V284, P30087, DOI 10.1074/jbc.M109.030718; Suuronen EJ, 2009, FASEB J, V23, P1447, DOI 10.1096/fj.08-111054; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; Taira M, 2008, EUR J PHARMACOL, V589, P264, DOI 10.1016/j.ejphar.2008.06.019; Trachtman H, 2004, J UROLOGY, V172, P1590, DOI 10.1097/01.ju.0000140445.82949.54; Vallender TW, 2006, FEBS LETT, V580, P4560, DOI 10.1016/j.febslet.2006.07.017; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; WANG DL, 1995, J CELL PHYSIOL, V163, P400, DOI 10.1002/jcp.1041630220; WHORWOOD CB, 1995, J MOL ENDOCRINOL, V15, P93, DOI 10.1677/jme.0.0150093; Wolf SC, 2006, BIOCHEM PHARMACOL, V71, P1175, DOI 10.1016/j.bcp.2006.01.001; Wu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027429; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839	58	16	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47360	10.1371/journal.pone.0047360	http://dx.doi.org/10.1371/journal.pone.0047360			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077601	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100100
J	Tam, AB; Mercado, EL; Hoffmann, A; Niwa, M				Tam, Arvin B.; Mercado, Ellen L.; Hoffmann, Alexander; Niwa, Maho			ER Stress Activates NF-kappa B by Integrating Functions of Basal IKK Activity, IRE1 and PERK	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION; MESSENGER-RNA; TRANSLATION INITIATION; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTORS; CARCINOMA-CELLS; KINASE-ACTIVITY; TUMOR-GROWTH	NF-kappa B, a transcription factor, becomes activated during the Unfolded Protein Response (UPR), an endoplasmic reticulum (ER) stress response pathway. NF-kappa B is normally held inactive by its inhibitor, I kappa B alpha. Multiple cellular pathways activate IKK (I kappa B alpha Kinase) which phosphorylate I kappa B alpha leading to its degradation and NF-kappa B activation. Here, we find that IKK is required for maximum activation of NF-kappa B in response to ER stress. However, unlike canonical NF kappa B activation, IKK activity does not increase during ER stress, but rather the level of basal IKK activity is critical for determining the extent of NF-kappa B activation. Furthermore, a key UPR initiator, IRE1, acts to maintain IKK basal activity through IRE1's kinase, but not RNase, activity. Inputs from IRE1 and IKK, in combination with translation repression by PERK, another UPR initiator, lead to maximal NF-kappa B activation during the UPR. These interdependencies have a significant impact in cancer cells with elevated IKK/NF-kappa B activity such as renal cell carcinoma cells (786-0). Inhibition of IKK by an IKK inhibitor, which significantly decreases NF-kappa B activity, is overridden by UPR induction, arguing for the importance of considering UPR activation in cancer treatment.	[Tam, Arvin B.; Niwa, Maho] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Mercado, Ellen L.; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Niwa, M (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	niwa@ucsd.edu			National Institutes of Health (NIH) [GM087415]; American Cancer Society [RSG-10-027-01-CSM, RSG-05-01-GMC]; NIH [GM071573]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087415, R01GM071573] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) (GM087415), and American Cancer Society (RSG-10-027-01-CSM & RSG-05-01-GMC) to MN and by NIH (GM071573) to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Laszlo CF, 2009, MOL CELL BIOCHEM, V328, P9, DOI 10.1007/s11010-009-0067-8; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; O'Dea EL, 2008, MOL CELL, V30, P632, DOI 10.1016/j.molcel.2008.03.017; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Papandreou I, BLOOD; Parker SH, 2006, MOL CELL BIOCHEM, V293, P173, DOI 10.1007/s11010-006-9239-y; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; STREWLER GJ, 1983, J CLIN INVEST, V71, P769, DOI 10.1172/JCI110825; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; WEK RC, 1994, TRENDS BIOCHEM SCI, V19, P491, DOI 10.1016/0968-0004(94)90136-8; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Yang JM, 2001, CANCER RES, V61, P4901; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	56	221	230	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e45078	10.1371/journal.pone.0045078	http://dx.doi.org/10.1371/journal.pone.0045078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110043	Green Published, gold			2022-12-27	WOS:000310262500002
J	Sarup, P; Pedersen, SMM; Nielsen, NC; Malmendal, A; Loeschcke, V				Sarup, Pernille; Pedersen, Simon Metz Mariendal; Nielsen, Niels Chr.; Malmendal, Anders; Loeschcke, Volker			The Metabolic Profile of Long-Lived Drosophila melanogaster	PLOS ONE			English	Article							NEURONAL CELL-DEATH; SELECTION; STRESS; SENESCENCE; RESISTANCE; LONGEVITY; MICE; LIFE; REPRODUCTION; RESPONSES	We investigated the age-related changes in the metabolic profile of male Drosophila melanogaster and compared the metabolic profile of flies selected for increased longevity to that of control flies of equal age. We found clear differences in metabolite composition between selection regimes and among age groups. Contrary to results found in a previous study of the transcriptome of these lines the metabolic profile did not show a younger pattern in longevity-selected (LS) flies than in same aged control (C) flies. Rather, many of the metabolites affected by age had levels common to older control individuals in the young LS flies. Furthermore, ageing affected the metabolome in a different LS specific direction. The selection induced difference increased with age. Some metabolites involved in oxidative phosphorylation changed with age highlighting the importance of mitochondrial function in the ageing process. However, these metabolites were not affected by selection for increased longevity, indicating that improvements of mitochondrial function were not involved in the increased lifespan of LS lines. Of the eight metabolites identified as having a significant difference in relative abundance between selection regimes in our study choline, lysine and glucose also show difference among lifespan phenotypes in C. elegans indicating that the correlation between the concentration of these metabolites and longevity was evolutionary conserved. Links between longevity and choline concentration is also found in mice making this metabolite an obvious target for further study.	[Sarup, Pernille; Loeschcke, Volker] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Pedersen, Simon Metz Mariendal; Nielsen, Niels Chr.; Malmendal, Anders] Aarhus Univ, Ctr Insoluble Prot Struct, Aarhus, Denmark; [Pedersen, Simon Metz Mariendal] Aarhus Univ, Dept Food Sci, Tjele, Denmark; [Malmendal, Anders] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	Aarhus University; Aarhus University; Aarhus University; University of Copenhagen	Sarup, P (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	pernille.sarup@biology.au.dk; malmendal@sund.ku.dk	Sarup, Pernille/B-8632-2014; Loeschcke, Volker/J-2527-2013; Malmendal, Anders/F-1198-2017; Malmendal, Anders/S-2014-2019; Sarup, Pernille/AAY-2230-2020	Sarup, Pernille/0000-0002-5838-1251; Loeschcke, Volker/0000-0003-1450-0754; Malmendal, Anders/0000-0002-8413-9717; Malmendal, Anders/0000-0002-8413-9717; Nielsen, Niels Chr./0000-0003-2978-4366	Danish Council for Independent Research, Natural Sciences [10-093806/FNU]; Danish Natural Sciences Research Council; Velux foundation; Lundbeck Foundation; Carlsbergfondet; FNU; Danish Dairy Research Fund; iNANO	Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Danish Natural Sciences Research Council(Danish Natural Science Research Council); Velux foundation(Velux Fonden); Lundbeck Foundation(Lundbeckfonden); Carlsbergfondet(Carlsberg Foundation); FNU(Danish Natural Science Research Council); Danish Dairy Research Fund; iNANO	This work is funded by The Danish Council for Independent Research, Natural Sciences: 10-093806/FNU, the Danish Natural Sciences Research Council (frame and centre grant to V. L.), Velux foundation, Lundbeck Foundation and Carlsbergfondet, and FNU (stipends to PS) for financial support, The Danish Dairy Research Fund and iNANO (stipend to SMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 2004, CLIN SCI, V107, P355, DOI 10.1042/CS20040148; Bayley M, 2010, PHYSIOL BIOCHEM ZOOL, V83, P541, DOI 10.1086/651459; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; Butler JA, 2010, FASEB J, V24, P4977, DOI 10.1096/fj.10-162941; Buttini M, 2002, J NEUROSCI, V22, P10539; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; CHEN PS, 1977, BIOCHEMISTRY-US, V16, P4080, DOI 10.1021/bi00637a022; Collatz Klaus-Guenter, 2006, P241, DOI 10.1016/B978-012369391-4/50022-9; Coquin L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.71; FAIRBANKS LD, 1970, J INSECT PHYSIOL, V16, P1429, DOI 10.1016/0022-1910(70)90141-1; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Fuchs S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-14; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hercus MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2105, DOI 10.1098/rspb.2000.1256; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Keun HC, 2003, ANAL CHIM ACTA, V490, P265, DOI 10.1016/S0003-2670(03)00094-1; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LUCKINBILL LS, 1984, EVOLUTION, V38, P996, DOI 10.1111/j.1558-5646.1984.tb00369.x; Makinen VP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100205; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Mishur RJ, 2012, MASS SPECTROM REV, V31, P70, DOI 10.1002/mas.20338; Mukhopadhyay A, 2007, TRENDS CELL BIOL, V17, P65, DOI 10.1016/j.tcb.2006.12.004; Okuda S, 1998, J NEUROCHEM, V70, P299; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Partridge L, 2009, AGING CELL, V8, P509, DOI 10.1111/j.1474-9726.2009.00498.x; Pearl R, 1923, AM NAT, V57, P153, DOI 10.1086/279913; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; Pereira CS, 2006, J PHYS CHEM B, V110, P15572, DOI 10.1021/jp060789l; Rose MR, 2008, REJUV RES, V11, P527, DOI 10.1089/rej.2008.0688; ROSEN DR, 1989, P NATL ACAD SCI USA, V86, P2478, DOI 10.1073/pnas.86.7.2478; Sarup P, 2011, AGE, V33, P69, DOI 10.1007/s11357-010-9162-8; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Schwarcz R, 2010, PROG NEUROBIOL, V90, P230, DOI 10.1016/j.pneurobio.2009.04.005; SERVICE PM, 1989, J INSECT PHYSIOL, V35, P447, DOI 10.1016/0022-1910(89)90120-0; Sgro CM, 2000, EVOLUTION, V54, P2152, DOI 10.1111/j.0014-3820.2000.tb01257.x; Soltow QA, 2010, INTEGR COMP BIOL, V50, P844, DOI 10.1093/icb/icq094; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Van Dam D, 2011, BRIT J PHARMACOL, V164, P1285, DOI 10.1111/j.1476-5381.2011.01299.x; Vermeulen CJ, 2007, EXP GERONTOL, V42, P153, DOI 10.1016/j.exger.2006.09.014; Vermeulen CJ, 2006, J EVOLUTION BIOL, V19, P216, DOI 10.1111/j.1420-9101.2005.00972.x; Waagner D, 2010, COMP BIOCHEM PHYS A, V157, P177, DOI 10.1016/j.cbpa.2010.06.171; Watson MJO, 1996, EVOLUTION, V50, P1182, DOI 10.1111/j.1558-5646.1996.tb02359.x; Wijeyesekera A, 2012, J PROTEOME RES, V11, P2224, DOI 10.1021/pr2010154; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; Zadori D, 2009, J NEURAL TRANSM, V116, P1403, DOI 10.1007/s00702-009-0263-4; ZWAAN B, 1995, EVOLUTION, V49, P649, DOI 10.2307/2410318	54	32	32	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47461	10.1371/journal.pone.0047461	http://dx.doi.org/10.1371/journal.pone.0047461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110072	gold, Green Published, Green Submitted			2022-12-27	WOS:000310193600015
J	Reverberi, M; Punelli, M; Smith, CA; Zjalic, S; Scarpari, M; Scala, V; Cardinali, G; Aspite, N; Pinzari, F; Payne, GA; Fabbri, AA; Fanelli, C				Reverberi, Massimo; Punelli, Marta; Smith, Carrie A.; Zjalic, Slaven; Scarpari, Marzia; Scala, Valeria; Cardinali, Giorgia; Aspite, Nicaela; Pinzari, Flavia; Payne, Gary A.; Fabbri, Anna A.; Fanelli, Corrado			How Peroxisomes Affect Aflatoxin Biosynthesis in Aspergillus Flavus	PLOS ONE			English	Article							OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; BETA-OXIDATION; MYCOTOXIN PRODUCTION; PARASITICUS; PROTEIN; ACID; METABOLISM; FUNGI; LIPOPEROXIDATION	In filamentous fungi, peroxisomes are crucial for the primary metabolism and play a pivotal role in the formation of some secondary metabolites. Further, peroxisomes are important site for fatty acids beta-oxidation, the formation of reactive oxygen species and for their scavenging through a complex of antioxidant activities. Oxidative stress is involved in different metabolic events in all organisms and it occurs during oxidative processes within the cell, including peroxisomal beta-oxidation of fatty acids. In Aspergillus flavus, an unbalance towards an hyper-oxidant status into the cell is a prerequisite for the onset of aflatoxin biosynthesis. In our preliminary results, the use of bezafibrate, inducer of both peroxisomal beta-oxidation and peroxisome proliferation in mammals, significantly enhanced the expression of pex11 and foxA and stimulated aflatoxin synthesis in A. flavus. This suggests the existence of a correlation among peroxisome proliferation, fatty acids beta-oxidation and aflatoxin biosynthesis. To investigate this correlation, A. flavus was transformed with a vector containing P33, a gene from Cymbidium ringspot virus able to induce peroxisome proliferation, under the control of the promoter of the Cu, Zn-sod gene of A. flavus. This transcriptional control closely relates the onset of the antioxidant response to ROS increase, with the proliferation of peroxisomes in A. flavus. The AfP33 transformant strain show an up-regulation of lipid metabolism and an higher content of both intracellular ROS and some oxylipins. The combined presence of a higher amount of substrates (fatty acids-derived), an hyper-oxidant cell environment and of hormone-like signals (oxylipins) enhances the synthesis of aflatoxins in the AfP33 strain. The results obtained demonstrated a close link between peroxisome metabolism and aflatoxin synthesis.	[Reverberi, Massimo; Punelli, Marta; Scarpari, Marzia; Scala, Valeria; Fabbri, Anna A.; Fanelli, Corrado] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Smith, Carrie A.] Oklahoma State Univ, Oklahoma City, OK USA; [Zjalic, Slaven] Univ Zadar, Dept Ecol Agron & Aquaculture, Zadar, Croatia; [Cardinali, Giorgia; Aspite, Nicaela] IFO S Gallicano, Rome, Italy; [Pinzari, Flavia] Minist Beni Culturali, IRCPAL, Rome, Italy; [Payne, Gary A.] N Carolina State Univ, Raleigh, NC 27695 USA	Sapienza University Rome; Oklahoma State University System; Oklahoma State University Center for Health Sciences; Oklahoma State University - Stillwater; University of Zadar; IRCCS Istituti Fisioterapici Ospitalieri (IFO); University of North Carolina; North Carolina State University	Reverberi, M (corresponding author), Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy.	massimo.reverberi@uniroma1.it	Pinzari, Flavia/S-1790-2018; Cardinali, Giorgia/H-1814-2016; reverberi, massimo/G-7715-2012	Pinzari, Flavia/0000-0002-1083-8734; Cardinali, Giorgia/0000-0002-7527-9451; reverberi, massimo/0000-0003-3671-6783; scala, valeria/0000-0001-9383-8766; Fanelli, Corrado/0000-0002-0804-3078				Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Barnett P, 2000, TRENDS BIOCHEM SCI, V25, P227, DOI 10.1016/S0968-0004(00)01579-6; Bartoszewska M, 2011, BIOTECHNOL LETT, V33, P1921, DOI 10.1007/s10529-011-0664-y; Berlot JP, 2000, LIPIDS, V35, P1397, DOI 10.1007/s11745-000-0657-0; Burow GB, 1997, MOL PLANT MICROBE IN, V10, P380, DOI 10.1094/MPMI.1997.10.3.380; Christensen SA, 2010, FUNGAL GENET BIOL, V47, P539; Corpas FJ, 2001, TRENDS PLANT SCI, V6, P145, DOI 10.1016/S1360-1385(01)01898-2; FABBRI AA, 1983, J GEN MICROBIOL, V129, P3447; Fahmy T., 2003, XLSTAT PRO 7 0 XLSTA; FANELLI C, 1989, MYCOPATHOLOGIA, V107, P115, DOI 10.1007/BF00707547; Fanelli C, 1985, Mycotoxin Res, V1, P65, DOI 10.1007/BF03192005; Gao XQ, 2009, TOXIN REV, V28, P79, DOI 10.1080/15569540802420584; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Halliwell B., 2007, FREE RADICAL BIO MED, P187; He ZM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-104; Jayashree T, 2000, FREE RADICAL BIO MED, V29, P981, DOI 10.1016/S0891-5849(00)00398-1; Kiel JAKW, 2005, FUNGAL GENET BIOL, V42, P154, DOI 10.1016/j.fgb.2004.10.010; Kiel JAKW, 2009, FUNCT INTEGR GENOMIC, V9, P167, DOI 10.1007/s10142-009-0110-6; Koo AJK, 2006, J BIOL CHEM, V281, P33511, DOI 10.1074/jbc.M607854200; Lopez-Huertas E, 2000, EMBO J, V19, P6770, DOI 10.1093/emboj/19.24.6770; Maggio-Hall LA, 2005, MOL PLANT MICROBE IN, V18, P783, DOI 10.1094/MPMI-18-0783; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; McCartney AW, 2005, PLANT CELL, V17, P3513, DOI 10.1105/tpc.105.036350; Moye-Rowley WS, 2003, EUKARYOT CELL, V2, P381, DOI 10.1128/EC.2.3.381-389.2003; Narasaiah KV, 2006, MYCOPATHOLOGIA, V162, P179, DOI 10.1007/s11046-006-0052-7; Navarro B, 2006, J GEN VIROL, V87, P705, DOI 10.1099/vir.0.81325-0; Navarro B, 2004, J VIROL, V78, P4744, DOI 10.1128/JVI.78.9.4744-4752.2004; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Nyathi Y, 2006, BBA-MOL CELL RES, V1763, P1478, DOI 10.1016/j.bbamcr.2006.08.031; PASSI S, 1985, J GEN MICROBIOL, V131, P687; PASSI S, 1984, APPL MICROBIOL BIOT, V19, P186, DOI 10.1007/BF00256452; Reverberi M, 2007, FOOD ADDIT CONTAM A, V24, P1070, DOI 10.1080/02652030701553244; Reverberi M, 2008, EUKARYOT CELL, V7, P988, DOI 10.1128/EC.00228-07; Reverberi M, 2010, APPL MICROBIOL BIOT, V87, P899, DOI 10.1007/s00253-010-2657-5; Reverberi M, 2010, APPL MICROBIOL BIOT, V85, P1935, DOI 10.1007/s00253-009-2220-4; Roze LV, 2011, J BIOL CHEM, V286, P35137, DOI 10.1074/jbc.M111.253468; Roze LV, 2011, FUNGAL GENET BIOL, V48, P35, DOI 10.1016/j.fgb.2010.05.006; Titorenko VI, 2011, TRAFFIC, V12, P252, DOI 10.1111/j.1600-0854.2010.01144.x; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; van Roermund CWT, 2000, J CELL BIOL, V150, P489, DOI 10.1083/jcb.150.3.489; Vasquez M, 2001, MOL CELL BIOCHEM, V216, P71, DOI 10.1023/A:1011060615234; Yessoufou A, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13071; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160	45	62	64	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e48097	10.1371/journal.pone.0048097	http://dx.doi.org/10.1371/journal.pone.0048097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094106	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200058
J	Burkhardt, W; Kraft, S; Ochs, M; Proquitte, H; Mense, L; Rudiger, M				Burkhardt, Wolfram; Kraft, Stephan; Ochs, Matthias; Proquitte, Hans; Mense, Lars; Ruediger, Mario			Persurf, a New Method to Improve Surfactant Delivery: A Study in Surfactant Depleted Rats	PLOS ONE			English	Article							PARTIAL LIQUID VENTILATION; RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; EXOGENOUS SURFACTANT; GAS-EXCHANGE; II CELLS; MECHANICAL VENTILATION; NATURAL SURFACTANT; BOVINE SURFACTANT; HEALTHY PIGLETS	Purpose: Exogenous surfactant is not very effective in adults with ARDS, since surfactant does not reach atelectatic alveoli. Perfluorocarbons (PFC) can recruit atelectatic areas but do not replace impaired endogenous surfactant. A surfactant-PFC-mixture could combine benefits of both therapies. The aim of the proof-of-principal-study was to produce a PFC-in-surfactant emulsion (Persurf) and to test in surfactant depleted Wistar rats whether Persurf achieves I.) a more homogenous pulmonary distribution and II.) a more homogenous recruitment of alveoli when compared with surfactant or PFC alone. Methods: Three different PFC were mixed with surfactant and phospholipid concentration in the emulsion was measured. After surfactant depletion, animals either received 30 ml/kg of PF5080, 100 mg/kg of stained (green dye) Curosurf (TM) or 30 ml/kg of Persurf. Lungs were fixated after 1 hour of ventilation and alveolar aeration and surfactant distribution was estimated by a stereological approach. Results: Persurf contained 3 mg/ml phospholipids and was stable for more than 48 hours. Persurf-administration improved oxygenation. Histological evaluation revealed a more homogenous surfactant distribution and alveolar inflation when compared with surfactant treated animals. Conclusions: In surfactant depleted rats administration of PFC-in-surfactant emulsion leads to a more homogenous distribution and aeration of the lung than surfactant alone.	[Burkhardt, Wolfram; Mense, Lars; Ruediger, Mario] Tech Univ Dresden, Dept Neonatol & Pediat Intens Care Med, Klin Kinderheilkunde, Univ Klinikum Carl Gustav Carus,Med Fak, D-01062 Dresden, Germany; [Kraft, Stephan] Klinikum Mutterhaus Borromaerinnen, Dept Pediat Surg, Trier, Germany; [Ochs, Matthias] Hannover Med Sch, Inst Funct & Appl Anat, D-3000 Hannover, Germany; [Proquitte, Hans] Univ Med Berlin, Charite, Clin Neonatol, Berlin, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rudiger, M (corresponding author), Tech Univ Dresden, Dept Neonatol & Pediat Intens Care Med, Klin Kinderheilkunde, Univ Klinikum Carl Gustav Carus,Med Fak, D-01062 Dresden, Germany.	mario.ruediger@uniklinikum-dresden.de	Mense, Lars/ABB-7080-2021		Deutsche Forschungsgemeinschaft (DFG) [SI 785/3-1, RU 1233/1-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by grants from the Deutsche Forschungsgemeinschaft (DFG SI 785/3-1 and RU 1233/1-2). No additional fundings received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendel-Stenzel Ellen M., 2000, Pediatr Crit Care Med, V1, P72, DOI 10.1097/00130478-200007000-00014; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burkhardt W, 2004, INTENS CARE MED, V30, P315, DOI 10.1007/s00134-003-2090-7; Burkhardt W, 2002, BIOL NEONATE, V82, P250, DOI 10.1159/000065886; Chappell SE, 2001, RESP MED, V95, P612, DOI 10.1053/rmed.2001.1114; Cox PN, 2003, INTENS CARE MED, V29, P2297, DOI 10.1007/s00134-003-1881-1; Diemel RV, 2002, CRIT CARE MED, V30, P1083, DOI 10.1097/00003246-200205000-00020; Doctor A, 2003, J APPL PHYSIOL, V95, P1248, DOI 10.1152/japplphysiol.00598.2002; EDWARDS AD, 1992, PEDIATR RES, V32, P532, DOI 10.1203/00006450-199211000-00007; Espinosa FF, 1999, J APPL PHYSIOL, V86, P391, DOI 10.1152/jappl.1999.86.1.391; Gregory TJ, 1997, AM J RESP CRIT CARE, V155, P1309, DOI 10.1164/ajrccm.155.4.9105072; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Guthmann F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-10; Hartog A, 1999, BRIT J ANAESTH, V82, P81, DOI 10.1093/bja/82.1.81; Jeng MJ, 2003, CRIT CARE MED, V31, P1166, DOI 10.1097/01.CCM.0000059312.90697.32; Krause MF, 2000, EUR RESPIR J, V15, P949, DOI 10.1034/j.1399-3003.2000.15e23.x; Krause MF, 2001, PEDIATR RES, V50, P34, DOI 10.1203/00006450-200107000-00009; LACHMANN B, 1980, ACTA ANAESTH SCAND, V24, P231, DOI 10.1111/j.1399-6576.1980.tb01541.x; Lachmann B, 1989, Eur Respir J Suppl, V3, p98s; LEACH CL, 1995, J PEDIATR-US, V126, P412, DOI 10.1016/S0022-3476(95)70461-2; Lewis JE, 2003, ANNU REV PHYSIOL, V65, P613, DOI 10.1146/annurev.physiol.65.092101.142434; Meister JC, 2000, PEDIATR RES, V47, P240, DOI 10.1203/00006450-200002000-00015; MODELL J H, 1970, Chest, V57, P263, DOI 10.1378/chest.57.3.263; Moller JC, 2003, INTENS CARE MED, V29, P437, DOI 10.1007/s00134-003-1650-1; Mrozek JD, 1999, CRIT CARE MED, V27, P1916, DOI 10.1097/00003246-199909000-00033; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; PETTY TL, 1979, CHEST, V75, P571, DOI 10.1378/chest.75.5.571; PETTY TL, 1977, AM REV RESPIR DIS, V115, P531; ROYALL JA, 1988, J PEDIATR-US, V112, P169, DOI 10.1016/S0022-3476(88)80053-2; Rudiger M, 1998, AM J PHYSIOL-LUNG C, V274, pL143, DOI 10.1152/ajplung.1998.274.1.L143; Rudiger M, 2003, PEDIATR RES, V54, P808, DOI 10.1203/01.PDR.000088070.62177.3A; Rudiger M, 2003, CRIT CARE MED, V31, P1190, DOI 10.1097/01.CCM.0000060008.96029.7D; Rudiger M, 2001, CRIT CARE MED, V29, P1786; Rudiger M, 2001, BIOL NEONATE, V79, P73, DOI 10.1159/000047070; Rudiger M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-40; Skinner J, 1997, ARCH DIS CHILD-FETAL, V76, pF67, DOI 10.1136/fn.76.2.F67; Walmrath D, 2002, EUR RESPIR J, V19, P805, DOI 10.1183/09031936.02.00243402; Weibel ER, 2007, J APPL PHYSIOL, V102, P459, DOI 10.1152/japplphysiol.00808.2006; Wemhoner A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-52; Wolf S, 2001, BRIT J ANAESTH, V87, P593, DOI 10.1093/bja/87.4.593; Wolfson MR, 1998, J APPL PHYSIOL, V84, P624, DOI 10.1152/jappl.1998.84.2.624	41	6	7	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47923	10.1371/journal.pone.0047923	http://dx.doi.org/10.1371/journal.pone.0047923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082229	Green Submitted, gold, Green Published			2022-12-27	WOS:000311146900126
J	Choi, K; Cho, SI; Hashizume, M; Kim, H				Choi, Kyunghi; Cho, Sung-il; Hashizume, Masahiro; Kim, Ho			Epidemiological Characteristics of Novel Influenza A (H1N1) in Antiviral Drug Users in Korea	PLOS ONE			English	Article							BODY-MASS INDEX; VIRUS-INFECTION; COHORT	Soon after the first novel influenza A (H1N1) death was documented in Korea on August 15, 2009, prompt treatment with antiviral drugs was recommended when an infection was suspected. Free antiviral drugs were distributed to patients who met the case definition in the treatment guidelines, and patients prescribed the antiviral drugs were included in the Antiviral Drug Surveillance System (ADSS). A total of 2,825,821 patients were reported to the ADSS from September 1 to December 31, 2009. Odds ratios were calculated to compare the risks of severe diseases, as indicated by general hospital admissions or intensive care unit (ICU) admissions according to demographic characteristics, underlying medical conditions, and behavioral factors. Approximately 6% of the total population received antiviral drugs during the study period. Of these, 2,709,611 (95.9%) were outpatients, 114,840 (4.06%) were hospitalized, and 1,370 (0.05%) were admitted to the ICU. Children aged 0-9 yr accounted for 33.94% of all reported cases, whereas only 3.89% of the patients were >= 60 yr. The estimated incidence of novel influenza A (H1N1) during the pandemic was 5.68/100 of all reported cases. Mortality due to influenza A (H1N1) during the pandemic was 0.33/100,000, with the highest mortality of 1.31/100,000 for patients aged >= 60 years. Severe pandemic H1N1 influenza was associated with the presence of one or more underlying medical conditions in elderly aged >= 60 years and with lower economic status. Moreover, influenza A (H1N1) appeared to be age-specific in terms of mortality. Although the incidence and admission rates of influenza A (H1N1) were higher in younger age groups, fatal cases were much more likely to occur in the elderly (>= 60 years). In contrast to earlier influenza A (H1N1) reports, the risks of a severe outcome were elevated among those who were underweight (body mass index, 18.5 kg/m(2)).	[Cho, Sung-il; Kim, Ho] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Cho, Sung-il; Kim, Ho] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Choi, Kyunghi] Natl Hlth Insurance Cooperat, Dept Insurance Benefits, Seoul, South Korea; [Hashizume, Masahiro] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Hashizume, Masahiro] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan	Seoul National University (SNU); Seoul National University (SNU); Nagasaki University; Nagasaki University	Kim, H (corresponding author), Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea.	hokim@snu.ac.kr	Kim, Ho/AAS-2402-2021; Cho, Sung-il/D-5703-2012	Kim, Ho/0000-0001-7472-3752; Hashizume, Masahiro/0000-0003-4720-1750; Cho, Sung-il/0000-0003-4085-1494	Global Research Lab through the National Research Foundation of Korea (NRF) [K21004000001-10A0500-00710]; Ministry of Education, Science and Technology	Global Research Lab through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Ho Kim was partially supported by the Global Research Lab (#K21004000001-10A0500-00710) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Blumentals WA, 2012, INFLUENZA OTHER RESP, V6, P28, DOI 10.1111/j.1750-2659.2011.00262.x; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; European Centre for Disease Prevention and Control Working group on influenza A (H1N1) v, 2009, EUROSURVEILLANCE, V14, P19238; Kim JH, 2010, J KOREAN MED SCI, V25, P1109, DOI 10.3346/jkms.2010.25.7.1109; Korea Centre for Disease Control and Prevention, 2010, PUBLIC HEATH WEEKLY, V3, P101; Korea Centre for Disease Control and Prevention, INFL A H1N1 2009 CON; Korea Centre for Disease Control and Prevention, 2009, PUBLIC HEATH WEEKLY, V2, P656; Korea Centre for Disease Control and Prevention, 2009, PRESS B         1020; Korea Centre for Disease Control and Prevention, GUID LAB DIAGN NOV I; Korea Centre for Disease Control and Prevention, 2010, PUBLIC HEATH WEEKLY, V3, P241; Korea Centre for Disease Control and Prevention, 2009, PUBLIC HEATH WEEKLY, V2, P785; Korea Centre for Disease Control and Prevention, 2009, PUBLIC HEATH WEEKLY, V2, P689; Korea Ministry of Health and Welfare, 2009, PRESS B         0922; Korea Ministry of Health and Welfare, 2010, PRESS B         0204; Korea Ministry of Health and Welfare, 2010, PRESS B         0305; Korea National Health Insurance Cooperation, NHIC STAT; Kumakura H, 2010, J VASC SURG, V52, P110, DOI 10.1016/j.jvs.2010.02.008; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Satpathy HK, 2009, POSTGRAD MED, V121, P106, DOI 10.3810/pgm.2009.11.2080; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; WHO, 20 WHO; Wilson N, 2009, EUROSURVEILLANCE, V14; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	27	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47634	10.1371/journal.pone.0047634	http://dx.doi.org/10.1371/journal.pone.0047634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082184	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900080
J	Zambrano, JL; Sorondo, O; Alcala, A; Vizzi, E; Diaz, Y; Ruiz, MC; Michelangeli, F; Liprandi, F; Ludert, JE				Luis Zambrano, Jose; Sorondo, Orlando; Alcala, Ana; Vizzi, Esmeralda; Diaz, Yuleima; Ruiz, Marie Christine; Michelangeli, Fabian; Liprandi, Ferdinando; Ludert, Juan E.			Rotavirus Infection of Cells in Culture Induces Activation of RhoA and Changes in the Actin and Tubulin Cytoskeleton	PLOS ONE			English	Article							NONSTRUCTURAL GLYCOPROTEIN NSP4; INTESTINAL EPITHELIAL-CELLS; INTRACELLULAR CALCIUM-CONCENTRATION; SPIKE PROTEIN VP4; VIRAL ENTEROTOXIN; SECRETORY PATHWAY; PLASMA-MEMBRANE; MICROTUBULES; EXPRESSION; ENTRY	Rotavirus infection induces an increase in [Ca2+](cyto), which in turn may affect the distribution of the cytoskeleton proteins in the infected cell. Changes in microfilaments, including the formation of stress fibers, were observed starting at 0.5 h.p.i. using fluorescent phalloidin. Western blot analysis indicated that RhoA is activated between 0.5 and 1 h.p.i. Neither the phosphorylation of RhoA nor the formation of stress fibers were observed in cells infected with virions pre-treated with an anti-VP5* non-neutralizing mAb, suggesting that RhoA activation is stimulated by the interaction of the virus with integrins forming the cell receptor complex. In addition, the structure of the tubulin cytoskeleton was also studied. Alterations of the microtubules were evident starting at 3 h.p.i. and by 7 h.p.i. when microtubules were markedly displaced toward the periphery of the cell cytoplasm. Loading of rotavirus-infected cells with either a Ca2+ chelator (BAPTA) or transfection with siRNAs to silence NSP4, reversed the changes observed in both the microfilaments and microtubules distribution, but not the appearance of stress fibers. These results indicate that alterations in the distribution of actin microfilaments are initiated early during infection by the activation of RhoA, and that latter changes in the Ca2+ homeostasis promoted by NSP4 during infection may be responsible for other alterations in the actin and tubulin cytoskeleton.	[Luis Zambrano, Jose; Sorondo, Orlando; Alcala, Ana; Vizzi, Esmeralda; Liprandi, Ferdinando] CMBC, IVIC, Caracas, Venezuela; [Sorondo, Orlando] Cent Univ Venezuela, Escuela Biol, Caracas, Venezuela; [Diaz, Yuleima] Univ Bergen, Bergen, Norway; [Ruiz, Marie Christine; Michelangeli, Fabian] CBB, IVIC, Caracas, Venezuela; [Ludert, Juan E.] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico	Venezuelan Institute Science Research; University of Central Venezuela; University of Bergen; Venezuelan Institute Science Research; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Zambrano, JL (corresponding author), CMBC, IVIC, Caracas, Venezuela.	jlzr@ivic.gob.ve; jludert@cinvestav.mx	Vizzi, Esmeralda/AAQ-2362-2021; Zambrano-Rouvier, José Luis/AAZ-6995-2021; Ludert, Juan E./H-5658-2019	Zambrano-Rouvier, José Luis/0000-0001-9884-2940; ALCALA, ANA/0000-0002-6882-4765; Vizzi, Esmeralda/0000-0001-6865-1617; Ludert, Juan Ernesto/0000-0003-4790-7681	IVIC [098, 858, 988]	IVIC	The authors declare financial funding by IVIC, and Venezuelan LOCTI Program (TOTAL VENEZUELA, S.A., Helmerich & Paine and Deloitte Group). This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Ball JM, 2005, VIRAL IMMUNOL, V18, P27, DOI 10.1089/vim.2005.18.27; Berkova Z, 2006, J VIROL, V80, P6061, DOI 10.1128/JVI.02167-05; Berkova Z, 2003, CELL CALCIUM, V34, P55, DOI 10.1016/S0143-4160(03)00022-8; Berkova Z, 2007, J VIROL, V81, P3545, DOI 10.1128/JVI.01080-06; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Bowman GD, 2000, J MOL BIOL, V304, P861, DOI 10.1006/jmbi.2000.4250; Brunet JP, 2000, J VIROL, V74, P10801, DOI 10.1128/JVI.74.22.10801-10806.2000; Brunet JP, 2000, J VIROL, V74, P2323, DOI 10.1128/JVI.74.5.2323-2332.2000; Bugarcic A, 2006, J VIROL, V80, P12343, DOI 10.1128/JVI.01378-06; Cabral-Romero C, 2006, MEM I OSWALDO CRUZ, V101, P603, DOI 10.1590/S0074-02762006000600006; Ruiz MC, 2009, THESCIENTIFICWORLDJO, V9, P1476, DOI 10.1100/tsw.2009.158; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; Cuadras MA, 2006, J VIROL, V80, P3935, DOI 10.1128/JVI.80.8.3935-3946.2006; Diaz Y, 2008, J VIROL, V82, P11331, DOI 10.1128/JVI.00577-08; Diaz Y, 2012, VIRUS RES, V167, P285, DOI 10.1016/j.virusres.2012.05.012; Dickman KG, 2000, AM J PHYSIOL-GASTR L, V279, pG757, DOI 10.1152/ajpgi.2000.279.4.G757; Dong YJ, 1997, P NATL ACAD SCI USA, V94, P3960, DOI 10.1073/pnas.94.8.3960; Estes M. K., 2001, FIELDS VIROLOGY; Gardet A, 2006, J VIROL, V80, P3947, DOI 10.1128/JVI.80.8.3947-3956.2006; Gardet A, 2007, J VIROL, V81, P4892, DOI 10.1128/JVI.02698-06; Gibbons TF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-278; Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003; Guerrero CA, 2000, J VIROL, V74, P9362, DOI 10.1128/JVI.74.20.9362-9371.2000; Huang H, 2004, BIOCHEM J, V380, P723, DOI 10.1042/BJ20031789; Huang H, 2001, BIOCHEMISTRY-US, V40, P4169, DOI 10.1021/bi002346s; Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549; Jourdan N, 1998, J VIROL, V72, P7228, DOI 10.1128/JVI.72.9.7228-7236.1998; KAPIKIAN AZ, 2001, FIELDS VIROLOGY; Kurtoglu M, 2007, ANTIOXID REDOX SIGN, V9, P1383, DOI 10.1089/ars.2007.1714; LIPRANDI F, 1990, J GEN VIROL, V71, P1395, DOI 10.1099/0022-1317-71-6-1395; Lopez S, 2004, TRENDS MICROBIOL, V12, P271, DOI 10.1016/j.tim.2004.04.003; Lopez T, 2005, J VIROL, V79, P184, DOI 10.1128/JVI.79.1.184-192.2005; Lundgren O, 2001, MICROBES INFECT, V3, P1145, DOI 10.1016/S1286-4579(01)01475-7; Martin D, 2010, J VIROL, V84, P2522, DOI 10.1128/JVI.01883-09; MIDTHUN K, 1985, J VIROL, V53, P949, DOI 10.1128/JVI.53.3.949-954.1985; Nejmeddine M, 2000, J VIROL, V74, P3313, DOI 10.1128/JVI.74.7.3313-3320.2000; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0; Rasband W, IMAGEJ IMAGE PROCESS; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Ruiz MC, 2005, VIROLOGY, V333, P54, DOI 10.1016/j.virol.2004.12.032; Seo NS, 2008, P NATL ACAD SCI USA, V105, P8811, DOI 10.1073/pnas.0803934105; Silvestri LS, 2005, J VIROL, V79, P15165, DOI 10.1128/JVI.79.24.15165-15174.2005; Steinberg BE, 2011, ANTIVIR RES, DOI [10.1016/j.antiviral.2011.10.019, DOI 10.1016/J.ANTIVI-RAL.2011.10.019]; Tafazoli F, 2001, J VIROL, V75, P1540, DOI 10.1128/JVI.75.3.1540-1546.2001; TIAN P, 1995, J VIROL, V69, P5763, DOI 10.1128/JVI.69.9.5763-5772.1995; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; WECLEWICZ K, 1994, J GEN VIROL, V75, P3267, DOI 10.1099/0022-1317-75-11-3267; WECLEWICZ K, 1993, J NEUROSCI RES, V36, P173, DOI 10.1002/jnr.490360207; Xu AM, 2000, EMBO J, V19, P6465, DOI 10.1093/emboj/19.23.6465; Yang WM, 2012, VIRUS RES, V163, P269, DOI 10.1016/j.virusres.2011.10.011; Zarnbrano JL, 2008, J VIROL, V82, P5815, DOI 10.1128/JVI.02719-07; Zhang MD, 2000, J VIROL, V74, P11663, DOI 10.1128/JVI.74.24.11663-11670.2000; Zhou H, 2005, J BIOL CHEM, V280, P10624, DOI 10.1074/jbc.M411900200	55	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47612	10.1371/journal.pone.0047612	http://dx.doi.org/10.1371/journal.pone.0047612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082182	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900078
J	Martinez, SM; Foucher, J; Combis, JM; Metivier, S; Brunetto, M; Capron, D; Bourliere, M; Bronowicki, JP; Dao, T; Maynard-Muet, M; Lucidarme, D; Merrouche, W; Forns, X; de Ledinghen, V				Martinez, Stella M.; Foucher, Juliette; Combis, Jean-Marc; Metivier, Sophie; Brunetto, Maurizia; Capron, Dominique; Bourliere, Marc; Bronowicki, Jean-Pierre; Thong Dao; Maynard-Muet, Marianne; Lucidarme, Damien; Merrouche, Wassil; Forns, Xavier; de Ledinghen, Victor			Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY FIBROSCAN; SIMPLE NONINVASIVE INDEX; PEGYLATED INTERFERON-ALPHA-2B; MARKER PANELS; BIOPSY; DIAGNOSIS; CIRRHOSIS; ALPHA-2B; DECREASE; PREDICT	Background/Aims: Liver stiffness (LS) measurement by means of transient elastography (TE) is accurate to predict fibrosis stage. The effect of antiviral treatment and virologic response on LS was assessed and compared with untreated patients with chronic hepatitis C (CHC). Methods: TE was performed at baseline, and at weeks 24, 48, and 72 in 515 patients with CHC. Results: 323 treated (62.7%) and 192 untreated patients (37.3%) were assessed. LS experienced a significant decline in treated patients and remained stable in untreated patients at the end of study (P<0.0001). The decline was significant for patients with baseline LS >= 7.1 kPa (P<0.0001 and P 0.03, for LS >= 9.5 and >= 7.1 kPa vs lower values, respectively). Sustained virological responders and relapsers had a significant LS improvement whereas a trend was observed in nonresponders (mean percent change -16%, -10% and -22%, for SVR, RR and NR, respectively, P 0.03 for SVR vs NR). In multivariate analysis, high baseline LS (P<0.0001) and ALT levels, antiviral therapy and non-1 genotype were independent predictors of LS improvement. Conclusions: LS decreases during and after antiviral treatment in patients with CHC. The decrease is significant in sustained responders and relapsers (particularly in those with high baseline LS) and suggests an improvement in liver damage.	[Foucher, Juliette; Merrouche, Wassil; de Ledinghen, Victor] CHU Bordeaux, Ctr Invest Fibrose Hepat, Hop Haut Leveque, Pessac, France; [Martinez, Stella M.; Forns, Xavier] Hosp Clin Barcelona, Liver Unit, IDIBAPS, Barcelona, Spain; [Martinez, Stella M.; Forns, Xavier] CIBERehd, Barcelona, Spain; [Combis, Jean-Marc] Clin Ambroise Pare, Toulouse, France; [Metivier, Sophie] CHU Purpan, Serv Hepatogastroenterol, Toulouse, France; [Brunetto, Maurizia] Univ Hosp Pisa, Hepatol Unit, Pisa, Italy; [Capron, Dominique] Amiens Univ Hosp, Dept Hepatogastroenterol, Amiens, France; [Bourliere, Marc] Hop St Joseph, Serv Hepatogastroenterol, Marseille, France; [Bronowicki, Jean-Pierre] CHU Nancy, Serv Hepatogastroenterol, INSERM 954, Vandoeuvre Les Nancy, France; [Thong Dao] CHU Cote Nacre, Serv Hepatogastroenterol & Nutr, Caen, France; [Maynard-Muet, Marianne] Hop Croix Rousse, Dept Gastroenterol & Hepatol, F-69317 Lyon, France; [Lucidarme, Damien] Univ Nord France, Serv Pathol Digest, Grp Hosp, Inst Catholique Lillois,Fac Libre Med Lille, Lille, France	CHU Bordeaux; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CHU de Toulouse; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Lyon; Universite de Lille - ISITE; Universite de Lille	de Ledinghen, V (corresponding author), CHU Bordeaux, Ctr Invest Fibrose Hepat, Hop Haut Leveque, Pessac, France.	victor.deledinghen@chu-bordeaux.fr	Brunetto, Maurizia/AAU-2906-2020	Brunetto, Maurizia/0000-0001-8364-9152; Forns, Xavier/0000-0002-8188-1764	Roche; Fundacion Banco Bilbao Vizcaya Argentaria (BBVA); Merck; Gilead; Janssen; Echosens; Bayer; MSD	Roche(Roche Holding); Fundacion Banco Bilbao Vizcaya Argentaria (BBVA)(BBVA Foundation); Merck(Merck & Company); Gilead(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Echosens; Bayer(Bayer AG); MSD	This is an independent study, supported in part by Roche. Stella Martinez was granted by Fundacion Banco Bilbao Vizcaya Argentaria (BBVA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Victor de Ledinghen receives consulting fees from Merck, Roche, Gilead, Janssen, Echosens and Bayer. Xavier Forns receives unrestricted grant support from Roche and MSD. Juliette Foucher is on the advisory board for Janssen. Thong Dao is a board member for Schering Plough and receives consulting fees from Roche and Gilead. Jean Marc Combis is employed by Clinique Ambroise Pare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Camma C, 2004, HEPATOLOGY, V39, P333, DOI 10.1002/hep.20073; Carrion JA, 2010, HEPATOLOGY, V51, P23, DOI 10.1002/hep.23240; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; de Ledinghen V, 2006, JAIDS-J ACQ IMM DEF, V41, P175; Fontana RJ, 2009, CLIN GASTROENTEROL H, V7, P219, DOI 10.1016/j.cgh.2008.10.034; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Lucidarme D, 2009, HEPATOLOGY, V49, P1083, DOI 10.1002/hep.22748; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; Ogawa E, 2009, ANTIVIR RES, V83, P127, DOI 10.1016/j.antiviral.2009.04.002; Patel K, 2009, J VIRAL HEPATITIS, V16, P178, DOI 10.1111/j.1365-2893.2008.01062.x; PERRAULT J, 1978, GASTROENTEROLOGY, V74, P103; Poynard T, 2003, HEPATOLOGY, V38, P481, DOI 10.1053/jhep.2003.50319; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Shiffman ML, 1997, HEPATOLOGY, V26, P780, DOI 10.1002/hep.510260335; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Vergniol J, 2009, J VIRAL HEPATITIS, V16, P132, DOI [10.1111/j.1365-2893.2008.01055.x, 10.1111/j.1365-2893.2008.01050.x]; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wang JH, 2010, J GASTROEN HEPATOL, V25, P964, DOI 10.1111/j.1440-1746.2009.06194.x; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	31	50	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47715	10.1371/journal.pone.0047715	http://dx.doi.org/10.1371/journal.pone.0047715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082200	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900097
J	Zhang, W; MacDonald, EM; Koepp, DM				Zhang, Wei; MacDonald, Elizabeth M.; Koepp, Deanna M.			The Stomatin-Like Protein SLP-1 and Cdk2 Interact with the F-Box Protein Fbw7-gamma	PLOS ONE			English	Article							PHOSPHORYLATION-DEPENDENT DEGRADATION; FBW7 UBIQUITIN LIGASE; CYCLIN-E; C-MYC; SUBSTRATE RECOGNITION; TUMOR-SUPPRESSOR; NOTCH; ISOFORM; SEL-10; INHIBITOR	Control of cellular proliferation is critical to cell viability. The F-box protein Fbw7 (hAgo/hCdc4/FBXW7) functions as a specificity factor for the Skp1-Cul1-F-box protein (SCF) ubiquitin ligase complex and targets several proteins required for cellular proliferation for ubiquitin-mediated destruction. Fbw7 exists as three splice variants but the mechanistic role of each is not entirely clear. We examined the regulation of the Fbw7-gamma isoform, which has been implicated in the degradation of c-Myc. We show here that Fbw7-gamma is an unstable protein and that its turnover is proteasome-dependent in transformed cells. Using a two-hybrid screen, we identified a novel interaction partner, SLP-1, which binds the N-terminal domain of Fbw7-gamma. Overexpression of SLP-1 inhibits the degradation of Fbw7-gamma, suggesting that this interaction can happen in vivo. When Fbw7-gamma is stabilized by overexpression of SLP-1, c-Myc protein abundance decreases, suggesting that the SCFFbw7-gamma complex maintains activity. We demonstrate that Cdk2 also binds the N-terminal domain of Fbw7-gamma as well as SLP-1. Interestingly, co-expression of Cdk2 and SLP-1 does not inhibit Fbw7-gamma degradation, suggesting that Cdk2 and SLP-1 may have opposing functions.	[Zhang, Wei; MacDonald, Elizabeth M.; Koepp, Deanna M.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Koepp, DM (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA.	koepp015@umn.edu			National Institutes of Health [R01 GM076663]; V Foundation for Cancer Research; Leukemia Research Fund; American Cancer Society Institutional Research Grant at the University of Minnesota; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; Leukemia Research Fund; American Cancer Society Institutional Research Grant at the University of Minnesota; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the National Institutes of Health grant R01 GM076663 to DMK and awards from the V Foundation for Cancer Research (www.jimmyv.org), the Leukemia Research Fund (www.leukemia-research.org) and a sub-award from the American Cancer Society Institutional Research Grant at the University of Minnesota (www.cancer.org). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bai C, 1996, METHOD ENZYMOL, V273, P331; Bonetti P, 2008, J CELL BIOL, V182, P19, DOI 10.1083/jcb.200711040; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Cizmecioglu O, 2012, J CELL SCI, V125, P981, DOI 10.1242/jcs.095075; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Green JB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-44; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hayami R, 2005, CANCER RES, V65, P6; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Sangfelt O, 2008, CELL CYCLE, V7, P1075, DOI 10.4161/cc.7.8.5648; Sedensky MM, 2004, AM J PHYSIOL-CELL PH, V287, pC468, DOI 10.1152/ajpcell.00182.2003; Seidel G, 1998, GENE, V225, P23, DOI 10.1016/S0378-1119(98)00532-0; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030; Zhang W, 2006, MOL CANCER RES, V4, P935, DOI 10.1158/1541-7786.MCR-06-0253; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	41	3	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47736	10.1371/journal.pone.0047736	http://dx.doi.org/10.1371/journal.pone.0047736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082202	Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900099
J	Khan, S; Jutzy, JMS; Valenzuela, MMA; Turay, D; Aspe, JR; Ashok, A; Mirshahidi, S; Mercola, D; Lilly, MB; Wall, NR				Khan, Salma; Jutzy, Jessica M. S.; Valenzuela, Malyn May A.; Turay, David; Aspe, Jonathan R.; Ashok, Arjun; Mirshahidi, Saied; Mercola, Dan; Lilly, Michael B.; Wall, Nathan R.			Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate Cancer	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; GENE-EXPRESSION; TUMOR-MARKERS; APOPTOSIS; BLOOD; RECURRENCE; RESISTANCE; INHIBITOR; PROTEINS; FUTURE	Background: Survivin is expressed in prostate cancer (PCa), and its downregulation sensitizes PCa cells to chemotherapeutic agents in vitro and in vivo. Small membrane-bound vesicles called exosomes, secreted from the endosomal membrane compartment, contain RNA and protein that they readily transport via exosome internalization into recipient cells. Recent progress has shown that tumor-derived exosomes play multiple roles in tumor growth and metastasis and may produce these functions via immune escape, tumor invasion and angiogenesis. Furthermore, exosome analysis may provide novel biomarkers to diagnose or monitor PCa treatment. Methods: Exosomes were purified from the plasma and serum from 39 PCa patients, 20 BPH patients, 8 prostate cancer recurrent and 16 healthy controls using ultracentrifugation and their quantities and qualities were quantified and visualized from both the plasma and the purified exosomes using ELISA and Western blotting, respectively. Results: Survivin was significantly increased in the tumor-derived samples, compared to those from BPH and controls with virtually no difference in the quantity of Survivin detected in exosomes collected from newly diagnosed patients exhibiting low (six) or high (nine) Gleason scores. Exosome Survivin levels were also higher in patients that had relapsed on chemotherapy compared to controls. Conclusions: These studies demonstrate that Survivin exists in plasma exosomes from both normal, BPH and PCa subjects. The relative amounts of exosomal Survivin in PCa plasma was significantly higher than in those with pre-inflammatory BPH and control plasma. This differential expression of exosomal Survivin was seen with both newly diagnosed and advanced PCa subjects with high or low-grade cancers. Analysis of plasma exosomal Survivin levels may offer a convenient tool for diagnosing or monitoring PCa and may, as it is elevated in low as well as high Gleason scored samples, be used for early detection.	[Khan, Salma; Jutzy, Jessica M. S.; Valenzuela, Malyn May A.; Turay, David; Aspe, Jonathan R.; Ashok, Arjun; Wall, Nathan R.] Loma Linda Univ, Ctr Hlth Dispar & Mol Med, Dept Biochem & Microbiol, Loma Linda, CA 92350 USA; [Mirshahidi, Saied] Loma Linda Univ, Ctr Canc, Loma Linda, CA 92350 USA; [Mirshahidi, Saied] Loma Linda Univ, Dept Microbiol, Loma Linda, CA 92350 USA; [Mirshahidi, Saied] Loma Linda Univ, Biospecimen Lab, Loma Linda, CA 92350 USA; [Lilly, Michael B.] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92717 USA; [Mercola, Dan; Lilly, Michael B.] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA; [Mercola, Dan] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA	Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Wall, NR (corresponding author), Loma Linda Univ, Ctr Hlth Dispar & Mol Med, Dept Biochem & Microbiol, Loma Linda, CA 92350 USA.	nwall@llu.edu	mercola, dan/L-4182-2013; Wall, Nathan R./H-7368-2015	mercola, dan/0000-0002-0281-9840; Wall, Nathan R./0000-0002-3235-4386; Jutzy, Jessica/0000-0001-9699-7957; Khan, Salma/0000-0003-2564-4358	Center for Health Disparities and Molecular Medicine; Loma Linda University; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001632] Funding Source: NIH RePORTER	Center for Health Disparities and Molecular Medicine; Loma Linda University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work has been funded in part from a generous start up fund to the PI (NRW) by the Center for Molecular Biology and Gene Therapy which has since been renamed the Center for Health Disparities and Molecular Medicine and from Loma Linda University. The PI has also contributed funds from his personal account. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bjartell A, 2011, ACTA ONCOL, V50, P76, DOI 10.3109/0284186X.2010.531284; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chang R T M, 2012, Practitioner, V256, P13; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Croswell JM, 2011, ONCOLOGY-NY, V25, P452; Denmeade SR, 1996, PROSTATE, V1, P120; Duijvesz D, 2011, EUR UROL, V59, P823, DOI 10.1016/j.eururo.2010.12.031; El-Attar HA, 2010, ASIAN PAC J CANCER P, V11, P897; Fine SW, 2008, J UROLOGY, V179, P1335, DOI 10.1016/j.juro.2007.11.057; Fiorentino M, 2010, UROL CLIN N AM, V37, P131, DOI 10.1016/j.ucl.2009.11.006; Fradet Y, 2009, CURR OPIN UROL, V19, P243, DOI 10.1097/MOU.0b013e32832a08b5; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; Howell SB, 2000, MOL UROL, V4, P225; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Khan S, 2009, BRIT J CANCER, V100, P1073, DOI 10.1038/sj.bjc.6604978; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Kishi H, 2004, J UROLOGY, V171, P1855, DOI 10.1097/01.ju.0000120317.88372.03; Klein EA, 2003, UROL CLIN N AM, V30, P315, DOI 10.1016/S0094-0143(02)00179-9; Koike H, 2008, UROLOGY, V72, P1229, DOI 10.1016/j.urology.2007.12.064; Koumangoye RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024234; Krajewska M, 1996, AM J PATHOL, V148, P1567; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Li YW, 2004, NEOPLASIA, V6, P354, DOI 10.1593/neo.03478; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; Mazzola CRE, 2011, PROG UROL, V21, P1, DOI 10.1016/j.purol.2010.07.004; Mikolajczyk SD, 2004, CLIN BIOCHEM, V37, P519, DOI 10.1016/j.clinbiochem.2004.05.016; Mitchell PJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-4; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Ploussard G, 2010, NAT REV UROL, V7, P101, DOI 10.1038/nrurol.2009.261; Quah BJC, 2005, BLOOD CELL MOL DIS, V35, P94, DOI 10.1016/j.bcmd.2005.05.002; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Shariat SF, 2004, CANCER, V100, P751, DOI 10.1002/cncr.20039; Shariat SF, 2011, ACTA ONCOL, V50, P61, DOI 10.3109/0284186X.2010.542174; Shen JJ, 2009, ACTA BIOCH BIOPH SIN, V41, P223, DOI 10.1093/abbs/gmp005; Sugahara K, 2004, INT J HEMATOL, V80, P52, DOI 10.1532/ijh97.04031; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Williams Ryan M, 2010, Front Biosci (Schol Ed), V2, P677; Zhang M, 2005, ONCOGENE, V24, P2474, DOI 10.1038/sj.onc.1208490	46	201	205	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46737	10.1371/journal.pone.0046737	http://dx.doi.org/10.1371/journal.pone.0046737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091600	Green Published, gold			2022-12-27	WOS:000310135800013
J	Vicente, CSL; Nascimento, F; Espada, M; Barbosa, P; Mota, M; Glick, BR; Oliveira, S				Vicente, Claudia S. L.; Nascimento, Francisco; Espada, Margarida; Barbosa, Pedro; Mota, Manuel; Glick, Bernard R.; Oliveira, Solange			Characterization of Bacteria Associated with Pinewood Nematode Bursaphelenchus xylophilus	PLOS ONE			English	Article							WILT DISEASE; POPULATION-DYNAMICS; BIOFILM FORMATION; PATHOGENICITY; EXOPOLYSACCHARIDES; MICROORGANISMS; SIDEROPHORES; INOCULATION; CELLULASES	Pine wilt disease (PWD) is a complex disease integrating three major agents: the pathogenic agent, the pinewood nematode Bursaphelenchus xylophilus; the insect-vector Monochamus spp.; and the host pine tree, Pinus sp. Since the early 80's, the notion that another pathogenic agent, namely bacteria, may play a role in PWD has been gaining traction, however the role of bacteria in PWD is still unknown. The present work supports the possibility that some B. xylophilus-associated bacteria may play a significant role in the development of this disease. This is inferred as a consequence of: (i) the phenotypic characterization of a collection of 35 isolates of B. xylophilus-associated bacteria, in different tests broadly used to test plant pathogenic and plant growth promoting bacteria, and (ii) greenhouse experiments that infer the pathogenicity of these bacteria in maritime pine, Pinus pinaster. The results illustrate the presence of a heterogeneous microbial community associated with B. xylophilus and the traits exhibited by at least, some of these bacteria, appear to be related to PWD symptoms. The inoculation of four specific B. xylophilus-associated bacteria isolates in P. pinaster seedlings resulted in the development of some PWD symptoms suggesting that these bacteria likely play an active role with B. xylophilus in PWD.	[Oliveira, Solange] Univ Evora, ICAAM, Lab Microbiol Solo, Evora, Portugal; [Vicente, Claudia S. L.; Nascimento, Francisco; Espada, Margarida; Barbosa, Pedro; Mota, Manuel] Univ Evora, ICAAM, NemaLab, Evora, Portugal; [Glick, Bernard R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Evora; University of Evora; University of Waterloo	Oliveira, S (corresponding author), Univ Evora, ICAAM, Lab Microbiol Solo, Evora, Portugal.	ismo@uevora.pt	Vicente, Claudia/C-6226-2019; Nascimento, Francisco X./F-6537-2016; Vicente, Cláudia SL/X-5058-2019; Mota, Manuel/G-6031-2019; Oliveira, Solange/M-4047-2013	Vicente, Claudia/0000-0002-3865-5358; Nascimento, Francisco X./0000-0003-1184-3794; Vicente, Cláudia SL/0000-0002-3865-5358; Mota, Manuel/0000-0002-4145-5031; Oliveira, Solange/0000-0003-4984-4805; Espada, Margarida/0000-0002-3826-711X	European Project REPHRAME - Development of improved methods for detection, control and eradication of pine wood nematode in support of EU Plant Health policy, European Union Seventh Framework Programme [FP7-KBBE-2010-4]; European Project BioReGent - Biocontrol and Bioremediation agents and their role in Agriculture and Forest health, European Union Seventh Framework Programme [247669]; Operational Programme for Competitiveness Factors - COMPETE; National Funds through FCT - Foundation for Science and Technology [PEst-C/AGR/UI0115/2011]	European Project REPHRAME - Development of improved methods for detection, control and eradication of pine wood nematode in support of EU Plant Health policy, European Union Seventh Framework Programme; European Project BioReGent - Biocontrol and Bioremediation agents and their role in Agriculture and Forest health, European Union Seventh Framework Programme; Operational Programme for Competitiveness Factors - COMPETE; National Funds through FCT - Foundation for Science and Technology	This work was supported by the European Project REPHRAME - Development of improved methods for detection, control and eradication of pine wood nematode in support of EU Plant Health policy, European Union Seventh Framework Programme FP7-KBBE-2010-4 and the European Project BioReGent - Biocontrol and Bioremediation agents and their role in Agriculture and Forest health, European Union Seventh Framework Programme FP7-PEOPLE-2009-IRSES (grant agreement no 247669); and FEDER Funds through the Operational Programme for Competitiveness Factors - COMPETE and National Funds through FCT - Foundation for Science and Technology under the Strategic Project PEst-C/AGR/UI0115/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; Andrews JH, 2000, ANNU REV PHYTOPATHOL, V38, P145, DOI 10.1146/annurev.phyto.38.1.145; Bhatt G, 2004, J BACTERIOL, V186, P7896, DOI 10.1128/JB.186.23.7896-7904.2004; deFreitas JR, 1997, BIOL FERT SOILS, V24, P358, DOI 10.1007/s003740050258; Dellagi A, 2009, PLANT PHYSIOL, V150, P1687, DOI 10.1104/pp.109.138636; DWORKIN M, 1958, J BACTERIOL, V75, P592, DOI 10.1128/JB.75.5.592-603.1958; EVANS AAF, 1970, J NEMATOL, V2, P99; Fang ZD, 1998, METHODS RES PLANT DI; Futai K., 1979, Bulletin, Kyoto University Forests, P23; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Han ZM, 2003, J PHYTOPATHOL, V151, P683, DOI 10.1046/j.1439-0434.2003.00790.x; Jones AM, 2011, J BACTERIOL, V193, P2767, DOI 10.1128/JB.00069-10; Kasana RC, 2008, CURR MICROBIOL, V57, P503, DOI 10.1007/s00284-008-9276-8; Kawazu K, 1998, SCI REPORTS FACULTY; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; KING EO, 1954, J LAB CLIN MED, V44, P301; Koczan JM, 2009, PHYTOPATHOLOGY, V99, P1237, DOI 10.1094/PHYTO-99-11-1237; Kwon HR, 2010, PEST MANAG SCI, V66, P634, DOI 10.1002/ps.1920; Li H, 2007, THESIS U GHENT; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; Mota M., 2008, PINE WILT DIS WORLDW; Naves P, 2005, J PEST SCI, V78, P57, DOI 10.1007/s10340-004-0068-z; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; OKU H, 1980, NATURWISSENSCHAFTEN, V67, P198, DOI 10.1007/BF01086307; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Proenca DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015191; Ramey BE, 2004, CURR OPIN MICROBIOL, V7, P602, DOI 10.1016/j.mib.2004.10.014; Rashid S, 2012, APPL SOIL ECOL, V61, P217, DOI 10.1016/j.apsoil.2011.09.011; Roriz M, 2011, EXP PARASITOL, V128, P357, DOI 10.1016/j.exppara.2011.04.008; Ryss A. Yu., 2011, Forestry Studies in China, V13, P132, DOI 10.1007/s11632-011-0205-8; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Sun YL, 2009, FEMS MICROBIOL LETT, V296, P131, DOI 10.1111/j.1574-6968.2009.01625.x; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Togashi K, 2006, POPUL ECOL, V48, P271, DOI 10.1007/s10144-006-0011-7; Urnesha S, 2008, J MICROBIOL METH, V72, P95, DOI 10.1016/j.mimet.2007.11.002; van Geel-Schutten GH, 1998, APPL MICROBIOL BIOT, V50, P697, DOI 10.1007/s002530051353; Vicente C, 2012, EUR J PLANT PATHOL, V133, P89, DOI 10.1007/s10658-011-9924-x; Vicente CSL, 2011, ANTON LEEUW INT J G, V100, P477, DOI 10.1007/s10482-011-9602-1; WALTON JD, 1994, PLANT PHYSIOL, V104, P1113, DOI 10.1104/pp.104.4.1113; Xie LQ, 2008, J PHYTOPATHOL, V156, P385, DOI 10.1111/j.1439-0434.2007.01357.x; YAMADA T, 1993, ANNU REV PHYTOPATHOL, V31, P253, DOI 10.1146/annurev.py.31.090193.001345; Zhao B., 2006, FRONT CHINA, V1, P324, DOI [10.1007/s11461-006-0037-1, DOI 10.1007/S11461-006-0037-1]; Zhao BG, 2003, NEMATOLOGY, V5, P899, DOI 10.1163/156854103773040817; Zhu LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038095	50	48	53	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46661	10.1371/journal.pone.0046661	http://dx.doi.org/10.1371/journal.pone.0046661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091599	Green Published, gold, Green Submitted			2022-12-27	WOS:000310135800012
J	Kabagambe, EK; Ordovas, JM; Hopkins, PN; Tsai, MY; Arnett, DK				Kabagambe, Edmond K.; Ordovas, Jose M.; Hopkins, Paul N.; Tsai, Michael Y.; Arnett, Donna K.			The Relation between Erythrocyte Trans Fat and Triglyceride, VLDL- and HDL-Cholesterol Concentrations Depends on Polyunsaturated Fat	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; METABOLIC SYNDROME; ADIPOSE-TISSUE; DIETARY-FAT; CARDIOVASCULAR-DISEASE; RICAN ADULTS; YOUNG MEN; ACIDS; RISK	Background: Trans fatty acids (TFA) lower HDL and increase triglyceride concentrations while polyunsaturated fatty acids (PUFA) lower triglycerides and may decrease HDL concentrations. The effect of the interaction between trans fat and PUFA on lipids is uncertain. Methods: Men and women (n = 1032) in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN) study were included. Fatty acids in erythrocyte membranes were measured with gas chromatography while data on potential confounders were obtained from questionnaires. To test the interaction between total erythrocyte PUFA (ePUFA) and TFA (eTFA) on lipid concentrations we distributed eTFA into tertiles and dichotomized ePUFA at the median concentration. Results: For the 1st, 2nd and 3rd tertiles of eTFA, multivariate-adjusted means+/-s.e.m for HDL were 46.2+/-1.1, 46.3+/-1.1 and 45.5+/-1.0 mg/dL among those with low ePUFA, respectively, while they were 50.0+/-1.1, 46.9+/-1.1 and 44.7+/-1.1 mg/dL among those with high ePUFA, respectively (P for interaction = 0.01). For the 1st, 2nd and 3rd tertiles of eTFA, multivariate-adjusted means+/-s.e.m for triglycerides were 178.6+/-11.3, 144.7+/-10.9 and 140.8+/-10.6, respectively, among those with low ePUFA, while they were 133.8+/-11.3, 145.7+/-10.9 and 149.3+/-11.5, respectively, among those with high ePUFA (P for interaction = 0.005). Results for VLDL were similar to those for triglycerides. No significant interactions were observed for LDL or total cholesterol. Conclusions: The relation between trans fat and HDL, VLDL and triglycerides may depend on PUFA. The benefit of avoiding trans fat may be greater among individuals with higher PUFA intake. Supplementation with PUFA among individuals with relatively high trans fat intake may have limited benefits on lipid profiles.	[Kabagambe, Edmond K.; Arnett, Donna K.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Kabagambe, Edmond K.; Arnett, Donna K.] Univ Alabama Birmingham, Sch Publ Hlth, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Hopkins, Paul N.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Tufts University; United States Department of Agriculture (USDA); Utah System of Higher Education; University of Utah; University of Minnesota System; University of Minnesota Twin Cities	Kabagambe, EK (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	edmond.kabagambe@vanderbilt.edu	; Ordovas, Jose/B-8727-2013	Tsai, Michael/0000-0001-7553-3408; Kabagambe, Edmond/0000-0002-8993-3186; Ordovas, Jose/0000-0002-7581-5680	National Heart, Lung, and Blood Institute [U01HL072524]; American Heart Association grant NSDG [0635323N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072524] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association grant NSDG; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Heart, Lung, and Blood Institute grant no. U01HL072524. EKK is supported by the American Heart Association grant NSDG # 0635323N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY M, 1994, ATHEROSCLEROSIS, V106, P99, DOI 10.1016/0021-9150(94)90086-8; Baylin A, 2003, J NUTR, V133, P1186, DOI 10.1093/jn/133.4.1186; Borba EF, 2006, CLIN DEV IMMUNOL, V13, P203, DOI 10.1080/17402520600876945; Cao J, 2006, CLIN CHEM, V52, P2265, DOI 10.1373/clinchem.2006.072322; Corella D, 2007, CLIN CHEM, V53, P1144, DOI 10.1373/clinchem.2006.084863; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; Kabagambe E, 2010, J HOPKINS U TXB DYSL, P238; Kabagambe EK, 2008, CLIN CHEM, V54, P154, DOI 10.1373/clinchem.2007.095059; Kabagambe EK, 2009, ATHEROSCLEROSIS, V203, P633, DOI 10.1016/j.atherosclerosis.2008.08.005; Kabagambe EK, 2003, EUR J CLIN NUTR, V57, P1447, DOI 10.1038/sj.ejcn.1601709; Khan S, 2002, J LIPID RES, V43, P979; KrisEtherton PM, 1997, AM J CLIN NUTR, V65, P1628, DOI 10.1093/ajcn/65.5.1628S; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2004, AM J CLIN NUTR, V79, P606, DOI 10.1093/ajcn/79.4.606; NCI, 2007, DIET HIST QUEST VERS; Noel SE, 2010, J NUTR, V140, P1846, DOI 10.3945/jn.110.124297; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; Saravanan N, 2005, EUR J ENDOCRINOL, V153, P159, DOI 10.1530/eje.1.01946; Shen J, 2007, J NUTR, V137, P1846, DOI 10.1093/jn/137.8.1846; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Tholstrup T, 2006, AM J CLIN NUTR, V83, P237; Tholstrup T, 2003, EUR J CLIN NUTR, V57, P735, DOI 10.1038/sj.ejcn.1601605; Thompson FE, 2002, J AM DIET ASSOC, V102, P212, DOI 10.1016/S0002-8223(02)90050-7; Tsai MY, 2005, J LAB CLIN MED, V145, P323, DOI 10.1016/j.lab.2005.03.009; Warensjo E, 2006, AM J CLIN NUTR, V84, P442; Williams CM, 1998, ATHEROSCLEROSIS, V141, pS87, DOI 10.1016/S0021-9150(98)00224-X	27	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47430	10.1371/journal.pone.0047430	http://dx.doi.org/10.1371/journal.pone.0047430			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077615	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100111
J	Shi, WF; Zhu, CD; Zheng, WM; Zheng, W; Ling, C; Carr, MJ; Higgins, DG; Zhang, Z				Shi, Weifeng; Zhu, Chaodong; Zheng, Weimin; Zheng, Wei; Ling, Cheng; Carr, Michael J.; Higgins, Desmond G.; Zhang, Zhong			Subgenotyping of Genotype C Hepatitis B Virus: Correcting Misclassifications and Identifying a Novel Subgenotype	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CLINICAL-SIGNIFICANCE; MAXIMUM-LIKELIHOOD; INFECTION; DISEASE; PAPUA; CLASSIFICATION; RECOMBINANT; PHILIPPINES; MUTATIONS	Background: More than ten subgenotypes of genotype C Hepatitis B virus (HBV) have been reported, including C1 to C16 and two C/D recombinant subgenotypes (CD1 and CD2), however, inconsistent designations of these subgenotypes still exist. Methodology/Principal Findings: We performed a phylogenetic analysis of all full-length genotype C HBV genome sequences to correct the misclassifications of HBV subgenotypes and to study the influence of recombination on HBV subgenotyping. Our results showed that although inclusion of the recombinant sequences changed the topology of the phylogenetic tree, it did not affect the subgenotyping of the non-recombinant sequences, except subgenotype C2. In addition, most of the subgenotypes have been properly designated. However, several misclassifications of HBV subgenotypes have been identified and corrected. For example, C11 proposed by Utsumi and colleagues in 2011 was found to be grouped with C12 proposed by Mulyanto and colleagues. Two sequences, GQ358157 and GU721029, previously designated as C6 have been re-designated as C12 and C7, respectively. Moreover, a quasi-subgenotype C2 was proposed, which included the old C2, several previously unclassified sequences and previously designated C14. In particular, we identified a novel subgenotype, tentative C14, which was well supported by phylogenetic analysis and sequence divergence of >4%. Conclusions/Significance: A number of misclassifications in the subgenotyping of genotype C HBV have been identified in this study. After correcting the misclassifications, we proposed a better classification for the subgenotyping of genotype C HBV, in which a novel quasi-subgenotype C2 and a novel subgenotype, tentative C14, were described. Based on this large-scale analysis, we propose that a novel subgenotype should only be reported after a complete comparison of all relevant sequences rather than a few representative sequences only.	[Shi, Weifeng; Zheng, Weimin; Ling, Cheng] Chinese Acad Sci, Guangzhou Inst Adv Technol, Guangzhou, Guangdong, Peoples R China; [Zhu, Chaodong; Zheng, Wei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Zheng, Wei] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Zheng, Wei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Carr, Michael J.] Natl Univ Ireland Univ Coll Dublin, Natl Virus Reference Lab, Dublin 4, Ireland; [Higgins, Desmond G.] Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Zhang, Zhong] Taishan Med Coll, Dept Basic Med, Tai An, Shandong, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University College Dublin; University College Dublin; Shandong First Medical University & Shandong Academy of Medical Sciences	Shi, WF (corresponding author), Chinese Acad Sci, Guangzhou Inst Adv Technol, Guangzhou, Guangdong, Peoples R China.	wf.shi@giat.ac.cn; zh.tsmc@yahoo.com.cn	ZHU, Chao-Dong/E-5961-2011	ZHU, Chao-Dong/0000-0002-9347-3178; Carr, Michael/0000-0003-0011-6209; Higgins, Des/0000-0002-3952-3285	Science Foundation Ireland [07/IN.1/B1783]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This study was partly supported by Science Foundation Ireland (PI grant 07/IN.1/B1783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahn SH, 2009, INTERVIROLOGY, V52, P321, DOI 10.1159/000237739; Cao GW, 2009, WORLD J GASTROENTERO, V15, P5761, DOI 10.3748/wjg.15.5761; Cavinta L, 2009, J CLIN MICROBIOL, V47, P3068, DOI 10.1128/JCM.01079-09; Cavinta L, 2009, J MED VIROL, V81, P983, DOI 10.1002/jmv.21475; Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chu CJ, 2002, HEPATOLOGY, V35, P1274, DOI 10.1053/jhep.2002.33161; Cui CY, 2002, J GEN VIROL, V83, P2773, DOI 10.1099/0022-1317-83-11-2773; Elkady A, 2008, J GASTROEN HEPATOL, V23, P474, DOI 10.1111/j.1440-1746.2008.05321.x; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guettouche T, 2005, ANTIVIR THER, V10, P593; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Huy TTT, 2004, J GEN VIROL, V85, P283, DOI 10.1099/vir.0.19633-0; Juniastuti S, 2011, J MED VIROL, V83, P225, DOI 10.1002/jmv.21963; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Lusida MI, 2008, J CLIN MICROBIOL, V46, P2160, DOI 10.1128/JCM.01681-07; Miyakawa Y, 2003, INTERVIROLOGY, V46, P329, DOI 10.1159/000074988; Mulyanto, 2012, VIRUS RES, V163, P129, DOI 10.1016/j.virusres.2011.09.002; Mulyanto, 2011, J MED VIROL, V83, P54, DOI 10.1002/jmv.21931; Mulyanto, 2010, ARCH VIROL, V155, P705, DOI 10.1007/s00705-010-0628-x; Mulyanto, 2009, ARCH VIROL, V154, P1047, DOI 10.1007/s00705-009-0406-9; Ni YH, 2004, GASTROENTEROLOGY, V127, P1733, DOI 10.1053/j.gastro.2004.09.048; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Pourkarim MR, 2011, CLIN MICROBIOL INFEC, V17, P947, DOI 10.1111/j.1469-0691.2010.03374.x; Pourkarim MR, 2010, J CLIN VIROL, V47, P356, DOI 10.1016/j.jcv.2010.01.015; Pourkarim MR, 2010, J MED VIROL, V82, P379, DOI 10.1002/jmv.21726; Sakamoto T, 2007, J INFECT DIS, V196, P1487, DOI 10.1086/523111; Sakamoto T, 2006, J GEN VIROL, V87, P1873, DOI 10.1099/vir.0.81714-0; Schaefer S, 2005, J VIRAL HEPATITIS, V12, P111, DOI 10.1111/j.1365-2893.2005.00584.x; Schaefer S, 2009, INTERVIROLOGY, V52, P323, DOI 10.1159/000242353; Shi WF, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-116; Shi WF, 2012, VIROLOGY, V427, P51, DOI 10.1016/j.virol.2012.01.030; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A., 2006, P 20 IEEE INT PAR DI, P8, DOI DOI 10.1109/IPDPS.2006.1639535; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Sugauchi F, 2001, J GEN VIROL, V82, P883, DOI 10.1099/0022-1317-82-4-883; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Thedja MD, 2011, ARCH VIROL, V156, P855, DOI 10.1007/s00705-011-0926-y; Utsumi T, 2009, J CLIN MICROBIOL, V47, P1842, DOI 10.1128/JCM.02328-08; Wang Z, 2007, J VIRAL HEPATITIS, V14, P426, DOI 10.1111/j.1365-2893.2006.00813.x; Wang ZH, 2005, J GEN VIROL, V86, P985, DOI 10.1099/vir.0.80771-0; Yin JH, 2008, CARCINOGENESIS, V29, P1685, DOI 10.1093/carcin/bgm301; Zhou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018708	47	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47271	10.1371/journal.pone.0047271	http://dx.doi.org/10.1371/journal.pone.0047271			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077582	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100084
J	Takeuchi, E; Sato, Y; Miura, E; Yamaura, H; Yuzaki, M; Yanagihara, D				Takeuchi, Eri; Sato, Yamato; Miura, Eriko; Yamaura, Hiroshi; Yuzaki, Michisuke; Yanagihara, Dai			Characteristics of Gait Ataxia in delta 2 Glutamate Receptor Mutant Mice, ho15J	PLOS ONE			English	Article							LONG-TERM DEPRESSION; CEREBELLAR INTERMEDIATE CORTEX; MOTOR COORDINATION; SPINOCEREBELLAR ACTIVITY; TREADMILL LOCOMOTION; PURKINJE-CELLS; WALKING CATS; LURCHER; MOUSE; HINDLIMB	The cerebellum plays a fundamental, but as yet poorly understood, role in the control of locomotion. Recently, mice with gene mutations or knockouts have been used to investigate various aspects of cerebellar function with regard to locomotion. Although many of the mutant mice exhibit severe gait ataxia, kinematic analyses of limb movements have been performed in only a few cases. Here, we investigated locomotion in ho15J mice that have a mutation of the delta 2 glutamate receptor. The cerebellum of ho15J mice shows a severe reduction in the number of parallel fiber-Purkinje synapses compared with wild-type mice. Analysis of hindlimb kinematics during treadmill locomotion showed abnormal hindlimb movements characterized by excessive toe elevation during the swing phase, and by severe hyperflexion of the ankles in ho15J mice. The great trochanter heights in ho15J mice were lower than in wild-type mice throughout the step cycle. However, there were no significant differences in various temporal parameters between ho15J and wild-type mice. We suggest that dysfunction of the cerebellar neuronal circuits underlies the observed characteristic kinematic abnormality of hindlimb movements during locomotion of ho15J mice.	[Takeuchi, Eri; Sato, Yamato; Yamaura, Hiroshi; Yanagihara, Dai] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Miura, Eriko; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Yuzaki, Michisuke; Yanagihara, Dai] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan	University of Tokyo; Keio University; Japan Science & Technology Agency (JST)	Yanagihara, D (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	dai-y@idaten.c.u-tokyo.ac.jp	Yuzaki, Michisuke/K-5328-2013	Yuzaki, Michisuke/0000-0002-5750-3544	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding provided by Grants-in-Aid for Scientific Research (A) and (B) and Priority Areas "Emergence of Adaptive Motor Function through Interaction between Body, Brain and Environment" from The Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Akay T, 2006, J NEUROPHYSIOL, V96, P642, DOI 10.1152/jn.00174.2006; ARSHAVSKY YI, 1983, TRENDS NEUROSCI, V6, P417, DOI 10.1016/0166-2236(83)90191-1; BOSCO G, 1993, J NEUROPHYSIOL, V70, P863, DOI 10.1152/jn.1993.70.2.863; Bosco G, 1997, J NEUROPHYSIOL, V78, P1421, DOI 10.1152/jn.1997.78.3.1421; Bosco G, 1996, J NEUROPHYSIOL, V76, P715, DOI 10.1152/jn.1996.76.2.715; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; CADDY KWT, 1975, BRAIN RES, V91, P276, DOI 10.1016/0006-8993(75)90548-X; CADDY KWT, 1976, BRAIN RES, V111, P396, DOI 10.1016/0006-8993(76)90783-6; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Earhart GM, 2001, J NEUROPHYSIOL, V85, P759, DOI 10.1152/jn.2001.85.2.759; FORTIER PA, 1987, EXP BRAIN RES, V66, P271, DOI 10.1007/bf00243304; GRUNER JA, 1980, EXP BRAIN RES, V40, P361; GUASTAVINO JM, 1990, BRAIN RES, V523, P199, DOI 10.1016/0006-8993(90)91488-3; Hirai H, 2005, EMBO REP, V6, P90, DOI 10.1038/sj.embor.7400312; Hirai H, 2003, NAT NEUROSCI, V6, P869, DOI 10.1038/nn1086; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Ilg W, 2007, BRAIN, V130, P786, DOI 10.1093/brain/awl376; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kurihara H, 1997, J NEUROSCI, V17, P9613; Lalouette A, 2001, NEUROSCIENCE, V105, P443, DOI 10.1016/S0306-4522(01)00193-2; Le Marec N, 2000, NEUROBIOL LEARN MEM, V73, P195, DOI 10.1006/nlme.1999.3926; Leblond H, 2003, J NEUROSCI, V23, P11411; Miyata M, 2001, EUR J NEUROSCI, V13, P1945, DOI 10.1046/j.0953-816x.2001.01570.x; Morton SM, 2003, J NEUROPHYSIOL, V89, P1844, DOI 10.1152/jn.00787.2002; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Morton SM, 2007, CEREBELLUM, V6, P79, DOI 10.1080/14734220601187741; Motohashi J, 2007, BRAIN RES, V1140, P153, DOI 10.1016/j.brainres.2006.03.068; Orlovsky GN, 1999, NEURONAL CONTROL LOC, P215; Palliyath S, 1998, MOVEMENT DISORD, V13, P958, DOI 10.1002/mds.870130616; Pereira JE, 2006, BEHAV BRAIN RES, V172, P212, DOI 10.1016/j.bbr.2006.04.027; UDO M, 1980, J NEUROPHYSIOL, V44, P119, DOI 10.1152/jn.1980.44.1.119; UDO M, 1979, BRAIN RES, V160, P559, DOI 10.1016/0006-8993(79)91087-4; UDO M, 1979, BRAIN RES, V166, P405, DOI 10.1016/0006-8993(79)90228-2	35	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47553	10.1371/journal.pone.0047553	http://dx.doi.org/10.1371/journal.pone.0047553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077633	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100128
J	Nolasco, N; Juarez, C; Morgado, E; Meza, E; Caba, M				Nolasco, Nahum; Juarez, Claudia; Morgado, Elvira; Meza, Enrique; Caba, Mario			A Circadian Clock in the Olfactory Bulb Anticipates Feeding during Food Anticipatory Activity	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; MAMMARY PHEROMONE; RABBIT PUPS; METABOLIC RHYTHMS; VOMERONASAL ORGAN; LOCUS-COERULEUS; NEWBORN RABBITS; NATURAL MODEL; MALE-MICE; RATS	Rabbit pups ingest food, in this case milk, once a day with circadian periodicity and are a natural model of food anticipatory activity. During nursing, several sensory systems receive information about properties of the food, one of them being the olfactory system, which has received little attention in relation to synchronization by food. In addition, the olfactory bulb has a circadian pacemaker that exhibits rhythms independently of the suprachiasmatic nucleus, but the biological functions of these rhythms are largely unknown. In the present contribution, we hypothesized that circadian suckling of milk synchronizes rhythms in the olfactory bulb. To this aim we explored by immunohistochemistry, rhythms of FOS and PER1 proteins, as indicators of activation and reporter of oscillations, respectively, through a complete 24-h cycle in periglomerular, mitral and granular cell layers of both the main and the accessory olfactory bulb. Subjects were 7-day-old rabbit pups scheduled to nurse during the night (02:00 h) or day (10:00 h), and also fasted subjects, to explore the possible persistence of oscillations. In the three layers of the main olfactory bulb, FOS was high at time of nursing, then further increased 1.5 h afterward, and then decreased to increase again in advance of the next nursing bout. This pattern persisted, without the postprandial increase, in fasted subjects with a shift in subjects nursed at 02:00. PER1 was increased 2-8 h after nursing and this increase persisted in most cell layers, with a shift, in fasted subjects. In the accessory olfactory bulb we only observed a consistent pattern of FOS expression in the mitral cell layer of nursed subjects, similar to that of the main olfactory bulb. We conclude that the main olfactory bulb is synchronized during milk ingestion, but during fasting its oscillations perhaps are modulated by the suprachiasmatic nucleus, as proposed for rodents.	[Juarez, Claudia; Morgado, Elvira; Meza, Enrique; Caba, Mario] Univ Veracruzana, Ctr Invest Biomed, Xalapa 91000, Veracruz, Mexico; [Nolasco, Nahum] Univ Veracruzana, CIB, Xalapa 91000, Veracruz, Mexico	Universidad Veracruzana; Universidad Veracruzana	Caba, M (corresponding author), Univ Veracruzana, Ctr Invest Biomed, Xalapa 91000, Veracruz, Mexico.	mcaba@uv.mx	Caba, Mario/H-7850-2019; Juarez, Claudia/AAZ-5026-2020	Caba, Mario/0000-0001-7475-3441; Meza, Jose Enrique/0000-0001-5232-3926; Juarez Portilla, Claudia/0000-0003-2215-058X	National Institutes of Health (NIH)/Fogarty [R01TW006636]; FOGARTY INTERNATIONAL CENTER [R01TW006636] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/Fogarty; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was partially funded by Grant R01TW006636 from National Institutes of Health (NIH)/Fogarty (MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Amir S, 1999, NEUROSCI LETT, V272, P175, DOI 10.1016/S0304-3940(99)00609-6; Caba M, 2008, EUR J NEUROSCI, V27, P432, DOI 10.1111/j.1460-9568.2008.06017.x; Caba M, 2009, EUR J NEUROSCI, V30, P1697, DOI 10.1111/j.1460-9568.2009.06964.x; Challet E, 2010, CELL TISSUE RES, V341, P1, DOI 10.1007/s00441-010-1001-9; Charra R, 2012, BEHAV BRAIN RES, V226, P179, DOI 10.1016/j.bbr.2011.09.008; COLEMAN GJ, 1990, PHYSIOL BEHAV, V47, P1145, DOI 10.1016/0031-9384(90)90365-B; Coureaud G, 2004, CHEM SENSES, V29, P341, DOI 10.1093/chemse/bjh037; Coureaud G, 2010, J COMP PHYSIOL A, V196, P779, DOI 10.1007/s00359-010-0548-y; Davidson AJ, 2001, PHYSIOL BEHAV, V72, P231, DOI 10.1016/S0031-9384(00)00417-0; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; DISTEL H, 1985, J COMP PHYSIOL A, V157, P599, DOI 10.1007/BF01351354; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Funk D, 2000, BRAIN RES, V866, P262, DOI 10.1016/S0006-8993(00)02249-6; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Granados-Fuentes D, 2011, J BIOL RHYTHM, V26, P552, DOI 10.1177/0748730411420247; Hamada T, 2011, BIOCHEM BIOPH RES CO, V409, P727, DOI 10.1016/j.bbrc.2011.05.076; HUDSON R, 1986, PHYSIOL BEHAV, V37, P123, DOI 10.1016/0031-9384(86)90394-X; Juarez C, 2012, EUR J NEUROSCI, V35, P1458, DOI 10.1111/j.1460-9568.2012.08051.x; Landry GJ, 2007, BRAIN RES, V1141, P108, DOI 10.1016/j.brainres.2007.01.032; Landry GJ, 2007, J BIOL RHYTHM, V22, P467, DOI 10.1177/0748730407307804; Landry GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024187; LEGORATTISANCHEZ MO, 1989, BRAIN RES BULL, V23, P283, DOI 10.1016/0361-9230(89)90210-4; Minana-Solis MC, 2009, CHRONOBIOL INT, V26, P808, DOI 10.1080/07420520903044240; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 1999, BRAIN RES, V842, P73, DOI 10.1016/S0006-8993(99)01836-3; MISTLBERGER RE, 1984, PHYSIOL BEHAV, V33, P227, DOI 10.1016/0031-9384(84)90104-5; MISTLBERGER RE, 1988, J BIOL RHYTHM, V3, P277, DOI 10.1177/074873048800300306; Montigny D, 2006, PHYSIOL BEHAV, V89, P742, DOI 10.1016/j.physbeh.2006.08.022; Montufar-Chaveznava R, 2012, NEUROSCIENCE, V207, P198, DOI 10.1016/j.neuroscience.2012.01.025; Morgado E, 2008, AM J PHYSIOL-REG I, V295, pR690, DOI 10.1152/ajpregu.00162.2008; Morgado E, 2011, EUR J NEUROSCI, V34, P1807, DOI 10.1111/j.1460-9568.2011.07898.x; Morgado E, 2010, HORM BEHAV, V58, P465, DOI 10.1016/j.yhbeh.2010.05.003; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; Rieux C, 2002, J BIOL RHYTHM, V17, P121, DOI 10.1177/074873002129002410; Sheck W.H., 1986, ATLAS RABBIT BRAIN S; SHIPLEY MT, 1985, BRAIN RES, V329, P294, DOI 10.1016/0006-8993(85)90537-2; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006	44	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47779	10.1371/journal.pone.0047779	http://dx.doi.org/10.1371/journal.pone.0047779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094084	gold, Green Published, Green Submitted			2022-12-27	WOS:000310050200044
J	Yang, SG; Wang, B; Chen, P; Yu, CB; Deng, M; Yao, J; Zhu, CX; Ren, JJ; Wu, W; Ju, B; Shen, JF; Chen, Y; Li, MD; Ruan, B; Li, LJ				Yang, Shi-gui; Wang, Bing; Chen, Ping; Yu, Cheng-bo; Deng, Min; Yao, Jun; Zhu, Chun-xia; Ren, Jing-jing; Wu, Wei; Ju, Bin; Shen, Jian-feng; Chen, Yu; Li, Ming D.; Ruan, Bing; Li, Lanjuan			Effectiveness of HBV Vaccination in Infants and Prediction of HBV Prevalence Trend under New Vaccination Plan: Findings of a Large-Scale Investigation	PLOS ONE			English	Article							B-VIRUS-INFECTION; HEPATITIS-B; TAIWAN; HIV-1	Background: Hepatitis B virus (HBV) infection remains a severe public health problem. Investigating its prevalence and trends is essential to prevention. Methods: To evaluate the effectiveness of HBV vaccination under the 1992 Intervention Program for infants and predicted HBV prevalence trends under the 2011 Program for all ages. We conducted a community-based investigation of 761,544 residents of 12 counties in Zhejiang Province selected according to their location, population density, and economic development. The HBV prevalence trends were predicted by a time-shifting approach. HBV surface antigen (HBsAg) and alanine amino transferase (ALT) were determined. Results: Of the 761,544 persons screened for HBsAg, 54,132 were positive (adjusted carrier rate 6.13%); 9,455 had both elevated ALT and a positive HBsAg test (standardized rate 1.18%). The standardized HBsAg carrier rate for persons aged <= 20 years was 1.51%. Key factors influencing HBV infection were sex, age, family history, drinking, smoking, employment as a migrant worker, and occupation. With the vaccination program implemented in 2011, we predict that by 2020, the HBsAg carrier rate will be 5.27% and that for individuals aged <= 34 years will reach the 2% upper limit of low prevalence according to the WHO criteria, with a standardized rate of 1.86%. Conclusions: The national HBV vaccination program for infants implemented in 1992 has greatly reduced the prevalence of HBV infection. The 2011 program is likely to reduce HBV infection in Zhejiang Province to a low moderate prevalence, and perinatal transmission is expected to be controlled by 2020.	[Yang, Shi-gui; Wang, Bing; Chen, Ping; Yu, Cheng-bo; Deng, Min; Zhu, Chun-xia; Ren, Jing-jing; Wu, Wei; Chen, Yu; Li, Ming D.; Ruan, Bing; Li, Lanjuan] Zhejiang Univ, Affiliated Hosp 1, Key Lab Infect Dis,Sch Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Yao, Jun] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Ju, Bin; Shen, Jian-feng] Zhejiang Prov Hlth Bur Ctr Informat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Provincial Center for Disease Control & Prevention	Li, MD (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Key Lab Infect Dis,Sch Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China.	ml2km@zju.edu.cn; hzruanbing@163.com; ljli@zju.edu.cn	Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019		Mega-Project for National Science and Technology Development under the "11th and 12th Five-Year Plan of China" [2009ZX10004-901, 2011ZX10004-901]; National Science and Technology Support Program of "11th Five-Year Plan" [2008BAH27B00]; National Natural Science Foundation of China [81001271]	Mega-Project for National Science and Technology Development under the "11th and 12th Five-Year Plan of China"; National Science and Technology Support Program of "11th Five-Year Plan"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by grants from the Mega-Project for National Science and Technology Development under the "11th and 12th Five-Year Plan of China" (2009ZX10004-901, 2011ZX10004-901), the National Science and Technology Support Program of "11th Five-Year Plan" (2008BAH27B00), and the National Natural Science Foundation of China (81001271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley RP, 2009, JAMA-J AM MED ASSOC, V302, P322, DOI 10.1001/jama.2009.1024; Chen HL, 1996, JAMA-J AM MED ASSOC, V276, P906, DOI 10.1001/jama.276.11.906; Chen YS, 2007, CHIN J EXP CLIN INFE, V1, P5; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Edmunds WJ, 1996, EPIDEMIOL INFECT, V117, P313, DOI 10.1017/S0950268800001497; Hampton T, 2008, JAMA-J AM MED ASSOC, V300, P2108, DOI 10.1001/jama.2008.573; KANE M, 1995, VACCINE, V13, pS47; Kuehn BM, 2010, JAMA-J AM MED ASSOC, V303, P713, DOI 10.1001/jama.2010.161; Lacerda R, 1997, AIDS, V11, pS15; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Launay O, 2011, JAMA-J AM MED ASSOC, V305, P1432, DOI 10.1001/jama.2011.351; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Mogensen TH, 2004, J VIROL, V78, P5883, DOI 10.1128/JVI.78.11.5883-5890.2004; Muthumani K, 2004, DNA CELL BIOL, V23, P239, DOI 10.1089/104454904773819824; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Razani-Boroujerdi S, 2004, CELL IMMUNOL, V230, P1, DOI 10.1016/j.cellimm.2004.07.007; Statistics ZPBo, 2011, MAIN DAT B 6 NAT CEN; Torpy Janet M, 2011, JAMA, V305, P1500, DOI 10.1001/jama.305.14.1500; Wittet S, 2001, HEPATITIS B VACCINE; World Health Organization, 2008, HEP B; Wu Gui-Ying, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P474; Xia GLL, 1996, INT HEPATOL COMMUN, V5, P12; Xu XQ, 2007, DIS SURVEILLANCE, V22, P3; Yang DB, 2004, S CHINA POPULATION, V19, P5; Yao J, 1997, DIS SURVEILLANCE, V12, P3; Yao J, 2000, CHINESE J VACCINES I, V6, P4; Yuen MF, 2003, ANTIVIR THER, V8, P531; Zhejiang CDC, 2007, PLAN IMPL SUPPL IMM	32	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47808	10.1371/journal.pone.0047808	http://dx.doi.org/10.1371/journal.pone.0047808			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094094	gold, Green Submitted, Green Published			2022-12-27	WOS:000310050200049
J	Jacques-Fricke, BT; Roffers-Agarwal, J; Gammill, LS				Jacques-Fricke, Bridget T.; Roffers-Agarwal, Julaine; Gammill, Laura S.			DNA Methyltransferase 3b Is Dispensable for Mouse Neural Crest Development	PLOS ONE			English	Article							DNMT3B; METHYLATION; TRANSITION; EXPRESSION; CELLS; GENERATION; FATE	The neural crest is a population of multipotent cells that migrates extensively throughout vertebrate embryos to form diverse structures. Mice mutant for the de novo DNA methyltransferase DNMT3b exhibit defects in two neural crest derivatives, the craniofacial skeleton and cardiac ventricular septum, suggesting that DNMT3b activity is necessary for neural crest development. Nevertheless, the requirement for DNMT3b specifically in neural crest cells, as opposed to interacting cell types, has not been determined. Using a conditional DNMT3b allele crossed to the neural crest cre drivers Wnt1-cre and Sox10-cre, neural crest DNMT3b mutants were generated. In both neural crest-specific and fully DNMT3b-mutant embryos, cranial neural crest cells exhibited only subtle migration defects, with increased numbers of dispersed cells trailing organized streams in the head. In spite of this, the resulting cranial ganglia, craniofacial skeleton, and heart developed normally when neural crest cells lacked DNMT3b. This indicates that DNTM3b is not necessary in cranial neural crest cells for their development. We conclude that defects in neural crest derivatives in DNMT3b mutant mice reflect a requirement for DNMT3b in lineages such as the branchial arch mesendoderm or the cardiac mesoderm that interact with neural crest cells during formation of these structures.	[Jacques-Fricke, Bridget T.; Roffers-Agarwal, Julaine; Gammill, Laura S.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Gammill, LS (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	gammi001@umn.edu	Gammill, Laura/GXH-9992-2022	Gammill, Laura/0000-0003-3914-5269; Roffers-Agarwal, Julaine/0000-0003-2730-7013	American Cancer Society [IRG-58-001-49-IRG32]; National Institutes of Health Individual Ruth L. Kirschstein National Research Service [F32 DE021651, F32 DE019973]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F32DE021651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F32DE019973] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health Individual Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by American Cancer Society grant #IRG-58-001-49-IRG32 (LSG), and National Institutes of Health Individual Ruth L. Kirschstein National Research Service Awards F32 DE021651 (BJF) and F32 DE019973 (JRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MS, 2008, DEV DYNAM, V237, P1021, DOI 10.1002/dvdy.21513; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012; Cedar H., 2009, EPIGENETIC SILENCING; Chai Y, 2000, DEVELOPMENT, V127, P1671; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Ehrlich M, 2003, CLIN IMMUNOL, V109, P17, DOI 10.1016/S1521-6616(03)00201-8; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gammill LS, 2006, DEVELOPMENT, V133, P99, DOI 10.1242/dev.02187; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Hari L, 2012, DEVELOPMENT, V139, P2107, DOI 10.1242/dev.073064; Hirasawa R, 2009, GENE EXPR PATTERNS, V9, P27, DOI 10.1016/j.gep.2008.09.002; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Katayama KI, 2011, P NATL ACAD SCI USA, V108, P7607, DOI 10.1073/pnas.1101347108; Kaufmann MH, 1992, ATLAS MOUSE DEV; KIRBY ML, 1985, ANAT RECORD, V213, P87, DOI 10.1002/ar.1092130112; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Le Douarin NM, 1999, NEURAL CREST, V2; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martins-Taylor K, 2012, EPIGENETICS-US, V7, P71, DOI 10.4161/epi.7.1.18750; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mouse Genome Informatics Group, 2003, MGI CDNA CLON LOAD; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rai K, 2010, J BIOL CHEM, V285, P4110, DOI 10.1074/jbc.M109.073676; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Roffers-Agarwal J, 2009, DEVELOPMENT, V136, P1879, DOI 10.1242/dev.032920; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Shafiei F, 2008, ONCOGENE, V27, P2602, DOI 10.1038/sj.onc.1210917; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strobl-Mazzulla PH, 2010, DEV CELL, V19, P460, DOI 10.1016/j.devcel.2010.08.009; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Watanabe D, 2006, NEUROSCIENCE, V142, P727, DOI 10.1016/j.neuroscience.2006.07.053	42	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47794	10.1371/journal.pone.0047794	http://dx.doi.org/10.1371/journal.pone.0047794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094090	Green Published, gold, Green Submitted			2022-12-27	WOS:000312384500025
J	Mackenzie, SM; Raible, DW				Mackenzie, Scott M.; Raible, David W.			Proliferative Regeneration of Zebrafish Lateral Line Hair Cells after Different Ototoxic Insults	PLOS ONE			English	Article							INNER-EAR; SUPPORTING CELL; SENSORY EPITHELIA; DIRECT TRANSDIFFERENTIATION; PROSENSORY PATCHES; LASER-ABLATION; NOTCH ACTIVITY; DEATH; NEUROMASTS; EXPRESSION	Sensory hair cells in the zebrafish lateral line regenerate rapidly and completely after damage. Previous studies have used a variety of ototoxins to kill lateral line hair cells to study different phenomena including mechanisms of hair cell death and regeneration. We sought to directly compare these ototoxins to determine if they differentially affected the rate and amount of hair cell replacement. In addition, previous studies have found evidence of proliferative hair cell regeneration in zebrafish, but both proliferation and non-mitotic direct transdifferentiation have been observed during hair cell regeneration in the sensory epithelia of birds and amphibians. We sought to test whether a similar combination of regenerative mechanisms exist in the fish. We analyzed the time course of regeneration after treatment with different ototoxic compounds and also labeled dividing hair cell progenitors. Certain treatments, including cisplatin and higher concentrations of dissolved copper, significantly delayed regeneration by one or more days. However, cisplatin did not block all regeneration as observed previously in the chick basilar papilla. The particular ototoxin did not appear to affect the mechanism of regeneration, as we observed evidence of recent proliferation in the majority of new hair cells in all cases. Inhibiting proliferation with flubendazole blocked the production of new hair cells and prevented the accumulation of additional precursors, indicating that proliferation has a dominant role during regeneration of lateral line hair cells.	[Mackenzie, Scott M.; Raible, David W.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Mackenzie, Scott M.; Raible, David W.] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Raible, DW (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	draible@uw.edu		Raible, David/0000-0002-5342-5841	National Institutes of Health [R01DC011269]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Institutes of Health grant R01DC011269. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HJ, 1997, INT J DEV NEUROSCI, V15, P375, DOI 10.1016/S0736-5748(96)00098-6; Adler HJ, 1996, NEUROSCI LETT, V205, P17, DOI 10.1016/0304-3940(96)12367-3; Baird RA, 1996, ANN NY ACAD SCI, V781, P59, DOI 10.1111/j.1749-6632.1996.tb15693.x; BAIRD RA, 1993, HEARING RES, V65, P164, DOI 10.1016/0378-5955(93)90211-I; Baird RA, 2000, P NATL ACAD SCI USA, V97, P11722, DOI 10.1073/pnas.97.22.11722; BALAK KJ, 1990, J NEUROSCI, V10, P2502; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham-McDonogh O, 2003, CURR OPIN NEUROBIOL, V13, P119, DOI 10.1016/S0959-4388(03)00018-7; Brignull HR, 2009, BRAIN RES, V1277, P12, DOI 10.1016/j.brainres.2009.02.028; Burns JC, 2012, J NEUROSCI, V32, P6570, DOI 10.1523/JNEUROSCI.6274-11.2012; Cafaro J, 2007, DEV DYNAM, V236, P156, DOI 10.1002/dvdy.21023; Coffin AB, 2009, HEARING RES, V253, P42, DOI 10.1016/j.heares.2009.03.004; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Forge A, 1998, J COMP NEUROL, V397, P69; Giari L, 2012, J APPL TOXICOL, V32, P293, DOI 10.1002/jat.1691; Go W, 2010, CELL CALCIUM, V48, P302, DOI 10.1016/j.ceca.2010.09.012; Hallam R, 2006, INT J AUDIOL, V45, P715, DOI 10.1080/14992020600957335; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107; Hernandez PP, 2007, DEV NEUROBIOL, V67, P637, DOI 10.1002/dneu.20386; Hernandez PP, 2006, HEARING RES, V213, P1, DOI 10.1016/j.heares.2005.10.015; Itoh M, 2001, MECH DEVELOP, V102, P263, DOI 10.1016/S0925-4773(01)00308-2; Jones JE, 1996, J NEUROSCI, V16, P649; Jorgenson J A, 1991, Hosp Pharm, V26, P609; Jorgenson JA, 1991, HOSP PHARM, V26, P615; Jorgenson JA, 1991, HOSP PHARM, V26, P609; Li L, 1997, INT J DEV NEUROSCI, V15, P433, DOI 10.1016/S0736-5748(96)00102-5; Lin V, 2011, J NEUROSCI, V31, P15329, DOI 10.1523/JNEUROSCI.2057-11.2011; Linbo TL, 2006, ENVIRON TOXICOL CHEM, V25, P597, DOI 10.1897/05-241R.1; LOMBARTE A, 1993, HEARING RES, V64, P166, DOI 10.1016/0378-5955(93)90002-I; Lopez-Schier H, 2006, P NATL ACAD SCI USA, V103, P18615, DOI 10.1073/pnas.0608536103; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; Matsuda M, 2010, DEVELOPMENT, V137, P3477, DOI 10.1242/dev.052761; Matsui JI, 2002, J NEUROSCI, V22, P1218, DOI 10.1523/JNEUROSCI.22-04-01218.2002; Millimaki BB, 2010, DEV BIOL, V338, P262, DOI 10.1016/j.ydbio.2009.12.011; Mizoguchi T, 2011, J NEUROSCI, V31, P15522, DOI 10.1523/JNEUROSCI.3948-11.2011; Namdaran P, 2012, J NEUROSCI, V32, P3516, DOI 10.1523/JNEUROSCI.3905-11.2012; Nayak GD, 2007, INT J DEV BIOL, V51, P597, DOI 10.1387/ijdb.072392gn; Nicolson T, 2005, ANNU REV GENET, V39, P9, DOI 10.1146/annurev.genet.39.073003.105049; Olivari FA, 2008, BRAIN RES, V1244, P1, DOI 10.1016/j.brainres.2008.09.050; Ou HC, 2007, HEARING RES, V233, P46, DOI 10.1016/j.heares.2007.07.003; Owens KN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000020; Owens KN, 2009, HEARING RES, V253, P32, DOI 10.1016/j.heares.2009.03.001; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Roberson DW, 1996, AUDIT NEUROSCI, V2, P195; Roberson DW, 2004, J NEUROSCI RES, V78, P461, DOI 10.1002/jnr.20271; ROBERSON DW, 1994, AM J OTOL, V15, P28; RUBEL EW, 1995, SCIENCE, V267, P701, DOI 10.1126/science.7839150; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Seiler C, 1999, J NEUROBIOL, V41, P424, DOI 10.1002/(SICI)1097-4695(19991115)41:3<424::AID-NEU10>3.0.CO;2-G; Slattery EL, 2010, J NEUROSCI, V30, P3473, DOI 10.1523/JNEUROSCI.4316-09.2010; Smith ME, 2006, J EXP BIOL, V209, P4193, DOI 10.1242/jeb.02490; Song JK, 1995, HEARING RES, V91, P63, DOI 10.1016/0378-5955(95)00170-0; Spagnuolo PA, 2010, BLOOD, V115, P4824, DOI 10.1182/blood-2009-09-243055; Stone JS, 2000, J COMP NEUROL, V417, P1, DOI 10.1002/(SICI)1096-9861(20000131)417:1<1::AID-CNE1>3.0.CO;2-E; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Taylor RR, 2005, J COMP NEUROL, V484, P105, DOI 10.1002/cne.20450; Ton C, 2005, HEARING RES, V208, P79, DOI 10.1016/j.heares.2005.05.005; Warchol ME, 1996, J NEUROSCI, V16, P5466; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Wibowo I, 2011, DEVELOPMENT, V138, P1143, DOI 10.1242/dev.060566; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3	66	38	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47257	10.1371/journal.pone.0047257	http://dx.doi.org/10.1371/journal.pone.0047257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094043	Green Published, Green Submitted, gold			2022-12-27	WOS:000312384500008
J	Wang, Y; Lane, A; Ding, P				Wang, Yu; Lane, Amanda; Ding, Ping			Sex-Biased Dispersal of a Frog (Odorrana schmackeri) Is Affected by Patch Isolation and Resource Limitation in a Fragmented Landscape	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC-EVIDENCE; PHILOPATRY; SCALE; SALAMANDER; EVOLUTION; SOFTWARE; BIRDS; FLOW	Sex-biased dispersal is widespread in the animal kingdom and is affected by numerous factors including mating system, social factors and environmental conditions. Unlike birds and mammals, there is no common trend in amphibians and explaining the direction and degree of sex-biased dispersal in species-specific cases is difficult. We conducted a study on dispersal of the Chinese piebald odorous frog (Odorrana schmackeri) in a fragmented landscape associated with dam construction. Ten microsatellite loci were used to analyze 382 samples sourced from 14 fragmented 'islands'. Assignment tests indicated a significant pattern of female-biased dispersal on one island with inconsistencies in the strength and direction of this pattern between nearby islands. The effects of four island attributes and two potential impact factors on the pattern of sex-biased dispersal were examined. We found that the extent of isolation from the mainland and the number of breeding sites both showed a negative correlation with female biased dispersal, such that the closer an island is to the mainland the more likely it is to display female biased dispersal, and the more breeding sites on an island the more male immigrants. Based on these results, we conclude that geographic isolation and limited breeding resources are the most likely explanation for the patterns of dispersal observed in this fragmented population of amphibians.	[Wang, Yu; Ding, Ping] Zhejiang Univ, Coll Life Sci, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China; [Lane, Amanda] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	Zhejiang University; University of Sydney	Ding, P (corresponding author), Zhejiang Univ, Coll Life Sci, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China.	dingping@zju.edu.cn	Ding, Ping/H-1817-2015		National Natural Science Foundation of China [30870315, 31100394]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (nos. 30870315, 31100394) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolin Michael F., 1993, Oxford Surveys in Evolutionary Biology, V9, P239; Austin JD, 2003, MOL ECOL, V12, P3165, DOI 10.1046/j.1365-294X.2003.01948.x; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Benjamini Y, 2001, ANN STAT, V29, P1165; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cabe PR, 2007, HEREDITY, V98, P53, DOI 10.1038/sj.hdy.6800905; Cano JM, 2008, MOL ECOL, V17, P3234, DOI 10.1111/j.1365-294X.2008.03837.x; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Fei L., 2009, FAUNA SINICA AMPHIBI, V3; Freeland J. R., 2011, MOL ECOLOGY; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Gauffre B, 2009, P R SOC B, V276, P3487, DOI 10.1098/rspb.2009.0881; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; HOWARD RD, 1983, AM NAT, V122, P301, DOI 10.1086/284137; Hu G, 2011, LANDSCAPE ECOL, V26, P1405, DOI 10.1007/s10980-011-9662-7; Knopp T, 2009, MOL ECOL, V18, P2996, DOI 10.1111/j.1365-294X.2009.04252.x; Lampert KP, 2003, MOL ECOL, V12, P3325, DOI 10.1046/j.1365-294X.2003.02016.x; Lane A, 2011, MOL ECOL, V20, P1870, DOI 10.1111/j.1365-294X.2011.05059.x; LAURANCE WF, 1991, BIOL CONSERV, V55, P77, DOI 10.1016/0006-3207(91)90006-U; Liebgold EB, 2011, MOL ECOL, V20, P249, DOI 10.1111/j.1365-294X.2010.04946.x; Macke E, 2011, SCIENCE, V334, P1127, DOI 10.1126/science.1212177; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Monsen KJ, 2003, MOL ECOL, V12, P3275, DOI 10.1046/j.1365-294X.2003.02001.x; Mossman CA, 1999, MOL ECOL, V8, P1063, DOI 10.1046/j.1365-294x.1999.00652.x; Neter J., 1996, APPL LINEAR STAT MOD; Nichols J., 2001, DISPERSAL; Nicolaus M, 2012, J ANIM ECOL, V81, P827, DOI 10.1111/j.1365-2656.2012.01959.x; Palo JU, 2004, MOL ECOL, V13, P2865, DOI 10.1111/j.1365-294X.2004.02286.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; R Development Core Team, 2012, R LANG ENV STAT COMP; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sheridan CM, 2010, MOL ECOL, V19, P5497, DOI 10.1111/j.1365-294X.2010.04876.x; Smith MA, 2006, ECOGRAPHY, V29, P649, DOI 10.1111/j.2006.0906-7590.04584.x; Trenham PC, 2005, ECOL APPL, V15, P1158, DOI 10.1890/04-1150; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vieites DR, 2006, MOL ECOL, V15, P1617, DOI 10.1111/j.1365-294X.2006.02874.x; Wang Y, 2009, ANIM CONSERV, V12, P329, DOI 10.1111/j.1469-1795.2009.00257.x; Wang Y, 2009, J ZHEJIANG NORMAL U, V32, P322; Wang Y, 2011, J GENET, V90, pE44; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wu JG, 2003, SCIENCE, V300, P1239, DOI 10.1126/science.1083312	49	17	17	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47683	10.1371/journal.pone.0047683	http://dx.doi.org/10.1371/journal.pone.0047683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094076	Green Submitted, Green Published, gold			2022-12-27	WOS:000312384500019
J	Zhang, MS; Jiao, YM; Wang, SX; Zhang, L; Huang, ZH; Chen, YX; Wu, H; Lu, S				Zhang, Mingshun; Jiao, Yanmei; Wang, Shixia; Zhang, Lu; Huang, Zuhu; Chen, Yuxin; Wu, Hao; Lu, Shan			Serum Neutralizing Activities from a Beijing Homosexual Male Cohort Infected with Different Subtypes of HIV-1 in China	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENV MOLECULAR CLONES; RATIONAL DESIGN; ANTIBODIES; BROAD; CLADES; PANEL	Protective antibodies play a critical role in an effective HIV vaccine; however, eliciting antibodies to block infection by viruses from diverse genetic subtypes remains a major challenge. As the world's most populous country, China has been under the threat of at least three major subtypes of circulating HIV-1 viruses. Understanding the cross reactivity and specificities of serum antibody responses that mediate broad neutralization of the virus in HIV-1 infected Chinese patients will provide valuable information for the design of vaccines to prevent HIV-1 transmission in China. Sera from a cohort of homosexual men, who have been managed by a major HIV clinical center in Beijing, China, were analyzed for cross-sectional neutralizing activities against pseudotyped viruses expressing Env antigens of the major subtype viruses (AE, BC and B subtypes) circulating in China. Neutralizing activities in infected patients' blood were most capable of neutralizing viruses in the homologous subtype; however, a subset of blood samples was able to achieve broad neutralizing activities across different subtypes. Such cross neutralizing activity took 1-2 years to develop and CD4 binding site antibodies were critical components in these blood samples. Our study confirmed the presence of broadly neutralizing sera in China's HIV-1 patient population. Understanding the specificity and breadth of these neutralizing activities can guide efforts for the development of HIV vaccines against major HIV-1 viruses in China.	[Zhang, Mingshun; Zhang, Lu; Huang, Zuhu; Lu, Shan] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Key Lab Infect Dis, Nanjing, Jiangsu, Peoples R China; [Zhang, Lu; Huang, Zuhu] Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Zhang, Mingshun; Wang, Shixia; Zhang, Lu; Huang, Zuhu; Lu, Shan] Nanjing Med Univ, Affiliated Hosp 1, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China; [Zhang, Mingshun] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Jiao, Yanmei; Wu, Hao] Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Wang, Shixia; Chen, Yuxin; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Capital Medical University; University of Massachusetts System; University of Massachusetts Worcester	Lu, S (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Key Lab Infect Dis, Nanjing, Jiangsu, Peoples R China.	shan.lu@umassmed.edu	Chen, Yuxin/AFR-3812-2022	Chen, Yuxin/0000-0001-5955-687X	China's National 11-5 Major Infectious Disease Program [2008ZX10001-006, 2008ZX10001-010]; Jiangsu Province Key Laboratory in Infectious Diseases; US NIH/NIAID [R01 AI65250, P01 AI AI082274, U19AI082676]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI082274] Funding Source: NIH RePORTER	China's National 11-5 Major Infectious Disease Program; Jiangsu Province Key Laboratory in Infectious Diseases; US NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by China's National 11-5 Major Infectious Disease Program (2008ZX10001-006 and 2008ZX10001-010), support from Jiangsu Province Key Laboratory in Infectious Diseases and US NIH/NIAID grants R01 AI65250, P01 AI AI082274, and U19AI082676. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bures R, 2002, J VIROL, V76, P2233, DOI 10.1128/JVI.76.5.2233-2244.2002; Chong HH, 2008, JAIDS-J ACQ IMM DEF, V47, P535, DOI 10.1097/QAI.0b013e3181663967; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; Gray RT, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/891593; Han XX, 2010, JAIDS-J ACQ IMM DEF, V53, pS27, DOI 10.1097/QAI.0b013e3181c7d5bf; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Jiao YM, 2010, CURR HIV RES, V8, P515, DOI 10.2174/157016210793499169; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Mascola JR, 1996, AIDS RES HUM RETROV, V12, P1319, DOI 10.1089/aid.1996.12.1319; Ministry of Health of the People's Republic of China, 2010, CHIN 2010 UNGASS COU; MONTEFIORI DC, 2004, CURRENT PROTOCOLS IM, P1; Moore JP, 1996, J VIROL, V70, P427, DOI 10.1128/JVI.70.1.427-444.1996; Nie JH, 2010, JAIDS-J ACQ IMM DEF, V53, P440, DOI 10.1097/QAI.0b013e3181cb8300; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Vaine M, 2008, J VIROL; Vaine M, 2010, VACCINE, V28, P2999, DOI 10.1016/j.vaccine.2010.02.006; van Gils MJ, 2010, CURR HIV RES, V8, P579, DOI 10.2174/157016210794088254; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang ST, 2011, VIRUS RES, V155, P137, DOI 10.1016/j.virusres.2010.09.012; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xu JJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-287; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443	29	1	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47548	10.1371/journal.pone.0047548	http://dx.doi.org/10.1371/journal.pone.0047548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094060	Green Published, gold			2022-12-27	WOS:000312384500014
J	Peletz, R; Simunyama, M; Sarenje, K; Baisley, K; Filteau, S; Kelly, P; Clasen, T				Peletz, Rachel; Simunyama, Martin; Sarenje, Kelvin; Baisley, Kathy; Filteau, Suzanne; Kelly, Paul; Clasen, Thomas			Assessing Water Filtration and Safe Storage in Households with Young Children of HIV-Positive Mothers: A Randomized, Controlled Trial in Zambia	PLOS ONE			English	Article							POINT-OF-USE; DRINKING-WATER; DEVELOPING-COUNTRIES; FLOCCULANT-DISINFECTANT; PREVENTING DIARRHEA; FEEDING PRACTICES; RURAL GUATEMALA; QUALITY; INTERVENTIONS; DISEASE	Background: Unsafe drinking water presents a particular threat to people living with HIV/AIDS (PLHIV) due to the increased risk of opportunistic infections, diarrhea-associated malabsorption of essential nutrients, and increased exposure to untreated water for children of HIV-positive mothers who use replacement feeding to reduce the risk of HIV transmission. This population may particularly benefit from an intervention to improve water quality in the home. Methods and Findings: We conducted a 12-month randomized, controlled field trial in Zambia among 120 households with children <2 years (100 with HIV-positive mothers and 20 with HIV-negative mothers to reduce stigma of participation) to assess a high-performance water filter and jerry cans for safe storage. Households were followed up monthly to assess use, drinking water quality (thermotolerant coliforms (TTC), an indicator of fecal contamination) and reported diarrhea (7-day recall) among children <2 years and all members of the household. Because previous attempts to blind the filter have been unsuccessful, we also assessed weight-for-age Z-scores (WAZ) as an objective measure of diarrhea impact. Filter use was high, with 96% (596/620) of household visits meeting the criteria for users. The quality of water stored in intervention households was significantly better than in control households (3 vs. 181 TTC/100 mL, respectively, p < 0.001). The intervention was associated with reductions in the longitudinal prevalence of reported diarrhea of 53% among children,2 years (LPR = 0.47, 95% CI: 0.30-0.73, p = 0.001) and 54% among all household members (LPR = 0.46, 95% CI: 0.30-0.70, p < 0.001). While reduced WAZ was associated with reported diarrhea (20.26; 95% CI: 20.37 to 20.14, p < 0.001), there was no difference in WAZ between intervention and control groups. Conclusion: In this population living with HIV/AIDS, a water filter combined with safe storage was used correctly and consistently, was highly effective in improving drinking water quality, and was protective against diarrhea.	[Peletz, Rachel; Baisley, Kathy; Filteau, Suzanne; Clasen, Thomas] London Sch Hyg & Trop Med, London WC1, England; [Simunyama, Martin; Sarenje, Kelvin; Kelly, Paul] Univ Teaching Hosp, Trop Gastroenterol & Nutr Grp, Lusaka, Zambia; [Kelly, Paul] Univ London, Barts & London Sch Med, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Zambia; University of London; Queen Mary University London	Peletz, R (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	Rachel.Peletz@lshtm.ac.uk		Kelly, Paul/0000-0003-0844-6448	Vestergaard-Frandsen SA; United States National Science Foundation; Vestergaard-Frandsen; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Vestergaard-Frandsen SA; United States National Science Foundation(National Science Foundation (NSF)); Vestergaard-Frandsen; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by Vestergaard-Frandsen SA and the United States National Science Foundation. Vestergaard-Frandsen SA is the manufacturer of the LifeStraw Family Filter used in the intervention. Besides supplying the filters, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RP and TC receive funding from Vestergaard-Frandsen for research and consulting. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2009, HIV INF FEED REV PRI; Arnold B, 2009, INT J EPIDEMIOL, V38, P1651, DOI 10.1093/ije/dyp241; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Barzilay EJ, 2011, AIDS CARE, V23, P330, DOI 10.1080/09540121.2010.507749; Boisson S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012613; Brantley Richard K., 2003, Braz J Infect Dis, V7, P16, DOI 10.1590/S1413-86702003000100003; Brown JM, 2008, WATER SCI TECHNOL, V58, P757, DOI 10.2166/wst.2008.439; Brown J, 2008, AM J TROP MED HYG, V79, P394, DOI 10.4269/ajtmh.2008.79.394; Bushen OY, 2004, CLIN INFECT DIS, V38, P1764, DOI 10.1086/421394; CDC, 2009, CDC GLOB HLTH REV SU; Central Statistical Office (CSO) MoHM Tropical Diseases Research Centre (TDRC) University of Zambia aMII, 2009, ZAMB DEM HLTH SURV 2; Chiller TM, 2006, B WORLD HEALTH ORGAN, V84, P28, DOI 10.2471/BLT.04.016980; Clasen T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub2; Clasen T, 2005, AM J TROP MED HYG, V73, P790, DOI 10.4269/ajtmh.2005.73.790; Clasen T, 2009, AM J TROP MED HYG, V80, P819, DOI 10.4269/ajtmh.2009.80.819; Cogill B, 2003, ANTHROPOMETRIC INDIC; Colindres R, 2008, AIDS CARE, V20, P139, DOI 10.1080/09540120701506804; Crump JA, 2005, BMJ-BRIT MED J, V331, P478, DOI 10.1136/bmj.38512.618681.E0; Dye TDV, 2011, AM J PUBLIC HEALTH, V101, P1515, DOI 10.2105/AJPH.2011.300127; Eaton A. D., 2005, STANDARD METHODS EXA; Fewtrell L, 2005, WATER SCI TECHNOL, V52, P133, DOI 10.2166/wst.2005.0244; Filteau S, 2009, TROP MED INT HEALTH, V14, P276, DOI 10.1111/j.1365-3156.2009.02220.x; Fox MP, 2009, INT J EPIDEMIOL, V38, P569, DOI 10.1093/ije/dyn249; Gundry S, 2004, J WATER HEALTH, V2, P1; Gwatkin DR, 2002, SOCIOECONOMIC DIFFER, V1996; Harris JR, 2009, J INFECT DIS, V200, P1186, DOI 10.1086/605841; Hayes RJ, 2009, INTERD STAT, P3; Hunter PR, 2009, ENVIRON SCI TECHNOL, V43, P8991, DOI 10.1021/es9028217; Isaac R, 2008, TROP DOCT, V38, P133, DOI 10.1258/td.2008.080087; Jensen PK, 2004, TROP MED INT HEALTH, V9, P1210, DOI 10.1111/j.1365-3156.2004.01329.x; Kangamba M., 2006, WATER SANITATION ASS; Kelly P, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-7; KORICH DG, 1990, APPL ENVIRON MICROB, V56, P1423, DOI 10.1128/AEM.56.5.1423-1428.1990; Lockwood K, 2006, WATER SANITATION ASS; Lugada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012435; Lule JR, 2005, AM J TROP MED HYG, V73, P926, DOI 10.4269/ajtmh.2005.73.926; Mausezahl D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000125; Makasa M, 2007, TROP MED INT HEALTH, V12, P594, DOI 10.1111/j.1365-3156.2007.01836.x; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Moore SR, 2010, GASTROENTEROLOGY, V139, P1156, DOI 10.1053/j.gastro.2010.05.076; Morris SS, 1996, AM J EPIDEMIOL, V144, P582, DOI 10.1093/oxfordjournals.aje.a008968; Omari AA, 2003, HEALTH POLICY PLANN, V18, P156, DOI 10.1093/heapol/czg020; Peletz R, 2011, AM J TROP MED HYG, V85, P318, DOI 10.4269/ajtmh.2011.11-0140; Pickering AJ, 2010, ENVIRON SCI TECHNOL, V44, P3267, DOI 10.1021/es903524m; Potgieter N, 2007, WATER SCI TECHNOL, V56, P125, DOI 10.2166/wst.2007.564; PSI, 2010, BAS HIV CAR PREV PAC; Reller ME, 2003, AM J TROP MED HYG, V69, P411, DOI 10.4269/ajtmh.2003.69.411; Schmidt WP, 2011, INT J EPIDEMIOL, V40, P1678, DOI 10.1093/ije/dyr152; Schmidt WP, 2009, ENVIRON SCI TECHNOL, V43, P986, DOI 10.1021/es802232w; Schmidt WP, 2009, J EPIDEMIOL COMMUNIT; Stark D, 2009, CLIN MICROBIOL REV, V22, P634, DOI 10.1128/CMR.00017-09; U. S Government, 2011, FY 2010 PEPFAR COUNT; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNICEF/WHO, 2009, DIRRH WHY CHILDR AR; USAID, 2008, PROGR GUID INT WAT S; USAID CDC, 2008, PROGR WAT SAN HYG WA; Waddington H, 2009, J DEV EFFECT, V1, P295, DOI 10.1080/19439340903141175; Water Supply & Sanitation Collaborative Council, 2009, HIV AIDS WASH WSSCC; WHO, 2004, WHO GUIDELINES DRINK, V3th; WHO, 2011, GUID DRINK WAT QUAL; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; World Health Organization, 2005, TREATM DIARRH MAN PH; WSP, 2007, WAT SAN HYG PEOPL LI; Xue JY, 2010, TROP MED INT HEALTH, V15, P1156, DOI 10.1111/j.1365-3156.2010.02595.x; Zwane AP, 2011, P NATL ACAD SCI USA, V108, P1821, DOI 10.1073/pnas.1000776108	65	33	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46548	10.1371/journal.pone.0046548	http://dx.doi.org/10.1371/journal.pone.0046548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082124	Green Published, Green Accepted, gold			2022-12-27	WOS:000311146900019
J	Robu, ME; Zhang, Y; Rhodes, J				Robu, Mara E.; Zhang, Yong; Rhodes, Jennifer			Rereplication in emi1-Deficient Zebrafish Embryos Occurs through a Cdh1-Mediated Pathway	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE PROGRESSION; DNA-REPLICATION; S-PHASE; PREVENTS REREPLICATION; MITOTIC PROGRESSION; TUMOR SUPPRESSION; EMI1; APC/C; CDC20	Disruption of early mitotic inhibitor 1 (Emi1) interferes with normal cell cycle progression and results in early embryonic lethality in vertebrates. During S and G2 phases the ubiquitin ligase complex APC/C is inhibited by Emi1 protein, thereby enabling the accumulation of Cyclins A and B so they can regulate replication and promote the transition from G2 phase to mitosis, respectively. Depletion of Emi1 prevents mitotic entry and causes rereplication and an increase in cell size. In this study, we show that the developmental and cell cycle defects caused by inactivation of zebrafish emi1 are due to inappropriate activation of APC/C through its cofactor Cdh1. Inhibiting/slowing progression into S-phase by depleting Cdt1, an essential replication licensing factor, partially rescued emi1 deficiency-induced rereplication and the increased cell size. The cell size effect was enhanced by co-depletion of cell survival regulator p53. These data suggest that the increased size of emi1-deficient cells is either directly or indirectly caused by the rereplication defects. Moreover, enforced expression of Cyclin A partially ablated the rereplicating population in emi1-deficient zebrafish embryos, consistent with the role of Cyclin A in origin licensing. Forced expression of Cyclin B partially restored the G1 population, in agreement with the established role of Cyclin B in mitotic progression and exit. However, expression of Cyclin B also partially inhibited rereplication in emi1-deficient embryos, suggesting a role for Cyclin B in regulating replication in this cellular context. As Cyclin A and B are substrates for APC/C-Cdh1 - mediated degradation, and Cdt1 is under control of Cyclin A, these data indicate that emi1 deficiency-induced defects in vivo are due to the dysregulation of an APC/C-Cdh1 molecular axis.	[Robu, Mara E.; Zhang, Yong; Rhodes, Jennifer] Temple Univ Hlth Syst, Immune Cell Dev & Host Def Program, Fox Chase Canc Ctr, Philadelphia, PA USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Rhodes, J (corresponding author), Temple Univ Hlth Syst, Immune Cell Dev & Host Def Program, Fox Chase Canc Ctr, Philadelphia, PA USA.	jennifer.rhodes@fccc.edu			William J. Avery postdoctoral fellowship	William J. Avery postdoctoral fellowship	This work was supported in part by a William J. Avery postdoctoral fellowship to MER (http://www.fccc.edu/research/postdoc/fellowships/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; Gottlieb TM, 1998, SEMIN CANCER BIOL, V8, P359, DOI 10.1006/scbi.1998.0098; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; HARTWELL LH, 1973, GENETICS, V74, P267; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jackson PK, 2004, TRENDS CELL BIOL, V14, P331, DOI 10.1016/j.tcb.2004.05.005; KANE DA, 1993, DEVELOPMENT, V119, P447; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee H, 2006, MOL CELL BIOL, V26, P5373, DOI 10.1128/MCB.00043-06; Li M, 2007, MOL CELL BIOL, V27, P3481, DOI 10.1128/MCB.02088-06; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nuckolls FJ, 1998, BIOCHEM BIOPH RES CO, V244, P280, DOI 10.1006/bbrc.1998.8205; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pines J, 2011, PHILOS T R SOC B, V366, P3625, DOI 10.1098/rstb.2011.0080; Prokhorova TA, 2003, P NATL ACAD SCI USA, V100, P13241, DOI 10.1073/pnas.2336104100; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2002, NATURE, V416, P850, DOI 10.1038/416850a; Rhodes J, 2009, MOL CELL BIOL, V29, P5911, DOI 10.1128/MCB.00558-09; Riley BB, 2010, DEV DYNAM, V239, P828, DOI 10.1002/dvdy.22227; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; SETHI N, 1991, MOL CELL BIOL, V11, P5592, DOI 10.1128/MCB.11.11.5592; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Sivaprasad U, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-8; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Soroldoni Daniele, 2009, V546, P117, DOI 10.1007/978-1-60327-977-2_8; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Verschuren EW, 2007, MOL CELL BIOL, V27, P7955, DOI 10.1128/MCB.00908-07; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang LX, 2008, DEVELOPMENT, V135, P2065, DOI 10.1242/dev.022673	53	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47658	10.1371/journal.pone.0047658	http://dx.doi.org/10.1371/journal.pone.0047658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082190	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900087
J	Sun, K; Liu, JM; Ning, G				Sun, Kan; Liu, Jianmin; Ning, Guang			Active Smoking and Risk of Metabolic Syndrome: A Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							LIFE-STYLE FACTORS; CIGARETTE-SMOKING; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; HEART-DISEASE; MALE WORKERS; FOLLOW-UP; MEN; ASSOCIATION; WEIGHT	Background: Epidemiological evidence suggests that smoking has been associated with emergence of metabolic syndrome. However, data on this issue are inconsistent and controversial. We therefore conducted a meta-analysis to examine the association between smoking and metabolic syndrome. Methodology and Principal Findings: We searched the Medline, Embase and the Cochrane Library database up to March 2012 to identify prospective cohort studies related to smoking and metabolic syndrome. Reference lists of retrieved articles were also reviewed. Summary effect estimates were derived using a random-effects model and stratified by gender, smoking dose, follow-up duration and geographical area. Primary analysis of 13 studies involving 56,691 participants and 8,688 cases detected a significant positive association between active smoking and risk of metabolic syndrome (pooled relative risk [RR] 1.26, 95% CI: 1.10-1.44). Estimates of effects were substantially consistent in the stratified analyses. In the dose-response analysis, risk of metabolic syndrome was stronger for active male smokers (pooled RR 1.34, 95% CI: 1.20-1.50) than it was for former male smokers (pooled RR 1.19, 95% CI: 1.00-1.42), and greater for heavy smokers (pooled RR 1.42, 95% CI: 1.27-1.59) compared with light smokers (pooled RR 1.10, 95% CI: 0.90-1.35). No evidence of statistical publication bias was found (Egger' s test P=0.227, Begg' s test P=0.113). Conclusions: Active smoking is associated with development of metabolic syndrome. Smoking cessation appears to reduce the risk of metabolic syndrome.	[Sun, Kan; Liu, Jianmin; Ning, Guang] Shanghai Jiao Tong Univ, Sch Med, Key Lab Endocrine & Metab Dis, Rui Jin Hosp,Minist Hlth,E Inst Shanghai Univ, Shanghai 200030, Peoples R China; [Sun, Kan; Liu, Jianmin; Ning, Guang] Shanghai Jiao Tong Univ, Shanghai Inst Endocrine & Metab Dis, Shanghai Clin Ctr Endocrine & Metab Dis, Sch Med,Rui Jin Hosp,Dept Endocrinol & Metab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ning, G (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Key Lab Endocrine & Metab Dis, Rui Jin Hosp,Minist Hlth,E Inst Shanghai Univ, Shanghai 200030, Peoples R China.	gning@sibs.ac.cn						ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Balhara Yatan Pal Singh, 2012, Indian J Endocrinol Metab, V16, P81, DOI 10.4103/2230-8210.91197; Bigazzi R, 2007, J NEPHROL, V20, P10; Carnethon MR, 2004, DIABETES CARE, V27, P2707, DOI 10.2337/diacare.27.11.2707; Cena H, 2011, NUTR REV, V69, P745, DOI 10.1111/j.1753-4887.2011.00446.x; Chiolero A, 2007, OBESITY, V15, P1311, DOI 10.1038/oby.2007.153; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Frei M, 2012, CLIN ORAL INVEST, V16, P755, DOI 10.1007/s00784-011-0583-2; GORDON T, 1975, AM HEART J, V90, P322, DOI 10.1016/0002-8703(75)90320-8; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; He Y, 2009, J AM COLL CARDIOL, V53, P363, DOI 10.1016/j.jacc.2008.08.073; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Holme I, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-154; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; International Diabetes Foundation, 2006, IDF CONS WORLDW DEF; Kawada T, 2010, OBES RES CLIN PRACT, V4, pE163, DOI 10.1016/j.orcp.2009.12.004; Kim BJ, 2009, DIABETES CARE, V32, P1314, DOI 10.2337/dc09-0060; Kim SG, 2007, J KOREAN MED SCI, V22, P968, DOI 10.3346/jkms.2007.22.6.968; Li YY, 2010, PREV MED, V51, P118, DOI 10.1016/j.ypmed.2010.04.016; Martiniuk ALC, 2006, TOB CONTROL, V15, P181, DOI 10.1136/tc.2005.013284; Nakanishi N, 2005, IND HEALTH, V43, P295, DOI 10.2486/indhealth.43.295; Onat A, 2007, ATHEROSCLEROSIS, V193, P380, DOI 10.1016/j.atherosclerosis.2006.07.002; Puustinen PJ, 2011, PSYCHOSOM MED, V73, P158, DOI 10.1097/PSY.0b013e3182037315; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; Strauss U, 1998, RECEPTOR CHANNEL, V6, P73; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Wannamethee SG, 2006, J AM GERIATR SOC, V54, P1909, DOI 10.1111/j.1532-5415.2006.00974.x; Wells G.A., 2004, NEWCASTLE OTTAWA SCA; WILKINS JN, 1982, PSYCHOPHARMACOLOGY, V78, P305, DOI 10.1007/BF00433730; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Wilsgaard T, 2007, DIABETES RES CLIN PR, V78, P217, DOI 10.1016/j.diabres.2007.03.006; Winkelmann BR, 2001, CURR MED RES OPIN, V17, P132, DOI 10.1185/0300799039117049; Woodward M, 2005, INT J EPIDEMIOL, V34, P1036, DOI 10.1093/ije/dyi104; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; World Health Organization, 2011, TOB FREE IN WHY IS T; Yang FY, 2008, ASIA PAC J CLIN NUTR, V17, P339; Zhu YX, 2011, BIOMED ENVIRON SCI, V24, P475, DOI 10.3967/0895-3988.2011.05.004	40	180	182	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47791	10.1371/journal.pone.0047791	http://dx.doi.org/10.1371/journal.pone.0047791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082217	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900114
J	Yamaoka, M; Maeda, N; Nakamura, S; Kashine, S; Nakagawa, Y; Hiuge-Shimizu, A; Okita, K; Imagawa, A; Matsuzawa, Y; Matsubara, K; Funahashi, T; Shimomura, I				Yamaoka, Masaya; Maeda, Norikazu; Nakamura, Seiji; Kashine, Susumu; Nakagawa, Yasuhiko; Hiuge-Shimizu, Aki; Okita, Kohei; Imagawa, Akihisa; Matsuzawa, Yuji; Matsubara, Ken-ichi; Funahashi, Tohru; Shimomura, Iichiro			A Pilot Investigation of Visceral Fat Adiposity and Gene Expression Profile in Peripheral Blood Cells	PLOS ONE			English	Article							METABOLIC SYNDROME; T-CELLS; CIRCADIAN-RHYTHMS; CLOCK GENES; OBESITY; ADIPOCYTOKINES; ACCUMULATION; INFLAMMATION; STRESS	Evidence suggests that visceral fat accumulation plays a central role in the development of metabolic syndrome. Excess visceral fat causes local chronic low-grade inflammation and dysregulation of adipocytokines, which contribute in the pathogenesis of the metabolic syndrome. These changes may affect the gene expression in peripheral blood cells. This study for the first time examined the association between visceral fat adiposity and gene expression profile in peripheral blood cells. The gene expression profile was analyzed in peripheral blood cells from 28 obese subjects by microarray analysis. Reverse transcription-polymerase chain reaction (RT-PCR) was performed using peripheral blood cells from 57 obese subjects. Obesity was defined as body mass index (BMI) greater than 25 kg/m(2) according to the Japanese criteria, and the estimated visceral fat area (eVFA) was measured by abdominal bioelectrical impedance. Analysis of gene expression profile was carried out with Agilent whole human genome 4644 K oligo-DNA microarray. The expression of several genes related to circadian rhythm, inflammation, and oxidative stress correlated significantly with visceral fat accumulation. Period homolog 1 (PER1) mRNA level in blood cells correlated negatively with visceral fat adiposity. Stepwise multiple regression analysis identified eVFA as a significant determinant of PER1 expression. In conclusion, visceral fat adiposity correlated with the expression of genes related to circadian rhythm and inflammation in peripheral blood cells.	[Yamaoka, Masaya; Maeda, Norikazu; Kashine, Susumu; Nakagawa, Yasuhiko; Hiuge-Shimizu, Aki; Okita, Kohei; Imagawa, Akihisa; Funahashi, Tohru; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan; [Nakamura, Seiji; Matsubara, Ken-ichi] DNA Chip Res Inc, Yokohama, Kanagawa, Japan; [Matsuzawa, Yuji] Sumitomo Hosp, Osaka, Japan	Osaka University; DNA Chip Research Inc.; Sumitomo Hospital	Maeda, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan.	norikazu_maeda@endmet.med.osaka-u.ac.jp			 [22590979];  [22126008]	; 	This work was supported in part by Grants-in-Aid for Scientific Research (C) no. 22590979 (to N.M.) and Scientific Research on Innovative Areas no. 22126008 (to T.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fukuya H, 2007, BIOCHEM BIOPH RES CO, V354, P924, DOI 10.1016/j.bbrc.2007.01.063; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gimble JM, 2011, NAT REV ENDOCRINOL, V7, P98, DOI 10.1038/nrendo.2010.214; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kullo IJ, 2002, AM J CARDIOL, V89, P1441, DOI 10.1016/S0002-9149(02)02366-4; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Nakatsuji Hideaki, 2010, Diabetes Care, V33, pe110, DOI 10.2337/dc10-0739; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ryo M, 2005, DIABETES CARE, V28, P451, DOI 10.2337/diacare.28.2.451; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	25	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47377	10.1371/journal.pone.0047377	http://dx.doi.org/10.1371/journal.pone.0047377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091619	gold, Green Submitted, Green Published			2022-12-27	WOS:000310135800042
J	Hoeschele, M; Cook, RG; Guillette, LM; Hahn, AH; Sturdy, CB				Hoeschele, Marisa; Cook, Robert G.; Guillette, Lauren M.; Hahn, Allison H.; Sturdy, Christopher B.			Auditory Same/Different Concept Learning and in Black-Capped Chickadees (Poecile atricapillus)	PLOS ONE			English	Article							SAME-DIFFERENT DISCRIMINATION; A-DEE CALL; BUDGERIGARS MELOPSITTACUS-UNDULATUS; NOTE-TYPE PERCEPTION; PARID VOCALIZATIONS; ABSOLUTE PITCH; RELATIVE PITCH; MECHANISMS; SPEECH; MEMORY	The concept learning was thought to be uniquely human, but has since been observed in many other species. Discriminating same from different is one abstract relation that has been studied frequently. In the current experiment, using operant conditioning, we tested whether black-capped chickadees (Poecile atricapillus) could discriminate sets of auditory stimuli based on whether all the sounds within a sequence were the same or different from one another. The chickadees were successful at solving this same/different relational task, and transferred their learning to same/different sequences involving novel combinations of training notes and novel notes within the range of pitches experienced during training. The chickadees showed limited transfer to pitches that was not used in training, suggesting that the processing of absolute pitch may constrain their relational performance. Our results indicate, for the first time, that black-capped chickadees readily form relational auditory same and different categories, adding to the list of perceptual, behavioural, and cognitive abilities that make this species an important comparative model for human language and cognition.	[Hoeschele, Marisa; Guillette, Lauren M.; Hahn, Allison H.; Sturdy, Christopher B.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Cook, Robert G.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Sturdy, Christopher B.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada	University of Alberta; Tufts University; University of Alberta	Sturdy, CB (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.	csturdy@ualberta.ca	Hoeschele, Marisa/R-2176-2019; Hoeschele, Marisa/R-6198-2018; Sturdy, Christopher B/A-4407-2009; Guillette, Lauren/K-8154-2013	Hoeschele, Marisa/0000-0002-2102-0882; Hoeschele, Marisa/0000-0002-2102-0882; Guillette, Lauren/0000-0002-8777-6543; Sturdy, Christopher/0000-0003-2721-3770	Natural Sciences and Engineering Research Council of Canada (NSERC); Discovery Accelerator Supplement (DAS); Alberta Ingenuity Fund (AIF); Canada Foundation for Innovation (CFI) Infrastructure Operating Fund (IOF); CFI; University of Alberta; NSERC; AIF; Izaak Walton Killam Memorial Scholarship (IWKMS) at the University of Alberta; National Science Foundation [0718804]; IWKMS at the University of Alberta	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Discovery Accelerator Supplement (DAS); Alberta Ingenuity Fund (AIF); Canada Foundation for Innovation (CFI) Infrastructure Operating Fund (IOF); CFI(Canada Foundation for Innovation); University of Alberta(University of Alberta); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); AIF; Izaak Walton Killam Memorial Scholarship (IWKMS) at the University of Alberta; National Science Foundation(National Science Foundation (NSF)); IWKMS at the University of Alberta	This research was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant and Discovery Accelerator Supplement (DAS), an Alberta Ingenuity Fund (AIF) New Faculty Grant, the Canada Foundation for Innovation (CFI) Infrastructure Operating Fund (IOF) and a CFI New Opportunities Grant along with start-up funding and CFI partner funding from the University of Alberta to CBS. MH was supported by a NSERC post-graduate scholarship, an AIF graduate student scholarship, and an Izaak Walton Killam Memorial Scholarship (IWKMS) at the University of Alberta. RGC's participation in this project was supported by a grant from the National Science Foundation # 0718804. LMG is supported by an IWKMS at the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YS, 2011, BEHAVIOUR, V148, P55, DOI 10.1163/000579510X545829; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Bloomfield LL, 2008, BEHAV PROCESS, V77, P73, DOI 10.1016/j.beproc.2007.06.011; Bloomfield LL, 2005, CAN J ZOOL, V83, P820, DOI 10.1139/Z05-067; Bloomfield LL, 2004, CAN J ZOOL, V82, P780, DOI 10.1139/Z04-046; Bregman MR, 2012, COGNITION, V122, P51, DOI 10.1016/j.cognition.2011.08.008; BRODBECK DR, 1994, ANIM LEARN BEHAV, V22, P119, DOI 10.3758/BF03199912; Charrier I, 2005, J COMP PSYCHOL, V119, P371, DOI 10.1037/0735-7036.119.4.371; Charrier I, 2004, CAN J ZOOL, V82, P769, DOI 10.1139/Z04-045; Comins JA, 2010, COGNITION, V117, P38, DOI 10.1016/j.cognition.2010.06.009; Cook R. G., 2006, COMP COGNITION EXPT, P307; Cook RG, 1997, J EXP PSYCHOL ANIM B, V23, P417, DOI 10.1037/0097-7403.23.4.417; Cook RG, 2003, BEHAV PROCESS, V62, P125, DOI 10.1016/S0376-6357(03)00022-6; Cook RG, 2009, J EXP PSYCHOL-ANIM B, V35, P108, DOI 10.1037/a0012621; CYNX J, 1986, J EXP PSYCHOL ANIM B, V12, P394; Deutsch D, 2006, J ACOUST SOC AM, V119, P719, DOI 10.1121/1.2151799; Deutsch D, 2004, MUSIC PERCEPT, V21, P339, DOI 10.1525/mp.2004.21.3.339; Deutsch D., 2006, ACOUST TODAY, V2, P11, DOI DOI 10.1121/1.2961141; DOOLING RJ, 1987, J COMP PSYCHOL, V101, P139, DOI 10.1037/0735-7036.101.2.139; DOOLING RJ, 1992, J COMP PSYCHOL, V106, P20, DOI 10.1037/0735-7036.106.1.20; Doumas LAA, 2008, PSYCHOL REV, V115, P1, DOI 10.1037/0033-295X.115.1.1; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; FICKEN MS, 1978, AUK, V95, P34, DOI 10.2307/4085493; Foote JR, 2008, BEHAV ECOL, V19, P1192, DOI 10.1093/beheco/arn087; Freedman DJ, 2008, NEUROSCI BIOBEHAV R, V32, P311, DOI 10.1016/j.neubiorev.2007.07.011; Gibson BM, 2004, LEARN BEHAV, V32, P183; Gibson BM, 2003, J EXP PSYCHOL ANIM B, V29, P84, DOI 10.1037//0097-7403.29.1.84; GLANZER M, 1966, J VERB LEARN VERB BE, V5, P351, DOI 10.1016/S0022-5371(66)80044-0; Guillette LM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00229; Guillette LM, 2011, P ROY SOC B-BIOL SCI, V278, P767, DOI 10.1098/rspb.2010.1669; Guillette LM, 2010, J COMP PSYCHOL, V124, P109, DOI 10.1037/a0017741; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HERRNSTEIN RJ, 1964, SCIENCE, V146, P549, DOI 10.1126/science.146.3643.549; HITCHCOCK CL, 1990, ANIM BEHAV, V40, P701, DOI 10.1016/S0003-3472(05)80699-2; Hoeschele M, 2012, ANIM COGN IN PRESS; Hoeschele M, 2012, J COMP PSYCHOL, V126, P57, DOI 10.1037/a0024627; Hoeschele M, 2009, J ACOUST SOC AM, V126, P2088, DOI 10.1121/1.3203736; Howell S. N, 1997, IDENTIFICATION GUIDE; HULSE SH, 1985, J COMP PSYCHOL, V99, P176, DOI 10.1037/0735-7036.99.2.176; Hummel JE, 1997, PSYCHOL REV, V104, P427, DOI 10.1037/0033-295X.104.3.427; Katz JS, 2006, J EXP PSYCHOL ANIM B, V32, P80, DOI 10.1037/0097-7403.32.1.80; KEANE M, 1987, Q J EXP PSYCHOL-A, V39, P29, DOI 10.1080/02724988743000015; Khallad Y, 2004, INT J PSYCHOL, V39, P73, DOI 10.1080/00207590344000349; Lee TTY, 2006, J COMP PSYCHOL, V120, P217, DOI 10.1037/0735-7036.120.3.217; Lohr B, 1998, J COMP PSYCHOL, V112, P36, DOI 10.1037/0735-7036.112.1.36; Moscicki MK, 2011, J ACOUST SOC AM, V129, P3327, DOI 10.1121/1.3560925; Moscicki MK, 2010, ACTA ORNITHOL, V45, P147, DOI 10.3161/000164510X551282; Murphy MS, 2008, BEHAV PROCESS, V77, P210, DOI 10.1016/j.beproc.2007.10.008; Njegovan M, 1997, J COMP PSYCHOL, V111, P294; NJEGOVAN M, 1994, BEHAV RES METH INSTR, V26, P26, DOI 10.3758/BF03204558; OKANOYA K, 1991, J COMP PSYCHOL, V105, P60, DOI 10.1037/0735-7036.105.1.60; Palya W.L., 2001, DOCUMENT SET HIGH PE; PARK TJ, 1985, J COMP PSYCHOL, V99, P391, DOI 10.1037/0735-7036.99.4.391; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; PEPPERBERG IM, 1987, ANIM LEARN BEHAV, V15, P423, DOI 10.3758/BF03205051; Saffran JR, 2001, DEV PSYCHOL, V37, P74, DOI 10.1037//0012-1649.37.1.74; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; SHERRY DF, 1989, WILSON BULL, V101, P289; SHETTLEWORTH SJ, 1982, J EXP PSYCHOL ANIM B, V8, P354, DOI 10.1037/0097-7403.8.4.354; Smith S.M., 1991, BLACK CAPPED CHICKAD; Sturz BR, 2009, J COMP PSYCHOL, V123, P90, DOI 10.1037/a0012905; Tyack PL, 2008, J COMP PSYCHOL, V122, P319, DOI 10.1037/a0013087; Wasserman EA, 2002, J EXP PSYCHOL ANIM B, V28, P347, DOI 10.1037//0097-7403.28.4.347; Wasserman EA, 2010, J EXP PSYCHOL-ANIM B, V36, P3, DOI 10.1037/a0016327; Weisman R, 2004, AM SCI, V92, P532; Weisman Ronald G., 2006, P71; Weisman RG, 2010, LEARN MOTIV, V41, P156, DOI 10.1016/j.lmot.2010.04.002; Wright AA, 2007, J COMP PSYCHOL, V121, P387, DOI 10.1037/0735-7036.121.4.387; Young ME, 2001, PSYCHON B REV, V8, P677, DOI 10.3758/BF03196203; Young ME, 1999, J EXP PSYCHOL ANIM B, V25, P475, DOI 10.1037/0097-7403.25.4.475; Zentall TR, 2008, COMP COGN BEHAV REV, V3, P13, DOI 10.3819/ccbr.2008.30002	72	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47691	10.1371/journal.pone.0047691	http://dx.doi.org/10.1371/journal.pone.0047691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077660	gold, Green Submitted, Green Published			2022-12-27	WOS:000309995100153
J	Thompson, ME; Zhou, A; Knott, CD				Thompson, Melissa Emery; Zhou, Amy; Knott, Cheryl D.			Low Testosterone Correlates with Delayed Development in Male Orangutans	PLOS ONE			English	Article							CAPTIVE MALE ORANGUTANS; CORTISOL-LEVELS; REPRODUCTIVE STRATEGIES; URINARY TESTOSTERONE; SUMATRAN ORANGUTANS; WILD ORANGUTANS; DOMINANCE RANK; LIFE-HISTORY; PATTERNS; BEHAVIOR	Male orangutans (Pongo spp.) display an unusual characteristic for mammals in that some adult males advance quickly to full secondary sexual development while others can remain in an adolescent-like form for a decade or more past the age of sexual maturity. Remarkably little is understood about how and why differences in developmental timing occur. While fully-developed males are known to produce higher androgen levels than arrested males, the longer-term role of steroid hormones in male life history variation has not been examined. We examined variation in testosterone and cortisol production among 18 fully-developed ("flanged") male orangutans in U. S. captive facilities. Our study revealed that while testosterone levels did not vary significantly according to current age, housing condition, and species origin, males that had undergone precocious development had higher testosterone levels than males that had experienced developmental arrest. While androgen variation had previously been viewed as a state-dependent characteristic of male developmental status, our study reveals that differences in the physiology of early and late developing males are detectable long past the developmental transition and may instead be trait-level characteristics associated with a male's life history strategy. Further studies are needed to determine how early in life differences in testosterone levels emerge and what consequences this variation may have for male behavioral strategies.	[Thompson, Melissa Emery] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Thompson, Melissa Emery; Zhou, Amy; Knott, Cheryl D.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Zhou, Amy] Univ Massachusetts, Sch Med, Worcester, MA USA; [Knott, Cheryl D.] Boston Univ, Dept Anthropol, Boston, MA 02215 USA	University of New Mexico; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; Boston University	Thompson, ME (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	memery@unm.edu	Emery Thompson, Melissa/A-1450-2008; Thompson, Melissa Emery/ABF-1790-2020	Emery Thompson, Melissa/0000-0003-2451-6397; Thompson, Melissa Emery/0000-0003-2451-6397	National Science Foundation [0936199]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by the National Science Foundation (grant 0936199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J, 2010, ANN NY ACAD SCI, V1204, P127, DOI 10.1111/j.1749-6632.2010.05531.x; Anderson HB, 2008, J HUM EVOL, V54, P34, DOI 10.1016/j.jhevol.2007.05.014; Beehner JC, 2006, BEHAV ECOL SOCIOBIOL, V59, P469, DOI 10.1007/s00265-005-0071-2; Chrousos GP, 1998, ANN NY ACAD SCI, V851, P311, DOI 10.1111/j.1749-6632.1998.tb09006.x; Creel SF, 2005, J MAMMAL, V86, P255, DOI 10.1644/BHE-002.1; CZEKALA NM, 1994, AM J PRIMATOL, V34, P29, DOI 10.1002/ajp.1350340107; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Ellison PT, 2002, HUM REPROD, V17, P3251, DOI 10.1093/humrep/17.12.3251; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; GALDIKAS BMF, 1985, AM J PRIMATOL, V8, P87, DOI 10.1002/ajp.1350080202; GRAHAM CE, 1990, MG PRIMATOL, V13, P33; Hacklander K, 2003, ANIM BEHAV, V65, P1133, DOI 10.1006/anbe.2003.2159; Hardy MP, 2002, BIOL REPROD, V67, P1750, DOI 10.1095/biolreprod.102.006312; Hauser B, 2008, GEN COMP ENDOCR, V158, P77, DOI 10.1016/j.ygcen.2008.05.006; Kingsley S., 1982, Perspectives in Vertebrate Science, V2, P215; Knott Cheryl, 1999, P50; Knott Cheryl D., 2009, P81; Knott Cheryl D., 2009, P171; Knott CD, 2010, P ROY SOC B-BIOL SCI, V277, P105, DOI 10.1098/rspb.2009.1552; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Maggioncalda AN, 1999, AM J PHYS ANTHROPOL, V109, P19, DOI 10.1002/(SICI)1096-8644(199905)109:1&lt;19::AID-AJPA3&gt;3.0.CO;2-3; Maggioncalda AN, 2002, AM J PHYS ANTHROPOL, V118, P25, DOI 10.1002/ajpa.10074; Maggioncalda AN, 2000, AM J PRIMATOL, V50, P67, DOI 10.1002/(SICI)1098-2345(200001)50:1<67::AID-AJP6>3.0.CO;2-V; Maple T.L., 1980, ORANGUTAN BEHAV; MITANI JC, 1985, ANIM BEHAV, V33, P392, DOI 10.1016/S0003-3472(85)80063-4; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Muller MN, 2003, AM J PRIMATOL, V60, P161, DOI 10.1002/ajp.10103; Munro C J, 1988, Prog Clin Biol Res, V285, P289; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Rijksen HD, 1978, MEDEDELINGEN LANDBOU; Robbins MM, 1997, AM J PRIMATOL, V43, P51, DOI 10.1002/(SICI)1098-2345(1997)43:1<51::AID-AJP4>3.0.CO;2-X; SAPOLSKY RM, 1992, BEHAV ENDOCRINOLOGY, P284; SCHURMANN CL, 1986, INT J PRIMATOL, V7, P265, DOI 10.1007/BF02736392; Setchell JM, 2002, AM J PRIMATOL, V56, P9, DOI 10.1002/ajp.1060; Singleton I, 2001, INT J PRIMATOL, V22, P877, DOI 10.1023/A:1012033919441; Strier KB, 1999, HORM BEHAV, V35, P125, DOI 10.1006/hbeh.1998.1505; TAUSSKY HH, 1954, J BIOL CHEM, V208, P853; TEBOEKHORST IJA, 1990, ANIM BEHAV, V39, P1098, DOI 10.1016/S0003-3472(05)80782-1; Utami Atmoko SS, 2000, BIMATURISM ORANG UTA; Utami SS, 2002, BEHAV ECOL, V13, P643, DOI 10.1093/beheco/13.5.643; Whitten PL, 1998, YEARB PHYS ANTHROPOL, V41, P1, DOI 10.1002/(SICI)1096-8644(1998)107:27+<1::AID-AJPA2>3.0.CO;2-H; Wich SA, 2004, J HUM EVOL, V47, P385, DOI 10.1016/j.jhevol.2004.08.006; WICKINGS EJ, 1992, PHYSIOL BEHAV, V52, P909, DOI 10.1016/0031-9384(92)90370-H; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; ZIEGLER TE, 1995, HORM BEHAV, V29, P407, DOI 10.1006/hbeh.1995.1028	46	24	25	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47282	10.1371/journal.pone.0047282	http://dx.doi.org/10.1371/journal.pone.0047282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077585	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100086
J	Sala, CD; Soler-Bistue, AJC; Korprapun, L; Zorreguieta, A; Tolmasky, ME				Davies Sala, Carol; Soler-Bistue, Alfonso J. C.; Korprapun, Leeann; Zorreguieta, Angeles; Tolmasky, Marcelo E.			Inhibition of Cell Division Induced by External Guide Sequences (EGS Technology) Targeting ftsZ	PLOS ONE			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; BACTERIAL CYTOKINESIS; PENETRATING PEPTIDE; AMIKACIN RESISTANCE; IN-VITRO; EXPRESSION; GROWTH; GENES; TRANSCRIPTION	EGS (external guide sequence) technology is a promising approach to designing new antibiotics. EGSs are short antisense oligoribonucleotides that induce RNase P-mediated cleavage of a target RNA by forming a precursor tRNA-like complex. The ftsZ mRNA secondary structure was modeled and EGSs complementary to two regions with high probability of being suitable targets were designed. In vitro reactions showed that EGSs targeting these regions bound ftsZ mRNA and elicited RNase P-mediated cleavage of ftsZ mRNA. A recombinant plasmid, pEGSb1, coding for an EGS that targets region "b" under the control of the T7 promoter was generated. Upon introduction of this plasmid into Escherichia coli BL21(DE3)(pLysS) the transformant strain formed filaments when expression of the EGS was induced. Concomitantly, E. coli harboring pEGSb1 showed a modest but significant inhibition of growth when synthesis of the EGSb1 was induced. Our results indicate that EGS technology could be a viable strategy to generate new antimicrobials targeting ftsZ.	[Davies Sala, Carol; Soler-Bistue, Alfonso J. C.; Korprapun, Leeann; Zorreguieta, Angeles] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cientificas & Tecnicas, Inst Invest Bioquim Buenos Aires,Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Soler-Bistue, Alfonso J. C.; Korprapun, Leeann; Tolmasky, Marcelo E.] Calif State Univ Fullerton, Dept Biol Sci, Coll Nat Sci & Math, Ctr Appl Biotechnol Studies, Fullerton, CA 92634 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires; California State University System; California State University Fullerton	Zorreguieta, A (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cientificas & Tecnicas, Inst Invest Bioquim Buenos Aires,Fdn Inst Leloir, Buenos Aires, DF, Argentina.	azorreguieta@leloir.org.ar; mtolmasky@fullerton.edu	Tolmasky, Marcelo/AAC-5316-2020; Soler-Bistué, Alfonso/AAV-3123-2021	Tolmasky, Marcelo/0000-0002-6298-7811; Soler-Bistué, Alfonso/0000-0002-3917-0002	National Institutes of Health [2R15AI047115]; X-240 Universidad de Buenos Aires; CONICET; National Institute on Minority Health and Health Disparities, National Institutes of Health [MHIRT 2T37MD001368]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI047115] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [T37MD001368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); X-240 Universidad de Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Institute on Minority Health and Health Disparities, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by a Public Health Service grant 2R15AI047115 (to M. E. T.) from the National Institutes of Health and X-240 Universidad de Buenos Aires (to A.Z.). A.Z. is a career member of Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). C. D. S. and A.J.C.S.B. were supported by fellowships from CONICET. L. K. was supported by grant MHIRT 2T37MD001368 from the National Institute on Minority Health and Health Disparities, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman S, 2011, PHILOS T R SOC B, V366, P2936, DOI 10.1098/rstb.2011.0142; Anko M, 2012, BBA-BIOMEMBRANES, V1818, P915, DOI 10.1016/j.bbamem.2011.12.028; Ayala JA., 1994, NEW COMPR BIOCH, V27, P73, DOI [10.1016/S0167-7306(08)60408-1, DOI 10.1016/S0167-7306(08)60408-1]; Benders GA, 2005, J BACTERIOL, V187, P4542, DOI 10.1128/JB.187.13.4542-4551.2005; Bistue AJCS, 2007, ANTIMICROB AGENTS CH, V51, P1918, DOI 10.1128/AAC.01500-06; Boberek JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013745; Cam K, 1996, NUCLEIC ACIDS RES, V24, P3065, DOI 10.1093/nar/24.15.3065; Corbin BD, 2007, J BACTERIOL, V189, P3026, DOI 10.1128/JB.01581-06; Czaplewski LG, 2009, BIOORG MED CHEM LETT, V19, P524, DOI 10.1016/j.bmcl.2008.11.021; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; de la Fuente A, 2001, BIOCHIMIE, V83, P109, DOI 10.1016/S0300-9084(00)01212-8; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Eriksson M, 2002, J BIOL CHEM, V277, P7144, DOI 10.1074/jbc.M106624200; Flardh K, 1997, MOL MICROBIOL, V24, P927, DOI 10.1046/j.1365-2958.1997.4001762.x; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Goh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006061; GOLDBLUM K, 1981, J BACTERIOL, V146, P128, DOI 10.1128/JB.146.1.128-132.1981; Goley ED, 2011, MOL MICROBIOL, V80, P1680, DOI 10.1111/j.1365-2958.2011.07677.x; Gopalan V, 2002, J BIOL CHEM, V277, P6759, DOI 10.1074/jbc.R100067200; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; GuerrierTakada C, 1997, P NATL ACAD SCI USA, V94, P8468, DOI 10.1073/pnas.94.16.8468; Hassane FS, 2010, CELL MOL LIFE SCI, V67, P715, DOI 10.1007/s00018-009-0186-0; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Haydon DJ, 2010, J MED CHEM, V53, P3927, DOI 10.1021/jm9016366; Holm T, 2011, METHODS MOL BIOL, V683, P207, DOI 10.1007/978-1-60761-919-2_15; Huang Q, 2007, CURR TOP MED CHEM, V7, P527, DOI 10.2174/156802607780059790; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Ko JH, 2008, RNA, V14, P1656, DOI 10.1261/rna.1120508; Lehto T, 2010, J CONTROL RELEASE, V141, P42, DOI 10.1016/j.jconrel.2009.08.028; LI Y, 1992, P NATL ACAD SCI USA, V89, P3185, DOI 10.1073/pnas.89.8.3185; Lundblad EW, 2010, NEW BIOTECHNOL, V27, P212, DOI 10.1016/j.nbt.2010.03.003; Mae M, 2009, J CONTROL RELEASE, V134, P221, DOI 10.1016/j.jconrel.2008.11.025; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; McKinney J, 2001, P NATL ACAD SCI USA, V98, P6605, DOI 10.1073/pnas.121180398; McKinney JS, 2004, NUCLEIC ACIDS RES, V32, P848, DOI 10.1093/nar/gkh219; Mellbye BL, 2010, J ANTIMICROB CHEMOTH, V65, P98, DOI 10.1093/jac/dkp392; Meng JR, 2009, ANTIMICROB AGENTS CH, V53, P2871, DOI 10.1128/AAC.01542-08; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Rice LB, 2010, INFECT CONT HOSP EP, V31, pS7, DOI 10.1086/655995; Sambrook J., 2001, MOL CLONING LAB MANU; Sarno R, 2003, ANTIMICROB AGENTS CH, V47, P3296, DOI 10.1128/AAC.47.10.3296-3304.2003; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Schaffner-Barbero C, 2012, ACS CHEM BIOL, V7, P268, DOI 10.1021/cb2003626; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shen N, 2009, P NATL ACAD SCI USA, V106, P8163, DOI 10.1073/pnas.0903491106; Bistue AJCS, 2009, P NATL ACAD SCI USA, V106, P13230, DOI 10.1073/pnas.0906529106; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Takara K, 2010, INT J PHARMACEUT, V396, P143, DOI 10.1016/j.ijpharm.2010.05.002; Tamura M, 2006, J BACTERIOL, V188, P5145, DOI 10.1128/JB.00367-06; Torres Adrian G, 2011, Artif DNA PNA XNA, V2, P71; Traglia G, 2012, BIORESEARCH IN PRESS; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Vivancos AP, 2010, GENOME RES, V20, P989, DOI 10.1101/gr.094318.109; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; Xiaos GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003719; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	60	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47690	10.1371/journal.pone.0047690	http://dx.doi.org/10.1371/journal.pone.0047690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110089	Green Published, gold, Green Submitted			2022-12-27	WOS:000310193600021
J	Greve, B; Bolling, T; Amler, S; Rossler, U; Gomolka, M; Mayer, C; Popanda, O; Dreffke, K; Rickinger, A; Fritz, E; Eckardt-Schupp, F; Sauerland, C; Braselmann, H; Sauter, W; Illig, T; Riesenbeck, D; Konemann, S; Willich, N; Mortl, S; Eich, HT; Schmezer, P				Greve, Burkhard; Boelling, Tobias; Amler, Susanne; Roessler, Ute; Gomolka, Maria; Mayer, Claudia; Popanda, Odilia; Dreffke, Kristin; Rickinger, Astrid; Fritz, Eberhard; Eckardt-Schupp, Friederike; Sauerland, Christina; Braselmann, Herbert; Sauter, Wiebke; Illig, Thomas; Riesenbeck, Dorothea; Koenemann, Stefan; Willich, Normann; Moertl, Simone; Eich, Hans Theodor; Schmezer, Peter			Evaluation of Different Biomarkers to Predict Individual Radiosensitivity in an Inter-Laboratory Comparison-Lessons for Future Studies	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; INDUCED DNA-DAMAGE; NORMAL TISSUE COMPLICATIONS; LYMPHOBLASTOID CELL-LINES; ALKALINE COMET ASSAY; DOUBLE-STRAND BREAKS; H2AX PHOSPHORYLATION; GEL-ELECTROPHORESIS; B-CELLS; RADIATION SENSITIVITY	Radiotherapy is a powerful cure for several types of solid tumours, but its application is often limited because of severe side effects in individual patients. With the aim to find biomarkers capable of predicting normal tissue side reactions we analysed the radiation responses of cells from individual head and neck tumour and breast cancer patients of different clinical radiosensitivity in a multicentric study. Multiple parameters of cellular radiosensitivity were analysed in coded samples of peripheral blood lymphocytes (PBLs) and derived lymphoblastoid cell lines (LCLs) from 15 clinical radio-hypersensitive tumour patients and compared to age-and sex-matched non-radiosensitive patient controls and 15 lymphoblastoid cell lines from age-and sex-matched healthy controls of the KORA study. Experimental parameters included ionizing radiation (IR)-induced cell death (AnnexinV), induction and repair of DNA strand breaks (Comet assay), induction of yH2AX foci (as a result of DNA double strand breaks), and whole genome expression analyses. Considerable inter-individual differences in IR-induced DNA strand breaks and their repair and/or cell death could be detected in primary and immortalised cells with the applied assays. The group of clinically radiosensitive patients was not unequivocally distinguishable from normal responding patients nor were individual overreacting patients in the test system unambiguously identified by two different laboratories. Thus, the in vitro test systems investigated here seem not to be appropriate for a general prediction of clinical reactions during or after radiotherapy due to the experimental variability compared to the small effect of radiation sensitivity. Genome-wide expression analysis however revealed a set of 67 marker genes which were differentially induced 6 h after in vitro-irradiation in lymphocytes from radio-hypersensitive and non-radiosensitive patients. These results warrant future validation in larger cohorts in order to determine parameters potentially predictive for clinical radiosensitivity.	[Greve, Burkhard; Boelling, Tobias; Riesenbeck, Dorothea; Koenemann, Stefan; Willich, Normann; Eich, Hans Theodor] Univ Hosp Muenster, Dept Radiotherapy, Munster, Germany; [Dreffke, Kristin; Fritz, Eberhard] FLI, Leibniz Inst Age Res, Jena, Germany; [Rickinger, Astrid; Eckardt-Schupp, Friederike; Moertl, Simone] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Radiat Biol, Neuherberg, Germany; [Roessler, Ute; Sauerland, Christina] Univ Hosp Muenster, Inst Biostat & Clin Res, Munster, Germany; [Braselmann, Herbert] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Mol Radiat Biol, Neuherberg, Germany; [Sauter, Wiebke; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol, Neuherberg, Germany; [Mayer, Claudia; Popanda, Odilia; Schmezer, Peter] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany; [Roessler, Ute; Gomolka, Maria] Fed Off Radiat Protect, Dept Radiat Protect & Hlth, Oberschleissheim, Germany	University of Munster; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munster; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ)	Greve, B (corresponding author), Univ Hosp Muenster, Dept Radiotherapy, Munster, Germany.	greveb@uni-muenster.de	Popanda, Odilia/P-6917-2019; Moertl, Simone/M-7353-2014; Fritz, Eberhard/N-6402-2017; Amler, Susanne/B-7611-2013; Sauerland, Maria Cristina/A-4154-2014	Moertl, Simone/0000-0003-0644-0878; Amler, Susanne/0000-0001-6903-2906; 	Federal Ministry for the Environment, Nature Conservation and Nuclear safety [StSch 4467]	Federal Ministry for the Environment, Nature Conservation and Nuclear safety	The project was financed by the Federal Ministry for the Environment, Nature Conservation and Nuclear safety (StSch 4467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapetite C, 1999, INT J CANCER, V83, P83, DOI 10.1002/(SICI)1097-0215(19990924)83:1<83::AID-IJC16>3.0.CO;2-8; Alsbeih G, 2010, RADIAT RES, V173, P505, DOI 10.1667/RR1769.1; Andrievski A, 2009, INT J RADIAT BIOL, V85, P369, DOI 10.1080/09553000902781147; Azria D, 2012, CRIT REV ONCOL HEMAT, V84, pE35, DOI 10.1016/j.critrevonc.2010.08.003; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; BAUMANN M, 1995, LATE SEQUELAE ONCOLO; Bergqvist M, 1998, CANCER LETT, V133, P9, DOI 10.1016/S0304-3835(98)00178-5; Bese NS, 2007, INT J RADIAT ONCOL, V68, P654, DOI 10.1016/j.ijrobp.2007.03.010; BMU, 2008, SCHRIFT STRAHL REAKT; Bordon E, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-4; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Crompton NEA, 2001, INT J RADIAT ONCOL, V49, P547, DOI 10.1016/S0360-3016(00)01477-2; Crompton NEA, 1999, INT J RADIAT ONCOL, V45, P707, DOI 10.1016/S0360-3016(99)00256-4; Dikomey E, 2003, INT J RADIAT ONCOL, V56, P1194, DOI 10.1016/S0360-3016(03)00188-3; Djuzenova CS, 2006, BRIT J CANCER, V94, P1194, DOI 10.1038/sj.bjc.6603005; Fernet M, 2008, CANCER RADIOTHER, V12, P614, DOI 10.1016/j.canrad.2008.07.013; Greve B, 2009, APOPTOSIS, V14, P226, DOI 10.1007/s10495-008-0294-6; Hamasaki K, 2007, ENVIRON MOL MUTAGEN, V48, P38, DOI 10.1002/em.20273; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Hernandez LAH, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-17; Klokov D, 2006, RADIOTHER ONCOL, V80, P223, DOI 10.1016/j.radonc.2006.07.026; Lee JM, 2004, J VIROL, V78, P12694, DOI 10.1128/JVI.78.22.12694-12697.2004; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; LOBRICH M, 1994, INT J RADIAT BIOL, V65, P623, DOI 10.1080/09553009414550731; Marples B, 1998, BRIT J CANCER, V77, P1108, DOI 10.1038/bjc.1998.184; Mayer C, 2011, CANCER LETT, V302, P20, DOI 10.1016/j.canlet.2010.12.006; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Mirzayans R, 2006, INT J RADIAT ONCOL, V66, P1498, DOI 10.1016/j.ijrobp.2006.08.064; National Cancer Institute (NCI), 1988, COMM TOX CRIT; Olive PL, 2008, RADIOTHER ONCOL, V86, P336, DOI 10.1016/j.radonc.2007.09.002; Perez CA, 1993, PRINCIPLES PRACTICE, V2nd, P53; Popanda O, 2003, INT J RADIAT ONCOL, V55, P1216, DOI 10.1016/S0360-3016(02)04415-2; Rajeswari N, 2000, CARCINOGENESIS, V21, P557, DOI 10.1093/carcin/21.4.557; Riesenbeck D, 2005, MULTIPARAMETRISCHE U; Rosenberger A, 2011, DNA REPAIR, V10, P322, DOI 10.1016/j.dnarep.2010.12.003; Rube CE, 2008, CLIN CANCER RES, V14, P6546, DOI 10.1158/1078-0432.CCR-07-5147; Rube CE, 2010, INT J RADIAT ONCOL, V76, P1206, DOI 10.1016/j.ijrobp.2009.10.009; Rzeszowska-Wolny J, 2008, INT J RADIAT BIOL, V84, P635, DOI 10.1080/09553000802087041; Schunck C, 2004, CYTOGENET GENOME RES, V104, P383, DOI 10.1159/000077520; Seegenschmiedt MH., 1998, WHO TOXICITY CRITERI; Severin E, 2006, INT J RADIAT ONCOL, V64, P242, DOI 10.1016/j.ijrobp.2005.06.020; Shahidi M, 2007, CANCER LETT, V257, P263, DOI 10.1016/j.canlet.2007.08.002; Sonis S, 2007, ORAL ONCOL, V43, P289, DOI 10.1016/j.oraloncology.2006.03.014; Starmans MHW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028320; Svensson JP, 2006, PLOS MED, V3, P1904, DOI 10.1371/journal.pmed.0030422; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Tucker SL, 1996, RADIOTHER ONCOL, V38, P103, DOI 10.1016/0167-8140(95)01669-4; Twardella D, 2003, RADIOTHER ONCOL, V69, P145, DOI 10.1016/S0167-8140(03)00166-X; Twardella D, 2002, RADIOTHER ONCOL, V62, P249, DOI 10.1016/S0167-8140(01)00491-1; Vasireddy RS, 2010, BRIT J CANCER, V102, P1511, DOI 10.1038/sj.bjc.6605666; Werbrouck J, 2010, ONCOL REP, V23, P571, DOI 10.3892/or_00000671; Williams JR, 2008, INT J RADIAT BIOL, V84, P151, DOI 10.1080/09553000701797021; Wistop A, 2005, STRAHLENTHER ONKOL, V181, P326, DOI 10.1007/s00066-005-1372-0; Zijno A, 2010, MUTAT RES-FUND MOL M, V684, P98, DOI 10.1016/j.mrfmmm.2009.12.008; Zou P, 2007, J VIROL, V81, P10029, DOI 10.1128/JVI.02241-06	55	43	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47185	10.1371/journal.pone.0047185	http://dx.doi.org/10.1371/journal.pone.0047185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110060	Green Published, gold, Green Submitted			2022-12-27	WOS:000310193600009
J	Akbarshahi, H; Menzel, M; Bauden, MP; Rosendahl, A; Andersson, R				Akbarshahi, Hamid; Menzel, Mandy; Bauden, Monika Posaric; Rosendahl, Ann; Andersson, Roland			Enrichment of Murine CD68(+)CCR2(+) and CD68(+)CD206(+) Lung Macrophages in Acute Pancreatitis-Associated Acute Lung Injury	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; INTERLEUKIN-6; BLOOD	Acute lung injury (ALI) is an important cause of mortality in critically ill patients. Acute pancreatitis (AP) is one of the risk factors for developing this syndrome. Among the inflammatory cells, macrophages have a key role in determining the severity of the acute lung injury. In the lungs, macrophages constitute a heterogeneous cell population distributed in different compartments. Changes in not only the macrophage count, but also in their phenotype have been seen during the course of lung injury. A murine ductal ligation model of acute pancreatitis showed substantial morphological changes in the pancreas and lungs. Immunohistochemistry showed neutrophil recruitment into both organs after 9 hours and later on. F4/80(+) cells in the pancreas increased in the ligated animals, though there was not a significant difference in their number in the lungs as compared to sham operated animals. Flow cytometry analysis of lung macrophages demonstrated an enrichment of F4/80(-) CD68(+)CCR2(+) and F4/80(-) CD68(+)CD206(+) lung macrophages in ligated animals ( AP) as compared to the sham operated group. The level of interleukin-6 in plasma increased 3 hours after ligation compared to the sham operated group, as a first indicator of a systemic inflammatory response. This study suggests a role for F4/80(-) CD68(+) macrophages in the pathogenesis of acute lung injury in acute pancreatitis. Studying lung macrophages for different phenotypic markers, their polarization, activation and recruitment, in the context of acute lung injury, is a novel area to potentially identify interventions which may improve the outcome of acute lung injury.	[Andersson, Roland] Skane Univ Hosp, Clin Sci Lund, Dept Surg, Lund, Sweden; [Akbarshahi, Hamid; Menzel, Mandy; Bauden, Monika Posaric; Rosendahl, Ann] Lund Univ, Dept Surg, Clin Sci Lund, Lund, Sweden	Lund University; Skane University Hospital; Lund University	Andersson, R (corresponding author), Skane Univ Hosp, Clin Sci Lund, Dept Surg, Lund, Sweden.	roland.andersson@med.lu.se	Akbarshahi, Hamid/C-1650-2018	Akbarshahi, Hamid/0000-0001-7748-286X; Menzel, Mandy/0000-0003-1286-2022	Evy and Gunnar Sandberg Foundation, Malmo, Sweden	Evy and Gunnar Sandberg Foundation, Malmo, Sweden	The study was supported by the Evy and Gunnar Sandberg Foundation, Malmo, Sweden. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann C, 2011, AM J PHYSL RENAL PHY; Aoun E, 2009, PANCREATOLOGY, V9, P777, DOI 10.1159/000214191; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065; Ikei S, 1998, J GASTROEN HEPATOL, V13, P1274, DOI 10.1111/j.1440-1746.1998.tb00617.x; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; KOIKE K, 1992, J SURG RES, V52, P656, DOI 10.1016/0022-4804(92)90145-P; Lo CJ, 1998, J SURG RES, V79, P179, DOI 10.1006/jsre.1998.5418; Lund H, 2006, SCAND J GASTROENTERO, V41, P234, DOI 10.1080/00365520510024133; Malleo G, 2007, THESCIENTIFICWORLDJO, V7, P431, DOI 10.1100/tsw.2007.98; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Meyerhotz DK, 2008, AM J SURG, V196, P675, DOI 10.1016/j.amjsurg.2008.07.009; Miyake Y, 2007, J IMMUNOL, V178, P5001, DOI 10.4049/jimmunol.178.8.5001; Pastor CM, 2003, CHEST, V124, P2341, DOI 10.1378/chest.124.6.2341; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Rongione AJ, 1997, GASTROENTEROLOGY, V112, P960, DOI 10.1053/gast.1997.v112.pm9041259; Samuel I, 2010, PANCREATOLOGY, V10, P536, DOI 10.1159/000320776; Shrivastava P, 2010, WORLD J GASTROENTERO, V16, P3995, DOI 10.3748/wjg.v16.i32.3995; Steer ML, 2001, RESP PHYSIOL, V128, P13, DOI 10.1016/S0034-5687(01)00259-6; Su Kim Hue, 2006, HPB (Oxford), V8, P264, DOI 10.1080/13651820500467358; Talamini G, 1999, AM J SURG, V177, P7, DOI 10.1016/S0002-9610(98)00296-7; Thenappan T, 2011, AM J RESP CRIT CARE, V183, P1080, DOI 10.1164/rccm.201008-1303OC; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52	30	23	25	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e42654	10.1371/journal.pone.0042654	http://dx.doi.org/10.1371/journal.pone.0042654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110041	Green Published, Green Submitted, gold			2022-12-27	WOS:000310193400001
J	Mi, XS; Feng, Q; Lo, ACY; Chang, RCC; Lin, B; Chung, SK; So, KF				Mi, Xue-Song; Feng, Qian; Lo, Amy Cheuk Yin; Chang, Raymond Chuen-Chung; Lin, Bin; Chung, Sookja Kim; So, Kwok-Fai			Protection of Retinal Ganglion Cells and Retinal Vasculature by Lycium Barbarum Polysaccharides in a Mouse Model of Acute Ocular Hypertension	PLOS ONE			English	Article							AMYLOID PEPTIDE NEUROTOXICITY; ISCHEMIA-REPERFUSION INJURY; GLYCATION END-PRODUCTS; BLOOD-BRAIN-BARRIER; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; ENDOTHELIAL-CELLS; PRECURSOR PROTEIN; RATS; ACCUMULATION	Acute ocular hypertension (AOH) is a condition found in acute glaucoma. The purpose of this study is to investigate the protective effect of Lycium barbarum polysaccharides (LBP) and its protective mechanisms in the AOH insult. LBP has been shown to exhibit neuroprotective effect in the chronic ocular hypertension (COH) experiments. AOH mouse model was induced in unilateral eye for one hour by introducing 90 mmHg ocular pressure. The animal was fed with LBP solution (1 mg/kg) or vehicle daily from 7 days before the AOH insult till sacrifice at either day 4 or day 7 post insult. The neuroprotective effects of LBP on retinal ganglion cells (RGCs) and blood-retinal-barrier (BRB) were evaluated. In control AOH retina, loss of RGCs, thinning of IRL thickness, increased IgG leakage, broken tight junctions, and decreased density of retinal blood vessels were observed. However, in LBP-treated AOH retina, there was less loss of RGCs with thinning of IRL thickness, IgG leakage, more continued structure of tight junctions associated with higher level of occludin protein and the recovery of the blood vessel density when compared with vehicle-treated AOH retina. Moreover, we found that LBP provides neuroprotection by down-regulating RAGE, ET-1, A beta and AGE in the retina, as well as their related signaling pathways, which was related to inhibiting vascular damages and the neuronal degeneration in AOH insults. The present study suggests that LBP could prevent damage to RGCs from AOH-induced ischemic injury; furthermore, through its effects on blood vessel protection, LBP would also be a potential treatment for vascular-related retinopathy.	[Mi, Xue-Song] Jinan Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Mi, Xue-Song; Feng, Qian; Chang, Raymond Chuen-Chung; Lin, Bin; Chung, Sookja Kim; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Mi, Xue-Song; Feng, Qian; Chang, Raymond Chuen-Chung; Lin, Bin; Chung, Sookja Kim; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Lo, Amy Cheuk Yin; Lin, Bin] Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Hong Kong, Hong Kong, Peoples R China; [So, Kwok-Fai] Jinan Univ, Joint Lab Brain Funct & Hlth BFAH, Hong Kong, Hong Kong, Peoples R China	Jinan University; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	So, KF (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	hrmaskf@hkucc.hku.hk	Chang, Raymond Chuen-Chung/C-1107-2009; Lo, Amy C. Y./C-1195-2009; Lin, Bin/E-9871-2010	Chang, Raymond Chuen-Chung/0000-0001-8538-7993; Lo, Amy C. Y./0000-0003-4239-6851; Lin, Bin/0000-0003-1309-3480; So, Kwok-Fai/0000-0003-4039-4246	Hong Kong Research Grant Council [2011CB707501]; fundamental Research Funds for The Central Universities [21609101]; Azalea Foundation	Hong Kong Research Grant Council(Hong Kong Research Grants Council); fundamental Research Funds for The Central Universities(Fundamental Research Funds for the Central Universities); Azalea Foundation	This study was supported by a GRF (General Research Fund) grant from Hong Kong Research Grant Council (National Basic Research Program of China (2011CB707501)), the fundamental Research Funds for The Central Universities (21609101), and Azalea (1972) Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226, DOI 10.1167/iovs.04-0450; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bui BV, 2005, INVEST OPHTH VIS SCI, V46, P202, DOI 10.1167/iovs.04-0421; Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; Chi ZL, 2010, HUM MOL GENET, V19, P2606, DOI 10.1093/hmg/ddq146; Chiu Kin, 2009, J Ocul Biol Dis Infor, V2, P127; Chiu K, 2010, J CELL BIOCHEM, V110, P311, DOI 10.1002/jcb.22539; Clark AF, 2003, NAT REV DRUG DISCOV, V2, P448, DOI 10.1038/nrd1106; Cui Q, 2007, NEUROSCIENCE, V146, P986, DOI 10.1016/j.neuroscience.2007.02.034; Da T, 2004, INVEST OPHTH VIS SCI, V45, P4477, DOI 10.1167/iovs.04-0940; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Donello JE, 2001, J PHARMACOL EXP THER, V296, P216; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; Goldblum D, 2007, INVEST OPHTH VIS SCI, V48, P5085, DOI 10.1167/iovs.06-1249; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Harada C, 2000, NEUROSCI LETT, V292, P134, DOI 10.1016/S0304-3940(00)01444-0; Ho YS, 2007, BRAIN RES, V1158, P123, DOI 10.1016/j.brainres.2007.04.075; Ho YS, 2009, CELL MOL NEUROBIOL, V29, P1233, DOI 10.1007/s10571-009-9419-x; Huang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021411; Jablonski M, 2011, PHYSIOL RES, V60, pS113, DOI 10.33549/physiolres.932186; Leung JWC, 2009, BRAIN RES, V1266, P121, DOI 10.1016/j.brainres.2009.01.070; Li LL, 2011, NEURAL REGEN RES, V6, P1720, DOI 10.3969/j.issn.1673-5374.2011.22.007; Li RS, 2006, CLIN EXP OPHTHALMOL, V34, P575, DOI 10.1111/j.1442-9071.2006.01279.x; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Lo ACY, 2005, J CEREBR BLOOD F MET, V25, P998, DOI 10.1038/sj.jcbfm.9600108; Maczurek A, 2008, ANN NY ACAD SCI, V1126, P147, DOI 10.1196/annals.1433.026; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; Murata H, 2008, INVEST OPHTH VIS SCI, V49, P5546, DOI 10.1167/iovs.07-1211; PENG XD, 2002, J NINGXIA MED COLL, V24, P79; Quehenberger P, 2000, DIABETES, V49, P1561, DOI 10.2337/diabetes.49.9.1561; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Sakamoto K, 2009, EXP EYE RES, V88, P974, DOI 10.1016/j.exer.2008.12.011; Shen B, 2010, BRAIN RES, V1342, P118, DOI 10.1016/j.brainres.2010.04.032; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b; SONG Y, 1995, J NINGXIA MED COLL, V17, P12; Stitt AW, 2001, BRIT J OPHTHALMOL, V85, P746, DOI 10.1136/bjo.85.6.746; Takita H, 2003, INVEST OPHTH VIS SCI, V44, P4497, DOI 10.1167/iovs.03-0052; Tezel G, 2007, INVEST OPHTH VIS SCI, V48, P1201, DOI 10.1167/iovs.06-0737; Tombran-Tink J., 2008, MECH GLAUCOMAS DIS P; Wall DS, 2004, INVEST OPHTH VIS SCI, V45, P3704, DOI 10.1167/iovs.03-1410; Whiteley W, 2011, STROKE, V42, P10, DOI 10.1161/STROKEAHA.110.588954; Yamagishi S, 1998, DIABETOLOGIA, V41, P1435, DOI 10.1007/s001250051089; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033596; Yang LP, 2010, NEURAL REGEN RES, V5, P273, DOI 10.3969/j.issn.1673-5374.2010.04.006; Yu MS, 2007, INT J MOL MED, V20, P261; Yu MS, 2005, EXP GERONTOL, V40, P716, DOI 10.1016/j.exger.2005.06.010; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510	53	74	82	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e45469	10.1371/journal.pone.0045469	http://dx.doi.org/10.1371/journal.pone.0045469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094016	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200001
J	Di Rienzo, F; Collet, C; Hoyek, N; Guillot, A				Di Rienzo, Franck; Collet, Christian; Hoyek, Nady; Guillot, Aymeric			Selective Effect of Physical Fatigue on Motor Imagery Accuracy	PLOS ONE			English	Article							POSTURAL CONTROL; MENTAL PRACTICE; MOVEMENT; REPRESENTATIONS; MOTONEURONS; PERFORMANCE; EMERGENCE; QUALITY	While the use of motor imagery (the mental representation of an action without overt execution) during actual training sessions is usually recommended, experimental studies examining the effect of physical fatigue on subsequent motor imagery performance are sparse and yielded divergent findings. Here, we investigated whether physical fatigue occurring during an intense sport training session affected motor imagery ability. Twelve swimmers (nine males, mean age 15.5 years) conducted a 45 min physically-fatiguing protocol where they swam from 70% to 100% of their maximal aerobic speed. We tested motor imagery ability immediately before and after fatigue state. Participants randomly imagined performing a swim turn using internal and external visual imagery. Self-reports ratings, imagery times and electrodermal responses, an index of alertness from the autonomic nervous system, were the dependent variables. Self-reports ratings indicated that participants did not encounter difficulty when performing motor imagery after fatigue. However, motor imagery times were significantly shortened during posttest compared to both pretest and actual turn times, thus indicating reduced timing accuracy. Looking at the selective effect of physical fatigue on external visual imagery did not reveal any difference before and after fatigue, whereas significantly shorter imagined times and electrodermal responses (respectively 15% and 48% decrease, p < 0.001) were observed during the posttest for internal visual imagery. A significant correlation (r = 0.64; p < 0.05) was observed between motor imagery vividness (estimated through imagery questionnaire) and autonomic responses during motor imagery after fatigue. These data support that unlike local muscle fatigue, physical fatigue occurring during intense sport training sessions is likely to affect motor imagery accuracy. These results might be explained by the updating of the internal representation of the motor sequence, due to temporary feedback originating from actual motor practice under fatigue. These findings provide insights to the co-dependent relationship between mental and motor processes.	[Di Rienzo, Franck; Collet, Christian; Hoyek, Nady; Guillot, Aymeric] Univ Lyon 1, CRIS EA Performance Mentale Motrice & Mat P3M 647, F-69000 Villeurbanne, France; [Guillot, Aymeric] Inst Univ France, F-75000 Paris, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut Universitaire de France	Guillot, A (corresponding author), Univ Lyon 1, CRIS EA Performance Mentale Motrice & Mat P3M 647, F-69000 Villeurbanne, France.	aymeric.guillot@univ-lyon1.fr						Borg G. A., 1998, BORGS RATING PERCEIV; Caeyenberghs K, 2009, DEVELOPMENTAL SCI, V12, P474, DOI 10.1111/j.1467-7687.2008.00803.x; Callow N., 2006, Journal of Imagery Research in Sport and Physical Activity, V1, P2, DOI 10.2202/1932-0191.1001; Choudhury S, 2007, CONSCIOUS COGN, V16, P886, DOI 10.1016/j.concog.2006.11.001; Collet C, 2011, EXERC SPORT SCI REV, V39, P85, DOI 10.1097/JES.0b013e31820ac5e0; Cumming J., 2008, ADV APPL SPORT PSYCH, P5, DOI [10.4324/9780203887073, DOI 10.4324/9780203887073]; Cumming JL, 2001, SPORT PSYCHOL, V15, P276, DOI 10.1123/tsp.15.3.276; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Demougeot L, 2011, J NEUROSCI, V31, P10712, DOI 10.1523/JNEUROSCI.6032-10.2011; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Gandevia SC, 1997, J PHYSIOL-LONDON, V505, P259, DOI 10.1111/j.1469-7793.1997.259bc.x; Grangeon M, 2011, APPL PSYCHOPHYS BIOF, V36, P47, DOI 10.1007/s10484-011-9145-2; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Guillot A, 2004, J PSYCHOPHYSIOL, V18, P190, DOI 10.1027/0269-8803.18.4.190; Guillot A, 2005, EUR J APPL PHYSIOL, V95, P186, DOI 10.1007/s00421-005-1400-x; Guillot A, 2005, BIOL SPORT, V22, P215; Guillot A, 2011, FUNCTIONAL MAGNETIC, V1; Guillot A., 2008, INT REV SPORT EXER P, V1, P31, DOI [10.1080/17509840701823139, DOI 10.1080/17509840701823139]; Guillot A, 2008, NEUROIMAGE, V41, P1471, DOI 10.1016/j.neuroimage.2008.03.042; Guillot A, 2012, INT REV SPORT EXER P, V5, P3, DOI 10.1080/1750984X.2011.623787; Hall CR, 1998, INT J SPORT PSYCHOL, V29, P73; Holmes PS, 2001, J APPL SPORT PSYCHOL, V13, P60, DOI 10.1080/10413200109339004; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Kanekar N, 2008, CLIN NEUROPHYSIOL, V119, P2304, DOI 10.1016/j.clinph.2008.06.015; Lorey B, 2009, EXP BRAIN RES, V194, P233, DOI 10.1007/s00221-008-1693-1; Louis M, 2011, J COGN PSYCHOL, V23, P374, DOI 10.1080/20445911.2011.521739; MacIntyre T, 2007, J IMAGERY RES SPORT, V2; Macuga KL, 2012, NEUROIMAGE, V59, P2798, DOI 10.1016/j.neuroimage.2011.09.083; Molina M, 2008, J EXP CHILD PSYCHOL, V99, P196, DOI 10.1016/j.jecp.2007.10.001; Morris T., 2005, IMAGERY SPORT; Munroe KJ, 2000, SPORT PSYCHOL, V14, P119, DOI 10.1123/tsp.14.2.119; Munroe-Chandler KJ, 2007, RES Q EXERCISE SPORT, V78, P103; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Olsson CJ, 2012, EXP NEUROL, V236, P46, DOI 10.1016/j.expneurol.2012.03.022; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; Paivio A., 1985, CANADIAN J APPL SPOR, V10, P22; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Roberts R, 2008, J SPORT EXERCISE PSY, V30, P200, DOI 10.1123/jsep.30.2.200; Roure R, 1999, PHYSIOL BEHAV, V66, P63, DOI 10.1016/S0031-9384(99)00026-8; Schuster C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-75; Schwoebel J, 2002, BRAIN COGNITION, V50, P1, DOI 10.1016/S0278-2626(02)00005-2; SIRIGU A, 1995, NEUROREPORT, V6, P997, DOI 10.1097/00001756-199505090-00012; Stinear C.M., 2010, NEUROPHYSIOLOGICAL F, P47, DOI DOI 10.1093/ACPROF:OSO/9780199546251.003.0004; Stinear CM, 2003, CLIN NEUROPHYSIOL, V114, P909, DOI 10.1016/S1388-2457(02)00373-5; Taylor JL, 2000, EUR J APPL PHYSIOL, V83, P106, DOI 10.1007/s004210000269; VERNETMAURY E, 1995, BEHAV BRAIN RES, V67, P103, DOI 10.1016/0166-4328(94)00148-9; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	49	18	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47207	10.1371/journal.pone.0047207	http://dx.doi.org/10.1371/journal.pone.0047207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082148	gold, Green Published			2022-12-27	WOS:000311146900044
J	Gallego, P; Planell, R; Benach, J; Querol, E; Perez-Pons, JA; Reverter, D				Gallego, Pablo; Planell, Raquel; Benach, Jordi; Querol, Enrique; Perez-Pons, Josep A.; Reverter, David			Structural Characterization of the Enzymes Composing the Arginine Deiminase Pathway in Mycoplasma penetrans	PLOS ONE			English	Article							FURIOSUS ORNITHINE CARBAMOYLTRANSFERASE; CARBAMOYL-PHOSPHATE SYNTHETASE; ARCHAEON PYROCOCCUS-FURIOSUS; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; ENTEROCOCCUS-FAECALIS; AGMATINE DEIMINASE; GROWTH-INHIBITION; ESCHERICHIA-COLI; METABOLISM	The metabolism of arginine towards ATP synthesis has been considered a major source of energy for microorganisms such as Mycoplasma penetrans in anaerobic conditions. Additionally, this pathway has also been implicated in pathogenic and virulence mechanism of certain microorganisms, i.e. protection from acidic stress during infection. In this work we present the crystal structures of the three enzymes composing the gene cluster of the arginine deiminase pathway from M. penetrans: arginine deiminase (ADI), ornithine carbamoyltransferase (OTC) and carbamate kinase (CK). The arginine deiminase (ADI) structure has been refined to 2.3 angstrom resolution in its apo-form, displaying an "open" conformation of the active site of the enzyme in comparison to previous complex structures with substrate intermediates. The active site pocket of ADI is empty, with some of the catalytic and binding residues far from their active positions, suggesting major conformational changes upon substrate binding. Ornithine carbamoyltransferase (OTC) has been refined in two crystal forms at 2.5 angstrom and 2.6 angstrom resolution, respectively, both displaying an identical dodecameric structure with a 23-point symmetry. The dodecameric structure of OTC represents the highest level of organization in this protein family and in M. penetrans it is constituted by a novel interface between the four catalytic homotrimers. Carbamate kinase (CK) has been refined to 2.5 angstrom resolution and its structure is characterized by the presence of two ion sulfates in the active site, one in the carbamoyl phosphate binding site and the other in the beta-phosphate ADP binding pocket of the enzyme. The CK structure also shows variations in some of the elements that regulate the catalytic activity of the enzyme. The relatively low number of metabolic pathways and the relevance in human pathogenesis of Mycoplasma penetrans places the arginine deiminase pathway enzymes as potential targets to design specific inhibitors against this human parasite.	[Gallego, Pablo; Planell, Raquel; Querol, Enrique; Perez-Pons, Josep A.; Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Gallego, Pablo; Planell, Raquel; Querol, Enrique; Perez-Pons, Josep A.; Reverter, David] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Benach, Jordi] ALBA Synchrotron Light Source, Experiments Div, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Reverter, D (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.	david.reverter@uab.cat	Reverter, David/H-5360-2015; Perez Pons, Josep Antoni/F-8622-2016	Reverter, David/0000-0002-5347-0992; Perez Pons, Josep Antoni/0000-0002-5062-2989	"Ministerio de Ciencia e Innovacion" of Spain [BFU2008-0364, BIO2007-67904-C02-01, BFU2010-22209-C02-01]; European Community [MIRG-CT-2007-200346]	"Ministerio de Ciencia e Innovacion" of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission)	This work was supported by grants from the "Ministerio de Ciencia e Innovacion" of Spain, BFU2008-0364 to DR. and BIO2007-67904-C02-01, BFU2010-22209-C02-01 to EQ, and from the European Community MIRG-CT-2007-200346 to DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAL AT, 1979, ANNU REV MICROBIOL, V33, P139, DOI 10.1146/annurev.mi.33.100179.001035; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAUR H, 1990, J BIOL CHEM, V265, P14728; BAUR H, 1989, EUR J BIOCHEM, V179, P53, DOI 10.1111/j.1432-1033.1989.tb14520.x; Biagini GA, 2003, MOL BIOCHEM PARASIT, V128, P11, DOI 10.1016/S0166-6851(03)00025-2; Brady BS, 2010, GENE, V462, P18, DOI 10.1016/j.gene.2010.04.007; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Clantin B, 2001, EUR J BIOCHEM, V268, P3937, DOI 10.1046/j.1432-1327.2001.02302.x; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; Das K, 2004, STRUCTURE, V12, P657, DOI 10.1016/j.str.2004.02.017; de las Rivas B, 2009, J MOL BIOL, V393, P425, DOI 10.1016/j.jmb.2009.08.002; Diaz-Munoz M, 2010, CURR MED CHEM, V17, P2253, DOI 10.2174/092986710791331031; Dillon Brian J, 2002, Med Sci Monit, V8, pBR248; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FALMAGNE P, 1985, J BACTERIOL, V161, P714, DOI 10.1128/JB.161.2.714-719.1985; Galkin A, 2005, J BIOL CHEM, V280, P34080, DOI 10.1074/jbc.M505471200; Galkin A, 2004, J BIOL CHEM, V279, P14001, DOI 10.1074/jbc.M313410200; Galkin A, 2010, ACTA CRYSTALLOGR F, V66, P386, DOI 10.1107/S1744309110004665; GAMPER M, 1991, J BACTERIOL, V173, P4742, DOI 10.1128/jb.173.15.4742-4750.1991; Griswold AR, 2006, J BACTERIOL, V188, P834, DOI 10.1128/JB.188.3.834-841.2006; HONZATKO RB, 1982, J MOL BIOL, V160, P219, DOI 10.1016/0022-2836(82)90175-9; HOUGHTON JE, 1984, P NATL ACAD SCI-BIOL, V81, P4864, DOI 10.1073/pnas.81.15.4864; Humm A, 1997, EMBO J, V16, P3373, DOI 10.1093/emboj/16.12.3373; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knodler LA, 1998, J BIOL CHEM, V273, P4470, DOI 10.1074/jbc.273.8.4470; Langley DB, 2000, J BIOL CHEM, V275, P20012, DOI 10.1074/jbc.M000585200; LEGRAIN C, 1977, EUR J BIOCHEM, V80, P401, DOI 10.1111/j.1432-1033.1977.tb11895.x; LINSTEAD D, 1983, MOL BIOCHEM PARASIT, V8, P241, DOI 10.1016/0166-6851(83)90046-4; Llacer JL, 2007, J BACTERIOL, V189, P1254, DOI 10.1128/JB.01216-06; Ludwig RA, 1992, MOL BIOCHEM PARASIT, V51, P29; LUTHI E, 1986, J GEN MICROBIOL, V132, P2667; Marina A, 1998, EUR J BIOCHEM, V253, P280, DOI 10.1046/j.1432-1327.1998.2530280.x; Massant J, 2004, BIOCHEM SOC T, V32, P306, DOI 10.1042/BST0320306; Massant J, 2003, ACTA CRYSTALLOGR D, V59, P2140, DOI 10.1107/S0907444903019231; MIYAZAKI K, 1990, CANCER RES, V50, P4522; Mouz N, 1996, P NATL ACAD SCI USA, V93, P9414, DOI 10.1073/pnas.93.18.9414; Murray-Rust J, 2001, NAT STRUCT BIOL, V8, P679, DOI 10.1038/90387; Nguyen VT, 1996, EUR J BIOCHEM, V236, P283, DOI 10.1111/j.1432-1033.1996.00283.x; Philip R, 2003, BRIT J CANCER, V88, P613, DOI 10.1038/sj.bjc.6600681; Pich OQ, 2006, MICROBIOL-SGM, V152, P519, DOI 10.1099/mic.0.28287-0; Planell R, 2008, THESIS U AUTONOMA BA; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Pollack JD, 1997, TRENDS MICROBIOL, V5, P413; Ramon-Maique S, 2010, J MOL BIOL, V397, P1261, DOI 10.1016/j.jmb.2010.02.038; Ramon-Maiques S, 2000, J MOL BIOL, V299, P463, DOI 10.1006/jmbi.2000.3779; RAZIN S, 1978, MICROBIOL REV, V42, P414, DOI 10.1128/MMBR.42.2.414-470.1978; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Ruepp A, 1993, PLANT PHYSIOL, V101, P429; Sankaranarayanan R, 2008, J MOL BIOL, V375, P1052, DOI 10.1016/j.jmb.2007.11.025; SCHOFIELD PJ, 1992, MOL BIOCHEM PARASIT, V51, P29, DOI 10.1016/0166-6851(92)90197-R; Schrodinger L., 2020, PYMOL; SIMON JP, 1982, J BACTERIOL, V152, P676; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; STALON V, 1967, BIOCHIM BIOPHYS ACTA, V139, P91, DOI 10.1016/0005-2744(67)90115-5; TERAYAMA H, 1982, BIOCHIM BIOPHYS ACTA, V720, P188, DOI 10.1016/0167-4889(82)90011-8; Uriarte M, 1999, J BIOL CHEM, V274, P16295, DOI 10.1074/jbc.274.23.16295; VANDERWAUVEN C, 1986, ARCH MICROBIOL, V145, P386, DOI 10.1007/BF00470876; VANDERWAUVEN C, 1984, J BACTERIOL, V160, P928, DOI 10.1128/JB.160.3.928-934.1984; VILLERET V, 1995, P NATL ACAD SCI USA, V92, P10762, DOI 10.1073/pnas.92.23.10762; Villeret V, 1998, P NATL ACAD SCI USA, V95, P2801, DOI 10.1073/pnas.95.6.2801; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YARLETT N, 1994, J EUKARYOT MICROBIOL, V41, P554, DOI 10.1111/j.1550-7408.1994.tb01516.x	63	10	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47886	10.1371/journal.pone.0047886	http://dx.doi.org/10.1371/journal.pone.0047886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082227	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900124
J	Landes, M; van Lettow, M; Chan, AK; Mayuni, I; Schouten, EJ; Bedell, RA				Landes, Megan; van Lettow, Monique; Chan, Adrienne K.; Mayuni, Isabell; Schouten, Erik J.; Bedell, Richard A.			Mortality and Health Outcomes of HIV-Exposed and Unexposed Children in a PMTCT Cohort in Malawi	PLOS ONE			English	Article							UNINFECTED MOTHERS; INFECTED MOTHERS; INFANTS; AFRICA; PREVENTION; TRANSMISSION; TUBERCULOSIS; PREVALENCE; UGANDA; WOMEN	Background: Mortality and morbidity among HIV-exposed children are thought to be high in Malawi. We sought to determine mortality and health outcomes of HIV-exposed and unexposed infants within a PMTCT program. Method: Data were collected as part of a retrospective cohort study in Zomba District, Malawi. HIV-infected mothers were identified via antenatal, delivery and postpartum records with a delivery date 18-20 months prior; the next registered HIV-uninfected mother was identified as a control. By interview and health record review, data on socio-demographic characteristics, service uptake, and health outcomes were collected. HIV-testing was offered to all exposed children. Results: 173 HIV-infected and 214 uninfected mothers were included. 4 stillbirths (1.0%) occurred; among the 383 livebirths, 41 (10.7%) children died by 20 months (32 (18.7%) HIV-exposed and 9 unexposed children (4.3%; p<0.0001)). Risk factors for child death included: HIV-exposure [adjOR2.9(95% CI 1.1-7.2)], low birthweight [adjOR2.5(1.0-6.3)], previous child death (adjOR25.1(6.5-97.5)] and maternal death [adjOR5.3(11.4-20.5)]. At 20 months, HIV-infected children had significantly poorer health outcomes than HIV-unexposed children and HIV-exposed but uninfected children (HIV-EU), including: hospital admissions, delayed development, undernutrition and restrictions in function (Lansky scale); no significant differences were seen between HIV-EU and HIV-unexposed children. Overall, no difference was seen at 20 months among HIV-infected, HIV-EU and HIV-unexposed groups in Z-scores (%<-22.0) for weight, height and BMI. Risk factors for poor functional health status at 20 months included: HIV-infection [adjOR8.9(2.4-32.6)], maternal illness [adjOR2.8(1.5-5.0)] and low birthweight [adjOR2.0(1.0-4.1)]. Conclusion: Child mortality remains high within this context and could be reduced through more effective PMTCT including prioritizing the treatment of maternal HIV infection to address the effect of maternal health and survival on infant health and survival. HIV-infected children demonstrated developmental delays, functional health and nutritional deficits that underscore the need for increased uptake of early infant diagnosis and institution of ART for all infected infants.	[Landes, Megan; van Lettow, Monique; Chan, Adrienne K.; Mayuni, Isabell; Bedell, Richard A.] Dignitas Int, Zomba, Malawi; [Landes, Megan; Chan, Adrienne K.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [van Lettow, Monique; Chan, Adrienne K.; Schouten, Erik J.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Schouten, Erik J.] Management Sci Hlth, Lilongwe, Malawi	University of Toronto; University of Toronto	van Lettow, M (corresponding author), Dignitas Int, Zomba, Malawi.	m.vanlettow@dignitasinternational.org	Bedell, Richard/AAC-2595-2020	Bedell, Richard/0000-0002-5687-8053	Department of Family and Community Medicine, University of Toronto	Department of Family and Community Medicine, University of Toronto(University of Toronto)	ML is supported by a New Investigator Award from the Department of Family and Community Medicine, University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abubakar A, 2008, TROP MED INT HEALTH, V13, P880, DOI 10.1111/j.1365-3156.2008.02079.x; [Anonymous], 2011, WORLD HLTH STAT; Brahmbhatt H, 2006, JAIDS-J ACQ IMM DEF, V41, P504, DOI 10.1097/01.qai.0000188122.15493.0a; Brahmbhatt H, 2003, AIDS, V17, P879, DOI 10.1097/00002030-200304110-00013; Gupta A, 2007, CLIN INFECT DIS, V45, P241, DOI 10.1086/518974; Hesseling AC, 2009, CLIN INFECT DIS, V48, P108, DOI 10.1086/595012; Kimani-Murage EW, 2001, BMC PEDIATR, V11, P23; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Kurewa EN, 2010, J PERINATOL, V30, P88, DOI 10.1038/jp.2009.121; LANSKY SB, 1987, CANCER, V60, P1651, DOI 10.1002/1097-0142(19871001)60:7<1651::AID-CNCR2820600738>3.0.CO;2-J; Liu KC, 2011, J ACQ IMMUN DEF SYND, V6, P1; Madhi SA, 2006, J CLIN VIROL, V36, P215, DOI 10.1016/j.jcv.2006.03.010; Malawi Ministry of Health, 2008, GUID ART PROV; Malawi MOH, 2008, HIV SYPH SER SURV NA; Manda SOM, 1999, SOC SCI MED, V48, P301, DOI 10.1016/S0277-9536(98)00359-1; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; Nalwoga A, 2010, TROP MED INT HEALTH, V15, P414, DOI 10.1111/j.1365-3156.2010.02476.x; Naniche D, 2009, AM J TROP MED HYG, V80, P870, DOI 10.4269/ajtmh.2009.80.870; Ndirangu J, 2012, ANTIVIR THER, V17, P81, DOI 10.3851/IMP1991; Ndirangu J, 2010, AIDS, V24, P593, DOI 10.1097/QAD.0b013e328335cff5; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Patel D, 2010, AIDS, V24, P437, DOI 10.1097/QAD.0b013e3283345f91; Payongayong E., 2006, SIMPLE HOUSEHOLD POV; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Shapiro RL, 2007, J INFECT DIS, V196, P562, DOI 10.1086/519847; UNAIDS, 2010, GLOB REP 2010 REP GL; van Lettow M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-426; Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43	29	58	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47337	10.1371/journal.pone.0047337	http://dx.doi.org/10.1371/journal.pone.0047337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082157	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900053
J	Leon-Sarmiento, FE; Bayona, EA; Bayona-Prieto, J; Osman, A; Doty, RL				Leon-Sarmiento, Fidias E.; Bayona, Edgardo A.; Bayona-Prieto, Jaime; Osman, Allen; Doty, Richard L.			Profound Olfactory Dysfunction in Myasthenia Gravis	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; SMELL IDENTIFICATION TEST; OF-PENNSYLVANIA SMELL; PARKINSONISM-DEMENTIA COMPLEX; NUCLEUS BASALIS; ODOR IDENTIFICATION; DISEASE; ALZHEIMERS; MEYNERT; BRAIN	In this study we demonstrate that myasthenia gravis, an autoimmune disease strongly identified with deficient acetylcholine receptor transmission at the post-synaptic neuromuscular junction, is accompanied by a profound loss of olfactory function. Twenty-seven MG patients, 27 matched healthy controls, and 11 patients with polymiositis, a disease with peripheral neuromuscular symptoms analogous to myasthenia gravis with no known central nervous system involvement, were tested. All were administered the University of Pennsylvania Smell Identification Test (UPSIT) and the Picture Identification Test (PIT), a test analogous in content and form to the UPSIT designed to control for non-olfactory cognitive confounds. The UPSIT scores of the myasthenia gravis patients were markedly lower than those of the age-and sex-matched normal controls [respective means (SDs) = 20.15 (6.40) & 35.67 (4.95); p<0.0001], as well as those of the polymiositis patients who scored slightly below the normal range [33.30 (1.42); p<0.0001]. The latter finding, along with direct monitoring of the inhalation of the patients during testing, implies that the MG-related olfactory deficit is unlikely due to difficulties sniffing, per se. All PIT scores were within or near the normal range, although subtle deficits were apparent in both the MG and PM patients, conceivably reflecting influences of mild cognitive impairment. No relationships between performance on the UPSIT and thymectomy, time since diagnosis, type of treatment regimen, or the presence or absence of serum anti-nicotinic or muscarinic antibodies were apparent. Our findings suggest that MG influences olfactory function to the same degree as observed in a number of neurodegenerative diseases in which central nervous system cholinergic dysfunction has been documented.	[Leon-Sarmiento, Fidias E.; Osman, Allen; Doty, Richard L.] Univ Penn, Perelman Sch Med, Ctr Smell & Taste, Philadelphia, PA 19104 USA; [Leon-Sarmiento, Fidias E.; Osman, Allen; Doty, Richard L.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Leon-Sarmiento, Fidias E.] IPS Ramon & Cajal Univ Nacl, Mediciencias Res Grp, Bogota, Colombia; [Bayona, Edgardo A.] Neuro Net, Lab Neurociencias Clin & Func, Bogota, Colombia; [Bayona-Prieto, Jaime] Grp Cirineoneurorehabil, Bucaramanga, Colombia	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Leon-Sarmiento, FE (corresponding author), Univ Penn, Perelman Sch Med, Ctr Smell & Taste, Philadelphia, PA 19104 USA.	feleones@gmail.com	Doty, Richard L/G-1602-2013		Department of Defense, USA [W81XWH-09-1-0467]	Department of Defense, USA(United States Department of Defense)	This work was partially supported by a grant from the Department of Defense, USA No. W81XWH-09-1-0467. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alkondon M, 1996, J PHARMACOL EXP THER, V278, P1460; ARENDT T, 1983, ACTA NEUROPATHOL, V61, P101, DOI 10.1007/BF00697388; ARENDT T, 1984, LANCET, V1, P173; Balestra B, 2000, J NEUROIMMUNOL, V102, P89, DOI 10.1016/S0165-5728(99)00145-9; BOHAN A, 1977, MEDICINE, V56, P255, DOI 10.1097/00005792-197707000-00001; Bohnen NI, 2010, BRAIN, V133, P1747, DOI 10.1093/brain/awq079; BURDACH KJ, 1987, PHYSIOL BEHAV, V41, P353, DOI 10.1016/0031-9384(87)90400-8; Chi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025016; Dalakas MC, 1987, POLYMYOSITIS DERMATO; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Devanand DP, 2010, NEUROBIOL AGING, V31, P1593, DOI 10.1016/j.neurobiolaging.2008.09.008; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; Doty RL, 2012, NEUROBIOL DIS, V46, P527, DOI 10.1016/j.nbd.2011.10.026; DOTY RL, 1987, BRAIN RES BULL, V18, P597, DOI 10.1016/0361-9230(87)90129-8; DOTY RL, 1992, ANN NEUROL, V32, P97, DOI 10.1002/ana.410320116; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; DOTY RL, 1991, NEUROLOGY, V41, P77, DOI 10.1212/WNL.41.5_Suppl_2.77; Doty RL, 1999, PHYSIOL BEHAV, V65, P801; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Fotiou F, 2000, J NEUROPSYCH CLIN N, V12, P514, DOI 10.1176/appi.neuropsych.12.4.514; Garcia-Osta A, 2006, J NEUROSCI, V26, P7919, DOI 10.1523/JNEUROSCI.1674-06.2006; Hawkins BT, 2005, AM J PHYSIOL-HEART C, V289, pH212, DOI 10.1152/ajpheart.01210.2004; Hellier JL, 2010, BRAIN RES, V1358, P140, DOI 10.1016/j.brainres.2010.08.027; HOKKANEN E, 1969, ACTA NEUROL SCAND, V45, P556; Iseki K, 2007, NEUROL SCI, V28, P114, DOI 10.1007/s10072-007-0799-8; IWASAKI Y, 1993, J NEUROL SCI, V114, P223, DOI 10.1016/0022-510X(93)90302-F; JACOB A, 1968, Journal of Medical Genetics, V5, P257, DOI 10.1136/jmg.5.4.257; Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16; Jech R, 1996, J NEUROL, V243, P547, DOI 10.1007/BF00886878; Keesey JC, 1999, J NEUROL SCI, V170, P77, DOI 10.1016/S0022-510X(99)00205-1; KEESEY JC, 1978, LANCET, V1, P777; KNOPF PM, 1995, NEUROPATH APPL NEURO, V21, P175, DOI 10.1111/j.1365-2990.1995.tb01047.x; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Leon F, 1995, Invest Clin, V36, P99; Leon-S FE, 2001, REV NEUROLOGIA, V32, P145, DOI 10.33588/rn.3202.2000280; Leon-S FE, 1996, ACTA NEUROL COLOMB, V12, P38; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; Lindstrom JM, 2000, MUSCLE NERVE, V23, P453, DOI 10.1002/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O; Mandairon N, 2006, EUR J NEUROSCI, V24, P3234, DOI 10.1111/j.1460-9568.2006.05212.x; Mandairon N, 2011, NEUROBIOL AGING, V32, P2254, DOI 10.1016/j.neurobiolaging.2009.12.024; McKeown DA, 1996, J NEUROL NEUROSUR PS, V61, P412, DOI 10.1136/jnnp.61.4.412; NAKANO I, 1983, ANN NEUROL, V13, P87, DOI 10.1002/ana.410130118; Paul RH, 2001, NEUROSCI BIOBEHAV R, V25, P75, DOI 10.1016/S0149-7634(00)00052-X; PESTRONK A, 1985, MUSCLE NERVE, V8, P233, DOI 10.1002/mus.880080309; Plomp JJ, 1996, J PHYSIOL-LONDON, V493, P175, DOI 10.1113/jphysiol.1996.sp021373; Pradilla G, 1983, ACTA PEDIAT COLOMB, V1, P7; RICHMAN DP, 1994, SEMIN NEUROL, V14, P106, DOI 10.1055/s-2008-1041066; ROGERS JD, 1985, ANN NEUROL, V17, P163, DOI 10.1002/ana.410170210; SAPHIER D, 1993, J NEUROL SCI, V114, P200, DOI 10.1016/0022-510X(93)90298-D; Steiner I, 1994, HDB MYASTHENIA GRAVI, P277; TAGLIAVINI F, 1984, NEUROSCI LETT, V44, P37, DOI 10.1016/0304-3940(84)90217-9; Tanaka S, 2007, BIOL PHARM BULL, V30, P291, DOI 10.1248/bpb.30.291; TUCKER DM, 1988, NEUROLOGY, V38, P1173, DOI 10.1212/WNL.38.8.1173; Vaknin-Dembinsky A, 2011, ARCH NEUROL-CHICAGO, V68, P1557, DOI 10.1001/archneurol.2011.200; Velayudhan L, 2009, J CLIN PSYCHOPHARM, V29, P387, DOI 10.1097/JCP.0b013e3181aba5a5; Vernino S, 1998, NEUROLOGY, V50, P1806, DOI 10.1212/WNL.50.6.1806; Vernino S, 2008, ANN NY ACAD SCI, V1132, P124, DOI 10.1196/annals.1405.011; VIETS HR, 1953, JAMA-J AM MED ASSOC, V153, P1273; VOLLMECKE TA, 1985, CHEM SENSES, V10, P413; WHITING PJ, 1987, J NEUROIMMUNOL, V16, P205, DOI 10.1016/0165-5728(87)90075-0	62	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e45544	10.1371/journal.pone.0045544	http://dx.doi.org/10.1371/journal.pone.0045544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082113	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900008
J	Scharer, RM; Patterson, WF; Carlson, JK; Poulakis, GR				Scharer, Rachel M.; Patterson, William F., III; Carlson, John K.; Poulakis, Gregg R.			Age and Growth of Endangered Smalltooth Sawfish (Pristis pectinata) Verified with LA-ICP-MS Analysis of Vertebrae	PLOS ONE			English	Article							CHONDRICHTHYAN FISHES; WESTERN ATLANTIC; UNITED-STATES; FRESH-WATER; SHARK; VALIDATION; PRECISION; CHEMISTRY; STRONTIUM; RECOVERY	Endangered smalltooth sawfish (Pristis pectinata) were opportunistically sampled in south Florida and aged by counting opaque bands in sectioned vertebrae (n = 15). Small sample size precluded traditional age verification, but fish collected in spring and summer had translucent vertebrae margins, while fish collected in winter had opaque margins. Trends in Sr:Ca measured across vertebrae with laser ablation-inductively coupled plasma-mass spectrometry corresponded well to annual salinity trends observed in sawfish estuarine nursery habitats in south Florida, thus serve as a chemical marker verifying annual formation of opaque bands. Based on that finding and assumptions about mean birth date and timing of opaque band formation, estimated age ranged from 0.4 y for a 0.60 m total length (TL) male to 14.0 y for a 4.35 m TL female. Von Bertalanffy growth parameters computed from size at age data were 4.48 m for L-infinity, 0.219 y(-1) for k, and -0.81 y for t(0). Results of this study have important implications for sawfish conservation as well as for inferring habitat residency of euryhaline elasmobranchs via chemical analysis of vertebrae.	[Scharer, Rachel M.; Patterson, William F., III] Univ W Florida, Dept Biol, Pensacola, FL 32514 USA; [Carlson, John K.] SE Fisheries Sci Ctr, Natl Marine Fisheries Serv, Panama City Lab, Panama City Beach, FL USA; [Poulakis, Gregg R.] Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commiss, Charlotte Harbor Field Lab, Port Charlotte, FL USA	State University System of Florida; University of West Florida; National Oceanic Atmospheric Admin (NOAA) - USA; Florida Fish & Wildlife Conservation Commission	Scharer, RM (corresponding author), Univ W Florida, Dept Biol, Pensacola, FL 32514 USA.	rachel.scharer@MyFWC.com			National Marine Fisheries Service Office of Protected Species	National Marine Fisheries Service Office of Protected Species	Funding was provided by that National Marine Fisheries Service Office of Protected Species. Sawfish were obtained under ESA permits #1352 (Mote Marine Laboratory), #1475 (Florida Fish and Wildlife Conservation Commission), and #13330 (NMFS Southeast Fisheries Science Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AH, 2011, FISH B-NOAA, V109, P454; Baremore IE, 2009, FISH RES, V99, P203, DOI 10.1016/j.fishres.2009.06.006; BEAMISH RJ, 1983, T AM FISH SOC, V112, P735, DOI 10.1577/1548-8659(1983)112<735:TFRFAV>2.0.CO;2; BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132; Beissinger S. R., 2002, POPULATION VIABILITY; Bethea DM, 2009, NOAA NMFS SMALLTOOTH; Bigelow HB, 1953, MEM SEARS FDN MAR 2; Boivin G, 1996, J BONE MINER RES, V11, P1302; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; Carlson JK, 2007, BIOL CONSERV, V136, P195, DOI 10.1016/j.biocon.2006.11.013; CHEN C T, 1990, Pacific Science, V44, P156; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; DOLAN TJ, 1984, J HYDROL, V74, P355, DOI 10.1016/0022-1694(84)90024-6; Faunce Craig H., 2004, Wetlands Ecology and Management, V12, P377, DOI 10.1007/s11273-004-4823-y; Francis MP, 2007, MAR FRESHWATER RES, V58, P10, DOI 10.1071/MF06069; Hale LF, 2006, ENVIRON BIOL FISH, V77, P317, DOI 10.1007/s10641-006-9124-2; IUCN, 2012, IUCN RED LIST THREAT; Natanson LJ, 2008, MAR ECOL PROG SER, V361, P267, DOI 10.3354/meps07399; National Marine Fisheries Service (NMFS), 2003, US FED REG, V68, P15674; Norton SL, 2012, MAR COAST FISH, V4, P473, DOI 10.1080/19425120.2012.676606; Phelps QE, 2012, CAN J FISH AQUAT SCI, V69, P930, DOI 10.1139/F2012-038; Poulakis GR, 2012, ENV BIOL FISH, V8; Poulakis Gregg R., 2004, Florida Scientist, V67, P27; Poulakis GR, 2011, MAR FRESHWATER RES, V62, P1165, DOI 10.1071/MF11008; Richardson CJ, 2010, WETL ECOL MANAG, V18, P517, DOI 10.1007/s11273-009-9156-4; SAS Institute, 2008, SAS STAT US GUID; Secor DH, 2000, FISH RES, V46, P359, DOI 10.1016/S0165-7836(00)00159-4; Seitz JC, 2006, MAR POLLUT BULL, V52, P1533, DOI 10.1016/j.marpolbul.2006.07.016; Seitz Jason C., 2002, Florida Scientist, V65, P256; Simpfendorfer CA, 2008, J FISH BIOL, V72, P711, DOI 10.1111/j.1095-8649.2007.01764.x; Simpfendorfer CA, 2000, ENVIRON BIOL FISH, V58, P371, DOI 10.1023/A:1007675111597; Simpfendorfer CA, 2002, ENDANGERED SPECIES U, V19, P45; Simpfendorfer CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016918; Tanaka S, 1991, NATURE CULTURE, V3, P71; Tillett BJ, 2011, MAR ECOL PROG SER, V434, P133, DOI 10.3354/meps09222; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; Wells BK, 2003, T AM FISH SOC, V132, P409, DOI 10.1577/1548-8659(2003)132<0409:RBWOAS>2.0.CO;2; Werry JM, 2011, MAR FRESHWATER RES, V62, P1421, DOI 10.1071/MF11136	41	39	40	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47850	10.1371/journal.pone.0047850	http://dx.doi.org/10.1371/journal.pone.0047850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082225	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900122
J	Williamson, SJ; Allen, LZ; Lorenzi, HA; Fadrosh, DW; Brami, D; Thiagarajan, M; McCrow, JP; Tovchigrechko, A; Yooseph, S; Venter, JC				Williamson, Shannon J.; Allen, Lisa Zeigler; Lorenzi, Hernan A.; Fadrosh, Douglas W.; Brami, Daniel; Thiagarajan, Mathangi; McCrow, John P.; Tovchigrechko, Andrey; Yooseph, Shibu; Venter, J. Craig			Metagenomic Exploration of Viruses throughout the Indian Ocean	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; DNA PACKAGING MOTOR; PHOTOSYNTHESIS GENES; SAMPLING EXPEDITION; MARINE-ENVIRONMENT; MIMIVIRUS RELATIVES; VIRAL COMMUNITIES; HOST INTERACTIONS; GIANT VIRUSES; PHOTOSYSTEM-I	The characterization of global marine microbial taxonomic and functional diversity is a primary goal of the Global Ocean Sampling Expedition. As part of this study, 19 water samples were collected aboard the Sorcerer II sailing vessel from the southern Indian Ocean in an effort to more thoroughly understand the lifestyle strategies of the microbial inhabitants of this ultra-oligotrophic region. No investigations of whole virioplankton assemblages have been conducted on waters collected from the Indian Ocean or across multiple size fractions thus far. Therefore, the goals of this study were to examine the effect of size fractionation on viral consortia structure and function and understand the diversity and functional potential of the Indian Ocean virome. Five samples were selected for comprehensive metagenomic exploration; and sequencing was performed on the microbes captured on 3.0-, 0.8- and 0.1 mu m membrane filters as well as the viral fraction (<0.1 mu m). Phylogenetic approaches were also used to identify predicted proteins of viral origin in the larger fractions of data from all Indian Ocean samples, which were included in subsequent metagenomic analyses. Taxonomic profiling of viral sequences suggested that size fractionation of marine microbial communities enriches for specific groups of viruses within the different size classes and functional characterization further substantiated this observation. Functional analyses also revealed a relative enrichment for metabolic proteins of viral origin that potentially reflect the physiological condition of host cells in the Indian Ocean including those involved in nitrogen metabolism and oxidative phosphorylation. A novel classification method, MGTAXA, was used to assess virus-host relationships in the Indian Ocean by predicting the taxonomy of putative host genera, with Prochlorococcus, Acanthochlois and members of the SAR86 cluster comprising the most abundant predictions. This is the first study to holistically explore virioplankton dynamics across multiple size classes and provides unprecedented insight into virus diversity, metabolic potential and virus-host interactions.	[Williamson, Shannon J.; Allen, Lisa Zeigler; Fadrosh, Douglas W.; Brami, Daniel; McCrow, John P.; Yooseph, Shibu; Venter, J. Craig] J Craig Venter Inst, San Diego, CA USA; [Lorenzi, Hernan A.; Thiagarajan, Mathangi; Tovchigrechko, Andrey] J Craig Venter Inst, Rockville, MD USA; [Allen, Lisa Zeigler] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	J. Craig Venter Institute; J. Craig Venter Institute; University of California System; University of California San Diego; Scripps Institution of Oceanography	Williamson, SJ (corresponding author), J Craig Venter Inst, San Diego, CA USA.	shannon.j.williamson@gmail.com		Yooseph, Shibu/0000-0001-5581-5002; McCrow, John/0000-0002-7014-5040; Lorenzi, Hernan/0000-0003-0910-7894	Office of Science (BER), U.S. Department of Energy [De-FC02-02ER63453]; Gordon and Betty Moore Foundation; National Science Foundation [0850256]; TeraGrid [DEB100001]; Direct For Biological Sciences [0850256] Funding Source: National Science Foundation	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF)); TeraGrid; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the Office of Science (BER), U.S. Department of Energy, Cooperative Agreement No. De-FC02-02ER63453, the Gordon and Betty Moore Foundation, the National Science Foundation award 0850256 and TeraGrid allocation DEB100001 on the Texas Advanced Computing Center Ranger. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, BIOINFORMATICS, V25, P563, DOI 10.1093/bioinformatics/btp003; Allen LZ, 2012, ISME J, V6, P1403, DOI 10.1038/ismej.2011.201; Alperovitch-Lavy A, 2011, ENVIRON MICROBIOL, V13, P24, DOI 10.1111/j.1462-2920.2010.02304.x; Andrews-Pfannkoch C, 2010, APPL ENVIRON MICROB, V76, P5039, DOI 10.1128/AEM.00204-10; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly F, 2009, ENVIRON MICROBIOL, V11, P2863, DOI 10.1111/j.1462-2920.2009.02021.x; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Badger JH, 2005, INT J SYST EVOL MICR, V55, P1021, DOI 10.1099/ijs.0.63510-0; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; Baumann S, 2007, VIROLOGY, V360, P209, DOI 10.1016/j.virol.2006.10.010; Beman JM, 2011, ISME J, V5, P1077, DOI 10.1038/ismej.2010.204; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; BRATBAK G, 1993, MAR ECOL PROG SER, V93, P39, DOI 10.3354/meps093039; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Casas V, 2004, ENVIRON MICROBIOL, V6, P1137, DOI 10.1111/j.1462-2920.2004.00647.x; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; Chan YW, 2007, FEMS MICROBIOL ECOL, V61, P65, DOI 10.1111/j.1574-6941.2007.00320.x; Chan YW, 2011, MOL BIOL EVOL, V28, P2269, DOI 10.1093/molbev/msr041; Claverie JM, 2009, J INVERTEBR PATHOL, V101, P172, DOI 10.1016/j.jip.2009.03.011; Clokie MRJ, 2006, J MAR BIOL ASSOC UK, V86, P499, DOI 10.1017/S0025315406013403; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P827, DOI 10.1111/j.1462-2920.2005.00969.x; DeAngelis PL, 1997, SCIENCE, V278, P1800, DOI 10.1126/science.278.5344.1800; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Draper B, 2007, J MOL BIOL, V369, P79, DOI 10.1016/j.jmb.2007.03.019; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; Filee J, 2007, TRENDS GENET, V23, P10, DOI 10.1016/j.tig.2006.11.002; Filee J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-320; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Kuhl M, 2005, NATURE, V433, P820, DOI 10.1038/433820a; Landstein D, 1998, VIROLOGY, V250, P388, DOI 10.1006/viro.1998.9388; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lorenzi HA, 2011, STAND GENOMIC SCI, V4, P418, DOI 10.4056/sigs.1694706; Lucks JB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000001; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Massana R, 2007, ENVIRON MICROBIOL, V9, P2660, DOI 10.1111/j.1462-2920.2007.01378.x; McDaniel L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003263; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Monier A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-12; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Moreau H, 2010, J VIROL, V84, P12555, DOI 10.1128/JVI.01123-10; Muro-Pastor MI, 2005, PHOTOSYNTH RES, V83, P135, DOI 10.1007/s11120-004-2082-7; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pride DT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-8; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Robins H, 2005, J BACTERIOL, V187, P8370, DOI 10.1128/JB.187.24.8370-8374.2005; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sabehi G, 2004, ENVIRON MICROBIOL, V6, P903, DOI 10.1111/j.1462-2920.2004.00676.x; Sandaa RA, 2008, RES MICROBIOL, V159, P374, DOI 10.1016/j.resmic.2008.04.013; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Sharon I, 2007, ISME J, V1, P492, DOI 10.1038/ismej.2007.67; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; Steward GF, 2000, LIMNOL OCEANOGR, V45, P1697, DOI 10.4319/lo.2000.45.8.1697; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tanenbaum DM, 2010, STAND GENOMIC SCI, V2, P229, DOI 10.4056/sigs.651139; Tucker KP, 2011, ISME J, V5, P822, DOI 10.1038/ismej.2010.188; Van Etten JL, 2010, ANNU REV MICROBIOL, V64, P83, DOI 10.1146/annurev.micro.112408.134338; Williamson SJ, 2008, ISME J, V2, P1112, DOI 10.1038/ismej.2008.73; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yooseph S, 2007, PLOS BIOL, V5, pe16, DOI DOI 10.1371/journal.pbio.0050016	82	87	88	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e42047	10.1371/journal.pone.0042047	http://dx.doi.org/10.1371/journal.pone.0042047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082107	Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900002
J	Zhao, W; Zheng, XF; Liu, YY; Yang, WL; Amirbekian, V; Diaz, LE; Huang, XD				Zhao, Wen; Zheng, Xiaofeng; Liu, Yuying; Yang, Wenlu; Amirbekian, Vardan; Diaz, Luis E.; Huang, Xudong			An MRI Study of Symptomatic Adhesive Capsulitis	PLOS ONE			English	Article							ROTATOR INTERVAL LESIONS; FROZEN SHOULDER; CORACOHUMERAL LIGAMENT; ARTHROGRAPHY; DIAGNOSIS; ANATOMY; PATHOLOGY; RELEASE; MOTION	Background: Appilication of MR imaging to diagnose Adhesive Capsulitis (AC) has previously been described. However, there is insufficient information available for the MRI analysis of AC. This study is to describe and evaluate the pathomorphology of the shoulder in Asian patients with AC compared to healthy volunteers. Methodology/Principal Findings: 60 Asian patients with clinically diagnosed AC and 60 healthy volunteers without frozen shoulder underwent MRI of the shoulder joint. All subjects who were age- and sex-matched control ones underwent routine MRI scans of the affected shoulder, including axial, oblique coronal, oblique sagittal T1WI SE and coronal oblique T2WI FSE sequences. Significant abnormal findings were observed on MRI, especially at the rotator cuff interval. The coracohumeral ligament (CHL), articular capsule thickness in the rotator cuff interval as well as the fat space under coracoid process were evaluated. MRI showed that patients with adhesive capsulitis had a significantly thickened coracohumeral ligament and articular capsule in the rotator cuff interval compared to the control subjects (4.2 vs. 2.4 mm, 7.2 vs. 4.4 mm; p<0.05). Partial or complete obliteration of the subcoracoid fat triangle was significantly more frequent in patients with adhesive capsulitis compared with control subjects (73% vs. 13%, 26% vs. 1.6%; p<0.001). Synovitis-like abnormality around the long biceps tendon was significantly more common in patients with adhesive capsulitis than in control subjects. With regards to the inter-observer variability, two MR radiologists had an excellent kappa value of 0.86. Conclusions/Significance: MRI can be used to show characteristic findings in diagnosing AC. Thickening of the CHL and the capsule at the rotator cuff interval and complete obliteration of the fat triangle under the coracoid process have been shown to be the most characteristic MR findings seen with AC.	[Huang, Xudong] Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA; [Huang, Xudong] Harvard Univ, Sch Med, Charlestown, MA USA; [Zhao, Wen] Beijing Aerosp Gen Hosp, Dept Orthoped, Beijing, Peoples R China; [Zheng, Xiaofeng] Beijing Aerosp Gen Hosp, Dept Radiol, Beijing, Peoples R China; [Liu, Yuying] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Yang, Wenlu] Shanghai Maritime Univ, Informat Engn Coll, Dept Elect Engn, Shanghai, Peoples R China; [Amirbekian, Vardan] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Amirbekian, Vardan] Harvard Univ, Sch Med, Boston, MA USA; [Diaz, Luis E.] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02118 USA; [Diaz, Luis E.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Medical University of South Carolina; Shanghai Maritime University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Huang, XD (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA.	xhuang3@partners.org	Huang, Xudong/D-9711-2018	Huang, Xudong/0000-0002-4811-1901	Beijing General Aerospace Hospital; Radiology Department of Brigham and Women's Hospital (BWH)	Beijing General Aerospace Hospital; Radiology Department of Brigham and Women's Hospital (BWH)	This study was supported by research funds from the Beijing General Aerospace Hospital. XH is partially supported by the Radiology Department of Brigham and Women's Hospital (BWH). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoretti N, 2006, CLIN IMAG, V30, P254, DOI 10.1016/j.clinimag.2006.01.022; Bennett WF, 2001, ARTHROSCOPY, V17, P173, DOI 10.1053/jars.2001.21239; BUNKER TD, 1995, J BONE JOINT SURG BR, V77, P677, DOI 10.1302/0301-620X.77B5.7559688; Carrillon Y, 1999, REV RHUM, V66, P201; Codman E., 1934, TENDINITIS SHORT ROT; Connell D, 2002, EUR RADIOL, V12, P2100, DOI 10.1007/s00330-002-1349-7; DePalma AF, 2008, CLIN ORTHOP RELAT R, V466, P552, DOI 10.1007/s11999-007-0101-7; EMIG EW, 1995, AM J ROENTGENOL, V164, P1457, DOI 10.2214/ajr.164.6.7754892; Fitzpatrick MJ, 2003, ARTHROSCOPY, V19, P70, DOI 10.1016/j.arthro.2003.09.047; HARRYMAN DT, 1992, J BONE JOINT SURG AM, V74A, P53, DOI 10.2106/00004623-199274010-00008; Holloway GB, 2001, J BONE JOINT SURG AM, V83A, P1682, DOI 10.2106/00004623-200111000-00010; Hulstyn M J, 1993, Orthop Rev, V22, P425; Jung JY, 2006, EUR RADIOL, V16, P791, DOI 10.1007/s00330-005-0020-5; Kim KC, 2009, J SHOULDER ELBOW SUR; Le Huec J C, 1996, J Shoulder Elbow Surg, V5, P41, DOI 10.1016/S1058-2746(96)80029-2; Lee MH, 2003, J COMPUT ASSIST TOMO, V27, P901, DOI 10.1097/00004728-200311000-00012; Lefevre-Colau MM, 2005, EUR RADIOL, V15, P2415, DOI 10.1007/s00330-005-2830-x; Manton GL, 2001, SKELETAL RADIOL, V30, P326, DOI 10.1007/s002560100326; McNally EG, 2007, SKELETAL RADIOL, V36, P1013, DOI 10.1007/s00256-007-0351-1; Mengiardi B, 2004, RADIOLOGY, V233, P486, DOI 10.1148/radiol.2332031219; Mohana-Borges AVR, 2004, RADIOGRAPHICS, V24, P69, DOI 10.1148/rg.241035081; NEER CS, 1992, CLIN ORTHOP RELAT R, P182; Nguyen BD, 2007, CLIN NUCL MED, V32, P535, DOI 10.1097/RLU.0b013e3180646ad3; Omari A, 2001, J SHOULDER ELB SURG, V10, P353, DOI 10.1067/mse.2001.115986; Ozaki J, 1996, ANN CHIR GYNAECOL FE, V85, P156; Rodeo SA, 1997, J ORTHOPAED RES, V15, P427, DOI 10.1002/jor.1100150316; SATTAR MA, 1985, DIABETES CARE, V8, P507, DOI 10.2337/diacare.8.5.507; Shaikh A, 2009, ORTHOPEDICS, V32, P2, DOI 10.3928/01477447-20090101-20; Siegel LB, 1999, AM FAM PHYSICIAN, V59, P1843; Sofka Carolyn M, 2008, HSS J, V4, P164, DOI 10.1007/s11420-008-9088-1; UITVLUGT G, 1993, ARTHROSCOPY, V9, P181, DOI 10.1016/S0749-8063(05)80371-8; WILEY A M, 1991, Arthroscopy, V7, P138, DOI 10.1016/0749-8063(91)90098-I	32	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47277	10.1371/journal.pone.0047277	http://dx.doi.org/10.1371/journal.pone.0047277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082152	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900048
J	Joshi, S; Saylor, BT; Wang, W; Peck, AB; Khan, SR				Joshi, Sunil; Saylor, Benjamin T.; Wang, Wei; Peck, Ammon B.; Khan, Saeed R.			Apocynin-Treatment Reverses Hyperoxaluria Induced Changes in NADPH Oxidase System Expression in Rat Kidneys: A Transcriptional Study	PLOS ONE			English	Article							RENAL EPITHELIAL-CELLS; VASCULAR SMOOTH-MUSCLE; CALCIUM-OXALATE NEPHROLITHIASIS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; INFLAMMATORY-BOWEL-DISEASE; INDUCED UP-REGULATION; HYDROXY-L-PROLINE; LARGE GENE LISTS; ETHYLENE-GLYCOL; NAD(P)H OXIDASE	Purpose: We have previously shown that production of reactive oxygen species (ROS) is an important contributor to renal injury and inflammation following exposure to oxalate (Ox) or calcium-oxalate (CaOx) crystals. The present study was conducted, utilizing global transcriptome analyses, to determine the effect of Apocynin on changes in the NADPH oxidase system activated in kidneys of rats fed a diet leading to hyperoxaluria and CaOx crystal deposition. Approach: Age-, sex- and weight-matched rats were either fed regular rat chow or regular rat chow supplemented with 5% w/w hydroxy-L-proline (HLP). Half of the rats on the HLP diet were also placed on Apocynin-supplemented H2O. After 28 days, each rat was euthanized, their kidneys freshly explanted and dissected to obtain both cortex and medulla tissues. Total RNA was extracted from each tissue and subjected to genomic microarrays to obtain global transcriptome data. KEGG was used to identify gene clusters with differentially expressed genes. Immunohistochemistry was used to confirm protein expressions of selected genes. Results: Genes encoding both membrane- and cytosolic-NADPH oxidase complex-associated proteins, together with p21rac and Rap1a, were coordinately up-regulated significantly in both renal medulla and cortex tissues in the HLP-fed rats compared to normal healthy untreated controls. Activation of NADPH oxidase appears to occur via the angiotensin-II/angiotensin-II receptor-2 pathway, although the DAG-PKC pathway of neutrophils may also contribute. Immuno histochemical staining confirmed up-regulated gene expressions. Simultaneously, genes encoding ROS scavenger proteins were down-regulated. HLP-fed rats receiving Apocynin had a complete reversal in the differential-expression of the NADPH oxidase system genes, despite showing similar levels of hyperoxaluria. Conclusions: A strong up-regulation of an oxidative/respiratory burst involving the NADPH oxidase system, activated via the angiotensin-II and most likely the DAG-PKC pathways, occurs in kidneys of hyperoxaluric rats. Apocynin treatment reversed this activation without affecting the levels of hyperoxaluria.	[Joshi, Sunil; Wang, Wei; Peck, Ammon B.; Khan, Saeed R.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Saylor, Benjamin T.; Peck, Ammon B.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Peck, Ammon B.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Khan, SR (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	Khan@pathology.ufl.edu		Joshi, Sunil/0000-0001-8230-980X	National Institutes of Health [RO1-DK078602]; University of Florida Center for the Study of Lithiasis; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Center for the Study of Lithiasis; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health grant #RO1-DK078602 and University of Florida Center for the Study of Lithiasis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BINDER HJ, 1974, GASTROENTEROLOGY, V67, P441; Chabrashvili T, 2002, HYPERTENSION, V39, P269, DOI 10.1161/hy0202.103264; Chamseddine AH, 2003, AM J PHYSIOL-HEART C, V285, pH2284, DOI 10.1152/ajpheart.00459.2003; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; DOBBINS JW, 1977, NEW ENGL J MED, V296, P298, DOI 10.1056/NEJM197702102960602; Ellmark SHM, 2005, CARDIOVASC RES, V65, P495, DOI 10.1016/j.cardiores.2004.10.026; Gao B, 2010, UROL INT, V85, P237, DOI 10.1159/000314947; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26; Grewal JS, 2005, BIOCHEM J, V387, P609, DOI 10.1042/BJ20041465; Hanna IR, 2004, FREE RADICAL BIO MED, V37, P1542, DOI 10.1016/j.freeradbiomed.2004.08.011; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HS, 2006, KIDNEY INT, V70, P699, DOI 10.1038/sj.ki.5001651; Huang HS, 2003, UROLOGY, V62, P1123, DOI 10.1016/S0090-4295(03)00764-7; Huang HS, 2002, J UROLOGY, V167, P2584, DOI 10.1016/S0022-5347(05)65042-2; HYLANDER E, 1978, SCAND J GASTROENTERO, V13, P577, DOI 10.3109/00365527809181767; Iida S, 1999, J AM SOC NEPHROL, V10, P986; JAMES LF, 1972, CLIN TOXICOL, V5, P231, DOI 10.3109/15563657208991002; Khan SR, 2006, KIDNEY INT, V70, P914, DOI 10.1038/sj.ki.5001699; Khan Saeed R, 2004, Clin Exp Nephrol, V8, P75; Khan SR, 2011, NEPHROL DIAL TRANSPL, V26, P1778, DOI 10.1093/ndt/gfq692; Khan SR, 2010, UROL RES, V38, P429, DOI 10.1007/s00240-010-0303-4; Khan SR, 2006, UROL RES, V34, P86, DOI 10.1007/s00240-005-0016-2; Khan SR, 1997, WORLD J UROL, V15, P236, DOI 10.1007/BF01367661; Khan SR, 2005, UROL RES, V33, P349, DOI 10.1007/s00240-005-0492-4; Khan SR, 2004, FRONT BIOSCI-LANDMRK, V9, P1450, DOI 10.2741/1347; Khan SR, 2002, J UROLOGY, V168, P1173, DOI 10.1016/S0022-5347(05)64621-6; KHAN SR, 1995, UROL RES, V23, P71, DOI 10.1007/BF00307936; Kleinman JG, 2004, NEPHRON PHYSIOL, V98, P43, DOI DOI 10.1159/000080263; Koul H, 1996, KIDNEY INT, V50, P1525, DOI 10.1038/ki.1996.467; Koul HK, 2002, J BIOL CHEM, V277, P36845, DOI 10.1074/jbc.M200832200; Koul S, 2008, UROL RES, V36, P1, DOI 10.1007/s00240-007-0130-4; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; LINDSJO M, 1989, SCAND J UROL NEPHROL, V23, P55, DOI 10.1080/00365599.1989.11690431; Marengo SR, 2002, J UROLOGY, V167, P2192, DOI 10.1016/S0022-5347(05)65127-0; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; McConnell N, 2002, BJU INT, V89, P835, DOI 10.1046/j.1464-410X.2002.02739.x; MENON M, 1982, J UROLOGY, V127, P148, DOI 10.1016/S0022-5347(17)53649-6; Morena M, 2002, KIDNEY INT, V61, pS109, DOI 10.1046/j.1523-1755.61.s80.20.x; Schepers MSJ, 2005, KIDNEY INT, V68, P1660, DOI 10.1111/j.1523-1755.2005.00576.x; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Shirotake S, 2012, AM J PATHOL, V180, P1008, DOI 10.1016/j.ajpath.2011.11.027; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Takac I, 2012, CURR HYPERTENS REP, V14, P70, DOI 10.1007/s11906-011-0238-3; Thamilselvan S, 1997, J UROLOGY, V157, P1059, DOI 10.1016/S0022-5347(01)65141-3; Thamilselvan S, 2005, BJU INT, V96, P117, DOI 10.1111/j.1464-410X.2005.05579.x; Umekawa T, 2005, NEPHROL DIAL TRANSPL, V20, P870, DOI 10.1093/ndt/gfh750; Umekawa T, 2004, J AM SOC NEPHROL, V15, P635, DOI 10.1097/01.ASN.0000113321.49771.2D; Umekawa T, 2003, NEPHROL DIAL TRANSPL, V18, P664, DOI 10.1093/ndt/gfg140; Umekawa T, 2002, KIDNEY INT, V61, P105, DOI 10.1046/j.1523-1755.2002.00106.x; UMEKAWA T, 2009, BJU INT; Umekawa T, 2006, BJU INT, V98, P656, DOI 10.1111/j.1464-410X.2006.06334.x; WILLIAMS HE, 1989, J UROLOGY, V141, P742, DOI 10.1016/S0022-5347(17)40999-2; WILLIAMS HE, 1968, AM J MED, V45, P715, DOI 10.1016/0002-9343(68)90207-6; Worcester EM, 2002, ENDOCRIN METAB CLIN, V31, P979, DOI 10.1016/S0889-8529(02)00035-X; Zuo J, 2011, NEPHROL DIAL TRANSPL, V26, P1785, DOI 10.1093/ndt/gfr035	66	31	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47738	10.1371/journal.pone.0047738	http://dx.doi.org/10.1371/journal.pone.0047738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091645	gold, Green Submitted, Green Published			2022-12-27	WOS:000310135800071
J	Kuzembayeva, M; Chiu, YF; Sugden, B				Kuzembayeva, Malika; Chiu, Ya-Fang; Sugden, Bill			Comparing Proteomics and RISC Immunoprecipitations to Identify Targets of Epstein-Barr Viral miRNAs	PLOS ONE			English	Article							MICRORNA-21 TARGETS; ENCODED MICRORNAS; VIRUS; IDENTIFICATION; GENES; CELLS	Epstein-Barr virus is a gamma-herpes virus that is causally associated with several lymphomas and carcinomas. This virus encodes at least 25 pre-miRNAs, which are expressed in infected cells to yield more than 50 detected mature miRNAs. miRNAs are small, non-coding RNAs that inhibit gene expression by promoting the inhibition of translation or of degradation of mRNAs. Currently, the function of these viral miRNAs and the contribution they provide to EBV's life-cycle remain largely unknown, due to difficulties in identifying cellular and viral genes regulated by these miRNAs. We have compared and contrasted two methods to identify targets of viral miRNAs in order to identify the advantages and limitations of each method to aid in uncovering the functions of EBV's miRNAs.	[Kuzembayeva, Malika; Chiu, Ya-Fang; Sugden, Bill] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sugden, B (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	sugden@oncology.wisc.edu	Chiu, Ya-Fang/AAS-7536-2020	Chiu, Ya-Fang/0000-0002-7506-9032	National Cancer Institute, National Institutes of Health [P01CA022443, R01CA133027, R01CA070723]; NATIONAL CANCER INSTITUTE [P01CA022443, R01CA133027, R01CA070723] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by grants from the National Cancer Institute, National Institutes of Health (grants P01CA022443, R01CA133027, and R01CA070723). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Dar W. A., 2010, Viral oncology: basic science and clinical applications, P425; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Dolken L, 2010, CELL HOST MICROBE, V7, P324, DOI 10.1016/j.chom.2010.03.008; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; KLEIN G, 1974, P NATL ACAD SCI USA, V71, P3283, DOI 10.1073/pnas.71.8.3283; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pratt ZL, 2009, VIROLOGY, V386, P387, DOI 10.1016/j.virol.2009.01.006; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Schramedei K, 2011, ONCOGENE, V30, P2975, DOI 10.1038/onc.2011.15; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Vollrath AL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-280; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09; Witkos TM, 2011, CURR MOL MED, V11, P93; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47409	10.1371/journal.pone.0047409	http://dx.doi.org/10.1371/journal.pone.0047409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091622	gold, Green Published, Green Submitted			2022-12-27	WOS:000310135800045
J	Ziebarth, JD; Bhattacharya, A; Cui, Y				Ziebarth, Jesse D.; Bhattacharya, Anindya; Cui, Yan			Integrative Analysis of Somatic Mutations Altering MicroRNA Targeting in Cancer Genomes	PLOS ONE			English	Article							CELL LUNG-CANCER; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; PROSTATE-CANCER; WIDE ASSOCIATION; LINKING POLYMORPHISMS; POLYMIRTS DATABASE; FUNCTIONAL IMPACT; GENETIC-VARIATION; PERIPHERAL-BLOOD	Determining the functional impact of somatic mutations is crucial to understanding tumorigenesis and metastasis. Recent sequences of several cancers have provided comprehensive lists of somatic mutations across entire genomes, enabling investigation of the functional impact of somatic mutations in non-coding regions. Here, we study somatic mutations in 3'UTRs of genes that have been identified in four cancers and computationally predict how they may alter miRNA targeting, potentially resulting in dysregulation of the expression of the genes harboring these mutations. We find that somatic mutations create or disrupt putative miRNA target sites in the 3'UTRs of many genes, including several genes, such as MITF, EPHA3, TAL1, SCG3, and GSDMA, which have been previously associated with cancer. We also integrate the somatic mutations with germline mutations and results of association studies. Specifically, we identify putative miRNA target sites in the 3'UTRs of BMPR1B, KLK3, and SPRY4 that are disrupted by both somatic and germline mutations and, also, are in linkage disequilibrium blocks with high scoring markers from cancer association studies. The somatic mutation in BMPR1B is located in a target site of miR-125b; germline mutations in this target site have previously been both shown to disrupt regulation of BMPR1B by miR-125b and linked with cancer.	[Ziebarth, Jesse D.; Bhattacharya, Anindya; Cui, Yan] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA; [Ziebarth, Jesse D.; Bhattacharya, Anindya; Cui, Yan] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Cui, Y (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA.	ycui2@uthsc.edu	Bhattacharya, Anindya/K-3740-2016	Cui, Yan/0000-0002-7577-6845	University of Tennessee Center for Integrative and Translational Genomics	University of Tennessee Center for Integrative and Translational Genomics	This work was partly supported by The University of Tennessee Center for Integrative and Translational Genomics. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Boehm JS, 2011, NAT REV GENET, V12, P487, DOI 10.1038/nrg3013; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cardoso BA, 2011, LEUKEMIA, V25, P1578, DOI 10.1038/leu.2011.140; Chakravarti N, 2007, CLIN CANCER RES, V13, P4817, DOI 10.1158/1078-0432.CCR-06-3026; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen AX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002259; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; D'Alessandro V, 2008, CELL ONCOL, V30, P291, DOI 10.3233/CLO-2008-0424; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feng NH, 2012, MOL BIOL REP, V39, P369, DOI 10.1007/s11033-011-0747-9; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fox BP, 2006, BIOCHEM BIOPH RES CO, V342, P1263, DOI 10.1016/j.bbrc.2006.02.099; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Godshalk SE, 2011, ONCOGENE, V30, P1542, DOI 10.1038/onc.2010.536; Greenberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027400; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hammell M, 2010, SEMIN CELL DEV BIOL, V21, P738, DOI 10.1016/j.semcdb.2010.01.004; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Jin Y, 2011, J BIOL CHEM, V286, P40104, DOI 10.1074/jbc.C111.296707; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Leidinger P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-262; Lewis-Tuffin LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013665; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Moss AC, 2009, CLIN CANCER RES, V15, P274, DOI 10.1158/1078-0432.CCR-08-1163; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Penney KL, 2011, CARCINOGENESIS, V32, P853, DOI 10.1093/carcin/bgr050; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ramsingh G, 2010, BLOOD, V116, P5316, DOI 10.1182/blood-2010-05-285395; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richardson K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-504; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Saeki N, 2009, GENE CHROMOSOME CANC, V48, P261, DOI 10.1002/gcc.20636; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Saito T, 2010, NEW BIOTECHNOL, V27, P243, DOI 10.1016/j.nbt.2010.02.016; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Schotte D, 2009, LEUKEMIA, V23, P313, DOI 10.1038/leu.2008.286; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi Z, 2011, J MOL BIOL, V413, P495, DOI 10.1016/j.jmb.2011.06.046; Siva K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001202; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Thomas LF, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr414; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017149; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026	91	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47137	10.1371/journal.pone.0047137	http://dx.doi.org/10.1371/journal.pone.0047137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091610	gold, Green Published, Green Submitted			2022-12-27	WOS:000310135800027
J	Gazos-Lopes, F; Mesquita, RD; Silva-Cardoso, L; Senna, R; Silveira, AB; Jablonka, W; Cudischevitch, CO; Carneiro, AB; Machado, EA; Lima, LG; Monteiro, RQ; Nussenzveig, RH; Folly, E; Romeiro, A; Vanbeselaere, J; Mendonca-Previato, L; Previato, JO; Valenzuela, JG; Ribeiro, JMC; Atella, GC; Silva-Neto, MAC				Gazos-Lopes, Felipe; Mesquita, Rafael Dias; Silva-Cardoso, Livia; Senna, Raquel; Silveira, Alan Barbosa; Jablonka, Willy; Cudischevitch, Cecilia Oliveira; Carneiro, Alan Brito; Machado, Ednildo Alcantara; Lima, Luize G.; Monteiro, Robson Queiroz; Nussenzveig, Roberto Henrique; Folly, Evelize; Romeiro, Alexandre; Vanbeselaere, Jorick; Mendonca-Previato, Lucia; Previato, Jose Osvaldo; Valenzuela, Jesus G.; Ribeiro, Jose Marcos Chaves; Atella, Georgia Correa; Cardoso Silva-Neto, Mario Alberto			Glycoinositolphospholipids from Trypanosomatids Subvert Nitric Oxide Production in Rhodnius prolixus Salivary Glands	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; BLOODSUCKING BUG; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORS; ANOPHELES-STEPHENSI; EPIMASTIGOTE FORMS; VECTOR SALIVA; RANGELI; CRUZI; SYNTHASE; INFECTION	Background: Rhodnius prolixus is a blood-sucking bug vector of Trypanosoma cruzi and T. rangeli. T. cruzi is transmitted by vector feces deposited close to the wound produced by insect mouthparts, whereas T. rangeli invades salivary glands and is inoculated into the host skin. Bug saliva contains a set of nitric oxide-binding proteins, called nitrophorins, which deliver NO to host vessels and ensure vasodilation and blood feeding. NO is generated by nitric oxide synthases (NOS) present in the epithelium of bug salivary glands. Thus, T. rangeli is in close contact with NO while in the salivary glands. Methodology/Principal Findings: Here we show by immunohistochemical, biochemical and molecular techniques that inositolphosphate-containing glycolipids from trypanosomatids downregulate NO synthesis in the salivary glands of R. prolixus. Injecting insects with T. rangeli-derived glycoinositolphospholipids (Tr GIPL) or T. cruzi-derived glycoinositolphospholipids (Tc GIPL) specifically decreased NO production. Salivary gland treatment with Tc GIPL blocks NO production without greatly affecting NOS mRNA levels. NOS protein is virtually absent from either Tr GIPL-or Tc GIPL-treated salivary glands. Evaluation of NO synthesis by using a fluorescent NO probe showed that T. rangeli-infected or Tc GIPL-treated glands do not show extensive labeling. The same effect is readily obtained by treatment of salivary glands with the classical protein tyrosine phosphatase (PTP) inhibitor, sodium orthovanadate (SO). This suggests that parasite GIPLs induce the inhibition of a salivary gland PTP. GIPLs specifically suppressed NO production and did not affect other anti-hemostatic properties of saliva, such as the anti-clotting and anti-platelet activities. Conclusions/Significance: Taken together, these data suggest that trypanosomatids have overcome NO generation using their surface GIPLs. Therefore, these molecules ensure parasite survival and may ultimately enhance parasite transmission.	[Gazos-Lopes, Felipe; Silva-Cardoso, Livia; Senna, Raquel; Silveira, Alan Barbosa; Jablonka, Willy; Cudischevitch, Cecilia Oliveira; Carneiro, Alan Brito; Lima, Luize G.; Monteiro, Robson Queiroz; Atella, Georgia Correa; Cardoso Silva-Neto, Mario Alberto] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Mesquita, Rafael Dias] Inst Fed Educ Ciencia & Tecnol Rio de Janeiro, Rio De Janeiro, Brazil; [Machado, Ednildo Alcantara; Romeiro, Alexandre; Mendonca-Previato, Lucia; Previato, Jose Osvaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Nussenzveig, Roberto Henrique] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Folly, Evelize] Univ Fed Fluminense, Inst Biol, Predio Inst Biol, Dept Biol Celular & Mol, Rio De Janeiro, Brazil; [Vanbeselaere, Jorick] Univ Lille 1, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France; [Ribeiro, Jose Marcos Chaves] NIAID, Vector Mol Biol Sect, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Gazos-Lopes, Felipe; Mesquita, Rafael Dias; Silva-Cardoso, Livia; Senna, Raquel; Silveira, Alan Barbosa; Jablonka, Willy; Cudischevitch, Cecilia Oliveira; Carneiro, Alan Brito; Folly, Evelize; Atella, Georgia Correa; Cardoso Silva-Neto, Mario Alberto] INCT EM, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Instituto Federal do Rio de Janeiro (IFRJ); Universidade Federal do Rio de Janeiro; University of Texas System; UTMD Anderson Cancer Center; Universidade Federal Fluminense; Universite de Lille - ISITE; Universite de Lille; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Silva-Neto, MAC (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	maneto@bioqmed.ufrj.br	Jablonka, Willy/D-2333-2017; Folly, Evelize/M-2409-2014; de Queiroz Monteiro, Robson/M-7097-2019; Machado, Ednildo A/G-9725-2013; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Folly das Chagas, Evelize/CAI-5848-2022; Atella, Georgia/AAK-7897-2020; Monteiro, Robson/GRX-0672-2022; Mesquita, Rafael Dias/AAH-4352-2022; Mesquita, Rafael Dias/AFP-3693-2022; Folly das Chagas, Evelize/CAF-9192-2022; Ribeiro, Jose/J-7011-2015	Folly, Evelize/0000-0001-6313-2447; Folly das Chagas, Evelize/0000-0001-6313-2447; Monteiro, Robson/0000-0002-5260-2332; Mesquita, Rafael Dias/0000-0002-2882-3362; Mesquita, Rafael Dias/0000-0002-2882-3362; Folly das Chagas, Evelize/0000-0001-6313-2447; Jablonka, Willy/0000-0001-5380-7797; Mendonca Previato, Lucia/0000-0003-3927-3244; Vanbeselaere, Jorick/0000-0002-1949-4835; G Lima, Luize/0000-0002-4167-6723; Previato, Jose Osvaldo/0000-0002-9233-9954; Ribeiro, Jose/0000-0002-9107-0818; Machado, Ednildo/0000-0002-4428-3829	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCT-Entomologia Molecular); International Foundation for Science (IFS-Sweden) [F/3619-1, F/2887-3]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000932, ZIAAI000810] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCT-Entomologia Molecular); International Foundation for Science (IFS-Sweden)(International Foundation for Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ) and Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCT-Entomologia Molecular). This work was also supported by two grants provided by the International Foundation for Science (IFS-Sweden) to Dr. G. C. Atella (F/3619-1) and to Dr. M. A. C. Silva-Neto (F/2887-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Almeida IC, 2001, J LEUKOCYTE BIOL, V70, P467; Andersen JF, 2010, TOXICON, V56, P1120, DOI 10.1016/j.toxicon.2009.11.002; Anhe ACB, 2007, GENET MOL RES, V6, P197; Arrighi RBG, 2009, DEV COMP IMMUNOL, V33, P216, DOI 10.1016/j.dci.2008.08.009; Basseri HR, 2002, EXP PARASITOL, V100, P226, DOI 10.1016/S0014-4894(02)00026-7; Bian Z, 2001, J INFECT DIS, V183, P612, DOI 10.1086/318528; CARTER HE, 1967, J LIPID RES, V8, P391; CHAMPAGNE DE, 1995, J BIOL CHEM, V270, P8691, DOI 10.1074/jbc.270.15.8691; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dinglasan RR, 2005, INFECT IMMUN, V73, P7797, DOI 10.1128/IAI.73.12.7797-7807.2005; ELPHICK MR, 1993, BRAIN RES, V619, P344, DOI 10.1016/0006-8993(93)91632-3; Feder D, 1997, J INSECT PHYSIOL, V43, P513, DOI 10.1016/S0022-1910(97)00010-3; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Ferreira LL, 2010, J INVERTEBR PATHOL, V105, P91, DOI 10.1016/j.jip.2010.05.013; Fiske CH, 1925, J BIOL CHEM, V66, P375; Folly E, 2003, BIOCHEM BIOPH RES CO, V310, P555, DOI 10.1016/j.bbrc.2003.09.038; GARCIA ES, 1994, EXP PARASITOL, V78, P287, DOI 10.1006/expr.1994.1030; Golodne DM, 2003, J BIOL CHEM, V278, P27766, DOI 10.1074/jbc.M212421200; Gomes SAO, 2008, ACTA TROP, V106, P137, DOI 10.1016/j.actatropica.2008.02.008; Gregory DJ, 2005, PARASITOLOGY, V130, pS27, DOI 10.1017/S0031182005008139; GULLIANI GL, 1976, AM J CLIN PATHOL, V65, P390; Hahn UK, 2001, J PARASITOL, V87, P778, DOI 10.1645/0022-3395(2001)087[0778:IONOIK]2.0.CO;2; HECKER H, 1990, PARASITOL RES, V76, P311, DOI 10.1007/BF00928185; Heneberg P, 2009, CURR MED CHEM, V16, P706, DOI 10.2174/092986709787458407; Jablonka W, 2011, MEM I OSWALDO CRUZ, V106, P546, DOI 10.1590/S0074-02762011000500005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; Medeiros MM, 2007, J LEUKOCYTE BIOL, V82, P488, DOI 10.1189/jlb.0706478; MELLO CB, 1995, J INVERTEBR PATHOL, V65, P261, DOI 10.1006/jipa.1995.1040; Mendonca-Previato L, 2005, CURR OPIN STRUC BIOL, V15, P499, DOI 10.1016/j.sbi.2005.08.011; Mesquita RD, 2008, INFECT IMMUN, V76, P5543, DOI 10.1128/IAI.00683-08; Milward AD, 2006, BBA-GEN SUBJECTS, V1760, P1411, DOI 10.1016/j.bbagen.2006.06.004; Montalibet J, 2005, METHODS, V35, P2, DOI 10.1016/j.ymeth.2004.07.002; Muller U, 1997, PROG NEUROBIOL, V51, P363, DOI 10.1016/S0301-0082(96)00067-6; Nogueira NFS, 2007, EXP PARASITOL, V116, P120, DOI 10.1016/j.exppara.2006.12.014; NUSSENZVEIG RH, 1995, J EXP BIOL, V198, P1093; OSBORN MJ, 1966, METHOD ENZYMOL, V8, P161; Patel B, 2006, J THROMB HAEMOST, V4, P2423, DOI 10.1111/j.1538-7836.2006.02160.x; Previato JO, 2004, ADV PARASIT, V56, P1, DOI 10.1016/S0065-308X(03)56001-8; PREVIATO JO, 1995, J BIOL CHEM, V270, P7241, DOI 10.1074/jbc.270.13.7241; PREVIATO JO, 1990, J BIOL CHEM, V265, P2518; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; REDMAN CA, 1995, BIOCHEM J, V311, P495, DOI 10.1042/bj3110495; RIBEIRO JMC, 1990, BRIT J PHARMACOL, V101, P932, DOI 10.1111/j.1476-5381.1990.tb14183.x; RIBEIRO JMC, 1993, SCIENCE, V260, P539, DOI 10.1126/science.8386393; RIBEIRO JMC, 1993, FEBS LETT, V330, P165, DOI 10.1016/0014-5793(93)80265-V; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P61, DOI 10.1016/j.ibmb.2003.09.004; RIBEIRO JMC, 1989, EXP PARASITOL, V69, P104, DOI 10.1016/0014-4894(89)90177-X; Rozen S, 2000, Methods Mol Biol, V132, P365; Silveira AB, 2006, INSECT BIOCHEM MOLEC, V36, P200, DOI 10.1016/j.ibmb.2006.01.015; Stefano GB, 2002, BRAIN RES, V924, P82, DOI 10.1016/S0006-8993(01)03227-9; SWEELEY CC, 1963, J AM CHEM SOC, V85, P2497, DOI 10.1021/ja00899a032; Tachado SD, 1997, P NATL ACAD SCI USA, V94, P4022, DOI 10.1073/pnas.94.8.4022; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vallejo GA, 2009, ACTA TROP, V110, P137, DOI 10.1016/j.actatropica.2008.10.001; Whitten MMA, 2007, INSECT BIOCHEM MOLEC, V37, P440, DOI 10.1016/j.ibmb.2007.02.001; Whitten MMA, 2001, EXP PARASITOL, V98, P44, DOI 10.1006/expr.2001.4615; Yuda M, 1996, EUR J BIOCHEM, V242, P807, DOI 10.1111/j.1432-1033.1996.0807r.x	63	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47285	10.1371/journal.pone.0047285	http://dx.doi.org/10.1371/journal.pone.0047285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077586	gold, Green Published, Green Submitted			2022-12-27	WOS:000309995100087
J	Gresle, MM; Alexandrou, E; Wu, QZ; Egan, G; Jokubaitis, V; Ayers, M; Jonas, A; Doherty, W; Friedhuber, A; Shaw, G; Sendtner, M; Emery, B; Kilpatrick, T; Butzkueven, H				Gresle, Melissa M.; Alexandrou, Estella; Wu, Qizhu; Egan, Gary; Jokubaitis, Vilija; Ayers, Margaret; Jonas, Anna; Doherty, William; Friedhuber, Anna; Shaw, Gerry; Sendtner, Michael; Emery, Ben; Kilpatrick, Trevor; Butzkueven, Helmut			Leukemia Inhibitory Factor Protects Axons in Experimental Autoimmune Encephalomyelitis via an Oligodendrocyte-Independent Mechanism	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; MULTIPLE-SCLEROSIS; FACTOR PREVENTS; DEMYELINATION; SURVIVAL; NEURONS; DEGENERATION; MOTONEURONS; INJURY; CNTF	Leukemia inhibitory factor (LIF) and Ciliary Neurotrophic factor (CNTF) are members of the interleukin-6 family of cytokines, defined by use of the gp130 molecule as an obligate receptor. In the murine experimental autoimmune encephalomyelitis (EAE) model, antagonism of LIF and genetic deletion of CNTF worsen disease. The potential mechanism of action of these cytokines in EAE is complex, as gp130 is expressed by all neural cells, and could involve immuno-modulation, reduction of oligodendrocyte injury, neuronal protection, or a combination of these actions. In this study we aim to investigate whether the beneficial effects of CNTF/LIF signalling in EAE are associated with axonal protection; and whether this requires signalling through oligodendrocytes. We induced MOG(35-55) EAE in CNTF, LIF and double knockout mice. On a CNTF null background, LIF knockout was associated with increased EAE severity (EAE grade 2.1+/-0.14 vs 2.6+/-0.19; P<0.05). These mice also showed increased axonal damage relative to LIF heterozygous mice, as indicated by decreased optic nerve parallel diffusivity on MRI (1540+/-207 mu m(2)-/s vs 1310+/-175 mu m(2)-/s; P<0.05), and optic nerve (-12.5%) and spinal cord (-16%) axon densities; and increased serum neurofilament-H levels (2.5 fold increase). No differences in inflammatory cell numbers or peripheral auto-immune T-cell priming were evident. Oligodendrocyte-targeted gp130 knockout mice showed that disruption of CNTF/LIF signalling in these cells has no effect on acute EAE severity. These studies demonstrate that endogenous CNTF and LIF act centrally to protect axons from acute inflammatory destruction via an oligodendrocyte-independent mechanism.	[Gresle, Melissa M.; Butzkueven, Helmut] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne Brain Ctr, Parkville, Vic, Australia; [Gresle, Melissa M.; Alexandrou, Estella; Jokubaitis, Vilija; Jonas, Anna; Doherty, William; Emery, Ben; Kilpatrick, Trevor; Butzkueven, Helmut] Florey Neurosci Inst, Parkville, Vic, Australia; [Alexandrou, Estella; Emery, Ben; Kilpatrick, Trevor] Univ Melbourne, Dept Anat, Parkville, Vic 3052, Australia; [Wu, Qizhu; Egan, Gary] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia; [Ayers, Margaret; Friedhuber, Anna] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Shaw, Gerry] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL USA; [Sendtner, Michael] Univ Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany	Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University; University of Melbourne; State University System of Florida; University of Florida; University of Wurzburg	Gresle, MM (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne Brain Ctr, Parkville, Vic, Australia.	mgresle@unimelb.edu.au	Egan, Gary F./A-1381-2013; Jokubaitis, Vilija G./AAD-5949-2019; Sendtner, Michael/J-1542-2012; Emery, Ben/I-6223-2013; Sendtner, Michael/M-8137-2014; , Gerry/X-2377-2019	Jokubaitis, Vilija G./0000-0002-3942-4340; Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; Egan, Gary/0000-0002-3186-4026; Kilpatrick, Trevor/0000-0003-3999-085X; gresle, melissa/0000-0003-0738-1136; Butzkueven, Helmut/0000-0003-3940-8727; Emery, Ben/0000-0002-9132-3045	National Multiple Sclerosis Society (United States of America) [RG3850A3/1]; National Health and Medical Research Council Australia [509088]; Melbourne Brain Centre at RMH [CRE fellowship]	National Multiple Sclerosis Society (United States of America); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Brain Centre at RMH [CRE fellowship]	This work was supported by the National Multiple Sclerosis Society (United States of America) [Project Grant RG3850A3/1 to HB and TK]; National Health and Medical Research Council Australia [Project Grant 509088 to HB and TK, and Career Development Award to HB]; Melbourne Brain Centre at RMH [CRE fellowship to MG]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBIN G, 1984, J NEUROCHEM, V43, P1468, DOI 10.1111/j.1471-4159.1984.tb05410.x; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Butzkueven H, 2006, GLIA, V53, P696, DOI 10.1002/glia.20321; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Cao W, 2011, IMMUNITY, V35, P273, DOI 10.1016/j.immuni.2011.06.011; CHEEMA SS, 1994, J NEUROSCI RES, V37, P213, DOI 10.1002/jnr.490370207; CHEEMA SS, 1994, NEUROREPORT, V5, P989, DOI 10.1097/00001756-199404000-00034; Compston A, 1996, Mult Scler, V1, P388; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2007, BRAIN, V130, P2566, DOI 10.1093/brain/awm206; Emery B, 2006, P NATL ACAD SCI USA, V103, P7859, DOI 10.1073/pnas.0602574103; Fasnacht N, 2008, SEMIN CELL DEV BIOL, V19, P379, DOI 10.1016/j.semcdb.2008.07.001; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; GOW A, 1992, J CELL BIOL, V119, P605, DOI 10.1083/jcb.119.3.605; Gresle MM, 2008, J NEUROSCI RES, V86, P3548, DOI 10.1002/jnr.21803; Haroon F, 2011, J IMMUNOL, V186, P6521, DOI 10.4049/jimmunol.1001135; Hendriks JJA, 2008, J NEUROIMMUNOL, V204, P52, DOI 10.1016/j.jneuroim.2008.07.015; Howell OW, 2010, J NEUROPATH EXP NEUR, V69, P1017, DOI 10.1097/NEN.0b013e3181f3a5b1; Kerr BJ, 2005, GLIA, V51, P73, DOI 10.1002/glia.20177; Kuhlmann T, 2006, AM J PATHOL, V169, P584, DOI 10.2353/ajpath.2006.051086; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lee TI, 2009, NEUROCHEM RES, V34, P109, DOI 10.1007/s11064-008-9682-0; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Linker RA, 2008, J IMMUNOL, V180, P2204, DOI 10.4049/jimmunol.180.4.2204; MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T; MAYER M, 1994, DEVELOPMENT, V120, P143; Menkhorst E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019665; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; Soilu-Hanninen M, 2000, J NEUROSCI RES, V59, P712, DOI 10.1002/(SICI)1097-4547(20000315)59:6<712::AID-JNR3>3.3.CO;2-C; Wu QZ, 2007, NEUROIMAGE, V37, P1138, DOI 10.1016/j.neuroimage.2007.06.029	35	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47379	10.1371/journal.pone.0047379	http://dx.doi.org/10.1371/journal.pone.0047379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077604	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100102
J	Judelson, HS; Shrivastava, J; Manson, J				Judelson, Howard S.; Shrivastava, Jolly; Manson, Joseph			Decay of Genes Encoding the Oomycete Flagellar Proteome in the Downy Mildew Hyaloperonospora arabidopsidis	PLOS ONE			English	Article							PHYTOPHTHORA-INFESTANS REVEALS; INTRAFLAGELLAR TRANSPORT; CHLAMYDOMONAS-REINHARDTII; GENOME SEQUENCE; EVOLUTION; PROTEINS; LOCUS; IDENTIFICATION; GERMINATION; COMPONENTS	Zoospores are central to the life cycles of most of the eukaryotic microbes known as oomycetes, but some genera have lost the ability to form these flagellated cells. In the plant pathogen Phytophthora infestans, genes encoding 257 proteins associated with flagella were identified by comparative genomics. These included the main structural components of the axoneme and basal body, proteins involved in intraflagellar transport, regulatory proteins, enzymes for maintaining ATP levels, and others. Transcripts for over three-quarters of the genes were up-regulated during sporulation, and persisted to varying degrees in the pre-zoospore stage (sporangia) and motile zoospores. Nearly all of these genes had orthologs in other eukaryotes that form flagella or cilia, but not species that lack the organelle. Orthologs of 211 of the genes were also absent from a sister taxon to P. infestans that lost the ability to form flagella, the downy mildew Hyaloperonospora arabidopsidis. Many of the genes retained in H. arabidopsidis were also present in other non-flagellates, suggesting that they play roles both in flagella and other cellular processes. Remnants of the missing genes were often detected in the H. arabidopsidis genome. Degradation of the genes was associated with local compaction of the chromosome and a heightened propensity towards genome rearrangements, as such regions were less likely to share synteny with P. infestans.	[Judelson, Howard S.; Shrivastava, Jolly; Manson, Joseph] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Judelson, HS (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	howard.judelson@ucr.edu			United States National Science Foundation; National Institute of Food and Agriculture of the United States Department of Agriculture	United States National Science Foundation(National Science Foundation (NSF)); National Institute of Food and Agriculture of the United States Department of Agriculture	This research was supported by grants to HSJ from the United States National Science Foundation, and the National Institute of Food and Agriculture of the United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Fong AMV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016725; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; Carvalho-Santos Z, 2011, J CELL BIOL, V194, P165, DOI 10.1083/jcb.201011152; Charles M, 2009, MOL BIOL EVOL, V26, P1651, DOI 10.1093/molbev/msp076; CLARK MC, 1978, CAN J MICROBIOL, V24, P1032, DOI 10.1139/m78-171; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Dick MW, 2001, STRAMINIPILOUS FUNGI; Eckhart L, 2006, MOL BIOL EVOL, V23, P2081, DOI 10.1093/molbev/msl077; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; HEATH IB, 1974, MYCOLOGIA, V66, P354, DOI 10.2307/3758372; Hodges ME, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-185; Hom EFY, 2011, CYTOSKELETON, V68, P555, DOI 10.1002/cm.20533; Hoyer-Fender S, 2010, SEMIN CELL DEV BIOL, V21, P142, DOI 10.1016/j.semcdb.2009.07.002; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Judelson HS, 2008, MOL PLANT MICROBE IN, V21, P433, DOI 10.1094/MPMI-21-4-0433; Judelson HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-700; Judelson HS, 2009, MOL GENET GENOMICS, V281, P193, DOI 10.1007/s00438-008-0407-5; Judelson HS, 1998, GENOME, V41, P605, DOI 10.1139/gen-41-4-605; Judelson HS, 2005, NAT REV MICROBIOL, V3, P47, DOI 10.1038/nrmicro1064; Judelson HS, 2002, MOL BIOL EVOL, V19, P1313, DOI 10.1093/oxfordjournals.molbev.a004192; Keeling PJ, 2009, J EUKARYOT MICROBIOL, V56, P1, DOI 10.1111/j.1550-7408.2008.00371.x; Keeling PJ, 2005, CURR OPIN GENET DEV, V15, P601, DOI 10.1016/j.gde.2005.09.003; Keeling PJ, 2004, DEV CELL, V6, P614, DOI 10.1016/S1534-5807(04)00135-2; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Lai JS, 2004, GENOME RES, V14, P1924, DOI 10.1101/gr.2701104; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Lauwaet T, 2011, INT J PARASITOL, V41, P1079, DOI 10.1016/j.ijpara.2011.06.001; Lechtreck KF, 2009, CELL MOTIL CYTOSKEL, V66, P469, DOI 10.1002/cm.20369; LeDizet M, 1998, AM J PHYSIOL-LUNG C, V275, pL1145, DOI 10.1152/ajplung.1998.275.6.L1145; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu YJJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-74; LUCK DJL, 1984, J CELL BIOL, V98, P789, DOI 10.1083/jcb.98.3.789; Marshall WF, 2001, CURR BIOL, V11, P308, DOI 10.1016/S0960-9822(01)00094-X; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Morris PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006133; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; OMOTO CK, 1981, NATURE, V290, P708, DOI 10.1038/290708a0; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pathak N, 2011, J BIOL CHEM, V286, P11685, DOI 10.1074/jbc.M110.209817; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; PENINGTON CJ, 1989, EXP MYCOL, V13, P158, DOI 10.1016/0147-5975(89)90021-2; Phirke P, 2011, DEV BIOL, V357, P235, DOI 10.1016/j.ydbio.2011.06.028; Portman N, 2009, J BIOL CHEM, V284, P5610, DOI 10.1074/jbc.M808859200; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Runge F, 2011, IMA FUNGUS, V2, P163, DOI 10.5598/imafungus.2011.02.02.07; Saeki M, 2006, BIOCHEM BIOPH RES CO, V342, P568, DOI 10.1016/j.bbrc.2006.02.009; Slusarenko AJ, 2003, MOL PLANT PATHOL, V4, P159, DOI 10.1046/j.1364-3703.2003.00166.x; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Strullu-Derrien C, 2011, P ROY SOC B-BIOL SCI, V278, P675, DOI 10.1098/rspb.2010.1603; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Wei M, 2010, CYTOSKELETON, V67, P71, DOI 10.1002/cm.20422; WRIGHT RL, 1985, J CELL BIOL, V101, P1903, DOI 10.1083/jcb.101.5.1903; Yagi T, 2000, CELL STRUCT FUNCT, V25, P263, DOI 10.1247/csf.25.263; Yamagishi T, 2009, J PHYCOL, V45, P1110, DOI 10.1111/j.1529-8817.2009.00722.x; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811	68	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47624	10.1371/journal.pone.0047624	http://dx.doi.org/10.1371/journal.pone.0047624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077652	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100146
J	Kessler, M; Hertel, D; Jungkunst, HF; Kluge, J; Abrahamczyk, S; Bos, M; Buchori, D; Gerold, G; Gradstein, SR; Kohler, S; Leuschner, C; Moser, G; Pitopang, R; Saleh, S; Schulze, CH; Sporn, SG; Steffan-Dewenter, I; Tjitrosoedirdjo, SS; Tscharntke, T				Kessler, Michael; Hertel, Dietrich; Jungkunst, Hermann F.; Kluge, Juergen; Abrahamczyk, Stefan; Bos, Merijn; Buchori, Damayanti; Gerold, Gerhard; Gradstein, S. Robbert; Koehler, Stefan; Leuschner, Christoph; Moser, Gerald; Pitopang, Ramadhanil; Saleh, Shahabuddin; Schulze, Christian H.; Sporn, Simone G.; Steffan-Dewenter, Ingolf; Tjitrosoedirdjo, Sri S.; Tscharntke, Teja			Can Joint Carbon and Biodiversity Management in Tropical Agroforestry Landscapes Be Optimized?	PLOS ONE			English	Article							FOREST SOILS; STOCKS; DIVERSITY; DEFORESTATION; CONVERSION; STORAGE; ROOT	Managing ecosystems for carbon storage may also benefit biodiversity conservation, but such a potential 'win-win' scenario has not yet been assessed for tropical agroforestry landscapes. We measured above-and below-ground carbon stocks as well as the species richness of four groups of plants and eight of animals on 14 representative plots in Sulawesi, Indonesia, ranging from natural rainforest to cacao agroforests that have replaced former natural forest. The conversion of natural forests with carbon stocks of 227-362 Mg C ha(-1) to agroforests with 82-211 Mg C ha(-1) showed no relationships to overall biodiversity but led to a significant loss of forest-related species richness. We conclude that the conservation of the forest-related biodiversity, and to a lesser degree of carbon stocks, mainly depends on the preservation of natural forest habitats. In the three most carbon-rich agroforestry systems, carbon stocks were about 60% of those of natural forest, suggesting that 1.6 ha of optimally managed agroforest can contribute to the conservation of carbon stocks as much as 1 ha of natural forest. However, agroforestry systems had comparatively low biodiversity, and we found no evidence for a tight link between carbon storage and biodiversity. Yet, potential win-win agroforestry management solutions include combining high shade-tree quality which favours biodiversity with cacao-yield adapted shade levels.	[Hertel, Dietrich; Gerold, Gerhard] Univ Gottingen, Inst Geog, Gottingen, Germany; [Kessler, Michael; Kluge, Juergen; Abrahamczyk, Stefan] Univ Zurich, Zurich, Switzerland; [Jungkunst, Hermann F.] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Kluge, Juergen] Univ Marburg, Fac Geog, Marburg, Germany; [Abrahamczyk, Stefan] Univ Munich, Dept Biol, Munich, Germany; [Bos, Merijn] Louis Bolk Inst, La Driebergen, Netherlands; [Buchori, Damayanti] Bogor Agr Univ, Dept Plant Protect, Fac Agr, IPB, Bogor, Indonesia; [Gradstein, S. Robbert] Museum Natl Hist Nat, Dept Systemat & Evolut UMS 602, F-75231 Paris, France; [Koehler, Stefan] Univ Rostock, Fac Agr & Environm Sci, Rostock, Germany; [Moser, Gerald] Univ Giessen, Dept Plant Ecol, Giessen, Germany; [Pitopang, Ramadhanil] Tadulako Univ, Dept Biol, Fac Math & Nat Sci, Palu, Indonesia; [Saleh, Shahabuddin] Univ Tadulako, Dept Agrotechnol, Fac Agr, Palu, Indonesia; [Schulze, Christian H.] Univ Vienna, Dept Anim Biodivers, Fac Life Sci, Vienna, Austria; [Sporn, Simone G.] FEMS Cent Off, Cl Delft, Netherlands; [Steffan-Dewenter, Ingolf] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, Wurzburg, Germany; [Tjitrosoedirdjo, Sri S.] Bogor Agr Univ, Dept Biol, Fac Math & Nat Sci, IPB, Bogor, Indonesia	University of Gottingen; University of Zurich; University of Koblenz & Landau; Philipps University Marburg; University of Munich; Bogor Agricultural University; Museum National d'Histoire Naturelle (MNHN); University of Rostock; Justus Liebig University Giessen; Universitas Tadulako; Universitas Tadulako; University of Vienna; University of Wurzburg; Bogor Agricultural University	Hertel, D (corresponding author), Univ Gottingen, Inst Geog, Gottingen, Germany.	Dietrich.Hertel@biologie.uni-goettingen.de	Buchori, Damayanti/L-5878-2017; Moser, Gerald/F-8085-2011; Kluge, Jurgen/D-6200-2011; Saleh, Shahabuddin/M-3553-2017; Abrahamczyk, Stefan/D-7316-2011; Tscharntke, Teja/N-5123-2014; Kessler, Michael/A-3605-2009	Buchori, Damayanti/0000-0002-2843-0737; Moser, Gerald/0000-0002-0030-2370; Kessler, Michael/0000-0003-4612-9937; Jungkunst, Hermann/0000-0002-9807-9401; PITOPANG, RAMADANIL/0000-0002-6449-9053; Steffan-Dewenter, Ingolf/0000-0003-1359-3944; Saleh, Shahabuddin/0000-0002-6683-5321; Sporn, Simone Goda/0000-0003-1424-528X	German Research Foundation (DFG) [SFB-552]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was funded by the German Research Foundation (DFG), grant SFB-552 (Collaborative Research Centre 'Stability of Rainforest Margins in Indonesia'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATBC/GTO Marburg declaration, 2009, URG NEED MAX BIOD CO; Baritz R, 2010, FOREST ECOL MANAG, V260, P262, DOI 10.1016/j.foreco.2010.03.025; Bekessy SA, 2008, CONSERV BIOL, V22, P510, DOI 10.1111/j.1523-1739.2008.00943.x; Campbell BM, 2009, GLOBAL ENVIRON CHANG, V19, P397, DOI 10.1016/j.gloenvcha.2009.07.010; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Clough Y, 2009, CONSERV LETT, V2, P197, DOI 10.1111/j.1755-263X.2009.00072.x; Clough Y, 2009, BIOL CONSERV, V142, P1032, DOI 10.1016/j.biocon.2008.12.027; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Ebeling J, 2008, PHILOS T R SOC B, V363, P1917, DOI 10.1098/rstb.2007.0029; FAOstat, 2009, STAT DAT; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Ghazoul J, 2010, TRENDS ECOL EVOL, V25, P396, DOI 10.1016/j.tree.2010.03.005; Grainger A, 2009, CURR BIOL, V19, pR974, DOI 10.1016/j.cub.2009.10.001; Hardner JJ, 2000, MITIG ADAPT STRAT GL, V5, P60; Hertel D, 2009, FOREST ECOL MANAG, V258, P1904, DOI 10.1016/j.foreco.2009.07.019; Hertel D, 2009, SOIL BIOL BIOCHEM, V41, P481, DOI 10.1016/j.soilbio.2008.11.020; Houghton R.A., 2008, TRENDS COMPENDIUM DA; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Huston MA, 2003, J ENVIRON MANAGE, V67, P77, DOI 10.1016/S0301-4797(02)00190-1; IPCC, 2006, IPCC GUIDELINES NATL, V5; Kessler M, 2011, J APPL ECOL, V48, P330, DOI 10.1111/j.1365-2664.2010.01932.x; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Matthews S, 2002, ECOL ECON, V40, P71, DOI 10.1016/S0921-8009(01)00269-5; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Perfecto I, 2007, ENVIRON SCI ENG, P227; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rahayu S., 2005, ABOVEGROUND STOCK CA, P21; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Smiley GL, 2008, AGROFOREST SYST, V73, P219, DOI 10.1007/s10457-008-9144-3; Sodhi NS, 2010, CONSERVATION BIOLOGY FOR ALL, P1; Sodhi NS., 2007, TROPICAL CONSERVATIO; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Strassburg BBN, 2010, CONSERV LETT, V3, P98, DOI 10.1111/j.1755-263X.2009.00092.x; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Zomer RJ, 2009, 89 ICRAF WORLD AGR C	43	39	40	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47192	10.1371/journal.pone.0047192	http://dx.doi.org/10.1371/journal.pone.0047192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077569	Green Published, Green Accepted, gold			2022-12-27	WOS:000309995100074
J	Mayega, RW; Makumbi, F; Rutebemberwa, E; Peterson, S; Ostenson, CG; Tomson, G; Guwatudde, D				Mayega, Roy William; Makumbi, Fredrick; Rutebemberwa, Elizeus; Peterson, Stefan; Ostenson, Claes-Goran; Tomson, Goran; Guwatudde, David			Modifiable Socio-Behavioural Factors Associated with Overweight and Hypertension among Persons Aged 35 to 60 Years in Eastern Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; DISEASE RISK-FACTORS; PHYSICAL-ACTIVITY; NONCOMMUNICABLE DISEASES; SOCIOECONOMIC-STATUS; INCOME COUNTRIES; OBESITY; POPULATION; PREVALENCE; WORLD	Background: Few studies have examined the behavioural correlates of non-communicable, chronic disease risk in low-income countries. The objective of this study was to identify socio-behavioural characteristics associated with being overweight or being hypertensive in a low-income setting, so as to highlight possible interventions and target groups. Methods: A population based survey was conducted in a Health and Demographic Surveillance Site (HDSS) in eastern Uganda. 1656 individuals aged 35 to 60 years had their Body Mass Index (BMI) and blood pressure (BP) assessed. Seven lifestyle factors were also assessed, using a validated questionnaire. Logistic regression was used to identify sociobehavioural factors associated with being overweight or being hypertensive. Results: Prevalence of overweight was found to be 18% (25.2% of women; 9.7% of men; p<0.001) while prevalence of obesity was 5.3% (8.3% of women; 2.2% of men). The prevalence of hypertension was 20.5%. Factors associated with being overweight included being female (OR 3.7; 95% CI 2.69-5.08), peri-urban residence (OR 2.5; 95% CI 1.46-3.01), higher socioeconomic status (OR 4.1; 95% CI 2.40-6.98), and increasing age (OR 1.8; 95% CI 1.12-2.79). Those who met the recommended minimum physical activity level, and those with moderate dietary diversity were less likely to be overweight (OR 0.5; 95% CI 0.35-0.65 and OR 0.7; 95% CI 0.49-3.01). Factors associated with being hypertensive included peri-urban residence (OR 2.4; 95% CI 1.60-3.66), increasing age (OR 4.5; 95% CI 2.94-6.96) and being over-weight (OR 2.8; 95% CI 1.98-3.98). Overweight persons in rural areas were significantly more likely to be hypertensive than those in peri-urban areas (p = 0.013). Conclusions: Being overweight in low-income settings is associated with sex, physical activity and dietary diversity and being hypertensive is associated with being overweight; these factors are modifiable. There is need for context-specific health education addressing disparities in lifestyles at community levels in rural Africa.	[Mayega, Roy William; Peterson, Stefan; Tomson, Goran] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Mayega, Roy William; Makumbi, Fredrick; Guwatudde, David] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Rutebemberwa, Elizeus; Peterson, Stefan] Makerere Univ, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda; [Ostenson, Claes-Goran] Karolinska Inst, Dept Mol Med, Stockholm, Sweden; [Ostenson, Claes-Goran] Karolinska Inst, Surg Endocrine & Diabet Unit, Stockholm, Sweden; [Peterson, Stefan] Uppsala Univ, Int Maternal & Child Hlth Unit, Uppsala, Sweden; [Tomson, Goran] Karolinska Inst, Dept Learning Informat Management & Eth LIME, Div Med Management Ctr MMC, Stockholm, Sweden; [Rutebemberwa, Elizeus] Iganga Mayuge Hlth & Demog Surveillance Site, Iganga, Uganda	Karolinska Institutet; Makerere University; Makerere University; Karolinska Institutet; Karolinska Institutet; Uppsala University; Karolinska Institutet	Mayega, RW (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden.	wromay2000@yahoo.co.uk		Tomson, Goran/0000-0001-9222-3604; Rutebemberwa, Elizeus/0000-0001-8363-7928	Swedish International Development Agency; Swedish International Development Agency (SIDA)	Swedish International Development Agency; Swedish International Development Agency (SIDA)	This work was supported by the Swedish International Development Agency. The Management of Iganga-Mayuge HDSS, and the Diabetes Research Group at Karolinska Institutet, especially Agneta Hilding and Anna-Karin Eriksson, are duly acknowledged for their technical input, as is Pauline Binder, of the Women and Child Health Department, Uppsala University, Sweden, for the language audit. The Family Health and Wealth Project provided the anthropometry equipment.; This work was funded by the Swedish International Development Agency (SIDA) through a joint training and capacity building program between Makerere University in Uganda and Karolinska Institutet in Sweden. The grant covered the costs of field work, including training of research assistants, data collection and entry (http://www.sida.se/English/Countries-and-regions/Africa/Uganda/Our-work-in-Uganda/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-801; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Aikins AD, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-5; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Bosu WK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-418; Bourne LT, 2002, PUBLIC HEALTH NUTR, V5, P157, DOI 10.1079/PHN2001288; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Cooper RS, 1998, BMJ-BRIT MED J, V316, P614, DOI 10.1136/bmj.316.7131.614; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Deurenberg P, 2001, BRIT J NUTR, V85, P135, DOI 10.1079/BJN2000273; Echouffo-Tcheugui JB, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-44; Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x; Fezeu L, 2006, INT J EPIDEMIOL, V35, P105, DOI 10.1093/ije/dyi214; Guthold R, 2011, AM J PREV MED, V41, P52, DOI 10.1016/j.amepre.2011.03.008; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Hilding A, 2006, DIABETOLOGIA, V49, P2589, DOI 10.1007/s00125-006-0402-5; Holdsworth M, 2004, INT J OBESITY, V28, P1561, DOI 10.1038/sj.ijo.0802739; HOSMER DW, 2000, WILEY PS TX, P1; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Lasky D, 2002, NUTRITION, V18, P417, DOI 10.1016/S0899-9007(01)00726-2; Maher D, 2010, B WORLD HEALTH ORGAN, V88, P943, DOI 10.2471/BLT.10.077891; Maher D, 2011, INT J EPIDEMIOL, V40, P160, DOI 10.1093/ije/dyq156; Maletnlema TN, 2002, PUBLIC HEALTH NUTR, V5, P163, DOI 10.1079/PHN2001289; Mazengo MC, 1997, ACTA TROP, V68, P313, DOI 10.1016/S0001-706X(97)00113-7; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Najdi A, 2011, PREV MED, V52, P355, DOI 10.1016/j.ypmed.2011.03.009; Newcombe DAL, 2005, DRUG ALCOHOL REV, V24, P217, DOI 10.1080/09595230500170266; Njelekela MA, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-30; Oladapo OO, 2010, CARDIOVASC J AFR, V21, P26; Organization WH, 2016, GLOBAL STATUS REPORT; Oyeyemi AL, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-156; Papathanasiou George, 2009, Hellenic J Cardiol, V50, P283; PPaBN Shanthi Mendis, 2011, WHO COLLABORATION WO; Ruel Marie T., 2003, Food and Nutrition Bulletin, V24, P231; Savy M, 2005, EUR J CLIN NUTR, V59, P703, DOI 10.1038/sj.ejcn.1602135; Seedat Y K, 2007, Cardiovasc J Afr, V18, P316; Sodjinou R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-84; Swindale A., 2005, MEASURING HOUSEHOLD; Thorogood M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-326; Turyatemba J., 2011, IGANGA MAYUGE DSS HE; Calverton M, 2007, UGANDA DEMOGRAPHIC H, P19; Unwin N, 2006, ANN TROP MED PARASIT, V100, P455, DOI 10.1179/136485906X97453; Unwin N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-272; Ustun B, 1998, DRUG ALCOHOL DEPEN, V50, P185; Wamala JF, 2009, AFR HEALTH SCI, V9, P153; WHO, 2011, STEPS MAN STEPS INST; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2000, INT GUID MON ALC CON; World Health Organization, 1995, PHYS STAT US INT ANT	53	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47632	10.1371/journal.pone.0047632	http://dx.doi.org/10.1371/journal.pone.0047632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077653	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100147
J	Montagna, M; Sassera, D; Griggio, F; Epis, S; Bandi, C; Gissi, C				Montagna, Matteo; Sassera, Davide; Griggio, Francesca; Epis, Sara; Bandi, Claudio; Gissi, Carmela			Tick-Box for 3 '-End Formation of Mitochondrial Transcripts in Ixodida, Basal Chelicerates and Drosophila	PLOS ONE			English	Article							CANDIDATUS-MIDICHLORIA-MITOCHONDRII; RNA PUNCTUATION MODEL; DNA-BINDING PROTEIN; TERMINATION FACTOR; GENE ARRANGEMENT; RIBOSOMAL-RNA; PARALLEL EVOLUTION; SEQUENCE ALIGNMENT; IXODES-RICINUS; WEB SERVER	According to the tRNA punctuation model, the mitochondrial genome (mtDNA) of mammals and arthropods is transcribed as large polycistronic precursors that are maturated by endonucleolytic cleavage at tRNA borders and RNA polyadenylation. Starting from the newly sequenced mtDNA of Ixodes ricinus and using a combination of mitogenomics and transcriptional analyses, we found that in all currently-sequenced tick lineages (Prostriata, Metastriata and Argasidae) the 3'-end of the polyadenylated nad1 and rrnL transcripts does not follow the tRNA punctuation model and is located upstream of a degenerate 17-bp DNA motif. A slightly different motif is also present downstream the 3'-end of nad1 transcripts in the primitive chelicerate Limulus polyphemus and in Drosophila species, indicating the ancient origin and the evolutionary conservation of this motif in arthropods. The transcriptional analyses suggest that this motif directs the 3'-end formation of the nad1/rrnL mature RNAs, likely working as a transcription termination signal or a processing signal of precursor transcripts. Moreover, as most regulatory elements, this motif is characterized by a taxon-specific evolution. Although this signal is not exclusive of ticks, making a play on words it has been named "Tick-Box", since it is a check mark that has to be verified for the 3'-end formation of some mt transcripts, and its consensus sequence has been here carefully characterized in ticks. Indeed, in the whole mtDNA of all ticks, the Tick-Box is always present downstream of nad1 and rrnL, mainly in non-coding regions (NCRs) and occasionally within trnL(CUN). However, some metastriates present a third Tick-Box at an intriguing site - inside the small NCR located at one end of a 3.4 kb translocated region, the other end of which exhibits the nad1 Tick-Box - hinting that this motif could have been involved in metastriate gene order rearrangements.	[Griggio, Francesca; Gissi, Carmela] Univ Milan, Dipartimento Biosci, Milan, Italy; [Montagna, Matteo; Sassera, Davide; Epis, Sara; Bandi, Claudio] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy	University of Milan; University of Milan	Gissi, C (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	carmela.gissi@unimi.it	Bandi, Claudio/J-7835-2018; EPIS, SARA/B-7708-2017; Montagna, Matteo/AAF-8281-2021	Bandi, Claudio/0000-0002-0181-4618; EPIS, SARA/0000-0001-8807-4802; Montagna, Matteo/0000-0003-4465-7146; Sassera, Davide/0000-0003-0442-5252; Gissi, Carmela/0000-0002-2269-079X	Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy (MIUR); European Cooperation in Science and Technology [FA0701]; Universita degli Studi di Milano	Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy (MIUR); European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Universita degli Studi di Milano	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy (MIUR: PRIN-2009 to CB and PRIN-2009 to CG); European Cooperation in Science and Technology (Cost Action FA0701 to CB) and Universita degli Studi di Milano (PUR project to CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abascal F, 2007, MOL BIOL EVOL, V24, P1; Adachi J, 1996, J MOL EVOL, V42, P459; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENKEL BF, 1988, NUCLEIC ACIDS RES, V16, P9880, DOI 10.1093/nar/16.20.9880; BERTHIER F, 1986, NUCLEIC ACIDS RES, V14, P4519, DOI 10.1093/nar/14.11.4519; Betley JN, 2002, CURR BIOL, V12, P1756, DOI 10.1016/S0960-9822(02)01220-4; Black WC, 1998, MOL BIOL EVOL, V15, P1772, DOI 10.1093/oxfordjournals.molbev.a025903; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; BOORE JL, 1995, NATURE, V376, P163, DOI 10.1038/376163a0; Campbell NJH, 1999, MOL BIOL EVOL, V16, P732, DOI 10.1093/oxfordjournals.molbev.a026158; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Choi EH, 2007, DNA SEQUENCE, V18, P459, DOI 10.1080/10425170701289883; CHRISTIANSON TW, 1988, MOL CELL BIOL, V8, P4502, DOI 10.1128/MCB.8.10.4502; CHRISTIANSON TW, 1986, P NATL ACAD SCI USA, V83, P6277, DOI 10.1073/pnas.83.17.6277; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Meo PD, 2012, NUCLEIC ACIDS RES, V40, pD1168, DOI 10.1093/nar/gkr1144; Drummond AJ, 2010, GENEIOUS V5 5 7 CREA; Dunlop JA, 2009, EXP APPL ACAROL, V48, P183, DOI 10.1007/s10493-009-9247-1; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fernandez-Silva P, 2001, NUCLEIC ACIDS RES, V29, P4736, DOI 10.1093/nar/29.22.4736; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Friedrich M, 1997, SYST BIOL, V46, P674, DOI 10.2307/2413500; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Gissi C, 2003, GENOME RES, V13, P2203, DOI 10.1101/gr.1227803; Grillo G, 2003, NUCLEIC ACIDS RES, V31, P3608, DOI 10.1093/nar/gkg548; HIXSON JE, 1986, J BIOL CHEM, V261, P2384; Horak IG, 2002, EXP APPL ACAROL, V28, P27, DOI 10.1023/A:1025381712339; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; Jones M, 2007, MOL PHYLOGENET EVOL, V43, P583, DOI 10.1016/j.ympev.2006.11.017; Keirans JE, 1999, ACAROLOGY, P344; Klimov PB, 2011, J HERED, V102, P283, DOI 10.1093/jhered/esr005; Klimov PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-598; Klompen JSH, 2000, CLADISTICS, V16, P79, DOI 10.1111/j.1096-0031.2000.tb00349.x; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; Krzeminski Wieslaw, 2003, Acta Zoologica Cracoviensia, V46, P153; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2000, MOL BIOL EVOL, V17, P813, DOI 10.1093/oxfordjournals.molbev.a026360; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; Lupi R, 2010, MITOCHONDRION, V10, P192, DOI 10.1016/j.mito.2010.01.004; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Mans BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023675; Masta SE, 2000, MOL BIOL EVOL, V17, P1091, DOI 10.1093/oxfordjournals.molbev.a026390; Masta SE, 2004, MOL BIOL EVOL, V21, P893, DOI 10.1093/molbev/msh096; Masta SE, 2008, MOL BIOL EVOL, V25, P949, DOI 10.1093/molbev/msn051; Masta SE, 2010, GENE, V449, P9, DOI 10.1016/j.gene.2009.09.009; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Montooth KL, 2009, J MOL EVOL, V69, P94, DOI 10.1007/s00239-009-9255-0; MUNDERLOH UG, 1994, J PARASITOL, V80, P533, DOI 10.2307/3283188; Murrell A, 2003, SYST PARASITOL, V56, P169, DOI 10.1023/B:SYPA.0000003802.36517.a0; Najm NA, 2012, PARASITOL RES, V110, P437, DOI 10.1007/s00436-011-2509-y; Nava S, 2009, FRONT BIOSCI-LANDMRK, V14, P2857, DOI 10.2741/3418; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Park SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-343; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Pesole G, 2000, BIOINFORMATICS, V16, P439, DOI 10.1093/bioinformatics/16.5.439; Polosa PL, 1999, NUCLEIC ACIDS RES, V27, P1890, DOI 10.1093/nar/27.8.1890; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Roberti M, 2003, NUCLEIC ACIDS RES, V31, P1597, DOI 10.1093/nar/gkg272; ROBERTI M, 1991, NUCLEIC ACIDS RES, V19, P6249, DOI 10.1093/nar/19.22.6249; Roberti M, 2006, NUCLEIC ACIDS RES, V34, P2109, DOI 10.1093/nar/gkl181; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Sassera D, 2006, INT J SYST EVOL MICR, V56, P2535, DOI 10.1099/ijs.0.64386-0; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shao R, 2004, INSECT MOL BIOL, V13, P219, DOI 10.1111/j.0962-1075.2004.00447.x; Shao RF, 2006, J MOL EVOL, V63, P251, DOI 10.1007/s00239-005-0196-y; Shao RF, 2005, J MOL EVOL, V60, P764, DOI 10.1007/s00239-004-0226-1; Shao RF, 2005, MOL BIOL EVOL, V22, P620, DOI 10.1093/molbev/msi047; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; Sonenshine D. E., 1993, ECOLOGY NIDICOLOUS T, V2; Sonenshine DE, 2005, TICK-BORNE DISEASES OF HUMANS, P12; Stewart JB, 2009, GENE, V445, P49, DOI 10.1016/j.gene.2009.06.006; VALVERDE JR, 1994, P NATL ACAD SCI USA, V91, P5368, DOI 10.1073/pnas.91.12.5368; VANETTEN RA, 1983, J BIOL CHEM, V258, P104; Xu G, 2003, J PARASITOL, V89, P452, DOI 10.1645/0022-3395(2003)089[0452:MPAITT]2.0.CO;2; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	80	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47538	10.1371/journal.pone.0047538	http://dx.doi.org/10.1371/journal.pone.0047538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077630	gold, Green Submitted, Green Published			2022-12-27	WOS:000309995100126
J	Peng, FW; Yao, HH; Akturk, HK; Buch, S				Peng, Fuwang; Yao, Honghong; Akturk, Halis Kaan; Buch, Shilpa			Platelet-Derived Growth Factor CC-Mediated Neuroprotection against HIV Tat Involves TRPC-Mediated Inactivation of GSK 3beta	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTECTS HUMAN NEURONS; CELL-SURVIVAL; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; REGULATORY PROTEIN; INDUCED APOPTOSIS; PI3K PATHWAY	Platelet-derived growth factor-CC (PDGF-CC) is the third member of the PDGF family, and has been implicated both in embryogenesis and development of the CNS. The biological function of this isoform however, remains largely unexplored in the context of HIV-associated dementia (HAD). In the present study, we demonstrate that exposure of human neuroblastoma cells SH-SY5Y to HIV transactivator protein Tat resulted in decreased intrinsic expression of PDGF-CC as evidenced by RT-PCR and western blot assays. Reciprocally, pretreatment of SH-SY5Y cells with PDGF-CC abrogated Tat-mediated neurotoxicity by mitigating apoptosis and neurite & MAP-2 loss. Using pharmacological and loss of function approaches we identified the role of phosphatidylinositol 3-kinase (PI3K)/Akt signaling in PDGF-CC-mediated neuroprotection. We report herein a novel role about the involvement of transient receptor potential canonical (TRPC) channel 1 in modulation of calcium transients in PDGF-CC-mediated neuroprotection. Furthermore we also demonstrated PDGF-CC-mediated inactivation of the downstream mediator - glycogen synthase kinase 3 beta (GSK3 beta) evidenced by its phosphorylation at Ser-9. This was further validated by gain and loss of function studies using cells transfected with either the wild type or mutant GSK3 beta constructs. Intriguingly, pretreatment of cells with either the PI3K inhibitor or TRPC blocker resulted in failure of PDGF-CC to inactivate GSK3 beta, thereby suggesting the intersection of PI3K and TRPC signaling at GSK3 beta. Taken together our findings lead to the suggestion that PDGF-CC could be developed as a therapeutic target to reverse Tat-mediated neurotoxicity with implications for HAD.	[Peng, Fuwang; Yao, Honghong; Buch, Shilpa] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Akturk, Halis Kaan] Creighton Med Ctr, Dept Med, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; Creighton University	Buch, S (corresponding author), Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	sbuch@unmc.edu	Akturk, Halis Kaan/I-5179-2019	Akturk, Halis Kaan/0000-0003-4518-5179; Buch, Shilpa/0000-0002-3103-6685	National Institutes of Health [MH-068212]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068212, P30MH062261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grant MH-068212 from the National Institutes of Health (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson DC, 1996, MOL MED, V2, P417, DOI 10.1007/BF03401901; Albright AV, 2003, J NEUROVIROL, V9, P222, DOI 10.1080/13550280390194073; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Alzheimer C, 2002, ADV EXP MED BIOL, V513, P335; Apati A, 2003, J BIOL CHEM, V278, P9235, DOI 10.1074/jbc.M205528200; Ariano P, 2011, CELL CALCIUM, V49, P387, DOI 10.1016/j.ceca.2011.03.007; Arrazola MS, 2009, J CELL PHYSIOL, V221, P658, DOI 10.1002/jcp.21902; Bachis A, 2005, ANN NY ACAD SCI, V1053, P247, DOI 10.1196/annals.1344.022; Bell JE, 1998, REV NEUROL-FRANCE, V154, P816; BRENNEMAN DE, 1988, NATURE, V335, P639, DOI 10.1038/335639a0; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen ZW, 2000, J VIROL, V74, P6501, DOI 10.1128/JVI.74.14.6501-6510.2000; Chung WH, 2006, JARO-J ASSOC RES OTO, V7, P373, DOI 10.1007/s10162-006-0050-y; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Colafrancesco V, 2011, ARCH ITAL BIOL, V149, P183, DOI 10.4449/aib.v149i2.1376; Constantino AA, 2011, NEUROTOX RES, V20, P277, DOI 10.1007/s12640-011-9241-3; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Cui W, 2011, BRAIN RES, V1394, P14, DOI 10.1016/j.brainres.2011.02.006; De Smedt H, 2011, CELL CALCIUM, V50, P207, DOI 10.1016/j.ceca.2011.06.004; Deierborg T, 2008, PROG NEUROBIOL, V85, P407, DOI 10.1016/j.pneurobio.2008.05.001; Ding H, 2000, MECH DEVELOP, V96, P209, DOI 10.1016/S0925-4773(00)00425-1; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DREYER EB, 1990, SCIENCE, V248, P364, DOI 10.1126/science.2326646; Egawa-Tsuzuki T, 2004, EXP NEUROL, V186, P89, DOI 10.1016/j.expneurol.2003.11.001; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Everall IP, 2002, MOL CELL NEUROSCI, V21, P493, DOI 10.1006/mcne.2002.1196; EVERALL IP, 1991, LANCET, V337, P1119, DOI 10.1016/0140-6736(91)92786-2; Facci L, 2003, NEUROREPORT, V14, P1467, DOI 10.1097/00001756-200308060-00012; GENDELMAN HE, 1994, J LEUKOCYTE BIOL, V56, P389, DOI 10.1002/jlb.56.3.389; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hashimoto M, 2002, J BIOL CHEM, V277, P32985, DOI 10.1074/jbc.M202803200; Heldin CH, 2002, ARCH BIOCHEM BIOPHYS, V398, P284, DOI 10.1006/abbi.2001.2707; HELDIN CH, 1990, J CELL SCI, V96, P193; Hof PR, 1998, EXP NEUROL, V153, P234, DOI 10.1006/exnr.1998.6881; Hollman AM, 2005, BIOTECHNOL PROGR, V21, P451, DOI 10.1021/bp049804z; Hudson L, 2000, J NEUROVIROL, V6, P145, DOI 10.3109/13550280009013158; Iskander S, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-7; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Korade Z, 2011, NEURON, V71, P955, DOI 10.1016/j.neuron.2011.09.002; Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Kucharzewska P, 2009, BIOCHEM BIOPH RES CO, V380, P413, DOI 10.1016/j.bbrc.2009.01.097; Kumar A, 1999, FEBS LETT, V462, P140, DOI 10.1016/S0014-5793(99)01487-8; Kuribara M, 2010, GEN COMP ENDOCR, V169, P123, DOI 10.1016/j.ygcen.2010.08.010; L'Episcopo F, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-49; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Lim JY, 2008, J NEUROSCI RES, V86, P2168, DOI 10.1002/jnr.21669; Liot G, 2004, EXP NEUROL, V187, P38, DOI 10.1016/j.expneurol.2004.01.002; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Lu M, 2010, J MOL ENDOCRINOL, V44, P285, DOI 10.1677/JME-09-0138; Ma MH, 1997, J VIROL, V71, P2495, DOI 10.1128/JVI.71.3.2495-2499.1997; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Mattson MP, 2004, ANN NY ACAD SCI, V1012, P37, DOI 10.1196/annals.1306.004; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; McGary EC, 2002, CLIN CANCER RES, V8, P3584; McManus CM, 2000, AM J PATHOL, V156, P1441, DOI 10.1016/S0002-9440(10)65013-4; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Mizoguchi Y, 2009, J IMMUNOL, V183, P7778, DOI 10.4049/jimmunol.0901326; Nath A, 1999, SEMIN NEUROL, V19, P113, DOI 10.1055/s-2008-1040830; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; Pei Y, DEVELOPMENT, V139, P1724; Peng FW, 2008, J NEUROVIROL, V14, P62, DOI 10.1080/13550280701809084; Peng FW, 2010, J BIOL CHEM, V285, P21615, DOI 10.1074/jbc.M110.107003; Pietz K, 1996, NEUROSCI LETT, V204, P101, DOI 10.1016/0304-3940(96)12326-0; Rappaport J, 1999, J LEUKOCYTE BIOL, V65, P458, DOI 10.1002/jlb.65.4.458; Salins P, 2007, NEUROSCI LETT, V412, P211, DOI 10.1016/j.neulet.2006.07.045; Sanders VJ, 2000, J NEUROSCI RES, V59, P671, DOI 10.1002/(SICI)1097-4547(20000301)59:5<671::AID-JNR10>3.0.CO;2-B; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Singh IN, 2004, J NEUROVIROL, V10, P141, DOI 10.1080/13550280490441103; Sossin WS, 2007, NAT NEUROSCI, V10, P537, DOI 10.1038/nn0507-537; Souaze F, 2006, CARCINOGENESIS, V27, P708, DOI 10.1093/carcin/bgi269; Subramaniam S, 2005, J NEUROSCI, V25, P2838, DOI 10.1523/JNEUROSCI.5060-04.2005; Tagami M, 1997, LAB INVEST, V76, P613; Tang ZS, 2010, J EXP MED, V207, P867, DOI 10.1084/jem.20091704; Turchan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-3; Vermijlen D, J EXP MED, V207, P807; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Wang L, 2010, APOPTOSIS, V15, P1470, DOI 10.1007/s10495-010-0547-z; Wiley CA, 1996, AIDS, V10, P843, DOI 10.1097/00002030-199607000-00007; Wu Y, 2007, APOPTOSIS, V12, P1365, DOI 10.1007/s10495-007-0065-9; Xu Y, 2004, P NATL ACAD SCI USA, V101, P7070, DOI 10.1073/pnas.0304859101; Yao HH, 2011, J NEUROSCI, V31, P5942, DOI 10.1523/JNEUROSCI.5618-10.2011; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zauli G, 2000, J BIOL CHEM, V275, P4159, DOI 10.1074/jbc.275.6.4159; Zhang SXL, 2003, FASEB J, V17, P1709, DOI 10.1096/fj.02-1111fje; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	95	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47572	10.1371/journal.pone.0047572	http://dx.doi.org/10.1371/journal.pone.0047572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077641	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100136
J	Szinte, M; Cavanagh, P				Szinte, Martin; Cavanagh, Patrick			Apparent Motion from Outside the Visual Field, Retinotopic Cortices May Register Extra-Retinal Positions	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; PSYCHOPHYSICS TOOLBOX; SUPERIOR COLLICULUS; SPACE CONSTANCY; PARIETAL CORTEX; FRONTAL-CORTEX; REPRESENTATION; MONKEYS; MAINTENANCE; STABILITY	Observers made a saccade between two fixation markers while a probe was flashed sequentially at two locations on a side screen. The first probe was presented in the far periphery just within the observer's visual field. This target was extinguished and the observers made a large saccade away from the probe, which would have left it far outside the visual field if it had still been present. The second probe was then presented, displaced from the first in the same direction as the eye movement and by about the same distance as the saccade step. Because both eyes and probes shifted by similar amounts, there was little or no shift between the first and second probe positions on the retina. Nevertheless, subjects reported seeing motion corresponding to the spatial displacement not the retinal displacement. When the second probe was presented, the effective location of the first probe lay outside the visual field demonstrating that apparent motion can be seen from a location outside the visual field to a second location inside the visual field. Recent physiological results suggest that target locations are "remapped" on retinotopic representations to correct for the effects of eye movements. Our results suggest that the representations on which this remapping occurs include locations that fall beyond the limits of the retina.	[Szinte, Martin; Cavanagh, Patrick] Univ Paris 05, Lab Psychol Percept, Paris, France; [Szinte, Martin; Cavanagh, Patrick] Ctr Natl Rech Sci, UMR 8158, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Szinte, M (corresponding author), Univ Paris 05, Lab Psychol Percept, Paris, France.	martin.szinte@gmail.com			Chaire d'Excellence Grant; French Ministere de l'Enseignement Superieur et de la Recherche Grant	Chaire d'Excellence Grant; French Ministere de l'Enseignement Superieur et de la Recherche Grant	This research was supported by a Chaire d'Excellence Grant to PC and a French Ministere de l'Enseignement Superieur et de la Recherche Grant to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361; CAELLI T, 1979, PERCEPTION, V8, P59, DOI 10.1068/p080059; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; Cavanagh P, 2010, TRENDS COGN SCI, V14, P147, DOI 10.1016/j.tics.2010.01.007; Colby CL, 1992, SCIENCE, V255, P90; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Curtis CE, 2004, J NEUROSCI, V24, P3944, DOI 10.1523/JNEUROSCI.5640-03.2004; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Deubel H, 1998, VISION RES, V38, P3147, DOI 10.1016/S0042-6989(98)00048-0; Deubel H, 2010, VISION RES, V50, P249, DOI 10.1016/j.visres.2009.09.020; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Fracasso A, 2010, J VISION, V10, DOI 10.1167/10.13.14; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Harrington D., 1981, VISUAL FIELDS TXB AT, V5th; Koch Carmen, 2007, P193, DOI 10.1016/B978-008044980-7/50011-2; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; ROCK I, 1962, AM J PSYCHOL, V75, P193, DOI 10.2307/1419603; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Szinte M, 2011, J VISION, V11, DOI 10.1167/11.2.4; Tark KJ, 2009, NAT NEUROSCI, V12, P1463, DOI 10.1038/nn.2406; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021	35	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47386	10.1371/journal.pone.0047386	http://dx.doi.org/10.1371/journal.pone.0047386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022WO	23077606	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100104
J	Zhang, Y; Ni, YY; Zhang, H; Pan, YC; Ma, JQ; Wang, L				Zhang, Yang; Ni, Yuanyuan; Zhang, Hao; Pan, Yongchu; Ma, Junqing; Wang, Lin			Association between GSTM1 and GSTT1 Allelic Variants and Head and Neck Squamous Cell Cancinoma	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; DRUG-METABOLIZING-ENZYMES; ORAL-CAVITY CANCER; GENETIC POLYMORPHISMS; RISK-FACTORS; LARYNGEAL CARCINOMA; DETOXIFICATION ENZYMES; NAT2 POLYMORPHISMS; CYTOCHROME P4501A1; CLASS-THETA	Backgrounds: GSTM1 and GSTT1 are involved in the detoxification of carcinogens such as smoking by-products, and polymorphisms in these two genes with a result of loss of enzyme activity may increase risk of carcinogenesis. Although many epidemiological studies have investigated the association between GSTM1 or GSTT1 null genotype and head and neck squamous cell carcinoma (HNSCC), the results remain conflicting. To elucidate the overall association of GSTM1, GSTT1 and HNSCC, we included all available studies and performed this meta-analysis. Methodology/Principal Findings: A dataset including 42 articles for GSTM1, 32 articles for GSTT1, and 15 articles for GSTM1 and GSTT1 in combination were identified by a search in PubMed. Associations beween HNSCC and polymorphisms of GSTM1 and GSTT1 alone and in combination were analysed by software RevMan 5.1. Stratification analysis on ethnicity and smoking status, sensitivity analysis, heterogeneity among studies and their publication bias were also tested. Association was found in overall analysis between HNSCC and GSTM1 and GSTT1 null genotype. Stratified by ethnicity, we found increased risks of HNSCC in carriers with GSTM1 null genotype in Asian, GSTT1 null genotype in South American, and dual null genotype in European and Asian. When stratified by smoking, a more significant association of GSTM1 null genotype with HNSCC risk was observed in smokers. Conclusions/Significance: This meta-analysis presented additional evidence of the association between GSTM1 and GSTT1 polymorphisms and HNSCC risk.	[Zhang, Yang; Ni, Yuanyuan; Zhang, Hao; Pan, Yongchu; Ma, Junqing; Wang, Lin] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Ma, JQ (corresponding author), Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China.	junqingma2000@hotmail.com; lw603@njmu.edu.cn			National Natural Science Foundation of China [81000457]; Natural Science Foundation of Jiangsu Province [BK2010529]; Priority Academic Program Development of Jiangsu Higher Education Institutions [2011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by the National Natural Science Foundation of China (81000457), Natural Science Foundation of Jiangsu Province (BK2010529), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar H, 2006, CANCER GENET CYTOGEN, V169, P89, DOI 10.1016/j.cancergencyto.2005.12.007; Amtha R, 2009, ASIAN PAC J CANCER P, V10, P21; Anantharaman D, 2007, CARCINOGENESIS, V28, P1455, DOI 10.1093/carcin/bgm038; Biselli Joice Matos, 2006, Braz J Otorhinolaryngol, V72, P654; Boccia S, 2008, J CANCER RES CLIN, V134, P93, DOI 10.1007/s00432-007-0254-5; Buch SC, 2008, HEAD NECK-J SCI SPEC, V30, P1139, DOI 10.1002/hed.20867; Capoluongo E, 2007, CLIN CHIM ACTA, V376, P174, DOI 10.1016/j.cca.2006.08.017; Casiglia Jeffrey, 2001, General Dentistry, V49, P72; Cha IH, 2007, YONSEI MED J, V48, P233, DOI 10.3349/ymj.2007.48.2.233; Chatzimichalis M, 2010, J LARYNGOL OTOL, V124, P318, DOI 10.1017/S002221510999154X; Cheng L, 1999, INT J CANCER, V84, P220, DOI 10.1002/(SICI)1097-0215(19990621)84:3<220::AID-IJC4>3.0.CO;2-S; Leme CVD, 2010, REV ASSOC MED BRAS, V56, P299, DOI 10.1590/S0104-42302010000300013; Drummond SN, 2004, ORAL ONCOL, V40, P52, DOI 10.1016/S1368-8375(03)00132-5; Drummond SN, 2005, ORAL ONCOL, V41, P515, DOI 10.1016/j.oraloncology.2004.12.014; Evans AJ, 2004, HEAD NECK-J SCI SPEC, V26, P63, DOI 10.1002/hed.10342; Gattas GJF, 2006, HEAD NECK-J SCI SPEC, V28, P819, DOI 10.1002/hed.20410; Gajecka M, 2005, MUTAT RES-FUND MOL M, V574, P112, DOI 10.1016/j.mrfmmm.2005.01.027; Gaudet MM, 2004, CARCINOGENESIS, V25, P735, DOI 10.1093/carcin/bgh054; Gonzalez MV, 1998, J CLIN PATHOL, V51, P294, DOI 10.1136/jcp.51.4.294; Gronau S, 2003, OTOLARYNG HEAD NECK, V128, P674, DOI 10.1016/S0194-5998(03)00176-1; Gronau S, 2003, ORAL DIS, V9, P62, DOI 10.1034/j.1601-0825.2003.02866.x; Hahn M, 2002, ORAL ONCOL, V38, P486, DOI 10.1016/S1368-8375(01)00086-0; Hamel N, 2000, INT J CANCER, V87, P452, DOI 10.1002/1097-0215(20000801)87:3<452::AID-IJC22>3.3.CO;2-N; Harth V, 2008, J TOXICOL ENV HEAL A, V71, P887, DOI 10.1080/15287390801988160; Hashibe M, 2003, CANCER EPIDEM BIOMAR, V12, P1509; Hatagima A, 2008, ORAL ONCOL, V44, P200, DOI 10.1016/j.oraloncology.2007.02.001; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Jahnke V, 1996, AM J SURG, V172, P671, DOI 10.1016/S0002-9610(96)00298-X; Jahnke V, 1997, EUR ARCH OTO-RHINO-L, V254, pS147, DOI 10.1007/BF02439747; Katoh T, 1999, INT J CANCER, V83, P606, DOI 10.1002/(SICI)1097-0215(19991126)83:5<606::AID-IJC6>3.3.CO;2-G; KEEN JH, 1978, J BIOL CHEM, V253, P5654; Ko Y, 2001, CANCER RES, V61, P4398; Landi S, 2000, MUTAT RES-REV MUTAT, V463, P247, DOI 10.1016/S1383-5742(00)00050-8; Li Li, 2004, Zhonghua Er Bi Yan Hou Ke Za Zhi, V39, P2; Li Qin, 2009, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V23, P1105; Losi-Guembarovski R, 2008, ANTICANCER RES, V28, P1023; Lourenco GJ, 2011, TUMOR BIOL, V32, P1209, DOI 10.1007/s13277-011-0224-z; McWilliams JE, 2000, HEAD NECK-J SCI SPEC, V22, P609, DOI 10.1002/1097-0347(200009)22:6<609::AID-HED10>3.0.CO;2-L; Morita S, 1999, INT J CANCER, V80, P685, DOI 10.1002/(SICI)1097-0215(19990301)80:5<685::AID-IJC9>3.0.CO;2-W; Nazar-Stewart V, 1999, CANCER EPIDEM BIOMAR, V8, P547; Olshan AF, 2000, CANCER EPIDEM BIOMAR, V9, P185; Ophuis MBO, 2006, ACTA OTO-LARYNGOL, V126, P311, DOI 10.1080/00016480500416355; Ophuis MBO, 1998, CANCER, V82, P936, DOI 10.1002/(SICI)1097-0142(19980301)82:5<936::AID-CNCR20>3.0.CO;2-0; Park JY, 1997, CANCER EPIDEM BIOMAR, V6, P791; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Peters ES, 2006, CANCER EPIDEM BIOMAR, V15, P2196, DOI 10.1158/1055-9965.EPI-06-0503; Puga A, 1997, CRIT REV TOXICOL, V27, P199, DOI 10.3109/10408449709021619; Reichart P A, 2001, Clin Oral Investig, V5, P207, DOI 10.1007/s00784-001-0132-5; Olivieri EHR, 2009, ORAL ONCOL, V45, pE73, DOI 10.1016/j.oraloncology.2009.03.004; Ruwali M, 2011, XENOBIOTICA, V41, P1122, DOI 10.3109/00498254.2011.614020; Ruwali M, 2009, ENVIRON MOL MUTAGEN, V50, P473, DOI 10.1002/em.20488; Sam SS, 2010, CANCER EPIDEMIOL, V34, P626, DOI 10.1016/j.canep.2010.05.007; Sato M, 1999, CARCINOGENESIS, V20, P1927, DOI 10.1093/carcin/20.10.1927; Schroder KR, 1996, ARCH TOXICOL, V70, P559, DOI 10.1007/s002040050313; SEIDEGARD J, 1988, P NATL ACAD SCI USA, V85, P7293, DOI 10.1073/pnas.85.19.7293; Sharma A, 2006, NEOPLASMA, V53, P309; Shukla D, 2012, BIOMED PAP MED FAC U; Singh AP, 2009, CANCER INVEST, V27, P869, DOI 10.1080/07357900902849657; Singh M, 2008, MUTAT RES-FUND MOL M, V638, P184, DOI 10.1016/j.mrfmmm.2007.10.003; Soucek P, 2010, NEOPLASMA, V57, P415, DOI 10.4149/neo_2010_05_415; Strange RC, 2000, TOXICOL LETT, V112, P357, DOI 10.1016/S0378-4274(99)00230-1; Sugimura T, 2006, J ORAL PATHOL MED, V35, P11, DOI 10.1111/j.1600-0714.2005.00364.x; Suzen HS, 2007, ONCOL RES, V16, P423; Tanimoto K, 1999, ORAL ONCOL, V35, P191, DOI 10.1016/S1368-8375(98)00094-3; To-Figueras J, 2002, CANCER LETT, V187, P95, DOI 10.1016/S0304-3835(02)00406-8; TRIZNA Z, 1995, AM J SURG, V170, P499, DOI 10.1016/S0002-9610(99)80339-0; Walker DM, 2003, PATHOLOGY, V35, P376, DOI 10.1080/00310290310001602558; Zintzaras E, 2005, BIOINFORMATICS, V21, P3672, DOI 10.1093/bioinformatics/bti536	70	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47579	10.1371/journal.pone.0047579	http://dx.doi.org/10.1371/journal.pone.0047579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077643	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100138
J	An, FM; Yamanaka, S; Allen, S; Roberts, LR; Gores, GJ; Pawlik, TM; Xie, Q; Ishida, M; Mezey, E; Ferguson-Smith, AC; Mori, Y; Selaru, FM				An, Fangmei; Yamanaka, Sumitaka; Allen, Sarah; Roberts, Lewis R.; Gores, Gregory J.; Pawlik, Timothy M.; Xie, Qing; Ishida, Masaharu; Mezey, Esteban; Ferguson-Smith, Anne C.; Mori, Yuriko; Selaru, Florin M.			Silencing of miR-370 in Human Cholangiocarcinoma by Allelic Loss and Interleukin-6 Induced Maternal to Paternal Epigenotype Switch	PLOS ONE			English	Article							INTRAHEPATIC CHOLANGIOCARCINOMA; EPIGENETIC ALTERATIONS; GENE-EXPRESSION; COLON-CANCER; GROWTH; PATHWAY; MICE; CHOLANGIOCYTES; METHYLATION; RELAXATION	Cholangiocarcinoma (CCA) is a highly lethal malignant tumor arising from the biliary tract epithelium. Interleukin-6 (IL-6) is a major mediator of inflammation and contributor to carcinogenesis within the biliary tree. Previous studies suggested that enforced IL-6 contributes to cholangiocarcinogenesis through hypermethylation of several genes implicated in CCA. However, the precise mechanisms of IL-6 effects in CCA remain unclear. We now demonstrate that microRNA (miR)-370 is underexpressed in a large cohort of human CCA vs. normal liver tissues. In addition, we show that IL-6 induces a time-dependent silencing of miR-370. In addition, demethylation of CCA cells results in upregulation of miR-370. Furthermore, we demonstrate that miR-370 is imprinted, and that the Intergenic Differentially Methylated Region (IG-DMR) responsible for imprinting regulation of this genomic locus is hypermethylated in response to IL-6 treatment. In addition, the IG-DMR is hypermethylated in human CCA specimens compared to normal matched controls, in the same location as the IL-6 induced hypermethylation. Finally, miR-370 was found to regulate WNT10B in luciferase as well as western blotting experiments. Our data indicate that the paternal allele of miR-370 is normally silenced through genomic imprinting and that the overexpression of IL-6 in CCA effectively suppresses the expression of miR-370 from the maternal allele, lending support to the theory that miR-370 silencing in human CCA follows a classic two-hit mechanism.	[An, Fangmei; Yamanaka, Sumitaka; Pawlik, Timothy M.; Ishida, Masaharu; Mezey, Esteban; Mori, Yuriko; Selaru, Florin M.] Johns Hopkins Univ Hosp, Div Gastroenterol & Hepatol, Baltimore, MD 21287 USA; [An, Fangmei; Xie, Qing] Shanghai Jiao Tong Univ, Sch Med, Dept Infect Dis, Ruijin Hosp, Shanghai 200030, Peoples R China; [An, Fangmei] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Gastroenterol, Wuxi, Jiangsu, Peoples R China; [Allen, Sarah; Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Roberts, Lewis R.; Gores, Gregory J.] Mayo Clin, Coll Med, Div Gastroenterol, Rochester, MN USA; [Roberts, Lewis R.; Gores, Gregory J.] Mayo Clin, Coll Med, Div Hepatol, Rochester, MN USA	Johns Hopkins University; Johns Hopkins Medicine; Shanghai Jiao Tong University; Jiangnan University; Nanjing Medical University; University of Cambridge; Mayo Clinic; Mayo Clinic	Selaru, FM (corresponding author), Johns Hopkins Univ Hosp, Div Gastroenterol & Hepatol, Baltimore, MD 21287 USA.	fselaru1@jhmi.edu	An, Fangmei/AAV-6977-2021; Pawlik, Timothy/AAO-9335-2020	Selaru, Florin/0000-0001-7990-8238; Roberts, Lewis/0000-0001-7885-8574; Ferguson-Smith, Anne/0000-0002-7608-5894	Wendy Will Case Cancer Fund; Biotechnology and Biological Sciences Research Council (BBSRC) studentship; National Institutes of Health (NIH) [AA000626]; American Gastroenterological Association grant; Flight Attendants Medical Research Institute (FAMRI) grant [072119_YCSA]; Johns Hopkins Clinician Scientist Award; Pilot Project from the The Hopkins Conte Digestive Diseases Basic and Translational Research Core Center; NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502, K08DK090154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA000626] Funding Source: NIH RePORTER	Wendy Will Case Cancer Fund; Biotechnology and Biological Sciences Research Council (BBSRC) studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association grant; Flight Attendants Medical Research Institute (FAMRI) grant; Johns Hopkins Clinician Scientist Award; Pilot Project from the The Hopkins Conte Digestive Diseases Basic and Translational Research Core Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Wendy Will Case Cancer Fund (to Y.M.), by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship to S.A., by an RO1 Award (AA000626) from the National Institutes of Health (NIH) to E. M., by an American Gastroenterological Association grant to F.M.S. (Fellowship to Faculty Transition Award), by a Flight Attendants Medical Research Institute (FAMRI) grant (072119_YCSA) to F. M. S., by the Johns Hopkins Clinician Scientist Award to F.M.S., by a Pilot Project from the The Hopkins Conte Digestive Diseases Basic and Translational Research Core Center to F. M. S., and by a K08 Award (DK090154-01) from the NIH to F.M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow DP, 2011, ANNU REV GENET, V45, P379, DOI 10.1146/annurev-genet-110410-132459; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Boumber Y, 2011, ONCOLOGY-NY, V25, P220; Brown KW, 1996, HUM MOL GENET, V5, P2027, DOI 10.1093/hmg/5.12.2027; Cazals-Hatem D, 2004, J HEPATOL, V41, P292, DOI 10.1016/j.jhep.2004.04.030; CROUSE HV, 1960, GENETICS, V45, P1429; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Harris TM, 1998, ONCOGENE, V16, P203, DOI 10.1038/sj.onc.1201519; Isomoto H, 2009, ONCOL REP, V22, P227, DOI 10.3892/or_00000428; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Kang YK, 2000, MODERN PATHOL, V13, P627, DOI 10.1038/modpathol.3880108; Khan NI, 2007, BRIT J HAEMATOL, V138, P338, DOI 10.1111/j.1365-2141.2007.06667.x; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Lee S, 2002, AM J PATHOL, V161, P1015, DOI 10.1016/S0002-9440(10)64262-9; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu X, 2008, ONCOGENE, V27, P1478, DOI 10.1038/sj.onc.1210769; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; Meng F, 2006, J HEPATOL, V44, P1055, DOI 10.1016/j.jhep.2005.10.030; Mori Y, 2004, CANCER RES, V64, P2434, DOI 10.1158/0008-5472.CAN-03-3508; Mori Y, 2006, GASTROENTEROLOGY, V131, P797, DOI 10.1053/j.gastro.2006.06.006; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Olaru AV, 2011, HEPATOLOGY; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; Randhawa GS, 1998, BLOOD, V91, P3144, DOI 10.1182/blood.V91.9.3144.3144_3144_3147; Razumilava N, HEPATOLOGY; Schwienbacher C, 2000, P NATL ACAD SCI USA, V97, P5445, DOI 10.1073/pnas.090087497; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Steg A, 2006, J MOL DIAGN, V8, P76, DOI 10.2353/jmoldx.2006.040402; SUZUKI H, 1994, NAT GENET, V6, P332, DOI 10.1038/ng0494-332; Tischoff I, 2006, J HEPATO-BILIARY-PAN, V13, P274, DOI 10.1007/s00534-005-1055-3; Tsuneyama K, 2000, DIGEST DIS SCI, V45, P366, DOI 10.1023/A:1005429130150; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; Yoshikawa H, 2007, MOL BIOL CELL, V18, P4292, DOI 10.1091/mbc.E06-10-0889; Zografos GN, 2011, HEPATOB PANCREAT DIS, V10, P10, DOI 10.1016/S1499-3872(11)60001-5; Zou TT, 2002, ONCOGENE, V21, P4855, DOI 10.1038/sj.onc.1205613; Zweers SJ, 2012, HEPATOLOGY	45	45	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e45606	10.1371/journal.pone.0045606	http://dx.doi.org/10.1371/journal.pone.0045606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110045	Green Submitted, Green Published, gold			2022-12-27	WOS:000310193400003
J	Ragnedda, G; Disanto, G; Giovannoni, G; Ebers, GC; Sotgiu, S; Ramagopalan, SV				Ragnedda, Giammario; Disanto, Giulio; Giovannoni, Gavin; Ebers, George C.; Sotgiu, Stefano; Ramagopalan, Sreeram V.			Protein-Protein Interaction Analysis Highlights Additional Loci of Interest for Multiple Sclerosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LARGE GENE LISTS; SUSCEPTIBILITY LOCI; TYROSINE KINASE; RISK; 4-O-SULFOTRANSFERASES; METAANALYSIS; EXPRESSION; RESOURCES; FAMILY	Genetic factors play an important role in determining the risk of multiple sclerosis (MS). The strongest genetic association in MS is located within the major histocompatibility complex class II region (MHC), but more than 50 MS loci of modest effect located outside the MHC have now been identified. However, the relative candidate genes that underlie these associations and their functions are largely unknown. We conducted a protein-protein interaction (PPI) analysis of gene products coded in loci recently reported to be MS associated at the genome-wide significance level and in loci suggestive of MS association. Our aim was to identify which suggestive regions are more likely to be truly associated, which genes are mostly implicated in the PPI network and their expression profile. From three recent independent association studies, SNPs were considered and divided into significant and suggestive depending on the strength of the statistical association. Using the Disease Association Protein-Protein Link Evaluator tool we found that direct interactions among genetic products were significantly higher than expected by chance when considering both significant regions alone (p<0.0002) and significant plus suggestive (p<0.007). The number of genes involved in the network was 43. Of these, 23 were located within suggestive regions and many of them directly interacted with proteins coded within significant regions. These included genes such as SYK, IL-6, CSF2RB, FCLR3, EIF4EBP2 and CHST12. Using the gene portal BioGPS, we tested the expression of these genes in 24 different tissues and found the highest values among immune-related cells as compared to non-immune tissues (p<0.001). A gene ontology analysis confirmed the immune-related functions of these genes. In conclusion, loci currently suggestive of MS association interact with and have similar expression profiles and function as those significantly associated, highlighting the fact that more common variants remain to be found to be associated to MS.	[Ragnedda, Giammario; Disanto, Giulio; Ebers, George C.; Ramagopalan, Sreeram V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ragnedda, Giammario; Disanto, Giulio; Ebers, George C.; Ramagopalan, Sreeram V.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci Clin Neurol, Oxford OX3 9DU, England; [Ragnedda, Giammario] Univ Sassari, Div Neurol, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Giovannoni, Gavin; Ramagopalan, Sreeram V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Sotgiu, Stefano] Univ Sassari, Dept Clin & Expt Med, Div Paediat Neuropsychiat, I-07100 Sassari, Italy; [Ramagopalan, Sreeram V.] London Sch Hyg & Trop Med, London WC1, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Sassari; University of London; Queen Mary University London; University of Sassari; University of London; London School of Hygiene & Tropical Medicine	Ramagopalan, SV (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	s.ramagopalan@qmul.ac.uk	sotgiu, stefano/M-1011-2017	McKeating, Jane/0000-0002-7229-5886; Ebers, George/0000-0003-4771-4177	Medical Research Council [G0801976]; Wellcome Trust [090532/Z/09/Z]; FISM-Fondazione Italiana Sclerosi Multipla-Cod [2010/B/5]; Bayer Schering Pharma; Multiple Sclerosis Society of the United Kingdom; Multiple Sclerosis Society of Canada Scientific Research Foundation; Medical Research Council [G0801975] Funding Source: researchfish; MRC [G0801975, G0801976] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); FISM-Fondazione Italiana Sclerosi Multipla-Cod(Fondazione Italiana Sclerosi Multipla (FISM)); Bayer Schering Pharma(Bayer AG); Multiple Sclerosis Society of the United Kingdom; Multiple Sclerosis Society of Canada Scientific Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by: the Medical Research Council [GRANT NUMBER G0801976]; the Wellcome Trust 090532/Z/09/Z and a research fellowship FISM-Fondazione Italiana Sclerosi Multipla-Cod.: [2010/B/5 to GD] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: GR reports no competing interest. GD reports no competing interest. GG serves on scientific advisory boards for Merck Serono and Biogen Idec and Vertex Pharmaceuticals; served on the editorial board of Multiple Sclerosis; has received speaker honoraria from Bayer Schering Pharma, Merck Serono, Biogen Idec, Pfizer Inc, Teva Pharmaceutical Industries Ltd.-sanofiaventis, Vertex Pharmaceuticals, Genzyme Corporation, Ironwood, and Novartis; has served as a consultant for Bayer Schering Pharma, Biogen Idec, GlaxoSmithKline, Merck Serono, Protein Discovery Laboratories, Teva Pharmaceutical Industries Ltd.-sanofi-aventis, UCB, Vertex Pharmaceuticals, GW Pharma, Novartis, and FivePrime; serves on the speakers bureau for Merck Serono; and has received research support from Bayer Schering Pharma, Biogen Idec, Merck Serono, Novartis, UCB, Merz Pharmaceuticals, LLC, Teva Pharmaceutical Industries Ltd.-sanofi-aventis, GW Pharma, and Ironwood. GCE serves on the editorial boards of the International Multiple Sclerosis Journal and Multiple Sclerosis and as Section Editor for BMC Medical Genetics; has received funding for travel or speaker honoraria from Bayer Schering Pharma, sanofi-aventis, Roche, and UCB; has served as a consultant to Biopartners, Bayer Schering Pharma, Howrey LLP, Heron Health, and Eli Lilly and Company; and receives research support from Bayer Schering Pharma, the Multiple Sclerosis Society of the United Kingdom, and the Multiple Sclerosis Society of Canada Scientific Research Foundation. SS reports no competing interest. SVR reports no competing interest.	Asquith KL, 2008, J IMMUNOL, V180, P1199, DOI 10.4049/jimmunol.180.2.1199; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Chen Q, 2008, MOL PSYCHIATR, V13, P930, DOI 10.1038/sj.mp.4002051; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hesslein DGT, 2011, BLOOD, V117, P3087, DOI 10.1182/blood-2010-06-292219; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kasper LH, 2010, NEUROLOGY, V74, pS2, DOI 10.1212/WNL.0b013e3181c97c8f; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Ramagopalan SV, 2009, GENOME MED, V1, DOI 10.1186/gm105; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Wang JH, 2011, GENOME MED, V3, DOI 10.1186/gm217; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yamada T, 1998, J ALLERGY CLIN IMMUN, V101, P677, DOI 10.1016/S0091-6749(98)70177-0	33	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e46730	10.1371/journal.pone.0046730	http://dx.doi.org/10.1371/journal.pone.0046730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094030	Green Published, gold, Green Submitted			2022-12-27	WOS:000312384500004
J	Goost, H; Witten, J; Heck, A; Hadizadeh, DR; Weber, O; Graff, I; Burger, C; Montag, M; Koerfer, F; Kabir, K				Goost, Hans; Witten, Johannes; Heck, Andreas; Hadizadeh, Dariusch R.; Weber, Oliver; Graeff, Ingo; Burger, Christof; Montag, Mareen; Koerfer, Felix; Kabir, Koroush			Image and Diagnosis Quality of X-Ray Image Transmission via Cell Phone Camera: A Project Study Evaluating Quality and Reliability	PLOS ONE			English	Article							MOBILE PHONE; TELERADIOLOGY; TOMOGRAPHY; HEALTH	Introduction: Developments in telemedicine have not produced any relevant benefits for orthopedics and trauma surgery to date. For the present project study, several parameters were examined during assessment of x-ray images, which had been photographed and transmitted via cell phone. Materials and Methods: A total of 100 x-ray images of various body regions were photographed with a Nokia cell phone and transmitted via email or MMS. Next, the transmitted photographs were reviewed on a laptop computer by five medical specialists and assessed regarding quality and diagnosis. Results: Due to their poor quality, the transmitted MMS images could not be evaluated and this path of transmission was therefore excluded. Mean size of transmitted x-ray email images was 394 kB (range: 265-590 kB, SD +/-59), average transmission time was 3.29 min +/-68 (CI 95%: 1.7-4.9). Applying a score from 1-10 (very poor - excellent), mean image quality was 5.8. In 83.2+/-4% (mean value +/- SD) of cases (median 82; 80-89%), there was agreement between final diagnosis and assessment by the five medical experts who had received the images. However, there was a markedly low concurrence ratio in the thoracic area and in pediatric injuries. Discussion: While the rate of accurate diagnosis and indication for surgery was high with a concurrence ratio of 83%, considerable differences existed between the assessed regions, with lowest values for thoracic images. Teleradiology is a cost-effective, rapid method which can be applied wherever wireless cell phone reception is available. In our opinion, this method is in principle suitable for clinical use, enabling the physician on duty to agree on appropriate measures with colleagues located elsewhere via x-ray image transmission on a cell phone.	[Goost, Hans; Witten, Johannes; Heck, Andreas; Weber, Oliver; Burger, Christof; Montag, Mareen; Koerfer, Felix; Kabir, Koroush] Univ Hosp Bonn, Dept Orthoped & Trauma Surg, Bonn, Germany; [Hadizadeh, Dariusch R.] Univ Hosp Bonn, Dept Radiol, Bonn, Germany; [Graeff, Ingo] Univ Hosp Bonn, Dept Anesthesiol & Intens Care Med, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Goost, H (corresponding author), Univ Hosp Bonn, Dept Orthoped & Trauma Surg, Bonn, Germany.	hans.goost@ukb.uni-bonn.de	Hadizadeh, Dariusch/J-4947-2016	Hadizadeh, Dariusch/0000-0003-1802-6025; Kabir, Koroush/0000-0003-1458-2825				Anderson K, 2001, LANCET, V358, P1343, DOI 10.1016/S0140-6736(01)06451-0; Armstrong DJ, 2004, RHEUMATOLOGY, V43, P1195, DOI 10.1093/rheumatology/keh286; Arsand Eirik, 2010, J Diabetes Sci Technol, V4, P328; Blake Holly, 2008, Nurs Stand, V23, P43; Caramella D, 2000, EUR J RADIOL, V33, P2, DOI 10.1016/S0720-048X(99)00104-7; Krishna S, 2009, TELEMED J E-HEALTH, V15, P231, DOI 10.1089/tmj.2008.0099; Lee S, 2008, J MED SYST, V32, P471, DOI 10.1007/s10916-008-9153-9; Phabphal K, 2008, J TELEMED TELECARE, V14, P439, DOI 10.1258/jtt.2008.080603; Reponen J, 2000, J TELEMED TELECARE, V6, P45, DOI 10.1258/1357633001933943; Ricci WM, 2002, J ORTHOP TRAUMA, V16, P1, DOI 10.1097/00005131-200201000-00001; Tachakra S, 2003, TELEMED J E-HEALTH, V9, P247, DOI 10.1089/153056203322502632; Thrall JH, 2007, RADIOLOGY, V244, P325, DOI 10.1148/radiol.2442070676	12	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e43402	10.1371/journal.pone.0043402	http://dx.doi.org/10.1371/journal.pone.0043402			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082108	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900003
J	Kesse-Guyot, E; Charreire, H; Andreeva, VA; Touvier, M; Hercberg, S; Galan, P; Oppert, JM				Kesse-Guyot, Emmanuelle; Charreire, Helene; Andreeva, Valentina A.; Touvier, Mathilde; Hercberg, Serge; Galan, Pilar; Oppert, Jean-Michel			Cross-Sectional and Longitudinal Associations of Different Sedentary Behaviors with Cognitive Performance in Older Adults	PLOS ONE			English	Article							LEISURE ACTIVITIES; PHYSICAL-ACTIVITY; ANTIOXIDANT VITAMINS; HEALTH OUTCOMES; RISK; DEMENTIA; IMPAIRMENT; PREVENTION; DECLINE; QUESTIONNAIRE	Background: The deleterious health effects of sedentary behaviors, independent of physical activity, are increasingly being recognized. However, associations with cognitive performance are not known. Purpose: To estimate the associations between different sedentary behaviors and cognitive performance in healthy older adults. Methods: Computer use, time spent watching television (TV), time spent reading and habitual physical activity levels were self-reported twice (in 2001 and 2007) by participants in the SUpplementation en Vitamines et MinerauX (SU.VI.MAX and SU.VI.MAX2) study. Cognitive performance was assessed at follow-up (in 2007-2009) via a battery of 6 neuropsychological tests used to derive verbal memory and executive functioning scores. Analyses (ANCOVA) were performed among 1425 men and 1154 women aged 65.6 +/- 4.5 at the time of the neuropsychological evaluation. We estimated mean differences with 95% confidence intervals (95%CI) in cognitive performance across categories of each type of sedentary behavior. Results: In multivariable cross-sectional models, compared to non-users, participants using the computer for 1 h/day displayed better verbal memory (mean difference=1.86; 95% CI: 0.95, 2.77) and executive functioning (mean difference=2.15; 95%CI: 1.22, 3.08). A negative association was also observed between TV viewing and executive functioning. Additionally, participants who increased their computer use by more than 30 min between 2001 and 2007 showed better performance on both verbal memory (mean difference=1.41; 95% CI: 0.55, 2.27) and executive functioning (mean difference=1.41; 95% CI: 0.53, 2.28) compared to those who decreased their computer use during that period. Conclusion: Specific sedentary behaviors are differentially associated with cognitive performance. In contrast to TV viewing, regular computer use may help maintain cognitive function during the aging process.	[Kesse-Guyot, Emmanuelle; Charreire, Helene; Andreeva, Valentina A.; Touvier, Mathilde; Hercberg, Serge; Galan, Pilar; Oppert, Jean-Michel] Univ Paris 13, Cnam, Inra U1125, Ctr Res Human Nutr Ile De France,UMR Inserm U557, Bobigny, France; [Charreire, Helene] Paris Est Creteil Univ, Lab Urba, Dept Geog, Urbanism Inst Paris, Paris, France; [Hercberg, Serge] Hop Avicenne, Dept Publ Hlth, F-93009 Bobigny, France; [Oppert, Jean-Michel] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, Ctr Res Human Nutr Ile De France,Dept Nutr, Paris, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Kesse-Guyot, E (corresponding author), Univ Paris 13, Cnam, Inra U1125, Ctr Res Human Nutr Ile De France,UMR Inserm U557, Bobigny, France.	e.kesse@uren.smbh.univ-paris13.fr	Pilar, Galan/F-2908-2017; Touvier, Mathilde/E-8817-2017; HERCBERG, Serge/B-4429-2008; Charreire, Helene/F-3037-2017; Oppert, Jean-Michel/F-2810-2017; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Andreeva, Valentina/F-2680-2017; Kesse-Guyot, Emmanuelle/K-4689-2012; Kesse-Guyot, Emmanuelle/F-2692-2017; Serge, Hercberg/F-3038-2017	Pilar, Galan/0000-0003-1706-3107; Touvier, Mathilde/0000-0002-8322-8857; HERCBERG, Serge/0000-0002-3168-1350; Charreire, Helene/0000-0002-1260-9812; Andreeva, Valentina/0000-0001-9480-5210; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Serge, Hercberg/0000-0002-3168-1350	French National Research Agency [ANR-05-PNRA-010]; French Ministry of Health; Mederic; Sodexo; Ipsen; MGEN; Pierre Fabre	French National Research Agency(French National Research Agency (ANR)); French Ministry of Health; Mederic; Sodexo; Ipsen(Ipsen); MGEN; Pierre Fabre	This work was funded by the French National Research Agency (noANR-05-PNRA-010), the French Ministry of Health, Mederic, Sodexo, Ipsen, MGEN and Pierre Fabre. Mederic and MGEN are French health insurance organizations, which are complementary to the National Health Insurance System. Ipsen and Pierre Fabre are private pharmaceutical companies. Sodexo, a food catering company, supported the study by organizing meetings between researchers and study participants. They financially supported the overall implementation of the research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Akbaraly TN, 2009, NEUROLOGY, V73, P854, DOI 10.1212/WNL.0b013e3181b7849b; Bertrais S, 2005, OBES RES, V13, P936, DOI 10.1038/oby.2005.108; Biddle SJH, 2007, AM J PREV MED, V33, P502, DOI 10.1016/j.amepre.2007.08.002; Clark BK, 2009, OBES REV, V10, P7, DOI 10.1111/j.1467-789X.2008.00508.x; Coley N, 2008, EPIDEMIOL REV, V30, P35, DOI 10.1093/epirev/mxn010; Czaja SJ, 2006, PSYCHOL AGING, V21, P333, DOI 10.1037/0882-7974.21.2.333; Delis DC, 2001, DELIS KAPLAN EXECUTI; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; FABRIGOULE C, 1995, J AM GERIATR SOC, V43, P485, DOI 10.1111/j.1532-5415.1995.tb06093.x; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hercberg S, 1998, INT J VITAM NUTR RES, V68, P3; Hughes T, 2010, REV NEUROLOGIA, V51, P259, DOI 10.33588/rn.5105.2010350; Ivanoiu A, 2005, J NEUROL, V252, P47, DOI 10.1007/s00415-005-0597-2; Iwasa H, 2012, J PSYCHOSOM RES, V72, P159, DOI 10.1016/j.jpsychores.2011.10.002; Jedrziewski AK, 2007, ALZHEIMERS DEMENT, V3, P98, DOI 10.1016/j.jalz.2007.01.009; Kesse-Guyot E, 2011, AM J CLIN NUTR; Kesse-Guyot E, 2012, J NUTR, V142, P76, DOI 10.3945/jn.111.144428; Kesse-Guyot E, 2011, AM J CLIN NUTR, V93, P200, DOI 10.3945/ajcn.2010.29761; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; KRISKA AM, 1990, DIABETES CARE, V13, P401, DOI 10.2337/diacare.13.4.401; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201; Mortimer JA, 2005, J GERIATR PSYCH NEUR, V18, P218, DOI 10.1177/0891988705281869; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; Rockwood K, 2007, ALZHEIMERS DEMENT, V3, pS38, DOI 10.1016/j.jalz.2007.01.003; Rundek T, 2006, NEUROLOGY, V66, P794, DOI 10.1212/01.wnl.0000209497.38834.d7; Singh-Manoux A, 2003, J EPIDEMIOL COMMUN H, V57, P907, DOI 10.1136/jech.57.11.907; Singh-Manoux A, 2010, AGE, V32, P509, DOI 10.1007/s11357-010-9147-7; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tucker AM, 2011, CURR ALZHEIMER RES, V8, P354; Tun PA, 2010, PSYCHOL AGING, V25, P560, DOI 10.1037/a0019543; Verghese J, 2006, NEUROLOGY, V66, P821, DOI 10.1212/01.wnl.0000202520.68987.48; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Verghese J, 2009, J GERIATR PSYCH NEUR, V22, P110, DOI 10.1177/0891988709332938; Vuillemin A, 2000, MED SCI SPORT EXER, V32, P1119, DOI 10.1097/00005768-200006000-00013; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wang JYJ, 2006, NEUROLOGY, V66, P911, DOI 10.1212/01.wnl.0000192165.99963.2a; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wilson RS, 2010, NEUROLOGY, V75, P990, DOI 10.1212/WNL.0b013e3181f25b5e; Wilson RS, 2003, NEUROLOGY, V61, P812, DOI 10.1212/01.WNL.0000083989.44027.05; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742	51	98	100	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47831	10.1371/journal.pone.0047831	http://dx.doi.org/10.1371/journal.pone.0047831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082222	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900119
J	Kim, T; Kim, HR; Kim, K; Lee, C				Kim, Taekjun; Kim, HyungGoo R.; Kim, Kayeon; Lee, Choongkil			Modulation of V1 Spike Response by Temporal Interval of Spatiotemporal Stimulus Sequence	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; CLASSICAL RECEPTIVE-FIELD; PRIMARY AUDITORY-CORTEX; SURROUND SUPPRESSION; FEEDBACK CONNECTIONS; GAMMA-OSCILLATIONS; SPATIAL SUMMATION; CORTICAL NETWORKS; MACAQUE MONKEYS	The spike activity of single neurons of the primary visual cortex (V1) becomes more selective and reliable in response to wide-field natural scenes compared to smaller stimuli confined to the classical receptive field (RF). However, it is largely unknown what aspects of natural scenes increase the selectivity of V1 neurons. One hypothesis is that modulation by surround interaction is highly sensitive to small changes in spatiotemporal aspects of RF surround. Such a fine-tuned modulation would enable single neurons to hold information about spatiotemporal sequences of oriented stimuli, which extends the role of V1 neurons as a simple spatiotemporal filter confined to the RF. In the current study, we examined the hypothesis in the V1 of awake behaving monkeys, by testing whether the spike response of single V1 neurons is modulated by temporal interval of spatiotemporal stimulus sequence encompassing inside and outside the RF. We used two identical Gabor stimuli that were sequentially presented with a variable stimulus onset asynchrony (SOA): the preceding one (S1) outside the RF and the following one (S2) in the RF. This stimulus configuration enabled us to examine the spatiotemporal selectivity of response modulation from a focal surround region. Although S1 alone did not evoke spike responses, visual response to S2 was modulated for SOA in the range of tens of milliseconds. These results suggest that V1 neurons participate in processing spatiotemporal sequences of oriented stimuli extending outside the RF.	[Kim, Taekjun; Kim, Kayeon; Lee, Choongkil] Seoul Natl Univ, Dept Psychol, Seoul, South Korea; [Kim, HyungGoo R.; Lee, Choongkil] Seoul Natl Univ, Program Brain Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, C (corresponding author), Seoul Natl Univ, Dept Psychol, Seoul, South Korea.	cklee@snu.ac.kr	Kim, HyungGoo/L-1308-2019	Kim, HyungGoo/0000-0002-9106-4960; Kim, Taekjun/0000-0002-8376-8861; Kim, Kayeon/0000-0002-4565-9429	Korean Ministry of Education, Science and Technology; Seoul National University	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Seoul National University	This research was supported by the Cognitive Neuroscience Research Program of the Korean Ministry of Education, Science and Technology, and the Brain Fusion Program of the Seoul National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2008, NEURON, V57, P135, DOI 10.1016/j.neuron.2007.11.019; ALLMEN M, 1993, CVGIP-IMAG UNDERSTAN, V58, P338, DOI 10.1006/ciun.1993.1046; Alonso JM, 2006, PROG BRAIN RES, V154, P3, DOI 10.1016/S0079-6123(06)54001-4; Angelucci A, 2002, J NEUROSCI, V22, P8633; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Bair W, 2003, J NEUROSCI, V23, P7690; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Brosch M, 2000, CEREB CORTEX, V10, P1155, DOI 10.1093/cercor/10.12.1155; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; Brosch M, 2008, EXP BRAIN RES, V184, P349, DOI 10.1007/s00221-007-1109-7; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Churchland AK, 2007, J NEUROPHYSIOL, V97, P272, DOI 10.1152/jn.00941.2005; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hedges JH, 2011, CURR BIOL, V21, P2023, DOI 10.1016/j.cub.2011.10.049; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KITANO M, 1995, EXP BRAIN RES, V104, P297; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; Lee J, 2010, J NEUROPHYSIOL, V104, P2556, DOI 10.1152/jn.01040.2009; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Marr D., 1982, VISION; Muller JR, 2003, J NEUROPHYSIOL, V90, P822, DOI 10.1152/jn.00005.2003; NELSON SB, 1991, J NEUROSCI, V11, P344; NELSON SB, 1991, J NEUROSCI, V11, P357; Nikolic D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000260; Nishimoto S, 2011, J NEUROSCI, V31, P14551, DOI 10.1523/JNEUROSCI.6801-10.2011; Ozeki H, 2004, J NEUROSCI, V24, P1428, DOI 10.1523/JNEUROSCI.3852-03.2004; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Series P, 2003, J PHYSIOL-PARIS, V97, P453, DOI 10.1016/j.jphysparis.2004.01.023; Series P, 2002, VISION RES, V42, P2781, DOI 10.1016/S0042-6989(02)00302-4; Sohal VS, 2005, P NATL ACAD SCI USA, V102, P18638, DOI 10.1073/pnas.0509291102; Terao M, 2008, NAT NEUROSCI, V11, P541, DOI 10.1038/nn.2111; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; WAGNER H, 1987, J NEUROSCI, V7, P3105; Walker GA, 1999, J NEUROSCI, V19, P10536; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Yin P, 2008, J NEUROPHYSIOL, V100, P3009, DOI 10.1152/jn.00828.2007; Yoon H, 2011, CHOICE RELATED LFP C, V483, P03	66	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47543	10.1371/journal.pone.0047543	http://dx.doi.org/10.1371/journal.pone.0047543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091631	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800055
J	Papachristoforou, A; Kagiava, A; Papaefthimiou, C; Termentzi, A; Fokialakis, N; Skaltsounis, AL; Watkins, M; Arnold, G; Theophilidis, G				Papachristoforou, Alexandros; Kagiava, Alexia; Papaefthimiou, Chrisovalantis; Termentzi, Aikaterini; Fokialakis, Nikolas; Skaltsounis, Alexios-Leandros; Watkins, Max; Arnold, Gerard; Theophilidis, George			The Bite of the Honeybee: 2-Heptanone Secreted from Honeybee Mandibles during a Bite Acts as a Local Anaesthetic in Insects and Mammals	PLOS ONE			English	Article							RAT SCIATIC-NERVE; APIS-MELLIFERA-CARNICA; VARROA-DESTRUCTOR; SODIUM-CHANNELS; BEES; LIDOCAINE; BLOCK; NEUROTOXICITY; PHEROMONES; METABOLISM	Honeybees secrete 2-heptanone (2-H) from their mandibular glands when they bite. Researchers have identified several possible functions: 2-H could act as an alarm pheromone to recruit guards and soldiers, it could act as a chemical marker, or it could have some other function. The actual role of 2-H in honeybee behaviour remains unresolved. In this study, we show that 2-H acts as an anaesthetic in small arthropods, such as wax moth larva (WML) and Varroa mites, which are paralysed after a honeybee bite. We demonstrated that honeybee mandibles can penetrate the cuticle of WML, introducing less than one nanolitre of 2-H into the WML open circulatory system and causing instantaneous anaesthetization that lasts for a few minutes. The first indication that 2-H acts as a local anaesthetic was that its effect on larval response, inhibition and recovery is very similar to that of lidocaine. We compared the inhibitory effects of 2-H and lidocaine on voltage-gated sodium channels. Although both compounds blocked the hNav1.6 and hNav1.2 channels, lidocaine was slightly more effective, 2.82 times, on hNav.6. In contrast, when the two compounds were tested using an ex vivo preparation-the isolated rat sciatic nerve-the function of the two compounds was so similar that we were able to definitively classify 2-H as a local anaesthetic. Using the same method, we showed that 2-H has the fastest inhibitory effect of all alkyl-ketones tested, including the isomers 3- and 4-heptanone. This suggests that natural selection may have favoured 2-H over other, similar compounds because of the associated fitness advantages it confers. Our results reveal a previously unknown role of 2-H in honeybee defensive behaviour and due to its minor neurotoxicity show potential for developing a new local anaesthetic from a natural product, which could be used in human and veterinary medicine.	[Papachristoforou, Alexandros; Kagiava, Alexia; Papaefthimiou, Chrisovalantis; Theophilidis, George] Aristotle Univ Thessaloniki, Sch Biol, Physiol Anim Lab, GR-54006 Thessaloniki, Greece; [Papachristoforou, Alexandros; Arnold, Gerard] CNRS, Lab Evolut, Gif Sur Yvette, France; [Papachristoforou, Alexandros; Arnold, Gerard] Univ Paris 11, Orsay, France; [Papachristoforou, Alexandros] Cyprus Univ Technol, Dept Agr Sci Biotechnol & Food Sci, Limassol, Cyprus; [Kagiava, Alexia] Cyprus Inst Neurol & Genet Neurosci, Nicosia, Cyprus; [Termentzi, Aikaterini; Fokialakis, Nikolas; Skaltsounis, Alexios-Leandros] Univ Athens, Fac Pharm, Dept Pharmacognosy & Nat Prod Chem, Athens, Greece; [Watkins, Max] Vita Europe Ltd, Basingstoke, Hants, England	Aristotle University of Thessaloniki; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Cyprus University of Technology; National & Kapodistrian University of Athens	Papachristoforou, A (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Physiol Anim Lab, GR-54006 Thessaloniki, Greece.	papachri@legs.cnrs-gif.fr	Fokialakis, Nikolas/AAD-1498-2020; Theophilidis, George/AAJ-2273-2020; skaltsounis, alexios leandros/AAE-9617-2019	Fokialakis, Nikolas/0000-0001-7028-1870; Papachristoforou, Alexandros/0000-0001-8123-6848; Kagiava, Alexia/0000-0002-3903-1299	Vita (Europe) Limited, UK; Vita (Europe) Limited; ChanTest Corporation (Cleveland OH, US); Conseil General de l' Essonne	Vita (Europe) Limited, UK; Vita (Europe) Limited; ChanTest Corporation (Cleveland OH, US); Conseil General de l' Essonne	The research was directed and funded by Vita (Europe) Limited, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: the research was funded through Vita (Europe) Limited, a small UK company specialising only in honeybee health. MW works for this company. The original studies examined honeybee behaviour and they discovered the anaesthetisation properties of 2-H in the mammalian peripheral nervous systems as an extension to the honeybee biology work. Vita has now filed a patent on the potential use of 2-heptanone as a local anaesthetic (International Patent Application number: PCT/GB2012/050157). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. All other authors have declared that no competing interests exist.; We thank the Cypriot Union of Beekeepers for providing the specimens for the trials. We thank Evagelos Gikas for analytical advice, Dimitris Fotaroudis for the statistical support, ChanTest Corporation (Cleveland OH, US) for the support on patch-clamp experiments and Sharilynn Wardrop for reviewing the paper. We thank Anais Carpentier for the support during SEM photography, which benefited from the facilities and expertise of the Imagif Cell Biology Unit of the Gif campus (www.imagif.cnrs.fr) which is supported by the Conseil General de l' Essonne.	ALBRO PW, 1984, CHEM-BIOL INTERACT, V51, P295, DOI 10.1016/0009-2797(84)90155-8; Aumeier P, 2001, APIDOLOGIE, V32, P81, DOI 10.1051/apido:2001113; BOCH R, 1971, J INSECT PHYSIOL, V17, P2277, DOI 10.1016/0022-1910(71)90077-1; BOCH R, 1970, J INSECT PHYSIOL, V16, P17, DOI 10.1016/0022-1910(70)90108-3; Boecking O, 1999, APIDOLOGIE, V30, P141, DOI 10.1051/apido:19990205; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Couvillon MJ, 2010, J CHEM ECOL, V36, P1306, DOI 10.1007/s10886-010-9881-4; Cummins TR, 2007, J PHYSIOL-LONDON, V582, P11, DOI 10.1113/jphysiol.2007.136671; EISCHEN FA, 1986, ANIM BEHAV, V34, P1070, DOI 10.1016/S0003-3472(86)80166-X; Engels W, 1997, J INSECT PHYSIOL, V43, P307, DOI 10.1016/S0022-1910(96)00110-2; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; FREE JB, 1985, J AGR SCI, V105, P255, DOI 10.1017/S0021859600056318; FREE JB, 1968, Z VERGL PHYSIOL, V61, P361, DOI 10.1007/BF00428008; Geronikaki A, 2009, EUR J MED CHEM, V44, P473, DOI 10.1016/j.ejmech.2008.04.006; Hung YC, 2009, REGION ANESTH PAIN M, V34, P333, DOI 10.1097/AAP.0b013e3181ac7f49; IMAOKA S, 1990, J PHARMACOL EXP THER, V255, P1385; Jianguo T, 2009, NEUROTOXICOLOGY, V30, P81; Kagiava A, 2011, ANTI-CANCER DRUG, V22, P273, DOI 10.1097/CAD.0b013e3283425888; Kagiava A, 2008, NEUROTOXICOLOGY, V29, P1100, DOI 10.1016/j.neuro.2008.09.005; KALICHMAN MW, 1988, ACTA NEUROPATHOL, V75, P583, DOI 10.1007/BF00686203; Kanai Y, 2000, ANESTH ANALG, V91, P944, DOI 10.1097/00000539-200010000-00033; Koh YC, 2012, TOXICON, V4, P497; Kroin JS, 2010, REGION ANESTH PAIN M, V35, P343, DOI 10.1097/AAP.0b013e3181e82df0; LAMBERT LA, 1994, ANESTHESIOLOGY, V80, P1082, DOI 10.1097/00000542-199405000-00017; Lensky Y, 1995, BEE WORLD, V76, P119, DOI 10.1080/0005772X.1995.11099258; Leterrier C, 2010, NEUROSCI LETT, V486, P92, DOI 10.1016/j.neulet.2010.08.079; Lewis RJ, 2012, TOXICON, V59, P524, DOI 10.1016/j.toxicon.2011.07.012; Marder E, 2005, CURR BIOL, V15, pR685, DOI 10.1016/j.cub.2005.08.022; MISUMI J, 1984, BRIT J IND MED, V41, P526; Moschou M, 2008, TOXICOL IN VITRO, V22, P267, DOI 10.1016/j.tiv.2007.09.005; MYERS RR, 1986, ANESTHESIOLOGY, V64, P29, DOI 10.1097/00000542-198601000-00006; Nielsen CK, 2005, PAIN, V118, P112, DOI 10.1016/j.pain.2005.08.002; Papachristoforou A, 2011, PESTIC BIOCHEM PHYS, V101, P109, DOI 10.1016/j.pestbp.2011.08.008; Paterson BA, 2010, J EXP BIOL, V213, P2483, DOI 10.1242/jeb.043026; PATTE F, 1989, J INSECT PHYSIOL, V35, P667, DOI 10.1016/0022-1910(89)90086-3; RIETH JP, 1986, J APICULT RES, V25, P78, DOI 10.1080/00218839.1986.11100697; ROBINSON GE, 1985, J INSECT PHYSIOL, V31, P277, DOI 10.1016/0022-1910(85)90003-4; RUTTNER F, 1992, APIDOLOGIE, V23, P173, DOI 10.1051/apido:19920210; SCHMALBRUCH H, 1986, ANAT REC, V215, P71, DOI 10.1002/ar.1092150111; SHEARER DA, 1965, NATURE, V206, P530, DOI 10.1038/206530a0; Sheets PL, 2011, BRIT J PHARMACOL, V164, P719, DOI 10.1111/j.1476-5381.2011.01209.x; SLAMA K, 1984, J COMP PHYSIOL, V154, P635, DOI 10.1007/BF00684418; Song WZ, 2011, INSECT BIOCHEM MOLEC, V41, P36, DOI 10.1016/j.ibmb.2010.09.010; STRUYE MH, 1994, APIDOLOGIE, V25, P384, DOI 10.1051/apido:19940405; VALLET A, 1991, J INSECT PHYSIOL, V37, P789, DOI 10.1016/0022-1910(91)90076-C	45	28	29	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47432	10.1371/journal.pone.0047432	http://dx.doi.org/10.1371/journal.pone.0047432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091624	Green Published, gold			2022-12-27	WOS:000310135800047
J	Du, YR; Liu, B; Guo, F; Xu, GF; Ding, YQ; Liu, Y; Sun, X; Xu, GL				Du, Yarui; Liu, Bo; Guo, Fan; Xu, Guifang; Ding, Yuqiang; Liu, Yong; Sun, Xin; Xu, Guoliang			The Essential Role of Mbd5 in the Regulation of Somatic Growth and Glucose Homeostasis in Mice	PLOS ONE			English	Article							CPG-BINDING DOMAIN; DNA METHYLATION; FACTOR I; HORMONE; INSULIN; GENE; PROTEINS; RECEPTOR; COMPLEX; TRANSCRIPTION	Methyl-CpG binding domain protein 5 (MBD5) belongs to the MBD family proteins, which play central roles in transcriptional regulation and development. The significance of MBD5 function is highlighted by recent studies implicating it as a candidate gene involved in human 2q23.1 microdeletion syndrome. To investigate the physiological role of Mbd5, we generated knockout mice. The Mbd5-deficient mice showed growth retardation, wasting and pre-weaning lethality. The observed growth retardation was associated with the impairment of GH/IGF-1 axis in Mbd5-null pups. Conditional knockout of Mbd5 in the brain resulted in the similar phenotypes as whole body deletion, indicating that Mbd5 functions in the nervous system to regulate postnatal growth. Moreover, the mutant mice also displayed enhanced glucose tolerance and elevated insulin sensitivity as a result of increased insulin signaling, ultimately resulting in disturbed glucose homeostasis and hypoglycemia. These results indicate Mbd5 as an essential factor for mouse postnatal growth and maintenance of glucose homeostasis.	[Du, Yarui; Liu, Bo; Guo, Fan; Xu, Guifang; Xu, Guoliang] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Ding, Yuqiang] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China; [Liu, Yong] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Sun, Xin] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Wisconsin System; University of Wisconsin Madison	Xu, GL (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	glxu@sibs.ac.cn	Guo, Fan/J-1857-2019; Guo, Fan/AAX-4952-2021; Liu, Bo/AAU-9183-2020	Guo, Fan/0000-0002-0165-073X; Ding, Yu-Qiang/0000-0003-1202-4635	Ministry of Science and Technology China [2007CB947503, 2009CB941101]; National Science Foundation of China [30730059, 31028012, 31000641]	Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology China (2007CB947503 and 2009CB941101), and National Science Foundation of China (30730059 to G. X., 31028012 to X. S. and 31000641 to Y.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Chung BHY, 2011, AM J MED GENET A, V155A, P424, DOI 10.1002/ajmg.a.33821; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; Fan GP, 2005, CELL RES, V15, P255, DOI 10.1038/sj.cr.7290294; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Grosso S, 2008, EPILEPSY RES, V79, P63, DOI 10.1016/j.eplepsyres.2007.12.011; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jaillard S, 2009, J MED GENET, V46, P847, DOI 10.1136/jmg.2008.058156; JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; KAUFMAN HE, 1954, SCIENCE, V120, P723, DOI 10.1126/science.120.3122.723; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Laget S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011982; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Liu JL, 1999, ENDOCRINOLOGY, V140, P5178, DOI 10.1210/en.140.11.5178; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Nowakowska BA, 2010, AM J MED GENET B, V153B, P1042, DOI 10.1002/ajmg.b.31071; Ooi GT, 1997, MOL ENDOCRINOL, V11, P997, DOI 10.1210/me.11.7.997; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Roloff TC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-1; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van Bon BWM, 2010, EUR J HUM GENET, V18, P163, DOI 10.1038/ejhg.2009.152; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wagenstaller J, 2007, AM J HUM GENET, V81, P768, DOI 10.1086/521274; Walenkamp MJE, 2007, EUR J ENDOCRINOL, V156, P155, DOI 10.1530/eje.1.02327; Williams SR, 2010, EUR J HUM GENET, V18, P436, DOI 10.1038/ejhg.2009.199; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	38	16	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47358	10.1371/journal.pone.0047358	http://dx.doi.org/10.1371/journal.pone.0047358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077600	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100099
J	Lambertsen, KL; Gramsbergen, JB; Sivasaravanaparan, M; Ditzel, N; Sevelsted-Moller, LM; Olivan-Viguera, A; Rabjerg, M; Wulff, H; Kohler, R				Lambertsen, Kate Lykke; Gramsbergen, Jan Bert; Sivasaravanaparan, Mithula; Ditzel, Nicholas; Sevelsted-Moller, Linda Maria; Olivan-Viguera, Aida; Rabjerg, Maj; Wulff, Heike; Kohler, Ralf			Genetic KCa3.1-Deficiency Produces Locomotor Hyperactivity and Alterations in Cerebral Monoamine Levels	PLOS ONE			English	Article							CA2+-ACTIVATED K+-CHANNEL; ACTIVATED POTASSIUM CHANNELS; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; INTERMEDIATE-CONDUCTANCE; BLOOD-PRESSURE; DEFICIENT MICE; BRAIN; DOPAMINE; SK3	Background: The calmodulin/calcium-activated K+ channel KCa3.1 is expressed in red and white blood cells, epithelia and endothelia, and possibly central and peripheral neurons. However, our knowledge about its contribution to neurological functions and behavior is incomplete. Here, we investigated whether genetic deficiency or pharmacological activation of KCa3.1 change behavior and cerebral monoamine levels in mice. Methodology/Principal Findings: In the open field test, KCa3.1-deficiency increased horizontal activity, as KCa3.1(-/-) mice travelled longer distances (approximate to 145% of KCa3.1(+/+)) and at higher speed (approximate to 1.5-fold of KCa3.1(+/+)). Working memory in the Y-maze was reduced by KCa3.1-deficiency. Motor coordination on the rotarod and neuromuscular functions were unchanged. In KCa3.1(-/-) mice, HPLC analysis revealed that turn-over rates of serotonin were reduced in frontal cortex, striatum and brain stem, while noradrenalin turn-over rates were increased in the frontal cortex. Dopamine turn-over rates were unaltered. Plasma catecholamine and corticosterone levels were unaltered. Intraperitoneal injections of 10 mg/kg of the KCa3.1/KCa2-activator SKA-31 reduced rearing and turning behavior in KCa3.1(+/+) but not in KCa3.1(-/-) mice, while 30 mg/kg SKA-31 caused strong sedation in 50% of the animals of either genotypes. KCa3.1(-/-) mice were hyperactive (approximate to+60%) in their home cage and SKA-31-administration reduced nocturnal physical activity in KCa3.1(+/+) but not in KCa3.1(-/-) mice. Conclusions/Significance: KCa3.1-deficiency causes locomotor hyperactivity and altered monoamine levels in selected brain regions, suggesting a so far unknown functional link of KCa3.1 channels to behavior and monoaminergic neurotransmission in mice. The tranquilizing effects of low-dose SKA-31 raise the possibility to use KCa3.1/KCa2 channels as novel pharmacological targets for the treatment of neuropsychiatric hyperactivity disorders.	[Sevelsted-Moller, Linda Maria; Rabjerg, Maj; Kohler, Ralf] Univ So Denmark, Inst Mol Med, Odense, Denmark; [Lambertsen, Kate Lykke; Gramsbergen, Jan Bert; Sivasaravanaparan, Mithula] Univ So Demark, Dept Neurobiol Res, Odense, Denmark; [Ditzel, Nicholas] Odense Univ Hosp, KMEB, DK-5000 Odense, Denmark; [Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Olivan-Viguera, Aida; Kohler, Ralf] Aragon Inst Hlth Sci I CS & ARAID, Zaragoza, Spain	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of California System; University of California Davis	Kohler, R (corresponding author), Univ So Denmark, Inst Mol Med, Odense, Denmark.	rkohler.iacs@aragon.es	Oliván-Viguera, Aida/I-4260-2015; Lambertsen, Kate L. Lykke/I-8676-2014; wulff, Heike/Z-2056-2019; Oliván-Viguera, Aida/ABG-4048-2020	Oliván-Viguera, Aida/0000-0001-5348-924X; Lambertsen, Kate L. Lykke/0000-0001-9276-4902; Oliván-Viguera, Aida/0000-0001-5348-924X; Rabjerg, Maj/0000-0002-6266-7906; Kohler, Ralf/0000-0001-9563-2913	Deutsche Forschungsgemeinschaft [KO1899/10/11]; Danish Parkinson Society; Lundbeckfonden; Carlsbergfondet; National Institutes of Health [R21 NS072585]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072585] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish Parkinson Society; Lundbeckfonden(Lundbeckfonden); Carlsbergfondet(Carlsberg Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by grants of the Deutsche Forschungsgemeinschaft (KO1899/10/11 to RK), the Danish Parkinson Society (to JBG), Lundbeckfonden (to KLL and to RK), Carlsbergfondet (to KLL), and the National Institutes of Health (R21 NS072585 to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Boettger MK, 2002, BRAIN, V125, P252, DOI 10.1093/brain/awf026; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Chen YJ, 2011, J CEREBR BLOOD F MET, V31, P2363, DOI 10.1038/jcbfm.2011.101; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Engbers JDT, 2012, P NATL ACAD SCI USA, V109, P2601, DOI 10.1073/pnas.1115024109; Fan Xueliang, 2012, Curr Top Behav Neurosci, V9, P273, DOI 10.1007/7854_2011_121; Gramsbergen JB, 2002, BRAIN RES, V935, P47, DOI 10.1016/S0006-8993(02)02451-4; Grgic I, 2009, PFLUG ARCH EUR J PHY, V458, P291, DOI 10.1007/s00424-008-0619-x; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jacobsen JPR, 2009, NEUROSCIENCE, V163, P73, DOI 10.1016/j.neuroscience.2009.05.062; Jacobsen JPR, 2008, GENES BRAIN BEHAV, V7, P836, DOI 10.1111/j.1601-183X.2008.00416.x; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kohler R, 2000, CIRC RES, V87, P496; Kohler R, 2010, PFLUG ARCH EUR J PHY, V459, P969, DOI 10.1007/s00424-010-0819-z; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Lambertsen KL, 2009, J NEUROSCI, V29, P1319, DOI 10.1523/JNEUROSCI.5505-08.2009; Lambertsen KL, 2001, BRAIN RES PROTOC, V7, P175, DOI 10.1016/S1385-299X(01)00062-9; Liang Z, 2011, J PHYSL; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; Mauler F, 2004, EUR J NEUROSCI, V20, P1761, DOI 10.1111/j.1460-9568.2004.03615.x; Neylon CB, 2004, J NEUROCHEM, V90, P1414, DOI 10.1111/j.1471-4159.2004.02593.x; Oades RD, 2002, BEHAV BRAIN RES, V130, P97, DOI 10.1016/S0166-4328(01)00440-5; Russell VA, 2002, BEHAV BRAIN RES, V130, P191, DOI 10.1016/S0166-4328(01)00425-9; Sankaranarayanan A, 2009, MOL PHARMACOL, V75, P281, DOI 10.1124/mol.108.051425; Santiago RM, 2010, PROG NEURO-PSYCHOPH, V34, P1104, DOI 10.1016/j.pnpbp.2010.06.004; Shakkottai VG, 2004, J CLIN INVEST, V113, P582, DOI 10.1172/JCI200420216; Shakkottai VG, 2011, J NEUROSCI, V31, P13002, DOI 10.1523/JNEUROSCI.2789-11.2011; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Toyama K, 2008, J CLIN INVEST; Vandorpe DH, 1998, J BIOL CHEM, V273, P21542, DOI 10.1074/jbc.273.34.21542; VANRENTERGHEM C, 1995, J NEUROCHEM, V65, P1274; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11	45	42	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47744	10.1371/journal.pone.0047744	http://dx.doi.org/10.1371/journal.pone.0047744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077667	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100159
J	Maddaluno, M; Grassia, G; Di Lauro, MV; Parisi, A; Maione, F; Cicala, C; De Filippis, D; Iuvone, T; Guglielmotti, A; Maffia, P; Mascolo, N; Ialenti, A				Maddaluno, Marcella; Grassia, Gianluca; Di Lauro, Maria Vittoria; Parisi, Antonio; Maione, Francesco; Cicala, Carla; De Filippis, Daniele; Iuvone, Teresa; Guglielmotti, Angelo; Maffia, Pasquale; Mascolo, Nicola; Ialenti, Armando			Bindarit Inhibits Human Coronary Artery Smooth Muscle Cell Proliferation, Migration and Phenotypic Switching	PLOS ONE			English	Article							ANTIINFLAMMATORY AGENT BINDARIT; MONOCYTE CHEMOTACTIC PROTEINS; NEOINTIMAL FORMATION; VASCULAR INJURY; MOLECULAR-MECHANISMS; HYPERLIPIDEMIC MICE; MCP-1 SYNTHESIS; PROTECTS MICE; DIFFERENTIATION; EXPRESSION	Bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs) synthesis, reduces neointimal formation in animal models of vascular injury and recently has been shown to inhibit in-stent late loss in a placebo-controlled phase II clinical trial. However, the mechanisms underlying the efficacy of bindarit in controlling neointimal formation/restenosis have not been fully elucidated. Therefore, we investigated the effect of bindarit on human coronary smooth muscle cells activation, drawing attention to the phenotypic modulation process, focusing on contractile proteins expression as well as proliferation and migration. The expression of contractile proteins was evaluated by western blot analysis on cultured human coronary smooth muscle cells stimulated with TNF-alpha (30 ng/mL) or fetal bovine serum (5%). Bindarit (100-300 mM) reduced the embryonic form of smooth muscle myosin heavy chain while increased smooth muscle alpha-actin and calponin in both TNF-alpha- and fetal bovine serum-stimulated cells. These effects were associated with the inhibition of human coronary smooth muscle cell proliferation/migration and both MCP-1 and MCP-3 production. The effect of bindarit on smooth muscle cells phenotypic switching was confirmed in vivo in the rat balloon angioplasty model. Bindarit (200 mg/Kg/day) significantly reduced the expression of the embryonic form of smooth muscle myosin heavy chain, and increased smooth muscle alpha-actin and calponin in the rat carodid arteries subjected to endothelial denudation. Our results demonstrate that bindarit induces the differentiated state of human coronary smooth muscle cells, suggesting a novel underlying mechanisms by which this drug inhibits neointimal formation.	[Maddaluno, Marcella; Grassia, Gianluca; Di Lauro, Maria Vittoria; Parisi, Antonio; Maione, Francesco; Cicala, Carla; De Filippis, Daniele; Iuvone, Teresa; Maffia, Pasquale; Mascolo, Nicola; Ialenti, Armando] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Guglielmotti, Angelo] ACRAF, Angelini, Rome, Italy; [Maffia, Pasquale] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of Naples Federico II; University of Glasgow	Mascolo, N (corresponding author), Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy.	nicoladomenicocferd.mascolo@unina.it; ialenti@unina.it	Grassia, Gianluca/H-7677-2019; cicala, carla/AAK-3831-2020	Grassia, Gianluca/0000-0001-7846-5594; cicala, carla/0000-0002-8977-8251	Angelini [004FA11072, 004FA10204]	Angelini	A.I. received the project grants (004FA11072; 004FA10204) from Angelini for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors discussed with the funders the study design and decision to publish.	Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Bhatia M, 2005, AM J PHYSIOL-GASTR L, V288, pG1259, DOI 10.1152/ajpgi.00435.2004; Bhatia M, 2008, INFLAMM RES, V57, P464, DOI 10.1007/s00011-008-7210-y; Charey DJ, 1991, ANNU REV PHYSIOL, V53, P161; Colombo A, 2012, J AM COLL CARDIOL, V59, pE11, DOI 10.1016/S0735-1097(12)60012-6; Denger S, 1999, ATHEROSCLEROSIS, V144, P15, DOI 10.1016/S0021-9150(99)00033-7; Grassia G, 2010, ARTERIOSCL THROM VAS, V30, P2458, DOI 10.1161/ATVBAHA.110.215467; Grassia G, 2009, CARDIOVASC RES, V84, P485, DOI 10.1093/cvr/cvp238; Ialenti A, 2011, ARTERIOSCL THROM VAS, V31, P2448, DOI 10.1161/ATVBAHA.111.230078; Indolfi C, 2000, J AM COLL CARDIOL, V35, P214, DOI 10.1016/S0735-1097(99)00526-4; Maddaluno M, 2011, ATHEROSCLEROSIS, V217, P113, DOI 10.1016/j.atherosclerosis.2011.04.002; Maffia P, 2006, CIRCULATION, V114, P430, DOI 10.1161/CIRCULATIONAHA.105.602714; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Marx SO, 2011, CIRC-CARDIOVASC INTE, V4, P104, DOI 10.1161/CIRCINTERVENTIONS.110.957332; Mirolo M, 2008, EUR CYTOKINE NETW, V19, P119, DOI 10.1684/ecn.2008.0133; Mora E, 2012, CELL CYCLE, V11, P159, DOI 10.4161/cc.11.1.18559; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parenti A, 2004, AM J PHYSIOL-HEART C, V286, pH1978, DOI 10.1152/ajpheart.00414.2003; Perico N, 2008, NAT REV DRUG DISCOV, V7, P936, DOI 10.1038/nrd2685; Regan CP, 2000, J CLIN INVEST, V106, P1139, DOI 10.1172/JCI10522; Rulli NE, 2009, ARTHRITIS RHEUM-US, V60, P2513, DOI 10.1002/art.24682; Schober A, 2004, CIRC RES, V95, P1125, DOI 10.1161/01.RES.0000149518.86865.3e; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Selzman CH, 2002, AM J PHYSIOL-HEART C, V283, pH1455, DOI 10.1152/ajpheart.00188.2002; Wada H, 2008, BIOCHEM BIOPH RES CO, V374, P731, DOI 10.1016/j.bbrc.2008.07.098	27	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47464	10.1371/journal.pone.0047464	http://dx.doi.org/10.1371/journal.pone.0047464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077623	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000309995100119
J	Pinto, P; Salgado, CG; Santos, N; Alencar, DO; Santos, S; Hutz, MH; Ribeiro-dos-Santos, A				Pinto, Pablo; Salgado, Claudio Guedes; Santos, Ney; Alencar, Dayse O.; Santos, Sidney; Hutz, Mara H.; Ribeiro-dos-Santos, Andrea			Polymorphisms in the CYP2E1 and GSTM1 Genes as Possible Protection Factors for Leprosy Patients	PLOS ONE			English	Article							ANTILEPROSY DRUGS; COMMON USE; POPULATION; GLUTATHIONE-S-TRANSFERASE-M1; SUSCEPTIBILITY	Background: The CYP2E1 and GSTM1 genes encode metabolic enzymes that have key functions in drug modification and elimination. Methodology/Principal Findings: We investigated the possible effects of CYP2E1 and GSTM1 polymorphisms in 71 leprosy patients and in 110 individuals from the general population. The GSTM1*0 null allele and INDEL CYP2E1*1D mutant genotypes were analyzed by conventional PCR, while CYP2E1 SNPs (1053C>T, 1293G>C and 7632T>A) were determined by RT-PCR. In leprosy patients, the GSTM1*0 and CYP2E1*5 alleles and the combined alleles GSTM1*0/CYP2E1*6 and GSTM1*0/CYP2E1*5 were significantly related to a baciloscopic index (BI) (BI<3), while the CYP2E1*6 allele was related to a better clinical evolution in the leprosy spectrum. Conclusions/Significance: Therefore, GSTM1*0, CYP2E1*5 and CYP2E1*6 may be possible protection factors for leprosy patients.	[Pinto, Pablo; Santos, Ney; Alencar, Dayse O.; Santos, Sidney; Ribeiro-dos-Santos, Andrea] Fed Univ Para, Inst Ciencias Biol, Lab Genet Humana & Med, BR-66059 Belem, Para, Brazil; [Salgado, Claudio Guedes] Fed Univ Para, Inst Ciencias Biol, Lab Dermatoimunol, BR-66059 Belem, Para, Brazil; [Hutz, Mara H.] Univ Fed Rio Grande do Sul, Dept Genet, Inst Biociencias, Rio Grande Do Sol, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Rio Grande do Sul	Ribeiro-dos-Santos, A (corresponding author), Fed Univ Para, Inst Ciencias Biol, Lab Genet Humana & Med, BR-66059 Belem, Para, Brazil.	akely@ufpa.br	Hutz, Mara H/I-4070-2012; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Salgado, Claudio G/K-8931-2012; Santos, Ândrea Ribeiro dos/B-6061-2013; Pinto, Pablo/T-6154-2019; Salgado, Claudio G/C-5206-2014	Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Salgado, Claudio G/0000-0003-3961-7764; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Salgado, Claudio G/0000-0003-3961-7764; Santos, Ney Pereira Carneiro dos/0000-0001-8087-7037; Hutz, Mara/0000-0002-9146-1229	FINEP (Financiadora de Estudos e Projetos), CNPq/Casadinho (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior); PROPES/UFPA (Universidade Federal do Para), FADESP (Fundacao de Amparo a Pesquisa)	FINEP (Financiadora de Estudos e Projetos), CNPq/Casadinho (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PROPES/UFPA (Universidade Federal do Para), FADESP (Fundacao de Amparo a Pesquisa)	This study was supported by FINEP (Financiadora de Estudos e Projetos), CNPq/Casadinho (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior) and PROPES/UFPA (Universidade Federal do Para), FADESP (Fundacao de Amparo a Pesquisa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcais A, 2005, CURR OPIN IMMUNOL, V17, P44, DOI 10.1016/j.coi.2004.11.006; Cho HR, 2011, INT J IMMUNOGENET, V38, P145, DOI 10.1111/j.1744-313X.2010.00987.x; Crawford CL, 2010, CLIN INFECT DIS, V51, P476, DOI 10.1086/655155; Douglas JG, 1999, CLIN PHARMACOKINET, V37, P127; Etienne D, 2000, LEPROSY REV, V73, pS35; Goulart Isabela Maria Bernades, 2002, Rev. Soc. Bras. Med. Trop., V35, P453, DOI 10.1590/S0037-86822002000500005; Hardman JG, 2004, GOODMAN GILMAN BASES; Hasler Julia A., 1999, Molecular Aspects of Medicine, V20, P1, DOI 10.1016/S0098-2997(99)00005-9; JOPLING WH, 1983, LEPROSY REV, V54, P261; JOPLING WH, 1985, LEPROSY REV, V56, P61; Kaur MR, 2006, J DERMATOL TREAT, V17, P211, DOI 10.1080/09546630600830588; Kayaalti Z, 2010, ALCOHOL, V1, P9; Konwar R, 2010, ASIAN PAC J CANCER P, V11, P1067; Li L, 2011, LEUKEMIA RES, V35, P762, DOI 10.1016/j.leukres.2010.12.001; Long J, 1999, MULTIPLE LOCUS HAPLO; Moreira Adriana Souza, 2006, Arq. Bras. Oftalmol., V69, P865, DOI 10.1590/S0004-27492006000600015; Moreira MBR, 2002, GUIA CONTROLE HANSEN; MORRISON NE, 1976, INT J LEPROSY, V44, P133; Moyer AM, 2007, CLIN CANCER RES, V13, P7207, DOI 10.1158/1078-0432.CCR-07-0635; Opromolla Diltor Vladmir Araujo, 1997, Medicina (Ribeirao Preto), V30, P345; PFALTZGRAFF RE, 1985, LEPROSY, P134; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Rivera RC, 2010, J BACTERIOL, V192, P3268; Rivers EC, 2008, CURR MED CHEM, V15, P1956, DOI 10.2174/092986708785132906; Sambrook J., 2002, MOL CLONING LAB MANU; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Souza Cacilda Silva, 1997, Medicina (Ribeirao Preto), V30, P325; Stretch R, 1999, Nurs Times, V95, P46; TSUTSUMI M, 1994, GASTROENTEROLOGY, V107, P1430, DOI 10.1016/0016-5085(94)90546-0; UEMATSU F, 1994, PHARMACOGENETICS, V4, P58, DOI 10.1097/00008571-199404000-00002; Vaishali BN, 2011, ASIATIC J BIOTECH RE, V2, P547; Wang SM, 2009, J HUM GENET, V54, P372, DOI 10.1038/jhg.2009.41; WIDERSTEN M, 1991, BIOCHEM J, V276, P519, DOI 10.1042/bj2760519; Yamada S, 2009, PHARMACOGENOMICS, V10, P1433, DOI [10.2217/pgs.09.66, 10.2217/PGS.09.66]; Yang BM, 2001, ALCOHOL, V23, P91, DOI 10.1016/S0741-8329(00)00135-X; Yano T, 2011, J BIOL CHEM, V286, P10276, DOI 10.1074/jbc.M110.200501	36	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47498	10.1371/journal.pone.0047498	http://dx.doi.org/10.1371/journal.pone.0047498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077626	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100122
J	Dowd, KP; Harrington, DM; Donnelly, AE				Dowd, Kieran P.; Harrington, Deirdre M.; Donnelly, Alan E.			Criterion and Concurrent Validity of the activPAL (TM) Professional Physical Activity Monitor in Adolescent Females	PLOS ONE			English	Article							ACCELEROMETER OUTPUT; SEDENTARY BEHAVIOR; UNITED-STATES; CALIBRATION; TIME; VALIDATION; INACTIVITY; ACTIGRAPH; PATTERNS; CHILDREN	Background: The activPAL has been identified as an accurate and reliable measure of sedentary behaviour. However, only limited information is available on the accuracy of the activPAL activity count function as a measure of physical activity, while no unit calibration of the activPAL has been completed to date. This study aimed to investigate the criterion validity of the activPAL, examine the concurrent validity of the activPAL, and perform and validate a value calibration of the activPAL in an adolescent female population. The performance of the activPAL in estimating posture was also compared with sedentary thresholds used with the ActiGraph accelerometer. Methodologies: Thirty adolescent females (15 developmental; 15 cross-validation) aged 15-18 years performed 5 activities while wearing the activPAL, ActiGraph GT3X, and the Cosmed K4B2. A random coefficient statistics model examined the relationship between metabolic equivalent (MET) values and activPAL counts. Receiver operating characteristic analysis was used to determine activity thresholds and for cross-validation. The random coefficient statistics model showed a concordance correlation coefficient of 0.93 (standard error of the estimate = 1.13). An optimal moderate threshold of 2997 was determined using mixed regression, while an optimal vigorous threshold of 8229 was determined using receiver operating statistics. The activPAL count function demonstrated very high concurrent validity (r = 0.96, p<0.01) with the ActiGraph count function. Levels of agreement for sitting, standing, and stepping between direct observation and the activPAL and ActiGraph were 100%, 98.1%, 99.2% and 100%, 0%, 100%, respectively. Conclusions: These findings suggest that the activPAL is a valid, objective measurement tool that can be used for both the measurement of physical activity and sedentary behaviours in an adolescent female population.	[Dowd, Kieran P.; Donnelly, Alan E.] Univ Limerick, Dept Phys Educ & Sport Sci, Limerick, Ireland; [Harrington, Deirdre M.] Pennington Biomed Res Ctr, Baton Rouge, LA USA	University of Limerick; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Dowd, KP (corresponding author), Univ Limerick, Dept Phys Educ & Sport Sci, Limerick, Ireland.	kieran.dowd@ul.ie	Donnelly, Alan E/D-9244-2012; Dowd, Kieran/L-5810-2016	Dowd, Kieran/0000-0002-1841-1604; Donnelly, Alan/0000-0002-6874-0991; Harrington, Deirdre/0000-0003-0278-6812	Irish Research Council for Science, Engineering and Technology (IRCSET)	Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology)	KD is supported by a studentship from the Irish Research Council for Science, Engineering and Technology (IRCSET), Shelbourne Rd., Dublin 4, Ireland. These funders had no role in the study design, collection, analysis and interpretation of the data, in the writing of the article and in the decision to submit the paper for publication.	Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Bassett DR, 2010, EXERC SPORT SCI REV, V38, P101, DOI 10.1097/JES.0b013e3181e373ee; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Butte NF, 2012, MED SCI SPORT EXER, V44, pS5, DOI 10.1249/MSS.0b013e3182399c0e; Chastin SFM, 2009, EUR J APPL PHYSIOL, V106, P893, DOI 10.1007/s00421-009-1090-x; Colley R., 2011, HLTH REP, V22, P4; Department of Transport, 2009, NAT CYCL POL FRAM; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Godfrey A, 2007, MED ENG PHYS, V29, P930, DOI 10.1016/j.medengphy.2006.10.001; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Harrington DM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-120; Harrington DM, 2011, J SPORT SCI, V29, P627, DOI 10.1080/02640414.2010.549499; Hart TL, 2011, MED SCI SPORT EXER, V43, P449, DOI 10.1249/MSS.0b013e3181ef5a93; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Jago R, 2007, J SPORT SCI, V25, P937, DOI 10.1080/02640410600908027; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kozey SL, 2010, MED SCI SPORT EXER, V42, P1776, DOI 10.1249/MSS.0b013e3181d479f2; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Martin A, 2011, PEDIATR EXERC SCI, V23, P468, DOI 10.1123/pes.23.4.468; Martinez-Gomez D, 2010, REV ESP CARDIOL, V63, P277, DOI 10.1016/S0300-8932(10)70086-5; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; POOLE DC, 1991, J APPL PHYSIOL, V71, P1245, DOI 10.1152/jappl.1991.71.4.1245; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Ridgers ND, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-15; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2007, PEDIATR EXERC SCI, V19, P145, DOI 10.1123/pes.19.2.145; Vonesh EF, 1996, BIOMETRICS, V52, P572, DOI 10.2307/2532896; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Welk GJ, 2005, MED SCI SPORT EXER, V37, pS501, DOI 10.1249/01.mss.0000185660.38335.de; ZWEIG MH, 1993, CLIN CHEM, V39, P561	43	75	76	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47633	10.1371/journal.pone.0047633	http://dx.doi.org/10.1371/journal.pone.0047633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094069	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000310050200036
J	Mendes, YS; Alves, NS; Souza, TLF; Sousa, IP; Bianconi, ML; Bernardi, RC; Pascutti, PG; Silva, JL; Gomes, AMO; Oliveira, AC				Mendes, Ygara S.; Alves, Nathalia S.; Souza, Theo L. F.; Sousa, Ivanildo P., Jr.; Lucia Bianconi, M.; Bernardi, Rafael C.; Pascutti, Pedro G.; Silva, Jerson L.; Gomes, Andre M. O.; Oliveira, Andrea C.			The Structural Dynamics of the Flavivirus Fusion Peptide-Membrane Interaction	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; PH-DEPENDENT FUSION; MOLECULAR-DYNAMICS; SYNTHETIC PEPTIDES; GLYCOPROTEIN; PROTEINS; MODEL; SIMULATIONS	Membrane fusion is a crucial step in flavivirus infections and a potential target for antiviral strategies. Lipids and proteins play cooperative roles in the fusion process, which is triggered by the acidic pH inside the endosome. This acidic environment induces many changes in glycoprotein conformation and allows the action of a highly conserved hydrophobic sequence, the fusion peptide (FP). Despite the large volume of information available on the virus-triggered fusion process, little is known regarding the mechanisms behind flavivirus-cell membrane fusion. Here, we evaluated the contribution of a natural single amino acid difference on two flavivirus FPs, FLA(G) ((98)DRGWGNGCGLFGK(110)) and FLA(H) ((98)DRGWGNHCGLFGK(110)), and investigated the role of the charge of the target membrane on the fusion process. We used an in silico approach to simulate the interaction of the FPs with a lipid bilayer in a complementary way and used spectroscopic approaches to collect conformation information. We found that both peptides interact with neutral and anionic micelles, and molecular dynamics (MD) simulations showed the interaction of the FPs with the lipid bilayer. The participation of the indole ring of Trp appeared to be important for the anchoring of both peptides in the membrane model, as indicated by MD simulations and spectroscopic analyses. Mild differences between FLA(G) and FLA(H) were observed according to the pH and the charge of the target membrane model. The MD simulations of the membrane showed that both peptides adopted a bend structure, and an interaction between the aromatic residues was strongly suggested, which was also observed by circular dichroism in the presence of micelles. As the FPs of viral fusion proteins play a key role in the mechanism of viral fusion, understanding the interactions between peptides and membranes is crucial for medical science and biology and may contribute to the design of new antiviral drugs.	[Mendes, Ygara S.; Alves, Nathalia S.; Lucia Bianconi, M.; Silva, Jerson L.; Gomes, Andre M. O.; Oliveira, Andrea C.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrutural, Rio De Janeiro, Brazil; [Mendes, Ygara S.; Alves, Nathalia S.; Lucia Bianconi, M.; Silva, Jerson L.; Gomes, Andre M. O.; Oliveira, Andrea C.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Souza, Theo L. F.] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil; [Sousa, Ivanildo P., Jr.] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Programa Vacinas Virais, Rio De Janeiro, Brazil; [Bernardi, Rafael C.; Pascutti, Pedro G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Oliveira, AC (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrutural, Rio De Janeiro, Brazil.	cheble@bioqmed.ufrj.br	Gomes, Andre M.O./C-4009-2014; Silva, Jerson/J-8984-2014; Oliveira, Andrea C/O-6695-2018; SILVA, JERSON Lima/GRF-1442-2022; de Souza, Theo LF/E-1705-2017; Sousa, Ivanildo/HCH-7825-2022; Sousa, ivanildo/ABC-1067-2020; Pascutti, Pedro/AAP-7752-2020	Gomes, Andre M.O./0000-0003-1052-8004; Silva, Jerson/0000-0001-9523-9441; SILVA, JERSON Lima/0000-0001-9523-9441; de Souza, Theo LF/0000-0002-0109-0357; Sousa, Ivanildo/0000-0003-1840-3302; Pascutti, Pedro/0000-0002-5454-560X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Universitaria Jose Bonifacio (FUJB); Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Programa de Apoio a Nucleos de Excelencia (PRONEX)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Universitaria Jose Bonifacio (FUJB); Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Programa de Apoio a Nucleos de Excelencia (PRONEX)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao Universitaria Jose Bonifacio (FUJB), Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB), Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB), and Programa de Apoio a Nucleos de Excelencia (PRONEX) to JLS, AMOG, and ACO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; EIDELMAN O, 1984, J BIOL CHEM, V259, P4622; EPAND RM, 1992, BIOPOLYMERS, V32, P309, DOI 10.1002/bip.360320403; Freitas MS, 2007, J BIOL CHEM, V282, P27306, DOI 10.1074/jbc.M611864200; Freitas MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015756; Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Gray C, 1996, BIOPHYS J, V70, P2275, DOI 10.1016/S0006-3495(96)79793-X; GRISHINA IB, 1994, FARADAY DISCUSS, V99, P245, DOI 10.1039/fd9949900245; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2; Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027; Jing W, 2003, J PEPT RES, V61, P219, DOI 10.1034/j.1399-3011.2003.00050.x; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Larios C, 2005, LUMINESCENCE, V20, P279, DOI 10.1002/bio.850; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Marrink SJ, 1996, FARADAY DISCUSS, V103, P191, DOI 10.1039/fd9960300191; Melo MN, 2009, J MOL BIOL, V392, P736, DOI 10.1016/j.jmb.2009.07.035; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Nieva JL, 2003, BBA-BIOMEMBRANES, V1614, P104, DOI 10.1016/S0005-2736(03)00168-8; Pan JH, 2010, BIOCHEMISTRY-US, V49, P287, DOI 10.1021/bi9017895; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pecheur EI, 1999, J MEMBRANE BIOL, V167, P1, DOI 10.1007/s002329900466; RAFALSKI M, 1990, BIOCHEMISTRY-US, V29, P7917, DOI 10.1021/bi00486a020; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; ROEHRIG JT, 1989, VIROLOGY, V171, P49, DOI 10.1016/0042-6822(89)90509-6; Sanchez SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029278; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Seligman SJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-27; Sousa IP, 2011, J BIOL CHEM, V286, P1730, DOI 10.1074/jbc.M110.198002; Stauffer F, 2008, MOL MEMBR BIOL, V25, P128, DOI 10.1080/09687680701633091; Takekiyo T, 2009, BIOCHEMISTRY-US, V48, P1543, DOI 10.1021/bi8019838; Tamm LK, 2000, BIOSCIENCE REP, V20, P501, DOI 10.1023/A:1010406920417; Tieleman DP, 1996, J CHEM PHYS, V105, P4871, DOI 10.1063/1.472323; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273; WHITE JM, 1990, ANNU REV PHYSIOL, V52, P675, DOI 10.1146/annurev.ph.52.030190.003331; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319	45	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47596	10.1371/journal.pone.0047596	http://dx.doi.org/10.1371/journal.pone.0047596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094066	gold, Green Published, Green Submitted			2022-12-27	WOS:000310050200033
J	Makino, CL; Wen, XH; Olshevskaya, EV; Peshenko, IV; Savchenko, AB; Dizhoor, AM				Makino, Clint L.; Wen, Xiao-Hong; Olshevskaya, Elena V.; Peshenko, Igor V.; Savchenko, Andrey B.; Dizhoor, Alexander M.			Enzymatic Relay Mechanism Stimulates Cyclic GMP Synthesis in Rod Photoresponse: Biochemical and Physiological Study in Guanylyl Cyclase Activating Protein 1 Knockout Mice	PLOS ONE			English	Article							OUTER SEGMENTS; DIFFUSION-COEFFICIENT; IN-VIVO; PHOTORECEPTORS; CALCIUM; EXPRESSION; RETGC; GCAPS; PHOTOTRANSDUCTION; CLONING	Regulation of cGMP synthesis by retinal membrane guanylyl cyclase isozymes (RetGC1 and RetGC2) in rod and cone photoreceptors by calcium-sensitive guanylyl cyclase activating proteins (GCAP1 and GCAP2) is one of the key molecular mechanisms affecting the response to light and is involved in congenital retinal diseases. The objective of this study was to identify the physiological sequence of events underlying RetGC activation in vivo, by studying the electrophysiological and biochemical properties of mouse rods in a new genetic model lacking GCAP1. The GCAP1(-/-) retinas expressed normal levels of RetGC isozymes and other phototransduction proteins, with the exception of GCAP2, whose expression was elevated in a compensatory fashion. RetGC activity in GCAP1(-/-) retinas became more sensitive to Ca2+ and slightly increased. The bright flash response in electroretinogram (ERG) recordings recovered quickly in GCAP1(-/-), as well as in RetGC1(-/-) GCAP1(-/-), and RetGC2(-/-) GCAP1(-/-) hybrid rods, indicating that GCAP2 activates both RetGC isozymes in vivo. Individual GCAP1(-/-) rod responses varied in size and shape, likely reflecting variable endogenous GCAP2 levels between different cells, but single-photon response (SPR) amplitude and time-to-peak were typically increased, while recovery kinetics remained faster than in wild type. Recovery from bright flashes in GCAP1(-/-) was prominently biphasic, because rare, aberrant SPRs producing the slower tail component were magnified. These data provide strong physiological evidence that rod photoresponse recovery is shaped by the sequential recruitment of RetGC isozyme activation by GCAPs according to the different GCAP sensitivities for Ca2+ and specificities toward RetGC isozymes. GCAP1 is the 'first-response' sensor protein that stimulates RetGC1 early in the response and thus limits the SPR amplitude, followed by activation of GCAP2 that adds stimulation of both RetGC1 and RetGC2 to speed-up photoreceptor recovery.	[Olshevskaya, Elena V.; Peshenko, Igor V.; Savchenko, Andrey B.; Dizhoor, Alexander M.] Salus Univ, Dept Basic Sci, Elkins Pk, PA USA; [Olshevskaya, Elena V.; Peshenko, Igor V.; Savchenko, Andrey B.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA USA; [Makino, Clint L.; Wen, Xiao-Hong] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Makino, Clint L.; Wen, Xiao-Hong] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School	Dizhoor, AM (corresponding author), Salus Univ, Dept Basic Sci, Elkins Pk, PA USA.	adizhoor@salus.edu	Makino, Clint Lawrence/H-8428-2019	Makino, Clint Lawrence/0000-0002-6005-9069; Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health [EY11522, EY011358, EY014104]; Lion's of Massachusetts; Pennsylvania Department of Health Formula Grant; NATIONAL EYE INSTITUTE [P30EY014104, R01EY011358, R01EY011522, R29EY011358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lion's of Massachusetts; Pennsylvania Department of Health Formula Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY11522 (AMD) and EY011358, EY014104 (CLM), Lion's of Massachusetts, and Pennsylvania Department of Health Formula Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BIRCH DG, 1995, INVEST OPHTH VIS SCI, V36, P1603; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Calvert PD, 1998, J GEN PHYSIOL, V111, P39, DOI 10.1085/jgp.111.1.39; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Jeon CJ, 1998, J NEUROSCI, V18, P8936; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; KOCH KW, 2006, CALCIUM BINDING PROT, V1, P3; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Nakatani K, 2002, BIOPHYS J, V82, P728, DOI 10.1016/S0006-3495(02)75435-0; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; OLSON A, 1993, BIOPHYS J, V65, P1335, DOI 10.1016/S0006-3495(93)81177-9; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602	46	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47637	10.1371/journal.pone.0047637	http://dx.doi.org/10.1371/journal.pone.0047637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082185	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900081
J	Pereira, MB; Zanetta, DMT; Abdulkader, RCRM				Pereira, Mariana B.; Zanetta, Dirce M. T.; Abdulkader, Regina C. R. M.			The Real Importance of Pre-Existing Comorbidities on Long-Term Mortality after Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ACUTE MYOCARDIAL-INFARCTION; REPLACEMENT THERAPY; PERITUBULAR CAPILLARIES; CHRONIC DIALYSIS; RISK-FACTOR; OUTCOMES; DEATH; SURVIVAL; DISEASE	Background: The causes of death on long-term mortality after acute kidney injury (AKI) have not been well studied. The purpose of the study was to evaluate the role of comorbidities and the causes of death on the long-term mortality after AKI. Methodology/Principal Findings: We retrospectively studied 507 patients who experienced AKI in 2005-2006 and were discharged free from dialysis. In June 2008 (median: 21 months after AKI), we found that 193 (38%) patients had died. This mortality is much higher than the mortality of the population of Sao Paulo City, even after adjustment for age. A multiple survival analysis was performed using Cox proportional hazards regression model and showed that death was associated with Khan's index indicating high risk [adjusted hazard ratio 2.54 (1.38-4.66)], chronic liver disease [1.93 (1.15-3.22)], admission to non-surgical ward [1.85 (1.30-2.61)] and a second AKI episode during the same hospitalization [1.74 (1.12-2.71)]. The AKI severity evaluated either by the worst stage reached during AKI (P=0.20) or by the need for dialysis (P=0.12) was not associated with death. The causes of death were identified by a death certificate in 85% of the non-survivors. Among those who died from circulatory system diseases (the main cause of death), 59% had already suffered from hypertension, 34% from diabetes, 47% from heart failure, 38% from coronary disease, and 66% had a glomerular filtration rate <60 previous to the AKI episode. Among those who died from neoplasms, 79% already had the disease previously. Conclusions: Among AKI survivors who were discharged free from dialysis the increased long-term mortality was associated with their pre-existing chronic conditions and not with the severity of the AKI episode. These findings suggest that these survivors should have a medical follow-up after hospital discharge and that all efforts should be made to control their comorbidities.	[Pereira, Mariana B.; Abdulkader, Regina C. R. M.] Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil; [Zanetta, Dirce M. T.] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Pereira, MB (corresponding author), Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil.	marianabpereira@yahoo.com.br	Zanetta, Dirce M T/G-4950-2013	Zanetta, Dirce Maria/0000-0002-7273-5087	CAPES ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior'')	CAPES ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior'')(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Mariana B Pereira received a Grant from CAPES ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom A, 2005, INTENS CARE MED, V31, P1222, DOI 10.1007/s00134-005-2681-6; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Bagshaw SM, 2006, AM J KIDNEY DIS, V48, P402, DOI 10.1053/j.ajkd.2006.06.002; Bagshaw SM, 2009, NEPHROL DIAL TRANSPL, V24, P2739, DOI 10.1093/ndt/gfp159; Barretti P, 1997, RENAL FAILURE, V19, P253, DOI 10.3109/08860229709026285; Basile DP, 2004, CURR OPIN NEPHROL HY, V13, P1, DOI 10.1097/00041552-200401000-00001; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Brown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039; Cerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107; Choi AI, 2010, KIDNEY INT, V78, P478, DOI 10.1038/ki.2010.171; Coca SG, 2010, KIDNEY INT, V78, P926, DOI 10.1038/ki.2010.259; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Deshpande P, 2011, HEPATOL INT, V5, P751, DOI 10.1007/s12072-011-9269-8; Franca E, 2008, INT J EPIDEMIOL, V37, P891, DOI 10.1093/ije/dyn121; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goldberg A, 2009, KIDNEY INT, V76, P900, DOI 10.1038/ki.2009.295; Goldberg R, 2008, ADV CHRONIC KIDNEY D, V15, P297, DOI 10.1053/j.ackd.2008.04.009; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; James MT, 2011, CIRCULATION, V123, P409, DOI 10.1161/CIRCULATIONAHA.110.970160; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; KHAN IH, 1993, LANCET, V341, P415, DOI 10.1016/0140-6736(93)93003-J; Khan IH, 1997, QJM-MON J ASSOC PHYS, V90, P781; Khosla N, 2009, CLIN J AM SOC NEPHRO, V4, P1914, DOI 10.2215/CJN.01690309; Kramer AA, 1999, KIDNEY INT, V55, P2362, DOI 10.1046/j.1523-1755.1999.00460.x; Lafrance JP, 2010, AM J KIDNEY DIS, V56, P651, DOI 10.1053/j.ajkd.2010.05.011; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liano F, 2007, KIDNEY INT, V71, P679, DOI 10.1038/sj.ki.5002086; Liano F, 2010, CLIN NEPHROL, V74, pS89; Loef BG, 2005, J AM SOC NEPHROL, V16, P195, DOI 10.1681/ASN.2003100875; Lopes JA, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-9; Macedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Mehta RH, 2010, AM J CARDIOL, V106, P1728, DOI 10.1016/j.amjcard.2010.07.045; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nair S, 2002, HEPATOLOGY, V35, P1179, DOI 10.1053/jhep.2002.33160; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Pechman KR, 2009, AM J PHYSIOL-REG I, V297, pR1358, DOI 10.1152/ajpregu.91022.2008; Ponce D, 2011, NEPHROL DIAL TRANSPL, V26, P3202, DOI 10.1093/ndt/gfr359; Schiffl H, 2011, INT UROL NEPHROL; Schiffl H, 2008, NEPHROL DIAL TRANSPL, V23, P2235, DOI 10.1093/ndt/gfn182; Siew ED, 2010, KIDNEY INT, V77, P536, DOI 10.1038/ki.2009.479; Singh P, 2010, CLIN J AM SOC NEPHRO, V5, P1690, DOI 10.2215/CJN.00830110; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Wald R, 2012, AM J MED, V125, P585, DOI 10.1016/j.amjmed.2012.01.016; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; WOODROW G, 1992, NEPHROL DIAL TRANSPL, V7, P230, DOI 10.1093/oxfordjournals.ndt.a092111	48	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47746	10.1371/journal.pone.0047746	http://dx.doi.org/10.1371/journal.pone.0047746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082206	Green Submitted, gold, Green Published			2022-12-27	WOS:000311146900103
J	Post, R; de Boer, KS; Malessy, MJA				Post, Rene; de Boer, Kornelis S.; Malessy, Martijn J. A.			Outcome following Nerve Repair of High Isolated Clean Sharp Injuries of the Ulnar Nerve	PLOS ONE			English	Article							ANTERIOR INTEROSSEOUS NERVE; LONG-TERM; MEDIAN NERVE; MOTOR BRANCH; UPPER-EXTREMITY; MICROSURGICAL REPAIR; SURGICAL-MANAGEMENT; HAND; STRENGTH; RECOVERY	Objective: The detailed outcome of surgical repair of high isolated clean sharp (HICS) ulnar nerve lesions has become relevant in view of the recent development of distal nerve transfer. Our goal was to determine the outcome of HICS ulnar nerve repair in order to create a basis for the optimal management of these lesions. Methods: High ulnar nerve lesions are defined as localized in the area ranging from the proximal forearm to the axilla just distal to the branching of the medial cord of the brachial plexus. A meta-analysis of the literature concerning high ulnar nerve injuries was performed. Additionally, a retrospective study of the outcome of nerve repair of HICS ulnar nerve injuries at our institution was performed. The Rotterdam Intrinsic Hand Myometer and the Rosen-Lundborg protocol were used. Results: The literature review identified 46 papers. Many articles presented outcomes of mixed lesion groups consisting of combined ulnar and median nerves, or the outcome of high and low level injuries was pooled. In addition, outcome was expressed using different scoring systems. 40 patients with HICS ulnar nerve lesions were found with sufficient data for further analysis. In our institution, 15 patients had nerve repair with a median interval between trauma and reconstruction of 17 days (range 0-516). The mean score of the motor and sensory domain of the Rosen's Scale instrument was 58% and 38% of the unaffected arm, respectively. Two-point discrimination never reached less then 12 mm. Conclusion: From the literature, it was not possible to draw a definitive conclusion on outcome of surgical repair of HICS ulnar nerve lesions. Detailed neurological function assessment of our own patients showed that some ulnar nerve function returned. Intrinsic muscle strength recovery was generally poor. Based on this study, one might cautiously argue that repair strategies of HICS ulnar nerve lesions need to be improved.	[Post, Rene; Malessy, Martijn J. A.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [de Boer, Kornelis S.] Leiden Univ, Med Ctr, Dept Rehabil, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Malessy, MJA (corresponding author), Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands.	malessy@lumc.nl	Malessy, Martijn/AAZ-9996-2021	Malessy, Martijn/0000-0003-1936-3664; Post, Rene/0000-0001-7844-6262				BARRIOS C, 1990, ACTA ORTHOP SCAND, V61, P46, DOI 10.3109/17453679008993065; BARRIOS C, 1991, J PEDIATR ORTHOPED, V11, P641; Battiston B, 1999, J HAND SURG-AM, V24A, P1185; Bell-Krotoski JA, 2009, REHABILITATION HAND, V1995, P109; BIRCH R, 1991, J BONE JOINT SURG BR, V73, P154, DOI 10.1302/0301-620X.73B1.1991753; Birch R, 1998, SURG DISORDERS PERIP; Bolitho DG, 1999, J HAND SURG-AM, V24A, P16; BONNEY G, 1984, CLIN PLAST SURG, V11, P137; Brandsma J W, 1995, J Hand Ther, V8, P185; Brown JM, 2009, NEUROSURGERY, V65, P966, DOI 10.1227/01.NEU.0000358951.64043.73; Bruyns CNP, 2003, J HAND SURG-AM, V28A, P28, DOI 10.1053/jhsu.2003.50026; Daneyemez M, 2005, TOHOKU J EXP MED, V205, P269, DOI 10.1620/tjem.205.269; DELLON AL, 1974, PLAST RECONSTR SURG, V53, P297, DOI 10.1097/00006534-197403000-00008; DEMEDINACELI L, 1991, J HAND SURG-BRIT EUR, V16B, P499, DOI 10.1016/0266-7681(91)90103-U; DeSmet L, 2006, EUR J PLAST SURG, V28, P523, DOI 10.1007/s00238-005-0010-5; Donzelli R, 1998, J Neurosurg Sci, V42, P79; Elsohemy A, 2009, PLAST RECONSTR SURG, V124, P1860, DOI 10.1097/PRS.0b013e3181bcee47; Galanakos SP, 2011, MICROSURG, V31, P253, DOI 10.1002/micr.20845; GAUL JS, 1982, J HAND SURG-AM, V7, P502, DOI 10.1016/S0363-5023(82)80048-8; HAASE J, 1980, J NEUROSURG, V53, P73, DOI 10.3171/jns.1980.53.1.0073; Haase SC, 2002, ANN PLAS SURG, V49, P285, DOI 10.1097/00000637-200209000-00008; HURST LC, 1991, J HAND SURG-AM, V16A, P207, DOI 10.1016/S0363-5023(10)80098-X; Jazayeri M, 2003, Electromyogr Clin Neurophysiol, V43, P277; Kale SS, 2011, J HAND SURG-AM, V36A, P1631, DOI 10.1016/j.jhsa.2011.06.029; KALOMIRI DE, 1995, ACTA ORTHOP SCAND, V66, P41, DOI 10.3109/17453679509157165; Ketchum L D, 1978, J Hand Surg Am, V3, P571; Kim DH, 2003, J NEUROSURG, V98, P993, DOI 10.3171/jns.2003.98.5.0993; Ladak A, 2011, NEUROSURGERY, V68, P1654, DOI 10.1227/NEU.0b013e31821246a8; LECLERCQ DC, 1985, J HAND SURG-AM, V10A, P997, DOI 10.1016/S0363-5023(85)80023-X; Lundborg G, 1997, J HAND SURG-AM, V22A, P99, DOI 10.1016/S0363-5023(05)80188-1; MACKEL R, 1983, BRAIN RES, V268, P49, DOI 10.1016/0006-8993(83)90389-X; Marx RG, 1999, J HAND SURG-AM, V24A, P185; Matejcik V, 2002, INJURY, V33, P627, DOI 10.1016/S0020-1383(02)00073-6; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; MILLESI H, 1976, J BONE JOINT SURG AM, V58, P209, DOI 10.2106/00004623-197658020-00008; MILLESI H, 1972, J BONE JOINT SURG AM, VA 54, P727, DOI 10.2106/00004623-197254040-00004; MITZ V, 1984, Annales de Chirurgie de la Main, V3, P193, DOI 10.1016/S0753-9053(84)80034-4; MOBERG E, 1990, SCAND J REHABIL MED, V22, P127; MONEIM MS, 1982, CLIN ORTHOP RELAT R, P65; Nicolaidis SC, 2001, MICROSURG, V21, P241, DOI 10.1002/micr.1047; Novak CB, 2002, J RECONSTR MICROSURG, V18, P459, DOI 10.1055/s-2002-33326; OMER GE, 1974, J BONE JOINT SURG AM, VA 56, P1615, DOI 10.2106/00004623-197456080-00010; Ozkan T, 2001, J HAND SURG-AM, V26A, P44, DOI 10.1053/jhsu.2001.20156; Pfaeffle HJ, 2007, HAND CLIN, V23, P291, DOI 10.1016/j.hcl.2007.06.003; Pienaar C, 2004, J HAND SURG-BRIT EUR, V29B, P438, DOI 10.1016/j.jhsb.2004.03.006; PLUCHINO F, 1981, ITAL J NEUROL SCI, V2, P139, DOI 10.1007/BF02335435; Rodriguez-Niedenfuhr T, 2002, CLIN ANAT, V15, P129, DOI 10.1002/ca.1107; Rosen B, 2001, J HAND SURG-BRIT EUR, V26, P196, DOI 10.1054/jhsb.2001.0567; Rosen B, 2000, SCAND J PLAST RECONS, V34, P71; Rosen B, 1998, J Hand Ther, V11, P251; Rosen B, 2000, J HAND SURG-AM, V25A, P535, DOI 10.1053/jhsu.2000.6458; Ruijs ACJ, 2007, J HAND SURG-BRIT EUR, V32E, P434, DOI 10.1016/j.jhsb.2007.02.012; Ruijs ACJ, 2005, PLAST RECONSTR SURG, V116, P484, DOI 10.1097/01.prs.0000172896.86594.07; SAKELLARIDES H, 1962, J BONE JOINT SURG AM, V44, P140, DOI 10.2106/00004623-196244010-00011; Schreuders TAR, 2004, J REHABIL MED, V36, P273, DOI 10.1080/16501970410033677; Schreuders TAR, 2004, J HAND SURG-AM, V29A, P318, DOI 10.1016/j.jhsa.2003.10.024; Schreuders TAR, 2006, J HAND THER, V19, P393, DOI 10.1197/j.jht.2006.07.024; Seddon HJ, 1975, SURG DISORDERS PERIP, P303; Seddon HJ, 1954, MED RES COUNCIL SPEC, V282; Seddon HJ, 1954, MED RES COUNCIL MRC; SINGH R, 1992, SURG NEUROL, V37, P425, DOI 10.1016/0090-3019(92)90130-F; SOLLERMAN C, 1995, SCAND J PLAST RECONS, V29, P167, DOI 10.3109/02844319509034334; Sud V, 2001, ANN PLAS SURG, V47, P555, DOI 10.1097/00000637-200111000-00015; Sunderland S., 1978, NERVES NERVE INJURIE; TRAIL IA, 1985, J HAND SURG-BRIT EUR, V10B, P345, DOI 10.1016/S0266-7681(85)80058-9; TREVETT MC, 1995, J HAND SURG-BRIT EUR, V20B, P444, DOI 10.1016/S0266-7681(05)80150-0; TRUMBLE TE, 1995, J HAND SURG-AM, V20A, P367, DOI 10.1016/S0363-5023(05)80089-9; Tung TH, 2010, J HAND SURG-AM, V35A, P332, DOI 10.1016/j.jhsa.2009.12.002; Van de Kar THJ, 2002, J HAND SURG-BRIT EUR, V27B, P345, DOI 10.1054/jhsb.2002.0778; VASTAMAKI M, 1993, J HAND SURG-BRIT EUR, V18B, P323, DOI 10.1016/0266-7681(93)90053-I; Vordemvenne T, 2007, CLIN NEUROL NEUROSUR, V109, P263, DOI 10.1016/j.clineuro.2006.11.006; Waldram M, 2003, TRAUMA, V5, P79, DOI DOI 10.1191/1460408603TA2370A; Wang Y, 1997, CHINESE MED J-PEKING, V110, P216; Williams H. Bruce, 1996, Microsurgery, V17, P597, DOI 10.1002/(SICI)1098-2752(1996)17:11<597::AID-MICR6>3.0.CO;2-M; Yuksel F, 2004, MICROSURG, V24, P363, DOI 10.1002/micr.20058; Zhang SC, 2012, ACTA NEUROCHIR, V154, P527, DOI 10.1007/s00701-011-1264-2	76	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47928	10.1371/journal.pone.0047928	http://dx.doi.org/10.1371/journal.pone.0047928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082230	Green Submitted, gold, Green Published			2022-12-27	WOS:000311146900127
J	Sinha, N; Pilder, S; Vijayaraghavan, S				Sinha, Nilam; Pilder, Stephen; Vijayaraghavan, Srinivasan			Significant Expression Levels of Transgenic PPP1CC2 in Testis and Sperm Are Required to Overcome the Male Infertility Phenotype of Ppp1cc Null Mice	PLOS ONE			English	Article							SERINE/THREONINE PROTEIN PHOSPHATASES; GLYCOGEN-SYNTHASE KINASE-3; DIFFERENTIAL EXPRESSION; EPIDIDYMAL SPERM; GENE; MOTILITY; FERTILITY; ISOFORMS; CELLS; RAT	PPP1CC2, one of four isoforms of the ser/thr protein phosphatase PP1, is a mammalian-specific splice variant of the Ppp1cc gene, and the only isoform whose expression is confined almost completely to spermatogenic cells. Additionally, PPP1CC2 is the sole isoform found in mammalian spermatozoa. Although PPP1CC1, the other Ppp1cc product, is expressed in many tissues including testis, the only phenotype resulting from deletion of Ppp1cc gene is male infertility. To determine which of the products of Ppp1cc is essential for male fertility, we created two PPP1CC2 transgenes, eTg-G2 and pTg-G2, where Ppp1cc2 expression was driven by the putative endogenous promoter of Ppp1cc or by the testis specific human Pgk2 promoter, respectively. Our results demonstrate that the 2.6-kb genomic region directly upstream of the Ppp1cc structural gene can drive expression of Ppp1cc2, and recapitulate the wild-type tissue specificity of PPP1CC2 in transgenic mice. More importantly, we show that expression of PPP1CC2 alone, via either promoter, is able not only to restore normal spermatogenesis, but the fertility of Ppp1cc null mice as well, provided that transgenic PPP1CC2 expression in testis reaches at least a lower threshold level equivalent to approximately 50% of its expression by a Ppp1cc +/- male. We conclude that the endogenous Ppp1cc promoter normally functions in the testis to maintain a sufficient level of PPP1CC2 expression for normal spermatogenesis to occur, and that production of spermatozoa capable of fertilization in vivo can take place in the complete absence of PPP1CC1 expression.	[Sinha, Nilam; Vijayaraghavan, Srinivasan] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Pilder, Stephen] Temple Univ, Dept Anat & Cell Biol, Sch Med, Philadelphia, PA 19122 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sinha, N (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	nilams@vet.upenn.edu; svijayar@kent.edu			National Institutes of Health [R01HD038520-08]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health grant R01HD038520-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER HM, 1993, BIOCHIM BIOPHYS ACTA, V1178, P228, DOI 10.1016/0167-4889(93)90014-G; BARTOOV B, 1993, HUM REPROD, V8, P65, DOI 10.1093/oxfordjournals.humrep.a137876; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Burton KA, 2006, MOL ENDOCRINOL, V20, P2504, DOI 10.1210/me.2006-0060; Chakrabarti R, 2007, BIOL REPROD, V76, P992, DOI 10.1095/biolreprod.106.058610; Cheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004861; Cohen PTW, 2002, J CELL SCI, V115, P241; Foster D L., 1994, PHYSL REPROD, V2; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Gibbons JA, 2007, J BIOL CHEM, V282, P21838, DOI 10.1074/jbc.M701272200; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Hirano K, 1996, FEBS LETT, V389, P191, DOI 10.1016/0014-5793(96)00577-7; Huang ZH, 2004, BIOL REPROD, V70, P439, DOI 10.1095/biolreprod.103.020024; KITAGAWA Y, 1990, BIOCHEM BIOPH RES CO, V171, P230, DOI 10.1016/0006-291X(90)91381-2; Lin Q, 1999, MOL PHYLOGENET EVOL, V12, P57, DOI 10.1006/mpev.1998.0560; Okano K, 1997, GENOMICS, V45, P211, DOI 10.1006/geno.1997.4907; ORGEBINCRIST MC, 1967, NATURE, V216, P816, DOI 10.1038/216816a0; ORGEBINCRIST MC, 1977, BIOL REPROD, V16, P358, DOI 10.1095/biolreprod16.3.358; Russell L. D., 1990, HISTOLOGICAL HISTOPA; San Agustin JT, 2001, BIOL REPROD, V65, P151, DOI 10.1095/biolreprod65.1.151; San Agustin JT, 2000, MOL BIOL CELL, V11, P3031, DOI 10.1091/mbc.11.9.3031; SASAKI K, 1990, JPN J CANCER RES, V81, P1272, DOI 10.1111/j.1349-7006.1990.tb02690.x; SHIMA H, 1993, BIOCHEM BIOPH RES CO, V194, P930, DOI 10.1006/bbrc.1993.1910; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Smith GD, 1996, BIOL REPROD, V54, P719, DOI 10.1095/biolreprod54.3.719; Smith GD, 1999, J ANDROL, V20, P47; Soler DC, 2009, BIOL REPROD, V81, P343, DOI 10.1095/biolreprod.109.076398; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Zhang LP, 1999, BIOL REPROD, V60, P1329, DOI 10.1095/biolreprod60.6.1329	30	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47623	10.1371/journal.pone.0047623	http://dx.doi.org/10.1371/journal.pone.0047623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082183	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900079
J	Young, MR; Bailey, RC; Odoyo-June, E; Irwin, TE; Obiero, W; Ongong'a, DO; Badia, JA; Agot, K; Nordstrom, SK				Young, Marisa R.; Bailey, Robert C.; Odoyo-June, Elijah; Irwin, Tracy E.; Obiero, Walter; Ongong'a, Dedan O.; Badia, Jacinta A.; Agot, Kawango; Nordstrom, Sherry K.			Safety of over Twelve Hundred Infant Male Circumcisions Using the Mogen Clamp in Kenya	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SUB-SAHARAN AFRICA; HIV PREVENTION; NEONATAL CIRCUMCISION; PLASTIBELL DEVICE; COMPLICATIONS; MEN; RAKAI	Background: Several sub-Saharan African countries plan to scale-up infant male circumcision (IMC) for cost-efficient HIV prevention. Little data exist about the safety of IMC in East and southern Africa. We calculated adverse event (AE) rate and risks for AEs associated with introduction of IMC services at five government health facilities in western Kenya. Methods: AE data were analyzed for IMC procedures performed between September, 2009 and November, 2011. Healthy infants aged <= 2 months and weighing >= 2.5 kg were eligible for IMC. Following parental consent, trained clinicians provided IMC services free of charge under local anesthesia using the Mogen clamp. Odds ratios and 95% confidence intervals were used to explore AE risk factors. Findings: A total of 1,239 IMC procedures were performed. Median age of infants was 4 days (IQR = 1, 16). The overall AE rate among infants reviewed post-operatively was 2.7% (18/678; 95% CI: 1.4, 3.9). There was one severe AE involving excision of a small piece of the lateral aspect of the glans penis. Other AEs were mild or moderate and were treated conservatively. Babies one month of age or older were more likely to have an AE (OR 3.20; 95% CI: 1.23, 8.36). AE rate did not differ by nurse versus clinical officer or number of previous procedures performed. Conclusion: IMC services provided in Kenyan Government hospitals in the context of routine IMC programming have AE rates comparable to those in developed countries. The optimal time for IMC is within the first month of life.	[Young, Marisa R.; Bailey, Robert C.] Univ Illinois, Chicago Sch Publ Hlth, Dept Epidemiol & Biostat, Chicago, IL 60607 USA; [Bailey, Robert C.; Odoyo-June, Elijah; Obiero, Walter] Nyanza Reprod Hlth Soc, Kisumu, Kenya; [Irwin, Tracy E.; Nordstrom, Sherry K.] Univ Illinois, Chicago Coll Med, Dept Obstet & Gynecol, Chicago, IL USA; [Ongong'a, Dedan O.] Nyanza Prov Gen Hosp, Dept Surg, Kisumu, Kenya; [Badia, Jacinta A.] CARE Int, Kisii, Kenya; [Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Young, MR (corresponding author), Univ Illinois, Chicago Sch Publ Hlth, Dept Epidemiol & Biostat, Chicago, IL 60607 USA.	myoung22@uic.edu	Young, Marisa/GXH-4437-2022		Male Circumcision Consortium [47394]; Bill and Melinda Gates Foundation; Chicago Developmental Center for AIDS Research	Male Circumcision Consortium; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Chicago Developmental Center for AIDS Research	This study was made possible through funding from the Male Circumcision Consortium (grant #47394). FHI 360 and the University of Illinois at Chicago, working with the Nyanza Reproductive Health Society, are partners in the Male Circumcision Consortium, which is funded by a grant to FHI 360 (www.fhi360.org) from the Bill and Melinda Gates Foundation (www.gatesfoundation.org/). Support to RCB was also provided by the Chicago Developmental Center for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis MC, 2004, OBSTET GYNECOL SURV, V59, P379, DOI 10.1097/00006254-200405000-00026; ALSAMARRAI AYI, 1988, SURG GYNECOL OBSTET, V167, P341; Amir M, 2000, J Pak Med Assoc, V50, P224; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey R C, 2001, Lancet Infect Dis, V1, P223, DOI 10.1016/S1473-3099(01)00117-7; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Banieghbal B, 2009, J PEDIATR UROL, V5, P359, DOI 10.1016/j.jpurol.2009.01.002; Ben Chaim J, 2005, ISR MED ASSOC J, V7, P368; Binagwaho A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000211; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; de Bruyn G, 2010, EXPERT REV ANTI-INFE, V8, P23, DOI 10.1586/ERI.09.120; Gray RH, 2009, AM J OBSTET GYNECOL, V200, pe41; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Horowitz M, 2001, J PEDIATR SURG, V36, P1047, DOI 10.1053/jpsu.2001.24739; Johnson Kristine E, 2008, Curr Infect Dis Rep, V10, P243, DOI 10.1007/s11908-008-0040-9; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Krill AJ, 2011, THESCIENTIFICWORLDJO, V11, P2458, DOI 10.1100/2011/373829; Manji KP, 2000, ANN TROP PAEDIATR, V20, P101, DOI 10.1080/02724936.2000.11748116; Moosa FA, 2010, J PAK MED ASSOC, V60, P664; Mwandi Z, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001130; Palit V, 2007, PEDIATR SURG INT, V23, P45, DOI 10.1007/s00383-006-1805-6; Patel HI, 2001, J PEDIATR SURG, V36, P235, DOI 10.1053/jpsu.2001.20062; Pieretti RV, 2010, PEDIATR SURG INT, V26, P515, DOI 10.1007/s00383-010-2566-9; Sherman J, 1996, J UROLOGY, V156, P842, DOI 10.1016/S0022-5347(01)65836-1; Tobian AAR, 2011, FUTURE MICROBIOL, V6, P739, DOI [10.2217/fmb.11.59, 10.2217/FMB.11.59]; Wawer MJ, 2011, LANCET, V377, P209, DOI 10.1016/S0140-6736(10)61967-8; Weiss H, 2010, NEONATAL CHILD MALE; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2010, AIDS, V24, pS61, DOI 10.1097/01.aids.0000390708.66136.f4; Weiss HA, 2010, BMC UROL, V10, DOI 10.1186/1471-2490-10-2; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; White RG, 2008, AIDS, V22, P1841, DOI 10.1097/QAD.0b013e32830e0137; WISWELL TE, 1989, PEDIATRICS, V83, P1011; WISWELL TE, 1993, CLIN PEDIATR, V32, P130, DOI 10.1177/000992289303200301; World Health Organization and Joint United Nations Programme on HIV/AIDS, 2007, TECHN CONS MAL CIRC; World Health Organization; Johns Hopkins Program for International Education in Gynecology and Obstetrics, 2010, MAN EARL INF MAL CIR; Young MR, 2012, FACTORS ASS UPTAKE I	37	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47395	10.1371/journal.pone.0047395	http://dx.doi.org/10.1371/journal.pone.0047395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082162	Green Published, gold			2022-12-27	WOS:000311146900058
J	Chiang, CW; Chen, YC; Lu, JC; Hsiao, YT; Chang, CW; Huang, PC; Chang, YT; Chang, PY; Wang, CT				Chiang, Chung-Wei; Chen, Yu-Chieh; Lu, Juu-Chin; Hsiao, Yu-Tien; Chang, Che-Wei; Huang, Pin-Chien; Chang, Yu-Tzu; Chang, Payne Y.; Wang, Chih-Tien			Synaptotagmin I Regulates Patterned Spontaneous Activity in the Developing Rat Retina via Calcium Binding to the C2AB Domains	PLOS ONE			English	Article							VISUAL-SYSTEM DEVELOPMENT; DENSE-CORE VESICLES; MAMMALIAN RETINA; RETINOGENICULATE PROJECTIONS; CA2+-TRIGGERED EXOCYTOSIS; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; BURSTING ACTIVITY; PLASMA-MEMBRANE; MOUSE RETINA	Background: In neonatal binocular animals, the developing retina displays patterned spontaneous activity termed retinal waves, which are initiated by a single class of interneurons (starburst amacrine cells, SACs) that release neurotransmitters. Although SACs are shown to regulate wave dynamics, little is known regarding how altering the proteins involved in neurotransmitter release may affect wave dynamics. Synaptotagmin (Syt) family harbors two Ca2+-binding domains (C2A and C2B) which serve as Ca2+ sensors in neurotransmitter release. However, it remains unclear whether SACs express any specific Syt isoform mediating retinal waves. Moreover, it is unknown how Ca2+ binding to C2A and C2B of Syt affects wave dynamics. Here, we investigated the expression of Syt I in the neonatal rat retina and examined the roles of C2A and C2B in regulating wave dynamics. Methodology/Principal Findings: Immunostaining and confocal microscopy showed that Syt I was expressed in neonatal rat SACs and cholinergic synapses, consistent with its potential role as a Ca2+ sensor mediating retinal waves. By combining a horizontal electroporation strategy with the SAC-specific promoter, we specifically expressed Syt I mutants with weakened Ca2+-binding ability in C2A or C2B in SACs. Subsequent live Ca2+ imaging was used to monitor the effects of these molecular perturbations on wave-associated spontaneous Ca2+ transients. We found that targeted expression of Syt I C2A or C2B mutants in SACs significantly reduced the frequency, duration, and amplitude of wave-associated Ca2+ transients, suggesting that both C2 domains regulate wave temporal properties. In contrast, these C2 mutants had relatively minor effects on pairwise correlations over distance for wave-associated Ca2+ transients. Conclusions/Significance: Through Ca2+ binding to C2A or C2B, the Ca2+ sensor Syt I in SACs may regulate patterned spontaneous activity to shape network activity during development. Hence, modulating the releasing machinery in presynaptic neurons (SACs) alters wave dynamics.	[Chiang, Chung-Wei; Chen, Yu-Chieh; Hsiao, Yu-Tien; Chang, Che-Wei; Huang, Pin-Chien; Wang, Chih-Tien] Natl Taiwan Univ, Inst Mol & Cell Biol, Taipei 10764, Taiwan; [Chiang, Chung-Wei; Chen, Yu-Chieh; Wang, Chih-Tien] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Wang, Chih-Tien] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Wang, Chih-Tien] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan; [Lu, Juu-Chin; Chang, Yu-Tzu] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan; [Chang, Payne Y.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Chang Gung University; University of Texas System; University of Texas Austin	Wang, CT (corresponding author), Natl Taiwan Univ, Inst Mol & Cell Biol, Taipei 10764, Taiwan.	chihtienwang@ntu.edu.tw	Lu, Juu-Chin/ABB-3198-2020; Chen, Yu-Chieh David/AAB-2927-2019; Wang, Chih-Tien/GRE-8232-2022	Lu, Juu-Chin/0000-0001-8523-6992; Chen, Yu-Chieh David/0000-0002-2597-7577; Wang, Chih-Tien/0000-0001-7639-7508; Chiang, Chung-Wei/0000-0002-9443-914X	NTU startup fund, National Science Council [NSC-100-2321-B-002-001, NSC-100-2311-B-002-010, NSC-97-2311-B-002-007-MY3]; National Health Research Institutes Grant [NHRI-EX100-9718NC]; NSC college student research fellowship [NSC-97-2815-C-002-042-B]	NTU startup fund, National Science Council; National Health Research Institutes Grant; NSC college student research fellowship	Funding was provided by NTU startup fund, National Science Council Grants (NSC-100-2321-B-002-001, NSC-100-2311-B-002-010 & NSC-97-2311-B-002-007-MY3), and National Health Research Institutes Grant (NHRI-EX100-9718NC) to CT Wang. CW Chiang received a NSC college student research fellowship (NSC-97-2815-C-002-042-B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; BORGES S, 1995, P NATL ACAD SCI USA, V92, P6896, DOI 10.1073/pnas.92.15.6896; Chalupa LM, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-25; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Cormack B, 1994, CURRENT PROTOCOLS MO; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; Donovan SL, 2006, NAT PROTOC, V1, P2710, DOI 10.1038/nprot.2006.454; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Feller MB, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-24; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 2002, J NEUROBIOL, V53, P556, DOI 10.1002/neu.10140; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; Ford KJ, 2012, J NEUROSCI, V32, P850, DOI 10.1523/JNEUROSCI.5309-12.2012; Greenlee MHW, 2001, J COMP NEUROL, V430, P306, DOI 10.1002/1096-9861(20010212)430:3<306::AID-CNE1032>3.0.CO;2-B; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Kochubey O, 2011, TRENDS NEUROSCI, V34, P237, DOI 10.1016/j.tins.2011.02.006; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Martinez A, 2008, J NEUROSCI, V28, P7492, DOI 10.1523/JNEUROSCI.1852-08.2008; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Patterson PH, 2007, SCIENCE, V318, P576, DOI 10.1126/science.1150196; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pham TA, 2001, NEURON, V31, P409, DOI 10.1016/S0896-6273(01)00381-6; Sherry DM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-54; Sherry DM, 2003, MOL VIS, V9, P673; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Soda T, 2003, J NEUROSCI, V23, P6272; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Torborg C, 2004, VISION RES, V44, P3347, DOI 10.1016/j.visres.2004.08.015; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Wang CT, 2007, J NEUROSCI, V27, P9130, DOI 10.1523/JNEUROSCI.1293-07.2007; Wang CT, 2006, J PHYSIOL-LONDON, V570, P295, DOI 10.1113/jphysiol.2005.097378; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zhang Z, 2011, MOL BIOL CELL, V22, P2324, DOI 10.1091/mbc.E11-02-0159; Zhang Z, 2010, MOL BIOL CELL, V21, P2821, DOI 10.1091/mbc.E10-04-0285; Zhang ZJ, 2009, NAT NEUROSCI, V12, P163, DOI 10.1038/nn.2252; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015	55	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47465	10.1371/journal.pone.0047465	http://dx.doi.org/10.1371/journal.pone.0047465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091625	Green Submitted, Green Published, gold			2022-12-27	WOS:000310135800048
J	Zhuang, JH; Peng, WH; Li, HL; Wang, W; Wei, YD; Li, WM; Xu, YW				Zhuang, Jianhui; Peng, Wenhui; Li, Hailing; Wang, Wei; Wei, Yidong; Li, Weiming; Xu, Yawei			Methylation of p15(INK4b) and Expression of ANRIL on Chromosome 9p21 Are Associated with Coronary Artery Disease	PLOS ONE			English	Article							DNA METHYLATION; CARDIOVASCULAR-DISEASE; NONCODING RNA; ANTISENSE RNA; POLYCOMB CBX7; HEART-DISEASE; LOCUS; ATHEROSCLEROSIS; RISK; HYPERMETHYLATION	Background: Genome-wide association studies have identified that multiple single nucleiotide polymorphisms on chromosome 9p21 are tightly associated with coronary artery disease (CAD). However, the mechanism linking this risk locus to CAD remains unclear. Methodology/Principal Findings: The methylation status of six candidate genes (BAX, BCL-2, TIMP3, p14(ARF), p15(INK4b) and p16(INK4a)) in 205 patients and controls who underwent coronary angiography were analyzed by quantitative MethyLight assay. Rs10757274 was genotyped and expression of INK4/ARF and antisense non-coding RNA in the INK4 locus (ANRIL) was determined by real-time RT-PCR. Compared with controls, DNA methylation levels at p15(INK4b) significantly increased in CAD patients (p = 0.006). To validate and dissect the methylation percentage of each target CpG site at p15(INK4b), pyrosequencing was performed, finding CpG + 314 and + 332 remarkably hypermethylated in CAD patients. Further investigation determined that p15(INK4b) hypermethylation prevalently emerged in lymphocytes of CAD patients (p = 0.013). The rs10757274 genotype was significantly associated with CAD (p = 0.003) and GG genotype carriers had a higher level of ANRIL exon 1-5 expression compared among three genotypes (p = 0.009). There was a stepwise increase in p15(INK4b) and p16(INK4a) methylation as ANRIL exon 1-5 expression elevated (r = 0.23, p = 0.001 and r = 0.24, p = 0.001, respectively), although neither of two loci methylation was directly linked to rs10757274 genotype. Conclusions/Significance: p15(INK4b) methylation is associated with CAD and ANRIL expression. The epigenetic changes in p15(INK4b) methylation and ANRIL expression may involve in the mechanisms of chromosome 9p21 on CAD development.	[Zhuang, Jianhui; Peng, Wenhui; Li, Hailing; Wei, Yidong; Li, Weiming; Xu, Yawei] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, Shanghai 200092, Peoples R China; [Wang, Wei] Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA	Tongji University; Rockefeller University	Peng, WH (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, Shanghai 200092, Peoples R China.	pwenhui@tongji.edu.cn; xuyawei@tongji.edu.cn	黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022		National Natural Science Foundation of China [30900520, 81070107]; Shanghai Rising-Star Program [10QA1405500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported by grants from National Natural Science Foundation of China No. 30900520 and No. 81070107, and a grant from Shanghai Rising-Star Program No. 10QA1405500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2010, CIRC-CARDIOVASC GENE, V3, P567, DOI 10.1161/CIRCGENETICS.110.958744; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Congrains A, 2012, ATHEROSCLEROSIS, V220, P449, DOI 10.1016/j.atherosclerosis.2011.11.017; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Eads CA, 2001, CANCER RES, V61, P3410; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gonzalez-Navarro H, 2010, J AM COLL CARDIOL, V55, P2258, DOI 10.1016/j.jacc.2010.01.026; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Holdt LM, 2012, ARTERIOSCL THROM VAS, V32, P196, DOI 10.1161/ATVBAHA.111.232678; Holdt LM, 2010, ARTERIOSCL THROM VAS, V30, P620, DOI 10.1161/ATVBAHA.109.196832; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kuo CL, 2011, ARTERIOSCL THROM VAS, V31, P2483, DOI 10.1161/ATVBAHA.111.234492; Li HL, 2011, CLIN CHEM LAB MED, V49, P1547, DOI 10.1515/CCLM.2011.236; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Makar KW, 2004, J IMMUNOL, V173, P4402, DOI 10.4049/jimmunol.173.7.4402; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mitra S, 2011, AM J PHYSIOL-HEART C, V301, pH506, DOI 10.1152/ajpheart.00252.2011; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; Nanayakkara PWB, 2008, NEPHROL DIAL TRANSPL, V23, P2586, DOI 10.1093/ndt/gfn040; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Paul TA, 2010, BLOOD, V115, P3098, DOI 10.1182/blood-2009-07-233858; Peng WH, 2009, CLIN CHEM LAB MED, V47, P917, DOI 10.1515/CCLM.2009.215; Preuss M, 2010, CIRC-CARDIOVASC GENE, V3, P475, DOI 10.1161/CIRCGENETICS.109.899443; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Silander K, 2009, GENOME MED, V1, DOI 10.1186/gm51; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhong CL, 2009, CLIN CANCER RES, V15, P2675, DOI 10.1158/1078-0432.CCR-08-1954; Zhou L, 2008, ARTERIOSCL THROM VAS, V28, P2085, DOI 10.1161/ATVBAHA.108.176065	48	67	73	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47193	10.1371/journal.pone.0047193	http://dx.doi.org/10.1371/journal.pone.0047193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091611	gold, Green Published			2022-12-27	WOS:000310135800030
J	Lankadeva, YR; Singh, RR; Hilliard, LM; Moritz, KM; Denton, KM				Lankadeva, Yugeesh R.; Singh, Reetu R.; Hilliard, Lucinda M.; Moritz, Karen M.; Denton, Kate M.			Blunted Sodium Excretion in Response to a Saline Load in 5 Year Old Female Sheep Following Fetal Uninephrectomy	PLOS ONE			English	Article							REDUCED NEPHRON ENDOWMENT; RENAL FUNCTIONAL RESERVE; ANGIOTENSIN-II; BLOOD-PRESSURE; AGING KIDNEY; HYPERTENSION; GROWTH; NATRIURESIS; INFUSION; DISEASE	Previously, we have shown that fetal uninephrectomy (uni-x) causes hypertension in female sheep by 2 years of age. Whilst the hypertension was not exacerbated by 5 years of age, these uni-x sheep had greater reductions in renal blood flow (RBF). To further explore these early indications of a decline in renal function, we investigated the renal response to a saline load (25 ml/kg/40 min) in 5-year old female uni-x and sham sheep. Basal mean arterial pressure was similar to 15 mmHg greater (P-Group<0.001), and sodium excretion (similar to 50%), glomerular filtration rate (similar to 30%, GFR) and RBF (similar to 40%) were all significantly lower (P-Group<0.01) in uni-x compared to sham animals. In response to saline loading, sodium excretion increased significantly in both groups (P-Time<0.001), however this response was blunted in uni-x sheep (P-GroupxTime<0.01). This was accompanied with an attenuated increase in GFR and fractional sodium excretion (both P-GroupxTime<0.05), and reduced activation of the renin-angiotensin system (both P<0.05), as compared to the sham group. The reduction in sodium excretion was associated with up-regulations in the renal gene expression of NHE3 and Na+/K+ ATPase alpha and beta subunits in the kidney cortex of the uni-x compared to the sham animals (P<0.05). Notably, neither group completely excreted the saline load within the recovery period, but the uni-x retained a higher percentage of the total volume (uni-x: 48+/-7%; sham: 22+/-9%, P<0.05). In conclusion, a reduced ability to efficiently regulate extracellular fluid homeostasis is evident in female sheep at 5 years of age, which was exacerbated in animals born with a congenital nephron deficit. Whilst there was no overt exacerbation of hypertension and renal insufficiency with age in the uni-x sheep, these animals may be more vulnerable to secondary renal insults.	[Lankadeva, Yugeesh R.; Hilliard, Lucinda M.; Denton, Kate M.] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia; [Singh, Reetu R.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Singh, Reetu R.; Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia	Monash University; Monash University; University of Queensland	Denton, KM (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia.	kate.denton@monash.edu	Denton, Kate/AAG-2423-2019; Lankadeva, Yugeesh/R-9253-2019; Moritz, Karen/G-2508-2015	Lankadeva, Yugeesh/0000-0002-3589-9111; Moritz, Karen/0000-0002-8085-0034; Krause, Lucinda/0000-0002-8634-6568; Denton, Kate/0000-0002-5929-4387	National Heart Foundation [G 05M 2110]; Monash University Research Fund; Faculty Scholarship, Monash University; Department of Physiology; Australian Postgraduate Award; Monash University, Faculty of Medicine, Nursing and Health Sciences Bridging Post-Doctoral Fellowship; National Health and Medical Research Council (NHMRC); NHMRC	National Heart Foundation(National Heart Foundation of Australia); Monash University Research Fund(Monash University); Faculty Scholarship, Monash University; Department of Physiology; Australian Postgraduate Award(Australian Government); Monash University, Faculty of Medicine, Nursing and Health Sciences Bridging Post-Doctoral Fellowship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a National Heart Foundation Grant (G 05M 2110) and Monash University Research Fund. YL was supported by a Faculty Scholarship, Monash University; Department of Physiology, RS was supported by an Australian Postgraduate Award and Monash University, Faculty of Medicine, Nursing and Health Sciences Bridging Post-Doctoral Fellowship. KM was supported by a National Health and Medical Research Council (NHMRC) Career Development Award and by an NHMRC Senior Research Fellowship and KD was supported by an NHMRC Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2002, AM J PHYSIOL-RENAL, V283, pF236, DOI 10.1152/ajprenal.00336.2001; Alwasel SH, 2012, PEDIATR NEPHROL, V27, P285, DOI 10.1007/s00467-011-1976-9; Baylis C, 1998, J AM SOC NEPHROL, V9, P699; Baylis C, 2009, NAT REV NEPHROL, V5, P384, DOI 10.1038/nrneph.2009.90; BHISITKUL DM, 1991, J PEDIATR-US, V118, P698, DOI 10.1016/S0022-3476(05)80029-0; Bie P, 2004, ACTA PHYSIOL SCAND, V181, P495, DOI 10.1111/j.1365-201X.2004.01323.x; Bie P, 2000, AM J PHYSIOL-REG I, V278, pR1, DOI 10.1152/ajpregu.2000.278.1.R1; Bubb KJ, 2007, J PHYSIOL-LONDON, V578, P871, DOI 10.1113/jphysiol.2006.121160; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; Dodic M, 2001, CIRC RES, V89, P623, DOI 10.1161/hh1901.097086; Dodic M, 1998, CLIN SCI, V94, P149, DOI 10.1042/cs0940149; Douglas-Denton R, 2002, J AM SOC NEPHROL, V13, P406, DOI 10.1681/ASN.V132406; EARLEY LE, 1966, ANN NY ACAD SCI, V139, P312, DOI 10.1111/j.1749-6632.1966.tb41206.x; Epstein M, 1996, J AM SOC NEPHROL, V7, P1106; FLISER D, 1993, J AM SOC NEPHROL, V3, P1371; Gallo LA, 2012, HYPERTENSION, V60, P206, DOI 10.1161/HYPERTENSIONAHA.112.195578; Gilbert JS, 2008, AM J PHYSIOL-REG I, V295, pR1941, DOI 10.1152/ajpregu.90724.2008; Girardi ACC, 2002, AM J PHYSIOL-RENAL, V283, pF1296, DOI 10.1152/ajprenal.00010.2002; Granger JP, 2002, CURR HYPERTENS REP, V4, P152, DOI 10.1007/s11906-002-0040-3; Granger JP, 1998, ADV PHYSIOL EDUC, V20, pS157, DOI 10.1152/advances.1998.275.6.S157; HALL JE, 1990, HYPERTENSION, V15, P547, DOI 10.1161/01.HYP.15.6.547; HAYSLETT JP, 1979, PHYSIOL REV, V59, P137, DOI 10.1152/physrev.1979.59.1.137; Hoang K, 2003, KIDNEY INT, V64, P1417, DOI 10.1046/j.1523-1755.2003.00207.x; HOLLENBERG NK, 1986, AM J MED, V81, P412, DOI 10.1016/0002-9343(86)90291-3; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; KASISKE BL, 1987, KIDNEY INT, V31, P1153, DOI 10.1038/ki.1987.122; Kett MM, 2011, AM J PHYSIOL-REG I, V300, pR791, DOI 10.1152/ajpregu.00791.2010; Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111; Moritz KM, 2010, PLACENTA, V31, pS40, DOI 10.1016/j.placenta.2010.01.006; Moritz KM, 2011, AM J PHYSIOL-REG I, V301, pR500, DOI 10.1152/ajpregu.00818.2010; Moritz KM, 2009, AM J PHYSIOL-RENAL, V296, pF1, DOI 10.1152/ajprenal.00049.2008; Moritz KM, 1999, CLIN EXP PHARMACOL P, V26, P857, DOI 10.1046/j.1440-1681.1999.03155.x; Moritz KM, 2002, HYPERTENSION, V39, P1071, DOI 10.1161/01.HYP.0000019131.77075.54; Moritz KM, 1999, PEDIATR NEPHROL, V13, P171, DOI 10.1007/s004670050587; Nuyt AM, 2008, CLIN SCI, V114, P1, DOI 10.1042/CS20070113; Ojeda NB, 2008, HYPERTENSION, V52, P44, DOI 10.1161/HYPERTENSIONAHA.107.092890; Ojeda NB, 2011, AM J PHYSIOL-REG I, V301, pR1199, DOI 10.1152/ajpregu.00219.2011; Ojeda NB, 2010, AM J PHYSIOL-REG I, V298, pR1421, DOI 10.1152/ajpregu.00096.2010; Peti-Peterdi J, 2010, J AM SOC NEPHROL, V21, P1093, DOI 10.1681/ASN.2009070759; POLLOCK CA, 1992, PFLUG ARCH EUR J PHY, V420, P159, DOI 10.1007/BF00374985; RABINOWE SL, 1987, HYPERTENSION, V10, P404, DOI 10.1161/01.HYP.10.4.404; ROWE JW, 1976, J GERONTOL, V31, P155, DOI 10.1093/geronj/31.2.155; RYDSTEDT LL, 1986, HYPERTENSION, V8, P217, DOI 10.1161/01.HYP.8.3.217; Sandgaard NCF, 2000, AM J PHYSIOL-REG I, V278, pR11, DOI 10.1152/ajpregu.2000.278.1.R11; Schnermann J, 2003, J AM SOC NEPHROL, V14, P1681, DOI 10.1097/01.ASN.0000069221.69551.30; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Singh RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042400; Singh RR, 2011, AM J PHYSIOL-RENAL, V301, pF319, DOI 10.1152/ajprenal.00139.2011; Singh RR, 2010, CLIN SCI, V118, P669, DOI 10.1042/CS20090479; Singh RR, 2009, J HYPERTENS, V27, P386, DOI 10.1097/HJH.0b013e32831bc778; Singh RR, 2011, AM J PHYSL RENAL PHY; TUCK ML, 1976, CIRC RES, V39, P711, DOI 10.1161/01.RES.39.5.711; Vehaskari VM, 2005, J AM SOC NEPHROL, V16, P2545, DOI 10.1681/ASN.2005030300; Yanes LL, 2011, AM J HYPERTENS, V24, P740, DOI 10.1038/ajh.2011.71	54	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47528	10.1371/journal.pone.0047528	http://dx.doi.org/10.1371/journal.pone.0047528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077628	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100124
J	Loha, E; Lunde, TM; Lindtjorn, B				Loha, Eskindir; Lunde, Torleif Markussen; Lindtjorn, Bernt			Effect of Bednets and Indoor Residual Spraying on Spatio-Temporal Clustering of Malaria in a Village in South Ethiopia: A Longitudinal Study	PLOS ONE			English	Article							SPATIAL-ANALYSIS; LEVEL; TRANSMISSION; INFECTION; DISEASE	Background: Understanding the spatio-temporal pattern of malaria transmission where prevention and control measures are in place will help to fine-tune strategies. The objective of this study was to assess the effect of mass distribution of bednets and indoor residual spraying (IRS) with insecticides on the spatio-temporal clustering of malaria in one malaria endemic village in south Ethiopia. Methods: A longitudinal study was conducted from April 2009 to April 2011. The average population was 6631 in 1346 locations. We used active and passive searches for malaria cases for 101 weeks. SatScan v9.1.1 was used to identify statistically significant retrospective space-time clusters. A discrete Poisson based model was applied with the aim of identifying areas with high rates. PASW Statistics 18 was used to build generalized Poisson loglinear model. Results: The total number of both types of malaria episodes was 622, giving 45.1 episodes per 1000 persons per year; among these, episodes of Plasmodium falciparum and vivax infection numbered 316 (22.9 per 1000 per year) and 306 (22.2 per 1000 per year), respectively. IRS with Dichlorodiphenyltrichloroethane (DDT) and later with Deltamethrin and free mass distribution of insecticide-treated nets (ITNs) were carried out during the study period. There was space-time clustering of malaria episodes at a household level. The spatio-temporal clustering of malaria was not influenced by free mass distribution of ITNs; however, the time-span of the spatio-temporal clustering of malaria cases ended after IRS with Deltamethrin. The presence of clusters on the south-east edge of the village was consistent with the finding of an increasing risk of acquiring malaria infection for individuals who lived closer to the identified vector breeding site. Conclusion: The risk of getting malaria infection varied significantly within one village. Free mass distribution of ITNs did not influence the spatio-temporal clustering of malaria, but IRS might have eliminated malaria clustering.	[Loha, Eskindir] Hawassa Univ, Sch Publ & Environm Hlth, Hawassa, Ethiopia; [Loha, Eskindir; Lunde, Torleif Markussen; Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Lunde, Torleif Markussen] Univ Bergen, Inst Geophys, Bergen, Norway	Hawassa University; University of Bergen; University of Bergen	Loha, E (corresponding author), Hawassa Univ, Sch Publ & Environm Hlth, Hawassa, Ethiopia.	eskindir_loha@yahoo.com	loha, eskindir/AAN-4925-2020; Lindtjorn, Bernt/K-9465-2018	Lindtjorn, Bernt/0000-0002-6267-6984; Shumbullo, Eskindir Loha/0000-0003-0003-2734; Lunde, Torleif Markussen/0000-0002-5047-9668	Centre for International Health, University of Bergen, Norway	Centre for International Health, University of Bergen, Norway	This research project was funded by Centre for International Health, University of Bergen, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHO TECHN REP SER; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; FMoH, 2008, ETH NAT MAL IND SURV; Frossling J, 2008, GEOSPATIAL HEALTH, V3, P39; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Ghebreyesus T. A., 2003, Ethiopian Journal of Health Development, V17, P1; Gregorio DI, 2006, INT J HLTH GEOGRAPHI, V5; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Kulldorff M., 2021, SATSCANTM USER GUIDE; Lengeler C, 2009, COCHRANE DATABASE SY, V2004; Loha E, 2012, AM J TROP MED HYG, V87, P450, DOI 10.4269/ajtmh.2012.12-0155; Mirghani SE, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-172; Perez AM, 2005, PREV VET MED, V71, P197, DOI 10.1016/j.prevetmed.2005.07.005; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RHB, 2011, SNNP REG HLTH BUR PL; Ricketts TC, 2003, ANNU REV PUBL HEALTH, V24, P1, DOI 10.1146/annurev.publhealth.24.100901.140924; Robertson C, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-16; Rushton G, 2003, ANNU REV PUBL HEALTH, V24, P43, DOI 10.1146/annurev.publhealth.24.012902.140843; Sadler RC, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-34; Wangdi K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-89; Wen L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-88; Wheeler DC, 2011, ENV HLTH, V10; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yeshiwondim AK, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-5; Zhou GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020318	28	28	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47354	10.1371/journal.pone.0047354	http://dx.doi.org/10.1371/journal.pone.0047354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077598	Green Published, gold			2022-12-27	WOS:000309809500044
J	van der Veen, DR; Shao, JP; Xi, Y; Li, L; Duffield, GE				van der Veen, Daan R.; Shao, Jinping; Xi, Yang; Li, Lei; Duffield, Giles E.			Cardiac Atrial Circadian Rhythms in PERIOD2::LUCIFERASE and per1:luc Mice: Amplitude and Phase Responses to Glucocorticoid Signaling and Medium Treatment	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; INDIVIDUAL FIBROBLASTS; PLASMA-CORTICOSTERONE; REVEALS PERSISTENT; PERIPHERAL-TISSUES; BLOOD-PRESSURE; HEART-RATE; TIME; METABOLISM	Circadian rhythms in cardiac function are apparent in e. g., blood pressure, heart rate, and acute adverse cardiac events. A circadian clock in heart tissue has been identified, but entrainment pathways of this clock are still unclear. We cultured tissues of mice carrying bioluminescence reporters of the core clock genes, period 1 or 2 (per1(luc) or PER2(LUC)) and compared in vitro responses of atrium to treatment with medium and a synthetic glucocorticoid (dexamethasone [DEX]) to that of the suprachiasmatic nucleus (SCN) and liver. We observed that PER2(LUC), but not per1(luc) is rhythmic in atrial tissue, while both per1(luc) and PER2(LUC) exhibit rhythmicity in other cultured tissues. In contrast to the SCN and liver, both per1(luc) and PER2(LUC) bioluminescence amplitudes were increased in response to DEX treatment, and the PER2(LUC) amplitude response was dependent on the time of treatment. Large phase-shift responses to both medium and DEX treatments were observed in the atrium, and phase responses to medium treatment were not attributed to serum content but the treatment procedure itself. The phase-response curves of atrium to both DEX and medium treatments were found to be different to the liver. Moreover, the time of day of the culturing procedure itself influenced the phase of the circadian clock in each of the cultured tissues, but the magnitude of this response was uniquely large in atrial tissue. The current data describe novel entrainment signals for the atrial circadian clock and specifically highlight entrainment by mechanical treatment, an intriguing observation considering the mechanical nature of cardiac tissue.	[van der Veen, Daan R.; Shao, Jinping; Xi, Yang; Li, Lei; Duffield, Giles E.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [van der Veen, Daan R.] Univ Surrey, Fac Hlth & Med Sci, Dept Biochem & Physiol, Guildford GU2 5XH, Surrey, England; [Shao, Jinping; Xi, Yang; Li, Lei] Nankai Univ, Dept Physiol, Sch Med, Tianjin 300071, Peoples R China	University of Notre Dame; University of Surrey; Nankai University	Duffield, GE (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	duffield.2@nd.edu	Li, Lei/F-5722-2015; van der Veen, Daan R/T-1013-2017	Li, Lei/0000-0001-9703-2102; van der Veen, Daan R/0000-0001-8037-1407; Xi, Yang/0000-0002-5990-2549	American Heart Association [10SDG4030011]; National Institute of General Medical Sciences [R01-GM087508, R01-GM083336]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083336, R01GM087508] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported from grants to GED from the American Heart Association (Scientist Development Grant 10SDG4030011) and the National Institute of General Medical Sciences (R01-GM087508), and R01-GM083336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1979, NEUROENDOCRINOLOGY, V29, P119, DOI 10.1159/000122913; Akashi M, 2000, GENE DEV, V14, P645; Akashi M, 2008, J NEUROSCI, V28, P4619, DOI 10.1523/JNEUROSCI.3410-07.2008; Allen G, 2001, J NEUROSCI, V21, P7937, DOI 10.1523/JNEUROSCI.21-20-07937.2001; Anderson RM, 2012, GROSS PHYSL CARDIOVA; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Butcher GQ, 2005, J NEUROSCI, V25, P5305, DOI 10.1523/JNEUROSCI.4361-04.2005; Davidson AJ, 2005, CLIN EXP HYPERTENS, V27, P307, DOI 10.1081/CEH-200048933; Dietz JR, 2005, CARDIOVASC RES, V68, P8, DOI 10.1016/j.cardiores.2005.06.008; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Habeler W, 2009, ORGANOGENESIS, V5, P62, DOI 10.4161/org.5.2.9091; Hu K, 2004, P NATL ACAD SCI USA, V101, P18223, DOI 10.1073/pnas.0408243101; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Kerkela R, 2011, AM J PHYSIOL-REG I, V300, pR140, DOI 10.1152/ajpregu.00853.2009; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kornmann B, 2007, COLD SPRING HARB SYM, V72, P319, DOI 10.1101/sqb.2007.72.041; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Li P, 1999, AM J PHYSIOL-REG I, V276, pR500, DOI 10.1152/ajpregu.1999.276.2.R500; Marquez S, 2004, FASEB J, V18, P519, DOI 10.1096/fj.03-0417fje; Martino T, 2004, J MOL MED, V82, P256, DOI 10.1007/s00109-003-0520-1; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Menger GJ, 2007, PHYSIOL GENOMICS, V29, P280, DOI 10.1152/physiolgenomics.00199.2006; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Pendergast JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008552; Reddy AB, 2002, J NEUROSCI, V22, P7326; Reilly DF, 2007, ARTERIOSCL THROM VAS, V27, P1694, DOI 10.1161/ATVBAHA.107.144923; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ripperger JA, 2011, FEBS LETT, V585, P1384, DOI 10.1016/j.febslet.2011.02.027; Schroeder A, 2011, AM J PHYSIOL-HEART C, V300, pH241, DOI 10.1152/ajpheart.00190.2010; Sheward WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009783; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Spies CM, 2011, BEST PRACT RES CL RH, V25, P891, DOI 10.1016/j.berh.2011.11.002; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tsuchiya Y, 2003, GENES CELLS, V8, P713, DOI 10.1046/j.1365-2443.2003.00669.x; Ulrich-Lai YM, 2006, AM J PHYSIOL-REG I, V290, pR1128, DOI 10.1152/ajpregu.00042.2003; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Willich SN, 1999, VASC MED, V4, P41, DOI 10.1191/135886399670596924; Wilsbacher LD, 2002, P NATL ACAD SCI USA, V99, P489, DOI 10.1073/pnas.012248599; Yamamoto T, 2005, J BIOL CHEM, V280, P42036, DOI 10.1074/jbc.M509600200; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005	57	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47692	10.1371/journal.pone.0047692	http://dx.doi.org/10.1371/journal.pone.0047692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110090	Green Submitted, Green Published, gold			2022-12-27	WOS:000310193600022
J	Mestre, G; Berbel, C; Tortajada, P; Alarcia, M; Coca, R; Gallemi, G; Garcia, I; Fernandez, MM; Aguilar, MC; Martinez, JA; Rodriguez-Bano, J				Mestre, Gabriel; Berbel, Cristina; Tortajada, Purificacion; Alarcia, Margarita; Coca, Roser; Gallemi, Gema; Garcia, Irene; Mar Fernandez, Mari; Carmen Aguilar, Mari; Antonio Martinez, Jose; Rodriguez-Bano, Jesus			"The 3/3 Strategy'': A Successful Multifaceted Hospital Wide Hand Hygiene Intervention Based on WHO and Continuous Quality Improvement Methodology	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; STATISTICAL PROCESS-CONTROL; PROCESS-CONTROL CHARTS; HEALTH-CARE WORKERS; INFECTION-CONTROL; PROGRAM; IMPACT; EPIDEMIOLOGY; PERFORMANCE; GUIDELINES	Background: Only multifaceted hospital wide interventions have been successful in achieving sustained improvements in hand hygiene (HH) compliance. Methodology/Principal Findings: Pre-post intervention study of HH performance at baseline (October 2007-December 2009) and during intervention, which included two phases. Phase 1 (2010) included multimodal WHO approach. Phase 2 (2011) added Continuous Quality Improvement (CQI) tools and was based on: a) Increase of alcohol hand rub (AHR) solution placement (from 0.57 dispensers/bed to 1.56); b) Increase in frequency of audits (three days every three weeks: "3/3 strategy''); c) Implementation of a standardized register form of HH corrective actions; d) Statistical Process Control (SPC) as time series analysis methodology through appropriate control charts. During the intervention period we performed 819 scheduled direct observation audits which provided data from 11,714 HH opportunities. The most remarkable findings were: a) significant improvements in HH compliance with respect to baseline (25% mean increase); b) sustained high level (82%) of HH compliance during intervention; c) significant increase in AHRs consumption over time; c) significant decrease in the rate of healthcare-acquired MRSA; d) small but significant improvements in HH compliance when comparing phase 2 to phase 1 [79.5% (95% CI: 78.2-80.7) vs 84.6% (95% CI: 83.8-85.4), p, 0.05]; e) successful use of control charts to identify significant negative and positive deviations (special causes) related to the HH compliance process over time ("positive'': 90.1% as highest HH compliance coinciding with the "World hygiene day''; and "negative'': 73.7% as lowest HH compliance coinciding with a statutory lay-off proceeding). Conclusions/Significance: CQI tools may be a key addition to WHO strategy to maintain a good HH performance over time. In addition, SPC has shown to be a powerful methodology to detect special causes in HH performance (positive and negative) and to help establishing adequate feedback to healthcare workers.	[Mestre, Gabriel; Berbel, Cristina; Tortajada, Purificacion] Delfos Med Ctr, Nosocomial Infect Control Unit, Barcelona, Catalonia, Spain; [Alarcia, Margarita; Coca, Roser; Gallemi, Gema; Garcia, Irene; Mar Fernandez, Mari; Carmen Aguilar, Mari] Delfos Med Ctr, Supervisor Nursing Dept, Barcelona, Catalonia, Spain; [Antonio Martinez, Jose] Hosp Clin Barcelona, Infect Dis Unit, Barcelona, Catalonia, Spain; [Rodriguez-Bano, Jesus] Univ Hosp Virgen Macarena, Infect Dis & Microbiol Unit, Seville, Spain	University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Virgen Macarena	Mestre, G (corresponding author), Delfos Med Ctr, Nosocomial Infect Control Unit, Barcelona, Catalonia, Spain.	mestre.ucin@centromedicodelfos.es	Rodríguez-Baño, Jesús/F-2453-2011	Rodríguez-Baño, Jesús/0000-0001-6732-9001	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III; European Development Regional Fund "A way to achieve Europe'' ERDF, Spanish Network for the Research in Infectious Diseases [REIPI RD06/0008]	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); European Development Regional Fund "A way to achieve Europe'' ERDF, Spanish Network for the Research in Infectious Diseases	In January 2011, Lab HARTMANN S.A, provided 200 bottles of hydroalcoholic gel and gel dispensers as an unrestricted collaboration for an educational program in infection control in Delfos Medical Center. GMR provides part-time consultancy activities for Lab HARTMANN S.A since April 2011. JRB received funding for research from Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III - co-financed by European Development Regional Fund "A way to achieve Europe'' ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008). The other authors declare no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data. The funders had no role in the design of the study, analysis of the data, writing of the manuscript, or decision to publish.	Aboumatar H, 2012, INFECT CONT HOSP EP, V33, P144, DOI 10.1086/663707; Allegranzi B, 2009, J HOSP INFECT, V73, P305, DOI 10.1016/j.jhin.2009.04.019; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Benneyan JC, 1998, INFECT CONT HOSP EP, V19, P265; Benneyan JC, 1998, INFECT CONT HOSP EP, V19, P194; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Boyce JM, 2011, INFECT CONT HOSP EP, V32, P1016, DOI 10.1086/662015; Carey R.G., 2003, IMPROVING HEALTHCARE; Cockburn J, 2004, MED J AUSTRALIA, V180, pS66; Cohen AL, 2008, INFECT CONT HOSP EP, V29, P901, DOI 10.1086/591741; Cummings KL, 2010, INFECT CONT HOSP EP, V31, P357, DOI 10.1086/651096; Curran E, 2008, J HOSP INFECT, V70, P127, DOI 10.1016/j.jhin.2008.06.013; D'Agata EMC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030170; Ebnother C, 2008, INFECT CONT HOSP EP, V29, P38, DOI 10.1086/524330; Eckmanns T, 2006, INFECT CONT HOSP EP, V27, P931, DOI 10.1086/507294; Erasmus V, 2009, INFECT CONT HOSP EP, V30, P415, DOI 10.1086/596773; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Gill AW, 2011, J HOSP INFECT, V78, P20, DOI 10.1016/j.jhin.2010.12.018; Gould DJ, 2007, J HOSP INFECT, V66, P109, DOI 10.1016/j.jhin.2007.02.009; Gould DJ, 2011, J HOSP INFECT, V77, P290, DOI 10.1016/j.jhin.2010.12.011; Grayson ML, 2008, MED J AUSTRALIA, V188, P633, DOI 10.5694/j.1326-5377.2008.tb01820.x; Hysong SJ, 2009, MED CARE, V47, P356, DOI 10.1097/MLR.0b013e3181893f6b; Jang JH, 2010, INFECT CONT HOSP EP, V31, P144, DOI 10.1086/649792; Johnson PDR, 2005, MED J AUSTRALIA, V183, P509, DOI 10.5694/j.1326-5377.2005.tb07151.x; Kohli E, 2009, INFECT CONT HOSP EP, V30, P222, DOI 10.1086/595692; Kretzer EK, 1998, AM J INFECT CONTROL, V26, P245, DOI 10.1016/S0196-6553(98)80008-4; LAFFEL G, 1989, JAMA-J AM MED ASSOC, V262, P2869, DOI DOI 10.1001/JAMA.1989.03430200113036; Larson EL, 2007, AM J INFECT CONTROL, V35, P666, DOI 10.1016/j.ajic.2006.10.006; Lee TC, 2009, INFECT CONT HOSP EP, V30, P249, DOI 10.1086/596042; MacDonald A, 2004, J HOSP INFECT, V56, P56, DOI 10.1016/S0195-6701(03)00293-7; MAYER JA, 1986, INFECT CONT HOSP EP, V7, P259, DOI 10.1017/S0195941700064171; Mohammed MA, 2008, QUAL SAF HEALTH CARE, V17, P137, DOI 10.1136/qshc.2004.012047; Mohammed MA, 2004, QUAL SAF HEALTH CARE, V13, P243, DOI 10.1136/qshc.2004.011650; Mohammed MA, 2001, LANCET, V357, P463, DOI 10.1016/S0140-6736(00)04019-8; Montgomery DC., 1991, INTRO STAT QUALITY C, V2nd ed.; Morton AP, 2007, J HOSP INFECT, V66, P296, DOI 10.1016/j.jhin.2007.04.019; Moulding NT, 1999, QUAL HEALTH CARE, V8, P177, DOI 10.1136/qshc.8.3.177; O'Boyle CA, 2001, AM J INFECT CONTROL, V29, P352, DOI 10.1067/mic.2001.18405; Pessoa-Silva CL, 2007, PEDIATRICS, V120, pE382, DOI 10.1542/peds.2006-3712; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008; Pittet D, 2001, EMERG INFECT DIS, V7, P234, DOI 10.3201/eid0702.010217; Pittet D, 2004, INFECT CONT HOSP EP, V25, P264, DOI 10.1086/502389; Pittet D, 2006, LANCET INFECT DIS, V6, P641, DOI 10.1016/S1473-3099(06)70600-4; Rose Louise, 2009, Intensive Crit Care Nurs, V25, P57, DOI 10.1016/j.iccn.2008.09.002; Sax H, 2007, J HOSP INFECT, V67, P9, DOI 10.1016/j.jhin.2007.06.004; Sax H, 2009, AM J INFECT CONTROL, V37, P827, DOI 10.1016/j.ajic.2009.07.003; SELLICK JA, 1993, INFECT CONT HOSP EP, V14, P649; Shewhart WA., 1931, EC CONTROL QUALITY M; Stewardson A, 2011, INFECT CONT HOSP EP, V32, P1029, DOI 10.1086/662023; Stone SP, 2007, LANCET INFECT DIS, V7, P282, DOI 10.1016/S1473-3099(07)70082-8; Thomas M, 2005, AM J INFECT CONTROL, V33, P368, DOI 10.1016/j.ajic.2005.03.011; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Whitby M, 2007, J HOSP INFECT, V65, P1, DOI 10.1016/j.jhin.2006.09.026; Whitby M, 2006, INFECT CONT HOSP EP, V27, P484, DOI 10.1086/503335; Zerr DM, 2005, PEDIATR INFECT DIS J, V24, P397, DOI 10.1097/01.inf.0000160944.14878.2b	56	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47200	10.1371/journal.pone.0047200	http://dx.doi.org/10.1371/journal.pone.0047200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110061	Green Published, gold, Green Submitted			2022-12-27	WOS:000310193400007
J	De Silva, I; Rozen, WM; Ramakrishnan, A; Mirkazemi, M; Baillieu, C; Ptasznik, R; Leong, J				De Silva, Inoka; Rozen, Warren M.; Ramakrishnan, Anand; Mirkazemi, Mansoor; Baillieu, Charles; Ptasznik, Ronnie; Leong, James			Achieving Adequate Margins in Ameloblastoma Resection: The Role for Intra-Operative Specimen Imaging. Clinical Report and Systematic Review	PLOS ONE			English	Review							MANDIBULAR AMELOBLASTOMA; SURGICAL-MANAGEMENT; ACCURACY; RECONSTRUCTION; RECURRENCE; MAXILLA; LESIONS; FIBULA; BONE	Background: Ameloblastoma is a locally aggressive odontogenic neoplasm. With local recurrence rates reaching 90%, only completeness of excision can facilitate cure. Surgical clearance has widely been based on pre-operative imaging to guide operative excision margins, however use of intra-operative specimen x-ray or frozen-section has been sought to improve clearance rates, and advanced imaging technologies in this role have been proposed. This manuscript aims to quantify the evidence for evaluating intra-operative resection margins and present the current standard in this role. Method: The current study comprises the first reported comparison of imaging modalities for assessing ameloblastoma margins. A case is presented in which margins are assessed with each of clinical assessment based on preoperative imaging, intra-operative specimen x-ray, intra-operative specimen computed tomography (CT) and definitive histology. Each modality is compared quantitatively. These results are compared to the literature through means of systematic review of current evidence. Results: A comparative study highlights the role for CT imaging over plain radiography. With no other comparative studies and a paucity of high level evidence establishing a role for intra-operative margin assessment in ameloblastoma in the literature, only level 4 evidence supporting the use of frozen section and specimen x-ray, and only one level 4 study assesses intra-operative CT. Conclusion: The current study suggests that intra-operative specimen CT offers an improvement over existing techniques in this role. While establishing a gold-standard will require higher level comparative studies, the use of intra-operative CT can facilitate accurate single-stage resection.	[De Silva, Inoka; Rozen, Warren M.; Ramakrishnan, Anand; Mirkazemi, Mansoor; Baillieu, Charles; Leong, James] Southern Hlth, Dandenong Hosp, Dept Plast & Reconstruct Surg, Dandenong, Vic, Australia; [De Silva, Inoka; Rozen, Warren M.; Ramakrishnan, Anand; Mirkazemi, Mansoor; Baillieu, Charles; Leong, James] Monash Univ, Fac Med, Dept Surg, Clayton, Vic, Australia; [Ptasznik, Ronnie] Southern Hlth, Dandenong Hosp, Dept Radiol, Dandenong, Vic, Australia	Monash University	Rozen, WM (corresponding author), Southern Hlth, Dandenong Hosp, Dept Plast & Reconstruct Surg, David St, Dandenong, Vic, Australia.	warrenrozen@hotmail.com	Rozen, Warren Matthew/AAE-6296-2022	Rozen, Warren Matthew/0000-0002-4092-182X				Adeline VL, 2008, J CRANIOFAC SURG, V19, P1589, DOI 10.1097/SCS.0b013e31818c0504; Bataineh AB, 2000, ORAL SURG ORAL MED O, V90, P155, DOI 10.1067/moe.2000.107971; Becelli R, 2011, J CRANIOFAC SURG, V22, P1163, DOI 10.1097/SCS.0b013e318210bc34; Bernaerts A, 2006, JBR-BTR, V89, P43; Black CC, 2010, ORAL SURG ORAL MED O, V110, P585, DOI 10.1016/j.tripleo.2010.02.040; Cankurtaran CZ, 2010, RADIOGRAPHICS, V30, P1415, DOI 10.1148/rg.305095200; Carlson ER, 2006, J ORAL MAXIL SURG, V64, P484, DOI 10.1016/j.joms.2005.11.032; Chuenchompoonut V, 2003, DENTOMAXILLOFAC RAD, V32, P80, DOI 10.1259/dmfr/29360754; CRANIN AN, 1987, J ORAL MAXIL SURG, V45, P800, DOI 10.1016/0278-2391(87)90207-2; CRAWLEY WA, 1978, CANCER-AM CANCER SOC, V42, P357, DOI 10.1002/1097-0142(197807)42:1<357::AID-CNCR2820420154>3.0.CO;2-H; Drevelengas A., 1994, EUR RADIOL, V4, P203, DOI DOI 10.10.1007/BF00606448; Feinberg SE, 1996, ORAL SURG ORAL MED O, V81, P383, DOI 10.1016/S1079-2104(96)80012-6; Forrest LA, 1997, AM J OTOLARYNG, V18, P396; Fox CM, 2012, PLAST RECONSTR SURG, V130, p214E, DOI 10.1097/PRS.0b013e31825500fd; GARDNER DG, 1984, J ORAL MAXIL SURG, V42, P161, DOI 10.1016/S0278-2391(84)80026-9; GARDNER DG, 1980, CANCER, V46, P2514, DOI 10.1002/1097-0142(19801201)46:11<2514::AID-CNCR2820461133>3.0.CO;2-9; Gephardt GN, 1996, ARCH PATHOL LAB MED, V120, P804; Ghandhi D, 2006, J ORAL MAXIL SURG, V64, P1010, DOI 10.1016/j.joms.2006.03.022; GOLD L, 1991, J ORAL MAXIL SURG, V49, P1214, DOI 10.1016/0278-2391(91)90419-M; Gortzak RAT, 2006, INT J ORAL MAX SURG, V35, P691, DOI 10.1016/j.ijom.2006.02.013; Guthrie D, 2012, J ORAL MAXI IN PRESS; Hashimoto K, 2000, J Oral Sci, V42, P211; Hong J, 2007, INT J ORAL MAX SURG, V36, P283, DOI 10.1016/j.ijom.2006.11.003; Imazawa M, 1986, ORAL RADIOL, V2, P91; Keszler A, 1996, Oral Dis, V2, P228; KRAMER I R, 1963, Br J Oral Surg, V1, P13, DOI 10.1016/S0007-117X(63)80044-X; MacIntosh RB., 1991, ORAL MAXILLOFAC SURG, V3, P73; MARX RE, 1993, J ORAL MAXIL SURG, V51, P304, DOI 10.1016/S0278-2391(10)80180-6; Matsumura K, 1990, B YAMAGUCHI MED SCH, V37, P113; Mendenhall WM, 2007, AM J CLIN ONCOL-CANC, V30, P645, DOI 10.1097/COC.0b013e3181573e59; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Montoro Jose Raphael de Moura Campos, 2008, Braz J Otorhinolaryngol, V74, P155; MULLER H, 1985, J MAXILLOFAC SURG, V13, P79, DOI 10.1016/S0301-0503(85)80021-7; PANDYA NJ, 1972, PLAST RECONSTR SURG, V50, P242, DOI 10.1097/00006534-197209000-00008; Park C, 1995, J KOREAN ACAD ORAL M, V25, P7; Rastogi V, 2010, J MAXILLOFAC ORAL SU, V9, P173, DOI 10.1007/s12663-010-0060-5; REICHART PA, 1995, ORAL ONCOL, V31B, P86; Sampson DE, 1999, J ORAL MAXIL SURG, V57, P1074, DOI 10.1016/S0278-2391(99)90328-2; Schaaf H, 2008, J CRANIO MAXILL SURG, V36, P234, DOI 10.1016/j.jcms.2008.02.006; SEHDEV MK, 1974, CANCER-AM CANCER SOC, V33, P324, DOI 10.1002/1097-0142(197402)33:2<324::AID-CNCR2820330205>3.0.CO;2-U; Sham E, 2009, ANZ J SURG, V79, P739, DOI 10.1111/j.1445-2197.2009.05061.x; SHATKIN S, 1965, ORAL SURG ORAL MED O, V20, P421, DOI 10.1016/0030-4220(65)90231-8; Singer SR, 2009, QUINTESSENCE INT, V40, P627; SMALL I A, 1955, Oral Surg Oral Med Oral Pathol, V8, P281, DOI 10.1016/0030-4220(55)90350-9; Taylor B G, 1968, CA Cancer J Clin, V18, P205, DOI 10.3322/canjclin.18.4.205; Tsai Chi-Ying, 2006, Chang Gung Med J, V29, P331; UENO S, 1986, J ORAL MAXIL SURG, V44, P361, DOI 10.1016/S0278-2391(86)80031-3; UNDERHILL TE, 1992, AM J ROENTGENOL, V159, P345, DOI 10.2214/ajr.159.2.1632353; Vayvada H, 2006, J ORAL MAXIL SURG, V64, P1532, DOI 10.1016/j.joms.2005.11.065; WILLIAMS TP, 1993, J ORAL MAXIL SURG, V51, P1064, DOI 10.1016/S0278-2391(10)80440-9; Winther C, 2011, APMIS, V119, P259, DOI 10.1111/j.1600-0463.2011.02725.x	51	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47897	10.1371/journal.pone.0047897	http://dx.doi.org/10.1371/journal.pone.0047897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094099	gold, Green Submitted, Green Published			2022-12-27	WOS:000310050200052
J	Russo, F; Di Bella, S; Nigita, G; Macca, V; Lagana, A; Giugno, R; Pulvirenti, A; Ferro, A				Russo, Francesco; Di Bella, Sebastiano; Nigita, Giovanni; Macca, Valentina; Lagana, Alessandro; Giugno, Rosalba; Pulvirenti, Alfredo; Ferro, Alfredo			miRandola: Extracellular Circulating MicroRNAs Database	PLOS ONE			English	Article							PAZ DOMAIN; CELLS; PLASMA; DISEASE; CANCER; RNA; COMPLEXES; MECHANISM; BIOMARKER; VESICLES	MicroRNAs are small noncoding RNAs that play an important role in the regulation of various biological processes through their interaction with cellular messenger RNAs. They are frequently dysregulated in cancer and have shown great potential as tissue-based markers for cancer classification and prognostication. microRNAs are also present in extracellular human body fluids such as serum, plasma, saliva, and urine. Most of circulating microRNAs are present in human plasma and serum cofractionate with the Argonaute2 (Ago2) protein. However, circulating microRNAs have been also found in membrane-bound vesicles such as exosomes. Since microRNAs circulate in the bloodstream in a highly stable, extracellular form, they may be used as blood-based biomarkers for cancer and other diseases. A knowledge base of extracellular circulating miRNAs is a fundamental tool for biomedical research. In this work, we present miRandola, a comprehensive manually curated classification of extracellular circulating miRNAs. miRandola is connected to miRo, the miRNA knowledge base, allowing users to infer the potential biological functions of circulating miRNAs and their connections with phenotypes. The miRandola database contains 2132 entries, with 581 unique mature miRNAs and 21 types of samples. miRNAs are classified into four categories, based on their extracellular form: miRNA-Ago2 (173 entries), miRNA-exosome (856 entries), miRNA-HDL (20 entries) and miRNA-circulating (1083 entries). miRandola is available online at: http://atlas.dmi.unict.it/mirandola/index.html.	[Russo, Francesco; Di Bella, Sebastiano; Giugno, Rosalba; Pulvirenti, Alfredo; Ferro, Alfredo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy; [Nigita, Giovanni; Macca, Valentina] Univ Catania, Dept Math & Comp Sci, Catania, Italy; [Lagana, Alessandro] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Human Genet, Columbus, OH 43210 USA	University of Catania; University of Catania; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Ferro, A (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Catania, Italy.	ferro@dmi.unict.it	Pulvirenti, Alfredo/I-7272-2018; Nigita, Giovanni/AAC-4090-2020; Di Bella, Sebastiano/V-6442-2019; Russo, Francesco/X-3055-2018	Pulvirenti, Alfredo/0000-0002-9764-0295; Nigita, Giovanni/0000-0001-8880-4334; Giugno, Rosalba/0000-0001-9843-7638; Russo, Francesco/0000-0001-9257-4359; Di Bella, Sebastiano/0000-0001-7161-303X	Associazione Sclerosi Tuberosa	Associazione Sclerosi Tuberosa	Valentina Macca has been supported by a fellowship sponsored by "Associazione Sclerosi Tuberosa", A. S. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen XM, 2009, WORLD J GASTROENTERO, V15, P1665, DOI 10.3748/wjg.15.1665; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gidlof O, 2011, CARDIOLOGY, V118, P217, DOI 10.1159/000328869; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; Hanke Merle, 2010, Urol Oncol, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lagana A, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap008; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mishima T, 2007, BRAIN RES, V1131, P37, DOI 10.1016/j.brainres.2006.11.035; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mocellin S, 2009, MINI-REV MED CHEM, V9, P70, DOI 10.2174/138955709787001802; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Romano P, 2011, BRIEF BIOINFORM, V12, P549, DOI 10.1093/bib/bbr055; Shi Y, 2009, SCI CHINA SER C, V52, P205, DOI 10.1007/s11427-009-0040-5; Siegel SR, 2012, MOL BIOL REP, V39, P6219, DOI 10.1007/s11033-011-1441-7; Silva J, 2011, EUR RESPIR J, V37, P617, DOI 10.1183/09031936.00029610; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Sun BK, 2008, J AM ACAD DERMATOL, V59, P725, DOI 10.1016/j.jaad.2008.08.017; Tomimaru Y, 2012, J HEPATOL, V56, P167, DOI 10.1016/j.jhep.2011.04.026; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zahm AM, 2011, J PEDIATR GASTR NUTR, V53, P26, DOI 10.1097/MPG.0b013e31822200cc	32	120	127	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47786	10.1371/journal.pone.0047786	http://dx.doi.org/10.1371/journal.pone.0047786			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094086	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200045
J	Cappellari, AR; Rockenbach, L; Dietrich, F; Clarimundo, V; Glaser, T; Braganhol, E; Abujamra, AL; Roesler, R; Ulrich, H; Battastini, AML				Cappellari, Angelica Regina; Rockenbach, Liliana; Dietrich, Fabricia; Clarimundo, Vanessa; Glaser, Talita; Braganhol, Elizandra; Abujamra, Ana Lucia; Roesler, Rafael; Ulrich, Henning; Liveira Battastini, Ana Maria			Characterization of Ectonucleotidases in Human Medulloblastoma Cell Lines: ecto-5 ' NT/CD73 in Metastasis as Potential Prognostic Factor	PLOS ONE			English	Article							CHILDHOOD MEDULLOBLASTOMA; EXTRACELLULAR METABOLISM; ALKALINE-PHOSPHATASE; ATP; INHIBITION; EXPRESSION; ADENOSINE; NUCLEOTIDES; ECTOENZYMES; GROWTH	Medulloblastoma (MB) is the most common malignant brain tumor in children and occurs mainly in the cerebellum. Important intracellular signaling molecules, such those present in the Sonic Hedgehog and Wnt pathways, are involved in its development and can also be employed to determine tumor grade and prognosis. Ectonucleotidases, particularly ecto-5'NT/CD73, are important enzymes in the malignant process of different tumor types regulating extracellular ATP and adenosine levels. Here, we investigated the activity of ectonucleotidases in three malignant human cell lines: Daoy and ONS76, being representative of primary MB, and the D283 cell line, derived from a metastatic MB. All cell lines secreted ATP into the extracellular medium while hydrolyze poorly this nucleotide, which is in agreement with the low expression and activity of pyrophosphate/phosphodiesterase, NTPDases and alkaline phosphatase. The analysis of AMP hydrolysis showed that Daoy and ONS76 completely hydrolyzed AMP, with parallel adenosine production (Daoy) and inosine accumulation (ONS76). On the other hand, D283 cell line did not hydrolyze AMP. Moreover, primary MB tumor cells, Daoy and ONS76 express the ecto-5'NT/CD73 while D283 representative of a metastatic tumor, revealed poor expression of this enzyme, while the ecto-adenosine deaminase showed higher expression in D283 compared to Daoy and ONS76 cells. Nuclear beta-catenin has been suggested as a marker for MB prognosis. Further it can promotes expression of ecto-5'NT/CD73 and suppression of adenosine deaminase. It was observed that Daoy and ONS76 showed greater nuclear beta-catenin immunoreactivity than D283, which presented mainly cytoplasmic immunoreactivity. In summary, the absence of ecto-5'NT/CD73 in the D283 cell line, a metastatic MB phenotype, suggests that high expression levels of this ectonucleotidase could be correlated with a poor prognosis in patients with MB.	[Cappellari, Angelica Regina; Rockenbach, Liliana; Dietrich, Fabricia; Clarimundo, Vanessa; Liveira Battastini, Ana Maria] Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas & Saude, Porto Alegre, RS, Brazil; [Glaser, Talita; Ulrich, Henning] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Braganhol, Elizandra] Univ Fed Pelotas, Ctr Ciencias Quim Farmaceut & Alimentos, Pelotas, RS, Brazil; [Abujamra, Ana Lucia; Roesler, Rafael] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Lab Pesquisa Canc, Porto Alegre, RS, Brazil; [Abujamra, Ana Lucia] ICI RS, Inst Canc Infantil RS, Porto Alegre, RS, Brazil; [Roesler, Rafael] Univ Fed Rio Grande do Sul, Dept Farmacol, Inst Ciencias Basicas & Saude, Porto Alegre, RS, Brazil; [Roesler, Rafael] Univ Fed Rio Grande do Sul, Inst Nacl Ciencia & Tecnol Translac Med, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Universidade Federal de Pelotas; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Battastini, AML (corresponding author), Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas & Saude, Porto Alegre, RS, Brazil.	abattastini@gmail.com	Dietrich, Fabrícia/F-8658-2019; Roesler, Rafael/U-9261-2019; Ulrich, Henning/C-5245-2013; Cappellari, Angélica/V-1481-2019; Braganhol, Elizandra/C-6439-2013; Glaser, Talita/C-3663-2014; Abujamra, Ana Lucia/D-4903-2013; Battastini, Ana M/E-2809-2012	Ulrich, Henning/0000-0002-2114-3815; Abujamra, Ana Lucia/0000-0002-4899-4644; Battastini, Ana M/0000-0001-6068-3278; Cappellari, Angelica Regina/0000-0002-8202-609X; Dietrich, Fabricia/0000-0002-6458-2359; Roesler, Rafael/0000-0001-6016-2261	Brazilian funding agency: CNPq [Proc. 303016/2009-4]; Brazilian funding agency: FIPEHCPA [Proc. 10-01320]; Brazilian funding agency: FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Science and Technology Facilities Council [ST/H002456/1] Funding Source: researchfish; STFC [ST/H002456/1] Funding Source: UKRI	Brazilian funding agency: CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian funding agency: FIPEHCPA; Brazilian funding agency: FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by the Brazilian funding agencies: CNPq (Proc. 303016/2009-4), FIPEHCPA (Proc. 10-01320), FAPESP (to Henning Ulrich). A. Cappellari was recipient of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Aerts I, 2011, CLIN NEUROL NEUROSUR, V113, P224, DOI 10.1016/j.clineuro.2010.11.018; Bavaresco L, 2008, MOL CELL BIOCHEM, V319, P61, DOI 10.1007/s11010-008-9877-3; Belcher SM, 2009, ENDOCRINOLOGY, V150, P1112, DOI 10.1210/en.2008-1363; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braganhol E, 2007, BBA-GEN SUBJECTS, V1770, P1352, DOI 10.1016/j.bbagen.2007.06.003; Castellino RC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-127; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Muoio VMF, 2011, ARQ NEURO-PSIQUIAT, V69, P328, DOI 10.1590/S0004-282X2011000300012; Franco R, 1997, PROG NEUROBIOL, V52, P283, DOI 10.1016/S0301-0082(97)00013-0; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Grobben B, 1999, J NEUROCHEM, V72, P826, DOI 10.1046/j.1471-4159.1999.0720826.x; Khaw AK, 2007, MUTAT RES-FUND MOL M, V625, P134, DOI 10.1016/j.mrfmmm.2007.06.005; Koeller KK, 2003, RADIOGRAPHICS, V23, P1613, DOI 10.1148/rg.236035168; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Morrone FB, 2005, J NEURO-ONCOL, V71, P135, DOI 10.1007/s11060-004-1383-1; Morrone FB, 2003, J NEURO-ONCOL, V64, P211, DOI 10.1023/A:1025699932270; Ohkubo S, 2000, BRIT J PHARMACOL, V131, P1667, DOI 10.1038/sj.bjp.0703750; Picher M, 2003, J BIOL CHEM, V278, P13468, DOI 10.1074/jbc.M300569200; Polakis P, 2000, GENE DEV, V14, P1837; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Rodini CO, 2010, ARQ NEURO-PSIQUIAT, V68, P947, DOI 10.1590/S0004-282X2010000600021; Roussel Martine F, 2011, F1000 Biol Rep, V3, P5, DOI 10.3410/B3-5; Sakura H, 1998, THROMB RES, V91, P83, DOI 10.1016/S0049-3848(98)00073-5; Schmidt AL, 2010, CNS NEUROL DISORD-DR, V9, P335, DOI 10.2174/187152710791292602; Spychala J, 2004, EXP CELL RES, V296, P99, DOI 10.1016/j.yexcr.2003.11.001; Spychala J, 2000, PHARMACOL THERAPEUT, V87, P161, DOI 10.1016/S0163-7258(00)00053-X; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Stefan Cristiana, 2006, Purinergic Signal, V2, P361, DOI 10.1007/s11302-005-5303-4; Stella J, 2009, UROL ONCOL, V28, P260; Strater Norbert, 2006, Purinergic Signal, V2, P343, DOI 10.1007/s11302-006-9000-8; Villar J, 2007, CANCER RES, V67, P10859, DOI 10.1158/0008-5472.CAN-07-2041; von Bueren AO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-10; Wink MR, 2003, CANCER LETT, V198, P211, DOI 10.1016/S0304-3835(03)00308-2; Wink MR, 2003, NEUROCHEM INT, V43, P621, DOI 10.1016/S0197-0186(03)00094-9; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	43	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47468	10.1371/journal.pone.0047468	http://dx.doi.org/10.1371/journal.pone.0047468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094051	Green Published, gold, Green Submitted			2022-12-27	WOS:000312384500011
J	Hicks, AN; Lorenzetti, D; Gilley, J; Lu, BS; Andersson, KE; Miligan, C; Overbeek, PA; Oppenheim, R; Bishop, CE				Hicks, Amy N.; Lorenzetti, Diego; Gilley, Jonathan; Lu, Baisong; Andersson, Karl-Erik; Miligan, Carol; Overbeek, Paul A.; Oppenheim, Ronald; Bishop, Colin E.			Nicotinamide Mononucleotide Adenylyltransferase 2 (Nmnat2) Regulates Axon Integrity in the Mouse Embryo	PLOS ONE			English	Article							WALLERIAN DEGENERATION; NEUROMUSCULAR SYNAPSES; SLEEPING-BEAUTY; C57BL/OLA MICE; TRANSPOSON; GENE; DYSFUNCTION; EXPRESSION; SURVIVAL; SYSTEM	Using transposon-mediated gene-trap mutagenesis, we have generated a novel mouse mutant termed Blad (Bloated Bladder). Homozygous mutant mice die perinatally showing a greatly distended bladder, underdeveloped diaphragm and a reduction in total skeletal muscle mass. Wild type and heterozygote mice appear normal. Using PCR, we identified a transposon insertion site in the first intron of Nmnat2 (Nicotinamide mononucleotide adenyltransferase 2). Nmnat2 is expressed predominantly in the brain and nervous system and has been linked to the survival of axons. Expression of this gene is undetectable in Nmnat2(blad/blad) mutants. Examination of the brains of E18.5 Nmnat2(blad/blad) mutant embryos did not reveal any obvious morphological changes. In contrast, E18.5 Nmnat2(blad/blad) homozygotes showed an approximate 60% reduction of spinal motoneurons in the lumbar region and a more than 80% reduction in the sensory neurons of the dorsal root ganglion (DRG). In addition, facial motoneuron numbers were severely reduced, and there was virtually a complete absence of axons in the hind limb. Our observations suggest that during embryogenesis, Nmnat2 plays an important role in axonal growth or maintenance. It appears that in the absence of Nmnat2, major target organs and tissues (e. g., muscle) are not functionally innervated resulting in perinatal lethality. In addition, neither Nmnat1 nor 3 can compensate for the loss of Nmnat2. Whilst there have been recent suggestions that Nmnat2 may be an endogenous modulator of axon integrity, this work represents the first in vivo study demonstrating that Nmnat2 is involved in axon development or survival in a mammal.	[Hicks, Amy N.; Lorenzetti, Diego; Lu, Baisong; Andersson, Karl-Erik; Bishop, Colin E.] Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA; [Gilley, Jonathan] Babraham Inst, Signalling Programme, Cambridge, England; [Miligan, Carol; Oppenheim, Ronald] Wake Forest Univ, Neurosci Program, Winston Salem, NC 27109 USA; [Miligan, Carol; Oppenheim, Ronald] Wake Forest Univ, Dept Neurobiol & Anat, Winston Salem, NC 27109 USA; [Miligan, Carol; Oppenheim, Ronald] Wake Forest Univ, Amyotroph Lateral Sclerosis Ctr, Winston Salem, NC 27109 USA; [Overbeek, Paul A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Wake Forest University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wake Forest University; Wake Forest University; Wake Forest University; Baylor College of Medicine	Hicks, AN (corresponding author), Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.	ahicks@wakehealth.edu	Lu, Baisong/B-5837-2013	Lu, Baisong/0000-0001-9240-558X; Overbeek, Paul/0000-0001-9784-2084; Hicks, Amy/0000-0001-7729-4156	National Institutes of Health (NIH) [U01 HD43421, NS069212]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD043421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069212] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to cite support by National Institutes of Health (NIH) grant type U01 HD43421 to CEB and NS069212 to RO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Ali YO, 2012, HUM MOL GENET, V21, P237, DOI 10.1093/hmg/ddr449; BEERMANN F, 1990, EMBO J, V9, P2819, DOI 10.1002/j.1460-2075.1990.tb07470.x; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Brunetti L, 2010, PROTEIN SCI, V19, P2440, DOI 10.1002/pro.526; CLARKE PGH, 1995, METHOD CELL BIOL, V46, P277; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; Feng Y, 2010, J NEUROSCI RES, V88, P3319, DOI 10.1002/jnr.22498; Feng Y, 2010, PROTEIN CELL, V1, P237, DOI 10.1007/s13238-010-0021-2; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; GLASS JD, 1993, J NEUROCYTOL, V22, P311, DOI 10.1007/BF01195555; Gould TW, 2007, NEUROSCI BIOBEHAV R, V31, P1073, DOI 10.1016/j.neubiorev.2007.04.015; HALL BK, 1990, J MORPHOL, V206, P45, DOI 10.1002/jmor.1052060105; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2006, CURR GENE THER, V6, P593, DOI 10.2174/156652306778520647; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; Ljungberg MC, 2012, HUM MOL GENET, V21, P251, DOI 10.1093/hmg/ddr492; Lu BS, 2007, MAMM GENOME, V18, P338, DOI 10.1007/s00335-007-9025-5; Mayer PR, 2010, J BIOL CHEM, V285, P40387, DOI 10.1074/jbc.M110.178913; OPPENHEIM RW, 1986, DEV BIOL, V114, P426, DOI 10.1016/0012-1606(86)90207-1; Oppenheim RW, 2008, FUNDAMENTAL NEUROSCI; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; PERRY VH, 1990, EUR J NEUROSCI, V2, P802, DOI 10.1111/j.1460-9568.1990.tb00472.x; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; Raffaelli N, 2001, METHOD ENZYMOL, V331, P281; ROBINSON MO, 1989, P NATL ACAD SCI USA, V86, P8437, DOI 10.1073/pnas.86.21.8437; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Wang BP, 2011, DEVELOPMENT, V138, P4487, DOI 10.1242/dev.067264; Winseck AK, 2006, EUR J NEUROSCI, V24, P2105, DOI 10.1111/j.1460-9568.2006.05107.x; Yan TT, 2010, NEUROCHEM INT, V56, P101, DOI 10.1016/j.neuint.2009.09.007; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416	38	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47869	10.1371/journal.pone.0047869	http://dx.doi.org/10.1371/journal.pone.0047869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082226	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900123
J	Jaud, T; Dragon, AC; Garcia, JV; Guinet, C				Jaud, Thomas; Dragon, Anne-Cecile; Garcia, Jade Vacquie; Guinet, Christophe			Relationship between Chlorophyll a Concentration, Light Attenuation and Diving Depth of the Southern Elephant Seal Mirounga leonina	PLOS ONE			English	Article							OCEANOGRAPHIC CONDITIONS; FORAGING STRATEGIES; KERGUELEN ISLANDS; CASE-1 WATERS; OCEAN; BEHAVIOR; TEMPERATURE; MOVEMENTS; PREDATOR; MODELS	Recently, a number of Antarctic marine environmental studies have used oceanographic parameters collected from instrumented top predators for ecological and physical information. Phytoplankton concentration is generally quantified through active measurement of chlorophyll fluorescence. In this study, light absorption coefficient (K-0.75) was used as an indicator of phytoplankton concentration. This measurement, easy to obtain and requiring low electric power, allows for assessing of the fine scale horizontal structuring of phytoplankton. As part of this study, Southern elephant seals (SES) were simultaneously equipped with a fluorometer and a light logger. Along the SES tracks, variations in K-0.75 were strongly correlated with chlorophyll, a concentration measured by the fluorometer within the euphotic layer. With regards to SES foraging behaviour, bottom depth of the seal's dive was highly dependent on light intensity at 150 m, indicating that the vertical distribution of SES's prey such as myctophids is tightly related to light level. Therefore, change in phytoplankton concentration may not only have a direct effect on SES's prey abundance but may also determine their vertical accessibility with likely consequences on SES foraging efficiency.	[Jaud, Thomas; Dragon, Anne-Cecile; Garcia, Jade Vacquie; Guinet, Christophe] Ctr Biol Chize, Marine Predator Dept, Villiers En Bois, France		Jaud, T (corresponding author), Ctr Biol Chize, Marine Predator Dept, Villiers En Bois, France.	jaud.thomas@gmail.com	Guinet, Christophe/AAR-8457-2020	VACQUIE GARCIA, Jade/0000-0002-3126-3423	Centre National d'Etudes Spatiale; Total Foundation; Agence Nationale de la Recherche though the Program ANR-VMC- IPSOS SEAL	Centre National d'Etudes Spatiale; Total Foundation(Total SA); Agence Nationale de la Recherche though the Program ANR-VMC- IPSOS SEAL(French National Research Agency (ANR))	Funding came from the Centre National d'Etudes Spatiale, the Total Foundation and the Agence Nationale de la Recherche though the Program ANR-VMC- IPSOS SEAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvain S, 2005, DEEP-SEA RES PT I, V52, P1989, DOI 10.1016/j.dsr.2005.06.015; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Bailleul F, 2007, DEEP-SEA RES PT II, V54, P343, DOI 10.1016/j.dsr2.2006.11.005; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; BATTY RS, 1990, MAR BIOL, V107, P383, DOI 10.1007/BF01313419; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4; Boehlert GW, 2001, J ATMOS OCEAN TECH, V18, P1882, DOI 10.1175/1520-0426(2001)018<1882:APESUI>2.0.CO;2; Boehme L, 2009, OCEAN SCI; BOYD IL, 1991, POLAR BIOL, V11, P259, DOI 10.1007/BF00238460; Bradshaw CJA, 2004, ICES J MAR SCI, V61, P1014, DOI 10.1016/j.icesjms.2004.07.012; Bricaud A, 1998, J GEOPHYS RES-OCEANS, V103, P31033, DOI 10.1029/98JC02712; Campagna C, 2006, DEEP-SEA RES PT I, V53, P1907, DOI 10.1016/j.dsr.2006.08.015; Catul V, 2011, REV FISH BIOL FISHER, V21, P339, DOI 10.1007/s11160-010-9176-4; Charrassin JB, 2008, P NATL ACAD SCI USA, V105, P11634, DOI 10.1073/pnas.0800790105; Cherel Y, 2008, MAR ECOL PROG SER, V370, P239, DOI 10.3354/meps07673; Croxall J, 1985, J ANIM ECOL, P1; Dragon AC, 2012, HORIZONTAL AREA REST; Dragon AC, 2012, MAR ECOL PROG SER, V447, P243, DOI 10.3354/meps09498; Dragon AC, 2010, PROG OCEANOGR, V87, P61, DOI 10.1016/j.pocean.2010.09.025; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529; GORDON HR, 1989, LIMNOL OCEANOGR, V34, P1389, DOI 10.4319/lo.1989.34.8.1389; Gould W.J., 2006, WEATHER, V61, P17, DOI [10.1256/wea.56.05, DOI 10.1256/WEA.56.05, DOI 10.1007/s00338-008-0361-z]; Hense I, 2000, J MARINE SYST, V27, P235, DOI 10.1016/S0924-7963(00)00070-1; Hooker SK, 2003, DEEP-SEA RES PT I, V50, P927, DOI 10.1016/S0967-0637(03)00055-4; Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753; Hulley PA, 1981, RESULTS RES CRUISES; ICHIYE T, 1967, PURE APPL GEOPHYS, V67, P143, DOI 10.1007/BF00880572; Kahru M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030430; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Klatt O, 2007, J ATMOS OCEAN TECH, V24, P1301, DOI 10.1175/JTECH2026.1; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Levy M, 2008, LECT NOTES PHYS, V744, P219, DOI 10.1007/978-3-540-75215-8_9; Lewis R, 2006, P ROY SOC B-BIOL SCI, V273, P2901, DOI 10.1098/rspb.2006.3642; Liu SH, 2003, J PLANKTON RES, V25, P1069, DOI 10.1093/plankt/25.9.1069; Loots C, 2007, POLAR BIOL, V30, P951, DOI 10.1007/s00300-007-0253-7; Lydersen C, 2004, J MARINE SYST, V46, P99, DOI 10.1016/j.jmarsys.2003.11.019; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McConnell BJ, 1996, CAN J ZOOL, V74, P1485, DOI 10.1139/z96-163; NELSON DM, 1991, LIMNOL OCEANOGR, V36, P1650, DOI 10.4319/lo.1991.36.8.1650; Rasmus KE, 2004, DEEP-SEA RES PT II, V51, P2583, DOI 10.1016/j.dsr2.2001.01.004; Roquet F, 2011, J ATMOSPHERIC OCEANI; Roquet F, 2009, J MARINE SYST, V78, P377, DOI 10.1016/j.jmarsys.2008.11.017; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; [Team RDC Computing RFfS], 2009, COMP RFFS; Teo SLH, 2009, AQUAT BIOL, V5, P195, DOI 10.3354/ab00152; Weimerskirch H, 1999, BIOL CONSERV, V87, P273, DOI 10.1016/S0006-3207(98)00039-1; Xing X, 2011, LIMNOLOGY OCEA UNPUB	49	36	37	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47444	10.1371/journal.pone.0047444	http://dx.doi.org/10.1371/journal.pone.0047444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082166	Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900062
J	Leung, JY; Nevins, JR				Leung, Janet Y.; Nevins, Joseph R.			E2F6 Associates with BRG1 in Transcriptional Regulation	PLOS ONE			English	Article							CELL-CYCLE; FAMILY-MEMBER; IN-VIVO; GROWTH SUPPRESSION; SWI/SNF COMPLEX; GENE; REPRESSION; ACTIVATION; EXPRESSION; ROLES	The E2F6 protein functions as an Rb-independent repressor of gene transcription. We have previously provided evidence suggesting a role for E2F6 in repression of E2F-responsive genes at S phase. Here, we have identified BRG1, the ATPase subunit of the SWI/SNF chromatin-remodeling complex, as an E2F6 interacting protein. Immunoprecipitation experiments demonstrate that BRG1 binds specifically to E2F6 and E2F4 but not the activator E2Fs. E2F6 was also able to interact with BAF155, a BRG1-associated factor, in the SWI/SNF complex. Chromatin immunoprecipitation assays demonstrate the binding of BRG1 coincident with E2F6 on G1/S gene promoters during S phase. Collectively, our studies suggest that E2F6 may recruit BRG1 in transcriptional regulation of genes important for G1/S phase transition of the cell cycle.	[Leung, Janet Y.; Nevins, Joseph R.] Duke Univ, Med Ctr, Duke Inst Genome Sci & Policy, Durham, NC 27708 USA; [Nevins, Joseph R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Duke University; Duke University	Nevins, JR (corresponding author), Duke Univ, Med Ctr, Duke Inst Genome Sci & Policy, Durham, NC 27708 USA.	j.nevins@duke.edu			National Cancer Institute [RO1-CA104663, U54-CA112952]; NATIONAL CANCER INSTITUTE [R01CA106520, U54CA112952, R01CA104663] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to JRN (RO1-CA104663 and U54-CA112952) from the National Cancer Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; CARLSON M, 1981, GENETICS, V98, P41; CARLSON M, 1981, GENETICS, V98, P25; Cartwright P, 1998, ONCOGENE, V17, P611, DOI 10.1038/sj.onc.1201975; Chi YQ, 2003, J BIOL CHEM, V278, P49806, DOI 10.1074/jbc.M309645200; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Gaubatz S, 1998, P NATL ACAD SCI USA, V95, P9190, DOI 10.1073/pnas.95.16.9190; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Ikeda M, 1996, P NATL ACAD SCI USA, V93, P3215, DOI 10.1073/pnas.93.8.3215; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Leung JY, 2008, ONCOGENE, V27, P4172, DOI 10.1038/onc.2008.55; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Logan N, 2005, ONCOGENE, V24, P5000, DOI 10.1038/sj.onc.1208703; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; Moon NS, 2005, DEV CELL, V9, P463, DOI 10.1016/j.devcel.2005.08.015; Morkel M, 1997, NATURE, V390, P567, DOI 10.1038/37507; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; NEIGEBORN L, 1984, GENETICS, V108, P845; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; RANDAZZO FM, 1994, DEV BIOL, V161, P229, DOI 10.1006/dbio.1994.1023; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; Storre J, 2002, EMBO REP, V3, P695, DOI 10.1093/embo-reports/kvf141; Takahashi Y, 2000, GENE DEV, V14, P804; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Trimarchi JM, 1998, P NATL ACAD SCI USA, V95, P2850, DOI 10.1073/pnas.95.6.2850; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; Wang S, 2002, EMBO J, V21, P3019, DOI 10.1093/emboj/cdf302; Wang S, 2004, EMBO J, V23, P2293, DOI 10.1038/sj.emboj.7600231; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	45	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47967	10.1371/journal.pone.0047967	http://dx.doi.org/10.1371/journal.pone.0047967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082233	gold, Green Submitted, Green Published			2022-12-27	WOS:000311146900130
J	Niu, HX; Chen, X; Gruppo, RA; Li, D; Wang, YH; Zhang, L; Wang, KM; Chai, WR; Sun, YP; Ding, ZR; Gartner, TK; Liu, JL				Niu, Haixia; Chen, Xue; Gruppo, Ralph A.; Li, Ding; Wang, Yanhua; Zhang, Lin; Wang, Kemin; Chai, Weiran; Sun, Yueping; Ding, Zhongren; Gartner, T. Kent; Liu, Junling			Integrin alpha IIb-Mediated PI3K/Akt Activation in Platelets	PLOS ONE			English	Article							IN SIGNAL-TRANSDUCTION; IMMOBILIZED FIBRINOGEN; CYTOPLASMIC DOMAIN; BINDING PROTEIN; CALCIUM-BINDING; THROMBOXANE A2; ALPHA(IIB)BETA(3); AGGREGATION; ADHESION; ALPHA-IIB-BETA-3	Integrin alpha II beta b3 mediated bidirectional signaling plays a critical role in thrombosis and haemostasis. Signaling mediated by the beta 3 subunit has been extensively studied, but alpha IIb mediated signaling has not been characterized. Previously, we reported that platelet granule secretion and TxA2 production induced by aIIb mediated outside-in signaling is negatively regulated by the b3 cytoplasmic domain residues R(724)KEFAKFEEER(734). In this study, we identified part of the signaling pathway utilized by aIIb mediated outside-in signaling. Platelets from humans and gene deficient mice, and genetically modified CHO cells as well as a variety of kinase inhibitors were used for this work. We found that aggregation of TxA2 production and granule secretion by beta 3 Delta 724 human platelets initiated by aIIb mediated outside-in signaling was inhibited by the Src family kinase inhibitor PP2 and the PI3K inhibitor wortmannin, respectively, but not by the MAPK inhibitor U0126. Also, PP2 and wortmannin, and the palmitoylated b3 peptide R(724)KEFAKFEEER(734), each inhibited the phosphorylation of Akt residue Ser473 and prevented TxA2 production and storage granule secretion. Similarly, Akt phosphorylation in mouse platelets stimulated by the PAR4 agonist peptide AYPGKF was alpha IIb beta 3-dependent, and blocked by PP2, wortmannin and the palmitoylated peptide p-RKEFAKFEEER. Akt was also phosphorylated in response to mAb D3 plus Fg treatment of CHO cells in suspension expressing alpha IIb beta 3-Delta 724 or alpha IIb beta 3E(724)AERKFERKFE(734), but not in cells expressing wild type alpha II beta b3. In summary, SFK(s) and PI3K/Akt signaling is utilized by alpha IIb-mediated outside-in signaling to activate platelets even in the absence of all but 8 membrane proximal residues of the beta 3 cytoplasmic domain. Our results provide new insight into the signaling pathway used by alpha IIb-mediated outside-in signaling in platelets.	[Niu, Haixia; Chen, Xue; Li, Ding; Wang, Yanhua; Zhang, Lin; Wang, Kemin; Chai, Weiran; Sun, Yueping; Liu, Junling] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200030, Peoples R China; [Gruppo, Ralph A.] Cincinnati Childrens Hosp, Hematol Oncol Dept, Cincinnati, OH USA; [Ding, Zhongren] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 200433, Peoples R China; [Ding, Zhongren] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China; [Gartner, T. Kent] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA	Shanghai Jiao Tong University; Cincinnati Children's Hospital Medical Center; Fudan University; Fudan University; University of Memphis	Liu, JL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200030, Peoples R China.	liujl@shsmu.edu.cn			National Natural Science Foundation of China [81170479]; National Basic Research Program of China (973 Program) [2012CB518001]; Shanghai Committee of Science and Technology [11DZ2260200]; National Institutes of Health [HL63216]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063216] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Program of National Natural Science Foundation of China (81170479 to J.L.), National Basic Research Program of China (973 Program) Grants 2012CB518001 (to J.L.), Shanghai Committee of Science and Technology (11DZ2260200) and the National Institutes of Health grant HL63216 (to T.K.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho MJ, 2003, J THROMB HAEMOST, V1, P363, DOI 10.1046/j.1538-7836.2003.00055.x; Cho MJ, 2003, BLOOD, V101, P2646, DOI 10.1182/blood-2002-05-1363; COLLER BS, 1980, BLOOD, V55, P169; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; Derrick JM, 1997, BIOCHEM J, V325, P309, DOI 10.1042/bj3250309; Derrick JM, 2001, THROMB HAEMOSTASIS, V86, P894, DOI 10.1055/s-0037-1616147; Deshmukh L, 2011, J BIOL CHEM, V286, P40943, DOI 10.1074/jbc.M111.231951; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; GARTNER TK, 1993, THROMB RES, V71, P47; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; KIEFFER N, 1991, J CELL BIOL, V113, P451, DOI 10.1083/jcb.113.2.451; KOUNS WC, 1990, J BIOL CHEM, V265, P20594; LEFKOVITS J, 1995, NEW ENGL J MED, V332, P1553, DOI 10.1056/NEJM199506083322306; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Liu J, 2008, J THROMB HAEMOST, V6, P1915, DOI 10.1111/j.1538-7836.2008.03135.x; Liu J, 2004, J THROMB HAEMOST, V2, P2213, DOI 10.1111/j.1538-7836.2004.01023.x; Liu JL, 2005, BLOOD, V105, P4345, DOI 10.1182/blood-2004-07-2718; Liu JL, 2005, BLOOD, V106, P2750, DOI 10.1182/blood-2005-04-1667; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; Naik UP, 2003, BLOOD, V102, P1355, DOI 10.1182/blood-2003-02-0591; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Resendiz JC, 2007, J THROMB HAEMOST, V5, P2484, DOI 10.1111/j.1538-7836.2007.02769.x; Shattil SJ, 2009, J THROMB HAEMOST, V7, P210, DOI 10.1111/j.1538-7836.2009.03397.x; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wang RG, 1997, J CLIN INVEST, V100, P2393, DOI 10.1172/JCI119780; Weng Z, 2010, BLOOD, V116, P2579, DOI 10.1182/blood-2010-03-277236; Xiang B, 2010, J THROMB HAEMOST, V8, P2032, DOI 10.1111/j.1538-7836.2010.03969.x; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642	43	24	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47356	10.1371/journal.pone.0047356	http://dx.doi.org/10.1371/journal.pone.0047356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082158	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900054
J	Vallee, B; Doudeau, M; Godin, F; Gombault, A; Tchalikian, A; de Tauzia, ML; Benedetti, H				Vallee, Beatrice; Doudeau, Michel; Godin, Fabienne; Gombault, Aurelie; Tchalikian, Aurelie; de Tauzia, Marie-Ludivine; Benedetti, Helene			Nf1 RasGAP Inhibition of LIMK2 Mediates a New Cross-Talk between Ras and Rho Pathways	PLOS ONE			English	Article							NEUROFIBROMATOSIS TYPE-1 GENE; GTPASE-ACTIVATING PROTEIN; SACCHAROMYCES-CEREVISIAE; ADENYLYL-CYCLASE; DROSOPHILA NF1; GAP; KINASES; BINDING; CELLS; PHOSPHORYLATION	Background: Ras GTPases mediate numerous biological processes through their ability to cycle between an inactive GDP-bound form and an active GTP-bound form. Guanine nucleotide exchange factors (GEFs) favor the formation of the active Ras-GTP, whereas GTPase activating proteins (GAPs) promote the formation of inactive Ras-GDP. Numerous studies have established complex signaling cross-talks between Ras GTPases and other members of the superfamily of small GTPases. GEFs were thought to play a major role in these cross-talks. However, recently GAPs were also shown to play crucial roles in these processes. Among RasGAPs, Nf1 is of special interest. Nf1 is responsible for the genetic disease Neurofibromatosis type I, and recent data strongly suggest that this RasGAP connects different signaling pathways. Methodology/Principal Findings: In order to know if the RasGAP Nf1 might play a role in connecting Ras GTPases to other small GTPase pathways, we systematically looked for new partners of Nf1, by performing a yeast two-hybrid screening on its SecPH domain. LIMK2, a major kinase of the Rho/ROCK/LIMK2/cofilin pathway, was identified in this screening. We confirmed this interaction by co-immunoprecipitation experiments, and further characterized it. We also demonstrated its specificity: the close related homolog of LIMK2, LIMK1, does not interact with the SecPH domain of Nf1. We then showed that SecPH partially inhibits the kinase activity of LIMK2 on cofilin. Our results furthermore suggest a precise mechanism for this inhibition: in fact, SecPH would specifically prevent LIMK2 activation by ROCK, its upstream regulator. Conclusions/Significance: Although previous data had already connected Nf1 to actin cytoskeleton dynamics, our study provides for the first time possible detailed molecular requirements of this involvement. Nf1/LIMK2 interaction and inhibition allows to directly connect neurofibromatosis type I to actin cytoskeleton remodeling, and provides evidence that the RasGAP Nf1 mediates a new cross-talk between Ras and Rho signaling pathways within the superfamily of small GTPases.	[Benedetti, Helene] Univ Orleans, CNRS, Ctr Biophys Mol, Orleans, France; INSERM, Orleans, France	Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Institut National de la Sante et de la Recherche Medicale (Inserm)	Benedetti, H (corresponding author), Univ Orleans, CNRS, Ctr Biophys Mol, Orleans, France.	helene.benedetti@cnrs-orleans.fr		Vallee, Beatrice/0000-0002-5161-354X	Ligue Nationale contre le cancer; Conseil regional du Centre; Canceropole Grand-Ouest; Association Neurofibromatoses et Recklinghausen	Ligue Nationale contre le cancer(Ligue nationale contre le cancer); Conseil regional du Centre(Region Centre-Val de Loire); Canceropole Grand-Ouest; Association Neurofibromatoses et Recklinghausen	Funding: Ligue Nationale contre le cancer, Conseil regional du Centre, Canceropole Grand-Ouest, and the Association Neurofibromatoses et Recklinghausen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008704; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boyanapalli M, 2006, BIOCHEM BIOPH RES CO, V340, P1200, DOI 10.1016/j.bbrc.2005.12.129; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Brown JA, 2012, MOL CELL NEUROSCI, V49, P13, DOI 10.1016/j.mcn.2011.08.008; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chautard H, 2004, EUKARYOT CELL, V3, P459, DOI 10.1128/EC.3.2.459-470.2004; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Corral T, 2003, J CELL PHYSIOL, V197, P214, DOI 10.1002/jcp.10349; D'Angelo I, 2006, EMBO REP, V7, P174, DOI 10.1038/sj.embor.7400602; Dang I, 2011, NEUROCHEM RES, V36, P1697, DOI 10.1007/s11064-011-0433-2; Dasgupta B, 2003, J NEUROSCI, V23, P8949; FREIDMAN JM, 1999, NEUROFIBROMATOSIS PH; GAUDIN JC, 1995, GENE, V163, P249, DOI 10.1016/0378-1119(95)00388-M; GREGORY PE, 1993, SOMAT CELL MOLEC GEN, V19, P265, DOI 10.1007/BF01233074; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; Guthrie C, 1991, GUIDE YEAST GENETICS; Gutmann DH, 1996, ONCOGENE, V12, P2121; Gutmann DH, 2001, HUM MOL GENET, V10, P747, DOI 10.1093/hmg/10.7.747; Harashima T, 2006, MOL CELL, V22, P819, DOI 10.1016/j.molcel.2006.05.011; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Huang Y, 2004, ONCOGENE, V23, P368, DOI 10.1038/sj.onc.1207075; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Kweh F, 2009, MOL CARCINOGEN, V48, P1005, DOI 10.1002/mc.20552; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mangoura D, 2006, ONCOGENE, V25, P735, DOI 10.1038/sj.onc.1209113; Maniatis T., 1989, MOL CLONING LAB MANU; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; Ozawa T, 2005, J BIOL CHEM, V280, P39524, DOI 10.1074/jbc.M503707200; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sandsmark DK, 2007, CANCER RES, V67, P4790, DOI 10.1158/0008-5472.CAN-06-4470; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; Shang X, 2007, J BIOL CHEM, V282, P8801, DOI 10.1074/jbc.M609375200; Starinsky-Elbaz S, 2009, MOL CELL NEUROSCI, V42, P278, DOI 10.1016/j.mcn.2009.07.014; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Tong JY, 2002, NAT NEUROSCI, V5, P95, DOI 10.1038/nn792; Turbyville TJ, 2010, MOL CANCER THER, V9, P1234, DOI 10.1158/1535-7163.MCT-09-0834; Upadhyaya MCDN, 1998, NEUROFIBROMATOSIS TY; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Yan JC, 2008, HUM MOL GENET, V17, P936, DOI 10.1093/hmg/ddm366; Yang XY, 2009, ONCOGENE, V28, P1401, DOI 10.1038/onc.2008.498	58	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47283	10.1371/journal.pone.0047283	http://dx.doi.org/10.1371/journal.pone.0047283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082153	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900049
J	Lauria, V; Attrill, MJ; Pinnegar, JK; Brown, A; Edwards, M; Votier, SC				Lauria, Valentina; Attrill, Martin J.; Pinnegar, John K.; Brown, Andrew; Edwards, Martin; Votier, Stephen C.			Influence of Climate Change and Trophic Coupling across Four Trophic Levels in the Celtic Sea	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; NORTH-ATLANTIC OSCILLATION; PLANKTON RECORDER DATA; LONG-TERM CHANGES; BALTIC SEA; C-HELGOLANDICUS; FISH COMMUNITY; SEABIRDS; FLUCTUATIONS; ECOSYSTEMS	Climate change has had profound effects upon marine ecosystems, impacting across all trophic levels from plankton to apex predators. Determining the impacts of climate change on marine ecosystems requires understanding the direct effects on all trophic levels as well as indirect effects mediated by trophic coupling. The aim of this study was to investigate the effects of climate change on the pelagic food web in the Celtic Sea, a productive shelf region in the Northeast Atlantic. Using long-term data, we examined possible direct and indirect 'bottom-up' climate effects across four trophic levels: phytoplankton, zooplankton, mid-trophic level fish and seabirds. During the period 1986-2007, although there was no temporal trend in the North Atlantic Oscillation index (NAO), the decadal mean Sea Surface Temperature (SST) in the Celtic Sea increased by 0.66 +/- 0.02 degrees C. Despite this, there was only a weak signal of climate change in the Celtic Sea food web. Changes in plankton community structure were found, however this was not related to SST or NAO. A negative relationship occurred between herring abundance (0- and 1-group) and spring SST ( 0- group: p = 0.02, slope = -0.30560.125; 1-group: p = 0.04, slope = -0.410 +/- 0.193). Seabird demographics showed complex species-specific responses. There was evidence of direct effects of spring NAO ( on black-legged kittiwake population growth rate: p = 0.03, slope = 0.0314 +/- 0.014) as well as indirect bottom- up effects of lagged spring SST (on razorbill breeding success: p = 0.01, slope = -0.144 +/- 0.05). Negative relationships between breeding success and population growth rate of razorbills and common guillemots may be explained by interactions between mid-trophic level fish. Our findings show that the impacts of climate change on the Celtic Sea ecosystem is not as marked as in nearby regions (e.g. the North Sea), emphasizing the need for more research at regional scales.	[Lauria, Valentina; Votier, Stephen C.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Attrill, Martin J.] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England; [Pinnegar, John K.] CEFAS, Lowestoft, Suffolk, England; [Brown, Andrew] Natural England, Peterborough, Cambs, England; [Edwards, Martin] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England	University of Plymouth; University of Plymouth; Centre for Environment Fisheries & Aquaculture Science	Lauria, V (corresponding author), Natl Univ Ireland, Dept Earth & Ocean Sci, Martin Ryan Inst, Galway, Ireland.	valentina.lauria@nuigalway.ie	Lauria, Valentina/R-9053-2018; Votier, Stephen C/G-2348-2014; Lauria, Valentina/AAG-4906-2021; Pinnegar, John K/C-4400-2012	Lauria, Valentina/0000-0002-4179-9133; Votier, Stephen C/0000-0002-0976-0167; Pinnegar, John/0000-0001-5061-9520; Attrill, Martin/0000-0002-4039-031X	Plymouth University; Natural England; Natural Environment Research Council [SAH01001] Funding Source: researchfish; NERC [SAH01001] Funding Source: UKRI	Plymouth University; Natural England; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was co-financed by Plymouth University and Natural England (PhD studentship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, IBIS, V135, P225, DOI 10.1111/j.1474-919X.1993.tb02838.x; AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; Ainley DG, 2003, ECOLOGY, V84, P709, DOI 10.1890/0012-9658(2003)084[0709:PRCAGS]2.0.CO;2; Alheit J, 1997, FISH OCEANOGR, V6, P130, DOI 10.1046/j.1365-2419.1997.00035.x; Arrhenius F, 1996, ICES J MAR SCI, V53, P701, DOI 10.1006/jmsc.1996.0089; Attrill MJ, 2002, NATURE, V417, P275, DOI 10.1038/417275a; Beaugrand G, 2000, MAR ECOL PROG SER, V200, P93, DOI 10.3354/meps200093; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Beaugrand G, 2009, GLOBAL CHANGE BIOL, V15, P1790, DOI 10.1111/j.1365-2486.2009.01848.x; Benvenuti S, 2001, IBIS, V143, P402, DOI 10.1111/j.1474-919X.2001.tb04941.x; Blaxter JHS, 1982, BIOL CLUPEOID FISHES, P1; Burnham KP, 2002, THEORETIC APPROACH; Cardinale M, 2004, 2004K2001 ICES CM; Carscadden JE, 2002, ICES J MAR SCI, V59, P1027, DOI 10.1006/jmsc.2002.1235; Clarke ED, 2003, J APPL ECOL, V40, P278, DOI 10.1046/j.1365-2664.2003.00802.x; Corten A, 1999, ICES J MAR SCI, V56, P207, DOI 10.1006/jmsc.1998.0429; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; DAAN N, 1985, T AM FISH SOC, V114, P499, DOI 10.1577/1548-8659(1985)114<499:PBNSHC>2.0.CO;2; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Dickey-Collas M, 2007, RESOLVING CLIMATE IM, P18; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; Durant JM, 2003, P ROY SOC B-BIOL SCI, V270, P1461, DOI 10.1098/rspb.2003.2397; Edwards M, 2001, ICES J MAR SCI, V58, P39, DOI 10.1006/jmsc.2000.0987; Ellis J. R., 2002, MARINE BIODIVERSITY, P45; Fauchald P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022729; Frederiksen M, 2008, J ANIM ECOL, V77, P1020, DOI 10.1111/j.1365-2656.2008.01422.x; Frederiksen M, 2007, MAR ECOL PROG SER, V350, P137, DOI 10.3354/meps07126; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Fromentin JM, 1996, MAR ECOL PROG SER, V134, P111, DOI 10.3354/meps134111; FURNESS R, 2004, SCOTTISH BIRD NEWS, V74, P18; Graham CT, 2009, J FISH BIOL, V74, P1143, DOI 10.1111/j.1095-8649.2009.02180.x; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hatch SA, 2000, CONDOR, V102, P145, DOI 10.1650/0010-5422(2000)102[0145:SMAPHU]2.0.CO;2; Henderson PA, 2007, J MAR BIOL ASSOC UK, V87, P589, DOI 10.1017/S0025315407052447; Hinder SL, 2012, NAT CLIM CHANGE, V2, P271, DOI [10.1038/nclimate1388, 10.1038/NCLIMATE1388]; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P5821, DOI 10.1016/S0967-0645(02)00321-1; *ICES, 2007, REP WORK GROUP REG E; [ICES ICES], 2008, ADVICE BOOK, V5, P12; KONARZEWSKI M, 1989, ORNIS SCAND, V20, P112, DOI 10.2307/3676877; Lynam CP, 2011, GLOBAL CHANGE BIOL, V17, P767, DOI 10.1111/j.1365-2486.2010.02352.x; McGinty N, 2011, J EXP MAR BIOL ECOL, V400, P120, DOI 10.1016/j.jembe.2011.02.013; Mitchell PI, 2004, SEABIRD POPULATIONS; OSPAR, 2000, QUAL STAT REP 2000 R, P149; OSPAR, 2002, QUAL STAT REP 2000 R; Osterblom H, 2006, MAR ECOL PROG SER, V323, P233, DOI 10.3354/meps323233; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Ottersen G, 2004, RESPONSE FISH POPULA, P231; Parent B, 2011, THESIS; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pinnegar JK, 2002, J APPL ECOL, V39, P377, DOI 10.1046/j.1365-2664.2002.00723.x; Pitois SG, 2006, ICES J MAR SCI, V63, P785, DOI 10.1016/j.icesjms.2006.03.009; Planque B, 1996, MAR ECOL PROG SER, V134, P101, DOI 10.3354/meps134101; Reid PC, 1998, NATURE, V391, P546, DOI 10.1038/35290; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Riou S, 2011, MAR ECOL PROG SER, V422, P105, DOI 10.3354/meps08968; Royama T, 1996, ANAL POPULATIONS DYN; Russell F. S., 1976, EGGS PLANKTONIC STAG; Team RDC, 2010, R LANG ENV STAT COMP; Toresen R, 2001, LOWELL WAKEFIELD FIS, P315; Toresen R, 2000, FISH FISH, V1, P231, DOI 10.1111/j.1467-2979.2000.00022.x; Voss R, 2009, OCEANOLOGIA, V51, P117, DOI 10.5697/oc.51-1.117; Votier SC, 2008, J ANIM ECOL, V77, P974, DOI 10.1111/j.1365-2656.2008.01421.x; Votier SC, 2005, ECOL LETT, V8, P1157, DOI 10.1111/j.1461-0248.2005.00818.x; Votier SC, 2009, MAR ECOL PROG SER, V393, P225, DOI 10.3354/meps08258; Wanless S, 2007, PROG OCEANOGR, V72, P30, DOI 10.1016/j.pocean.2006.07.007; [No title captured]	70	25	27	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47408	10.1371/journal.pone.0047408	http://dx.doi.org/10.1371/journal.pone.0047408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091621	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000310135800044
J	Nkurunungi, G; Lutangira, JE; Lule, SA; Akurut, H; Kizindo, R; Fitchett, JR; Kizito, D; Sebina, I; Muhangi, L; Webb, EL; Cose, S; Elliott, AM				Nkurunungi, Gyaviira; Lutangira, Jimreeves E.; Lule, Swaib A.; Akurut, Hellen; Kizindo, Robert; Fitchett, Joseph R.; Kizito, Dennison; Sebina, Ismail; Muhangi, Lawrence; Webb, Emily L.; Cose, Stephen; Elliott, Alison M.			Determining Mycobacterium tuberculosis Infection among BCG-Immunised Ugandan Children by T-SPOT.TB and Tuberculin Skin Testing	PLOS ONE			English	Article							HEALTH-CARE WORKERS; CALMETTE-GUERIN VACCINATION; ENZYME-LINKED IMMUNOSPOT; GAMMA RELEASE ASSAY; LATENT; DIAGNOSIS; RESPONSES; DISEASE; REPRODUCIBILITY; METAANALYSIS	Background: Children with latent tuberculosis infection (LTBI) represent a huge reservoir for future disease. We wished to determine Mycobacterium tuberculosis (M.tb) infection prevalence among BCG-immunised five-year-old children in Entebbe, Uganda, but there are limited data on the performance of immunoassays for diagnosis of tuberculosis infection in children in endemic settings. We therefore evaluated agreement between a commercial interferon gamma release assay (T-SPOT.TB) and the tuberculin skin test (TST; 2 units RT-23 tuberculin; positive defined as diameter >= 10 mm), along with the reproducibility of T-SPOT. TB on short-term follow-up, in this population. Methodology/Principal Findings: We recruited 907 children of which 56 were household contacts of TB patients. They were tested with T-SPOT. TB at age five years and then re-examined with T-SPOT. TB (n = 405) and TST (n = 319) approximately three weeks later. The principal outcome measures were T-SPOT. TB and TST positivity. At five years, 88 (9.7%) children tested positive by T-SPOT. TB. More than half of those that were T-SPOT. TB positive at five years were negative at follow-up, whereas 96% of baseline negatives were consistently negative. We observed somewhat better agreement between initial and follow-up T-SPOT. TB results among household TB contacts (kappa = 0.77) than among non-contacts (kappa = 0.39). Agreement between T-SPOT. TB and TST was weak (kappa = 0.28 and kappa = 0.40 for T-SPOT. TB at 5 years and follow-up, respectively). Of 28 children who were positive on both T-SPOT. TB tests, 14 (50%) had a negative TST. Analysis of spot counts showed high levels of instability in responses between baseline and follow-up, indicating variability in circulating numbers of T cells specific for certain M.tb antigens. Conclusions/Significance: We found that T-SPOT. TB positives are unstable over a three-week follow-up interval, and that TST compares poorly with T-SPOT. TB, making the categorisation of children as TB-infected or TB-uninfected difficult. Existing tools for the diagnosis of TB infection are unsatisfactory in determining infection among children in this setting.	[Nkurunungi, Gyaviira; Lutangira, Jimreeves E.; Lule, Swaib A.; Akurut, Hellen; Kizindo, Robert; Kizito, Dennison; Sebina, Ismail; Muhangi, Lawrence; Cose, Stephen; Elliott, Alison M.] MRC, Coinfect Studies Programme, Uganda Virus Res Inst Uganda Res Unit AIDS, Entebbe, Uganda; [Fitchett, Joseph R.; Cose, Stephen; Elliott, Alison M.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Webb, Emily L.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Nkurunungi, G (corresponding author), MRC, Coinfect Studies Programme, Uganda Virus Res Inst Uganda Res Unit AIDS, Entebbe, Uganda.	gyaviira.nkurunungi@mrcuganda.org	Cose, Stephen/H-4851-2019; Nkurunungi, Gyaviira/L-6558-2019	Cose, Stephen/0000-0002-5156-037X; Sebina, Ismail/0000-0003-3232-3472; Lule, Swaib/0000-0002-6271-2033; Webb, Emily/0000-0002-4019-7456; Elliott, Alison/0000-0003-2818-9549; Nkurunungi, Gyaviira/0000-0003-4062-9105	Wellcome Trust [064693, 079110, 086801]; UK Medical Research Council; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by Wellcome Trust (www.wellcome.ac.uk) grant numbers 064693, 079110 and 086801. E. Webb was supported in part by the UK Medical Research Council (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2012, VACCINE, V30, P2083, DOI 10.1016/j.vaccine.2012.01.053; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; Barnes PF, 2001, AM J RESP CRIT CARE, V163, P807, DOI 10.1164/ajrccm.163.4.ed0201c; Canadian Tuberculosis Committee (CTC), 2008, Can Commun Dis Rep, V34, P1; Chee CBE, 2001, AM J RESP CRIT CARE, V164, P958, DOI 10.1164/ajrccm.164.6.2101093; Chee CBE, 2007, AM J RESP CRIT CARE, V175, P282, DOI 10.1164/rccm.200608-1109OC; Codecasa L, 2006, J CLIN MICROBIOL, V44, P1944, DOI 10.1128/JCM.02265-05; Cruz AT, 2011, PEDIATRICS, V127, pE31, DOI 10.1542/peds.2010-1725; Detjen AK, 2009, CLIN VACCINE IMMUNOL, V16, P1170, DOI 10.1128/CVI.00168-09; Doberne D, 2011, J CLIN MICROBIOL, V49, P3061, DOI 10.1128/JCM.01136-11; Elliott AM, 2007, CLIN TRIALS, V4, P42, DOI 10.1177/1740774506075248; Elliott AM, 2010, VACCINE, V29, P247, DOI 10.1016/j.vaccine.2010.10.047; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; FINE PEM, 1994, LANCET, V344, P1245, DOI 10.1016/S0140-6736(94)90748-X; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Joshi R, 2011, EUR RESPIR J, V38, P1475, DOI 10.1183/09031936.00014611; Kakkar F, 2010, CAN J INFECT DIS MED, V21, pE111, DOI 10.1155/2010/129616; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lucas M, 2010, THORAX, V65, P442, DOI 10.1136/thx.2009.127555; Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; MIGLIORI GB, 1994, EUR RESPIR J, V7, P946; Mutsvangwa J, 2010, THORAX, V65, P315, DOI 10.1136/thx.2009.124891; National Tuberculosis and Leprosy Program, 2005, UG NAT PROGR SURV RE; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Okada K, 2008, EPIDEMIOL INFECT, V136, P1179, DOI 10.1017/S0950268807009831; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Perry S, 2008, CLIN VACCINE IMMUNOL, V15, P425, DOI 10.1128/CVI.00398-07; Sauzullo I, 2011, TUBERCULOSIS, V91, P322, DOI 10.1016/j.tube.2011.05.004; Shams H, 2005, AM J RESP CRIT CARE, V172, P1161, DOI 10.1164/rccm.200505-748OC; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Stein CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004094; Stott H, 1973, Tubercle, V54, P1; Tissot F, 2005, CLIN INFECT DIS, V40, P211, DOI 10.1086/426434; Uganda MoH, 2006, NAT POL GUID TB HIV; Uganda MoH, 2010, MAN NAT TUB LEPR PRO; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2011, US TUB INT GAMM REL	50	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47340	10.1371/journal.pone.0047340	http://dx.doi.org/10.1371/journal.pone.0047340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077594	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000309995100094
J	Gonzalez-Jose, R; Charlin, J				Gonzalez-Jose, Rolando; Charlin, Judith			Relative Importance of Modularity and Other Morphological Attributes on Different Types of Lithic Point Weapons: Assessing Functional Variations	PLOS ONE			English	Article							DESIGN; INTEGRATION; TECHNOLOGY; EVOLUTION; STONES	The specific using of different prehistoric weapons is mainly determined by its physical properties, which provide a relative advantage or disadvantage to perform a given, particular function. Since these physical properties are integrated to accomplish that function, examining design variables and their pattern of integration or modularity is of interest to estimate the past function of a point. Here we analyze a composite sample of lithic points from southern Patagonia likely formed by arrows, thrown spears and hand-held points to test if they can be viewed as a two-module system formed by the blade and the stem, and to evaluate the degree in which shape, size, asymmetry, blade: stem length ratio, and tip angle explain the observed variance and differentiation among points supposedly aimed to accomplish different functions. To do so we performed a geometric morphometric analysis on 118 lithic points, departing from 24 two-dimensional landmark and semi landmarks placed on the point's contour. Klingenberg's covariational modularity tests were used to evaluate different modularity hypotheses, and a composite PCA including shape, size, asymmetry, blade: stem length ratio, and tip angle was used to estimate the importance of each attribute to explaining variation patterns. Results show that the blade and the stem can be seen as "near decomposable units'' in the points integrating the studied sample. However, this modular pattern changes after removing the effects of reduction. Indeed, a resharpened point tends to show a tip/rest of the point modular pattern. The composite PCA analyses evidenced three different patterns of morphometric attributes compatible with arrows, thrown spears, and hand-held tools. Interestingly, when analyzed independently, these groups show differences in their modular organization. Our results indicate that stone tools can be approached as flexible designs, characterized by a composite set of interacting morphometric attributes, and evolving on a modular way.	[Gonzalez-Jose, Rolando] Ctr Nacl Patagon CONICET, Unidad Invest Diversidad Sistemat & Evoluc, Puerto Madryn, Argentina; [Charlin, Judith] Univ Buenos Aires, Inst Multidisciplinario Hist & Ciencias Humanas C, Buenos Aires, DF, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Gonzalez-Jose, R (corresponding author), Ctr Nacl Patagon CONICET, Unidad Invest Diversidad Sistemat & Evoluc, Puerto Madryn, Argentina.	rolando@cenpat.edu.ar		Charlin, Judith/0000-0003-0687-510X; Gonzalez-Jose, Rolando/0000-0002-8128-9381				Ahler SA, 2000, J ARCHAEOL SCI, V27, P799, DOI 10.1006/jasc.1999.0503; Andrefsky W, 2006, AM ANTIQUITY, V71, P743, DOI 10.2307/40035887; Baldwin CY, 2003, DESIGN RULES POWER M, P1; Bement Leland., 2002, FOLSOM TECHNOLOGY LI, P135; Bird J., 1946, HDB S AM INDIANS, P17; Bird J.B., 1988, TRAVELS ARCHAEOLOGY, DOI 10.2307/j.ctt20h6v8q; Bird J, 1938, GEOGR REV, V28, P250, DOI 10.2307/210474; BLEED P, 1986, AM ANTIQUITY, V51, P737, DOI 10.2307/280862; Buchanan B, 2006, J ARCHAEOL SCI, V33, P185, DOI 10.1016/j.jas.2005.07.008; Callebaut W, 2005, MODULARITY UNDERSTAN; Castineira C, 2011, LAT AM ANTIQ, V22, P335, DOI 10.7183/1045-6635.22.3.335; Charlin J, 2012, AM ANTIQUITY, V77, P221, DOI 10.7183/0002-7316.77.2.221; Cotterell B., 1990, MECH PREINDUSTRIAL T, P160; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; FLENNIKEN JJ, 1986, AM ANTIQUITY, V51, P603, DOI 10.2307/281755; Foley R, 2003, EVOL ANTHROPOL, V12, P109, DOI 10.1002/evan.10108; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Hallgrimsson B, 2009, EVOL BIOL, V36, P355, DOI 10.1007/s11692-009-9076-5; Hughes S., 1994, J ARCHAEOL METHOD TH, V5, P345; Hunzicker DA, 2008, PLAINS ANTHROPOL, V53, P291, DOI 10.1179/pan.2008.020; Iriarte Javier, 1995, ARQUEOLOGIA URUGUAY, P142; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Knecht H, 1997, INTERD CONT, P191; Krohs U, 2009, VIENNA SER THEOR BIO, P259; Morrow Juliet., 2002, SPECIAL PUBLICATION, P141; Nami H, 1984, PREP INFORM INVESTIG, V1, P85107; ODELL GH, 1986, J FIELD ARCHAEOL, V13, P195, DOI 10.1179/009346986791535780; Otero J Gomez, 2011, 8 JORN ARQ PAT MAL M; Pahl G., 2007, ENG DESIGN SYSTEMATI; Ratto N., 1994, ARQUEOLOGIA CAZADORE, V5, P105; Ratto N, 1992, PALIMPSESTO, V1, P37; Ratto N., 2003, THESIS U BUENOS AIRE; Ratto N., 1990, SHINCAL, V3, P171; Ratto N., 1991, ARQUEOLOGIA, V1, P151; Rohlf F. J, 2004, TPSDIG VERSION 1 4; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2007, TPSRELW; Rohlf J, 2004, TPSUTIL VERSION 1 26; Schlosser G, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P1; Schlosser G, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P519; SCHLOSSER G, 2003, MODULARITY DEV EVOLU, P1; Shott MJ, 2007, LITHIC TECHNOL, V32, P203; Shott MJ, 1997, AM ANTIQUITY, V62, P86, DOI 10.2307/282380; Simon H. A., 1969, SCI ARTIFICIAL; THOMAS DH, 1978, AM ANTIQUITY, V43, P461, DOI 10.2307/279405; Thulman DK, 2012, J ARCHAEOL SCI, V39, P1599, DOI 10.1016/j.jas.2012.01.004; TOWNER RH, 1990, J FIELD ARCHAEOL, V17, P311, DOI 10.1179/009346990791548231; Wagner GP, 1996, AM ZOOL, V36, P36; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267	51	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e48009	10.1371/journal.pone.0048009	http://dx.doi.org/10.1371/journal.pone.0048009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094104	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200056
J	Ramirez, F; Navarro, J; Afan, I; Hobson, KA; Delgado, A; Forero, MG				Ramirez, Francisco; Navarro, Joan; Afan, Isabel; Hobson, Keith A.; Delgado, Antonio; Forero, Manuela G.			Adapting to a Changing World: Unraveling the Role of Man-Made Habitats as Alternative Feeding Areas for Slender-Billed Gull (Chroicocephalus genei)	PLOS ONE			English	Article							REPRODUCTIVE OUTPUT; POPULATION-DYNAMICS; STABLE-ISOTOPES; HERRING GULL; DIET; DONANA; GROWTH; FOOD; MANAGEMENT; DELTA-C-13	Current rates of wildlife habitat loss have placed increasing demands on managers to develop, validate and implement tools aimed at improving our ability to evaluate such impacts on wildlife. Here, we present a case study conducted at the Natural Area of Donana (SW Spain) where remote sensing and stable isotope (delta C-13, delta N-15) analyses of individuals were combined to unravel (1) the effect of variations in availability of natural food resources (i.e. from natural marshes) on reproductive performance of a Slender-billed Gull (Chroicocephalus genei) population, and (2) the role of two adjacent, artificial systems (a fish farm and saltmines) as alternate anthropogenic feeding areas. Based on long-term (1983-2004) remote-sensing, we inferred the average extent of flooded area at the marshland (a proxy to natural resource availability) annually. Estimated flooded areas (ranging from extreme drought [ca. 151 ha, 1995] to high moisture [15,049 ha, 2004]) were positively related to reproductive success of gulls (estimated for the 1993-2004 period, and ranging from ca. 0 to 1.7 fledglings per breeding pairs), suggesting that habitat availability played a role in determining their reproductive performance. Based on blood delta C-13 and delta N-15 values of fledglings, 2001-2004, and a Bayesian isotopic mixing model, we conclude that saltmines acted as the main alternative foraging habitat for gulls, with relative contributions increasing as the extent of marshland decreased. Although adjacent, anthropogenic systems have been established as the preferred breeding sites for this gull population, dietary switches towards exploitation of alternative (anthropogenic) food resources negatively affected the reproductive output of this species, thus challenging the perception that these man-made systems are necessarily a reliable buffer against loss of natural feeding habitats. The methodology and results derived from this study could be extended to a large suite of threatened natural communities worldwide, thus providing a useful framework for management and conservation.	[Ramirez, Francisco; Forero, Manuela G.] Estn Biol Donana, Dept Biol Conservac, Seville, Spain; [Navarro, Joan] Inst Ciencias Mar, E-08039 Barcelona, Spain; [Afan, Isabel] Estn Biol Donana, Lab SIG & Teledetecc, Seville, Spain; [Hobson, Keith A.] Environm Canada, Saskatoon, SK, Canada; [Delgado, Antonio] Inst Andaluz Ciencias Tierra, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Environment & Climate Change Canada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT)	Ramirez, F (corresponding author), Estn Biol Donana, Dept Biol Conservac, Seville, Spain.	ramirez@ebd.csic.es	Huertas, Antonio Delgado/F-6866-2011; Hobson, Keith/Q-9306-2019; Afán, Isabel/F-4783-2015; Ramírez, Francisco/I-3553-2014; Navarro, Joan/C-2119-2009	Huertas, Antonio Delgado/0000-0002-7240-1570; Afán, Isabel/0000-0003-3874-0461; Ramírez, Francisco/0000-0001-9670-486X; Navarro, Joan/0000-0002-5756-9543	EcoGenes project [264125]; Juan de la Cierva program (Ministerio de Economia y Competividad); Spanish Ministry [REN2002-0045, CGL2009-09801, CGL2006-02247/BOS]; Obra Social/Fundacion Cajasol; Environment Canada	EcoGenes project; Juan de la Cierva program (Ministerio de Economia y Competividad); Spanish Ministry(Spanish Government); Obra Social/Fundacion Cajasol; Environment Canada(CGIAR)	During writing, FR and JN were supported by postdoctoral contracts from FP7-REGPOT 2010-1 (Grant No. 264125 of EcoGenes project) and the Juan de la Cierva program (Ministerio de Economia y Competividad), respectively. Research funds were provided by a grant from the Spanish Ministry REN2002-0045 (CGL2009-09801 and CGL2006-02247/BOS for historical data on inundation levels) and by funds provided by Obra Social/Fundacion Cajasol. KAH benefitted from funds provided by Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2002, WATERBIRDS, V25, P253, DOI 10.1675/1524-4695(2002)025[0253:CIPBAB]2.0.CO;2; Bustamante J, 2006, P 1 GLOBWETLAND S OR; Bustamante J, 2009, J ENVIRON MANAGE, V90, P2219, DOI 10.1016/j.jenvman.2007.08.021; Carey C, 2001, CONSERV BIOL, V15, P903, DOI 10.1046/j.1523-1739.2001.015004903.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cramp S., 1983, BIRDS W PALEARTIC; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Diaz-Delgado R, 2010, CONSERVATION MONITORING IN FRESHWATER HABITATS: A PRACTICAL GUIDE AND CASE STUDIES, P325, DOI 10.1007/978-1-4020-9278-7_28; Dies Jose Ignacio, 2000, Ardeola, V47, P255; DOLMAN PM, 1995, IBIS, V137, pS38, DOI 10.1111/j.1474-919X.1995.tb08456.x; FASOLA M, 1989, B ZOOL, V56, P61; Figuerola J, 2003, GLOBAL ECOL BIOGEOGR, V12, P427, DOI 10.1046/j.1466-822X.2003.00043.x; HOBSON KA, 1993, MAR ECOL PROG SER, V95, P7, DOI 10.3354/meps095007; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Jouventin P., 1991, Oxford Ornithology Series, P297; Kerr LA, 2007, MAR ECOL PROG SER, V349, P245, DOI 10.3354/meps07064; KLAASSEN M, 1990, ARDEA, V78, P67; Kloskowski J, 2009, AQUAT CONSERV, V19, P815, DOI 10.1002/aqc.1027; Longoni V, 2010, WATERBIRDS, V33, P83, DOI 10.1675/063.033.s106; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Masero JA, 2003, BIODIVERS CONSERV, V12, P1157, DOI 10.1023/A:1023021320448; MASSIAS A, 1990, ORNIS SCAND, V21, P187, DOI 10.2307/3676778; Moody AT, 2012, J ORNITHOL, V153, P1067, DOI 10.1007/s10336-012-0836-0; MURPHY EC, 1984, AUK, V101, P532, DOI 10.1093/auk/101.3.532; Navarro J, 2010, MAR BIOL, V157, P2453, DOI 10.1007/s00227-010-1509-2; Nehls G, 1996, ARDEA, V84, P23; Norris DR, 2007, J APPL ECOL, V44, P875, DOI 10.1111/j.1365-2664.2007.01329.x; Oro D, 2006, P ROY SOC B-BIOL SCI, V273, P379, DOI 10.1098/rspb.2005.3287; Oro D, 2002, WATERBIRDS, V25, P67, DOI 10.1675/1524-4695(2002)025[0067:BBAPDO]2.0.CO;2; Osborne PE, 2001, J APPL ECOL, V38, P458, DOI 10.1046/j.1365-2664.2001.00604.x; PARNELL A, 2008, STABLE ISOTOPE ANAL; Pedrocchi V, 1996, ORNIS FENNICA, V73, P124; Phillips RA, 1999, BIRD STUDY, V46, P174, DOI 10.1080/00063659909461129; PIEROTTI R, 1982, ECOLOGY, V63, P854, DOI 10.2307/1936804; PIEROTTI R, 1990, BIOSCIENCE, V40, P568, DOI 10.2307/1311297; Pinaud D, 2005, MAR ECOL PROG SER, V298, P295, DOI 10.3354/meps298295; Pons X, 1990, REMOTE SENS ENVIRON, V48, P191; Ramirez F, 2011, ENVIRON SCI TECHNOL, V45, P5118, DOI 10.1021/es200026w; Ramirez F, 2011, ESTUAR COAST SHELF S, V92, P217, DOI 10.1016/j.ecss.2010.12.035; Ramos R, 2011, DIVERS DISTRIB, V17, P338, DOI 10.1111/j.1472-4642.2010.00736.x; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; RUBEGA M, 1994, BIOL CONSERV, V70, P205, DOI 10.1016/0006-3207(94)90164-3; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P2069, DOI 10.1098/rspb.2006.3507; Santoro S, 2010, BIRD STUDY, V57, P515, DOI 10.1080/00063657.2010.501371; Sergio F, 2011, OECOLOGIA, V166, P79, DOI 10.1007/s00442-010-1795-x; Serrano L., 2006, LIMNETICA, V25, P11, DOI DOI 10.1016/S1001-6058(15)60453-X; Smedes F, 1999, ANALYST, V124, P1711, DOI 10.1039/a905904k; Stearns S.C., 1992, pi; Sutherland WJ, 1996, P ROY SOC B-BIOL SCI, V263, P1325, DOI 10.1098/rspb.1996.0194; SYDEMAN WJ, 1991, J ANIM ECOL, V60, P135, DOI 10.2307/5450; TAMHANE AC, 1979, J AM STAT ASSOC, V74, P471, DOI 10.2307/2286358; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Verkuil Y, 2003, ARDEA, V91, P71; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; WALMSLEY JG, 2000, SALTWORKS PRESERVING, P81; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wanless S, 1996, J APPL ECOL, V33, P1420, DOI 10.2307/2404781	58	23	25	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47551	10.1371/journal.pone.0047551	http://dx.doi.org/10.1371/journal.pone.0047551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094062	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200030
J	Leger, D; Beck, F; Richard, JB; Godeau, E				Leger, Damien; Beck, Francois; Richard, Jean-Baptiste; Godeau, Emmanuelle			Total Sleep Time Severely Drops during Adolescence	PLOS ONE			English	Article							CARDIOMETABOLIC RISK; DURATION; MEMORY; MARKERS; INFLAMMATION; METAANALYSIS; DEPRIVATION; PREVALENCE; CHILDHOOD; COGNITION	Restricted sleep duration among young adults and adolescents has been shown to increase the risk of morbidities such as obesity, diabetes or accidents. However there are few epidemiological studies on normal total sleep time (TST) in representative groups of teen-agers which allow to get normative data. Purpose: To explore perceived total sleep time on schooldays (TSTS) and non schooldays (TSTN) and the prevalence of sleep initiating insomnia among a nationally representative sample of teenagers. Methods: Data from 9,251 children aged 11 to 15 years-old, 50.7% of which were boys, as part of the cross-national study 2011 HBSC were analyzed. Self-completion questionnaires were administered in classrooms. An estimate of TSTS and TSTN (week-ends and vacations) was calculated based on specifically designed sleep habits report. Sleep deprivation was estimated by a TSTN - TSTS difference >2 hours. Sleep initiating nsomnia was assessed according to International classification of sleep disorders (ICSD 2). Children who reported sleeping 7 hours or less per night were considered as short sleepers. Results: A serious drop of TST was observed between 11 yo and 15 yo, both during the schooldays (9 hours 26 minutes vs. 7 h 55 min.; p < 0.001) and at a lesser extent during week-ends (10 h 17 min. vs. 9 h 44 min.; p < 0.001). Sleep deprivation concerned 16.0% of chidren aged of 11 yo vs. 40.5% of those of 15 yo (p < 0.001). Too short sleep was reported by 2.6% of the 11 yo vs. 24.6% of the 15 yo (p < 0.001). Conclusion: Despite the obvious need for sleep in adolescence, TST drastically decreases with age among children from 11 to 15 yo which creates significant sleep debt increasing with age.	[Leger, Damien] Univ Paris 05, Hotel Dieu, APHP, Ctr Sommeil & Vigilance, Paris, France; [Beck, Francois; Richard, Jean-Baptiste] Univ Paris 05, Cermes 3, CNRS UMR 821,Inserm EHESS U988, INPES,Direct Affaires Sci,Equipe Cesames,Ctr Rech, St Denis, France; [Godeau, Emmanuelle] Univ Toulouse 3, UMR INSERM Toulouse 3 1027, F-31062 Toulouse, France; [Godeau, Emmanuelle] Serv Med Rectorat, Toulouse, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Leger, D (corresponding author), Univ Paris 05, Hotel Dieu, APHP, Ctr Sommeil & Vigilance, Paris, France.	damien.leger@htd.aphp.fr		Beck, Francois/0000-0002-4880-1638; Richard, Jean-Baptiste/0000-0002-4193-9159	INPES (Institut National de Prevention et d'education pour la Sante) (French national Institute of prevention and health education); INSERM; WHO (Worl Health Organisation)	INPES (Institut National de Prevention et d'education pour la Sante) (French national Institute of prevention and health education); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); WHO (Worl Health Organisation)	This study was supported by INPES (Institut National de Prevention et d'education pour la Sante) (French national Institute of prevention and health education) and INSERM. Internationally, it was supported by the WHO (Worl Health Organisation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Balkin TJ, 2008, CHEST, V134, P653, DOI 10.1378/chest.08-1064; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Carskadon MA, 2011, PEDIATR CLIN N AM, V58, P637, DOI 10.1016/j.pcl.2011.03.003; Clemens Z, 2005, NEUROSCIENCE, V132, P529, DOI 10.1016/j.neuroscience.2005.01.011; Currie C, 2009, INT J PUBLIC HEALTH, V54, P131, DOI 10.1007/s00038-009-5404-x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Faraut B, 2011, BRAIN BEHAV IMMUN, V25, P16, DOI 10.1016/j.bbi.2010.08.001; Fitzgerald CT, 2011, J CLIN SLEEP MED, V7, P351, DOI 10.5664/JCSM.1188; Garaulet M, 2011, INT J OBESITY, V35, P1308, DOI 10.1038/ijo.2011.149; Gujar N, 2011, CEREB CORTEX, V21, P115, DOI 10.1093/cercor/bhq064; Harel-Fisch Y, 2011, J ADOLESCENCE, V34, P639, DOI 10.1016/j.adolescence.2010.09.008; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Huang YS, 2010, SLEEP MED, V11, P1035, DOI 10.1016/j.sleep.2010.04.009; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kim SJ, 2011, ARCH PEDIAT ADOL MED, V165, P806, DOI 10.1001/archpediatrics.2011.128; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Laberge L, 2011, J ADOLESCENT HEALTH, V48, P289, DOI 10.1016/j.jadohealth.2010.07.003; Leger D, 2011, SLEEP MED, V12, P454, DOI 10.1016/j.sleep.2010.12.012; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Martinez-Gomez D, 2011, SLEEP MED, V12, P997, DOI 10.1016/j.sleep.2011.05.009; Mindell JA, 2011, SLEEP MED, V12, P203, DOI 10.1016/j.sleep.2011.01.003; Mullington JM, 2010, BEST PRACT RES CL EN, V24, P775, DOI 10.1016/j.beem.2010.08.014; National Institutes of health, INF SLEEP; National Sleep Foundation, 2010, SLEEP TEENS BIOL BEH; National Sleep Foundation (NSF), 2006, SLEEP AM POLL NAT SU; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Owens JA, 2012, PEDIATRICS, V129, P987, DOI 10.1542/peds.2012-0755A; Philip P, 2006, SLEEP MED REV, V10, P347, DOI 10.1016/j.smrv.2006.04.002; Regestein Q, 2010, PSYCHIAT RES, V176, P34, DOI 10.1016/j.psychres.2008.11.006; Roberts C, 2009, INT J PUBLIC HEALTH, V54, P140, DOI 10.1007/s00038-009-5405-9; Roberts RE, 2011, BEHAV SLEEP MED, V9, P18, DOI 10.1080/15402002.2011.533991; Schreck KA, 2011, J SLEEP RES, V10, P1365; Seegers V, 2011, AM J EPIDEMIOL, V173, P621, DOI 10.1093/aje/kwq389; Short MA, 2011, SLEEP, V34, P797, DOI 10.5665/SLEEP.1052; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Thorleifsdottir B, 2002, J PSYCHOSOM RES, V53, P529, DOI 10.1016/S0022-3999(02)00444-0; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Touchette E, 2009, SLEEP MED REV, V13, P355, DOI 10.1016/j.smrv.2008.12.001; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Wells JCK, 2008, INT J OBESITY, V32, P1042, DOI 10.1038/ijo.2008.37; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; Wolson AR, 1998, CHILD DEV, V69, P875; World Health organisation, 2005, WHO TECHN M SLEEP HL	49	86	89	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e45204	10.1371/journal.pone.0045204	http://dx.doi.org/10.1371/journal.pone.0045204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082111	Green Published, gold			2022-12-27	WOS:000311146900006
J	Hayes, CN; Akamatsu, S; Tsuge, M; Miki, D; Akiyama, R; Abe, H; Ochi, H; Hiraga, N; Imamura, M; Takahashi, S; Aikata, H; Kawaoka, T; Kawakami, Y; Ohishi, W; Chayama, K				Hayes, C. Nelson; Akamatsu, Sakura; Tsuge, Masataka; Miki, Daiki; Akiyama, Rie; Abe, Hiromi; Ochi, Hidenori; Hiraga, Nobuhiko; Imamura, Michio; Takahashi, Shoichi; Aikata, Hiroshi; Kawaoka, Tomokazu; Kawakami, Yoshiiku; Ohishi, Waka; Chayama, Kazuaki			Hepatitis B Virus-Specific miRNAs and Argonaute2 Play a Role in the Viral Life Cycle	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; MICRORNA EXPRESSION; CORE PROTEIN; P-BODIES; RNA; REPLICATION; INFECTION; PHOSPHORYLATION; SUPPRESSION; PROGRESSION	Disease-specific serum miRNA profiles may serve as biomarkers and might reveal potential new avenues for therapy. An HBV-specific serum miRNA profile associated with HBV surface antigen (HBsAg) particles has recently been reported, and AGO2 and miRNAs have been shown to be stably associated with HBsAg in serum. We identified HBV-associated serum miRNAs using the Toray 3D array system in 10 healthy controls and 10 patients with chronic hepatitis B virus (HBV) infection. 19 selected miRNAs were then measured by quantitative RT-PCR in 248 chronic HBV patients and 22 healthy controls. MiRNA expression in serum versus liver tissue was also compared using biopsy samples. To examine the role of AGO2 during the HBV life cycle, we analyzed intracellular co-localization of AGO2 and HBV core (HBcAg) and surface (HBsAg) antigens using immunocytochemistry and proximity ligation assays in stably transfected HepG2 cells. The effect of AGO2 ablation on viral replication was assessed using siRNA. Several miRNAs, including miR-122, miR-22, and miR-99a, were up-regulated at least 1.5 fold (P<2E-08) in serum of HBV-infected patients. AGO2 and HBcAg were found to physically interact and co-localize in the ER and other subcellular compartments. HBs was also found to co-localize with AGO2 and was detected in multiple subcellular compartments. Conversely, HBx localized non-specifically in the nucleus and cytoplasm, and no interaction between AGO2 and HBx was detected. SiRNA ablation of AGO2 suppressed production of HBV DNA and HBs antigen in the supernatant. Conclusion: These results suggest that AGO2 and HBV-specific miRNAs might play a role in the HBV life cycle.	[Hayes, C. Nelson; Akamatsu, Sakura; Miki, Daiki; Akiyama, Rie; Abe, Hiromi; Ochi, Hidenori; Hiraga, Nobuhiko; Imamura, Michio; Takahashi, Shoichi; Aikata, Hiroshi; Kawaoka, Tomokazu; Kawakami, Yoshiiku; Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan; [Hayes, C. Nelson; Akamatsu, Sakura; Miki, Daiki; Akiyama, Rie; Abe, Hiromi; Ochi, Hidenori; Hiraga, Nobuhiko; Imamura, Michio; Takahashi, Shoichi; Kawaoka, Tomokazu; Kawakami, Yoshiiku; Chayama, Kazuaki] RIKEN, Ctr Genom Med, Lab Digest Dis, Hiroshima, Japan; [Hayes, C. Nelson; Akamatsu, Sakura; Tsuge, Masataka; Miki, Daiki; Akiyama, Rie; Ochi, Hidenori; Hiraga, Nobuhiko; Imamura, Michio; Aikata, Hiroshi; Kawaoka, Tomokazu; Kawakami, Yoshiiku; Ohishi, Waka; Chayama, Kazuaki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan; [Tsuge, Masataka] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan; [Ohishi, Waka] Radiat Effects Res Fdn, Dept Clin Studies, Hiroshima, Japan	Hiroshima University; RIKEN; Hiroshima University; Hiroshima University; Radiation Effects Research Foundation - Japan	Chayama, K (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan.	chayama@hiroshima-u.ac.jp	Hayes, C. Nelson N/G-4596-2019; Tsuge, Masataka/G-5246-2019; Miki, Daiki/L-5069-2018; Abe-Chayama, Hiromi/M-8256-2019; Chayama, Kazuaki/B-2493-2016	Tsuge, Masataka/0000-0001-7591-8287; Miki, Daiki/0000-0002-6505-9826; Chayama, Kazuaki/0000-0002-5530-5341	Ministry of Health, Labor and Welfare; Ministry of Education Culture Sports Science and Technology, Government of Japan; Grants-in-Aid for Scientific Research [24659368, 24791023] Funding Source: KAKEN	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education Culture Sports Science and Technology, Government of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for scientific research and development from the Ministry of Health, Labor and Welfare and Ministry of Education Culture Sports Science and Technology, Government of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Bouttier M, 2012, NUCLEIC ACIDS RES, V40, P775, DOI 10.1093/nar/gkr762; Brechot C, 2010, PATHOL BIOL, V58, P278, DOI 10.1016/j.patbio.2010.05.001; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Chen Y, 2008, PHARM RES-DORDR, V25, P72, DOI 10.1007/s11095-007-9504-0; Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Fields B. N., 2007, FIELDS VIROLOGY; Giner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000996; HEERMANN KH, 1984, J VIROL, V52, P396, DOI 10.1128/JVI.52.2.396-402.1984; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Hu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034165; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Jiang RQ, 2011, CLIN CANCER RES, V17, P5593, DOI 10.1158/1078-0432.CCR-10-1734; Johnston M, 2010, MOL BIOL CELL, V21, P1462, DOI 10.1091/mbc.E09-10-0885; Lan YT, 1999, VIROLOGY, V259, P342, DOI 10.1006/viro.1999.9798; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Liu AM, 2011, OMICS, V15, P187, DOI 10.1089/omi.2010.0098; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Narbus CM, 2011, J VIROL, V85, P12087, DOI 10.1128/JVI.05843-11; Novellino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031952; Pare JM, 2009, MOL BIOL CELL, V20, P3273, DOI 10.1091/mbc.E09-01-0082; Patient R, 2007, J VIROL, V81, P3842, DOI 10.1128/JVI.02741-06; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Qiu LP, 2010, BIOCHEM BIOPH RES CO, V398, P771, DOI 10.1016/j.bbrc.2010.07.021; Ren M, 2012, ANTIVIRAL RES; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Sir D, 2010, AUTOPHAGY, V6, P548, DOI 10.4161/auto.6.4.11669; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Tsuge M, 2005, HEPATOLOGY, V42, P1046, DOI 10.1002/hep.20892; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wang Y, 2006, GASTROENTEROLOGY, V130, P883, DOI 10.1053/j.gastro.2005.12.028; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Wilson JA, 2011, J VIROL, V85, P2342, DOI 10.1128/JVI.02046-10; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195	50	49	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47490	10.1371/journal.pone.0047490	http://dx.doi.org/10.1371/journal.pone.0047490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091627	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800050
J	Lind, G; Gallentoft, L; Danielsen, N; Schouenborg, J; Pettersson, LME				Lind, Gustav; Gallentoft, Lina; Danielsen, Nils; Schouenborg, Jens; Pettersson, Lina M. E.			Multiple Implants Do Not Aggravate the Tissue Reaction in Rat Brain	PLOS ONE			English	Article							SILICON MICROELECTRODE ARRAYS; FIBRILLARY ACIDIC PROTEIN; SPINAL-CORD-INJURY; SUBVENTRICULAR ZONE; NEURITE OUTGROWTH; NEURAL IMPLANTS; CEREBRAL-CORTEX; ASTROCYTES; EXPRESSION; CELLS	Chronically implanted microelectrodes are an invaluable tool for neuroscientific research, allowing long term recordings in awake and behaving animals. It is known that all such electrodes will evoke a tissue reaction affected by its' size, shape, surface structure, fixation mode and implantation method. However, the possible correlation between tissue reactions and the number of implanted electrodes is not clear. We implanted multiple wire bundles into the brain of rats and studied the correlation between the astrocytic and microglial reaction and the positioning of the electrode in relation to surrounding electrodes. We found that an electrode implanted in the middle of a row of implants is surrounded by a significantly smaller astrocytic scar than single ones. This possible interaction was only seen between implants within the same hemisphere, no interaction with the contralateral hemisphere was found. More importantly, we found no aggravation of tissue reactions as a result of a larger number of implants. These results highlight the possibility of implanting multiple electrodes without aggravating the glial scar surrounding each implant.	[Lind, Gustav; Gallentoft, Lina; Danielsen, Nils; Schouenborg, Jens; Pettersson, Lina M. E.] Lund Univ, Fac Med, Neuronano Res Ctr, Dept Expt Med Sci, Lund, Sweden	Lund University	Lind, G (corresponding author), Lund Univ, Fac Med, Neuronano Res Ctr, Dept Expt Med Sci, Lund, Sweden.	gustav.lind@med.lu.se		Gallentoft, Lina/0000-0003-2686-6446; Danielsen, Nils/0000-0002-4917-8294; Pettersson, Lina/0000-0002-6847-8823; Schouenborg, Jens/0000-0002-2815-6918	Knut and Alice Wallenberg foundation; Swedish Research Council [600012701]; Medical Faculty, Lund University	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty, Lund University	This work was funded by the Knut and Alice Wallenberg foundation and by a Linneaus grant #600012701 from the Swedish Research Council and the Medical Faculty, Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Andjelkovic AV, 1999, GLIA, V28, P225, DOI 10.1002/(SICI)1098-1136(199912)28:3<225::AID-GLIA6>3.0.CO;2-6; Awan NR, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0982; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Biran R, 2007, J BIOMED MATER RES A, V82A, P169, DOI 10.1002/jbm.a.31138; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; CAVANAGH JB, 1970, J ANAT, V106, P471; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; He W, 2005, BIOMATERIALS, V26, P2983, DOI 10.1016/j.biomaterials.2004.08.021; He W, 2006, J NEURAL ENG, V3, P316, DOI 10.1088/1741-2560/3/4/009; Johansson F, 2009, ACTA BIOMATER, V5, P2230, DOI 10.1016/j.actbio.2009.02.010; Kim S, 2009, BIOMED MICRODEVICES, V11, P453, DOI 10.1007/s10544-008-9251-y; Kipke DR, 2008, J NEUROSCI, V28, P11830, DOI 10.1523/JNEUROSCI.3879-08.2008; Komitova M, 2011, GLIA, V59, P800, DOI 10.1002/glia.21152; Kozai TDY, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046011; Krack P, 2002, MOVEMENT DISORD, V17, pS188, DOI 10.1002/mds.10163; LATOV N, 1979, DEV BIOL, V72, P381, DOI 10.1016/0012-1606(79)90127-1; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Lind G, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046005; Linsmeier CE, 2008, BIOMATERIALS, V29, P4598, DOI 10.1016/j.biomaterials.2008.08.028; Linsmeier CE, 2009, NANO LETT, V9, P4184, DOI 10.1021/nl902413x; Lu Y, 2009, BIOMATERIALS, V30, P4143, DOI 10.1016/j.biomaterials.2009.04.030; McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055005; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024; Skousen JL, 2011, PROG BRAIN RES, V194, P167, DOI 10.1016/B978-0-444-53815-4.00009-1; Stice P, 2007, J NEURAL ENG, V4, P42, DOI 10.1088/1741-2560/4/2/005; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Thelin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016267; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Williams JC, 1999, BRAIN RES PROTOC, V4, P303, DOI 10.1016/S1385-299X(99)00034-3; Williams JC, 2007, J NEURAL ENG, V4, P410, DOI 10.1088/1741-2560/4/4/007; Winslow BD, 2010, BIOMATERIALS, V31, P9163, DOI 10.1016/j.biomaterials.2010.05.050	42	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47509	10.1371/journal.pone.0047509	http://dx.doi.org/10.1371/journal.pone.0047509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091629	gold, Green Published, Green Submitted			2022-12-27	WOS:000310135800052
J	Liu, HL; Hallen, MA; Endow, SA				Liu, Hong-Lei; Hallen, Mark A.; Endow, Sharyn A.			Altered Nucleotide-Microtubule Coupling and Increased Mechanical Output by a Kinesin Mutant	PLOS ONE			English	Article							MEIOTIC SPINDLE; CRYSTAL-STRUCTURE; STRUCTURAL MODEL; MOTOR PROTEIN; NCD; BINDING; CONFORMATIONS; PURIFICATION; ACTIVATION; DYNAMICS	Kinesin motors hydrolyze ATP to produce force and do work in the cell - how the motors do this is not fully understood, but is thought to depend on the coupling of ATP hydrolysis to microtubule binding by the motor. Transmittal of conformational changes from the microtubule-to the nucleotide-binding site has been proposed to involve the central beta-sheet, which could undergo large structural changes important for force production. We show here that mutation of an invariant residue in loop L7 of the central beta-sheet of the Drosophila kinesin-14 Ncd motor alters both nucleotide and microtubule binding, although the mutated residue is not present in either site. Mutants show weak-ADP/tight-microtubule binding, instead of tight-ADP/weak-microtubule binding like wild type - they hydrolyze ATP faster than wild type, move faster in motility assays, and assemble long spindles with greatly elongated poles, which are also produced by simulations of assembly with tighter microtubule binding and faster sliding. The mutated residue acts like a mechanochemical coupling element - it transmits changes between the microtubule-binding and active sites, and can switch the state of the motor, increasing mechanical output by the motor. One possibility, based on our findings, is that movements by the residue and the loop that contains it could bend or distort the central beta-sheet, mediating free energy changes that lead to force production.	[Liu, Hong-Lei; Endow, Sharyn A.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Hallen, Mark A.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Hallen, Mark A.; Endow, Sharyn A.] Duke Univ, Med Ctr, Program Struct Biol & Biophys, Durham, NC USA	Duke University; Duke University; Duke University	Endow, SA (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	sharyn.endow@duke.edu		Endow, Sharyn A./0000-0002-0907-8889; Liu, Hong-Lei/0000-0003-3858-0373	National Institutes of Health [GM046225]; March of Dimes Birth Defects Foundation [1-FY07-443]; National Defense Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Birth Defects Foundation(March of Dimes); National Defense Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grant #GM046225 from the National Institutes of Health (http://www.nih.gov/) and grant #1-FY07-443 from the March of Dimes Birth Defects Foundation (http://www.marchofdimes.com/)to S. A. E., and a National Defense Science and Engineering Graduate Fellowship Award (http://ndseg.asee.org/) to M. A. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Crevel IMTC, 1996, J MOL BIOL, V257, P66, DOI 10.1006/jmbi.1996.0147; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Endow SA, 1997, J CELL BIOL, V137, P1321, DOI 10.1083/jcb.137.6.1321; Endow SA, 1996, J CELL SCI, V109, P2429; Grant BJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001207; Hallen MA, 2011, BIOPHYS CHEM, V154, P56, DOI 10.1016/j.bpc.2011.01.001; Hallen MA, 2009, BIOPHYS J, V97, P2191, DOI 10.1016/j.bpj.2009.08.008; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Heuston E, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-19; Higuchi H, 2004, EMBO J, V23, P2993, DOI 10.1038/sj.emboj.7600306; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; Howard J., 2001, MECH MOTOR PROTEINS; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; Liang ZY, 2009, CURR BIOL, V19, P163, DOI 10.1016/j.cub.2008.12.017; Liu HL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00236; Matthies HJG, 1996, J CELL BIOL, V134, P455, DOI 10.1083/jcb.134.2.455; MULLER H. J., 1932, Proceedings. 6th Int. Congr. Genet., V1, P213; Nitta R, 2008, NAT STRUCT MOL BIOL, V15, P1067, DOI 10.1038/nsmb.1487; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rasband W., 2006, IMAGEJ; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Skold HN, 2005, J CELL SCI, V118, P1745, DOI 10.1242/jcs.02304; Song H, 1997, BIOTECHNIQUES, V22, P82, DOI 10.2144/97221bm18; Song H, 1997, P NATL ACAD SCI USA, V94, P322, DOI 10.1073/pnas.94.1.322; Song HB, 1998, NATURE, V396, P587, DOI 10.1038/25153; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Wagenbach M, 2008, J CELL BIOL, V183, P617, DOI 10.1083/jcb.200805145; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; YAMAMOTO AH, 1989, EMBO J, V8, P3543, DOI 10.1002/j.1460-2075.1989.tb08526.x; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531; Zou JW, 2008, J CELL BIOL, V180, P459, DOI 10.1083/jcb.200711031	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47148	10.1371/journal.pone.0047148	http://dx.doi.org/10.1371/journal.pone.0047148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077560	gold, Green Submitted, Green Published			2022-12-27	WOS:000310135800028
J	Aoyagi, K; Ohara-Imaizumi, M; Nishiwaki, C; Nakamichi, Y; Ueki, K; Kadowaki, T; Nagamatsu, S				Aoyagi, Kyota; Ohara-Imaizumi, Mica; Nishiwaki, Chiyono; Nakamichi, Yoko; Ueki, Kohjiro; Kadowaki, Takashi; Nagamatsu, Shinya			Acute Inhibition of PI3K-PDK1-Akt Pathway Potentiates Insulin Secretion through Upregulation of Newcomer Granule Fusions in Pancreatic beta-Cells	PLOS ONE			English	Article							SMALL G-PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; MICE LACKING; KINASE; ACTIVATION; 1ST-PHASE; AKT; PHOSPHORYLATES; TRANSLOCATION	In glucose-induced insulin secretion from pancreatic beta-cells, a population of insulin granules fuses with the plasma membrane without the typical docking process (newcomer granule fusions), however, its mechanism is unclear. In this study, we investigated the PI3K signaling pathways involved in the upregulation of newcomer granule fusions. Acute treatment with the class IA-selective PI3K inhibitors, PIK-75 and PI-103, enhanced the glucose-induced insulin secretion. Total internal reflection fluorescent microscopy revealed that the PI3K inhibitors increased the fusion events from newcomer granules. We developed a new system for transfection into pancreatic islets and demonstrated the usefulness of this system in order for evaluating the effect of transfected genes on the glucose-induced secretion in primary cultured pancreatic islets. Using this transfection system together with a series of constitutive active mutants, we showed that the PI3K-3-phosphoinositide dependent kinase-1 (PDK1)-Akt pathway mediated the potentiation of insulin secretion. The Akt inhibitor also enhanced the glucose-induced insulin secretion in parallel with the upregulation of newcomer granule fusions, probably via increased motility of intracellular insulin granules. These data suggest that the PI3K-PDK1-Akt pathway plays a significant role in newcomer granule fusions, probably through an alteration of the dynamics of the intracellular insulin granules.	[Aoyagi, Kyota; Ohara-Imaizumi, Mica; Nishiwaki, Chiyono; Nakamichi, Yoko; Nagamatsu, Shinya] Kyorin Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Ueki, Kohjiro; Kadowaki, Takashi] Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Tokyo, Japan	Kyorin University; University of Tokyo	Nagamatsu, S (corresponding author), Kyorin Univ, Dept Biochem, Sch Med, Tokyo, Japan.	shinya@ks.kyorin-u.ac.jp			Japan Society for Promotion of Science [B-20390260, 23113724, 20570189]; Research Foundation for Opto-Science and Technology; Novo Nordisk Pharma; Kyorin University School of Medicine Collaboration Project	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Foundation for Opto-Science and Technology; Novo Nordisk Pharma(Novo Nordisk); Kyorin University School of Medicine Collaboration Project	This research was supported by grants from the Grants-in-Aid for Scientific Research (KAKENHI), Japan Society for Promotion of Science B-20390260, 23113724, 20570189), Research Foundation for Opto-Science and Technology, Novo Nordisk Pharma, and Kyorin University School of Medicine Collaboration Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Aoyagi K, 2010, BIOCHEM J, V432, P375, DOI 10.1042/BJ20100864; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Collier JJ, 2004, BIOCHEM BIOPH RES CO, V324, P1018, DOI 10.1016/j.bbrc.2004.09.149; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; Dominguez V, 2011, J BIOL CHEM, V286, P4216, DOI 10.1074/jbc.M110.200295; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; El-Kholy W, 2003, FASEB J, V17, P720, DOI 10.1096/fj.02-0802fje; Eto K, 2002, DIABETES, V51, P87, DOI 10.2337/diabetes.51.1.87; Galandrini R, 2005, BLOOD, V106, P577, DOI 10.1182/blood-2004-10-4100; HAGIWARA S, 1995, BIOCHEM BIOPH RES CO, V214, P51, DOI 10.1006/bbrc.1995.2255; Hashimoto M, 2002, J BIOL CHEM, V277, P32985, DOI 10.1074/jbc.M202803200; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Itakura M, 2005, J NEUROCHEM, V94, P502, DOI 10.1111/j.1471-4159.2005.03242.x; Kaneko K, 2010, CELL METAB, V12, P619, DOI 10.1016/j.cmet.2010.11.005; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Komuro R, 1996, GENES CELLS, V1, P943, DOI 10.1046/j.1365-2443.1996.760276.x; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; MacDonald PE, 2004, ENDOCRINOLOGY, V145, P4078, DOI 10.1210/en.2004-0028; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Nunoi K, 2000, BIOCHEM BIOPH RES CO, V270, P798, DOI 10.1006/bbrc.2000.2514; Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P41271, DOI 10.1074/jbc.C400360200; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Ohara-Imaizumi M, 2009, BIOCHEM BIOPH RES CO, V385, P291, DOI 10.1016/j.bbrc.2009.04.155; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Saito T, 2003, J BIOL CHEM, V278, P36718, DOI 10.1074/jbc.M305114200; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182; Yang F, 2001, NAT NEUROSCI, V4, P19, DOI 10.1038/82858; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06; Zawalich WS, 2000, ENDOCRINOLOGY, V141, P3287, DOI 10.1210/en.141.9.3287	51	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47381	10.1371/journal.pone.0047381	http://dx.doi.org/10.1371/journal.pone.0047381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077605	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100103
J	Singh, DK; Laremore, TN; Smith, PB; Maximova, SN; McNellis, TW				Singh, Dharmendra K.; Laremore, Tatiana N.; Smith, Philip B.; Maximova, Siela N.; McNellis, Timothy W.			Knockdown of FIBRILLIN4 Gene Expression in Apple Decreases Plastoglobule Plastoquinone Content	PLOS ONE			English	Article							LIPOCALIN PROTEIN FAMILY; PLASTID ULTRASTRUCTURE; LIPOPROTEIN PARTICLES; ARABIDOPSIS-THALIANA; QUINONE DISTRIBUTION; THYLAKOID MEMBRANES; MASS-SPECTROMETRY; PHOTOSYSTEM-II; CHLOROPLASTS; STRESS	Fibrillin4 (FBN4) is a protein component of plastoglobules, which are antioxidant-rich sub-compartments attached to the chloroplast thylakoid membranes. FBN4 is required for normal plant biotic and abiotic stress resistance, including bacterial pathogens, herbicide, high light intensity, and ozone; FBN4 is also required for the accumulation of osmiophilic material inside plastoglobules. In this study, the contribution of FBN4 to plastoglobule lipid composition was examined using cultivated apple trees in which FBN4 gene expression was knocked down using RNA interference. Chloroplasts and plastoglobules were isolated from leaves of wild-type and fbn4 knock-down trees. Total lipids were extracted from chloroplasts and plastoglobules separately, and analyzed using liquid chromatography-mass spectrometry (LC-MS). Three lipids were consistently present at lower levels in the plastoglobules from fbn4 knock-down apple leaves compared to the wild-type as determined by LC-MS multiple ion monitoring. One of these species had a molecular mass and fragmentation pattern that identified it as plastoquinone, a known major component of plastoglobules. The plastoquinone level in fbn4 knock-down plastoglobules was less than 10% of that in wild-type plastoglobules. In contrast, plastoquinone was present at similar levels in the lipid extracts of whole chloroplasts from leaves of wild-type and fbn4 knock-down trees. These results suggest that the partitioning of plastoquinone between the plastoglobules and the rest of the chloroplast is disrupted in fbn4 knock-down leaves. These results indicate that FBN4 is required for high-level accumulation of plastoquinone and some other lipids in the plastoglobule. The dramatic decrease in plastoquinone content in fbn4 knock-down plastoglobules is consistent with the decreased plastoglobule osmiophilicity previously described for fbn4 knock-down plastoglobules. Failure to accumulate the antioxidant plastoquinone in the fbn4 knock-down plastoglobules might contribute to the increased stress sensitivity of fbn4 knock-down trees.	[Singh, Dharmendra K.; McNellis, Timothy W.] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA; [Singh, Dharmendra K.] Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA; [Laremore, Tatiana N.; Smith, Philip B.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Maximova, Siela N.] Penn State Univ, Dept Hort, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	McNellis, TW (corresponding author), Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA.	twm4@psu.edu	; Singh, Dharmendra Kumar/I-4882-2014	Laremore, Tatiana/0000-0002-1036-8963; Singh, Dharmendra Kumar/0000-0002-6494-1710	United States National Science Foundation Plant Genome Research Program [DBI0420394]	United States National Science Foundation Plant Genome Research Program	This research was supported by a grant from the United States National Science Foundation Plant Genome Research Program (Award Number DBI0420394) to TWM, SNM, Robert M. Crassweller, and James W. Travis. Funder URL: www.nsf.gov. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Bailey JL, 1963, BIOCHIM BIOPHYS ACTA, V78, P163; BARR R, 1967, AM J BOT, V54, P365, DOI 10.2307/2440765; BISHOP NI, 1971, ANNU REV BIOCHEM, V40, P197, DOI 10.1146/annurev.bi.40.070171.001213; Blanksby SJ, 2010, ANNU REV ANAL CHEM, V3, P433, DOI 10.1146/annurev.anchem.111808.073705; Breemen RBV, 1998, J CHROMATOGR A, V794, P245; Brehelin C, 2007, TRENDS PLANT SCI, V12, P260, DOI 10.1016/j.tplants.2007.04.003; DERUERE J, 1994, PLANT CELL, V6, P119, DOI 10.1105/tpc.6.1.119; DURET S, 1986, ENVIRON RES, V39, P96, DOI 10.1016/S0013-9351(86)80011-1; Eymery F, 1999, PLANT PHYSIOL BIOCH, V37, P305, DOI 10.1016/S0981-9428(99)80029-1; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; GREENWOOD AD, 1963, BIOCHIM BIOPHYS ACTA, V78, P148, DOI 10.1016/0006-3002(63)91620-2; Havaux M, 2005, PLANT CELL, V17, P3451, DOI 10.1105/tpc.105.037036; Hiltbrunner A, 2001, J CELL BIOL, V154, P309, DOI 10.1083/jcb.200104022; Hundal T, 1995, ARCH BIOCHEM BIOPHYS, V324, P117, DOI 10.1006/abbi.1995.9920; Jones AME, 2006, PROTEOMICS, V6, P4155, DOI 10.1002/pmic.200500172; Kessler F, 2007, ADV BIOCHEM ENG BIOT, V107, P153, DOI 10.1007/10_2007_054; Kruk J, 1997, CHEM PHYS LIPIDS, V87, P73, DOI 10.1016/S0009-3084(97)00027-3; Kruk J, 2008, BBA-BIOENERGETICS, V1777, P154, DOI 10.1016/j.bbabio.2007.10.008; Lohmann A, 2006, J BIOL CHEM, V281, P40461, DOI 10.1074/jbc.M609412200; OKAMOTO T, 1985, J CHROMATOGR, V342, P35, DOI 10.1016/S0378-4347(00)84487-4; Panou-Filotheou H, 2001, ANN BOT-LONDON, V88, P207, DOI 10.1006/anbo.2001.1441; Pshibytko NL, 2003, RUSS J PLANT PHYSL+, V50, P44, DOI 10.1023/A:1021932317144; Rey P, 2000, PLANT J, V21, P483, DOI 10.1046/j.1365-313x.2000.00699.x; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Simkin AJ, 2007, PHYTOCHEMISTRY, V68, P1545, DOI 10.1016/j.phytochem.2007.03.014; Singh DK, 2011, TRENDS PLANT SCI, V16, P432, DOI 10.1016/j.tplants.2011.03.014; Singh DK, 2010, PLANT PHYSIOL, V154, P1281, DOI 10.1104/pp.110.164095; SOLL J, 1980, ARCH BIOCHEM BIOPHYS, V204, P544, DOI 10.1016/0003-9861(80)90066-1; STEINMULLER D, 1985, PLANTA, V163, P201, DOI 10.1007/BF00393507; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Teshima K, 2005, ANAL BIOCHEM, V338, P12, DOI 10.1016/j.ab.2004.12.007; TEVINI M, 1985, PLANTA, V163, P91, DOI 10.1007/BF00395902; VALENTINE RC, 1958, NATURE, V181, P832, DOI 10.1038/181832b0; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; WIGGLESWORTH VB, 1957, PROC R SOC SER B-BIO, V147, P185, DOI 10.1098/rspb.1957.0043; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083	39	21	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47547	10.1371/journal.pone.0047547	http://dx.doi.org/10.1371/journal.pone.0047547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077632	gold, Green Published, Green Submitted			2022-12-27	WOS:000309809500052
J	Wu, ZF; Sun, LH; Wang, HJ; Yao, JS; Jiang, CL; Xu, WH; Yang, ZX				Wu, Zhifeng; Sun, Lihua; Wang, Hongjun; Yao, Jianshe; Jiang, Chuanlu; Xu, Wenhui; Yang, Zhengxiang			MiR-328 Expression Is Decreased in High-Grade Gliomas and Is Associated with Worse Survival in Primary Glioblastoma	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; ADJUVANT TEMOZOLOMIDE; BREAST-CANCER; STEM-CELLS; MICRORNAS; RADIOTHERAPY; CONCOMITANT; TUMORS; ASTROCYTOMA; PROGRESSION	MicroRNAs, a group of small endogenous, noncoding RNAs, are aberrantly expressed in many human cancers and can act as oncogene or anti-oncogene. Recent evidence suggests that some miRNAs have prognostic value for tumors. MiR-328 is known as a tumor suppressor; however, its relationship with the clinicopathological features of glioblastoma (GBM) and its prognostic value has yet not been investigated. We found that expression of miR-328 was significantly decreased both in anaplastic and GBM cohorts and that low miR-328 expression also conferred poor survival in primary GBM (PGBM) patients. MiR-328 might, therefore, serve as an independent prognostic marker. Furthermore, expression profiles of miR-328-associated mRNAs were established via microarrays for 60 GBM samples. The ontology of the miR-328-associated genes was then analyzed, which identified gene sets tightly related to cell mitosis. In addition, ectopic expression of miR-328 inhibited U87 cell proliferation and induced U87 cell cycle arrest. In conclusion, this is the first report showing that miR-328 is associated with patient's survival time and that miR-328 might serve as an independent prognostic biomarker for GBM.	[Wu, Zhifeng; Sun, Lihua; Yao, Jianshe; Yang, Zhengxiang] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Neurosurg, Wuxi, Peoples R China; [Wang, Hongjun; Jiang, Chuanlu] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin, Peoples R China; [Xu, Wenhui] Jiangsu Univ, Affiliated Yixin Peoples Hosp, Dept Neurosurg, Yixin, Peoples R China	Nanjing Medical University; Harbin Medical University; Jiangsu University	Yang, ZX (corresponding author), Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Neurosurg, Wuxi, Peoples R China.	neuro_slh@126.com; wuxiyangz@126.com	wu, zhi/GXH-3041-2022		Jiangsu Province's Science Development Foundation [Z201012]	Jiangsu Province's Science Development Foundation	This work is supported by Jiangsu Province's Science Development Foundation (project number Z201012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Calligaris D, 2010, CELL MOL LIFE SCI, V67, P1089, DOI 10.1007/s00018-009-0245-6; Chen L, 2012, ACTA GASTRO-ENT BELG, V75, P22; Corsini LR, 2012, EXPERT OPIN THER TAR, V16, pS103, DOI 10.1517/14728222.2011.650632; Donson AM, 2007, PEDIATR BLOOD CANCER, V48, P403, DOI 10.1002/pbc.20803; Fridman E, 2010, J MOL DIAGN, V12, P687, DOI 10.2353/jmoldx.2010.090187; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x; Li WQ, 2010, MED SCI MONITOR, V16, pHY27; Liu XQ, 2007, BIOCHEM BIOPH RES CO, V353, P960, DOI 10.1016/j.bbrc.2006.12.142; Luo XJ, 2011, EUR J PHARMACOL, V670, P427, DOI 10.1016/j.ejphar.2011.08.026; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Niyazi M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-153; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Okumus NO, 2012, ANN SAUDI MED, V32, P250, DOI 10.5144/0256-4947.2012.250; Pichler M, 2012, BR J CANC; Schaefer A, 2010, NAT REV UROL, V7, P286, DOI 10.1038/nrurol.2010.45; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun LH, 2011, BRAIN RES, V1389, P9, DOI 10.1016/j.brainres.2011.03.013; Takahashi S, 2012, J NEURO-ONCOL, V106, P519, DOI 10.1007/s11060-011-0706-2; Tin AS, 2012, ANTI-CANCER DRUG, V23, P370, DOI 10.1097/CAD.0b013e32834f6ea8; Wang ZX, 2011, J SURG ONCOL, V104, P847, DOI 10.1002/jso.22008; Yan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030339; Zhang W, 2012, NEURO-ONCOLOGY, V14, P712, DOI 10.1093/neuonc/nos089; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003	33	45	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47270	10.1371/journal.pone.0047270	http://dx.doi.org/10.1371/journal.pone.0047270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077581	gold, Green Published, Green Submitted			2022-12-27	WOS:000309809500040
J	Ballenberger, N; Lluis, A; von Mutius, E; Illi, S; Schaub, B				Ballenberger, Nikolaus; Lluis, Anna; von Mutius, Erika; Illi, Sabina; Schaub, Bianca			Novel Statistical Approaches for Non-Normal Censored Immunological Data: Analysis of Cytokine and Gene Expression Data	PLOS ONE			English	Article								Background: For several immune-mediated diseases, immunological analysis will become more complex in the future with datasets in which cytokine and gene expression data play a major role. These data have certain characteristics that require sophisticated statistical analysis such as strategies for non-normal distribution and censoring. Additionally, complex and multiple immunological relationships need to be adjusted for potential confounding and interaction effects. Objective: We aimed to introduce and apply different methods for statistical analysis of non-normal censored cytokine and gene expression data. Furthermore, we assessed the performance and accuracy of a novel regression approach in order to allow adjusting for covariates and potential confounding. Methods: For non-normally distributed censored data traditional means such as the Kaplan-Meier method or the generalized Wilcoxon test are described. In order to adjust for covariates the novel approach named Tobit regression on ranks was introduced. Its performance and accuracy for analysis of non-normal censored cytokine/gene expression data was evaluated by a simulation study and a statistical experiment applying permutation and bootstrapping. Results: If adjustment for covariates is not necessary traditional statistical methods are adequate for non-normal censored data. Comparable with these and appropriate if additional adjustment is required, Tobit regression on ranks is a valid method. Its power, type-I error rate and accuracy were comparable to the classical Tobit regression. Conclusion: Non-normally distributed censored immunological data require appropriate statistical methods. Tobit regression on ranks meets these requirements and can be used for adjustment for covariates and potential confounding in large and complex immunological datasets.	[Ballenberger, Nikolaus; Lluis, Anna; von Mutius, Erika; Illi, Sabina; Schaub, Bianca] Ludwig Maximilians Univ Munchen, Dept Pulm & Allergy, Univ Childrens Hosp Munich, Munich, Germany	University of Munich	Schaub, B (corresponding author), Ludwig Maximilians Univ Munchen, Dept Pulm & Allergy, Univ Childrens Hosp Munich, Munich, Germany.	Bianca.Schaub@med.uni-muenchen.de	Schaub, Bianca/B-9935-2019	Schaub, Bianca/0000-0003-1652-8873; von Mutius, Erika/0000-0002-8893-4515	Comprehensive Pneumology Centre; German Research Association (Deutsche Forschungsgemeinschaft), DFG:Sonderforschungsbereich SBF [TR22, TPA22]	Comprehensive Pneumology Centre; German Research Association (Deutsche Forschungsgemeinschaft), DFG:Sonderforschungsbereich SBF(German Research Foundation (DFG))	Comprehensive Pneumology Centre (BS), German Research Association (Deutsche Forschungsgemeinschaft), DFG:Sonderforschungsbereich SBF TR22 (TPA22, BS, NB, AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARABMAZAR A, 1982, ECONOMETRICA, V50, P1055, DOI 10.2307/1912776; Austin PC, 2000, QUAL LIFE RES, V9, P901, DOI 10.1023/A:1008938326604; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Buckley TJ, 1997, ENVIRON INT, V23, P705, DOI 10.1016/S0160-4120(97)00071-8; CONOVER W. J, 1980, PRACTICAL NONPARAMET; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; COX DR, 1972, J R STAT SOC B, V34, P187; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Helsel D. R., 2005, NONDETECTS DATA ANAL; Hobbs KE, 2003, ENVIRON POLLUT, V121, P239, DOI 10.1016/S0269-7491(02)00218-X; IMAN RL, 1979, TECHNOMETRICS, V21, P499, DOI 10.2307/1268289; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KRUSKAL WH, 1953, J AM STAT ASSOC, V48, P907, DOI 10.2307/2281082; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; PRENTICE RL, 1978, BIOMETRIKA, V65, P167, DOI 10.1093/biomet/65.1.167; SAS Institute, 2009, SAS 9 2 WIND; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Uh HW, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-59; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	22	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e46423	10.1371/journal.pone.0046423	http://dx.doi.org/10.1371/journal.pone.0046423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110049	Green Published, Green Submitted, gold			2022-12-27	WOS:000310262500005
J	Sohni, A; Mulas, F; Ferrazzi, F; Luttun, A; Bellazzi, R; Huylebroeck, D; Ekker, SC; Verfaillie, CM				Sohni, Abhishek; Mulas, Francesca; Ferrazzi, Fulvia; Luttun, Aernout; Bellazzi, Riccardo; Huylebroeck, Danny; Ekker, Stephen C.; Verfaillie, Catherine M.			TGF beta 1-Induced Baf60c Regulates both Smooth Muscle Cell Commitment and Quiescence	PLOS ONE			English	Article							ADULT PROGENITOR CELLS; CHROMATIN-REMODELING COMPLEX; IN-VIVO; STEM-CELLS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CARG ELEMENTS; DIFFERENTIATION; PROMOTER; MICE	Smooth muscle cells (SMCs) play critical roles in a number of diseases; however, the molecular mechanism underlying their development is unclear. Although the role of TGF beta 1 signaling in SMC development is well established, the downstream molecular signals are not fully understood. We used several rat multipotent adult progenitor cell ((r)MAPC) lines that express levels of Oct4 mRNA similar to hypoblast stem cells (HypoSC), and can differentiate robustly to mesodermal and endodermal cell types. TGF beta 1 alone, or with PDGF-BB, induces differentiation of rMAPCs to SMCs, which expressed structural SMC proteins, including a-smooth muscle actin (alpha SMA), and contribute to the SMC coat of blood vessels in vivo. A genome-wide time-course transcriptome analysis revealed that transcripts of Baf60c, part of the SWI/SNF actin binding chromatin remodeling complex D-3 (SMARCD3/BAF60c), were significantly induced during MAPC-SMC differentiation. We demonstrated that BAF60c is a necessary co-regulator of TGF beta 1 mediated induction of SMC genes. Knock-down of Baf60c decreased SMC gene expression in rMAPCs whereas ectopic expression of Baf60c was sufficient to commit rMAPCs to SMCs in the absence of exogenous cytokines. TGF beta 1 activates Baf60c via the direct binding of SMAD2/3 complexes to the Baf60c promoter region. Chromatin-and co-immunoprecipitation studies demonstrated that regulation of SMC genes by BAF60c is mediated via interaction with SRF binding CArG box-containing promoter elements in SMC genes. We noted that compared with TGF beta 1, Baf60c overexpression in rMAPC yielded SMC with a more immature phenotype. Similarly, Baf60c induced an immature phenotype in rat aortic SMCs marked by increased cell proliferation and decreased contractile marker expression. Thus, Baf60c is important for TGF beta-mediated commitment of primitive stem cells (rMAPCs) to SMCs and is associated with induction of a proliferative state of quiescent SMCs. The MAPC-SMC differentiation system may be useful for identification of additional critical (co-) regulators of SMC development.	[Sohni, Abhishek; Verfaillie, Catherine M.] Katholieke Univ Leuven, Dept Dev & Regenerat, Stem Cell Inst, Louvain, Belgium; [Sohni, Abhishek; Ekker, Stephen C.; Verfaillie, Catherine M.] Univ Minnesota, Minneapolis, MN USA; [Mulas, Francesca; Bellazzi, Riccardo] Univ Pavia, Ctr Tissue Engn, I-27100 Pavia, Italy; [Ferrazzi, Fulvia; Bellazzi, Riccardo] Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy; [Luttun, Aernout] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Huylebroeck, Danny] Katholieke Univ Leuven, Lab Mol Biol Celgen, Dept Dev & Regenerat, Louvain, Belgium; [Ekker, Stephen C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	KU Leuven; University of Minnesota System; University of Minnesota Twin Cities; University of Pavia; University of Pavia; KU Leuven; KU Leuven; Mayo Clinic	Verfaillie, CM (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Stem Cell Inst, Louvain, Belgium.	Catherine.verfaillie@med.kuleuven.be	Bellazzi, Riccardo/J-6432-2018; Luttun, Aernout/AAZ-6540-2020; Ferrazzi, Fulvia/C-1161-2008; Verfaillie, Catherine/H-5148-2013	Bellazzi, Riccardo/0000-0002-6974-9808; Luttun, Aernout/0000-0001-7902-9524; Ferrazzi, Fulvia/0000-0003-4011-4638; Verfaillie, Catherine/0000-0001-7564-4079; Ekker, Stephen/0000-0003-0726-4212; Huylebroeck, Danny/0000-0003-4862-1079	European Union (STROKEMAP) [FP6-037186]; K.U.Leuven [EIW-B4855-EF/05/11, ETH-C1900-PF, EME-C2161-GOA/11/012]; Fondazione Cariplo grant; FIRB ITALBIONET grant by the Italian Ministry of Research	European Union (STROKEMAP)(European Commission); K.U.Leuven(KU Leuven); Fondazione Cariplo grant(Fondazione Cariplo); FIRB ITALBIONET grant by the Italian Ministry of Research	The work was supported in part by grants from the European Union (STROKEMAP, FP6-037186) to CMV and AL, grants from K.U.Leuven (EIW-B4855-EF/05/11, ETH-C1900-PF) to CMV and K.U.Leuven (EME-C2161-GOA/11/012) to CMV and DH. Fondazione Cariplo grant (2008-2006) "Bioinformatics for Tissue Engineering: Creation of an International Research Group" to RB and FM, and FIRB ITALBIONET grant by the Italian Ministry of Research to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranguren XL, 2007, BLOOD, V109, P2634, DOI 10.1182/blood-2006-06-030411; Bergwerff M, 1998, CIRC RES, V82, P221; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DeRuiter MC, 1997, CIRC RES, V80, P444, DOI 10.1161/01.RES.80.4.444; Di Camillo B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S10; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Drake CJ, 1998, ANN NY ACAD SCI, V857, P155, DOI 10.1111/j.1749-6632.1998.tb10115.x; Forcales SV, 2012, EMBO J, V31, P301, DOI 10.1038/emboj.2011.391; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; KEMP PR, 1995, BIOCHEM J, V310, P1037, DOI 10.1042/bj3101037; Kume T, 2000, DEVELOPMENT, V127, P1387; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lo Nigro A, 2012, J MOL CELL BIOL; Mack CP, 1999, CIRC RES, V84, P852; Manabe I, 2001, J CLIN INVEST, V107, P823, DOI 10.1172/JCI11385; Martin JG, 2000, EUR RESPIR J, V16, P349, DOI 10.1034/j.1399-3003.2000.16b25.x; Maschhoff KL, 2003, GENE, V320, P23, DOI 10.1016/j.gene.2003.07.002; Mericskay M, 2000, DEV BIOL, V226, P192, DOI 10.1006/dbio.2000.9865; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; MIN BH, 1990, J BIOL CHEM, V265, P16667; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Ochi H, 2008, J BIOL CHEM, V283, P3529, DOI 10.1074/jbc.M708594200; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Roobrouck VD, 2011, STEM CELLS, V29, P871, DOI 10.1002/stem.633; Ross JJ, 2006, J CLIN INVEST, V116, P3139, DOI 10.1172/JCI28184; ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207; ROSS R, 1984, AM J PATHOL, V114, P79; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Subramanian K, 2010, METHODS MOL BIOL, V636, P55, DOI 10.1007/978-1-60761-691-7_4; Takeuchi JK, 2007, P NATL ACAD SCI USA, V104, P846, DOI 10.1073/pnas.0608118104; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Ulloa-Montoya F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r163; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; Yang X, 1999, DEVELOPMENT, V126, P1571; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47629	10.1371/journal.pone.0047629	http://dx.doi.org/10.1371/journal.pone.0047629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110084	Green Published, gold, Green Submitted			2022-12-27	WOS:000310262500015
J	Caljon, G; De Ridder, K; Stijlemans, B; Coosemans, M; Magez, S; De Baetselier, P; Van den Abbeele, J				Caljon, Guy; De Ridder, Karin; Stijlemans, Benoit; Coosemans, Marc; Magez, Stefan; De Baetselier, Patrick; Van den Abbeele, Jan			Tsetse Salivary Gland Proteins 1 and 2 Are High Affinity Nucleic Acid Binding Proteins with Residual Nuclease Activity	PLOS ONE			English	Article							GLOSSINA-MORSITANS-MORSITANS; SERRATIA-MARCESCENS ENDONUCLEASE; NEUTROPHIL EXTRACELLULAR TRAPS; DUPLEX-SPECIFIC NUCLEASE; FLY SALIVA; PLATELET-AGGREGATION; ESCHERICHIA-COLI; IDENTIFICATION; MECHANISM; HEPATOPANCREAS	Analysis of the tsetse fly salivary gland EST database revealed the presence of a highly enriched cluster of putative endonuclease genes, including tsal1 and tsal2. Tsal proteins are the major components of tsetse fly (G. morsitans morsitans) saliva where they are present as monomers as well as high molecular weight complexes with other saliva proteins. We demonstrate that the recombinant tsetse salivary gland proteins 1&2 (Tsal1&2) display DNA/RNA non-specific, high affinity nucleic acid binding with K-D values in the low nanomolar range and a non-exclusive preference for duplex. These Tsal proteins exert only a residual nuclease activity with a preference for dsDNA in a broad pH range. Knockdown of Tsal expression by in vivo RNA interference in the tsetse fly revealed a partially impaired blood digestion phenotype as evidenced by higher gut nucleic acid, hematin and protein contents.	[Caljon, Guy; De Ridder, Karin; Van den Abbeele, Jan] Inst Trop Med Antwerp ITM, Unit Vet Protozool, Dept Biomed Sci, Antwerp, Belgium; [Caljon, Guy; Stijlemans, Benoit; Magez, Stefan; De Baetselier, Patrick] VUB, Unit Cellular & Mol Immunol, Brussels, Belgium; [Caljon, Guy; Stijlemans, Benoit; Magez, Stefan; De Baetselier, Patrick] VIB, Lab Myeloid Cell Immunol, Brussels, Belgium; [Coosemans, Marc] Inst Trop Med Antwerp ITM, Unit Med Entomol, Dept Biomed Sci, Antwerp, Belgium	Institute of Tropical Medicine (ITM); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Institute of Tropical Medicine (ITM)	Caljon, G (corresponding author), Inst Trop Med Antwerp ITM, Unit Vet Protozool, Dept Biomed Sci, Antwerp, Belgium.	gcaljon@itg.be; jvdabbeele@itg.be	Magez, Stefan/AAC-5682-2021; Magez, Stefan/D-9497-2014; De Baetselier, Patrick/D-3866-2014; Caljon, Guy/E-1310-2017; Stijlemans, Benoit/AAD-9122-2021	Magez, Stefan/0000-0003-3760-7968; Magez, Stefan/0000-0003-3760-7968; Caljon, Guy/0000-0002-4870-3202; Stijlemans, Benoit/0000-0003-0082-9751; Van Den Abbeele, Jan/0000-0002-4533-4480	InterUniversity Attraction Poles Programme [IAP] of the Belgian Science Policy; Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen; ERC starting grant "NANOSYM"; ITM; VUB; IWT PhD grant [IWT1149]	InterUniversity Attraction Poles Programme [IAP] of the Belgian Science Policy; Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen(FWO); ERC starting grant "NANOSYM"; ITM(Defence Research & Development Organisation (DRDO)); VUB; IWT PhD grant	This work was supported by the InterUniversity Attraction Poles Programme [IAP] of the Belgian Science Policy, the Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen, the ERC starting grant "NANOSYM", ITM and VUB institutional funding and an IWT PhD grant [IWT1149, Instituut voor de aanmoediging van innovatie door wetenschap en technologie in Vlaanderen]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-213; Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; Anisimova VE, 2008, GENE, V418, P41, DOI 10.1016/j.gene.2008.04.005; BALL TK, 1987, GENE, V57, P183, DOI 10.1016/0378-1119(87)90121-1; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BROWN RP, 1980, J ENTOMOL SOC S AFR, V43, P195; Caljon G, 2006, INFECT IMMUN, V74, P6324, DOI 10.1128/IAI.01046-06; Caljon G, 2006, INT J PARASITOL, V36, P1025, DOI 10.1016/j.ijpara.2006.05.002; Caljon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009671; Caljon G, 2009, INSECT BIOCHEM MOLEC, V39, P332, DOI 10.1016/j.ibmb.2009.01.010; Calvo E, 2006, J EXP BIOL, V209, P2651, DOI 10.1242/jeb.02267; Cappello M, 1996, AM J TROP MED HYG, V54, P475, DOI 10.4269/ajtmh.1996.54.475; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; ELLIS JA, 1986, VET PATHOL, V23, P661, DOI 10.1177/030098588602300603; FRIEDHOFF P, 1994, NUCLEIC ACIDS RES, V22, P3280, DOI 10.1093/nar/22.16.3280; Friedhoff P, 1996, NUCLEIC ACIDS RES, V24, P2632, DOI 10.1093/nar/24.14.2632; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Haddow JD, 2002, INSECT BIOCHEM MOLEC, V32, P1045, DOI 10.1016/S0965-1748(02)00042-5; KUNITZ M, 1950, J GEN PHYSIOL, V33, P349, DOI 10.1085/jgp.33.4.349; Li S, 2000, GENE, V252, P83, DOI 10.1016/S0378-1119(00)00226-2; Li S, 2001, INSECT MOL BIOL, V10, P69, DOI 10.1046/j.1365-2583.2001.00240.x; MANT MJ, 1981, BRIT J HAEMATOL, V48, P601, DOI 10.1111/j.1365-2141.1981.00601.x; MILLER MD, 1994, NAT STRUCT BIOL, V1, P461, DOI 10.1038/nsb0794-461; NESTLE M, 1969, J BIOL CHEM, V244, P5219; PEACOCK AJ, 1982, J INSECT PHYSIOL, V28, P553, DOI 10.1016/0022-1910(82)90036-1; Peeters E, 2004, MOL MICROBIOL, V54, P321, DOI 10.1111/j.1365-2958.2004.04274.x; Rangarajan ES, 2001, FEMS MICROBIOL REV, V25, P583, DOI 10.1111/j.1574-6976.2001.tb00593.x; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Shlyapnikov SV, 2000, ACTA CRYSTALLOGR D, V56, P567, DOI 10.1107/S090744490000322X; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Van Den Abbeele J, 2007, INSECT BIOCHEM MOLEC, V37, P1075, DOI 10.1016/j.ibmb.2007.06.006; Van Den Abbeele J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000926; Wang WY, 2000, BIOCHEM J, V346, P799, DOI 10.1042/0264-6021:3460799; WORRALL AF, 1990, J BIOL CHEM, V265, P21889	35	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47233	10.1371/journal.pone.0047233	http://dx.doi.org/10.1371/journal.pone.0047233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110062	Green Published, gold, Green Submitted			2022-12-27	WOS:000310193600010
J	Yoshida, H; Ashikawa, Y; Itoh, S; Nakagawa, T; Asanuma, A; Tanabe, S; Inoue, Y; Hidaka, H				Yoshida, Hideo; Ashikawa, Yuka; Itoh, Shinsuke; Nakagawa, Takashi; Asanuma, Akimune; Tanabe, Sohei; Inoue, Yoshihiro; Hidaka, Hiroyoshi			K-134, a Phosphodiesterase 3 Inhibitor, Prevents Brain Damage by Inhibiting Thrombus Formation in a Rat Cerebral Infarction Model	PLOS ONE			English	Article							PERIPHERAL ARTERY-DISEASE; THERAPY; STROKE; CLOPIDOGREL	Background: K-134 is a more potent antiplatelet drug with a selective inhibitory effect on phosphodiesterase 3 (PDE3) compared with its analogue, cilostazol. Objectives: This study was performed to compare the ameliorating effects of K-134 and cilostazol on brain damage in an experimental photothrombotic cerebral infarction model. Methods and Results: We investigated the effects of oral preadministration of PDE3 inhibitors in a rat stroke model established by photothrombotic middle cerebral artery (MCA) occlusion. K-134 significantly prolonged MCA occlusion time at doses >10 mg/kg, and reduced cerebral infarct size at 30 mg/kg in the stroke model (n = 12, 87.5 +/- 65.6 vs. 126.8 +/- 67.5 mm(3), P<0.01), indicating its potent antithrombotic effect. On the other hand, the effects of cilostazol on MCA occlusion time and cerebral infarct size are relatively weak even at the high dosage of 300 mg/kg. Furthermore, K-134 blocked rat platelet aggregation more potently than cilostazol in vitro. Also in an arteriovenous shunt thrombosis model, K-134 showed an antithrombotic effect greater than cilostazol. Conclusions: These findings suggest that K-134, which has strong antithrombotic activity, is a promising drug for prevention of cerebral infarction associated with platelet hyperaggregability.	[Yoshida, Hideo; Ashikawa, Yuka; Itoh, Shinsuke; Nakagawa, Takashi; Asanuma, Akimune; Tanabe, Sohei] Kowa Co Ltd, Tokyo New Drug Res Labs, Tokyo, Japan; [Inoue, Yoshihiro; Hidaka, Hiroyoshi] D Western Therapeut Inst Inc, Nagoya, Aichi, Japan	Kowa Company, Ltd.	Yoshida, H (corresponding author), Kowa Co Ltd, Tokyo New Drug Res Labs, Tokyo, Japan.	hiyosida@kowa.co.jp		Itoh, Shinsuke/0000-0001-9567-8188				Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; Bailey EL, 2011, INT J STROKE, V6, P434, DOI 10.1111/j.1747-4949.2011.00659.x; Bramer SL, 1999, CLIN PHARMACOKINET, V37, P1, DOI 10.2165/00003088-199937002-00001; Brass EP, 2012, J VASC SURG, V55, P381, DOI 10.1016/j.jvs.2011.09.004; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Honda F, 2006, STROKE, V37, P223, DOI 10.1161/01.STR.0000196977.76702.6d; Ito H, 2010, J CEREBR BLOOD F MET, V30, P343, DOI 10.1038/jcbfm.2009.220; Keravis T, 2012, BRIT J PHARMACOL, V165, P1288, DOI 10.1111/j.1476-5381.2011.01729.x; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; OKUDA Y, 1993, CARDIOVASC DRUG REV, V11, P451, DOI 10.1111/j.1527-3466.1993.tb00200.x; Sasaki Y, 2012, EUR J PHARMACOL, V689, P132, DOI 10.1016/j.ejphar.2012.05.014; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; Steg PG, 2011, J THROMB HAEMOST, V9, P325, DOI 10.1111/j.1538-7836.2011.04277.x; Sudo T, 2000, BIOCHEM PHARMACOL, V59, P347, DOI 10.1016/S0006-2952(99)00346-9; UMEMURA K, 1995, THROMB RES, V80, P209, DOI 10.1016/0049-3848(95)00169-R; UMEMURA K, 1995, JPN J PHARMACOL, V67, P253, DOI 10.1254/jjp.67.253; WATSON BD, 1987, J NEUROSURG, V66, P748, DOI 10.3171/jns.1987.66.5.0748; Yoshida H, 2012, ATHEROSCLEROSIS, V221, P84, DOI 10.1016/j.atherosclerosis.2011.12.044; Yoslhida H, 2011, THROMB HAEMOSTASIS, V105, P487, DOI 10.1160/TH10-07-0439	22	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e46432	10.1371/journal.pone.0046432	http://dx.doi.org/10.1371/journal.pone.0046432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110051	gold, Green Published, Green Submitted			2022-12-27	WOS:000310193600003
J	de Oliveira, VL; Keijsers, RRMC; van de Kerkhof, PCM; Seyger, MMB; Fasse, E; Svensson, L; Latta, M; Norsgaard, H; Labuda, T; Hupkens, P; van Erp, PEJ; Joosten, I; Koenen, HJPM				de Oliveira, Vivian L.; Keijsers, Romy R. M. C.; van de Kerkhof, Peter C. M.; Seyger, Marieke M. B.; Fasse, Esther; Svensson, Lars; Latta, Markus; Norsgaard, Hanne; Labuda, Tord; Hupkens, Pieter; van Erp, Piet E. J.; Joosten, Irma; Koenen, Hans J. P. M.			Humanized Mouse Model of Skin Inflammation Is Characterized by Disturbed Keratinocyte Differentiation and Influx of IL-17A Producing T Cells	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; ATOPIC-DERMATITIS; TH17 CELLS; IL-17-PRODUCING CELLS; PSORIATIC EPIDERMIS; IN-VIVO; DISEASE; EXPRESSION; MICE; COMBINATION	Humanized mouse models offer a challenging possibility to study human cell function in vivo. In the huPBL-SCID-huSkin allograft model human skin is transplanted onto immunodeficient mice and allowed to heal. Thereafter allogeneic human peripheral blood mononuclear cells are infused intra peritoneally to induce T cell mediated inflammation and microvessel destruction of the human skin. This model has great potential for in vivo study of human immune cells in (skin) inflammatory processes and for preclinical screening of systemically administered immunomodulating agents. Here we studied the inflammatory skin response of human keratinocytes and human T cells and the concomitant systemic human T cell response. As new findings in the inflamed human skin of the huPBL-SCID-huSkin model we here identified: 1. Parameters of dermal pathology that enable precise quantification of the local skin inflammatory response exemplified by acanthosis, increased expression of human beta-defensin-2, Elafin, K16, Ki67 and reduced expression of K10 by microscopy and immunohistochemistry. 2. Induction of human cytokines and chemokines using quantitative real-time PCR. 3. Influx of inflammation associated IL-17A-producing human CD4+ and CD8+ T cells as well as immunoregulatory CD4+ Foxp3+ cells using immunohistochemistry and -fluorescence, suggesting that active immune regulation is taking place locally in the inflamed skin. 4. Systemic responses that revealed activated and proliferating human CD4+ and CD8+ T cells that acquired homing marker expression of CD62L and CLA. Finally, we demonstrated the value of the newly identified parameters by showing significant changes upon systemic treatment with the T cell inhibitory agents cyclosporine-A and rapamycin. In summary, here we equipped the huPBL-SCID-huSkin humanized mouse model with relevant tools not only to quantify the inflammatory dermal response, but also to monitor the peripheral immune status. This combined approach will gain our understanding of the dermal immunopathology in humans and benefit the development of novel therapeutics for controlling inflammatory skin diseases.	[de Oliveira, Vivian L.; Keijsers, Romy R. M. C.; Fasse, Esther; Joosten, Irma; Koenen, Hans J. P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Med Immunol, NL-6525 ED Nijmegen, Netherlands; [Keijsers, Romy R. M. C.; van de Kerkhof, Peter C. M.; Seyger, Marieke M. B.; van Erp, Piet E. J.] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands; [Hupkens, Pieter] Radboud Univ Nijmegen, Med Ctr, Dept Plast Surg, NL-6525 ED Nijmegen, Netherlands; [Svensson, Lars; Latta, Markus] LEO Pharma, Dept Dis Pharmacol, Ballerup, Denmark; [Norsgaard, Hanne; Labuda, Tord] LEO Pharma, Dept Mol Biomed, Ballerup, Denmark	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; LEO Pharma; LEO Pharma	Koenen, HJPM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Med Immunol, NL-6525 ED Nijmegen, Netherlands.	h.koenen@labgk.umcn.nl	Fasse, Esther/K-3794-2016; de Oliveira, Vivian Leite/AAJ-9491-2020; Koenen, Hans J.P.M./A-2852-2014; van Erp, Piet/B-4061-2008; Hupkens, P./L-4400-2015; van de Kerkhof, P.C.M./H-8059-2014; Joosten, Irma/N-4418-2013; Seyger, M.M.B./L-4648-2015	de Oliveira, Vivian Leite/0000-0003-2523-0374; van Erp, Piet/0000-0002-6955-8817; Joosten, Irma/0000-0003-2950-4977; Norsgaard, Hanne/0000-0002-5249-6701	VanderEs Research Foundation; LEO Pharma A/S	VanderEs Research Foundation; LEO Pharma A/S	Part of this work was supported by a research grant from the VanderEs Research Foundation and other part was supported by a research grant from LEO Pharma A/S. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript. However, they have been involved in a few sample analyses and data discussions in addition to manuscript reviewing.	ALKEMADE JAC, 1994, J CELL SCI, V107, P2335; Clark RA, 2007, BLOOD, V109, P194, DOI 10.1182/blood-2006-02-002873; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; de Jongh GJ, 2005, J INVEST DERMATOL, V125, P1163, DOI 10.1111/j.0022-202X.2005.23935.x; Di Cesare A, 2008, J INVEST DERMATOL, V128, P2569, DOI 10.1038/jid.2008.283; Dudda JC, 2008, J EXP MED, V205, P1559, DOI 10.1084/jem.20072594; Feng G, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002099; Franssen MEJ, 2004, CYTOM PART B-CLIN CY, V57B, P32, DOI 10.1002/cyto.b.10069; Gallo RL, 1998, J INVEST DERMATOL, V111, P739, DOI 10.1046/j.1523-1747.1998.00361.x; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Aspizua SG, 2010, AM J PATHOL, V177, P3112, DOI 10.2353/ajpath.2010.100078; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Igney FH, 2004, TRENDS PHARMACOL SCI, V25, P543, DOI 10.1016/j.tips.2004.08.004; Issa F, 2010, TRANSPLANTATION, V90, P1321, DOI 10.1097/TP.0b013e3181ff8772; Kamsteeg M, 2010, BRIT J DERMATOL, V162, P568, DOI 10.1111/j.1365-2133.2009.09547.x; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Langewouters AMG, 2007, J DERMATOL TREAT, V18, P279, DOI 10.1080/09546630701395044; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu LZ, 2006, IMMUNITY, V25, P511, DOI 10.1016/j.immuni.2006.06.019; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; MOSIER DE, 1993, J EXP MED, V177, P191, DOI 10.1084/jem.177.1.191; MUELLER W, 1979, NEW ENGL J MED, V301, P555; MURRAY AG, 1994, P NATL ACAD SCI USA, V91, P9146, DOI 10.1073/pnas.91.19.9146; Murray AG, 1998, AM J PATHOL, V153, P627, DOI 10.1016/S0002-9440(10)65604-0; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nickoloff BJ, 1999, AM J PATHOL, V155, P145, DOI 10.1016/S0002-9440(10)65109-7; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; NONOMURA K, 1994, J INVEST DERMATOL, V103, P88, DOI 10.1111/1523-1747.ep12391802; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Paul C, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2011.03989.x; Peric M, 2008, J IMMUNOL, V181, P8504, DOI 10.4049/jimmunol.181.12.8504; Rohrl J, 2010, J BIOL CHEM, V285, P7028, DOI 10.1074/jbc.M109.091090; Sagoo P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002076; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SCHALKWIJK J, 1993, J INVEST DERMATOL, V100, P390, DOI 10.1111/1523-1747.ep12471990; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sigmundsdottir H, 2001, CLIN EXP IMMUNOL, V126, P365, DOI 10.1046/j.1365-2249.2001.01688.x; Takizawa Y, 1997, ARCH DERMATOL RES, V289, P213, DOI 10.1007/s004030050182; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Tomura M, 2010, J IMMUNOL, V184, P4646, DOI 10.4049/jimmunol.0903946; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; WroneSmith T, 1996, J CLIN INVEST, V98, P1878, DOI 10.1172/JCI118989; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	57	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e45509	10.1371/journal.pone.0045509	http://dx.doi.org/10.1371/journal.pone.0045509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094018	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200003
J	Dunham, CM; Chirichella, TJ				Dunham, C. Michael; Chirichella, Thomas J.			Trauma Activation Patients: Evidence for Routine Alcohol and Illicit Drug Screening	PLOS ONE			English	Article								Background: Statistics from the National Trauma Data Bank imply that discretionary blood alcohol and urine drug testing is common. However, there is little evidence to determine which patients are appropriate for routine testing, based on information available at trauma center arrival. In 2002, Langdorf reported alcohol and illicit drug rates in Trauma Activation Patients. Methodology/Principal Findings: This is a retrospective investigation of alcohol and illicit drug rates in consecutive St. Elizabeth Health Center (SEHC) trauma patients. SEHC Trauma Activation Patients are compared with the Langdorf Activation Patients and with the SEHC Trauma Nonactivation Patients. Minimum Rates are positive tests divided by total patients (tested and not tested). Activation patients: The minimum alcohol rates were: SEHC 23.1%, Langdorf 28.2%, combined 24.8%. The minimum illicit drug rates were: SEHC 15.7%, Langdorf 23.5, combined 18.3%. The minimum alcohol and/or illicit drug rates were: SEHC 33.4%, Langdorf 41.8%, combined 36.2%. Nonactivation patients: The SEHC minimum alcohol rate was 4.7% and the minimum illicit drug rate was 6.0%. Conclusions: Alcohol and illicit drug rates were significantly greater for Trauma Activation Patients, when compared to Nonactivation Patients. At minimum, Trauma Activation Patients are likely to have a 1-in-3 positive test for alcohol and/or an illicit drug. This substantial rate suggests that Trauma Activation Patients, a readily discernible group at trauma center arrival, are appropriate for routine alcohol and illicit drug testing. However, discretionary testing is more reasonable for Trauma Nonactivation Patients, because minimum rates are low.	[Dunham, C. Michael; Chirichella, Thomas J.] St Elizabeth Hlth Ctr, Trauma Crit Serv, Youngstown, OH USA		Dunham, CM (corresponding author), St Elizabeth Hlth Ctr, Trauma Crit Serv, Youngstown, OH USA.	dunham.michael@sbcglobal.net		Dunham, C. Michael/0000-0002-7842-9750				American College of Surgeons - Committee on Trauma, 2008, ADV TRAUM LIF SUPP D; Bast RP, 2000, SOUTH MED J, V93, P397; Blondell RD, 2005, J TRAUMA, V58, P561, DOI 10.1097/01.TA.0000152638.54978.53; Blondell RD, 2002, J STUD ALCOHOL, V63, P380, DOI 10.15288/jsa.2002.63.380; Buchfuhrer LA, 1996, J ADDICT DIS, V15, P65, DOI 10.1300/J069v15n01_05; Committee on Trauma American College of Surgeons, 2006, COMM TRAUM AM COLL S; Cowperthwaite Matthew C, 2011, J Trauma Manag Outcomes, V5, P3, DOI 10.1186/1752-2897-5-3; Langdorf M I, 2002, Eur J Emerg Med, V9, P115, DOI 10.1097/00063110-200206000-00003; London JA, 2007, ARCH SURG-CHICAGO, V142, P633, DOI 10.1001/archsurg.142.7.633; Madan AK, 1999, J TRAUMA, V47, P568, DOI 10.1097/00005373-199909000-00026; Soderstrom CA, 2001, J TRAUMA, V51, P557, DOI 10.1097/00005373-200109000-00024; Vitale S, 2006, DRUG ALCOHOL DEPEN, V82, P1, DOI 10.1016/j.drugalcdep.2005.08.017	12	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47999	10.1371/journal.pone.0047999	http://dx.doi.org/10.1371/journal.pone.0047999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094103	Green Submitted, gold, Green Published			2022-12-27	WOS:000310050200055
J	Zeng, XT; Tu, ML; Liu, DY; Zheng, D; Zhang, J; Leng, WD				Zeng, Xian-Tao; Tu, Ming-Li; Liu, Dong-Yan; Zheng, Dong; Zhang, Jing; Leng, WeiDong			Periodontal Disease and Risk of Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							GLOBAL BURDEN; ORAL-HEALTH; ASSOCIATION; DISABILITY; MORTALITY; OLDER; BIAS	Background: Many epidemiological studies have found a positive association between periodontal disease (PD) and risk of chronic obstructive pulmonary disease (COPD), but this association is varied and even contradictory among studies. We performed a meta-analysis to ascertain the relationship between PD and COPD. Methods: PubMed and Embase database were searched up to January 10, 2012, for relevant observational studies on the association between PD and risk of COPD. Data from the studies selected were extracted and analyzed independently by two authors. The meta-analysis was performed using the Comprehensive Meta-Analysis software. Results: Fourteen observational studies (one nested case-control, eight case-control, and five cross-sectional) involving 3,988 COPD patients were yielded. Based on random-effects meta-analysis, a significant association between PD and COPD was identified (odds ratio = 2.08, 95% confidence interval = 1.48-2.91; P<0.001), with sensitivity analysis showing that the result was robust. Subgroups analyses according to study design, ethnicity, assessment of PD/COPD, and adjusted/unadjusted odds ratios also revealed a significant association. Publication bias was detected. Conclusions: Based on current evidence, PD is a significant and independent risk factor of COPD. However, whether a causal relationships exists remains unclear. Morever, we suggest performing randomized controlled trails to explore whether periodontal interventions are beneficial in regulating COPD pathogenesis and progression.	[Zeng, Xian-Tao; Liu, Dong-Yan; Leng, WeiDong] Hubei Univ Medicne, Dept Stomatol, Taihe Hosp, Shiyan, Hubei Province, Peoples R China; [Tu, Ming-Li; Zhang, Jing] Hubei Univ Medicne, Dept Resp Med, Taihe Hosp, Shiyan, Hubei Province, Peoples R China; [Zheng, Dong; Leng, WeiDong] Hubei Univ Medicne, Sch Stomatol, Shiyan, Hubei Province, Peoples R China	Hubei University of Medicine; Hubei University of Medicine; Hubei University of Medicine	Leng, WD (corresponding author), Hubei Univ Medicne, Dept Stomatol, Taihe Hosp, Shiyan, Hubei Province, Peoples R China.	lengtaihe@163.com		Zeng, Xian-Tao/0000-0003-1262-725X	Hubei University of Medcine [2011 CZX01]	Hubei University of Medcine	This research was supported (in part) by the Intramural Research Program of the Hubei University of Medcine (2011 CZX01), without commercial, or not-for-profit sectors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Azarpazhooh A, 2006, J PERIODONTOL, V77, P1465, DOI 10.1902/jop.2006.060010; Blaizot A, 2009, INT DENT J, V59, P197, DOI 10.1922/IDJ_2114Sixou13; Corbridge S, 2012, AM J NURS, V112, P46, DOI 10.1097/01.NAJ.0000412639.08764.21; Coulthwaite L, 2007, BRIT J BIOMED SCI, V64, P180, DOI 10.1080/09674845.2007.11732784; CROXSON LJ, 1984, INT DENT J, V34, P28; Cullinan MP, 2009, AUST DENT J, V54, pS62, DOI 10.1111/j.1834-7819.2009.01144.x; Deo Vikas, 2009, Indian J Dent Res, V20, P466, DOI 10.4103/0970-9290.59456; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fatemi K, 2009, J MASH DENT SCH, V33, P214; Garcia R I, 2001, Ann Periodontol, V6, P71, DOI 10.1902/annals.2001.6.1.71; Gomes-Filho Isaac S, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5811; Hayes C, 1998, Ann Periodontol, V3, P257, DOI 10.1902/annals.1998.3.1.257; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hill K, 2010, CAN MED ASSOC J, V182, P673, DOI 10.1503/cmaj.091784; Hyman JJ, 2004, J PERIODONTOL, V75, P9, DOI 10.1902/jop.2004.75.1.9; Katancik JA, 2005, J PERIODONTOL, V76, P2161, DOI 10.1902/jop.2005.76.11-S.2161; Kowalski Marcin, 2005, Pol Merkur Lekarski, V19, P537; Leuckfeld I, 2008, RESP MED, V102, P488, DOI 10.1016/j.rmed.2007.12.001; Liu ZQ, 2012, J CLIN PERIODONTOL, V39, P45, DOI 10.1111/j.1600-051X.2011.01808.x; MCKUSICK KA, 1974, SCAND J RESPIR DIS, P51; Megson E, 2010, INT J EVID-BASED HEA, V8, P129, DOI 10.1111/j.1744-1609.2010.00171.x; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mojon Philippe, 2002, J Can Dent Assoc, V68, P340; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Pierce CA, 2008, ORGAN RES METHODS, V11, P188, DOI 10.1177/1094428106296641; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Prasanna Surya J, 2011, J Indian Soc Periodontol, V15, P359, DOI 10.4103/0972-124X.92570; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Russell S L, 1999, Spec Care Dentist, V19, P128, DOI 10.1111/j.1754-4505.1999.tb01413.x; Scannapieco F A, 1998, Ann Periodontol, V3, P251, DOI 10.1902/annals.1998.3.1.251; Scannapieco FA, 1999, J PERIODONTOL, V70, P793, DOI 10.1902/jop.1999.70.7.793; Scannapieco FA, 2001, J PERIODONTOL, V72, P50, DOI 10.1902/jop.2001.72.1.50; Scannapieco Frank A, 2003, Ann Periodontol, V8, P54, DOI 10.1902/annals.2003.8.1.54; Sharma N, 2011, J PERIODONTOL, V82, P1155, DOI 10.1902/jop.2011.100582; Si Y, 2012, J PERIODONTOL; Terpenning M S, 2001, Ann Periodontol, V6, P66, DOI 10.1902/annals.2001.6.1.66; Terpenning MS, 2001, J AM GERIATR SOC, V49, P557, DOI 10.1046/j.1532-5415.2001.49113.x; Wang ZM, 2009, J CLIN PERIODONTOL, V36, P750, DOI 10.1111/j.1600-051X.2009.01448.x; Xiong X, 2007, OBSTET GYNECOL SURV, V62, P605, DOI 10.1097/01.ogx.0000279292.63435.40; Zhou X, 2012, J CLIN PERIODONTOL, V39, P350, DOI 10.1111/j.1600-051X.2012.01852.x	45	84	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e46508	10.1371/journal.pone.0046508	http://dx.doi.org/10.1371/journal.pone.0046508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094025	gold, Green Published, Green Submitted			2022-12-27	WOS:000310050200009
J	Sartorius, T; Staiger, H; Ketterer, C; Heni, M; Machicao, F; Guilherme, A; Grallert, H; Schulze, MB; Boeing, H; Stefan, N; Fritsche, A; Czech, MP; Haring, HU				Sartorius, Tina; Staiger, Harald; Ketterer, Caroline; Heni, Martin; Machicao, Fausto; Guilherme, Adilson; Grallert, Harald; Schulze, Matthias B.; Boeing, Heiner; Stefan, Norbert; Fritsche, Andreas; Czech, Michael P.; Haering, Hans-Ulrich			Association of Common Genetic Variants in the MAP4K4 Locus with Prediabetic Traits in Humans	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE INFLAMMATION; INSULIN-RESISTANCE; C-JUN; RISK; GLUCOSE; MECHANISMS	Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) is expressed in all diabetes-relevant tissues and mediates cytokine-induced insulin resistance. We investigated whether common single nucleotide polymorphisms (SNPs) in the MAP4K4 locus associate with glucose intolerance, insulin resistance, impaired insulin release, or elevated plasma cytokines. The best hit was tested for association with type 2 diabetes. Subjects (N = 1,769) were recruited from the Tubingen Family (TUF) study for type 2 diabetes and genotyped for tagging SNPs. In a subgroup, cytokines were measured. Association with type 2 diabetes was tested in a prospective case-cohort study (N = 2,971) derived from the EPIC-Potsdam study. Three SNPs (rs6543087, rs17801985, rs1003376) revealed nominal and two SNPs (rs11674694, rs11678405) significant associations with 2-hour glucose levels. SNPs rs6543087 and rs11674694 were also nominally associated with decreased insulin sensitivity. Another two SNPs (rs2236936, rs2236935) showed associations with reduced insulin release, driven by effects in lean subjects only. Three SNPs (rs11674694, rs13003883, rs2236936) revealed nominal associations with IL-6 levels. SNP rs11674694 was significantly associated with type 2 diabetes. In conclusion, common variation in MAP4K4 is associated with insulin resistance and beta-cell dysfunction, possibly via this gene's role in inflammatory signalling. This variation's impact on insulin sensitivity may be more important since its effect on insulin release vanishes with increasing BMI.	[Sartorius, Tina; Staiger, Harald; Machicao, Fausto; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany; [Sartorius, Tina; Staiger, Harald; Ketterer, Caroline; Machicao, Fausto; Grallert, Harald; Schulze, Matthias B.; Boeing, Heiner; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich] German Ctr Diabet Res DZD, Neuherberg, Germany; [Sartorius, Tina; Staiger, Harald; Ketterer, Caroline; Heni, Martin; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany; [Guilherme, Adilson; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Res Unit Mol Epidemiol, Inst Epidemiol, Neuherberg, Germany; [Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Fritsche, Andreas] Univ Tubingen, Dept Internal Med, Div Nutr & Prevent Med, D-7400 Tubingen, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Haring, HU (corresponding author), Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014; Schulze, Matthias B/AAH-6906-2021; Grallert, Harald/B-3424-2013	Schulze, Matthias B/0000-0002-0830-5277; Heni, Martin/0000-0002-8462-3832; Staiger, Harald/0000-0002-9507-5333; Stefan, Norbert/0000-0002-2186-9595	German Federal Ministry of Education and Research (BMBF) [01 GI 0925]; BMBF [01 EA 9401]; European Union [SOC 95201408 05F02, SOC 98200769 05F02]; German Cancer Aid [70-2488-Ha I]; German Research Foundation (DFG) [STE 1096/3-1]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); German Cancer Aid(Deutsche Krebshilfe); German Research Foundation (DFG)(German Research Foundation (DFG))	The present study was supported in part by a grant (01 GI 0925) from the German Federal Ministry of Education and Research (BMBF) to the German Centre for Diabetes Research (DZD e.V.). The recruitment phase of the EPIC-Potsdam study was supported by the BMBF (01 EA 9401) and the European Union (SOC 95201408 05F02). The follow-up of the EPIC-Potsdam study was supported by German Cancer Aid (70-2488-Ha I) and the European Union (SOC 98200769 05F02). N.S. is currently supported by a Heisenberg professorship from the German Research Foundation (DFG, STE 1096/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Bouzakri K, 2011, DIABETES, V60, P1111, DOI 10.2337/db10-1178; Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058; Haupt A, 2009, J CLIN ENDOCR METAB, V94, P1775, DOI 10.1210/jc.2008-1876; Herzberg-Schafer SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014194; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jin WZ, 2009, CLIN SCI, V116, P99, DOI 10.1042/CS20080090; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Kroder G, 1996, J CLIN INVEST, V97, P1471, DOI 10.1172/JCI118569; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Perry JRB, 2008, CURR OPIN CLIN NUTR, V11, P371, DOI 10.1097/MCO.0b013e32830349a1; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118	27	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47647	10.1371/journal.pone.0047647	http://dx.doi.org/10.1371/journal.pone.0047647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094072	Green Published, Green Submitted, gold			2022-12-27	WOS:000312384500016
J	De Saedeleer, CJ; Copetti, T; Porporato, PE; Verrax, J; Feron, O; Sonveaux, P				De Saedeleer, Christophe J.; Copetti, Tamara; Porporato, Paolo E.; Verrax, Julien; Feron, Olivier; Sonveaux, Pierre			Lactate Activates HIF-1 in Oxidative but Not in Warburg-Phenotype Human Tumor Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE; TRANSPORTER MCT4; LACTIC-ACID; TCA CYCLE; HYPOXIA; METABOLISM; INHIBITION; ANGIOGENESIS; HIF-1-ALPHA	Cancer can be envisioned as a metabolic disease driven by pressure selection and intercellular cooperativeness. Together with anaerobic glycolysis, the Warburg effect, formally corresponding to uncoupling glycolysis from oxidative phosphorylation, directly participates in cancer aggressiveness, supporting both tumor progression and dissemination. The transcription factor hypoxia-inducible factor-1 (HIF-1) is a key contributor to glycolysis. It stimulates the expression of glycolytic transporters and enzymes supporting high rate of glycolysis. In this study, we addressed the reverse possibility of a metabolic control of HIF-1 in tumor cells. We report that lactate, the end-product of glycolysis, inhibits prolylhydroxylase 2 activity and activates HIF-1 in normoxic oxidative tumor cells but not in Warburg-phenotype tumor cells which also expressed lower basal levels of HIF-1 alpha. These data were confirmed using genotypically matched oxidative and mitochondria-depleted glycolytic tumor cells as well as several different wild-type human tumor cell lines of either metabolic phenotype. Lactate activates HIF-1 and triggers tumor angiogenesis and tumor growth in vivo, an activity that we found to be under the specific upstream control of the lactate transporter monocarboxylate transporter 1 (MCT1) expressed in tumor cells. Because MCT1 also gates lactate-fueled tumor cell respiration and mediates pro-angiogenic lactate signaling in endothelial cells, MCT1 inhibition is confirmed as an attractive anticancer strategy in which a single drug may target multiple tumor-promoting pathways.	[De Saedeleer, Christophe J.; Copetti, Tamara; Porporato, Paolo E.; Verrax, Julien; Feron, Olivier; Sonveaux, Pierre] UCL, IREC, Brussels, Belgium	Universite Catholique Louvain	Sonveaux, P (corresponding author), UCL, IREC, Brussels, Belgium.	pierre.sonveaux@uclouvain.be	Porporato, Paolo E./A-9932-2018; FERON, Olivier/AAM-6395-2020	Porporato, Paolo E./0000-0001-8519-1552; FERON, Olivier/0000-0001-5360-0286; Sonveaux, Pierre/0000-0001-6484-8834	European Research Council [243188 TUMETABO]; Fonds National de la Recherche Scientifique (F.R.S.-FNRS); Fonds de la Recherche Scientifique Medicale (FRSM), an Action de Recherche Concertee from the Communaute Francaise de Belgique [ARC 09/14-020]; NEOANGIO research program from the Region Wallonne de Belgique; Fondation Belge contre le Cancer [200-2008]; Fonds Speciaux de la Recherche (FSR) of the Universite catholique de Louvain (UCL); J. Maisin Foundation; St. Luc Foundation	European Research Council(European Research Council (ERC)European Commission); Fonds National de la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique Medicale (FRSM), an Action de Recherche Concertee from the Communaute Francaise de Belgique(Fonds de la Recherche Scientifique - FNRS); NEOANGIO research program from the Region Wallonne de Belgique; Fondation Belge contre le Cancer; Fonds Speciaux de la Recherche (FSR) of the Universite catholique de Louvain (UCL); J. Maisin Foundation; St. Luc Foundation	This work was supported by grants from the European Research Council (FP7/2007-2013 European Research Council Independent Researcher Starting Grant No. 243188 TUMETABO to P. Sonveaux), the Fonds National de la Recherche Scientifique (F.R.S.-FNRS), the Fonds de la Recherche Scientifique Medicale (FRSM), an Action de Recherche Concertee from the Communaute Francaise de Belgique (ARC 09/14-020 to O. Feron. and P. Sonveaux), the NEOANGIO research program from the Region Wallonne de Belgique (to O. Feron), the Fondation Belge contre le Cancer (200-2008 to O. Feron and P. Sonveaux), the Fonds Speciaux de la Recherche (FSR) of the Universite catholique de Louvain (UCL), and the J. Maisin and St. Luc Foundations (to O. Feron). O. Feron is an Honorary Research Director, P. Sonveaux is a Research Associate, and J. Verrax is a Postdoctoral Researcher of the F.R.S.-FNRS. C. J. De Saedeleer is a Televie Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bouzin C, 2007, J IMMUNOL, V178, P1505, DOI 10.4049/jimmunol.178.3.1505; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dhup S, 2012, CURR PHARM DESIGN, V18, P1319, DOI 10.2174/138161212799504902; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Finch NA, 2009, PROTEIN J, V28, P362, DOI 10.1007/s10930-009-9202-3; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hewitson KS, 2007, J BIOL CHEM, V282, P3293, DOI 10.1074/jbc.M608337200; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Martinez-Outschoorn UE, 2011, INT J BIOCHEM CELL B, V43, P1045, DOI 10.1016/j.biocel.2011.01.023; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Moon EJ, 2010, P NATL ACAD SCI USA, V107, P20477, DOI 10.1073/pnas.1006646107; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; Pollard PJ, 2003, ANN MED, V35, P632, DOI 10.1080/07853890310018458; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; RIDEOUT D, 1994, INT J CANCER, V57, P247, DOI 10.1002/ijc.2910570220; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Sonveaux P, 2003, CANCER RES, V63, P1012; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; STRAGAND JJ, 1981, CANCER RES, V41, P3364; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Walenta S, 2004, CURR MED CHEM, V11, P2195, DOI 10.2174/0929867043364711; Walenta S, 2001, INT J RADIAT ONCOL, V51, P840, DOI 10.1016/S0360-3016(01)01700-X; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P1772, DOI 10.4161/cc.10.11.15659; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; WU R, 1959, J BIOL CHEM, V234, P1036	58	156	159	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46571	10.1371/journal.pone.0046571	http://dx.doi.org/10.1371/journal.pone.0046571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082126	Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900021
J	Garcia, PJ; Carcamo, CP; Garnett, GP; Campos, PE; Holmes, KK				Garcia, Patricia J.; Carcamo, Cesar P.; Garnett, Geoff P.; Campos, Pablo E.; Holmes, King K.			Improved STD Syndrome Management by a Network of Clinicians and Pharmacy Workers in Peru: The PREVEN Network	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; RANDOMIZED CONTROLLED-TRIAL; PRIVATE PHARMACIES; MULTICOMPONENT INTERVENTION; ANTIBIOTICS; NEPAL; COMMUNITY; KNOWLEDGE; DRUGGISTS; THAILAND	Background: Sexually Transmitted diseases (STD) syndrome management has been one cornerstone of STD treatment. Persons with STD symptoms in many countries, especially those with limited resources, often initially seek care in pharmacies. The objective of the study was to develop and evaluate an integrated network of physicians, midwives and pharmacy workers trained in STD syndromic management (The PREVEN Network) as part of a national urban community-randomized trial of sexually transmitted infection prevention in Peru. Methods and Findings: After a comprehensive census of physicians, midwives, and pharmacies in ten intervention and ten control cities, we introduced seminars and workshops for pharmacy workers, and continuing education for physicians and midwives in intervention cities and invited graduates to join the PREVEN Network. "Prevention Salespersons'' visited pharmacies, boticas and clinicians regularly for educational support and collection of information on numbers of cases of STD syndromes seen at pharmacies and by clinicians in intervention cities. Simulated patients evaluated outcomes of training of pharmacy workers with respect to adequate STD syndrome management, recommendations for condom use and for treatment of partners. In intervention cities we trained, certified, and incorporated into the PREVEN Network the workers at 623 (80.6%) of 773 pharmacies and 701 (69.6%) of 1007 physicians and midwives in private practice. Extremely high clinician and pharmacy worker turnover, 13.4% and 44% respectively in the first year, dictated continued training of new pharmacy workers and clinicians. By the end of the intervention the Network included 792 pharmacies and 597 clinicians. Pharmacies reported more cases of STDs than did clinicians. Evaluations by simulated patients showed significant and substantial improvements in the management of STD syndromes at pharmacies in intervention cities but not in control cities. Conclusions: Training pharmacy workers linked to a referral network of clinicians proved feasible and acceptable. High turnover was challenging but over come.	[Garcia, Patricia J.; Carcamo, Cesar P.; Campos, Pablo E.] Univ Peruana Cayetano Heredia, Sch Publ Hlth, STI AIDS Unit, Lima, Peru; [Garnett, Geoff P.] Univ London Imperial Coll Sci Technol & Med, London, England; [Holmes, King K.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Garcia, Patricia J.; Carcamo, Cesar P.; Holmes, King K.] Univ Washington, Dept Med, Seattle, WA USA; [Holmes, King K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Holmes, King K.] Univ Washington, Ctr AIDS & STD, Seattle, WA 98195 USA	Universidad Peruana Cayetano Heredia; Imperial College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Garcia, PJ (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth, STI AIDS Unit, Lima, Peru.	patricia.garcia@upch.pe	Garnett, Geoffrey P/A-9312-2008; , Holmes/K-6215-2019		Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative [059131/Z/99/Z, 078835/Z/05/Z, 078835/Z/05/B]; National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID) STD Cooperative Research Center NIAID [AI31448]; National Institutes of Health (NIH) Fogarty International Center Global Health Framework (A Global Health Demonstration Program in Peru) [PAR-05-050]; NIH Center for AIDS Research [P30-AI27757]; NIH Andean CIPRA [U19 AI053218]; USAID-Peru; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031448, U01AI031448, U19AI053218, P30AI027757] Funding Source: NIH RePORTER	Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative(Burroughs Wellcome FundWellcome Trust); National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID) STD Cooperative Research Center NIAID; National Institutes of Health (NIH) Fogarty International Center Global Health Framework (A Global Health Demonstration Program in Peru); NIH Center for AIDS Research; NIH Andean CIPRA; USAID-Peru(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative 059131/Z/99/Z, 078835/Z/05/Z, and 078835/Z/05/B; the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID) STD Cooperative Research Center NIAID AI31448, the National Institutes of Health (NIH) Fogarty International Center Global Health Framework (A Global Health Demonstration Program in Peru PAR-05-050), the NIH Center for AIDS Research P30-AI27757 and the NIH Andean CIPRA U19 AI053218; and USAID-Peru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavestrello L, 2002, REV MED CHILE, V130, P1265; Bestane W J, 1980, AMB Rev Assoc Med Bras, V26, P2; Bista KP, 2002, SEX TRANSM INFECT, V78, P223, DOI 10.1136/sti.78.3.223; Canchihuaman FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019318; Chalker J, 2005, SOC SCI MED, V60, P131, DOI 10.1016/j.socscimed.2004.04.019; Chalker J, 2002, TROP MED INT HEALTH, V7, P803, DOI 10.1046/j.1365-3156.2002.00934.x; Chalker J, 2000, SEX TRANSM INFECT, V76, P299, DOI 10.1136/sti.76.4.299; Cooper RJ, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-57; Cordova A, 1993, P 9 INT C AIDS 6 11, P840; FERRITER ME, 1991, J AUTOM CHEM, V13, P123, DOI 10.1155/S146392469100024X; Garcia P, 2003, B WORLD HEALTH ORGAN, V81, P806; Garcia PJ, 2007, SEX TRANSM INFECT, V83, P142, DOI 10.1136/sti.2006.022657; Garcia PJ, 1998, SEX TRANSM INFECT, V74, pS153; Garcia PJ, 2012, LANCET; Grigoryan L, 2008, J ANTIMICROB CHEMOTH, V61, P1172, DOI 10.1093/jac/dkn054; Hsieh Evelyn J., 2006, Rev Panam Salud Publica, V20, P223, DOI 10.1590/S1020-49892006000900002; Hsieh EJ, 2008, REV PANAM SALUD PUBL, V24, P271, DOI 10.1590/S1020-49892008001000007; Khan MMH, 2006, INT J QUAL HEALTH C, V18, P66, DOI 10.1093/intqhc/mzi086; Kwena Z A, 2008, East Afr Med J, V85, P419; Lopez R, 1990, MORBILIDAD MEDICAMEN; Mainous AG, 2009, ANN FAM MED, V7, P431, DOI 10.1370/afm.999; Mayta-Tristan P, 2008, LANCET, V371, P1577, DOI 10.1016/S0140-6736(08)60685-6; Organizacion Internacional para las Migraciones Instituto Nacional de Estadistica e Informatica & Direccion General de Migraciones y Naturalizacion, 2008, PER EST MIGR INT PER; Prempree P, 2007, SEX HEALTH, V4, P17, DOI 10.1071/SH06035; Reeves D, 2007, J ANTIMICROB CHEMOTH, V59, P333, DOI 10.1093/jac/dkl502; Rollnick S, 1995, BEHAV COGN PSYCHOTH, V23, P325, DOI DOI 10.1017/S135246580001643X; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Stergachis A, 1999, SEX TRANSM DIS, V26, pS44, DOI 10.1097/00007435-199904001-00010; STIGMA, 2019, GUID MAN SEX TRANSM; Tuladhar SM, 1998, AIDS, V12, pS81; Turner AN, 2003, SEX TRANSM INFECT, V79, P224, DOI 10.1136/sti.79.3.224; VANDERGEEST S, 1987, SOC SCI MED, V25, P293, DOI 10.1016/0277-9536(87)90232-2; Ward K, 2003, SEX TRANSM DIS, V30, P609, DOI 10.1097/01.OLQ.0000079521.04451.10	33	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47750	10.1371/journal.pone.0047750	http://dx.doi.org/10.1371/journal.pone.0047750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082208	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900105
J	Hawkes, C; Webster, J				Hawkes, Corinna; Webster, Jacqui			National Approaches to Monitoring Population Salt Intake: A Trade-Off between Accuracy and Practicality?	PLOS ONE			English	Article							URINARY SODIUM-EXCRETION; HYPERTENSION; REDUCTION; SAMPLE	Aims: There is strong evidence that diets high in salt are bad for health and that salt reduction strategies are cost effective. However, whilst it is clear that most people are eating too much salt, obtaining an accurate assessment of population salt intake is not straightforward, particularly in resource poor settings. The objective of this study is to identify what approaches governments are taking to monitoring salt intake, with the ultimate goal of identifying what actions are needed to address challenges to monitoring salt intake, especially in low and middle-income countries. Methods and Results: A written survey was issued to governments to establish the details of their monitoring methods. Of the 30 countries that reported conducting formal government salt monitoring activities, 73% were high income countries. Less than half of the 30 countries, used the most accurate assessment of salt through 24 hour urine, and only two of these were developing countries. The remainder mainly relied on estimates through dietary surveys. Conclusions: The study identified a strong need to establish more practical ways of assessing salt intake as well as technical support and advice to ensure that low and middle income countries can implement salt monitoring activities effectively.	[Hawkes, Corinna] World Canc Res Fund Int, London, England; [Webster, Jacqui] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia	George Institute for Global Health; University of Sydney	Hawkes, C (corresponding author), World Canc Res Fund Int, London, England.	c.hawkes@wcrf.org		Webster, Jacqui/0000-0003-3513-3340	Health Canada; National Health and Medical Council Partnership Project; World Health Organisation	Health Canada; National Health and Medical Council Partnership Project; World Health Organisation(World Health Organization)	Corinna Hawkes received funding from Health Canada to conduct the survey reported in this study. Jacqui Webster was supported in her research on salt reduction throughout the period of this study by a National Health and Medical Council Partnership Project. She also received funding from the World Health Organisation to facilitate the development of salt reduction strategies in Pacific Islands and Mongolia and was commissioned by Health Canada to draft a Framework for Monitoring and Evaluation of Salt Reduction Strategies for WHO Member States. The funders were a member of a group that advised on the study. They therefore provided comments on the study design. They also participated by responding to the questionnaire. They played no role in data collection other than responding to the questionnaire. They played a role in the analysis by providing comments on drafts of the report. As recipients of the questionnaire, they also provided comments on the final manuscript (as did all recipients). The funders also provided the authors with permission to publish the manuscript in an academic journal.	Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; BIBBINSDOMINGO K, 2010, NEW ENGL J MED; Boorman J., 2008, SALT INTAKE PROCESSE; Cappuccio FP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4995; Charlton KE, 2007, POLICY BRIEF; Choudhury S, 2010, CIRCULATION, V122, pE352; EU Platform on Diet Physical Activity and Health, 2009, NAT SALT IN IMPL EU; Ferrante D, 2011, REV PANAM SALUD PUBL, V29, P69, DOI 10.1590/S1020-49892011000200001; Harrington J, 2008, PSYCHOL REPORTS, V6; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; Luft FC RL, 1979, HYPERTENSION, P261; Mann SJ, 2010, AM J HYPERTENS, V23, P743, DOI 10.1038/ajh.2010.57; Margerison C., 2006, ASIA PAC J CLIN NUTR, V15, pS37; Mohan S, 2009, CAN MED ASSOC J, V181, P605, DOI 10.1503/cmaj.090361; National Centre for Social Research/Medical Research Council, 2008, ASS DIET SOD LEV AD; National Institute for Food and Nutrition Science, 2010, IMPL HUNG SALT RED P; New Zealand Ministry of Health, 2011, FOC NUTR KEY FIND 20; Organization WH, 2016, GLOBAL STATUS REPORT; Ortega RM, 2011, BRIT J NUTR, V105, P787, DOI 10.1017/S000711451000423X; Penney S., 2009, DROPPING SALT PRACTI; Powles J, 2003, GAC SANIT S2, V17, P163; Radhika G, 2007, J Assoc Physicians India, V55, P405; Reinivuo H, 2006, EUR J CLIN NUTR, V60, P1160, DOI 10.1038/sj.ejcn.1602431; Ribic CH, 2010, PUBLIC HEALTH NUTR, V13, P1803, DOI 10.1017/S136898001000025X; Sarno F, 2009, REV SAUDE PUBL, V43, P219, DOI 10.1590/S0034-89102009005000002; Singapore Ministry of Health, 1998, SING NAT NUTR SURV; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; Van den Hooven C, 2007, 24 UURS URINE EXCRET; Webster J, 2011, J HYPERTENSION; WHO/PAHO Regional Expert Group for Cardiovascular Disease Prevention through Population-wide Dietary Salt Reduction (Sub-group for research and surveillance), 2010, PROT POP LEV SOD DET; Windhauser MM, 1999, J AM DIET ASSOC, V99, pS76, DOI 10.1016/S0002-8223(99)00420-4; World Action on Salt & Health, 2011, WASH INTR; World Bank, 2012, COUNTR CLASS INC; World Health Organisation and the Government of Canada, 2011, P TECHN M JOIN UNPUB	37	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46727	10.1371/journal.pone.0046727	http://dx.doi.org/10.1371/journal.pone.0046727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082128	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000311146900023
J	Lai, LM; Zhao, XC; Jiang, LH; Wang, YJ; Luo, LG; Zheng, YR; Chen, X; Rimmington, GM				Lai, Liming; Zhao, Xuechun; Jiang, Lianhe; Wang, Yongji; Luo, Liangguo; Zheng, Yuanrun; Chen, Xi; Rimmington, Glyn M.			Soil Respiration in Different Agricultural and Natural Ecosystems in an Arid Region	PLOS ONE			English	Article							WATER-CONTENT; TEMPERATURE SENSITIVITY; MICROBIAL BIOMASS; CARBON-DIOXIDE; FOREST SOIL; CO2 EFFLUX; LAND-USE; VEGETATION; SALINITY; DEPENDENCE	The variation of different ecosystems on the terrestrial carbon balance is predicted to be large. We investigated a typical arid region with widespread saline/alkaline soils, and evaluated soil respiration of different agricultural and natural ecosystems. Soil respiration for five ecosystems together with soil temperature, soil moisture, soil pH, soil electric conductivity and soil organic carbon content were investigated in the field. Comparing with the natural ecosystems, the mean seasonal soil respiration rates of the agricultural ecosystems were 96%-386% higher and agricultural ecosystems exhibited lower CO2 absorption by the saline/alkaline soil. Soil temperature and moisture together explained 48%, 86%, 84%, 54% and 54% of the seasonal variations of soil respiration in the five ecosystems, respectively. There was a significant negative relationship between soil respiration and soil electrical conductivity, but a weak correlation between soil respiration and soil pH or soil organic carbon content. Our results showed that soil CO2 emissions were significantly different among different agricultural and natural ecosystems, although we caution that this was an observational, not manipulative, study. Temperature at the soil surface and electric conductivity were the main driving factors of soil respiration across the five ecosystems. Care should be taken when converting native vegetation into cropland from the point of view of greenhouse gas emissions.	[Lai, Liming; Zhao, Xuechun; Jiang, Lianhe; Wang, Yongji; Zheng, Yuanrun] Chinese Acad Sci, Key Lab Resource Plants, Beijing Bot Garden, W China Subalpine Bot Garden,Inst Bot, Beijing, Peoples R China; [Zhao, Xuechun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Luo, Liangguo] Chinese Acad Agr Sci, Key Lab Agr Environm, Inst Environm & Sustainable Dev Agr, Minist Agr, Beijing 100193, Peoples R China; [Chen, Xi] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Xinjiang, Peoples R China; [Rimmington, Glyn M.] Wichita State Univ, Global Learning Coll Engn, Wichita, KS USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Wichita State University	Zheng, YR (corresponding author), Chinese Acad Sci, Key Lab Resource Plants, Beijing Bot Garden, W China Subalpine Bot Garden,Inst Bot, Beijing, Peoples R China.	zhengyr@ibcas.ac.cn	liming, lai/HGB-0743-2022		China National Key Basic Research Program [2009CB825103]	China National Key Basic Research Program(National Basic Research Program of China)	This work was supported by China National Key Basic Research Program (2009CB825103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsberry L, 2000, ECOL APPL, V10, P1110, DOI 10.1890/1051-0761(2000)010[1110:CIATEO]2.0.CO;2; Bao S D, 1999, METHODS AGROCHEMICAL, P25; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P1756, DOI 10.1111/j.1365-2486.2004.00816.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Borken W, 2002, GLOBAL CHANGE BIOL, V8, P1205, DOI 10.1046/j.1365-2486.2002.00547.x; Bowden RD, 1998, SOIL BIOL BIOCHEM, V30, P1591, DOI 10.1016/S0038-0717(97)00228-9; Brooks PD, 2005, GLOBAL CHANGE BIOL, V11, P231, DOI 10.1111/j.1365-2486.2004.00877.x; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Eswaran H, 2000, GLOBAL CLIMATE CHANGE AND PEDOGENIC CARBONATES, P15; HOUGHTON RA, 1995, GLOB CHANGE BIOL, V1, P275, DOI 10.1111/j.1365-2486.1995.tb00026.x; Jia B, 2006, J ARID ENVIRON, V67, P60, DOI 10.1016/j.jaridenv.2006.02.002; Lal R, 2004, ENVIRON MANAGE, V33, P528, DOI 10.1007/s00267-003-9110-9; Lavigne MB, 2004, TREE PHYSIOL, V24, P415, DOI 10.1093/treephys/24.4.415; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Litton CM, 2008, GLOBAL CHANGE BIOL, V14, P726, DOI 10.1111/j.1365-2486.2008.01546.x; Liu XZ, 2002, PLANT SOIL, V240, P213, DOI 10.1023/A:1015744126533; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo Y., 2006, SOIL RESP ENV, P107; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Mo W, 2005, AGR FOREST METEOROL, V134, P81, DOI 10.1016/j.agrformet.2005.08.015; Nelson PN, 1996, SOIL BIOL BIOCHEM, V28, P433, DOI 10.1016/0038-0717(96)00002-8; Parsons AN, 2004, ECOSYSTEMS, V7, P286, DOI 10.1007/s10021-003-0132-1; Pavelka M, 2007, PLANT SOIL, V292, P171, DOI 10.1007/s11104-007-9213-9; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rao DLN, 1996, ARID SOIL RES REHAB, V10, P311, DOI 10.1080/15324989609381446; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Sardinha M, 2003, APPL SOIL ECOL, V23, P237, DOI 10.1016/S0929-1393(03)00027-1; Saviozzi A, 2001, PLANT SOIL, V233, P251, DOI 10.1023/A:1010526209076; Sayer EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001299; Sotta ED, 2004, GLOBAL CHANGE BIOL, V10, P601, DOI 10.1111/j.1529-8817.2003.00761.x; SPSS, 2000, SPSS WIND VERS 13 0; Thornley JHM, 2001, ANN BOT-LONDON, V87, P591, DOI 10.1006/anbo.2001.1372; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; Vincent G, 2006, SOIL BIOL BIOCHEM, V38, P2527, DOI 10.1016/j.soilbio.2006.03.009; Wagai R, 1998, SOIL BIOL BIOCHEM, V30, P1501, DOI 10.1016/S0038-0717(98)00041-8; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; WEBER MG, 1990, FOREST ECOL MANAG, V31, P1, DOI 10.1016/0378-1127(90)90107-M; Wong VNL, 2008, BIOL FERT SOILS, V44, P943, DOI 10.1007/s00374-008-0279-1; Xie JX, 2009, ENVIRON GEOL, V56, P953, DOI 10.1007/s00254-008-1197-0; Zhang LH, 2010, J ARID ENVIRON, V74, P1200, DOI 10.1016/j.jaridenv.2010.05.031; Zheng Y, 2006, J ARID ENVIRON, V66, P113, DOI 10.1016/j.jaridenv.2005.09.005	46	49	54	10	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e48011	10.1371/journal.pone.0048011	http://dx.doi.org/10.1371/journal.pone.0048011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082234	Green Published, gold			2022-12-27	WOS:000311146900131
J	Lai, MC; Lombardo, MV; Ruigrok, ANV; Chakrabarti, B; Wheelwright, SJ; Auyeung, B; Allison, C; Baron-Cohen, S				Lai, Meng-Chuan; Lombardo, Michael V.; Ruigrok, Amber N. V.; Chakrabarti, Bhismadev; Wheelwright, Sally J.; Auyeung, Bonnie; Allison, Carrie; Baron-Cohen, Simon		MRC AIMS Consortium	Cognition in Males and Females with Autism: Similarities and Differences	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; FUSIFORM FACE AREA; SPECTRUM DISORDERS; SEX-DIFFERENCES; ASPERGER-SYNDROME; EXECUTIVE DYSFUNCTION; INFANTILE-AUTISM; DIAGNOSTIC INTERVIEW; FACIAL EXPRESSION; CHILDHOOD AUTISM	The male bias in autism spectrum conditions (ASC) has led to females with ASC being under-researched. This lack of attention to females could hide variability due to sex that may explain some of the heterogeneity within ASC. In this study we investigate four key cognitive domains (mentalizing and emotion perception, executive function, perceptual attention to detail, and motor function) in ASC, to test for similarities and differences between males and females with and without ASC (n = 128 adults; n = 32 per group). In the mentalizing and facial emotion perception domain, males and females with ASC showed similar deficits compared to neurotypical controls. However, in attention to detail and dexterity involving executive function, although males with ASC showed poorer performance relative to neurotypical males, females with ASC performed comparably to neurotypical females. We conclude that performance in the social-cognitive domain is equally impaired in male and female adults with ASC. However, in specific non-social cognitive domains, performance within ASC depends on sex. This suggests that in specific domains, cognitive profiles in ASC are modulated by sex.	[Lai, Meng-Chuan; Lombardo, Michael V.; Ruigrok, Amber N. V.; Chakrabarti, Bhismadev; Wheelwright, Sally J.; Auyeung, Bonnie; Allison, Carrie; Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Chakrabarti, Bhismadev] Univ Reading, Ctr Integrat Neurosci & Neurodynam, Sch Psychol & Clin Language Sci, Reading, Berks, England	University of Cambridge; University of Reading	Lai, MC (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England.	mcl45@cam.ac.uk	Lombardo, Michael V/J-1773-2012; Bailey, Anthony/J-2860-2014; Ecker, Christine/E-5194-2010; Murphy, Clodagh M/F-1464-2010; Lai, Meng-Chuan/K-7407-2016; Catani, Marco/H-7801-2012	Lombardo, Michael V/0000-0001-6780-8619; Bailey, Anthony/0000-0003-4257-972X; Ecker, Christine/0000-0002-1003-5931; Murphy, Clodagh M/0000-0002-6350-0155; Lai, Meng-Chuan/0000-0002-9593-5508; Bullmore, Edward/0000-0002-8955-8283; Chakrabarti, Bhismadev/0000-0002-6649-7895; Murphy, Declan/0000-0002-6664-7451; Baron-Cohen, Simon/0000-0001-9217-2544; Craig, Michael/0000-0002-5311-8673; Wheelwright, Sally/0000-0003-0657-2483; Ruigrok, Amber/0000-0001-7711-8056; opoku, anita/0000-0001-7243-8157; Happe, Francesca/0000-0001-9226-4000; Jones, Derek K/0000-0003-4409-8049; Henty, Julian/0000-0001-8694-451X; Catani, Marco/0000-0002-5488-6463; Daly, Eileen/0000-0003-3625-3467; Jezzard, Peter/0000-0001-7912-2251	United Kingdom Medical Research Council [GO 400061]; Waterloo Foundation [921/1247]; Wellcome Trust; British Academy; MRC [G0600977, G0400061] Funding Source: UKRI; Medical Research Council [G0600977, G0400061] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1045, NF-SI-0510-10268] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Waterloo Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); British Academy; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The project was funded by the United Kingdom Medical Research Council (GO 400061, http://www.mrc.ac.uk/index.html). MCL was supported by the Waterloo Foundation during the period of this study (921/1247, http://www.waterloofoundation.org.uk/index.html), MVL was supported by the Wellcome Trust (http://www.wellcome.ac.uk/) and the British Academy (http://www.britac.ac.uk/), and SBC was supported by the Wellcome Trust (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; American Psychiatric Association, 2011, DSM 5 DEV PROP REV A; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashwin C, 2006, SOC NEUROSCI-UK, V1, P349, DOI 10.1080/17470910601040772; Ashwin C, 2007, NEUROPSYCHOLOGIA, V45, P2, DOI 10.1016/j.neuropsychologia.2006.04.014; Asperger H, 1944, ARCH PSYCHIAT NERVEN, V117, P76, DOI 10.1007/BF01837709; Attwood T, 2006, PATTERN ABILITIES DE; Attwood T., 2007, COMPLETE GUIDE ASPER; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baron-Cohen S, 2005, J AUTISM DEV DISORD, V35, P807, DOI 10.1007/s10803-005-0026-5; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Beacher FD, 2012, AM J NEURORADIOL, V33, P83, DOI 10.3174/ajnr.A2880; Bloss CS, 2007, J AM ACAD CHILD PSY, V46, P515, DOI 10.1097/chi.0b013e318030e28b; Bolte S, 2011, AUTISM, V15, P497, DOI 10.1177/1362361310391116; Boucher J., 2009, AUTISTIC SPECTRUM CH; Boucher J, 2012, AUTISM, V16, P226, DOI 10.1177/1362361311430403; Burack JA, 2002, DEV PSYCHOPATHOL, V14, P225, DOI 10.1017/S095457940200202X; Carter AS, 2007, J AUTISM DEV DISORD, V37, P86, DOI 10.1007/s10803-006-0331-7; Charman T, 2011, BRAIN RES, V1380, P10, DOI 10.1016/j.brainres.2010.10.075; Constantino JN, 2011, PEDIATR RES, V69, p55R, DOI 10.1203/PDR.0b013e318212ec6e; Corden B, 2008, NEUROPSYCHOLOGIA, V46, P137, DOI 10.1016/j.neuropsychologia.2007.08.005; Davis G, 2007, CURR BIOL, V17, pR851, DOI 10.1016/j.cub.2007.08.003; Dowell LR, 2009, NEUROPSYCHOLOGY, V23, P563, DOI 10.1037/a0015640; Dworzynski K, 2012, J AM ACAD CHILD PSY, V51, P788, DOI 10.1016/j.jaac.2012.05.018; Ecker C, 2012, ARCH GEN PSYCHIAT, V69, P195, DOI 10.1001/archgenpsychiatry.2011.1251; Fombonne E., 2005, HDB AUTISM PERVASIVE, V1, P42; Fournier KA, 2010, J AUTISM DEV DISORD, V40, P1227, DOI 10.1007/s10803-010-0981-3; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; Geurts HM, 2009, TRENDS COGN SCI, V13, P74, DOI 10.1016/j.tics.2008.11.006; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; GLASS GV, 1972, REV EDUC RES, V42, P237, DOI 10.2307/1169991; Golan O, 2006, DEV PSYCHOPATHOL, V18, P591, DOI 10.1017/S0954579406060305; Golarai G, 2006, CLIN NEUROSCI RES, V6, P145, DOI 10.1016/j.cnr.2006.08.001; Green D, 2009, DEV MED CHILD NEUROL, V51, P311, DOI 10.1111/j.1469-8749.2008.03242.x; Green DM, 1966, SIGNAL DETECTION THE; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Hartley SL, 2009, J AUTISM DEV DISORD, V39, P1715, DOI 10.1007/s10803-009-0810-8; Hernandez N, 2009, NEUROPSYCHOLOGIA, V47, P1004, DOI 10.1016/j.neuropsychologia.2008.10.023; Hill EL, 2004, DEV REV, V24, P189, DOI 10.1016/j.dr.2004.01.001; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Hilton CL, 2012, AUTISM, V16, P430, DOI 10.1177/1362361311423018; Hines M, 2010, TRENDS COGN SCI, V14, P448, DOI 10.1016/j.tics.2010.07.005; Holtmann M, 2007, DEV MED CHILD NEUROL, V49, P361, DOI 10.1111/j.1469-8749.2007.00361.x; Howard MA, 2000, NEUROREPORT, V11, P2931, DOI 10.1097/00001756-200009110-00020; HUGHES C, 1994, NEUROPSYCHOLOGIA, V32, P477, DOI 10.1016/0028-3932(94)90092-2; Humphreys K, 2007, NEUROPSYCHOLOGIA, V45, P685, DOI 10.1016/j.neuropsychologia.2006.08.003; Idring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041280; Jansiewicz EM, 2006, J AUTISM DEV DISORD, V36, P613, DOI 10.1007/s10803-006-0109-y; Jarrold C, 2005, DEVELOPMENTAL SCI, V8, P344, DOI 10.1111/j.1467-7687.2005.00422.x; Jeste SS, 2011, CURR OPIN NEUROL, V24, P132, DOI 10.1097/WCO.0b013e3283446450; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; Jones CRG, 2011, J CHILD PSYCHOL PSYC, V52, P275, DOI 10.1111/j.1469-7610.2010.02328.x; Kaland N, 2007, AUTISM, V11, P81, DOI 10.1177/1362361307070988; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Kopp Svenny, 1992, Eur Child Adolesc Psychiatry, V1, P89, DOI 10.1007/BF02091791; Kopp S, 2011, RES DEV DISABIL, V32, P2875, DOI 10.1016/j.ridd.2011.05.017; Koyama T, 2009, J AUTISM DEV DISORD, V39, P135, DOI 10.1007/s10803-008-0610-6; Krebs JF, 2011, J AUTISM DEV DISORD, V41, P796, DOI 10.1007/s10803-010-1098-4; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Lai MC, 2010, BIOL PSYCHIAT, V68, P1092, DOI 10.1016/j.biopsych.2010.06.027; Lemon JM, 2011, J AUTISM DEV DISORD, V41, P352, DOI 10.1007/s10803-010-1039-2; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Lombardo MV, 2011, NEUROIMAGE, V56, P1832, DOI 10.1016/j.neuroimage.2011.02.067; Lombardo MV, 2010, BRAIN, V133, P611, DOI 10.1093/brain/awp306; LORD C, 1985, J AUTISM DEV DISORD, V15, P185, DOI 10.1007/BF01531604; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; LORD C, 1982, J AUTISM DEV DISORD, V12, P317, DOI 10.1007/BF01538320; Losh M, 2009, ARCH GEN PSYCHIAT, V66, P518, DOI 10.1001/archgenpsychiatry.2009.34; Loucas T, 2010, INT J LANG COMM DIS, V45, P275, DOI 10.3109/13682820902936433; Lundqvist D., 1998, KAROLINSKA DIRECTED; MacNeil LK, 2012, NEUROPSYCHOLOGY, V26, P165, DOI 10.1037/a0026955; Mandy W, 2012, J AUTISM DEV DISORD, V42, P1304, DOI 10.1007/s10803-011-1356-0; Mari M, 2003, PHILOS T ROY SOC B, V358, P393, DOI 10.1098/rstb.2002.1205; Mattila ML, 2011, J AM ACAD CHILD PSY, V50, P583, DOI 10.1016/j.jaac.2011.04.001; MCLENNAN JD, 1993, J AUTISM DEV DISORD, V23, P217, DOI 10.1007/BF01046216; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Moran JM, 2011, P NATL ACAD SCI USA, V108, P2688, DOI 10.1073/pnas.1011734108; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mottron L, 2001, DEVELOPMENT OF AUTISM: PERSPECTIVES FROM THEORY AND RESEARCH, P131; Neumann D, 2006, SOC COGN AFFECT NEUR, V1, P194, DOI 10.1093/scan/nsl030; Nicholson KG, 1996, PERCEPT MOTOR SKILL, V82, P3, DOI 10.2466/pms.1996.82.1.3; Nordahl CW, 2011, P NATL ACAD SCI USA, V108, P20195, DOI 10.1073/pnas.1107560108; Nyden A, 2000, EUR CHILD ADOLES PSY, V9, P180, DOI 10.1007/s007870070041; O'Hearn K, 2010, NEUROPSYCHOLOGIA, V48, P3955, DOI 10.1016/j.neuropsychologia.2010.08.024; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Ozonoff S, 1997, J AUTISM DEV DISORD, V27, P59, DOI 10.1023/A:1025821222046; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1107, DOI 10.1111/j.1469-7610.1991.tb00352.x; Ozonoff S., 1997, AUTISM EXECUTIVE DIS, P179, DOI DOI 10.1093/MED:PSYCH/9780198523499.003.0006; Pan CY, 2009, J AUTISM DEV DISORD, V39, P1694, DOI 10.1007/s10803-009-0813-5; Pilowsky T, 1998, J AUTISM DEV DISORD, V28, P143, DOI 10.1023/A:1026092632466; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P765, DOI 10.1111/1469-7610.00375; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P777, DOI 10.1017/S0021963098002613; Plaisted K, 1999, J CHILD PSYCHOL PSYC, V40, P733, DOI 10.1111/1469-7610.00489; Provost B, 2007, J AUTISM DEV DISORD, V37, P321, DOI 10.1007/s10803-006-0170-6; Puleo CM, 2012, AUTISM, V16, P367, DOI 10.1177/1362361311427154; Ropar D, 2001, J CHILD PSYCHOL PSYC, V42, P539, DOI 10.1017/S002196300100717X; RUMSEY JM, 1985, J AUTISM DEV DISORD, V15, P23, DOI 10.1007/BF01837896; RUMSEY JM, 1988, J CLIN EXP NEUROPSYC, V10, P201, DOI 10.1080/01688638808408236; Rutherford MD, 2008, J AUTISM DEV DISORD, V38, P1371, DOI 10.1007/s10803-007-0525-7; Sasson NJ, 2006, J AUTISM DEV DISORD, V36, P381, DOI 10.1007/s10803-006-0076-3; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Schumann CM, 2009, BIOL PSYCHIAT, V66, P942, DOI 10.1016/j.biopsych.2009.07.007; Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102; Senju A, 2012, NEUROSCIENTIST, V18, P108, DOI 10.1177/1073858410397208; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; Skuse DH, 2007, TRENDS GENET, V23, P387, DOI 10.1016/j.tig.2007.06.003; Smith MJL, 2010, NEUROPSYCHOLOGIA, V48, P2777, DOI 10.1016/j.neuropsychologia.2010.03.008; Solomon M, 2012, J AUTISM DEV DISORD, V42, P48, DOI 10.1007/s10803-011-1215-z; Sutherland A, 2010, BRAIN, V133, P2089, DOI 10.1093/brain/awq122; Szatmari P, 2012, AM J MED GENET B, V159B, P5, DOI 10.1002/ajmg.b.31238; Tantam D., 2009, CAN WORLD AFFORD AUT; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Tracy JL, 2011, J AUTISM DEV DISORD, V41, P102, DOI 10.1007/s10803-010-1030-y; Trevarthen C, 2001, J CHILD PSYCHOL PSYC, V42, P3, DOI 10.1111/1469-7610.00701; TSAI L, 1981, J AUTISM DEV DISORD, V11, P165, DOI 10.1007/BF01531682; TSAI LY, 1983, BRIT J PSYCHIAT, V142, P373, DOI 10.1192/bjp.142.4.373; Turner MA, 1999, J CHILD PSYCHOL PSYC, V40, P189, DOI 10.1111/1469-7610.00432; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Wallace GL, 2011, J AUTISM DEV DISORD, V41, P1475, DOI 10.1007/s10803-010-1170-0; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; White SJ, 2011, J AUTISM DEV DISORD, V41, P1565, DOI 10.1007/s10803-011-1182-4; WING L, 1981, PSYCHIAT RES, V5, P129, DOI 10.1016/0165-1781(81)90043-3; Wing L, 2011, RES DEV DISABIL, V32, P768, DOI 10.1016/j.ridd.2010.11.003; Witkin, 1971, MANUAL GROUP EMBEDDE; WOLFF S, 1995, J CHILD PSYCHOL PSYC, V36, P793, DOI 10.1111/j.1469-7610.1995.tb01330.x; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Zwaigenbaum L, 2012, J AUTISM DEV DISORD, V42, P2585, DOI 10.1007/s10803-012-1515-y	137	120	120	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47198	10.1371/journal.pone.0047198	http://dx.doi.org/10.1371/journal.pone.0047198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23094036	Green Accepted, Green Published, gold			2022-12-27	WOS:000311146900042
J	Zhu, CT; Rand, DM				Zhu, Chen-Tseh; Rand, David M.			A Hydrazine Coupled Cycling Assay Validates the Decrease in Redox Ratio under Starvation in Drosophila	PLOS ONE			English	Article							NICOTINAMIDE-ADENINE-DINUCLEOTIDE; SINGLE EXTRACTION PROCEDURE; PYRIDINE-NUCLEOTIDES; TRIPHOSPHOPYRIDINE NUCLEOTIDE; GENETIC-VARIATION; NADH; METABOLISM; STATE; VALUES; DEHYDROGENASE	A commonly used enzymatic recycling assay for pyridine nucleotides has been adapted to directly measure the NAD(+)/NADH redox ratio in Drosophila melanogaster. This method is also suitable for quantification of NADP(+) and NADPH. The addition of a coupling reaction removing acetaldehyde produced from the alcohol dehydrogenase (ADH) reaction was shown to improve the linearity of NAD(H) assay. The advantages of this assay method are that it allows the determination of both NAD(+) and NADH simultaneously while keeping enzymatic degradation of pyridine nucleotides minimal and also achieving better sensitivity. This method was used to determine the redox ratio of D. melanogaster and validated substantial decrease of redox ratio during starvation.	[Zhu, Chen-Tseh; Rand, David M.] Brown Univ, Dept Ecol & Evolut Biol, Providence, RI 02912 USA	Brown University	Zhu, CT (corresponding author), Brown Univ, Dept Ecol & Evolut Biol, Providence, RI 02912 USA.	ctzhu@brown.edu	Zhu, Chen-Tseh (Lei)/A-9761-2014		National Institutes of Health [1RO1AG027849, 2RO1GM067862]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the National Institutes of Health: 1RO1AG027849 and 2RO1GM067862, both to D.M.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; BESSHO M, 1989, ANAL BIOCHEM, V182, P304, DOI 10.1016/0003-2697(89)90599-X; BURCH HB, 1967, J BIOL CHEM, V242, P4546; Candeias LP, 1998, J CHEM SOC PERK T 2, P2333, DOI 10.1039/a806431h; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; de Graef MR, 1999, J BACTERIOL, V181, P2351, DOI 10.1128/JB.181.8.2351-2357.1999; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; GLOCK GE, 1955, BIOCHEM J, V61, P381, DOI 10.1042/bj0610381; Hoffmann A, 2001, J CELL PHYSIOL, V188, P33, DOI 10.1002/jcp.1092; KHAN S, 1995, BBA-MOL CELL RES, V1269, P153, DOI 10.1016/0167-4889(95)00112-6; Kohen R, 1997, ARCH GERONTOL GERIAT, V24, P103, DOI 10.1016/S0167-4943(96)00744-3; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; LINKLATER HA, 1985, ANAL BIOCHEM, V148, P44, DOI 10.1016/0003-2697(85)90625-6; LOWRY OH, 1961, J BIOL CHEM, V236, P2756; LOWRY OH, 1961, J BIOL CHEM, V236, P2746; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; MORK J, 1985, CAN J FISH AQUAT SCI, V42, P1580, DOI 10.1139/f85-198; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NOY N, 1985, MECH AGEING DEV, V29, P63, DOI 10.1016/0047-6374(85)90047-8; OGATA ES, 1990, PEDIATR RES, V27, P56, DOI 10.1203/00006450-199001000-00017; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; PLACE AR, 1979, P NATL ACAD SCI USA, V76, P2354, DOI 10.1073/pnas.76.5.2354; REISS PD, 1984, ANAL BIOCHEM, V140, P162, DOI 10.1016/0003-2697(84)90148-9; RHODES MJC, 1968, PHYTOCHEMISTRY, V7, P337, DOI 10.1016/S0031-9422(00)90872-0; Sun FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034525; TANFORD C, 1967, J AM CHEM SOC, V89, P729, DOI 10.1021/ja00980a001; TISCHLER ME, 1977, ARCH BIOCHEM BIOPHYS, V184, P222, DOI 10.1016/0003-9861(77)90346-0; Umemura K, 2005, ANAL BIOCHEM, V338, P131, DOI 10.1016/j.ab.2004.10.020; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; WU JT, 1986, CLIN CHEM, V32, P314; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; YAN RT, 1987, ANAL BIOCHEM, V164, P362, DOI 10.1016/0003-2697(87)90505-7; YANCEY PH, 1978, J COMP PHYSIOL, V125, P129, DOI 10.1007/BF00686748; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9; Zhang QH, 2002, SCIENCE, V295, P1895	39	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47584	10.1371/journal.pone.0047584	http://dx.doi.org/10.1371/journal.pone.0047584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082179	gold, Green Submitted, Green Published			2022-12-27	WOS:000311146900075
J	Biacchesi, S; Merour, E; Lamoureux, A; Bernard, J; Bremont, M				Biacchesi, Stephane; Merour, Emilie; Lamoureux, Annie; Bernard, Julie; Bremont, Michel			Both STING and MAVS Fish Orthologs Contribute to the Induction of Interferon Mediated by RIG-I	PLOS ONE			English	Article							ANTIVIRAL SIGNALING PROTEIN; INNATE IMMUNE RECOGNITION; NF-KAPPA-B; ADAPTER PROTEIN; RNA HELICASE; JAPANESE FLOUNDER; RAINBOW-TROUT; IFN RESPONSE; GENE; VIRUS	Viral infections are detected in most cases by the host innate immune system through pattern-recognition receptors (PRR), the sensors for pathogen-associated molecular patterns (PAMPs), which induce the production of cytokines, such as type I interferons (IFN). Recent identification in mammalian and teleost fish of cytoplasmic viral RNA sensors, RIG-I-like receptors (RLRs), and their mitochondrial adaptor: the mitochondrial antiviral signaling (MAVS) protein, also called IPS-1, highlight their important role in the induction of IFN at the early stage of a virus infection. More recently, an endoplasmic reticulum (ER) adaptor: the stimulator of interferon genes (STING) protein, also called MITA, ERIS and MPYS, has been shown to play a pivotal role in response to both non-self-cytosolic RNA and dsDNA. In this study, we cloned STING cDNAs from zebrafish and showed that it was an ortholog to mammalian STING. We demonstrated that overexpression of this ER protein in fish cells led to a constitutive induction of IFN and interferon-stimulated genes (ISGs). STING-overexpressing cells were almost fully protected against RNA virus infection with a strong inhibition of both DNA and RNA virus replication. In addition, we found that together with MAVS, STING was an important player in the RIG-I IFN-inducing pathway. This report provides the demonstration that teleost fish possess a functional RLR pathway in which MAVS and STING are downstream signaling molecules of RIG-I. The Sequences presented in this article have been submitted to GenBank under accession numbers: Zebrafish STING (HE856619); EPC STING (HE856620); EPC IRF3 (HE856621); EPC IFN promoter (HE856618).	[Biacchesi, Stephane; Merour, Emilie; Lamoureux, Annie; Bernard, Julie; Bremont, Michel] INRA, CRJ, Unite Virol & Immunol Mol, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Biacchesi, S (corresponding author), INRA, CRJ, Unite Virol & Immunol Mol, Jouy En Josas, France.	stephane.biacchesi@jouy.inra.fr	BIACCHESI, STEPHANE/A-6924-2010	BIACCHESI, STEPHANE/0000-0002-7020-2391	animal health department of the Institut National de la Recherche Agronomique (INRA)	animal health department of the Institut National de la Recherche Agronomique (INRA)	This work was supported by the animal health department of the Institut National de la Recherche Agronomique (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Bergan V, 2010, MOL IMMUNOL, V47, P2005, DOI 10.1016/j.molimm.2010.04.015; Biacchesi S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-12; Biacchesi S, 2010, J VIROL, V84, P10038, DOI 10.1128/JVI.00343-10; Biacchesi S, 2009, J VIROL, V83, P7815, DOI 10.1128/JVI.00404-09; Boudinot P, 1999, J VIROL, V73, P1846, DOI 10.1128/JVI.73.3.1846-1852.1999; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chang MX, 2011, J VIROL, V85, P8403, DOI 10.1128/JVI.00445-10; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Feng H, 2011, FISH SHELLFISH IMMUN, V30, P1159, DOI 10.1016/j.fsi.2011.03.002; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gomez-Casado E, 2011, VACCINE, V29, P2657, DOI 10.1016/j.vaccine.2011.01.097; Holland JW, 2008, MOL IMMUNOL, V46, P269, DOI 10.1016/j.molimm.2008.08.265; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; LANGDON JS, 1986, J FISH DIS, V9, P263, DOI 10.1111/j.1365-2761.1986.tb01011.x; Lauksund S, 2009, DEV COMP IMMUNOL, V33, P1196, DOI 10.1016/j.dci.2009.06.012; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Ohtani M, 2012, DEV COMP IMMUNOL, V36, P697, DOI 10.1016/j.dci.2011.10.008; Ohtani M, 2011, DEV COMP IMMUNOL, V35, P554, DOI 10.1016/j.dci.2010.12.013; Ohtani M, 2010, J IMMUNOL, V185, P7507, DOI 10.4049/jimmunol.1001850; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Simora RMC, 2010, FISH SHELLFISH IMMUN, V29, P979, DOI 10.1016/j.fsi.2010.08.012; Sullivan C, 2007, J IMMUNOL, V178, P4517, DOI 10.4049/jimmunol.178.7.4517; Sun F, 2011, J IMMUNOL, V187, P2531, DOI 10.4049/jimmunol.1100642; Sun F, 2010, J IMMUNOL, V185, P7573, DOI 10.4049/jimmunol.1002401; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030802; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Winton J, 2010, J FISH DIS, V33, P701, DOI 10.1111/j.1365-2761.2010.01165.x; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	63	75	83	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47737	10.1371/journal.pone.0047737	http://dx.doi.org/10.1371/journal.pone.0047737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091644	Green Published, gold, Green Submitted			2022-12-27	WOS:000310135800070
J	Lyst, SJ; Davis, K; Gigg, J; Hager, R				Lyst, Sophie J.; Davis, Katherine; Gigg, John; Hager, Reinmar			Effects of Increased Spatial Complexity on Behavioural Development and Task Performance in Lister Hooded Rats	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; IBOTENIC ACID LESIONS; ENVIRONMENTAL ENRICHMENT; LABORATORY RATS; HOUSING CONDITIONS; MIXED LITTERS; MICE; HIPPOCAMPUS; CONSOLIDATION; NUCLEUS	Enhancing laboratory animal welfare, particularly in rodents, has been achieved through environmental enrichment in caging systems. Traditional enrichment such as adding objects has shown to impact development, reproductive and maternal performance as well as cognition. However, effects of increased spatial complexity as part of larger novel caging systems have not been investigated. While adoption of caging systems with increased spatial complexity seems uncontroversial from a welfare perspective, effects of such housing on the development and task performance of experimental animals remains unclear. In this study, we investigate differences in key behaviours and cognitive performance between Lister Hooded rats housed in traditional (single-shelf) cages ("basic') and those housed in larger cages with an additional shelf ("enriched'). We found minor differences in maternal behaviour, such as nursing and offspring development. Further, we compared task performance in females, using a hippocampus-dependent task (T-maze) and a hippocampus-independent task (Novel Object Recognition, NOR). While in the T-maze no differences in either the rate of learning or probe trial performance were found, in the NOR task females housed in enriched cages performed better than those housed in basic cages. Our results show that increased spatial complexity does not significantly affect development and maternal performance but may enhance learning in females for a non-spatial task. Increased spatial complexity does not appear to have the same effects on behaviour and development as traditional enrichment. Thus, our results suggest no effect of housing conditions on the development of most behaviours in experimental animals housed in spatially enriched caging systems.	[Lyst, Sophie J.; Davis, Katherine; Gigg, John; Hager, Reinmar] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Lyst, SJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	sophie.lyst@manchester.ac.uk	Hager, Reinmar/F-8659-2012	Gigg, John/0000-0001-8253-1582	NERC [NE/F013418/1]; Natural Environment Research Council [NE/F013418/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a NERC Research Fellowship NE/F013418/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anna I, 2002, LAB ANIM-UK, V36, P243, DOI 10.1258/002367702320162379; ANNETT LE, 1989, BEHAV BRAIN RES, V31, P231, DOI 10.1016/0166-4328(89)90005-3; BERNSTEIN L, 1973, J PSYCHOSOM RES, V17, P85, DOI 10.1016/0022-3999(73)90008-1; BLOM HJM, 1995, APPL ANIM BEHAV SCI, V43, P279, DOI 10.1016/0168-1591(95)00561-6; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; CHAMOVE AS, 1989, LAB ANIM, V23, P215, DOI 10.1258/002367789780810608; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; GONYOU HW, 1994, J ANIM SCI, V72, P2171, DOI 10.2527/1994.7282171x; Grayson B, 2007, BEHAV BRAIN RES, V184, P31, DOI 10.1016/j.bbr.2007.06.012; Hager R, 2005, ETHOLOGY, V111, P705, DOI 10.1111/j.1439-0310.2005.01097.x; Hager R, 2003, NATURE, V421, P533, DOI 10.1038/nature01239; Hager R, 2007, ANIM BEHAV, V74, P1039, DOI 10.1016/j.anbehav.2007.01.021; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Harris AP, 2009, ANIM BEHAV, V77, P1459, DOI 10.1016/j.anbehav.2009.02.019; Her Majesty's Stationery Office, 1995, COD PRACT HOUS CAR A; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Leach M. C., 2000, Journal of Applied Animal Welfare Science, V3, P81, DOI 10.1207/S15327604JAWS0302_1; Martin P, 1996, MEASURING BEHAV; Nevison CM, 1999, ANIM WELFARE, V8, P361; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; PACTEAU C, 1989, BEHAV BRAIN RES, V34, P79, DOI 10.1016/S0166-4328(89)80092-0; Rolls A, 2011, P NATL ACAD SCI USA, V108, P13305, DOI 10.1073/pnas.1015633108; Schrijver NCA, 2004, BEHAV BRAIN RES, V152, P307, DOI 10.1016/j.bbr.2003.10.016; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Sutcliffe JS, 2007, BEHAV BRAIN RES, V177, P117, DOI 10.1016/j.bbr.2006.10.029; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; Townsend P, 1997, ANIM WELFARE, V6, P95; Tsai PP, 2002, LAB ANIM-UK, V36, P411, DOI 10.1258/002367702320389071; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5	32	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47640	10.1371/journal.pone.0047640	http://dx.doi.org/10.1371/journal.pone.0047640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091636	gold, Green Published, Green Submitted			2022-12-27	WOS:000310135800060
J	Sobolewski, P; Kandel, J; Eckmann, DM				Sobolewski, Peter; Kandel, Judith; Eckmann, David M.			Air Bubble Contact with Endothelial Cells Causes a Calcium-Independent Loss in Mitochondrial Membrane Potential	PLOS ONE			English	Article							PROTEIN-KINASE-C; LIQUID INTERFACES; GAS EMBOLISM; GLYCOCALYX; MECHANOTRANSDUCTION; PATHOPHYSIOLOGY; ADSORPTION; SYNDECAN-4; KINETICS; LAYER	Objective: Gas microembolism remains a serious risk associated with surgical procedures and decompression. Despite this, the signaling consequences of air bubbles in the vasculature are poorly understood and there is a lack of pharmacological therapies available. Here, we investigate the mitochondrial consequences of air bubble contact with endothelial cells. Methods and Results: Human umbilical vein endothelial cells were loaded with an intracellular calcium indicator (Fluo-4) and either a mitochondrial calcium indicator (X-Rhod-1) or mitochondrial membrane potential indicator (TMRM). Contact with 50-150 mu m air bubbles induced concurrent rises in intracellular and mitochondrial calcium, followed by a loss of mitochondrial membrane potential. Pre-treating cells with 1 mu mol/L ruthenium red, a TRPV family calcium channel blocker, did not protect cells from the mitochondrial depolarization, despite blocking the intracellular calcium response. Mitigating the interactions between the air-liquid interface and the endothelial surface layer with 5% BSA or 0.1% Pluronic F-127 prevented the loss of mitochondrial membrane potential. Finally, inhibiting protein kinase C-alpha (PKC alpha), with 5 mmol/L Go6976, protected cells from mitochondrial depolarization, but did not affect the intracellular calcium response. Conclusions: Our results indicate that air bubble contact with endothelial cells activates a novel, calcium-independent, PKC alpha-dependent signaling pathway, which results in mitochondrial depolarization. As a result, mitochondrial dysfunction is likely to be a key contributor to the pathophysiology of gas embolism injury. Further, this connection between the endothelial surface layer and endothelial mitochondria may also play an important role in vascular homeostasis and disease.	[Sobolewski, Peter; Eckmann, David M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Kandel, Judith; Eckmann, David M.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Eckmann, DM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	eckmanndm@uphs.upenn.edu	Sobolewski, Peter/I-7177-2013; Eckmann, David/O-5472-2016	Sobolewski, Peter/0000-0002-2097-0990; Eckmann, David/0000-0002-8954-8827	Office of Naval Research [N00014-08-1-0436, N00014-10-1-0074]; National Institutes of Health [R01 HL067986]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954, R01HL067986] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by: Office of Naval Research N00014-08-1-0436 and N00014-10-1-0074 to D.M.E. National Institutes of Health R01 HL067986 to D.M.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON RH, 1992, J PHYSIOL-LONDON, V445, P473, DOI 10.1113/jphysiol.1992.sp018934; Barak M, 2005, CHEST, V128, P2918, DOI 10.1378/chest.128.4.2918; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Eckmann DM, 2006, ANN NY ACAD SCI, V1077, P256, DOI 10.1196/annals.1362.039; Franzen CA, 2009, MOL CANCER RES, V7, P1045, DOI 10.1158/1541-7786.MCR-09-0017; GRAHAM DE, 1979, J COLLOID INTERF SCI, V70, P403, DOI 10.1016/0021-9797(79)90048-1; GRAHAM DE, 1979, J COLLOID INTERF SCI, V70, P427, DOI 10.1016/0021-9797(79)90050-X; Hansen FK, 1995, J COLLOID INTERF SCI, V176, P408, DOI 10.1006/jcis.1995.9951; HELPS SC, 1990, STROKE, V21, P94, DOI 10.1161/01.STR.21.1.94; Klinger AL, 2011, INTEGR BIOL-UK, V3, P1033, DOI 10.1039/c1ib00017a; Kobayashi S, 2011, UNDERSEA HYPERBAR M, V38, P27; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Lampe JW, 2010, LANGMUIR, V26, P2452, DOI 10.1021/la903703u; Liao ZZ, 2011, LANGMUIR, V27, P12775, DOI 10.1021/la203053g; Lou S, 2011, INT J ARTIF ORGANS, V34, P1039, DOI 10.5301/ijao.5000010; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mirski MA, 2007, ANESTHESIOLOGY, V106, P164, DOI 10.1097/00000542-200701000-00026; Moon JJ, 2005, J CELL PHYSIOL, V203, P166, DOI 10.1002/jcp.20220; Multhaupt HAB, 2009, J PHYSIOL PHARMACOL, V60, P31; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Sobolewski P, 2011, AM J PHYSIOL-CELL PH, V301, pC679, DOI 10.1152/ajpcell.00046.2011; Suzuki A, 2004, ANESTHESIOLOGY, V101, P97, DOI 10.1097/00000542-200407000-00016; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; van Hulst RA, 2003, CLIN PHYSIOL FUNCT I, V23, P237; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Wang Y, 2006, BIOCHEM PHARMACOL, V72, P881, DOI 10.1016/j.bcp.2006.06.032; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959	30	25	25	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47254	10.1371/journal.pone.0047254	http://dx.doi.org/10.1371/journal.pone.0047254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091614	Green Submitted, Green Published, gold			2022-12-27	WOS:000310135800036
J	Tao, R; Zhang, S; Li, Q; Geng, HY				Tao, Ran; Zhang, Shen; Li, Qi; Geng, Haiyan			Modulation of Self-Esteem in Self- and Other-Evaluations Primed by Subliminal and Supraliminal Faces	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; INDIVIDUAL-DIFFERENCES; INVISIBLE FACES; OWN FACE; EXPLICIT; NAME; INFORMATION; RECOGNITION; SUPPRESSION; ADVANTAGE	Background: Past research examining implicit self-evaluation often manipulated self-processing as task-irrelevant but presented self-related stimuli supraliminally. Even when tested with more indirect methods, such as the masked priming paradigm, participants' responses may still be subject to conscious interference. Our study primed participants with either their own or someone else's face, and adopted a new paradigm to actualize strict face-suppression to examine participants' subliminal self-evaluation. In addition, we investigated how self-esteem modulates one's implicit self-evaluation and validated the role of awareness in creating the discrepancy on past findings between measures of implicit self-evaluation and explicit self-esteem. Methodology/Principal Findings: Participants' own face or others' faces were subliminally presented with a Continuous Flash Suppression (CFS) paradigm in Experiment 1, but supraliminally presented in Experiment 2, followed by a valence judgment task of personality adjectives. Participants also completed the Rosenberg Self-Esteem Scale in each experiment. Results from Experiment 1 showed a typical bias of self-positivity among participants with higher self-esteem, but only a marginal self-positivity bias and a significant other-positivity bias among those with lower self-esteem. However, self-esteem had no modulating effect in Experiment 2: All participants showed the self-positivity bias. Conclusions/Significance: Our results provide direct evidence that self-evaluation manifests in different ways as a function of awareness between individuals with different self-views: People high and low in self-esteem may demonstrate different automatic reactions in the subliminal evaluations of the self and others; but the involvement of consciousness with supraliminally presented stimuli may reduce this dissociation.	[Tao, Ran; Li, Qi; Geng, Haiyan] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Zhang, Shen] Univ Wisconsin, Dept Psychol, Whitewater, WI 53190 USA	Peking University; University of Wisconsin System	Geng, HY (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	hygeng@pku.edu.cn			National Natural Science Foundation of China [30870763, 31271202, J1103602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30870763, 31271202, J1103602) (http://www.nsfc.gov.cn). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1989, PSYCHOL REV, V96, P358, DOI 10.1037/0033-295X.96.2.358; ALICKE MD, 1985, J PERS SOC PSYCHOL, V49, P1621, DOI 10.1037/0022-3514.49.6.1621; BALDWIN MW, 1994, J SOC CLIN PSYCHOL, V13, P380, DOI 10.1521/jscp.1994.13.4.380; BANAJI MR, 1994, ANNU REV PSYCHOL, V45, P297, DOI 10.1146/annurev.psych.45.1.297; Banse R, 1999, J SOC PERS RELAT, V16, P803, DOI 10.1177/0265407599166007; Bredart S, 2006, Q J EXP PSYCHOL, V59, P46, DOI 10.1080/17470210500343678; Brown JD, 2001, COGNITION EMOTION, V15, P615; Chen Hong, 2006, Eat Behav, V7, P152, DOI 10.1016/j.eatbeh.2005.08.012; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; Dijksterhuis A, 2004, J PERS SOC PSYCHOL, V86, P345, DOI 10.1037/0022-3514.86.2.345; Dodgson PG, 1998, J PERS SOC PSYCHOL, V75, P178, DOI 10.1037/0022-3514.75.1.178; DUNNING D, 1989, J PERS SOC PSYCHOL, V57, P1082, DOI 10.1037/0022-3514.57.6.1082; Epley N, 2008, PERS SOC PSYCHOL B, V34, P1159, DOI 10.1177/0146167208318601; Fennell M., 2007, HDB HOMEWORK ASSIGNM, P297, DOI DOI 10.1007/978-0-387-29681-4_18; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Gilbert DT, 1995, J PERS SOC PSYCHOL, V79, P438; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hetts JJ, 1999, J EXP SOC PSYCHOL, V35, P512, DOI 10.1006/jesp.1999.1391; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; HOORENS V, 1990, PSYCHOL BELG, V30, P23; Ibanez A, 2011, BRAIN RES, V1398, P72, DOI 10.1016/j.brainres.2011.05.014; Jame W, 1890, PRINCIPLE PSYCHOL, V1; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Jiang Y, 2009, NEUROIMAGE, V44, P1171, DOI 10.1016/j.neuroimage.2008.09.038; Jones JT, 2002, J EXP SOC PSYCHOL, V38, P170, DOI 10.1006/jesp.2001.1497; Kiefer M, 2012, ADV COGN PSYCHOL, V8, P50, DOI [10.2478/v10053-008-0102-4, 10.5709/acp-0102-4]; Koole SL, 2001, J PERS SOC PSYCHOL, V80, P669, DOI 10.1037//0022-3514.80.4.669; Krizan Z, 2008, J RES PERS, V42, P1635, DOI 10.1016/j.jrp.2008.07.002; Lavie N, 2003, PSYCHOL SCI, V14, P510, DOI 10.1111/1467-9280.03453; Liu Y, 1990, DICT MODERN CHINESE; Ma YN, 2010, J EXP PSYCHOL HUMAN, V36, P619, DOI 10.1037/a0015797; Marcel AJ, 1974, M EXP PSYCH SOC STIR; Mezulis AH, 2004, PSYCHOL BULL, V130, P711, DOI 10.1037/0033-2909.130.5.711; Morita T, 2008, J COGNITIVE NEUROSCI, V20, P342, DOI 10.1162/jocn.2008.20024; Mussweiler T, 2004, J EXP SOC PSYCHOL, V40, P689, DOI 10.1016/j.jesp.2004.01.004; Oikawa H, 2012, NEUROIMAGE, V59, P3668, DOI 10.1016/j.neuroimage.2011.10.098; Pahl S, 2005, EXP PSYCHOL, V52, P303, DOI 10.1027/1618-3169.52.4.303; PERLOFF LS, 1986, J PERS SOC PSYCHOL, V50, P502, DOI 10.1037/0022-3514.50.3.502; Ranganath KA, 2008, J EXP SOC PSYCHOL, V44, P386, DOI 10.1016/j.jesp.2006.12.008; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Sommer KL, 2002, PERS SOC PSYCHOL B, V28, P926, DOI 10.1177/01467202028007006; Spalding LR, 1999, PSYCHOL SCI, V10, P535, DOI 10.1111/1467-9280.00202; TAYLOR SE, 1995, PERS SOC PSYCHOL B, V21, P1278, DOI 10.1177/01461672952112005; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Tesser A., 1988, ADV EXP SOC PSYCHOL, V21, P181, DOI 10.1016/S0065-2601(08)60227-0; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Wentura D, 2005, J EXP SOC PSYCHOL, V41, P654, DOI 10.1016/j.jesp.2004.02.005; Zeigler-Hill V, 2006, J PERS, V74, P119, DOI 10.1111/j.1467-6494.2005.00371.x	51	15	15	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47103	10.1371/journal.pone.0047103	http://dx.doi.org/10.1371/journal.pone.0047103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	024UX	23091607	gold, Green Submitted, Green Published			2022-12-27	WOS:000310135800023
J	Chen, J; Wang, W; Zhang, T; Ji, JJ; Qian, QR; Lu, LG; Fu, HL; Jin, WL; Cui, DX				Chen, Jun; Wang, Wei; Zhang, Tao; Ji, Jiajia; Qian, Qirong; Lu, Lungeng; Fu, Hualin; Jin, Weilin; Cui, Daxiang			Differential Expression of Phospholipase C Epsilon 1 Is Associated with Chronic Atrophic Gastritis and Gastric Cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; CRUCIAL ROLE; PLC-EPSILON; INFLAMMATION; CARCINOMA; GENE	Background: Chronic inflammation plays a causal role in gastric tumor initiation. The identification of predictive biomarkers from gastric inflammation to tumorigenesis will help us to distinguish gastric cancer from atrophic gastritis and establish the diagnosis of early-stage gastric cancer. Phospholipase C epsilon 1 (PLC epsilon 1) is reported to play a vital role in inflammation and tumorigenesis. This study was aimed to investigate the clinical significance of PLC epsilon 1 in the initiation and progression of gastric cancer. Methodology/Principal Findings: Firstly, the mRNA and protein expression of PLC epsilon 1 were analyzed by reverse transcription-PCR and Western blotting in normal gastric mucous epithelial cell line GES-1 and gastric cancer cell lines AGS, SGC7901, and MGC803. The results showed both mRNA and protein levels of PLC epsilon 1 were up-regulated in gastric cancer cells compared with normal gastric mucous epithelial cells. Secondly, this result was confirmed by immunohistochemical detection in a tissue microarray including 74 paired gastric cancer and adjacent normal tissues. Thirdly, an independence immunohistochemical analysis of 799 chronic atrophic gastritis tissue specimens demonstrated that PLC epsilon 1 expression in atrophic gastritis tissues were down-regulated since PLC epsilon 1 expression was negative in 524 (65.6%) atrophic gastritis. In addition, matched clinical tissues from atrophic severe gastritis and gastric cancer patients were used to further confirm the previous results by analyzing mRNA and protein levels expression of PLC epsilon 1 in clinical samples. Conclusions/Significances: Our results suggested that PLC epsilon 1 protein may be a potential biomarker to distinguish gastric cancer from inflammation lesion, and could have great potential in applications such as diagnosis and pre-warning of early-stage gastric cancer.	[Chen, Jun; Ji, Jiajia; Fu, Hualin; Jin, Weilin; Cui, Daxiang] Shanghai Jiao Tong Univ, Inst Micro Nano Sci & Technol, Key Lab Thin Film & Microfabricat Technol, Dept Bionano Sci & Engn,Dept Educ, Shanghai 200030, Peoples R China; [Wang, Wei] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wei] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Tao] Fujian Acad Med Sci, Dept Immunol, Fuzhou, Peoples R China; [Qian, Qirong] Second Mil Med Univ, Changzheng Hosp, Dept Surg, Shanghai, Peoples R China; [Lu, Lungeng] Shanghai Jiao Tong Univ, Inst Digest Dis, Affiliated Hosp 1, Shanghai 200030, Peoples R China; [Jin, Weilin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Sun Yat Sen University; Sun Yat Sen University; Naval Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Cui, DX (corresponding author), Shanghai Jiao Tong Univ, Inst Micro Nano Sci & Technol, Key Lab Thin Film & Microfabricat Technol, Dept Bionano Sci & Engn,Dept Educ, Shanghai 200030, Peoples R China.	dxcui@sjtu.edu.cn	Jin, Wei-Lin/A-8355-2013	Jin, Wei-Lin/0000-0001-8011-2405	National Key Basic Research Program of China (973 Project) [2010CB933900]; New Century Excellent Talent of Ministry of Education of China [NCET-08-0350]; Special Infection Diseases Key Project of China [2009ZX10004-311]; National Natural Science Foundation of China [31170961, 31100717]; Shanghai Science and Technology Fund [12ZR1415800]; Shanghai Jiao Tong University Innovation Fund For Postgraduates [Z-340-007]	National Key Basic Research Program of China (973 Project)(National Basic Research Program of China); New Century Excellent Talent of Ministry of Education of China; Special Infection Diseases Key Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Fund; Shanghai Jiao Tong University Innovation Fund For Postgraduates	This work was supported by National Key Basic Research Program of China (973 Project) (2010CB933900), New Century Excellent Talent of Ministry of Education of China (NCET-08-0350), Special Infection Diseases Key Project of China (2009ZX10004-311), National Natural Science Foundation of China (31170961 and 31100717), Shanghai Science and Technology Fund (12ZR1415800) and Shanghai Jiao Tong University Innovation Fund For Postgraduates (Z-340-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Boyer O, 2010, J MED GENET, V47, P445, DOI 10.1136/jmg.2009.076166; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Chen L, 2011, BIOSENS BIOELECTRON, V26, P3246, DOI 10.1016/j.bios.2010.12.034; Cheng HL, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.014; Cui DX, 2005, WORLD J GASTROENTERO, V11, P1273, DOI 10.3748/wjg.v11.i9.1273; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Harada Y, 2011, BIOCHEM BIOPH RES CO, V414, P106, DOI 10.1016/j.bbrc.2011.09.032; He M, 2011, ADV FUNCT MATER, V21, P4470, DOI 10.1002/adfm.201101040; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hu LZ, 2010, J IMMUNOL, V184, P993, DOI 10.4049/jimmunol.0901816; Huang P, 2011, BIOMATERIALS, V32, P3447, DOI 10.1016/j.biomaterials.2011.01.032; Humans IWGotEoCRt, 1994, SCHIST LIV FLUK HEL; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; Inoue M, 2000, CANCER LETT, V161, P105, DOI 10.1016/S0304-3835(00)00603-0; Kong YF, 2010, SMALL, V6, P2367, DOI 10.1002/smll.201001050; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Li ZM, 2010, MOL PHARMACEUT, V7, P94, DOI 10.1021/mp9001415; Ou LP, 2010, CANCER GENET CYTOGEN, V200, P110, DOI 10.1016/j.cancergencyto.2010.01.021; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Qian YB, 2006, CANCER, V107, P1562, DOI 10.1002/cncr.22206; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Takenaka N, 2011, EUR J IMMUNOL, V41, P202, DOI 10.1002/eji.201040675; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031932; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94	32	19	25	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47563	10.1371/journal.pone.0047563	http://dx.doi.org/10.1371/journal.pone.0047563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077637	Green Submitted, gold, Green Published			2022-12-27	WOS:000309995100132
J	Wang, PS; Chen, HC; Wu, HM; Lirng, JF; Wu, YT; Soong, BW				Wang, Po-Shan; Chen, Hung-Chieh; Wu, Hsiu-Mei; Lirng, Jiing-Feng; Wu, Yu-Te; Soong, Bing-Wen			Association between Proton Magnetic Resonance Spectroscopy Measurements and CAG Repeat Number in Patients with Spinocerebellar Ataxias 2, 3, or 6	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; POLYGLUTAMINE-INDUCED NEURODEGENERATION; AGE-OF-ONSET; SCA2; TYPE-6; MODEL; FAMILIES	The aim of this study was to correlate magnetic resonance spectroscopy (MRS) measurements, including that for the N-acetyl aspartate (NAA)/creatine (Cr) ratio in the vermis (denoted V-NAA), right cerebellar hemisphere (R-NAA), and left (L-NAA) cerebellar hemisphere, with the clinical scale for the assessment and rating of ataxia (SARA) score for patients with spinocerebellar ataxia (SCA) types 2, 3, and 6. A total of 24 patients with SCA2, 48 with SCA3, and 16 with SCA6 were recruited; 12 patients with SCA2, 43 with SCA3, and 8 with SCA6 underwent detailed magnetic resonance neuroimaging. Forty-four healthy, age-matched individuals without history of neurologic disease served as control subjects. V-NAA and patient age were used to calculate the predicted age at which a patient with SCA2 or SCA3 would reach an onset V-NAA value. Results showed the following: the NAA/Cr ratio decreased with increasing age in patients with SCA but not in control subjects; the SARA score increased progressively with age and duration of illness; V-NAA showed a better correlation with SARA score than R-NAA in patients with SCA2 or SCA3; the ratio of age to V-NAA correlated well with CAG repeat number; the retrospectively predicted age of onset for SCA2 and SCA3 was consistent with patient-reported age of onset; R-NAA showed a better correlation with SARA score than V-NAA in patients with SCA6; V-NAA and R-NAA correlated with clinical severity (SARA score) in patients with SCA. The correlation between CAG repeat number and age could be expressed as a simple linear function, which might explain previous observations claiming that the greater the CAG repeat number, the earlier the onset of illness and the faster the disease progression. These findings support the use of MRS values to predict age of disease onset and to retrospectively evaluate the actual age of disease onset in SCA.	[Wu, Yu-Te] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Wang, Po-Shan] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Wang, Po-Shan] Municipal Gandau Hosp, Dept Med, Taipei, Taiwan; [Wang, Po-Shan; Chen, Hung-Chieh; Soong, Bing-Wen] Natl Yang Ming Univ, Dept Neurol, Sch Med, Taipei 112, Taiwan; [Wang, Po-Shan; Chen, Hung-Chieh; Soong, Bing-Wen] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Chen, Hung-Chieh; Wu, Hsiu-Mei; Lirng, Jiing-Feng] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Chen, Hung-Chieh; Wu, Hsiu-Mei; Lirng, Jiing-Feng] Natl Yang Ming Univ, Dept Radiol, Sch Med, Taipei 112, Taiwan; [Wu, Yu-Te] Taipei Vet Gen Hosp, Integrated Brain Res Lab, Dept Med Res & Educ, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Wu, YT (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	yutewu163@163.com; bwsoong@ym.edu.tw	Chen, hung-chieh/AAH-6591-2019	Chen, hung-chieh/0000-0003-3544-5045	Taipei Veterans General Hospital [V99C1-155, V100C-129, VGHUST100-G7-3-2, VGHUST101-G4-2-4]; National Science Council [NSC99-2221-E-075-003, NSC99-2221-E-010-012, NSC100-2221-E-010-009, NSC101-2221-E-010-004-MY2, NSC101-2314-B-733-001-MY2]; NSC; National Central University, Taiwan [NSC100-2911-I-008-001]; Center for Dynamical Biomarkers and Translational Medicine; National Central University, Chungli, Taiwan; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plansic	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan); National Central University, Taiwan; Center for Dynamical Biomarkers and Translational Medicine; National Central University, Chungli, Taiwan; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plansic	The study was funded in part by the Taipei Veterans General Hospital (V99C1-155, V100C-129, VGHUST100-G7-3-2, VGHUST101-G4-2-4), the National Science Council (NSC99-2221-E-075-003, NSC99-2221-E-010-012, NSC100-2221-E-010-009, NSC101-2221-E-010-004-MY2, NSC101-2314-B-733-001-MY2), NSC supported for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC100-2911-I-008-001), Center for Dynamical Biomarkers and Translational Medicine, National Central University, Chungli, Taiwan and Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plansic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettencourt C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-35; Boesch SM, 2001, J MAGN RESON IMAGING, V13, P553, DOI 10.1002/jmri.1078; Boesch SM, 2007, J MAGN RESON IMAGING, V25, P564, DOI 10.1002/jmri.20846; D'Abreu A, 2010, PARKINSONISM RELAT D, V16, P2, DOI 10.1016/j.parkreldis.2009.08.012; Danielsen ER, 1998, MAGNETIC RESONANCE S; Di Prospero NA, 2005, NAT REV GENET, V6, P756, DOI 10.1038/nrg1690; Dohlinger S, 2008, CEREBELLUM, V7, P204, DOI 10.1007/s12311-008-0025-0; Durr A, 1995, BRAIN, V118, P1573, DOI 10.1093/brain/118.6.1573; Estrada R, 1999, ACTA NEUROPATHOL, V97, P306, DOI 10.1007/s004010050989; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; Guerrini L, 2004, BRAIN, V127, P1785, DOI 10.1093/brain/awh201; Jiang H, 2005, J NEUROL SCI, V236, P25, DOI 10.1016/j.jns.2005.04.009; Kumar P, 2010, PHARMACOL REP, V62, P1; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Oz G, 2011, CEREBELLUM, V10, P208, DOI 10.1007/s12311-010-0213-6; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Oz G, 2010, MOVEMENT DISORD, V25, P1253, DOI 10.1002/mds.23067; Oz G, 2010, J NEUROSCI, V30, P3831, DOI 10.1523/JNEUROSCI.5612-09.2010; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Schulz JB, 2010, NEUROIMAGE, V49, P158, DOI 10.1016/j.neuroimage.2009.07.027; Soong BW, 2001, ARCH NEUROL-CHICAGO, V58, P1105, DOI 10.1001/archneur.58.7.1105; Stevanin G, 2002, ADV EXP MED BIOL, V516, P47; Takahashi H, 1998, ACTA NEUROPATHOL, V95, P333, DOI 10.1007/s004010050807; TAKIYAMA Y, 1994, NEUROLOGY, V44, P1302, DOI 10.1212/WNL.44.7.1302; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Wang PS, 2007, J NEUROL, V254, P838, DOI 10.1007/s00415-006-0383-9; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	28	14	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47479	10.1371/journal.pone.0047479	http://dx.doi.org/10.1371/journal.pone.0047479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23094053	gold, Green Published, Green Submitted			2022-12-27	WOS:000309807700085
J	Nilsson, A; Forngren, B; Bjurstrom, S; Goodwin, RJA; Basmaci, E; Gustafsson, I; Annas, A; Hellgren, D; Svanhagen, A; Andren, PE; Lindberg, J				Nilsson, Anna; Forngren, Benita; Bjurstrom, Sivert; Goodwin, Richard J. A.; Basmaci, Elisa; Gustafsson, Ingela; Annas, Anita; Hellgren, Dennis; Svanhagen, Alexander; Andren, Per E.; Lindberg, Johan			In Situ Mass Spectrometry Imaging and Ex Vivo Characterization of Renal Crystalline Deposits Induced in Multiple Preclinical Drug Toxicology Studies	PLOS ONE			English	Article							LASER CAPTURE MICRODISSECTION; TISSUE-SECTIONS; RAT-BRAIN; MALDI; DISCOVERY; TOXICITY; UTILITY; MS	Drug toxicity observed in animal studies during drug development accounts for the discontinuation of many drug candidates, with the kidney being a major site of tissue damage. Extensive investigations are often required to reveal the mechanisms underlying such toxicological events and in the case of crystalline deposits the chemical composition can be problematic to determine. In the present study, we have used mass spectrometry imaging combined with a set of advanced analytical techniques to characterize such crystalline deposits in situ. Two potential microsomal prostaglandin E synthase 1 inhibitors, with similar chemical structure, were administered to rats over a seven day period. This resulted in kidney damage with marked tubular degeneration/regeneration and crystal deposits within the tissue that was detected by histopathology. Results from direct tissue section analysis by matrix-assisted laser desorption ionization mass spectrometry imaging were combined with data obtained following manual crystal dissection analyzed by liquid chromatography mass spectrometry and nuclear magnetic resonance spectroscopy. The chemical composition of the crystal deposits was successfully identified as a common metabolite, bisulphonamide, of the two drug candidates. In addition, an un-targeted analysis revealed molecular changes in the kidney that were specifically associated with the area of the tissue defined as pathologically damaged. In the presented study, we show the usefulness of combining mass spectrometry imaging with an array of powerful analytical tools to solve complex toxicological problems occurring during drug development.	[Nilsson, Anna; Andren, Per E.] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Forngren, Benita; Bjurstrom, Sivert; Basmaci, Elisa; Gustafsson, Ingela; Annas, Anita; Hellgren, Dennis; Svanhagen, Alexander; Lindberg, Johan] AstraZeneca R&D, Safety Assessment, Sodertalje, Sweden; [Goodwin, Richard J. A.] AstraZeneca R&D, DMPK IM, Global Distribut Imaging, Sodertalje, Sweden	Uppsala University; AstraZeneca; AstraZeneca	Nilsson, A (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden.	anna.nilsson@farmbio.uu.se		Andren, Per/0000-0002-4062-7743	Swedish Research Council [2008-5597, 2009-6050, 2010-5421]; K&A Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); K&A Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This study was sponsored by the Swedish Research Council (http://www.vr.se), grant no. 2008-5597, 2009-6050, 2010-5421, and the K&A Wallenberg Foundation (http://www.wallenberg.com/kaw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Aberg KM, 2008, J CHROMATOGR A, V1192, P139, DOI 10.1016/j.chroma.2008.03.033; Beckonert O, 2010, NAT PROTOC, V5, P1019, DOI 10.1038/nprot.2010.45; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Cazares LH, 2011, ANAL BIOANAL CHEM, V401, P17, DOI 10.1007/s00216-011-5003-6; Clarke CJ, 2008, TOXICOL PATHOL, V36, P140, DOI 10.1177/0192623307310947; Dieterle F, 2008, CURR OPIN DRUG DISC, V11, P60; Drexler Dieter M., 2007, Journal of Pharmacological and Toxicological Methods, V55, P279, DOI 10.1016/j.vascn.2006.11.004; Drexler DM, 2011, ANAL BIOANAL CHEM, V399, P2645, DOI 10.1007/s00216-010-4370-8; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fernandez JA, 2011, ANAL BIOANAL CHEM, V401, P29, DOI 10.1007/s00216-011-4696-x; Goodsaid FM, 2009, CLIN PHARMACOL THER, V86, P490, DOI 10.1038/clpt.2009.149; Goodwin RJA, 2010, ANAL CHEM, V82, P3868, DOI 10.1021/ac100398y; Goodwin RJA, 2011, ANAL CHEM, V83, P9694, DOI 10.1021/ac202630t; Goodwin RJA, 2010, BIOANALYSIS, V2, P279, DOI 10.4155/BIO.09.180; Guillarme D, 2010, TRAC-TREND ANAL CHEM, V29, P15, DOI 10.1016/j.trac.2009.09.008; Izzedine H, 2005, AM J KIDNEY DIS, V45, P804, DOI 10.1053/j.ajkd.2005.02.010; Khatib-Shahidi S, 2006, ANAL CHEM, V78, P6448, DOI 10.1021/ac060788p; Kuhlmann J, 2006, CURR CLIN PHARMACOL, V1, P185, DOI 10.2174/157488406776872578; MONRO AM, 1990, REGUL TOXICOL PHARM, V12, P137, DOI 10.1016/S0273-2300(05)80055-8; Mustafa Dana, 2008, V428, P159; Nilsson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011411; Pellegatti M, 2011, EXPERT OPIN DRUG MET, V7, P137, DOI 10.1517/17425255.2011.545053; Perazella MA, 1999, AM J MED, V106, P459, DOI 10.1016/S0002-9343(99)00041-8; Prideaux B, 2010, METHODS MOL BIOL, V656, P405, DOI 10.1007/978-1-60761-746-4_23; Seeley EH, 2011, J BIOL CHEM, V286, P25459, DOI 10.1074/jbc.R111.225854; Solon EG, 2010, AAPS J, V12, P11, DOI 10.1208/s12248-009-9158-4; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Sugiura Y, 2010, J NEUROIMMUNE PHARM, V5, P31, DOI 10.1007/s11481-009-9162-6	28	38	39	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47353	10.1371/journal.pone.0047353	http://dx.doi.org/10.1371/journal.pone.0047353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110069	gold, Green Published, Green Submitted			2022-12-27	WOS:000310193600014
J	Roy, BM; Zhukov, DV; Maynard, JA				Roy, Benjamin M.; Zhukov, Dmitriy V.; Maynard, Jennifer A.			Flanking Residues Are Central to DO11.10 T Cell Hybridoma Stimulation by Ovalbumin 323-339	PLOS ONE			English	Article							MHC CLASS-II; MAJOR HISTOCOMPATIBILITY COMPLEX; MYELIN BASIC-PROTEIN; PEPTIDE-BINDING; ANTIGEN PRESENTATION; KINETIC STABILITY; ANCHOR RESIDUES; HIGH-AFFINITY; TCR BINDING; HLA-DR	T cell activation requires formation of a tri-molecular interaction between a major histocompatibility complex (MHC), peptide, and T cell receptor. In a common model system, the ovalbumin epitope 323-339 binds the murine class II MHC, I-A(d), in at least three distinct registers. The DO11.10 T cell recognizes the least stable of these, as determined by peptide-MHC dissociation rates. Using exogenous peptides and peptide insertions into a carrier protein in combination with IL-2 secretion assays, we show that the alternate registers do not competitively inhibit display of the active register four. In contrast, this weakly binding register is stabilized by the presence of N-terminal flanking residues active in MHC binding. The DO11.10 hybridoma is sensitive to the presence of specific wild-type residues extending to at least the P-3 peptide position. Transfer of the P-4 to P-2 flanking residues to a hen egg lysozyme epitope also presented by I-A(d) increases the activity of that epitope substantially. These results illustrate the inherent complexity in delineating the interaction of multiple registers based on traditional thermodynamic measurements and demonstrate the potential of flanking residue modification for increasing the activity of weakly bound epitopes. The latter technique represents an alternative to substitution of anchor residues within a weakly bound register, which we show can significantly decrease the activity of the epitope to a responding T cell.	[Roy, Benjamin M.; Zhukov, Dmitriy V.; Maynard, Jennifer A.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Roy, Benjamin M.] Univ Minnesota, Dept Chem Engn, Minneapolis, MN USA	University of Texas System; University of Texas Austin; University of Minnesota System; University of Minnesota Twin Cities	Maynard, JA (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	maynard@che.utexas.edu			Packard Foundation; NSF [DBI-0964137]; NIH [1R01GM095638]; Div Of Biological Infrastructure [0964137] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095638] Funding Source: NIH RePORTER	Packard Foundation(The David & Lucile Packard Foundation); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this project was provided by the Packard Foundation, NSF DBI-0964137 and NIH 1R01GM095638 to JAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiru N, 2000, J AUTOIMMUN, V14, P231, DOI 10.1006/jaut.2000.0369; Bakker ABH, 1997, INT J CANCER, V70, P302, DOI 10.1002/(SICI)1097-0215(19970127)70:3<302::AID-IJC10>3.0.CO;2-H; Bankovich AJ, 2004, MOL IMMUNOL, V40, P1033, DOI 10.1016/j.molimm.2003.11.016; Bordner AJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-41; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Castellino F, 1997, HUM IMMUNOL, V54, P159, DOI 10.1016/S0198-8859(97)00078-5; Chang ST, 2006, BIOINFORMATICS, V22, P2761, DOI 10.1093/bioinformatics/btl479; Chaves FA, 2006, BIOCHEMISTRY-US, V45, P6426, DOI 10.1021/bi060194g; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; DANG LH, 1993, J IMMUNOL, V150, P4206; Dyall R, 1998, J EXP MED, V188, P1553, DOI 10.1084/jem.188.9.1553; Fairchild PJ, 1996, INT IMMUNOL, V8, P1035, DOI 10.1093/intimm/8.7.1035; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Gervois N, 1996, J EXP MED, V183, P2403, DOI 10.1084/jem.183.5.2403; Godkin AJ, 1998, J IMMUNOL, V161, P850; Godkin AJ, 2001, J IMMUNOL, V166, P6720, DOI 10.4049/jimmunol.166.11.6720; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; Jiang W, 2010, P NATL ACAD SCI USA, V107, P13258, DOI 10.1073/pnas.1006344107; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Landais E, 2009, J IMMUNOL, V183, P7949, DOI 10.4049/jimmunol.0902493; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Levisetti MG, 2007, J IMMUNOL, V178, P6051, DOI 10.4049/jimmunol.178.10.6051; LIANG MN, 1995, INT IMMUNOL, V7, P1397, DOI 10.1093/intimm/7.9.1397; Lovitch SB, 2006, J IMMUNOL, V176, P2958, DOI 10.4049/jimmunol.176.5.2958; MARTINEAU P, 1992, GENE, V113, P35, DOI 10.1016/0378-1119(92)90667-E; Maverakis E, 2008, J AUTOIMMUN, V31, P59, DOI 10.1016/j.jaut.2008.02.004; McBeth C, 2008, J MOL BIOL, V375, P1306, DOI 10.1016/j.jmb.2007.11.020; McFarland BJ, 1999, BIOCHEMISTRY-US, V38, P16663, DOI 10.1021/bi991393l; McFarland BJ, 2002, MED RES REV, V22, P168, DOI 10.1002/med.10006; Nanda NK, 2000, J EXP MED, V192, P781, DOI 10.1084/jem.192.6.781; NELSON CA, 1992, P NATL ACAD SCI USA, V89, P7380, DOI 10.1073/pnas.89.16.7380; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Russell HI, 1999, EUR J IMMUNOL, V29, P905, DOI 10.1002/(SICI)1521-4141(199903)29:03<905::AID-IMMU905>3.0.CO;2-8; Scott CA, 1998, IMMUNITY, V8, P319, DOI 10.1016/S1074-7613(00)80537-3; Seamons A, 2003, J EXP MED, V197, P1391, DOI 10.1084/jem.20022226; Seibel JL, 1997, J EXP MED, V185, P1919, DOI 10.1084/jem.185.11.1919; SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; Sundberg EJ, 2003, STRUCTURE, V11, P1151, DOI 10.1016/S0969-2126(03)00187-4; Valmori D, 1999, INT IMMUNOL, V11, P1971, DOI 10.1093/intimm/11.12.1971; Vogt AB, 1997, HUM IMMUNOL, V54, P170, DOI 10.1016/S0198-8859(97)00077-3; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Weaver JM, 2008, J IMMUNOL, V181, P3039, DOI 10.4049/jimmunol.181.5.3039; Weaver JM, 2009, IMMUNOL RES	56	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47585	10.1371/journal.pone.0047585	http://dx.doi.org/10.1371/journal.pone.0047585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110081	Green Published, Green Submitted, gold			2022-12-27	WOS:000310193600017
J	Tanskanen, MM; Westerterp, KR; Uusitalo, AL; Atalay, M; Hakkinen, K; Kinnunen, HO; Kyrolainen, H				Tanskanen, Minna M.; Westerterp, Klaas R.; Uusitalo, Arja L.; Atalay, Mustafa; Hakkinen, Keijo; Kinnunen, Hannu O.; Kyrolainen, Heikki			Effects of Easy-to-Use Protein-Rich Energy Bar on Energy Balance, Physical Activity and Performance during 8 Days of Sustained Physical Exertion	PLOS ONE			English	Article							LEAN BODY-MASS; CARBOHYDRATE AVAILABILITY; DIETARY-PROTEIN; EXERCISE; WEIGHT; FIELD; EXPENDITURE; MEN; SLEEP; WATER	Background: Previous military studies have shown an energy deficit during a strenuous field training course (TC). This study aimed to determine the effects of energy bar supplementation on energy balance, physical activity (PA), physical performance and well-being and to evaluate ad libitum fluid intake during wintertime 8-day strenuous TC. Methods: Twenty-six men (age 20 +/- 1 yr.) were randomly divided into two groups: The control group (n = 12) had traditional field rations and the experimental (Ebar) group (n = 14) field rations plus energy bars of 4.1 MJ.day(-1). Energy (EI) and water intake was recorded. Fat-free mass and water loss were measured with deuterium dilution and elimination, respectively. The energy expenditure was calculated using the intake/balance method and energy availability as (EI/estimated basal metabolic rate). PA was monitored using an accelerometer. Physical performance was measured and questionnaires of upper respiratory tract infections (URTI), hunger and mood state were recorded before, during and after TC. Results: Ebar had a higher EI and energy availability than the controls. However, decreases in body mass and fat mass were similar in both groups representing an energy deficit. No differences were observed between the groups in PA, water balance, URTI symptoms and changes in physical performance and fat-free mass. Ebar felt less hunger after TC than the controls and they had improved positive mood state during the latter part of TC while controls did not. Water deficit associated to higher PA. Furthermore, URTI symptoms and negative mood state associated negatively with energy availability and PA. Conclusion: An easy-to-use protein-rich energy bars did not prevent energy deficit nor influence PA during an 8-day TC. The high content of protein in the bars might have induced satiation decreasing energy intake from field rations. PA and energy intake seems to be primarily affected by other factors than energy supplementation such as mood state.	[Tanskanen, Minna M.; Hakkinen, Keijo; Kyrolainen, Heikki] Univ Jyvaskyla, Dept Biol Phys Act, Jyvaskyla, Finland; [Westerterp, Klaas R.] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands; [Uusitalo, Arja L.] Helsinki Univ Hosp, Dept Clin Physiol & Nucl Med, Helsinki, Finland; [Atalay, Mustafa] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Kinnunen, Hannu O.] Polar Electro Oy, Kempele, Finland	University of Jyvaskyla; Maastricht University; University of Helsinki; Helsinki University Central Hospital; University of Eastern Finland	Tanskanen, MM (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, Jyvaskyla, Finland.	minna.m.tanskanen@jyu.fi		Kyrolainen, Heikki/0000-0003-3822-1733; Kinnunen, Hannu/0000-0001-9190-8708	Finnish Ministry of Education; Finnish Cultural Foundation; Polar Electro Oy; Scientific Advisory Board for Defense	Finnish Ministry of Education; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Polar Electro Oy; Scientific Advisory Board for Defense	This study was granted by the Finnish Ministry of Education, Finnish Cultural Foundation, Polar Electro Oy and the Scientific Advisory Board for Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany JA, 2008, J APPL PHYSIOL, V105, P58, DOI 10.1152/japplphysiol.00005.2008; BAHR R, 1991, ACTA PHYSIOL SCAND, V141, P555, DOI 10.1111/j.1748-1716.1991.tb09117.x; Barrett B, 2005, J CLIN EPIDEMIOL, V58, P609, DOI 10.1016/j.jclinepi.2004.11.019; Bell DG, 2002, MIL MED, V167, P692, DOI 10.1093/milmed/167.8.692; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Brouwer E., 1965, EAAP PUB, V11, P441, DOI DOI 10.4236/NS.2011.312129; Brugniaux JV, 2010, BRIT J SPORT MED, V44, P245, DOI 10.1136/bjsm.2007.045575; Castell LM, 2010, MIL MED, V175, P158, DOI 10.7205/MILMED-D-09-00065; Cline AD, 2000, AVIAT SPACE ENVIR MD, V71, P37; COOPER KH, 1968, J AMER MED ASSOC, V203, P201, DOI 10.1001/jama.203.3.201; Costa RJS, 2005, INT J SPORTS MED, V26, P880, DOI 10.1055/s-2005-837467; Cox GR, 2010, J APPL PHYSIOL, V109, P126, DOI 10.1152/japplphysiol.00950.2009; de Graaf C, 2005, APPETITE, V44, P23, DOI 10.1016/j.appet.2004.08.008; DELANY JP, 1989, J APPL PHYSIOL, V67, P1922, DOI 10.1152/jappl.1989.67.5.1922; EDWARDS JSA, 1991, MIL MED, V156, P466, DOI 10.1093/milmed/156.9.466; FJELD CR, 1988, AM J CLIN NUTR, V48, P671, DOI 10.1093/ajcn/48.3.671; Flakoll PJ, 2004, J APPL PHYSIOL, V96, P951, DOI 10.1152/japplphysiol.00811.2003; FOGELHOLM M, 1994, SPORTS MED, V18, P249, DOI 10.2165/00007256-199418040-00004; Fortes MB, 2011, APPL PHYSIOL NUTR ME, V36, P967, DOI [10.1139/h11-124, 10.1139/H11-124]; Friedl KE, 2000, J APPL PHYSIOL, V88, P1820, DOI 10.1152/jappl.2000.88.5.1820; Hawley JA, 2010, EXERC SPORT SCI REV, V38, P152, DOI 10.1097/JES.0b013e3181f44dd9; Hirsch ES, 2005, APPETITE, V44, P33, DOI 10.1016/j.appet.2004.04.010; Hodgdon J A, 1991, Arctic Med Res, V50 Suppl 6, P132; HOYT RW, 1991, J APPL PHYSIOL, V71, P16, DOI 10.1152/jappl.1991.71.1.16; JOHNSON MJ, 1994, MED SCI SPORT EXER, V26, P235, DOI 10.1249/00005768-199402000-00015; Kinnunen H, 2009, MED SCI SPORTS EXERC, V40, P172; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Kyrolainen H, 2008, EUR J APPL PHYSIOL, V102, P539, DOI 10.1007/s00421-007-0619-0; Lieberman HR, 2008, AM J CLIN NUTR, V88, P667, DOI 10.1093/ajcn/88.3.667; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; Mettler S, 2010, MED SCI SPORT EXER, V42, P326, DOI 10.1249/MSS.0b013e3181b2ef8e; Montain SJ, 2008, MED SCI SPORT EXER, V40, P1970, DOI 10.1249/MSS.0b013e31817f4d58; Montain SJ, 1997, AVIAT SPACE ENVIR MD, V68, P384; Nindl BC, 1997, INT J SPORTS MED, V18, P317, DOI 10.1055/s-2007-972640; Nindl BC, 2002, MED SCI SPORT EXER, V34, P1814, DOI 10.1097/00005768-200211000-00019; PACE N, 1945, J BIOL CHEM, V158, P685; Pikosky MA, 2008, MED SCI SPORT EXER, V40, P505, DOI [10.1249/mss.0b013e31815f6643, 10.1249/MSS.0b013e31815f6643]; POPPER R, 1989, MIL MED, V154, P619; Rintamaki H, 1998, INFLUENCE WATER CARB; ROGNUM TO, 1986, ERGONOMICS, V29, P859, DOI 10.1080/00140138608967198; SCHOELLER DA, 1980, AM J CLIN NUTR, V33, P2686, DOI 10.1093/ajcn/33.12.2686; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Spence L, 2007, MED SCI SPORT EXER, V39, P577, DOI 10.1249/mss.0b013e31802e851a; Tanskanen M, 2009, SCAND J MED SCI SPOR, V19, P871, DOI 10.1111/j.1600-0838.2008.00857.x; Tanskanen MM, 2011, J STRENGTH COND RES, V25, P787, DOI 10.1519/JSC.0b013e3181c1fa5d; Tharion WJ, 2005, APPETITE, V44, P47, DOI 10.1016/j.appet.2003.11.010; THOMPSON JL, 1995, MED SCI SPORT EXER, V27, P347; Uusitalo AIT, 1998, INT J SPORTS MED, V19, P532, DOI 10.1055/s-2007-971956; Venkatraman JT, 2002, SPORTS MED, V32, P323, DOI 10.2165/00007256-200232050-00004; VIITASALO JT, 1987, INT J SPORTS MED, V8, P281, DOI 10.1055/s-2008-1025670; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Welsh TT, 2008, INT J SPORTS MED, V29, P45, DOI 10.1055/s-2007-964970; Westerterp KR, 2005, BRIT J NUTR, V93, P199, DOI 10.1079/BJN20041310; WESTERTERP KR, 1995, OBES RES, V3, P49, DOI 10.1002/j.1550-8528.1995.tb00007.x; Westerterp-Plantenga MS, 2006, INT J OBESITY, V30, pS16, DOI 10.1038/sj.ijo.0803487; Witard OC, 2011, MED SCI SPORT EXER, V43, P598, DOI 10.1249/MSS.0b013e3181f684c9; Zachwieja JJ, 2001, INT J SPORTS MED, V22, P310, DOI 10.1055/s-2001-13822	57	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47771	10.1371/journal.pone.0047771	http://dx.doi.org/10.1371/journal.pone.0047771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094083	Green Published, Green Submitted, gold			2022-12-27	WOS:000312384500021
J	Chen, ZQ; Ding, WH; Xu, K; Tan, J; Sun, CY; Gou, YC; Tong, SJ; Xia, GW; Fang, ZJ; Ding, Q				Chen, Zhongqing; Ding, Weihong; Xu, Ke; Tan, Jun; Sun, Chuanyu; Gou, Yuancheng; Tong, Shijun; Xia, Guowei; Fang, Zujun; Ding, Qiang			The 1973 WHO Classification Is More Suitable than the 2004 WHO Classification for Predicting Prognosis in Non-Muscle- Invasive Bladder Cancer	PLOS ONE			English	Article							PAPILLARY UROTHELIAL NEOPLASMS; GROWTH-FACTOR RECEPTOR-3; IMMUNOHISTOCHEMICAL EXPRESSION; WHO/ISUP CLASSIFICATION; PROGRESSION; TUMORS; RECURRENCE; CARCINOMA; TA; PATHOLOGY	Background: Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) is critical for urologist. Histological grade provides significant prognostic information, especially for prediction of progression. Currently, the 1973 and the 2004 WHO classification co-exist. Which system is better for predicting rumor recurrence and progression still a matter for debate. Methodology/Principal Findings: 348 patients diagnosed with Non-muscle invasive bladder cancer were enrolled in our retrospective study. Paraffin sections were assessed by an experienced urological pathologist according to both the 1973 and 2004 WHO classifications. Tumor recurrence and progression was followed-up in all patients. During follow-up, corresponding 5-year recurrence-free survival rates of G1, G2 and G3 were 82.1%, 55.9%, 32.1% and the 5-year progressionfree survival rates were 95.9%, 84.4% and 43.3%, respectively. The 5-year recurrence-free survival rates of papillary urothelial neoplasm of low malignant potential (PUNLMP), low-grade papillary urothelial carcinoma(LGPUC) and high-grade papillary urothelial carcinoma (HGPUC) were 69.8%, 67.1% and 42.0% respectively and the 5-year progression-free survival rates were 100%, 90.9% and 54.8% respectively. In multivariate analysis, the 1973 WHO classification significantly associated with both tumor recurrence and progression(p = 0.010 and p = 0.022, respectively); the 2004 WHO classification correlated with tumor progression(p = 0.019), while was not proved to be a variable that can predict the risk of recurrence(p = 0.547). Kaplan-Meier plots showed that both the 1973 WHO and the 2004 WHO classifications were significantly associated with progression-free survival (p<0.0001, log-rank test). For prediction of recurrence, significant differences were observed between the tumor grades classified using the 1973 WHO grading system (p<0.0001, log-rank test), while a significant overlap was observed between PUNLMP and LG plots using the 2004 WHO grading system(p = 0.616, log-rank test). Conclusion/Significance: Both the 1973 WHO and the 2004 WHO Classifications are effective in predicting tumor progression in Non-muscle invasive bladder cancer, while the 1973 WHO Classification is more suitable for predicting tumor recurrence.	[Ding, Weihong; Xu, Ke; Sun, Chuanyu; Gou, Yuancheng; Tong, Shijun; Xia, Guowei; Fang, Zujun; Ding, Qiang] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Chen, Zhongqing] Fudan Univ, Huashan Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Tan, Jun] Fudan Univ, Sch Publ Hlth, Dept Biostat & Social Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Xu, K (corresponding author), Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	drkexu@163.com			Health Bureau of Shanghai Municipality [XYQ2011028]	Health Bureau of Shanghai Municipality	This work was made possible due to the generous support of Health Bureau of Shanghai Municipality (XYQ2011028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 1998, BRIT J UROL, V81, P692; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Barbisan F, 2008, CANCER-AM CANCER SOC, V112, P636, DOI 10.1002/cncr.23212; Bryan RT, 2002, BJU INT, V90, P846, DOI 10.1046/j.1464-410X.2002.03053.x; Campbell PA, 2004, BJU INT, V93, P1228, DOI 10.1111/j.1464-410X.2004.04848.x; Cheng L, 1999, CANCER, V86, P2102, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2102::AID-CNCR31>3.3.CO;2-L; Eble JN, 2004, WHO CLASSIFICATION T, P89; EDGE SB, 2009, AJCC CANC STAGING MA, P447; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Fernandez-Gomez J, 2008, EUR UROL, V53, P992, DOI 10.1016/j.eururo.2007.10.006; Fujii Y, 2003, BJU INT, V92, P559, DOI 10.1046/j.1464-410X.2003.04415.x; Holmang S, 2001, J UROLOGY, V165, P1124, DOI 10.1016/S0022-5347(05)66443-9; Jones TD, 2006, J UROLOGY, V175, P1995, DOI 10.1016/S0022-5347(06)00267-9; KURTH KH, 1995, EUR J CANCER, V31A, P1840, DOI 10.1016/0959-8049(95)00287-S; Lopez-Beltran A, 2004, EUR UROL, V46, P170, DOI 10.1016/j.eururo.2004.03.017; MacLennan GT, 2007, EUR UROL, V51, P889, DOI 10.1016/j.eururo.2006.10.037; May M, 2010, EUR UROL, V57, P850, DOI 10.1016/j.eururo.2009.03.052; Montironi R, 2008, HISTOPATHOLOGY, V53, P621, DOI 10.1111/j.1365-2559.2008.03025.x; Mostofi FK, 1973, HISTOLOGICAL TYPING; Oosterhuis JWA, 2002, J CLIN PATHOL, V55, P900, DOI 10.1136/jcp.55.12.900; Pan CC, 2010, AM J CLIN PATHOL, V133, P788, DOI 10.1309/AJCP12MRVVHTCKEJ; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pavone-Macaluso M, 2006, BJU INT, V98, P1161, DOI 10.1111/j.1464-410X.2006.06445.x; Soloway MS, 2007, EUR UROL, V52, P1564, DOI 10.1016/j.eururo.2007.07.011; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Tosoni I, 2000, BJU INT, V85, P48, DOI 10.1046/j.1464-410x.2000.00356.x; Rhijn BWG, 2010, EUR UROL, V57, P1052, DOI 10.1016/j.eururo.2009.09.022; van Rhijn BWG, 2003, J CLIN ONCOL, V21, P1912, DOI 10.1200/JCO.2003.05.073; van Rhijn BWG, 2002, J PATHOL, V198, P245, DOI 10.1002/path.1202; Yin H, 2004, AM J CLIN PATHOL, V121, P679, DOI 10.1039/0KATYHQBJD5XHQ8J	30	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47199	10.1371/journal.pone.0047199	http://dx.doi.org/10.1371/journal.pone.0047199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082147	Green Submitted, gold, Green Published			2022-12-27	WOS:000311146900043
J	Mason, L; O'Sullivan, N; Bentall, RP; El-Deredy, W				Mason, Liam; O'Sullivan, Noreen; Bentall, Richard P.; El-Deredy, Wael			Better Than I Thought: Positive Evaluation Bias in Hypomania	PLOS ONE			English	Article							FEEDBACK-RELATED NEGATIVITY; BIPOLAR DISORDER; PUNISHMENT SENSITIVITY; BEHAVIORAL ACTIVATION; ANTERIOR CINGULATE; REWARD PREDICTION; MANIC SYMPTOMS; DOPAMINE; IMPULSIVITY; SPECTRUM	Background: Mania is characterised by increased impulsivity and risk-taking, and psychological accounts argue that these features may be due to hypersensitivity to reward. The neurobiological mechanisms remain poorly understood. Here we examine reinforcement learning and sensitivity to both reward and punishment outcomes in hypomania-prone individuals not receiving pharmacotherapy. Method: We recorded EEG from 45 healthy individuals split into three groups by low, intermediate and high self-reported hypomanic traits. Participants played a computerised card game in which they learned the reward contingencies of three cues. Neural responses to monetary gain and loss were measured using the feedback-related negativity (FRN), a component implicated in motivational outcome evaluation and reinforcement learning. Results: As predicted, rewards elicited a smaller FRN in the hypomania-prone group relative to the low hypomania group, indicative of greater reward responsiveness. The hypomania-prone group also showed smaller FRN to losses, indicating diminished response to negative feedback. Conclusion: Our findings indicate that proneness to hypomania is associated with both reward hypersensitivity and discounting of punishment. This positive evaluation bias may be driven by aberrant reinforcement learning signals, which fail to update future expectations. This provides a possible neural mechanism explaining risk-taking and impaired reinforcement learning in BD. Further research will be needed to explore the potential value of the FRN as a biological vulnerability marker for mania and pathological risk-taking.	[Mason, Liam; El-Deredy, Wael] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [O'Sullivan, Noreen; Bentall, Richard P.] Univ Liverpool, Sch Hlth Sci, Liverpool L69 3BX, Lancs, England	University of Manchester; University of Liverpool	Mason, L (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	Liam.Mason@manchester.ac.uk	El-deredy, Wael/H-6521-2015	El-deredy, Wael/0000-0002-9822-1092; Mason, Liam/0000-0003-3957-1436	Medical Research Council; Economic and Social Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	LM received interdisciplinary funding from the Medical Research Council and Economic and Social Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2008, NEUROPSYCHOPHARMACOL, V33, P2217, DOI 10.1038/sj.npp.1301620; Akiskal HS, 2000, J AFFECT DISORDERS, V59, pS5, DOI 10.1016/S0165-0327(00)00203-2; Angst J, 2002, BIPOLAR DISORD, V4, P11, DOI 10.1034/j.1399-5618.4.s1.1.x; APA, 2000, DIAGN STAT MAN MENT; Bauer MS, 2005, BRIT J PSYCHIAT, V187, P87, DOI 10.1192/bjp.187.1.87; Bentall RP, 2012, CLIN PSYCHO IN PRESS; Berk M, 2007, ACTA PSYCHIAT SCAND, V116, P41, DOI 10.1111/j.1600-0447.2007.01058.x; Bermpohl F, 2010, HUM BRAIN MAPP, V31, P958, DOI 10.1002/hbm.20909; Blumberg HP, 2000, BIOL PSYCHIAT, V48, P1045, DOI 10.1016/S0006-3223(00)00962-8; Carver C, 2008, COGNITIVE THERAPY RE; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cassidy F, 1998, ARCH GEN PSYCHIAT, V55, P27, DOI 10.1001/archpsyc.55.1.27; Chandler RA, 2009, BIOL PSYCHIAT, V66, P840, DOI 10.1016/j.biopsych.2009.05.011; Cohen MX, 2007, NEUROIMAGE, V35, P968, DOI 10.1016/j.neuroimage.2006.11.056; Cookson J, 2001, BRIT J PSYCHIAT, V178, pS148, DOI 10.1192/bjp.178.41.s148; Depue RA, 1993, BIOL ENV PROCESSES N, P127; ECKBLAD M, 1986, J ABNORM PSYCHOL, V95, P214, DOI 10.1037/0021-843X.95.3.214; Elliott R, 1998, PSYCHOL MED, V28, P559, DOI 10.1017/S0033291798006709; Ernst M, 2006, PSYCHOL MED, V36, P299, DOI 10.1017/S0033291705005891; Foti D, 2009, BIOL PSYCHOL, V81, P1, DOI 10.1016/j.biopsycho.2008.12.004; Franken IHA, 2007, BIOL PSYCHOL, V75, P45, DOI 10.1016/j.biopsycho.2006.11.003; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Goldberg JF, 2009, AM J PSYCHIAT, V166, P173, DOI 10.1176/appi.ajp.2008.08050746; Goldstein RZ, 2006, INT J PSYCHOPHYSIOL, V62, P272, DOI 10.1016/j.ijpsycho.2006.05.006; Goodwin F, 1990, MANIC DEPRESSIVE ILL; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gray JA, 1991, NEUROBIOLOGY LEARNIN, P273; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; HajiHosseini A, 2012, NEUROIMAGE, V60, P1678, DOI 10.1016/j.neuroimage.2012.01.125; Hall JR, 2007, PSYCHOL SCI, V18, P326, DOI 10.1111/j.1467-9280.2007.01899.x; Harmon-Jones E, 2002, J PERS SOC PSYCHOL, V82, P610, DOI 10.1037//0022-3514.82.4.610; Hewig J, 2010, BIOL PSYCHIAT, V67, P781, DOI 10.1016/j.biopsych.2009.11.009; Hofmann BU, 2006, BRIT J CLIN PSYCHOL, V45, P105, DOI 10.1348/014466505X35317; Holmes AJ, 2008, ARCH GEN PSYCHIAT, V65, P179, DOI 10.1001/archgenpsychiatry.2007.19; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2008, PSYCHOPHYSIOLOGY, V45, P688, DOI 10.1111/j.1469-8986.2008.00668.x; HOYLE MH, 1973, INT STAT REV, V41, P203, DOI 10.2307/1402836; JACOBS D, 1986, PSYCHOL MED, V16, P323, DOI 10.1017/S0033291700009132; Johnson SL, 2011, ACTA PSYCHIAT SCAND, V123, P206, DOI 10.1111/j.1600-0447.2010.01602.x; Johnson SL, 2006, COGNITIVE THER RES, V30, P377, DOI 10.1007/s10608-006-9044-7; Johnson SL, 2005, CLIN PSYCHOL REV, V25, P241, DOI 10.1016/j.cpr.2004.11.002; Johnson SL, 2005, CLIN PSYCHOL REV, V25, P1008, DOI 10.1016/j.cpr.2005.06.004; Kamarajan C, 2010, J PSYCHIATR RES, V44, P576, DOI 10.1016/j.jpsychires.2009.11.019; Kamarajan C, 2009, BEHAV BRAIN RES, V197, P62, DOI 10.1016/j.bbr.2008.08.011; Kwapil TR, 2000, J ABNORM PSYCHOL, V109, P222, DOI 10.1037/0021-843X.109.2.222; Lam D, 2004, J AFFECT DISORDERS, V79, P193, DOI 10.1016/S0165-0327(02)00462-7; Luque D, 2012, J COGNITIVE NEUROSCI, V24, P794, DOI 10.1162/jocn_a_00145; Marco-Pallares J, 2011, PSYCHOPHYSIOLOGY, V48, P852, DOI 10.1111/j.1469-8986.2010.01152.x; Mason L, 2012, BIOL PSYCHI IN PRESS; Mason L, 2012, BIOL PSYCHIAT, V71, P530, DOI 10.1016/j.biopsych.2011.10.008; Meyer B, 1999, J PSYCHOPATHOL BEHAV, V21, P275, DOI 10.1023/A:1022119414440; Meyer TD, 2006, PSYCHIAT RES, V141, P103, DOI 10.1016/j.psychres.2005.07.023; Mies GW, 2011, PSYCHOL MED, P1; O'Sullivan N, 2011, NEUROPSYCHOLOGIA, V49, P2825, DOI 10.1016/j.neuropsychologia.2011.06.008; Oberg SAK, 2011, NEUROPSYCHOLOGIA; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Onoda K, 2010, NEUROREPORT, V21, P736, DOI 10.1097/WNR.0b013e32833bfd36; PATTERSON CM, 1993, PSYCHOL REV, V100, P716, DOI 10.1037/0033-295X.100.4.716; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Phillips ML, 2007, SCHIZOPHRENIA BULL, V33, P893, DOI 10.1093/schbul/sbm060; Pine A, 2010, J NEUROSCI, V30, P8888, DOI 10.1523/JNEUROSCI.6028-09.2010; Pizzagalli DA, 2010, NEUROPSYCHOPHARMACOL; Pizzagalli DA, 2008, BIOL PSYCHIAT, V64, P162, DOI 10.1016/j.biopsych.2007.12.001; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Potts GF, 2006, NEUROSCI LETT, V397, P130, DOI 10.1016/j.neulet.2005.12.003; POWER MJ, 1994, J RES PERS, V28, P263, DOI 10.1006/jrpe.1994.1019; Santesso DL, 2011, PSYCHOPHYSIOLOGY, V48, P1481, DOI 10.1111/j.1469-8986.2011.01229.x; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Segalowitz SJ, 2011, SOCIAL COGNITIVE AFF; Sharot T, 2011, NATURE NEUROSCIENCE; Swann AC, 2003, J AFFECT DISORDERS, V73, P105, DOI 10.1016/S0165-0327(02)00328-2; Swann AC, 2001, PSYCHIAT RES, V101, P195, DOI 10.1016/S0165-1781(00)00249-3; Swann AC, 2008, J AFFECT DISORDERS, V106, P241, DOI 10.1016/j.jad.2007.07.011; Urosevic S, 2008, CLIN PSYCHOL REV, V28, P1188, DOI 10.1016/j.cpr.2008.04.004; van Meel CS, 2011, J CHILD PSYCHOL PSYC, V52, P942, DOI 10.1111/j.1469-7610.2010.02352.x; Voon V, 2010, NEURON, V65, P135, DOI 10.1016/j.neuron.2009.12.027; Weissman AN, 1978, P M AM ED RES ASS TO; Willner P, 2005, J AFFECT DISORDERS, V86, P37, DOI 10.1016/j.jad.2004.12.010; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yasuda A, 2004, NEUROREPORT, V15, P2561, DOI 10.1097/00001756-200411150-00027	82	28	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47754	10.1371/journal.pone.0047754	http://dx.doi.org/10.1371/journal.pone.0047754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082210	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900107
J	Miladinovic, B; Kumar, A; Mhaskar, R; Kim, S; Schonwetter, R; Djulbegovic, B				Miladinovic, Branko; Kumar, Ambuj; Mhaskar, Rahul; Kim, Sehwan; Schonwetter, Ronald; Djulbegovic, Benjamin			A Flexible Alternative to the Cox Proportional Hazards Model for Assessing the Prognostic Accuracy of Hospice Patient Survival	PLOS ONE			English	Article							PALLIATIVE PERFORMANCE SCALE; PREDICTION MODELS; CANCER; FRAMEWORK; TOOLS; CARE	Prognostic models are often used to estimate the length of patient survival. The Cox proportional hazards model has traditionally been applied to assess the accuracy of prognostic models. However, it may be suboptimal due to the inflexibility to model the baseline survival function and when the proportional hazards assumption is violated. The aim of this study was to use internal validation to compare the predictive power of a flexible Royston-Parmar family of survival functions with the Cox proportional hazards model. We applied the Palliative Performance Scale on a dataset of 590 hospice patients at the time of hospice admission. The retrospective data were obtained from the Lifepath Hospice and Palliative Care center in Hillsborough County, Florida, USA. The criteria used to evaluate and compare the models' predictive performance were the explained variation statistic R-2, scaled Brier score, and the discrimination slope. The explained variation statistic demonstrated that overall the Royston-Parmar family of survival functions provided a better fit (R-2=0.298; 95% CI:0.236-0.358) than the Cox model (R-2=0.156; 95% CI: 0.111-0.203). The scaled Brier scores and discrimination slopes were consistently higher under the Royston-Parmar model. Researchers involved in prognosticating patient survival are encouraged to consider the Royston-Parmar model as an alternative to Cox.	[Miladinovic, Branko; Kumar, Ambuj; Mhaskar, Rahul; Djulbegovic, Benjamin] Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33620 USA; [Kim, Sehwan; Schonwetter, Ronald] HPC Healthcare, Temple Terrace, FL USA; [Djulbegovic, Benjamin] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Miladinovic, B (corresponding author), Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33620 USA.	bmiladin@health.usf.edu	Djulbegovic, Benjamin/I-3661-2012; Florida, University of South/GRT-0107-2022; Kumar, Ambuj/I-4940-2012; Miladinovic, Branko/I-4938-2012; KUMAR, ASHOK/AAF-4055-2021; Kumar, Ambuj/U-5268-2019	Djulbegovic, Benjamin/0000-0003-0671-1447; Florida, University of South/0000-0002-3728-6052; Miladinovic, Branko/0000-0002-7000-1258; KUMAR, ASHOK/0000-0002-9244-0622; 	United States Army Medical Research and Material Command [DOA W81 XWH-09-0175]	United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This study was supported by the United States Army Medical Research and Material Command grant DOA W81 XWH-09-0175. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, CANCER INVEST, V27, P235, DOI 10.1080/07357900802572110; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Anderson F, 1996, J PALLIAT CARE, V12, P5, DOI 10.1177/082585979601200102; [Anonymous], 2010, STAT VERS 11 COMP PR; Binquet C, 2008, STAT MED, V27, P6470, DOI 10.1002/sim.3447; Chow E, 2001, CLIN ONCOL-UK, V13, P209, DOI 10.1007/s001740170078; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cox D. R., 1984, ANAL SURVIVAL DATA; Downing M, 2007, J PALLIAT CARE, V23, P245, DOI 10.1177/082585970702300402; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Fainsinger RL, 2000, J PALLIATIVE CARE, V16, P29, DOI 10.1177/082585970001600106; Graf E, 1999, STAT MED, V18, P2529; Harrold Joan, 2005, J Palliat Med, V8, P503, DOI 10.1089/jpm.2005.8.503; Head Barbara, 2005, J Palliat Med, V8, P492, DOI 10.1089/jpm.2005.8.492; Ho Francis, 2008, BMC Palliat Care, V7, P10, DOI 10.1186/1472-684X-7-10; Hu B, 2006, STAT MED, V25, P1383, DOI 10.1002/sim.2300; Jackson C, 2012, FLEXIBLE PARAMETRIC; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Lau F, 2007, J PALLIAT CARE, V23, P93, DOI 10.1177/082585970702300205; Lau F, 2009, J PAIN SYMPTOM MANAG, V37, P965, DOI 10.1016/j.jpainsymman.2008.08.003; Lau F, 2009, J PAIN SYMPTOM MANAG, V38, P134, DOI 10.1016/j.jpainsymman.2008.05.017; Lau F, 2008, J PALLIAT CARE, V24, P282, DOI 10.1177/082585970802400412; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-21; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Morita T, 1999, J PAIN SYMPTOM MANAG, V18, P2; Morita T, 2001, J PAIN SYMPTOM MANAG, V21, P282, DOI 10.1016/S0885-3924(01)00258-5; Olajide C, 2007, J PALLIAT MED, V10, P111, DOI 10.1089/jpm.2006.0125; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Royston P, 2011, FLEXIBLE PARAMETRIC; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Royston P, 2001, STATA J, V1, P1, DOI 10.1177/1536867X0100100101; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Vickers AJ, 2011, J CLIN ONCOL, V29, P2951, DOI 10.1200/JCO.2011.36.1329; Virik K, 2002, J PAIN SYMPTOM MANAG, V23, P455, DOI 10.1016/S0885-3924(02)00407-4	41	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47804	10.1371/journal.pone.0047804	http://dx.doi.org/10.1371/journal.pone.0047804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082220	gold, Green Submitted, Green Published			2022-12-27	WOS:000311146900117
J	Wang, Y; Chen, Y; Zhou, Q; Huang, S; Ning, K; Xu, J; Kalin, RM; Rolfe, S; Huang, WE				Wang, Yun; Chen, Yin; Zhou, Qian; Huang, Shi; Ning, Kang; Xu, Jian; Kalin, Robert M.; Rolfe, Stephen; Huang, Wei E.			A Culture-Independent Approach to Unravel Uncultured Bacteria and Functional Genes in a Complex Microbial Community	PLOS ONE			English	Article							CATABOLIC NAG GENES; SP STRAIN U2; RIBOSOMAL-RNA; NAPHTHALENE-DEGRADATION; SYSTEMS MICROBIOLOGY; NUCLEOTIDE-SEQUENCE; METAGENOMICS; DNA; CELL; METABOLISM	Most microorganisms in nature are uncultured with unknown functionality. Sequence-based metagenomics alone answers 'who/what are there?' but not 'what are they doing and who is doing it and how?'. Function-based metagenomics reveals gene function but is usually limited by the specificity and sensitivity of screening strategies, especially the identification of clones whose functional gene expression has no distinguishable activity or phenotypes. A 'biosensor-based genetic transducer' (BGT) technique, which employs a whole-cell biosensor to quantitatively detect expression of inserted genes encoding designated functions, is able to screen for functionality of unknown genes from uncultured microorganisms. In this study, BGT was integrated with Stable isotope probing (SIP)-enabled Metagenomics to form a culture-independent SMB toolbox. The utility of this approach was demonstrated in the discovery of a novel functional gene cluster in naphthalene contaminated groundwater. Specifically, metagenomic sequencing of the C-13-DNA fraction obtained by SIP indicated that an uncultured Acidovorax sp. was the dominant key naphthalene degrader in-situ, although three culturable Pseudomonas sp. degraders were also present in the same groundwater. BGT verified the functionality of a new nag2 operon which coexisted with two other nag and two nah operons for naphthalene biodegradation in the same microbial community. Pyrosequencing analysis showed that the nag2 operon was the key functional operon in naphthalene degradation in-situ, and shared homology with both nag operons in Ralstonia sp. U2 and Polaromonas naphthalenivorans CJ2. The SMB toolbox will be useful in providing deep insights into uncultured microorganisms and unravelling their ecological roles in natural environments.	[Wang, Yun; Huang, Wei E.] Univ Sheffield, Kroto Res Inst, Sheffield, S Yorkshire, England; [Chen, Yin] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Zhou, Qian; Huang, Shi; Ning, Kang; Xu, Jian] Chinese Acad Sci, Key Lab Biofuels, BioEnergy Genome Ctr, Qingdao, Peoples R China; [Zhou, Qian; Huang, Shi; Ning, Kang; Xu, Jian] Chinese Acad Sci, Qingdao Inst BioEnergy & Bioproc Technol, Shandong Key Lab Energy Genet, Qingdao, Peoples R China; [Kalin, Robert M.] Univ Strathclyde, David Livingstone Ctr Sustainabil, Glasgow, Lanark, Scotland; [Rolfe, Stephen] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Warwick; Chinese Academy of Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; University of Strathclyde; University of Sheffield	Huang, WE (corresponding author), Univ Sheffield, Kroto Res Inst, Sheffield, S Yorkshire, England.	w.huang@shef.ac.uk	Chen, Yin/C-2669-2009; Kalin, Robert/E-8620-2011; Huang, Shi/X-8824-2019; Rolfe, Stephen/GQB-3258-2022; Xu, Jian/G-8430-2012; Huang, Wei/N-6880-2019; Ning, Kang/ABD-3446-2020	Chen, Yin/0000-0002-0367-4276; Kalin, Robert/0000-0003-3768-3848; Huang, Shi/0000-0002-7529-2269; Xu, Jian/0000-0002-0548-8477; Huang, Wei/0000-0003-1302-6528; Rolfe, Stephen/0000-0003-2141-4707; Ning, Kang/0000-0003-3325-5387	Chinese Scholarship Council; BBSRC-LINK grant [BRM19108, BRM19109]; Biotechnology and Biological Sciences Research Council [BRM19108] Funding Source: researchfish	Chinese Scholarship Council(China Scholarship Council); BBSRC-LINK grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Chinese Scholarship Council for providing studentship to YW. We are indebted to Professor Wolfgang Hillen (Friedrich-Alexander-Universitat Erlangen Nurnberg) for supplying the plasmid vector pWH1274 and Professor Colin Murrell (the University of Warwick) for advice on DNA-SIP. We also thank BBSRC-LINK grant (references BRM19108 and BRM19109) for site knowledge and samples. We are grateful to Prof Victor de Lorenzo for helpful and critical discussion.	Allen CCR, 1997, APPL ENVIRON MICROB, V63, P151, DOI 10.1128/AEM.63.1.151-155.1997; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Andam CP, 2011, NAT REV MICROBIOL, V9, P543, DOI 10.1038/nrmicro2593; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P457; Bode HB, 2005, ANGEW CHEM INT EDIT, V44, P6828, DOI 10.1002/anie.200501080; Bosch R, 2000, GENE, V245, P65, DOI 10.1016/S0378-1119(00)00038-X; CANE PA, 1982, J GEN MICROBIOL, V128, P2281; Cardenas E, 2008, CURR OPIN BIOTECH, V19, P544, DOI 10.1016/j.copbio.2008.10.010; Carreno CA, 2010, HDB HYDROCARBON LIPI, P4563; Chen Y, 2010, TRENDS MICROBIOL, V18, P157, DOI 10.1016/j.tim.2010.02.002; Dennis JJ, 2004, J MOL BIOL, V341, P753, DOI 10.1016/j.jmb.2004.06.034; Dietrich JA, 2010, ANNU REV BIOCHEM, V79, P563, DOI 10.1146/annurev-biochem-062608-095938; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Ferguson AS, 2007, J APPL MICROBIOL, V102, P1227, DOI 10.1111/j.1365-2672.2007.03398.x; Ferrer M, 2009, MICROB BIOTECHNOL, V2, P31, DOI 10.1111/j.1751-7915.2008.00057.x; Fortman JL, 2005, CHEMBIOCHEM, V6, P960, DOI 10.1002/cbic.200400428; Fuchs BM, 1998, APPL ENVIRON MICROB, V64, P4973; Galvao TC, 2005, TRENDS BIOTECHNOL, V23, P497, DOI 10.1016/j.tibtech.2005.08.002; Gillespie DE, 2002, APPL ENVIRON MICROB, V68, P4301, DOI 10.1128/AEM.68.9.4301-4306.2002; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; GRUND E, 1992, APPL ENVIRON MICROB, V58, P1874, DOI 10.1128/AEM.58.6.1874-1877.1992; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Head IM, 1998, MICROB ECOL, V35, P1, DOI 10.1007/s002489900056; Huang WE, 2005, ENVIRON MICROBIOL, V7, P1339, DOI 10.1111/j.1462-5822.2005.00821.x; Huang WE, 2008, ENVIRON MICROBIOL, V10, P1668, DOI 10.1111/j.1462-2920.2008.01583.x; Huang WE, 2009, APPL ENVIRON MICROB, V75, P234, DOI 10.1128/AEM.01861-08; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Jeon CO, 2006, APPL ENVIRON MICROB, V72, P1086, DOI 10.1128/AEM.72.2.1086-1095.2006; Jones RM, 2003, J BACTERIOL, V185, P5847, DOI 10.1128/JB.185.19.5847-5853.2003; JUNI E, 1969, J BACTERIOL, V98, P281, DOI 10.1128/JB.98.1.281-288.1969; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Moser R, 2001, APPL MICROBIOL BIOT, V55, P609, DOI 10.1007/s002530000489; Murrell JC, 2011, STABLE ISOTOPE PROBING AND RELATED TECHNOLOGIES, P1; Neufeld JD, 2007, NAT PROTOC, V2, P860, DOI 10.1038/nprot.2007.109; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Sambrook J., 2002, MOL CLONING LAB MANU; Schloss PD, 2003, CURR OPIN BIOTECH, V14, P303, DOI 10.1016/S0958-1669(03)00067-3; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Song YZ, 2009, ENVIRON SCI TECHNOL, V43, P7931, DOI 10.1021/es901349r; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Torres-Cortes G, 2011, ENVIRON MICROBIOL, V13, P1101, DOI 10.1111/j.1462-2920.2010.02422.x; Uchiyama T, 2005, NAT BIOTECHNOL, V23, P88, DOI 10.1038/nbt1048; Uchiyama T, 2010, APPL ENVIRON MICROB, V76, P7029, DOI 10.1128/AEM.00464-10; Venter JC, 2003, SCIENTIST, V17, P8; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Vieites JM, 2009, FEMS MICROBIOL REV, V33, P236, DOI 10.1111/j.1574-6976.2008.00152.x; Whitfield J, 2005, SCIENCE, V310, P960, DOI 10.1126/science.310.5750.960; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Williamson LL, 2005, APPL ENVIRON MICROB, V71, P6335, DOI 10.1128/AEM.71.10.6335-6344.2005; YEN KM, 1982, P NATL ACAD SCI-BIOL, V79, P874, DOI 10.1073/pnas.79.3.874; Zhang DY, 2012, MICROB BIOTECHNOL, V5, P87, DOI 10.1111/j.1751-7915.2011.00301.x; Zhang DY, 2011, MICROB BIOTECHNOL, V4, P89, DOI 10.1111/j.1751-7915.2010.00228.x; Zhou NY, 2001, J BACTERIOL, V183, P700, DOI 10.1128/JB.183.2.700-708.2001	61	23	26	5	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47530	10.1371/journal.pone.0047530	http://dx.doi.org/10.1371/journal.pone.0047530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082176	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000311146900072
J	White, SN; Mousel, MR; Herrmann-Hoesing, LM; Reynolds, JO; Leymaster, KA; Neibergs, HL; Lewis, GS; Knowles, DP				White, Stephen N.; Mousel, Michelle R.; Herrmann-Hoesing, Lynn M.; Reynolds, James O.; Leymaster, Kreg A.; Neibergs, Holly L.; Lewis, Gregory S.; Knowles, Donald P.			Genome-Wide Association Identifies Multiple Genomic Regions Associated with Susceptibility to and Control of Ovine Lentivirus	PLOS ONE			English	Article							PROGRESSIVE PNEUMONIA VIRUS; MAEDI-VISNA VIRUS; SMALL RUMINANT LENTIVIRUSES; LINKAGE DISEQUILIBRIUM; CAPRINE ARTHRITIS; POLAR OVERDOMINANCE; ENCEPHALITIS-VIRUS; TOOL SET; SHEEP; BREED	Background: Like human immunodeficiency virus (HIV), ovine lentivirus (OvLV) is macrophage-tropic and causes lifelong infection. OvLV infects one quarter of U. S. sheep and induces pneumonia and body condition wasting. There is no vaccine to prevent OvLV infection and no cost-effective treatment for infected animals. However, breed differences in prevalence and proviral concentration have indicated a genetic basis for susceptibility to OvLV. A recent study identified TMEM154 variants in OvLV susceptibility. The objective here was to identify additional loci associated with odds and/or control of OvLV infection. Methodology/Principal Findings: This genome-wide association study (GWAS) included 964 sheep from Rambouillet, Polypay, and Columbia breeds with serological status and proviral concentration phenotypes. Analytic models accounted for breed and age, as well as genotype. This approach identified TMEM154 (nominal P = 9.2x10(-7); empirical P = 0.13), provided 12 additional genomic regions associated with odds of infection, and provided 13 regions associated with control of infection (all nominal <1x10(-5)). Rapid decline of linkage disequilibrium with distance suggested many regions included few genes each. Genes in regions associated with odds of infection included DPPA2/DPPA4 (empirical P = 0.006), and SYTL3 (P = 0.051). Genes in regions associated with control of infection included a zinc finger cluster (ZNF192, ZSCAN16, ZNF389, and ZNF165; P = 0.001), C19orf42/TMEM38A (P = 0.047), and DLGAP1 (P = 0.092). Conclusions/Significance: These associations provide targets for mutation discovery in sheep susceptibility to OvLV. Aside from TMEM154, these genes have not been associated previously with lentiviral infection in any species, to our knowledge. Further, data from other species suggest functional hypotheses for future testing of these genes in OvLV and other lentiviral infections. Specifically, SYTL3 binds and may regulate RAB27A, which is required for enveloped virus assembly of human cytomegalovirus. Zinc finger transcription factors have been associated with positive selection for repression of retroviral replication. DLGAP1 binds and may regulate DLG1, a known regulator of HIV infectivity.	[White, Stephen N.; Reynolds, James O.; Knowles, Donald P.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [White, Stephen N.; Herrmann-Hoesing, Lynn M.; Knowles, Donald P.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Mousel, Michelle R.; Lewis, Gregory S.] ARS, US Sheep Expt Stn, USDA, Dubois, IN USA; [Leymaster, Kreg A.] ARS, Genet & Breeding Res Unit, US Meat Anim Res Ctr, USDA, Clay Ctr, NE USA; [Neibergs, Holly L.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Washington State University	White, SN (corresponding author), ARS, Anim Dis Res Unit, USDA, Pullman, WA USA.	Stephen.White@ars.usda.gov	; Mousel, Michelle/I-6398-2013	White, Stephen N./0000-0001-9255-6054; Mousel, Michelle/0000-0003-1367-7005	USDA-ARS CWA [5348-32000-031-00D]	USDA-ARS CWA(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by USDA-ARS CWA No. 5348-32000-031-00D. (http://www.ars.usda.gov/main/main.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Blacklaws BA, 2012, COMP IMMUNOL MICROB, V35, P259, DOI 10.1016/j.cimid.2011.12.003; Blacklaws BA, 2010, CURR HIV RES, V8, P26, DOI 10.2174/157016210790416406; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Caroline L, 2010, CURR HIV RES, V8, P94, DOI 10.2174/157016210790416415; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Cortez-Romero C, 2011, REPROD DOMEST ANIM, V46, pe1, DOI 10.1111/j.1439-0531.2010.01608.x; CUTLIP RC, 1986, VET MICROBIOL, V12, P283, DOI 10.1016/0378-1135(86)90057-X; CUTLIP RC, 1992, AM J VET RES, V53, P976; DEBOER GF, 1979, RES VET SCI, V26, P202, DOI 10.1016/S0034-5288(18)32917-5; Du Juan, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P542; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Fraile-Ramos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015318; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V281, P1226, DOI 10.1006/bbrc.2001.4512; GATES NL, 1978, J AM VET MED ASSOC, V173, P1575; Heaton MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002467; Heidtman M, 2005, MOL BIOL CELL, V16, P1673, DOI 10.1091/mbc.E04-10-0873; Herrmann LM, 2003, CLIN DIAGN LAB IMMUN, V10, P862, DOI 10.1128/CDLI.10.5.862-865.2003; Herrmann-Hoesing LM, 2007, CLIN VACCINE IMMUNOL, V14, P1274, DOI 10.1128/CVI.00095-07; Herrmann-Hoesing LM, 2009, CLIN VACCINE IMMUNOL, V16, P551, DOI 10.1128/CVI.00459-08; Herrmann-Hoesing LM, 2008, IMMUNOGENETICS, V60, P749, DOI 10.1007/s00251-008-0328-9; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HOUWERS DJ, 1989, RES VET SCI, V46, P5, DOI 10.1016/S0034-5288(18)31108-1; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Hu ZL, 2007, MAMM GENOME, V18, P1, DOI 10.1007/s00335-006-0105-8; HULET CV, 1984, J ANIM SCI, V58, P15, DOI 10.2527/jas1984.58115x; InfoSheet, 2003, OIL SEEDS WORLD MARK, P1; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Keen JE, 1997, PREV VET MED, V30, P81, DOI 10.1016/S0167-5877(96)01121-X; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim ES, 2009, ANIM GENET, V40, P279, DOI 10.1111/j.1365-2052.2008.01831.x; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Madan B, 2009, MOL CELL BIOL, V29, P3186, DOI 10.1128/MCB.01970-08; Marshall K, 2009, ANIM GENET, V40, P262, DOI 10.1111/j.1365-2052.2008.01836.x; Nakamura T, 2011, MOL CELL BIOL, V31, P4366, DOI 10.1128/MCB.05701-11; NARAYAN O, 1988, ANN NEUROL, V23, pS95, DOI 10.1002/ana.410230725; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Perugi F, 2009, MOL BIOL CELL, V20, P498, DOI 10.1091/mbc.E08-02-0189; Peterson K, 2008, THERIOGENOLOGY, V69, P433, DOI 10.1016/j.theriogenology.2007.10.013; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, 2010, ANIM GENET, V41, P346, DOI 10.1111/j.1365-2052.2009.02011.x; Reina R, 2009, VET J, V182, P31, DOI 10.1016/j.tvjl.2008.05.008; Satoh K, 1997, GENES CELLS, V2, P415, DOI 10.1046/j.1365-2443.1997.1310329.x; Seldin MF, 2007, CURR OPIN GENET DEV, V17, P177, DOI 10.1016/j.gde.2007.03.002; Slager RE, 2011, EUR RESPIR MONOGR, P82, DOI 10.1183/1025448x.10001010; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; SNOWDER GD, 1990, J AM VET MED ASSOC, V197, P475; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Team R. D. C, 2011, R LANG ENV STAT COMP; TERRILL CE, 1958, J ANIM SCI, V17, P944, DOI 10.2527/jas1958.174944x; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Torsteinsdottir S, 2007, FRONT BIOSCI-LANDMRK, V12, P1532, DOI 10.2741/2166; Yamazaki D, 2011, CELL METAB, V14, P231, DOI 10.1016/j.cmet.2011.05.011; Yokoyama K, 2011, J BIOL CHEM, V286, P5375, DOI 10.1074/jbc.M110.171702; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	59	37	40	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47829	10.1371/journal.pone.0047829	http://dx.doi.org/10.1371/journal.pone.0047829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082221	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900118
J	Zarringhalam, K; Meyer, MM; Dotu, I; Chuang, JH; Clote, P				Zarringhalam, Kourosh; Meyer, Michelle M.; Dotu, Ivan; Chuang, Jeffrey H.; Clote, Peter			Integrating Chemical Footprinting Data into RNA Secondary Structure Prediction	PLOS ONE			English	Article							SELECTIVE 2'-HYDROXYL ACYLATION; SINGLE NUCLEOTIDE RESOLUTION; PRIMER EXTENSION SHAPE; PSEUDOKNOTS; STABILITY; SEQUENCES; SOFTWARE; BACTERIA	Chemical and enzymatic footprinting experiments, such as shape (selective 2'-hydroxyl acylation analyzed by primer extension), yield important information about RNA secondary structure. Indeed, since the 2'-hydroxyl is reactive at flexible (loop) regions, but unreactive at base-paired regions, shape yields quantitative data about which RNA nucleotides are basepaired. Recently, low error rates in secondary structure prediction have been reported for three RNAs of moderate size, by including base stacking pseudo-energy terms derived from shape data into the computation of minimum free energy secondary structure. Here, we describe a novel method, RNAsc (RNA soft constraints), which includes pseudo-energy terms for each nucleotide position, rather than only for base stacking positions. We prove that RNAsc is self-consistent, in the sense that the nucleotide-specific probabilities of being unpaired in the low energy Boltzmann ensemble always become more closely correlated with the input shape data after application of RNAsc. From this mathematical perspective, the secondary structure predicted by RNAsc should be 'correct', in as much as the shape data is 'correct'. We benchmark RNAsc against the previously mentioned method for eight RNAs, for which both shape data and native structures are known, to find the same accuracy in 7 out of 8 cases, and an improvement of 25% in one case. Furthermore, we present what appears to be the first direct comparison of shape data and in-line probing data, by comparing yeast asp-tRNA shape data from the literature with data from in-line probing experiments we have recently performed. With respect to several criteria, we find that shape data appear to be more robust than in-line probing data, at least in the case of asp-tRNA.	[Zarringhalam, Kourosh; Meyer, Michelle M.; Dotu, Ivan; Chuang, Jeffrey H.; Clote, Peter] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Boston College	Clote, P (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	peter.clote@bc.edu		Dotu, Ivan/0000-0002-0438-9557; Chuang, Jeffrey/0000-0002-3298-2358	Division Of Mathematical Sciences [1016618] Funding Source: National Science Foundation	Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Bailor MH, 2010, SCIENCE, V327, P202, DOI 10.1126/science.1181085; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BANERJEE AR, 1993, BIOCHEMISTRY-US, V32, P153, DOI 10.1021/bi00052a021; Bellaousov S, 2010, RNA, V16, P1870, DOI 10.1261/rna.2125310; Cho SS, 2009, P NATL ACAD SCI USA, V106, P17349, DOI 10.1073/pnas.0906625106; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Ding Y, 2004, NUCL ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Duncan CDS, 2008, BIOCHEMISTRY-US, V47, P8504, DOI 10.1021/bi800207b; Forties RA, 2010, BIOINFORMATICS, V26, P61, DOI 10.1093/bioinformatics/btp627; Garey MR, 1990, COMPUTERS INTRACTABI; Higgs PG, 1996, PHYS REV LETT, V76, P704, DOI 10.1103/PhysRevLett.76.704; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kladwang W, 2011, BIOCHEMISTRY-US, V50, P8049, DOI [10.1021/bi4200524n, 10.1021/bi200524n]; Kladwang W, 2011, RNA, V17, P522, DOI 10.1261/rna.2516311; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Lyngso RB, 2000, J COMPUT BIOL, V7, P409, DOI 10.1089/106652700750050862; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mathews D, 2000, CURRENT PROTOCOLS NU; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 2005, BIOINFORMATICS, V21, P2246, DOI 10.1093/bioinformatics/bti349; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Meyer MM, 2008, RNA, V14, P685, DOI 10.1261/rna.937308; Novikova IV, 2012, NUCL ACIDS RES; Quarrier S, 2010, RNA, V16, P1108, DOI 10.1261/rna.1988510; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Tabaska JE, 1998, BIOINFORMATICS, V14, P691, DOI 10.1093/bioinformatics/14.8.691; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Washietl S, 2010, METHODS MOL BIOL, V609, P285, DOI 10.1007/978-1-60327-241-4_17; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	42	60	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e45160	10.1371/journal.pone.0045160	http://dx.doi.org/10.1371/journal.pone.0045160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091593	Green Submitted, Green Published, gold			2022-12-27	WOS:000310135800003
J	Stanton, MA; Mann, J				Stanton, Margaret A.; Mann, Janet			Early Social Networks Predict Survival in Wild Bottlenose Dolphins	PLOS ONE			English	Article							TURSIOPS SP.; REPRODUCTIVE SUCCESS; SEX-DIFFERENCES; GROUP-SIZE; SHARK BAY; STRESS; BONDS; AGGRESSION; EXPERIENCE; EVOLUTION	A fundamental question concerning group-living species is what factors influence the evolution of sociality. Although several studies link adult social bonds to fitness, social patterns and relationships are often formed early in life and are also likely to have fitness consequences, particularly in species with lengthy developmental periods, extensive social learning, and early social bond-formation. In a longitudinal study of bottlenose dolphins (Tursiops sp.), calf social network structure, specifically the metric eigenvector centrality, predicted juvenile survival in males. Additionally, male calves that died post-weaning had stronger ties to juvenile males than surviving male calves, suggesting that juvenile males impose fitness costs on their younger counterparts. Our study indicates that selection is acting on social traits early in life and highlights the need to examine the costs and benefits of social bonds during formative life history stages.	[Stanton, Margaret A.; Mann, Janet] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Stanton, Margaret A.] Georgetown Univ, Dept Anthropol, Washington, DC USA; [Mann, Janet] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA	Georgetown University; Georgetown University; Georgetown University	Stanton, MA (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.	mastanton@gwu.edu	Mann, Janet/L-2311-2019	Mann, Janet/0000-0003-0664-175X	Explorer's Club Washington Group; Georgetown University Center For the Environment; Georgetown University Graduate School of Arts and Sciences; NSF [0941487, 0918308, 0316800, 9753044]; ONR BAA [9-001, 10230702]; Georgetown University; Brach Foundation; Eppley Foundation for Research; National Geographic Society Committee for Research and Exploration	Explorer's Club Washington Group; Georgetown University Center For the Environment; Georgetown University Graduate School of Arts and Sciences; NSF(National Science Foundation (NSF)); ONR BAA(Office of Naval Research); Georgetown University; Brach Foundation; Eppley Foundation for Research; National Geographic Society Committee for Research and Exploration(National Geographic Society)	Funding was provided by The Explorer's Club Washington Group, Georgetown University Center For the Environment, Georgetown University Graduate School of Arts and Sciences, and grants to J.M., NSF (#s 0941487, 0918308, 0316800, 9753044), ONR BAA (#09-001 grant #10230702), Georgetown University, Brach Foundation, Eppley Foundation for Research, and the National Geographic Society Committee for Research and Exploration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillargeon S, 2007, J STAT SOFTW, V19; Barocas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022375; Bates D., 2011, IME4 LINEAR MIXED EF; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Brent LJN, 2011, PHYSIOL BEHAV, V102, P76, DOI 10.1016/j.physbeh.2010.09.022; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; Connor RC, 1998, TRENDS ECOL EVOL, V13, P228, DOI 10.1016/S0169-5347(98)01326-3; Connor RC, 2000, CETACEAN SOCIETIES, P91; Connor RC, 2001, P ROY SOC B-BIOL SCI, V268, P263, DOI 10.1098/rspb.2000.1357; Connor RC, 2011, BIOL LETTERS, V7, P623, DOI 10.1098/rsbl.2010.0852; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; De Waal FBM, 2003, ANIMAL SOCIAL COMPLEXITY, P230; DEWAAL FBM, 1993, CHILD DEV, V64, P897, DOI 10.2307/1131225; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Fay MP, 2010, J STAT SOFTW, V36, P1; Frere CH, 2010, P NATL ACAD SCI USA, V107, P19949, DOI 10.1073/pnas.1007997107; Fries ABW, 2005, P NATL ACAD SCI USA, V102, P17237, DOI 10.1073/pnas.0504767102; Gibson QA, 2008, ANIM BEHAV, V76, P389, DOI 10.1016/j.anbehav.2008.01.022; Harvey P.H., 1987, P181; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Krause J, 2002, LIVING GROUPS; Krutzen M, 2004, MOL ECOL, V13, P1975, DOI 10.1111/j.1365-294X.2004.02192.x; Lea AJ, 2010, P NATL ACAD SCI USA, V107, P21587, DOI 10.1073/pnas.1009882107; Lehmann J, 2009, P ROY SOC B-BIOL SCI, V276, P4417, DOI 10.1098/rspb.2009.1409; LEIGH SR, 2007, PRIMATES PERSPECTIVE, P396; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mann Janet, 2006, P107; McDonald DB, 2007, P NATL ACAD SCI USA, V104, P10910, DOI 10.1073/pnas.0701159104; Quinn GP, 2003, EXPT DESIGN DATA ANA; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Scott EM, 2005, BEHAVIOUR, V142, P21, DOI 10.1163/1568539053627712; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Stanton MA, 2011, ANIM BEHAV, V82, P405, DOI 10.1016/j.anbehav.2011.05.026; Tamashiro KLK, 2005, FRONT NEUROENDOCRIN, V26, P27, DOI 10.1016/j.yfrne.2005.03.001; Tsai Y, 2012, MAR MAMMAL SCI, DOI [10.1111/j.1748-7692.2011.00559, DOI 10.1111/J.1748-7692.2011.00559]; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; van den Berg CL, 1999, DEV PSYCHOBIOL, V34, P129, DOI 10.1002/(SICI)1098-2302(199903)34:2<129::AID-DEV6>3.3.CO;2-C; Veenema AH, 2009, FRONT NEUROENDOCRIN, V30, P497, DOI 10.1016/j.yfrne.2009.03.003; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014	50	138	139	3	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47508	10.1371/journal.pone.0047508	http://dx.doi.org/10.1371/journal.pone.0047508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077627	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100123
J	Ryder, VJ; Chopra, I; O'Neill, AJ				Ryder, Victoria J.; Chopra, Ian; O'Neill, Alex J.			Increased Mutability of Staphylococci in Biofilms as a Consequence of Oxidative Stress	PLOS ONE			English	Article							D-AMINO ACIDS; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC PENETRATION; MUTATION FREQUENCIES; GENE-EXPRESSION; AUREUS; RESISTANCE; LIMITATION; SURVIVAL; STRAINS	Objectives: To investigate the development of mutational resistance to antibiotics in staphylococcal biofilms. Method: Mutation frequencies to resistance against mupirocin and rifampicin were determined for planktonic cultures and for biofilms generated using either a novel static biofilm model or by continuous flow. DNA microarray analysis was performed to detect differences in transcriptional profiles between planktonic and biofilm cultures. Results: The mutability of biofilm cultures increased up to 60-fold and 4-fold for S. aureus and S. epidermidis, respectively, compared with planktonic cultures. Incorporation of antioxidants into S. aureus biofilms reduced mutation frequencies, indicating that increased oxidative stress underlies the heightened mutability. Transcriptional profiling of early biofilm cultures revealed up-regulation of the superoxide dismutase gene, sodA, also suggestive of enhanced oxidative stress in these cultures. The addition of catalase to biofilms of S. aureus SH1000 reduced mutation frequencies, a finding which implicated hydrogen peroxide in increased biofilm mutability. However, catalase had no effect on biofilm mutability in S. aureus UAMS-1, suggesting that there is more than one mechanism by which the mutability of staphylococci may increase during the biofilm mode of growth. Conclusion: Our findings suggest that biofilms represent an enriched source of mutational resistance to antibiotics in the staphylococci.	[O'Neill, Alex J.] Univ Leeds, Fac Biol Sci, Antimicrobial Res Ctr, Leeds, W Yorkshire, England; Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	O'Neill, AJ (corresponding author), Univ Leeds, Fac Biol Sci, Antimicrobial Res Ctr, Leeds, W Yorkshire, England.	a.j.oneill@leeds.ac.uk	Savage, Victoria J/H-3277-2013	Savage, Victoria J/0000-0002-5381-0731; O'Neill, Alex/0000-0003-3222-5493	Biotechnology and Biological Sciences Research Council (BBSRC); British Society for Antimicrobial Chemotherapy [GA849]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Society for Antimicrobial Chemotherapy	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC PhD studentship) and the British Society for Antimicrobial Chemotherapy (Grant no. GA849). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2003, BRIT J DERMATOL, V148, P526, DOI 10.1046/j.1365-2133.2003.05162.x; Allegrucci M, 2008, J BACTERIOL, V190, P6330, DOI 10.1128/JB.00707-08; Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; [Anonymous], 1991, J Antimicrob Chemother, V27 Suppl D, P1; Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; ASHBY MJ, 1994, J ANTIMICROB CHEMOTH, V33, P443, DOI 10.1093/jac/33.3.443; Bae Taeok, 2008, V416, P103, DOI 10.1007/978-1-59745-321-9_7; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Cescutti P, 1998, EUR J BIOCHEM, V251, P971, DOI 10.1046/j.1432-1327.1998.2510971.x; Clements MO, 1999, J BACTERIOL, V181, P3898, DOI 10.1128/JB.181.13.3898-3903.1999; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Cumming G, 2009, STAT MED, V28, P205, DOI 10.1002/sim.3471; Cvitkovitch DG, 2004, MICROBIAL BIOFILMS, P192; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Driffield K, 2008, J ANTIMICROB CHEMOTH, V61, P1053, DOI 10.1093/jac/dkn044; Ehlers LJ, 1999, WATER SCI TECHNOL, V39, P163, DOI 10.2166/wst.1999.0353; Foster TJ, 1998, METHOD MICROBIOL, V27, P433; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Heimberger T S, 1989, Infect Dis Clin North Am, V3, P221; HERLES S, 1994, J DENT RES, V73, P1748, DOI 10.1177/00220345940730111101; Hochbaum AI, 2011, J BACTERIOL, V193, P5616, DOI 10.1128/JB.05534-11; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Izano EA, 2009, MICROB PATHOGENESIS, V46, P207, DOI 10.1016/j.micpath.2009.01.004; Jensen PO, 2010, FEMS IMMUNOL MED MIC, V59, P292, DOI 10.1111/j.1574-695X.2010.00706.x; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Karavolos MH, 2003, MICROBIOL-SGM, V149, P2749, DOI 10.1099/mic.0.26353-0; Kato Y, 2010, J ANTIMICROB CHEMOTH, V65, P37, DOI 10.1093/jac/dkp394; Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Li H, 2009, ARCH MICROBIOL, V191, P853, DOI 10.1007/s00203-009-0514-7; Macfarlane S, 2008, J CLIN GASTROENTEROL, V42, pS142, DOI 10.1097/MCG.0b013e31816207df; O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x; O'Neill AJ, 2002, J ANTIMICROB CHEMOTH, V50, P161, DOI 10.1093/jac/dkf118; O'Neill AJ, 2001, J ANTIMICROB CHEMOTH, V47, P647, DOI 10.1093/jac/47.5.647; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; Schierle CF, 2009, WOUND REPAIR REGEN, V17, P354, DOI 10.1111/j.1524-475X.2009.00489.x; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Woodford N, 2007, CLIN MICROBIOL INFEC, V13, P5, DOI 10.1111/j.1469-0691.2006.01492.x; Zobell CE, 1943, J BACTERIOL, V46, P39, DOI 10.1128/JB.46.1.39-56.1943	47	49	49	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47695	10.1371/journal.pone.0047695	http://dx.doi.org/10.1371/journal.pone.0047695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110091	gold, Green Published, Green Submitted			2022-12-27	WOS:000310310200069
J	Liu, HY; Le Trinh, T; Dong, HJ; Keith, R; Nelson, D; Liu, C				Liu, Hongyan; Le Trinh, Thu; Dong, Huijia; Keith, Robertson; Nelson, David; Liu, Chen			Iron Regulator Hepcidin Exhibits Antiviral Activity against Hepatitis C Virus	PLOS ONE			English	Article							INTERFERING RNAS; MEDICAL PROGRESS; IN-VIVO; EXPRESSION; CELLS; STAT3; LIVER; REPLICATION; ACTIVATION; INFECTION	Hepatitis C viral infection affects 170 million people worldwide. It causes serious chronic liver diseases. HCV infection has been implicated in iron accumulation in the liver and iron overload has been shown to be a potential cofactor for HCV associated hepatocellular carcinoma progression. The underlying mechanisms are not understood. Human hepcidin, a 25 amino acid peptide mainly produced by hepatocytes, is a key regulator of iron metabolism. Alteration of hepcidin expression levels has been reported in the setting of chronic HCV infection and hepatocellular carcinoma. In this study, we aim to examine the interactions between HCV infection and hepcidin expression in liver cells. We found that hepcidin expression was suppressed in HCV infected cells. The suppressive effect appears to be regulated by histone acetylation but not DNA methylation. Moreover, we found that hepcidin had a direct antiviral activity against HCV replication in cell culture. The antiviral effect is associated with STAT3 activation. In conclusion, hepcidin can induce intracellular antiviral state while HCV has a strategy to suppress hepcidin expression. This may be a novel mechanism by which HCV circumvents hepatic innate antiviral defense.	[Liu, Hongyan; Le Trinh, Thu; Dong, Huijia; Liu, Chen] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Keith, Robertson] Med Coll Georgia, Dept Biochem & Mol Biol, Georgia Canc Ctr, Augusta, GA 30912 USA; [Nelson, David] Univ Florida, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida; University System of Georgia; Augusta University; State University System of Florida; University of Florida	Liu, C (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	liu@pathology.ufl.edu		Robertson, Keith/0000-0002-7508-3328	University of Florida Open-Access Publishing Fund; Dr. Chen Liu's NIH [NIH RR023976, NIH CA133086]; NATIONAL CANCER INSTITUTE [R01CA133086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR023976] Funding Source: NIH RePORTER	University of Florida Open-Access Publishing Fund; Dr. Chen Liu's NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. This work was supported by Dr. Chen Liu's NIH grants NIH RR023976 and NIH CA133086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elmonem Elhamy, 2009, J Egypt Natl Canc Inst, V21, P333; Alla V, 2005, SEMIN LIVER DIS, V25, P461, DOI 10.1055/s-2005-923317; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Bartolomei G, 2011, J GEN VIROL, V92, P2072, DOI 10.1099/vir.0.032706-0; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Charlton M, 2001, AM J TRANSPLANT, V1, P197, DOI 10.1034/j.1600-6143.2001.001003197.x; Choi SO, 2007, BIOCHEM BIOPH RES CO, V356, P312, DOI 10.1016/j.bbrc.2007.02.137; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fensterl V., 2001, J INTERFERON CYTOKIN, V31, P71; Fujita N, 2008, J HEPATOL, V49, P702, DOI 10.1016/j.jhep.2008.05.014; Fujita N, 2007, MOL MED, V13, P97, DOI 10.2119/2006-00057.Fujita; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Gardi C, 2002, BIOCHEM PHARMACOL, V64, P1139, DOI 10.1016/S0006-2952(02)01257-1; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kijima H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-167; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lauth X, 2005, J BIOL CHEM, V280, P9272, DOI 10.1074/jbc.M411154200; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Lukavsky PJ, 2009, VIRUS RES, V139, P166, DOI 10.1016/j.virusres.2008.06.004; Miura K, 2008, HEPATOLOGY, V48, P1420, DOI 10.1002/hep.22486; Nairz M, 2008, EUR J IMMUNOL, V38, P1923, DOI 10.1002/eji.200738056; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; Okada S, 1996, PATHOL INT, V46, P311, DOI 10.1111/j.1440-1827.1996.tb03617.x; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pictrangelo A, 2004, NAT CLIN PRACT GASTR, V1, P39, DOI 10.1038/ncpgasthep0019; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pietrangelo A, 2007, AM J HEMATOL, V82, P1142, DOI 10.1002/ajh.21101; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Schwarz P., J GASTROENTEROL; She HY, 2002, AM J PHYSIOL-GASTR L, V283, pG719, DOI 10.1152/ajpgi.00108.2002; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Sugimoto R, 2009, HEPATOL RES, V39, P619, DOI 10.1111/j.1872-034X.2009.00497.x; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wallace DF, 2006, BIOCHIMIE, V88, P31, DOI 10.1016/j.biochi.2005.07.003; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Zhu HZ, 2003, J VIROL, V77, P5493, DOI 10.1128/JVI.77.9.5493-5498.2003; Zhu HZ, 2004, BIOCHEM BIOPH RES CO, V324, P518, DOI 10.1016/j.bbrc.2004.09.081	49	35	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e46631	10.1371/journal.pone.0046631	http://dx.doi.org/10.1371/journal.pone.0046631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110054	gold, Green Published, Green Submitted			2022-12-27	WOS:000310193400005
J	Taillard, J; Capelli, A; Sagaspe, P; Anund, A; Akerstedt, T; Philip, P				Taillard, Jacques; Capelli, Aurore; Sagaspe, Patricia; Anund, Anna; Akerstedt, Torbjorn; Philip, Pierre			In-Car Nocturnal Blue Light Exposure Improves Motorway Driving: A Randomized Controlled Trial	PLOS ONE			English	Article							SLEEP; PERFORMANCE; ALERTNESS; AGE; WAVELENGTH; DIPHENHYDRAMINE; SENSITIVITY; VIGILANCE; FATIGUE; DRIVER	Prolonged wakefulness greatly decreases nocturnal driving performance. The development of in-car countermeasures is a future challenge to prevent sleep-related accidents. The aim of this study is to determine whether continuous exposure to monochromatic light in the short wavelengths (blue light), placed on the dashboard, improves night-time driving performance. In this randomized, double-blind, placebo-controlled, cross-over study, 48 healthy male participants (aged 20-50 years) drove 400 km (250 miles) on motorway during night-time. They randomly and consecutively received either continuous blue light exposure (GOLite, Philips, 468 nm) during driving or 2*200 mg of caffeine or placebo of caffeine before and during the break. Treatments were separated by at least 1 week. The outcomes were number of inappropriate line crossings (ILC) and mean standard deviation of the lateral position (SDLP). Eight participants (17%) complained about dazzle during blue light exposure and were removed from the analysis. Results from the 40 remaining participants (mean age +/- SD: 32.9+/-11.1) showed that countermeasures reduced the number of inappropriate line crossings (ILC) (F(2,91.11) = 6.64; p<0.05). Indeed, ILC were lower with coffee (12.51 [95% CI, 5.86 to 19.66], p = 0.001) and blue light (14.58 [CI, 8.75 to 22.58], p = 0.003) than with placebo (26.42 [CI, 19.90 to 33.71]). Similar results were found for SDLP. Treatments did not modify the quality, quantity and timing of 3 subsequent nocturnal sleep episodes. Despite a lesser tolerance, a non-inferior efficacy of continuous nocturnal blue light exposure compared with caffeine suggests that this in-car countermeasure, used occasionally, could be used to fight nocturnal sleepiness at the wheel in blue light-tolerant drivers, whatever their age. More studies are needed to determine the reproducibility of data and to verify if it can be generalized to women.	[Taillard, Jacques; Capelli, Aurore; Sagaspe, Patricia; Philip, Pierre] Univ Bordeaux, Bordeaux, France; [Taillard, Jacques; Capelli, Aurore; Sagaspe, Patricia; Philip, Pierre] CNRS, USR 3413, Bordeaux, France; [Anund, Anna] Swedish Rd & Transport Res Inst VTI, Linkoping, Sweden; [Akerstedt, Torbjorn] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; VTI; Stockholm University	Taillard, J (corresponding author), Univ Bordeaux, USR 3413, Bordeaux, France.	jack.taillard@gmail.com	PHILIP, Pierre/AAS-8889-2020; Taillard, Jacques/H-5063-2018	PHILIP, Pierre/0000-0003-3267-634X; Taillard, Jacques/0000-0001-9067-8189; Anund, Anna/0000-0002-4790-7094; SAGASPE, Patricia/0000-0003-2845-1199	French Ministry "Ministere de l'Ecologie, du Developpement Durable, des Transports et du Logement (MEDDTL)'	French Ministry "Ministere de l'Ecologie, du Developpement Durable, des Transports et du Logement (MEDDTL)'	This research was supported by an ERANET transport ENT 15 grant (Sleepiness at the wheel) from the French Ministry "Ministere de l'Ecologie, du Developpement Durable, des Transports et du Logement (MEDDTL)''. PHILIPS provided 2 portable blue lights (goLITE BLU (R)) and VINCI autoroute/ASF allowed us use their highways for our research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2006, SLEEP, V29, P55, DOI 10.1093/sleep/29.1.55; Akerstedt T, 2011, PROG BRAIN RES, V190, P169, DOI 10.1016/B978-0-444-53817-8.00011-6; Algvere PV, 2006, ACTA OPHTHALMOL SCAN, V84, P4, DOI 10.1111/j.1600-0420.2005.00627.x; Anderson JL, 2009, ACTA PSYCHIAT SCAND, V120, P203, DOI 10.1111/j.1600-0447.2009.01345.x; Anund A, 2008, J SLEEP RES, V17, P16, DOI 10.1111/j.1365-2869.2008.00633.x; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Chellappa, 2012, J CLIN ENDOCRINOLOGY; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Derogatis LR, 2000, HANDBOOK OF PSYCHOLOGICAL ASSESSMENT IN PRIMARY CARE SETTINGS, P297; Duffy JF, 2009, J AM GERIATR SOC, V57, P1245, DOI 10.1111/j.1532-5415.2009.02303.x; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lockley SW, 2006, SLEEP, V29, P161; OHANLON JF, 1995, ALLERGY, V50, P234, DOI 10.1111/j.1398-9995.1995.tb01140.x; OHANLON JF, 1986, ACTA PSYCHIAT SCAND, V74, P95, DOI 10.1111/j.1600-0447.1986.tb08985.x; Pack AI, 1995, ACCIDENT ANAL PREV, V27, P769, DOI 10.1016/0001-4575(95)00034-8; PARTINEN M, 1995, J SLEEP RES, V4, P150, DOI 10.1111/j.1365-2869.1995.tb00205.x; Philip P, 2005, SLEEP, V28, P1511, DOI 10.1093/sleep/28.12.1511; Philip P, 2005, ACCIDENT ANAL PREV, V37, P473, DOI 10.1016/j.aap.2004.07.007; Philip P, 2004, J SLEEP RES, V13, P105, DOI 10.1111/j.1365-2869.2004.00399.x; Philip P, 2006, ANN INTERN MED, V144, P785, DOI 10.7326/0003-4819-144-11-200606060-00004; Phipps-Nelson J, 2009, CHRONOBIOL INT, V26, P891, DOI 10.1080/07420520903044364; RAMAEKERS JG, 1994, EUR J CLIN PHARMACOL, V47, P261, DOI 10.1007/BF02570506; Reyner LA, 1998, SLEEP, V21, P46; Sagaspe P, 2007, SLEEP, V30, P1808, DOI 10.1093/sleep/30.12.1808; Sagaspe P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003493; Sagberg F, 1999, ACCIDENT ANAL PREV, V31, P639, DOI 10.1016/S0001-4575(99)00023-8; Schwarz JFA, IN CAR COUN IN PRESS; Turner PL, 2008, BRIT J OPHTHALMOL, V92, P1439, DOI 10.1136/bjo.2008.141747; Verster JC, 2003, PSYCHOPHARMACOLOGY, V169, P84, DOI 10.1007/s00213-003-1462-6; Verster JC, 2011, J SLEEP RES, V20, P585, DOI 10.1111/j.1365-2869.2010.00901.x; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; Wright KP, 1999, BEHAV BRAIN RES, V103, P185, DOI 10.1016/S0166-4328(99)00042-X	35	30	31	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e46750	10.1371/journal.pone.0046750	http://dx.doi.org/10.1371/journal.pone.0046750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	023QT	23094031	Green Published, gold			2022-12-27	WOS:000310050200013
J	Alguacil, MD; Torrecillas, E; Torres, P; Garcia-Orenes, F; Roldan, A				del Mar Alguacil, Maria; Torrecillas, Emma; Torres, Pilar; Garcia-Orenes, Fuensanta; Roldan, Antonio			Long-Term Effects of Irrigation with Waste Water on Soil AM Fungi Diversity and Microbial Activities: The Implications for Agro-Ecosystem Resilience	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; COMMUNITY; COLONIZATION; NITROGEN; ECOLOGY	The effects of irrigation with treated urban wastewater (WW) on the arbuscular mycorrhizal fungi (AMF) diversity and soil microbial activities were assayed on a long-term basis in a semiarid orange-tree orchard. After 43 years, the soil irrigated with fresh water (FW) had higher AMF diversity than soils irrigated with WW. Microbial activities were significantly higher in the soils irrigated with WW than in those irrigated with FW. Therefore, as no negative effects were observed on crop vitality and productivity, it seems that the ecosystem resilience gave rise to the selection of AMF species better able to thrive in soils with higher microbial activity and, thus, to higher soil fertility.	[del Mar Alguacil, Maria; Torrecillas, Emma; Roldan, Antonio] CSIC Ctr Edafol & Biol Aplicada Segura, Dept Soil & Water Conservat, Murcia, Spain; [Torres, Pilar] Univ Miguel Hernandez, Area Bot, Dept Biol Aplicada, Alicante, Spain; [Garcia-Orenes, Fuensanta] Univ Miguel Hernandez, Dept Agroquim & Medio Ambiente, Grp Edafol Ambiental, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche	Alguacil, MD (corresponding author), CSIC Ctr Edafol & Biol Aplicada Segura, Dept Soil & Water Conservat, Campus Espinardo, Murcia, Spain.	mmalguacil@cebas.csic.es	Roldan, Antonio/F-6241-2013; del Mar Alguacil, Maria/M-3859-2014	del Mar Alguacil, Maria/0000-0001-8495-8707; Garcia-Orenes, Fuensanta/0000-0003-3463-3140; Roldan, Antonio/0000-0002-2610-7784	Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain)	Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain)(German Research Foundation (DFG))	MM Alguacil was supported by the Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain).	Adrover M, 2012, J ENVIRON MANAGE, V95, pS188, DOI 10.1016/j.jenvman.2010.08.017; Chen WP, 2008, J ENVIRON QUAL, V37, pS36, DOI 10.2134/jeq2007.0315; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Alguacil MD, 2010, SOIL BIOL BIOCHEM, V42, P1114, DOI 10.1016/j.soilbio.2010.03.012; Alguacil MD, 2009, APPL ENVIRON MICROB, V75, P4254, DOI 10.1128/AEM.00316-09; Friedel JK, 2000, BIOL FERT SOILS, V31, P414, DOI 10.1007/s003749900188; Gollotte A, 2004, MYCORRHIZA, V14, P111, DOI 10.1007/s00572-003-0244-7; Gosling P, 2006, AGR ECOSYST ENVIRON, V113, P17, DOI 10.1016/j.agee.2005.09.009; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamilton AJ, 2007, VADOSE ZONE J, V6, P823, DOI 10.2136/vzj2007.0026; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; Jumpponen A, 2005, BIOL FERT SOILS, V41, P217, DOI 10.1007/s00374-005-0845-8; Mangkoedihardjo S., 2006, Journal of Applied Sciences, V6, P1409; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Oehl F, 2010, SOIL BIOL BIOCHEM, V42, P724, DOI 10.1016/j.soilbio.2010.01.006; Ortega-Larrocea MP, 2007, APPL SOIL ECOL, V37, P129, DOI 10.1016/j.apsoil.2007.06.002; Pawlowska TE, 2004, APPL ENVIRON MICROB, V70, P6643, DOI 10.1128/AEM.70.11.6643-6649.2004; Qadir M, 2007, AGR WATER MANAGE, V87, P2, DOI 10.1016/j.agwat.2006.03.018; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Soil Survey Staff, 2010, KEYS SOIL TAX; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stenberg B, 1999, ACTA AGR SCANDINAV B; Tabatabai M.A., 1982, AGRONOMY, P501; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ter Braak C.F.J., 2004, CANOCO REFERENCE MAN; Toljander JF, 2008, FEMS MICROBIOL ECOL, V65, P323, DOI 10.1111/j.1574-6941.2008.00512.x; Treseder KK, 2002, NEW PHYTOL, V155, P507, DOI 10.1046/j.1469-8137.2002.00470.x; Trouvelot S, 1999, MYCORRHIZA, V8, P203, DOI 10.1007/s005720050235; van der Heijden MGA, 2007, NEW PHYTOL, V174, P244, DOI 10.1111/j.1469-8137.2007.02041.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Van Tuinen D, 1998, MOL ECOL, V7, P879, DOI 10.1046/j.1365-294x.1998.00410.x; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027	32	22	22	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47680	10.1371/journal.pone.0047680	http://dx.doi.org/10.1371/journal.pone.0047680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094075	Green Submitted, Green Published, gold			2022-12-27	WOS:000312384500018
J	Hodgson, JA; Thomas, CD; Dytham, C; Travis, JMJ; Cornell, SJ				Hodgson, Jenny A.; Thomas, Chris D.; Dytham, Calvin; Travis, Justin M. J.; Cornell, Stephen J.			The Speed of Range Shifts in Fragmented Landscapes	PLOS ONE			English	Article							CLIMATE-CHANGE; HABITAT FRAGMENTATION; METAPOPULATION MODELS; CONNECTIVITY; CONSERVATION; DISPERSAL; PERSISTENCE; ADAPTATION; STRATEGIES; MANAGEMENT	Species may be driven extinct by climate change, unless their populations are able to shift fast enough to track regions of suitable climate. Shifting will be faster as the proportion of suitable habitat in the landscape increases. However, it is not known how the spatial arrangement of habitat will affect the speed of range advance, especially when habitat is scarce, as is the case for many specialist species. We develop methods for calculating the speed of advance that are appropriate for highly fragmented, stochastic systems. We reveal that spatial aggregation of habitat tends to reduce the speed of advance throughout a wide range of species parameters: different dispersal distances and dispersal kernel shapes, and high and low extinction probabilities. In contrast, aggregation increases the steady-state proportion of habitat that is occupied (without climate change). Nonetheless, we find that it is possible to achieve both rapid advance and relatively high patch occupancy when the habitat has a "channeled" pattern, resembling corridors or chains of stepping stones. We adapt techniques from electrical circuit theory to predict the rate of advance efficiently for complex, realistic landscape patterns, whereas the rate cannot be predicted by any simple statistic of aggregation or fragmentation. Conservationists are already advocating corridors and stepping stones as important conservation tools under climate change, but they are vaguely defined and have so far lacked a convincing basis in fundamental population biology. Our work shows how to discriminate properties of a landscape's spatial pattern that affect the speed of colonization (including, but not limited to, patterns like corridors and chains of stepping stones), and properties that affect a species' probability of persistence once established. We can therefore point the way to better land use planning approaches, which will provide functional habitat linkages and also maintain local population viability.	[Hodgson, Jenny A.; Thomas, Chris D.; Dytham, Calvin] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Travis, Justin M. J.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Cornell, Stephen J.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England	University of York - UK; University of Aberdeen; University of Leeds	Hodgson, JA (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	jenny.hodgson@york.ac.uk	Travis, Justin/B-8571-2014; Cornell, Stephen J/D-3955-2009; Thomas, Chris D/A-1460-2014; Thomas, Chris D/A-1894-2012	Travis, Justin/0000-0002-5785-4272; Thomas, Chris D/0000-0003-2822-1334; Thomas, Chris D/0000-0003-2822-1334; Hodgson, Jenny/0000-0003-2297-3631; Dytham, Calvin/0000-0002-4111-9484	Natural Environment Research Council [NE/G006377/1]; NERC [NE/G006377/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	JAH and CDT were funded by Natural Environment Research Council grant NE/G006377/1; www.nerc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Ball F, 2010, MATH BIOSCI, V224, P53, DOI 10.1016/j.mbs.2009.12.003; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chipperfield JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017040; Collingham YC, 2000, ECOL APPL, V10, P131, DOI 10.1890/1051-0761(2000)010[0131:IOHFAP]2.0.CO;2; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dewhirst S, 2009, ECOLOGY, V90, P1338, DOI 10.1890/08-0115.1; Dytham C, 1995, OIKOS, V74, P340, DOI 10.2307/3545665; Early R, 2011, ECOL LETT, V14, P1125, DOI 10.1111/j.1461-0248.2011.01681.x; Frank K, 1998, LANDSCAPE ECOL, V13, P363, DOI 10.1023/A:1008054906030; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Hanski K, 2003, THEOR POPUL BIOL, V64, P119, DOI 10.1016/S0040-5809(03)00022-4; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Heinz SK, 2005, LANDSCAPE ECOL, V20, P83, DOI 10.1007/s10980-004-0678-0; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; Hodgson JA, 2011, CONSERV LETT, V4, P289, DOI 10.1111/j.1755-263X.2011.00177.x; Hodgson JA, 2011, J APPL ECOL, V48, P148, DOI 10.1111/j.1365-2664.2010.01919.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Kinezaki N, 2003, THEOR POPUL BIOL, V64, P291, DOI 10.1016/S0040-5809(03)00091-1; Kinezaki N, 2010, THEOR POPUL BIOL, V78, P298, DOI 10.1016/j.tpb.2010.09.002; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; McInerny G, 2007, ECOL INFORM, V2, P1, DOI 10.1016/j.ecoinf.2006.12.001; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Moilanen A., 2009, SPATIAL CONSERVATION; Mustin K, 2009, OIKOS, V118, P131, DOI 10.1111/j.1600-0706.2008.17025.x; Ovaskainen O, 2001, THEOR POPUL BIOL, V60, P281, DOI 10.1006/tpbi.2001.1548; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; Phillips SJ, 2008, ECOL APPL, V18, P1200, DOI 10.1890/07-0507.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schippers P, 2011, ECOGRAPHY, V34, P909, DOI 10.1111/j.1600-0587.2011.06712.x; Travis JMJ, 2010, DIVERS DISTRIB, V16, P877, DOI 10.1111/j.1472-4642.2010.00687.x; Urban DL, 2009, ECOL LETT, V12, P260, DOI 10.1111/j.1461-0248.2008.01271.x; Vos CC, 2010, LANDSCAPE ECOL, V25, P1465, DOI 10.1007/s10980-010-9535-5; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; With KA, 2004, RISK ANAL, V24, P803, DOI 10.1111/j.0272-4332.2004.00480.x; With KA, 1997, OIKOS, V79, P219, DOI 10.2307/3546007	45	58	58	1	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47141	10.1371/journal.pone.0047141	http://dx.doi.org/10.1371/journal.pone.0047141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082145	Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900040
J	Ma, BW; Bokulich, NA; Castillo, PA; Kananurak, A; Underwood, MA; Mills, DA; Bevins, CL				Ma, Betty W.; Bokulich, Nicholas A.; Castillo, Patricia A.; Kananurak, Anchasa; Underwood, Mark A.; Mills, David A.; Bevins, Charles L.			Routine Habitat Change: A Source of Unrecognized Transient Alteration of Intestinal Microbiota in Laboratory Mice	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; RIBOSOMAL-RNA GENES; GUT MICROBIOTA; MOUSE; HOST; OBESITY; 16S; COMMUNITIES; DATABASE; MODEL	The mammalian intestine harbors a vast, complex and dynamic microbial population, which has profound effects on host nutrition, intestinal function and immune response, as well as influence on physiology outside of the alimentary tract. Imbalance in the composition of the dense colonizing bacterial population can increase susceptibility to various acute and chronic diseases. Valuable insights on the association of the microbiota with disease critically depend on investigation of mouse models. Like in humans, the microbial community in the mouse intestine is relatively stable and resilient, yet can be influenced by environmental factors. An often-overlooked variable in research is basic animal husbandry, which can potentially alter mouse physiology and experimental outcomes. This study examined the effects of common husbandry practices, including food and bedding alterations, as well as facility and cage changes, on the gut microbiota over a short time course of five days using three culture-independent techniques, quantitative PCR, terminal restriction fragment length polymorphism (TRFLP) and next generation sequencing (NGS). This study detected a substantial transient alteration in microbiota after the common practice of a short cross-campus facility transfer, but found no comparable alterations in microbiota within 5 days of switches in common laboratory food or bedding, or following an isolated cage change in mice acclimated to their housing facility. Our results highlight the importance of an acclimation period following even simple transfer of mice between campus facilities, and highlights that occult changes in microbiota should be considered when imposing husbandry variables on laboratory animals.	[Ma, Betty W.; Castillo, Patricia A.; Kananurak, Anchasa; Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Ma, Betty W.] Univ Calif Davis, Residency Program Lab Anim Med, Sch Vet Med, Ctr Lab Anim Sci, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Mills, David A.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA; [Underwood, Mark A.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Bevins, CL (corresponding author), Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA.	clbevins@ucdavis.edu	Mills, David/GXF-1821-2022; Bevins, Charles L/P-4438-2015; Mills, David Andrew/G-2282-2011	Bevins, Charles L/0000-0003-2725-2622; Mills, David Andrew/0000-0003-1913-9865	National Institutes of Health [HD059127, AI032738, AI099519, AI076246]; Thai Royal Government (The Development and Promotion of Science and Technology Talents Project, Thailand); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738, R21AI099519, R01AI032738, R01AI076246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thai Royal Government (The Development and Promotion of Science and Technology Talents Project, Thailand); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported in part by financial support by the National Institutes of Health (HD059127, AI032738, AI099519, and AI076246) and the Thai Royal Government (The Development and Promotion of Science and Technology Talents Project, Thailand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Backhed F, 2011, ANN NUTR METAB, V58, P44, DOI 10.1159/000328042; Bleich A, 2012, COMP IMMUNOL MICROB, V35, P81, DOI 10.1016/j.cimid.2011.12.006; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035507; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036357; Bokulich NA, 2012, FOOD MICROBIOL, V31, P126, DOI 10.1016/j.fm.2012.02.007; Candela M, 2011, CRIT REV MICROBIOL, V37, P1, DOI 10.3109/1040841X.2010.501760; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gonzalez Antonio, 2011, Dialogues Clin Neurosci, V13, P55; Gordon JI, 2011, P NATL ACAD SCI USA, V108, P4513, DOI 10.1073/pnas.1101958108; Gurfein BT, 2012, MOL MED, V18, P606, DOI 10.2119/molmed.2012.00053; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hill DA, 2012, NAT MED; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Jennings M, 1998, LAB ANIM-UK, V32, P233, DOI 10.1258/002367798780559301; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Malakoff D, 2000, SCIENCE, V288, P248, DOI 10.1126/science.288.5464.248; Mathis D, 2012, IMMUNOL REV, V245, P239, DOI 10.1111/j.1600-065X.2011.01084.x; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Plottel CS, 2011, CELL HOST MICROBE, V10, P324, DOI 10.1016/j.chom.2011.10.003; Rasmussen S, 2011, J AM ASSOC LAB ANIM, V50, P479; Reeb-Whitaker CK, 2001, LAB ANIM-UK, V35, P58, DOI 10.1258/0023677011911381; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Schellinck HM, 2010, ADV STUD BEHAV, V41, P255, DOI 10.1016/S0065-3454(10)41007-4; Scupham AJ, 2006, APPL ENVIRON MICROB, V72, P793, DOI 10.1128/AEM.72.1.793-801.2006; Sekirov I, 2009, J PHYSIOL-LONDON, V587, P4159, DOI 10.1113/jphysiol.2009.172742; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; SOAVE O, 1991, CORNELL VET, V81, P357; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; TULI JS, 1995, LAB ANIM, V29, P132, DOI 10.1258/002367795780740249; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zaneveld J, 2008, CURR OPIN CHEM BIOL, V12, P109, DOI 10.1016/j.cbpa.2008.01.015	58	39	39	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47416	10.1371/journal.pone.0047416	http://dx.doi.org/10.1371/journal.pone.0047416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082164	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900060
J	Khaidakov, M; Mehta, JL				Khaidakov, Magomed; Mehta, Jawahar L.			Oxidized LDL Triggers Pro-Oncogenic Signaling in Human Breast Mammary Epithelial Cells Partly via Stimulation of MiR-21	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ENDOTHELIAL-CELLS; CANCER CELLS; SCAVENGER RECEPTOR; POOR-PROGNOSIS; NADPH OXIDASE; EXPRESSION; 12-LIPOXYGENASE; GENE; OBESITY	Dyslipidemia and obesity are primary risk factors for the development of atherosclerosis and are also epidemiologically linked to increased susceptibility to a variety of cancers including breast cancer. One of the prominent features of dyslipidemia is enhanced production of oxidized LDL (ox-LDL), which has been shown to be implicated in key steps of atherogenesis including inflammatory signaling and proliferation of vascular cells. In this study we analyzed the effects of ox-LDL in human mammary epithelial cells (MCF10A). MCF10A cells avidly internalized dil-ox-LDL and exhibited increased proliferative response to ox-LDL within the range of 1-50 mu g/ml in a dose-dependent manner. Treatment of cells with 20 mu g/ml ox-LDL for 2 and 12 hours was associated with upregulation of LOX-1 and CD36 scavenger receptors while MSR1 and CXLC16 receptors did not change. Ox-LDL-treated cells displayed significant upregulation of NADPH oxidases (subunits P22(phox) and P47(phox)), lipoxygenases-12 and -15, and cytoplasmic, but not mitochondrial, SOD. Ox-LDL also triggered phosphorylation of I kappa B alpha coupled with nuclear translocation of NF-kappa B and stimulated p44/42 MAPK, PI3K and Akt while intracellular PTEN (PI3K/Akt pathway inhibitor and target of miR-21) declined. Quantitative PCR revealed increased expression of hsa-miR-21 in ox-LDL treated cells coupled with inhibition of miR-21 target genes. Further, transfection of MCF10A cells with miR-21 inhibitor prevented ox-LDL mediated stimulation of PI3K and Akt. We conclude that, similarly to vascular cells, mammary epithelial cells respond to ox-LDL by upregulation of proliferative and pro-inflammatory signaling. We also report for the first time that part of ox-LDL triggered reactions in MCF10A cells is mediated by oncogenic hsa-miR-21 through inhibition of its target gene PTEN and consequent activation of PI3K/Akt pathway.	[Khaidakov, Magomed; Mehta, Jawahar L.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Khaidakov, Magomed; Mehta, Jawahar L.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences	Khaidakov, M (corresponding author), Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA.	mkhaidakov@uams.edu; MehtaJL@uams.edu	Mehta, jl/AAB-8832-2019; Mehta, JL/AAG-7572-2020	Mehta, jl/0000-0003-0384-2097; 	Department of Veterans Affairs; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, Washington, DC	Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, Washington, DC(US Department of Veterans Affairs)	The work was funded by grant from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by funds from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, Washington, DC.	Bae YS, 2009, CIRC RES; Bonci Desiree, 2010, Recent Pat Cardiovasc Drug Discov, V5, P156, DOI 10.2174/157489010793351962; Brinkley TE, 2008, OBESITY, V16, P1454, DOI 10.1038/oby.2008.213; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Chow SE, 2007, J APPL PHYSIOL, V102, P1520, DOI 10.1152/japplphysiol.00881.2006; Cleary MP, 2010, VET PATHOL, V47, P202, DOI 10.1177/0300985809357753; Connolly JM, 1998, CANCER LETT, V132, P107, DOI 10.1016/S0304-3835(98)00171-2; Dandapat A, 2007, ARTERIOSCL THROM VAS, V27, P2435, DOI 10.1161/ATVBAHA.107.152272; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dunn S, 2008, BIOCHEM J, V409, P349, DOI 10.1042/BJ20071196; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Guo AM, 2011, CANCER CHEMOTH PHARM, V68, P1273, DOI 10.1007/s00280-011-1595-y; Heinloth A, 2000, J AM SOC NEPHROL, V11, P1819, DOI 10.1681/ASN.V11101819; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Khaidakov M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020277; Lee SI, 2011, CANCER METAST REV, V30, P481, DOI 10.1007/s10555-011-9321-0; Li M, 2010, CELL PHYSIOL BIOCHEM, V25, P649, DOI 10.1159/000315084; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mehta JL, 2004, CAN J CARDIOL, V20, p32B; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Natarajan R, 1997, J CLIN ENDOCR METAB, V82, P1790, DOI 10.1210/jc.82.6.1790; Nixon JB, 2004, PROSTAG LEUKOTR ESS, V70, P7, DOI 10.1016/j.plefa.2003.06.001; Oh AS, 2001, MOL ENDOCRINOL, V15, P1344, DOI 10.1210/me.15.8.1344; Park SH, 2011, CLIN CHIM ACTA, V412, P435, DOI 10.1016/j.cca.2010.11.017; PARTHASARATHY S, 1989, P NATL ACAD SCI USA, V86, P1046, DOI 10.1073/pnas.86.3.1046; Piao YS, 2008, CARCINOGENESIS, V29, P440, DOI 10.1093/carcin/bgm274; RANKIN SM, 1991, J LIPID RES, V32, P449; Romieu I, 2009, SALUD PUBLICA MEXICO, V51, pS172, DOI 10.1590/S0036-36342009000800007; Salzman R, 2009, ANTICANCER RES, V29, P4227; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shureiqi I, 1999, CARCINOGENESIS, V20, P1985, DOI 10.1093/carcin/20.10.1985; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Singh SP, 2005, J PHARMACOL EXP THER, V313, P855, DOI 10.1124/jpet.104.080754; Takahashi Y, 2005, ANTIOXID REDOX SIGN, V7, P425, DOI 10.1089/ars.2005.7.425; Tang SH, 2002, J BIOL CHEM, V277, P16189, DOI 10.1074/jbc.M111936200; Tong WG, 2002, BIOCHEM BIOPH RES CO, V296, P942, DOI 10.1016/S0006-291X(02)02014-4; Vohra RS, 2006, TRENDS CARDIOVAS MED, V16, P60, DOI 10.1016/j.tcm.2005.12.001; Wadsack C, 2003, INT J BIOCHEM CELL B, V35, P441, DOI 10.1016/S1357-2725(02)00272-8; Wang WY, 2010, CARDIOVASC RES, V85, P845, DOI 10.1093/cvr/cvp367; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yin B, 2011, INT J ONCOL, V38, P1041, DOI 10.3892/ijo.2011.901; Yoshinaga M, 2004, PROSTAG OTH LIPID M, V73, P111, DOI 10.1016/j.prostaglandins.2004.01.001; Yu S, 2011, BIOCHEM BIOPH RES CO, V407, P44, DOI 10.1016/j.bbrc.2011.02.096	49	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46973	10.1371/journal.pone.0046973	http://dx.doi.org/10.1371/journal.pone.0046973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091604	Green Published, gold, Green Submitted			2022-12-27	WOS:000310135800019
J	Sundararaj, S; Singh, D; Saxena, AK; Vashisht, K; Sijwali, PS; Dixit, R; Pandey, KC				Sundararaj, Srinivasan; Singh, Deepak; Saxena, Ajay K.; Vashisht, Kapil; Sijwali, Puran S.; Dixit, Rajnikant; Pandey, Kailash C.			The Ionic and Hydrophobic Interactions Are Required for the Auto Activation of Cysteine Proteases of Plasmodium falciparum	PLOS ONE			English	Article							HUMAN PROCATHEPSIN-B; CATHEPSIN-B; PROTEIN STRUCTURES; MALARIA PARASITES; STRUCTURAL BASIS; INHIBITION; HEMOGLOBIN; PROPEPTIDE; BIOSYNTHESIS; ZYMOGEN	The Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3 are major hemoglobinases and potential antimalarial drug targets. Our previous studies demonstrated that these enzymes are equipped with specific domains for specific functions. Structural and functional analysis of falcipains showed that they have unique domains including a refolding domain and a hemoglobin binding domain. As with many proteases, falcipain-2 and falcipain-3 are synthesized as inactive zymogens. However, it is not known how these enzymes get activated for hemoglobin hydrolysis. In this study, we are presenting the first evidence that salt bridges and hydrophobic interactions are required for the auto activation of cysteine proteases of P. falciparum. To investigate the mechanism of activation of these enzymes, we expressed the wild type protein as well as different mutants in E. coli. Refolding was assessed by circular dichroism. Both CD and trans activation data showed that the wild type enzymes and mutants are rich in secondary structures with similar folds. Our study revealed that prodomain-mature domain of falcipain-2 and falcipain-3 interacts via salt bridges and hydrophobic interactions. We mutated specific residues of falcipain-2 and falcipain-3, and evaluated their ability to undergo auto processing. Mutagenesis result showed that two salt bridges (Arg(185)-Glu(221), Glu(210)-Lys(403)) in falcipain-2, and one salt bridge (Arg(202)-Glu(238)) in falcipain-3, play crucial roles in the activation of these enzymes. Further study revealed that hydrophobic interactions present both in falcipain-2 (Phe(214), Trp(449) Trp(453)) and falcipain-3 (Phe(231) Trp(457) Trp(461)) also play important roles in the activation of these enzymes. Our results revealed the interactions involved in auto processing of two major hemoglobinases of malaria parasite.	[Sundararaj, Srinivasan; Singh, Deepak; Vashisht, Kapil; Dixit, Rajnikant; Pandey, Kailash C.] Indian Council Med Res, Natl Inst Malaria Res, Host Parasite Interact Biol Grp, New Delhi, India; [Saxena, Ajay K.] Jawaharlal Nehru Univ, Sch Life Sci, Struct Biol Lab, New Delhi 110067, India; [Sijwali, Puran S.] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Jawaharlal Nehru University, New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Pandey, KC (corresponding author), Indian Council Med Res, Natl Inst Malaria Res, Host Parasite Interact Biol Grp, New Delhi, India.	kailashcp@mrcindia.org	Dixit, Rajnikant/D-2566-2009; vashisht, kapil/ABB-3966-2020; Sundararaj, Srinivasan/AAF-6809-2019	Dixit, Rajnikant/0000-0002-3536-8329; sundararaj, Srinivasan/0000-0002-9112-2454	Department of Biotechnology, Government of India; Ramalingaswami Fellowship	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Ramalingaswami Fellowship	Work in the laboratory is supported by Department of Biotechnology, Government of India. KCP is a recipient of a Ramalingaswami Fellowship. The authors thank NIMR for extramural funds for setting a new laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; Dahl EL, 2005, MOL BIOCHEM PARASIT, V139, P205, DOI 10.1016/j.molbiopara.2004.11.009; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eramian D, 2008, PROTEIN SCI, V17, P1881, DOI 10.1110/ps.036061.108; Fidock DA, 2010, NATURE, V465, P297, DOI 10.1038/465297a; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FOX T, 1992, BIOCHEMISTRY-US, V31, P12571, DOI 10.1021/bi00165a005; Groves MR, 1998, PROTEINS, V32, P504, DOI 10.1002/(SICI)1097-0134(19980901)32:4<504::AID-PROT8>3.0.CO;2-F; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jerala R, 1998, J BIOL CHEM, V273, P11498, DOI 10.1074/jbc.273.19.11498; KOMINAMI E, 1988, FEBS LETT, V231, P225, DOI 10.1016/0014-5793(88)80736-1; Laurent-Matha V, 2006, J BIOCHEM, V139, P363, DOI 10.1093/jb/mvj037; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V262, P159, DOI 10.1016/0003-9861(88)90178-6; Pandey KC, 2006, PLOS PATHOG, V2, P1031, DOI 10.1371/journal.ppat.0020117; Pandey KC, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/345195; Pandey KC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005694; Pandey KC, 2005, P NATL ACAD SCI USA, V102, P9138, DOI 10.1073/pnas.0502368102; Pandey KC, 2004, J BIOL CHEM, V279, P3484, DOI 10.1074/jbc.M310536200; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Rosenthal PJ, 2002, CURR PHARM DESIGN, V8, P1659, DOI 10.2174/1381612023394197; Rozman J, 1999, FEBS LETT, V459, P358, DOI 10.1016/S0014-5793(99)01302-2; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2002, J BIOL CHEM, V277, P14910, DOI 10.1074/jbc.M109680200; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Subramanian S, 2007, J BIOL CHEM, V282, P24961, DOI 10.1074/jbc.M703316200; Subramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005156; Turk D, 1996, FEBS LETT, V384, P211, DOI 10.1016/0014-5793(96)00309-2; Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103; WHO, 2008, WHO WORLD MAL REP; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601	35	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47227	10.1371/journal.pone.0047227	http://dx.doi.org/10.1371/journal.pone.0047227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077573	Green Submitted, Green Published, gold			2022-12-27	WOS:000310135800033
J	Chopra, A; Patel, A; Shieh, AC; Janmey, PA; Kresh, JY				Chopra, Anant; Patel, Akash; Shieh, Adrian C.; Janmey, Paul A.; Kresh, J. Yasha			alpha-Catenin Localization and Sarcomere Self-Organization on N-Cadherin Adhesive Patterns Are Myocyte Contractility Driven	PLOS ONE			English	Article							CELL-CELL ADHESION; CARDIAC MYOCYTES; TRACTIONAL FORCES; COMPLEX; ACTIN; SHAPE; EXTENSION; DYNAMICS; CONTACTS; TENSION	The N-cadherin (N-cad) complex plays a crucial role in cardiac cell structure and function. Cadherins are adhesion proteins linking adjacent cardiac cells and, like integrin adhesions, are sensitive to force transmission. Forces through these adhesions are capable of eliciting structural and functional changes in myocytes. Compared to integrins, the mechanisms of force transduction through cadherins are less explored. alpha-catenin is a major component of the cadherin-catenin complex, thought to provide a link to the cell actin cytoskeleton. Using N-cad micropatterned substrates in an adhesion constrainment model, the results from this study show that alpha-catenin localizes to regions of highest internal stress in myocytes. This localization suggests that alpha-catenin acts as an adaptor protein associated with the cadherin mechanosensory apparatus, which is distinct from mechanosensing through integrins. Myosin inhibition in cells bound by integrins to fibronectin-coated patterns disrupts myofibiril organization, whereas on N-cad coated patterns, myosin inhibition leads to better organized myofibrils. This result indicates that the two adhesion systems provide independent mechanisms for regulating myocyte structural organization.	[Janmey, Paul A.; Kresh, J. Yasha] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Chopra, Anant; Patel, Akash; Kresh, J. Yasha] Drexel Univ, Coll Med, Dept Cardiothorac Surg, Philadelphia, PA 19104 USA; [Chopra, Anant; Shieh, Adrian C.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Drexel University; Drexel University	Janmey, PA (corresponding author), Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA.	janmey@mail.med.upenn.edu; jkresh@drexelmed.edu		Shieh, Adrian/0000-0001-9569-361X	National Institute of Health from the National Institute of General Medical Sciences [GM083272]; Joseph Di Palma Heart Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083272] Funding Source: NIH RePORTER	National Institute of Health from the National Institute of General Medical Sciences; Joseph Di Palma Heart Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by Grants from the National Institute of Health GM083272, from the National Institute of General Medical Sciences and the Joseph Di Palma Heart Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERLE H, 1994, J CELL SCI, V107, P3655; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Bischofs IB, 2008, BIOPHYS J, V95, P3488, DOI 10.1529/biophysj.108.134296; Borghi N, 2010, P NATL ACAD SCI USA, V107, P13324, DOI 10.1073/pnas.1002662107; Bray MA, 2008, CELL MOTIL CYTOSKEL, V65, P641, DOI 10.1002/cm.20290; Chandran PL, 2009, CELL MOL BIOENG, V2, P13, DOI 10.1007/s12195-009-0044-z; Chopra A, 2011, AM J PHYSIOL-HEART C, V300, pH1252, DOI 10.1152/ajpheart.00515.2010; Deshpande VS, 2006, P NATL ACAD SCI USA, V103, P14015, DOI 10.1073/pnas.0605837103; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; GONCHAROVA EJ, 1992, DEVELOPMENT, V114, P173; Grosberg A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001088; IMANAKAYOSHIDA K, 1993, CELL MOTIL CYTOSKEL, V26, P301, DOI 10.1002/cm.970260405; JOU TS, 1995, P NATL ACAD SCI USA, V92, P5067, DOI 10.1073/pnas.92.11.5067; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Kresh JY, 2011, PFLUG ARCH EUR J PHY, V462, P75, DOI 10.1007/s00424-011-0954-1; Li J, 2006, CLIN MED RES, V4, P42, DOI 10.3121/cmr.4.1.42; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Saffitz JE, 2005, ANN NY ACAD SCI, V1047, P336, DOI 10.1196/annals.1341.030; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; SINCLAIR GB, 1984, INT J MECH SCI, V26, P477, DOI 10.1016/0020-7403(84)90002-X; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Tseng QZ, 2011, LAB CHIP, V11, P2231, DOI 10.1039/c0lc00641f; Uda Y, 2011, BIOCHEM BIOPH RES CO, V415, P396, DOI 10.1016/j.bbrc.2011.10.080; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zemljic-Harpf A, 2009, J INVEST MED, V57, P849, DOI 10.2310/JIM.0b013e3181c5e074	36	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47592	10.1371/journal.pone.0047592	http://dx.doi.org/10.1371/journal.pone.0047592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077648	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100143
J	Gwak, HS; Kim, TH; Jo, GH; Kim, YJ; Kwak, HJ; Kim, JH; Yin, J; Yoo, H; Lee, SH; Park, JB				Gwak, Ho-Shin; Kim, Tae Hoon; Jo, Guk Heui; Kim, Youn-Jae; Kwak, Hee-Jin; Kim, Jong Heon; Yin, Jinlong; Yoo, Heon; Lee, Seung Hoon; Park, Jong Bae			Silencing of MicroRNA-21 Confers Radio-Sensitivity through Inhibition of the PI3K/AKT Pathway and Enhancing Autophagy in Malignant Glioma Cell Lines	PLOS ONE			English	Article							HUMAN GLIOBLASTOMA CELLS; RADIATION-INDUCED APOPTOSIS; TUMOR-SUPPRESSOR PDCD4; IONIZING-RADIATION; DNA-DAMAGE; IN-VIVO; POSTMITOTIC APOPTOSIS; PREMITOTIC APOPTOSIS; SIGNALING PATHWAYS; GENE RESPONSES	Radiation is a core part of therapy for malignant glioma and is often provided following debulking surgery. However, resistance to radiation occurs in most patients, and the underlying molecular mechanisms of radio-resistance are not fully understood. Here, we demonstrated that microRNA 21 (miR-21), a well-known onco-microRNA in malignant glioma, is one of the major players in radio-resistance. Radio-resistance in different malignant glioma cell lines measured by cytotoxic cell survival assay was closely associated with miR-21 expression level. Blocking miR-21 with anti-miR-21 resulted in radio-sensitization of U373 and U87 cells, whereas overexpression of miR-21 lead to a decrease in radio-sensitivity of LN18 and LN428 cells. Anti-miR-21 sustained gamma-H2AX DNA foci formation, which is an indicator of double-strand DNA damage, up to 24 hours and suppressed phospho-Akt (ser473) expression after exposure to c-irradiation. In a cell cycle analysis, a significant increase in the G(2)/M phase transition by anti-miR-21 was observed at 48 hours after irradiation. Interestingly, our results showed that anti-miR-21 increased factors associated with autophagosome formation and autophagy activity, which was measured by acid vesicular organelles, LC3 protein expression, and the percentage of GFP-LC3 positive cells. Furthermore, augmented autophagy by anti-miR-21 resulted in an increase in the apoptotic population after irradiation. Our results show that miR-21 is a pivotal molecule for circumventing radiation-induced cell death in malignant glioma cells through the regulation of autophagy and provide a novel phenomenon for the acquisition of radio-resistance.	[Gwak, Ho-Shin; Kim, Tae Hoon; Jo, Guk Heui; Kim, Youn-Jae; Kwak, Hee-Jin; Yin, Jinlong; Yoo, Heon; Lee, Seung Hoon; Park, Jong Bae] Natl Canc Ctr, Res Inst & Hosp, Specif Organs Canc Branch, Goyang, South Korea; [Kim, Jong Heon] Natl Canc Ctr, Res Inst & Hosp, Canc Cell & Mol Biol Branch, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Park, JB (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Specif Organs Canc Branch, Goyang, South Korea.	jbp@ncc.re.kr			National Cancer Center Grant of South Korea [1010171, 1010172, 1110110, 1210043-1, 1210320-1, 1210042-1]; Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science, and Technology [2009-0089971]; Korea Health Technology R&D project, Ministry of Health & Welfare, Republic of Korea [A110878]; National Research Foundation Grant of South Korea [2012-0008362]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [1230920-1]	National Cancer Center Grant of South Korea; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Health Technology R&D project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation Grant of South Korea(National Research Foundation of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Jong Bae Park was supported by the National Cancer Center Grant (1010171 and 1010172) of South Korea; Ho-Shin Gwak was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2009-0089971); Jinlong Yin was supported by a grant of the Korea Health Technology R&D project, Ministry of Health & Welfare, Republic of Korea (A110878); Jong Heon Kim was supported by the National Cancer Center Grant (1110110) and the National Research Foundation Grant (2012-0008362) of South Korea; Youn-Jae Kim was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (1230920-1); Heon Yoo was supported by the National Cancer Center Grant (1210043-1) of South Korea; Seung Hoon Lee was supported by the National Cancer Center Grant (1210320-1 and 1210042-1) of South Korea. EJB(SEPT23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, no additional external funding was received for this study.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Azzam EI, 2003, CANCER RES, V63, P7128; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chautard E, 2010, NEURO-ONCOLOGY, V12, P434, DOI 10.1093/neuonc/nop059; Chen G, 2010, ONCOL REP, V23, P997, DOI 10.3892/or_00000725; Chen Y, 2008, CANCER LETT, V272, P197, DOI 10.1016/j.canlet.2008.06.034; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; DEWEY WC, 1995, INT J RADIAT ONCOL, V33, P781, DOI 10.1016/0360-3016(95)00214-8; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gewirtz DA, 2009, RADIOTHER ONCOL, V92, P323, DOI 10.1016/j.radonc.2009.05.022; Grana TM, 2002, CANCER RES, V62, P4142; Gupta AK, 2001, CANCER RES, V61, P4278; Gupta AK, 2002, CLIN CANCER RES, V8, P885; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Ito H, 2005, INT J ONCOL, V26, P1401; Ito H, 2006, JNCI-J NATL CANCER I, V98, P625, DOI 10.1093/jnci/djj161; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kao GD, 2007, J BIOL CHEM, V282, P21206, DOI 10.1074/jbc.M703042200; Khodarev NN, 2001, P NATL ACAD SCI USA, V98, P12665, DOI 10.1073/pnas.211443698; Koul D, 2010, NEURO-ONCOLOGY, V12, P559, DOI 10.1093/neuonc/nop058; Kumaraswamy S, 2008, CANCER RES, V68, P3819, DOI 10.1158/0008-5472.CAN-08-0016; Kwak HJ, 2011, ONCOGENE; Lee CM, 2006, CLIN CANCER RES, V12, P250, DOI 10.1158/1078-0432.CCR-05-1084; Li B, 2004, ONCOGENE, V23, P4594, DOI 10.1038/sj.onc.1207602; Li Y, 2009, BRAIN RES, V1286, P13, DOI 10.1016/j.brainres.2009.06.053; Lu X, 2006, CANCER RES, V66, P1052, DOI 10.1158/0008-5472.CAN-05-3459; Luo S, 2007, CELL DEATH DIFFER, V14, P1247, DOI 10.1038/sj.cdd.4402149; Martin LM, 2010, CANC TREAT REV; Nelson DA, 2004, GENE DEV, V18, P1223, DOI 10.1101/gad.1212404; Ning SC, 1999, RADIAT RES, V151, P659, DOI 10.2307/3580204; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Otomo T, 2004, J RADIAT RES, V45, P53, DOI 10.1269/jrr.45.53; Paglin S, 2001, CANCER RES, V61, P439; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Prevo R, 2008, CANCER RES, V68, P5915, DOI 10.1158/0008-5472.CAN-08-0757; Ren Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-27; Rhee CH, 1999, ONCOGENE, V18, P2711, DOI 10.1038/sj.onc.1202623; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rosenzweig KE, 1997, CLIN CANCER RES, V3, P1149; Shinomiya N, 2000, INT J RADIAT ONCOL, V47, P767, DOI 10.1016/S0360-3016(99)00517-9; Shinomiya N, 2001, J CELL MOL MED, V5, P240, DOI 10.1111/j.1582-4934.2001.tb00158.x; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; WALKER MD, 1979, INT J RADIAT ONCOL, V5, P1725, DOI 10.1016/0360-3016(79)90553-4; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Yao KC, 2003, J NEUROSURG, V98, P378, DOI 10.3171/jns.2003.98.2.0378; Yin E, 2003, INT J RADIAT BIOL, V79, P759, DOI 10.1080/09553000310001610961; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhang Chun-zhi, 2009, Zhonghua Yixue Yichuanxue Zazhi, V26, P634, DOI [10.3760/cma.j.issn.1003-9406.2009.06.007, 10.3760/cma.j.issn.1003-9406.2009.06.006]; Zhou X, LAB INVEST, V90, P144; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	60	117	132	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47449	10.1371/journal.pone.0047449	http://dx.doi.org/10.1371/journal.pone.0047449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077620	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100116
J	Makedonska, J; Wright, BW; Strait, DS				Makedonska, Jana; Wright, Barth W.; Strait, David S.			The Effect of Dietary Adaption on Cranial Morphological Integration in Capuchins (Order Primates, Genus Cebus)	PLOS ONE			English	Article							DEVELOPMENTAL INTEGRATION; MASTICATORY SYSTEM; BONE-GROWTH; ONTOGENETIC VARIATION; SIGMODON-FULVIVENTER; POSTNATAL-GROWTH; CORTICAL BONE; HUMAN SKULL; IN-VIVO; EVOLUTION	A fundamental challenge of morphology is to identify the underlying evolutionary and developmental mechanisms leading to correlated phenotypic characters. Patterns and magnitudes of morphological integration and their association with environmental variables are essential for understanding the evolution of complex phenotypes, yet the nature of the relevant selective pressures remains poorly understood. In this study, the adaptive significance of morphological integration was evaluated through the association between feeding mechanics, ingestive behavior and craniofacial variation. Five capuchin species were examined, Cebus apella sensu stricto, Cebus libidinosus, Cebus nigritus, Cebus olivaceus and Cebus albifrons. Twenty three-dimensional landmarks were chosen to sample facial regions experiencing high strains during feeding, characteristics affecting muscular mechanical advantage and basicranial regions. Integration structure and magnitude between and within the oral and zygomatic subunits, between and within blocks maximizing modularity and within the face, the basicranium and the cranium were examined using partial-least squares, eigenvalue variance, integration indices compared inter-specifically at a common level of sampled population variance and cluster analyses. Results are consistent with previous findings reporting a relative constancy of facial and cranial correlation patterns across mammals, while covariance magnitudes vary. Results further suggest that food material properties structure integration among functionally-linked facial elements and possibly integration between the face and the basicranium. Hard-object-feeding capuchins, especially C. apella s.s., whose faces experience particularly high biomechanical loads are characterized by higher facial and cranial integration especially compared to C. albifrons, likely because morphotypes compromising feeding performance are selected against in species relying on obdurate fallback foods. This is the first study to report a link between food material properties and facial and cranial integration. Furthermore, results do not identify the consistent presence of cranial modules yielding support to suggestions that despite the distinct embryological imprints of its elements the cranium of placental mammals is not characterized by a modular architecture.	[Makedonska, Jana; Strait, David S.] SUNY Albany, Dept Anthropol, Albany, NY 12222 USA; [Wright, Barth W.] Kansas City Univ Med & Biosci, Dept Anat, Kansas City, MO USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Kansas City University of Medicine & Biosciences	Makedonska, J (corresponding author), SUNY Albany, Dept Anthropol, Albany, NY 12222 USA.	jmakedonska@gmail.com			National Science Foundation BCS [1028815]; Division Of Behavioral and Cognitive Sci [1028815] Funding Source: National Science Foundation	National Science Foundation BCS(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by National Science Foundation BCS 1028815 to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Ackermann RR, 2005, J HUM EVOL, V48, P175, DOI 10.1016/j.jhevol.2004.11.001; Alfaro JWL, 2012, AM J PRIMATOL, V74, P273, DOI 10.1002/ajp.22007; Alfaro JWL, 2012, J BIOGEOGR, V39, P272, DOI 10.1111/j.1365-2699.2011.02609.x; ANAPOL F, 1994, AM J PHYS ANTHROPOL, V94, P239, DOI 10.1002/ajpa.1330940208; Auffray Jean-Christophe, 1999, P309; Bastir M, 2005, AM J PHYS ANTHROPOL, V128, P26, DOI 10.1002/ajpa.20191; Bastir M, 2004, AM J PHYS ANTHROPOL, V123, P340, DOI 10.1002/ajpa.10313; Bastir M, 2008, ANAT REC, V291, P130, DOI 10.1002/ar.20636; Bastir M, 2005, DEV PRIMATOL-PROG PR, P265, DOI 10.1007/0-387-27614-9_12; Bastir M, 2006, J ANAT, V209, P637, DOI 10.1111/j.1469-7580.2006.00644.x; Bastir M, 2006, ARCH ORAL BIOL, V51, P814, DOI 10.1016/j.archoralbio.2006.03.009; Bastir M, 2009, EVOL BIOL, V36, P57, DOI 10.1007/s11692-008-9037-4; Bearder S.K., 1980, International Journal of Primatology, V1, P103, DOI 10.1007/BF02735592; BEECHER RM, 1983, J CRAN GENET DEV BIO, V3, P193; BEECHER RM, 1981, ANGLE ORTHOD, V51, P61; Bentolila V, 1998, BONE, V23, P275, DOI 10.1016/S8756-3282(98)00104-5; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bookstein FL, 1996, NATO ADV SCI INST SE, V284, P131; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; BOUVIER M, 1981, J MORPHOL, V167, P1, DOI 10.1002/jmor.1051670102; Bouvier M, 1996, ARCH ORAL BIOL, V41, P941, DOI 10.1016/S0003-9969(96)00047-7; Brandt Hartwin, 2007, CONSTANTINO; Brocardo Carlos Rodrigo, 2010, Neotropical Primates, V17, P70; BROWN AD, 1990, FOLIA PRIMATOL, V54, P187, DOI 10.1159/000156443; BURR DB, 1993, J BIOMECH, V26, P613, DOI 10.1016/0021-9290(93)90023-8; BURR DB, 1985, J BIOMECH, V18, P189, DOI 10.1016/0021-9290(85)90204-0; Byron CD, 2009, J HUM EVOL, V57, P649, DOI 10.1016/j.jhevol.2008.11.006; Campbell Christina J., 2011, PRIMATES PERSPECTIVE; Cheverud J.M., 1989, Progress in Zoology, V35, P196; Cheverud J.M., 1988, P94; Cheverud JM, 2004, J EXP ZOOL PART B, V302B, P424, DOI 10.1002/jez.b.21008; CHEVERUD JM, 1982, EVOLUTION, V36, P499, DOI 10.1111/j.1558-5646.1982.tb05070.x; CHEVERUD JM, 1995, AM NAT, V145, P63, DOI 10.1086/285728; Cheverud JM, 1996, AM ZOOL, V36, P44; CHEVERUD JM, 1992, AM J PHYS ANTHROPOL, V88, P323, DOI 10.1002/ajpa.1330880307; CHEVERUD JM, 1992, AM J PHYS ANTHROPOL, V87, P167, DOI 10.1002/ajpa.1330870205; CHEVERUD JM, 1984, J THEOR BIOL, V110, P155, DOI 10.1016/S0022-5193(84)80050-8; COLE TM, 1992, J HUM EVOL, V23, P253, DOI 10.1016/S0047-2484(05)80003-X; CORRUCCINI RS, 1984, J CRAN GENET DEV BIO, V4, P135; DAEGLING DJ, 1992, INT J PRIMATOL, V13, P545, DOI 10.1007/BF02547832; Daegling DJ, 2004, AM J PHYS ANTHROPOL, V124, P346, DOI 10.1002/ajpa.10356; DERUITER JR, 1986, BEHAVIOUR, V98, P240, DOI 10.1163/156853986X00982; DICKINSON C, 1990, AM J PHYS ANTHROPOL, V81, P215; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; ENLOW DH, 1969, AMER J ORTHODONTICS, V56, P6, DOI 10.1016/0002-9416(69)90254-1; Enlow DH, 1996, ESSENTIALS FACIAL GR; ESCOUFIER Y, 1973, BIOMETRICS, V29, P751, DOI 10.2307/2529140; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; Ford SM, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P229; Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI; FRAGASZY DM, 1995, J COMP PSYCHOL, V109, P339, DOI 10.1037/0735-7036.109.4.339; Goswami A, 2006, EVOLUTION, V60, P169; Goswami A, 2006, AM NAT, V168, P270, DOI 10.1086/505758; Goswami A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000995; Hallgrimsson Benedikt, 2007, Novartis Found Symp, V284, P164; Harcourt, 1980, THESIS U WITWATERSRA; Harcourt CS, 1984, THESIS U CAMBRIDGE; Harvati K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024024; Herring Susan W., 1993, P153; Hylander W.L., 1988, P55; HYLANDER WL, 1994, AM J PHYS ANTHROPOL, V94, P523, DOI 10.1002/ajpa.1330940407; HYLANDER WL, 1991, AM J PHYS ANTHROPOL, V86, P1, DOI 10.1002/ajpa.1330860102; HYLANDER WL, 1985, AM ZOOL, V25, P315; HYLANDER WL, 1979, AM J PHYS ANTHROPOL, V51, P433, DOI 10.1002/ajpa.1330510317; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; IZAWA K, 1977, Primates, V18, P773, DOI 10.1007/BF02382930; IZAWA K, 1975, Primates, V16, P295, DOI 10.1007/BF02381557; JANSON CH, 1984, Z TIERPSYCHOL, V65, P177; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; KAY RF, 1981, AM J PHYS ANTHROPOL, V55, P141, DOI 10.1002/ajpa.1330550202; KINZEY WG, 1974, J HUM EVOL, V3, P193, DOI 10.1016/0047-2484(74)90177-8; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; LANDE R, 1984, GENET RES, V44, P309, DOI 10.1017/S0016672300026549; LANDE R, 1980, GENETICS, V94, P203; LANYON LE, 1979, J BIOMECH, V12, P593, DOI 10.1016/0021-9290(79)90079-4; LANYON LE, 1982, J BIOMECH, V15, P141, DOI 10.1016/0021-9290(82)90246-9; Lee TC, 2002, J ANAT, V201, P437, DOI 10.1046/j.1469-7580.2002.00123.x; LEIGH SR, 1992, J HUM EVOL, V23, P27, DOI 10.1016/0047-2484(92)90042-8; Lieberman DE, 2004, J EXP ZOOL PART B, V302B, P284, DOI 10.1002/jez.b.21004; Lieberman DE, 2003, J EXP BIOL, V206, P3125, DOI 10.1242/jeb.00514; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Ludwig G, 2006, REV BRAS ZOOL, V23, P888, DOI 10.1590/S0101-81752006000300039; Marroig G, 2004, J EVOLUTION BIOL, V17, P144, DOI 10.1046/j.1420-9101.2003.00653.x; Marroig G, 2001, EVOLUTION, V55, P2576; Marshall AJ, 2007, INT J PRIMATOL, V28, P1218, DOI 10.1007/s10764-007-9218-5; Martinez-Abadias N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026425; Masterson TJ, 1997, AM J PHYS ANTHROPOL, V104, P487, DOI 10.1002/(SICI)1096-8644(199712)104:4<487::AID-AJPA5>3.3.CO;2-J; McCarthy RC, 2001, ANAT REC, V264, P247, DOI 10.1002/ar.1167; McFarlin SC, 2008, J ANAT, V213, P308, DOI 10.1111/j.1469-7580.2008.00947.x; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; MORI S, 1993, BONE, V14, P103, DOI 10.1016/8756-3282(93)90235-3; Morriss-Kay GM, 2001, J ANAT, V199, P143; MOSS ML, 1957, ANAT REC, V127, P569, DOI 10.1002/ar.1091270307; MOSS ML, 1960, AM J PHYS ANTHROPOL, V18, P281, DOI 10.1002/ajpa.1330180406; MOSS ML, 1975, ARCH ORAL BIOL, V20, P489, DOI 10.1016/0003-9969(75)90209-5; Nash L.T., 1989, Human Evolution, V4, P199, DOI 10.1007/BF02435449; Nash LT, 1998, AM J PRIMATOL, V10, P57; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; NODEN DM, 1988, DEVELOPMENT, V103, P121; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Pavlicev M, 2009, EVOL BIOL, V36, P157, DOI 10.1007/s11692-008-9042-7; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; PERES CA, 1994, BIOTROPICA, V26, P98, DOI 10.2307/2389114; Porto A, 2009, EVOL BIOL, V36, P118, DOI 10.1007/s11692-008-9038-3; Ravosa MJ, 2003, AM J PHYS ANTHROPOL, P175; Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169; Rimoli J., 2008, PRIMATOLOGIA NO BRAS, V9, P130; Robinson J.G., 1986, SMITHSONIAN CONTRIBU, V27, P1, DOI DOI 10.5479/SI.00810282.431; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Ross CF, 2001, AM J PHYS ANTHROPOL, V116, P108, DOI 10.1002/ajpa.1106; Roth VL, 1996, AM ZOOL, V36, P14; Shirai LT, 2010, J EXP ZOOL PART B, V314B, P663, DOI 10.1002/jez.b.21367; Sholts SB, 2010, J FORENSIC SCI, V55, P871, DOI 10.1111/j.1556-4029.2010.01380.x; Sholts SB, 2010, INT J OSTEOARCHAEOL, DOI [10.1002/oa.1156, DOI 10.1002/0A.1156]; Sidor CA, 2001, EVOLUTION, V55, P1419; Silva J. S., 2001, THESIS U FEDERAL RIO; Singleton M, 2005, DEV PRIMATOL-PROG PR, P319, DOI 10.1007/0-387-27614-9_15; Slice DE, 2005, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/0-387-27614-9; Spector JA, 2002, PLAST RECONSTR SURG, V109, P645, DOI 10.1097/00006534-200202000-00035; SPENCER MA, 1993, AM J PHYS ANTHROPOL, V91, P1, DOI 10.1002/ajpa.1330910102; Spencer MA, 1998, J HUM EVOL, V34, P25, DOI 10.1006/jhev.1997.0180; Spencer MA, 1999, AM J PHYS ANTHROPOL, V108, P483, DOI 10.1002/(SICI)1096-8644(199904)108:4<483::AID-AJPA7>3.0.CO;2-L; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; Strait DS, 2001, AM J PHYS ANTHROPOL, V114, P273, DOI 10.1002/ajpa.1041; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Thompson EN, 2003, J EXP BIOL, V206, P923, DOI 10.1242/jeb.00181; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Vinyard CJ, 2007, AM J PRIMATOL, V69, P46, DOI 10.1002/ajp.20326; Vinyard CJ, 2003, AM J PHYS ANTHROPOL, V120, P153, DOI 10.1002/ajpa.10129; WAGNER GP, 1984, J MATH BIOL, V21, P77, DOI 10.1007/BF00275224; Wagner GP, 2008, NATURE, V452, P470, DOI 10.1038/nature06756; WEIDENREICH FRANZ, 1941, TRANS AMER PHIL SOC, V31, P321; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601; Wood B, 2001, AM J PHYS ANTHROPOL, V116, P13, DOI 10.1002/ajpa.1097; Wright BW, 2009, AM J PHYS ANTHROPOL, V140, P687, DOI 10.1002/ajpa.21116; Wright BW, 2005, J HUM EVOL, V48, P473, DOI 10.1016/j.jhevol.2005.01.006; Yezerinac SM, 1992, SYST BIOL, V421, P734; Young NM, 2006, J ANAT, V209, P623, DOI 10.1111/j.1469-7580.2006.00639.x; Young NM, 2010, P NATL ACAD SCI USA, V107, P3400, DOI 10.1073/pnas.0911856107; Young NM, 2009, EVOL BIOL, V36, P88, DOI 10.1007/s11692-009-9053-z; Young NM, 2005, EVOLUTION, V59, P2691; YOUNG RW, 1959, AM J ANAT, V105, P383, DOI 10.1002/aja.1001050304; Yu JC, 2001, J CRANIOFAC SURG, V12, P391, DOI 10.1097/00001665-200107000-00018; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zelditch ML, 2009, EVOL BIOL, V36, P71, DOI 10.1007/s11692-008-9034-7; ZELDITCH ML, 1988, EVOLUTION, V42, P28, DOI 10.1111/j.1558-5646.1988.tb04105.x; ZELDITCH ML, 1989, EVOLUTION, V43, P814, DOI 10.1111/j.1558-5646.1989.tb05179.x; ZELDITCH ML, 1989, J MAMMAL, V70, P477, DOI 10.2307/1381419	158	28	28	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e40398	10.1371/journal.pone.0040398	http://dx.doi.org/10.1371/journal.pone.0040398			58	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110039	Green Published, gold			2022-12-27	WOS:000310262500001
J	Lu, QL; Yao, YH; Yao, YF; Liu, SZ; Huang, Y; Lu, S; Bai, Y; Zhou, BS; Xu, Y; Li, L; Wang, N; Wang, L; Zhang, J; Cheng, X; Qin, GJ; Ma, W; Xu, CQ; Tu, X; Wang, Q				Lu, Qiulun; Yao, Yihong; Yao, Yufeng; Liu, Shizhi; Huang, Yuan; Lu, Shan; Bai, Ying; Zhou, Bisheng; Xu, Yan; Li, Lei; Wang, Nan; Wang, Li; Zhang, Jie; Cheng, Xiang; Qin, Gangjian; Ma, Wei; Xu, Chengqi; Tu, Xin; Wang, Qing			Angiogenic Factor AGGF1 Promotes Therapeutic Angiogenesis in a Mouse Limb Ischemia Model	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; KLIPPEL-TRENAUNAY-SYNDROME; ENDOTHELIAL GROWTH-FACTOR; LOWER-EXTREMITY; GENE-TRANSFER; HINDLIMB ISCHEMIA; CLINICAL-TRIAL; PLASMID DNA; BLOOD-FLOW; SUSCEPTIBILITY	Background: Peripheral arterial disease (PAD) is a common disease accounting for about 12% of the adult population, and causes significant morbidity and mortality. Therapeutic angiogenesis using angiogenic factors has been considered to be a potential treatment option for PAD patients. In this study, we assessed the potential of a new angiogenic factor AGGF1 for therapeutic angiogenesis in a critical limb ischemia model in mice for PAD. Methods and Results: We generated a unilateral hindlimb ischemia model in mice by ligation of the right common iliac artery and femoral artery. Ischemic mice with intrasmuscular administration of DNA for an expression plasmid for human AGGF1 (AGGF1 group) resulted in increased expression of both AGGF1 mRNA and protein after the administration compared with control mice with injection of the empty vector (control group). Color PW Doppler echocardiography showed that the blood flow in ischemic hindlimbs was significantly increased in the AGGF1 group compared to control mice at time points of 7, 14, and 28 days after DNA administration (n = 9/group, P = 0.049, 0.001, and 0.001, respectively). Increased blood flow in the AGGF1 group was correlated to increased density of CD31-positive vessels and decreased necrosis in muscle tissues injected with AGGF1 DNA compared with the control tissue injected with the empty vector. Ambulatory impairment was significantly reduced in the AGGF1 group compared to the control group (P = 0.004). The effect of AGGF1 was dose-dependent. At day 28 after gene transfer, AGGF1 was significantly better in increasing blood flow than FGF-2 (P = 0.034), although no difference was found for tissue necrosis and ambulatory impairment. Conclusions: These data establish AGGF1 as a candidate therapeutic agent for therapeutic angiogenesis to treat PAD.	[Lu, Qiulun; Yao, Yihong; Yao, Yufeng; Liu, Shizhi; Huang, Yuan; Lu, Shan; Bai, Ying; Zhou, Bisheng; Xu, Yan; Li, Lei; Wang, Nan; Wang, Li; Zhang, Jie; Xu, Chengqi; Tu, Xin; Wang, Qing] Huazhong Univ Sci & Technol, Cardio X Inst, Ctr Human Genome Res, Minist Educ,Coll Life Sci & Technol,Key Lab Mol B, Wuhan 430074, Peoples R China; [Cheng, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Cardiol, Wuhan 430074, Peoples R China; [Qin, Gangjian] Northwestern Univ, Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL USA; [Xu, Chengqi] First Hosp Wuhan City, Wuhan, Peoples R China; [Wang, Qing] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Ctr Cardiovasc Genet, Cleveland, OH 44106 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Northwestern University; Cleveland Clinic Foundation	Tu, X (corresponding author), Huazhong Univ Sci & Technol, Cardio X Inst, Ctr Human Genome Res, Minist Educ,Coll Life Sci & Technol,Key Lab Mol B, Wuhan 430074, Peoples R China.	xtu@mail.hust.edu.cn; qkwang@mail.hust.edu.cn	Cheng, Xiang/K-2190-2012; Wang, Li/AAM-2454-2021; Zhou, Bisheng/B-6607-2011; Zhou, Bisheng/K-2160-2019; Lu, Qiulun/A-7073-2018; Zhou, Bisheng/M-3143-2016	Wang, Li/0000-0002-8969-7427; Xu, Chengqi/0000-0002-4269-6830; Zhou, Bisheng/0000-0003-1551-0612	Fundamental Research Funds for the Central Universities [2010MS015, 2011TS082]; State Key Laboratory of Freshwater Ecology and Biotechnology [2011FB16]; Hubei Province Natural Science Key Program [2008CDA047]; Key Academic Program Leader Award of Wuhan City [200951830560]; National Natural Science Foundation of China [81070106]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); Hubei Province Natural Science Key Program; Key Academic Program Leader Award of Wuhan City; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Fundamental Research Funds for the Central Universities (2010MS015, 2011TS082), a grant from the State Key Laboratory of Freshwater Ecology and Biotechnology (2011FB16), a Hubei Province Natural Science Key Program (2008CDA047) and a Key Academic Program Leader Award of Wuhan City (200951830560), and the National Natural Science Foundation of China (81070106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner I, 2000, ANN INTERN MED, V132, P880, DOI 10.7326/0003-4819-132-11-200006060-00005; Bosch-Marce M, 2007, CIRC RES, V101, P1310, DOI 10.1161/CIRCRESAHA.107.153346; Brevetti G, 2010, CIRCULATION, V122, P1862, DOI 10.1161/CIRCULATIONAHA.109.918417; Costantini V, 2002, THROMB RES, V106, pV285, DOI 10.1016/S0049-3848(02)00104-4; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; DAVIS HL, 1993, HUM GENE THER, V4, P733, DOI 10.1089/hum.1993.4.6-733; Dieter RS, 2003, VASC MED, V8, P233, DOI 10.1191/1358863x03vm506ra; Fan C, 2009, J BIOL CHEM, V284, P23331, DOI 10.1074/jbc.M109.036079; Fitzgerald SM, 2007, AM J PHYSIOL-HEART C, V293, pH1072, DOI 10.1152/ajpheart.00072.2007; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Ha XQ, 2008, NEURAL REGEN RES, V3, P625; Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; Hiraoka K, 2003, CIRCULATION, V108, P2689, DOI 10.1161/01.CIR.0000093275.78676.F4; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; Hu Y, 2008, ANN HUM GENET, V72, P636, DOI 10.1111/j.1469-1809.2008.00458.x; Lange S, 2003, DIABETES CARE, V26, P3357, DOI 10.2337/diacare.26.12.3357; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Matyas L, 2005, HUM GENE THER, V16, P1202, DOI 10.1089/hum.2005.16.1202; Mughal NA, 2012, BRIT J SURG, V99, P6, DOI 10.1002/bjs.7743; Nikol S, 2008, MOL THER, V16, P972, DOI 10.1038/mt.2008.33; Olin JW, 2010, MAYO CLIN PROC, V85, P678, DOI 10.4065/mcp.2010.0133; Powell RJ, 2004, VASC MED, V9, P193, DOI 10.1191/1358863x04vm557oa; Qi X, 2010, EUR J PHARMACOL, V634, P121, DOI 10.1016/j.ejphar.2010.02.038; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Taniyama Y, 2001, GENE THER, V8, P181, DOI 10.1038/sj.gt.3301379; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Timur AA, 2005, CELL MOL LIFE SCI, V62, P1434, DOI 10.1007/s00018-005-4523-7; Tongers J, 2008, CIRCULATION, V118, P9, DOI 10.1161/CIRCULATIONAHA.108.784371; Tsurumi Y, 1996, CIRCULATION, V94, P3281, DOI 10.1161/01.CIR.94.12.3281; VOGT MT, 1992, J CLIN EPIDEMIOL, V45, P529, DOI 10.1016/0895-4356(92)90102-S; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Weitz JI, 1996, CIRCULATION, V94, P3026, DOI 10.1161/01.CIR.94.11.3026; Welten GMJM, 2009, J CARDIOVASC SURG, V50, P109; Welten GMJM, 2008, J AM COLL CARDIOL, V51, P1588, DOI 10.1016/j.jacc.2007.11.077; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wu L, 2008, J BIOL CHEM, V283, P6968, DOI 10.1074/jbc.M709721200; Zhang T, 2008, CIRCULATION, V118, pS461	41	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e46998	10.1371/journal.pone.0046998	http://dx.doi.org/10.1371/journal.pone.0046998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110058	Green Published, gold, Green Submitted			2022-12-27	WOS:000310193600007
J	Hsu, RJ; Ho, JY; Cha, TL; Yu, DS; Wu, CL; Huang, WP; Chu, PL; Chen, YH; Chen, JT; Yu, CP				Hsu, Ren-Jun; Ho, Jar-Yi; Cha, Tai-Lung; Yu, Dah-Shyong; Wu, Chieh-Lin; Huang, Wei-Ping; Chu, Pauling; Chen, Ying-Hsin; Chen, Jiann-Torng; Yu, Cheng-Ping			WNT10A Plays an Oncogenic Role in Renal Cell Carcinoma by Activating WNT/beta-catenin Pathway	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; PRIMARY GASTRIC-CANCER; SIGNALING PATHWAY; BETA-CATENIN; HEPATOCELLULAR-CARCINOMA; STEM-CELLS; NONCANONICAL WNT; ANTAGONIST GENE; INHIBITS PROLIFERATION	Renal cell carcinoma (RCC) is a malignancy with poor prognosis. WNT/beta-catenin signaling dysregulation, especially beta-catenin overactivation and WNT antagonist silencing, is associated with RCC carcinogenesis and progression. However, the role of WNT ligands in RCC has not yet been determined. We screened 19 WNT ligands from normal kidney and RCC cell lines and tissues and found that WNT10A was significantly increased in RCC cell lines and tissues as compared to that in normal controls. The clinical significance of increase in WNT10A was evaluated by performing an immunohistochemical association study in a 19-year follow-up cohort comprising 284 RCC and 267 benign renal disease (BRD) patients. The results of this study showed that WNT10A was dramatically upregulated in RCC tissues as compared to that in BRD tissues. This result suggests that WNT10A, nuclear beta-catenin, and nuclear cyclin D1 act as independent risk factors for RCC carcinogenesis and progression, with accumulative risk effects. Molecular validation of cell line models with gain- or loss-of-function designs showed that forced WNT10A expression induced RCC cell proliferation and aggressiveness, including higher chemoresistance, cell migration, invasiveness, and cell transformation, due to the activation of beta-catenin-dependent signaling. Conversely, WNT10A siRNA knockdown decreased cell proliferation and aggressiveness of RCC cells. In conclusion, we showed that WNT10A acts as an autocrine oncogene both in RCC carcinogenesis and progression by activating WNT/beta-catenin signaling.	[Hsu, Ren-Jun; Yu, Cheng-Ping] Natl Def Med Ctr, Triserv Gen Hosp, Biobank Management Ctr, Taipei, Taiwan; [Hsu, Ren-Jun; Ho, Jar-Yi; Wu, Chieh-Lin; Huang, Wei-Ping; Yu, Cheng-Ping] Natl Def Med Ctr, Triserv Gen Hosp, Grad Inst Pathol & Parasitol, Taipei, Taiwan; [Ho, Jar-Yi; Cha, Tai-Lung; Yu, Dah-Shyong; Yu, Cheng-Ping] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Cha, Tai-Lung; Yu, Dah-Shyong] Natl Def Med Ctr, Triserv Gen Hosp, Div Urol, Taipei, Taiwan; [Chu, Pauling] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Chen, Ying-Hsin] Natl Def Med Ctr, Triserv Gen Hosp, Dept Emergency Med, Taipei, Taiwan; [Chen, Jiann-Torng] Natl Def Med Ctr, Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Yu, CP (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Biobank Management Ctr, Taipei, Taiwan.	cpyupath@yahoo.com.tw		Yu, Cheng-Ping/0000-0002-0693-5056; Wu, Chieh-Lin (Stanley)/0000-0002-7090-7172; Ho, Jar-Yi/0000-0001-6933-041X	National Science Council [NSC100-2320-B-016-010-]; Tri-Service General Hospital [TSGH-C98-04, TSGH-C98-10-S01, TSGH-C99-004, TSGH-C99-146, TSGH-C99-009-10-S01, TSGH-C100-135, TSGH-C100-007-009-10-S01]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	This work was supported by the National Science Council (NSC100-2320-B-016-010-) and the Tri-Service General Hospital (TSGH-C98-04, TSGH-C98-10-S01, TSGH-C99-004, TSGH-C99-146, TSGH-C99-009-10-S01, TSGH-C100-135 and TSGH-C100-007-009-10-S01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422; Bilim V, 2000, CLIN CANCER RES, V6, P460; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Bomben R, 2007, BLOOD, V109, P2989, DOI 10.1182/blood-2006-10-051110; Bruder E, 2007, MODERN PATHOL, V20, P1217, DOI 10.1038/modpathol.3800957; Bui TD, 1997, ONCOGENE, V14, P1249, DOI 10.1038/sj.onc.1200936; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Chen K, 2008, PEDIATR BLOOD CANCER, V51, P349, DOI 10.1002/pbc.21595; Cheng XX, 2005, CANCER LETT, V223, P339, DOI 10.1016/j.canlet.2004.11.013; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Clement G, 2006, ONCOGENE, V25, P3084, DOI 10.1038/sj.onc.1209338; Costa VL, 2010, EPIGENETICS-US, V5, P343, DOI 10.4161/epi.5.4.11749; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Dai W, 2011, CLIN CANCER RES, V17, P4052, DOI 10.1158/1078-0432.CCR-10-3021; Fu L, 2011, GUT, V60, P1635, DOI 10.1136/gut.2011.241638; Gelebart P, 2008, BLOOD, V112, P5171, DOI 10.1182/blood-2008-02-139212; Guillen-Ahlers H, 2008, CURR DRUG TARGETS, V9, P591, DOI 10.2174/138945008784911813; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Hirata H, 2011, INT J CANCER, V128, P1793, DOI 10.1002/ijc.25507; Hirata H, 2010, CANCER RES, V70, P1896, DOI 10.1158/0008-5472.CAN-09-3549; Hirata H, 2009, CLIN CANCER RES, V15, P5678, DOI 10.1158/1078-0432.CCR-09-0558; Hirata H, 2009, CANCER-AM CANCER SOC, V115, P4488, DOI 10.1002/cncr.24491; Katoh M, 2001, INT J ONCOL, V19, P1003; Katoh M, 2001, BIOCHEM BIOPH RES CO, V289, P1093, DOI 10.1006/bbrc.2001.6076; Kawakami K, 2011, INT J CANCER, V128, P541, DOI 10.1002/ijc.25357; Kawakami K, 2009, CANCER RES, V69, P8603, DOI 10.1158/0008-5472.CAN-09-2534; Kawamoto K, 2008, INT J CANCER, V123, P535, DOI 10.1002/ijc.23514; Kikuchi A, 2008, CANCER SCI, V99, P202, DOI 10.1111/j.1349-7006.2007.00675.x; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Kim YS, 2000, PATHOL INT, V50, P725, DOI 10.1046/j.1440-1827.2000.01111.x; Kirikoshi H, 2001, INT J ONCOL, V19, P997; Kirikoshi H, 2001, BIOCHEM BIOPH RES CO, V283, P798, DOI 10.1006/bbrc.2001.4855; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; KWAN H, 1992, MOL CELL BIOL, V12, P147, DOI 10.1128/MCB.12.1.147; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Li ZG, 2008, ONCOGENE, V27, P596, DOI 10.1038/sj.onc.1210694; Lin YC, 2010, J MED SCI, V30, P199; Liu X, 2008, ONCOGENE, V27, P1478, DOI 10.1038/sj.onc.1210769; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mazieres J, 2005, ONCOGENE, V24, P5396, DOI 10.1038/sj.onc.1208568; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Mccoy KE, 2011, DEV DYNAM, V240, P1558, DOI 10.1002/dvdy.22626; Miyakoshi T, 2008, ENDOCR PATHOL, V19, P261, DOI 10.1007/s12022-008-9048-9; Nakamura Y, 2005, AM J PATHOL, V167, P97, DOI 10.1016/S0002-9440(10)62957-4; Nygren MK, 2007, BRIT J HAEMATOL, V136, P400, DOI 10.1111/j.1365-2141.2006.06442.x; Okoye Ujunwa C, 2008, J Mol Signal, V3, P16, DOI 10.1186/1750-2187-3-16; Olson DJ, 1998, EXP CELL RES, V241, P134, DOI 10.1006/excr.1998.4030; Park JK, 2009, NEOPLASMA, V56, P119, DOI 10.4149/neo_2009_02_119; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Roberts DM, 2007, NAT STRUCT MOL BIOL, V14, P463, DOI 10.1038/nsmb0607-463; Roman-Gomez J, 2007, BLOOD, V109, P3462, DOI 10.1182/blood-2006-09-047043; Saini S, 2011, NAT REV UROL, V8, P690, DOI 10.1038/nrurol.2011.146; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Serra R, 2011, J MAMMARY GLAND BIOL, V16, P157, DOI 10.1007/s10911-011-9205-5; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sinnberg T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023429; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Sun M, 2011, EUR UROL, V60, P644, DOI 10.1016/j.eururo.2011.06.041; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Thiago LS, 2010, BIOMED PHARMACOTHER, V64, P63, DOI 10.1016/j.biopha.2009.09.005; Tickenbrock L, 2008, INT J ONCOL, V33, P1215, DOI 10.3892/ijo_00000111; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; Uraguchi M, 2004, J DENT RES, V83, P327, DOI 10.1177/154405910408300411; Urakami S, 2006, CLIN CANCER RES, V12, P6989, DOI 10.1158/1078-0432.CCR-06-1194; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Wang W, 2010, CANCER INVEST, V28, P230, DOI 10.3109/07357900903095698; Wang XH, 2009, CELL CYCLE, V8, P1567, DOI 10.4161/cc.8.10.8489; Wei W, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-16; Wend P, 2010, SEMIN CELL DEV BIOL, V21, P855, DOI 10.1016/j.semcdb.2010.09.004; Yan LQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016515; Ying Y, 2009, EPIGENETICS-US, V4, P307, DOI 10.4161/epi.4.5.9371; You L, 2006, DRUG NEWS PERSPECT, V19, P27, DOI 10.1358/dnp.2006.19.1.965871; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; You L, 2004, CANCER RES, V64, P5385, DOI 10.1158/0008-5472.CAN-04-1227; Yuan FJ, 2010, MOL CELL BIOCHEM, V343, P155, DOI 10.1007/s11010-010-0509-3; Zhang XL, 2010, NEOPLASMA, V57, P545, DOI 10.4149/neo_2010_06_545	90	47	47	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47649	10.1371/journal.pone.0047649	http://dx.doi.org/10.1371/journal.pone.0047649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094073	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200038
J	Leguebe, M; Nguyen, C; Capece, L; Hoang, Z; Giorgetti, A; Carloni, P				Leguebe, Michael; Chuong Nguyen; Capece, Luciana; Zung Hoang; Giorgetti, Alejandro; Carloni, Paolo			Hybrid Molecular Mechanics/Coarse-Grained Simulations for Structural Prediction of G-Protein Coupled Receptor/Ligand Complexes	PLOS ONE			English	Article							LOCAL-STRUCTURE MODEL; FORCE-FIELD; MULTISCALE SIMULATIONS; UNFOLDING TRANSITION; GLOBULAR-PROTEINS; RESP MODEL; DYNAMICS; ACTIVATION; RESTRAINTS; SOFTWARE	Understanding how ligands bind to G-protein coupled receptors (GPCRs) provides insights into a myriad of cell processes and is crucial for drug development. Here we extend a hybrid molecular mechanics/coarse-grained (MM/CG) approach applied previously to enzymes to GPCR/ligand complexes. The accuracy of this method for structural predictions is established by comparison with recent atomistic molecular dynamics simulations on the human beta 2 adrenergic receptor, a member of the GPCRs superfamily. The results obtained with the MM/CG methodology show a good agreement with previous all-atom classical dynamics simulations, in particular in the structural description of the ligand binding site. This approach could be used for high-throughput predictions of ligand poses in a variety of GPCRs.	[Leguebe, Michael; Chuong Nguyen; Capece, Luciana; Giorgetti, Alejandro; Carloni, Paolo] German Res Sch Simulat Sci, Julich, Germany; [Leguebe, Michael] Inst Math Bordeaux, INRIA Bordeaux Sud Ouest, Talence, France; [Chuong Nguyen; Capece, Luciana; Giorgetti, Alejandro; Carloni, Paolo] JARA High Performance Comp, Julich, Germany; [Capece, Luciana] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Zung Hoang] Vietnam Natl Univ Ho Chi Minh City, Ho Chi Minh City, Vietnam; [Giorgetti, Alejandro] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy; [Carloni, Paolo] Forschungszentrum Julich, Inst Adv Simulat, Intitute Computat Biomed IAS 5, D-52425 Julich, Germany	Centre National de la Recherche Scientifique (CNRS); Inria; International Center for Genetic Engineering & Biotechnology (ICGEB); Vietnam National University Hochiminh City; University of Verona; Helmholtz Association; Research Center Julich	Giorgetti, A (corresponding author), German Res Sch Simulat Sci, Julich, Germany.	alejandro.giorgetti@univr.it	Carloni, Paolo/H-8736-2013; Nguyen, Chuong/F-3473-2011	Nguyen, Chuong/0000-0001-8373-981X; Carloni, Paolo/0000-0002-9010-0149; Giorgetti, Alejandro/0000-0001-8738-6150; LEGUEBE, Michael/0000-0001-9908-5005	Deutsche Forschungsgemeinschaft [CA 973/6-1]; Vietnam National Foundation for Science and Technology Development [DFG.2011.01]; Project ISS [UPR- 20009-1301355 (CUP I85J08000040005)]; JARA-HPC on RWTH Compute Cluster [jara0023]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Vietnam National Foundation for Science and Technology Development; Project ISS; JARA-HPC on RWTH Compute Cluster	This work has been supported in part by a grant from the Deutsche Forschungsgemeinschaft (CA 973/6-1), by a grant from Vietnam National Foundation for Science and Technology Development (DFG.2011.01), and by a grant from the Project ISS UPR- 20009-1301355 (CUP I85J08000040005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ursula Rothlisberger for kindly providing the trajectories of the all-atom MD simulations, and Justin Finnerty and Alexander Peyser for comments on the manuscript. Computer resources provided by the Julich Supercomputing Center on JUROPA and by JARA-HPC on RWTH Compute Cluster (project ID jara0023) is greatly acknowledged.	ABE H, 1981, BIOPOLYMERS, V20, P1013, DOI 10.1002/bip.1981.360200512; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Ayton GS, 2007, CURR OPIN STRUC BIOL, V17, P192, DOI 10.1016/j.sbi.2007.03.004; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; GO N, 1981, BIOPOLYMERS, V20, P991, DOI 10.1002/bip.1981.360200511; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Kalli AC, 2011, P NATL ACAD SCI USA, V108, P11890, DOI 10.1073/pnas.1104505108; Kutzner C, 2007, J COMPUT CHEM, V28, P2075, DOI 10.1002/jcc.20703; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Messer BM, 2010, PROTEINS, V78, P1212, DOI 10.1002/prot.22640; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; NADLER W, 1987, P NATL ACAD SCI USA, V84, P7933, DOI 10.1073/pnas.84.22.7933; Neri M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.218102; Neri M, 2008, BIOPHYS J, V94, P71, DOI 10.1529/biophysj.107.116301; Nygaard R, 2010, J BIOL CHEM, V285, P19625, DOI 10.1074/jbc.M110.106021; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paesani F, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2386157; Rompler H, 2011, NAT COMMUN, V2, P17; Rompler H, 2007, MOL INTERV, V7, P17, DOI 10.1124/mi.7.1.5; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Rzepiela AJ, 2011, PHYS CHEM CHEM PHYS, V13, P10437, DOI 10.1039/c0cp02981e; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sgourakis NG, 2010, J MOL BIOL, V398, P161, DOI 10.1016/j.jmb.2010.02.032; Shi Q, 2006, J PHYS CHEM B, V110, P15045, DOI 10.1021/jp062700h; Taylor MRG, 2007, PHARMACOGENOMICS J, V7, P29, DOI 10.1038/sj.tpj.6500393; Vanni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001053; Villa E, 2005, P NATL ACAD SCI USA, V102, P6783, DOI 10.1073/pnas.0409387102; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Yarnitzky T, 2010, CURR OPIN DRUG DISC, V13, P317	38	38	38	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47332	10.1371/journal.pone.0047332	http://dx.doi.org/10.1371/journal.pone.0047332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094046	Green Published, gold			2022-12-27	WOS:000310050200022
J	Jonas, JB; Jonas, SB; Jonas, RA; Holbach, L; Dai, Y; Sun, XH; Panda-Jonas, S				Jonas, Jost B.; Jonas, Shefali B.; Jonas, Rahul A.; Holbach, Leonhard; Dai, Yi; Sun, Xinghuai; Panda-Jonas, Songhomitra			Parapapillary Atrophy: Histological Gamma Zone and Delta Zone	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; HIGH MYOPIA; NORMAL EYES; GLAUCOMA; NERVE; BETA; HISTOMORPHOMETRY; ANATOMY	Background: To examine histomorphometrically the parapapillary region in human eyes. Methodology/Principal Findings: The histomorphometric study included 65 human globes (axial length: 21-37 mm). On anterior-posterior histological sections, we measured the distance Bruch's membrane end (BME)-optic nerve margin ("Gamma zone"), BME-retinal pigment epithelium (RPE) ("Beta zone"), BME-beginning of non-occluded choriocapillaris, and BME-beginning of photoreceptor layer. "Delta zone" was defined as part of gamma zone in which blood vessels of at least 50 mm diameter were not present over a length of >300 mu m. Beta zone (mean length: 0.35 +/- 0.52 mm) was significantly (P = 0.01) larger in the glaucoma group than in the non-glaucomatous group. It was not significantly (P = 0.28) associated with axial length. Beta zone was significantly (P = 0.004) larger than the region with occluded choriocapillaris. Gamma zone (mean length: 0.63 +/- 1.25 mm) was associated with axial length (P<0.001; r(2) = 0.73) with an increase starting at an axial length of 26.5 mm. It was not significantly (P = 0.24) associated with glaucomatous optic neuropathy. Delta zone (present only in eyes with axial length of >= 27 mm) was associated with axial length (P = 0.001) and scleral flange length (P, 0.001) but not with glaucoma (P = 0.73). Conclusions/Significance: Parapapillary gamma zone (peripapillary sclera without overlying choroid, Bruch's membrane and deep retinal layers) was related with axial globe elongation and was independent of glaucoma. Delta zone (no blood vessels >50 mu m diameter within gamma zone) was present only in highly axially elongated globes and was not related with glaucoma. Beta zone (Bruch's membrane without RPE) was correlated with glaucoma but not with globe elongation. Since the region with occluded choriocapillaris was smaller than beta zone, complete loss of RPE may have occurred before complete choriocapillaris closure.	[Jonas, Jost B.; Jonas, Shefali B.; Jonas, Rahul A.; Panda-Jonas, Songhomitra] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, D-6900 Heidelberg, Germany; [Holbach, Leonhard] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany; [Dai, Yi; Sun, Xinghuai] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Vis Sci, Shanghai 200433, Peoples R China; [Sun, Xinghuai] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; Fudan University; Fudan University	Jonas, JB (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, D-6900 Heidelberg, Germany.	Jost.Jonas@umm.de	Dai, Yi/AAX-2979-2021; Jonas, Rahul A/N-9304-2017	Jonas, Rahul/0000-0002-5389-3047				Burgoyne CF, 2001, J GLAUCOMA, V10, pS16, DOI 10.1097/00061198-200110001-00007; FANTES FE, 1989, OPHTHALMOLOGY, V96, P20; Guist G, 1934, COINCIDENT OPHTHALMO; Hayashi K, 2012, INVEST OPHTH VIS SCI, V53, P1499, DOI 10.1167/iovs.11-8572; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P908; Jonas JB, 2005, AM J OPHTHALMOL, V139, P346, DOI 10.1016/j.ajo.2004.07.047; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P134, DOI 10.1007/BF00164651; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Jonas JB, 2010, ACTA OPHTHALMOL, V88, pe317, DOI 10.1111/j.1755-3768.2010.02022.x; KUBOTA T, 1993, BRIT J OPHTHALMOL, V77, P103, DOI 10.1136/bjo.77.2.103; Lee KYC, 2010, INVEST OPHTH VIS SCI, V51, P666, DOI 10.1167/iovs.09-3663; Manjunath V, 2011, OPHTHALMOLOGY, V118, P531, DOI 10.1016/j.ophtha.2010.07.013; Na Jung Hwa, 2010, Korean J Ophthalmol, V24, P353, DOI 10.3341/kjo.2010.24.6.353; Nonaka A, 2011, INVEST OPHTH VIS SCI, V52, P6706, DOI 10.1167/iovs.11-7580; Ohno-Matsui K, 2011, INVEST OPHTH VIS SCI, V52, P9644, DOI 10.1167/iovs.11-8597; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Park SC, 2010, INVEST OPHTH VIS SCI, V51, P6408, DOI 10.1167/iovs.09-5100; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu LA, 2010, ACTA OPHTHALMOL, V88, pe350, DOI 10.1111/j.1755-3768.2009.01770.x	21	158	163	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47237	10.1371/journal.pone.0047237	http://dx.doi.org/10.1371/journal.pone.0047237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094040	Green Published, gold			2022-12-27	WOS:000312384500006
J	Beguer-Pon, M; Benchetrit, J; Castonguay, M; Aarestrup, K; Campana, SE; Stokesbury, MJW; Dodson, JJ				Beguer-Pon, Melanie; Benchetrit, Jose; Castonguay, Martin; Aarestrup, Kim; Campana, Steven E.; Stokesbury, Michael J. W.; Dodson, Julian J.			Shark Predation on Migrating Adult American Eels (Anguilla rostrata) in the Gulf of St. Lawrence	PLOS ONE			English	Article							TUNA THUNNUS-THYNNUS; EUROPEAN SILVER EEL; LATE FRESH-WATER; PATTERNS; TEMPERATURE; RECRUITMENT; PORBEAGLE; SURVIVAL; BEHAVIOR; MAKO	In an attempt to document the migratory pathways and the environmental conditions encountered by American eels during their oceanic migration to the Sargasso Sea, we tagged eight silver eels with miniature satellite pop-up tags during their migration from the St. Lawrence River in Quebec, Canada. Surprisingly, of the seven tags that successfully transmitted archived data, six were ingested by warm-gutted predators, as observed by a sudden increase in water temperature. Gut temperatures were in the range of 20 to 25 degrees C-too cold for marine mammals but within the range of endothermic fish. In order to identify the eel predators, we compared their vertical migratory behavior with those of satellite-tagged porbeagle shark and bluefin tuna, the only endothermic fishes occurring non-marginally in the Gulf of St. Lawrence. We accurately distinguished between tuna and shark by using the behavioral criteria generated by comparing the diving behavior of these two species with those of our unknown predators. Depth profile characteristics of most eel predators more closely resembled those of sharks than those of tuna. During the first days following tagging, all eels remained in surface waters and did not exhibit diel vertical migrations. Three eels were eaten at this time. Two eels exhibited inverse diel vertical migrations (at surface during the day) during several days prior to predation. Four eels were eaten during daytime, whereas the two night-predation events occurred at full moon. Although tagging itself may contribute to increasing the eel's susceptibility to predation, we discuss evidence suggesting that predation of silver-stage American eels by porbeagle sharks may represent a significant source of mortality inside the Gulf of St. Lawrence and raises the possibility that eels may represent a reliable, predictable food resource for porbeagle sharks.	[Beguer-Pon, Melanie; Benchetrit, Jose; Dodson, Julian J.] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Castonguay, Martin] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Mont Joli, PQ G5H 3Z4, Canada; [Aarestrup, Kim] Tech Univ Denmark, Natl Inst Aquat Resource, Silkeborg, Denmark; [Campana, Steven E.] Canadian Shark Res Lab Bedford, Inst Oceanog, Dartmouth, NS, Canada; [Stokesbury, Michael J. W.] Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada	Laval University; Fisheries & Oceans Canada; Technical University of Denmark; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Acadia University	Beguer-Pon, M (corresponding author), Univ Laval, Dept Biol, Pavillon Vachon, Quebec City, PQ G1K 7P4, Canada.	melanie.beguer.1@ulaval.ca	Campana, Steven/L-7918-2019; Aarestrup, Kim/AAK-9155-2021	Campana, Steven/0000-0002-7453-3761; Aarestrup, Kim/0000-0001-8521-6270	Natural Science and Engineering Research Council of Canada; Canadian Foundation for Innovation	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	Funding for this project was provided to Julian J. Dodson and Martin Castonguay as part of the Ocean Tracking Strategic Network funded by the Natural Science and Engineering Research Council of Canada and the Canadian Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup K, 2008, FISHERIES MANAG ECOL, V15, P435, DOI 10.1111/j.1365-2400.2008.00639.x; Aarestrup K, 2010, AQUAT BIOL, V9, P263, DOI 10.3354/ab00260; Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Austin D, 2006, J ANIM ECOL, V75, P408, DOI 10.1111/j.1365-2656.2006.01057.x; Burgerhout E, 2011, NATURWISSENSCHAFTEN, V98, P631, DOI 10.1007/s00114-011-0805-0; Campana SE, 2010, CAN J FISH AQUAT SCI, V67, P769, DOI 10.1139/F10-020; CAREY FG, 1969, COMP BIOCHEM PHYSIOL, V28, P199, DOI 10.1016/0010-406X(69)91335-8; CASTONGUAY M, 1994, CAN J FISH AQUAT SCI, V51, P479, DOI 10.1139/f94-050; Castonguay Martin, 1994, Fisheries Oceanography, V3, P197, DOI 10.1111/j.1365-2419.1994.tb00097.x; Chase BC, 2002, FISH B-NOAA, V100, P168; Daverat F, 2006, MAR ECOL PROG SER, V307, P247, DOI 10.3354/meps307247; Dekker W, 2003, FISHERIES MANAG ECOL, V10, P365, DOI 10.1111/j.1365-2400.2003.00352.x; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Gilbert D, 1997, CAN J FISH AQUAT SCI, V54, P57, DOI 10.1139/cjfas-54-S1-57; Goldman KJ, 2004, ENVIRON BIOL FISH, V71, P403, DOI 10.1007/s10641-004-6588-9; Gunn J., 2001, TUNA PHYSL ECOLOGY E, P167, DOI 10.1016/S1546-5098(01)19006-0; Hulbert LB, 2005, J FISH BIOL, V67, P490, DOI 10.1111/j.0022-1112.2005.00757.x; Jellyman D, 2005, MAR ECOL PROG SER, V286, P261, DOI 10.3354/meps286261; Jellyman D, 2002, MAR ECOL PROG SER, V233, P207, DOI 10.3354/meps233207; Jellyman D, 2010, MAR ECOL PROG SER, V404, P241, DOI 10.3354/meps08468; Joyce WN, 2002, ICES J MAR SCI, V59, P1263, DOI 10.1006/jmsc.2002.1286; Kerstetter DW, 2004, FISH B-NOAA, V102, P750; Manabe R, 2011, MAR ECOL PROG SER, V437, P229, DOI 10.3354/meps09266; Methling C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020797; Musyl MK, 2011, MAR ECOL PROG SER, V433, P1, DOI 10.3354/meps09202; Nagasawa Kazuya, 1998, North Pacific Anadromous Fish Commission Bulletin, V1, P419; Pleizier NK, J FISH BIOL IN PRESS; Polovina JJ, 2008, MAR BIOL, V153, P257, DOI 10.1007/s00227-007-0801-2; Rencher AC, 2002, METHODS MULTIVARIATE; Schmidt J., 1925, Annual Report Smithsonian Institution, V1924, P279; Schmidt J, 1923, PHILOS T R SOC LON B, V211, P179, DOI 10.1098/rstb.1923.0004; Sepulveda CA, 2004, MAR BIOL, V145, P191, DOI 10.1007/s00227-004-1356-0; Stokesbury MJW, 2011, BIOL CONSERV, V144, P2684, DOI 10.1016/j.biocon.2011.07.029; Tesch F-W., 2003, EEL; Therriault J.-C., 1991, CAN SPEC PUBL FISH A; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; Velez-Espino LA, 2010, REV FISH BIOL FISHER, V20, P163, DOI 10.1007/s11160-009-9127-0; Westerberg H, 2011, MIGRATION BEHAV STOC; Westerberg H, 2007, ICES J MAR SCI, V64, P1457, DOI 10.1093/icesjms/fsm079; Williams R, 2010, MAR ECOL PROG SER, V414, P249, DOI 10.3354/meps08718	40	65	66	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46830	10.1371/journal.pone.0046830	http://dx.doi.org/10.1371/journal.pone.0046830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082131	Green Published, gold			2022-12-27	WOS:000311146900026
J	Huser, A; Rohwedder, A; Apostolopoulou, AA; Widmann, A; Pfitzenmaier, JE; Maiolo, EM; Selcho, M; Pauls, D; von Essen, A; Gupta, T; Sprecher, SG; Birman, S; Riemensperger, T; Stocker, RF; Thum, AS				Huser, Annina; Rohwedder, Astrid; Apostolopoulou, Anthi A.; Widmann, Annekathrin; Pfitzenmaier, Johanna E.; Maiolo, Elena M.; Selcho, Mareike; Pauls, Dennis; von Essen, Alina; Gupta, Tripti; Sprecher, Simon G.; Birman, Serge; Riemensperger, Thomas; Stocker, Reinhard F.; Thum, Andreas S.			The Serotonergic Central Nervous System of the Drosophila Larva: Anatomy and Behavioral Function	PLOS ONE			English	Article							MOTH MANDUCA-SEXTA; CONTAINING NEURONS; IMMUNOREACTIVE NEURONS; OLFACTORY MEMORY; DECISION-MAKING; LIGHT-AVOIDANCE; HEAD INVOLUTION; MUSHROOM BODIES; BIOGENIC-AMINES; TERM-MEMORY	The Drosophila larva has turned into a particularly simple model system for studying the neuronal basis of innate behaviors and higher brain functions. Neuronal networks involved in olfaction, gustation, vision and learning and memory have been described during the last decade, often up to the single-cell level. Thus, most of these sensory networks are substantially defined, from the sensory level up to third-order neurons. This is especially true for the olfactory system of the larva. Given the wealth of genetic tools in Drosophila it is now possible to address the question how modulatory systems interfere with sensory systems and affect learning and memory. Here we focus on the serotonergic system that was shown to be involved in mammalian and insect sensory perception as well as learning and memory. Larval studies suggested that the serotonergic system is involved in the modulation of olfaction, feeding, vision and heart rate regulation. In a dual anatomical and behavioral approach we describe the basic anatomy of the larval serotonergic system, down to the single-cell level. In parallel, by expressing apoptosis-inducing genes during embryonic and larval development, we ablate most of the serotonergic neurons within the larval central nervous system. When testing these animals for naive odor, sugar, salt and light perception, no profound phenotype was detectable; even appetitive and aversive learning was normal. Our results provide the first comprehensive description of the neuronal network of the larval serotonergic system. Moreover, they suggest that serotonin per se is not necessary for any of the behaviors tested. However, our data do not exclude that this system may modulate or fine-tune a wide set of behaviors, similar to its reported function in other insect species or in mammals. Based on our observations and the availability of a wide variety of genetic tools, this issue can now be addressed.	[Huser, Annina; Rohwedder, Astrid; Apostolopoulou, Anthi A.; Widmann, Annekathrin; Pfitzenmaier, Johanna E.; Maiolo, Elena M.; von Essen, Alina; Gupta, Tripti; Sprecher, Simon G.; Stocker, Reinhard F.; Thum, Andreas S.] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Selcho, Mareike; Pauls, Dennis] Univ Wurzburg, Bioctr, Theodor Boveri Inst, Wurzburg, Germany; [Birman, Serge] CNRS, ESPCI Neurobiol Unit, Paris, France; [Riemensperger, Thomas] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Rohwedder, Astrid; Apostolopoulou, Anthi A.; Widmann, Annekathrin; Pfitzenmaier, Johanna E.; Thum, Andreas S.] Univ Konstanz, Dept Biol, Constance, Germany	University of Fribourg; University of Wurzburg; Centre National de la Recherche Scientifique (CNRS); University of Gottingen; University of Konstanz	Thum, AS (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	andreas.thum@uni-konstanz.de	Apostolopoulou, Anthi/AAX-5004-2020; Thum, Andreas S/B-1083-2013; Sprecher, Simon/K-4249-2015	Critelli, Salvatore/0000-0001-7325-0228; Widmann, Annekathrin/0000-0003-1387-6805; Thum, Andreas/0000-0002-3830-6596; Pauls, Dennis/0000-0001-8330-8120; Apostolopoulou, Anthi/0000-0002-8174-4372; Selcho, Mareike/0000-0002-6405-2972; Sprecher, Simon/0000-0001-9060-3750	DFG [TH1584/1-1]; SNF [31003A_132812/1]; Zukunftskolleg of the University Konstanz	DFG(German Research Foundation (DFG)); SNF; Zukunftskolleg of the University Konstanz	This work was supported by DFG grant TH1584/1-1, SNF grant 31003A_132812/1 and the Zukunftskolleg of the University Konstanz to AST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT MK, 1991, GENETICS, V129, P783; ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Becnel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020800; Bicker G, 1999, MICROSC RES TECHNIQ, V44, P166, DOI 10.1002/(SICI)1097-0029(19990115/01)44:2/3<166::AID-JEMT8>3.0.CO;2-T; Blenau W, 2005, ARCH INSECT BIOCHEM, V59, P99, DOI 10.1002/arch.20072; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Bossing T, 1996, MECH DEVELOP, V55, P53, DOI 10.1016/0925-4773(95)00490-4; BRAND AH, 1995, CURR OPIN NEUROBIOL, V5, P572, DOI 10.1016/0959-4388(95)80061-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; BUDNIK V, 1989, J NEUROSCI, V9, P2866; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Chen J, 2008, DEV BIOL, V320, P30, DOI 10.1016/j.ydbio.2008.03.038; Colomb J, 2007, J COMP NEUROL, V502, P834, DOI 10.1002/cne.21312; Dacks AM, 2006, J COMP NEUROL, V498, P727, DOI 10.1002/cne.21076; Dasari S, 2006, J COMP PHYSIOL B, V176, P349, DOI 10.1007/s00360-005-0058-3; Diegelmann S, 2002, GENESIS, V34, P95, DOI 10.1002/gene.10112; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Dumstrei K, 2003, J COMP NEUROL, V455, P451, DOI 10.1002/cne.10484; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Gerber B, 2004, J EXP BIOL, V207, P179, DOI 10.1242/jeb.00718; Gerber B, 2009, RESULTS PROBL CELL D, V47, P139, DOI 10.1007/400_2008_9; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Giang T, 2011, J NEUROGENET, V25, P17, DOI 10.3109/01677063.2011.553002; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; GREEN AR, 1990, ANN NY ACAD SCI, V600, P237; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Hendel T, 2005, J COMP PHYSIOL A, V191, P265, DOI 10.1007/s00359-004-0574-8; HOMBERG U, 1989, J COMP NEUROL, V288, P243, DOI 10.1002/cne.902880204; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Ito K, 1998, LEARN MEMORY, V5, P52; Iyengar BG, 2006, J COMP NEUROL, V499, P583, DOI 10.1002/cne.21133; Johnson O, 2011, NEUROSCIENCE, V192, P372, DOI 10.1016/j.neuroscience.2011.06.058; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; KAMYSHEV NG, 1983, PHARMACOL BIOCHEM BE, V18, P677, DOI 10.1016/0091-3057(83)90005-9; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Keene AC, 2006, CURR BIOL, V16, P1524, DOI 10.1016/j.cub.2006.06.022; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Keene AC, 2011, J NEUROSCI, V31, P6527, DOI 10.1523/JNEUROSCI.6165-10.2011; KENT KS, 1987, J NEUROBIOL, V18, P451, DOI 10.1002/neu.480180506; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Lee PT, 2011, P NATL ACAD SCI USA, V108, P13794, DOI 10.1073/pnas.1019483108; Lee T, 1999, DEVELOPMENT, V126, P4065; Louis M, 2008, J VIS EXP; Lundell MJ, 1996, MOL CELL NEUROSCI, V7, P46, DOI 10.1006/mcne.1996.0004; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Michels B, 2005, LEARN MEMORY, V12, P224, DOI 10.1101/lm.92805; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Neckameyer WS, 2007, GENES BRAIN BEHAV, V6, P756, DOI 10.1111/j.1601-183X.2007.00307.x; Neckameyer WS, 2010, DEV NEUROSCI-BASEL, V32, P217, DOI 10.1159/000304888; NECKAMEYER WS, 1992, J BIOL CHEM, V267, P4199; Nichols CD, 2007, DEV NEUROBIOL, V67, P752, DOI 10.1002/dneu.20370; Niewalda T, 2008, CHEM SENSES, V33, P685, DOI 10.1093/chemse/bjn037; NOVAK MG, 1994, J MED ENTOMOL, V31, P600, DOI 10.1093/jmedent/31.4.600; NOVAK MG, 1995, J EXP BIOL, V198, P167; Olivier B, 1995, PHARMACOPSYCHIATRY, V28, P80, DOI 10.1055/s-2007-979624; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pauls D, 2010, J NEUROSCI, V30, P10655, DOI 10.1523/JNEUROSCI.1281-10.2010; Pauls D, 2010, CHEM SENSES, V35, P335, DOI 10.1093/chemse/bjq023; PRUZAN A, 1977, BEHAV GENET, V7, P457, DOI 10.1007/BF01066781; Rohwedder A, 2012, CHEM SENSES; Roman G, 2004, BIOESSAYS, V26, P1243, DOI 10.1002/bies.20120; Roy B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-20; SALECKER I, 1990, HISTOCHEMISTRY, V94, P463, DOI 10.1007/BF00272608; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Scherer S, 2003, LEARN MEMORY, V10, P217, DOI 10.1101/lm.57903; Schipanski A, 2008, CHEM SENSES, V33, P563, DOI 10.1093/chemse/bjn024; Schleyer M, 2011, LEARN MEMORY, V18, P639, DOI 10.1101/lm.2163411; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Sitaraman D, 2012, J NEUROGENET; Sitaraman D, 2012, J NEUROGENET, V26, P238, DOI 10.3109/01677063.2012.666298; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Sykes PA, 2005, DEV BIOL, V286, P207, DOI 10.1016/j.ydbio.2005.07.025; TAGHERT PH, 1984, J NEUROSCI, V4, P989; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; von Essen AMHJ, 2011, BEHAV NEUROSCI, V125, P921, DOI 10.1037/a0025758; von Essen AM, 2011, BEHAV NEUROSCI; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Westenberg HGM, 1996, J AFFECT DISORDERS, V40, P85, DOI 10.1016/0165-0327(96)00043-2; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wilkinson LO, 1991, SEROTONIN RECEPTOR S, P147; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Xu J, 2008, NAT NEUROSCI, V11, P676, DOI 10.1038/nn.2119; Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032	103	54	54	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47518	10.1371/journal.pone.0047518	http://dx.doi.org/10.1371/journal.pone.0047518			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082175	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000311146900071
J	Li, HM; Chen, D; Zhang, J				Li, Huimin; Chen, Dan; Zhang, Jing			Analysis of Intron Sequence Features Associated with Transcriptional Regulation in Human Genes	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN GENES; HUMAN GENOME; CPG ISLANDS; ENHANCER; IDENTIFICATION; METHYLATION; EXPRESSION; PROMOTER; ELEMENTS; PATTERNS	Although some preliminary work has revealed the potential transcriptional regulatory function of the introns in eukaryotes, additional evidences are needed to support this conjecture. In this study, we perform systemic analyses of the sequence characteristics of human introns. The results show that the first introns are generally longer and C, G and their dinucleotide compositions are over-represented relative to other introns, which are consistent with the previous findings. In addition, some new phenomena concerned with transcriptional regulation are found: i) the first introns are enriched in CpG islands; and ii) the percentages of the first introns containing TATA, CAAT and GC boxes are relatively higher than other position introns. The similar features of introns are observed in tissue-specific genes. The results further support that the first introns of human genes are likely to be involved in transcriptional regulation, and give an insight into the transcriptional regulatory regions of genes.	[Chen, Dan; Zhang, Jing] Yunnan Univ, Sch Math & Stat, Kunming, Peoples R China; [Li, Huimin; Chen, Dan] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Li, Huimin] Yunnan Univ Nationalities, Sch Math & Comp Sci, Kunming, Peoples R China	Yunnan University; Yunnan University; Yunnan Minzu University	Zhang, J (corresponding author), Yunnan Univ, Sch Math & Stat, Kunming, Peoples R China.	zhangjing@ynu.edu.cn			Science Foundation of Yunnan Province [2007A023M]; National Natural Science Foundation of China [11261066]	Science Foundation of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants from the Science Foundation of Yunnan Province (2007A023M) and a grant from the National Natural Science Foundation of China (11261066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosc LVG, 2005, J BIOL CHEM, V280, P26113, DOI 10.1074/jbc.M411972200; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Chen CF, 2002, P NATL ACAD SCI USA, V99, P2930, DOI 10.1073/pnas.052692099; Choi J, 2006, DEV BIOL, V296, P537, DOI 10.1016/j.ydbio.2006.04.470; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gazave E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r21; Ge BS, 2003, J IMMUNOL, V171, P4210, DOI 10.4049/jimmunol.171.8.4210; Haverty PM, 2002, NUCLEIC ACIDS RES, V30, P214, DOI 10.1093/nar/30.1.214; Hu HY, 2007, GENOMICS, V90, P421, DOI 10.1016/j.ygeno.2007.07.003; Hu J, 2010, COMPUT BIOL CHEM, V34, P106, DOI 10.1016/j.compbiolchem.2010.03.008; Hwang ES, 2002, J IMMUNOL, V169, P248, DOI 10.4049/jimmunol.169.1.248; Kalari Krishna R., 2006, In Silico Biology, V6, P237; Klamut HJ, 1996, HUM MOL GENET, V5, P1599, DOI 10.1093/hmg/5.10.1599; Lamond AI, 1999, NATURE, V397, P655, DOI 10.1038/17697; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; [李慧敏 Li Huimin], 2010, [云南大学学报. 自然科学版, Journal of Yunnan University. Natural Science], V32, P338; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Makalowski W, 2000, GENE, V259, P61, DOI 10.1016/S0378-1119(00)00436-4; Marino-Ramirez L, 2004, NUCLEIC ACIDS RES, V32, P949, DOI 10.1093/nar/gkh246; Morello L, 2008, CURR GENOMICS, V9, P227, DOI 10.2174/138920208784533629; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Wilson MA, 2002, J CELL BIOCHEM, V85, P601, DOI 10.1002/jcb.10168; Ying S, 2010, J INVEST DERMATOL, V130, P2543, DOI 10.1038/jid.2010.179; Zhang J, 2003, COMPUT BIOL CHEM, V27, P497, DOI 10.1016/j.compbiolchem.2003.09.005	34	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46784	10.1371/journal.pone.0046784	http://dx.doi.org/10.1371/journal.pone.0046784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082130	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900025
J	Regier, DA; Diorio, C; Ethier, MC; Alli, A; Alexander, S; Boydell, KM; Gassas, A; Taylor, J; Kellow, C; Mills, D; Sung, L				Regier, Dean A.; Diorio, Caroline; Ethier, Marie-Chantal; Alli, Amanda; Alexander, Sarah; Boydell, Katherine M.; Gassas, Adam; Taylor, Jonathan; Kellow, Charis; Mills, Denise; Sung, Lillian			Discrete Choice Experiment to Evaluate Factors That Influence Preferences for Antibiotic Prophylaxis in Pediatric Oncology	PLOS ONE			English	Article							MORTALITY	Background: Bacterial and fungal infections in pediatric oncology patients cause morbidity and mortality. The clinical utility of antimicrobial prophylaxis in children is uncertain and the personal utility of these agents is disputed. Objectives were to use a discrete choice experiment to: (1) describe the importance of attributes to parents and healthcare providers when deciding between use and non-use of antibacterial and antifungal prophylaxis; and (2) estimate willingness-to-pay for prophylactic strategies. Methods: Attributes were chances of infection, death and side effects, route of administration and cost of pharmacotherapy. Respondents were randomized to a discrete choice experiment outlining hypothetical treatment options to prevent antibacterial or antifungal infections. Each respondent was presented 16 choice tasks and was asked to choose between two unlabeled treatment options and an opt-out alternative (no prophylaxis). Results: 102 parents and 60 healthcare providers participated. For the antibacterial discrete choice experiment, frequency of administration was significantly associated with utility for parents but not for healthcare providers. Increasing chances of infection, death, side effects and cost were all significantly associated with decreased utility for parents and healthcare providers in both the antibacterial and antifungal discrete choice experiment. Parental willingness-to-pay was higher than healthcare providers for both strategies. Conclusion: Chances of infection, death, side effects and costs were all significantly associated with utility. Parents have higher willingness-to-pay for these strategies compared with healthcare providers. This knowledge can help to develop prophylaxis programs.	[Regier, Dean A.] British Columbia Canc Res Agcy, Canadian Ctr Appl Res Canc Control, Vancouver, BC, Canada; [Diorio, Caroline; Ethier, Marie-Chantal; Alli, Amanda; Taylor, Jonathan; Kellow, Charis; Sung, Lillian] Hosp Sick Children, Program Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada; [Alexander, Sarah; Gassas, Adam; Mills, Denise; Sung, Lillian] Hosp Sick Children, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada; [Boydell, Katherine M.] Hosp Sick Children, Community Hlth Syst Resource Grp, Toronto, ON M5G 1X8, Canada; [Ethier, Marie-Chantal] McMaster Univ, Program Hlth Res Methodol, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University	Sung, L (corresponding author), British Columbia Canc Res Agcy, Canadian Ctr Appl Res Canc Control, Vancouver, BC, Canada.	lillian.sung@sickkids.ca	Boydell, Katherine/AAR-2918-2021	Boydell, Katherine/0000-0002-1464-8532; Regier, Dean/0000-0001-8876-0511; Diorio, Caroline/0000-0002-8005-3836	Canadian Institutes of Health Research [87719]; Pediatric Oncology Group of Ontario Research Unit	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pediatric Oncology Group of Ontario Research Unit	LS is supported by a New Investigator Award from the Canadian Institutes of Health Research (Grant no. 87719). This research is supported by the Pediatric Oncology Group of Ontario Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gafter-Gvili A, 2005, ANN INTERN MED, V142, P979, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00008; Kuderer NM, 2006, CANCER-AM CANCER SOC, V106, P2258, DOI 10.1002/cncr.21847; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lehrnbecher T, 2009, BRIT J HAEMATOL, V147, P125, DOI 10.1111/j.1365-2141.2009.07844.x; Louviere J., 2002, STATED CHOICE METHOD; Louviere J. J., 2000, STATED CHOICE METHOD, DOI DOI 10.1017/CBO9780511753831; Regier DA, 2010, AM J HUM GENET, V86, P765, DOI 10.1016/j.ajhg.2010.03.009; Robenshtok E, 2007, J CLIN ONCOL, V25, P5471, DOI 10.1200/JCO.2007.12.3851; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; SMALL KA, 1981, ECONOMETRICA, V49, P105, DOI 10.2307/1911129; Street D. J., 2007, CONSTRUCTION OPTIMAL; Sung LL, 2007, BLOOD, V110, P3532, DOI 10.1182/blood-2007-05-091942; Telser H, 2002, HEALTH ECON, V11, P129, DOI 10.1002/hec.653	13	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47470	10.1371/journal.pone.0047470	http://dx.doi.org/10.1371/journal.pone.0047470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082169	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900065
J	Williams, TM; Loman, NJ; Ebruke, C; Musher, DM; Adegbola, RA; Pallen, MJ; Weinstock, GM; Antonio, M				Williams, Tiffany M.; Loman, Nicholas J.; Ebruke, Chinelo; Musher, Daniel M.; Adegbola, Richard A.; Pallen, Mark J.; Weinstock, George M.; Antonio, Martin			Genome Analysis of a Highly Virulent Serotype 1 Strain of Streptococcus pneumoniae from West Africa	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; MULTIPLE SEQUENCE ALIGNMENT; MOLECULAR EPIDEMIOLOGY; MOSAIC CHROMOSOMES; BINDING-PROTEINS; IDENTIFICATION; GENES; CHILDREN; MENINGITIS; DIVERSITY	Streptococcus pneumoniae is a leading cause of pneumonia, meningitis, and bacteremia, estimated to cause 2 million deaths annually. The majority of pneumococcal mortality occurs in developing countries, with serotype 1 a leading cause in these areas. To begin to better understand the larger impact that serotype 1 strains have in developing countries, we characterized virulence and genetic content of PNI0373, a serotype 1 strain from a diseased patient in The Gambia. PNI0373 and another African serotype 1 strain showed high virulence in a mouse intraperitoneal challenge model, with 20% survival at a dose of 1 cfu. The PNI0373 genome sequence was similar in structure to other pneumococci, with the exception of a 100 kb inversion. PNI0373 showed only15 lineage specific CDS when compared to the pan-genome of pneumococcus. However analysis of non-core orthologs of pneumococcal genomes, showed serotype 1 strains to be closely related. Three regions were found to be serotype 1 associated and likely products of horizontal gene transfer. A detailed inventory of known virulence factors showed that some functions associated with colonization were absent, consistent with the observation that carriage of this highly virulent serotype is unusual. The African serotype 1 strains thus appear to be closely related to each other and different from other pneumococci despite similar genetic content.	[Williams, Tiffany M.; Weinstock, George M.] Washington Univ, Genome Inst, St Louis, MO 63130 USA; [Loman, Nicholas J.; Pallen, Mark J.] Univ Birmingham, Ctr Syst Biol, Birmingham, W Midlands, England; [Ebruke, Chinelo; Adegbola, Richard A.; Antonio, Martin] MRC Labs, Bacterial Dis Programme, Banjul, Gambia; [Musher, Daniel M.] Michael E DeBakey VA Med Ctr, Infect Dis Sect, Houston, TX USA	Washington University (WUSTL); University of Birmingham; MRC Laboratory Molecular Biology; Baylor College of Medicine	Weinstock, GM (corresponding author), Washington Univ, Genome Inst, St Louis, MO 63130 USA.	gweinsto@genome.wustl.edu	Weinstock, George M/C-6314-2013; Loman, Nicholas/Z-1573-2019	Weinstock, George M/0000-0002-2997-4592; Loman, Nicholas/0000-0002-9843-8988; Pallen, Mark/0000-0003-1807-3657	NIH-NHGRI [U54HG003079, U54HG004968]; Medical Research Council, UK; MRC [MC_U190074190, MC_U190081991] Funding Source: UKRI; Medical Research Council [MC_U190081991, MC_U190074190] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968, U54HG003079] Funding Source: NIH RePORTER	NIH-NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Research was supported by grants from NIH-NHGRI U54HG003079 and U54HG004968. We also thank The Medical Research Council, UK for funding in The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Antonio M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-81; Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Bogaert D, 2004, VACCINE, V22, P2209, DOI 10.1016/j.vaccine.2003.11.038; BORODOVSKY M, 1993, BIOSYSTEMS, V30, P161, DOI 10.1016/0303-2647(93)90068-N; Bridy-Pappas AE, 2005, PHARMACOTHERAPY, V25, P1193, DOI 10.1592/phco.2005.25.9.1193; Bruckner R, 2004, INT J MED MICROBIOL, V294, P157, DOI 10.1016/j.ijmm.2004.06.019; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Chiavolini D, 2008, CLIN MICROBIOL REV, V21, P666, DOI 10.1128/CMR.00012-08; Chou AC, 2008, J MED MICROBIOL, V57, P839, DOI 10.1099/jmm.0.47612-0; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fedson DS, 1999, VACCINE, V17, pS11, DOI 10.1016/S0264-410X(99)00122-X; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Garcia-Suarez MDM, 2006, ENFERM INFEC MICR CL, V24, P512, DOI 10.1157/13092469; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Glover DT, 2008, INFECT IMMUN, V76, P2767, DOI 10.1128/IAI.01126-07; Gonzalez BE, 2004, J CLIN MICROBIOL, V42, P2810, DOI 10.1128/JCM.42.6.2810-2812.2004; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Holliman RE, 2007, T ROY SOC TROP MED H, V101, P405, DOI 10.1016/j.trstmh.2006.08.014; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hsieh Yu-Chia, 2008, Chang Gung Med J, V31, P117; Jefferies JMC, 2007, J INFECT DIS, V196, P936, DOI 10.1086/520091; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaplan V, 2002, AM J RESP CRIT CARE, V165, P766, DOI 10.1164/ajrccm.165.6.2103038; Kirkham LAS, 2006, J CLIN MICROBIOL, V44, P151, DOI 10.1128/JCM.44.1.151-159.2006; Klugman Keith P., 2008, P317; KLUGMAN KP, 1988, J INFECT DIS, V158, P956, DOI 10.1093/infdis/158.5.956; KOSTYUKOVA NN, 1995, FEMS IMMUNOL MED MIC, V10, P133, DOI 10.1111/j.1574-695X.1995.tb00022.x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lopez R, 2004, INT MICROBIOL, V7, P163; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mehiri-Zghal E, 2010, DIAGN MICR INFEC DIS, V66, P225, DOI 10.1016/j.diagmicrobio.2009.05.008; Mitchell J, 2007, MOL MICROBIOL, V64, P844, DOI 10.1111/j.1365-2958.2007.05703.x; Molina R, 2009, EMBO REP, V10, P246, DOI 10.1038/embor.2008.245; Mulholland K, 1999, VACCINE, V17, pS79, DOI 10.1016/S0264-410X(99)00112-7; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Ng MP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-192; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Organization WH, 1999, PNEUM VACC, P177; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Ramdani-Bouguessa N, 2003, ANTIMICROB AGENTS CH, V47, P824, DOI 10.1128/AAC.47.2.824-826.2003; Romero P, 2009, J BACTERIOL, V191, P4854, DOI 10.1128/JB.01272-08; Sandgren A, 2005, J INFECT DIS, V192, P791, DOI 10.1086/432513; Silva NA, 2006, INFECT IMMUN, V74, P3513, DOI 10.1128/IAI.00079-06; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; Trooskens G, 2005, BIOINFORMATICS, V21, P3801, DOI 10.1093/bioinformatics/bti590; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940; YOTHER J, 1982, INFECT IMMUN, V36, P184, DOI 10.1128/IAI.36.1.184-188.1982; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	75	27	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e26742	10.1371/journal.pone.0026742	http://dx.doi.org/10.1371/journal.pone.0026742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082106	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900001
J	All, AH; Bazley, FA; Gupta, S; Pashai, N; Hu, C; Pourmorteza, A; Kerr, C				All, Angelo H.; Bazley, Faith A.; Gupta, Siddharth; Pashai, Nikta; Hu, Charles; Pourmorteza, Amir; Kerr, Candace			Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors Aid in Functional Recovery of Sensory Pathways following Contusive Spinal Cord Injury	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SOMATOSENSORY-EVOKED POTENTIALS; NEURAL STEM/PROGENITOR CELLS; LOCOMOTOR RECOVERY; PRECURSOR CELLS; MOUSE MODEL; RAT; BIOLUMINESCENCE; DIFFERENTIATION; TRANSPLANTATION	Background: Transplantations of human stem cell derivatives have been widely investigated in rodent models for the potential restoration of function of neural pathways after spinal cord injury (SCI). Studies have already demonstrated cells survival following transplantation in SCI. We sought to evaluate survival and potential therapeutic effects of transplanted human embryonic stem (hES) cell-derived oligodendrocyte progenitor cells (OPCs) in a contusive injury in rats. Bioluminescence imaging was utilized to verify survivability of cells up to 4 weeks, and somatosensory evoked potential (SSEPs) were recorded at the cortex to monitor function of sensory pathways throughout the 6-week recovery period. Principal Findings: hES cells were transduced with the firefly luciferase gene and differentiated into OPCs. OPCs were transplanted into the lesion epicenter of rat spinal cords 2 hours after inducing a moderate contusive SCI. The hES-treatment group showed improved SSEPs, including increased amplitude and decreased latencies, compared to the control group. The bioluminescence of transplanted OPCs decreased by 97% in the injured spinal cord compared to only 80% when injected into an uninjured spinal cord. Bioluminescence increased in both experimental groups such that by week 3, no statistical difference was detected, signifying that the cells survived and proliferated independent of injury. Post-mortem histology of the spinal cords showed integration of human cells expressing mature oligodendrocyte markers and myelin basic protein without the expression of markers for astrocytes (GFAP) or pluripotent cells (OCT4). Conclusions: hES-derived OPCs transplanted 2 hours after contusive SCI survive and differentiate into OLs that produce MBP. Treated rats demonstrated functional improvements in SSEP amplitudes and latencies compared to controls as early as 1 week post-injury. Finally, the hostile injury microenvironment at 2 hours post-injury initially caused increased cell death but did not affect the long-term cell proliferation or survival, indicating that cells can be transplanted sooner than conventionally accepted.	[All, Angelo H.; Bazley, Faith A.; Gupta, Siddharth; Pashai, Nikta; Hu, Charles; Pourmorteza, Amir] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [All, Angelo H.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Kerr, Candace] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	All, AH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	hmn@jhu.edu; ckerr@som.umaryland.edu			Maryland Stem Cell Research Fund (MSCRF) [2007-MSCRFII-0159-00, 2009-MSCRFII-0091-00]; National Institutes of Health (NICHD) [R21HD057487-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057487] Funding Source: NIH RePORTER	Maryland Stem Cell Research Fund (MSCRF); National Institutes of Health (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors would like to thank the Maryland Stem Cell Research Fund (MSCRF): Grant #2007-MSCRFII-0159-00 (awarded to CK) and Grant #2009-MSCRFII-0091-00 (awarded to AA). We would also like to thank the National Institutes of Health (NICHD): Grant #R21HD057487-01A1 (awarded to CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; AGRAWAL G, 2009, EMBC 2009 ANN INT C, P2086; Agrawal G, 2010, J CLIN NEUROSCI, V17, P1159, DOI 10.1016/j.jocn.2010.02.005; Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7; Agrawal G, 2009, J CLIN NEUROSCI, V16, P1052, DOI 10.1016/j.jocn.2008.08.009; All AH, 2010, NEUROL SCI, V31, P595, DOI 10.1007/s10072-010-0329-y; All AH, 2009, J NEUROL SCI, V284, P81, DOI 10.1016/j.jns.2009.04.025; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Arnhold S, 2004, INVEST OPHTH VIS SCI, V45, P4251, DOI 10.1167/iovs.03-1108; Bazley FA, 2012, J NEUROSURG IN PRESS; Bazley FA, 2011, IEEE ENG MED BIO, P2005, DOI 10.1109/IEMBS.2011.6090564; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Curt A, 1998, ARCH PHYS MED REHAB, V79, P81, DOI 10.1016/S0003-9993(98)90213-1; Dietz V, 1998, ELECTROMYOGR MOTOR C, V109, P140, DOI 10.1016/S0924-980X(98)00002-2; Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Erceg S, 2010, STEM CELLS, V28, P1541, DOI 10.1002/stem.489; Faulkner J, 2005, TRANSPL IMMUNOL, V15, P131, DOI 10.1016/j.trim.2005.09.007; Geron, 2010, SAF STUD GRNOPC1 SPI; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Hwang DH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-117; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kerr CL, 2010, INT J NEUROSCI, V120, P305, DOI 10.3109/00207450903585290; Kumagai G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007706; Letzen BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010480; Lu HZ, 2010, DIFFERENTIATION, V80, P228, DOI 10.1016/j.diff.2010.09.179; Maybhate A, 2012, CRIT CARE MED, V40, P573, DOI 10.1097/CCM.0b013e318232d97e; Michelini E, 2009, METHODS MOL BIOL, V574, P1, DOI 10.1007/978-1-60327-321-3_1; Moloney TC, 2010, NEUROREHAB NEURAL RE, V24, P645, DOI 10.1177/1545968309357745; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Ogawa D, 2009, J NEUROSCI RES, V87, P307, DOI 10.1002/jnr.21843; Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje; Park S, 2012, CYTOTHERAPY; Rossi SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011852; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; Sher F, 2009, STEM CELLS, V27, P1582, DOI 10.1002/stem.76; Su ZD, 2011, J NEUROTRAUM, V28, P1089, DOI 10.1089/neu.2010.1597; Takahashi Y, 2011, CELL TRANSPLANT, V20, P727, DOI 10.3727/096368910X536554; Tsuji O, 2011, NEUROTHERAPEUTICS, V8, P668, DOI 10.1007/s13311-011-0063-z; Walczak P, 2011, GLIA, V59, P499, DOI 10.1002/glia.21119; Wang YP, 2011, J NEUROSCI, V31, P6053, DOI 10.1523/JNEUROSCI.5524-09.2011; Zeng X, 2011, CELL TRANSPLANT, V20, P1881, DOI 10.3727/096368911X566181	43	40	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47645	10.1371/journal.pone.0047645	http://dx.doi.org/10.1371/journal.pone.0047645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091637	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800062
J	Lin, CH; Song, TJ; Lin, YK; Chiu, YC				Lin, Ching-Hung; Song, Tzu-Jiun; Lin, Yu-Kai; Chiu, Yao-Chu			Mirrored Prominent Deck B Phenomenon: Frequent Small Losses Override Infrequent Large Gains in the Inverted Iowa Gambling Task	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; SOMATIC MARKER HYPOTHESIS; DECISION-MAKING; ORBITOFRONTAL CORTEX; WORKING-MEMORY; HUMAN ALTRUISM; SCHIZOPHRENIA; ADOLESCENTS; PERFORMANCE; PUNISHMENT	Since Bechara et al. pioneered its development, the Iowa Gambling Task (IGT) has been widely applied to elucidate decision behavior and medial prefrontal function. Although most decision makers can hunch the final benefits of IGT, ventromedial prefrontal lesions generate a myopic choice pattern. Additionally, the Iowa group developed a revised IGT (inverted IGT, iIGT) to confirm the IGT validity. Each iIGT trial was generated from the trial of IGT by multiplying by a "2" to create an inverted monetary value. Thus, bad decks A and B in the IGT become good decks iA and iB in the iIGT; additionally, good decks C and D in the IGT become bad decks iC and iD in the iIGT. Furthermore, IGT possessed mostly the gain trials, and iIGT possessed mainly the loss trials. Therefore, IGT is a frequent-gain-based task, and iIGT is a frequent-loss-based task. However, a growing number of IGT-related studies have identified confounding factors in IGT (i.e., gain-loss frequency), which are demonstrated by the prominent deck B phenomenon (PDB phenomenon). Nevertheless, the mirrored PDB phenomenon and guiding power of gain-loss frequency in iIGT have seldom been reexamined. This experimental finding supports the prediction based on gain-loss frequency. This study identifies the mirrored PDB phenomenon. Frequent small losses override occasional large gains in deck iB of the iIGT. Learning curve analysis generally supports the phenomenon based on gain-loss frequency rather than final outcome. In terms of iIGT and simple versions of iIGT, results of this study demonstrate that high-frequency loss, rather than a satisfactory final outcome, dominates the preference of normal decision makers under uncertainty. Furthermore, normal subjects prefer "no immediate punishment" rather than "final reward" under uncertainty.	[Lin, Ching-Hung; Song, Tzu-Jiun; Lin, Yu-Kai; Chiu, Yao-Chu] Soochow Univ, Dept Psychol, Taipei, Taiwan; [Lin, Ching-Hung] Taipei Vet Gen Hosp, Dept Med Res & Educ, Lab Integrated Brain Res, Taipei, Taiwan; [Lin, Ching-Hung] Natl Chiao Tung Univ, Biomed Elect Translat Res Ctr, Hsinchu, Taiwan; [Lin, Ching-Hung] China Med Univ Hosp, Biomed Engn Res & Dev Ctr, Taichung, Taiwan	Soochow University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chiu, YC (corresponding author), Soochow Univ, Dept Psychol, Taipei, Taiwan.	yaochu@mail2000.com.tw		Lin, Ching-Hung/0000-0003-3618-0579	National Science Council of the Republic of China, Taiwan [NSC 94-2413-H031-002]; "Aim for the Top University Plan" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C.	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); "Aim for the Top University Plan" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C.	The authors would like to thank the National Science Council of the Republic of China, Taiwan, for financially supporting this research under Contract No. NSC 94-2413-H031-002. This work was also supported by the "Aim for the Top University Plan" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C. The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn WY, 2008, COGNITIVE SCI, V32, P1376, DOI 10.1080/03640210802352992; Bark R, 2005, PSYCHIAT RES, V134, P131, DOI 10.1016/j.psychres.2004.04.013; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 1998, J NEUROSCI, V18, P428; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bechara A., 2007, IOWA GAMBLING TASK P; Caroselli JS, 2006, APPL NEUROPSYCHOL, V13, P203, DOI 10.1207/s15324826an1304_1; CATANIA AC, 1980, J EXP ANAL BEHAV, V34, P77, DOI 10.1901/jeab.1980.34-77; Chiu YC, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-37; Chiu YC, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-13; Chiu YC, 2006, REEXAMINING EFFECT L; Crone EA, 2005, CHILD NEUROPSYCHOL, V11, P245, DOI 10.1080/092970490911261; Crone EA, 2004, DEV NEUROPSYCHOL, V25, P251, DOI 10.1207/s15326942dn2503_2; Crone EA, 2004, PSYCHOPHYSIOLOGY, V41, P531, DOI 10.1111/j.1469-8986.2004.00197.x; Crone EA, 2003, PERSONALITY INDIVIDU, V34, P1, DOI DOI 10.1016/S0191-8869(02)00386-0; Damasio A, 1994, DESCARTES ERROR EMOT; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Davis C, 2008, J INT NEUROPSYCH SOC, V14, P1063, DOI 10.1017/S1355617708081204; Dawkins R., 1987, BLIND WATCHMAKER; Dawkins Richard, 1976, SELFISH GENE; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Desmeules R, 2008, J BEHAV DECIS MAKING, V21, P211, DOI 10.1002/bdm.583; Domjan M, 2002, PRICIPLES LEARNING B; Dretsch MN, 2008, BRAIN COGNITION, V66, P83, DOI 10.1016/j.bandc.2007.05.006; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2004, CURR OPIN NEUROBIOL, V14, P784, DOI 10.1016/j.conb.2004.10.007; Fernie G, 2006, BRAIN COGNITION, V60, P94, DOI 10.1016/j.bandc.2005.09.011; Fernie G, 2007, FACTORS AFFECTING LE; Ferster C.B., 1957, SCHEDULES REINFORCEM, DOI 10.1037/10627-000; Franken IHA, 2006, JUDGM DECIS MAK, V1, P153; Fum D, 2008, SOMATIC MARKERS FREQ; Geurts HM, 2006, J ABNORM CHILD PSYCH, V34, P813, DOI 10.1007/s10802-006-9059-2; Heilman RM, 2010, EMOTION, V10, P257, DOI 10.1037/a0018489; HERRNSTE.RJ, 1974, J EXP ANAL BEHAV, V21, P159, DOI 10.1901/jeab.1974.21-159; Horstmann A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00061; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huizenga HM, 2007, DEVELOPMENTAL SCI, V10, P814, DOI 10.1111/j.1467-7687.2007.00621.x; Johnson CA, 2008, NEUROPSYCHOLOGIA, V46, P714, DOI 10.1016/j.neuropsychologia.2007.09.012; Kim YT, 2006, ALCOHOL CLIN EXP RES, V30, P466, DOI 10.1111/j.1530-0277.2006.00051.x; Knutson B, 2004, SCIENCE, V305, P1246, DOI 10.1126/science.1102822; Lin CH, 2011, ANN C NEUR; Lin CH, 2008, 6 ANN M SOC NEUR PAR; Lin CH, 2004, PREFERENCES DECISION; Lin CH, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-16; Lin CH, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-45; MacPherson SE, 2002, PSYCHOL AGING, V17, P598, DOI 10.1037//0882-7974.17.4.598; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Martino DJ, 2007, PSYCHIAT RES, V152, P121, DOI 10.1016/j.psychres.2006.03.002; Must A, 2006, J AFFECT DISORDERS, V90, P209, DOI 10.1016/j.jad.2005.12.005; Napoli A, 2010, 10 INT C COGN MOD PH; O'Carroll RE, 2003, J NEUROL NEUROSUR PS, V74, P376, DOI 10.1136/jnnp.74.3.376; Overman WH, 2004, NEUROPSYCHOLOGIA, V42, P1838, DOI 10.1016/j.neuropsychologia.2004.03.014; Patterson JC, 2002, NEUROIMAGE, V17, P1797, DOI 10.1006/nimg.2002.1306; Rachlin H., 1991, INTRO MODERN BEHAV; Ridley Matt, 1996, ORIGINS VIRTUE; Ritter LM, 2004, SCHIZOPHR RES, V68, P65, DOI 10.1016/S0920-9964(03)00086-0; Rodriguez-Sanchez JM, 2005, SCHIZOPHR RES, V77, P279, DOI 10.1016/j.schres.2005.04.023; Schwartz B., 2002, PSYCHOL LEARNING BEH, V5th; Sevy S, 2007, SCHIZOPHR RES, V92, P74, DOI 10.1016/j.schres.2007.01.005; Skinner B.F., 1938, BEHAV ORG EXPT ANAL; Stocco A, 2008, BRAIN COGNITION, V66, P253, DOI 10.1016/j.bandc.2007.09.002; Stocco A, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-1; Takano Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009368; Toplak ME, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-8; Turnbull OH, 2006, NEUROPSYCHOLOGIA, V44, P300, DOI 10.1016/j.neuropsychologia.2005.04.019; Upton DJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00034; Wagar BM, 2006, COGN AFFECT BEHAV NE, V6, P277, DOI 10.3758/CABN.6.4.277; Wilder KE, 1998, SCHIZOPHR RES, V30, P169, DOI 10.1016/S0920-9964(97)00135-7; Windmann S, 2006, J COGNITIVE NEUROSCI, V18, P1198, DOI 10.1162/jocn.2006.18.7.1198	77	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47202	10.1371/journal.pone.0047202	http://dx.doi.org/10.1371/journal.pone.0047202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	024UX	23091612	Green Submitted, Green Published, gold			2022-12-27	WOS:000310135800031
J	Patil, SS; Gentschev, I; Adelfinger, M; Donat, U; Hess, M; Weibel, S; Nolte, I; Frentzen, A; Szalay, AA				Patil, Sandeep S.; Gentschev, Ivaylo; Adelfinger, Marion; Donat, Ulrike; Hess, Michael; Weibel, Stephanie; Nolte, Ingo; Frentzen, Alexa; Szalay, Aladar A.			Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MICROVASCULAR DENSITY; BREAST-TUMORS; NUDE-MICE; PET DOGS; THERAPY; CANCER; MODEL; MICROENVIRONMENT; ANGIOGENESIS	Virotherapy using oncolytic vaccinia virus (VACV) strains is one promising new strategy for cancer therapy. We have previously reported that oncolytic vaccinia virus strains expressing an anti-VEGF (Vascular Endothelial Growth Factor) single-chain antibody (scAb) GLAF-1 exhibited significant therapeutic efficacy for treatment of human tumor xenografts. Here, we describe the use of oncolytic vaccinia virus GLV-1h109 encoding GLAF-1 for canine cancer therapy. In this study we analyzed the virus-mediated delivery and production of scAb GLAF-1 and the oncolytic and immunological effects of the GLV-1h109 vaccinia virus strain against canine soft tissue sarcoma and canine prostate carcinoma in xenograft models. Cell culture data demonstrated that the GLV-1h109 virus efficiently infect, replicate in and destroy both tested canine cancer cell lines. In addition, successful expression of GLAF-1 was demonstrated in virus-infected canine cancer cells and the antibody specifically recognized canine VEGF. In two different xenograft models, the systemic administration of the GLV-1h109 virus was found to be safe and led to anti-tumor and immunological effects resulting in the significant reduction of tumor growth in comparison to untreated control mice. Furthermore, tumor-specific virus infection led to a continued production of functional scAb GLAF-1, resulting in inhibition of angiogenesis. Overall, the GLV-1h109-mediated cancer therapy and production of immunotherapeutic anti-VEGF scAb may open the way for combination therapy concept i.e. vaccinia virus mediated oncolysis and intratumoral production of therapeutic drugs in canine cancer patients.	[Patil, Sandeep S.; Gentschev, Ivaylo; Adelfinger, Marion; Donat, Ulrike; Hess, Michael; Weibel, Stephanie; Szalay, Aladar A.] Univ Wurzburg, Dept Biochem, Wurzburg, Germany; [Gentschev, Ivaylo; Frentzen, Alexa; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Nolte, Ingo] Univ Vet Med, Small Anim Clin, Hannover, Germany; [Szalay, Aladar A.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany; [Szalay, Aladar A.] Univ Calif San Diego, Moores Canc Ctr, Dept Radiat Oncol, La Jolla, CA 92093 USA	University of Wurzburg; University of Veterinary Medicine Hannover, Foundation; University of Wurzburg; University of Wurzburg; University of California System; University of California San Diego	Szalay, AA (corresponding author), Univ Wurzburg, Dept Biochem, Wurzburg, Germany.	aaszalay@genelux.com	Gentschev, Ivaylo/AAJ-5819-2021; Gentschev, Ivaylo/F-9454-2011	Gentschev, Ivaylo/0000-0003-3743-6329	Research and Development Division of Genelux Corporation, San Diego, USA; Genelux Corp., San Diego, USA; Genelux Corporation; German Excellence Initiative; German Research Foundation (DFG); University of Wuerzburg in the funding programme Open Access Publishing; Genelux	Research and Development Division of Genelux Corporation, San Diego, USA; Genelux Corp., San Diego, USA; Genelux Corporation; German Excellence Initiative; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg in the funding programme Open Access Publishing; Genelux	The research was supported by the Research and Development Division of Genelux Corporation, San Diego, USA, and a Service Grant to the University of Wurzburg, Germany also funded by Genelux Corp., San Diego, USA. IG AF and AAS are employees and shareholders of Genelux. MA, UD, MH and SW were supported by grants of Genelux Corporation. SSP is a graduate fellow and supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wuerzburg. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I. Gentschev, A. Frentzen and A. A. Szalay have financial interests in Genelux Corporation, and M. Adelfinger U. Donar, M. Hess and S. Weibel were supported by grants of Genelux Corporation. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. However, no direct financial support was provided by Genelux for the completion of this study.	Arendt M, 2009, VET COMP ONCOL, V7, P153, DOI 10.1111/j.1476-5829.2009.00187.x; Breitbach CJ, 2007, MOL THER, V15, P1686, DOI 10.1038/sj.mt.6300215; de Queiroz GF, 2010, J VET DIAGN INVEST, V22, P105, DOI 10.1177/104063871002200121; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Frentzen A, 2009, P NATL ACAD SCI USA, V106, P12915, DOI 10.1073/pnas.0900660106; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gentschev I, 2009, CANCER GENE THER, V16, P320, DOI 10.1038/cgt.2008.87; Gentschev I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/489759; Gentschev I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037239; Gentschev I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022069; Gentschev I, 2010, J ONCOL, V2010, DOI 10.1155/2010/736907; Gerber HP, 2000, CANCER RES, V60, P6253; Gerber HP, 2005, CANCER RES, V65, P671; Gil M, 2011, BRIT J CANCER, V105, P1512, DOI 10.1038/bjc.2011.429; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Hemminki A, 2003, MOL THER, V7, P163, DOI 10.1016/S1525-0016(02)00049-7; Hess M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-172; Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9; John LB, 2012, CANCER RES, V72, P1651, DOI 10.1158/0008-5472.CAN-11-2788; Kamstock D, 2007, CANCER IMMUNOL IMMUN, V56, P1299, DOI 10.1007/s00262-007-0282-7; Kelsey JL, 1998, EPIDEMIOL REV, V20, P204, DOI 10.1093/oxfordjournals.epirev.a017981; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Ochando JC, 2012, IMMUNOL RES; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Patil SS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-3; Patruno R, 2009, J CELL MOL MED, V13, P555, DOI 10.1111/j.1582-4934.2008.00355.x; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Quesada AR, 2007, BIOESSAYS, V29, P1159, DOI 10.1002/bies.20655; Reimann-Berg N, 2011, CYTOGENET GENOME RES, V132, P16, DOI 10.1159/000317077; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Suter SE, 2005, CLIN CANCER RES, V11, P1579, DOI 10.1158/1078-0432.CCR-04-1944; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146; Zizzo N, 2010, LEUKEMIA LYMPHOMA, V51, P291, DOI 10.3109/10428190903452818	39	25	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47472	10.1371/journal.pone.0047472	http://dx.doi.org/10.1371/journal.pone.0047472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091626	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800049
J	Seehase, M; Collins, JJP; Kuypers, E; Jellema, RK; Ophelders, DRMG; Ospina, OL; Perez-Gil, J; Bianco, F; Garzia, R; Razzetti, R; Kramer, BW				Seehase, Matthias; Collins, Jennifer J. P.; Kuypers, Elke; Jellema, Reint K.; Ophelders, Daan R. M. G.; Ospina, Olga L.; Perez-Gil, J.; Bianco, Federico; Garzia, Raffaella; Razzetti, Roberta; Kramer, Boris W.			New Surfactant with SP-B and C Analogs Gives Survival Benefit after Inactivation in Preterm Lambs	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; IMMATURE NEWBORN RABBITS; PULMONARY SURFACTANT; EXOGENOUS SURFACTANT; NATURAL SURFACTANT; PREMATURE RABBITS; PROTEIN-A; FILMS; INFLAMMATION; INFANTS	Background: Respiratory distress syndrome in preterm babies is caused by a pulmonary surfactant deficiency, but also by its inactivation due to various conditions, including plasma protein leakage. Surfactant replacement therapy is well established, but clinical observations and in vitro experiments suggested that its efficacy may be impaired by inactivation. A new synthetic surfactant (CHF 5633), containing synthetic surfactant protein B and C analogs, has shown comparable effects on oxygenation in ventilated preterm rabbits versus Poractant alfa, but superior resistance against inactivation in vitro. We hypothesized that CHF 5633 is also resistant to inactivation by serum albumin in vivo. Methodology/Principal Findings: Nineteen preterm lambs of 127 days gestational age (term = 150 days) received CHF 5633 or Poractant alfa and were ventilated for 48 hours. Ninety minutes after birth, the animals received albumin with CHF 5633 or Poractant alfa. Animals received additional surfactant if PaO2 dropped below 100 mmHg. A pressure volume curve was done post mortem and markers of pulmonary inflammation, surfactant content and biophysiology, and lung histology were assessed. CHF 5633 treatment resulted in improved arterial pH, oxygenation and ventilation efficiency index. The survival rate was significantly higher after CHF 5633 treatment (5/7) than after Poractant alfa (1/8) after 48 hours of ventilation. Biophysical examination of the surfactant recovered from bronchoalveolar lavages revealed that films formed by CHF 5633-treated animals reached low surface tensions in a wider range of compression rates than films from Poractant alfa-treated animals. Conclusions: For the first time a synthetic surfactant containing both surfactant protein B and C analogs showed significant benefit over animal derived surfactant in an in vivo model of surfactant inactivation in premature lambs.	[Seehase, Matthias; Collins, Jennifer J. P.; Kuypers, Elke; Jellema, Reint K.; Ophelders, Daan R. M. G.; Kramer, Boris W.] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Bianco, Federico; Garzia, Raffaella; Razzetti, Roberta] Chiesi Farmaceutici SpA, Dept Res & Dev, Parma, Italy; [Ospina, Olga L.; Perez-Gil, J.] Univ Complutense, Fac Biol, Dept Biochem, E-28040 Madrid, Spain; [Ospina, Olga L.] Pontificia Univ Javeriana, Dept Phys, Bogota, Colombia	Maastricht University; Chiesi Pharmaceuticals Inc; Complutense University of Madrid; Pontificia Universidad Javeriana	Kramer, BW (corresponding author), Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands.	b.kramer@mumc.nl	Kramer, Boris/AAO-3183-2021; Jellema, Reint/AAW-1214-2020; Perez-Gil, Jesus/H-3102-2019; Ospina-Ramírez, Olga Lucía/AAF-8248-2019	Jellema, Reint/0000-0002-6918-0930; Perez-Gil, Jesus/0000-0003-3587-7147; Collins, Jennifer/0000-0002-7556-0526; Ophelders, Daan/0000-0001-7410-5102	VENI from the Dutch Research Council (NWO) [BWK 016.096.1441]; Spanish Ministry of Economy and Competitivity [BIO2009-09694, CSD2007-00010]; Community of Madrid [S2009MAT-1507]; Chiesi Pharmaceutici SpA (Parma, Italy)	VENI from the Dutch Research Council (NWO); Spanish Ministry of Economy and Competitivity(Spanish Government); Community of Madrid(Comunidad de Madrid); Chiesi Pharmaceutici SpA (Parma, Italy)(Chiesi Pharmaceuticals Inc)	BWK is supported by a VENI grant (No. BWK 016.096.141) from the Dutch Research Council (NWO). OLO and JPG are supported by grants from the Spanish Ministry of Economy and Competitivity (BIO2009-09694, CSD2007-00010) and Community of Madrid (S2009MAT-1507). This study was funded by Chiesi Pharmaceutici SpA (Parma, Italy). Preparations of CHF 5633 synthetic surfactant and Curosurf (R) were also supplied by Chiesi Pharmaceutici SpA. FB, RR and RG participated in the interpretation of the data and review of the manuscript, but otherwise the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almlen A, 2008, J APPL PHYSIOL, V104, P1101, DOI 10.1152/japplphysiol.00865.2007; Almlen A, 2010, NEONATOLOGY, V98, P91, DOI 10.1159/000276980; Aman J, 2011, CRIT CARE MED, V39, P89, DOI 10.1097/CCM.0b013e3181feb46a; Been JV, 2007, EUR J PEDIATR, V166, P889, DOI 10.1007/s00431-007-0501-4; Behrman RE, 2007, PRETERM BIRTH CAUSES; Blanco F., 2001, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000144; Calkovska A, 2008, PULM PHARMACOL THER, V21, P393, DOI 10.1016/j.pupt.2007.10.003; Casals C, 1998, AM J RESP CRIT CARE, V157, P43, DOI 10.1164/ajrccm.157.1.9611106; Davis AJ, 1998, AM J RESP CRIT CARE, V157, P553, DOI 10.1164/ajrccm.157.2.97-08019; Friedrich W, 2000, Eur J Med Res, V5, P277; Gastiasoro-Cuesta E, 2006, PEDIATRICS, V117, P295, DOI 10.1542/peds.2005-0378; Gizzi C, 2010, J MATERN-FETAL NEO M, V23, P41, DOI 10.3109/14767058.2010.509912; Gomez-Gil L, 2009, BIOPHYS J, V97, P2736, DOI 10.1016/j.bpj.2009.08.045; Hilgendorff A, 2006, BIOL NEONATE, V90, P210, DOI 10.1159/000093820; Jobe AH, 2008, NEONATOLOGY, V94, P190, DOI 10.1159/000143721; Johansson J, 2003, J APPL PHYSIOL, V95, P2055, DOI 10.1152/japplphysiol.00153.2003; Koeppen M, 2011, J VIS EXP; Kramer B. W., 2007, Intensivmedizin und Notfallmedizin, V44, P403, DOI 10.1007/s00390-007-0809-3; Kramer BW, 2008, J PERINATOL, V28, pS21, DOI 10.1038/jp.2008.46; Kramer BW, 2001, AM J RESP CRIT CARE, V163, P158, DOI 10.1164/ajrccm.163.1.2005084; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Lopez-Rodriguez E, 2011, BIOPHYS J, V100, P646, DOI 10.1016/j.bpj.2010.12.3715; Lu KW, 2011, BBA-BIOMEMBRANES, V1808, P2366, DOI 10.1016/j.bbamem.2011.06.013; Sarrasague MM, 2011, RESP PHYSIOL NEUROBI, V175, P316, DOI 10.1016/j.resp.2010.12.009; Miedema M, 2011, AM J RESP CRIT CARE; MIZUNO K, 1995, PEDIATR RES, V37, P271, DOI 10.1203/00006450-199503000-00004; Nag K, 2010, J COLLOID INTERF SCI, V352, P456, DOI 10.1016/j.jcis.2010.08.058; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; RIDER ED, 1993, AM REV RESPIR DIS, V147, P669, DOI 10.1164/ajrccm/147.3.669; Roggini M, 2010, Minerva Pediatr, V62, P217; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sato A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039392; Schurch D, 2010, BIOPHYS J, V99, P3290, DOI 10.1016/j.bpj.2010.09.039; Taeusch HW, 2005, BIOPHYS J, V89, P1769, DOI 10.1529/biophysj.105.062620; van Kaam AH, 2011, NEONATOLOGY, V100, P71, DOI 10.1159/000322004; Wirbelauer J, 2009, J PERINATOL, V29, pS18, DOI 10.1038/jp.2009.30; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	39	64	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47631	10.1371/journal.pone.0047631	http://dx.doi.org/10.1371/journal.pone.0047631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091635	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800059
J	Ma, YB; Xu, YX; Yestrepsky, BD; Sorenson, RJ; Chen, M; Larsen, SD; Sun, HM				Ma, Yibao; Xu, Yuanxi; Yestrepsky, Bryan D.; Sorenson, Roderick J.; Chen, Meng; Larsen, Scott D.; Sun, Hongmin			Novel Inhibitors of Staphylococcus aureus Virulence Gene Expression and Biofilm Formation	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS; PROTEIN-A; ANTIMICROBIAL PEPTIDES; ANTIBIOTIC DEVELOPMENT; PUBLIC-HEALTH; REGULATOR AGR; ALPHA-TOXIN; INFECTIONS; EPIDERMIDIS; MICROORGANISMS	Staphylococcus aureus is a major human pathogen and one of the more prominent pathogens causing biofilm related infections in clinic. Antibiotic resistance in S. aureus such as methicillin resistance is approaching an epidemic level. Antibiotic resistance is widespread among major human pathogens and poses a serious problem for public health. Conventional antibiotics are either bacteriostatic or bacteriocidal, leading to strong selection for antibiotic resistant pathogens. An alternative approach of inhibiting pathogen virulence without inhibiting bacterial growth may minimize the selection pressure for resistance. In previous studies, we identified a chemical series of low molecular weight compounds capable of inhibiting group A streptococcus virulence following this alternative anti-microbial approach. In the current study, we demonstrated that two analogs of this class of novel anti-virulence compounds also inhibited virulence gene expression of S. aureus and exhibited an inhibitory effect on S. aureus biofilm formation. This class of anti-virulence compounds could be a starting point for development of novel anti-microbial agents against S. aureus.	[Yestrepsky, Bryan D.; Sorenson, Roderick J.; Larsen, Scott D.] Univ Michigan, Coll Pharm, Vahlteich Med Chem Core, Ann Arbor, MI 48109 USA; [Ma, Yibao; Xu, Yuanxi; Sun, Hongmin] Univ Missouri, Dept Internal Med, Columbia, MO USA; [Chen, Meng] Nanova Inc, Columbia, MO USA	University of Michigan System; University of Michigan; University of Missouri System; University of Missouri Columbia	Larsen, SD (corresponding author), Univ Michigan, Coll Pharm, Vahlteich Med Chem Core, 428 Church St, Ann Arbor, MI 48109 USA.	sdlarsen@umich.edu; sunh@health.missouri.edu	Ma, Yibao/H-3849-2016	Ma, Yibao/0000-0002-3270-8893	National Institutes of Health (NIH) [P01HL573461, T32 GM007767]; University of Michigan Life Sciences Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Life Sciences Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grant P01HL573461 (HS), University of Michigan Life Sciences Institute Innovation Partnership grant (HS and SDL), and NIH Pharmacological Sciences Training Program Grant T32 GM007767 (BDY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, FEMS IMMUNOL MED MIC, V58, P147, DOI 10.1111/j.1574-695X.2009.00601.x; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Bax R, 2000, INT J ANTIMICROB AG, V16, P51, DOI 10.1016/S0924-8579(00)00189-8; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Boles B.R., 2011, TRENDS MICROBIOL; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cramton SE, 2001, METHOD ENZYMOL, V336, P239, DOI 10.1016/S0076-6879(01)36593-X; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Deighton MA, 2001, METHOD ENZYMOL, V336, P177, DOI 10.1016/S0076-6879(01)36589-8; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hartford OM, 2001, J BIOL CHEM, V276, P2466, DOI 10.1074/jbc.M007979200; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Jiang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018514; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kobayashi SD, 2009, CURR OPIN PHARMACOL, V9, P545, DOI 10.1016/j.coph.2009.07.009; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; McGillivray SM, 2012, ANTIMICROB AGENTS CH, V56, P1854, DOI 10.1128/AAC.05131-11; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; NOVICK RP, 1965, J BACTERIOL, V90, P467, DOI 10.1128/JB.90.2.467-480.1965; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2004, FRONT BIOSCI-LANDMRK, V9, P841, DOI 10.2741/1295; Otto M, 2009, MED RES REV, P1; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Quoc PHT, 2007, INFECT IMMUN, V75, P1079, DOI 10.1128/IAI.01143-06; Rasko DA, 2009, CURR PROTOC MICROBIO; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; REGASSA LB, 1992, INFECT IMMUN, V60, P3381, DOI 10.1128/IAI.60.8.3381-3388.1992; Rice K, 2001, INFECT IMMUN, V69, P159, DOI 10.1128/IAI.69.1.159-169.2001; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; Shanks RMQ, 2005, INFECT IMMUN, V73, P4596, DOI 10.1128/IAI.73.8.4596-4606.2005; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Shaw LN, 2005, J BACTERIOL, V187, P1751, DOI 10.1128/JB.187.5.1751-1762.2005; Smagur J, 2009, BIOL CHEM, V390, P361, DOI 10.1515/BC.2009.042; Sun H, 2011, J THROMB HAEMOST, V9, P189, DOI 10.1111/j.1538-7836.2011.04316.x; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Sun HM, 2012, P NATL ACAD SCI USA, V109, P3469, DOI 10.1073/pnas.1201031109; Sun HM, 2009, BLOOD, V113, P1358, DOI 10.1182/blood-2008-07-170506; Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084; Waldor MK, 2006, NEW ENGL J MED, V354, P296, DOI 10.1056/NEJMcibr054591; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang R, 2012, BIOTECHNOL BIOENG, V109, P336, DOI 10.1002/bit.23342; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004; Zhang LQ, 2010, PROTEIN EXPRES PURIF, V69, P204, DOI 10.1016/j.pep.2009.09.007	74	57	61	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47255	10.1371/journal.pone.0047255	http://dx.doi.org/10.1371/journal.pone.0047255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077578	Green Submitted, gold, Green Published			2022-12-27	WOS:000309995100081
J	Bahuon, C; Despres, P; Pardigon, N; Panthier, JJ; Cordonnier, N; Lowenski, S; Richardson, J; Zientara, S; Lecollinet, S				Bahuon, Celine; Despres, Philippe; Pardigon, Nathalie; Panthier, Jean-Jacques; Cordonnier, Nathalie; Lowenski, Steeve; Richardson, Jennifer; Zientara, Stephan; Lecollinet, Sylvie			IS-98-ST1 West Nile Virus Derived from an Infectious cDNA Clone Retains Neuroinvasiveness and Neurovirulence Properties of the Original Virus	PLOS ONE			English	Article							2',5'-OLIGOADENYLATE SYNTHETASE 1B; AMINO-ACID SUBSTITUTION; VIRULENCE; PROTEIN; INHIBITION; DETERMINANTS; REPLICATION; PHENOTYPE; CONFERS; STRAIN	Infectious clones of West Nile virus (WNV) have previously been generated and used to decipher the role of viral proteins in WNV virulence. The majority of molecular clones obtained to date have been derived from North American, Australian, or African isolates. Here, we describe the construction of an infectious cDNA clone of a Mediterranean WNV strain, IS-98-ST1. We characterized the biological properties of the recovered recombinant virus in cell culture and in mice. The growth kinetics of recombinant and parental WNV were similar in Vero cells. Moreover, the phenotype of recombinant and parental WNV was indistinguishable as regards viremia, viral load in the brain, and mortality in susceptible and resistant mice. Finally, the pathobiology of the infectious clone was examined in embryonated chicken eggs. The capacity of different WNV strains to replicate in embryonated chicken eggs closely paralleled their ability to replicate in mice, suggesting that inoculation of embryonated chicken eggs could provide a practical in vivo model for the study of WNV pathogenesis. In conclusion, the IS-98-ST1 infectious clone will allow assessment of the impact of selected mutations and novel genomic changes appearing in emerging European strains pathogenicity and endemic or epidemic potential. This will be invaluable in the context of an increasing number of outbreaks and enhanced severity of infections in the Mediterranean basin and Eastern Europe.	[Bahuon, Celine; Lowenski, Steeve; Richardson, Jennifer; Zientara, Stephan; Lecollinet, Sylvie] Agence Natl Seurite Sanit Alimentat Environm Trav, UMR VIROLOGIE ANSES INRA ENVA 1161, Maisons Alfort, France; [Despres, Philippe; Pardigon, Nathalie] Inst Pasteur, Dept Virol, Unite Interact Mol Flavivirus Hotes, Paris, France; [Panthier, Jean-Jacques] Inst Pasteur, Mouse Funct Genet, Paris, France; [Cordonnier, Nathalie] Ecole Natl Vet Alfort, Unite Histol & Anat Pathol, Maisons Alfort, France	INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ecole Nationale Veterinaire d'Alfort (ENVA)	Bahuon, C (corresponding author), Agence Natl Seurite Sanit Alimentat Environm Trav, UMR VIROLOGIE ANSES INRA ENVA 1161, Maisons Alfort, France.	celine.bahuon@anses.fr	Zientara, Stephan/AAA-7661-2021; Lecollinet, Sylvie/M-1728-2019; Lecollinet, Sylvie/AAV-5276-2021; Zientara, Stephan/A-5336-2016; PANTHIER, Jean-Jacques/I-4366-2014	Zientara, Stephan/0000-0002-6733-8503; Zientara, Stephan/0000-0003-0089-8175; PANTHIER, Jean-Jacques/0000-0002-7966-0663; Lecollinet, Sylvie/0000-0001-8535-2133; Richardson, Jennifer/0000-0002-4137-3984	French agency for food, environmental and occupational health and safety (ANSES)	French agency for food, environmental and occupational health and safety (ANSES)(French National Research Agency (ANR))	This study was funded by the French agency for food, environmental and occupational health and safety (ANSES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No external funding was received for this study.	Abdul-Careem MF, 2007, POULTRY SCI, V86, P1351, DOI 10.1093/ps/86.7.1351; Audsley M, 2011, VIROLOGY, V414, P63, DOI 10.1016/j.virol.2011.03.008; Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005; Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Bondre VP, 2007, J GEN VIROL, V88, P875, DOI 10.1099/vir.0.82403-0; Borisevich V, 2006, VIROLOGY, V349, P371, DOI 10.1016/j.virol.2006.02.013; Botha EM, 2008, EMERG INFECT DIS, V14, P222, DOI 10.3201/eid1402.070457; Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097; Brnic D, 2012, J VIROL, V86, P2512, DOI 10.1128/JVI.05663-11; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; Crespo R, 2009, AVIAN DIS, V53, P608, DOI 10.1637/8829-040209-ResNote.1; Deas TS, 2005, J VIROL, V79, P4599, DOI 10.1128/JVI.79.8.4599-4609.2005; Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008; Evans JD, 2007, J VIROL, V81, P11809, DOI 10.1128/JVI.00791-07; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Hall RA, 2002, CURR TOP MICROBIOL, V267, P253; Jacobsen ID, 2010, INFECT IMMUN, V78, P2995, DOI 10.1128/IAI.00268-10; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Kajaste-Rudnitski A, 2006, J BIOL CHEM, V281, P4624, DOI 10.1074/jbc.M508649200; Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997; KHROMYKH AA, 1994, J VIROL, V68, P4580, DOI 10.1128/JVI.68.7.4580-4588.1994; Kinney RM, 2006, J GEN VIROL, V87, P3611, DOI 10.1099/vir.0.82299-0; Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002; Liang QL, 2011, MOL IMMUNOL, V48, P924, DOI 10.1016/j.molimm.2010.12.011; Linke S, 2007, J VIROL METHODS, V146, P355, DOI 10.1016/j.jviromet.2007.05.021; Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006; Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005; Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003; Lucas M, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-9; Ma DL, 2009, ANTIVIR RES, V83, P53, DOI 10.1016/j.antiviral.2009.03.006; Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; May FJ, 2011, J VIROL, V85, P2964, DOI 10.1128/JVI.01963-10; Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09; Mertens E, 2010, VIROLOGY, V399, P176, DOI 10.1016/j.virol.2009.12.036; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039; Papa A, 2010, EUROSURVEILLANCE, V15; Pugachev KV, 2004, J VIROL, V78, P1032, DOI 10.1128/JVI.78.2.1032-1038.2004; Puig-Basagoiti F, 2007, VIROLOGY, V361, P229, DOI 10.1016/j.virol.2006.11.012; Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sambrook J., 2001, MOL CLONING; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Schlick P, 2009, J VIROL, V83, P5581, DOI 10.1128/JVI.02653-08; Senne DA, 2000, AVIAN DIS, V44, P642, DOI 10.2307/1593105; Seregin A, 2006, VIROLOGY, V356, P115, DOI 10.1016/j.virol.2006.07.038; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; Simon-Chazottes D, 2011, VIROLOGY, V417, P147, DOI 10.1016/j.virol.2011.05.018; Sotelo E, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-11; Sotelo E, 2009, VIROLOGY, V395, P289, DOI 10.1016/j.virol.2009.09.013; Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208; Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007; Yamshchikov G, 2004, VIROLOGY, V330, P304, DOI 10.1016/j.virol.2004.09.014; Yamshchikov V, 2001, VIROLOGY, V281, P272, DOI 10.1006/viro.2000.0793; Yamshchikov VF, 2001, VIROLOGY, V281, P294, DOI 10.1006/viro.2000.0795; Yu L, 2008, VACCINE, V26, P5981, DOI 10.1016/j.vaccine.2008.08.064	59	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47666	10.1371/journal.pone.0047666	http://dx.doi.org/10.1371/journal.pone.0047666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110088	Green Submitted, Green Published, gold			2022-12-27	WOS:000310193600020
J	Rieger, AM; Konowalchuk, JD; Grayfer, L; Katzenback, BA; Havixbeck, JJ; Kiemele, MD; Belosevic, M; Barreda, DR				Rieger, Aja M.; Konowalchuk, Jeffrey D.; Grayfer, Leon; Katzenback, Barbara A.; Havixbeck, Jeffrey J.; Kiemele, Moira D.; Belosevic, Miodrag; Barreda, Daniel R.			Fish and Mammalian Phagocytes Differentially Regulate Pro-Inflammatory and Homeostatic Responses In Vivo	PLOS ONE			English	Article							ZYMOSAN-INDUCED PERITONITIS; APOPTOTIC CELLS; B-CELLS; REACTIVE OXYGEN; TGF-BETA; MACROPHAGE; RESOLUTION; EXPRESSION; CLEARANCE; RECEPTOR	Phagocytosis is a cellular mechanism that is important to the early induction of antimicrobial responses and the regulation of adaptive immunity. At an inflammatory site, phagocytes serve as central regulators for both pro-inflammatory and homeostatic anti-inflammatory processes. However, it remains unclear if this is a recent evolutionary development or whether the capacity to balance between these two seemingly contradictory processes is a feature already displayed in lower vertebrates. In this study, we used murine (C57BL/6) and teleost fish (C. auratus) in vitro and in vivo models to assess the evolutionary conservation of this dichotomy at a site of inflammation. At the level of the macrophage, we found that teleost fish already displayed divergent pro-inflammatory and homeostatic responses following internalization of zymosan or apoptotic bodies, respectively, and that these were consistent with those of mice. However, fish and mice displayed significant differences in vivo with regards to the level of responsiveness to zymosan and apoptotic bodies, the identity of infiltrating leukocytes, their rate of infiltration, and the kinetics and strength of resulting antimicrobial responses. Unlike macrophages, significant differences were identified between teleost and murine neutrophilic responses. We report for the first time that activated murine, but not teleost neutrophils, possess the capacity to internalize apoptotic bodies. This internalization translates into reduction of neutrophil ROS production. This may play an important part in the recently identified anti-inflammatory activity that mammalian neutrophils display during the resolution phase of inflammation. Our observations are consistent with continued honing of inflammatory control mechanisms from fish to mammals, and provide added insights into the evolutionary path that has resulted in the integrated, multilayered responses that are characteristic of higher vertebrates.	[Rieger, Aja M.; Konowalchuk, Jeffrey D.; Grayfer, Leon; Katzenback, Barbara A.; Havixbeck, Jeffrey J.; Kiemele, Moira D.; Belosevic, Miodrag; Barreda, Daniel R.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Belosevic, Miodrag] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Barreda, Daniel R.] Univ Alberta, Dept Agr Forestry & Nutr Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Barreda, DR (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	dan.barreda@ualberta.ca	Belosevic, Miodrag/C-6729-2008; Belosevic, Miodrag/G-9396-2018; Barreda, Daniel/A-2613-2014; Katzenback, Barb/M-1292-2013	Belosevic, Miodrag/0000-0002-6412-8236; Belosevic, Miodrag/0000-0002-6412-8236; Barreda, Daniel/0000-0003-4630-2840; Katzenback, Barb/0000-0001-6171-5040	Natural Sciences and Engineering Council of Canada (NSERC) grants; NSERC Vanier doctoral scholarship; NSERC; Alberta Ingenuity doctoral scholarship; NSERC PGS-D doctoral scholarship	Natural Sciences and Engineering Council of Canada (NSERC) grants; NSERC Vanier doctoral scholarship; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity doctoral scholarship; NSERC PGS-D doctoral scholarship	This work was supported by Natural Sciences and Engineering Council of Canada (NSERC) grants to DRB and MB. AMR was supported by NSERC Vanier doctoral scholarship. BAK was supported by NSERC and Alberta Ingenuity doctoral scholarships and LG was supported by NSERC PGS-D doctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HA, 2002, CELL DEATH DIFFER, V9, P616, DOI 10.1038/sj.cdd.4401013; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Bianchi SM, 2008, AM J RESP CRIT CARE, V177, P35, DOI 10.1164/rccm.200612-1804OC; Bittencourt MD, 2001, BLOOD, V98, P224, DOI 10.1182/blood.V98.1.224; Borgeson E, 2011, INFECT IMMUN, V79, P1489, DOI 10.1128/IAI.00777-10; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Chadzinska M, 2008, DEV COMP IMMUNOL, V32, P509, DOI 10.1016/j.dci.2007.08.008; Christenson K, J LEUKOC BIOL, V90, P1055; Cuzzocrea S, 1997, SHOCK, V8, P268, DOI 10.1097/00024382-199710000-00006; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Erwig LP, 2007, AM J PATHOL, V171, P2, DOI 10.2353/ajpath.2007.070135; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Fadeel B, 2010, BIOCHEM BIOPH RES CO, V396, P7, DOI 10.1016/j.bbrc.2010.02.106; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; Fullard JF, 2009, APOPTOSIS, V14, P1029, DOI 10.1007/s10495-009-0335-9; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Gregory CD, 2004, IMMUNOLOGY, V113, P1, DOI 10.1111/j.1365-2567.2004.01959.x; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Johann AM, 2006, CELL DEATH DIFFER, V13, P1533, DOI 10.1038/sj.cdd.4401832; Katzenback BA, 2012, FISH SHELLFISH IMMUN, V32, P434, DOI 10.1016/j.fsi.2011.12.003; Katzenback BA, 2009, DEV COMP IMMUNOL, V33, P601, DOI 10.1016/j.dci.2008.10.011; Keen D, 2008, J Wound Care, V17, P218; Keen D, 2008, J WOUND CARE, V17, P222; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Kleinclauss F, 2006, CELL DEATH DIFFER, V13, P41, DOI 10.1038/sj.cdd.4401699; Kolaczkowska E, 2008, INFLAMM RES, V57, P272, DOI 10.1007/s00011-007-7131-1; Leitch AE, 2011, J LEUKOCYTE BIOL, V90, P841, DOI 10.1189/jlb.0511222; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Maderna P, 2003, BBA-MOL BASIS DIS, V1639, P141, DOI 10.1016/j.bbadis.2003.09.004; Majji S, 2009, DEV COMP IMMUNOL, V33, P224, DOI 10.1016/j.dci.2008.08.010; Martinez-Martin N, 2011, IMMUNITY, V35, P208, DOI 10.1016/j.immuni.2011.06.003; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MILLER NW, 1994, J IMMUNOL, V152, P2180; Munoz LE, 2010, AUTOIMMUN REV, V10, P38, DOI 10.1016/j.autrev.2010.08.015; Nakashima M, 2012, J LEUKOCYTE BIOL, V91, P537, DOI 10.1189/jlb.0411214; Nascimento-Silva V, 2007, THROMB HAEMOSTASIS, V97, P88, DOI 10.1160/TH06-06-0315; Neumann NF, 2000, FISH SHELLFISH IMMUN, V10, P1, DOI 10.1006/fsim.1999.0221; Neumann NF, 1998, DEV COMP IMMUNOL, V22, P417, DOI 10.1016/S0145-305X(98)00023-8; Overland HS, 2010, FISH SHELLFISH IMMUN, V28, P193, DOI 10.1016/j.fsi.2009.10.021; Parra D, 2012, J LEUKOCYTE BIOL, V91, P525, DOI 10.1189/jlb.0711372; Pini M, 2010, J LEUKOCYTE BIOL, V87, P51, DOI 10.1189/jlb.0309188; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Potter PK, 2003, J IMMUNOL, V170, P3223, DOI 10.4049/jimmunol.170.6.3223; Reiter I, 1999, J IMMUNOL, V163, P1730; Rieger A, 2008, NAT REV IMMUNOL, V8, P486, DOI 10.1038/nri2315-c1; Rieger AM, 2010, DEV COMP IMMUNOL, V34, P1144, DOI 10.1016/j.dci.2010.06.006; Saas P, 2007, TRANSPLANTATION, V84, pS31, DOI 10.1097/01.tp.0000269113.59857.d6; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serinkan BF, 2005, CELL DEATH DIFFER, V12, P1141, DOI 10.1038/sj.cdd.4401619; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Stafford JL, 2001, DEV COMP IMMUNOL, V25, P447, DOI 10.1016/S0145-305X(01)00015-5; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Tassiulas I, 2007, HUM IMMUNOL, V68, P156, DOI 10.1016/j.humimm.2006.12.008; Underhill DM, 2003, J ENDOTOXIN RES, V9, P176, DOI 10.1179/096805103125001586; van Lent PLEM, 2001, J LEUKOCYTE BIOL, V70, P708; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Weigert A, 2009, BIOL CHEM, V390, P379, DOI 10.1515/BC.2009.048; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wu Y, 2012, NEUROCHEM RES, V37, P1690, DOI 10.1007/s11064-012-0776-3; Zamboni DS, 2003, INFECT IMMUN, V71, P1225, DOI 10.1128/IAI.71.3.1225-1233.2003; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zouali M, 2008, FRONT BIOSCI, V13, P4852, DOI 10.2741/3044	69	40	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47070	10.1371/journal.pone.0047070	http://dx.doi.org/10.1371/journal.pone.0047070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110059	Green Published, Green Submitted, gold			2022-12-27	WOS:000310193600008
J	Kothera, L; Godsey, MS; Doyle, MS; Savage, HM				Kothera, Linda; Godsey, Marvin S., Jr.; Doyle, Michael S.; Savage, Harry M.			Characterization of Culex pipiens Complex (Diptera: Culicidae) Populations in Colorado, USA Using Microsatellites	PLOS ONE			English	Article							WEST-NILE-VIRUS; EASTERN UNITED-STATES; CHAIN-REACTION ASSAY; VECTOR COMPETENCE; NORTH-AMERICA; F-STATISTICS; FRONT RANGE; MOSQUITOS; SOFTWARE; QUINQUEFASCIATUS	Mosquitoes such as those in the Culex pipiens complex are important vectors of disease. This study was conducted to genetically characterize Cx. pipiens complex populations in the state of Colorado, USA, and to determine the number of genetic clusters represented by the data. Thirteen populations located among four major river basins were sampled (n = 597 individuals) using a panel of 14 microsatellites. The lowest-elevation sites had the highest Expected Heterozygosity (H-E) values (range 0.54-0.65). AMOVA results indicated the presence of statistically significant amounts of variation within each level when populations were analyzed as one group or when they were grouped either by river basin or by their position on the east or west side of the Rocky Mountains. Most pairwise F-ST values were significant via permutation test (range 0-0.10), with the highest values from comparisons with Lamar, in southeast CO. A neighbor joining tree based on Cavalli-Sforza and Edwards's chord distances was consistent with the geographic locations of populations, as well as with the AMOVA results. There was a significant isolation by distance effect, and the cluster analysis resolved five groups. Individuals were also assayed with an additional microsatellite marker, Cxpq78, proposed to be monomorphic in Cx. pipiens but polymorphic in the closely related but biologically distinct species Cx. quinquefasciatus. Low frequencies (<= 3%) of Cx. quinquefasciatus alleles for this marker were noted, and mostly confined to populations along the Interstate 25 corridor. Pueblo was distinct in that it had 10% Cx. quinquefasciatus alleles, mostly of one allele size. The degree of population genetic structure observed in this study is in contrast with that of Cx. tarsalis, the other major vector of WNV in the western U.S., and likely reflects the two species' different dispersal strategies.	[Kothera, Linda; Godsey, Marvin S., Jr.; Doyle, Michael S.; Savage, Harry M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA	Kothera, L (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.	lkothera@cdc.gov						Abreu AG, 2012, MOL ECOL RESOUR, V12, P374, DOI 10.1111/j.1755-0998.2011.03109.x; Aspen S, 2003, J AM MOSQUITO CONTR, V19, P115; Barker CM, 2009, J VECTOR ECOL, V34, P276, DOI [10.1111/j.1948-7134.2009.00036.x, 10.3376/038.034.0214]; BARR AR, 1957, AM J TROP MED HYG, V6, P153, DOI 10.4269/ajtmh.1957.6.153; Bataille A, 2010, MOL ECOL, V19, P4491, DOI 10.1111/j.1365-294X.2010.04843.x; Bolling BG, 2007, J AM MOSQUITO CONTR, V23, P37, DOI 10.2987/8756-971X(2007)23[37:ESATCF]2.0.CO;2; Bolling BG, 2009, J MED ENTOMOL, V46, P1519, DOI 10.1603/033.046.0641; CAVALLISFORZA LL, 1967, EVOLUTION, V32, P550; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; CRABTREE MB, 1995, AM J TROP MED HYG, V53, P105, DOI 10.4269/ajtmh.1995.53.105; Darsie RFJ, 2005, IDENTIFICATION GEOGR; Edillo FE, 2007, J MED ENTOMOL, V44, P145, DOI 10.1603/0022-2585(2007)44[145:ASOBAM]2.0.CO;2; Edillo F, 2009, AM J TROP MED HYG, V81, P842, DOI 10.4269/ajtmh.2009.08-0605; Eisen L, 2008, J MED ENTOMOL, V45, P800, DOI 10.1603/0022-2585(2008)45[800:MSRCAA]2.0.CO;2; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Huang SM, 2008, AM J TROP MED HYG, V79, P518, DOI 10.4269/ajtmh.2008.79.518; Huang SM, 2011, AM J TROP MED HYG, V85, P434, DOI 10.4269/ajtmh.2011.10-0679; Keyghobadi N, 2004, MOL ECOL NOTES, V4, P20, DOI 10.1046/j.1471-8286.2003.00557.x; Kilpatrick AM, 2010, AM J TROP MED HYG, V83, P607, DOI 10.4269/ajtmh.2010.10-0005; Kothera L, 2010, J MED ENTOMOL, V47, P805, DOI 10.1603/ME10031; Kothera L, 2009, J MED ENTOMOL, V46, P236, DOI 10.1603/033.046.0208; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Lindsey NP, 2008, VECTOR-BORNE ZOONOT, V8, P35, DOI 10.1089/vbz.2007.0137; Merrill SA, 2005, AM J TROP MED HYG, V72, P304, DOI 10.4269/ajtmh.2005.72.304; MITCHELL CJ, 1980, ST LOUIS ENCEPHALITI, P313; Nei M., 1987, MOL EVOLUTIONARY GEN; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reisen W, 2004, EMERG INFECT DIS, V10, P1369, DOI 10.3201/eid1008.040077; Reisen WK, 2008, J MED ENTOMOL, V45, P1126, DOI 10.1603/0022-2585(2008)45[1126:DVICDC]2.0.CO;2; REITER P, 1983, MOSQ NEWS, V43, P496; Richards SL, 2010, AM J TROP MED HYG, V83, P126, DOI 10.4269/ajtmh.2010.09-0776; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Savage HM, 2007, VECTOR-BORNE ZOONOT, V7, P365, DOI 10.1089/vbz.2006.0602; Smith JL, 2005, MOL ECOL NOTES, V5, P697, DOI 10.1111/j.1471-8286.2005.01034.x; TSAI TF, 1988, AM J EPIDEMIOL, V128, P285, DOI 10.1093/oxfordjournals.aje.a114969; Urbanelli S, 1997, J MED ENTOMOL, V34, P116, DOI 10.1093/jmedent/34.2.116; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Venkatesan M, 2010, MOL ECOL, V19, P1573, DOI 10.1111/j.1365-294X.2010.04577.x; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Winters AM, 2008, AM J TROP MED HYG, V78, P654, DOI 10.4269/ajtmh.2008.78.654	49	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47602	10.1371/journal.pone.0047602	http://dx.doi.org/10.1371/journal.pone.0047602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094068	gold, Green Published			2022-12-27	WOS:000310050200035
J	Aghajani, M; Mahdavi, MRV; Najafabadi, MK; Ghazanfari, T				Aghajani, Marjan; Mahdavi, Mohammad Reza Vaez; Najafabadi, Mohsen Khalili; Ghazanfari, Tooba			RETRACTED: The Effect of Social Stress on Chronic Pain Perception in Female and Male Mice (Retracted article. See vol. 11, e0156567, 2016)	PLOS ONE			English	Article; Retracted Publication							SOCIOECONOMIC-STATUS; GENDER-DIFFERENCES; INDUCED ANALGESIA; FOOD-DEPRIVATION; FORMALIN TEST; ANTINOCICEPTION; HYPERALGESIA; MODULATION; WOMEN; INSTABILITY	The current investigations on social stress primarily point to the negative health consequences of being in a stressful social hierarchy. The repetitive nature of such stressors seems to affect behavioral response to pain both in rodents and humans. Moreover, a large discrepancy in the possibility of social stresses affecting pain perception in the two genders exists. The present study examined the effect of chronic social stress on nociceptive responses of both sexes by implementing of food deprivation, food intake inequality and unstable social status (cage-mate change every 3 days) for a period of 14 days in 96 Balb/c mice. In this regard we injected 20 mu l formalin 2% into the plantar surface of hind paw at the end of stress period and scored pain behaviors of all subjects, then serum concentrations of proinflammatory cytokines were measured. Our results showed that there was significant difference in chronic phase of formalin test following implementation of food deprivation and inequality (P<0.05) as compared to control group, so that pain perception was decreased considerably and this decline in inequality exposed subjects was well above isolated ones (P<0.05); whereas unstable social situation did not affect pain perception. Moreover, IL-1 and IL-6 concentrations in serum of stressed mice of both genders were well above control group (P<0.05). Finally, despite chronic pain perception in control and unstable male subjects was larger than females; the decrease of chronic pain perception in male stressed animals (poverty and inequality experienced subjects) was much more than stressed females. These results revealed that although food deprivation and social inequality can induce hypoalgesia, some socioeconomic situations like social instability don't affect pain sensation, whereas there were similar increases of proinflammatory cytokines level in all socially stressed subjects. In addition, males display larger hypoalgesic responses to inequality as compared with females.	[Aghajani, Marjan; Mahdavi, Mohammad Reza Vaez; Najafabadi, Mohsen Khalili] Shahed Univ, Fac Med Sci, Dept Physiol, Tehran, Iran; [Aghajani, Marjan; Mahdavi, Mohammad Reza Vaez; Ghazanfari, Tooba] Shahed Univ, Equ & Hlth Res Dept, Tehran, Iran; [Aghajani, Marjan; Ghazanfari, Tooba] Shahed Univ, Fac Med Sci, Dept Immunol, Tehran, Iran	Shahed University; Shahed University; Shahed University	Mahdavi, MRV (corresponding author), Shahed Univ, Fac Med Sci, Dept Physiol, Tehran, Iran.	vaezmahdavi@shaded.ac.ir	Vaez-Mahdavi, Mohammad-Reza/I-8185-2016; Khalili, Mohsen/H-2622-2016	Vaez-Mahdavi, Mohammad-Reza/0000-0002-1490-4364; , marjan/0000-0002-7617-271X; Khalili, Mohsen/0000-0002-7154-676X	Shahed Medical University [87/14/A/P]	Shahed Medical University	This research was provided by financial support and supervision of Shahed Medical University (grant number: 87/14/A/P) but this funding source had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	ALMAY BGL, 1980, PSYCHOPHARMACOLOGY, V67, P139, DOI 10.1007/BF00431968; Baigi A, 2001, EUR J PUBLIC HEALTH, V11, P420, DOI 10.1093/eurpub/11.4.420; Barrett AC, 2002, EUR J PHARMACOL, V452, P163, DOI 10.1016/S0014-2999(02)02274-4; Berkley KJ, 2006, AM J PHYSIOL-REG I, V291, pR241, DOI 10.1152/ajpregu.00287.2006; Bi S, 2003, AM J PHYSIOL-REG I, V285, pR1030, DOI 10.1152/ajpregu.00734.2002; Bileviciute-Ljungar I, 2006, J PHARMACOL EXP THER, V317, P220, DOI 10.1124/jpet.105.096032; Bodnar RJ, 2010, HORM BEHAV, V58, P72, DOI 10.1016/j.yhbeh.2009.09.012; Borsook TK, 2010, PAIN, V151, P372, DOI 10.1016/j.pain.2010.07.022; Brekke M, 2002, SOC SCI MED, V54, P221, DOI 10.1016/S0277-9536(01)00018-1; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Cicero TJ, 2002, J PHARMACOL EXP THER, V300, P695, DOI 10.1124/jpet.300.2.695; Craig K.D., 2006, WALL MELLZACKS TXB P, V5th, P231; Dao TTT, 2000, J OROFAC PAIN, V14, P169; Davies KA, 2009, EUR J PAIN, V13, P635, DOI 10.1016/j.ejpain.2008.07.003; Farrell C., 2008, TACKLING HLTH INEQUA; Fillingim R B, 2000, Curr Rev Pain, V4, P24; Fillingim RB, 2000, NEUROSCI BIOBEHAV R, V24, P485, DOI 10.1016/S0149-7634(00)00017-8; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Ford GK, 2008, PAIN, V140, P3, DOI 10.1016/j.pain.2008.09.023; Gaumond I, 2005, BRAIN RES, V1052, P105, DOI 10.1016/j.brainres.2005.06.011; Gioiosa L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004143; Glynn P, 1999, THORAX, V54, P51, DOI 10.1136/thx.54.1.51; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Hargraves WA, 2005, PAIN, V114, P455, DOI 10.1016/j.pain.2005.01.010; Heidary F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003705; Hoff J, 2000, LAB ANIMAL, V29, P47; Imbe H, 2006, FRONT BIOSCI-LANDMRK, V11, P2179, DOI 10.2741/1960; Institute for Laboratory Animal Research, 2009, REC ASS PAIN, P47; Jablonska B, 2006, EUR J PAIN, V10, P435, DOI 10.1016/j.ejpain.2005.06.003; Jordan KP, 2008, PAIN, V137, P652, DOI 10.1016/j.pain.2008.02.030; Kasdallah AG, 2005, CR BIOL, V328, P463, DOI 10.1016/j.crvi.2005.02.003; Klatzkin Rebecca R, 2010, Eur J Pain, V14, P77, DOI 10.1016/j.ejpain.2009.01.002; Latza U, 2000, SPINE, V25, P1390, DOI 10.1097/00007632-200006010-00011; Machelska H, 2003, J NEUROIMMUNOL, V141, P30, DOI 10.1016/S0165-5728(03)00213-3; Marcinkiewcz CA, 2009, BRAIN RES, V1251, P112, DOI 10.1016/j.brainres.2008.11.042; McEwen BS, 2010, METABOLISM, V59, pS9, DOI 10.1016/j.metabol.2010.07.012; Mogil JS, 2000, NEUROSCI BIOBEHAV R, V24, P375, DOI 10.1016/S0149-7634(00)00015-4; Mojarab S., 2010, World Applied Sciences Journal, V8, P680; Murali V., 2004, ADV PSYCHIAT TREAT, V10, P216, DOI DOI 10.1192/APT.10.3.216; Myers CD, 2003, CLIN J PAIN, V19, P225, DOI 10.1097/00002508-200307000-00005; Nikolov V, 2010, PROCD SOC BEHV, V5, P289, DOI 10.1016/j.sbspro.2010.07.090; POTTER M, 1985, CURR TOP MICROBIOL, V122, P1; Racine M, 2012, PAIN, V153, P619, DOI 10.1016/j.pain.2011.11.026; Riecke BF, 2010, OSTEOARTHR CARTILAGE, V18, P746, DOI 10.1016/j.joca.2010.02.012; Rivat C, 2007, NEUROPSYCHOPHARMACOL, V32, P2217, DOI 10.1038/sj.npp.1301340; Saastamoinen P, 2005, PAIN, V114, P364, DOI 10.1016/j.pain.2004.12.033; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; Sherman JJ, 2006, AM J PHYSIOL-REG I, V291, pR245, DOI 10.1152/ajpregu.00920.2005; Silasi G, 2008, BEHAV BRAIN RES, V188, P219, DOI 10.1016/j.bbr.2007.10.030; Spooner MF, 2007, NEUROSCIENCE, V150, P675, DOI 10.1016/j.neuroscience.2007.09.037; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; Sternberg WF, 1999, PHYSIOL BEHAV, V68, P63, DOI 10.1016/S0031-9384(99)00164-X; Sufka KJ, 1998, EUR J PAIN-LONDON, V2, P351, DOI 10.1016/S1090-3801(98)90033-7; Tatli MM, 2000, PEDIATR INT, V42, P289, DOI 10.1046/j.1442-200x.2000.01217.x; vanHaasteren GAC, 1996, J ENDOCRINOL, V150, P169, DOI 10.1677/joe.0.1500169; Vendruscolo LF, 2004, BRAIN RES, V1030, P277, DOI 10.1016/j.brainres.2004.10.016; Villemure C, 2002, PAIN, V95, P195, DOI 10.1016/S0304-3959(02)00007-6; Vincler M, 2001, PHARMACOL BIOCHEM BE, V69, P315, DOI 10.1016/S0091-3057(01)00506-8; VONKNORRING L, 1979, NEUROPSYCHOBIOLOGY, V5, P322, DOI 10.1159/000117698; YAMADA K, 1995, BEHAV BRAIN RES, V67, P133, DOI 10.1016/0166-4328(94)00150-E; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	61	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47218	10.1371/journal.pone.0047218	http://dx.doi.org/10.1371/journal.pone.0047218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082150	Green Submitted, gold, Green Published			2022-12-27	WOS:000311146900046
J	Branstetter, BK; Finneran, JJ; Fletcher, EA; Weisman, BC; Ridgway, SH				Branstetter, Brian K.; Finneran, James J.; Fletcher, Elizabeth A.; Weisman, Brian C.; Ridgway, Sam H.			Dolphins Can Maintain Vigilant Behavior through Echolocation for 15 Days without Interruption or Cognitive Impairment	PLOS ONE			English	Article							CONTINUOUS AUDITORY VIGILANCE; BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; STENELLA-LONGIROSTRIS; SPINNER DOLPHINS; SHARK PREDATION; CETACEAN SLEEP; HABITAT USE; EVOLUTION; RISK	In dolphins, natural selection has developed unihemispheric sleep where alternating hemispheres of their brain stay awake. This allows dolphins to maintain consciousness in response to respiratory demands of the ocean. Unihemispheric sleep may also allow dolphins to maintain vigilant states over long periods of time. Because of the relatively poor visibility in the ocean, dolphins use echolocation to interrogate their environment. During echolocation, dolphin produce clicks and listen to returning echoes to determine the location and identity of objects. The extent to which individual dolphins are able to maintain continuous vigilance through this active sense is unknown. Here we show that dolphins may continuously echolocate and accurately report the presence of targets for at least 15 days without interruption. During a total of three sessions, each lasting five days, two dolphins maintained echolocation behaviors while successfully detecting and reporting targets. Overall performance was between 75 to 86% correct for one dolphin and 97 to 99% correct for a second dolphin. Both animals demonstrated diel patterns in echolocation behavior. A 15-day testing session with one dolphin resulted in near perfect performance with no significant decrement over time. Our results demonstrate that dolphins can continuously monitor their environment and maintain long-term vigilant behavior through echolocation.	[Branstetter, Brian K.; Ridgway, Sam H.] Natl Marine Mammal Fdn, San Diego, CA USA; [Finneran, James J.; Weisman, Brian C.] USA, Marine Mammal Program, Space & Naval Warfare Syst Ctr Pacific, San Diego, CA USA; [Fletcher, Elizabeth A.] Sci Applicat Int Corp, Maritime Serv Div, San Diego, CA 92121 USA	Naval Information Warfare Center Pacific; Science Applications International Corporation (SAIC)	Branstetter, BK (corresponding author), Natl Marine Mammal Fdn, San Diego, CA USA.	brian.branstetter@nmmpfoundation.org	Branstetter, Brian/ABE-2593-2020	Ridgway, Sam/0000-0001-7474-9880	U.S. Navy Marine Mammal Program	U.S. Navy Marine Mammal Program	This project was funded by the U.S. Navy Marine Mammal Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LANG ENV STAT COMP; Au W. W., 1993, SONAR DOLPHINS; Au WWL., 1980, ANIMAL SONAR SYSTEMS, P251, DOI DOI 10.1007/978-1-4684-7254-7_10; Aubauer R, 2000, J ACOUST SOC AM, V107, P2750, DOI 10.1121/1.428661; AUDET D, 1990, J MAMMAL, V71, P420, DOI 10.2307/1381955; Bates D., 2009, IME4 LINEAR MIXED EF; Benoit-Bird KJ, 2009, J ACOUST SOC AM, V125, P539, DOI 10.1121/1.2967477; Benoit-Bird KJ, 2009, J ACOUST SOC AM, V125, P125, DOI 10.1121/1.2967480; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; COCKCROFT VG, 1989, S AFR J ZOOL, V24, P305; Connor RC, 2001, MG BEH ECOL, P408; Crawley MJ, 2009, MIXED EFFECTS MODEL, P627; Finneran JJ, 2010, J ACOUST SOC AM, V128, P1483, DOI 10.1121/1.3471915; Goley PD, 1999, MAR MAMMAL SCI, V15, P1054, DOI 10.1111/j.1748-7692.1999.tb00877.x; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Heithaus MR, 2001, MAR MAMMAL SCI, V17, P526, DOI 10.1111/j.1748-7692.2001.tb01002.x; Houser DS, 2006, J ACOUST SOC AM, V120, P4090, DOI 10.1121/1.2357993; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Kloepper LN, 2012, J EXP BIOL, V215, P1306, DOI 10.1242/jeb.066605; Lammers MO, 2003, MAR MAMMAL SCI, V19, P249, DOI 10.1111/j.1748-7692.2003.tb01107.x; Lilly J. C., 1964, HDB PHYSL ENV, P741; Lyamin O, 2007, PHYSIOL BEHAV, V92, P725, DOI 10.1016/j.physbeh.2007.05.064; Lyamin OI, 2008, NEUROSCI BIOBEHAV R, V32, P1451, DOI 10.1016/j.neubiorev.2008.05.023; Moore PW, 2008, J ACOUST SOC AM, V124, P3324, DOI 10.1121/1.2980453; Moss CF, 2001, J ACOUST SOC AM, V110, P2207, DOI 10.1121/1.1398051; Mukhametov L. M., 1984, EXPT BRAIN RES S, P227, DOI [10.1007/978-3-[ 642-69554-4_17spinal, DOI 10.1007/978-3-642-69554-E]; MUKHAMETOV LM, 1988, SLEEP 86, P154; Pillay P, 2004, J SLEEP RES, V13, P353, DOI 10.1111/j.1365-2869.2004.00419.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rattenborg NC, 1999, BEHAV BRAIN RES, V105, P163, DOI 10.1016/S0166-4328(99)00070-4; Ridgway S. H., 1991, J ACOUST SOC AM, V90, P2335, DOI [10.1121/1.402199, DOI 10.1121/1.402199]; Ridgway S, 2006, J EXP BIOL, V209, P3621, DOI 10.1242/jeb.02405; Ridgway S, 2009, J EXP BIOL, V212, P1519, DOI 10.1242/jeb.027896; Ridgway SH, 2002, BRAIN BEHAV EVOLUT, V60, P265, DOI 10.1159/000067192; Treves A, 2000, ANIM BEHAV, V60, P711, DOI 10.1006/anbe.2000.1528; Verfuss UK, 2009, J EXP BIOL, V212, P823, DOI 10.1242/jeb.022137	36	23	23	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47478	10.1371/journal.pone.0047478	http://dx.doi.org/10.1371/journal.pone.0047478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082170	gold, Green Submitted, Green Published			2022-12-27	WOS:000311146900066
J	Niska, JA; Meganck, JA; Pribaz, JR; Shahbazian, JH; Lim, E; Zhang, N; Rice, BW; Akin, A; Ramos, RI; Bernthal, NM; Francis, KP; Miller, LS				Niska, Jared A.; Meganck, Jeffrey A.; Pribaz, Jonathan R.; Shahbazian, Jonathan H.; Lim, Ed; Zhang, Ning; Rice, Brad W.; Akin, Ali; Ramos, Romela Irene; Bernthal, Nicholas M.; Francis, Kevin P.; Miller, Lloyd S.			Monitoring Bacterial Burden, Inflammation and Bone Damage Longitudinally Using Optical and mu CT Imaging in an Orthopaedic Implant Infection in Mice	PLOS ONE			English	Article							IN-VIVO; MOUSE MODEL; ARTHROPLASTY; VANCOMYCIN; DIAGNOSIS; BIOFILMS; DISEASES; SURGERY; SITE	Background: Recent advances in non-invasive optical, radiographic and mu CT imaging provide an opportunity to monitor biological processes longitudinally in an anatomical context. One particularly relevant application for combining these modalities is to study orthopaedic implant infections. These infections are characterized by the formation of persistent bacterial biofilms on the implanted materials, causing inflammation, periprosthetic osteolysis, osteomyelitis, and bone damage, resulting in implant loosening and failure. Methodology/Principal Findings: An orthopaedic implant infection model was used in which a titanium Kirshner-wire was surgically placed in femurs of LysEGFP mice, which possess EGFP-fluorescent neutrophils, and a bioluminescent S. aureus strain (Xen29; 1x10(3) CFUs) was inoculated in the knee joint before closure. In vivo bioluminescent, fluorescent, X-ray and mu CT imaging were performed on various postoperative days. The bacterial bioluminescent signals of the S. aureus-infected mice peaked on day 19, before decreasing to a basal level of light, which remained measurable for the entire 48 day experiment. Neutrophil EGFP-fluorescent signals of the S. aureus-infected mice were statistically greater than uninfected mice on days 2 and 5, but afterwards the signals for both groups approached background levels of detection. To visualize the three-dimensional location of the bacterial infection and neutrophil infiltration, a diffuse optical tomography reconstruction algorithm was used to co-register the bioluminescent and fluorescent signals with mu CT images. To quantify the anatomical bone changes on the mu CT images, the outer bone volume of the distal femurs were measured using a semi-automated contour based segmentation process. The outer bone volume increased through day 48, indicating that bone damage continued during the implant infection. Conclusions/Significance: Bioluminescent and fluorescent optical imaging was combined with X-ray and mu CT imaging to provide noninvasive and longitudinal measurements of the dynamic changes in bacterial burden, neutrophil recruitment and bone damage in a mouse orthopaedic implant infection model.	[Shahbazian, Jonathan H.; Ramos, Romela Irene; Miller, Lloyd S.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Niska, Jared A.; Pribaz, Jonathan R.; Bernthal, Nicholas M.] Univ Calif Los Angeles, David Geffen Sch Med, Orthopaed Hosp Dept Orthopaed Surg, Orthopaed Hosp Res Ctr, Los Angeles, CA 90095 USA; [Meganck, Jeffrey A.; Lim, Ed; Zhang, Ning; Rice, Brad W.; Akin, Ali; Francis, Kevin P.] Caliper, Alameda, CA USA; [Akin, Ali] Novartis Inst BioMed Res Inc, Emeryville, CA USA	Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Novartis	Miller, LS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA.	lloydmiller@jhmi.edu	Hamblin, Mike/AAB-2511-2022; Hamblin, Michael R/H-2758-2019	Hamblin, Michael R/0000-0001-6431-4605; Miller, Lloyd/0000-0002-8332-2210; Niska, Jared/0000-0002-7779-7949	H & H Lee Surgical Resident Research Scholars Program; National Institutes of Health [R01-AI078910, R24-CA92865]; NATIONAL CANCER INSTITUTE [R24CA092865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078910] Funding Source: NIH RePORTER	H & H Lee Surgical Resident Research Scholars Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an H & H Lee Surgical Resident Research Scholars Program (to JAN) and National Institutes of Health grants R01-AI078910 (to LSM) and R24-CA92865 (to the UCLA Small Animal Imaging Resource Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CS, 2009, J ORTHOP RES, V27, P701, DOI 10.1002/jor.20815; Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; Bauer TW, 2006, J BONE JOINT SURG AM, V88A, P869, DOI 10.2106/JBJS.E.01149; Bernthal NM, 2011, J ORTHOP RES, V29, P1621, DOI 10.1002/jor.21414; Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580; Cho JS, 2011, J INVEST DERMATOL, V131, P907, DOI 10.1038/jid.2010.417; Cook SD, 2009, CLIN ORTHOP RELAT R, V467, P3213, DOI 10.1007/s11999-009-1087-0; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Deirmengian CA, 2012, J BONE JOINT SURG AM, V94A, P182, DOI 10.2106/JBJS.K.01262; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007; Faust N, 2000, BLOOD, V96, P719; Foster WK, 2011, PHYS MED BIOL, V56, P315, DOI 10.1088/0031-9155/56/2/002; Fulkerson E, 2006, J BONE JOINT SURG AM, V88A, P1231, DOI 10.2106/JBJS.E.00004; Ghanem E, 2008, J BONE JOINT SURG AM, V90A, P1637, DOI 10.2106/JBJS.G.00470; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Johnson LC, 2011, BONE, V48, P141, DOI 10.1016/j.bone.2010.05.033; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Kim MH, 2011, BLOOD, V117, P3343, DOI 10.1182/blood-2010-07-296970; Klinck RJ, 2008, MED ENG PHYS, V30, P888, DOI 10.1016/j.medengphy.2007.11.004; Kuo C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717898; Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022; Lee J, 2006, J BONE JOINT SURG AM, V88A, P1705, DOI 10.2106/JBJS.E.01156; Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799; Ning XH, 2011, NAT MATER, V10, P602, DOI [10.1038/NMAT3074, 10.1038/nmat3074]; Niska JA, 2012, ANTIMICROB AGENTS CH, V56, P2590, DOI 10.1128/AAC.06291-11; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Panizzi P, 2011, NAT MED, V17, P1142, DOI 10.1038/nm.2423; Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519; Reumann MK, 2010, TRENDS BIOTECHNOL, V28, P93, DOI 10.1016/j.tibtech.2009.11.004; Sjollema J, 2010, BIOMATERIALS, V31, P1984, DOI 10.1016/j.biomaterials.2009.11.068; Snoeks TJA, 2011, BONE, V48, P106, DOI 10.1016/j.bone.2010.07.027; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7	38	61	64	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47397	10.1371/journal.pone.0047397	http://dx.doi.org/10.1371/journal.pone.0047397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082163	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900059
J	Soukup, ST; Spanier, B; Grunz, G; Bunzel, D; Daniel, H; Kulling, SE				Soukup, Sebastian T.; Spanier, Britta; Gruenz, Gregor; Bunzel, Diana; Daniel, Hannelore; Kulling, Sabine E.			Formation of Phosphoglycosides in Caenorhabditis elegans: A Novel Biotransformation Pathway	PLOS ONE			English	Article							LIFE-SPAN; PHYTOESTROGENS GENISTEIN; DAIDZEIN; BIOAVAILABILITY; THERMOTOLERANCE; GLYCOSIDES; GENETICS; STRESS	Background: Caenorhabditis elegans (C. elegans) has become a widely used model to explore the effect of food constituents as well as on life-span extension. The results imply that besides essential nutrients several flavonoids are able to impact the aging process. What is less investigated is the bioavailability and biotransformation of these compounds in C. elegans. In the present study, we focused on the soy isoflavone genistein and its metabolism in the nematode as a basis for assessing whether this model system mimics the mammalian condition. Principal Findings: C. elegans was exposed to 100 mM genistein for 48 hours. The worm homogenate was extracted and analyzed by liquid chromatography (LC). 11 metabolites of genistein were detected and characterized using LC electrospray ionization mass spectrometry. All genistein metabolites formed by C. elegans were found to be sugar conjugates, primarily genistein-O-glucosides. The dominant metabolite was identified as genistein-7-O-phosphoglucoside. Further interesting metabolites include two genistein-di-O-glycosides, a genistein-O-disaccharide as well as a genistein-O-phosphodisaccharide. Conclusions/Significance: Our study provides evidence for a novel biotransformation pathway in C. elegans leading to conjugative metabolites which are not known for mammals. The metabolism of genistein in mammals and in C. elegans differs widely which may greatly impact the bioactivity. These differences need to be appropriately taken into consideration when C. elegans is used as a model to assess possible health or aging effects.	[Soukup, Sebastian T.; Bunzel, Diana; Kulling, Sabine E.] Max Rubner Inst, Dept Safety & Qual Fruit & Vegetables, Fed Res Inst Nutr & Food, Karlsruhe, Germany; [Spanier, Britta; Gruenz, Gregor; Daniel, Hannelore] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Dept Biochem, Freising Weihenstephan, Germany	Technical University of Munich	Kulling, SE (corresponding author), Max Rubner Inst, Dept Safety & Qual Fruit & Vegetables, Fed Res Inst Nutr & Food, Karlsruhe, Germany.	sabine.kulling@mri.bund.de	Daniel, Hannelore/B-8982-2009	Kulling, Sabine E./0000-0002-9956-2702	Max Rubner-Institute, Federal Research Institute of Nutrition and Food, Germany	Max Rubner-Institute, Federal Research Institute of Nutrition and Food, Germany	The work was supported by the Max Rubner-Institute, Federal Research Institute of Nutrition and Food, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, PLANTA MED, V75, P216, DOI 10.1055/s-0028-1088378; Ablajan K, 2011, J MASS SPECTROM, V46, P77, DOI 10.1002/jms.1867; BRENNER S, 1974, GENETICS, V77, P71; Brown MK, 2006, PHARMACOL BIOCHEM BE, V85, P620, DOI 10.1016/j.pbb.2006.10.017; Cuyckens F, 2004, J MASS SPECTROM, V39, P1, DOI [10.1002/jms.585, 10.1002/jms.622]; Fischer M, 2012, MOL NUTR FOOD RES, V56, P957, DOI 10.1002/mnfr.201200006; Gruber J, 2007, ANN NY ACAD SCI, V1100, P530, DOI 10.1196/annals.1395.059; Grunz G, 2012, MECH AGEING DEV, V133, P1, DOI 10.1016/j.mad.2011.11.005; Hosoda K, 2011, DRUG METAB DISPOS, V39, P1762, DOI 10.1124/dmd.111.038281; Hulme SE, 2011, ANGEW CHEM INT EDIT, V50, P4774, DOI 10.1002/anie.201005461; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Ko JH, 2006, FEMS MICROBIOL LETT, V258, P263, DOI 10.1111/j.1574-6968.2006.00226.x; Laing ST, 2010, BIOCHEM J, V432, P505, DOI 10.1042/BJ20101346; Mathew S, 2012, PROCESS BIOCHEM, V47, P528, DOI 10.1016/j.procbio.2011.11.012; Mortensen A, 2009, MOL NUTR FOOD RES, V53, pS266, DOI 10.1002/mnfr.200800478; Pugazhendhi D, 2008, J ENDOCRINOL, V197, P503, DOI 10.1677/JOE-07-0384; Shimoda K, 2010, NUTRIENTS, V2, P171, DOI 10.3390/nu2020171; Surco-Laos F, 2011, FOOD FUNCT, V2, P445, DOI 10.1039/c1fo10049a; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wong CK, 1997, BIOCHEM BIOPH RES CO, V233, P579, DOI 10.1006/bbrc.1997.6502; Wood W B, 1988, Dev Biol (N Y 1985), V5, P57; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x; Yuan B, 2012, J AGR FOOD CHEM, V60, P1428, DOI 10.1021/jf204421c; Zhang Y, 1999, J NUTR, V129, P399, DOI 10.1093/jn/129.2.399	24	4	4	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46914	10.1371/journal.pone.0046914	http://dx.doi.org/10.1371/journal.pone.0046914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082135	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900030
J	Valenzuela, R; Espinosa, A; Gonzalez-Manan, D; D'Espessailles, A; Fernandez, V; Videla, LA; Tapia, G				Valenzuela, Rodrigo; Espinosa, Alejandra; Gonzalez-Manan, Daniel; D'Espessailles, Amanda; Fernandez, Virginia; Videla, Luis A.; Tapia, Gladys			N-3 Long-Chain Polyunsaturated Fatty Acid Supplementation Significantly Reduces Liver Oxidative Stress in High Fat Induced Steatosis	PLOS ONE			English	Article							INSULIN-RESISTANCE; EICOSAPENTAENOIC ACID; DESATURASE ACTIVITY; METABOLIC SYNDROME; HEPATIC STEATOSIS; ADIPOSE-TISSUE; DISEASE; OMEGA-3-FATTY-ACIDS; RATIO; INFLAMMATION	Omega-3 (n-3) long-chain polyunsaturated fatty acids (n-3 LCPUFA) are associated with several physiological functions, suggesting that their administration may prevent non transmissible chronic diseases. Therefore, we investigate whether dietary n-3 LCPUFA supplementation triggers an antioxidant response preventing liver steatosis in mice fed a high fat diet (HFD) in relation to n-3 LCPUFA levels. Male C57BL/6J mice received (a) control diet (10% fat, 20% protein, 70% carbohydrate), (b) control diet plus n-3 LCPUFA (108 mg/kg/day eicosapentaenoic acid plus 92 mg/kg/day docosahexaenoic acid), (c) HFD (60% fat, 20% protein, 20% carbohydrate), or (d) HFD plus n-3 LCPUFA for 12 weeks. Parameters of liver steatosis, glutathione status, protein carbonylation, and fatty acid analysis were determined, concomitantly with insulin resistance and serum tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta, and IL-6 levels. HFD significantly increased total fat and triacylglyceride contents with macrovesicular steatosis, concomitantly with higher fasting serum glucose and insulin levels, HOMA, and serum TNF-alpha, IL-1 beta, and IL-6. Reduced and total liver glutathione contents were diminished by HFD, with higher GSSG/GSH ratio and protein carbonylation, n-3 LCPUFA depletion and elevated n-6/n-3 ratio over control values. These changes were either reduced or normalized to control values in animals subjected to HFD and n-3 LCPUFA, with significant increased hepatic total n-3 LCPUFA content and reduced n-6/n-3 ratio being observed after n-3 LCPUFA supplementation alone. So, repletion of liver n-3 LCPUFA levels by n-3 LCPUFA dietary supplementation in HFD obese mice reduces hepatic lipid content, with concomitant antioxidant and anti-inflammatory responses favouring insulin sensitivity.	[Gonzalez-Manan, Daniel; D'Espessailles, Amanda; Fernandez, Virginia; Videla, Luis A.; Tapia, Gladys] Univ Chile, Fac Med, Mol & Clin Pharmacol Program, Inst Biomed Sci, Santiago 7, Chile; [Valenzuela, Rodrigo] Univ Chile, Fac Med, Sch Nutr & Dietet, Santiago 7, Chile; [Espinosa, Alejandra] Univ Chile, Fac Med, Sch Med Technol, Santiago 7, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Tapia, G (corresponding author), Univ Chile, Fac Med, Mol & Clin Pharmacol Program, Inst Biomed Sci, Santiago 7, Chile.	gtapia@med.uchile.cl			FONDECYT (National Fund for Scientific and Technological Development) [1110043]	FONDECYT (National Fund for Scientific and Technological Development)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by grant 1110043 from FONDECYT (National Fund for Scientific and Technological Development) to G. T., Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Allard JP, 2008, J HEPATOL, V48, P300, DOI 10.1016/j.jhep.2007.09.009; Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Araya J, 2010, OBESITY, V18, P1460, DOI 10.1038/oby.2009.379; Aronis A, 2005, FREE RADICAL BIO MED, V38, P1221, DOI 10.1016/j.freeradbiomed.2005.01.015; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brenner RR, 2003, PROSTAG LEUKOTR ESS, V68, P151, DOI 10.1016/S0952-3278(02)00265-X; Capanni M, 2006, ALIMENT PHARM THER, V23, P1143, DOI 10.1111/j.1365-2036.2006.02885.x; Delarue J, 2004, REPROD NUTR DEV, V44, P289, DOI 10.1051/rnd:2004033; DELEVE LD, 1991, PHARMACOL THERAPEUT, V52, P287, DOI 10.1016/0163-7258(91)90029-L; DEMOZ A, 1992, LIPIDS, V27, P968, DOI 10.1007/BF02535573; Elizondo A, 2008, BIOL RES, V41, P59, DOI [10.4067/S0716-97602008000100008, /S0716-97602008000100008]; Fabbrini E, 2008, GASTROENTEROLOGY, V134, P424, DOI 10.1053/j.gastro.2007.11.038; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Hatzitolios Apostolos, 2004, Indian J Gastroenterol, V23, P131; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MORRISON WR, 1964, J LIPID RES, V5, P600; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; Pettinelli P, 2009, BBA-MOL BASIS DIS, V1792, P1080, DOI 10.1016/j.bbadis.2009.08.015; Piro S, 2008, NUTR METAB CARDIOVAS, V18, P545, DOI 10.1016/j.numecd.2007.08.002; Poudyal H, 2011, PROG LIPID RES, V50, P372, DOI 10.1016/j.plipres.2011.06.003; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shapiro H, 2011, CLIN NUTR, V30, P6, DOI 10.1016/j.clnu.2010.06.001; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Spadaro L, 2008, DIGEST LIVER DIS, V40, P194, DOI 10.1016/j.dld.2007.10.003; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Tanaka N, 2008, J CLIN GASTROENTEROL, V42, P413, DOI 10.1097/MCG.0b013e31815591aa; Videla LA, 2006, TRENDS MOL MED, V12, P555, DOI 10.1016/j.molmed.2006.10.001; Warensjo E, 2008, AM J CLIN NUTR, V88, P203, DOI 10.1093/ajcn/88.1.203; Zhou YE, 2009, BRIT J NUTR, V102, P888, DOI 10.1017/S0007114509301609; Zhu FS, 2008, WORLD J GASTROENTERO, V14, P6395, DOI 10.3748/wjg.14.6395; Zuniga J, 2010, FREE RADICAL RES, V44, P854, DOI 10.3109/10715762.2010.485995	44	90	90	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46400	10.1371/journal.pone.0046400	http://dx.doi.org/10.1371/journal.pone.0046400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082120	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900015
J	Seto, J; Busse, B; Gupta, HS; Schafer, C; Krauss, S; Dunlop, JWC; Masic, A; Kerschnitzki, M; Zaslansky, P; Boesecke, P; Catala-Lehnen, P; Schinke, T; Fratzl, P; Jahnen-Dechent, W				Seto, Jong; Busse, Bjoern; Gupta, Himadri S.; Schaefer, Cora; Krauss, Stefanie; Dunlop, John W. C.; Masic, Admir; Kerschnitzki, Michael; Zaslansky, Paul; Boesecke, Peter; Catala-Lehnen, Philip; Schinke, Thorsten; Fratzl, Peter; Jahnen-Dechent, Willi			Accelerated Growth Plate Mineralization and Foreshortened Proximal Limb Bones in Fetuin-A Knockout Mice	PLOS ONE			English	Article							ANGLE X-RAY; CALCIUM-PHOSPHATE; CALCIPROTEIN PARTICLES; ALPHA-2HS GLYCOPROTEIN; APATITE FORMATION; SERUM; CALCIFICATION; INHIBITION; COMPLEX; NANOBACTERIA	The plasma protein fetuin-A/alpha2-HS-glycoprotein (genetic symbol Ahsg) is a systemic inhibitor of extraskeletal mineralization, which is best underscored by the excessive mineral deposition found in various tissues of fetuin-A deficient mice on the calcification-prone genetic background DBA/2. Fetuin-A is known to accumulate in the bone matrix thus an effect of fetuin-A on skeletal mineralization is expected. We examined the bones of fetuin-A deficient mice maintained on a C57BL/6 genetic background to avoid bone disease secondary to renal calcification. Here, we show that fetuin-A deficient mice display normal trabecular bone mass in the spine, but increased cortical thickness in the femur. Bone material properties, as well as mineral and collagen characteristics of cortical bone were unaffected by the absence of fetuin-A. In contrast, the long bones especially proximal limb bones were severely stunted in fetuin-A deficient mice compared to wildtype littermates, resulting in increased biomechanical stability of fetuin-A deficient femora in three-point-bending tests. Elevated backscattered electron signal intensities reflected an increased mineral content in the growth plates of fetuin-A deficient long bones, corroborating its physiological role as an inhibitor of excessive mineralization in the growth plate cartilage matrix - a site of vigorous physiological mineralization. We show that in the case of fetuin-A deficiency, active mineralization inhibition is a necessity for proper long bone growth.	[Schaefer, Cora; Jahnen-Dechent, Willi] Rhein Westfal TH Aachen, Biointerface Lab, Helmholtz Inst Biomed Engn, Aachen, Germany; [Seto, Jong; Gupta, Himadri S.; Krauss, Stefanie; Dunlop, John W. C.; Masic, Admir; Kerschnitzki, Michael; Zaslansky, Paul; Fratzl, Peter] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Busse, Bjoern; Catala-Lehnen, Philip; Schinke, Thorsten] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany; [Boesecke, Peter] European Synchrotron Radiat Facil, Beamline ID2, F-38043 Grenoble, France	Helmholtz Association; RWTH Aachen University; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; European Synchrotron Radiation Facility (ESRF)	Jahnen-Dechent, W (corresponding author), Rhein Westfal TH Aachen, Biointerface Lab, Helmholtz Inst Biomed Engn, Aachen, Germany.	willi.jahnen@rwth-aachen.de	Gupta, Himadri S/J-2129-2012; Busse, Björn/AAC-4033-2020; Dunlop, John W C/A-1997-2012; Fratzl, Peter/H-9095-2012; zaslansky, paul/AAB-7322-2021; Busse, Björn/O-8462-2016; Jahnen-Dechent, Willi/A-7608-2011	Busse, Björn/0000-0002-3099-8073; Dunlop, John W C/0000-0003-2741-6383; Fratzl, Peter/0000-0003-4437-7830; zaslansky, paul/0000-0002-8714-4992; Busse, Björn/0000-0002-3099-8073; Gupta, Himadri Shikhar/0000-0003-2201-8933; Catala-Lehnen, Philip/0000-0001-5475-6741; Masic, Admir/0000-0002-1207-4926; Jahnen-Dechent, Willi/0000-0003-1315-4407	Max Planck Society; Deutsche Forschungsgemeinschaft [JA 562/10]; Helmholtz Zentrum Berlin fur Materialien und Energie-BESSY II; EU Marie Curie EST Fellowship on Biomimetic Systems [MEST-CT-2004-504465]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Zentrum Berlin fur Materialien und Energie-BESSY II; EU Marie Curie EST Fellowship on Biomimetic Systems	Funding for this work is made possible through the Max Planck Society, Deutsche Forschungsgemeinschaft (JA 562/10), and the Helmholtz Zentrum Berlin fur Materialien und Energie-BESSY II. JS was supported by EU Marie Curie EST Fellowship on Biomimetic Systems, MEST-CT-2004-504465. Support from the European Synchrotron Radiation Facility (ESRF) through the allocation of synchrotron beamtime for experiment SC-2301 at beamline ID2 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON BA, 1976, CALC TISS RES, V22, P27; Binkert C, 1999, J BIOL CHEM, V274, P28514, DOI 10.1074/jbc.274.40.28514; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; DICKSON IR, 1975, NATURE, V256, P430, DOI 10.1038/256430a0; Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103; Hamano T, 2010, J AM SOC NEPHROL, V21, P1998, DOI 10.1681/ASN.2009090944; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Heiss A, 2010, BIOPHYS J, V99, P3986, DOI 10.1016/j.bpj.2010.10.030; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; ISHIKAWA Y, 1991, J CELL PHYSIOL, V149, P222, DOI 10.1002/jcp.1041490208; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; JahnenDechent W, 1997, J BIOL CHEM, V272, P31496, DOI 10.1074/jbc.272.50.31496; Jiang Q, 2010, J INVESTIGATIVE DERM; Kazanci M, 2006, J STRUCT BIOL, V156, P489, DOI 10.1016/j.jsb.2006.06.011; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee C, 2009, FRONT BIOSCI-LANDMRK, V14, P2911, DOI 10.2741/3422; Lehmann W, 2004, BONE, V35, P1247, DOI 10.1016/j.bone.2004.08.017; Loohuis KMO, 2010, KIDNEY INT, V77, P77, DOI 10.1038/ki.2009.407; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; MCKEE MD, 1993, J BONE MINER RES, V8, P485; Megens M, 1997, LANGMUIR, V13, P6120, DOI 10.1021/la970422v; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Parfitt AM, 2002, BONE, V30, P337, DOI 10.1016/S8756-3282(01)00668-8; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pasch A, 2012, J AM SOC NEPHROL, P1; Pedersen KO, 1944, NATURE, V154, P575, DOI 10.1038/154575a0; Price P, 2009, J BIOL CHEM; Price PA, 2003, J BIOL CHEM, V278, P22153, DOI 10.1074/jbc.M300739200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Rasband W, IMAGEJ; Reynolds JL, 2005, J AM SOC NEPHROL, V16, P2920, DOI 10.1681/ASN.2004100895; Rochette CN, 2009, CHEMBIOCHEM, V10, P735, DOI 10.1002/cbic.200800719; Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021; Rothenberg AB, 2007, PEDIATR RADIOL, V37, P1264, DOI 10.1007/s00247-007-0604-0; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schmidt K, 2005, J CELL BIOL, V168, P899, DOI 10.1083/jcb.200408013; Seitz S, 2010, OSTEOPOROSIS INT, V21, P119, DOI 10.1007/s00198-009-0933-y; Smith ER, 2012, NEPHROL DIAL TRANSPL, V27, P1957, DOI 10.1093/ndt/gfr609; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; TERMINE JD, 1988, CIBA FDN S, V136, P178; Toroian D, 2008, CALCIFIED TISSUE INT, V82, P116, DOI 10.1007/s00223-007-9085-2; TRIFFITT JT, 1976, NATURE, V262, P226, DOI 10.1038/262226a0; Wald J, 2011, SOFT MATTER, V7, P2869, DOI 10.1039/c0sm01191f; Westenfeld R, 2009, J AM SOC NEPHROL; Westenfeld R, 2007, NEPHROL DIAL TRANSPL, V22, P1537, DOI 10.1093/ndt/gfm094; Woodard JC, 1997, BONE, V21, P171, DOI 10.1016/S8756-3282(97)00099-9; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008058; Young J, 2009, BRIT J CRIMINOL, V49, P4, DOI 10.1093/bjc/azn074	56	41	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47338	10.1371/journal.pone.0047338	http://dx.doi.org/10.1371/journal.pone.0047338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091616	gold, Green Published, Green Submitted			2022-12-27	WOS:000310135800039
J	Wheeler, APS; Morad, S; Buchholz, N; Knight, MM				Wheeler, Andrew P. S.; Morad, Samir; Buchholz, Noor; Knight, Martin M.			The Shape of the Urine Stream - From Biophysics to Diagnostics	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; HOME UROFLOWMETRY; TRACT SYMPTOMS; FLOW; URETHROTOMY; DILATION; THERAPY; DEVICE; DROP; MEN	We develop a new computational model of capillary-waves in free-jet flows, and apply this to the problem of urological diagnosis in this first ever study of the biophysics behind the characteristic shape of the urine stream as it exits the urethral meatus. The computational fluid dynamics model is used to determine the shape of a liquid jet issuing from a non-axisymmetric orifice as it deforms under the action of surface tension. The computational results are verified with experimental modelling of the urine stream. We find that the shape of the stream can be used as an indicator of both the flow rate and orifice geometry. We performed volunteer trials which showed these fundamental correlations are also observed in vivo for male healthy volunteers and patients undergoing treatment for low flow rate. For healthy volunteers, self estimation of the flow shape provided an accurate estimation of peak flow rate (+/- 2%). However for the patients, the relationship between shape and flow rate suggested poor meatal opening during voiding. The results show that self measurement of the shape of the urine stream can be a useful diagnostic tool for medical practitioners since it provides a non-invasive method of measuring urine flow rate and urethral dilation.	[Wheeler, Andrew P. S.] Univ Southampton, Southampton, Hants, England; [Morad, Samir; Knight, Martin M.] Queen Mary Univ London, Sch Engn & Mat Sci, London, England; [Buchholz, Noor] Newham Univ Hosp, Dept Urol, London, England	University of Southampton; University of London; Queen Mary University London	Wheeler, APS (corresponding author), Univ Southampton, Southampton, Hants, England.	a.wheeler@soton.ac.uk	Wheeler, Andrew/B-4485-2013	Wheeler, Andrew/0000-0001-5526-5266; Knight, Martin/0000-0003-3755-1597				Addla SK, 2010, NEUROUROL URODYNAM, V29, P1301, DOI 10.1002/nau.20846; Boci R, 1999, NEUROUROL URODYNAM, V18, P25, DOI 10.1002/(SICI)1520-6777(1999)18:1<25::AID-NAU5>3.0.CO;2-O; Caffarel J, 2006, NEUROUROL URODYNAM, V25, P632; Caffarel J, 2007, NEUROUROL URODYNAM, V26, P474, DOI 10.1002/nau.20383; Currie RJ, 1998, UROLOGY, V52, P1118, DOI 10.1016/S0090-4295(98)00404-X; delaRosette JJMCH, 1996, BRIT J UROL, V78, P385, DOI 10.1046/j.1464-410X.1996.00115.x; Dietz HP, 2007, INT UROGYNECOL J, V18, P665, DOI 10.1007/s00192-007-0376-y; EGGERS J, 1994, J FLUID MECH, V262, P205, DOI 10.1017/S0022112094000480; Eggers J, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/3/036601; GOLOMB J, 1992, J UROLOGY, V147, P1044, DOI 10.1016/S0022-5347(17)37462-1; Greenwell TJ, 2004, J UROLOGY, V172, P275, DOI 10.1097/01.ju.0000132156.76403.8f; Jonas U, 1996, J UROLOGY, V156, P1040, DOI 10.1016/S0022-5347(01)65695-7; Lin SP, 1998, ANNU REV FLUID MECH, V30, P85, DOI 10.1146/annurev.fluid.30.1.85; Madersbacher S, 2004, EUR UROL, V46, P547, DOI 10.1016/j.eururo.2004.07.016; Neal DE, 1997, LANCET, V350, P305, DOI 10.1016/S0140-6736(05)63382-X; Nitti Victor W, 2005, Rev Urol, V7 Suppl 6, pS14; PAPAGEORGIOU DT, 1995, PHYS FLUIDS, V7, P1529, DOI 10.1063/1.868540; Pel JJM, 2002, NEUROUROL URODYNAM, V21, P48, DOI 10.1002/nau.2112; Rayleigh L, 1878, P LONDON MATH SOC S, P3; Reynard JM, 1996, BRIT J UROL, V77, P813, DOI 10.1046/j.1464-410X.1996.00097.x; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Steenkamp JW, 1997, J UROLOGY, V157, P98, DOI 10.1016/S0022-5347(01)65296-0; WASSON JH, 1995, NEW ENGL J MED, V332, P75, DOI 10.1056/NEJM199501123320202; Wiygul J, 2009, CURR OPIN UROL, V19, P3, DOI 10.1097/MOU.0b013e32831a6ec6	24	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47133	10.1371/journal.pone.0047133	http://dx.doi.org/10.1371/journal.pone.0047133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091609	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800026
J	Dewailly, E; Rouja, P; Forde, M; Peek-Ball, C; Cote, S; Smith, E; Drescher, O; Robertson, L				Dewailly, Eric; Rouja, Philippe; Forde, Martin; Peek-Ball, Cheryl; Cote, Suzanne; Smith, Emma; Drescher, Olivia; Robertson, Lyndon			Evaluation of a Public Health Intervention to Lower Mercury Exposure from Fish Consumption in Bermuda	PLOS ONE			English	Article							CORD BLOOD	Objectives: To assess the efficacy of a public health intervention to reduce blood mercury (Hg) concentration levels in pregnant Bermudian women. Methods: In 2003, we conducted a study entitled "Prenatal exposure of the Bermudian Population to Environmental Contaminants" which provided Bermuda's first baseline data on prenatal exposure to several environmental contaminants, including Hg. The mean Hg concentration from 42 healthy newborns measured in umbilical cord blood was 41.3 nmol/L, ranging from 5-160 nmol/L. This concentration was much higher than expected, being approximately 8 times the general levels found in Canada and the U. S. Furthermore, we estimated that 85% of total Hg measured was in the form of methylmercury (MeHg), indicating that seafood consumption was the primary source of Hg exposure during pregnancy in Bermuda. Locally sourced seafood was identified as the most significant possible contributory source of Hg exposure. In 2005 the authors began a complementary research programme to study the levels of Hg in local commercial fish species. Coming out of this research were specific local fish consumption guidelines issued by the Department of Health advising pregnant women to avoid those local fish species found to be high in Hg while still encouraging consumption of fish species having lower Hg levels. Results: In 2010, under another research initiative, we returned to Bermuda to carry out another evaluation of Hg in human blood. Hg was measured in the blood of 49 pregnant women. The arithmetic mean Hg blood concentration was 6.6 nmol/L and the geometric mean 4.2 nmol/L. The maximum concentration found was 24 nmol/L. Conclusions: Hg exposure of Bermudian pregnant women has dropped significantly by a factor of around 5 since the foetal cord blood study in 2003.	[Dewailly, Eric; Cote, Suzanne; Drescher, Olivia] CHUQ, Dept Populat Hlth & Environm, Res Ctr, Quebec City, PQ, Canada; [Rouja, Philippe] Govt Bermuda, Dept Conservat Serv, Flatts, Bermuda; [Forde, Martin] St Georges Univ, Sch Med, Dept Publ Hlth & Prevent Med, St Georges, Grenada; [Peek-Ball, Cheryl] Govt Bermuda, Dept Hlth, Hamilton, Bermuda; [Smith, Emma] Univ W Indies, Dept Biol & Chem Sci, Cave Hill, Barbados; [Robertson, Lyndon] St Georges Univ, Windward Isl Res & Educ Fdn WINDREF, St Georges, Grenada	Laval University; University West Indies Mona Jamaica; University West Indies Cave Hill Campus	Dewailly, E (corresponding author), CHUQ, Dept Populat Hlth & Environm, Res Ctr, Quebec City, PQ, Canada.	eric.dewailly@crchul.ulaval.ca	Forde, Martin S/E-9565-2014	Forde, Martin/0000-0002-7643-2745	XL foundation of Bermuda; Lepercq foundation; International Development Research Centre's Global Health Research Initiative's Teasdale Corti program	XL foundation of Bermuda; Lepercq foundation; International Development Research Centre's Global Health Research Initiative's Teasdale Corti program	Phase I was supported by research grants from the XL foundation of Bermuda and the Lepercq foundation. Phase II was supported by research grants from the International Development Research Centre's Global Health Research Initiative's Teasdale Corti program and the Lepercq Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAP, 2011, MERC ARCT; Boucher O, 2012, ENVIRON HEALTH PERSP, V120, P1456, DOI 10.1289/ehp.1204976; CDC, 2010, 4 NAT REP HUM EXP EN; Dewailly E, 2008, FOOD ADDIT CONTAM A, V25, P1328, DOI 10.1080/02652030802175285; Dewailly E., 2008, OCEANS HUMAN HLTH RI, P181; Goyer R., 2000, TOXICOLOGICAL EFFECT; Health Canada, 2010, REP HUM BIOM ENV CHE; Larque E, 2012, BRIT J NUTR, V107, pS77, DOI 10.1017/S0007114512001481; Legrand M, 2010, REV CANADIENNE SANTE, V101, P28; Rhainds M, 1999, ARCH ENVIRON HEALTH, V54, P40, DOI 10.1080/00039899909602235; Stern AH, 2003, ENVIRON HEALTH PERSP, V111, P1465, DOI 10.1289/ehp.6187; WHO, 2003, WHO TECHN SER	12	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47388	10.1371/journal.pone.0047388	http://dx.doi.org/10.1371/journal.pone.0047388			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077607	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100105
J	Rosenfield, SM; Bowden, ET; Cohen-Missner, S; Gibby, KA; Ory, V; Henke, RT; Riegel, AT; Wellstein, A				Rosenfield, Sonia M.; Bowden, Emma T.; Cohen-Missner, Shani; Gibby, Krissa A.; Ory, Virginie; Henke, Ralf T.; Riegel, Anna T.; Wellstein, Anton			Pleiotrophin (PTN) Expression and Function and in the Mouse Mammary Gland and Mammary Epithelial Cells	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; GROWTH-FACTOR PLEIOTROPHIN; RECEPTOR TYROSINE KINASE; HUMAN BREAST-CANCER; 3-DIMENSIONAL CULTURE MODELS; ACTIVATED PROTEIN-KINASE; HEMATOPOIETIC STEM-CELLS; MOLECULE HB-GAM; MESSENGER-RNA; BRANCHING MORPHOGENESIS	Expression of the heparin-binding growth factor, pleiotrophin (PTN) in the mammary gland has been reported but its function during mammary gland development is not known. We examined the expression of PTN and its receptor ALK (Anaplastic Lymphoma Kinase) at various stages of mouse mammary gland development and found that their expression in epithelial cells is regulated in parallel during pregnancy. A 30-fold downregulation of PTN mRNA expression was observed during mid-pregnancy when the mammary gland undergoes lobular-alveolar differentiation. After weaning of pups, PTN expression was restored although baseline expression of PTN was reduced significantly in mammary glands of mice that had undergone multiple pregnancies. We found PTN expressed in epithelial cells of the mammary gland and thus used a monoclonal anti-PTN blocking antibody to elucidate its function in cultured mammary epithelial cells (MECs) as well as during gland development. Real-time impedance monitoring of MECs growth, migration and invasion during anti-PTN blocking antibody treatment showed that MECs motility and invasion but not proliferation depend on the activity of endogenous PTN. Increased number of mammospheres with laminin deposition after anti-PTN blocking antibody treatment of MECs in 3D culture and expression of progenitor markers suggest that the endogenously expressed PTN inhibits the expansion and differentiation of epithelial progenitor cells by disrupting cell-matrix adhesion. In vivo, PTN activity was found to inhibit ductal outgrowth and branching via the inhibition of phospho ERK1/2 signaling in the mammary epithelial cells. We conclude that PTN delays the maturation of the mammary gland by maintaining mammary epithelial cells in a progenitor phenotype and by inhibiting their differentiation during mammary gland development.	[Rosenfield, Sonia M.; Cohen-Missner, Shani; Gibby, Krissa A.; Ory, Virginie; Henke, Ralf T.; Riegel, Anna T.; Wellstein, Anton] Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20057 USA; [Bowden, Emma T.] MedImmune, Gaithersburg, MD USA	Georgetown University; AstraZeneca; Medimmune	Wellstein, A (corresponding author), Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20057 USA.	wellstea@georgetown.edu		Wellstein, Anton/0000-0002-0570-4950	NCI/NIH [RO1 CA101811]; Pharmaceutical Manufacturers Association; Department of Defense Breast Cancer Research Program [BC083308]; NATIONAL CANCER INSTITUTE [R01CA101811, T32CA009686, P50CA058185] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pharmaceutical Manufacturers Association; Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants awarded to AW from the NCI/NIH (RO1 CA101811); to Shani Cohen-Missner from the Pharmaceutical Manufacturers Association (Fellowship); to Sonia M. Rosenfield from the Department of Defense Breast Cancer Research Program (Predoctoral Grant: BC083308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amet LEA, 2001, MOL CELL NEUROSCI, V17, P1014, DOI 10.1006/mcne.2001.0998; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Bachelard-Cascales E, 2010, STEM CELLS, V28, P1081, DOI 10.1002/stem.435; Ball SM, 1998, ANAT REC, V250, P459, DOI 10.1002/(SICI)1097-0185(199804)250:4<459::AID-AR9>3.0.CO;2-S; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; CAPETANAKI Y, 1990, ONCOGENE, V5, P645; Chang YC, 2007, P NATL ACAD SCI USA, V104, P10888, DOI 10.1073/pnas.0704366104; CHAUHAN AK, 1993, P NATL ACAD SCI USA, V90, P679, DOI 10.1073/pnas.90.2.679; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; CZUBAYKO F, 1994, J BIOL CHEM, V269, P21358; Czubayko F, 1997, GENE THER, V4, P943, DOI 10.1038/sj.gt.3300483; CZUBAYKO F, 1995, BREAST CANCER RES TR, V36, P157, DOI 10.1007/BF00666037; Czubayko F, 1996, P NATL ACAD SCI USA, V93, P14753, DOI 10.1073/pnas.93.25.14753; D'Cruz CM, 2002, MOL ENDOCRINOL, V16, P2034, DOI 10.1210/me.2002-0073; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; FANG WJ, 1992, J BIOL CHEM, V267, P25889; GARLAND HO, 1987, J ENDOCRINOL, V113, P435, DOI 10.1677/joe.0.1130435; Henke RT, 2006, METHODS, V38, P253, DOI 10.1016/j.ymeth.2005.11.013; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hienola A, 2004, MOL CELL NEUROSCI, V26, P75, DOI 10.1016/j.mcn.2004.01.018; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Imai S, 1998, J CELL BIOL, V143, P1113, DOI 10.1083/jcb.143.4.1113; Istvanffy R, 2011, BLOOD, V118, P2712, DOI 10.1182/blood-2010-05-287235; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Jung CG, 2004, FASEB J, V18, P1237, DOI 10.1096/fj.03-0927fje; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Kuo AH, 2007, ONCOGENE, V26, P859, DOI 10.1038/sj.onc.1209840; LaRocca J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024432; Ledoux D, 1997, J HISTOCHEM CYTOCHEM, V45, P1239, DOI 10.1177/002215549704500907; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li G, 2005, CALCIFIED TISSUE INT, V76, P299, DOI 10.1007/s00223-004-0145-6; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; MACMAHON B, 1970, B WORLD HEALTH ORGAN, V43, P209; Marzan CV, 2011, DEV BIOL, V349, P125, DOI 10.1016/j.ydbio.2010.10.018; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; MILNER PG, 1992, BIOCHEMISTRY-US, V31, P12023, DOI 10.1021/bi00163a009; MITSIADIS TA, 1995, DEVELOPMENT, V121, P37; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mou L, INVEST OPHTHALMOL VI, V51, P396; O'Brien J, 2010, J MAMMARY GLAND BIOL, V15, P353, DOI 10.1007/s10911-010-9185-x; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Orr B, 2011, PROSTATE, V71, P305, DOI 10.1002/pros.21244; Pavlov I, 2002, MOL CELL NEUROSCI, V20, P330, DOI 10.1006/mcne.2002.1104; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Perez-Pinera P, 2007, BIOCHEM BIOPH RES CO, V362, P5, DOI 10.1016/j.bbrc.2007.06.050; Perez-Pinera P, 2007, BIOCHEM BIOPH RES CO, V358, P399, DOI 10.1016/j.bbrc.2007.04.137; Petersen W, 2004, ARCH ORTHOP TRAUM SU, V124, P603, DOI 10.1007/s00402-003-0582-0; Pufe T, 2003, OSTEOARTHR CARTILAGE, V11, P260, DOI 10.1016/S1063-4584(02)00385-0; Pufe T, 2003, ARTHRITIS RHEUM, V48, P660, DOI 10.1002/art.10839; RIEGEL AT, 1994, BREAST CANCER RES TR, V31, P309; ROSNER B, 1994, AM J EPIDEMIOL, V139, P819, DOI 10.1093/oxfordjournals.aje.a117079; RUSSO IH, 1978, J NATL CANCER I, V61, P1439; Russo J, 1982, Breast Cancer Res Treat, V2, P5, DOI 10.1007/BF01805718; Sakural H, 2001, DEVELOPMENT, V128, P3283; Schulte AM, 1997, TUMOUR ANGIOGENESIS, P273; Schulte AM, 1996, P NATL ACAD SCI USA, V93, P14759, DOI 10.1073/pnas.93.25.14759; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SINGER PA, 1986, J BIOL CHEM, V261, P538; Souttou B, 1997, J BIOL CHEM, V272, P19588, DOI 10.1074/jbc.272.31.19588; Stingl J, 2006, NATURE, P1; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Stylianou DC, 2009, ONCOGENE, V28, P3296, DOI 10.1038/onc.2009.184; Szabat E, 1996, DEV BIOL, V178, P77, DOI 10.1006/dbio.1996.0199; Tassi E, 2011, AM J PATHOL, V179, P2220, DOI 10.1016/j.ajpath.2011.07.043; THORDARSON G, 1995, CARCINOGENESIS, V16, P2847, DOI 10.1093/carcin/16.11.2847; Tiede BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008035; Tilli MT, 2005, MOL ENDOCRINOL, V19, P644, DOI 10.1210/me.2004-0106; Tso JY, 2011, US Patent, P1, Patent No. 7888485; VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387; Visvader JE, 2006, CANCER RES, V66, P9798, DOI 10.1158/0008-5472.CAN-06-2254; Weber D, 2000, CANCER RES, V60, P5284; WELLSTEIN A, 1992, J BIOL CHEM, V267, P2582; WELLSTEIN A, 2010, SCI WEBINAR SERIES A; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Weng TT, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-80; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Yanagisawa H, 2010, NEUROSCI RES, V66, P111, DOI 10.1016/j.neures.2009.10.002; Yang JH, 1999, CARCINOGENESIS, V20, P623, DOI 10.1093/carcin/20.4.623; Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47; Zhang N, 1997, J BIOL CHEM, V272, P16733, DOI 10.1074/jbc.272.27.16733	87	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47876	10.1371/journal.pone.0047876	http://dx.doi.org/10.1371/journal.pone.0047876			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077670	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100162
J	Ylilauri, M; Pentikainen, OT				Ylilauri, Mikko; Pentikainen, Olli T.			Structural Mechanism of N-Methyl-D-Aspartate Receptor Type 1 Partial Agonism	PLOS ONE			English	Article							LIGAND-BINDING CORE; SITE PARTIAL AGONIST; NMDA RECEPTORS; MOLECULAR-DYNAMICS; GLUTAMATE-RECEPTOR; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURES; SYNAPTIC PLASTICITY; SUBUNIT; DOMAIN	N-methyl-D-aspartate (NMDA) receptors belong to a family of ionotropic glutamate receptors that contribute to the signal transmission in the central nervous system. NMDA receptors are heterotetramers that usually consist of two GluN1 and GluN2 monomers. The extracellular ligand-binding domain (LBD) of a monomer is comprised of discontinuous segments that form the functional domains D1 and D2. While the binding of a full agonist glycine to LBD of GluN1 is linked to cleft closure and subsequent ion-channel opening, partial agonists are known to activate the receptor only sub-maximally. Although the crystal structures of the LBD of related GluA2 receptor explain the mechanism for the partial agonism, structures of GluN1-LBD cannot distinguish the difference between full and partial agonists. It is, however, probable that the partial agonists of GluN1 alter the structure of the LBD in order to result in a different pharmacological response than seen with full agonists. In this study, we used molecular dynamics simulations to reveal an intermediate closure-stage for GluN1, which is unseen in crystal structures. According to our calculations, this intermediate closure is not a transient stage but an energetically stable conformation. Our results demonstrate that the partial agonist cannot exert firm GluN1-LBD closure, especially if there is even a small force that disrupts the LBD closure. Accordingly, this result suggests the importance of forces from the ion channel for the relationship between pharmacological response and the structure of the LBD of members of this receptor family.	[Pentikainen, Olli T.] Univ Jyvaskyla, Computat Biosci Lab, Dept Biol & Environm Sci, Jyvaskyla, Finland; Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland	University of Jyvaskyla; University of Jyvaskyla	Pentikainen, OT (corresponding author), Univ Jyvaskyla, Computat Biosci Lab, Dept Biol & Environm Sci, Jyvaskyla, Finland.	olli.t.pentikainen@jyu.fi	Pentikäinen, Olli T/E-1980-2012	Pentikäinen, Olli T/0000-0001-7188-4016	National Doctoral Programme in Informational and Structural Biology	National Doctoral Programme in Informational and Structural Biology	This study was funded by the National Doctoral Programme in Informational and Structural Biology (M.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen PE, 2008, J PHYSIOL-LONDON, V586, P227, DOI 10.1113/jphysiol.2007.143172; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dravid SM, 2010, J NEUROSCI, V30, P2741, DOI 10.1523/JNEUROSCI.5390-09.2010; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frydenvang K, 2009, J BIOL CHEM, V284, P14219, DOI 10.1074/jbc.M808547200; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kaye SL, 2006, J BIOL CHEM, V281, P12736, DOI 10.1074/jbc.M512728200; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kussius CL, 2009, NAT NEUROSCI, V12, P1114, DOI 10.1038/nn.2361; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Lash-Van Wyhe LL, 2010, NEUROPHARMACOLOGY, V58, P640, DOI 10.1016/j.neuropharm.2009.11.013; Lau AY, 2007, STRUCTURE, V15, P1203, DOI 10.1016/j.str.2007.07.015; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lisman JE, 2001, CURR BIOL, V11, pR788, DOI 10.1016/S0960-9822(01)00472-9; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moretti L, 2004, J STRUCT BIOL, V145, P205, DOI 10.1016/j.jsb.2003.10.016; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Moskal JR, 2011, NEUROSCI BIOBEHAV R, V35, P1982, DOI 10.1016/j.neubiorev.2011.06.006; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Pentikainen U, 2006, ORG BIOMOL CHEM, V4, P1058, DOI 10.1039/b515111b; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Postila PA, 2011, J CHEM INF MODEL, V51, P1037, DOI 10.1021/ci2000055; Postila PA, 2010, NEUROPHARMACOLOGY, V58, P515, DOI 10.1016/j.neuropharm.2009.08.019; Priestley T, 1998, BRIT J PHARMACOL, V124, P1767, DOI 10.1038/sj.bjp.0702010; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schlick T, 1999, J COMPUT PHYS, V151, P9, DOI 10.1006/jcph.1999.6182; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Talukder I, 2011, J GEN PHYSIOL, V138, P179, DOI 10.1085/jgp.201110623; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Urwyler S, 2009, J MED CHEM, V52, P5093, DOI 10.1021/jm900363q; Vijayan R, 2010, PHYS CHEM CHEM PHYS, V12, P14057, DOI 10.1039/c004336b; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Wood PL, 2008, NEUROREPORT, V19, P1059, DOI 10.1097/WNR.0b013e32830435c9	53	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47604	10.1371/journal.pone.0047604	http://dx.doi.org/10.1371/journal.pone.0047604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077649	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100144
J	Botia, B; Legastelois, R; Alaux-Cantin, S; Naassila, M				Botia, Beatrice; Legastelois, Remi; Alaux-Cantin, Stephanie; Naassila, Mickael			Expression of Ethanol-Induced Behavioral Sensitization Is Associated with Alteration of Chromatin Remodeling in Mice	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; COCAINE; DOPAMINE; AMPHETAMINE; RECEPTORS; RESPONSES; BINDING; INDUCTION; AMYGDALA; RELAPSE	Background: Ethanol-induced behavioral sensitization (EIBS) is proposed to play a role in early and recurring steps of addiction. EIBS does not occur uniformly in all animals even from the same inbred strain. Since recent data demonstrate that epigenetic mechanisms are likely to be involved in the development and the persistence of ethanol-related behaviors, we explored the involvement of epigenetic mechanisms in ethanol response after EIBS development. Methodology: DBA/2J mice were i.p. injected with saline or ethanol (2 g/kg) once a day for 10 consecutive days. At day 17, ethanol-treated mice were split in resistant and sensitized groups. Brains were then removed 30 min after a saline or 2 g/kg ethanol challenge to assess i) gene expression using PCR array targeting 84 epigenetic-related genes and ii) histone deacetylases (HDAC), histone acetylases (HAT) and DNA methyltransferases (DNMT) activities as well as H4K12 acetylation. Principal Findings: Acute ethanol administration decreased dnmt1, esco2 and rps6ka5 genes expression. These genes were similarly altered in sensitized but not in resistant mice after an ethanol challenge, suggesting that resistant mice were tolerant to the transcriptional outcomes of an ethanol challenge. Whereas global HAT or DNMT activity was not affected, global HDAC activity was reduced after an acute ethanol injection. HDAC inhibition occurred in all ethanol-treated mice but with a lesser extent in sensitized animals. As a consequence, H4 acetylation was specifically potentiated in the core of the Nac proportionally to the striatal HDAC activity decrease. Conclusions/Significance: The present study highlights that the contrasted behavioral response to an ethanol challenge between resistant and sensitized mice may be mediated by epigenetic mechanisms occurring specifically in the striatum. Here we show that vulnerability to ethanol dependence and relapse could be, at least in part, due to individual variability in acute ethanol-induced epigenetic response.	[Botia, Beatrice; Legastelois, Remi; Alaux-Cantin, Stephanie; Naassila, Mickael] Univ Picardie Jules Verne, Unite Format & Rech Pharm, Inst Natl Sante & Rech Med, Res Grp Alcohol & Pharmacodependences,ERI 24, Amiens, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Naassila, M (corresponding author), Univ Picardie Jules Verne, Unite Format & Rech Pharm, Inst Natl Sante & Rech Med, Res Grp Alcohol & Pharmacodependences,ERI 24, Amiens, France.	mickael.naassila@inserm.fr	Naassila, Mickael/N-5146-2016	Naassila, Mickael/0000-0002-9788-0918	National Agency for Research; Conseil Regional de Picardie (CRP); Mission interministerielle de lutte contre la drogue et la toxicomanie (Mildt) - Inserm - Institute of Cancer [APE09002ESA]; Institut de France/Fondation NRJ "Biology of addiction"; ERDF Grant/INTERREG IVA program [4096]; Ministere de l'Enseignement superieur et de la Recherche; CRP	National Agency for Research(French National Research Agency (ANR)); Conseil Regional de Picardie (CRP)(Region Hauts-de-France); Mission interministerielle de lutte contre la drogue et la toxicomanie (Mildt) - Inserm - Institute of Cancer; Institut de France/Fondation NRJ "Biology of addiction"; ERDF Grant/INTERREG IVA program; Ministere de l'Enseignement superieur et de la Recherche; CRP	This study was supported by the National Agency for Research (SENSIBALCO grant, SAMENTA 2011), the Conseil Regional de Picardie (CRP), the Mission interministerielle de lutte contre la drogue et la toxicomanie (Mildt) - Inserm - Institute of Cancer (Contract APE09002ESA), Institut de France/Fondation NRJ "Biology of addiction" and ERDF Grant/INTERREG IVA program No4096 "AlcoBinge". RL is supported by a doctoral Fellowship from the Ministere de l'Enseignement superieur et de la Recherche. BB is supported by a post-doctoral fellowship from the CRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao KP, 2011, INT J NEUROPSYCHOPH, V14, P175, DOI 10.1017/S1461145710000441; Anier K, 2010, NEUROPSYCHOPHARMACOL, V35, P2450, DOI 10.1038/npp.2010.128; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Brami-Cherrier K, 2009, J NEUROCHEM, V108, P1323, DOI 10.1111/j.1471-4159.2009.05879.x; Cadoni C, 2000, EUR J PHARMACOL, V387, pR23, DOI 10.1016/S0014-2999(99)00843-2; CADOR M, 1995, NEUROSCIENCE, V65, P385, DOI 10.1016/0306-4522(94)00524-9; Camarini R, 2000, INT J NEUROPSYCHOPH, V3, P303, DOI 10.1017/S146114570000211X; de Araujo NP, 2009, PHYSIOL BEHAV, V96, P12, DOI 10.1016/j.physbeh.2008.07.029; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Didone V, 2008, PSYCHOPHARMACOLOGY, V201, P249, DOI 10.1007/s00213-008-1266-9; DiRocco DP, 2009, J NEUROSCI, V29, P2393, DOI 10.1523/JNEUROSCI.4356-08.2009; Fee JR, 2007, NEUROSCIENCE, V150, P14, DOI 10.1016/j.neuroscience.2007.08.027; Fuchs RA, 2005, NEUROPSYCHOPHARMACOL, V30, P296, DOI 10.1038/sj.npp.1300579; Gutierrez-Mecinas M, 2011, P NATL ACAD SCI USA, V108, P13806, DOI 10.1073/pnas.1104383108; Harrison SJ, 2009, PSYCHOPHARMACOLOGY, V207, P47, DOI 10.1007/s00213-009-1629-x; Host L, 2011, J PSYCHOPHARMACOL, V25, P222, DOI 10.1177/0269881109348173; Kalda A, 2007, BEHAV BRAIN RES, V181, P76, DOI 10.1016/j.bbr.2007.03.027; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim AK, 2010, BEHAV BRAIN RES, V207, P441, DOI 10.1016/j.bbr.2009.10.032; Kim BJ, 2008, BIOCHEM BIOPH RES CO, V372, P298, DOI 10.1016/j.bbrc.2008.05.056; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; Martin TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034236; MASUR J, 1988, PSYCHOPHARMACOLOGY, V96, P547, DOI 10.1007/BF02180038; Nordquist RE, 2007, EUR NEUROPSYCHOPHARM, V17, P532, DOI 10.1016/j.euroneuro.2006.12.005; O'Brien ES, 2011, NEUROPSYCHOPHARMACOL, V36, P1518, DOI 10.1038/npp.2011.37; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; Pascual M, 2009, J NEUROCHEM, V108, P920, DOI 10.1111/j.1471-4159.2008.05835.x; Pascual M, 2012, NEUROPHARMACOLOGY, V62, P2309, DOI 10.1016/j.neuropharm.2012.01.011; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PERUGINI M, 1994, J PHARMACOL EXP THER, V270, P690; Quadros IMH, 2002, ADDICT BIOL, V7, P291, DOI 10.1080/13556210220139505; Quadros IMH, 2002, EUR J PHARMACOL, V442, P55, DOI 10.1016/S0014-2999(02)01503-0; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Sakharkar AJ, 2012, ALCOHOL CLIN EXP RES, V36, P61, DOI 10.1111/j.1530-0277.2011.01581.x; Sanchis-Segura C, 2009, NEUROPSYCHOPHARMACOL, V34, P2642, DOI 10.1038/npp.2009.125; Shukla SD, 2008, ALCOHOL CLIN EXP RES, V32, P1525, DOI 10.1111/j.1530-0277.2008.00729.x; Souza-Formigoni MLO, 1999, PSYCHOPHARMACOLOGY, V146, P262, DOI 10.1007/s002130051115; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; Svedruzic ZM, 2011, PROG MOL BIOL TRANSL, V101, P221, DOI 10.1016/B978-0-12-387685-0.00006-8; Tian WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033435; Vanderschuren LJMJ, 2010, CURR TOP BEHAV NEURO, V3, P179, DOI 10.1007/7854_2009_21; Xu CM, 2011, J NEUROCHEM, V118, P126, DOI 10.1111/j.1471-4159.2011.07281.x	42	50	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47527	10.1371/journal.pone.0047527	http://dx.doi.org/10.1371/journal.pone.0047527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110077	Green Published, gold			2022-12-27	WOS:000310193400011
J	Beloribi, S; Ristorcelli, E; Breuzard, G; Silvy, F; Bertrand-Michel, J; Beraud, E; Verine, A; Lombardo, D				Beloribi, Sadia; Ristorcelli, Elodie; Breuzard, Gilles; Silvy, Francoise; Bertrand-Michel, Justine; Beraud, Evelyne; Verine, Alain; Lombardo, Dominique			Exosomal Lipids Impact Notch Signaling and Induce Death of Human Pancreatic Tumoral SOJ-6 Cells	PLOS ONE			English	Article							CHOLESTEROL ACCUMULATION; ENDOPLASMIC-RETICULUM; GAMMA-SECRETASE; MEMBRANE; APOPTOSIS; RAFTS; PHOSPHORYLATION; TRAFFICKING; ACTIVATION; CERAMIDE	Exosomes are of increasing interest as alternative mode of cell-to-cell communication. We previously reported that exosomes secreted by human SOJ-6 pancreatic tumor cells induce (glyco) protein ligand-independent cell death and inhibit Notch-1 pathway, this latter being particularly active during carcinogenesis and in cancer stem cells. Therefore, we asked whether exosomal lipids were key-elements for cell death and hypothesized that cholesterol-rich membrane microdomains were privileged sites of exosome interactions with tumor cells. To address these questions and based on the lipid composition of exosomes from SOJ-6 cells (Ristorcelli et al. (2008) FASEB J. 22; 3358-3369) enriched in cholesterol and sphingomyelin (lipids forming liquid-ordered phase, Lo) and depleted in phospholipids (lipids forming liquid-disordered phase, Ld), we designed Synthetic Exosome-Like Nanoparticles (SELN) with ratios Lo/Ld from 3.0 to 6.0 framing that of SOJ-6 cell exosomes. SELN decreased tumor cell survival, the higher the Lo/Ld ratio, the lower the cell survival. This decreased survival was due to activation of cell death with inhibition of Notch pathway. FRET analyses indicated fusions/exchanges of SELN with cell membranes. Fluorescent SELN co-localized with the ganglioside GM1 then with Rab5A, markers of lipid microdomains and of early endosomes, respectively. These interactions occurred at lipid microdomains of plasma and/or endosome membranes where the Notch-1 pathway matures. We thus demonstrated a major role for lipids in interactions between SELN and tumor cells, and in the ensued cell death. To our knowledge this is the first report on such effects of lipidic nanoparticles on tumor cell behavior. This may have implications in tumor progression.	[Beloribi, Sadia; Ristorcelli, Elodie; Breuzard, Gilles; Silvy, Francoise; Beraud, Evelyne; Verine, Alain; Lombardo, Dominique] Aix Marseille Univ, CRO2, Marseille, France; [Beloribi, Sadia; Ristorcelli, Elodie; Breuzard, Gilles; Silvy, Francoise; Beraud, Evelyne; Verine, Alain; Lombardo, Dominique] INSERM, UMR 911, F-13258 Marseille, France; [Bertrand-Michel, Justine] CHU Purpan, INSERM IFR BMT MetaToul, Lipid Core Facil, Toulouse, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lombardo, D (corresponding author), Aix Marseille Univ, CRO2, Marseille, France.	dominique.lombardo@univ-amu.fr	breuzard, gilles/C-4735-2013	breuzard, gilles/0000-0001-8178-2080	INSERM (Paris, France); Aix-Marseille Universite (Marseille, France)	INSERM (Paris, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Aix-Marseille Universite (Marseille, France)	This work was funded by INSERM (Paris, France) and Aix-Marseille Universite (Marseille, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Crescence L, 2012, J IMMUNOL, V189, P3386, DOI 10.4049/jimmunol.1102647; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Escrevente C, 2001, BMC CANCER, V27, P108; Fasano C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000612; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fujii Y, 1990, Hum Cell, V3, P31; Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Laulagnier K, 2005, BLOOD CELL MOL DIS, V35, P116, DOI 10.1016/j.bcmd.2005.05.010; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Levade T, 2002, NEUROCHEM RES, V27, P601, DOI 10.1023/A:1020215815013; Luketic L, 2007, J IMMUNOL, V179, P5024, DOI 10.4049/jimmunol.179.8.5024; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Murai T, 2011, J BIOL CHEM, V286, P1999, DOI 10.1074/jbc.M110.184010; Nieuwland R, 2010, THROMB RES, V125, pS49, DOI 10.1016/j.thromres.2010.01.037; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Panicot-Dubois L, 2004, NEOPLASIA, V6, P713, DOI 10.1593/neo.04298; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Ristorcelli E, 2008, FASEB J, V22, P3358, DOI 10.1096/fj.07-102855; Ristorcelli E, 2009, INT J CANCER, V125, P1016, DOI 10.1002/ijc.24375; Ross AH, 2009, P NATL ACAD SCI USA, V106, P1297, DOI 10.1073/pnas.0812473106; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Steinert S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002933; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tao LW, 2011, STEM CELLS, V29, P119, DOI 10.1002/stem.552; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Vo K, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-138; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Zakharova L, 2007, J CELL PHYSIOL, V212, P174, DOI 10.1002/jcp.21013	47	57	60	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47480	10.1371/journal.pone.0047480	http://dx.doi.org/10.1371/journal.pone.0047480			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094054	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200026
J	Lo, MK; Peeples, ME; Bellini, WJ; Nichol, ST; Rota, PA; Spiropoulou, CF				Lo, Michael K.; Peeples, Mark E.; Bellini, William J.; Nichol, Stuart T.; Rota, Paul A.; Spiropoulou, Christina F.			Distinct and Overlapping Roles of Nipah Virus P Gene Products in Modulating the Human Endothelial Cell Antiviral Response	PLOS ONE			English	Article							DEPENDENT INTERFERON INDUCTION; PARAMYXOVIRUS V PROTEINS; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; SENDAI-VIRUS; MESSENGER-RNA; MEASLES-VIRUS; C-PROTEIN; W-PROTEIN; RIG-I	Nipah virus (NiV) is a highly pathogenic zoonotic paramyxovirus that causes fatal encephalitis in up to 75% of infected humans. Like other paramyxoviruses, NiV employs co-transcriptional mRNA editing during transcription of the phosphoprotein (P) gene to generate additional mRNAs encoding the V and W proteins. The C protein is translated from the P mRNA, but in an alternative reading frame. There is evidence from both in vitro and in vivo studies to show that the P gene products play a role in NiV pathogenesis. We have developed a reverse genetic system to dissect the individual roles of the NiV P gene products in limiting the antiviral response in primary human microvascular lung endothelial cells, which represent important targets in human NiV infection. By characterizing growth curves and early antiviral responses against a number of recombinant NiVs with genetic modifications altering expression of the proteins encoded by the P gene, we observed that multiple elements encoded by the P gene have both distinct and overlapping roles in modulating virus replication as well as in limiting expression of antiviral mediators such as IFN-beta, CXCL10, and CCL5. Our findings corroborate observations from in vivo hamster infection studies, and provide molecular insights into the attenuation and the histopathology observed in hamsters infected with C, V, and W-deficient NiVs. The results of this study also provide an opportunity to verify the results of earlier artificial plasmid expression studies in the context of authentic viral infection.	[Lo, Michael K.; Nichol, Stuart T.; Spiropoulou, Christina F.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Atlanta, GA 30329 USA; [Lo, Michael K.; Bellini, William J.; Rota, Paul A.] Ctr Dis Control & Prevent, Measles Mumps Rubella & Herpes Virus Branch, Atlanta, GA USA; [Peeples, Mark E.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Peeples, Mark E.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Lo, MK (corresponding author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Atlanta, GA 30329 USA.	mko2@cdc.gov	Peeples, Mark E./AAX-5193-2021	Peeples, Mark E./0000-0002-4582-317X; Lo, Michael/0000-0002-0409-7896	Centers for Disease Control and Prevention; National Institutes of Health [AI069014]; ASM/CCID Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069014, R01AI093848] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASM/CCID Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by core funding from the Centers for Disease Control and Prevention, and by National Institutes of Health AI069014 to MEP. MKL was supported in part by an ASM/CCID Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Arankalle VA, 2011, EMERG INFECT DIS, V17, P907, DOI 10.3201/eid1705.100968; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Childs KS, 2009, J VIROL, V83, P1465, DOI 10.1128/JVI.01768-08; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Ciancanelli MJ, 2009, J VIROL, V83, P7828, DOI 10.1128/JVI.02610-08; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; CURRAN J, 1990, ENZYME, V44, P244, DOI 10.1159/000468762; CURRAN J, 1991, EMBO J, V10, P3079, DOI 10.1002/j.1460-2075.1991.tb07860.x; Delenda C, 1998, VIROLOGY, V242, P327, DOI 10.1006/viro.1998.9027; Devaux P, 2008, J VIROL, V82, P5359, DOI 10.1128/JVI.00169-08; Fukuhara N, 2002, VIROLOGY, V299, P172, DOI 10.1006/viro.2002.1516; Geisbert TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010690; GIORGI C, 1983, CELL, V35, P829, DOI 10.1016/0092-8674(83)90115-0; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hagmaier K, 2006, J GEN VIROL, V87, P3649, DOI 10.1099/vir.0.82261-0; Halpin K, 2004, J GEN VIROL, V85, P701, DOI 10.1099/vir.0.19685-0; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; Hausmann S, 1999, J VIROL, V73, P343, DOI 10.1128/JVI.73.1.343-351.1999; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Homaira N, 2010, EPIDEMIOL INFECT, P1; Hooper P, 2001, MICROBES INFECT, V3, P315, DOI 10.1016/S1286-4579(01)01385-5; Horikami SM, 1996, VIROLOGY, V222, P383, DOI 10.1006/viro.1996.0435; HOVANESSIAN AG, 1987, EMBO J, V6, P1273, DOI 10.1002/j.1460-2075.1987.tb02364.x; Kato A, 1997, J VIROL, V71, P7266, DOI 10.1128/JVI.71.10.7266-7272.1997; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kolakofsky D, 2005, J GEN VIROL, V86, P1869, DOI 10.1099/vir.0.80986-0; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; Kulkarni S, 2009, J VIROL; LISTON P, 1995, J VIROL, V69, P6742, DOI 10.1128/JVI.69.11.6742-6750.1995; Lo MK, 2012, EMERG INFECT DIS, V18, P248, DOI 10.3201/eid1802.111492; Lo MK, 2011, BIOLOGY OF PARAMYXOVIRUSES, P211; Lo MK, 2010, VIROLOGY, V404, P78, DOI 10.1016/j.virol.2010.05.005; Lo MK, 2009, J GEN VIROL, V90, P398, DOI 10.1099/vir.0.007294-0; Lo MK, 2008, J CLIN VIROL; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Malykhina O, 2011, J VIROL, V85, P4792, DOI 10.1128/JVI.02399-10; Marianneau P, 2010, EMERG INFECT DIS, V16, P507, DOI 10.3201/eid1603.091346; Mathieu C, 2012, J VIROL; Mathieu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032157; Mathieu C, 2011, J VIROL, V85, P7863, DOI 10.1128/JVI.00549-11; Mattion NM, 1996, J VIROL, V70, P8124, DOI 10.1128/JVI.70.11.8124-8127.1996; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Mebatsion T, 2003, J VIROL, V77, P9259, DOI 10.1128/JVI.77.17.9259-9265.2003; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Middleton DJ, 2002, J COMP PATHOL, V126, P124, DOI 10.1053/jcpa.2001.0532; Mungall BA, 2006, J VIROL, V80, P12293, DOI 10.1128/JVI.01619-06; Murphy SK, 1998, J VIROL, V72, P10, DOI 10.1128/JVI.72.1.10-19.1998; Nakatsu Y, 2008, J VIROL, V82, P8296, DOI 10.1128/JVI.00108-08; Nakatsu Y, 2006, J VIROL, V80, P11861, DOI 10.1128/JVI.00751-06; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Pallister J, 2009, J VIROL, V83, P11979, DOI 10.1128/JVI.01847-09; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Patterson JB, 2000, VIROLOGY, V267, P80, DOI 10.1006/viro.1999.0118; Prescott J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011159; Prescott JB, 2007, J IMMUNOL, V179, P1796, DOI 10.4049/jimmunol.179.3.1796; Rahman MA, 2011, VECTOR BORNE ZOONOTI; Rahman SA, 2010, EMERG INFECT DIS, V16, P1990, DOI 10.3201/eid1612.091790; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Rodriguez JJ, 2004, J VIROL, V78, P5358, DOI 10.1128/JVI.78.10.5358-5367.2004; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; ROTA PA, 1994, VIROLOGY, V198, P724, DOI 10.1006/viro.1994.1086; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Schneider H, 1997, VIROLOGY, V227, P314, DOI 10.1006/viro.1996.8339; Seto J, 2010, J VIROL, V84, P10965, DOI 10.1128/JVI.01335-10; Shaw ML, 2005, J VIROL, V79, P6078, DOI 10.1128/JVI.79.10.6078-6088.2005; Shaw ML, 2004, J VIROL, V78, P5633, DOI 10.1128/JVI.78.11.5633-5641.2004; Sleeman K, 2008, J GEN VIROL, V89, P1300, DOI 10.1099/vir.0.83582-0; Sparrer KMJ, 2012, J VIROL, V86, P796, DOI 10.1128/JVI.05899-11; Sweetman DA, 2001, VIROLOGY, V281, P193, DOI 10.1006/viro.2000.0805; Tapparel C, 1998, J VIROL, V72, P3117, DOI 10.1128/JVI.72.4.3117-3128.1998; Tober C, 1998, J VIROL, V72, P8124, DOI 10.1128/JVI.72.10.8124-8132.1998; Virtue ER, 2011, J VIROL, V85, P4031, DOI 10.1128/JVI.02412-10; von Messling V, 2006, J VIROL, V80, P6084, DOI 10.1128/JVI.00357-06; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Walpita P, 2007, J GEN VIROL, V88, P2542, DOI 10.1099/vir.0.83035-0; Weingartl HM, 2006, J VIROL, V80, P7929, DOI 10.1128/JVI.00263-06; Williamson MM, 2001, J COMP PATHOL, V124, P273, DOI 10.1053/jcpa.2001.0464; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; Yoneda M, 2006, P NATL ACAD SCI USA, V103, P16508, DOI 10.1073/pnas.0606972103; Yoneda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012709; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	96	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47790	10.1371/journal.pone.0047790	http://dx.doi.org/10.1371/journal.pone.0047790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094089	Green Submitted, Green Published, gold			2022-12-27	WOS:000310050200046
J	Manabe, T; Hanh, TT; Lam, DM; Do, THV; Pham, TPT; Dinh, TTH; Tran, TMP; Minh, DH; Takasaki, J; Chau, NQ; Toan, LQ; Kudo, K				Manabe, Toshie; Tran Thuy Hanh; Doan Manh Lam; Do Thi Hong Van; Pham Thi Phuong Thuy; Dinh Thi Thanh Huyen; Tran Thi Mai Phuong; Dang Hung Minh; Takasaki, Jin; Ngo Quy Chau; Ly Quoc Toan; Kudo, Koichiro			Knowledge, Attitudes, Practices and Emotional Reactions among Residents of Avian Influenza (H5N1) Hit Communities in Vietnam	PLOS ONE			English	Article							A H1N1 VIRUS; HUMAN INFECTION; PNEUMONIA; CAMBODIA; MEXICO	Background: Awareness of individuals' knowledge and predicting their behavior and emotional reactions is crucial when evaluating clinical preparedness for influenza pandemics with a highly pathogenic virus. Knowledge, attitude, and practice (KAP) relating to avian influenza (H5N1) virus infection among residents in communities where H5N1 patients occurred in Vietnam has not been reported. Methods and Principal Findings: Face-to-face interviews including KAP survey were conducted in Bac Kan province, located in the northeast mountainous region of Vietnam. Participants were residents who lived in a community where H5N1 cases have ever been reported (event group, n = 322) or one where cases have not been reported (non-event group, n = 221). Data on emotional reactions of participants and healthcare-seeking behavior after the event in neighboring areas were collected as well as information on demographics and environmental measures, information sources, and KAP regarding H5N1. These data were compared between two groups. Higher environmental risk of H5N1 and improper poultry-handling behaviors were identified in the event group. At the time of the event, over 50% of the event group sought healthcare for flu-like symptoms or because they were scared. Awareness of the event influenced KAP scores. Healthcare-seeking behavior and attention to H5N1 poultry outbreaks diminished in the event group as time passed after the outbreak compared with the non-event group. Factors that motivated participants to seek healthcare sooner were knowledge of early access to healthcare and the risk of eating sick/dead poultry, and perception of the threat of H5N1. Conclusions: Awareness of H5N1 patients in neighboring areas can provoke panic in residents and influence their healthcare-seeking behavior. Periodic education to share experiences on the occurrence of H5N1 patients and provide accurate information may help prevent panic and infection and reduce mortality. Local conditions should be taken into account when emphasizing the need for early access to healthcare.	[Manabe, Toshie; Takasaki, Jin; Kudo, Koichiro] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Tran Thuy Hanh; Dang Hung Minh; Ngo Quy Chau] Bach Mai Hosp, Hanoi, Vietnam; [Pham Thi Phuong Thuy; Dinh Thi Thanh Huyen; Tran Thi Mai Phuong] NCGM BMH Med Collaborat Ctr, Hanoi, Vietnam	National Center for Global Health & Medicine - Japan	Manabe, T (corresponding author), Natl Ctr Global Hlth & Med, Tokyo, Japan.	manabe@dcc.go.jp			Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2010, MED PRIN PRACT, V19, P421, DOI 10.1159/000320299; [Anonymous], 2021, HUM INF AV INFL AH5N; Barennes H, 2007, EMERG INFECT DIS, V13, P1126, DOI 10.3201/eid1307.061197; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Di Giuseppe G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-36; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Dominguez-Cherit G, 2010, JAMA-J AM MED ASSOC, V302, P1880; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Grijalva-Otero I, 2009, ARCH MED RES, V40, P662, DOI 10.1016/j.arcmed.2009.10.010; Hien ND, 2009, EMERG INFECT DIS, V15, P19, DOI 10.3201/eid1501.080073; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Leslie T, 2008, EMERG INFECT DIS, V14, P1459, DOI 10.3201/eid1409.071382; Mai TQL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003339; Manabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030384; Manabe T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023711; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Vong S, 2008, EMERG INFECT DIS, V14, P1303, DOI 10.3201/eid1408.070912; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; WHO, 2010, CUM NUMB CONF HUM CA; World Health Organization, 2010, AV INFL SIT VIETN UP; World Health Organization, 2010, WKLY EPIDEMIOL REC, V86, P161; *WORLD ORG AN HLTH, 2010, OIE DAIL UPD AV INFL; Xiang NJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-34; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	28	29	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47560	10.1371/journal.pone.0047560	http://dx.doi.org/10.1371/journal.pone.0047560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094063	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200031
J	Poole, E; Bain, M; Teague, L; Takei, Y; Laskey, R; Sinclair, J				Poole, Emma; Bain, Mark; Teague, Linda; Takei, Yoshinori; Laskey, Ron; Sinclair, John			The Cellular Protein MCM3AP Is Required for Inhibition of Cellular DNA Synthesis by the IE86 Protein of Human Cytomegalovirus	PLOS ONE			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; IE2 86-KILODALTON PROTEIN; BOX-BINDING-PROTEIN; NF-KAPPA-B; S-PHASE; RETINOBLASTOMA PROTEIN; CYCLE PROGRESSION; GENE-EXPRESSION; NUCLEAR ANTIGEN; REPLICATION	Like all DNA viruses, human cytomegalovirus (HCMV) infection is known to result in profound effects on host cell cycle. Infection of fibroblasts with HCMV is known to induce an advance in cell cycle through the G(0)-G(1) phase and then a subsequent arrest of cell cycle in early S-phase, presumably resulting in a cellular environment optimum for high levels of viral DNA replication whilst precluding replication of cellular DNA. Although the exact mechanisms used to arrest cell cycle by HCMV are unclear, they likely involve a number of viral gene products and evidence points to the ability of the virus to prevent licensing of cellular DNA synthesis. One viral protein known to profoundly alter cell cycle is the viral immediate early 86 (IE86) protein - an established function of which is to initially drive cells into early S phase but then inhibit cellular DNA synthesis. Here we show that, although IE86 interacts with the cellular licensing factor Cdt1, it does not inhibit licensing of cellular origins. Instead, IE86-mediated inhibition of cellular DNA synthesis requires mini-chromosome-maintenance 3 (MCM3) associated protein (MCM3AP), which can cause subsequent inhibition of initiation of cellular DNA synthesis in a licensing-independent manner.	[Poole, Emma; Bain, Mark; Teague, Linda; Sinclair, John] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Takei, Yoshinori; Laskey, Ron] Univ Cambridge, Hutchison MRC Res Ctr, Cambridge CB2 2QQ, England; [Takei, Yoshinori; Laskey, Ron] Univ Cambridge, Dept Zool, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge	Sinclair, J (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England.	js@mole.bio.cam.ac.uk		Poole, Emma/0000-0003-3904-6121	British Medical Research Council [G0701279]; MRC [G0701279, G9202171] Funding Source: UKRI; Medical Research Council [G9202171, G0701279] Funding Source: researchfish	British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the British Medical Research Council funding (G0701279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2000, GENE, V255, P219, DOI 10.1016/S0378-1119(00)00336-X; Ahn JH, 2000, VIROLOGY, V274, P39, DOI 10.1006/viro.2000.0448; BEPPU T, 1994, J HISTOCHEM CYTOCHEM, V42, P1177, DOI 10.1177/42.8.7913107; Biswas N, 2003, J VIROL, V77, P2369, DOI 10.1128/JVI.77.4.2369-2376.2003; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Bonin LR, 1997, J VIROL, V71, P5861, DOI 10.1128/JVI.71.8.5861-5870.1997; Bresnahan WA, 1998, J BIOL CHEM, V273, P22075, DOI 10.1074/jbc.273.34.22075; Bryant LA, 2000, J VIROL, V74, P7230, DOI 10.1128/JVI.74.16.7230-7237.2000; Burgdorf SW, 2011, J VIROL, V85, P11098, DOI 10.1128/JVI.05315-11; CASWELL R, 1993, J GEN VIROL, V74, P2691, DOI 10.1099/0022-1317-74-12-2691; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Frouin I, 2003, J BIOL CHEM, V278, P39265, DOI 10.1074/jbc.C300098200; Gill RB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-9; HAGEMEIER C, 1994, EMBO J, V13, P2897, DOI 10.1002/j.1460-2075.1994.tb06584.x; JUPP R, 1993, J VIROL, V67, P7539, DOI 10.1128/JVI.67.12.7539-7546.1993; Kalejta RF, 2004, J CELL BIOCHEM, V93, P37, DOI 10.1002/jcb.20177; Kapasi AJ, 2008, J VIROL, V82, P394, DOI 10.1128/JVI.01681-07; Kono Y, 2002, GENES CELLS, V7, P821, DOI 10.1046/j.1365-2443.2002.00562.x; KOTHARI S, 1991, NUCLEIC ACIDS RES, V19, P1767, DOI 10.1093/nar/19.8.1767; Kuipers MA, 2011, J CELL BIOL, V192, P29, DOI 10.1083/jcb.201007111; Li CH, 2010, PROTEIN CELL, V1, P227, DOI 10.1007/s13238-010-0032-z; Li X, 1996, EXP CELL RES, V222, P28, DOI 10.1006/excr.1996.0004; Lin DI, 2008, P NATL ACAD SCI USA, V105, P8079, DOI 10.1073/pnas.0800077105; Lu MS, 1999, J VIROL, V73, P676, DOI 10.1128/JVI.73.1.676-683.1999; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morin J, 1996, J VIROL, V70, P6402, DOI 10.1128/JVI.70.9.6402-6404.1996; Murphy EA, 2000, J VIROL, V74, P7108, DOI 10.1128/JVI.74.15.7108-7118.2000; Noris E, 2002, J VIROL, V76, P12135, DOI 10.1128/JVI.76.23.12135-12148.2002; Pajovic S, 1997, MOL CELL BIOL, V17, P6459, DOI 10.1128/MCB.17.11.6459; Petrik DT, 2006, J VIROL, V80, P3872, DOI 10.1128/JVI.80.8.3872-3883.2006; Petrik DT, 2007, J VIROL, V81, P5807, DOI 10.1128/JVI.02437-06; PLACHTER B, 1993, VIROLOGY, V193, P642, DOI 10.1006/viro.1993.1172; Poma EE, 1996, J VIROL, V70, P7867, DOI 10.1128/JVI.70.11.7867-7877.1996; Poole E, 2006, EMBO J, V25, P4390, DOI 10.1038/sj.emboj.7601287; Poole E, 2011, J GEN VIROL, V92, P1539, DOI 10.1099/vir.0.031377-0; Poole E, 2009, J VIROL, V83, P3581, DOI 10.1128/JVI.02072-08; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; Qian Z, 2008, PLOS PATHOG, V6; Reeves M, 2006, J VIROL, V80, P9998, DOI 10.1128/JVI.01297-06; Sanchez V, 2008, CURR TOP MICROBIOL, V325, P243; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Shechter D, 2004, P NATL ACAD SCI USA, V101, P10845, DOI 10.1073/pnas.0404143101; Shi YL, 2007, J BIOL CHEM, V282, P9236, DOI 10.1074/jbc.M609256200; Sinclair J, 2000, J GEN VIROL, V81, P1553, DOI 10.1099/0022-1317-81-6-1553; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOMMER MH, 1994, J VIROL, V68, P6223, DOI 10.1128/JVI.68.10.6223-6231.1994; Song YJ, 2010, ACTA VIROL, V54, P125, DOI 10.4149/av_2010_02_125; Song YJ, 2005, J VIROL, V79, P2597, DOI 10.1128/JVI.79.4.2597-2603.2005; Song YJ, 2002, P NATL ACAD SCI USA, V99, P2836, DOI 10.1073/pnas.052010099; Stinski MF, 2008, CURR TOP MICROBIOL, V325, P133; Straschewski S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009174; Takei Y, 2002, J BIOL CHEM, V277, P43121, DOI 10.1074/jbc.C200442200; Takei Y, 2001, EMBO REP, V2, P119, DOI 10.1093/embo-reports/kve026; Wickramasinghe VO, 2011, J MOL BIOL, V406, P355, DOI 10.1016/j.jmb.2010.12.035; Wickramasinghe VO, 2010, CURR BIOL, V20, P25, DOI 10.1016/j.cub.2009.10.078; Wiebusch L, 2003, EMBO REP, V4, P42, DOI 10.1038/sj.embor.embor707; Wiebusch L, 2001, EMBO J, V20, P1086, DOI 10.1093/emboj/20.5.1086; Zhou J, 2005, EMBO J, V24, P1406, DOI 10.1038/sj.emboj.7600609	59	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e45686	10.1371/journal.pone.0045686	http://dx.doi.org/10.1371/journal.pone.0045686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094019	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200004
J	Tewari, S; Khan, S; Hopkins, N; Srinivasan, N; Reicher, S				Tewari, Shruti; Khan, Sammyh; Hopkins, Nick; Srinivasan, Narayanan; Reicher, Stephen			Participation in Mass Gatherings Can Benefit Well-Being: Longitudinal and Control Data from a North Indian Hindu Pilgrimage Event	PLOS ONE			English	Article							SOCIAL IDENTITY; HEALTH; RELIGION; SPIRITUALITY; EXPERIENCE; STRESSORS; AGENDA; CALL	How does participation in a long-duration mass gathering (such as a pilgrimage event) impact well-being? There are good reasons to believe such collective events pose risks to health. There are risks associated with communicable diseases. Moreover, the physical conditions at such events (noise, crowding, harsh conditions) are often detrimental to well-being. Yet, at the same time, social psychological research suggests participation in group-related activities can impact well-being positively, and we therefore investigated if participating in a long-duration mass gathering can actually bring such benefits. In our research we studied one of the world's largest collective events - a demanding month-long Hindu religious festival in North India. Participants (comprising 416 pilgrims who attended the gathering for the whole month of its duration, and 127 controls who did not) completed measures of self-assessed well-being and symptoms of ill-health at two time points. The first was a month before the gathering commenced, the second was a month after it finished. We found that those participating in this collective event reported a longitudinal increase in well-being relative to those who did not participate. Our data therefore imply we should reconceptualise how mass gatherings impact individuals. Although such gatherings can entail significant health risks, the benefits for well-being also need recognition. Indeed, an exclusive focus on risk is misleading and limits our understanding of why such events may be so attractive. More importantly, as our research is longitudinal and includes a control group, our work adds robust evidence to the social psychological literature concerning the relationship between participation in social group activities and well-being.	[Khan, Sammyh; Hopkins, Nick] Univ Dundee, Sch Psychol, Dundee, Scotland; [Tewari, Shruti; Srinivasan, Narayanan] Univ Allahabad, Ctr Behav & Cognit Sci, Allahabad 211002, Uttar Pradesh, India; [Reicher, Stephen] Univ St Andrews, Sch Psychol, St Andrews, Scotland	University of Dundee; University of Allahabad; University of St Andrews	Hopkins, N (corresponding author), Univ Dundee, Sch Psychol, Dundee, Scotland.	n.p.hopkins@dundee.ac.uk	Srinivasan, Narayanan/E-7882-2010; Khan, Sammyh/AAS-7704-2020	Srinivasan, Narayanan/0000-0001-5342-0381; Khan, Sammyh/0000-0001-7048-9786; Hopkins, Nick/0000-0003-3052-1854	ESRC (UK) [RES-062-23-1449]; Economic and Social Research Council [ES/G00711X/1] Funding Source: researchfish; ESRC [ES/G00711X/1] Funding Source: UKRI	ESRC (UK)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by an ESRC (UK) research grant entitled "Collective participation and social identification: A study of the individual, interpersonal and collective dimensions of attendance at the Magh Mela'' (RES-062-23-1449). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8; [Anonymous], 2000, MEAS HLTH DAYS; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Drury J., 2009, INT J MASS EMERGENCI, V27, P66, DOI DOI 10.1007/S13398-014-0173-7.2; Durkheim E, 1965, ELEMENTARY FORMS REL; Ehrenreich B., 2006, DANCING STREETS; George LK, 2000, J SOC CLIN PSYCHOL, V19, P102, DOI 10.1521/jscp.2000.19.1.102; George LK, 2002, PSYCHOL INQ, V13, P190, DOI 10.1207/S15327965PLI1303_04; Getz D, 2008, TOURISM MANAGE, V29, P403, DOI 10.1016/j.tourman.2007.07.017; Getz Donald, 2010, INT J EVENT MANAGEME, V5, P1, DOI DOI 10.12691/ajssm-4-2-4; Gleibs IH, 2011, AGING MENT HEALTH, V15, P456, DOI 10.1080/13607863.2010.536137; Graham J, 2010, PERS SOC PSYCHOL REV, V14, P140, DOI 10.1177/1088868309353415; Green M, 2010, J RELIG HEALTH, V49, P149, DOI 10.1007/s10943-009-9242-1; Haslam C, 2010, PSYCHOL AGING, V25, P157, DOI 10.1037/a0018256; Haslam SA, 2009, APPL PSYCHOL-INT REV, V58, P1, DOI 10.1111/j.1464-0597.2008.00379.x; Haslam SA, 2005, BRIT J SOC PSYCHOL, V44, P355, DOI 10.1348/014466605X37468; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Ising H, 2004, Noise Health, V6, P5; James A, 2003, BRIT J HEALTH PSYCH, V8, P359, DOI 10.1348/135910703322370905; Lim C, 2010, AM SOCIOL REV, V75, P914, DOI 10.1177/0003122410386686; Memish ZA, 2012, LANCET INFECT DIS, V12, P56, DOI 10.1016/S1473-3099(11)70337-1; Nordin A, 2011, NUMEN-INT REV HIST R, V58, P632, DOI 10.1163/156852711X593287; PAULUS PB, 1978, ENVIRON PSYCH NONVER, V3, P107, DOI 10.1007/BF01135608; Peterson C, 2008, APPL PSYCHOL-INT REV, V57, P19, DOI 10.1111/j.1464-0597.2008.00352.x; Powell LH, 2003, AM PSYCHOL, V58, P36, DOI 10.1037/0003-066X.58.1.36; Ruback RB, 1997, J CROSS CULT PSYCHOL, V28, P23, DOI 10.1177/0022022197281002; Ruback RB, 2002, J CROSS CULT PSYCHOL, V33, P100, DOI 10.1177/0022022102033001007; Salsman JM, 2005, PERS SOC PSYCHOL B, V31, P522, DOI 10.1177/0146167204271563; Seeman TE, 2003, AM PSYCHOL, V58, P53, DOI 10.1037/0003-066X.58.1.53; Steffen R, 2012, LANCET INFECT DIS, V12, P142, DOI 10.1016/S1473-3099(11)70293-6; Tam JS, 2012, LANCET INFECT DIS, V12, P231, DOI 10.1016/S1473-3099(11)70353-X; Tully M, 2002, KUMBH MELA; Turner Victor, 1969, RITUAL PROCESS; Tyler T. R., 2000, COOPERATION GROUPS P; Walton GM, 2011, SCIENCE, V331, P1447, DOI 10.1126/science.1198364; Wegge J, 2006, WORK STRESS, V20, P60, DOI 10.1080/02678370600655553	36	78	78	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47291	10.1371/journal.pone.0047291	http://dx.doi.org/10.1371/journal.pone.0047291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082155	gold, Green Published, Green Accepted			2022-12-27	WOS:000311146900051
J	Ueda, P; Tong, LL; Viedma, C; Chandy, SJ; Marrone, G; Simon, A; Lundborg, CS				Ueda, Peter; Tong, Leilei; Viedma, Cristobal; Chandy, Sujith J.; Marrone, Gaetano; Simon, Anna; Lundborg, Cecilia Stalsby			Food Marketing towards Children: Brand Logo Recognition, Food-Related Behavior and BMI among 3-13-Year-Olds in a South Indian Town	PLOS ONE			English	Article							OBESITY; OVERWEIGHT; KNOWLEDGE; THREAT	Objectives: To assess exposure to marketing of unhealthy food products and its relation to food related behavior and BMI in children aged 3-13, from different socioeconomic backgrounds in a south Indian town. Methods: Child-parent pairs (n = 306) were recruited at pediatric clinics. Exposure to food marketing was assessed by a digital logo recognition test. Children matched 18 logos of unhealthy food (high in fat/sugar/salt) featured in promotion material from the food industry to pictures of corresponding products. Children's nutritional knowledge, food preferences, purchase requests, eating behavior and socioeconomic characteristics were assessed by a digital game and parental questionnaires. Anthropometric measurements were recorded. Results: Recognition rates for the brand logos ranged from 30% to 80%. Logo recognition ability increased with age (p<0.001) and socioeconomic level (p<0.001 comparing children in the highest and lowest of three socioeconomic groups). Adjusted for gender, age and socioeconomic group, logo recognition was associated with higher BMI (p = 0.022) and nutritional knowledge (p<0.001) but not to unhealthy food preferences or purchase requests. Conclusions: Children from higher socioeconomic groups in the region had higher brand logo recognition ability and are possibly exposed to more food marketing. The study did not lend support to a link between exposure to marketing and poor eating behavior, distorted nutritional knowledge or increased purchase requests. The correlation between logo recognition and BMI warrants further investigation on food marketing towards children and its potential role in the increasing burden of non-communicable diseases in this part of India.	[Ueda, Peter; Chandy, Sujith J.; Marrone, Gaetano; Lundborg, Cecilia Stalsby] Karolinska Inst, Div Global Hlth IHCAR, Stockholm, Sweden; [Tong, Leilei] Stockholm Sch Econ, S-11383 Stockholm, Sweden; [Viedma, Cristobal] Royal Inst Technol, Stockholm, Sweden; [Chandy, Sujith J.; Simon, Anna] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India	Karolinska Institutet; Stockholm School of Economics; Royal Institute of Technology; Christian Medical College & Hospital (CMCH) Vellore	Ueda, P (corresponding author), Karolinska Inst, Div Global Hlth IHCAR, Stockholm, Sweden.	peter.ueda@gmail.com	Ueda, Peter/AGH-9915-2022; Ueda, Peter/AAB-8961-2020	Ueda, Peter/0000-0002-3275-8743; Ueda, Peter/0000-0002-3275-8743; Marrone, Gaetano/0000-0002-2991-1663; Stalsby Lundborg, Cecilia/0000-0001-6525-1861	Swedish International Development Cooperation Agency	Swedish International Development Cooperation Agency	The study was funded by the Swedish International Development Cooperation Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BUSINESS STANDARD; Berkey CS, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e56; Borzekowski DLG, 2001, J AM DIET ASSOC, V101, P42, DOI 10.1016/S0002-8223(01)00012-8; CALFAS KJ, 1991, J DEV BEHAV PEDIATR, V12, P185; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Consumers International, 2008, JUNK FOOD TRAP MARKT; Escelante de Cruz A, 2004, JUNK FOOD GENERATION; FISCHER PM, 1991, JAMA-J AM MED ASSOC, V266, P3145, DOI 10.1001/jama.266.22.3145; Goyal Ramesh K, 2010, J Assoc Physicians India, V58, P151; Gupta R, 2003, J Assoc Physicians India, V51, P470; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Hastings G., 2003, REV RES EFFECTS FOOD; International Institute for Population Sciences (IIPS) and Macro International, 2008, NAT FAM HLTH SURV NF; Jain Seema, 2010, Indian J Public Health, V54, P158, DOI 10.4103/0019-557X.75740; JEFFREY DB, 1982, HEALTH EDUC QUART, V9, P174; Kaur P., 2006, CHILDREN FAMILY PURC; Kelly J, 2006, BRIT FOOD J, V108, P413, DOI 10.1108/00070700610661376; Kennedy C, 2000, J Pediatr Nurs, V15, P272, DOI 10.1053/jpdn.2000.8676; Kopelman CA, 2007, J PUBLIC HEALTH-UK, V29, P358, DOI 10.1093/pubmed/fdm067; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Reddy KS, 2007, J AM COLL CARDIOL, V50, P1370, DOI 10.1016/j.jacc.2007.04.097; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Sharma K, 2010, BUSINESS TODAY  1212; STONEMAN Z, 1981, DEV PSYCHOL, V17, P853; Vadehra S, 2010, YOUNG CONSUMERS, V11, P153; *WHO, 2010, SET REC MARK FOODS N; World Diabetes Foundation, 2011, DIAB FACTS; Wright, 1981, J APPL DEV PSYCHOL, V1, P329	29	14	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47000	10.1371/journal.pone.0047000	http://dx.doi.org/10.1371/journal.pone.0047000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082137	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000311146900032
J	Buzoianu, SG; Walsh, MC; Rea, MC; O'Donovan, O; Gelencser, E; Ujhelyi, G; Szabo, E; Nagy, A; Ross, RP; Gardiner, GE; Lawlor, PG				Buzoianu, Stefan G.; Walsh, Maria C.; Rea, Mary C.; O'Donovan, Orla; Gelencser, Eva; Ujhelyi, Gabriella; Szabo, Erika; Nagy, Andras; Ross, R. Paul; Gardiner, Gillian E.; Lawlor, Peadar G.			Effects of Feeding Bt Maize to Sows during Gestation and Lactation on Maternal and Offspring Immunity and Fate of Transgenic Material	PLOS ONE			English	Article							GENETICALLY-MODIFIED MAIZE; BACILLUS-THURINGIENSIS; HEALTH-RISKS; NON-GM; SYSTEM; DNA; BIOCHEMISTRY; MECHANISMS; MODELS; SAFETY	Background: We aimed to determine the effect of feeding transgenic maize to sows during gestation and lactation on maternal and offspring immunity and to assess the fate of transgenic material. Methodology/Principal Findings: On the day of insemination, sows were assigned to one of two treatments (n = 12/treatment); 1) non-Bt control maize diet or 2) Bt-MON810 maize diet, which were fed for similar to 143 days throughout gestation and lactation. Immune function was assessed by leukocyte phenotyping, haematology and Cry1Ab-specific antibody presence in blood on days 0, 28 and 110 of gestation and at the end of lactation. Peripheral-blood mononuclear cell cytokine production was investigated on days 28 and 110 of gestation. Haematological analysis was performed on offspring at birth (n = 12/treatment). Presence of the cry1Ab transgene was assessed in sows' blood and faeces on day 110 of gestation and in blood and tissues of offspring at birth. Cry1Ab protein presence was assessed in sows' blood during gestation and lactation and in tissues of offspring at birth. Blood monocyte count and percentage were higher (P<0.05), while granulocyte percentage was lower (P<0.05) in Bt maize-fed sows on day 110 of gestation. Leukocyte count and granulocyte count and percentage were lower (P<0.05), while lymphocyte percentage was higher (P<0.05) in offspring of Bt maize-fed sows. Bt maize-fed sows had a lower percentage of monocytes on day 28 of lactation and of CD4(+)CD8(+) lymphocytes on day 110 of gestation, day 28 of lactation and overall (P<0.05). Cytokine production was similar between treatments. Transgenic material or Cry1Ab-specific antibodies were not detected in sows or offspring. Conclusions/Significance: Treatment differences observed following feeding of Bt maize to sows did not indicate inflammation or allergy and are unlikely to be of major importance. These results provide additional data for Bt maize safety assessment.	[Buzoianu, Stefan G.; Walsh, Maria C.; Lawlor, Peadar G.] TEAGASC, Pig Dev Dept, Anim & Grassland Res & Innovat Ctr, Fermoy, Cork, Ireland; [Buzoianu, Stefan G.; O'Donovan, Orla; Gardiner, Gillian E.] Waterford Inst Technol, Dept Chem & Life Sci, Waterford, Ireland; [Rea, Mary C.; Ross, R. Paul] Teagasc Food Res Ctr, Fermoy, Cork, Ireland; [Rea, Mary C.; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Gelencser, Eva; Ujhelyi, Gabriella; Szabo, Erika; Nagy, Andras] Cent Food Res Inst, Budapest, Hungary	Teagasc; South East Technological University (SETU); Teagasc; University College Cork	Lawlor, PG (corresponding author), TEAGASC, Pig Dev Dept, Anim & Grassland Res & Innovat Ctr, Moorepk, Fermoy, Cork, Ireland.	peadar.lawlor@teagasc.ie	Ross, Paul/A-7584-2015; Stefan, Buzoianu/F-3030-2010; Erika, Koppányné Szabó/M-4548-2017; Nagy, András/M-1437-2017; Gelencser, Eva/A-2842-2013; walsh, maria/H-3662-2013	Ross, Paul/0000-0003-4876-8839; Rea, Mary/0000-0003-3782-0232; O' Donovan, Orla/0000-0003-3980-8835	European Union's Seventh Framework Programme [211820]; Teagasc Walsh Fellowship Programme	European Union's Seventh Framework Programme; Teagasc Walsh Fellowship Programme	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 211820 and the Teagasc Walsh Fellowship Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016346; Andersson HC, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2150; Bailey M, 2006, VET RES, V37, P443, DOI 10.1051/vetres:2006013; Bailey M, 2009, DEV COMP IMMUNOL, V33, P375, DOI 10.1016/j.dci.2008.07.003; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; Batista R, 2010, REGUL TOXICOL PHARM, V58, pS8, DOI 10.1016/j.yrtph.2010.08.019; Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426; Butts CL, 2008, CELL IMMUNOL, V252, P7, DOI 10.1016/j.cellimm.2007.09.009; Chowdhury EH, 2003, J ANIM SCI, V81, P2546; de Vendomois JS, 2010, INT J BIOL SCI, V6, P590; Domingo JL, 2011, ENVIRON INT, V37, P734, DOI 10.1016/j.envint.2011.01.003; Dona A, 2009, CRIT REV FOOD SCI, V49, P164, DOI 10.1080/10408390701855993; EFSA (European Food Safety Authority). S, 2009, EFSA J, V1149, P1, DOI DOI 10.2903/J.EFSA.2009.1149; Egeli AK, 1998, ACTA VET SCAND, V39, P381; Einspanier R, 2004, EUR FOOD RES TECHNOL, V218, P269, DOI 10.1007/s00217-003-0842-9; Einspanier R, 2001, EUR FOOD RES TECHNOL, V212, P129, DOI 10.1007/s002170000248; Feldman BF., 2006, SCHALMS VET HEMATOLO; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Fonseca C, 2012, J PROTEOMICS, V75, P2027, DOI 10.1016/j.jprot.2012.01.005; Gaskell G, 2010, EUR24537 EUROPEANS B; GASKELL GSS, 2005, EUROPEANS BIOTECHNOL; Hartnell G. F., 2007, BEST PRACTICES CONDU; Helm RM, 2000, CURR OPIN IMMUNOL, V12, P647, DOI 10.1016/S0952-7915(00)00157-6; Helm RM, 2002, J ALLERGY CLIN IMMUN, V109, P136, DOI 10.1067/mai.2002.120551; HILL M, 1995, EUPHYTICA, V85, P119, DOI 10.1007/BF00023939; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Lehrer SB, 2009, REGUL TOXICOL PHARM, V54, pS46, DOI 10.1016/j.yrtph.2009.01.001; Lewis AJ., 2001, SWINE NUTR, V2; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Lutz B, 2005, J AGR FOOD CHEM, V53, P1453, DOI 10.1021/jf049222x; Mazza R, 2005, TRANSGENIC RES, V14, P775, DOI 10.1007/s11248-005-0009-5; Moughan P J, 1992, World Rev Nutr Diet, V67, P40; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Murtaugh MP, 2002, VET IMMUNOL IMMUNOP, V87, P109, DOI 10.1016/S0165-2427(02)00042-9; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Osborne J., 2010, PRACTICAL ASSESSMENT, V15; Pappas PA, 2004, SESUG 2004 P SE SAS, V2004, pTU04; Patterson JK, 2008, EXP BIOL MED, V233, P651, DOI 10.3181/0709-MR-262; Poole JA, 2004, CLIN REV ALLERG IMMU, V26, P161, DOI 10.1385/CRIAI:26:3:161; Prescott VE, 2006, PHARMACOL THERAPEUT, V111, P374, DOI 10.1016/j.pharmthera.2005.10.005; Reddy J, 2000, VET IMMUNOL IMMUNOP, V74, P31, DOI 10.1016/S0165-2427(00)00164-1; Rothkotter HJ, 2009, DEV COMP IMMUNOL, V33, P267, DOI 10.1016/j.dci.2008.06.016; SAS Institute Inc, 2010, SAS STAT 9 22 US GUI; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Snell C, 2012, FOOD CHEM TOXICOL, V50, P1134, DOI 10.1016/j.fct.2011.11.048; Szczepanik M, 2006, J PHYSIOL PHARMACOL, V57, P15; Takeshita H, 2000, BIOCHEM BIOPH RES CO, V269, P481, DOI 10.1006/bbrc.2000.2300; Trabalza-Marinucci M, 2008, LIVEST SCI, V113, P178, DOI 10.1016/j.livsci.2007.03.009; van Haver E, 2008, FOOD CHEM TOXICOL, V46, pS2, DOI 10.1016/j.fct.2008.02.008; Wal JM, 2003, REGUL TOXICOL PHARM, V38, P98, DOI 10.1016/S0273-2300(03)00079-5; Walsh MC, 2008, FEMS MICROBIOL ECOL, V64, P317, DOI 10.1111/j.1574-6941.2008.00454.x; Walsh MC, 2013, BRIT J NUTR, V109, P873, DOI 10.1017/S0007114512002607; Walsh MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036141; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011; Walsh MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027177; Wiedemann S, 2009, MAMM BIOL, V74, P193, DOI 10.1016/j.mambio.2008.07.002	59	25	27	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47851	10.1371/journal.pone.0047851	http://dx.doi.org/10.1371/journal.pone.0047851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091650	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800076
J	Dwivedi, OP; Tabassum, R; Chauhan, G; Ghosh, S; Marwaha, RK; Tandon, N; Bharadwaj, D				Dwivedi, Om Prakash; Tabassum, Rubina; Chauhan, Ganesh; Ghosh, Saurabh; Marwaha, Raman K.; Tandon, Nikhil; Bharadwaj, Dwaipayan			Common Variants of FTO Are Associated with Childhood Obesity in a Cross-Sectional Study of 3,126 Urban Indian Children	PLOS ONE			English	Article							BODY-MASS INDEX; CHINESE CHILDREN; GENE; RISK; OVERWEIGHT	Background: FTO variants are robustly associated with obesity and related traits in many population and shown to have variable impact during life course. Although studies have shown association of FTO variants with adiposity in adult Indian, its association in Indian children is yet to be confirmed. Methods: Here we examined association of FTO variants (rs9939609 and rs8050136) with obesity and related anthropometric and biochemical traits in 3,126 Indian children (aged 11-17 years) including 2,230 normal-weight and 896 over-weight/obese children. We also compared effects observed in the present study with that observed in previous studies on South Asian adults and children of other ethnic groups. Results: The variant rs9939609 showed significant association with risk of obesity [OR = 1.21, P = 2.5x10(-3)] and its measures BMI, weight, waist circumference and hip circumference [beta range = 0.11 to 0.14 Z-score units; P range = 1.3x10(-4) to 1.6x10(-7)] in children. The observed effect sizes in Indian children were similar to those reported for European children. Variant rs9939609 explained 0.88% of BMI variance in Indian children. The effect sizes of rs9939609 on BMI and WC were similar to 2 fold higher in children than adults. Interestingly rs9939609 was also associated with serum levels of thyroid stimulating hormone (TSH) [beta = 0.10 Z-score, P = 5.8x10(-3)]. The other variant rs8050136 was in strong linkage disequilibrium with rs9939609 (r(2) = 0.97) and provided similar association results. Conclusion: The study provides first report of association of FTO variants with obesity and related anthropometric traits in Indian children with higher impact in children compared to adults. We also demonstrated association of FTO variant with serum levels of TSH, indicating putative influence of FTO in hypothalamic-pituitary-thyroid axis.	[Tandon, Nikhil] All India Inst Med Sci, Dept Endocrinol, New Delhi, India; [Dwivedi, Om Prakash; Tabassum, Rubina; Chauhan, Ganesh; Bharadwaj, Dwaipayan] CSIR Inst Genom & Integrat Biol, Genom & Mol Med Unit, Delhi, India; [Ghosh, Saurabh] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Marwaha, Raman K.] Inst Nucl Med & Allied Sci, Dept Endocrinol & Thyroid Res, Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Statistical Institute; Indian Statistical Institute Kolkata; Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS)	Tandon, N (corresponding author), All India Inst Med Sci, Dept Endocrinol, New Delhi, India.	nikhil_tandon@hotmail.com; db@igib.res.in	Marwaha, Raman/AAQ-7475-2021; CHAUHAN, GANESH/AAI-5110-2021	Tabassum, Rubina/0000-0002-3120-3041; Chauhan, Ganesh/0000-0002-8564-5021; Marwaha, Raman/0000-0002-9698-4280; Bharadwaj, Dwaipayan/0000-0001-5268-8482	Diabetes mellitus-New drug discovery R&D, molecular mechanisms and genetic & epidemiological factors [NWP0032-OB4]; Council of Scientific and Industrial Research (CSIR), Government of India; Fogarty International Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health [1 D43 HD065249]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [D43HD065249] Funding Source: NIH RePORTER	Diabetes mellitus-New drug discovery R&D, molecular mechanisms and genetic & epidemiological factors; Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by "Diabetes mellitus-New drug discovery R&D, molecular mechanisms and genetic & epidemiological factors" (NWP0032-OB4), funded by Council of Scientific and Industrial Research (CSIR), Government of India. RT received a postdoctoral fellowship from the Fogarty International Center and the Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health (1 D43 HD065249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Biondi B, 2010, J CLIN ENDOCR METAB, V95, P3614, DOI 10.1210/jc.2010-1245; Chauhan G, 2011, J HUM GENET, V56, P720, DOI 10.1038/jhg.2011.87; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; INdian DIabetes COnsortium, 2011, Hugo J, V5, P65, DOI 10.1007/s11568-011-9157-2; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Kirkpatrick CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011053; Larder R, 2011, TRENDS ENDOCRIN MET, V22, P53, DOI 10.1016/j.tem.2010.11.001; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Loos RJF, 2008, OBES REV, V9, P246, DOI 10.1111/j.1467-789X.2008.00481.x; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Marwaha RK, 2006, INDIAN PEDIATR, V43, P943; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sonestedt E, 2009, AM J CLIN NUTR, V90, P1418, DOI 10.3945/ajcn.2009.27958; Sovio U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001307; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tabassum R, 2012, DIABETES, V61, P626, DOI 10.2337/db11-1501; Vasan SK, 2012, OBESITY, V20, P2268, DOI 10.1038/oby.2012.64; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273	27	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47772	10.1371/journal.pone.0047772	http://dx.doi.org/10.1371/journal.pone.0047772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091647	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800073
J	Richardson, SM; Purmessur, D; Baird, P; Ben, P; Freemont, AJ; Hoyland, JA				Richardson, Stephen M.; Purmessur, Devina; Baird, Pauline; Probyn, Ben; Freemont, Anthony J.; Hoyland, Judith A.			Degenerate Human Nucleus Pulposus Cells Promote Neurite Outgrowth in Neural Cells	PLOS ONE			English	Article							HUMAN INTERVERTEBRAL DISC; NERVE GROWTH-FACTOR; HUMAN NEUROBLASTOMA-CELLS; IN-VITRO; NEUROTROPHIC FACTOR; EXPRESSION; INGROWTH; MODEL; PROTEOGLYCAN; REGENERATION	Innervation of nociceptive nerve fibres into the normally aneural nucleus pulposus (NP) of the intervertebral disc (IVD) occurs during degeneration resulting in discogenic back pain. The neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), which are associated with stimulation of axonal outgrowth and nociception by neuronal cells, are both expressed by NP cells, with BDNF levels increasing with disease severity. However the mechanism of interaction between human NP cells and neural cells has yet to be fully elucidated. Therefore the aim of this study was to determine whether non-degenerate or degenerate human NP cells inhibit or stimulate neural outgrowth and whether any outgrowth is mediated by NGF or BDNF. Human NP cells from non-degenerate and degenerate IVD were cultured in alginate beads then co-cultured for 48 hours with human SH-SY5Y neuroblastoma cells. Co-culture of non-degenerate NP cells with neural cells resulted in both an inhibition of neurite outgrowth and reduction in percentage of neurite expressing cells. Conversely co-culture with degenerate NP cells resulted in an increase in both neurite length and percentage of neurite expressing cells. Addition of anti-NGF to the co-culture with degenerate cells resulted in a decrease in percentage of neurite expressing cells, while addition of anti-BDNF resulted in a decrease in both neurite length and percentage of neurite expressing cells. Our findings show that while non-degenerate NP cells are capable of inhibiting neurite outgrowth from human neural cells, degenerate NP cells stimulate outgrowth. Neurotrophin blocking studies demonstrated that both NGF and BDNF, secreted by degenerate NP cells, may play a role in this stimulation with BDNF potentially playing the predominant role. These findings suggest that NP cells are capable of regulating nerve ingrowth and that neoinnervation occurring during IVD degeneration may be stimulated by the NP cells themselves.	[Richardson, Stephen M.; Purmessur, Devina; Baird, Pauline; Probyn, Ben; Freemont, Anthony J.; Hoyland, Judith A.] Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Ctr Regenerat Med, Manchester, Lancs, England	University of Manchester	Hoyland, JA (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Ctr Regenerat Med, Manchester, Lancs, England.	Judith.a.hoyland@manchester.ac.uk	Richardson, Stephen/A-4124-2009; Freemont, Tony J/A-9000-2015; Purmessur (Walter), Devina/J-8821-2015; Hoyland, Judith A/P-5168-2014	Richardson, Stephen/0000-0002-7637-4135; Freemont, Tony J/0000-0002-9780-208X; Hoyland, Judith A/0000-0003-4876-5208	Biotechnology and Biological Sciences Research Council (BBSRC); Pfizer via a BBSRC CASE studentship	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer via a BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC) and Pfizer via a BBSRC CASE studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2007, SPINE, V32, P635, DOI 10.1097/01.brs.0000257556.90850.53; BOGDUK N, 1981, J ANAT, V132, P39; Coppes MH, 1997, SPINE, V22, P2342, DOI 10.1097/00007632-199710150-00005; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Freemont AJ, 2002, J PATHOL, V197, P286, DOI 10.1002/path.1108; Gingras M, 2003, FASEB J, V17, P2124, DOI 10.1096/fj.02-1180fje; Gruber HE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2456; Hynds DL, 1997, J NEUROSCI RES, V47, P617, DOI 10.1002/(SICI)1097-4547(19970315)47:6<617::AID-JNR7>3.0.CO;2-G; Hynds DL, 1999, EXP NEUROL, V160, P244, DOI 10.1006/exnr.1999.7212; JACKSON HC, 1966, J BONE JOINT SURG AM, VA 48, P1272, DOI 10.2106/00004623-196648070-00002; Johnson WEB, 2002, ARTHRITIS RHEUM-US, V46, P2658, DOI 10.1002/art.10585; Johnson WEB, 2006, SPINE, V31, P1187, DOI 10.1097/01.brs.0000217669.04903.61; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608; MARTIN DM, 1993, J CELL PHYSIOL, V155, P290, DOI 10.1002/jcp.1041550210; Melrose J, 2002, SPINE, V27, P1278, DOI 10.1097/00007632-200206150-00007; Moon HJ, 2012, SPINE, V37, P2, DOI 10.1097/BRS.0b013e31820cd2d8; Olmarker K, 2005, SPINE, V30, P1501, DOI 10.1097/01.brs.0000167823.17687.ec; Orita S, 2011, SPINE, V36, P1737, DOI 10.1097/BRS.0b013e31821d7b9f; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; PEREZPOLO JR, 1979, DEV BIOL, V71, P341, DOI 10.1016/0012-1606(79)90174-X; Purmessur D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2487; Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91, DOI 10.1136/mp.55.2.91; Snow DM, 2001, MICROSC RES TECHNIQ, V54, P273, DOI 10.1002/jemt.1140; Tang XQ, 2007, J NEUROSCI, V27, P6068, DOI 10.1523/JNEUROSCI.1442-07.2007; Tolofari SK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2898; Yamauchi K, 2009, SPINE, V34, P2263, DOI 10.1097/BRS.0b013e3181a5521d	29	45	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47735	10.1371/journal.pone.0047735	http://dx.doi.org/10.1371/journal.pone.0047735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091643	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800069
J	Yao, R; Ma, YL; Liang, W; Li, HH; Ma, ZJ; Yu, X; Liao, YH				Yao, Rui; Ma, Yu-Lan; Liang, Wei; Li, Huan-Huan; Ma, Zhi-Jun; Yu, Xian; Liao, Yu-Hua			MicroRNA-155 Modulates Treg and Th17 Cells Differentiation and Th17 Cell Function by Targeting SOCS1	PLOS ONE			English	Article							CD4(+) T-CELLS; PREVENTS DEVELOPMENT; SUPPRESSOR; STAT3; INDUCTION; ACTIVATION; EXPRESSION; RECEPTOR; ABSENCE; T(H)17	MicroRNA (miR)-155 is a critical player in both innate and adaptive immune responses. It can influence CD4(+) T cell lineage choice. To clarify the role of miR-155 in CD4(+) CD25(+) regulatory T (Treg)/T helper (Th) 17 cell differentiation and function, as well as the mechanism involved, we performed gain- and loss-of-function analysis by transfection pre-miR-155 and anti-miR155 into purified CD4+T cells. The results showed that miR-155 positively regulated both Treg and Th17 cell differentiation. It also induced the release of interleukin (IL)-17A by Th17 cells, but not the release of IL-10 and transforming growth factor (TGF)-beta 1 by Treg cells. Furthermore, we found that miR-155 reacted through regulating Janus kinase/signal transducer and activator of transcription (JAK/STAT) rather than TGF-beta/mothers against decapentaplegic homolog (SMAD) signaling pathway in the process of Treg and Th17 cells differentiation. This may because suppressors of cytokine signaling (SOCS) 1, the important negative regulator of JAK/STAT signaling pathway, was the direct target of miR-155 in this process, but SMAD2 and SMAD5 were not. Therefore, we demonstrated that miR-155 enhanced Treg and Th17 cells differentiation and IL-17A production by targeting SOCS1.	[Yao, Rui; Ma, Yu-Lan; Liang, Wei; Li, Huan-Huan; Yu, Xian; Liao, Yu-Hua] Huazhong Univ Sci & Technol, Inst Cardiol, Lab Cardiovasc Immunol, Wuhan 430074, Hubei, Peoples R China; [Ma, Zhi-Jun] Huazhong Univ Sci & Technol, Union Hosp, Dept Gen Surg, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liao, YH (corresponding author), Huazhong Univ Sci & Technol, Inst Cardiol, Lab Cardiovasc Immunol, Wuhan 430074, Hubei, Peoples R China.	liaoyh27@163.com			National Natural Science Foundation of China [81000085]; Doctor and Novo-teacher Foundation of the Chinese National Ministry of Education [20090142120049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctor and Novo-teacher Foundation of the Chinese National Ministry of Education	The work described in this article was supported by the National Natural Science Foundation of China (No. 81000085)(http://www.nsfc.gov.cn/Portal0/default152.htm), Doctor and Novo-teacher Foundation of the Chinese National Ministry of Education (No. 20090142120049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AS, 2009, CURR OPIN IMMUNOL, V21, P161, DOI 10.1016/j.coi.2009.03.013; Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Chan HC, 2010, LUPUS, V19, P696, DOI 10.1177/0961203309357437; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen W, 2002, J EXP MED, V198, P1875; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gomez-Guerrero C, 2004, J IMMUNOL, V172, P6969, DOI 10.4049/jimmunol.172.11.6969; Isomaki P, 2007, RHEUMATOLOGY, V46, P1538, DOI 10.1093/rheumatology/kem198; Jager LD, 2011, J NEUROIMMUNOL, V232, P108, DOI 10.1016/j.jneuroim.2010.10.018; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Lee TL, 2006, MOL CANCER THER, V5, P8, DOI 10.1158/1535-7163.MCT-05-0069; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; McLaren JE, 2009, CYTOKINE GROWTH F R, V20, P125, DOI 10.1016/j.cytogfr.2008.11.003; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Mujtaba MG, 2005, J IMMUNOL, V175, P5077, DOI 10.4049/jimmunol.175.8.5077; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; Numata K, 2007, J IMMUNOL, V178, P3777, DOI 10.4049/jimmunol.178.6.3777; O Flowers L, 2005, ONCOGENE, V24, P2114, DOI 10.1038/sj.onc.1208437; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Ortiz-Munoz G, 2009, ARTERIOSCL THROM VAS, V29, P525, DOI 10.1161/ATVBAHA.108.173781; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Turka LA, 2008, FRONT BIOSCI-LANDMRK, V13, P1440, DOI 10.2741/2773; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wei L, 2008, SEMIN CELL DEV BIOL, V19, P394, DOI 10.1016/j.semcdb.2008.07.011; Weniger MA, 2006, ONCOGENE, V25, P2679, DOI 10.1038/sj.onc.1209151; Xie JJ, 2010, CYTOKINE, V49, P185, DOI 10.1016/j.cyto.2009.09.007; Yu CR, 2011, INVEST OPHTH VIS SCI, V52, P6978, DOI 10.1167/iovs.11-7688; Yu HR, 2003, J LEUKOCYTE BIOL, V74, P952, DOI 10.1189/jlb.0902474; Zhan YF, 2009, IMMUNOL CELL BIOL, V87, P473, DOI 10.1038/icb.2009.23	46	224	249	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46082	10.1371/journal.pone.0046082	http://dx.doi.org/10.1371/journal.pone.0046082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091595	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800005
J	Sanz, AB; Sanchez-Nino, MD; Carrasco, S; Manzarbeitia, F; Ruiz-Andres, O; Selgas, R; Ruiz-Ortega, M; Gonzalez-Enguita, C; Egido, J; Ortiz, A				Belen Sanz, Ana; Dolores Sanchez-Nino, Maria; Carrasco, Susana; Manzarbeitia, Felix; Ruiz-Andres, Olga; Selgas, Rafael; Ruiz-Ortega, Marta; Gonzalez-Enguita, Carmen; Egido, Jesus; Ortiz, Alberto			Inflammatory Cytokines and Survival Factors from Serum Modulate Tweak-Induced Apoptosis in PC-3 Prostate Cancer Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; B PATHWAY ACTIVATION; TUBULAR EPITHELIUM; WEAK INDUCER; FAS LIGAND; RECEPTOR; FN14; TRAIL; DEATH; EXPRESSION	Tumor necrosis factor-like weak inducer of apoptosis (TWEAK, TNFSF12) is a member of the tumor necrosis factor superfamily. TWEAK activates the Fn14 receptor, and may regulate cell death, survival and proliferation in tumor cells. However, there is little information on the function and regulation of this system in prostate cancer. Fn14 expression and TWEAK actions were studied in two human prostate cancer cell lines, the androgen-independent PC-3 cell line and androgen-sensitive LNCaP cells. Additionally, the expression of Fn14 was analyzed in human biopsies of prostate cancer. Fn14 expression is increased in histological sections of human prostate adenocarcinoma. Both prostate cancer cell lines express constitutively Fn14, but, the androgen-independent cell line PC-3 showed higher levels of Fn14 that the LNCaP cells. Fn14 expression was up-regulated in PC-3 human prostate cancer cells in presence of inflammatory cytokines (TNF alpha/IFN gamma) as well as in presence of bovine fetal serum. TWEAK induced apoptotic cell death in PC-3 cells, but not in LNCaP cells. Moreover, in PC-3 cells, co-stimulation with TNF alpha/IFN gamma/TWEAK induced a higher rate of apoptosis. However, TWEAK or TWEAK/TNF alpha/IFN gamma did not induce apoptosis in presence of bovine fetal serum. TWEAK induced cell death through activation of the Fn14 receptor. Apoptosis was associated with activation of caspase-3, release of mitochondrial cytochrome C and an increased Bax/BclxL ratio. TWEAK/Fn14 pathway activation promotes apoptosis in androgen-independent PC-3 cells under certain culture conditions. Further characterization of the therapeutic target potential of TWEAK/Fn14 for human prostate cancer is warranted.	[Carrasco, Susana; Manzarbeitia, Felix; Ruiz-Andres, Olga; Ruiz-Ortega, Marta; Gonzalez-Enguita, Carmen; Egido, Jesus; Ortiz, Alberto] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Madrid, Spain; [Carrasco, Susana; Ruiz-Andres, Olga; Ruiz-Ortega, Marta; Egido, Jesus; Ortiz, Alberto] Fdn Renal Inigo Alvarez Toledo, Madrid, Spain; [Belen Sanz, Ana; Dolores Sanchez-Nino, Maria; Selgas, Rafael] IdiPAZ, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz	Ortiz, A (corresponding author), Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Madrid, Spain.	aortiz@fjd.es	Sanz, Ana Belen/C-9489-2013; Gonzalez Enguita, Carmen/GWQ-3941-2022; Ortega, Marta Ruiz/AAN-2136-2020; ortiz, alberto/Y-7582-2018; Ruiz-Ortega, Marta/D-3584-2012; Sanchez-Niño, Maria Dolores/B-7350-2019; Gonzalez Enguita, Maria Del Carmen/N-7830-2018; ruiz-ortega, marta/D-3584-2012	Sanz, Ana Belen/0000-0002-0255-5689; Ortega, Marta Ruiz/0000-0002-1495-6535; ortiz, alberto/0000-0002-9805-9523; Ruiz-Ortega, Marta/0000-0002-1495-6535; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409; Carrasco Navarro, Susana/0000-0003-3746-0580; Gonzalez Enguita, Maria Del Carmen/0000-0002-5881-6614; ruiz-ortega, marta/0000-0002-1403-2690	Fondo de Investigacion Sanitaria (FIS) [PS09/00447]; Instituto de Salud Carlos III-Redes Tematicas de Investigacion Cooperativa en Salud(ISCIII-RETIC) [REDinREN/RD06/0016]	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Instituto de Salud Carlos III-Redes Tematicas de Investigacion Cooperativa en Salud(ISCIII-RETIC)	Grant support from Fondo de Investigacion Sanitaria (FIS) PS09/00447, Instituto de Salud Carlos III-Redes Tematicas de Investigacion Cooperativa en Salud(ISCIII-RETIC)REDinREN/RD06/0016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345; Alonso V, 2009, LIFE SCI, V85, P421, DOI 10.1016/j.lfs.2009.07.005; Sanz AB, 2011, KIDNEY INT, V80, P708, DOI 10.1038/ki.2011.180; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Bucur O, 2006, FRONT BIOSCI-LANDMRK, V11, P1549, DOI 10.2741/1903; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, P110, DOI 10.2215/CJN.02790608; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Cornforth AN, 2008, ONCOGENE, V27, P4422, DOI 10.1038/onc.2008.80; Culp PA, 2010, CLIN CANCER RES, V16, P497, DOI 10.1158/1078-0432.CCR-09-1929; Dai L, 2009, CANCER LETT, V283, P159, DOI 10.1016/j.canlet.2009.03.036; Dionne S, 2010, ANTICANCER RES, V30, P157; Sanchez-Nino MD, 2010, J AM SOC NEPHROL, V21, P610, DOI 10.1681/ASN.2009020227; Festuccia C, 2008, INT J ONCOL, V33, P381, DOI 10.3892/ijo_00000019; Guseva NV, 2004, J CELL BIOCHEM, V91, P70, DOI 10.1002/jcb.10707; Huang MG, 2011, CARCINOGENESIS, V32, P1589, DOI 10.1093/carcin/bgr182; Hwang C, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-26; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Justo P, 2006, KIDNEY INT, V70, P1750, DOI 10.1038/sj.ki.5001866; Kaduka Y, 2005, BIOCHEM BIOPH RES CO, V331, P384, DOI 10.1016/j.bbrc.2005.03.176; Kaplan MJ, 2000, J IMMUNOL, V164, P2897, DOI 10.4049/jimmunol.164.6.2897; Kaplan MJ, 2002, J IMMUNOL, V169, P6020, DOI 10.4049/jimmunol.169.10.6020; Kim HS, 2010, PROSTATE, V70, P1540, DOI 10.1002/pros.21189; Kralisch S, 2008, ATHEROSCLEROSIS, V199, P440, DOI 10.1016/j.atherosclerosis.2007.10.022; Lorz C, 2000, J AM SOC NEPHROL, V11, P1266, DOI 10.1681/ASN.V1171266; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Martin-Ventura JL, 2011, ATHEROSCLEROSIS, V214, P486, DOI 10.1016/j.atherosclerosis.2010.11.009; Michaelson JS, 2011, MABS-AUSTIN, V3, P362, DOI 10.4161/mabs.3.4.16090; Michaelson JS, 2009, RESULTS PROBL CELL D, V49, P145, DOI 10.1007/400_2008_18; Michaelson JS, 2012, CANC BIOL THER, V13, P20564; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Molano A, 2009, IMMUNOL LETT, V125, P119, DOI 10.1016/j.imlet.2009.06.010; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Munoz-Garcia B, 2006, STROKE, V37, P2044, DOI 10.1161/01.STR.0000230648.00027.00; Nakayama M, 2003, BIOCHEM BIOPH RES CO, V306, P819, DOI 10.1016/S0006-291X(03)01051-9; Nastiuk KL, 2008, CANCER BIOL THER, V7, P1171, DOI 10.4161/cbt.7.8.6712; Nesterov A, 2001, J BIOL CHEM, V276, P10767, DOI 10.1074/jbc.M005196200; Novoyatleva T, 2010, CARDIOVASC RES, V85, P681, DOI 10.1093/cvr/cvp360; O'Kane HF, 2006, J UROLOGY, V175, P432, DOI 10.1016/S0022-5347(05)00160-6; Ortiz A, 2000, KIDNEY INT, V57, P969, DOI 10.1046/j.1523-1755.2000.00925.x; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; Perez-Martinez FC, 2007, J CLIN PATHOL, V60, P290, DOI 10.1136/jcp.2006.037853; Rodriguez-Berriguete G, 2012, PROSTATE, V72, P40, DOI 10.1002/pros.21404; Royuela M, 2008, HISTOL HISTOPATHOL, V23, P1279, DOI 10.14670/HH-23.1279; Sanz AB, 2009, J CELL MOL MED, V13, P3329, DOI 10.1111/j.1582-4934.2009.00766.x; Sanz AB, 2008, J AM SOC NEPHROL, V19, P695, DOI 10.1681/ASN.2007050577; Shirley S, 2013, CANCER LETT, V332, P141, DOI 10.1016/j.canlet.2010.10.009; Snyder CF, 2010, PROSTATE CANCER P D, V13, P58, DOI 10.1038/pcan.2009.39; Tenniswood M, 2004, CANCER BIOL THER, V3, P769, DOI 10.4161/cbt.3.8.1028; Tiller G, 2009, ENDOCRINOLOGY, V150, P5373, DOI 10.1210/en.2009-0488; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Wang DF, 2010, CANCER LETT, V294, P91, DOI 10.1016/j.canlet.2010.01.027; Watts GS, 2007, INT J CANCER, V121, P2132, DOI 10.1002/ijc.22898; WILLIAMSON BD, 1983, P NATL ACAD SCI-BIOL, V80, P5397, DOI 10.1073/pnas.80.17.5397; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Xia Li-Ping, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P575	61	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47440	10.1371/journal.pone.0047440	http://dx.doi.org/10.1371/journal.pone.0047440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077618	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100114
J	Huang, CC; Chan, WL; Luo, JC; Chen, YC; Chen, TJ; Chung, CM; Huang, PH; Lin, SJ; Chen, JW; Leu, HB				Huang, Chin-Chou; Chan, Wan-Leong; Luo, Jiing-Chyuan; Chen, Yu-Chun; Chen, Tzeng-Ji; Chung, Chia-Min; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang			Gastroesophageal Reflux Disease and Atrial Fibrillation: A Nationwide Population-Based Study	PLOS ONE			English	Article							CATHETER ABLATION; RISK; EPIDEMIOLOGY; ESOPHAGITIS; MANAGEMENT; LOCUS	Objectives: Precise mechanisms of atrial fibrillation (AF) are uncertain, but their association with esophageal disorders has been recently proposed. The association between gastroesophageal reflux disease (GERD), the most common gastroesophageal disorder, and AF remains undetermined. We therefore aimed to investigate the association between GERD and later development of AF. Methods and Results: Patients with GERD were identified from the 1,000,000-person cohort dataset sampled from the Taiwan National Health Insurance database. The study cohort comprised 29,688 newly diagnosed adult GERD patients; 29,597 randomly selected age-, gender-, comobidity-matched subjects comprised the comparison cohort. Cox proportional hazard regressions were performed as a means of comparing the AF-free survival rate for the two cohorts. During a maximum three years of follow-up, a total of 351 patients experienced AF, including 184 (0.62%) patients in the GERD cohort and 167 (0.56%) in the control group. The log-rank test showed that patients with GERD had significantly higher incidence of AF than those without GERD (p = 0.024). After Cox proportional hazard regression model analysis, GERD was independently associated with the increased risk of AF (hazard ratio, 1.31; 95% confidence interval, 1.06-1.61, p = 0.013). Conclusion: GERD was independently associated with an increased risk of future AF in a nationwide population-based cohort.	[Huang, Chin-Chou; Chan, Wan-Leong; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Huang, Chin-Chou; Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chan, Wan-Leong; Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Luo, Jiing-Chyuan] Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Huang, Chin-Chou; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Huang, Po-Hsun; Lin, Shing-Jong; Leu, Hsin-Bang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Luo, Jiing-Chyuan] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Chen, Yu-Chun] Natl Yang Ming Univ Hosp, Dept Med Res & Educ, Yi Lan, Taiwan; [Chung, Chia-Min] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Leu, HB (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan.	hbleu@vghtpe.gov.tw	Chen, YuChun/L-1052-2019; Chen, Yu Chun/K-6635-2019; Chen, Yu-Chun/B-1227-2012; Chen, TJ/AAH-8430-2021	Chen, YuChun/0000-0002-4124-1949; Chen, Yu-Chun/0000-0002-4124-1949; 	Taipei Veterans General Hospital, Taipei, Taiwan [V99B1-011, V99C1-125, V100B-013]; Yen Tjing Ling Medical Foundation, Taipei, Taiwan [CI-97-13, CI-98-16]; National Science Council [NSC 100-2314-B-075-055]; UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council [NSC-99-2911-I-009-101-A2]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Yen Tjing Ling Medical Foundation, Taipei, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan); UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council	The present study was partly supported by research grants from the V99B1-011, V99C1-125, and V100B-013 from Taipei Veterans General Hospital, Taipei, Taiwan; CI-97-13 and CI-98-16 from the Yen Tjing Ling Medical Foundation, Taipei, Taiwan; NSC 100-2314-B-075-055 and UST-UCSD International Center of Excellence in Advanced Bio-engineering NSC-99-2911-I-009-101-A2 from the National Science Council. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Bunch TJ, 2008, AM J CARDIOL, V102, P1207, DOI 10.1016/j.amjcard.2008.06.048; Bureau of National Health Insurance, 2002, 2001 NAT HLTH INS AN; Chang CS, 1997, AM J GASTROENTEROL, V92, P668; Chauhan A, 1996, J AM COLL CARDIOL, V27, P1621, DOI 10.1016/0735-1097(96)00041-1; Chen KY, 2009, AM J MED SCI, V338, P453, DOI 10.1097/MAJ.0b013e3181b51fbd; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; DODDS WJ, 1982, NEW ENGL J MED, V307, P1547, DOI 10.1056/NEJM198212163072503; Ellinor PT, 2003, CIRCULATION, V107, P2880, DOI 10.1161/01.CIR.0000077910.80718.49; Fock KM, 2008, J GASTROEN HEPATOL, V23, P8, DOI 10.1111/j.1440-1746.2007.05249.x; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Gerson L, 2006, J CLIN GASTROENTEROL, V40, P828, DOI 10.1097/01.mcg.0000225571.42890.a5; Gillinov AM, 2004, ANN THORAC SURG, V78, P1836, DOI 10.1016/S0003-4975(03)01434-6; Goh KL, 2004, J GASTROEN HEPATOL, V19, pS22, DOI 10.1111/j.1440-1746.2004.03591.x; Gordon J, 2002, EUR J CARDIO-THORAC, V21, P587, DOI 10.1016/S1010-7940(01)01172-1; Ho KY, 2006, J GASTROEN HEPATOL, V21, P1362, DOI 10.1111/j.1440-1746.2006.04341.x; Hoorn EJ, 2010, AM J KIDNEY DIS, V56, P112, DOI 10.1053/j.ajkd.2009.11.019; Hou YL, 2007, J AM COLL CARDIOL, V50, P61, DOI 10.1016/j.jacc.2007.02.066; Huang CC, 2011, AM J CARDIOL, V107, P1028, DOI 10.1016/j.amjcard.2010.11.026; Huang CC, 2010, AM J CARDIOL, V105, P1705, DOI 10.1016/j.amjcard.2010.01.348; Issac TT, 2007, J AM COLL CARDIOL, V50, P2021, DOI 10.1016/j.jacc.2007.06.054; Kanoupakis EM, 2000, AM J CARDIOL, V86, P954, DOI 10.1016/S0002-9149(00)01129-2; Kollarik M, 2009, PULM PHARMACOL THER, V22, P130, DOI 10.1016/j.pupt.2008.12.017; Kunz JS, 2009, CLIN CARDIOL, V32, P584, DOI 10.1002/clc.20660; Lee CH, 2007, AM J MED, V120, pe1; Lee YC, 2006, J GASTROEN HEPATOL, V21, P798, DOI 10.1111/j.1440-1746.2005.04034.x; Lin LJ, 2008, CLIN THER, V30, P1726, DOI 10.1016/j.clinthera.2008.09.010; Maixent JM, 1998, J CARDIOVASC ELECTR, V9, P612, DOI 10.1111/j.1540-8167.1998.tb00942.x; Marcus GM, 2010, J INNOVATIONS CARD R, V1, P85, DOI 10.19102/icrm.2010.011206; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Nishida K, 2011, CIRCULATION, V123, P137, DOI 10.1161/CIRCULATIONAHA.110.972778; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; Rieder F, 2007, GASTROENTEROLOGY, V132, P154, DOI 10.1053/j.gastro.2006.10.009; Schauerte P, 2000, CIRCULATION, V102, P2774, DOI 10.1161/01.CIR.102.22.2774; Shaheen NJ, 2006, AM J GASTROENTEROL, V101, P2128, DOI 10.1111/j.1572-0241.2006.00723.x; SPECHLER SJ, 1992, DIGESTION, V51, P24, DOI 10.1159/000200911; Stollberger C, 2003, J GASTROENTEROL, V38, P1109, DOI 10.1007/s00535-003-1216-6; Tsao HM, 2005, CHEST, V128, P2581, DOI 10.1378/chest.128.4.2581; Weigl M, 2003, SOUTH MED J, V96, P1128, DOI 10.1097/01.SMJ.0000084294.77504.4B	41	27	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47575	10.1371/journal.pone.0047575	http://dx.doi.org/10.1371/journal.pone.0047575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077642	Green Submitted, gold, Green Published			2022-12-27	WOS:000309995100137
J	Chen, FQ; Chen, C; Yang, SL; Gong, W; Wang, Y; Cianflone, K; Tang, JR; Wang, DW				Chen, Fuqiong; Chen, Chen; Yang, Shenglan; Gong, Wei; Wang, Yan; Cianflone, Katherine; Tang, Jiarong; Wang, Dao Wen			Let-7b Inhibits Human Cancer Phenotype by Targeting Cytochrome P450 Epoxygenase 2J2	PLOS ONE			English	Article							ARACHIDONIC-ACID EPOXYGENASE; MOLECULAR-CLONING; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; CELL-GROWTH; MICRORNAS; EXPRESSION; PROLIFERATION; METABOLISM; APOPTOSIS	Background: MicroRNAs (miRNAs) are small, noncoding RNA molecules of 20 to 22 nucleotides that regulate gene expression by binding to their 39 untranslated region (3'UTR). Increasing data implicate altered miRNA participation in the progress of cancer. We previously reported that CYP2J2 epoxygenase promotes human cancer phenotypes. But whether and how CYP2J2 is regulated by miRNA is not understood. Methods and Results: Using bioinformatics analysis, we found potential target sites for miRNA let-7b in 3'UTR of human CYP2J2. Luciferase and western blot assays revealed that CYP2J2 was regulated by let-7b. In addition, let-7b decreased the enzymatic activity of endogenous CYP2J2. Furthermore, let-7b may diminish cell proliferation and promote cell apoptosis of tumor cells via posttranscriptional repression of CYP2J2. Tumor xenografts were induced in nude mice by subcutaneous injection of MDA-MB-435 cells. The let-7b expression vector, pSilencer-let-7b, was injected through tail vein every 3 weeks. Let-7b significantly inhibited the tumor phenotype by targeting CYP2J2. Moreover, quantitative real-time polymerase chain reaction and western blotting were used to determine the expression levels of let-7b and CYP2J2 protein from 18 matched lung squamous cell cancer and adjacent normal lung tissues; the expression level of CYP2J2 was inversely proportional to that of let-7b. Conclusions: Our results demonstrated that the decreased expression of let-7b could lead to the high expression of CYP2J2 protein in cancerous tissues. These findings suggest that miRNA let-7b reduces CYP2J2 expression, which may contribute to inhibiting tumor phenotypes.	[Chen, Fuqiong; Chen, Chen; Yang, Shenglan; Gong, Wei; Wang, Yan; Tang, Jiarong; Wang, Dao Wen] Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Chen, Fuqiong; Chen, Chen; Yang, Shenglan; Gong, Wei; Wang, Yan; Tang, Jiarong; Wang, Dao Wen] Huazhong Univ Sci & Technol, Gene Therapy Ctr, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Cianflone, Katherine] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Laval University	Chen, FQ (corresponding author), Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	jrtang@tjh.tjmu.edu.cn; dwwang@tjh.tjmu.edu.cn	, Chen/R-4321-2019		National Basic Research Program "973" [2012CB517801]; NSFC [30930039, 81070236]	National Basic Research Program "973"(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by grant from the National Basic Research Program "973" (No. 2012CB517801) and NSFC (No. 30930039 and 81070236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Capdevila JH, 2000, J LIPID RES, V41, P163; Chen C, 2009, J PHARMACOL EXP THER, V329, P908, DOI 10.1124/jpet.109.152017; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Jiang JG, 2005, CANCER RES, V65, P4707, DOI 10.1158/0008-5472.CAN-04-4173; Jiang JG, 2007, CANCER RES, V67, P6665, DOI 10.1158/0008-5472.CAN-06-3643; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; KARARA A, 1993, J BIOL CHEM, V268, P13565; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Mott JL, 2009, HEPATOLOGY, V50, P630, DOI 10.1002/hep.23010; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; Wu S, 1996, J BIOL CHEM, V271, P3460; Wu S, 1997, J BIOL CHEM, V272, P12551, DOI 10.1074/jbc.272.19.12551; Yang SL, 2007, AM J PHYSIOL-HEART C, V293, pH142, DOI 10.1152/ajpheart.00783.2006; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhao YC, 2011, BREAST CANCER RES TR, V127, P69, DOI 10.1007/s10549-010-0972-2	28	25	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39197	10.1371/journal.pone.0039197	http://dx.doi.org/10.1371/journal.pone.0039197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	23082159	Green Published, gold, Green Submitted			2022-12-27	WOS:000305781700022
J	Igo, RP; Kopplin, LJ; Joseph, P; Truitt, B; Fondran, J; Bardenstein, D; Aldave, AJ; Croasdale, CR; Price, MO; Rosenwasser, M; Lass, JH; Iyengar, SK				Igo, Robert P., Jr.; Kopplin, Laura J.; Joseph, Peronne; Truitt, Barbara; Fondran, Jeremy; Bardenstein, David; Aldave, Anthony J.; Croasdale, Christopher R.; Price, Marianne O.; Rosenwasser, Miriam; Lass, Jonathan H.; Iyengar, Sudha K.		FECD Genetics Multi-Ctr Study Grp	Differing Roles for TCF4 and COL8A2 in Central Corneal Thickness and Fuchs Endothelial Corneal Dystrophy	PLOS ONE			English	Article							MISSENSE MUTATIONS; SLC4A11 MUTATIONS; GENE; COLLAGEN; POLYMORPHISMS; ASSOCIATION; LOCUS; HERITABILITY; VARIANTS; PROTEIN	Fuchs endothelial corneal dystrophy (FECD) is the most common late-onset, vision-threatening corneal dystrophy in the United States, affecting about 4% of the population. Advanced FECD involves a thickening of the cornea from stromal edema and changes in Descemet membrane. To understand the relationship between FECD and central corneal thickness (CCT), we characterized common genetic variation in COL8A2 and TCF4, genes previously implicated in CCT and/or FECD. Other genes previously associated with FECD (PITX2, ZEB1, SLC4A11), and genes only known to affect CCT (COL5A1, FOXO1, AVGR8, ZNF469) were also interrogated. FECD probands, relatives and controls were recruited from 32 clinical sites; a total of 532 cases and 204 controls were genotyped and tested for association of FECD case/control status, a 7-step FECD severity scale and CCT, adjusting for age and sex. Association of FECD grade with TCF4 was highly significant (OR = 6.01 at rs613872; p = 4.8 x 10(-25)), and remained significant when adjusted for changes in CCT (OR = 4.84; p = 2.2 x 10(-16)). Association of CCT with TCF4 was also significant (p = 6.1 x 10(-7)), but was abolished with adjustment for FECD grade (p = 0.92). After adjusting for FECD grade, markers in other genes examined were modestly associated (p similar to 0.001) with FECD and/or CCT. Thus, common variants in TCF4 appear to influence FECD directly, and CCT secondarily via FECD. Additionally, changes in corneal thickness due to the effect of other loci may modify disease severity, age-at-onset, or other biomechanical characteristics.	[Igo, Robert P., Jr.; Joseph, Peronne; Truitt, Barbara; Fondran, Jeremy; Lass, Jonathan H.; Iyengar, Sudha K.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Kopplin, Laura J.] Casey Eye Inst, Dept Ophthalmol, Portland, OR USA; [Kopplin, Laura J.; Bardenstein, David; Lass, Jonathan H.; Iyengar, Sudha K.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Kopplin, Laura J.; Bardenstein, David; Lass, Jonathan H.; Iyengar, Sudha K.] Univ Hosp Cleveland, Inst Eye, Cleveland, OH 44106 USA; [Aldave, Anthony J.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Aldave, Anthony J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Croasdale, Christopher R.] David Duehr Dean Clin, Madison, WI USA; [Price, Marianne O.] Price Vis Grp, Indianapolis, IN USA; [Rosenwasser, Miriam] Cent Penn Eye Inst, Hershey, PA USA; [Iyengar, Sudha K.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Case Western Reserve University	Iyengar, SK (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	ski@case.edu	Igo, Rob/P-3438-2019; /S-1190-2019	Igo, Rob/0000-0002-0024-1993; /0000-0001-7488-250X; Price, Marianne/0000-0002-6652-534X	National Eye Institute [R01EY16482, R21 EY015145, P30 EY11373]; Research to Prevent Blindness; Ohio Lions Eye Research Foundation; U.S. Public Health Service Resource Grant from the National Center for Research Resources [RR03655]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016482, R21EY015145, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; U.S. Public Health Service Resource Grant from the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Eye Institute (grant numbers R01EY16482, R21 EY015145, P30 EY11373), Research to Prevent Blindness and the Ohio Lions Eye Research Foundation. Some of the results of this paper were obtained by using the program package S.A.G.E., which is supported by a U.S. Public Health Service Resource Grant (RR03655) from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu A, 2008, AM J HUM GENET, V82, P1217, DOI 10.1016/j.ajhg.2008.04.001; Afshari NA, 2009, INVEST OPHTH VIS SCI, V50, P1093, DOI 10.1167/iovs.08-1839; Aldave AJ, 2007, AM J MED GENET A, V143A, P2549, DOI 10.1002/ajmg.a.31978; Aldave AJ, 2006, INVEST OPHTH VIS SCI, V47, P3787, DOI 10.1167/iovs.05-1635; ALSBIRK PH, 1978, ACTA OPHTHALMOL, V56, P105; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asai-Coakwell M, 2006, INVEST OPHTH VIS SCI, V47, P4905, DOI 10.1167/iovs.06-0457; Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Bohnsack BL, 2012, INVEST OPHTH VIS SCI, V53, P7, DOI 10.1167/iovs.11-8494; Charlesworth J, 2010, INVEST OPHTH VIS SCI, V50, P4087; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Desir J, 2007, J MED GENET, V44, P322, DOI 10.1136/jmg.2006.046904; Desronvil T, 2010, MOL VIS, V16, P2185; Ehlers N, 1998, ACTA OPHTHALMOL SCAN, V76, P314, DOI 10.1034/j.1600-0420.1998.760312.x; Eye Bank Association of America, 2010, STAT REP; Gottsch JD, 2006, CORNEA, V25, P485, DOI 10.1097/01.ico.0000178726.11693.14; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P4504, DOI 10.1167/iovs.05-0497; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Gutti V, 2010, OCULAR DIS MECH MANA; Hemadevi B, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-3; Hopfer U, 2005, FASEB J, V19, P1232, DOI 10.1096/fj.04-3019com; Jiao XD, 2007, J MED GENET, V44, P64, DOI 10.1136/jmg.2006.044644; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Jun AS, 2012, HUM MOL GENET, V21, P384, DOI 10.1093/hmg/ddr473; Kniestedt C, 2006, OPHTHALMOLOGY, V113, P1791, DOI 10.1016/j.ophtha.2006.05.017; Kobayashi A, 2004, JPN J OPHTHALMOL, V48, P195, DOI 10.1007/s10384-003-0063-6; Kopplin LJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P433, DOI 10.1001/archopthalmol.2011.1626; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Kuot A, 2012, EUR J HUM GENET, V20, P632, DOI 10.1038/ejhg.2011.248; Landers JA, 2009, INVEST OPHTH VIS SCI, V50, P4087, DOI 10.1167/iovs.08-3271; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018044; Liskova P, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9495; Liskova P, 2010, OPHTHALMIC GENET, V31, P230, DOI 10.3109/13816810.2010.518577; Louttit MD, 2012, CORNEA, V31, P26, DOI 10.1097/ICO.0b013e31821c9b8f; Lu R, 2012, STEM CELLS, V30, P753, DOI 10.1002/stem.1032; Lu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000947; Mackey DA, 2012, CORNEA, V31, P162, DOI 10.1097/ICO.0b013e318226155f; Mehta JS, 2008, INVEST OPHTH VIS SCI, V49, P184, DOI 10.1167/iovs.07-0847; Mok JW, 2009, EYE, V23, P895, DOI 10.1038/eye.2008.116; Musch DC, 2011, INVEST OPHTH VIS SCI, V52, P6959, DOI 10.1167/iovs.11-7771; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Puk O, 2009, INVEST OPHTH VIS SCI, V50, P5653, DOI 10.1167/iovs.09-3550; Ramprasad Vedam L, 2007, Hum Mutat, V28, P522, DOI 10.1002/humu.9487; Riazuddin SA, 2012, AM J HUM GENET, V90, P533, DOI 10.1016/j.ajhg.2012.01.013; Riazuddin SA, 2011, INVEST OPHTH VIS SCI, V52, P2825, DOI 10.1167/iovs.10-6497; Riazuddin SA, 2010, HUM MUTAT, V31, P1261, DOI 10.1002/humu.21356; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; S.A.G.E, 2011, STAT ANAL GENETIC EP; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Shimizu S, 2004, AM J MED GENET A, V130A, P372, DOI 10.1002/ajmg.a.30267; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P3919, DOI 10.1167/iovs.05-1619; Thalamuthu A, 2011, INVEST OPHTH VIS SCI, V52, P5573, DOI 10.1167/iovs.11-7568; Toh TY, 2005, INVEST OPHTH VIS SCI, V46, P3718, DOI 10.1167/iovs.04-1497; Vincent AL, 2009, MOL VIS, V15, P2544; Vitart V, 2010, HUM MOL GENET, V19, P4304, DOI 10.1093/hmg/ddq349; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Vithana EN, 2011, HUM MOL GENET, V20, P649, DOI 10.1093/hmg/ddq511; WILSON SE, 1988, AM J OPHTHALMOL, V106, P270, DOI 10.1016/0002-9394(88)90360-1; Wright EMMB, 2011, AM J HUM GENET, V88, P767, DOI 10.1016/j.ajhg.2011.05.007; Zheng YF, 2008, INVEST OPHTH VIS SCI, V49, P4303, DOI 10.1167/iovs.08-1934	67	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e46742	10.1371/journal.pone.0046742	http://dx.doi.org/10.1371/journal.pone.0046742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110055	Green Submitted, Green Published, gold			2022-12-27	WOS:000310193600005
J	Goodison, S; Chang, MR; Dai, YF; Urquidi, V; Rosser, CJ				Goodison, Steve; Chang, Myron; Dai, Yunfeng; Urquidi, Virginia; Rosser, Charles J.			A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; URINARY INTERLEUKIN-8; APOLIPOPROTEIN-E; BIOMARKER; TERE1	Accurate urinary assays for bladder cancer (BCa) detection would benefit both patients and healthcare systems. Through genomic and proteomic profiling of urine components, we have previously identified a panel of biomarkers that can outperform current urine-based biomarkers for the non-invasive detection of BCa. Herein, we report the diagnostic utility of various multivariate combinations of these biomarkers. We performed a case-controlled validation study in which voided urines from 127 patients (64 tumor bearing subjects) were analyzed. The urinary concentrations of 14 biomarkers (IL-8, MMP-9, MMP-10, SDC1, CCL18, PAI-1, CD44, VEGF, ANG, CA9, A1AT, OPN, PTX3, and APOE) were assessed by enzyme-linked immunosorbent assay (ELISA). Diagnostic performance of each biomarker and multivariate models were compared using receiver operating characteristic curves and the chi-square test. An 8-biomarker model achieved the most accurate BCa diagnosis (sensitivity 92%, specificity 97%), but a combination of 3 of the 8 biomarkers (IL-8, VEGF, and APOE) was also highly accurate (sensitivity 90%, specificity 97%). For comparison, the commercial BTA-Trak ELISA test achieved a sensitivity of 79% and a specificity of 83%, and voided urine cytology detected only 33% of BCa cases in the same cohort. These datashow that a multivariate urine-based assay can markedly improve the accuracy of non-invasive BCa detection. Further validation studies are under way to investigate the clinical utility of this panel of biomarkers for BCa diagnosis and disease monitoring.	[Rosser, Charles J.] Univ Texas MD Anderson Canc Ctr, Sect Urol Oncol, Orlando, FL USA; [Goodison, Steve; Urquidi, Virginia] Univ Texas MD Anderson Canc Ctr, Canc Res Inst, Orlando, FL USA; [Chang, Myron; Dai, Yunfeng] Univ Florida, Dept Biostat, Gainesville, FL USA; [Urquidi, Virginia; Rosser, Charles J.] Nonagen Biosci Corp, Orlando, FL USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; State University System of Florida; University of Florida	Rosser, CJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Urol Oncol, Orlando, FL USA.	Charles.rosser@orlandohealth.com			Flight Attendant Medical Research Institute; Florida Department of Health James and Esther King Team Science Award [10KT-01]; National Cancer Institute [RO1 CA116161]; NATIONAL CANCER INSTITUTE [R01CA116161] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; Florida Department of Health James and Esther King Team Science Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by research grants from Flight Attendant Medical Research Institute (CJR), Florida Department of Health James and Esther King Team Science Award 10KT-01 (CJR), and National Cancer Institute RO1 CA116161 (SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Banos JLG, 2001, UROLOGY, V57, P685, DOI 10.1016/S0090-4295(00)01090-6; Bian W, 2007, INT J UROL, V14, P108, DOI 10.1111/j.1442-2042.2007.01670.x; Bossuyt PM, 2004, FAM PRACT, V21, P4, DOI 10.1093/fampra/cmh103; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Crew JP, 1999, J UROLOGY, V161, P799, DOI 10.1016/S0022-5347(01)61772-5; Eissa Sanaa, 2007, Cancer Biomarkers, V3, P275; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Grossman HB, 2005, JAMA-J AM MED ASSOC, V293, P810, DOI 10.1001/jama.293.7.810; Ho YY, 2001, J BIOL CHEM, V276, P43455, DOI 10.1074/jbc.M105325200; Jeon SH, 2001, ONCOL REP, V8, P1265; Kocak H, 2004, CLIN BIOCHEM, V37, P673, DOI 10.1016/j.clinbiochem.2004.02.005; Leon LF, 1998, BIOMETRICS, V54, P1165, DOI 10.2307/2533866; Linden M, 2012, PROTEOMICS, V12, P135, DOI 10.1002/pmic.201000810; Lokeshwar VB, 2005, UROLOGY, V66, P35, DOI 10.1016/j.urology.2005.08.064; McGarvey TW, 2005, J CELL BIOCHEM, V95, P419, DOI 10.1002/jcb.20432; Mian BM, 2003, CLIN CANCER RES, V9, P3167; Montironi R, 2005, INT J SURG PATHOL, V13, P143, DOI 10.1177/106689690501300203; Rosser CJ, 2009, CANCER EPIDEM BIOMAR, V18, P444, DOI 10.1158/1055-9965.EPI-08-1002; Sheryka E, 2003, UROLOGY, V62, P162, DOI 10.1016/S0090-4295(03)00134-1; Urquidi V, 2012, J UROLOGY, V188, P2211; Urquidi V, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-12; Urquidi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037797; Urquidi V, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2012.01.016; Yang N, 2011, CLIN CANCER RES, V17, P3349, DOI 10.1158/1078-0432.CCR-10-3121	27	74	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47469	10.1371/journal.pone.0047469	http://dx.doi.org/10.1371/journal.pone.0047469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094052	Green Submitted, Green Published, gold			2022-12-27	WOS:000310050200025
J	Bertelsen, K; Dorosz, J; Hansen, SK; Nielsen, NC; Vosegaard, T				Bertelsen, Kresten; Dorosz, Jerzy; Hansen, Sara Krogh; Nielsen, Niels Chr.; Vosegaard, Thomas			Mechanisms of Peptide-Induced Pore Formation in Lipid Bilayers Investigated by Oriented P-31 Solid-State NMR Spectroscopy	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ANTIMICROBIAL PEPTIDE; MEMBRANE-PROTEINS; ROTATIONAL DIFFUSION; PHOSPHOLIPID-BILAYERS; MOLECULAR-DYNAMICS; ALAMETHICIN; MODEL; N-15; CONFORMATION	There is a considerable interest in understanding the function of antimicrobial peptides (AMPs), but the details of their mode of action is not fully understood. This motivates extensive efforts in determining structural and mechanistic parameters for AMP's interaction with lipid membranes. In this study we show that oriented-sample P-31 solid-state NMR spectroscopy can be used to probe the membrane perturbations and -disruption by AMPs. For two AMPs, alamethicin and novicidin, we observe that the majority of the lipids remain in a planar bilayer conformation but that a number of lipids are involved in the peptide anchoring. These lipids display reduced dynamics. Our study supports previous studies showing that alamethicin adopts a transmembrane arrangement without significant disturbance of the surrounding lipids, while novicidin forms toroidal pores at high concentrations leading to more extensive membrane disturbance.	[Bertelsen, Kresten; Dorosz, Jerzy; Hansen, Sara Krogh; Nielsen, Niels Chr.; Vosegaard, Thomas] Univ Aarhus, Dept Chem, Interdisciplinary Nanosci Ctr INANO, Ctr Insoluble Prot Struct InSPIN, Aarhus, Denmark; [Vosegaard, Thomas] Univ Aarhus, Sch Engn, Dept Engn, Aarhus, Denmark	Aarhus University; Aarhus University	Nielsen, NC (corresponding author), Univ Aarhus, Dept Chem, Interdisciplinary Nanosci Ctr INANO, Ctr Insoluble Prot Struct InSPIN, Aarhus, Denmark.	ncn@inano.au.dk; tv@chem.au.dk		Nielsen, Niels Chr./0000-0003-2978-4366; Vosegaard, Thomas/0000-0001-5414-4550	Danish National Research Foundation; Danish Natural Science Research Council, Lundbeckfonden; Danish Center for Scientific Computing (DCSC); Danish Biotechnology Instrument Centre (DABIC)	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Natural Science Research Council, Lundbeckfonden(Danish Natural Science Research CouncilLundbeckfonden); Danish Center for Scientific Computing (DCSC); Danish Biotechnology Instrument Centre (DABIC)	Support from the Danish National Research Foundation, the Danish Natural Science Research Council, Lundbeckfonden, the Danish Center for Scientific Computing (DCSC), and the Danish Biotechnology Instrument Centre (DABIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisenbrey C, 2004, J AM CHEM SOC, V126, P16676, DOI 10.1021/ja0468675; Bak M, 2000, J MAGN RESON, V147, P296, DOI 10.1006/jmre.2000.2179; Bak M, 2001, BIOPHYS J, V81, P1684, DOI 10.1016/S0006-3495(01)75822-5; Bechinger B, 2001, BIOCHEMISTRY-US, V40, P9428, DOI 10.1021/bi010162n; Bertelsen K, 2007, J AM CHEM SOC, V129, P14717, DOI 10.1021/ja0749690; Bertelsen K, 2011, J PHYS CHEM B, V115, P1767, DOI 10.1021/jp110866g; Bertelsen K, 2009, J AM CHEM SOC, V131, P18335, DOI 10.1021/ja908604u; BROWN MF, 1978, BIOPHYS J, V21, pA205; Cady SD, 2007, J AM CHEM SOC, V129, P5719, DOI 10.1021/ja070305e; CAFISO DS, 1994, ANNU REV BIOPH BIOM, V23, P141, DOI 10.1146/annurev.bb.23.060194.001041; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; Dittmer J, 2009, J PHYS CHEM B, V113, P6928, DOI 10.1021/jp811494p; Dubos RJ, 1941, J EXP MED, V73, P629, DOI 10.1084/jem.73.5.629; FENSKE DB, 1991, BIOPHYS J, V59, P55, DOI 10.1016/S0006-3495(91)82198-1; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; FOX RO, 1982, NATURE, V300, P325, DOI 10.1038/300325a0; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; GIBSON TR, 1985, PEPTIDES, V6, P615, DOI 10.1016/0196-9781(85)90162-7; Glaubitz C, 1998, J MAGN RESON, V130, P305, DOI 10.1006/jmre.1997.1344; GRIFFIN RG, 1976, J AM CHEM SOC, V98, P851, DOI 10.1021/ja00419a044; Hallock KJ, 2003, BIOPHYS J, V84, P3052, DOI 10.1016/S0006-3495(03)70031-9; Haney EF, 2010, CHEM PHYS LIPIDS, V163, P82, DOI 10.1016/j.chemphyslip.2009.09.002; He K, 1996, BIOPHYS J, V71, P2669, DOI 10.1016/S0006-3495(96)79458-4; HE K, 1995, BIOCHEMISTRY-US, V34, P15614, DOI 10.1021/bi00048a002; HERZFELD J, 1978, BIOCHEMISTRY-US, V17, P2711, DOI 10.1021/bi00607a003; Hong M, 2006, CHEM PHYS LETT, V432, P296, DOI 10.1016/j.cplett.2006.10.067; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Maragakis LL, 2008, EXPERT REV ANTI-INFE, V6, P751, DOI 10.1586/14787210.6.5.751; MARTIN DR, 1976, BIOCHEM J, V153, P181, DOI 10.1042/bj1530181; MathWorks Inc, MATLAB; Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; MOHR H, 1978, BIOCHIM BIOPHYS ACTA, V526, P375, DOI 10.1016/0005-2744(78)90129-8; NIELSEN NC, 1995, J BIOMOL NMR, V5, P311, DOI 10.1007/BF00211758; Nielsen SB, 2010, J COLLOID INTERF SCI, V345, P248, DOI 10.1016/j.jcis.2010.01.065; Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121; Oren Z, 1998, BIOPOLYMERS, V47, P451; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Park SH, 2006, J AM CHEM SOC, V128, P7402, DOI 10.1021/ja0606632; Park SH, 2006, J MAGN RESON, V178, P162, DOI 10.1016/j.jmr.2005.08.008; Picard F, 1996, BIOPHYS J, V70, P1737, DOI 10.1016/S0006-3495(96)79736-9; Prenner EJ, 1997, BIOCHEMISTRY-US, V36, P7906, DOI 10.1021/bi962785k; PRIMOR N, 1980, BIOCHIM BIOPHYS ACTA, V626, P299, DOI 10.1016/0005-2795(80)90124-5; Prongidi-Fix L, 2007, J AM CHEM SOC, V129, P8430, DOI 10.1021/ja072668k; Saint-Laurent A, 1998, BIOCHEM CELL BIOL, V76, P465; Salnikov ES, 2009, BIOPHYS J, V96, P86, DOI 10.1529/biophysj.108.136242; Sani MA, 2011, BIOPHYS J, V100, pL40, DOI 10.1016/j.bpj.2011.03.005; SANSOM MSP, 1993, EUR BIOPHYS J BIOPHY, V22, P105, DOI 10.1007/BF00196915; SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1; SEELIG J, 1977, Q REV BIOPHYS, V10, P353, DOI 10.1017/S0033583500002948; SMITH SO, 1992, ANNU REV BIOPH BIOM, V21, P25, DOI 10.1146/annurev.bb.21.060192.000325; Soong R, 2010, J AM CHEM SOC, V132, P5779, DOI 10.1021/ja910807e; Soubias O, 2005, BIOPHYS J, V89, P1120, DOI 10.1529/biophysj.105.059857; Strandberg E, 2009, BIOPHYS J, V96, P3223, DOI 10.1016/j.bpj.2009.02.040; Thogersen L, 2008, BIOPHYS J, V95, P4337, DOI 10.1529/biophysj.108.133330; Tieleman DP, 1998, FARADAY DISCUSS, V111, P209; Toraya S, 2004, BIOPHYS J, V87, P3323, DOI 10.1529/biophysj.104.046102; Tosner Z, 2009, J MAGN RESON, V197, P120, DOI 10.1016/j.jmr.2008.11.020; Vad B, 2010, BBA-PROTEINS PROTEOM, V1804, P806, DOI 10.1016/j.bbapap.2009.12.006; Vosegaard T, 2002, MONATSH CHEM, V133, P1555, DOI 10.1007/s00706-002-0519-2; Vosegaard T, 2008, J AM CHEM SOC, V130, P5028, DOI 10.1021/ja8000612; Wi S, 2008, J PHYS CHEM B, V112, P11402, DOI 10.1021/jp801825k; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	64	32	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47745	10.1371/journal.pone.0047745	http://dx.doi.org/10.1371/journal.pone.0047745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094079	Green Published, gold, Green Submitted			2022-12-27	WOS:000312384500020
J	Carter, EJ; Williams, DL; Minshew, NJ; Lehman, JF				Carter, Elizabeth J.; Williams, Diane L.; Minshew, Nancy J.; Lehman, Jill F.			Is He Being Bad? Social and Language Brain Networks during Social Judgment in Children with Autism	PLOS ONE			English	Article							FUSIFORM FACE AREA; ASPERGER-SYNDROME; SPECTRUM DISORDERS; PEER INTERACTION; WORKING-MEMORY; MIND REGIONS; FMRI; COMPREHENSION; ADOLESCENTS; ACTIVATION	Individuals with autism often violate social rules and have lower accuracy in identifying and explaining inappropriate social behavior. Twelve children with autism (AD) and thirteen children with typical development (TD) participated in this fMRI study of the neurofunctional basis of social judgment. Participants indicated in which of two pictures a boy was being bad (Social condition) or which of two pictures was outdoors (Physical condition). In the within-group Social-Physical comparison, TD children used components of mentalizing and language networks [bilateral inferior frontal gyrus (IFG), bilateral medial prefrontal cortex (mPFC), and bilateral posterior superior temporal sulcus (pSTS)], whereas AD children used a network that was primarily right IFG and bilateral pSTS, suggesting reduced use of social and language networks during this social judgment task. A direct group comparison on the Social-Physical contrast showed that the TD group had greater mPFC, bilateral IFG, and left superior temporal pole activity than the AD group. No regions were more active in the AD group than in the group with TD in this comparison. Both groups successfully performed the task, which required minimal language. The groups also performed similarly on eyetracking measures, indicating that the activation results probably reflect the use of a more basic strategy by the autism group rather than performance disparities. Even though language was unnecessary, the children with TD recruited language areas during the social task, suggesting automatic encoding of their knowledge into language; however, this was not the case for the children with autism. These findings support behavioral research indicating that, whereas children with autism may recognize socially inappropriate behavior, they have difficulty using spoken language to explain why it is inappropriate. The fMRI results indicate that AD children may not automatically use language to encode their social understanding, making expression and generalization of this knowledge more difficult.	[Carter, Elizabeth J.] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA; [Carter, Elizabeth J.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Williams, Diane L.] Duquesne Univ, Dept Speech Language Pathol, Pittsburgh, PA 15219 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Lehman, Jill F.] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Carter, EJ (corresponding author), Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA.	ejcarter@gmail.com	Williams, Diane L/B-4128-2017	Williams, Diane L/0000-0001-7135-9019; Carter, Elizabeth J./0000-0002-2735-148X	National Institute of Child Health and Human Development Autism Center of Excellence [P50HD055748]; National Institute on Deafness and Other Communication Disorders [DC006691]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC006691] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development Autism Center of Excellence; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a National Institute of Child Health and Human Development Autism Center of Excellence grant (P50HD055748, PI: NJM) and a National Institute on Deafness and Other Communication Disorders K23 award (DC006691, PI: DLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ANDO H, 1979, CHILD PSYCHIAT HUM D, V9, P131, DOI 10.1007/BF01433475; Bachevalier J, 2006, NEUROSCI BIOBEHAV R, V30, P97, DOI 10.1016/j.neubiorev.2005.07.002; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Baron-Cohen S., 2001, J DEV LEARNING DISOR, V5, P47, DOI DOI 10.1111/J.1467-7687.2008.00720.X; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BARONCOHEN S, 1986, BRIT J DEV PSYCHOL, V4, P113, DOI 10.1111/j.2044-835X.1986.tb01003.x; Bauminger N, 2003, J AUTISM DEV DISORD, V33, P489, DOI 10.1023/A:1025827427901; Berthoz S, 2002, BRAIN, V125, P1696, DOI 10.1093/brain/awf190; BOUCHER J, 1981, J AUTISM DEV DISORD, V11, P293, DOI 10.1007/BF01531512; Bronsard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014358; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Carter EJ, 2011, NEUROIMAGE, V54, P1634, DOI 10.1016/j.neuroimage.2010.08.077; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Dominick KC, 2007, RES DEV DISABIL, V28, P145, DOI 10.1016/j.ridd.2006.02.003; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Grandin T., 1995, THINKING PICTURES; Grant CM, 2005, AUTISM, V9, P317, DOI 10.1177/1362361305055418; Gray C.A., 2010, NEW SOCIAL STORY BOO, V10th ed; Grezes J, 2009, NEUROPSYCHOLOGIA, V47, P1816, DOI 10.1016/j.neuropsychologia.2009.02.021; Groen WB, 2010, CEREB CORTEX, V20, P1937, DOI 10.1093/cercor/bhp264; Happe F, 1996, NEUROREPORT, V8, P197, DOI 10.1097/00001756-199612200-00040; Harris GJ, 2006, BRAIN COGNITION, V61, P54, DOI 10.1016/j.bandc.2005.12.015; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Humphrey N, 2011, AUTISM, V15, P397, DOI 10.1177/1362361310387804; HURLBURT RT, 1994, PSYCHOL MED, V24, P385, DOI 10.1017/S0033291700027367; Jellema T, 2009, AUTISM RES, V2, P192, DOI 10.1002/aur.83; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Kana RK, 2009, SOC NEUROSCI-UK, V4, P135, DOI 10.1080/17470910802198510; Kanner L, 1943, NERV CHILD, V2, P217; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Kim JW, 2005, COGNITIVE BRAIN RES, V25, P659, DOI 10.1016/j.cogbrainres.2005.08.018; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Kuchinke L, 2011, NEUROPSYCHOLOGIA, V49, P331, DOI 10.1016/j.neuropsychologia.2010.12.026; Laurent AC, 2004, TOP LANG DISORD, V24, P286, DOI 10.1097/00011363-200410000-00006; Lombardo MV, 2011, NEUROIMAGE, V56, P1832, DOI 10.1016/j.neuroimage.2011.02.067; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Loveland KA, 2001, J AUTISM DEV DISORD, V31, P367, DOI 10.1023/A:1010608518060; Mason R.A., 2006, HDB PSYCHOLINGUISTIC, P765, DOI [10.1016/B978-012369374-7/50020-1, DOI 10.1016/B978-012369374-7/50020-1]; Mason RA, 2008, NEUROPSYCHOLOGIA, V46, P269, DOI 10.1016/j.neuropsychologia.2007.07.018; Mitchell JP, 2002, P NATL ACAD SCI USA, V99, P15238, DOI 10.1073/pnas.232395699; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Myers GC, 1994, GOOFUS GALLANT; Nah YH, 2011, AUTISM, V15, P185, DOI 10.1177/1362361309353616; Ohnishi T, 2004, NEUROREPORT, V15, P1483, DOI 10.1097/01.wnr.0000127464.17770.1f; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; PERNER J, 1989, CHILD DEV, V60, P689, DOI 10.2307/1130734; Pierce K, 1997, J AUTISM DEV DISORD, V27, P265, DOI 10.1023/A:1025898314332; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Quirmbach LM, 2009, J AUTISM DEV DISORD, V39, P299, DOI 10.1007/s10803-008-0628-9; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rutter M, 2001, AUTISM DIAGNOSTIC IN; Sahyoun CP, 2010, NEUROPSYCHOLOGIA, V48, P86, DOI 10.1016/j.neuropsychologia.2009.08.013; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Senju A, 2010, DEV PSYCHOPATHOL, V22, P353, DOI 10.1017/S0954579410000106; Silani G, 2008, SOC NEUROSCI-UK, V3, P97, DOI 10.1080/17470910701577020; Spencer MD, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.18; Takahashi H, 2004, NEUROIMAGE, V23, P967, DOI 10.1016/j.neuroimage.2004.07.054; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wang AT, 2007, ARCH GEN PSYCHIAT, V64, P698, DOI 10.1001/archpsyc.64.6.698; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Williams DL, 2005, ARCH CLIN NEUROPSYCH, V20, P1, DOI 10.1016/j.acn.2002.08.001; Wolford G, 2000, J NEUROSCI, V20, part. no.; Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104	80	16	16	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47241	10.1371/journal.pone.0047241	http://dx.doi.org/10.1371/journal.pone.0047241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082151	Green Published, Green Accepted, gold			2022-12-27	WOS:000311146900047
J	Malaza, A; Mossong, J; Barnighausen, T; Newell, ML				Malaza, Abraham; Mossong, Joel; Baernighausen, Till; Newell, Marie-Louise			Hypertension and Obesity in Adults Living in a High HIV Prevalence Rural Area in South Africa	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; SOCIOECONOMIC-STATUS; COHORT PROFILE; HEALTH SURVEY; POPULATION; DISEASE; MORTALITY; EPIDEMIC; WEIGHT; BURDEN	Hypertension and excess body weight are major risk factors of cardiovascular morbidity and mortality in developing countries. In countries with a high HIV prevalence, it is unknown how increased antiretroviral treatment and care (ART) coverage has affected the prevalence of overweight, obesity, and hypertension. We conducted a health survey in 2010 based on the WHO STEPwise approach in 14,198 adult resident participants of a demographic surveillance area in rural South Africa to investigate factors associated with hypertension and excess weight including HIV infection and ART status. Women had a significantly higher median body mass index (BMI) than men (26.4 vs. 21.2 kg/m(2), p<0.001). The prevalence of obesity (BMI >= 30 kg/m(2)) in women (31.3%, 95% confidence interval (CI) 30.2-32.4) was 6.5 times higher than in men (4.9%, 95% CI 4.1-5.7), whereas prevalence of hypertension (systolic or diastolic blood pressure >= 140 or 90 mm Hg, respectively) was 1.4 times higher in women than in men (28.5% vs 20.8%, p<0.001). In multivariable regression analysis, both hypertension and obesity were significantly associated with sex, age, HIV and ART status. The BMI of women and men on ART was on average 3.8 (95% CI 3.2-3.8) and 1.7 (95% CI 0.9-2.5) kg/m(2) lower than of HIV-negative women and men, respectively. The BMI of HIV-infected women and men not on ART was on average 1.2 (95% CI 0.8-1.6) and 0.4 (95% CI -0.1-0.9) kg/m(2) lower than of HIV-negative women and men, respectively. Obesity was a bigger risk factor for hypertension in men (adjusted odds ratio (aOR) 2.99, 95% CI 2.00-4.48) than in women (aOR 1.64, 95% CI 1.39-1.92) and overweight (25 <= BMI<30) was a significant risk factor for men only (aOR 1.53 95% CI 1.14-2.06). Our study suggests that, cardiovascular risk factors of hypertension and obesity differ substantially between women and men in rural South Africa.	[Malaza, Abraham; Mossong, Joel; Baernighausen, Till; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, Kwazulu Natal, South Africa; [Baernighausen, Till] Harvard Univ, Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Newell, Marie-Louise] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England	University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; University of London; University College London	Mossong, J (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, Kwazulu Natal, South Africa.	jmossong@africacentre.ac.za	Mossong, Joël/D-4998-2009; Bärnighausen, Till/Y-2388-2019; Newell, Marie-Louise/AAE-8222-2019	Mossong, Joël/0000-0003-0717-9835; Newell, Marie-Louise/0000-0002-1074-7699	Wellcome Trust [050534]; German government through the Centre for International Migration and Development (CIM)	Wellcome Trust(Wellcome TrustEuropean Commission); German government through the Centre for International Migration and Development (CIM)	This study was funded by the Wellcome Trust core grant (#050534) including the household and individual health surveillance. JM received partial financial support from the German government through the Centre for International Migration and Development (CIM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MA, 2009, SAMJ S AFR MED J, V99, P661; [Anonymous], 2003, J HYPERTENS, V21, P1011; Barnighausen T, 2008, J HUM HYPERTENS, V22, P236, DOI 10.1038/sj.jhh.1002308; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Chimbindi N, 2012, 19 INT AIDS C WASH U; DEVILLIERS MA, 1988, S AFR J SCI, V84, P601; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Herbst AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-47; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Islam FM, 2012, HIV MED; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Joubert J, 2007, SAMJ S AFR MED J, V97, P683; Kruger HS, 2007, PUBLIC HLTH NUTR, V8; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Mufunda J, 2006, J HUM HYPERTENS, V20, P59, DOI 10.1038/sj.jhh.1001924; Organization WH, 2016, GLOBAL STATUS REPORT; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Rodgers A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P851; Shisana O., 2009, S AFRICAN HIV PREVAL; Steyn K, 2001, J HYPERTENS, V19, P1717, DOI 10.1097/00004872-200110000-00004; Swinburn BA, LANCET, V378, P804; Tanser F, 2012, C RETR OPP INF CROI; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Thomas F, 2005, HYPERTENSION, V46, P654, DOI 10.1161/01.HYP.0000184282.51550.00; van der Merwe MT, 2006, OBES REV, V7, P315, DOI 10.1111/j.1467-789X.2006.00237.x; Walker ARP, 2001, PUBLIC HEALTH, V115, P368, DOI 10.1038/sj.ph.1900790; Wanke CA, 2000, CLIN INFECT DIS, V31, P803, DOI 10.1086/314027; WHO, 2000, OB PREV MAN GLOB EP; WHO, 2003, STEPS FRAM SURV WHO; World Health Organization, 2010, UN ACC SCAL PRIOR HI	37	86	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47761	10.1371/journal.pone.0047761	http://dx.doi.org/10.1371/journal.pone.0047761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082211	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900108
J	O'Connell, NE; Cossar, J; Marston, L; Wand, BM; Bunce, D; Moseley, GL; De Souza, LH				O'Connell, Neil E.; Cossar, John; Marston, Louise; Wand, Benedict M.; Bunce, David; Moseley, G. Lorimer; De Souza, Lorraine H.			Rethinking Clinical Trials of Transcranial Direct Current Stimulation: Participant and Assessor Blinding Is Inadequate at Intensities of 2mA	PLOS ONE			English	Article							PREFRONTAL CORTEX; PAIN; DEPRESSION; MODULATION	Background: Many double-blind clinical trials of transcranial direct current stimulation (tDCS) use stimulus intensities of 2 mA despite the fact that blinding has not been formally validated under these conditions. The aim of this study was to test the assumption that sham 2 mA tDCS achieves effective blinding. Methods: A randomised double blind crossover trial. 100 tDCS-naive healthy volunteers were incorrectly advised that they there were taking part in a trial of tDCS on word memory. Participants attended for two separate sessions. In each session, they completed a word memory task, then received active or sham tDCS (order randomised) at 2 mA stimulation intensity for 20 minutes and then repeated the word memory task. They then judged whether they believed they had received active stimulation and rated their confidence in that judgement. The blinded assessor noted when red marks were observed at the electrode sites post-stimulation. Results: tDCS at 2 mA was not effectively blinded. That is, participants correctly judged the stimulation condition greater than would be expected to by chance at both the first session (kappa level of agreement (kappa) 0.28, 95% confidence interval (CI) 0.09 to 0.47 p = 0.005) and the second session (kappa = 0.77, 95% CI 0.64 to 0.90), p = <0.001) indicating inadequate participant blinding. Redness at the reference electrode site was noticeable following active stimulation more than sham stimulation (session one, kappa = 0.512, 95% CI 0.363 to 0.66, p<0.001; session two, kappa = 0.677, 95%CI 0.534 to 0.82) indicating inadequate assessor blinding. Conclusions: Our results suggest that blinding in studies using tDCS at intensities of 2 mA is inadequate. Positive results from such studies should be interpreted with caution.	[O'Connell, Neil E.; Cossar, John; De Souza, Lorraine H.] Brunel Univ, Sch Hlth Sci & Social Care, Rehabil Res Ctr, London, England; [Marston, Louise] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Wand, Benedict M.] Univ Notre Dame Australia, Sch Physiotherapy, Fremantle, WA, Australia; [Bunce, David] Brunel Univ, Ctr Cognit & Neuroimaging, London, England; [Moseley, G. Lorimer] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Moseley, G. Lorimer] Neurosci Res Australia, Sydney, NSW, Australia	Brunel University; University of London; University College London; University of Notre Dame Australia; Brunel University; University of South Australia; Neuroscience Research Australia	O'Connell, NE (corresponding author), Brunel Univ, Sch Hlth Sci & Social Care, Rehabil Res Ctr, London, England.	neil.oconnell@brunel.ac.uk	Marston, Louise/A-8535-2012; Moseley, Lorimer/A-7095-2009; Wand, Benedict/C-3341-2011; O'CONNELL, NEIL/A-6907-2014	Marston, Louise/0000-0002-9973-1131; Moseley, Lorimer/0000-0002-3750-4945; O'CONNELL, NEIL/0000-0003-1989-4537; Bunce, David/0000-0003-3265-2700; Wand, Benedict/0000-0002-0297-0292	National Health & Medical Research Council of Australia [571090]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	GLM is supported by the National Health & Medical Research Council of Australia ID 571090. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No corporate funding or sponsorship was received for the conduct of this study. No government or institutional funding was received for the conduct of this study.	Altman D.G., 1991, PRACTICAL STATISTIC; Ambrus GG, 2012, BRAIN STIMUL, V5, P499, DOI 10.1016/j.brs.2011.12.001; Bartley EJ, 2012, ANN BEHAV MED, V43, P343, DOI 10.1007/s12160-012-9345-x; Bastani A, 2012, CLIN NEUROPHYSIOL, V123, P644, DOI 10.1016/j.clinph.2011.08.029; Berger VW., 2003, J MODERN APPL STAT M, V2, P8, DOI [10.22237/jmasm/1051747680, DOI 10.22237/JMASM/1051747680]; Berger VW, 2012, J CLIN EPID IN PRESS; Boggio PS, 2008, DRUG ALCOHOL DEPEN, V92, P55, DOI 10.1016/j.drugalcdep.2007.06.011; Boggio PS, 2009, CLIN J PAIN, V25, P691, DOI 10.1097/AJP.0b013e3181af1414; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Brunoni AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004824; Butler DS, 2003, EXPLAIN PAIN, V2nd; Fregni F, 2008, J CLIN PSYCHIAT, V69, P32, DOI 10.4088/JCP.v69n0105; Fregni F, 2006, ARTHRITIS RHEUM-US, V54, P3988, DOI 10.1002/art.22195; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Goldman RL, 2011, APPETITE, V56, P741, DOI 10.1016/j.appet.2011.02.013; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Klatzkin RR, 2010, EUR J PAIN, V14, P77, DOI 10.1016/j.ejpain.2009.01.002; Loo CK, 2012, BRIT J PSYCHIAT, V200, P52, DOI 10.1192/bjp.bp.111.097634; Loo CK, 2010, INT J NEUROPSYCHOPH, V13, P61, DOI 10.1017/S1461145709990411; McFadden JL, 2011, BRAIN STIMUL, V4, P38, DOI 10.1016/j.brs.2010.05.002; Montenegro RA, 2012, APPETITE, V58, P333, DOI 10.1016/j.appet.2011.11.008; Mori F, 2010, J PAIN, V11, P436, DOI 10.1016/j.jpain.2009.08.011; Nitsche MA, 2009, EXP NEUROL, V219, P14, DOI 10.1016/j.expneurol.2009.03.038; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; O'Connell NE, 2010, COCHRANE DB SYST REV, V9; O'Connell NE, 2011, CLIN J PAIN IN PRESS; Priori A, 2009, BRAIN STIMUL, V2, P241, DOI 10.1016/j.brs.2009.02.004; Rezaii T, 2012, J PAIN, V13, P646, DOI 10.1016/j.jpain.2012.04.002; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	32	182	183	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47514	10.1371/journal.pone.0047514	http://dx.doi.org/10.1371/journal.pone.0047514			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082174	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000311146900070
J	van den Bergh, MR; Biesbroek, G; Rossen, JWA; Piters, WAAD; Bosch, AATM; van Gils, EJM; Wang, XH; Boonacker, CWB; Veenhoven, RH; Bruin, JP; Bogaert, D; Sanders, EAM				van den Bergh, Menno R.; Biesbroek, Giske; Rossen, John W. A.; Piters, Wouter A. A. de Steenhuijsen; Bosch, Astrid A. T. M.; van Gils, Elske J. M.; Wang, Xinhui; Boonacker, Chantal W. B.; Veenhoven, Reinier H.; Bruin, Jacob P.; Bogaert, Debby; Sanders, Elisabeth A. M.			Associations between Pathogens in the Upper Respiratory Tract of Young Children: Interplay between Viruses and Bacteria	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; RANDOMIZED CONTROLLED-TRIAL; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; HAEMOPHILUS-INFLUENZAE; SYNCYTIAL VIRUS; MICROBIOTA; COLONIZATION; COMMUNITY; CARRIAGE	Background: High rates of potentially pathogenic bacteria and respiratory viruses can be detected in the upper respiratory tract of healthy children. Investigating presence of and associations between these pathogens in healthy individuals is still a rather unexplored field of research, but may have implications for interpreting findings during disease. Methodology/Principal Findings: We selected 986 nasopharyngeal samples from 433 6- to 24-month-old healthy children that had participated in a randomized controlled trial. We determined the presence of 20 common respiratory viruses using real-time PCR. Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Staphylococcus aureus were identified by conventional culture methods. Information on risk factors was obtained by questionnaires. We performed multivariate logistic regression analyses followed by partial correlation analysis to identify the overall pattern of associations. S. pneumoniae colonization was positively associated with the presence of H. influenzae (adjusted odds ratio 1.60, 95% confidence interval 1.18-2.16), M. catarrhalis (1.78, 1.29-2.47), human rhinoviruses (1.63, 1.19-2.22) and enteroviruses (1.97, 1.26-3.10), and negatively associated with S. aureus presence (0.59, 0.35-0.98). H. influenzae was positively associated with human rhinoviruses (1.63, 1.22-2.18) and respiratory syncytial viruses (2.78, 1.06-7.28). M. catarrhalis colonization was positively associated with coronaviruses (1.99, 1.01-3.93) and adenoviruses (3.69, 1.29-10.56), and negatively with S. aureus carriage (0.42, 0.25-0.69). We observed a strong positive association between S. aureus and influenza viruses (4.87, 1.59-14.89). In addition, human rhinoviruses and enteroviruses were positively correlated (2.40, 1.66-3.47), as were enteroviruses and human bocavirus, WU polyomavirus, parainfluenza viruses, and human parechovirus. A negative association was observed between human rhinoviruses and coronaviruses. Conclusions/Significance: Our data revealed high viral and bacterial prevalence rates and distinct bacterial-bacterial, viral-bacterial and viral-viral associations in healthy children, hinting towards the complexity and potential dynamics of microbial communities in the upper respiratory tract. This warrants careful consideration when associating microbial presence with specific respiratory diseases.	[van den Bergh, Menno R.; Biesbroek, Giske; Piters, Wouter A. A. de Steenhuijsen; Bosch, Astrid A. T. M.; van Gils, Elske J. M.; Wang, Xinhui; Bogaert, Debby; Sanders, Elisabeth A. M.] Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [van den Bergh, Menno R.; van Gils, Elske J. M.; Veenhoven, Reinier H.] Spaarne Hosp, Res Ctr, Linnaeus Inst, Hoofddorp, Netherlands; [Rossen, John W. A.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Boonacker, Chantal W. B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bruin, Jacob P.] Reg Publ Hlth Lab, Haarlem, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Spaarne Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Utrecht University; Utrecht University Medical Center	Bogaert, D (corresponding author), Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, Wilhelmina Childrens Hosp, Utrecht, Netherlands.	d.bogaert@umcutrecht.nl	Rossen, John W/G-7564-2011; de Steenhuijsen Piters, Wouter/AAI-9952-2020	Rossen, John W/0000-0002-7167-8623; de Steenhuijsen Piters, Wouter/0000-0002-1144-4067; Bogaert, Debby/0000-0003-2651-7000	Netherlands Organisation for Scientific Research through NWO-VENI [91610121]; ZonMW [91209010]; Dutch Ministry of Health; Pfizer; Baxter; GlaxoSmithKline	Netherlands Organisation for Scientific Research through NWO-VENI; ZonMW(Netherlands Organization for Health Research and Development); Dutch Ministry of Health; Pfizer(Pfizer); Baxter; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by The Netherlands Organisation for Scientific Research through NWO-VENI Grant 91610121, ZonMW Grant 91209010 and the Dutch Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DB declares to have received consulting fees from Pfizer. EAMS declares to have received unrestricted research support from Pfizer and Baxter, consulting fees from Pfizer and GlaxoSmithKline, lecturing fees from Pfizer, and grant support for vaccine studies from Pfizer and GlaxoSmithKline. RHV declares to have received research support from GlaxoSmithKline and Pfizer for vaccine studies and consulting fees from GlaxoSmithKline. None of the fees or grants listed here were received for the research described in this paper. For all other authors no conflicts of interest were declared. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2001, ENCY MATH; Avadhanula V, 2006, J VIROL, V80, P1629, DOI 10.1128/JVI.80.4.1629-1636.2006; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; HUEBNER RJ, 1957, ANN NY ACAD SCI, V67, P430, DOI 10.1111/j.1749-6632.1957.tb46066.x; Ishizuka S, 2003, J INFECT DIS, V188, P1928, DOI 10.1086/379833; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Jacoby P, 2007, VACCINE, V25, P2458, DOI 10.1016/j.vaccine.2006.09.020; Jansen AGSC, 2008, EPIDEMIOL INFECT, V136, P1448, DOI 10.1017/S0950268807000271; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Klugman KP, 2007, SCIENCE, V316, P49; Koon K, 2010, EMERG INFECT DIS, V16, P1976, DOI 10.3201/eid1612.091697; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Margolis E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-59; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Peltola V, 2011, PEDIATR INFECT DIS J, V30, P456, DOI 10.1097/INF.0b013e318208ee82; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Rivers TM, 1937, J BACTERIOL, V33, P1; Selva L, 2009, P NATL ACAD SCI USA, V106, P1234, DOI 10.1073/pnas.0809600106; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; van de Pol AC, 2006, CRIT CARE, V10, DOI 10.1186/cc4895; van de Pol AC, 2007, J CLIN MICROBIOL, V45, P2260, DOI 10.1128/JCM.00848-07; van de Pol AC, 2009, EMERG INFECT DIS, V15, P454, DOI 10.3201/eid1503.081203; van Gils EJM, 2011, VACCINE, V29, P7595, DOI 10.1016/j.vaccine.2011.08.049; van Gils EJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020229; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; Wiertsema SP, 2011, J MED VIROL, V83, P2008, DOI 10.1002/jmv.22221; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	40	141	145	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47711	10.1371/journal.pone.0047711	http://dx.doi.org/10.1371/journal.pone.0047711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082199	Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900096
J	Ying, HY; Shen, X; Yue, BYJT				Ying, Hongyu; Shen, Xiang; Yue, Beatrice Y. J. T.			Establishment of Inducible Wild Type and Mutant Myocilin-GFP-Expressing RGC5 Cell Lines	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OLFACTOMEDIN-HOMOLOGY DOMAIN; RETINAL GANGLION-CELLS; TRABECULAR MESHWORK; EXTRACELLULAR-MATRIX; RHO-GTPASES; PROTEIN INTERACTIONS; BARRIER INTEGRITY; GENE MYOCILIN; NON-SECRETION	Background: Myocilin is gene linked directly to juvenile- and adult-onset open angle glaucoma. Mutations including Gln368stop (Q368X) and Pro370Leu (P370L) have been identified in patients. The exact role of myocilin and its functional association with glaucoma are still unclear. In the present study, we established tetracycline-inducible (Tet-on) wild type and mutant myocilin-green fluorescence protein (GFP) expressing RGC5 stable cell lines and studied the changes in cell migration and barrier function upon induction. Methodology/Principal Findings: After several rounds of selection, clones that displayed low, moderate, or high expression of wild type, Q368X or P370L myocilin-GFP upon doxycycline (Dox) induction were obtained. The levels of wild type and mutant myocilin-GFP in various clones were confirmed by Western blotting. Compared to non-induced controls, the cell migration was retarded, the actin stress fibers were fewer and shorter, and the trypsinization time needed for cells to round up was reduced when wild type or mutant myocilin was expressed. The barrier function was in addition aberrant following induced expression of wild type, Q368X or P370L myocilin. Immunoblotting further showed that tight junction protein occludin was downregulated in induced cells. Conclusions/Significance: Tet-on inducible, stable RGC5 cell lines were established. These cell lines, expressing wild type or mutant (Q368X or P370L) myocilin-GFP upon Dox induction, are valuable in facilitating studies such as proteomics, as well as functional and pathogenesis investigations of disease-associated myocilin mutants. The barrier function was found impaired and the migration of cells was hindered with induced expression of wild type and mutant myocilin in RGC5 cell lines. The reduction in barrier function might be related to the declined level of occludin. The retarded cell migration was consistent with demonstrated myocilin phenotypes including the loss of actin stress fibers, lowered RhoA activities and compromised cell-matrix adhesiveness.	[Ying, Hongyu; Shen, Xiang; Yue, Beatrice Y. J. T.] Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yue, BYJT (corresponding author), Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	Beatyue@uic.edu			National Eye Institute, National Institutes of Health, Bethesda, Maryland [EY018828, EY01792]; Cless Family Foundation, Northbrook; NATIONAL EYE INSTITUTE [R01EY005628, P30EY001792, R01EY018828] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cless Family Foundation, Northbrook; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, National Institutes of Health, Bethesda, Maryland (grant EY018828 to B.Y.J.T.Y. and core grant EY01792) and by the Cless Family Foundation, Northbrook. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P179, DOI 10.1007/s00418-007-0358-7; BILL A, 1975, INVEST OPHTH VISUAL, V14, P1; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Caballero M, 2000, BBA-MOL BASIS DIS, V1502, P447, DOI 10.1016/S0925-4439(00)00068-5; Choi J, 2005, INVEST OPHTH VIS SCI, V46, P214, DOI 10.1167/iovs.04-0765; Clark AF, 2001, FASEB J, V15, P1251, DOI 10.1096/fj.00-0663fje; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; CUNHAVAZ J, 1979, SURV OPHTHALMOL, V23, P279, DOI 10.1016/0039-6257(79)90158-9; Ezzat MK, 2008, EXP EYE RES, V87, P376, DOI 10.1016/j.exer.2008.07.002; Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Filla MS, 2002, INVEST OPHTH VIS SCI, V43, P151; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; Garcia JGN, 1997, AM J PHYSIOL-LUNG C, V273, pL172, DOI 10.1152/ajplung.1997.273.1.L172; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Goldwich A, 2009, HISTOCHEM CELL BIOL, V131, P167, DOI 10.1007/s00418-008-0518-4; Gould DB, 2004, MOL CELL BIOL, V24, P9019, DOI 10.1128/MCB.24.20.9019-9025.2004; Harvey R, 2007, INVEST OPHTH VIS SCI, V48, P1884, DOI 10.1167/iovs.06-0990; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Joe MK, 2005, BIOCHEM BIOPH RES CO, V336, P1201, DOI 10.1016/j.bbrc.2005.09.006; Jurynec MJ, 2003, MOL CELL NEUROSCI, V23, P69, DOI 10.1016/S1044-7431(03)00019-8; Kameda T, 2012, INVEST OPHTH VIS SCI, V53, P3092, DOI 10.1167/iovs.11-8018; Karali A, 2000, INVEST OPHTH VIS SCI, V41, P729; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Koga T, 2010, AM J PATHOL, V176, P343, DOI 10.2353/ajpath.2010.090194; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lee JG, 2009, INVEST OPHTH VIS SCI, V50, P2067, DOI 10.1167/iovs.08-3135; Lee OT, 2008, CURR EYE RES, V33, P849, DOI 10.1080/02713680802429210; Li YX, 2006, BIOCHEM BIOPH RES CO, V339, P797, DOI 10.1016/j.bbrc.2005.11.082; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Nusrat A, 2000, J BIOL CHEM, V275, P29816, DOI 10.1074/jbc.M002450200; Park BC, 2007, GENES CELLS, V12, P969, DOI 10.1111/j.1365-2443.2007.01102.x; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Rao PV, 2000, EXP EYE RES, V71, P637, DOI 10.1006/exer.2000.0920; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rozsa F W, 1998, Mol Vis, V4, P20; Runkle EA, 2011, METHODS MOL BIOL, V686, P133, DOI 10.1007/978-1-60761-938-3_5; Russell P, 2001, INVEST OPHTH VIS SCI, V42, P983; Sakai H, 2007, J CELL PHYSIOL, V213, P775, DOI 10.1002/jcp.21147; Sakai H, 2006, INVEST OPHTH VIS SCI, V47, P4427, DOI 10.1167/iovs.06-0047; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; Schwechter BR, 2007, INVEST OPHTH VIS SCI, V48, P2845, DOI 10.1167/iovs.06-1364; Senatorov V, 2006, J NEUROSCI, V26, P11903, DOI 10.1523/JNEUROSCI.3020-06.2006; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Shen X, 2008, J BIOL CHEM, V283, P603, DOI 10.1074/jbc.M708250200; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Shivanna M, 2010, J OCUL PHARMACOL TH, V26, P1, DOI 10.1089/jop.2009.0025; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Srinivas SP, 2012, EXP EYE RES, V95, P8, DOI 10.1016/j.exer.2011.09.009; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Swiderski RE, 2000, INVEST OPHTH VIS SCI, V41, P3420; Takahashi H, 1998, BIOCHEM BIOPH RES CO, V248, P104, DOI 10.1006/bbrc.1998.8917; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Torrado M, 2002, HUM MOL GENET, V11, P1291, DOI 10.1093/hmg/11.11.1291; Ueda J, 2002, INVEST OPHTH VIS SCI, V43, P1068; Underwood JL, 1999, AM J PHYSIOL-CELL PH, V277, pC330, DOI 10.1152/ajpcell.1999.277.2.C330; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Wentz-Hunter K, 2004, EXP CELL RES, V297, P39, DOI 10.1016/j.yexcr.2004.02.024; Wentz-Hunter K, 2002, INVEST OPHTH VIS SCI, V43, P176; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806; Yang C, 2009, INVEST OPHTH VIS SCI, V50, P1290, DOI 10.1167/iovs.08-1920; Ying HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009168; Yue BYJT, 1996, SURV OPHTHALMOL, V40, P379; Zhou Y, 2008, INVEST OPHTH VIS SCI, V49, P1932, DOI 10.1167/iovs.07-1339; Zhuo YH, 2010, MOL VIS, V16, P61	78	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47307	10.1371/journal.pone.0047307	http://dx.doi.org/10.1371/journal.pone.0047307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082156	Green Published, gold			2022-12-27	WOS:000311146900052
J	Nienhaus, U; Aegerter-Wilmsen, T; Aegerter, CM				Nienhaus, Ulrike; Aegerter-Wilmsen, Tinri; Aegerter, Christof M.			In-Vivo Imaging of the Drosophila Wing Imaginal Disc over Time: Novel Insights on Growth and Boundary Formation	PLOS ONE			English	Article							MORPHOGEN GRADIENT; GENE-EXPRESSION; DYNAMICS; PROLIFERATION; MECHANISM; PROTEIN; NOTCH; VEIN; SIZE	In developmental biology, the sequence of gene induction and pattern formation is best studied over time as an organism develops. However, in the model system of Drosophila larvae this oftentimes proves difficult due to limitations in imaging capabilities. Using the larval wing imaginal disc, we show that both overall growth, as well as the creation of patterns such as the distinction between the anterior(A) and posterior(P) compartments and the dorsal(D) and ventral(V) compartments can be studied directly by imaging the wing disc as it develops inside a larva. Imaged larvae develop normally, as can be seen by the overall growth curve of the wing disc. Yet, the fact that we can follow the development of individual discs through time provides the opportunity to simultaneously assess individual variability. We for instance find that growth rates can vary greatly over time. In addition, we observe that mechanical forces act on the wing disc within the larva at times when there is an increase in growth rates. Moreover, we observe that A/P boundary formation follows the established sequence and a smooth boundary is present from the first larval instar on. The division of the wing disc into a dorsal and a ventral compartment, on the other hand, develops quite differently. Contrary to expectation, the specification of the dorsal compartment starts with only one or two cells in the second larval instar and a smooth boundary is not formed until the third larval instar.	[Nienhaus, Ulrike; Aegerter, Christof M.] Univ Zurich, Inst Phys, Zurich, Switzerland; [Aegerter-Wilmsen, Tinri] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich; University of Zurich	Aegerter, CM (corresponding author), Univ Zurich, Inst Phys, Zurich, Switzerland.	aegerter@physik.uzh.ch		Aegerter, Christof/0000-0002-7200-7987	Swiss National Science Foundation; Forschungskredit of UZH; SystemsX.ch as part of the RTD WingX	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungskredit of UZH; SystemsX.ch as part of the RTD WingX	This work was supported by the Swiss National Science Foundation (www.snf.ch), the Forschungskredit of UZH as well as SystemsX.ch as part of the RTD WingX, www.systemsx.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Aldaz S, 2010, P NATL ACAD SCI USA, V107, P14217, DOI 10.1073/pnas.1008623107; Ben-Zvi D, 2011, CURR BIOL, V21, P1391, DOI 10.1016/j.cub.2011.07.015; Bialek W, 2004, SCIENCE, V303, P788, DOI 10.1126/science.1095480; Bittig T, 2009, EUR PHYS J E, V30, P93, DOI 10.1140/epje/i2009-10507-6; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; BROWER DL, 1984, NATURE, V310, P496, DOI 10.1038/310496a0; BROWER DL, 1986, EMBO J, V5, P2649, DOI 10.1002/j.1460-2075.1986.tb04547.x; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; DAMBLYCHAUDIERE C, 1986, DEV BIOL, V113, P288, DOI 10.1016/0012-1606(86)90164-8; Donaldson T, 2004, GENETICS, V167, P687, DOI 10.1534/genetics.103.019588; Fuger P, 2007, NAT PROTOC, V2, P3285, DOI 10.1038/nprot.2007.472; Garcia-Bellido A, 1998, GENETICS, V148, P539; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Hamaratoglu F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001182; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Kanodia J, 2009, P NATL ACAD SCI USA, V106, P1087; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; MADHAVAN MM, 1977, ROUX ARCH DEV BIOL, V183, P269, DOI 10.1007/BF00848459; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; Milan M, 2005, DEV DYNAM, V233, P804, DOI 10.1002/dvdy.20384; Milan M, 2003, DEVELOPMENT, V130, P553, DOI 10.1242/dev.00276; Milan M, 1999, MOL CELL, V4, P1073, DOI 10.1016/S1097-2765(00)80235-X; Ng M, 1996, NATURE, V381, P316, DOI 10.1038/381316a0; Nienhaus U, 2009, MECH DEVELOP, V126, P942, DOI 10.1016/j.mod.2009.09.002; Oda H, 2001, J CELL SCI, V114, P493; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; TABATA T, 1995, DEVELOPMENT, V121, P3359; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wang SH, 2000, GENE DEV, V14, P2271, DOI 10.1101/gad.827000; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Weihe U, 2001, DEVELOPMENT, V128, P4615; Wessells RJ, 1999, DEV BIOL, V216, P243, DOI 10.1006/dbio.1999.9459; Zecca M, 2002, DEVELOPMENT, V129, P1357; Zecca M, 2002, DEVELOPMENT, V129, P1369; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	42	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47594	10.1371/journal.pone.0047594	http://dx.doi.org/10.1371/journal.pone.0047594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091633	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000310135800057
J	Frosini, S; Lardicci, C; Balestri, E				Frosini, Silvia; Lardicci, Claudio; Balestri, Elena			Global Change and Response of Coastal Dune Plants to the Combined Effects of Increased Sand Accretion (Burial) and Nutrient Availability	PLOS ONE			English	Article							ATMOSPHERIC NITROGEN DEPOSITION; SALT SPRAY; SEA-LEVEL; GROWTH; PERSPECTIVE; ECOSYSTEMS; BIODIVERSITY; VEGETATION; RESOURCES; GRASSLAND	Coastal dune plants are subjected to natural multiple stresses and vulnerable to global change. Some changes associated with global change could interact in their effects on vegetation. As vegetation plays a fundamental role in building and stabilizing dune systems, effective coastal habitat management requires a better understanding of the combined effects of such changes on plant populations. A manipulative experiment was conducted along a Mediterranean dune system to examine the individual and combined effects of increased sediment accretion (burial) and nitrogen enrichment associated with predicted global change on the performance of young clones of Sporobolus virginicus, a widespread dune stabilizing species. Increased burial severity resulted in the production of taller but thinner shoots, while nutrient enrichment stimulated rhizome production. Nutrient enrichment increased total plant biomass up to moderate burial levels (50% of plant height), but it had not effect at the highest burial level (100% of plant height). The effects of such factors on total biomass, shoot biomass and branching were influenced by spatial variation in natural factors at the scale of hundreds of metres. These results indicate that the effects of burial and nutrient enrichment on plant performance were not independent. Their combined effects may not be predicted by knowing the individual effects, at least under the study conditions. Under global change scenarios, increased nutrient input could alleviate nutrient stress in S. virginicus, enhancing clonal expansion and productivity, but this benefit could be offset by increased sand accretion levels equal or exceeding 100% of plant height. Depletion of stored reserves for emerging from sand could increase plant vulnerability to other stresses in the long-term. The results emphasize the need to incorporate statistical designs for detecting non-independent effects of multiple changes and adequate spatial replication in future works to anticipate the impact of global change on dune ecosystem functioning.	[Frosini, Silvia; Lardicci, Claudio; Balestri, Elena] Univ Pisa, Dept Biol, Pisa, Italy	University of Pisa	Balestri, E (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	ebalestri@biologia.unipi.it	Balestri, Elena/AAV-5021-2021; lardicci, claudio/K-8698-2018	Balestri, Elena/0000-0002-4497-0418; LARDICCI, CLAUDIO/0000-0001-5356-7914	University of Pisa; Solvay Chimica Italia S.p.A. of Rosignano Solvay; Solvay Chimica Italia S.p.A.	University of Pisa; Solvay Chimica Italia S.p.A. of Rosignano Solvay; Solvay Chimica Italia S.p.A.	This work was a part of the Ph.D. thesis of S. Frosini supported by a fellowship from the University of Pisa. The study was partially funded by Solvay Chimica Italia S.p.A. of Rosignano Solvay (www.solvay.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: CL receives grant/research support from Solvay Chimica Italia S.p.A. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. All other authors have nothing to disclose.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Bach CE, 1998, ECOL ENTOMOL, V23, P238, DOI 10.1046/j.1365-2311.1998.00133.x; Balestri E, 2004, MAR BIOL, V145, P61, DOI 10.1007/s00227-004-1301-2; Balestri E, 2012, ESTUAR COAST SHELF S, V99, P74, DOI 10.1016/j.ecss.2011.12.017; Bell HL, 2003, AM J BOT, V90, P1416, DOI 10.3732/ajb.90.10.1416; Bouwman AF, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003576; BREEN CM, 1977, HYDROBIOLOGIA, V54, P135, DOI 10.1007/BF00034987; Brown AC, 2002, ENVIRON CONSERV, V29, P62, DOI 10.1017/S037689290200005X; Brown JF, 1997, J ECOL, V85, P151, DOI 10.2307/2960647; Clayton WD., 1974, FLORA TROPICAL E AFR; Conti F., 2005, ANNOTATED CHECKLIST, V4, P227; D'Ulisse A., 1996, J COAST CONSERV, V2, P3, DOI [10.1007/BF02743032, DOI 10.1007/BF02743032]; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Everard M, 2010, AQUAT CONSERV, V20, P476, DOI 10.1002/aqc.1114; Feagin RA, 2005, FRONT ECOL ENVIRON, V3, P359, DOI 10.2307/3868584; Flamini G, 2003, FLAVOUR FRAG J, V18, P460, DOI 10.1002/ffj.1253; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gilbert M, 2008, OECOLOGIA, V156, P169, DOI 10.1007/s00442-008-0968-3; Gilbert ME, 2008, PHYSIOL PLANTARUM, V134, P464, DOI 10.1111/j.1399-3054.2008.01153.x; Gilbert ME, 2010, AUSTRAL ECOL, V35, P53, DOI 10.1111/j.1442-9993.2009.02011.x; Gorley C.K., 2006, GETTING STARTED PRIM; Gormally CL, 2010, ESTUAR COAST, V33, P1237, DOI 10.1007/s12237-010-9269-2; Gornish ES, 2010, GLOBAL CHANGE BIOL, V16, P2668, DOI 10.1111/j.1365-2486.2009.02144.x; Gratani L, 2007, FITOSOCIOLOGIA, V44, P11; Greaver TL, 2010, GLOBAL CHANGE BIOL, V16, P1860, DOI 10.1111/j.1365-2486.2010.02168.x; Griffiths ME, 2006, PLANT ECOL, V186, P69, DOI 10.1007/s11258-006-9113-8; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gutierrez J.L., 2010, TRANSP OPT NETW ICTO, P1; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HARRIS D, 1986, J ECOL, V74, P1057, DOI 10.2307/2260233; Hesp P. A., 2007, PLANT DISTURBANCE EC, P215; Houle G, 1997, AM J BOT, V84, P1729, DOI 10.2307/2446472; Jones MLM, 2004, PLANT BIOLOGY, V6, P598, DOI 10.1055/s-2004-821004; Kooijman AM, 1998, J ECOL, V86, P511, DOI 10.1046/j.1365-2745.1998.00273.x; Leithead HL, 1971, USDA HDB, V389; MARCUM KB, 1992, NEW PHYTOL, V120, P281, DOI 10.1111/j.1469-8137.1992.tb05665.x; Martinez ML, 2004, ECOL STU AN, V171, P3; MAUN M. A., 2009, BIOL COASTAL SAND DU, P197; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; Maun MA, 2004, ECOL STU AN, V171, P119; MAUN MA, 1984, J ECOL, V72, P565, DOI 10.2307/2260067; Maun MA, 2009, BIOL COASTAL SAND DU; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; NAIDOO G, 1992, OECOLOGIA, V90, P445, DOI 10.1007/BF00317704; Owen NW, 2004, J VEG SCI, V15, P669, DOI 10.1111/j.1654-1103.2004.tb02309.x; Phoenix GK, 2012, GLOBAL CHANGE BIOL, V18, P1197, DOI 10.1111/j.1365-2486.2011.02590.x; Phoenix GK, 2006, GLOBAL CHANGE BIOL, V12, P470, DOI 10.1111/j.1365-2486.2006.01104.x; Plassmann K, 2009, SCI TOTAL ENVIRON, V407, P1391, DOI 10.1016/j.scitotenv.2008.10.012; Provoost S, 2011, J COAST CONSERV, V15, P207, DOI 10.1007/s11852-009-0068-5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Remke E, 2009, ECOSYSTEMS, V12, P1173, DOI 10.1007/s10021-009-9282-0; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salman A.H.P.M., 1992, EUROPEAN COASTAL DUN, P439; Sandrini-Neto L., 2011, GAD R PACKAGE ANOVA; Scartazza A, 2007, CLIMA E CAMBIAMENTI, P245; Snedecor GW, 1980, STAT METHODS, V7th; Stallins JA, 2003, ANN ASSOC AM GEOGR, V93, P13, DOI 10.1111/1467-8306.93102; SYKES MT, 1990, ACTA BOT NEERL, V39, P171, DOI 10.1111/j.1438-8677.1990.tb01485.x; Titlyanova AA, 1999, J VEG SCI, V10, P307, DOI 10.2307/3237060; TROELSTRA SR, 1990, PLANT SOIL, V127, P1, DOI 10.1007/BF00010831; Tsoar H, 2005, PHYSICA A, V357, P50, DOI 10.1016/j.physa.2005.05.067; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; Valverde T, 1997, J COASTAL RES, V13, P497; van den Berg LJL, 2005, ENVIRON POLLUT, V138, P77, DOI 10.1016/j.envpol.2005.02.024; Van Der Maarel Eddy, 1993, V2 PART A, P7; Van Der Meulen F, 2004, ECOL STU AN, V171, P259; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wilson JB, 1999, ECOL LETT, V2, P233; Zhang JH, 1996, ANN BOT-LONDON, V78, P591, DOI 10.1006/anbo.1996.0165	72	30	30	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47561	10.1371/journal.pone.0047561	http://dx.doi.org/10.1371/journal.pone.0047561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077636	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100131
J	Heinze, DM; Carmical, JR; Aronson, JF; Thangamani, S				Heinze, Dar M.; Carmical, J. Russ; Aronson, Judith F.; Thangamani, Saravanan			Early Immunologic Events at the Tick-Host Interface	PLOS ONE			English	Article							IXODES-SCAPULARIS; PROTEIN; MOUSE; TRANSMISSION; EXPRESSION; VIRUS; INFESTATIONS; INTERFERES; ATTACHMENT; INHIBITION	Ixodes species ticks are competent vectors of tick-borne viruses including tick-borne encephalitis and Powassan encephalitis. Tick saliva has been shown to facilitate and enhance viral infection. This likely occurs by saliva-mediated modulation of host responses into patterns favorable for viral infection and dissemination. Because of the rapid kinetics of tick-borne viral transmission, this modulation must occur as early as tick attachment and initiation of feeding. In this study, cutaneous bite-site lesions were analyzed using Affymetrix mouse genome 430A 2.0 arrays and histopathology at 1, 3, 6, and 12 hours after uninfected Ixodes scapularis nymphal tick attachment. At 1 and 3 hrs after attachment, the gene expression profile is markedly different than at later time points. Upregulated gene ontology term clusters enriched at 1 and 3 hrs were related to post-translational modification. At 6 and 12 hrs, cytoskeletal rearrangements, DNA replication/cell division, inflammation, and chemotaxis were prominent clusters. At 6 and 12 hrs, extracellular matrix, signaling, and DNA binding clusters were downregulated. Histopathological analysis shows minimal inflammation at 1 and 3 hrs but an appreciable neutrophil infiltrate at 6 and 12 hrs. In addition, putative hyperemia, localized necrosis, and increased ECM deposition were identified. Putting the gene expression and histopathology analysis together suggests early tick feeding is characterized by modulation of host responses in resident cells that merges into a nascent, neutrophil-driven immune response by 12 hrs post-attachment.	[Heinze, Dar M.; Aronson, Judith F.; Thangamani, Saravanan] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Heinze, Dar M.; Aronson, Judith F.; Thangamani, Saravanan] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX USA; [Carmical, J. Russ] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Thangamani, S (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX USA.	sathanga@utmb.edu	Thangamani, Saravanan/E-7371-2010	Thangamani, Saravanan/0000-0002-4269-5993	National Institute of Allergy and Infectious Diseases [T32AI007526]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007526] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DH was supported by the National Institute of Allergy and Infectious Diseases award number T32AI007526. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev AN, 1996, EXP APPL ACAROL, V20, P713, DOI 10.1007/BF00051556; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Beaufays J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003987; BINNINGTON KC, 1978, INT J PARASITOL, V8, P97, DOI 10.1016/0020-7519(78)90004-8; Bouchard K., 2005, BIOL DIS VECTORS, V2, P705; Coulombe PA, 2004, EUR J CELL BIOL, V83, P735, DOI 10.1078/0171-9335-00443; des Vignes F, 2001, J INFECT DIS, V183, P773, DOI 10.1086/318818; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Ebel GD, 2004, AM J TROP MED HYG, V71, P268, DOI 10.4269/ajtmh.2004.71.3.0700268; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Guo XY, 2009, INFECT IMMUN, V77, P2320, DOI 10.1128/IAI.01507-08; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Hajnicka V, 2001, PARASITE IMMUNOL, V23, P483, DOI 10.1046/j.1365-3024.2001.00403.x; Heinze DM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-26; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inoue KI, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/101659; Jiang Y, 2010, LETT APPL MICROBIOL, V50, P468, DOI 10.1111/j.1472-765X.2010.02824.x; Jiang Y, 2009, ARCH VIROL, V154, P639, DOI 10.1007/s00705-009-0352-6; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; KAUFMAN WR, 1989, PARASITOL TODAY, V5, P47; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; MCSWAIN JL, 1982, J PARASITOL, V68, P100, DOI 10.2307/3281330; Meuter S, 2007, MOL CELL BIOL, V27, P983, DOI 10.1128/MCB.01648-06; Meuter S, 2008, CYTOKINE, V44, P248, DOI 10.1016/j.cyto.2008.08.009; Montgomery RR, 2004, INFECT IMMUN, V72, P2989, DOI 10.1128/IAI.72.5.2989-2994.2004; Narasimhan S, 2007, CELL HOST MICROBE, V2, P7, DOI 10.1016/j.chom.2007.06.001; Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Schoeler GB, 1999, EXP PARASITOL, V92, P239, DOI 10.1006/expr.1999.4426; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schuijt TJ, 2011, CELL HOST MICROBE, V10, P136, DOI 10.1016/j.chom.2011.06.010; Sierra DA, 2002, GENOMICS, V79, P177, DOI 10.1006/geno.2002.6693; Skallova A, 2008, J IMMUNOL, V180, P6186, DOI 10.4049/jimmunol.180.9.6186; Tyson KR, 2008, J IMMUNOL, V180, P3964, DOI 10.4049/jimmunol.180.6.3964; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Vancova I, 2010, PARASITE IMMUNOL, V32, P460, DOI 10.1111/j.1365-3024.2010.01203.x; Ward PP, 2008, AM J PATHOL, V172, P1019, DOI 10.2353/ajpath.2008.061145; Wikel SK, 1999, INT J PARASITOL, V29, P851, DOI 10.1016/S0020-7519(99)00042-9; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032	46	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47301	10.1371/journal.pone.0047301	http://dx.doi.org/10.1371/journal.pone.0047301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077588	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100089
J	Smith, MK; Annis, SL; Kaplan, JJ; Drummond, F				Smith, Michelle K.; Annis, Seanna L.; Kaplan, Jennifer J.; Drummond, Frank			Using Peer Discussion Facilitated by Clicker Questions in an Informal Education Setting: Enhancing Farmer Learning of Science	PLOS ONE			English	Article							LONG-TERM RETENTION; AUDIENCE RESPONSE SYSTEMS; COURSES	Blueberry growers in Maine attend annual Cooperative Extension presentations given by university faculty members. These presentations cover topics, such as, how to prevent plant disease and monitor for insect pests. In 2012, in order to make the sessions more interactive and promote learning, clicker questions and peer discussion were incorporated into the presentations. Similar to what has been shown at the undergraduate level, after peer discussion, more blueberry growers gave correct answers to multiple-choice questions than when answering independently. Furthermore, because blueberry growers are characterized by diverse levels of education, experience in the field etc., we were able to determine whether demographic factors were associated with changes in performance after peer discussion. Taken together, our results suggest that clicker questions and peer discussion work equally well with adults from a variety of demographic backgrounds without disadvantaging a subset of the population and provide an important learning opportunity to the least formally educated members. Our results also indicate that clicker questions with peer discussion were viewed as a positive addition to university-related informal science education sessions.	[Smith, Michelle K.; Annis, Seanna L.; Drummond, Frank] Univ Maine, Sch Biol & Ecol, Orono, ME USA; [Smith, Michelle K.] Univ Maine, Maine Res STEM Educ Ctr, Orono, ME USA; [Kaplan, Jennifer J.] Univ Georgia, Dept Stat, Athens, GA 30602 USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University System of Georgia; University of Georgia	Smith, MK (corresponding author), Univ Maine, Sch Biol & Ecol, Orono, ME USA.	michelle.k.smith@maine.edu			National Science Foundation [0962805]; University of Maine Center for Excellence in Teaching and Assessment; Direct For Education and Human Resources [0962805] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Maine Center for Excellence in Teaching and Assessment; Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	M.S. is supported in part by the National Science Foundation under Grant#0962805. University of Maine Center for Excellence in Teaching and Assessment provided funding to purchase the clickers. Maine Agricultural and Forest Experiment Station paid the publication charges, this is journal article number 3295. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruff D., 2009, TEACHING CLASSROOM R; Crossgrove K, 2008, CBE-LIFE SCI EDUC, V7, P146, DOI 10.1187/cbe.07-08-0060; Crouch CH, 2001, AM J PHYS, V69, P970, DOI 10.1119/1.1374249; Doucet M, 2009, MED TEACH, V31, pE570, DOI 10.3109/01421590903193539; Franz N., 2010, Journal of Rural Social Sciences (JRSS), V25, P37; Freeman Scott, 2007, CBE Life Sci Educ, V6, P132, DOI 10.1187/cbe.06-09-0194; Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225; Grudens-Shuck N., 2003, J EXT, V41, p4FEA2; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; Karaman S, 2011, SOC BEHAV PERSONAL, V39, P1431, DOI 10.2224/sbp.2011.39.10.1431; King DB, 2008, J SCI EDUC TECHNOL, V17, P544, DOI 10.1007/s10956-008-9121-7; Knight Jennifer K, 2005, Cell Biol Educ, V4, P298, DOI 10.1187/05-06-0082; Kroma MA, 2006, J SUSTAIN AGR, V28, P5, DOI 10.1300/J064v28n04_03; Lasry N., 2008, PHYS TEACH, V46, P242, DOI DOI 10.1119/1.2895678; Marx JD, 2007, AM J PHYS, V75, P87, DOI 10.1119/1.2372468; Mayer RE, 2009, CONTEMP EDUC PSYCHOL, V34, P51, DOI 10.1016/j.cedpsych.2008.04.002; Mazur E, 1997, PEER INSTRUCTION; Millar J., 2007, EUROPEAN J AGR ED EX, V4, P37; Penuel W.R., 2006, ED TECHNOLOGY RES DE, V55, P315; Porter Leo, 2011, P 7 INT WORKSHOP COM, p45aAS52, DOI [DOI 10.1145/2016911.2016923, 10.1145/2016911.2016923]; Prather EE, 2009, ASTRONOMY ED REV, V8; Reay NW, 2008, AM J PHYS, V76, P171, DOI 10.1119/1.2820392; Rose A, 2012, MAINE AGR F IN PRESS; Rubio EI, 2008, AM J ROENTGENOL, V190, pW319, DOI 10.2214/AJR.07.3038; Smith MK, 2011, CBE-LIFE SCI EDUC, V10, P55, DOI 10.1187/cbe.10-08-0101; Smith MK, 2009, SCIENCE, V323, P122, DOI 10.1126/science.1165919; Stowell JR, 2007, TEACH PSYCHOL, V34, P253, DOI 10.1080/00986280701700391	27	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47564	10.1371/journal.pone.0047564	http://dx.doi.org/10.1371/journal.pone.0047564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022WO	23077638	Green Submitted, gold, Green Published			2022-12-27	WOS:000309995100133
J	Twig, G; Afek, A; Shamiss, A; Derazne, E; Tzur, D; Gordon, B; Tirosh, A				Twig, Gilad; Afek, Arnon; Shamiss, Ari; Derazne, Estela; Tzur, Dorit; Gordon, Barak; Tirosh, Amir			White Blood Cell Count and the Risk for Coronary Artery Disease in Young Adults	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; HEART-DISEASE; LEUKOCYTE COUNT; ATHEROSCLEROSIS RISK; TRIGLYCERIDE LEVELS; MEN; ASSOCIATION; PREDICTOR	Background: The association between white blood cell (WBC) count and coronary artery disease (CAD) is unknown in young adults. Our objective was to assess the association between WBC count and its changes over time with CAD incidence in the Metabolic, Life-style and Nutrition Assessment in Young adults (MELANY) study, a cohort of Israeli army personnel. Methods and Findings: 29,120 apparently healthy young men (mean age; 31.2 +/- 5.5 years) with a normal baseline WBC count (3,000-12,000 cells/mm(3)) were followed during a mean follow up of 7.5 +/- 3.8 years for incidence of CAD. Participants were screened every 3-5 years using a stress test, and CAD was confirmed by coronary angiography. In a multivariate model adjusted for age, body mass index (BMI), LDL- and HDL-cholesterol, blood pressure, family history of CAD, physical activity, diabetes, triglycerides and smoking status, WBC levels (divided to quintiles) above 6,900 cells/mm(3) (quintile 4) were associated with a 2.17-fold increase (95% CI = 1.18-3.97) in the risk for CAD as compared with men in quintile 1 (WBC <= 5,400 cells/mm(3)). When modeled as a continuous variable, a WBC increment of 1000 cells/mm(3) was associated with a 17.4% increase in CAD risk (HR 1.174; 95% CI = 1.067-1.290, p = 0.001). A decrease in the WBC level (within the normal range) during the follow-up period was associated with increased physical activity and decreased triglyceride levels as well as with reduced incidence of CAD. Conclusions: WBC count is an independent risk factor for CAD in young adults at values well within the normal range. WBC count may assist in detecting subgroups of young men at either low or high risk for progression to CAD.	[Twig, Gilad] Chaim Sheba Med Ctr, Dept Med B, IL-52621 Tel Hashomer, Israel; [Twig, Gilad; Tirosh, Amir] Chaim Sheba Med Ctr, Dr Pinchas Borenstein Talpiot Med Leadership Prog, IL-52621 Tel Hashomer, Israel; [Twig, Gilad; Derazne, Estela; Tzur, Dorit; Gordon, Barak] Chaim Sheba Med Ctr, Israel Def Forces Med Corps, IL-52621 Tel Hashomer, Israel; [Afek, Arnon; Shamiss, Ari] Chaim Sheba Med Ctr, Chaim Sheba Med Ctr Management, IL-52621 Tel Hashomer, Israel; [Afek, Arnon; Shamiss, Ari; Derazne, Estela; Gordon, Barak] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Tirosh, Amir] Harvard Univ, Brigham & Womens Hosp, Sch Publ Hlth, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health	Twig, G (corresponding author), Chaim Sheba Med Ctr, Dept Med B, IL-52621 Tel Hashomer, Israel.	Gilad.Twig@gmail.com; Atirosh@partners.org	Gordon, Barak/L-6139-2018; Twig, Gilad/C-4373-2018	Gordon, Barak/0000-0002-5283-722X; Twig, Gilad/0000-0003-2829-3645; Tirosh, Amir/0000-0003-2210-5906	Pinchas Borenstein Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Israel Defense Forces Medical Corps; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529] Funding Source: NIH RePORTER	Pinchas Borenstein Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Israel Defense Forces Medical Corps; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	GT and AT were supported by a grant from the Pinchas Borenstein Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-Hashomer, Israel, and by the Israel Defense Forces Medical Corps. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara A, 1993, REV PORT CARDIOL, V12, P899; Amaro A, 1993, Rev Port Cardiol, V12, P913; Aronow HD, 2003, J AM COLL CARDIOL, V41, p17A; Asadollahi K, 2010, QJM-INT J MED, V103, P285, DOI 10.1093/qjmed/hcp182; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; FRIEDMAN GD, 1974, NEW ENGL J MED, V290, P1275, DOI 10.1056/NEJM197406062902302; GILLUM RF, 1993, AM HEART J, V125, P855, DOI 10.1016/0002-8703(93)90181-8; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Jee SH, 2005, AM J EPIDEMIOL, V162, P1062, DOI 10.1093/aje/kwi326; Kim HC, 2010, J AM COLL CARDIOL, V55, P2080, DOI 10.1016/j.jacc.2009.12.047; Lee CD, 2001, AM J EPIDEMIOL, V154, P758, DOI 10.1093/aje/154.8.758; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; Mizuno Y, 2011, J ATHEROSCLER THROMB, V18, P351, DOI 10.5551/jat.7591; Navas-Nacher EL, 2001, ANN INTERN MED, V134, P433, DOI 10.7326/0003-4819-134-6-200103200-00007; PHILLIPS AN, 1992, AM J EPIDEMIOL, V136, P59, DOI 10.1093/oxfordjournals.aje.a116421; Roux AVD, 2002, DIABETES CARE, V25, P1976, DOI 10.2337/diacare.25.11.1976; SCHLANT RC, 1982, CIRCULATION, V66, P401, DOI 10.1161/01.CIR.66.2.401; Shankar A, 2007, ATHEROSCLEROSIS, V192, P177, DOI 10.1016/j.atherosclerosis.2006.04.029; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Sweetnam PM, 1997, AM J EPIDEMIOL, V145, P416; Takeda Y, 2003, JPN HEART J, V44, P201, DOI 10.1536/jhj.44.201; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Tirosh A, 2008, DIABETES CARE, V31, P2032, DOI 10.2337/dc08-0825; Tirosh A, 2007, ANN INTERN MED, V147, P377, DOI 10.7326/0003-4819-147-6-200709180-00007; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Tirosh A, 2010, HYPERTENSION, V56, P203, DOI 10.1161/HYPERTENSIONAHA.109.146415; Urbina EM, 2004, ATHEROSCLEROSIS, V176, P157, DOI 10.1016/j.atherosclerosis.2004.04.023; Weijenberg MP, 1996, ARTERIOSCL THROM VAS, V16, P499, DOI 10.1161/01.ATV.16.4.499; Wheeler JG, 2004, EUR HEART J, V25, P1287, DOI 10.1016/j.ehj.2004.05.002	30	46	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47183	10.1371/journal.pone.0047183	http://dx.doi.org/10.1371/journal.pone.0047183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077568	Green Published, gold, Green Submitted			2022-12-27	WOS:000309809500036
J	Kandiyil, N; Altaf, N; Hosseini, AA; MacSweeney, ST; Auer, DP				Kandiyil, Neghal; Altaf, Nishath; Hosseini, Akram A.; MacSweeney, Shane T.; Auer, Dorothee P.			Lower Prevalence of Carotid Plaque Hemorrhage in Women, and Its Mediator Effect on Sex Differences in Recurrent Cerebrovascular Events	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; INTRAPLAQUE HEMORRHAGE; RISK-FACTORS; SYMPTOMATIC PATIENTS; ARTERY STENOSIS; ENDARTERECTOMY; STROKE; ASSOCIATION; DISEASE; SURGERY	Background and Purpose: Women are at lower risk of stroke, and appear to benefit less from carotid endarterectomy (CEA) than men. We hypothesised that this is due to more benign carotid disease in women mediating a lower risk of recurrent cerebrovascular events. To test this, we investigated sex differences in the prevalence of MRI detectable plaque hemorrhage (MRI PH) as an index of plaque instability, and secondly whether MRI PH mediates sex differences in the rate of cerebrovascular recurrence. Methods: Prevalence of PH between sexes was analysed in a single centre pooled cohort of 176 patients with recently symptomatic, significant carotid stenosis (106 severe [>= 70%], 70 moderate [50-69%]) who underwent prospective carotid MRI scanning for identification of MRI PH. Further, a meta-analysis of published evidence was undertaken. Recurrent events were noted during clinical follow up for survival analysis. Results: Women with symptomatic carotid stenosis (50%>=) were less likely to have plaque hemorrhage (PH) than men (46% vs. 70%) with an adjusted OR of 0.23 [95% CI 0.10-0.50, P<0.0001] controlling for other known vascular risk factors. This negative association was only significant for the severe stenosis subgroup (adjusted OR 0.18, 95% CI 0.067-0.50) not the moderate degree stenosis. Female sex in this subgroup also predicted a longer time to recurrent cerebral ischemic events (HR 0.38 95% CI 0.15-0.98, P = 0.045). Further addition of MRI PH or smoking abolished the sex effects with only MRI PH exerting a direct effect. Meta-analysis confirmed a protective effect of female sex on development of PH: unadjusted OR for presence of PH = 0.54 (95% CI 0.45-0.67, p<0.00001). Conclusions: MRI PH is significantly less prevalent in women. Women with MRI PH and severe stenosis have a similar risk as men for recurrent cerebrovascular events. MRI PH thus allows overcoming the sex bias in selection for CEA.	[Kandiyil, Neghal; Altaf, Nishath; Hosseini, Akram A.; Auer, Dorothee P.] Univ Nottingham, Div Radiol & Imaging Sci, Nottingham NG7 2RD, England; [Kandiyil, Neghal; Altaf, Nishath; MacSweeney, Shane T.] Univ Nottingham Hosp, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Auer, DP (corresponding author), Univ Nottingham, Div Radiol & Imaging Sci, Nottingham NG7 2RD, England.	dorothee.auer@nottingham.ac.uk		Auer, Dorothee P./0000-0002-4745-3635	Department of Health [PB-PG-0107-11438] Funding Source: Medline; National Institute for Health Research [PB-PG-0107-11438] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Alamowitch S, 2005, STROKE, V36, P27, DOI 10.1161/01.STR.0000149622.12636.1f; Altaf N, 2008, RADIOLOGY, V248, P202, DOI 10.1148/radiol.2481070300; Altaf N, 2008, J VASC SURG, V47, P337, DOI 10.1016/j.jvs.2007.09.064; Altaf N, 2007, STROKE, V38, P1633, DOI 10.1161/STROKEAHA.106.473066; AS Aghi M, 2001, INITIATION MAINTENAN, V1, P49; Bitar R, 2008, RADIOLOGY, V249, P259, DOI 10.1148/radiol.2491071517; Bond R, 2005, CEREBROVASC DIS, V20, P69, DOI 10.1159/000086509; Cheung HMC, 2011, RADIOLOGY, V260, P841, DOI 10.1148/radiol.11101652; Derksen WJM, 2011, ATHEROSCLEROSIS, V214, P139, DOI 10.1016/j.atherosclerosis.2010.10.022; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; DiBardino D, 2000, ANN VASC SURG, V14, P340, DOI 10.1007/s100169910078; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Goode NA, 2007, EUR STROK C GLASG UK; Hellings WE, 2007, J VASC SURG, V45, P289, DOI 10.1016/j.jvs.2006.09.051; Hellings WE, 2010, CIRCULATION, V121, P1941, DOI 10.1161/CIRCULATIONAHA.109.887497; Kurosaki Y, 2011, NEUROSURGERY, V68, P62, DOI 10.1227/NEU.0b013e3181fc60a8; Kwee RM, 2010, STROKE, V41, P1389, DOI 10.1161/STROKEAHA.109.575670; Meese SR, 2004, J NEUROL NEUROSUR PS, V75, P1759, DOI 10.1136/jnnp.2003.030486; Murphy RE, 2003, CIRCULATION, V107, P3053, DOI 10.1161/01.CIR.0000074204.92443.37; Qiao Y, 2012, AM J NEURORADIOL, V33, P755, DOI 10.3174/ajnr.A2863; Redgrave JNE, 2006, CIRCULATION, V113, P2320, DOI 10.1161/CIRCULATIONAHA.105.589044; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rothwell PM, 2004, STROKE, V35, P2855, DOI 10.1161/01.STR.0000147040.20446.f6; Sidhu PS, 1997, CLIN RADIOL, V52, P654, DOI 10.1016/S0009-9260(97)80027-X; Turc G, 2012, ARTERIOSCL THROM VAS, V32, P492, DOI 10.1161/ATVBAHA.111.239335	28	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47319	10.1371/journal.pone.0047319	http://dx.doi.org/10.1371/journal.pone.0047319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110067	Green Published, Green Submitted, gold			2022-12-27	WOS:000310262500008
J	Loddenkemper, T; Syed, TU; Ramgopal, S; Gulati, D; Thanaviratananich, S; Kothare, SV; Alshekhlee, A; Koubeissi, MZ				Loddenkemper, Tobias; Syed, Tanvir U.; Ramgopal, Sriram; Gulati, Deepak; Thanaviratananich, Sikawat; Kothare, Sanjeev V.; Alshekhlee, Amer; Koubeissi, Mohamad Z.			Risk Factors Associated with Death in In-Hospital Pediatric Convulsive Status Epilepticus	PLOS ONE			English	Article							REFRACTORY STATUS EPILEPTICUS; CONTINUOUS MIDAZOLAM; CLINICAL-FEATURES; TERM MORTALITY; UNITED-STATES; 1ST EPISODE; CHILDREN; EPILEPSY; CHILDHOOD; EFFICACY	Objective: To evaluate in-patient mortality and predictors of death associated with convulsive status epilepticus (SE) in a large, multi-center, pediatric cohort. Patients and Methods: We identified our cohort from the KID Inpatient Database for the years 1997, 2000, 2003 and 2006. We queried the database for convulsive SE, associated diagnoses, and for inpatient death. Univariate logistic testing was used to screen for potential risk factors. These risk factors were then entered into a stepwise backwards conditional multivariable logistic regression procedure. P-values less than 0.05 were taken as significant. Results: We identified 12,365 (5,541 female) patients with convulsive SE aged 0-20 years (mean age 6.2 years, standard deviation 5.5 years, median 5 years) among 14,965,571 pediatric inpatients (0.08%). Of these, 117 died while in the hospital (0.9%). The most frequent additional admission ICD-9 code diagnoses in addition to SE were cerebral palsy, pneumonia, and respiratory failure. Independent risk factors for death in patients with SE, assessed by multivariate calculation, included near drowning (Odds ratio [OR] 43.2; Confidence Interval [CI] 4.4-426.8), hemorrhagic shock (OR 17.83; CI 6.5-49.1), sepsis (OR 10.14; CI 4.0-25.6), massive aspiration (OR 9.1; CI 1.8-47), mechanical ventilation >96 hours (OR9; 5.6-14.6), transfusion (OR 8.25; CI 4.3-15.8), structural brain lesion (OR7.0; CI 3.1-16), hypoglycemia (OR5.8; CI 1.75-19.2), sepsis with liver failure (OR 14.4; CI 5-41.9), and admission in December (OR3.4; CI 1.6-4.1). African American ethnicity (OR 0.4; CI 0.2-0.8) was associated with a decreased risk of death in SE. Conclusion: Pediatric convulsive SE occurs in up to 0.08% of pediatric inpatient admissions with a mortality of up to 1%. There appear to be several risk factors that can predict mortality. These may warrant additional monitoring and aggressive management.	[Loddenkemper, Tobias; Ramgopal, Sriram; Kothare, Sanjeev V.] Childrens Hosp Boston, Dept Neurol, Boston, MA USA; [Loddenkemper, Tobias; Ramgopal, Sriram; Kothare, Sanjeev V.] Harvard Univ, Sch Med, Boston, MA USA; [Syed, Tanvir U.; Gulati, Deepak; Thanaviratananich, Sikawat; Koubeissi, Mohamad Z.] Case Western Reserve Univ & Univ Hosp, Dept Neurol, Cleveland, OH USA; [Alshekhlee, Amer] St Louis Univ, Dept Neurol, St Louis, MO 63103 USA; [Koubeissi, Mohamad Z.] George Washington Univ, Dept Neurol, Washington, DC USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Case Western Reserve University; Case Western Reserve University Hospital; Saint Louis University; George Washington University	Ramgopal, S (corresponding author), Childrens Hosp Boston, Dept Neurol, Boston, MA USA.	Sriram.ramgopal@childrens.harvard.edu		thanaviratananich, sikawat/0000-0001-8773-9470; Ramgopal, Sriram/0000-0002-1389-5726; Loddenkemper, Tobias/0000-0003-2074-0674; Kothare, Sanjeev/0000-0001-7849-6649	National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) [1R21NS076859-01]; Career Development Fellowship Award from Harvard Medical School; Children's Hospital Boston; Program for Quality and Safety at Children's Hospital Boston; Payer Provider Quality Initiative; Translational Research Project at Children's Hospital Boston; Epilepsy Foundation of America [EF-213583, EF-213882]; Center for Integration of Medicine & Innovative Technology (CIMIT/DoD); National Institute of Health [1 RC1 HL099749-01 (R21), RFA-HL-09-001]; Harvard Catalyst; Coulter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009001, RC1HL099749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076859] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Career Development Fellowship Award from Harvard Medical School; Children's Hospital Boston; Program for Quality and Safety at Children's Hospital Boston; Payer Provider Quality Initiative; Translational Research Project at Children's Hospital Boston; Epilepsy Foundation of America; Center for Integration of Medicine & Innovative Technology (CIMIT/DoD); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst; Coulter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	TL serves on the Laboratory Accreditation Board for Long Term (Epilepsy and ICU) Monitoring (ABRET), serves as an Associate Editor for Seizure, serves on the American Board of Clinical Neurophysiology, and on the Council of the American Clinical Neurophysiology Society, performs Video EEG longterm monitoring, EEGs, and other electrophysiological studies at Children's Hospital Boston and bills for these procedures (20%), receives support from National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) 1R21NS076859-01 (2011-2013), is supported by a Career Development Fellowship Award from Harvard Medical School and Children's Hospital Boston, by the Program for Quality and Safety at Children's Hospital Boston, from the Payer Provider Quality Initiative, the Translational Research Project at Children's Hospital Boston, receives funding from the Epilepsy Foundation of America (EF-213583 & EF-213882), and from the Center for Integration of Medicine & Innovative Technology (CIMIT/DoD), and received investigator initiated research support from Eisai and Lundbeck. Drs. TS, SR, DG, and ST have nothing to disclose. Dr. SK performs Video EEG longterm monitoring, EEGs, and other electrophysiological studies at Children's Hospital Boston and bills for these procedures, is interim medical director of the Center for Pediatric Sleep Disorders at Children's Hospital Boston, and has received research support from National Institute of Health (1 RC1 HL099749-01 (R21) (2009-12), and RFA-HL-09-001 (2010-14) and the Harvard Catalyst (2010-11). He also serves on the editorial board of the journal Pediatric Neurology. Dr. AA has nothing to disclose. Dr. MK has no conflict of interest related to the current work, has received grant support from the Coulter Foundation, and is on the Speakers' Bureaus of UCB and Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2011, OV KIDS INP DAT KID; Ahmad S, 2006, LANCET, V367, P1591, DOI 10.1016/S0140-6736(06)68696-0; AICARDI J, 1970, EPILEPSIA, V11, P187, DOI 10.1111/j.1528-1157.1970.tb03880.x; Asadi-Pooya AA, 2005, EPILEPSY BEHAV, V7, P502, DOI 10.1016/j.yebeh.2005.07.005; Banerjee P, 2007, EPILEPSY COMPREHENSI, V1, P45; Barnard C, 1999, J CHILD NEUROL, V14, P787, DOI 10.1177/088307389901401204; Berg AT, 2004, NEUROLOGY, V63, P1027, DOI 10.1212/01.WNL.0000138425.54223.DC; Berg AT, 2001, NEUROLOGY, V56, P1445, DOI 10.1212/WNL.56.11.1445; Brevoord JCD, 2005, J CHILD NEUROL, V20, P476, DOI 10.1177/088307380502000602; Callenbach PMC, 2001, PEDIATRICS, V107, P1259, DOI 10.1542/peds.107.6.1259; Chen L, 2009, EUR J NEUROL, V16, P444, DOI 10.1111/j.1468-1331.2008.02404.x; CHEVRIE JJ, 1979, EPILEPSIA, V20, P643, DOI 10.1111/j.1528-1157.1979.tb04848.x; Chin RFM, 2004, J NEUROL NEUROSUR PS, V75, P1584, DOI 10.1136/jnnp.2003.032797; Day JF, 2009, J MED ENTOMOL, V46, P1498, DOI 10.1603/033.046.0638; de Pont ACJM, 2011, NETH J MED, V69, P196; DELORENZO RJ, 1992, EPILEPSIA, V33, pS15; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; DODSON WE, 1993, JAMA-J AM MED ASSOC, V270, P854; DUNN DW, 1988, J CHILD NEUROL, V3, P167, DOI 10.1177/088307388800300303; Gulati Sheffali, 2005, Indian Journal of Pediatrics, V72, P105, DOI 10.1007/BF02760691; Hayashi K, 2007, PEDIATR NEUROL, V36, P366, DOI 10.1016/j.pediatrneurol.2007.02.012; Kang Du Cheol, 2005, Yonsei Medical Journal, V46, P27; Karasalihoglu S, 2003, PEDIATR INT, V45, P429, DOI 10.1046/j.1442-200X.2003.01758.x; Kim SJ, 2001, PEDIATR NEUROL, V25, P217, DOI 10.1016/S0887-8994(01)00311-3; Knake S, 2001, EPILEPSIA, V42, P714, DOI 10.1046/j.1528-1157.2001.01101.x; KONRAD F, 1994, CHEST, V105, P237, DOI 10.1378/chest.105.1.237; Koubeissi M, 2007, NEUROLOGY, V69, P886, DOI 10.1212/01.wnl.0000269791.96189.70; Kramer U, 2005, J CHILD NEUROL, V20, P184, DOI 10.1177/08830738050200030301; Li JM, 2009, EPILEPSY BEHAV, V14, P146, DOI 10.1016/j.yebeh.2008.09.005; Lin KL, 2009, PEDIATR NEUROL, V41, P413, DOI 10.1016/j.pediatrneurol.2009.06.004; Logroscino G, 2005, EPILEPSIA, V46, P46, DOI 10.1111/j.1528-1167.2005.00409.x; Logroscino G, 2002, NEUROLOGY, V58, P537, DOI 10.1212/WNL.58.4.537; Logroscino G, 1997, EPILEPSIA, V38, P1344, DOI 10.1111/j.1528-1157.1997.tb00073.x; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; Maegaki Y, 2005, NEUROPEDIATRICS, V36, P186, DOI 10.1055/s-2005-865611; Mah JK, 1999, PEDIATR NEUROL, V20, P364, DOI 10.1016/S0887-8994(99)00012-0; MAYTAL J, 1989, PEDIATRICS, V83, P323; Molinero MR, 2009, EPILEPSIA, V50, P2314, DOI 10.1111/j.1528-1167.2009.02266.x; Morrison G, 2006, INTENS CARE MED, V32, P2070, DOI 10.1007/s00134-006-0362-8; Mpimbaza A, 2008, PEDIATRICS, V121, pE58, DOI 10.1542/peds.2007-0930; Muchohi SN, 2008, BRIT J CLIN PHARMACO, V65, P12, DOI 10.1111/j.1365-2125.2007.02966.x; Ogutu BR, 2002, BRIT J CLIN PHARMACO, V53, P49, DOI 10.1046/j.0306-5251.2001.01529.x; Ozdemir D, 2005, SEIZURE-EUR J EPILEP, V14, P129, DOI 10.1016/j.seizure.2004.12.005; Prasad K, 2007, BRIT J CLIN PHARMACO, V63, P640, DOI 10.1111/j.1365-2125.2007.02931.x; RYAN CA, 1993, CAN MED ASSOC J, V148, P781; Sahin M, 2001, EPILEPSIA, V42, P1461, DOI 10.1046/j.1528-1157.2001.21301.x; Scholtes FBJ, 1996, SEIZURE-EUR J EPILEP, V5, P177, DOI 10.1016/S1059-1311(96)80033-1; Sharip A, 2006, PEDIATR INFECT DIS J, V25, P191, DOI 10.1097/01.inf.0000202065.03366.0c; Siddiqui Tahir Saeed, 2008, J Ayub Med Coll Abbottabad, V20, P51; Sillanpaa M, 2002, ANN NEUROL, V52, P303, DOI 10.1002/ana.10286; Singhi S, 2002, J CHILD NEUROL, V17, P106, DOI 10.1177/088307380201700203; Sodarangani M, 2008, LANCET NEUROL, V7, P145, DOI [10.1016/SI474-4422(07)70331-9, 10.1016/S1474-4422(07)70331-9]; Tabarki B, 2001, SEIZURE-EUR J EPILEP, V10, P365, DOI 10.1053/seiz.2000.0495; Waterhouse EJ, 1999, EPILEPSIA, V40, P752, DOI 10.1111/j.1528-1157.1999.tb00774.x; Wilson FC, 2003, NEUROREHABILITATION, V18, P291; Wu YW, 2002, NEUROLOGY, V58, P1070, DOI 10.1212/WNL.58.7.1070	56	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47474	10.1371/journal.pone.0047474	http://dx.doi.org/10.1371/journal.pone.0047474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110074	Green Published, gold			2022-12-27	WOS:000310262500012
J	Benatar, JR; Mortimer, J; Stretton, M; Stewart, RAH				Benatar, Jocelyne R.; Mortimer, John; Stretton, Matthew; Stewart, Ralph A. H.			A Booklet on Participants' Rights to Improve Consent for Clinical Research: A Randomized Trial	PLOS ONE			English	Article							INFORMED-CONSENT	Objective: Information on the rights of subjects in clinical trials has become increasingly complex and difficult to understand. This study evaluates whether a simple booklet which is relevant to all research studies improves the understanding of rights needed for subjects to provide informed consent. Methods: 21 currently used informed consent forms (ICF) from international clinical trials were separated into information related to the specific research study, and general information on participants' rights. A booklet designed to provide information on participants' rights which used simple language was developed to replace this information in current ICF's Readability of each component of ICF's and the booklet was then assessed using the Flesch-Kincaid Reading ease score (FK). To further evaluate the booklet 282 hospital inpatients were randomised to one of three ways to present research information; a standard ICF, the booklet combined with a short ICF, or the booklet combined with a simplified ICF. Comprehension of information related to the research proposal and to participant's rights was assessed by questionnaire. Results: Information related to participants' rights contributed an average of 44% of the words in standard ICFs, and was harder to read than information describing the clinical trial (FK 25 versus (vs.) 41 respectively, p = 0.0003). The booklet reduced the number of words and improved FK from 25 to 42. The simplified ICF had a slightly higher FK score than the standard ICF (50 vs. 42). Comprehension assessed in inpatients was better for the booklet and short ICF 62%, (95% confidence interval (CI) 56 to 67) correct, or simplified ICF 62% (CI 58 to 68) correct compared to 52%, (CI 47 to 57) correct for the standard ICF, p = 0.009. This was due to better understanding of questions on rights (62% vs. 49% correct, p = 0.0008). Comprehension of study related information was similar for the simplified and standard ICF (60% vs. 64% correct, p = 0.68). Conclusions: A booklet provides a simple consistent approach to providing information on participant rights which is relevant to all research studies, and improves comprehension of patients who typically participate in clinical trials.	[Benatar, Jocelyne R.; Mortimer, John; Stretton, Matthew; Stewart, Ralph A. H.] Univ Auckland, Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1, New Zealand	Auckland City Hospital; University of Auckland	Benatar, JR (corresponding author), Univ Auckland, Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1, New Zealand.	Jocelyne.Benatar@adhb.govt.nz		benatar, jocelyne/0000-0002-6724-8997	ADHB Charitable trust	ADHB Charitable trust	The ADHB Charitable trust provided financial support for the study A+4291. A report was submitted to the funders following completion of the study. The funders had no role in study design, data collection or analysis, the decision to publish or preparation of the manuscript.	Albala Ilene, 2010, IRB, V32, P7; [Anonymous], 1996, BRIT MED J, V313, P1448; Ben-Shahar O, 2010, THE CHICAGO WORKING, P1; Benatar JR, 2012, N Z MED J IN PRESS; BERGLER JH, 1980, CLIN PHARMACOL THER, V27, P435, DOI 10.1038/clpt.1980.60; Burman W, 2003, CONTROL CLIN TRIALS, V24, P245, DOI 10.1016/S0197-2456(03)00003-5; Cohn E, 2007, J NURS SCHOLARSHIP, V39, P273, DOI 10.1111/j.1547-5069.2007.00180.x; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Goldfarb N. M, 2006, J CLIN RES BEST PRAC, V2, P1; HOWARD JM, 1981, CONTROL CLIN TRIALS, V2, P287, DOI 10.1016/0197-2456(81)90019-2; Hudson M, 2010, TE ARA TIKA GUIDELIN, P1; International Conference on Harmonisation Good Clinical Practice, 2010, INTERNATIONAL CONFER; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Kass NE, 2011, J GEN INTERN MED, V26, P1324, DOI 10.1007/s11606-011-1778-6; Kincaid J. P., 1975, I SIMULATION TRAININ, V56, P1; Marco CA, 2008, J EMERG MED, V34, P269, DOI 10.1016/j.jemermed.2007.06.026; MILLER C, 1994, J CLIN RES DRUG DEV, V8, P237; Schneider CE, 2010, HASTINGS CENT REP, V40, P9; Simons KW, 2001, OFF J EUR COMMUNITIE, V121, P34; Stryker JE, 2006, PATIENT EDUC COUNS, V63, P104, DOI 10.1016/j.pec.2005.09.006; The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1979, THE BELMONT REPORT E; Williams BF, 2003, LANCET, V361, P918, DOI 10.1016/S0140-6736(03)12773-0; Wirshing DA, 1998, AM J PSYCHIAT, V155, P1508, DOI 10.1176/ajp.155.11.1508	23	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47023	10.1371/journal.pone.0047023	http://dx.doi.org/10.1371/journal.pone.0047023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094034	gold, Green Submitted, Green Published			2022-12-27	WOS:000310050200015
J	Cryan, PM; Jameson, JW; Baerwald, EF; Willis, CKR; Barclay, RMR; Snider, EA; Crichton, EG				Cryan, Paul M.; Jameson, Joel W.; Baerwald, Erin F.; Willis, Craig K. R.; Barclay, Robert M. R.; Snider, E. Apple; Crichton, Elizabeth G.			Evidence of Late-Summer Mating Readiness and Early Sexual Maturation in Migratory Tree-Roosting Bats Found Dead at Wind Turbines	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; LONG-EARED BATS; PLECOTUS-AURITUS; PENILE SPINES; GLANS-PENIS; FATALITIES; CHIROPTERA; PATTERNS; SPERMATOZOA; SURVIVAL	Understanding animal mating systems is an important component of their conservation, yet the precise mating times for many species of bats are unknown. The aim of this study was to better understand the details and timing of reproductive events in species of bats that die most frequently at wind turbines in North America, because such information can help inform conservation strategies. We examined the reproductive anatomy of hoary bats (Lasiurus cinereus), eastern red bats (L. borealis), and silver-haired bats (Lasionycteris noctivagans) found dead beneath industrial-scale wind turbines to learn more about when they mate. We evaluated 103 L. cinereus, 18 L. borealis, and 47 Ln. noctivagans from wind energy facilities in the United States and Canada. Histological analysis revealed that most male L. cinereus and L. borealis, as well as over half the Ln. noctivagans examined had sperm in the caudae epididymides by late August, indicating readiness to mate. Testes regression in male hoary bats coincided with enlargement of seminal vesicles and apparent growth of keratinized spines on the glans penis. Seasonality of these processes also suggests that mating could occur during August in L. cinereus. Spermatozoa were found in the uterus of an adult female hoary bat collected in September, but not in any other females. Ovaries of all females sampled had growing secondary or tertiary follicles, indicating sexual maturity even in first-year females. Lasiurus cinereus, L. borealis, and Ln. noctivagans are the only North American temperate bats in which most first-year young of both sexes are known to sexually mature in their first autumn. Our findings provide the first detailed information published on the seasonal timing of mating readiness in these species most affected by wind turbines.	[Cryan, Paul M.; Snider, E. Apple] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Jameson, Joel W.; Willis, Craig K. R.] Univ Winnipeg, Dept Biol, Winnipeg, MB R3B 2E9, Canada; [Jameson, Joel W.; Willis, Craig K. R.] Univ Winnipeg, Ctr Forest Interdisciplinary Res, Winnipeg, MB R3B 2E9, Canada; [Baerwald, Erin F.; Barclay, Robert M. R.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Snider, E. Apple] US Forest Serv, Steamboat Springs, CO USA; [Crichton, Elizabeth G.] Univ Queensland, Gatton, Qld, Australia	United States Department of the Interior; United States Geological Survey; University of Winnipeg; University of Winnipeg; University of Calgary; United States Department of Agriculture (USDA); United States Forest Service; University of Queensland	Cryan, PM (corresponding author), US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA.	cryanp@usgs.gov	Willis, Craig K.R./F-5218-2013	Baerwald, Erin/0000-0002-6399-4749; Willis, Craig/0000-0002-0985-8607; Cryan, Paul/0000-0002-2915-8894	U.S. Fish and Wildlife Service; United States Geological Survey; Sustainable Development Innovation Fund of Manitoba Conservation; Natural Science and Engineering Research Council (NSERC, Canada); Bat Conservation International; University of Calgary's Institute for Sustainable Energy, Environment and Economy; Alberta Wind Energy; TransAlta; Enmax; Suncor	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); United States Geological Survey(United States Geological Survey); Sustainable Development Innovation Fund of Manitoba Conservation; Natural Science and Engineering Research Council (NSERC, Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Bat Conservation International; University of Calgary's Institute for Sustainable Energy, Environment and Economy; Alberta Wind Energy; TransAlta; Enmax; Suncor	This research was funded in part by the U.S. Fish and Wildlife Service, the United States Geological Survey, grants to CW from the Sustainable Development Innovation Fund of Manitoba Conservation, grants to CW and RB from the Natural Science and Engineering Research Council (NSERC, Canada), and funding to RB and EB from Bat Conservation International, the University of Calgary's Institute for Sustainable Energy, Environment and Economy, TransAlta, Enmax, Suncor, and Alberta Wind Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P1; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; ARONSON LR, 1967, ANAT REC, V157, P71, DOI 10.1002/ar.1091570111; Arteaga-Silva M, 2008, PHYSIOL BEHAV, V94, P412, DOI 10.1016/j.physbeh.2008.02.007; Baerwald EF, 2008, CURR BIOL, V18, pR695, DOI 10.1016/j.cub.2008.06.029; Baerwald EF, 2011, J WILDLIFE MANAGE, V75, P1103, DOI 10.1002/jwmg.147; Baerwald EF, 2009, J WILDLIFE MANAGE, V73, P1077, DOI 10.2193/2008-233; Barbour R.W., 1969, BATS AM; Barclay RMR, 2003, BAT ECOLOGY, P209; Brunet-Rossinni Anja K., 2009, P315; Cockrum E. L., 1955, Transactions of the Kansas Academy of Science, V58, P487, DOI 10.2307/3626410; Crichton Elizabeth G., 2000, P295, DOI 10.1016/B978-012195670-7/50008-4; Cryan P. M., 2011, ENVIRON LAW, V41, P355; Cryan PM, 2008, J WILDLIFE MANAGE, V72, P845, DOI 10.2193/2007-371; Cryan PM, 2007, BIOL CONSERV, V139, P1, DOI 10.1016/j.biocon.2007.05.019; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; DIXSON AF, 1991, PHYSIOL BEHAV, V49, P557, DOI 10.1016/0031-9384(91)90280-2; Druecker JD, 1972, ASPECTS REPROD MYOTI; Encarnacao JA, 2006, J MAMMAL, V87, P93, DOI 10.1644/04-MAMM-A-141R2.1; Entwistle AC, 1998, J ZOOL, V244, P63, DOI 10.1017/S0952836998001071; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Fleming TH, 2003, BAT ECOLOGY, P156; GUSTAFSON AW, 1979, J REPROD FERTIL, V56, P317; GUTHRIE MARY J., 1933, JOUR MAMMAL, V14, P199, DOI 10.2307/1373819; HOOPER EMMET T., 1959, OCCAS PAPERS MUS ZOOL UNIV MICHIGAN, V613, P1; KERMOTT LH, 1988, J ZOOL, V214, P519, DOI 10.1111/j.1469-7998.1988.tb03757.x; Kleiman D. G., 1969, Lynx, VNo. 10, P65; Kokurewicz Tomasz, 1992, Myotis, V30, P95; KRUTZSCH PH, 1975, AM J ANAT, V143, P163, DOI 10.1002/aja.1001430203; Krutzsch PH, 1987, AM J ANAT, V178, P617; Krutzsch Philip H., 2000, P91, DOI 10.1016/B978-012195670-7/50005-9; Krutzsch PH, 2009, ACTA CHIROPTEROL, V11, P89, DOI 10.3161/150811009X465712; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Lane JE, 2011, ANIM BEHAV, V81, P909, DOI 10.1016/j.anbehav.2011.02.003; Lupold S, 2004, BIOL J LINN SOC, V83, P497, DOI 10.1111/j.1095-8312.2004.00407.x; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; Myers P., 1977, University Calif. Publs Zool., VNo. 107, P1; OXBERRY BA, 1979, J REPROD FERTIL, V56, P359; PEARSON OP, 1952, J MAMMAL, V33, P273, DOI 10.2307/1375769; Polak M, 2010, P ROY SOC B-BIOL SCI, V277, P1371, DOI 10.1098/rspb.2009.1720; RACEY PA, 1979, J REPROD FERTIL, V56, P391; RACEY PA, 1974, J REPROD FERTIL, V41, P169; Racey Paul A., 2000, P363, DOI 10.1016/B978-012195670-7/50010-2; Rasweiler John J., 2000, P157, DOI 10.1016/B978-012195670-7/50006-0; RYAN JM, 1991, J MAMMAL, V72, P658, DOI 10.2307/1381827; SACHS BD, 1984, ANAT REC, V210, P45, DOI 10.1002/ar.1092100108; Solick Donald I., 2012, Bat Research News, V53, P15; SPEAKMAN JR, 1986, J ZOOL, V210, P515; Tuttle M.D., 1982, P105; Wimsatt WA, 1944, ANAT REC, V88, P193, DOI 10.1002/ar.1090880206; WIMSATT WA, 1945, J MAMMAL, V26, P23, DOI 10.2307/1375029; WIMSATT WA, 1966, AM J ANAT, V119, P25, DOI 10.1002/aja.1001190104; Wimsatt WA, 1960, B MUS COMP ZOOL HARV, V124, P259	54	48	49	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47586	10.1371/journal.pone.0047586	http://dx.doi.org/10.1371/journal.pone.0047586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094065	Green Submitted, Green Published, gold			2022-12-27	WOS:000310050200032
J	Rombach, SM; Aerts, JMFG; Poorthuis, BJHM; Groener, JEM; Donker-Koopman, W; Hendriks, E; Mirzaian, M; Kuiper, S; Wijburg, FA; Hollak, CEM; Linthorst, GE				Rombach, Saskia M.; Aerts, Johannes M. F. G.; Poorthuis, Ben J. H. M.; Groener, Johanna E. M.; Donker-Koopman, Wilma; Hendriks, Erik; Mirzaian, Mina; Kuiper, Sijmen; Wijburg, Frits A.; Hollak, Carla E. M.; Linthorst, Gabor E.			Long-Term Effect of Antibodies against Infused Alpha-Galactosidase A in Fabry Disease on Plasma and Urinary (lyso)Gb3 Reduction and Treatment Outcome	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; AGALSIDASE-BETA THERAPY; GLOBOTRIAOSYLSPHINGOSINE; GLOBOTRIAOSYLCERAMIDE; CERAMIDE; EFFICACY	Introduction: Enzyme replacement therapy (ERT) with alpha-Galactosidase A (aGal A) may cause antibody (AB) formation against aGal A in males with Fabry disease (FD). Anti agalsidase ABs negatively influence globotriaosylceramide (Gb3) reduction. We investigated the impact of agalsidase AB on Gb3 and lysoGb3 and clinical outcome in Fabry patients on ERT. Methods: Adult male and female patients on ERT for at least one year were included. Urinary Gb3 was measured by HPLC, plasma lysoGb3 by LC-ESI-MS/MS and AB with a neutralization assay. Results: Of the 59 patients evaluable patients, 0/30 females and 17/29 males developed anti-agalsidase antibodies (AB+). Only 3/17 males had transient (low) titers (tolerized). All AB+ patients developed antibodies during the first year of treatment. Change of agalsidase preparation (or dose) did not induce antibody formation. AB+ males had significant less decline in plasma lysoGb3 compared to AB- males (p = 0.04). Urinary Gb3 levels decreased markedly in AB- but remained comparable to baseline in AB+ males (p<0.01). (Lyso) Gb3 reduction in plasma and urine on ERT was correlated with LVmass reduction in females and development white matter lesions and stroke. Conclusion: In male patients antibodies against aGal A remained present up to 10 years of ERT. The presence of these antibodies is associated with a less robust decrease in plasma lysoGb3 and a profound negative effect on urinary Gb3 reduction, which may reflect worse treatment outcome.	[Rombach, Saskia M.; Hollak, Carla E. M.; Linthorst, Gabor E.] Univ Amsterdam, Acad Med Ctr, Div Internal Med, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands; [Aerts, Johannes M. F. G.; Poorthuis, Ben J. H. M.; Groener, Johanna E. M.; Donker-Koopman, Wilma; Hendriks, Erik; Mirzaian, Mina; Kuiper, Sijmen; Wijburg, Frits A.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Linthorst, GE (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Internal Med, Dept Endocrinol & Metab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	g.e.linthorst@amc.nl	Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565; Hollak, Carla/0000-0003-0464-1078; Mirzaian, Mina/0000-0001-9404-2903; Wijburg, Frits/0000-0002-0950-1368	Netherlands Organization for Health Research and Development (ZON-MW)	Netherlands Organization for Health Research and Development (ZON-MW)(Netherlands Organization for Health Research and Development)	This study was funded by The Netherlands Organization for Health Research and Development (ZON-MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Bekri Soumeya, 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P289, DOI 10.2174/187152506778520718; Benichou B, 2009, MOL GENET METAB, V96, P4, DOI 10.1016/j.ymgme.2008.10.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Breunig F, 2006, KIDNEY INT, V69, P1216, DOI 10.1038/sj.ki.5000208; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Garman RD, 2004, CLIN EXP IMMUNOL, V137, P496, DOI 10.1111/j.1365-2249.2004.02567.x; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Groener JEM, 2007, CLIN CHEM, V53, P742, DOI 10.1373/clinchem.2006.079012; Hollak CEM, 2009, MOL GENET METAB, V96, P1, DOI 10.1016/j.ymgme.2008.10.013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Linthorst GE, 2004, KIDNEY INT, V66, P1589, DOI 10.1111/j.1523-1755.2004.00924.x; Lubanda JC, 2009, GENET MED, V11, P256, DOI 10.1097/GIM.0b013e3181981d82; Mendelsohn NJ, 2009, NEW ENGL J MED, V360, P194, DOI 10.1056/NEJMc0806809; Rombach SM, 2010, BBA-MOL BASIS DIS, V9, P1; Sanchez-Nino MD, 2011, NEPHROL DIAL TRANSPL, V26, P1797, DOI 10.1093/ndt/gfq306; Schellekens H, 2008, CLIN THER, V30, pS50, DOI 10.1016/S0149-2918(08)80041-0; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2009, NEPHROL DIAL TRANSPL, V24, P2102, DOI 10.1093/ndt/gfp031; Smid BE, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-69; van Breemen MJ, 2011, BBA-MOL BASIS DIS, V1812, P70, DOI 10.1016/j.bbadis.2010.09.007; Vedder AC, 2007, J INHERIT METAB DIS, V30, P68, DOI 10.1007/s10545-006-0484-8; Vedder AC, 2008, MOL GENET METAB, V94, P319, DOI 10.1016/j.ymgme.2008.03.003; Vedder AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000598; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; Wilcox WR, 2012, MOL GENET METAB, V105, P443, DOI 10.1016/j.ymgme.2011.12.006; Young E, 2005, ACTA PAEDIATR, V94, P51, DOI 10.1080/08035320510028111	29	84	86	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47805	10.1371/journal.pone.0047805	http://dx.doi.org/10.1371/journal.pone.0047805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094092	gold, Green Published, Green Submitted			2022-12-27	WOS:000310050200048
J	Cong, WN; Cai, H; Wang, R; Daimon, CM; Maudsley, S; Raber, K; Canneva, F; von Horsten, S; Martin, B				Cong, Wei-na; Cai, Huan; Wang, Rui; Daimon, Caitlin M.; Maudsley, Stuart; Raber, Kerstin; Canneva, Fabio; von Hoersten, Stephan; Martin, Bronwen			Altered Hypothalamic Protein Expression in a Rat Model of Huntington's Disease	PLOS ONE			English	Article							EXPANDED CAG REPEAT; NEUROENDOCRINE CHANGES; GLUCOSE-HOMEOSTASIS; ALZHEIMERS-DISEASE; STRIATAL ATROPHY; RODENT MODELS; BODY-WEIGHT; WHOLE-BODY; BRAIN; MICE	Huntington's disease (HD) is a neurodegenerative disorder, which is characterized by progressive motor impairment and cognitive alterations. Changes in energy metabolism, neuroendocrine function, body weight, euglycemia, appetite function, and circadian rhythm can also occur. It is likely that the locus of these alterations is the hypothalamus. We used the HD transgenic (tg) rat model bearing 51 CAG repeats, which exhibits similar HD symptomology as HD patients to investigate hypothalamic function. We conducted detailed hypothalamic proteome analyses and also measured circulating levels of various metabolic hormones and lipids in pre-symptomatic and symptomatic animals. Our results demonstrate that there are significant alterations in HD rat hypothalamic protein expression such as glial fibrillary acidic protein (GFAP), heat shock protein-70, the oxidative damage protein glutathione peroxidase (Gpx4), glycogen synthase1 (Gys1) and the lipid synthesis enzyme acylglycerol-3-phosphate O-acyltransferase 1 (Agpat1). In addition, there are significant alterations in various circulating metabolic hormones and lipids in pre-symptomatic animals including, insulin, leptin, triglycerides and HDL, before any motor or cognitive alterations are apparent. These early metabolic and lipid alterations are likely prodromal signs of hypothalamic dysfunction. Gaining a greater understanding of the hypothalamic and metabolic alterations that occur in HD, could lead to the development of novel therapeutics for early interventional treatment of HD.	[Cong, Wei-na; Cai, Huan; Wang, Rui; Daimon, Caitlin M.; Martin, Bronwen] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA; [Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Raber, Kerstin; Canneva, Fabio; von Hoersten, Stephan] Univ Erlangen Nurnberg, Dept Expt Therapy, D-91054 Erlangen, Germany	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Erlangen Nuremberg	Martin, B (corresponding author), NIA, Metab Unit, NIH, Baltimore, MD 21224 USA.	martinbro@mail.nih.gov	Maudsley, Stuart/Q-4782-2019; von Hörsten, Stephan/G-9005-2015; Maudsley, Stuart/AAV-9929-2021; Cai, Huan/B-6578-2016; Wang, Rui/I-5643-2019	von Hörsten, Stephan/0000-0001-6409-0664; Maudsley, Stuart/0000-0002-1868-184X; Cai, Huan/0000-0001-7731-8891; Wang, Rui/0000-0001-7015-0272; Martin, Bronwen/0000-0002-9185-6925	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Aziz NA, 2010, CLIN ENDOCRINOL, V73, P206, DOI 10.1111/j.1365-2265.2009.03661.x; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; BAMFORD KA, 1995, NEUROLOGY, V45, P1867, DOI 10.1212/WNL.45.10.1867; Bellinger FP, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-8; Bjorkqvist M, 2007, MOVEMENT DISORD, V22, P1952, DOI 10.1002/mds.21447; Boey D, 2007, PEPTIDES, V28, P390, DOI 10.1016/j.peptides.2006.07.031; BRANDT J, 1988, ANN NEUROL, V23, P555, DOI 10.1002/ana.410230605; Braunstein KE, 2010, HUM MOL GENET, V19, P4385, DOI 10.1093/hmg/ddq361; Cai H, 2012, CURR ALZHEIMER RES, V9, P5, DOI 10.2174/156720512799015064; CHADWICK W, 2010, INT J ALZHEIMERS DIS, DOI DOI 10.4061/2010/604792; Chadwick W, 2011, J SIGNAL TRANSDUCT, V2011; Chadwick W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036975; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021638; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; DEWHURST K, 1970, EUR NEUROL, V3, P278, DOI 10.1159/000113980; Ding WG, 1997, DIABETES, V46, P615, DOI 10.2337/diabetes.46.4.615; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Faivre E, 2012, EUR J PHARMACOL, V674, P294, DOI 10.1016/j.ejphar.2011.11.007; FARRER LA, 1985, CLIN GENET, V27, P62; Field BCT, 2010, NAT REV ENDOCRINOL, V6, P444, DOI 10.1038/nrendo.2010.93; Gabery S, 2010, ACTA NEUROPATHOL, V120, P777, DOI 10.1007/s00401-010-0742-6; Griffiths SD, 2007, MOL BIOTECHNOL, V36, P81, DOI 10.1007/s12033-007-0005-5; Hamilton JM, 2004, J NEUROL NEUROSUR PS, V75, P209, DOI 10.1136/jnnp.2003.017822; Hashimoto K-I, 2012, CLIN ENDOCRINOL META; Holness MJ, 2003, BIOCHEM J, V369, P687, DOI 10.1042/BJ20021509; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; Hult S, 2010, CURR DRUG TARGETS, V11, P1237, DOI 10.2174/1389450111007011237; Hurlbert MS, 1999, DIABETES, V48, P649, DOI 10.2337/diabetes.48.3.649; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Kipps CM, 2005, J NEUROL NEUROSUR PS, V76, P650, DOI 10.1136/jnnp.2004.047993; KREMER HPH, 1989, J NEUROL SCI, V90, P335, DOI 10.1016/0022-510X(89)90120-2; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; Lalli G, 2009, J CELL SCI, V122, P1499, DOI 10.1242/jcs.044339; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Leoni V, 2011, NEUROSCI LETT, V494, P245, DOI 10.1016/j.neulet.2011.03.025; Li SH, 2004, NEUROSCIENTIST, V10, P467, DOI 10.1177/1073858404266777; Lopez M, 2008, CURR OPIN CLIN NUTR, V11, P483, DOI 10.1097/MCO.0b013e328302f3d8; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martin B, 2008, HISTOL HISTOPATHOL, V23, P237, DOI 10.14670/HH-23.237; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004146; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002750; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Martin B, 2009, J BIOL CHEM, V284, P2493, DOI 10.1074/jbc.M804545200; Mayers RM, 2005, BIOCHEM SOC T, V33, P367, DOI 10.1042/BST0330367; McBride JL, 2006, P NATL ACAD SCI USA, V103, P9345, DOI 10.1073/pnas.0508875103; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Nguyen HP, 2006, HUM MOL GENET, V15, P3177, DOI 10.1093/hmg/ddl394; Paulsen JS, 2006, BIOL PSYCHIAT, V59, P57, DOI 10.1016/j.biopsych.2005.06.003; Petersen A, 2009, NEURODEGENER DIS, V6, P154, DOI 10.1159/000225377; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; PODOLSKY S, 1977, GERONTOLOGY, V23, P55, DOI 10.1159/000212174; Pohl R, 2004, P NUTR SOC, V63, P259, DOI 10.1079/PNS2004341; Popovic V, 2004, EUR J ENDOCRINOL, V151, P451, DOI 10.1530/eje.0.1510451; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Rosas HD, 2005, NEUROLOGY, V65, P745, DOI 10.1212/01.wnl.0000174432.87383.87; Rothman SM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.005; Salvatore E, 2011, J NEUROL NEUROSUR PS, V82, P543, DOI 10.1136/jnnp.2010.208553; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; Scherbaum WA, 1998, EXP CLIN ENDOCR DIAB, V106, P97, DOI 10.1055/s-0029-1211958; SCHWARTZ TW, 1978, J CLIN INVEST, V61, P781, DOI 10.1172/JCI108992; SHIWACH R, 1994, ACTA PSYCHIAT SCAND, V90, P241, DOI 10.1111/j.1600-0447.1994.tb01587.x; Soneson C, 2010, NEUROBIOL DIS, V40, P531, DOI 10.1016/j.nbd.2010.07.013; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Stranahan AM, 2010, NEUROBIOL AGING, V31, P1937, DOI 10.1016/j.neurobiolaging.2008.10.016; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Tomita T, 2011, ISLETS, V3, P166, DOI 10.4161/isl.3.4.15875; Trejo A, 2004, NUTRITION, V20, P192, DOI 10.1016/j.nut.2003.10.007; Valenza M, 2010, J NEUROSCI, V30, P10844, DOI 10.1523/JNEUROSCI.0917-10.2010; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; WHITTIER JR, 1976, JAMA-J AM MED ASSOC, V235, P1423, DOI 10.1001/jama.1976.03260400011003; Wolf RC, 2007, BRAIN, V130, P2845, DOI 10.1093/brain/awm210; Zhao WQ, 2007, J NEUROCHEM, V100, P1211, DOI 10.1111/j.1471-4159.2006.04311.x	82	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47240	10.1371/journal.pone.0047240	http://dx.doi.org/10.1371/journal.pone.0047240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094041	Green Submitted, gold, Green Published			2022-12-27	WOS:000312384500007
J	Masino, MA; Abbinanti, MD; Eian, J; Harris-Warrick, RM				Masino, Mark A.; Abbinanti, Matthew D.; Eian, John; Harris-Warrick, Ronald M.			TTX-Resistant NMDA Receptor-Mediated Membrane Potential Oscillations in Neonatal Mouse Hb9 Interneurons	PLOS ONE			English	Article							RAT SPINAL-CORD; METHYL-D-ASPARTATE; CENTRAL PATTERN GENERATORS; CAT NEOCORTICAL NEURONS; LOCOMOTOR-LIKE ACTIVITY; FICTIVE LOCOMOTION; VOLTAGE OSCILLATIONS; IN-VITRO; LUMBAR MOTONEURONS; COMMISSURAL INTERNEURONS	Conditional neuronal membrane potential oscillations have been identified as a potential mechanism to help support or generate rhythmogenesis in neural circuits. A genetically identified population of ventromedial interneurons, called Hb9, in the mouse spinal cord has been shown to generate TTX-resistant membrane potential oscillations in the presence of NMDA, serotonin and dopamine, but these oscillatory properties are not well characterized. Hb9 interneurons are rhythmically active during fictive locomotor-like behavior. In this study, we report that exogenous N-Methyl-D-Aspartic acid (NMDA) application is sufficient to produce membrane potential oscillations in Hb9 interneurons. In contrast, exogenous serotonin and dopamine application, alone or in combination, are not sufficient. The properties of NMDA-induced oscillations vary among the Hb9 interneuron population; their frequency and amplitude increase with increasing NMDA concentration. NMDA does not modulate the T-type calcium current (I-Ca(T)), which is thought to be important in generating locomotor-like activity, in Hb9 neurons. These results suggest that NMDA receptor activation is sufficient for the generation of TTX-resistant NMDA-induced membrane potential oscillations in Hb9 interneurons. Citation: Masino MA, Abbinanti MD, Eian J, Harris-Warrick RM (2012) TTX-Resistant NMDA Receptor-Mediated Membrane Potential Oscillations in Neonatal Mouse Hb9 Interneurons. PLoS ONE 7(10): e47940. doi: 10.1371/journal.pone.0047940	[Masino, Mark A.; Eian, John] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Abbinanti, Matthew D.; Harris-Warrick, Ronald M.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	University of Minnesota System; University of Minnesota Twin Cities; Cornell University	Masino, MA (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	masino@umn.edu		Harris-Warrick, Ronald/0000-0002-7668-6075	National Institutes of Health [R01-NS065054, R01-NS35631, R01-NS17323]; Minnesota Medical Foundation Grant [4052-9238-11]; Office of the Dean of the Graduate School of the University of Minnesota [21934]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035631, R01NS065054, R01NS017323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Medical Foundation Grant; Office of the Dean of the Graduate School of the University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01-NS065054 (MAM) and R01-NS35631 and R01-NS17323 (to RMHW), Minnesota Medical Foundation Grant 4052-9238-11 (MAM) and Office of the Dean of the Graduate School of the University of Minnesota (Grant-in-Aid of Research, Artistry and Scholarship 21934 (MAM)). NIH: www.nih.gov MMF: www.mmf.umn.edu GIA: www.research.umn.edu/advance/gia.html#.T_2YrGDcFBw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbinanti MD, 2012, J NEUROPHYSIOL, V107, P2212, DOI 10.1152/jn.00768.2011; Anderson TM, 2012, J NEUROPHYSIOL, V107, P103, DOI 10.1152/jn.00583.2011; Arshavsky YI, 1997, CURR OPIN NEUROBIOL, V7, P781, DOI 10.1016/S0959-4388(97)80136-5; Beato M, 1997, P ROY SOC B-BIOL SCI, V264, P877, DOI 10.1098/rspb.1997.0122; Brownstone RM, 2008, BRAIN RES REV, V57, P64, DOI 10.1016/j.brainresrev.2007.06.025; CALABRESE RL, 1997, COMPUT NEUR, P119; CAZALETS JR, 1995, J NEUROSCI, V15, P4943; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Cowley KC, 2005, J NEUROPHYSIOL, V94, P3805, DOI 10.1152/jn.00016.2005; Cowley KC, 1997, J NEUROPHYSIOL, V77, P247, DOI 10.1152/jn.1997.77.1.247; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Crone SA, 2009, J NEUROSCI, V29, P7098, DOI 10.1523/JNEUROSCI.1206-09.2009; Diaz-Rios M, 2007, J NEUROPHYSIOL, V98, P2157, DOI 10.1152/jn.00430.2007; FLATMAN JA, 1983, BRAIN RES, V266, P169, DOI 10.1016/0006-8993(83)91323-9; FLATMAN JA, 1986, BRAIN RES, V363, P62, DOI 10.1016/0006-8993(86)90659-1; Fouad K, 2010, J NEUROPHYSIOL, V104, P2975, DOI 10.1152/jn.00499.2010; Gabbay H, 2002, J NEUROPHYSIOL, V88, P732, DOI 10.1152/jn.2002.88.2.732; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; Han P, 2007, J NEUROSCI, V27, P13192, DOI 10.1523/JNEUROSCI.1279-07.2007; Harris-Warrick RM, 2002, CURR OPIN NEUROBIOL, V12, P646, DOI 10.1016/S0959-4388(02)00377-X; HarrisWarrick RM, 1995, CURR OPIN NEUROBIOL, V5, P721, DOI 10.1016/0959-4388(95)89098-R; HERNANDEZ P, 1991, EXP BRAIN RES, V85, P66; Hinckley CA, 2006, J NEUROSCI, V26, P8477, DOI 10.1523/JNEUROSCI.0395-06.2006; HOCHMAN S, 1994, J NEUROPHYSIOL, V72, P2559, DOI 10.1152/jn.1994.72.5.2559; HOCHMAN S, 1994, J NEUROPHYSIOL, V72, P565, DOI 10.1152/jn.1994.72.2.565; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Kremer E, 1997, J NEUROPHYSIOL, V77, P1155, DOI 10.1152/jn.1997.77.3.1155; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; Kwan AC, 2010, J NEUROPHYSIOL, V104, P3323, DOI 10.1152/jn.00679.2010; Kwan AC, 2009, J NEUROSCI, V29, P11601, DOI 10.1523/JNEUROSCI.1612-09.2009; LERESCHE N, 1991, J PHYSIOL-LONDON, V441, P155, DOI 10.1113/jphysiol.1991.sp018744; LERESCHE N, 1990, NEUROSCI LETT, V113, P72, DOI 10.1016/0304-3940(90)90497-W; MacLean JN, 1997, EUR J NEUROSCI, V9, P2702, DOI 10.1111/j.1460-9568.1997.tb01699.x; MacLean JN, 2001, J NEUROPHYSIOL, V86, P1131, DOI 10.1152/jn.2001.86.3.1131; MacLean JN, 1998, J NEUROPHYSIOL, V79, P2804, DOI 10.1152/jn.1998.79.5.2804; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; MARDER E, 1984, J NEUROPHYSIOL, V51, P1362, DOI 10.1152/jn.1984.51.6.1362; MULLONEY B, 1981, BRAIN RES, V229, P25, DOI 10.1016/0006-8993(81)90742-3; Pena F, 2004, J NEUROSCI, V24, P7549, DOI 10.1523/JNEUROSCI.1871-04.2004; PERKEL DH, 1974, SCIENCE, V185, P181, DOI 10.1126/science.185.4146.181; Plouffe B, 2010, METHOD ENZYMOL, V484, P295, DOI [10.1016/B978-0-12-381298-8.00016-2, 10.1016/S0076-6879(10)84016-9]; ROBERTS A, 1995, J NEUROPHYSIOL, V73, P485, DOI 10.1152/jn.1995.73.2.485; Schmidt BJ, 1998, ANN NY ACAD SCI, V860, P189, DOI 10.1111/j.1749-6632.1998.tb09049.x; SCHWINDT P, 1977, BRAIN RES, V120, P173, DOI 10.1016/0006-8993(77)90510-8; SCHWINDT PC, 1980, J NEUROPHYSIOL, V43, P1700, DOI 10.1152/jn.1980.43.6.1700; SIGVARDT KA, 1985, BRAIN RES, V336, P390, DOI 10.1016/0006-8993(85)90676-6; SILLAR KT, 1994, EUR J MORPHOL, V32, P293; SMITH JC, 1988, FASEB J, V2, P2283, DOI 10.1096/fasebj.2.7.2450802; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; Tazerart S, 2008, J NEUROSCI, V28, P8577, DOI 10.1523/JNEUROSCI.1437-08.2008; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; WALLEN P, 1987, J NEUROSCI, V7, P2745; WALLEN P, 1985, NEUROSCI LETT, V56, P87, DOI 10.1016/0304-3940(85)90112-0; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821; Wilson JM, 2007, J NEUROPHYSIOL, V98, P2370, DOI 10.1152/jn.00338.2007; Wilson JM, 2010, J NEUROSCI, V30, P1137, DOI 10.1523/JNEUROSCI.1401-09.2010; Wilson JM, 2005, J NEUROSCI, V25, P5710, DOI 10.1523/JNEUROSCI.0274-05.2005; WILSON WA, 1974, SCIENCE, V186, P932, DOI 10.1126/science.186.4167.932; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhong GS, 2007, J NEUROSCI, V27, P4507, DOI 10.1523/JNEUROSCI.0124-07.2007; Ziskind-Conhaim L, 2008, J NEUROPHYSIOL, V100, P2254, DOI 10.1152/jn.90437.2008; Ziskind-Conhaim L, 2010, ANN NY ACAD SCI, V1198, P72, DOI 10.1111/j.1749-6632.2010.05533.x	67	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47940	10.1371/journal.pone.0047940	http://dx.doi.org/10.1371/journal.pone.0047940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094101	gold, Green Published			2022-12-27	WOS:000312384500029
J	Gasselhuber, A; Dreher, MR; Rattay, F; Wood, BJ; Haemmerich, D				Gasselhuber, Astrid; Dreher, Matthew R.; Rattay, Frank; Wood, Bradford J.; Haemmerich, Dieter			Comparison of Conventional Chemotherapy, Stealth Liposomes and Temperature-Sensitive Liposomes in a Mathematical Model	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; TARGETED DRUG-DELIVERY; MICROVASCULAR PERMEABILITY; THERMOSENSITIVE LIPOSOMES; CONTENT RELEASE; CANCER-THERAPY; IN-VITRO; TUMOR; DOXORUBICIN; ACCUMULATION	Various liposomal drug carriers have been developed to overcome short plasma half-life and toxicity related side effects of chemotherapeutic agents. We developed a mathematical model to compare different liposome formulations of doxorubicin (DOX): conventional chemotherapy (Free-DOX), Stealth liposomes (Stealth-DOX), temperature sensitive liposomes (TSL) with intra-vascular triggered release (TSL-i), and TSL with extra-vascular triggered release (TSL-e). All formulations were administered as bolus at a dose of 9 mg/kg. For TSL, we assumed locally triggered release due to hyperthermia for 30 min. Drug concentrations were determined in systemic plasma, aggregate body tissue, cardiac tissue, tumor plasma, tumor interstitial space, and tumor cells. All compartments were assumed perfectly mixed, and represented by ordinary differential equations. Contribution of liposomal extravasation was negligible in the case of TSL-i, but was the major delivery mechanism for Stealth-DOX and for TSL-e. The dominant delivery mechanism for TSL-i was release within the tumor plasma compartment with subsequent tissue-and cell uptake of released DOX. Maximum intracellular tumor drug concentrations for Free-DOX, Stealth-DOX, TSL-i, and TSL-e were 3.4, 0.4, 100.6, and 15.9 mu g/g, respectively. TSL-i and TSL-e allowed for high local tumor drug concentrations with reduced systemic exposure compared to Free-DOX. While Stealth-DOX resulted in high tumor tissue concentrations compared to Free-DOX, only a small fraction was bioavailable, resulting in little cellular uptake. Consistent with clinical data, Stealth-DOX resulted in similar tumor intracellular concentrations as Free-DOX, but with reduced systemic exposure. Optimal release time constants for maximum cellular uptake for Stealth-DOX, TSL-e, and TSL-i were 45 min, 11 min, and <3 s, respectively. Optimal release time constants were shorter for MDR cells, with similar to 4 min for Stealth-DOX and for TSL-e. Tissue concentrations correlated well quantitatively with a prior in-vivo study. Mathematical models may thus allow optimization of drug delivery systems to achieve a better therapeutic index.	[Gasselhuber, Astrid; Haemmerich, Dieter] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Dreher, Matthew R.; Wood, Bradford J.] NIH, Ctr Intervent Oncol Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA; [Gasselhuber, Astrid; Rattay, Frank] Vienna Univ Technol, Inst Anal & Sci Comp, A-1040 Vienna, Austria; [Haemmerich, Dieter] Clemson Univ, Dept Bioengn, Clemson, SC USA	Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Technische Universitat Wien; Clemson University	Haemmerich, D (corresponding author), Med Univ S Carolina, Dept Pediat, 171 Ashley Ave, Charleston, SC 29425 USA.	haemmer@musc.edu	Haemmerich, Dieter/C-7521-2009; Wood, Bradford J/M-7995-2017; Rattay, Frank/A-2231-2015	Wood, Bradford J/0000-0002-4297-0051; Rattay, Frank/0000-0002-2819-8827; Haemmerich, Dieter/0000-0003-1127-7024	National Institutes of Health [R01CA118990, R21CA135519]; NIH Center for Interventional Oncology; NIH Intramural Research Program; Extramural Research Facilities Program of the National Center for Research Resources [C06 RR018823]; NATIONAL CANCER INSTITUTE [R01CA118990, R21CA135519, ZIDBC011242] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL040012, ZIACL040015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for Interventional Oncology; NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Extramural Research Facilities Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CLINICAL CENTER	This work was supported by National Institutes of Health grants R01CA118990, R21CA135519 to DH, and by the NIH Center for Interventional Oncology and NIH Intramural Research Program. The work was conducted in a facility constructed with support from the National Institutes of Health, Grant Number C06 RR018823 from the Extramural Research Facilities Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan FL, 2002, J CONTROL RELEASE, V79, P29, DOI 10.1016/S0168-3659(01)00549-1; Allen TM, 2005, CLIN CANCER RES, V11, P3567, DOI 10.1158/1078-0432.CCR-04-2517; Andresen TL, 2005, PROG LIPID RES, V44, P68, DOI 10.1016/j.plipres.2004.12.001; Bally MB, 1998, J LIPOSOME RES, V8, P299, DOI 10.3109/08982109809035537; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; Brouckaert P, 2004, INT J CANCER, V109, P442, DOI 10.1002/ijc.11703; Castelli DD, 2009, NMR BIOMED, V22, P1084, DOI 10.1002/nbm.1416; Doroshow JH, 2006, CANC CHEMOTHERAPY BI; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Dromi S, 2007, CLIN CANCER RES, V13, P2722, DOI 10.1158/1078-0432.CCR-06-2443; Drummond DC, 1999, PHARMACOL REV, V51, P691; El-Kareh AW, 2000, NEOPLASIA, V2, P325, DOI 10.1038/sj.neo.7900096; El-Kareh AW, 2005, NEOPLASIA, V7, P705, DOI 10.1593/neo.05118; Fenske DB, 2001, CURR OPIN MOL THER, V3, P153; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon A, 1997, ADV DRUG DELIVER REV, V24, P337, DOI 10.1016/S0169-409X(96)00476-0; Gasselhuber A, 2012, INT J HYPERTHER, V28, P337, DOI 10.3109/02656736.2012.677930; Gasselhuber A, 2010, INT J HYPERTHER, V26, P499, DOI 10.3109/02656731003623590; GIGLI M, 1989, CANCER RES, V49, P560; Gustafson DL, 2002, J PHARM SCI, V91, P1488, DOI 10.1002/jps.10161; Hauck ML, 2006, CLIN CANCER RES, V12, P4004, DOI 10.1158/1078-0432.CCR-06-0226; Hossann M, 2007, BBA-BIOMEMBRANES, V1768, P2491, DOI 10.1016/j.bbamem.2007.05.021; Jackson TL, 2003, J THEOR BIOL, V220, P201, DOI 10.1006/jtbi.2003.3156; JAIN RK, 1987, CANCER RES, V47, P3039; KERR DJ, 1986, BIOCHEM PHARMACOL, V35, P2817, DOI 10.1016/0006-2952(86)90195-4; Kong G, 2000, CANCER RES, V60, P6950; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Li L, 2010, J CONTROL RELEASE, V143, P274, DOI 10.1016/j.jconrel.2010.01.006; Lindner LH, 2008, J CONTROL RELEASE, V125, P112, DOI 10.1016/j.jconrel.2007.10.009; Manzoor A, 2010, THESIS DUKE U; Mills JK, 2004, METHOD ENZYMOL, V387, P82; Needham D, 2001, ADV DRUG DELIVER REV, V53, P285, DOI 10.1016/S0169-409X(01)00233-2; Negussie AH, INT J HYPERTHERMIA, V27, P140; Patel P, 2008, INT J HYPERTHER, V24, P537, DOI 10.1080/02656730802064621; Poon RTP, 2009, EXPERT OPIN PHARMACO, V10, P333, DOI [10.1517/14656560802677874 , 10.1517/14656560802677874]; RICHES AC, 1973, J PHYSIOL-LONDON, V228, P279, DOI 10.1113/jphysiol.1973.sp010086; Schutt DJ, 2008, MED PHYS, V35, P3462, DOI 10.1118/1.2948388; Sinek JP, 2008, J MATH BIOL; Staruch R, INT J HYPERTHERMIA, V27, P156; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; VANDERVIJGH WJF, 1990, CANCER CHEMOTH PHARM, V26, P9, DOI 10.1007/BF02940286; Vora J, 1996, J PHARM PHARMACOL, V48, P1264, DOI 10.1111/j.2042-7158.1996.tb03934.x; WU NZ, 1993, MICROVASC RES, V46, P231, DOI 10.1006/mvre.1993.1049; WU NZ, 1993, CANCER RES, V53, P3765; YATVIN MB, 1978, SCIENCE, V202, P1290, DOI 10.1126/science.364652; YUAN F, 1994, CANCER RES, V54, P3352; YUAN F, 1993, MICROVASC RES, V45, P269, DOI 10.1006/mvre.1993.1024; Zhang AL, 2009, J HEAT TRANS-T ASME, V131, DOI 10.1115/1.3072952	48	72	75	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47453	10.1371/journal.pone.0047453	http://dx.doi.org/10.1371/journal.pone.0047453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082168	gold, Green Submitted, Green Published			2022-12-27	WOS:000311146900064
J	Luo, H; Guo, P; Zhou, QQ				Luo, Han; Guo, Ping; Zhou, Qiquan			Role of TLR4/NF-kappa B in Damage to Intestinal Mucosa Barrier Function and Bacterial Translocation in Rats Exposed to Hypoxia	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; TUMOR-NECROSIS-FACTOR; TIGHT JUNCTIONS; GUT FLORA; KAPPA-B; COLITIS; DISEASE; INJURY; INFLAMMATION; ENVIRONMENT	The role of Toll-like receptor 4 (TLR4)/nuclear factor-kappa-B (NF-kappa B) in intestinal mucosal barrier damage and bacterial translocation under hypoxic exposure is unclear. Here, we investigated their role using an acute hypobaric hypoxia model. Adult Sprague-Dawley rats were divided into control (C), hypoxia (H), hypoxia+NF-kappa B inhibitor pyrrolidinedithiocarbamic acid (PDTC) (100 mg. kg) (HP), hypoxia+0.5 mg/kg lipopolysaccharide (HPL), and hypoxia+PDTC+LPS (HPL) group. Except control group, other four groups were placed in a hypobaric chamber set at 7000 m. Samples were collected at 72 h after pressure reduction. Damage in ultrastructure of the intestinal tract was examined by transmission electron microscopy and bacterial translocation was detected by cultivation. Kinetic turbidimetric assay was used to measure the serum LPS. ELISA was performed to detect TNF-alpha and IL-6 serum concentrations. Fluorescent quantitative RT-PCR was used to measure TLR4 mRNA levels was measured using quantitative RT-PCR and protein of NF-kappa B p65 was measured by western blotting. Different degrees of intestinal mucosa damage were observed in groups H and HL. The damage was significantly alleviated after blockage of the TLR4/NF-kappa B signaling pathway. PDTC-treatment also reversed hyoxia- and LPS-induced bacterial translocation rate and increased serum levels of LPS, TNF-alpha, and IL-6. TLR4 mRNA levels and NF-kappa B p65 expression were consistent with the serum factor results. This study suggested that TLR4 and NF-kappa B expression increased in rat intestinal tissues after acute hypoxia exposure. PDTC-treatment reversed TLR4 and NF-kappa B upregulation and alleviated damage to the intestinal tract and bacterial translocation. Thus, the TLR4/NF-kappa B signaling pathway may be critical to the mechanism underlying hypoxia-induced damage to intestinal barrier function and bacterial translocation.	[Luo, Han; Guo, Ping; Zhou, Qiquan] Third Mil Med Univ, Dept High Altitude Dis, Coll High Altitude Mil Med, Chongqing, Peoples R China; [Luo, Han; Guo, Ping; Zhou, Qiquan] Minist Educ, Key Lab High Altitude Med, Chongqing, Peoples R China; [Luo, Han; Guo, Ping; Zhou, Qiquan] Key Lab High Altitude Med PLA, Chongqing, Peoples R China	Army Medical University	Zhou, QQ (corresponding author), Third Mil Med Univ, Dept High Altitude Dis, Coll High Altitude Mil Med, Chongqing, Peoples R China.	zhouqq9918@yahoo.com.cn			National Science and Technology Ministry [2009BAI85B03]; Chinese People's Liberation Army Eleventh Five-year Plan for Scientific and Technological Research [2008G093]	National Science and Technology Ministry; Chinese People's Liberation Army Eleventh Five-year Plan for Scientific and Technological Research	This work was funded by the National Science and Technology Ministry (Grant # 2009BAI85B03) and Chinese People's Liberation Army Eleventh Five-year Plan for Scientific and Technological Research (Grant # 2008G093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida J, 2006, WORLD J GASTROENTERO, V12, P1493, DOI 10.3748/wjg.v12.i10.1493; Bellot Pablo, 2008, Gastroenterol Hepatol, V31, P508; Buchholz BM, 2010, NEUROGASTROENT MOTIL, V22, P232, DOI 10.1111/j.1365-2982.2009.01464.x; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Cui W., 2007, WORLD CHINESE J DIGE, V15, P1788; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Deitch EA, 2002, SURGERY, V131, P241, DOI 10.1067/msy.2002.116408; Farrell CP, 2012, J EPITHEL BIOL PHARM, V5, P13; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Gao JS, 2009, WORD J GASTROENTEROL, V17, P1540; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Igawa S, 2011, EXP DERMATOL, V20, P53, DOI 10.1111/j.1600-0625.2010.01170.x; Kelly Caleb J, 2012, J Epithel Biol Pharmacol, V5, P67, DOI 10.2174/1875044301205010067; Neal MD, 2006, J IMMUNOL, V176, P3070, DOI 10.4049/jimmunol.176.5.3070; Noreen M, 2012, INFLAMM RES, V61, P177, DOI 10.1007/s00011-011-0427-1; Ohkawara T, 2005, CLIN EXP IMMUNOL, V141, P412, DOI 10.1111/j.1365-2249.2005.02877.x; Peterson CY, 2010, SURG INFECT, V11, P137, DOI 10.1089/sur.2009.053; Recavarren-Arce S, 2005, HISTOPATHOLOGY, V46, P374, DOI 10.1111/j.1365-2559.2005.02102.x; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Shimizu K, 2006, J TRAUMA, V60, P126, DOI 10.1097/01.ta.0000197374.99755.fe; Soares AL, 2010, SHOCK, V34, P306, DOI 10.1097/SHK.0b013e3181cdc585; Spehlmann ME, 2009, CURR OPIN GASTROEN, V25, P92, DOI 10.1097/MOG.0b013e328324f857; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; VanDeventer SJH, 1997, GUT, V40, P443, DOI 10.1136/gut.40.4.443; Walser EM, 2006, CARDIOVASC INTER RAD, V29, P102, DOI 10.1007/s00270-004-0220-4; Wang ZT, 2004, WORLD J GASTROENTERO, V10, P1619, DOI 10.3748/wjg.v10.i11.1619; Wei LP, 2010, MICROVASC RES, V80, P158, DOI 10.1016/j.mvr.2010.01.003; [吴文明 WU Wen-ming], 2010, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V35, P592; Wullaert A, 2010, INT J MED MICROBIOL, V300, P49, DOI 10.1016/j.ijmm.2009.08.007; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004; Zhang FangXin, 2010, Zhongguo Weishengtaxixue Zazhi / Chinese Journal of Microecology, V22, P1; Zhou B., 2009, CHIN J GASTROENTEROL, V18, P751; Zhou QQ, 2011, WORLD J GASTROENTERO, V17, P1584, DOI 10.3748/wjg.v17.i12.1584	36	49	53	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46291	10.1371/journal.pone.0046291	http://dx.doi.org/10.1371/journal.pone.0046291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082119	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900014
J	Ramos, CG; da Costa, PJP; Doring, G; Leitao, JH				Ramos, Christian G.; da Costa, Paulo J. P.; Doering, Gerd; Leitao, Jorge H.			The Novel Cis-Encoded Small RNA h2cR Is a Negative Regulator of hfq2 in Burkholderia cenocepacia	PLOS ONE			English	Article							MESSENGER-RNA; GENE-EXPRESSION; BINDING; PROTEIN; RPOS; IDENTIFICATION; PREDICTION; VIRULENCE; CEPACIA; DSRA	Small non-coding regulatory RNAs (sRNAs) post-transcriptionally affect multiple phenotypes in prokaryotes and eukaryotes, yet most of the underlying regulatory mechanisms and the nature of the target mRNAs remain unclear. Here we report the identification and functional analysis of the novel cis-encoded sRNA h2cR, from the human opportunistic pathogen Burkholderia cenocepacia J2315. The sRNA was found to negatively regulate the hfq2 mRNA, through binding to part of the 5'-UTR region of the hfq2 mRNA, resulting in accelerated hfq2 mRNA decay and reduced protein levels in exponentially growing cells. Both the h2cR transcript and the hfq2 mRNA are stabilized by the other B. cenocepacia RNA chaperone, Hfq. Infection experiments using the nematode Caenorhabditis elegans revealed that down-regulation of Hfq2 by h2cR decreases the B. cenocepacia ability to colonize and persist within the nematode, suggesting a role for h2cR on bacterial persistence in the host.	[Leitao, Jorge H.] Univ Tecn Lisboa, Inst Super Tecn, Dept Bioengn, P-1096 Lisbon, Portugal; [Ramos, Christian G.; da Costa, Paulo J. P.; Leitao, Jorge H.] Univ Tecn Lisboa, Inst Super Tecn, Inst Biotechnol & Bioengn, P-1096 Lisbon, Portugal; [Doering, Gerd] Univ Tubingen, Inst Med Mikrobiol & Hyg, Tubingen, Germany	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Leitao, JH (corresponding author), Univ Tecn Lisboa, Inst Super Tecn, Dept Bioengn, P-1096 Lisbon, Portugal.	jorgeleitao@ist.utl.pt	Leitão, Jorge H./A-5122-2012; Ramos, Christian G/A-8588-2010; Ramos, Christian Gomes/H-5855-2019	Leitão, Jorge H./0000-0001-8850-274X; Ramos, Christian G/0000-0003-0970-7750; Ramos, Christian Gomes/0000-0003-0970-7750	Fundacao Ciencia e a Tecnologia, Portugal [PTDC/BIA-MIC/119091/2010]	Fundacao Ciencia e a Tecnologia, Portugal	This work was partially supported by Fundacao Ciencia e a Tecnologia, Portugal (contract PTDC/BIA-MIC/119091/2010), a Post-Doc grant to CGR and a research grant to JP da Costa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beich-Frandsen M, 2011, NUCLEIC ACIDS RES, V39, P4900, DOI 10.1093/nar/gkq1346; Bejerano-Sagie M, 2007, CURR OPIN MICROBIOL, V10, P189, DOI 10.1016/j.mib.2007.03.009; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Coenye T, 2007, FEMS MICROBIOL LETT, V276, P83, DOI 10.1111/j.1574-6968.2007.00916.x; Coenye T, 2011, ANTIMICROB AGENTS CH, V55, P1912, DOI 10.1128/AAC.01571-10; Folichon M, 2003, NUCLEIC ACIDS RES, V31, P7302, DOI 10.1093/nar/gkg915; Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Hwang W, 2011, NUCLEIC ACIDS RES, V39, P5131, DOI 10.1093/nar/gkr075; KAJITANI M, 1994, J BACTERIOL, V176, P531, DOI 10.1128/JB.176.2.531-534.1994; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Liu JM, 2010, CURR OPIN MICROBIOL, V13, P18, DOI 10.1016/j.mib.2009.11.004; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Marsh EK, 2012, APPL ENVIRON MICROB, V78, P2075, DOI 10.1128/AEM.07486-11; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; McNealy TL, 2005, J BACTERIOL, V187, P1527, DOI 10.1128/JB.187.4.1527-1532.2005; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Olsen AS, 2010, J MOL BIOL, V404, P173, DOI 10.1016/j.jmb.2010.09.038; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Peeters E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-90; Rajkowitsch L, 2007, RNA, V13, P2053, DOI 10.1261/rna.671807; Ramos CG, 2011, J BACTERIOL, V193, P1515, DOI 10.1128/JB.01375-10; Ramos CG, 2010, MICROB PATHOGENESIS, V48, P168, DOI 10.1016/j.micpath.2010.02.006; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Roberts SA, 2007, MOL MICROBIOL, V66, P1506, DOI 10.1111/j.1365-2958.2007.06015.x; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Sobrero P, 2011, ARCH MICROBIOL, V193, P629, DOI 10.1007/s00203-011-0701-1; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Sousa SA, 2011, INT J MICROBIOL; Sousa SA, 2010, MICROBIOL-SGM, V156, P896, DOI 10.1099/mic.0.035139-0; Sousa SA, 2008, MICROB PATHOGENESIS, V45, P331, DOI 10.1016/j.micpath.2008.08.002; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Updegrove T, 2008, BIOCHEMISTRY-US, V47, P11184, DOI 10.1021/bi800479p; Vandamme P, 2003, RES MICROBIOL, V154, P91, DOI 10.1016/S0923-2508(03)00026-3; Vecerek B, 2005, RNA, V11, P976, DOI 10.1261/rna.2360205; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Wassarman KM, 2002, CELL, V109, P141, DOI 10.1016/S0092-8674(02)00717-1; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47896	10.1371/journal.pone.0047896	http://dx.doi.org/10.1371/journal.pone.0047896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082228	Green Submitted, gold, Green Published			2022-12-27	WOS:000311146900125
J	Shan, L; Chen, YA; Davis, L; Han, G; Zhu, WW; Molina, AD; Arango, H; LaPolla, JP; Hoffman, MS; Sellers, T; Kirby, T; Nicosia, SV; Sutphen, R				Shan, Lian; Chen, Y. Ann; Davis, Lorelei; Han, Gang; Zhu, Weiwei; Molina, Ashley D.; Arango, Hector; LaPolla, James P.; Hoffman, Mitchell S.; Sellers, Thomas; Kirby, Tyler; Nicosia, Santo V.; Sutphen, Rebecca			Measurement of Phospholipids May Improve Diagnostic Accuracy in Ovarian Cancer	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; LYSOPHOSPHATIDIC ACID; GYNECOLOGIC ONCOLOGIST; POTENTIAL BIOMARKER; GENE-EXPRESSION; PELVIC MASS; MANAGEMENT; CA125; CLASSIFICATION; SELECTION	Background: More than two-thirds of women who undergo surgery for suspected ovarian neoplasm do not have cancer. Our previous results suggest phospholipids as potential biomarkers of ovarian cancer. In this study, we measured the serum levels of multiple phospholipids among women undergoing surgery for suspected ovarian cancer to identify biomarkers that better predict whether an ovarian mass is malignant. Methodology/Principal Findings: We obtained serum samples preoperatively from women with suspected ovarian cancer enrolled through a prospective, population-based rapid ascertainment system. Samples were analyzed from all women in whom a diagnosis of epithelial ovarian cancer (EOC) was confirmed and from benign disease cases randomly selected from the remaining (non-EOC) samples. We measured biologically relevant phospholipids using liquid chromatography/electrospray ionization mass spectrometry. We applied a powerful statistical and machine learning approach, Hybrid huberized support vector machine (HH-SVM) to prioritize phospholipids to enter the biomarker models, and used cross-validation to obtain conservative estimates of classification error rates. Results: The HH-SVM model using the measurements of specific combinations of phospholipids supplements clinical CA125 measurement and improves diagnostic accuracy. Specifically, the measurement of phospholipids improved sensitivity (identification of cases with preoperative CA125 levels below 35) among two types of cases in which CA125 performance is historically poor - early stage cases and those of mucinous histology. Measurement of phospholipids improved the identification of early stage cases from 65% (based on CA125) to 82%, and mucinous cases from 44% to 88%. Conclusions/Significance: Levels of specific serum phospholipids differ between women with ovarian cancer and those with benign conditions. If validated by independent studies in the future, these biomarkers may serve as an adjunct at the time of clinical presentation, to distinguish between women with ovarian cancer and those with benign conditions with shared symptoms and features.	[Molina, Ashley D.; Sutphen, Rebecca] Univ S Florida, Epidemiol Ctr, Morsani Coll Med, Tampa, FL 33620 USA; [Shan, Lian; Davis, Lorelei] Frantz Biomarkers LLC, Mentor, OH USA; [Chen, Y. Ann; Han, Gang; Zhu, Weiwei; Sellers, Thomas] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Arango, Hector] W Coast Gynecol Oncol, Clearwater, FL USA; [LaPolla, James P.] Womens Canc Associates, Gynecol Oncol, St Petersburg, FL USA; [Nicosia, Santo V.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Sutphen, R (corresponding author), Univ S Florida, Epidemiol Ctr, Morsani Coll Med, Tampa, FL 33620 USA.	Rebecca.Sutphen@epi.usf.edu		Han, Gang/0000-0002-5781-5169; Chen, yian/0000-0003-1468-3490	American Cancer Society [CRTG-00-196]; National Cancer Institute, Department of Defense [R01-CA106414, DAMD17-98-1-8659]; Celma Mastry Ovarian Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA106414, P30CA076292] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute, Department of Defense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Department of Defense); Celma Mastry Ovarian Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the American Cancer Society (CRTG-00-196), the National Cancer Institute (R01-CA106414), Department of Defense DAMD17-98-1-8659 and the Celma Mastry Ovarian Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carney ME, 2002, GYNECOL ONCOL, V84, P36, DOI 10.1006/gyno.2001.6460; Carter Jori S, 2011, Female Patient (Parsippany), V36, P30; Christine M, 2012, EVOLUTION TRANSLATIO; CURTIN JP, 1994, GYNECOL ONCOL, V55, pS42, DOI 10.1006/gyno.1994.1340; Dorigo O, 2011, CANCER PREV RES, V4, P1356, DOI 10.1158/1940-6207.CAPR-11-0378; EINHORN N, 1992, OBSTET GYNECOL, V80, P14; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Goode EL, 2010, NAT GENET; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Heinzelmann-Schwarz VA, 2006, BRIT J CANCER, V94, P904, DOI 10.1038/sj.bjc.6603003; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; KILLACKEY MA, 1988, OBSTET GYNECOL, V71, P319; KOONINGS PP, 1989, OBSTET GYNECOL, V74, P921; Marchini S, 2008, CLIN CANCER RES, V14, P7850, DOI 10.1158/1078-0432.CCR-08-0523; MAYER AR, 1992, GYNECOL ONCOL, V47, P223, DOI 10.1016/0090-8258(92)90110-5; Meleh M, 2007, J CHROMATOGR B, V858, P287, DOI 10.1016/j.jchromb.2007.08.008; Menon U, 2005, J CLIN ONCOL, V23, P7919, DOI 10.1200/JCO.2005.01.6642; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; Morrow CP, 1993, TUMORS OCARY CLASSIF; Murdoch WJ, 2004, EXP BIOL MED, V229, P546, DOI 10.1177/153537020422900613; Ness RB, 1999, JNCI-J NATL CANCER I, V91, P1459, DOI 10.1093/jnci/91.17.1459; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; Partridge E, 2009, OBSTET GYNECOL, V113, P775, DOI 10.1097/AOG.0b013e31819cda77; Pozlep B, 2007, EUR J GYNAECOL ONCOL, V28, P394; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Sedlakova I, 2008, EUR J GYNAECOL ONCOL, V29, P511; Sedlakova I, 2006, Ceska Gynekol, V71, P312; Shan L, COMMUNICATION; Skates SJ, 2003, J CLIN ONCOL S, V21, P206, DOI DOI 10.1200/JC0.2003.02.955; Skates SJ, 2011, CANCER PREV RES, V4, P1401, DOI 10.1158/1940-6207.CAPR-10-0402; Sutphen R, 2004, CANCER EPIDEM BIOMAR, V13, P1185; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang L, 2008, BIOINFORMATICS, V24, P412, DOI 10.1093/bioinformatics/btm579; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Yoon HR, 2003, J CHROMATOGR B, V788, P85, DOI 10.1016/S1570-0232(02)01031-0	39	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46846	10.1371/journal.pone.0046846	http://dx.doi.org/10.1371/journal.pone.0046846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082132	Green Submitted, gold, Green Published			2022-12-27	WOS:000311146900027
J	Wang, X; Li, YM; Li, WQ; Huang, CG; Lu, YC; Hou, LJ				Wang, Xiang; Li, Yi-Ming; Li, Wei-Qing; Huang, Cheng-Guang; Lu, Yi-Cheng; Hou, Li-Jun			Effect of Clazosentan in Patients with Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							DELAYED CEREBRAL-ISCHEMIA; ENDOTHELIN RECEPTOR ANTAGONIST; ANGIOGRAPHIC VASOSPASM; CLINICAL-TRIALS; DOUBLE-BLIND; OUTCOME EVENT; HYPOPERFUSION; PHASE	Background: Cerebral vasospasm is the most important potentially treatable cause of mortality and morbidity following aneurysmal subarachnoid hemorrhage (aSAH). Clazosentan, a selective endothelinreceptor antagonist, has been suggested to help reduce the incidence of vasospasm in patients with aSAH. However, the results were controversial in previous trials. This meta-analysis attempts to assess the effect of clazosentan in patients with aSAH. Methodology/Principal Findings: We systematically searched Pubmed, Embase, and the Cochrane Library from their inception until June, 2012. All randomized controlled trials (RCTs) related to the effect of clazosentan in aSAH were included. The primary outcomes included the incidence of angiographic vasospasm, new cerebral infarction (NCI), delayed ischemic neurological deficits (DIND), and vasospasm-related morbidity/mortality (M/M); the second outcomes included the occurrence of rescue therapy, all-cause-mortality, and poor outcome. 4 RCTs were included with a total of 2156 patients. The risk of angiographic vasospasm (relative risk [RR]=0.58; 95% CI, 0.48 to 0.71), DIND (RR=0.76; 95% CI, 0.62 to 0.92), and vasospasm-related M/M (RR=0.80; 95% CI, 0.67 to 0.96) were statistically significantly reduced in the clazosentan group. Patients treated with clazosentan had a reduced occurrence of rescue therapy (RR=0.62; 95% CI, 0.49 to 0.79). However, no statistically significant effects were observed in NCI (RR=0.74; 95% CI, 0.52 to 1.04), mortality (RR=1.03; 95% CI, 0.71 to 1.49), and poor outcome (RR=1.12; 95% CI, 0.96 to 1.30). Conclusions/Significance: Our pooling data supports that clazosentan is probably effective in preventing the occurrence of angiographic vasospasm, vasospasm-related DIND, vasospasm related M/M, and rescue therapy. However, no evidence lends significant supports to the benefits of clazosentan in decreasing the occurrence of NCI, mortality or improving the functional outcome.	[Wang, Xiang; Li, Yi-Ming; Huang, Cheng-Guang; Lu, Yi-Cheng; Hou, Li-Jun] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Li, Wei-Qing] Second Mil Med Univ, Changzheng Hosp, Dept Pathol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Huang, CG (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China.	huang64@163.com; lj_hou@hotmail.com		Wang, Xiang/0000-0001-7465-606X	National Key Technology RD Program [2009BAI87B01]; Shanghai Committee of International Science and Technology Cooperation, China [09410705100]	National Key Technology RD Program(National Key Technology R&D Program); Shanghai Committee of International Science and Technology Cooperation, China	This study was supported by the National Key Technology R&D Program (2009BAI87B01) and Shanghai Committee of International Science and Technology Cooperation, China (09410705100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth M, 2007, ACTA NEUROCHIR, V149, P911, DOI 10.1007/s00701-007-1249-3; Chow M, 2002, NEUROSURGERY, V51, P1333, DOI 10.1227/01.NEU.0000035902.55640.38; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Crowley RW, 2011, STROKE, V42, P919, DOI 10.1161/STROKEAHA.110.597005; Dhar R, 2012, STROKE, V43, P1788, DOI 10.1161/STROKEAHA.111.646836; Etminan N, 2011, J CEREBR BLOOD F MET, V31, P1443, DOI 10.1038/jcbfm.2011.7; Ibrahim GM, 2011, J NEUROSURG, V115, P1191, DOI 10.3171/2011.7.JNS11725; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JENNETT B, 1975, LANCET, V1, P480; Kramer A, 2009, STROKE, V40, P3403, DOI 10.1161/STROKEAHA.109.560243; Kreiter KT, 2009, STROKE, V40, P2362, DOI 10.1161/STROKEAHA.109.547331; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; Macdonald RL, 2012, STROKE, V43, P1463, DOI 10.1161/STROKEAHA.111.648980; Macdonald RL, 2012, STROKE, V43, P1082, DOI 10.1161/STROKEAHA.111.634071; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Rabinstein AA, 2011, LANCET NEUROL, V10, P593, DOI 10.1016/S1474-4422(11)70122-3; Ryttlefors M, 2010, NEUROSURGERY, V67, P911, DOI 10.1227/NEU.0b013e3181ed11ab; Sabri M, 2011, STROKE, V42, P1454, DOI 10.1161/STROKEAHA.110.604728; Schubert GA, 2008, J NEUROSURG, V109, P1134, DOI 10.3171/JNS.2008.109.12.1134; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Vajkoczy P, 2005, J NEUROSURG, V103, P9, DOI 10.3171/jns.2005.103.1.0009; van Giersbergen PLM, 2007, EUR J CLIN PHARMACOL, V63, P151, DOI 10.1007/s00228-006-0117-z; Vatter H, 2007, NEUROSURGERY, V60, P1100, DOI 10.1227/01.NEU.0000255471.75752.4B; Vergouwen MDI, 2011, NEUROCRIT CARE, V15, P308, DOI 10.1007/s12028-011-9586-8; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Vergouwen MDI, 2010, NEUROCRIT CARE, V12, P342, DOI 10.1007/s12028-010-9331-8; Woitzik J, 2012, J CEREBR BLOOD F MET, V32, P203, DOI 10.1038/jcbfm.2011.169; Wong GKC, 2011, LANCET NEUROL, V10, P871, DOI 10.1016/S1474-4422(11)70189-2	30	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47778	10.1371/journal.pone.0047778	http://dx.doi.org/10.1371/journal.pone.0047778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082215	Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900112
J	Yuan, HW; Wang, CX; Zhang, N; Bai, Y; Shi, YZ; Zhou, Y; Wang, YL; Zhang, T; Zhou, J; Yu, X; Sun, XY; Liu, ZR; Zhao, XQ; Wang, YJ				Yuan, Huai Wu; Wang, Chun Xue; Zhang, Ning; Bai, Ying; Shi, Yu Zhi; Zhou, Yong; Wang, Yi Long; Zhang, Tong; Zhou, Juan; Yu, Xin; Sun, Xin Yu; Liu, Zhao Rui; Zhao, Xing Quan; Wang, Yong Jun			Poststroke Depression and Risk of Recurrent Stroke at 1 Year in a Chinese Cohort Study	PLOS ONE			English	Article							MORTALITY; SYMPTOMS; ASSOCIATION; SCALE	Background: Studies show that poststroke depression (PSD) increases mortality risk at 1 year. However, whether PSD increases the risk of recurrent stroke at 1 year remains unclear. This study was to investigate whether PSD at 2 weeks following a stroke could increase risk of recurrent stroke at 1 year. Methods and Results: This was a multi-centered prospective cohort study. A total of 2306 patients with acute stroke were enrolled in our study. PSD was diagnosed according to the criteria set by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). The outcomes of recurrent stroke were followed up via face-to-face or phone interview. A total of 1713 patients had complete follow-up data, with 481 (28.1%) cases of PSD and 158 (9.2%) cases of cumulative recurrent stroke at 1 year. Multivariate logistic regression analysis showed a 49% increase of OR of recurrent stroke at 1 year in patients with PSD, compared to patients without PSD following a stroke (OR = 1.49, 95% CI: 1.03-2.15). There was no significant correlation between anti-depressant drugs and the risk of recurrent stroke at 1 year following a stroke (OR = 1.96, 95%: CI 0.95-4.04). Conclusions: Based on the DSM-IV diagnostic criteria, nearly 3 out of 10 hospitalized stroke patients in China were diagnosed with PSD at 2 weeks following a stroke. PSD is associated with a higher risk of recurrent stroke at 1 year. Our study did not find benefit of anti-depressant drugs in reducing such risk.	[Yuan, Huai Wu; Wang, Chun Xue; Zhang, Ning; Bai, Ying; Shi, Yu Zhi; Zhou, Yong; Wang, Yi Long; Zhang, Tong; Zhao, Xing Quan; Wang, Yong Jun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Zhou, Juan] Capital Med Univ, Beijing Daxing Dist Hosp, Dept Neurol, Beijing, Peoples R China; [Yu, Xin; Sun, Xin Yu; Liu, Zhao Rui] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China	Capital Medical University; Capital Medical University; Peking University	Yuan, HW (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	Yhw0202@hotmail.com; chunxue.sen@gmail.com	sun, xinyu/GXG-5674-2022; Zhang, Tong/HGC-1090-2022	Shi, YuZhi/0000-0002-4018-6984	Beijing Science and Technology Committee [7102050]; National Science Foundation [81071115]; Young Scientists Fund of the Beijing Health Bureau [2009-009]; National 11th Five-year Scientific and Technological Brainstorm Project [2006BA101A11]; Pfizer Pharmaceutical Company	Beijing Science and Technology Committee; National Science Foundation(National Science Foundation (NSF)); Young Scientists Fund of the Beijing Health Bureau; National 11th Five-year Scientific and Technological Brainstorm Project; Pfizer Pharmaceutical Company(Pfizer)	This study was funded jointly by the Beijing Science and Technology Committee (grant no. 7102050, www.bjkw.gov.cn), the National Science Foundation (grant no. 81071115, www.nsfc.gov.cn), the Young Scientists Fund of the Beijing Health Bureau (grant No. 2009-009, www.bjhb.gov.cn), and the National 11th Five-year Scientific and Technological Brainstorm Project (grant No. 2006BA101A11, www.most.gov.cn). This study was also supported by Pfizer Pharmaceutical Company (www.pfizer.com). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; Chen Z., 2008, 3 NATL SURVEY CAUSE, V1, P14; Elkind MSV, 2009, AM J MED, V122, P7, DOI 10.1016/j.amjmed.2009.02.005; Ellekjaer H, 1997, STROKE, V28, P2180, DOI 10.1161/01.STR.28.11.2180; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; House A, 2001, STROKE, V32, P696, DOI 10.1161/01.STR.32.3.696; Jia Q, 2011, STROKE, V42, P2758, DOI 10.1161/STROKEAHA.111.621649; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; KUNITZ SC, 1984, STROKE, V15, P740, DOI 10.1161/01.STR.15.4.740; LIPSEY JR, 1984, LANCET, V1, P297; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; Meng X, 2011, STROKE, V42, P3619, DOI 10.1161/STROKEAHA.111.624148; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Peters R, 2010, AGE AGEING, V39, P439, DOI 10.1093/ageing/afq042; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Ventetuolo CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030480; Wassertheil Smoller S, 2004, ARCH INTERN MED, V164, P289; Whooley MA, 1998, ARCH INTERN MED, V158, P2129, DOI 10.1001/archinte.158.19.2129; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711	23	49	58	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46906	10.1371/journal.pone.0046906	http://dx.doi.org/10.1371/journal.pone.0046906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082134	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900029
J	Ren, JN; Zhao, YZ; Yuan, YJ; Han, G; Li, WQ; Huang, Q; Tong, ZH; Li, JS				Ren, Jianan; Zhao, Yunzhao; Yuan, Yujie; Han, Gang; Li, Weiqin; Huang, Qian; Tong, Zhihui; Li, Jieshou			Complement Depletion Deteriorates Clinical Outcomes of Severe Abdominal Sepsis: A Conspirator of Infection and Coagulopathy in Crime?	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTENSIVE-CARE-UNIT; INFLAMMATORY RESPONSE; SERUM PROCALCITONIN; SCORING SYSTEM; SEPTIC SHOCK; PLASMA; COAGULATION; PERITONITIS; ACTIVATION	Background: The complement depletion commonly occurred during sepsis, but it was often underestimated compared with severe infection or coagulation dysfunction. Objective: This study was designed to investigate the alteration of complement system in patients with severe abdominal sepsis and evaluate the role of complement depletion in prognosis of such patients. The relationship between complement depletion and infection or coagulopathy was also explored. Methods: Forty-five patients with severe abdominal sepsis were prospectively conducted among individuals referral to SICU. Currently recommended treatments, such as early goal-directed resuscitation, source control and antibiotics therapy, were performed. Acute physiology and chronic health evaluation II (APACHE II) and sepsis related organ failure assessment (SOFA) scores were employed to evaluate severity. Plasma levels of C3, C4, CRP, PCT, D-dimer and other parameters were detected within eight times of observation. The 28-day mortality, length of stay, and postoperative complications were compared between complement depletion and non-complement depletion groups. Results: Within the study period, eight (17.8%) patients died, five of them suffering from complement depletion. The overall incidence of complement depletion was 64.4%. At admission, mean complement C3 and C4 levels were 0.70 and 0.13 mg/mL, respectively. Using ROC analysis for mortality prediction, the area under the curve of C3 was 0.926 (95% CI, 0.845-0.998, P<0.001), with optimal cutpoint value of 0.578 mg/mL. Complement C3 depletion was shown to be no correlation to severity scores, however, strongly correlated with elevated D-dimer, PCT concentrations and increased postoperative complications. Conclusions: Complement C3 depletion was found to be connected to poor prognosis in severe abdominal sepsis. This depletion seems to be associated with coagulopathy and aggravated infection during sepsis, which should be paid close attention in critical care.	[Ren, Jianan; Zhao, Yunzhao; Yuan, Yujie; Han, Gang; Li, Weiqin; Huang, Qian; Tong, Zhihui; Li, Jieshou] Nanjing Univ, Sch Med, Jingling Hosp, Dept Surg, Nanjing, Jiangsu, Peoples R China	Nanjing University	Ren, JN (corresponding author), Nanjing Univ, Sch Med, Jingling Hosp, Dept Surg, Nanjing, Jiangsu, Peoples R China.	JiananR@gmail.com	Li, jie/GXG-4583-2022; ZHAO, YUAN/HCI-5831-2022; Yuan, Yujie/O-9873-2018; zhao, YZ/GXH-6401-2022	Yuan, Yujie/0000-0001-5786-4377; Ren, Jianan/0000-0002-7978-8093	Natural Science Foundation of Jiangsu Province for Distinguished Scholars [BK2010017]; High-Level Personnel Training Project, Jiangsu, China [BRA2011232]	Natural Science Foundation of Jiangsu Province for Distinguished Scholars; High-Level Personnel Training Project, Jiangsu, China	This study was supported by grants from the Climbing Program in Natural Science Foundation of Jiangsu Province for Distinguished Scholars (No. BK2010017) and the High-Level Personnel Training Project, Jiangsu, China (BRA2011232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Bearfield P, 2010, CRITICAL CARE, V14, pP223; Bee TK, 2008, J TRAUMA, V65, P337, DOI 10.1097/TA.0b013e31817fa451; CHAPMAN R, 1964, AM J SURG, V108, P157, DOI 10.1016/0002-9610(64)90005-4; Delibegovic Samir, 2011, Med Arh, V65, P82; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Iakovleva I I, 1999, Anesteziol Reanimatol, P23; Jones AE, 2009, CRIT CARE MED, V37, P1649, DOI 10.1097/CCM.0b013e31819def97; Ke L, 2012, J HEPATO-BIL-PAN SCI, V19, P259, DOI 10.1007/s00534-011-0414-5; Kulkarni SV, 2007, AM J SURG, V194, P549, DOI 10.1016/j.amjsurg.2007.01.031; Kupreishvili K, 2011, J HEART VALVE DIS, V20, P29; Lambris John D, 2012, Adv Exp Med Biol, V946, pv; Leendertse M, 2010, J INFECT DIS, V201, P544, DOI 10.1086/650341; LIN RY, 1993, CLIN IMMUNOL IMMUNOP, V69, P136, DOI 10.1006/clin.1993.1161; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Martinez JL, 2012, J GASTROINTEST SURG, V16, P156, DOI 10.1007/s11605-011-1703-7; Muller B, 2001, J CLIN ENDOCR METAB, V86, P396, DOI 10.1210/jc.86.1.396; OH TE, 1993, CRIT CARE MED, V21, P698, DOI 10.1097/00003246-199305000-00013; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; Peng ZY, 2010, CONTRIB NEPHROL, V165, P322, DOI 10.1159/000313773; Selberg O, 2000, CRIT CARE MED, V28, P2793, DOI 10.1097/00003246-200008000-00019; Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013; Silasi-Mansat R, 2010, BLOOD, V116, P1002, DOI 10.1182/blood-2010-02-269746; Silvester W, 1997, AM J KIDNEY DIS, V30, pS38, DOI 10.1016/S0272-6386(97)90541-2; SIRIO CA, 1992, CRIT CARE MED, V20, P1207, DOI 10.1097/00003246-199209000-00006; Taylor R, 2007, LANCET ONCOL, V8, P370, DOI 10.1016/S1470-2045(07)70114-6; Ward PA, 2009, J CELL MOL MED, V13, P4154, DOI 10.1111/j.1582-4934.2009.00893.x; Wolbink GJ, 1998, J INFECT DIS, V177, P81, DOI 10.1086/513803; WONG DT, 1995, CRIT CARE MED, V23, P1177, DOI 10.1097/00003246-199507000-00005; Yalcindag A, 2006, J ALLERGY CLIN IMMUN, V117, P1455, DOI 10.1016/j.jaci.2006.01.048; Yealy DM, 2009, JAMA-J AM MED ASSOC, V302, P1115, DOI 10.1001/jama.2009.1318; Younger JG, 2010, ACAD EMERG MED, V17, P353, DOI 10.1111/j.1553-2712.2010.00713.x; Yuan SM, 2011, REV BRAS CIR CARDIOV, V26, P573, DOI 10.5935/1678-9741.20110047; Yuan YJ, 2012, INT IMMUNOPHARMACOL, V12, P271, DOI 10.1016/j.intimp.2011.11.022; Yuan YJ, 2011, J SURG RES, V168, pE87, DOI 10.1016/j.jss.2011.01.062; ZIMMERMAN JE, 1988, CRIT CARE MED, V16, P318, DOI 10.1097/00003246-198804000-00003	38	27	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47095	10.1371/journal.pone.0047095	http://dx.doi.org/10.1371/journal.pone.0047095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091606	Green Submitted, Green Published, gold			2022-12-27	WOS:000310135800022
J	Tessadori, F; van Weerd, JH; Burkhard, SB; Verkerk, AO; de Pater, E; Boukens, BJ; Vink, A; Christoffels, VM; Bakkers, J				Tessadori, Federico; van Weerd, Jan Hendrik; Burkhard, Silja B.; Verkerk, Arie O.; de Pater, Emma; Boukens, Bastiaan J.; Vink, Aryan; Christoffels, Vincent M.; Bakkers, Jeroen			Identification and Functional Characterization of Cardiac Pacemaker Cells in Zebrafish	PLOS ONE			English	Article							DEVELOPING HUMAN HEART; SINOATRIAL NODE; CONDUCTION SYSTEM; MOLECULAR ANALYSIS; MESSENGER-RNA; VENOUS POLE; DIFFERENTIATION; TISSUES; MYOCARDIUM; EXPRESSION	In the mammalian heart a conduction system of nodes and conducting cells generates and transduces the electrical signals evoking myocardial contractions. Specialized pacemaker cells initiating and controlling cardiac contraction rhythmicity are localized in an anatomically identifiable structure of myocardial origin, the sinus node. We previously showed that in mammalian embryos sinus node cells originate from cardiac progenitors expressing the transcription factors T-box transcription factor 3 (Tbx3) and Islet-1 (Isl1). Although cardiac development and function are strikingly conserved amongst animal classes, in lower vertebrates neither structural nor molecular distinguishable components of a conduction system have been identified, questioning its evolutionary origin. Here we show that zebrafish embryos lacking the LIM/homeodomain-containing transcription factor Isl1 display heart rate defects related to pacemaker dysfunction. Moreover, 3D reconstructions of gene expression patterns in the embryonic and adult zebrafish heart led us to uncover a previously unidentified, Isl1-positive and Tbx2b-positive region in the myocardium at the junction of the sinus venosus and atrium. Through their long interconnecting cellular protrusions the identified Isl1-positive cells form a ring-shaped structure. In vivo labeling of the Isl1-positive cells by transgenic technology allowed their isolation and electrophysiological characterization, revealing their unique pacemaker activity. In conclusion we demonstrate that Isl1-expressing cells, organized as a ring-shaped structure around the venous pole, hold the pacemaker function in the adult zebrafish heart. We have thereby identified an evolutionary conserved, structural and molecular distinguishable component of the cardiac conduction system in a lower vertebrate.	[van Weerd, Jan Hendrik; Verkerk, Arie O.; Boukens, Bastiaan J.; Christoffels, Vincent M.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands; [Tessadori, Federico; Burkhard, Silja B.; de Pater, Emma; Bakkers, Jeroen] Univ Med Ctr Utrecht, Hubrecht Inst KNAW, Utrecht, Netherlands; [Vink, Aryan] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Bakkers, Jeroen] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Christoffels, VM (corresponding author), Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Anat Embryol & Physiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	V.M.Christoffels@amc.uva.nl; j.bakkers@hubrecht.eu	Bakkers, Jeroen/H-5551-2011; Vink, Aryan/E-3585-2010	Bakkers, Jeroen/0000-0002-9418-0422; Tessadori, Federico/0000-0001-9975-0546; de Pater, Emma/0000-0002-7195-6769; van Weerd, Jan Hendrik/0000-0001-7955-8477; Verkerk, Arie/0000-0003-2140-834X; Boukens, Bastiaan J/0000-0001-6449-145X	Royal Dutch Academy of Arts and Sciences (KNAW); Netherlands Organization for Scientific Research (NWO/ALW) [864.08.009]; European Commission [HEALTH-2007-B-223463]; Rembrandt Institute; NICHD	Royal Dutch Academy of Arts and Sciences (KNAW); Netherlands Organization for Scientific Research (NWO/ALW)(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre); Rembrandt Institute; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Work in J. Bakkers' laboratory was supported by the Royal Dutch Academy of Arts and Sciences (KNAW) and the Netherlands Organization for Scientific Research (NWO/ALW) grant 864.08.009. Work in V. Christoffels' laboratory was supported by the European Commission under the FP7 Integrated Project CardioGeNet (HEALTH-2007-B-223463) and by the Rembrandt Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank K. Kawakami for providing the galFF plasmid and the Tg(UAS:GFP) and Tg(UAS:RFP) fish. The Islet-1 homeobox monoclonal antibody 39.4D5 developed by Jessell, T.M./Brenner-Morton, S. was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Ammirabile G, 2012, CARDIOVASC RES, V93, P291, DOI 10.1093/cvr/cvr314; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Baruscotti M, 2011, P NATL ACAD SCI USA, V108, P1705, DOI 10.1073/pnas.1010122108; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Bussmann J, 2011, DEVELOPMENT, V138, P4327, DOI 10.1242/dev.068080; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Christoffels VM, 2009, CIRC-ARRHYTHMIA ELEC, V2, P195, DOI 10.1161/CIRCEP.108.829341; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Dobrzynski H, 2005, CIRCULATION, V111, P846, DOI 10.1161/01.CIR.0000152100.04087.DB; Dupays L, 2005, J MOL CELL CARDIOL, V38, P787, DOI 10.1016/j.yjmcc.2005.02.021; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; Flack M, 1910, J PHYSIOL-LONDON, V41, P64; Frank DU, 2012, P NATL ACAD SCI USA, V109, pE154, DOI 10.1073/pnas.1115165109; Glukhov AV, 2010, AM J PHYSIOL-HEART C, V299, pH482, DOI 10.1152/ajpheart.00756.2009; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; Keith A, 1907, J ANAT PHYSIOL, V41, P172; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Mommersteeg MTM, 2007, CIRC RES, V100, P354, DOI 10.1161/01.RES.0000258019.74591.b3; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Puskaric S, 2010, HUM MOL GENET, V19, P4625, DOI 10.1093/hmg/ddq393; Sanchez-Quintana D, 2005, HEART, V91, P189, DOI 10.1136/hrt.2003.031542; Shi WM, 1999, CIRC RES, V85, pE1; Sizarov A, 2011, CIRC-ARRHYTHMIA ELEC, V4, P532, DOI 10.1161/CIRCEP.111.963421; Sizarov A, 2010, CIRCULATION, V122, P798, DOI 10.1161/CIRCULATIONAHA.110.953844; Solc David, 2007, Exp Clin Cardiol, V12, P113; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Verkerk AO, 2007, EUR HEART J, V28, P2472, DOI 10.1093/eurheartj/ehm339; Verkerk AO, 2009, HEART RHYTHM, V6, P1485, DOI 10.1016/j.hrthm.2009.07.024; VIRAGH S, 1980, DEV BIOL, V80, P28, DOI 10.1016/0012-1606(80)90496-0; Weinberger F, 2012, CIRC RES; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Yamamoto M, 2006, CARDIOVASC RES, V72, P271, DOI 10.1016/j.cardiores.2006.07.026	46	123	123	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47644	10.1371/journal.pone.0047644	http://dx.doi.org/10.1371/journal.pone.0047644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077655	Green Submitted, gold, Green Published			2022-12-27	WOS:000310135800061
J	Coats, RO; Wann, JP				Coats, Rachel O.; Wann, John P.			Reaching a Better Understanding of the Control of Bimanual Movements in Older Adults	PLOS ONE			English	Article							VISUAL FEEDBACK-CONTROL; 2 HANDS; COORDINATION	The ability to interact skilfully with the environment is essential for independent living and therefore a critical factor for the aging population. Here we investigate the differences between young and older adults in a bimanual reaching task where the goal is to bring two objects together to the same location with a synchronous placement. Older (mean age 74) and young (mean age 20) adults were asked to pick up two spatially disparate objects, one in each hand, and bring them together to place them in one of three trays laid out in front of them from left to right. The results showed that the older adults were no more detrimentally affected than the young by asymmetric bimanual movements compared to symmetric ones, and both groups completed their movements in the same time. Nevertheless, compared to the young, the older adult group produced reaches characterised by higher peak velocities (although this effect was marginal), shorter hover times, and where the movement distance varied for each hand the scaling of the kinematic profile across the two limbs diverged from that found with younger participants. They then spent longer than the young in the final adjustment phase and during this phase they made more adjustments than the young, and as a result were more synchronous in terms of the final placement of the objects. It seems that the older adults produced reach movements that were designed to reach the vicinity of the tray quite rapidly, after which time they made discreet adjustments to their initial trajectories in order to exercise the precision necessary to place the objects in the tray. These findings are consistent with the idea that older adults have problems using online control (as they wait until they can fixate both objects before making adjustments).	[Coats, Rachel O.] Univ Leeds, Ctr Sport & Exercise Sci, Leeds LS2 9JT, W Yorkshire, England; [Wann, John P.] Royal Holloway Univ London, Dept Psychol, London, England	University of Leeds; University of London; Royal Holloway University London	Coats, RO (corresponding author), Univ Leeds, Ctr Sport & Exercise Sci, Leeds LS2 9JT, W Yorkshire, England.	r.o.a.coats@leeds.ac.uk	Coats, Rachel/AAH-6980-2019	Coats, Rachel/0000-0003-4415-408X	Economic and Social Research Council (ESRC)	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The authors would like the thank the Economic and Social Research Council (ESRC) http://www.esrc.ac.uk/for funding the first author's PhD for which this data was collected. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangert AS, 2010, NEUROPSYCHOLOGIA, V48, P1165, DOI 10.1016/j.neuropsychologia.2009.11.013; Bingham GP, 2008, EXP BRAIN RES, V184, P283, DOI 10.1007/s00221-007-1107-9; Bruyn JL, 2009, Q J EXP PSYCHOL, V62, P1328, DOI 10.1080/17470210802483891; Coats RO, 2011, EXP BRAIN RES, V214, P139, DOI 10.1007/s00221-011-2813-x; Fling BW, 2012, CEREB CORTEX, V22, P2643, DOI 10.1093/cercor/bhr349; Fling BW, 2011, J COGNITIVE NEUROSCI, V23, P2171, DOI 10.1162/jocn.2010.21600; Goble DJ, 2009, NEUROSCI BIOBEHAV R, V33, P271, DOI 10.1016/j.neubiorev.2008.08.012; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Jackson G, 1999, DANCE MAG, V73, P90; KELSO JAS, 1979, J EXP PSYCHOL HUMAN, V5, P229, DOI 10.1037/0096-1523.5.2.229; MARTENIUK RG, 1984, Q J EXP PSYCHOL-A, V36, P335, DOI 10.1080/14640748408402163; Mason AH, 2009, HUM MOVEMENT SCI, V28, P48, DOI 10.1016/j.humov.2008.09.002; Miller KA, 2012, Q J EXP PSYCHOL; Riek S, 2003, EXP BRAIN RES, V153, P59, DOI 10.1007/s00221-003-1581-7; SEIDLER RD, 1995, QUEST, V47, P386, DOI 10.1080/00336297.1995.10484165; Seidler-Dobrin RD, 1998, EXP BRAIN RES, V119, P467, DOI 10.1007/s002210050362; Srinivasan D, 2010, EXP BRAIN RES, V203, P391, DOI 10.1007/s00221-010-2241-3; Stelmach G.E., 1988, J GERONTOL, V43, P18	18	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47222	10.1371/journal.pone.0047222	http://dx.doi.org/10.1371/journal.pone.0047222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022WO	23077572	Green Published, gold			2022-12-27	WOS:000309995100077
J	Gong, YL; Wang, ZG; Liang, ZH; Duan, HX; Ouyang, LC; Yu, Q; Xu, Z; Shen, GX; Weng, XF; Wu, XW				Gong, Yeli; Wang, Zhigang; Liang, Zhihui; Duan, Hongxia; Ouyang, Lichen; Yu, Qian; Xu, Zhe; Shen, Guanxin; Weng, Xiufang; Wu, Xiongwen			Soluble MOG35-55/I-A(b) Dimers Ameliorate Experimental Autoimmune Encephalomyelitis by Reducing Encephalitogenic T Cells	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; PEPTIDE COMPLEXES; TCR; INDUCTION; ANTIGEN; RECOGNITION; ACTIVATION; TOLERANCE; THERAPY; BINDING	The MOG35-55 peptide-induced experimental autoimmune encephalomyelitis (EAE) model in C57BL/6 mice is a useful animal model to explore therapeutic approaches to T cell-mediated autoimmune diseases because the dominant T-cell epitope(s) have been defined. It is rational that antigen-specific immunosuppression can be induced by using MHC-peptide complexes as specific TCR ligand(s) that interact with autoreactive T cells in the absence of co-stimulation. In this study, a soluble divalent MOG35-55/I-A(b) fusion protein (MOG35-55/I-A(b) dimer) was constructed to specifically target the autoreactive CD4(+) T cells in the EAE mouse. Intraperitoneal administration of the MOG35-55/I-A(b) dimer significantly delayed and ameliorated EAE symptoms by reducing EAE-related inflammation in the mouse CNS and reducing encephalitogenic Th1 and Th17 cells in the peripheral lymphoid organs. We observed that dimer intervention at a concentration of 1.2 nM suppressed MOG35-55 peptide-specific 2D2 transgenic T cells (2D2 T cells) proliferation by over 90% after in vitro activation with MOG35-55 peptide. The mechanisms involved in this antigen-specific dimer-mediated suppression were found to be downregulated TCR-CD3 expression as well as upregulated expression of membrane-bound TGF-beta (mTGF-beta) and IL-10 suppressive cytokines by the autoreactive CD4(+) T cells. Collectively, our data demonstrates that soluble divalent MHC class II molecules can abrogate pathogenic T cells in EAE. Furthermore, our data suggests that this strategy may provide an efficient and clinically useful option to treat autoimmune diseases.	[Gong, Yeli; Wang, Zhigang; Liang, Zhihui; Duan, Hongxia; Ouyang, Lichen; Yu, Qian; Xu, Zhe; Shen, Guanxin; Weng, Xiufang; Wu, Xiongwen] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Weng, XF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China.	wengxiufang@hotmail.com; xiongwenwu@hotmail.com	Duan, Hongxia/GSE-5955-2022	Duan, Hongxia/0000-0003-3995-1228	National Natural Science Foundation of China [30801017, 30972697]; Chinese Department of Science and Technology [2007CB512900, 2008AA02Z113]; International Science and Technology Cooperation Program of China [2011DFA31030]; Deutsche Forschungsgemeinschaft [SFB/Transregio TRR60]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Department of Science and Technology; International Science and Technology Cooperation Program of China; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This publication was made possible by grants from the National Natural Science Foundation of China (No. 30801017, No. 30972697), the "973" and the "863" project of the Chinese Department of Science and Technology (2007CB512900, 2008AA02Z113), and the International Science and Technology Cooperation Program of China (2011DFA31030) and Deutsche Forschungsgemeinschaft (SFB/Transregio TRR60). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABASTADO JP, 1995, J EXP MED, V182, P439, DOI 10.1084/jem.182.2.439; Appel H, 2000, J BIOL CHEM, V275, P312, DOI 10.1074/jbc.275.1.312; Appleman LJ, 2003, IMMUNOL REV, V192, P161, DOI 10.1034/j.1600-065X.2003.00009.x; Bai XF, 2004, J EXP MED, V200, P447, DOI 10.1084/jem.20040131; BARBER LD, 1993, ANNU REV CELL BIOL, V9, P163; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Burrows GG, 2001, J IMMUNOL, V167, P4386, DOI 10.4049/jimmunol.167.8.4386; Carey B, 2005, CLIN IMMUNOL, V116, P65, DOI 10.1016/j.clim.2005.02.013; Casares S, 2001, Int Rev Immunol, V20, P547, DOI 10.3109/08830180109045578; Casares S, 2002, NAT IMMUNOL, V3, P383, DOI 10.1038/ni770; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Cottrez F, 2000, J IMMUNOL, V165, P4848, DOI 10.4049/jimmunol.165.9.4848; DALPORTO J, 1993, P NATL ACAD SCI USA, V90, P6671, DOI 10.1073/pnas.90.14.6671; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Gor DO, 2003, NAT IMMUNOL, V4, P503, DOI 10.1038/ni0603-503; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Huan JY, 2004, J IMMUNOL, V172, P4556, DOI 10.4049/jimmunol.172.7.4556; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; MATSUMOTO Y, 1994, IMMUNOLOGY, V81, P1; Nakayama T, 2010, SEMIN IMMUNOL, V22, P303, DOI 10.1016/j.smim.2010.04.010; Offner H, 2011, J NEUROIMMUNOL, V231, P7, DOI 10.1016/j.jneuroim.2010.09.013; Preda I, 2005, EUR J IMMUNOL, V35, P2762, DOI 10.1002/eji.200526158; Rickert U, 2006, TRANSPLANTATION, V81, P1337, DOI 10.1097/01.tp.0000205770.07196.e6; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Schodin BA, 1996, IMMUNITY, V5, P137, DOI 10.1016/S1074-7613(00)80490-2; Shevach EM, 2004, ARTHRITIS RHEUM, V50, P2721, DOI 10.1002/art.20500; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Sinha S, 2007, J NEUROSCI, V27, P12531, DOI 10.1523/JNEUROSCI.3599-07.2007; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Subramanian S, 2009, STROKE, V40, P2539, DOI 10.1161/STROKEAHA.108.543991; Wang CH, 2003, J IMMUNOL, V171, P1934, DOI 10.4049/jimmunol.171.4.1934; Wasserman HA, 2008, J IMMUNOL, V180, P7259, DOI 10.4049/jimmunol.180.11.7259; WEINSHENKER BG, 1991, NEUROLOGY, V41, P1047, DOI 10.1212/WNL.41.7.1047; Weng XF, 2007, TRANSPLANTATION, V84, P1298, DOI 10.1097/01.tp.0000288231.97880.bd; Wong WF, 2011, J BIOL CHEM, V286, P11110, DOI 10.1074/jbc.M110.166694; Zhang MH, 2009, TRANSPLANTATION, V87, P8, DOI 10.1097/TP.0b013e31818b6141	39	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47435	10.1371/journal.pone.0047435	http://dx.doi.org/10.1371/journal.pone.0047435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077616	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100112
J	Lee, JH; Hong, CS; Lee, S; Yang, JE; Park, YI; Lee, D; Hyeon, T; Jung, S; Paik, SR				Lee, Jung-Ho; Hong, Chul-Suk; Lee, Soonkoo; Yang, Jee-Eun; Park, Yong Il; Lee, Daekyun; Hyeon, Taeghwan; Jung, Seunho; Paik, Seung R.			Radiating Amyloid Fibril Formation on the Surface of Lipid Membranes through Unit-Assembly of Oligomeric Species of alpha-Synuclein	PLOS ONE			English	Article							PARKINSONS-DISEASE; LEWY BODIES; ALZHEIMERS-DISEASE; PROTEIN AGGREGATION; FIBRILLIZATION; PATHOGENESIS; MECHANISM; LESIONS	Background: Lewy body in the substantia nigra is a cardinal pathological feature of Parkinson's disease. Despite enormous efforts, the cause-and-effect relationship between Lewy body formation and the disorder is yet to be explicitly unveiled. Methodology/Principal Findings: Here, we showed that radiating amyloid fibrils (RAFs) were instantly developed on the surface of synthetic lipid membranes from the beta-sheet free oligomeric species of alpha-synuclein through a unit-assembly process. The burgeoning RAFs were successfully matured by feeding them with additional oligomers, which led to concomitant dramatic shrinkage and disintegration of the membranes by pulling off lipid molecules to the extending fibrils. Mitochondria and lysosomes were demonstrated to be disrupted by the oligomeric alpha-synuclein via membrane-dependent fibril formation. Conclusion: The physical structure formation of amyloid fibrils, therefore, could be considered as detrimental to the cells by affecting membrane integrity of the intracellular organelles, which might be a molecular cause for the neuronal degeneration observed in Parkinson's disease.	[Lee, Jung-Ho; Hong, Chul-Suk; Lee, Soonkoo; Yang, Jee-Eun; Park, Yong Il; Lee, Daekyun; Hyeon, Taeghwan; Paik, Seung R.] Seoul Natl Univ, Coll Engn, Inst Chem Proc, Sch Chem & Biol Engn, Seoul, South Korea; [Jung, Seunho] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea	Seoul National University (SNU); Konkuk University	Paik, SR (corresponding author), Seoul Natl Univ, Coll Engn, Inst Chem Proc, Sch Chem & Biol Engn, Seoul, South Korea.	srpaik@snu.ac.kr	Jung, Seunho/D-4555-2011; Park, Yong Il/AAI-1187-2019	Park, Yong Il/0000-0003-3167-4908	National Research Foundation of Korea (NRF); Korea government [Ministry of Education, Science, and Technology; MEST] [2012-0002064, 2012-013582]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government [Ministry of Education, Science, and Technology; MEST](Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by the National Research Foundation of Korea (NRF) grants funded by the Korea government [Ministry of Education, Science, and Technology; MEST] (2012-0002064, 2012-013582). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhak G, 2009, BMB REP, V42, P541, DOI 10.5483/BMBRep.2009.42.9.541; Bhak G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004177; Bush AI, 2002, P NATL ACAD SCI USA, V99, P7317, DOI 10.1073/pnas.122249699; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Lee D, 2011, ANGEW CHEM INT EDIT, V50, P1332, DOI 10.1002/anie.201004301; Lee JH, 2008, BIOPHYS J, V95, pL16, DOI 10.1529/biophysj.108.135186; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McNaught KSP, 2006, NEUROBIOL AGING, V27, P530, DOI 10.1016/j.neurobiolaging.2005.08.012; Paik SR, 1997, ARCH BIOCHEM BIOPHYS, V344, P325, DOI 10.1006/abbi.1997.0207; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; ROY S, 1969, J PATHOL, V99, P39, DOI 10.1002/path.1710990106; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576	26	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47580	10.1371/journal.pone.0047580	http://dx.doi.org/10.1371/journal.pone.0047580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077644	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100139
J	Miyamoto, T; Nakayama, EE; Yokoyama, M; Ibe, S; Takehara, S; Kono, K; Yokomaku, Y; Pizzato, M; Luban, J; Sugiura, W; Sato, H; Shioda, T				Miyamoto, Tadashi; Nakayama, Emi E.; Yokoyama, Masaru; Ibe, Shiro; Takehara, Shunpei; Kono, Ken; Yokomaku, Yoshiyuki; Pizzato, Massimo; Luban, Jeremy; Sugiura, Wataru; Sato, Hironori; Shioda, Tatsuo			The Carboxyl-Terminus of Human Immunodeficiency Virus Type 2 Circulating Recombinant form 01_AB Capsid Protein Affects Sensitivity to Human TRIM5 alpha	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY; RESTRICTION FACTOR; CYNOMOLGUS MONKEY; HIV-1 INFECTION; RHESUS-MONKEY; WEST-AFRICA; HUMAN-CELLS; AMINO-ACID; SIMULATIONS; DYNAMICS	Human immunodeficiency virus (HIV) type 2 shows limited geographical distribution compared with HIV type 1. Although 8 genetic groups of HIV type 2 (HIV-2) have been described, recombinant viruses between these groups are rarely observed. Recently, three HIV-2 patients in Japan were described with rapidly progressive, acquired immunodeficiency. These patients were infected with an A/B inter-group recombinant designated CRF01_AB. Here, we characterize the capsid protein (CA) encoded by the viruses from these patients. HIV-2 CRF01_AB CA showed unique amino acid sequence almost equally distinct from group A and group B viruses. Notably, HIV-2 CRF01_AB CA showed potent resistance to human TRIM5 alpha. In addition to the previously identified amino acid position 119 in the N-terminal domain of CA, we found that HIV-2 CRF01_AB-specific amino acid substitutions in the C-terminal domain also were necessary for resistance to human TRIM5 alpha. These results indicate that retroviruses can evade TRIM5 alpha by substitution at residues within the C-terminal domain of CA.	[Miyamoto, Tadashi; Nakayama, Emi E.; Takehara, Shunpei; Kono, Ken; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan; [Yokoyama, Masaru; Sato, Hironori] Natl Inst Infect Dis, Lab Viral Genom, Pathogen Genom Ctr, Tokyo, Japan; [Ibe, Shiro; Yokomaku, Yoshiyuki; Sugiura, Wataru] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Dept Infect & Immunol,Naka Ku, Nagoya, Aichi, Japan; [Pizzato, Massimo; Luban, Jeremy] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland	Osaka University; National Institute of Infectious Diseases (NIID); Nagoya Medical Center; University of Geneva	Shioda, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan.	shioda@biken.osaka-u.ac.jp	Pizzato, Massimo/AFL-0051-2022	Pizzato, Massimo/0000-0002-9491-1483; Luban, Jeremy/0000-0001-5650-4054	Health Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology, Japan [23590541, 23390111]; Ministry of Health, Labour, and Welfare, Japan [H22-AIDS-003]; Swiss National Fund [3100A0-128655]; NIH [RO1AI59159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059159] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23390111] Funding Source: KAKEN	Health Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Swiss National Fund(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Health Science Foundation; the Ministry of Education, Culture, Sports, Science, and Technology, Japan (23590541 to EEN, 23390111 to TS), the Ministry of Health, Labour, and Welfare, Japan (H22-AIDS-003 to HS), Swiss National Fund grant 3100A0-128655 to JL, and NIH grant RO1AI59159 to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2006, J VIROL, V80, P9754, DOI 10.1128/JVI.01052-06; Bailey GD, 2012, J MOL BIOL, V417, P212, DOI 10.1016/j.jmb.2012.01.014; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Case D, 2006, AMBER 9; Damond F, 2004, AIDS RES HUM RETROV, V20, P666, DOI 10.1089/0889222041217392; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; HUET T, 1990, NATURE, V345, P356, DOI 10.1038/345356a0; Ibe S, 2010, JAIDS-J ACQ IMM DEF, V54, P241, DOI 10.1097/QAI.0b013e3181dc98c1; Inagaki N, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-90; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kinomoto M, 2005, J VIROL, V79, P5996, DOI 10.1128/JVI.79.10.5996-6004.2005; Kono K, 2008, VIROLOGY, V373, P447, DOI 10.1016/j.virol.2007.12.022; Kono K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-72; LASFARGUES EY, 1976, CANCER RES, V36, P67; Lee K, 2001, ANTIMICROB AGENTS CH, V45, P138, DOI 10.1128/AAC.45.1.138-144.2001; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; Miyamoto T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022779; Nakayama EE, 2005, J VIROL, V79, P8870, DOI 10.1128/JVI.79.14.8870-8877.2005; Nakayama EE, 2010, REV MED VIROL, V20, P77, DOI 10.1002/rmv.637; Onyango CO, 2010, VACCINE, V28, pB60, DOI 10.1016/j.vaccine.2009.08.060; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rowland-Jones SL, 2007, NAT IMMUNOL, V8, P329, DOI 10.1038/ni0407-329; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sebastian S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-40; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shirakawa K, 2008, NAT STRUCT MOL BIOL, V15, P1184, DOI 10.1038/nsmb.1497; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Song H, 2007, J VIROL, V81, P7280, DOI 10.1128/JVI.00406-07; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103	46	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47757	10.1371/journal.pone.0047757	http://dx.doi.org/10.1371/journal.pone.0047757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094081	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200042
J	Euser, SM; Nagelkerke, NJ; Schuren, F; Jansen, R; Den Boer, JW				Euser, Sjoerd M.; Nagelkerke, Nico J.; Schuren, Frank; Jansen, Ruud; Den Boer, Jeroen W.			Genome Analysis of Legionella pneumophila Strains Using a Mixed-Genome Microarray	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; LEGIONNAIRES-DISEASE; SEQUENCE TYPES; PATHOGENS; VIRULENCE; CLASSIFICATION; SEROGROUPS; EPIDEMIC; OUTBREAK; FEATURES	Background: Legionella, the causative agent for Legionnaires' disease, is ubiquitous in both natural and man-made aquatic environments. The distribution of Legionella genotypes within clinical strains is significantly different from that found in environmental strains. Developing novel genotypic methods that offer the ability to distinguish clinical from environmental strains could help to focus on more relevant (virulent) Legionella species in control efforts. Mixed-genome microarray data can be used to perform a comparative-genome analysis of strain collections, and advanced statistical approaches, such as the Random Forest algorithm are available to process these data. Methods: Microarray analysis was performed on a collection of 222 Legionella pneumophila strains, which included patient-derived strains from notified cases in the Netherlands in the period 2002-2006 and the environmental strains that were collected during the source investigation for those patients within the Dutch National Legionella Outbreak Detection Programme. The Random Forest algorithm combined with a logistic regression model was used to select predictive markers and to construct a predictive model that could discriminate between strains from different origin: clinical or environmental. Results: Four genetic markers were selected that correctly predicted 96% of the clinical strains and 66% of the environmental strains collected within the Dutch National Legionella Outbreak Detection Programme. Conclusions: The Random Forest algorithm is well suited for the development of prediction models that use mixed-genome microarray data to discriminate between Legionella strains from different origin. The identification of these predictive genetic markers could offer the possibility to identify virulence factors within the Legionella genome, which in the future may be implemented in the daily practice of controlling Legionella in the public health environment.	[Euser, Sjoerd M.; Jansen, Ruud; Den Boer, Jeroen W.] Reg Publ Hlth Lab Kennemerland, Haarlem, Netherlands; [Nagelkerke, Nico J.] United Arab Emirates Univ, Dept Community Med, Al Ain, U Arab Emirates; [Schuren, Frank] TNO Microbiol & Syst Biol, Zeist, Netherlands	United Arab Emirates University; Netherlands Organization Applied Science Research	Euser, SM (corresponding author), Reg Publ Hlth Lab Kennemerland, Haarlem, Netherlands.	s.euser@streeklabhaarlem.nl			Vitens water supply company	Vitens water supply company	This study was supported by a grant from Vitens water supply company (www.vitens.nl). This company had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli OAT, 2003, MICROBIOL-SGM, V149, P631, DOI 10.1099/mic.0.25980-0; Amaro F, 2012, J BACTERIOL, V194, P1613, DOI 10.1128/JB.06626-11; [Anonymous], JAARR SURV RESP INF; Blasi F, 2004, EUR RESPIR J, V24, P171, DOI 10.1183/09031936.04.00135703; BOLLIN GE, 1985, J CLIN MICROBIOL, V21, P674, DOI 10.1128/JCM.21.5.674-677.1985; Borchardt J, 2008, EUR J CLIN MICROBIOL, V27, P29, DOI 10.1007/s10096-007-0392-3; Braun J J, 2004, Ned Tijdschr Geneeskd, V148, P836; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Cazalet C, 2008, GENOME RES, V18, P431, DOI 10.1101/gr.7229808; Cazalet C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000851; Chiarini A, 2008, NEW MICROBIOL, V31, P217; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Den Boer JW, 2008, CLIN MICROBIOL INFEC, V14, P459, DOI 10.1111/j.1469-0691.2008.01973.x; Den Boer JW, 2007, INT J HYG ENVIR HEAL, V210, P1, DOI 10.1016/j.ijheh.2006.07.002; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Doleans A, 2004, J CLIN MICROBIOL, V42, P458, DOI 10.1128/JCM.42.1.458-460.2004; Dominguez A, 2009, INT J TUBERC LUNG D, V13, P407; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Fry Norman K., 1999, Clin Microbiol Infect, V5, P462, DOI 10.1111/j.1469-0691.1999.tb00176.x; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Harrison TG, 2009, EUR J CLIN MICROBIOL, V28, P781, DOI 10.1007/s10096-009-0705-9; Hoffmann K, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-229; Huang TD, 2010, J CLIN MICROBIOL, V48, P2091, DOI 10.1128/JCM.02342-09; Joseph C. A., 2010, EUROSURVEILLANCE, V15, P1; Kool JL, 2000, EPIDEMIOL INFECT, V125, P599, DOI 10.1017/S095026880000474X; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; Schwender H, 2008, BIOMETRICAL J, V50, P911, DOI 10.1002/bimj.200810475; Steinert M, 2007, INT J MED MICROBIOL, V297, P577, DOI 10.1016/j.ijmm.2007.03.009; Wolk DM, 2009, J CLIN MICROBIOL, V47, P758, DOI 10.1128/JCM.01714-08; Woodhead M, 2002, EUR RESPIR J, V20, p20S, DOI 10.1183/09031936.02.00702002; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087; Yzerman E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-433	33	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47437	10.1371/journal.pone.0047437	http://dx.doi.org/10.1371/journal.pone.0047437			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094048	Green Published, gold, Green Submitted			2022-12-27	WOS:000312384500010
J	Wubet, T; Christ, S; Schoning, I; Boch, S; Gawlich, M; Schnabel, B; Fischer, M; Buscot, F				Wubet, Tesfaye; Christ, Sabina; Schoening, Ingo; Boch, Steffen; Gawlich, Melanie; Schnabel, Beatrix; Fischer, Markus; Buscot, Francois			Differences in Soil Fungal Communities between European Beech (Fagus sylvatica L.) Dominated Forests Are Related to Soil and Understory Vegetation	PLOS ONE			English	Article							MICROBIAL DIVERSITY; MYCORRHIZAL FUNGI; RARE BIOSPHERE; BACTERIAL; REVEAL; RUSSULALES	Fungi are important members of soil microbial communities with a crucial role in biogeochemical processes. Although soil fungi are known to be highly diverse, little is known about factors influencing variations in their diversity and community structure among forests dominated by the same tree species but spread over different regions and under different managements. We analyzed the soil fungal diversity and community composition of managed and unmanaged European beech dominated forests located in three German regions, the Schwa "bische Alb in Southwestern, the Hainich-Dun in Central and the Schorfheide Chorin in the Northeastern Germany, using internal transcribed spacer (ITS) rDNA pyrotag sequencing. Multiple sequence quality filtering followed by sequence data normalization revealed 1655 fungal operational taxonomic units. Further analysis based on 722 abundant fungal OTUs revealed the phylum Basidiomycota to be dominant (54%) and its community to comprise 71.4% of ectomycorrhizal taxa. Fungal community structure differed significantly (p <= 0.001) among the three regions and was characterized by non-random fungal OTUs co-occurrence. Soil parameters, herbaceous understory vegetation, and litter cover affected fungal community structure. However, within each study region we found no difference in fungal community structure between management types. Our results also showed region specific significant correlation patterns between the dominant ectomycorrhizal fungal genera. This suggests that soil fungal communities are region-specific but nevertheless composed of functionally diverse and complementary taxa.	[Wubet, Tesfaye; Gawlich, Melanie; Schnabel, Beatrix; Buscot, Francois] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany; [Christ, Sabina] Fraunhofer Inst Cell Therapy & Immunol, Dept Diagnost, Leipzig, Germany; [Buscot, Francois] Univ Leipzig, Inst Biol, Chair Soil Ecol, Leipzig, Germany; [Schoening, Ingo] Max Planck Inst Biogeochem, Dept Biogeochem Proc, Jena, Germany; [Boch, Steffen; Fischer, Markus] Univ Bern, Inst Plant Sci & Bot Garden, Bern, Switzerland	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Fraunhofer Gesellschaft; Leipzig University; Max Planck Society; University of Bern	Wubet, T (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany.	tesfaye.wubet@ufz.de	Buscot, Francois/A-4125-2016; Boch, Steffen/L-5436-2016; Wubet, Tesfaye/C-6241-2012; Fischer, Markus/C-6411-2008; Schöning, Ingo/D-3341-2009	Buscot, Francois/0000-0002-2364-0006; Wubet, Tesfaye/0000-0001-8572-4486; Fischer, Markus/0000-0002-5589-5900; Schöning, Ingo/0000-0002-9830-5026; Christ, Sabina/0000-0001-6886-8154	DFG [1374, BU-941/18-1, Fi-1246/6-1, SCHR1181/1-1]	DFG(German Research Foundation (DFG))	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (BU-941/18-1, Fi-1246/6-1 and SCHR1181/1-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer R, 2006, MYCOL PROG, V5, P67, DOI 10.1007/s11557-006-0505-x; Aponte C, 2010, SOIL BIOL BIOCHEM, V42, P788, DOI 10.1016/j.soilbio.2010.01.014; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Buee M, 2005, MYCORRHIZA, V15, P235, DOI 10.1007/s00572-004-0313-6; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burke DJ, 2009, APPL ENVIRON MICROB, V75, P7639, DOI 10.1128/AEM.01648-09; Buscot F, 2005, SOIL BIOL, V3, P3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Christ S, 2011, SOIL BIOL BIOCHEM, V43, P1292, DOI 10.1016/j.soilbio.2011.02.022; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geml J, 2010, NEW PHYTOL, V187, P494, DOI 10.1111/j.1469-8137.2010.03283.x; Geml J, 2009, MOL ECOL, V18, P2213, DOI 10.1111/j.1365-294X.2009.04192.x; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gotelli NJ, 2000, ECOSIM NULL MODELS S; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Kasel S, 2008, SOIL BIOL BIOCHEM, V40, P1724, DOI 10.1016/j.soilbio.2008.02.011; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Koide RT, 2011, ANN FOREST SCI, V68, P45, DOI 10.1007/s13595-010-0006-6; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lim YW, 2010, J MICROBIOL, V48, P284, DOI 10.1007/s12275-010-9369-5; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Pandey Ram Vinay, 2010, BMC Res Notes, V3, P3, DOI 10.1186/1756-0500-3-3; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Revelle W., 2011, PSYCH PROCEDURES PSY; Rinaldi AC, 2008, FUNGAL DIVERS, V33, P1; Roberts D.W., 2010, LABDSV ORDINATION MU; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Taylor LL, 2009, GEOBIOLOGY, V7, P171, DOI 10.1111/j.1472-4669.2009.00194.x; Team R. D. C, 2011, R LANG ENV STAT COMP; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10	50	78	82	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47500	10.1371/journal.pone.0047500	http://dx.doi.org/10.1371/journal.pone.0047500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094057	Green Submitted, Green Published, gold			2022-12-27	WOS:000312384500012
J	Chen, CM; Bentham, J; Cosgrove, C; Braganca, J; Cuenda, A; Bamforth, SD; Schneider, JE; Watkins, H; Keavney, B; Davies, B; Bhattacharya, S				Chen, Chiann-mun; Bentham, Jamie; Cosgrove, Catherine; Braganca, Jose; Cuenda, Ana; Bamforth, Simon D.; Schneider, Juergen E.; Watkins, Hugh; Keavney, Bernard; Davies, Benjamin; Bhattacharya, Shoumo			Functional Significance of SRJ Domain Mutations in CITED2	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MELANOCYTE-SPECIFIC GENE; TRANSCRIPTION FACTOR; CARDIAC-MALFORMATIONS; HEART DEVELOPMENT; BINDING-PROTEIN; MOUSE MODEL; ES CELLS; COACTIVATOR; ACTIVATION	CITED2 is a transcriptional co-activator with 3 conserved domains shared with other CITED family members and a unique Serine-Glycine Rich Junction (SRJ) that is highly conserved in placental mammals. Loss of Cited2 in mice results in cardiac and aortic arch malformations, adrenal agenesis, neural tube and placental defects, and partially penetrant defects in left-right patterning. By screening 1126 sporadic congenital heart disease (CHD) cases and 1227 controls, we identified 19 variants, including 5 unique non-synonymous sequence variations (N62S, R92G, T166N, G180-A187del and A187T) in patients. Many of the CHD-specific variants identified in this and previous studies cluster in the SRJ domain. Transient transfection experiments show that T166N mutation impairs TFAP2 co-activation function and ES cell proliferation. We find that CITED2 is phosphorylated by MAPK1 in vitro at T166, and that MAPK1 activation enhances the coactivation function of CITED2 but not of CITED2-T166N. In order to investigate the functional significance in vivo, we generated a T166N mutation of mouse Cited2. We also used PhiC31 integrase-mediated cassette exchange to generate a Cited2 knock-in allele replacing the mouse Cited2 coding sequence with human CITED2 and with a mutant form deleting the entire SRJ domain. Mouse embryos expressing only CITED2-T166N or CITED2-SRJ-deleted alleles surprisingly show no morphological abnormalities, and mice are viable and fertile. These results indicate that the SRJ domain is dispensable for these functions of CITED2 in mice and that mutations clustering in the SRJ region are unlikely to be the sole cause of the malformations observed in patients with sporadic CHD. Our results also suggest that coding sequence mutations observed in case-control studies need validation using in vivo models and that predictions based on structural conservation and in vitro functional assays, or even in vivo global loss of function models, may be insufficient.	[Chen, Chiann-mun; Bentham, Jamie; Cosgrove, Catherine; Braganca, Jose; Bamforth, Simon D.; Schneider, Juergen E.; Watkins, Hugh; Bhattacharya, Shoumo] Univ Oxford, Dept Cardiovasc Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Bamforth, Simon D.; Keavney, Bernard] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Cuenda, Ana] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	University of Oxford; Wellcome Centre for Human Genetics; Newcastle University - UK; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Bhattacharya, S (corresponding author), Univ Oxford, Dept Cardiovasc Med, Wellcome Trust Ctr Human Genet, Oxford, England.	sbhattac@well.ox.ac.uk	Braganca, Jose/F-4410-2012; Bhattacharya, Shoumo/F-4127-2010; Davies, Ben/GYD-9163-2022; Bamforth, Simon David/I-1277-2019	Braganca, Jose/0000-0001-9566-400X; Bhattacharya, Shoumo/0000-0002-5571-0478; Davies, Ben/0000-0003-3405-507X; Bamforth, Simon David/0000-0002-5666-4485; Chen, Chiann-mun/0000-0002-7007-3649; Watkins, Hugh/0000-0002-5287-9016; Keavney, Bernard/0000-0001-9573-0812; Davies, Benjamin/0000-0003-3623-600X	Wellcome Trust [083228/Z/07/Z, 090532/Z/09/Z]; British Heart Foundation [CH/09/003, PG/07/045/22690]; British Heart Foundation [RG/10/17/28553, RG/08/012/25941, FS/11/50/29038] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by grants from the Wellcome Trust (083228/Z/07/Z to S. B. and 090532/Z/09/Z to the Wellcome Trust Centre for Human Genetics; www.wellcome.ac.uk), and grants from the British Heart Foundation (CH/09/003 and PG/07/045/22690; www.bhf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R, 2000, HEART, V11, P89; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Barbera JPM, 2002, HUM MOL GENET, V11, P283, DOI 10.1093/hmg/11.3.283; Bentham J, 2008, ANN NY ACAD SCI, V1123, P10, DOI 10.1196/annals.1420.003; Bentham J, 2010, HUM MOL GENET, V19, P3394, DOI 10.1093/hmg/ddq251; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200; Braganca J, 2002, J BIOL CHEM, V277, P8559, DOI 10.1074/jbc.M110850200; Burn J., 2002, PRINCIPLES PRACTICE; Campbell David G, 2002, J Biomol Tech, V13, P119; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Chen Y, 2008, DEVELOPMENT, V135, P2939, DOI 10.1242/dev.021097; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Feijoo C, 2005, J CELL SCI, V118, P397, DOI 10.1242/jcs.01655; FERENCZ C, 1989, J AM COLL CARDIOL, V14, P756, DOI 10.1016/0735-1097(89)90122-8; Ferencz Charlotte, 1993, Cardiology Clinics, V11, P557; Fitzky BU, 2001, J CLIN INVEST, V108, P905, DOI 10.1172/JCI200112103; Floro KL, 2011, HUM MOL GENET, V20, P1097, DOI 10.1093/hmg/ddq554; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; HOFFMAN JIE, 2002, PAEDIAT CARDIOLOGY, P111; Janknecht R, 1996, ONCOGENE, V12, P1961; Karel F., 2001, FUNCTIONAL ANATOMY V; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Kuma Y, 2004, BIOCHEM J, V379, P133, DOI 10.1042/BJ20031559; Michell AC, 2010, DEV DYNAM, V239, P1988, DOI 10.1002/dvdy.22334; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mody N, 2003, BIOCHEM J, V372, P567, DOI 10.1042/BJ20030193; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Qayyum SR, 2001, ANAT RECORD, V264, P273, DOI 10.1002/ar.1162; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ruiz-Perez VL, 2007, DEVELOPMENT, V134, P2903, DOI 10.1242/dev.007542; RUNCIMAN SIC, 1995, ANAT RECORD, V243, P71, DOI 10.1002/ar.1092430109; Schneider JE, 2003, J MOL CELL CARDIOL, V35, P217, DOI 10.1016/S0022-2828(02)00291-2; Shioda T, 1996, P NATL ACAD SCI USA, V93, P12298, DOI 10.1073/pnas.93.22.12298; Shioda T, 1997, GENE, V204, P235, DOI 10.1016/S0378-1119(97)00551-9; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Sun HB, 1998, P NATL ACAD SCI USA, V95, P13555, DOI 10.1073/pnas.95.23.13555; Wassif CA, 2001, HUM MOL GENET, V10, P555, DOI 10.1093/hmg/10.6.555; Weninger WJ, 2005, DEVELOPMENT, V132, P1337, DOI 10.1242/dev.01696; Withington SL, 2006, DEV BIOL, V294, P67, DOI 10.1016/j.ydbio.2006.02.025; Yang Xiao-fei, 2010, Zhonghua Er Ke Za Zhi, V48, P293; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	59	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46256	10.1371/journal.pone.0046256	http://dx.doi.org/10.1371/journal.pone.0046256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082118	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900013
J	Holland, D; McEvoy, LK; Desikan, RS; Dale, AM				Holland, Dominic; McEvoy, Linda K.; Desikan, Rahul S.; Dale, Anders M.		Alzheimer's Dis Neuroimaging	Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; BRAIN ATROPHY RATES; CEREBROSPINAL-FLUID; CSF BIOMARKERS; PHOSPHORYLATED-TAU; OLDER-ADULTS; NEUROFIBRILLARY PATHOLOGY; NATIONAL INSTITUTE; STRUCTURAL MRI; AMYLOID BURDEN	The tau and amyloid pathobiological processes underlying Alzheimer disease (AD) progresses slowly over periods of decades before clinical manifestation as mild cognitive impairment (MCI), then more rapidly to dementia, and eventually to end-stage organ failure. The failure of clinical trials of candidate disease modifying therapies to slow disease progression in patients already diagnosed with early AD has led to increased interest in exploring the possibility of early intervention and prevention trials, targeting MCI and cognitively healthy (HC) populations. Here, we stratify MCI individuals based on cerebrospinal fluid (CSF) biomarkers and structural atrophy risk factors for the disease. We also stratify HC individuals into risk groups on the basis of CSF biomarkers for the two hallmark AD pathologies. Results show that the broad category of MCI can be decomposed into subsets of individuals with significantly different average regional atrophy rates. By thus selectively identifying individuals, combinations of these biomarkers and risk factors could enable significant reductions in sample size requirements for clinical trials of investigational AD-modifying therapies, and provide stratification mechanisms to more finely assess response to therapy. Power is sufficiently high that detecting efficacy in MCI cohorts should not be a limiting factor in AD therapeutics research. In contrast, we show that sample size estimates for clinical trials aimed at the preclinical stage of the disorder (HCs with evidence of AD pathology) are prohibitively large. Longer natural history studies are needed to inform design of trials aimed at the presymptomatic stage.	[Holland, Dominic; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [McEvoy, Linda K.; Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Holland, D (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	dominic.holland@gmail.com			National Institutes of Health (NIH) [R01AG031224, R01AG22381, U54NS056883, P50NS22343, P50MH081755]; NIA [K01AG029218]; NIH-NIBIB [T32 EB005970]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH081755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS022343, U54NS056883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022381, R01AG031224, K01AG029218] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health (NIH) grants R01AG031224, R01AG22381, U54NS056883, P50NS22343, and P50MH081755 (A. M. D.); NIA K01AG029218 (LKM)); NIH-NIBIB T32 EB005970 (RSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2001, ACTA NEUROPATHOL, V101, P167; Bakkour A, 2009, NEUROLOGY, V72, P1048, DOI 10.1212/01.wnl.0000340981.97664.2f; Bateman RJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt59; Becker JA, 2011, ANN NEUROL, V69, P1032, DOI 10.1002/ana.22333; Bonk J, 2010, J AM GERIATR SOC, V58, pS303, DOI 10.1111/j.1532-5415.2010.02937.x; Bourgeat P, 2010, NEUROLOGY, V74, P121, DOI 10.1212/WNL.0b013e3181c918b5; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braak H, 2012, ALZHEIMERS DEMENT, V8, P227, DOI 10.1016/j.jalz.2012.01.011; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Bulic B, 2010, NEUROPHARMACOLOGY, V59, P276, DOI 10.1016/j.neuropharm.2010.01.016; Cardenas VA, 2011, NEUROBIOL AGING, V32, P572, DOI 10.1016/j.neurobiolaging.2009.04.011; Cedarbaum JM, 2012, ALZHEIMERS DEMENT; Chan D, 2003, LANCET, V362, P1121, DOI 10.1016/S0140-6736(03)14469-8; Chetelat G, 2012, NEUROLOGY, V78, P477, DOI 10.1212/WNL.0b013e318246d67a; Craig-Schapiro R, 2009, NEUROBIOL DIS, V35, P128, DOI 10.1016/j.nbd.2008.10.003; Cummings Jeffrey L, 2011, Alzheimers Dement, V7, pe13, DOI 10.1016/j.jalz.2010.06.004; de Leon MJ, 2007, ANN NY ACAD SCI, V1097, P114, DOI 10.1196/annals.1379.012; Delrieu J, 2012, J NEUROCHEM, V120, P186, DOI 10.1111/j.1471-4159.2011.07458.x; Desikan RS, 2011, ANN NEUROL, V70, P657, DOI 10.1002/ana.22509; Desikan RS, 2012, ARCH NEUROL; Dickerson BC, 2012, NEUROLOGY, V78, P84, DOI 10.1212/WNL.0b013e31823efc6c; Duyckaerts C, 2011, ACTA NEUROPATHOL, V121, P145, DOI 10.1007/s00401-010-0794-7; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fennema-Notestine C, 2009, HUM BRAIN MAPP, V30, P3238, DOI 10.1002/hbm.20744; Fjell AM, 2010, CEREB CORTEX, V20, P2069, DOI 10.1093/cercor/bhp279; Fjell AM, 2010, J NEUROSCI, V30, P2088, DOI 10.1523/JNEUROSCI.3785-09.2010; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Fox NC, 2000, ARCH NEUROL-CHICAGO, V57, P339, DOI 10.1001/archneur.57.3.339; Fox NC, 2011, NEUROIMAGE, V57, P15, DOI 10.1016/j.neuroimage.2011.01.077; Ghidoni R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/697036; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; Gold M, 2010, DEMENT GERIATR COGN, V30, P131, DOI 10.1159/000318845; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; Grill JD, 2012, NEUROBIOL AGING; Gunnarsson MD, 2007, DEMENT GERIATR COGN, V24, P247, DOI 10.1159/000107099; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heister D, 2011, NEUROLOGY, V77, P1619, DOI 10.1212/WNL.0b013e3182343314; Herrmann N, 2011, DRUGS, V71, P2031, DOI 10.2165/11595870-000000000-00000; Holland D., 2011, HUM BRAIN MAPP; Holland D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042325; Holland D, 2011, MED IMAGE ANAL, V15, P489, DOI 10.1016/j.media.2011.02.005; Holland D, 2009, P NATL ACAD SCI USA, V106, P20954, DOI 10.1073/pnas.0906053106; Hua X, 2011, NEUROIMAGE, V57, P5, DOI 10.1016/j.neuroimage.2011.01.079; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Hyman BT, 2011, ARCH NEUROL-CHICAGO, V68, P1062, DOI 10.1001/archneurol.2011.70; HYMAN BT, 1993, J NEUROPATH EXP NEUR, V52, P594, DOI 10.1097/00005072-199311000-00006; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Jack CR, 2012, RADIOLOGY, V263, P343, DOI 10.1148/radiol.12110433; Jack CR, 2011, ARCH NEUROL-CHICAGO, V68, P1526, DOI 10.1001/archneurol.2011.183; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P474, DOI 10.1016/j.jalz.2011.04.007; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2005, NEUROLOGY, V65, P1227, DOI 10.1212/01.wnl.0000180958.22678.91; Jack CR, 2003, NEUROLOGY, V60, P253, DOI 10.1212/01.WNL.0000042480.86872.03; Johnson KA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006213; Koikkalainen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031112; Lee GJ, 2012, BIOL PSYCHIAT, V71, P814, DOI 10.1016/j.biopsych.2011.12.024; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Leung KK, 2012, NEUROIMAGE, V59, P3995, DOI 10.1016/j.neuroimage.2011.10.068; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Leung KK, 2010, NEUROIMAGE, V50, P516, DOI 10.1016/j.neuroimage.2009.12.059; Leuzy A, 2012, EXPERT REV NEUROTHER, V12, P557, DOI [10.1586/ern.12.38, 10.1586/ERN.12.38]; Lorenzi M, 2010, NEUROBIOL AGING, V31, P1443, DOI 10.1016/j.neurobiolaging.2010.04.036; Markesbery WR, 2006, ARCH NEUROL-CHICAGO, V63, P38, DOI 10.1001/archneur.63.1.38; Mattsson N, 2012, J ALZHEIMERS DIS, V30, P767, DOI 10.3233/JAD-2012-120019; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; McDonald CR, 2009, NEUROLOGY, V73, P457, DOI 10.1212/WNL.0b013e3181b16431; McEvoy LK, 2010, EXPERT REV NEUROTHER, V10, P1675, DOI 10.1586/ERN.10.162; McEvoy LK, 2010, ALZ DIS ASSOC DIS, V24, P269, DOI 10.1097/WAD.0b013e3181d1b814; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; McMurdo MET, 2011, AGE AGEING, V40, P659, DOI 10.1093/ageing/afr115; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Mody L, 2008, J AM GERIATR SOC, V56, P2340, DOI 10.1111/j.1532-5415.2008.02015.x; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; Murphy EA, 2010, NEUROIMAGE, V53, P1310, DOI 10.1016/j.neuroimage.2010.07.016; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Poulin SP, 2011, PSYCHIAT RES-NEUROIM, V194, P7, DOI 10.1016/j.pscychresns.2011.06.014; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reuter M, 2012, NEUROIMAGE; Ridha BH, 2008, J NEUROL, V255, P567, DOI 10.1007/s00415-008-0750-9; Rosner B, 2011, FUNDAMENTALS BIOSTAT, Vxvii; Sancesario GM, 2012, J ALZHEIMERS DIS, V31, P865, DOI 10.3233/JAD-2012-120211; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Schott JM, 2010, NEUROBIOL AGING, V31, P1452, DOI 10.1016/j.neurobiolaging.2010.04.011; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Storandt M, 2012, NEUROBIOL AGING, V33, P2262, DOI 10.1016/j.neurobiolaging.2011.11.029; Thompson WK, 2011, NEUROIMAGE, V57, P1, DOI 10.1016/j.neuroimage.2010.11.092; Tondelli M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.018; Vellas B, 2011, PROG NEUROBIOL, V95, P594, DOI 10.1016/j.pneurobio.2011.08.014; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; Vemuri P, 2008, NEUROIMAGE, V42, P559, DOI 10.1016/j.neuroimage.2008.05.012; Vos S, 2012, NEUROBIOL AGING; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; West MJ, 2004, NEUROBIOL AGING, V25, P1205, DOI 10.1016/j.neurobiolaging.2003.12.005; Whitwell JL, 2008, NEUROLOGY, V71, P743, DOI 10.1212/01.wnl.0000324924.91351.7d; Whitwell JL, 2008, NEUROLOGY, V70, P512, DOI 10.1212/01.wnl.0000280575.77437.a2; Williams MM, 2012, ALZHEIMERS DEMENT; Wisniewski H M, 1982, Exp Brain Res, VSuppl 5, P3; Witham MD, 2007, DRUG AGING, V24, P187, DOI 10.2165/00002512-200724030-00002	116	54	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47739	10.1371/journal.pone.0047739	http://dx.doi.org/10.1371/journal.pone.0047739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082203	Green Published, gold			2022-12-27	WOS:000311146900100
J	Kumar, T; Jha, SK				Kumar, Tankesh; Jha, Sushil K.			Sleep Deprivation Impairs Consolidation of Cued Fear Memory in Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PARADOXICAL SLEEP; CIRCADIAN MODULATION; SYNAPTIC PLASTICITY; AVOIDANCE-BEHAVIOR; LATERAL AMYGDALA; STRESS-DISORDER; REM-SLEEP; EXPRESSION; RHYTHM	Post-learning sleep facilitates negative memory consolidation and also helps preserve it over several years. It is believed, therefore, that sleep deprivation may help prevent consolidation of fearful memory. Its effect, however, on consolidation of negative/frightening memories is not known. Cued fear-conditioning (CuFC) is a widely used model to understand the neural basis of negative memory associated with anxiety disorders. In this study, we first determined the suitable circadian timing for consolidation of CuFC memory and changes in sleep architecture after CuFC. Thereafter, we studied the effect of sleep deprivation on CuFC memory consolidation. Three sets of experiments were performed in male Wistar rat (n = 51). In experiment-I, animals were conditioned to cued-fear by presenting ten tone-shock paired stimuli during lights-on (7 AM) (n = 9) and lights-off (7 PM) (n = 9) periods. In experiment-II, animals were prepared for polysomnographic recording (n = 8) and changes in sleep architecture after CuFC was determined. Further in experiment-III, animals were cued fear-conditioned during the lights-off period and were randomly divided into four groups: Sleep-Deprived (SD) (n = 9), Non-Sleep Deprived (NSD) (n = 9), Stress Control (SC) (n = 9) and Tone Control (n = 7). Percent freezing amount, a hallmark of fear, was compared statistically in these groups. Rats trained during the lights-off period exhibited significantly more freezing compared to lights-on period. In CuFC trained animals, total sleep amount did not change, however, REM sleep decreased significantly. Further, out of total sleep time, animals spent proportionately more time in NREM sleep. Nevertheless, SD animals exhibited significantly less freezing compared to NSD and SC groups. These data suggest that sleep plays an important role in the consolidation of cued fear-conditioned memory.	[Kumar, Tankesh; Jha, Sushil K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Jha, SK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sushilkjha@mail.jnu.ac.in	Jha, Sushil/R-3059-2019	Jha, Sushil/0000-0001-8638-898X	Council of Scientific and Industrial Research (CSIR), New Delhi, India; Department of Science & Technology (DST); DST-PURSE; Capacity Build-up funds; University Grants Commission UGC-RNW; UGC-CAS	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science & Technology (DST)(Department of Science & Technology (India)); DST-PURSE; Capacity Build-up funds; University Grants Commission UGC-RNW(University Grants Commission, India); UGC-CAS(University Grants Commission, IndiaChinese Academy of Sciences)	Funding to SKJ from Council of Scientific and Industrial Research (CSIR), New Delhi, India is highly acknowledged. Funding from other sources such as Department of Science & Technology (DST), DST-PURSE, Capacity Build-up funds, University Grants Commission UGC-RNW and UGC-CAS is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; Backhaus J, 2006, BIOL PSYCHIAT, V60, P1324, DOI 10.1016/j.biopsych.2006.03.051; Bjorness TE, 2005, LEARN MEMORY, V12, P352, DOI 10.1101/lm.84805; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Campbell IG, 2002, J NEUROPHYSIOL, V88, P1073, DOI 10.1152/jn.2002.88.2.1073; CATALA MD, 1985, PHYSIOL BEHAV, V34, P327, DOI 10.1016/0031-9384(85)90191-X; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Chowdhury A, 2011, NEUROBIOL LEARN MEM, V95, P355, DOI 10.1016/j.nlm.2011.01.009; DAVIES JA, 1973, PSYCHOPHARMACOLOGIA, V32, P211, DOI 10.1007/BF00428692; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Gerstner JR, 2010, NAT REV NEUROSCI, V11, P577, DOI 10.1038/nrn2881; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Hale MW, 2006, BRAIN RES BULL, V71, P174, DOI 10.1016/j.brainresbull.2006.09.001; Hennevin E, 1998, BEHAV NEUROSCI, V112, P839, DOI 10.1037/0735-7044.112.4.839; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; Hill S, 2008, BRAIN RES BULL, V76, P605, DOI 10.1016/j.brainresbull.2008.02.024; Holland P, 2007, CURR BIOL, V17, pR179, DOI 10.1016/j.cub.2006.12.033; Ishikawa A, 2006, EUR J NEUROSCI, V24, P243, DOI 10.1111/j.1460-9568.2006.04874.x; Jha SK, 2005, J NEUROSCI, V25, P9266, DOI 10.1523/JNEUROSCI.2722-05.2005; Jha SK, 2005, EUR J NEUROSCI, V21, P1077, DOI 10.1111/j.1460-9568.2005.03920.x; Knight DC, 2009, NEUROIMAGE, V45, P208, DOI 10.1016/j.neuroimage.2008.11.015; Kuriyama K, 2010, BIOL PSYCHIAT, V68, P991, DOI 10.1016/j.biopsych.2010.08.015; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liu DLJ, 2008, NEUROBIOL LEARN MEM, V89, P36, DOI 10.1016/j.nlm.2007.09.001; Loh DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012546; Lyon LC, 2005, P NATL ACAD SCI USA, V102, P12589, DOI 10.1073/pnas.0503847102; Madan V, 2008, INT J LIFE SCI TECHN, V1, P9; Madan V, 2008, SLEEP, V31, P497, DOI 10.1093/sleep/31.4.497; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; McDonald RJ, 2002, LEARN MOTIV, V33, P230, DOI 10.1006/lmot.2001.1111; Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pawlyk AC, 2005, BIOL PSYCHIAT, V57, P268, DOI 10.1016/j.biopsych.2004.11.008; Payne JD, 2011, J COGNITIVE NEUROSCI, V23, P1285, DOI 10.1162/jocn.2010.21526; PITMAN RK, 1989, BIOL PSYCHIAT, V26, P221, DOI 10.1016/0006-3223(89)90033-4; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Ruskin DN, 2004, EUR J NEUROSCI, V19, P3121, DOI 10.1111/j.0953-816X.2004.03426.x; Sanford LD, 2003, BEHAV BRAIN RES, V147, P193, DOI 10.1016/S0166-4328(03)00180-3; Sanford LD, 2003, BEHAV GENET, V33, P43, DOI 10.1023/A:1021051516829; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Smith Carlyle, 1996, Physiology and Behavior, V59, P93, DOI 10.1016/0031-9384(95)02054-3; Valentinuzzi VS, 2001, ANIM LEARN BEHAV, V29, P133, DOI 10.3758/BF03192822; Vecsey CG, 2009, NATURE, V461, P1122, DOI 10.1038/nature08488; Wagner U, 2006, BIOL PSYCHIAT, V60, P788, DOI 10.1016/j.biopsych.2006.03.061; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; WITTING W, 1993, BRAIN RES BULL, V30, P157, DOI 10.1016/0361-9230(93)90053-E	52	51	53	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47042	10.1371/journal.pone.0047042	http://dx.doi.org/10.1371/journal.pone.0047042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082139	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900034
J	Sarvestani, AS; Bufumbo, L; Geiger, JD; Sienko, KH				Sarvestani, Amir Sabet; Bufumbo, Leonard; Geiger, James D.; Sienko, Kathleen H.			Traditional Male Circumcision in Uganda: A Qualitative Focus Group Discussion Analysis	PLOS ONE			English	Article							SOUTH-AFRICA; HIV PREVENTION; EASTERN CAPE; MEN; KENYA; ACCEPTABILITY; COMPLICATIONS; TRIAL; XHOSA; RISK	Background: The growing body of evidence attesting to the effectiveness of clinical male circumcision in the prevention of HIV/AIDS transmission is prompting the majority of sub-Saharan African governments to move towards the adoption of voluntary medical male circumcision (VMMC). Even though it is recommended to consider collaboration with traditional male circumcision (TMC) providers when planning for VMMC, there is limited knowledge available about the TMC landscape and traditional beliefs. Methodology and Main Findings: During 2010-11 over 25 focus group discussions (FGDs) were held with clan leaders, traditional cutters, and their assistants to understand the practice of TMC in four ethnic groups in Uganda. Cultural significance and cost were among the primary reasons cited for preferring TMC over VMMC. Ethnic groups in western Uganda circumcised boys at younger ages and encountered lower rates of TMC related adverse events compared to ethnic groups in eastern Uganda. Cutting styles and post-cut care also differed among the four groups. The use of a single razor blade per candidate instead of the traditional knife was identified as an important and recent change. Participants in the focus groups expressed interest in learning about methods to reduce adverse events. Conclusion: This work reaffirmed the strong cultural significance of TMC within Ugandan ethnic groups. Outcomes suggest that there is an opportunity to evaluate the involvement of local communities that still perform TMC in the national VMMC roll-out plan by devising safer, more effective procedures through innovative approaches.	[Sienko, Kathleen H.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Sienko, Kathleen H.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Sarvestani, Amir Sabet] Univ Michigan, Design Sci Program, Ann Arbor, MI 48109 USA; [Bufumbo, Leonard] Family Hlth Int, Kampala, Uganda; [Geiger, James D.] Univ Michigan, Dept Pediat Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sienko, KH (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	sienko@umich.edu	Sabet Sarvestani, Amir/A-6668-2013	Sabet Sarvestani, Amir/0000-0001-9779-262X	Gates Grand Challenges Exploration Phase I Grant; University of Michigan Center for Global Health Junior Faculty Engagement Award	Gates Grand Challenges Exploration Phase I Grant; University of Michigan Center for Global Health Junior Faculty Engagement Award	Sources of funding for this work included the Gates Grand Challenges Exploration Phase I Grant (http://www.grandchallenges.org/explorations/) and the University of Michigan Center for Global Health Junior Faculty Engagement Award (http://www.globalhealth.umich.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2008, B WORLD HEALTH ORGAN, V86, P669, DOI 10.2471/BLT.08.051482; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Brown JE, 2001, SEX TRANSM DIS, V28, P608, DOI 10.1097/00007435-200110000-00007; CROWLEY IP, 1990, BRIT J UROL, V66, P318, DOI 10.1111/j.1464-410X.1990.tb14936.x; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Herman-Roloff A., 2011, PLOS ONE, V6; Lagarde E, 2003, AIDS, V17, P89, DOI 10.1097/00002030-200301030-00012; Magoha GAO, 1999, E AFR MED J, V76, P583; Maughan-Brown B, 2011, JAIDS-J ACQ IMM DEF, V58, P499, DOI 10.1097/QAI.0b013e31823584c1; Meissner O, 2007, SAMJ S AFR MED J, V97, P371; Miller V, 2008, WORKSH CONV FOR COLL; Peltzer K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-64; Peltzer K, 2010, AFR J TRADIT COMPLEM, V7, P153; Shaffer DN, 2007, JAIDS-J ACQ IMM DEF, V45, P371, DOI 10.1097/QAI.0b013e318095a3da; Uganda Ministry of Health, 2006, HIV AIDS SER SURV; Uganda Ministry of Health, 2010, MASS MAL CIRC ROLL O; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Wambura M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-373; WHO (World Health Organization), 2009, COUNTR EXP SCAL UP M; Wilcken A, 2010, B WORLD HEALTH ORGAN, V88, P907, DOI 10.2471/BLT.09.072975; World Health Organization, 2008, OP GUID SCAL MAL CIR	22	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e45316	10.1371/journal.pone.0045316	http://dx.doi.org/10.1371/journal.pone.0045316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082112	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900007
J	Yu, CC; Furukawa, M; Kobayashi, K; Shikishima, C; Cha, PC; Sese, J; Sugawara, H; Iwamoto, K; Kato, T; Ando, J; Toda, T				Yu, Chih-Chieh; Furukawa, Mari; Kobayashi, Kazuhiro; Shikishima, Chizuru; Cha, Pei-Chieng; Sese, Jun; Sugawara, Hiroko; Iwamoto, Kazuya; Kato, Tadafumi; Ando, Juko; Toda, Tatsushi			Genome-Wide DNA Methylation and Gene Expression Analyses of Monozygotic Twins Discordant for Intelligence Levels	PLOS ONE			English	Article							CHILDHOOD; PROTEIN; BLOOD; IDENTIFICATION; STABILITY; EPIGENOME; NICOTINE; REVEALS; ABILITY; GROWTH	Human intelligence, as measured by intelligence quotient (IQ) tests, demonstrates one of the highest heritabilities among human quantitative traits. Nevertheless, studies to identify quantitative trait loci responsible for intelligence face challenges because of the small effect sizes of individual genes. Phenotypically discordant monozygotic (MZ) twins provide a feasible way to minimize the effects of irrelevant genetic and environmental factors, and should yield more interpretable results by finding epigenetic or gene expression differences between twins. Here we conducted array-based genome-wide DNA methylation and gene expression analyses using 17 pairs of healthy MZ twins discordant intelligently. ARHGAP18, related to Rho GTPase, was identified in pair-wise methylation status analysis and validated via direct bisulfite sequencing and quantitative RT-PCR. To perform expression profile analysis, gene set enrichment analysis (GSEA) between the groups of twins with higher IQ and their co-twins revealed up-regulated expression of several ribosome-related genes and DNA replication-related genes in the group with higher IQ. To focus more on individual pairs, we conducted pair-wise GSEA and leading edge analysis, which indicated up-regulated expression of several ion channel-related genes in twins with lower IQ. Our findings implied that these groups of genes may be related to IQ and should shed light on the mechanism underlying human intelligence.	[Yu, Chih-Chieh; Furukawa, Mari; Kobayashi, Kazuhiro; Cha, Pei-Chieng; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 657, Japan; [Shikishima, Chizuru] Keio Univ, Keio Adv Res Ctr, Tokyo, Japan; [Sese, Jun] Tokyo Inst Technol, Dept Comp Sci, Grad Sch Informat Sci & Engn, Tokyo 152, Japan; [Sugawara, Hiroko; Kato, Tadafumi] RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Saitama, Japan; [Iwamoto, Kazuya] Univ Tokyo, Dept Mol Psychiat, Grad Sch Med, Tokyo, Japan; [Ando, Juko] Keio Univ, Fac Letters, Tokyo, Japan	Kobe University; Keio University; Tokyo Institute of Technology; RIKEN; University of Tokyo; Keio University	Toda, T (corresponding author), Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 657, Japan.	toda@med.kobe-u.ac.jp	Kato, Tadafumi/J-3583-2014; nakamura, asuka/S-7235-2016; Kobayashi, Kazuhiro/AAH-8638-2021	Kato, Tadafumi/0000-0001-7856-3952; Kobayashi, Kazuhiro/0000-0001-7801-147X; Sese, Jun/0000-0003-3495-4382	JST, CREST; Ministry of Education, Culture, Sports, Science and Technology of Japan [22129006]; Japan Society for the Promotion of Science [23650136];  [21223002];  [20390099]	JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	We deeply thank all the study subjects. The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE33478. This research was supported by JST, CREST.; This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (22129006 to TT) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; by Grants-in-Aid for Scientific Research (S) (21223002 to JA and TT); by Scientific Research (B) (20390099 to TT); and by Challenging Exploratory Research (23650136 to KK) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Bilder RM, 2009, NEUROSCIENCE, V164, P30, DOI 10.1016/j.neuroscience.2009.01.027; Biousse V, 1997, NEUROLOGY, V49, P1136, DOI 10.1212/WNL.49.4.1136; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Butcher LM, 2005, HUM MOL GENET, V14, P1315, DOI 10.1093/hmg/ddi142; BUXTON A, 1994, PHARMACOL BIOCHEM BE, V49, P1067, DOI 10.1016/0091-3057(94)90266-6; Cai CC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-589; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Davydov V, 2003, NEUROBIOL AGING, V24, P953, DOI 10.1016/S0197-4580(02)00229-4; Deary IJ, 2012, NATURE, V482, P212, DOI 10.1038/nature10781; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Haggarty P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011329; Haworth CMA, 2009, BEHAV GENET, V39, P359, DOI 10.1007/s10519-009-9262-3; Holliday R, 2006, EPIGENETICS-US, V1, P76, DOI 10.4161/epi.1.2.2762; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Jacobs N, 2001, BEHAV GENET, V31, P209, DOI 10.1023/A:1010257512183; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Karthikeyan S, 2003, STRUCTURE, V11, P265, DOI 10.1016/S0969-2126(03)00024-8; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maeda M, 2011, MOL BIOL CELL, V22, P3840, DOI 10.1091/mbc.E11-04-0364; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; Nakauchi S, 2007, EUR J NEUROSCI, V25, P2666, DOI 10.1111/j.1460-9568.2007.05513.x; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Nishikawa K, 2003, BIOCHEM BIOPH RES CO, V304, P176, DOI 10.1016/S0006-291X(03)00555-2; O'Brien TW, 2005, GENE, V354, P147, DOI 10.1016/j.gene.2005.03.026; Payton A, 2009, NEUROPSYCHOL REV, V19, P451, DOI 10.1007/s11065-009-9116-z; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; PLOMIN R, 1980, INTELLIGENCE, V4, P15, DOI 10.1016/0160-2896(80)90003-3; Potkin SG, 2010, NEUROIMAGE, V53, P839, DOI 10.1016/j.neuroimage.2010.06.036; Rodriguez S, 2007, HUM GENET, V122, P1, DOI 10.1007/s00439-007-0378-3; Schroeder DI, 2011, GENOME RES, V21, P1583, DOI 10.1101/gr.119131.110; Shikishima C, 2006, TWIN RES HUM GENET, V9, P811, DOI 10.1375/twin.9.6.811; Shikishima C, 2009, INTELLIGENCE, V37, P256, DOI 10.1016/j.intell.2008.10.010; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugawara H, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.26; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Thiel CM, 2008, NEUROSCIENCE, V152, P381, DOI 10.1016/j.neuroscience.2007.10.061; Tuteja N, 2003, J EXP BOT, V54, P2201, DOI 10.1093/jxb/erg246; van Nieuwpoort IC, 2008, EUR J ENDOCRINOL, V159, pS53, DOI 10.1530/EJE-08-0279; Vinkhuyzen AAE, 2011, MOL PSYCHIATR, V16, P4, DOI 10.1038/mp.2010.12; Wright M, 2001, Twin Res, V4, P48, DOI 10.1375/1369052012146; Zekri L, 2005, MOL CELL BIOL, V25, P8703, DOI 10.1128/MCB.25.19.8703-8716.2005	52	20	21	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47081	10.1371/journal.pone.0047081	http://dx.doi.org/10.1371/journal.pone.0047081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082141	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900036
J	Xie, XB; Yin, JQ; Wen, LL; Gao, ZH; Zou, CY; Wang, J; Huang, G; Tang, QL; Colombo, C; He, WL; Jia, Q; Shen, JN				Xie, Xian-biao; Yin, Jun-qiang; Wen, Li-li; Gao, Zhen-hua; Zou, Chang-ye; Wang, Jin; Huang, Gang; Tang, Qing-lian; Colombo, Chiara; He, Wei-ling; Jia, Qiang; Shen, Jing-nan			Critical Role of Heat Shock Protein 27 in Bufalin-Induced Apoptosis in Human Osteosarcomas: A Proteomic-Based Research	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; HIGH-GRADE OSTEOSARCOMA; AKT ACTIVATION; CYTOCHROME-C; HSP27; LEUKEMIA; LINES; METHOTREXATE; CINOBUFAGIN; INHIBITION	Bufalin is the primary component of the traditional Chinese herb "Chan Su''. Evidence suggests that this compound possesses potent anti-tumor activities, although the exact molecular mechanism(s) is unknown. Our previous study showed that bufalin inhibited growth of human osteosarcoma cell lines U2OS and U2OS/MTX300 in culture. Therefore, this study aims to further clarify the in vitro and in vivo anti-osteosarcoma effects of bufalin and its molecular mechanism of action. We found bufalin inhibited both methotrexate (MTX) sensitive and resistant human osteosarcoma cell growth and induced G2/M arrest and apoptosis. Using a comparative proteomics approach, 24 differentially expressed proteins following bufalin treatment were identified. In particular, the level of an anti-apoptotic protein, heat shock protein 27 (Hsp27), decreased remarkably. The down-regulation of Hsp27 and alterations of its partner signaling molecules (the decrease in p-Akt, nuclear NF-kappa B p65, and co-immunoprecipitated cytochrome c/Hsp27) were validated. Hsp27 over-expression protected against bufalin-induced apoptosis, reversed the dephosphorylation of Akt and preserved the level of nuclear NF-kappa B p65 and co-immunoprecipitated Hsp27/cytochrome c. Moreover, bufalin inhibited MTX-resistant osteosarcoma xenograft growth, and a down-regulation of Hsp27 in vivo was observed. Taken together, bufalin exerted potent anti-osteosarcoma effects in vitro and in vivo, even in MTX resistant osteosarcoma cells. The down-regulation of Hsp27 played a critical role in bufalin-induced apoptosis in osteosarcoma cells. Bufalin may have merit to be a potential chemotherapeutic agent for osteosarcoma, particularly in MTX-resistant groups.	[Jia, Qiang] Guizhou Acad Sci, Inst Biol, Guiyang, Peoples R China; [Xie, Xian-biao; Yin, Jun-qiang; Gao, Zhen-hua; Zou, Chang-ye; Wang, Jin; Huang, Gang; Tang, Qing-lian; He, Wei-ling; Shen, Jing-nan] Sun Yat Sen Univ, Affiliated Hosp 1, Bone & Soft Tissue Tumor Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wen, Li-li] Sun Yat Sen Univ, Ctr Canc, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China; [Colombo, Chiara] Ist Nazl Tumori, Dept Surg, I-20133 Milan, Italy	Sun Yat Sen University; Sun Yat Sen University; Fondazione IRCCS Istituto Nazionale Tumori Milan	Jia, Q (corresponding author), Guizhou Acad Sci, Inst Biol, Guiyang, Peoples R China.	ytjq0629_cn@sina.com; shenjingnan@21cn.com	Colombo, Chiara/C-4303-2017	Colombo, Chiara/0000-0001-8031-5528	National Natural Science Foundation of China [30973504, 81102040]; Natural Science Foundation of Guangdong Province [8251008901000019]; Ministry of Science and Technology of Guizhou Province, China [G[2009]4013, NY[2009]3021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Ministry of Science and Technology of Guizhou Province, China	This work was supported by grants from National Natural Science Foundation of China (No 30973504, No 81102040); Natural Science Foundation of Guangdong Province (No 8251008901000019); and the Ministry of Science and Technology of Guizhou Province, China (G[2009]4013 and NY[2009]3021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benini S, 1999, INT J CANCER, V80, P581, DOI 10.1002/(SICI)1097-0215(19990209)80:4<581::AID-IJC16>3.3.CO;2-F; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; Chiu PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031648; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Delepine N, 1996, CANCER-AM CANCER SOC, V78, P2127, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2127::AID-CNCR13>3.3.CO;2-Z; Dong YH, 2011, APOPTOSIS, V16, P394, DOI 10.1007/s10495-011-0573-5; Ferguson WS, 2001, CANCER INVEST, V19, P292, DOI 10.1081/CNV-100102557; Gibert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029719; Guo K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-100; Guo QC, 2007, ACTA PHARMACOL SIN, V28, P850, DOI 10.1111/j.1745-7254.2007.00603.x; Han KQ, 2007, WORLD J GASTROENTERO, V13, P3374, DOI 10.3748/wjg.v13.i24.3374; Hsu HS, 2011, CANCER-AM CANCER SOC, V117, P1516, DOI 10.1002/cncr.25599; Jiang YT, 2010, CYTOTECHNOLOGY, V62, P573, DOI 10.1007/s10616-010-9310-0; Kawazoe N, 1999, ONCOGENE, V18, P2413, DOI 10.1038/sj.onc.1202555; Krenn L, 1998, PHYTOCHEMISTRY, V48, P1, DOI 10.1016/S0031-9422(97)00426-3; Na L, 2006, CARCINOGENESIS, V27, P1222, DOI 10.1093/carcin/bgi306; Moon A, 2010, PATHOLOGY, V42, P421, DOI 10.3109/00313025.2010.493866; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; NUMAZAWA S, 1994, J CELL PHYSIOL, V160, P113, DOI 10.1002/jcp.1041600114; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Picci P, 2010, ANN ONCOL, V21, P1366, DOI 10.1093/annonc/mdp502; Qi FH, 2011, CANCER SCI, V102, P951, DOI 10.1111/j.1349-7006.2011.01900.x; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; SERRA M, 1993, ANTICANCER RES, V13, P323; SIROTNAK FM, 1978, CANCER RES, V38, P345; Uozaki H, 2000, PATHOL RES PRACT, V196, P665, DOI 10.1016/S0344-0338(00)80118-1; Watabe M, 1998, ONCOGENE, V16, P779, DOI 10.1038/sj.onc.1201592; Whelan JS, 2011, ANN ONCOL; Xie XB, 2011, CLIN CANCER RES, V17, P5901, DOI 10.1158/1078-0432.CCR-11-0660; Yeh JY, 2003, PROSTATE, V54, P112, DOI 10.1002/pros.10172; Yin JQ, 2007, ACTA PHARMACOL SIN, V28, P712, DOI 10.1111/j.1745-7254.2007.00559.x; Zhang Y, 2007, CLIN CANCER RES, V13, P2855, DOI 10.1158/1078-0432.CCR-06-2090	38	37	43	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47375	10.1371/journal.pone.0047375	http://dx.doi.org/10.1371/journal.pone.0047375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091618	Green Published, gold, Green Submitted			2022-12-27	WOS:000310135800041
J	Dymond, S; Schlund, MW; Roche, B; De Houwer, J; Freegard, GP				Dymond, Simon; Schlund, Michael W.; Roche, Bryan; De Houwer, Jan; Freegard, Gary P.			Safe From Harm: Learned, Instructed, and Symbolic Generalization Pathways of Human Threat-Avoidance	PLOS ONE			English	Article							NEURAL SYSTEMS; EXPERIENTIAL AVOIDANCE; ANXIETY DISORDERS; CONDITIONED FEAR; BEHAVIOR; TRANSFORMATION; MECHANISMS; ETIOLOGY; AMYGDALA	Avoidance of threatening or unpleasant events is usually an adaptive behavioural strategy. Sometimes, however, avoidance can become chronic and lead to impaired daily functioning. Excessive threat-avoidance is a central diagnostic feature of anxiety disorders, yet little is known about whether avoidance acquired in the absence of a direct history of conditioning with a fearful event differs from directly learned avoidance. In the present study, we tested whether avoidance acquired indirectly via verbal instructions and symbolic generalization result in similar levels of avoidance behaviour and threat-beliefs to avoidance acquired after direct learning. Following fear conditioning in which one conditioned stimulus was paired with shock (CS+) and another was not (CS-), participants either learned or were instructed to make a response that cancelled impending shock. Three groups were then tested with a learned CS+ and CS- (learned group), instructed CS+ (instructed group), and generalized CS+ (derived group) presentations. Results showed similar levels of avoidance behaviour and threat-belief ratings about the likelihood of shock across each of the three pathways despite the different mechanisms by which they were acquired. Findings have implications for understanding the aetiology of clinical avoidance in anxiety.	[Dymond, Simon; Freegard, Gary P.] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Schlund, Michael W.] Kennedy Krieger Inst, Dept Behav Psychol, Baltimore, MD USA; [Schlund, Michael W.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Schlund, Michael W.] Univ N Texas, Dept Behav Anal, Denton, TX 76203 USA; [Roche, Bryan] Natl Univ Ireland, Dept Psychol, Maynooth, Kildare, Ireland; [De Houwer, Jan] Univ Ghent, Dept Psychol, B-9000 Ghent, Belgium	Swansea University; Kennedy Krieger Institute; Johns Hopkins University; University of North Texas System; University of North Texas Denton; Maynooth University; Ghent University	Dymond, S (corresponding author), Swansea Univ, Dept Psychol, Swansea, W Glam, Wales.	s.o.dymond@swansea.ac.uk	Roche, Bryan/ABG-1773-2021; Dymond, Simon/M-5524-2019; Dymond, Simon/D-8503-2014; De Houwer, Jan/ABF-6866-2021	Dymond, Simon/0000-0003-1319-4492; Dymond, Simon/0000-0003-1319-4492; De Houwer, Jan/0000-0003-0488-5224	Department of Psychology, Swansea University	Department of Psychology, Swansea University	This research was supported by intramural funding from the Department of Psychology, Swansea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew C, 2008, CLIN PSYCHOL REV, V28, P1249, DOI 10.1016/j.cpr.2008.05.003; Augustson EM, 1997, J BEHAV THER EXP PSY, V28, P181, DOI 10.1016/S0005-7916(97)00008-6; Barnes-Holmes Y., 2001, THESIS NATL U IRELAN; Beckers T, BIOL PSYCHO IN PRESS; Bouton ME, 2001, PSYCHOL REV, V108, P4, DOI 10.1037//0033-295X.108.1.4; De Houwer J, 2005, PERCEPT PSYCHOPHYS, V67, P659, DOI 10.3758/BF03193522; De Houwer J, 2011, PERSPECT PSYCHOL SCI, V6, P202, DOI 10.1177/1745691611400238; Declercq M, 2009, J EXP PSYCHOL ANIM B, V35, P123, DOI 10.1037/a0012927; Delgado MR, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.033.2009; Dunsmoor JE, 2012, BIOL PSYCHOL, V89, P300, DOI 10.1016/j.biopsycho.2011.11.002; Dunsmoor JE, 2011, NEUROIMAGE, V55, P1878, DOI 10.1016/j.neuroimage.2011.01.041; Dunsmoor JE, 2011, LEARN MEMORY, V18, P156, DOI 10.1101/lm.2016411; Dunsmoor JE, 2009, LEARN MEMORY, V16, P460, DOI 10.1101/lm.1431609; Dymond S, 2000, BEHAV ANALYST, V23, P239, DOI 10.1007/BF03392013; Dymond S., 2008, PSYCHOL REC, V58, P271; Dymond S, 2007, J EXP ANAL BEHAV, V88, P249, DOI 10.1901/jeab.2007.22-07; Dymond S, 2011, BEHAV RES THER, V49, P614, DOI 10.1016/j.brat.2011.06.007; Dymond S, 2009, BEHAV ANALYST, V32, P7, DOI 10.1007/BF03392173; Field AP, 2008, J ABNORM PSYCHOL, V117, P214, DOI 10.1037/0021-843X.117.1.214; Field AP, 2006, CLIN PSYCHOL REV, V26, P857, DOI 10.1016/j.cpr.2005.05.010; Gannon S, 2011, PSYCHOL REC, V61, P227, DOI 10.1007/BF03395758; HAYES SC, 1986, BEHAV ANALYST, V9, P175, DOI 10.1007/BF03391944; Hayes SC, 1996, J CONSULT CLIN PSYCH, V64, P1152, DOI 10.1037/0022-006X.64.6.1152; HAYES SC, 1992, AM PSYCHOL, V47, P1383, DOI 10.1037/0003-066X.47.11.1383; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Lommen MJJ, 2010, PERS INDIV DIFFER, V49, P1001, DOI 10.1016/j.paid.2010.08.012; Lovibond P.F., 2006, FEAR LEARNING, P117, DOI DOI 10.1037/11474-006; MERCKELBACH H, 1992, BEHAV RES THER, V30, P543, DOI 10.1016/0005-7967(92)90039-J; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Muris P, 2010, CLIN CHILD FAM PSYCH, V13, P129, DOI 10.1007/s10567-010-0064-1; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Olsson A, 2011, ASS LEARNING CONDITI, P454; Olsson A, 2007, SOC COGN AFFECT NEUR, V2, P3, DOI 10.1093/scan/nsm005; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; RACHMAN S, 1977, BEHAV RES THER, V15, P375, DOI 10.1016/0005-7967(77)90041-9; Roche BT, 2008, PSYCHOL REC, V58, P443, DOI 10.1007/BF03395628; Schlund MW, 2011, BEHAV BRAIN RES, V225, P437, DOI 10.1016/j.bbr.2011.07.054; Schlund MW, 2010, NEUROIMAGE, V53, P769, DOI 10.1016/j.neuroimage.2010.06.058; Schlund MW, 2010, NEUROIMAGE, V52, P710, DOI 10.1016/j.neuroimage.2010.04.244; Sidman M., 1994, EQUIVALENCE RELATION; Smyth S, 2006, J EXP ANAL BEHAV, V85, P223, DOI 10.1901/jeab.2006.02-05; Vervliet B, 2010, BEHAV RES THER, V48, P1078, DOI 10.1016/j.brat.2010.07.002; Wasserman E. A., 2018, ENCY RES DESIGN, V3, DOI [DOI 10.4135/9781412961288, 10.4135/9781412961288]; Zvolensky MJ, 2006, BEHAV RES THER, V44, P1219, DOI 10.1016/j.brat.2006.06.001	46	57	57	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47539	10.1371/journal.pone.0047539	http://dx.doi.org/10.1371/journal.pone.0047539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022WO	23077631	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100127
J	Yanagawa, A; Fujiwara-Tsujii, N; Akino, T; Yoshimura, T; Yanagawa, T; Shimizu, S				Yanagawa, Aya; Fujiwara-Tsujii, Nao; Akino, Toshiharu; Yoshimura, Tsuyoshi; Yanagawa, Takashi; Shimizu, Susumu			Odor Aversion and Pathogen-Removal Efficiency in Grooming Behavior of the Termite Coptotermes formosanus	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; ENTOMOPATHOGENIC FUNGI; BEAUVERIA-BASSIANA; ISOPTERA; VIRULENCE; SHIRAKI; RHINOTERMITIDAE; DEGRADATION; MECHANISMS; REPELLENCY	The results of biocontrol with entomopathogens in termites have been discouraging because of the strong social hygiene behavior for removing pathogens from termite colonies. However, the mechanism of pathogen detection is still unclear. For the successful application of biopesticides to termites in nature, it would be beneficial to identify substances that could disrupt the termite's ability to perceive pathogens. We hypothesized that termites can perceive pathogens and this ability plays an important role in effective hygiene behavior. In this study, pathogen-detection in the subterranean termite Coptotermes formosanus was investigated. We performed quantitative assays on conidia removal by grooming behavior using epifluoresence microscopy and Y-maze tests to examine the perception of fungal odor by termites. Three species each of high-and low-virulence entomopathogenic fungi were used in each test. The results demonstrated that termites removed conidia more effectively from a nestmate's cuticle if its odor elicited stronger aversion. Highly virulent pathogens showed higher attachment rates to termite surfaces and their odors were more strongly avoided than those of low-virulence isolates in the same species. Moreover, termites appeared to groom each other more persistently when they had more conidia on their bodies. In brief, insect perception of pathogen-related odor seems to play a role in the mechanism of their hygiene behavior.	[Yanagawa, Aya; Yoshimura, Tsuyoshi] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Fujiwara-Tsujii, Nao] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Akino, Toshiharu] Kyoto Inst Technol, Dept Appl Biol, Kyoto 606, Japan; [Yanagawa, Takashi] Kurume Univ, Biostat Ctr, Kurume, Fukuoka 830, Japan; [Shimizu, Susumu] Kyushu Univ, Inst Biol Control, Fukuoka 812, Japan	Kyoto University; National Institute of Agrobiological Sciences - Japan; Kyoto Institute of Technology; Kurume University; Kyushu University	Yanagawa, A (corresponding author), Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan.	ayanagawa@rish.kyoto-u.ac.jp			Kyoto University; Grants-in-Aid for Scientific Research [24880019] Funding Source: KAKEN	Kyoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Kyoto University: The corresponding author have been funded 'the start-up fundation' from the affiliation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucias D. G., 1996, Pflanzenschutz-Nachrichten Bayer (English ed.), V49, P103; BOUCIAS DG, 1988, APPL ENVIRON MICROB, V54, P1795, DOI 10.1128/AEM.54.7.1795-1805.1988; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Chouvenc T, 2010, J ECON ENTOMOL, V103, P1327, DOI 10.1603/EC09407; Clarkson JM, 1996, TRENDS MICROBIOL, V4, P197, DOI 10.1016/0966-842X(96)10022-6; Crespo R, 2000, MYCOLOGIA, V92, P528, DOI 10.2307/3761512; Culliney TW, 2000, B ENTOMOL RES, V90, P9, DOI 10.1017/S0007485300000031; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Dong CJ, 2007, MICROBIOL RES, V162, P53, DOI 10.1016/j.micres.2006.07.001; Ferron P, 1981, HDB MICROBIAL CONTRO, P465; FLOYD MA, 1976, J INSECT PHYSIOL, V22, P697, DOI 10.1016/0022-1910(76)90235-3; Gao Q, 2012, ACTA ETHOL, V15, P55, DOI 10.1007/s10211-011-0108-7; Holder DJ, 2005, APPL ENVIRON MICROB, V71, P5260, DOI 10.1128/AEM.71.9.5260-5266.2005; HUNG SY, 1992, J INVERTEBR PATHOL, V60, P152, DOI 10.1016/0022-2011(92)90089-M; Hussain A, 2010, BIOL CONTROL, V55, P166, DOI 10.1016/j.biocontrol.2010.08.009; Hussain A, 2010, J INVERTEBR PATHOL, V104, P166, DOI 10.1016/j.jip.2010.03.004; Jackson MA, 2010, BIOCONTROL, V55, P129, DOI 10.1007/s10526-009-9240-y; Lax AR, 2003, PEST MANAG SCI, V59, P788, DOI 10.1002/ps.721; LIN HC, 1992, J CHEM ECOL, V18, P1623, DOI 10.1007/BF00993234; Mburu DM, 2009, J INSECT PHYSIOL, V55, P774, DOI 10.1016/j.jinsphys.2009.04.015; Milner RJ, 1998, BIOL CONTROL, V11, P240, DOI 10.1006/bcon.1997.0574; Mulrooney JE, 2007, J ECON ENTOMOL, V100, P488, DOI 10.1603/0022-0493(2007)100[488:HROTAA]2.0.CO;2; Nishi O, 2010, P TRG 7 2010 PAC RIM; Pedrini N, 2007, COMP BIOCHEM PHYS C, V146, P124, DOI 10.1016/j.cbpc.2006.08.003; Quesada-Moraga E, 2006, J APPL ENTOMOL, V130, P442, DOI 10.1111/j.1439-0418.2006.01079.x; Rath AC, 2000, BIOCONTROL SCI TECHN, V10, P563, DOI 10.1080/095831500750016370; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rosengaus RB, 2001, BEHAV ECOL SOCIOBIOL, V50, P546, DOI 10.1007/s002650100394; Rosengaus RB, 1998, BEHAV ECOL SOCIOBIOL, V44, P125, DOI 10.1007/s002650050523; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; SAS Institute Inc, 1999, SAS 9 1 3 SERV PACK; Seger C, 2005, HELV CHIM ACTA, V88, P802, DOI 10.1002/hlca.200590057; Shimizu S, 2003, APPL ENTOMOL ZOOL, V38, P125, DOI 10.1303/aez.2003.125; Staples JA, 2000, SOCIOBIOLOGY, V36, P133; STLEGER RJ, 1986, J INVERTEBR PATHOL, V47, P167, DOI 10.1016/0022-2011(86)90043-1; Sun JZ, 2008, ENVIRON ENTOMOL, V37, P755, DOI 10.1603/0046-225X(2008)37[755:IOMAAT]2.0.CO;2; Sun JZ, 2002, J INVERTEBR PATHOL, V81, P78, DOI 10.1016/S0022-2011(02)00152-0; Talael-Hassanloui R, 2007, J INVERTEBR PATHOL, V94, P102, DOI 10.1016/j.jip.2006.09.009; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Verma M, 2009, INT BIODETER BIODEGR, V63, P959, DOI 10.1016/j.ibiod.2009.05.009; Yanagawa A., 2005, JPN J ENV ENTOMOL ZO, V16, P17, DOI DOI 10.11257/JJEEZ.16.17; Yanagawa A, 2008, J INVERTEBR PATHOL, V97, P165, DOI 10.1016/j.jip.2007.09.005; Yanagawa A, 2011, J INVERTEBR PATHOL, V108, P1, DOI 10.1016/j.jip.2011.06.001; Yanagawa A, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14101; Yanagawa A, 2010, SOCIOBIOLOGY, V56, P255; Yanagawa A, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.0601; ZOBERI MH, 1995, MYCOLOGIA, V87, P354, DOI 10.2307/3760831	47	26	29	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47412	10.1371/journal.pone.0047412	http://dx.doi.org/10.1371/journal.pone.0047412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077609	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100107
J	del Pino, J; Jimenez, JL; Ventoso, I; Castello, A; Munoz-Fernandez, MA; de Haro, C; Berlanga, JJ				del Pino, Javier; Luis Jimenez, Jose; Ventoso, Ivan; Castello, Alfredo; Angeles Munoz-Fernandez, Ma; de Haro, Cesar; Jose Berlanga, Juan			GCN2 Has Inhibitory Effect on Human Immunodeficiency Virus-1 Protein Synthesis and Is Cleaved upon Viral Infection	PLOS ONE			English	Article							FACTOR 2-ALPHA KINASE; INITIATION-FACTOR 4G; POLY(A)-BINDING PROTEIN; HIV-1 PROTEASE; POLY(A)-DEPENDENT TRANSLATION; DROSOPHILA-MELANOGASTER; EFFICIENT CLEAVAGE; MAMMALIAN-CELLS; BINDING-PROTEIN; GENE-EXPRESSION	The reversible phosphorylation of the alpha-subunit of eukaryotic translation initiation factor 2 (eIF2alpha) is a well-characterized mechanism of translational control in response to a wide variety of cellular stresses, including viral infection. Beside PKR, the eIF2alpha kinase GCN2 participates in the cellular response against viral infection by RNA viruses with central nervous system tropism. PKR has also been involved in the antiviral response against HIV-1, although this antiviral effect is very limited due to the distinct mechanisms evolved by the virus to counteract PKR action. Here we report that infection of human cells with HIV-1 conveys the proteolytic cleavage of GCN2 and that purified HIV-1 and HIV-2 proteases produce direct proteolysis of GCN2 in vitro, abrogating the activation of GCN2 by HIV-1 RNA. Transfection of distinct cell lines with a plasmid encoding an HIV-1 cDNA clone competent for a single round of replication resulted in the activation of GCN2 and the subsequent eIF2alpha phosphorylation. Moreover, transfection of GCN2 knockout cells or cells with low levels of phosphorylated eIF2alpha with the same HIV-1 cDNA clone resulted in a marked increase of HIV-1 protein synthesis. Also, the over-expression of GCN2 in cells led to a diminished viral protein synthesis. These findings suggest that viral RNA produced during HIV-1 infection activates GCN2 leading to inhibition of viral RNA translation, and that HIV-1 protease cleaves GCN2 to overcome its antiviral effect.	[del Pino, Javier; Ventoso, Ivan; Castello, Alfredo; de Haro, Cesar; Jose Berlanga, Juan] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Luis Jimenez, Jose] Hosp Gen Univ Gregorio Maranon, Plataforma Lab, Madrid, Spain; [Angeles Munoz-Fernandez, Ma] Hosp Gen Univ Gregorio Maranon, Lab Mol Immunobiol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital	Berlanga, JJ (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain.	jberlanga@cbm.uam.es	Jiménez, José Luis/AAK-6193-2020; Ventoso, Iván/N-4018-2014; Castello, Alfredo/U-6317-2018; Palomares, Alfredo Castello/K-8062-2019; Berlanga, Juan José/N-1718-2015	Jiménez, José Luis/0000-0001-6187-6223; Ventoso, Iván/0000-0001-7887-3520; Castello, Alfredo/0000-0002-1499-4662; Palomares, Alfredo Castello/0000-0002-1499-4662; Berlanga, Juan José/0000-0002-2408-6561; Munoz-Fernandez/0000-0002-0813-4500	Direccion General de Investigacion Cientifica y Tecnica (DGICYT) [BFU2007-62987, BFU2006-12822]; Fundacion Ramon Areces; Universidad Autonoma de Madrid and the Government of Madrid [PS09-02029, RD06-0006-0035]; Fondo de Investigaciones Sanitarias [PS09-02029, RD06-0006-0035, PI081495]; Ministerio de Ciencia y Tecnologia (Government of Spain); Programa de Investigacion de la Consejeria de Sanidad de la Comunidad de Madrid	Direccion General de Investigacion Cientifica y Tecnica (DGICYT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; Universidad Autonoma de Madrid and the Government of Madrid; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Ciencia y Tecnologia (Government of Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Programa de Investigacion de la Consejeria de Sanidad de la Comunidad de Madrid	This work was supported in part by grants BFU2007-62987 (to CDH) BFU2006-12822 and BFU2009-09469 (to JJB) from the Direccion General de Investigacion Cientifica y Tecnica (DGICYT), a grant from the Fundacion Ramon Areces (to CDH), a grant from Universidad Autonoma de Madrid and the Government of Madrid (to JJB), grants PS09-02029 and RD06-0006-0035 (to MAM-F) and PI081495 (to JLJ) from Fondo de Investigaciones Sanitarias, and an institutional grant from the Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa. JDP was supported by a Ph.D. fellowship from the Ministerio de Ciencia y Tecnologia (Government of Spain). JLJ is supported by Programa de Investigacion de la Consejeria de Sanidad de la Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABE R, 1995, BIOCHEM BIOPH RES CO, V215, P928, DOI 10.1006/bbrc.1995.2553; Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Balvay L, 2007, NAT REV MICROBIOL, V5, P128, DOI 10.1038/nrmicro1599; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Berlanga JJ, 1998, J BIOL CHEM, V273, P32340, DOI 10.1074/jbc.273.48.32340; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Castello A, 2006, J MOL BIOL, V355, P942, DOI 10.1016/j.jmb.2005.11.024; Castello A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007997; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Chonco L, 2012, J CONTROL RELEASE, V161, P949, DOI 10.1016/j.jconrel.2012.04.050; Clerzius G, 2011, REV MED VIROL, V21, P42, DOI 10.1002/rmv.674; Clerzius G, 2009, J VIROL, V83, P10119, DOI 10.1128/JVI.02457-08; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Gelinas JF, 2011, J VIROL, V85, P8460, DOI 10.1128/JVI.00240-11; Gordon-Alonso M, 2012, J IMMUNOL, V189, P689, DOI 10.4049/jimmunol.1103708; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002; Li XH, 2010, MOL CELL BIOCHEM, V339, P127, DOI 10.1007/s11010-009-0376-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAITRA RK, 1994, VIROLOGY, V204, P823, DOI 10.1006/viro.1994.1601; Ohlmann T, 2002, J MOL BIOL, V318, P9, DOI 10.1016/S0022-2836(02)00070-0; Perez MAS, 2010, J PHYS CHEM B, V114, P2525, DOI 10.1021/jp910958u; Pomar N, 2003, EUR J BIOCHEM, V270, P293, DOI 10.1046/j.1432-1033.2003.03383.x; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; RITTENHOUSE J, 1990, BIOCHEM BIOPH RES CO, V171, P60, DOI 10.1016/0006-291X(90)91356-W; Santoyo J, 1997, J BIOL CHEM, V272, P12544, DOI 10.1074/jbc.272.19.12544; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; Ventoso I, 2010, J VIROL, V84, P5043, DOI 10.1128/JVI.02188-09; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Zhan K, 2002, MOL CELL BIOL, V22, P7134, DOI 10.1128/MCB.22.20.7134-7146.2002	49	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47272	10.1371/journal.pone.0047272	http://dx.doi.org/10.1371/journal.pone.0047272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110064	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000310193600011
J	Matulova, M; Rajova, J; Vlasatikova, L; Volf, J; Stepanova, H; Havlickova, H; Sisak, F; Rychlik, I				Matulova, Marta; Rajova, Jana; Vlasatikova, Lenka; Volf, Jiri; Stepanova, Hana; Havlickova, Hana; Sisak, Frantisek; Rychlik, Ivan			Characterization of Chicken Spleen Transcriptome after Infection with Salmonella enterica Serovar Enteritidis	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE PLAYS; IMMUNE-RESPONSE; CELL-SURFACE; EXPRESSION; TYPHIMURIUM; LIPOCALIN; RECEPTOR; AVIDIN; GENE; MACROPHAGES	In this study we were interested in identification of new markers of chicken response to Salmonella Enteritidis infection. To reach this aim, gene expression in the spleens of naive chickens and those intravenously infected with S. Enteritidis with or without previous oral vaccination was determined by 454 pyrosequencing of splenic mRNA/cDNA. Forty genes with increased expression at the level of transcription were identified. The most inducible genes encoded avidin (AVD), extracellular fatty acid binding protein (EXFABP), immune responsive gene 1 (IRG1), chemokine ah221 (AH221), trappin-6-like protein (TRAP6) and serum amyloid A (SAA). Using cDNA from sorted splenic B-lymphocytes, macrophages, CD4, CD8 and gamma delta T-lymphocytes, we found that the above mentioned genes were preferentially expressed in macrophages. AVD, EXFABP, IRG1, AH221, TRAP6 and SAA were induced also in the cecum of chickens orally infected with S. Enteritidis on day 1 of life or day 42 of life. Unusual results were obtained for the immunoglobulin encoding transcripts. Prior to the infection, transcripts coding for the constant parts of IgM, IgY, IgA and Ig light chain were detected in B-lymphocytes. However, after the infection, immunoglobulin encoding transcripts were expressed also by T-lymphocytes and macrophages. Expression of AVD, EXFABP, IRG1, AH221, TRAP6, SAA and all immunoglobulin genes can be therefore used for the characterization of the course of S. Enteritidis infection in chickens.	[Matulova, Marta; Rajova, Jana; Vlasatikova, Lenka; Volf, Jiri; Stepanova, Hana; Havlickova, Hana; Sisak, Frantisek; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic	Czech Veterinary Research Institute	Rychlik, I (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	Štěpánová, Hana/GPG-3735-2022; , Ivan/GPS-9674-2022	, Ivan/0000-0001-7995-6483	Czech Ministry of Agriculture [MZE0002716202]; Czech Ministry of Education [CZ.1.05/2.1.00/01.0006-ED0006/01/01]; Czech Science Foundation [P502/12/0303]	Czech Ministry of Agriculture(Ministry of Agriculture, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This work has been supported by the project MZE0002716202 of the Czech Ministry of Agriculture, AdmireVet project CZ.1.05/2.1.00/01.0006-ED0006/01/01 from the Czech Ministry of Education and Czech Science Foundation project P502/12/0303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler T, 2006, J LEUKOCYTE BIOL, V79, P628, DOI 10.1189/jlb.0905520; Beal RK, 2006, INFECT IMMUN, V74, P1442, DOI 10.1128/IAI.74.2.1442-1444.2006; Beal RK, 2004, VET IMMUNOL IMMUNOP, V100, P151, DOI 10.1016/j.vetimm.2004.04.005; Beal RK, 2004, AVIAN PATHOL, V33, P25, DOI 10.1080/03079450310001636282; Berndt A, 2007, INFECT IMMUN, V75, P5993, DOI 10.1128/IAI.00695-07; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Campbell EJ, 2000, J IMMUNOL, V165, P3366, DOI 10.4049/jimmunol.165.6.3366; Cancedda FD, 1996, J BIOL CHEM, V271, P20163, DOI 10.1074/jbc.271.33.20163; Cancedda FD, 2002, MOL CELL BIOCHEM, V239, P221, DOI 10.1023/A:1020548118241; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOK GP, 1995, INT IMMUNOL, V7, P89, DOI 10.1093/intimm/7.1.89; Correnti C, 2011, STRUCTURE, V19, P1796, DOI 10.1016/j.str.2011.09.019; Coudevylle N, 2011, BIOCHEMISTRY-US, V50, P9192, DOI 10.1021/bi201115q; Coudevylle N, 2010, J BIOL CHEM, V285, P41646, DOI 10.1074/jbc.M110.123331; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; Di Marco E, 2003, J CELL PHYSIOL, V196, P464, DOI 10.1002/jcp.10310; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; DOZIN B, 1992, J BIOL CHEM, V267, P2979; ELO HA, 1980, EXPERIENTIA, V36, P312, DOI 10.1007/BF01952296; Furutani Y, 1998, J BIOCHEM-TOKYO, V124, P491, DOI 10.1093/oxfordjournals.jbchem.a022140; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; KEMP DJ, 1980, P NATL ACAD SCI-BIOL, V77, P2876, DOI 10.1073/pnas.77.5.2876; KORPELA J, 1984, EUR J CELL BIOL, V33, P105; Marikovsky M, 2003, J IMMUNOL, V170, P2993, DOI 10.4049/jimmunol.170.6.2993; Marikovsky M, 2002, INT J CANCER, V97, P34, DOI 10.1002/ijc.1565; Matulova M, 2012, VACCINE, V30, P2090, DOI 10.1016/j.vaccine.2012.01.050; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032346; Miura Y, 1998, BLOOD, V92, P2815, DOI 10.1182/blood.V92.8.2815.420k09_2815_2822; Nagai Y, 2002, BLOOD, V99, P1699, DOI 10.1182/blood.V99.5.1699; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Pasare C, 1999, EUR J IMMUNOL, V29, P1219, DOI 10.1002/(SICI)1521-4141(199904)29:04&lt;1219::AID-IMMU1219&gt;3.0.CO;2-H; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rozen S, 2000, Methods Mol Biol, V132, P365; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; STAVNEZER J, 1986, J IMMUNOL, V137, P3978; Tremblay GM, 2002, CHEST, V121, P582, DOI 10.1378/chest.121.2.582; Zerega B, 2004, MATRIX BIOL, V23, P35, DOI 10.1016/j.matbio.2004.02.002; Zerega B, 2001, J CELL SCI, V114, P1473	40	58	60	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e48101	10.1371/journal.pone.0048101	http://dx.doi.org/10.1371/journal.pone.0048101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094107	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200059
J	Zhou, WZ; Quah, ST; Verma, CS; Liu, Y; Lane, DP; Brown, CJ				Zhou, Weizhuang; Quah, Soo T.; Verma, Chandra S.; Liu, Yun; Lane, David P.; Brown, Christopher J.			Improved eIF4E Binding Peptides by Phage Display Guided Design: Plasticity of Interacting Surfaces Yield Collective Effects	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; AMINO-ACIDS; CAP; INITIATION; CANCER; CRYSTALLOGRAPHY; REFINEMENT; EXPRESSION; PROTEINS	Eukaryotic initiation factor (eIF)4E is over-expressed in many types of cancer such as breast, head and neck, and lung. A consequence of increased levels of eIF4E is the preferential translation of pro-tumorigenic proteins (e.g. c-Myc and vascular endothelial growth factor) and as a result is regarded as a potential therapeutic target. In this work a novel phage display peptide has been isolated against eIF4E. From the phage sequence two amino acids were delineated which improved binding when substituted into the eIF4G1 sequence. Neither of these substitutions were involved in direct interactions with eIF4E and acted either via optimization of the helical capping motif or restricting the conformational flexibility of the peptide. In contrast, substitutions of the remaining phage derived amino acids into the eIF4G1 sequence disrupted binding of the peptide to eIF4E. Interestingly when some of these disruptive substitutions were combined with key mutations from the phage peptide, they lead to improved affinities. Atomistic computer simulations revealed that the phage and the eIF4G1 derivative peptide sequences differ subtly in their interaction sites on eIF4E. This raises the issue, especially in the context of planar interaction sites such as those exhibited by eIF4E, that given the intricate plasticity of protein surfaces, the construction of structure-activity relationships should account for the possibility of significant movement in the spatial positioning of the peptide binding interface, including significant librational motions of the peptide.	[Zhou, Weizhuang; Verma, Chandra S.; Liu, Yun] ASTAR, Bioinformat Inst, Singapore, Singapore; [Quah, Soo T.; Lane, David P.; Brown, Christopher J.] ASTAR, Lab P53, Singapore, Singapore; [Verma, Chandra S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Verma, Chandra S.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Verma, CS (corresponding author), ASTAR, Bioinformat Inst, Singapore, Singapore.	chandra@bii.a-star.edu.sg; cjbrown@p53lab.a-star.edu.sg		Liu, Yun/0000-0003-4079-8275; Zhou, Weizhuang/0000-0003-4228-8201; Lane, David/0000-0003-0551-3545				Blagden SP, 2011, NAT REV CLIN ONCOL, V8, P280, DOI 10.1038/nrclinonc.2011.16; Bolhassani A, 2011, BBA-REV CANCER, V1816, P232, DOI 10.1016/j.bbcan.2011.07.006; Brown CJ, 2011, J MOL BIOL, V405, P736, DOI 10.1016/j.jmb.2010.10.045; Brown CJ, 2009, CELL CYCLE, V8, P1905, DOI 10.4161/cc.8.12.8742; Case D. A., 2010, AMBERTOOLS15 AMBER; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daniels TR, 2011, BIOCH BIOPHYS ACTA; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; Doig AJ, 1997, PROTEIN SCI, V6, P147; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Graff JR, 2003, CLIN EXP METASTAS, V20, P265, DOI 10.1023/A:1022943419011; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; Kim YW, 2011, NAT PROTOC, V6, P761, DOI 10.1038/nprot.2011.324; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Macias AT, 2005, J COMPUT CHEM, V26, P1452, DOI 10.1002/jcc.20281; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Montanaro L, 2004, CELL CYCLE, V3, P1387, DOI 10.4161/cc.3.11.1251; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sillerud LO, 2005, CURR PROTEIN PEPT SC, V6, P151, DOI 10.2174/1389203053545462; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Worth CL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-161	31	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47235	10.1371/journal.pone.0047235	http://dx.doi.org/10.1371/journal.pone.0047235			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094039	Green Published, gold			2022-12-27	WOS:000310050200018
J	Chen, LH; Hu, W; Tan, SL; Wang, M; Ma, ZB; Zhou, SY; Deng, XM; Zhang, Y; Huang, C; Yang, GX; He, GY				Chen, Lihong; Hu, Wei; Tan, Shenglong; Wang, Min; Ma, Zhanbing; Zhou, Shiyi; Deng, Xiaomin; Zhang, Yang; Huang, Chao; Yang, Guangxiao; He, Guangyuan			Genome-Wide Identification and Analysis of MAPK and MAPKK Gene Families in Brachypodium distachyon	PLOS ONE			English	Article							PROTEIN-KINASE CASCADE; SALT STRESS; ENHANCES SENSITIVITY; ARABIDOPSIS; TRANSCRIPTION; EXPRESSION; ETHYLENE; PATHWAY; PLANTS; MPK4	MAPK cascades are universal signal transduction modules and play important roles in plant growth, development and in response to a variety of biotic and abiotic stresses. Although MAPKs and MAPKKs have been systematically investigated in several plant species including Arabidopsis, rice and poplar, no systematic analysis has been conducted in the emerging monocot model plant Brachypodium distachyon. In the present study, a total of 16 MAPK genes and 12 MAPKK genes were identified from B. distachyon. An analysis of the genomic evolution showed that both tandem and segment duplications contributed significantly to the expansion of MAPK and MAPKK families. Evolutionary relationships within subfamilies were supported by exon-intron organizations and the architectures of conserved protein motifs. Synteny analysis between B. distachyon and the other two plant species of rice and Arabidopsis showed that only one homolog of B. distachyon MAPKs was found in the corresponding syntenic blocks of Arabidopsis, while 13 homologs of B. distachyon MAPKs and MAPKKs were found in that of rice, which was consistent with the speciation process of the three species. In addition, several interactive protein pairs between the two families in B. distachyon were found through yeast two hybrid assay, whereas their orthologs of a pair in Arabidopsis and other plant species were not found to interact with each other. Finally, expression studies of closely related family members among B. distachyon, Arabidopsis and rice showed that even recently duplicated representatives may fulfill different functions and be involved in different signal pathways. Taken together, our data would provide a foundation for evolutionary and functional characterization of MAPK and MAPKK gene families in B. distachyon and other plant species to unravel their biological roles.	[Chen, Lihong; Hu, Wei; Wang, Min; Ma, Zhanbing; Zhou, Shiyi; Deng, Xiaomin; Zhang, Yang; Huang, Chao; Yang, Guangxiao; He, Guangyuan] HUST, Coll Life Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Genet Engn Int Cooperat Base Chinese Minist Sci &, Wuhan, Peoples R China; [Tan, Shenglong] HUST, Sch Comp Sci & Technol, Serv Comp Technol & Syst Lab, Cluster & Grid Comp Lab, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yang, GX (corresponding author), HUST, Coll Life Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Genet Engn Int Cooperat Base Chinese Minist Sci &, Wuhan, Peoples R China.	ygx@mail.hust.edu.cn; hegy@mail.hust.edu.cn	tan, sheng/GSN-2599-2022		Key Projects of International Cooperation of Chinese Ministry of Science and Technology [2009DFB20290, 2009DFB30340]; National Project of Oceanic and Public welfare Industry of China [201005013]; Chinese State Council Special Major Programs [2009ZX08016-001A]	Key Projects of International Cooperation of Chinese Ministry of Science and Technology; National Project of Oceanic and Public welfare Industry of China; Chinese State Council Special Major Programs	This study was financially supported by the Key Projects of International Cooperation of Chinese Ministry of Science and Technology (2009DFB20290 and 2009DFB30340, http://www.cistc.gov.cn/englishversion/), National Project of Oceanic and Public welfare Industry of China (201005013, http://www.most.gov.cn/eng/programmes1/) and the Chinese State Council Special Major Programs (2009ZX08016-001A, http://www.most.gov.cn/eng/programmes1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2001, EMBO J, V20, P1051, DOI 10.1093/emboj/20.5.1051; Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Beck M, 2011, NEW PHYTOL, V189, P1069, DOI 10.1111/j.1469-8137.2010.03565.x; Beck M, 2010, PLANT CELL, V22, P755, DOI 10.1105/tpc.109.071746; Bevan MW, 2010, CURR OPIN BIOTECH, V21, P211, DOI 10.1016/j.copbio.2010.03.006; Boudsocq M, 2005, PLANT PHYSIOL, V138, P1185, DOI 10.1104/pp.105.061275; Chen T, 2012, PLANT CELL, V24, P823, DOI 10.1105/tpc.112.095984; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Gudesblat GE, 2007, NEW PHYTOL, V173, P713, DOI 10.1111/j.1469-8137.2006.01953.x; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jang CS, 2006, PLANT PHYSIOL, V142, P1148, DOI 10.1104/pp.106.082891; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Jung KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003337; Kong FL, 2012, GENE, V499, P108, DOI 10.1016/j.gene.2012.01.048; Kumar Sachin, 2009, BMC Res Notes, V2, P93, DOI 10.1186/1756-0500-2-93; Lee SK, 2011, J BIOSCIENCES, V36, P139, DOI 10.1007/s12038-011-9002-8; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Ohme-Takagi M, 2000, PLANT CELL PHYSIOL, V41, P1187, DOI 10.1093/pcp/pcd057; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Qiu JL, 2008, PLANT PHYSIOL, V148, P212, DOI 10.1104/pp.108.120006; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Takahashi Y, 2010, PLANT CELL PHYSIOL, V51, P1766, DOI 10.1093/pcp/pcq135; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wilson C, 1997, PLANT CELL, V9, P2093, DOI 10.1105/tpc.9.11.2093; Wise RA, 2007, CHEST, V132, P1191, DOI 10.1378/chest.07-0455; Xu J, 2008, J BIOL CHEM, V283, P26996, DOI 10.1074/jbc.M801392200; Yoo SD, 2008, PLANT SIGNAL BEHAV, V3, P848, DOI 10.4161/psb.3.10.5995; Zeng QN, 2011, PLANT J, V67, P895, DOI 10.1111/j.1365-313X.2011.04642.x; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032153; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439	55	47	60	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46744	10.1371/journal.pone.0046744	http://dx.doi.org/10.1371/journal.pone.0046744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082129	Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900024
J	Devjak, R; Tacer, KF; Juvan, P; Klun, IV; Rozman, D; Bokal, EV				Devjak, Rok; Tacer, Klementina Fon; Juvan, Peter; Klun, Irma Virant; Rozman, Damjana; Bokal, Eda Vrtacnik			Cumulus Cells Gene Expression Profiling in Terms of Oocyte Maturity in Controlled Ovarian Hyperstimulation Using GnRH Agonist or GnRH Antagonist	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; SERINE-PROTEASE INHIBITOR-E2; GRANULOSA-CELLS; EXTRACELLULAR-MATRIX; GROWTH-FACTORS; ANDROGEN RECEPTOR; FSH RECEPTOR; GONADOTROPIN; CETRORELIX; STIMULATION	In in vitro fertilization (IVF) cycles controlled ovarian hyperstimulation (COH) is established by gonadotropins in combination with gonadotropin-releasing hormone (GnRH) agonists or antagonists, to prevent premature luteinizing hormone (LH) surge. The aim of our study was to improve the understanding of gene expression profile of cumulus cells (CC) in terms of ovarian stimulation protocol and oocyte maturity. We applied Affymetrix gene expression profiling in CC of oocytes at different maturation stages using either GnRH agonists or GnRH antagonists. Two analyses were performed: the first involved CC of immature metaphase I (MI) and mature metaphase II (MII) oocytes where 359 genes were differentially expressed, and the second involved the two GnRH analogues where no differentially expressed genes were observed at the entire transcriptome level. A further analysis of 359 differentially genes was performed, focusing on anti-Mullerian hormone receptor 2 (AMHR2), follicle stimulating hormone receptor (FSHR), vascular endothelial growth factor C (VEGFC) and serine protease inhibitor E2 (SERPINE2). Among other differentially expressed genes we observed a marked number of new genes connected to cell adhesion and neurotransmitters such as dopamine, glycine and gamma-Aminobutyric acid (GABA). No differential expression in CC between the two GnRH analogues supports the findings of clinical studies where no significant difference in live birth rates between both GnRH analogues has been proven.	[Devjak, Rok; Klun, Irma Virant; Bokal, Eda Vrtacnik] Univ Med Ctr Ljubljana, Dept Obstet & Gynecol, Div Reprod Med, Ljubljana, Slovenia; [Tacer, Klementina Fon; Juvan, Peter; Rozman, Damjana] Univ Ljubljana, Fac Med, Inst Biochem, Ctr Funct Genom & Biochips, Ljubljana 61000, Slovenia; [Tacer, Klementina Fon] Univ Ljubljana, Fac Vet, Inst Hyg & Pathol Anim Nutr, Ljubljana, Slovenia	University Medical Centre Ljubljana; University of Ljubljana; University of Ljubljana	Bokal, EV (corresponding author), Univ Med Ctr Ljubljana, Dept Obstet & Gynecol, Div Reprod Med, Ljubljana, Slovenia.	eda.bokal@guest.arnes.si		Rozman, Damjana/0000-0002-6501-2163; Juvan, Peter/0000-0003-2873-5247	Slovenian Research Agency [P1-0104, L3-4162]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency (www.arrs.gov.si) grants P1-0104 and L3-4162. Rok Devjak is funded as young researcher by Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2002, FERTIL STERIL, V78, P1164, DOI 10.1016/S0015-0282(02)04242-5; Al-Inany HG, 2011, HUM REPROD UPDATE, V17, P435, DOI 10.1093/humupd/dmr004; Al-Inany HG, 2009, GONADOTROPHIN RELEAS; Albano C, 2000, HUM REPROD, V15, P526, DOI 10.1093/humrep/15.3.526; Andersen CY, 2010, HUM REPROD, V25, P1282, DOI 10.1093/humrep/deq019; Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Assou S, 2011, HUM REPROD UPDATE, V17, P272, DOI 10.1093/humupd/dmq036; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Bedard J, 2003, MOL REPROD DEV, V64, P152, DOI 10.1002/mrd.10239; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berditchevski F, 2001, J CELL SCI, V114, P4143; BODIS J, 1992, FERTIL STERIL, V57, P1008; BODIS J, 1992, GYNECOL OBSTET INVES, V33, P165, DOI 10.1159/000294873; Bokal EV, 2005, HUM REPROD, V20, P1562, DOI 10.1093/humrep/deh789; Cao MJ, 2006, MATRIX BIOL, V25, P342, DOI 10.1016/j.matbio.2006.05.005; Cao MJ, 2006, REPRODUCTION, V131, P125, DOI 10.1530/rep.1.00849; Catteau-Jonard S, 2008, J CLIN ENDOCR METAB, V93, P4456, DOI 10.1210/jc.2008-1231; DIEDRICH K, 1994, HUM REPROD, V9, P788, DOI 10.1093/oxfordjournals.humrep.a138597; Diedrich K, 2001, SEMIN REPROD MED, V19, P213, DOI 10.1055/s-2001-18040; Duffy DM, 2005, J CLIN ENDOCR METAB, V90, P1021, DOI 10.1210/jc.2004-1229; Einspanier R, 1999, J REPROD FERTIL, P359; Felberbaum R, 1996, J ASSIST REPROD GEN, V13, P216, DOI 10.1007/BF02065939; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fleiss JL, 1999, DESIGN ANAL CLIN EXP; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gomez R, 2006, ENDOCRINOLOGY, V147, P5400, DOI 10.1210/en.2006-0657; Goossens K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-1; Grondahl ML, 2011, REPROD BIOMED ONLINE, V22, P389, DOI 10.1016/j.rbmo.2010.12.005; Haouzi D, 2009, HUM REPROD, V24, P2868, DOI 10.1093/humrep/dep263; Hayden C, 2008, EUR J ENDOCRINOL, V159, pS17, DOI 10.1530/EJE-08-0354; Jaatinen R, 1996, J CLIN ENDOCR METAB, V81, P3877, DOI 10.1210/jc.81.11.3877; Jozwik M, 2006, HUM REPROD, V21, P2776, DOI 10.1093/humrep/del038; Kawashima I, 2008, REPRODUCTION, V136, P9, DOI 10.1530/REP-08-0074; Keith L, 2002, INT J FERTIL WOMEN M, V47, P254; Kolibianakis EM, 2006, HUM REPROD UPDATE, V12, P651, DOI 10.1093/humupd/dml038; Laitinen M, 1997, ENDOCRINOLOGY, V138, P4748, DOI 10.1210/en.138.11.4748; Li QL, 2008, MOL HUM REPROD, V14, P673, DOI 10.1093/molehr/gan064; Ludwig M, 2000, ARCH GYNECOL OBSTET, V264, P29, DOI 10.1007/PL00007479; Ludwig M, 2001, Arch Gynecol Obstet, V265, P175, DOI 10.1007/s00404-001-0267-2; Maman E, 2011, MOL HUM REPROD, V17, P399, DOI 10.1093/molehr/gar010; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Mayerhofer A, 1998, P NATL ACAD SCI USA, V95, P10990, DOI 10.1073/pnas.95.18.10990; McElroy SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010979; Nielsen ME, 2010, MOL HUM REPROD, V17, P63; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Ouandaogo ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027179; Regassa A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-57; Rodgers RJ, 2003, REPRODUCTION, V126, P415, DOI 10.1530/rep.0.1260415; Salhab M, 2011, THERIOGENOLOGY, V75, P90, DOI 10.1016/j.theriogenology.2010.07.014; SCHMUTZLER R K, 1988, Human Reproduction (Oxford), V3, P29; Slomczynska M, 2001, FOLIA HISTOCHEM CYTO, V39, P9; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visser JA, 2006, REPRODUCTION, V131, P1, DOI 10.1530/rep.1.00529; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015; Yung Y, 2010, MOL CELL ENDOCRINOL, V328, P104, DOI 10.1016/j.mce.2010.07.019	58	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47106	10.1371/journal.pone.0047106	http://dx.doi.org/10.1371/journal.pone.0047106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082142	Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900037
J	Hanoch, Y; Gummerum, M; Rolison, J				Hanoch, Yaniv; Gummerum, Michaela; Rolison, Jonathan			Second-to-Fourth Digit Ratio and Impulsivity: A Comparison between Offenders and Nonoffenders	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SENSATION SEEKING; RISK-TAKING; TESTOSTERONE; PERSONALITY; ASSOCIATION; INMATES; SAMPLE; AGGRESSION; EDUCATION	Personality characteristics, particularly impulsive tendencies, have long been conceived as the primary culprit in delinquent behavior. One crucial question to emerge from this line of work is whether impulsivity has a biological basis. To test this possibility, 44 male offenders and 46 nonoffenders completed the Eysenck Impulsivity Questionnaire, and had their 2D:4D ratio measured. Offenders exhibited smaller right hand digit ratio measurements compared to non-offenders, but higher impulsivity scores. Both impulsivity and 2D:4D ratio measurements significantly predicted criminality (offenders vs. nonoffenders). Controlling for education level, the 2D:4D ratio measurements had remained a significant predictor of criminality, while impulsivity scores no longer predicted criminality significantly. Our data, thus, indicates that impulsivity but not 2D:4D ratio measurements relate to educational attainment. As offenders varied in their number of previous convictions and the nature of their individual crimes, we also tested for differences in 2D:4D ratio and impulsivity among offenders. Number of previous convictions did not correlate significantly with the 2D:4D ratio measurements or impulsivity scores. Our study established a link between a biological marker and impulsivity among offenders (and lack thereof among non-offenders), which emphasise the importance of studying the relationship between biological markers, impulsivity and criminal behavior.	[Hanoch, Yaniv; Gummerum, Michaela] Univ Plymouth, Sch Psychol, Cognit Inst, Plymouth PL4 8AA, Devon, England; [Rolison, Jonathan] Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland	University of Plymouth; Queens University Belfast	Hanoch, Y (corresponding author), Univ Plymouth, Sch Psychol, Cognit Inst, Plymouth PL4 8AA, Devon, England.	yaniv.hanoch@plymouth.ac.uk		Hanoch, Yaniv/0000-0001-9453-4588				Aluja A, 2005, NEUROPSYCHOBIOLOGY, V51, P28, DOI 10.1159/000082852; Aluja A, 2009, J PSYCHIATR RES, V43, P906, DOI 10.1016/j.jpsychires.2008.11.008; Anderson DA, 1999, J LAW ECON, V42, P611, DOI 10.1086/467436; Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; Barratt E. S., 1985, ADV PERSONALITY ASSE, P113; BARRATT ES, 1983, PERS INDIV DIFFER, V4, P387, DOI 10.1016/0191-8869(83)90004-1; Binder A, 1987, HDB JUVENILE DELINQU, P1032; Blanchard A., 2010, BRIT J FORENSIC PRAC, V12, P23, DOI [10.5042/bjfp.2010.0183, DOI 10.5042/BJFP.2010.0183]; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; EYSENCK SBG, 1978, PSYCHOL REP, V43, P1247, DOI 10.2466/pr0.1978.43.3f.1247; Gordon V, 2011, PSYCHOL CRIME LAW, V17, P305, DOI 10.1080/10683160903203946; Gottfredson M.R., 1990, GEN THEORY CRIME; Hampson E, 2008, ARCH SEX BEHAV, V37, P133, DOI 10.1007/s10508-007-9263-3; Herschl LC, 2012, AM J ADDICTION, V21, P363, DOI 10.1111/j.1521-0391.2012.00246.x; Hiraishi K, 2012, ARCH SEX BEHAV, V41, P711, DOI 10.1007/s10508-011-9889-z; Honekopp J, 2011, PERS INDIV DIFFER, V51, P77, DOI 10.1016/j.paid.2011.03.010; Jaroni JL, 2004, ADDICT BEHAV, V29, P1171, DOI 10.1016/j.addbeh.2004.03.014; Lemiere J, 2010, DEV MED CHILD NEUROL, V52, pE202, DOI 10.1111/j.1469-8749.2010.03684.x; Lochner L, 2004, AM ECON REV, V94, P155, DOI 10.1257/000282804322970751; Lynam DR, 2004, J QUANT CRIMINOL, V20, P319, DOI 10.1007/s10940-004-5867-0; Manning JT, 1998, EVOL HUM BEHAV, V19, P273, DOI 10.1016/S1090-5138(98)00024-5; Manning JT, 2003, EVOL HUM BEHAV, V24, P399, DOI 10.1016/S1090-5138(03)00052-7; Martel MM, 2008, BEHAV NEUROSCI, V122, P273, DOI 10.1037/0735-7044.122.2.273; McDougall C., 2009, EVALUATION HM PRISON; Niv S, 2012, BEHAV GENET, V42, P378, DOI 10.1007/s10519-011-9518-6; Pearson M, 2012, EXPT EC IN PRESS; Roberti JW, 2004, J RES PERS, V38, P256, DOI 10.1016/S0092-6566(03)00067-9; Sapienza P, 2009, P NATL ACAD SCI USA, V106, P15268, DOI 10.1073/pnas.0907352106; Stevenson JC, 2007, AM J HUM BIOL, V19, P41, DOI 10.1002/ajhb.20571	31	26	26	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47140	10.1371/journal.pone.0047140	http://dx.doi.org/10.1371/journal.pone.0047140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082144	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000311146900039
J	Ngo, S; Chiang, V; Ho, E; Le, L; Guo, ZF				Ngo, Sam; Chiang, Vicky; Ho, Elaine; Le, Linh; Guo, Zhefeng			Prion Domain of Yeast Ure2 Protein Adopts a Completely Disordered Structure: A Solid-Support EPR Study	PLOS ONE			English	Article							REVEALS CONFORMATIONAL EQUILIBRIA; LABELED SIDE-CHAINS; RESIDUAL STRUCTURE; SPIN; MOTION; STATE; FIBRILS; CORE; CONSERVATION; DIMENSIONS	Amyloid fibril formation is associated with a range of neurodegenerative diseases in humans, including Alzheimer's, Parkinson's, and prion diseases. In yeast, amyloid underlies several non-Mendelian phenotypes referred to as yeast prions. Mechanism of amyloid formation is critical for a complete understanding of the yeast prion phenomenon and human amyloid-related diseases. Ure2 protein is the basis of yeast prion [URE3]. The Ure2p prion domain is largely disordered. Residual structures, if any, in the disordered region may play an important role in the aggregation process. Studies of Ure2p prion domain are complicated by its high aggregation propensity, which results in a mixture of monomer and aggregates in solution. Previously we have developed a solid-support electron paramagnetic resonance (EPR) approach to address this problem and have identified a structured state for the Alzheimer's amyloid-beta monomer. Here we use solid-support EPR to study the structure of Ure2p prion domain. EPR spectra of Ure2p prion domain with spin labels at every fifth residue from position 10 to position 75 show similar residue mobility profile for denaturing and native buffers after accounting for the effect of solution viscosity. These results suggest that Ure2p prion domain adopts a completely disordered structure in the native buffer. A completely disordered Ure2p prion domain implies that the amyloid formation of Ure2p, and likely other Q/N-rich yeast prion proteins, is primarily driven by inter-molecular interactions.	[Ngo, Sam; Chiang, Vicky; Ho, Elaine; Le, Linh; Guo, Zhefeng] Univ Calif Los Angeles, Inst Mol Biol, Brain Res Inst, Dept Neurol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Guo, ZF (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Brain Res Inst, Dept Neurol, Los Angeles, CA 90024 USA.	zhefeng@ucla.edu	Guo, Zhefeng/A-2069-2013	Guo, Zhefeng/0000-0003-1992-7255	Larry L. Hillblom Foundation [2008-A-005-SUP]	Larry L. Hillblom Foundation	Funding was provided by the Larry L. Hillblom Foundation (Grant 2008-A-005-SUP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Baudin-Baillieu A, 2003, MOL BIOL CELL, V14, P3449, DOI 10.1091/mbc.e03-01-0007; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Belle V, 2008, PROTEINS, V73, P973, DOI 10.1002/prot.22125; Bond CJ, 1997, P NATL ACAD SCI USA, V94, P13409, DOI 10.1073/pnas.94.25.13409; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Edskes HK, 2002, P NATL ACAD SCI USA, V99, P16384, DOI 10.1073/pnas.162349599; Fei L, 2010, PRION, V4, P9, DOI 10.4161/pri.4.1.10670; Fei L, 2009, J BIOL CHEM, V284, P11134, DOI 10.1074/jbc.M809673200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grigoryants VM, 2000, BIOPHYS J, V78, P2702, DOI 10.1016/S0006-3495(00)76814-7; Gu L, 2012, J BIOL CHEM, V287, P9081, DOI 10.1074/jbc.M111.292086; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; KAWAHARA K, 1966, J BIOL CHEM, V241, P3228; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Kryndushkin DS, 2011, J MOL BIOL, V409, P263, DOI 10.1016/j.jmb.2011.03.067; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lopez CJ, 2009, PROTEIN SCI, V18, P1637, DOI 10.1002/pro.180; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; MATSUMURA M, 1989, SCIENCE, V243, P792, DOI 10.1126/science.2916125; McCoy J, 2011, P NATL ACAD SCI USA, V108, P1331, DOI 10.1073/pnas.1017877108; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Ngo S, 2011, J BIOL CHEM, V286, P29691, DOI 10.1074/jbc.M111.269092; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Pierce MM, 2005, BIOCHEMISTRY-US, V44, P321, DOI 10.1021/bi047964d; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Routledge KE, 2009, J MOL BIOL, V389, P776, DOI 10.1016/j.jmb.2009.04.042; Schneider D. J., 1989, SPIN LABELING THEORY, P1; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Wilchek M, 2003, J BIOCHEM BIOPH METH, V55, P67, DOI 10.1016/S0165-022X(02)00178-1	43	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47248	10.1371/journal.pone.0047248	http://dx.doi.org/10.1371/journal.pone.0047248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077577	Green Submitted, Green Published, gold			2022-12-27	WOS:000310135800035
J	Alvi, AHK; Sayyed, AH; Naeem, M; Ali, M				Alvi, Anwaar H. K.; Sayyed, Ali H.; Naeem, Muhammad; Ali, Muhammad			Field Evolved Resistance in Helicoverpa armigera (Lepidoptera: Noctuidae) to Bacillus thuringiensis Toxin Cry1Ac in Pakistan	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; CROSS-RESISTANCE; DIAMONDBACK MOTH; INHERITANCE; GENETICS; POPULATION; INDOXACARB; MECHANISM; COTTON; CROPS	Helicoverpa armigera (Hubner) is one of the most destructive pests of several field and vegetable crops, with indiscriminate use of insecticides contributing to multiple instances of resistance. In the present study we assessed whether H. armigera had developed resistance to Bt cotton and compared the results with several conventional insecticides. Furthermore, the genetics of resistance was also investigated to determine the inheritance to Cry1Ac resistance. To investigate the development of resistance to Bt cotton, and selected foliar insecticides, H. armigera populations were sampled in 2010 and 2011 in several cotton production regions in Pakistan. The resistance ratios (RR) for Cry1Ac, chlorpyrifos, profenofos, cypermethrin, spinosad, indoxacarb, abamectin and deltamethrin were 580-fold, 320-, 1110-, 1950-, 200-, 380, 690, and 40-fold, respectively, compared with the laboratory susceptible (Lab-PK) population. Selection of the field collected population with Cry1Ac in 2010 for five generations increased RR to 5440-fold. The selection also increased RR for deltamethrin, chlorpyrifos, profenofos, cypermethrin, spinosad, indoxacarb, abamectin to 125-folds, 650-, 2840-, 9830-, 370-, 3090-, 1330-fold. The estimated LC50s for reciprocal crosses were 105 mu g/ml (Cry1Ac-SEL female x Lab-PK male) and 81 g mu g/ml (Lab-PK female x 6Cry1Ac-SEL male) suggesting that the resistance to Cry1Ac was autosomal; the degree of dominance (D-LC) was 0.60 and 0.57 respectively. Mixing of enzyme inhibitors significantly decreased resistance to Cry1Ac suggesting that the resistance to Cry1Ac and other insecticides tested in the present study was primarily metabolic. Resistance to Cry1Ac was probably due to a single but unstable factor suggesting that crop rotation with non-Bt cotton or other crops could reduce the selection pressure for H. armigera and improve the sustainability of Bt cotton.	[Alvi, Anwaar H. K.; Sayyed, Ali H.; Ali, Muhammad] Bahauddin Zakariya Univ, Inst Mol Biol & Biotechnol, Multan, Pakistan; [Alvi, Anwaar H. K.; Naeem, Muhammad] PMAS Arid Agr Univ, Dept Entomol, Rawalpindi, Pakistan	Bahauddin Zakariya University; Arid Agriculture University	Sayyed, AH (corresponding author), Bahauddin Zakariya Univ, Inst Mol Biol & Biotechnol, Multan, Pakistan.	ali_sayyed@outlook.com	Naqvi, Sayyed Hussnain Ali/I-7283-2015		Higher Education Commission of Pakistan; IRSIP (International Research Support Initiative Program)	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); IRSIP (International Research Support Initiative Program)	These studies were part of PhD work by the first author, and sincere thanks are due to the Higher Education Commission of Pakistan for granting a PhD Merit Scholarship to carry out studies at PMAS Arid University, Rawalpindi/BZU, Multan Pakistan and an IRSIP (International Research Support Initiative Program) fellowship for studies at the University of Sussex, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; AHMAD M, 1995, J ECON ENTOMOL, V88, P771, DOI 10.1093/jee/88.4.771; Ahmad M, 2002, PEST MANAG SCI, V58, P203, DOI 10.1021/ps.440; Ahrnad M, 2007, PEST MANAG SCI, V63, P1002, DOI 10.1002/ps.1430; Bourguet D, 2000, J ECON ENTOMOL, V93, P1588, DOI 10.1603/0022-0493-93.6.1588; Carriere Y, 2001, J ECON ENTOMOL, V94, P315, DOI 10.1603/0022-0493-94.2.315; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; FINNEY D J, 1971, P333; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Horowitz AR, 2003, ARCH INSECT BIOCHEM, V54, P177, DOI 10.1002/arch.10115; King ABS, 1994, INSECT PESTS COTTON, P445; LANDE R, 1981, GENETICS, V99, P541; LeOra S, 2003, POLO PLUS; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; McCaffery AR, 1998, PHILOS T R SOC B, V353, P1735, DOI 10.1098/rstb.1998.0326; Sayyed AH, 2000, APPL ENVIRON MICROB, V66, P1509, DOI 10.1128/AEM.66.4.1509-1516.2000; Sayyed AH, 2008, PEST MANAG SCI, V64, P813, DOI 10.1002/ps.1570; Sayyed AH, 2006, PEST MANAG SCI, V62, P1045, DOI 10.1002/ps.1270; Sayyed AH, 2008, J ECON ENTOMOL, V101, P1927, DOI 10.1603/0022-0493-101.6.1927; Shad SA, 2010, PEST MANAG SCI, V66, P839, DOI 10.1002/ps.1950; Sokal R. R., 1981, BIOMETRY; TABASHNIK BE, 1991, J ECON ENTOMOL, V84, P703, DOI 10.1093/jee/84.3.703; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	26	48	49	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47309	10.1371/journal.pone.0047309	http://dx.doi.org/10.1371/journal.pone.0047309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077589	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100090
J	Cheng, SQ; Fan, CG; Sinha, S; Bobik, TA				Cheng, Shouqiang; Fan, Chenguang; Sinha, Sharmistha; Bobik, Thomas A.			The PduQ Enzyme Is an Alcohol Dehydrogenase Used to Recycle NAD(+) Internally within the Pdu Microcompartment of Salmonella enterica	PLOS ONE			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; L-THREONINE KINASE; SHELL PROTEIN; LISTERIA-MONOCYTOGENES; ESCHERICHIA-COLI; COENZYME-A; TYPHIMURIUM; ORGANELLES; ETHANOLAMINE; GENES	Salmonella enterica uses a bacterial microcompartment (MCP) for coenzyme B-12-dependent 1,2-propanediol (1,2-PD) utilization (Pdu). The Pdu MCP consists of a protein shell that encapsulates enzymes and cofactors required for metabolizing 1,2-PD as a carbon and energy source. Here we show that the PduQ protein of S. enterica is an iron-dependent alcohol dehydrogenase used for 1,2-PD catabolism. PduQ is also demonstrated to be a new component of the Pdu MCP. In addition, a series of in vivo and in vitro studies show that a primary function of PduQ is to recycle NADH to NAD(+) internally within the Pdu MCP in order to supply propionaldehyde dehydrogenase (PduP) with its required cofactor (NAD(+)). Genetic tests determined that a pduQ deletion mutant grew slower than wild-type Salmonella on 1,2-PD and that this phenotype was not complemented by a non-MCP associated Adh2 from Zymomonas that catalyzes the same reaction. This suggests that PduQ has a MCP-specific function. We also found that a pduQ deletion mutant had no growth defect in a genetic background having a second mutation that prevents MCP formation which further supports a MCP-specific role for PduQ. Moreover, studies with purified Pdu MCPs demonstrated that the PduQ enzyme can convert NADH to NAD(+) to supply the PduP reaction in vitro. Cumulatively, these studies show that the PduQ enzyme is used to recycle NADH to NAD(+) internally within the Pdu MCP. To our knowledge, this is the first report of internal recycling as a mechanism for cofactor homeostasis within a bacterial MCP.	[Sinha, Sharmistha; Bobik, Thomas A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Cheng, Shouqiang] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Fan, Chenguang] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	Iowa State University; Northwestern University; Feinberg School of Medicine; Yale University	Bobik, TA (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	bobik@iastate.edu	Fan, Cheguang/O-9709-2016; Cheng, Shouqiang/K-6794-2013	Fan, Cheguang/0000-0003-0662-1185; Cheng, Shouqiang/0000-0001-6417-2635; Sinha, Sharmistha/0000-0003-2459-650X	National Institutes of Healt [AI081146]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081146] Funding Source: NIH RePORTER	National Institutes of Healt(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Healt grant AI081146 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; Brinsmade SR, 2005, J BACTERIOL, V187, P8039, DOI 10.1128/JB.187.23.8039-8046.2005; Buchrieser C, 2003, FEMS IMMUNOL MED MIC, V35, P207, DOI 10.1016/S0928-8244(02)00448-0; CHEN P, 1994, J BACTERIOL, V176, P5474, DOI 10.1128/JB.176.17.5474-5482.1994; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Cheng SQ, 2010, J BACTERIOL, V192, P5071, DOI 10.1128/JB.00575-10; Conner CP, 1998, P NATL ACAD SCI USA, V95, P4641, DOI 10.1073/pnas.95.8.4641; Corchero JL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-92; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Fan CG, 2008, J BIOL CHEM, V283, P11322, DOI 10.1074/jbc.M800287200; Fan CG, 2009, J BIOL CHEM, V284, P20240, DOI 10.1074/jbc.M109.027425; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Heithoff DM, 1999, J BACTERIOL, V181, P799, DOI 10.1128/JB.181.3.799-807.1999; JETER RM, 1990, J GEN MICROBIOL, V136, P887, DOI 10.1099/00221287-136-5-887; Johnson CLV, 2001, J BACTERIOL, V183, P1577, DOI 10.1128/JB.183.5.1577-1584.2001; Johnson CLV, 2004, J BACTERIOL, V186, P7881, DOI 10.1128/JB.186.23.7881-7887.2004; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; Kinney JN, 2011, PHOTOSYNTH RES, V109, P21, DOI 10.1007/s11120-011-9624-6; KINOSHITA S, 1985, APPL MICROBIOL BIOT, V22, P249; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Leal NA, 2003, ARCH MICROBIOL, V180, P353, DOI 10.1007/s00203-003-0601-0; Liu Y, 2007, J BACTERIOL, V189, P1589, DOI 10.1128/JB.01151-06; Moon JH, 2011, J MOL BIOL, V407, P413, DOI 10.1016/j.jmb.2011.01.045; Mori K, 1997, BIOSCI BIOTECH BIOCH, V61, P1729, DOI 10.1271/bbb.61.1729; Mori K, 1999, BIOCHEMISTRY-US, V38, P13170, DOI 10.1021/bi9911738; OBRADORS N, 1988, J BACTERIOL, V170, P2159, DOI 10.1128/jb.170.5.2159-2162.1988; Palacios S, 2003, J BACTERIOL, V185, P2802, DOI 10.1128/JB.185.9.2802-2810.2003; Papapostolou D, 2009, MOL BIOSYST, V5, P723, DOI 10.1039/b902440a; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Parsons JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014009; Penrod JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; RONDON MR, 1995, J BACTERIOL, V177, P7119, DOI 10.1128/JB.177.24.7119-7124.1995; RONDON MR, 1995, J BACTERIOL, V177, P5434, DOI 10.1128/jb.177.19.5434-5439.1995; Sambrook J., 2001, MOL CLONING LAB MANU; Sampson EM, 2008, J BACTERIOL, V190, P2966, DOI 10.1128/JB.01925-07; SCHMIEGER H, 1971, MOL GEN GENET, V110, P378, DOI 10.1007/BF00438281; Sinha S, 2012, J BACTERIOL, V194, P1912, DOI 10.1128/JB.06529-11; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tartof K.D., 1987, BETHESDA RES LAB FOC, V9, P12; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wang J, 1998, J AM CHEM SOC, V120, P5793, DOI 10.1021/ja9735970; Warren JW, 2000, PLASMID, V44, P138, DOI 10.1006/plas.2000.1477; Winter SE, 2011, GUT MICROBES, V2, P58, DOI 10.4161/gmic.2.1.14911; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006	64	54	56	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47144	10.1371/journal.pone.0047144	http://dx.doi.org/10.1371/journal.pone.0047144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077559	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100068
J	Lee, AY; Gregorius, J; Kerlan, RK; Gordon, RL; Fidelman, N				Lee, Andrew Y.; Gregorius, John; Kerlan, Robert K., Jr.; Gordon, Roy L.; Fidelman, Nicholas			Percutaneous Transhepatic Balloon Dilation of Biliary-Enteric Anastomotic Strictures after Surgical Repair of Iatrogenic Bile Duct Injuries	PLOS ONE			English	Article							LAPAROSCOPIC CHOLECYSTECTOMY; MANAGEMENT; HEPATICOJEJUNOSTOMY; EXPERIENCE; SURVIVAL; SURGERY	Purpose: To evaluate the efficacy of percutaneous balloon dilation of biliary-enteric anastomotic strictures resulting from surgical repair of laparoscopic cholecystectomy-related bile duct injuries. Material and Methods: A total of 61 patients were referred to our institution from 1995 to 2010 for treatment of obstruction at the biliary-enteric anastomosis following surgical repair of laparoscopic cholecystectomy-related bile duct injuries. Of these 61 patients, 27 underwent surgical revision upon stricture diagnosis, and 34 patients were managed using balloon dilation. Of these 34 patients, 2 were lost to follow up, leaving 32 patients for analysis. The primary study objective was to determine the clinical success rate of balloon dilation of biliary-enteric anastomotic strictures. Secondary study objectives included determining anastomosis patency, rates of stricture recurrence following treatment, and morbidity. Results: Balloon dilation of biliary-enteric anastomotic strictures was clinically successful in 21 of 32 patients (66%). Anastomotic stricture recurred in one of 21 patients (5%) after an average of 13.1 years of follow-up. Patients who were unsuccessfully managed with balloon dilation required significantly more invasive procedures (6.8 v. 3.4; p = 0.02) and were left with an indwelling biliary catheter for a significantly longer period of time (8.8 v. 2.0 months; p = 0.02) than patients whose strictures could be resolved by balloon dilation. No significant differences in the number of balloon dilations performed (p = 0.17) or in the maximum balloon diameter used (p = 0.99) were demonstrated for patients with successful or unsuccessful balloon dilation outcomes. Conclusion: Percutaneous balloon dilation of anastomotic biliary strictures following surgical repair of laparoscopic cholecystectomy-related injuries may result in lasting patency of the biliary-enteric anastomosis.	[Lee, Andrew Y.; Gregorius, John; Kerlan, Robert K., Jr.; Gordon, Roy L.; Fidelman, Nicholas] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Fidelman, N (corresponding author), Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA.	Nicholas.Fidelman@ucsf.edu	Lee, Andrew/GVU-2817-2022					Archer SB, 2001, ANN SURG, V234, P549, DOI 10.1097/00000658-200110000-00014; BISMUTH H, 1982, BILIARY TRACT, V5, P209; Chaudhary A, 2002, DIGEST SURG, V19, P22, DOI 10.1159/000052001; DAVIDS PHP, 1993, ANN SURG, V217, P237, DOI 10.1097/00000658-199303000-00004; de Reuver PR, 2007, SURGERY, V142, P1, DOI 10.1016/j.surg.2007.03.004; DEZIEL DJ, 1993, AM J SURG, V165, P9, DOI 10.1016/S0002-9610(05)80397-6; Fischer CP, 2009, HPB, V11, P32, DOI 10.1111/j.1477-2574.2008.00002.x; Flum DR, 2003, JAMA-J AM MED ASSOC, V290, P2168, DOI 10.1001/jama.290.16.2168; Goykhman Y, 2008, J GASTROINTEST SURG, V12, P1412, DOI 10.1007/s11605-008-0538-3; Johnson SR, 2000, SURGERY, V128, P668, DOI 10.1067/msy.2000.108422; Kocher M, 2007, EUR J RADIOL, V62, P170, DOI 10.1016/j.ejrad.2007.01.032; Lillemoe KD, 2000, ANN SURG, V232, P430, DOI 10.1097/00000658-200009000-00015; MacFadyen BV, 1998, SURG ENDOSC-ULTRAS, V12, P315, DOI 10.1007/s004649900661; Misra S, 2004, J AM COLL SURGEONS, V198, P218, DOI 10.1016/j.jamcollsurg.2003.09.020; PELLEGRINI CA, 1984, AM J SURG, V147, P175, DOI 10.1016/0002-9610(84)90054-0; PITT HA, 1982, AM J SURG, V144, P14, DOI 10.1016/0002-9610(82)90595-5; Stewart L, 2004, J GASTROINTEST SURG, V8, P523, DOI 10.1016/j.gassur.2004.02.010; STEWART L, 1995, ARCH SURG-CHICAGO, V130, P1123; TERBLANCHE J, 1990, SURGERY, V108, P828; Walsh RM, 2004, J AM COLL SURGEONS, V199, P192, DOI 10.1016/j.jamcollsurg.2004.02.029; Yan JQ, 2007, WORLD J GASTROENTERO, V13, P6598, DOI 10.3748/wjg.13.6598	21	17	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e46478	10.1371/journal.pone.0046478	http://dx.doi.org/10.1371/journal.pone.0046478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110053	Green Submitted, gold, Green Published			2022-12-27	WOS:000310262500007
J	Boianelli, A; Bidossi, A; Gualdi, L; Mulas, L; Mocenni, C; Pozzi, G; Vicino, A; Oggioni, MR				Boianelli, Alessandro; Bidossi, Alessandro; Gualdi, Luciana; Mulas, Laura; Mocenni, Chiara; Pozzi, Gianni; Vicino, Antonio; Oggioni, Marco R.			A Non-Linear Deterministic Model for Regulation of Diauxic Lag on Cellobiose by the Pneumococcal Multidomain Transcriptional Regulator CelR	PLOS ONE			English	Article							PNEUMONIAE VIRULENCE FACTORS; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; METABOLISM; GROWTH; GENE; TRANSFORMATION; COLONIZATION; SUBSTRATE; LACTOSE	When grown on glucose and beta-glucosides, S. pneumoniae shows sequential use of sugars resulting in diauxic growth with variable time extent of the lag phase separating the biphasic growth curve. The pneumococcal beta-glucoside uptake locus containing the PTS transporter spr0276-82, is regulated by a multi-domain transcriptional regulator CelR. In this work, we address the contribution of phosphorylation of the phosphorylable cysteine in the EIIB domain of CelR to diauxic lag. Utilising site-directed mutagenesis of the phosphorylable amino acids in the EIIB and EIIA domains of CelR, we show that the EIIB domain activation is linked to the duration of the lag phase. Analysis of mutants for other PTS systems indicates that a second beta-glucoside PTS (spr0505), not able to support growth on cellobiose, is responsible for the lag during diauxic growth. A mathematical model of the process is devised together with a nonlinear identification procedure which provides model parameter estimates characterizing the single phases of bacterial growth. Parameter identification performed on data recorded in appropriate experiments on mutants allows for establishing a relationship between a specific model parameter, the EIIB domain and the time extent of the diauxic lag. The experimental results and the related insights provided by the mathematical model provide evidence that the conflicting activation of the CelR regulator is at the origin of the lag phase during sequential growth on glucose and cellobiose. This data is the first description of diauxic lag regulation involving two PTS and a multidomain regulator and could serve as a promising approach for studying the S. pneumoniae growth process on complex carbon sources as possibly encountered in the human host.	[Bidossi, Alessandro; Gualdi, Luciana; Mulas, Laura; Pozzi, Gianni; Oggioni, Marco R.] Univ Siena, Dept Biotechnol, LAMMB, I-53100 Siena, Italy; [Boianelli, Alessandro; Mocenni, Chiara; Vicino, Antonio] Univ Siena, Dept Informat Engn, Ctr Complex Syst Studies CSC, I-53100 Siena, Italy; [Pozzi, Gianni; Oggioni, Marco R.] Azienda Osped Univ Senese, UOC Batteriol, Siena, Italy	University of Siena; University of Siena; University of Siena; University Hospital of Siena	Oggioni, MR (corresponding author), Univ Siena, Dept Biotechnol, LAMMB, Via Laterina 8, I-53100 Siena, Italy.	oggioni@unisi.it	Pozzi, Gianni/Q-2713-2018; Mocenni, Chiara/X-4424-2019; Mocenni, Chiara/AAU-5018-2021; Oggioni, Marco Rinaldo/K-3839-2016	Pozzi, Gianni/0000-0002-9557-4714; Mocenni, Chiara/0000-0002-1259-6003; Oggioni, Marco Rinaldo/0000-0003-4117-793X; VICINO, Antonio/0000-0002-7969-4054	European Commission [PNEUMOPATH FP7-HEALTH-222983, ADITECH FP7-HEALTH-280873]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The work was in part funded by the European Commission grants PNEUMOPATH FP7-HEALTH-222983 and ADITECH FP7-HEALTH-280873. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Boianelli A, 2011, P 18 WORLD C INT FED, V44, P11773, DOI [10.3182/20110828-6-IT-1002.02372., DOI 10.3182/20110828-6-IT-1002.02372]; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dopazo J, 2001, MICROB DRUG RESIST, V7, P99, DOI 10.1089/10766290152044995; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fu WG, 1999, BIOCHEM ENG J, V3, P163, DOI 10.1016/S1369-703X(99)00014-5; GUILD WR, 1976, J BACTERIOL, V125, P125, DOI 10.1128/JB.125.1.125-135.1976; Hava DL, 2003, MOL MICROBIOL, V50, P1103, DOI 10.1046/j.1365-2958.2003.03764.x; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Iannelli F, 2004, MOL BIOTECHNOL, V26, P81, DOI 10.1385/MB:26:1:81; Inada T, 1996, GENES CELLS, V1, P293, DOI 10.1046/j.1365-2443.1996.24025.x; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; Joyet P, 2010, MOL MICROBIOL, V76, P1279, DOI 10.1111/j.1365-2958.2010.07175.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KOMPALA DS, 1986, BIOTECHNOL BIOENG, V28, P1044, DOI 10.1002/bit.260280715; Kovarova-Kovar K, 1998, MICROBIOL MOL BIOL R, V62, P646; McKessar SJ, 2007, J BACTERIOL, V189, P1342, DOI 10.1128/JB.01170-06; Monod J, 1942, THESIS U PARIS FRANC; Narang A, 1997, CHEM ENG SCI, V52, P2567, DOI 10.1016/S0009-2509(97)00073-0; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; SALLES C, 1992, NUCLEIC ACIDS RES, V20, P6103, DOI 10.1093/nar/20.22.6103; Shafeeq S, 2011, MICROBIOL-SGM, V157, P2854, DOI 10.1099/mic.0.051359-0; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Zeng L, 2009, J BACTERIOL, V191, P2153, DOI 10.1128/JB.01641-08	26	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47393	10.1371/journal.pone.0047393	http://dx.doi.org/10.1371/journal.pone.0047393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110070	Green Submitted, Green Published, gold			2022-12-27	WOS:000310193400009
J	Sathiamoorthy, S; Shin, JA				Sathiamoorthy, Sarmitha; Shin, Jumi A.			Boundaries of the Origin of Replication: Creation of a pET-28a-Derived Vector with p15A Copy Control Allowing Compatible Coexistence with pET Vectors	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; NUCLEOTIDE-SEQUENCE; CLONING VEHICLES; GENE-PRODUCT; COLE1 DNA; RNA-I; PLASMID; NUMBER; PRIMER; CONSTRUCTION	During our studies involving protein-DNA interactions, we constructed plasmid pSAM to fulfill two requirements: 1) to facilitate transfer of cloned sequences from widely used expression vector pET-28a(+), and 2) to provide a vector compatible with pBR322-derived plasmids for use in cells harboring two different plasmids. Vector pSAM is a pET-28a(+)-derived plasmid with the p15A origin of replication (ori); pET-28a(+) contains the pBR322 replicon that is incompatible with other pBR322-derived plasmids. By replacing the original pET-28a(+) replicon-comprising the ori, RNAI, RNAII, and Rom-with the p15A replicon, we generated pSAM, which contains the pET-28a(+) multiple cloning site and is now compatible with pBR322-derived vectors. Plasmid copy number was assessed using quantitative PCR: pSAM copy number was maintained at 18 +/- 4 copies per cell, consistent with that of other p15A-type vectors. Compatibility with pBR322-derived vectors was tested with pGEX-6p-1 and pSAM, which maintained their copy numbers of 49 +/- 10 and 14 +/- 4, respectively, when both were present within the same cell. Swapping of the ori is a common practice; however, it is vital that all regions of the original replicon be removed. Additional vector pSAMRNAI illustrated that incompatibility remains when portions of the replicon, such as RNAI and/or Rom, are retained; pSAMRNAI, which contains the intact RNAI but not ROM, lowered the copy number of pGEX-6p-1 to 18 +/- 2 in doubly transformed cells due to retention of the pET-28a(+)-derived RNAI. Thus, pSAMRNAI is incompatible with vectors controlled by the pBR322 replicon and further demonstrates the need to remove all portions of the original replicon and to quantitatively assess copy number, both individually and in combination, to ensure vector compatibility. To our knowledge, this is the first instance where the nascent vector has been quantitatively assessed for both plasmid copy number and compatibility. New vector pSAM provides ease of transferring sequences from commonly used pET-28a(+) into a vector compatible with the pBR322 family of plasmids. This essential need is currently not filled.	[Sathiamoorthy, Sarmitha; Shin, Jumi A.] Univ Toronto, Dept Chem, Mississauga, ON L5L 1C6, Canada; [Shin, Jumi A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University Toronto Mississauga; University of Toronto	Shin, JA (corresponding author), Univ Toronto, Dept Chem, Mississauga, ON L5L 1C6, Canada.	jumi.shin@utoronto.ca			Collaborative Health Research Project Grant [CHRP 385829]; National Sciences and Engineering Research Council Discovery Grant (NSERC); Canadian Foundation for Innovation/Ontario Innovation Trust New Opportunities Grant [CFI/OIT 7856]; University of Toronto	Collaborative Health Research Project Grant; National Sciences and Engineering Research Council Discovery Grant (NSERC); Canadian Foundation for Innovation/Ontario Innovation Trust New Opportunities Grant; University of Toronto(University of Toronto)	This work was supported by a Collaborative Health Research Project Grant (CHRP 385829, http://www.cihr-irsc.gc.ca/), National Sciences and Engineering Research Council Discovery Grant (NSERC, http://www.nserc-crsng.gc.ca/), Canadian Foundation for Innovation/Ontario Innovation Trust New Opportunities Grant (CFI/OIT 7856), and the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbas Paulina, 2004, Methods Mol Biol, V267, P77; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Burgos JS, 2002, MOL CELL PROBE, V16, P257, DOI 10.1006/mcpr.2002.0419; Camps Manel, 2010, Recent Pat DNA Gene Seq, V4, P58; Carapuca E, 2007, MOL BIOTECHNOL, V37, P120, DOI 10.1007/s12033-007-0007-3; CESARENI G, 1982, P NATL ACAD SCI-BIOL, V79, P6313, DOI 10.1073/pnas.79.20.6313; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHEN ST, 1987, J BACTERIOL, V169, P913, DOI 10.1128/jb.169.2.913-916.1987; CHIANG CS, 1991, PLASMID, V26, P186, DOI 10.1016/0147-619X(91)90042-U; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Fujimura H, 1996, BIOLOGICALS, V24, P67, DOI 10.1006/biol.1996.0007; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hahn FM, 2001, J BACTERIOL, V183, P1, DOI 10.1128/JB.183.1.1-11.2001; Held D., 2003, INNOVATIONS; Hiszczynska-Sawicka E, 1997, PLASMID, V38, P174, DOI 10.1006/plas.1997.1307; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; LACATENA RM, 1981, NATURE, V294, P623, DOI 10.1038/294623a0; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; MOSER DR, 1983, J BACTERIOL, V154, P809, DOI 10.1128/JB.154.2.809-818.1983; NORDSTROM K, 1990, CELL, V63, P1121, DOI 10.1016/0092-8674(90)90405-4; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; PROJAN SJ, 1983, PLASMID, V9, P182, DOI 10.1016/0147-619X(83)90019-7; Pushnova EA, 2000, ANAL BIOCHEM, V284, P70, DOI 10.1006/abio.2000.4668; Schmidt T, 1996, J BIOTECHNOL, V49, P219, DOI 10.1016/0168-1656(96)01519-2; Shahravan SH, 2011, ANAL CHEM, V83, P9643, DOI 10.1021/ac2024602; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAMM J, 1985, P NATL ACAD SCI USA, V82, P2257, DOI 10.1073/pnas.82.8.2257; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Zeng JM, 2010, PROTEIN EXPRES PURIF, V69, P47, DOI 10.1016/j.pep.2009.09.002	34	11	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47259	10.1371/journal.pone.0047259	http://dx.doi.org/10.1371/journal.pone.0047259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110063	Green Published, Green Submitted, gold			2022-12-27	WOS:000310193400008
J	Caldarelli, G; Cristelli, M; Gabrielli, A; Pietronero, L; Scala, A; Tacchella, A				Caldarelli, Guido; Cristelli, Matthieu; Gabrielli, Andrea; Pietronero, Luciano; Scala, Antonio; Tacchella, Andrea			A Network Analysis of Countries' Export Flows: Firm Grounds for the Building Blocks of the Economy	PLOS ONE			English	Article							EVOLUTION; SYSTEMS	In this paper we analyze the bipartite network of countries and products from UN data on country production. We define the country-country and product-product projected networks and introduce a novel method of filtering information based on elements' similarity. As a result we find that country clustering reveals unexpected socio-geographic links among the most competing countries. On the same footings the products clustering can be efficiently used for a bottom-up classification of produced goods. Furthermore we mathematically reformulate the "reflections method'' introduced by Hidalgo and Hausmann as a fixpoint problem; such formulation highlights some conceptual weaknesses of the approach. To overcome such an issue, we introduce an alternative methodology (based on biased Markov chains) that allows to rank countries in a conceptually consistent way. Our analysis uncovers a strong non-linear interaction between the diversification of a country and the ubiquity of its products, thus suggesting the possible need of moving towards more efficient and direct non-linear fixpoint algorithms to rank countries and products in the global market.	[Caldarelli, Guido; Cristelli, Matthieu; Gabrielli, Andrea; Pietronero, Luciano; Scala, Antonio; Tacchella, Andrea] ISC CNR Inst Complex Syst, Rome, Italy; [Caldarelli, Guido] IMT Inst Market Technol, Lucca, Italy; [Caldarelli, Guido; Gabrielli, Andrea; Pietronero, Luciano; Scala, Antonio] LIMS London Inst Math Sci, London, England; [Cristelli, Matthieu; Pietronero, Luciano; Tacchella, Andrea] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); IMT School for Advanced Studies Lucca; Sapienza University Rome	Cristelli, M (corresponding author), ISC CNR Inst Complex Syst, Rome, Italy.	matthieu.cristelli@roma1.infn.it	Scala, Antonio/H-9153-2019; Scala, Antonio/GRS-5823-2022; Caldarelli, Guido/AAB-8206-2022; Pietronero, Luciano/O-4473-2018; Scala, Antonio/A-2098-2012; Gabrielli, Andrea/A-7175-2008; Caldarelli, Guido/A-5274-2010	Scala, Antonio/0000-0002-3414-2686; Pietronero, Luciano/0000-0001-6424-8863; Scala, Antonio/0000-0002-3414-2686; Tacchella, Andrea/0000-0003-3940-9404; Gabrielli, Andrea/0000-0003-3705-7281; Caldarelli, Guido/0000-0001-9377-3616	EU FET Open project FOC [255987]; CNR-PNR National Project "Crisis-Lab''	EU FET Open project FOC; CNR-PNR National Project "Crisis-Lab''	We thank EU FET Open project FOC nr.255987 and CNR-PNR National Project "Crisis-Lab'' for support.	[Anonymous], 2009, MINORITY GAMES, P5588; Arrow KJ, 2010, NATL BUREAU EC RES W; Auconi P, 2011, ORTHOD CRANIOFAC RES, V14, P189, DOI 10.1111/j.1601-6343.2011.01523.x; BALASSA B, 1965, MANCH SCH ECON SOC, V33, P99, DOI 10.1111/j.1467-9957.1965.tb00050.x; Battiston S, 2007, J ECON DYN CONTROL, V31, P2061, DOI 10.1016/j.jedc.2007.01.004; Bellman R., 1997, INTRO MATRIX ANAL; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; BRUN C, 2003, GENOME BIOL, V5; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Caldarelli G., 2007, SCALE FREE NETWORKS; Capocci A, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/28006; Dasgupta P, 2010, POVERTY TRAPS EXPLOR; Dasgupta P, 2009, TECHNICAL REPORT; De Masi G, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066112; Farmer JD, 1999, P NATL ACAD SCI USA, V96, P9991, DOI 10.1073/pnas.96.18.9991; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fu DF, 2005, P NATL ACAD SCI USA, V102, P18801, DOI 10.1073/pnas.0509543102; Gabrielli A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.208701; Galluccio S, 1997, PHYSICA A, V245, P423, DOI 10.1016/S0378-4371(97)00316-6; Garlaschelli D, 2007, NAT PHYS, V3, P813, DOI 10.1038/nphys729; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Johnson N, 2011, NATURE, V469, P302, DOI 10.1038/469302a; Majumder SR, 2009, P NATL ACAD SCI USA, V106, P679, DOI 10.1073/pnas.0805037106; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; MANTEGNA RN, 2000, INTRO ECONOPHYSICS C; Page Lawrence, 1999, 199966 STANF INFOLAB; Podobnik B, 2010, P NATL ACAD SCI; Scala A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044521; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; Shamma J, 2008, COOPERATIVE CONTROL; Stanley HE, 2002, P NATL ACAD SCI USA, V99, P2561, DOI 10.1073/pnas.022582899; Tacchella A, 2012, J EC DYNAMICS UNPUB; Zlatic V, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066109	41	101	103	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47278	10.1371/journal.pone.0047278	http://dx.doi.org/10.1371/journal.pone.0047278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094044	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000310050200020
J	Cardoso, AA; Jiang, YL; Luo, MH; Reed, AM; Shahda, S; He, Y; Maitra, A; Kelley, MR; Fishel, ML				Cardoso, Angelo A.; Jiang, Yanlin; Luo, Meihua; Reed, April M.; Shahda, Safi; He, Ying; Maitra, Anirban; Kelley, Mark R.; Fishel, Melissa L.			APE1/Ref-1 Regulates STAT3 Transcriptional Activity and APE1/Ref-1-STAT3 Dual-Targeting Effectively Inhibits Pancreatic Cancer Cell Survival	PLOS ONE			English	Article							SIGNALING PROTEIN APE1/REF-1; SMALL-MOLECULE INHIBITOR; DNA-REPAIR ENZYME; APURINIC/APYRIMIDINIC ENDONUCLEASE-1; ENHANCED SENSITIVITY; REDOX FUNCTION; TUMOR-GROWTH; ACTIVATION; EXPRESSION; TRANSDUCER	Pancreatic cancer is a largely incurable disease, and increasing evidence supports strategies targeting multiple molecular mediators of critical functions of pancreatic ductal adenocarcinoma cells. Intracellular redox state modulates the activity of various signal transduction pathways and biological processes, including cell survival, drug resistance and responsiveness to microenvironmental factors. Recently, it has been shown that the transcription factor STAT3 is under redox control, but the mechanisms involved in its regulation are unknown. Here, we demonstrate for the first time that STAT3 DNA binding and transcriptional activity is directly regulated by the redox function of the APE1/Ref-1 endonuclease, using overexpression and redox-specific mutational strategies, and gene knockdown. Also, pharmacological blockade of APE1/Ref-1 by the redox-selective inhibitor E3330 abrogates STAT3 DNA binding. Since APE1/Ref-1 also exerts redox control on other cancer-associated transcription factors, we assessed the impact of dual-targeting of STAT3 signaling and APE1/Ref-1 redox on pancreatic cancer cell functions. We observed that disruption of APE1/Ref-1 redox activity synergizes with STAT3 blockade to potently inhibit the proliferation and viability of human PDAC cells. Mechanistically, we show that STAT3-APE1/Ref-1 dual targeting promotes marked tumor cell apoptosis, with engagement of caspase-3 signaling, which are significantly increased in comparison to the effects triggered by single target blockade. Also, we show that STAT3-APE1/Ref-1 dual blockade results in significant inhibition of tumor cell migration. Overall, this work demonstrates that the transcriptional activity of STAT3 is directly regulated by the redox function of APE1/Ref-1, and that concurrent blockade of STAT3 and APE1/Ref-1 redox synergize effectively inhibit critical PDAC cell functions.	[Jiang, Yanlin; Luo, Meihua; Reed, April M.; He, Ying; Kelley, Mark R.; Fishel, Melissa L.] Herman B Wells Ctr Pediat Res, Dept Pediat, Sect Hematol Oncol, Indianapolis, IN USA; [Cardoso, Angelo A.; Shahda, Safi] Indiana Univ Sch Med, Dept Med, Div Hematol Oncol, Indianapolis, IN USA; [Maitra, Anirban] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Kelley, Mark R.; Fishel, Melissa L.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN USA; [Kelley, Mark R.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Johns Hopkins University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Fishel, ML (corresponding author), Herman B Wells Ctr Pediat Res, Dept Pediat, Sect Hematol Oncol, Indianapolis, IN USA.	mfishel@iupui.edu	Fishel, Melissa L./AAH-6608-2020	Fishel, Melissa L./0000-0002-9436-6382; Kelley, Mark/0000-0002-6120-9532	National Institutes of Health National Cancer Institute (NCI) [CA121168, CA114571, CA121168S1, CA122298, CA113669, CA134292, CA134767]; Riley Children's Foundation; Ralph W. and Grace M. Showalter Research Trust; NATIONAL CANCER INSTITUTE [R01CA121168, R01CA113669, R21CA122298, R01CA167291, R01CA134767, P01CA134292, R01CA114571] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Riley Children's Foundation; Ralph W. and Grace M. Showalter Research Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support for this work was provided by the National Institutes of Health National Cancer Institute (NCI) CA121168, CA114571, and CA121168S1 (MRK), CA122298 (MLF), CA113669, CA134292 and CA134767 (AM) the Riley Children's Foundation (MRK) www.rileykids.org/and the Ralph W. and Grace M. Showalter Research Trust Fund (MLF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Bapat A, 2010, J PHARMACOL EXP THER, V334, P988, DOI 10.1124/jpet.110.169128; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Ferbeyre G, 2011, BBA-REV CANCER, V1815, P104, DOI 10.1016/j.bbcan.2010.10.004; Fishel ML, 2008, DNA REPAIR, V7, P177, DOI 10.1016/j.dnarep.2007.09.008; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fishel ML, 2011, MOL CANCER THER, V10, P1698, DOI 10.1158/1535-7163.MCT-11-0107; Fishel ML, 2010, EXP HEMATOL, V38, P1178, DOI 10.1016/j.exphem.2010.08.011; Georgiadis MM, 2008, MUTAT RES-FUND MOL M, V643, P54, DOI 10.1016/j.mrfmmm.2008.04.008; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Greten FR, 2002, GASTROENTEROLOGY, V123, P2052, DOI 10.1053/gast.2002.37075; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Groner B, 2008, SEMIN CELL DEV BIOL, V19, P341, DOI 10.1016/j.semcdb.2008.06.005; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Jackson MW, 2006, J BIOL CHEM, V281, P16814, DOI 10.1074/jbc.M511617200; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; Jiang YL, 2010, CANCER INVEST, V28, P885, DOI 10.3109/07357907.2010.512816; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jordan BF, 2005, CLIN CANCER RES, V11, P529; Kelley MR, 2010, CANCER DRUG DISCOV D, P133, DOI 10.1007/978-1-4419-6615-5_7; Kramer OH, 2010, MOL CELL ENDOCRINOL, V315, P40, DOI 10.1016/j.mce.2009.10.007; Li L, 2004, BIOCHEM BIOPH RES CO, V322, P1005, DOI 10.1016/j.bbrc.2004.08.014; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Liby KT, 2010, CANCER PREV RES, V3, P1427, DOI 10.1158/1940-6207.CAPR-10-0197; Luo M, 2008, ANTIOXID REDOX SIGN, V10, P1853, DOI 10.1089/ars.2008.2120; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Preston IR, 2005, CIRCULATION, V111, P782, DOI 10.1161/01.CIR.0000155254.86840.47; Qiu ZJ, 2007, CANCER SCI, V98, P1099, DOI 10.1111/j.1349-7006.2007.00485.x; Rabik CA, 2008, J PHARMACOL EXP THER, V327, P442, DOI 10.1124/jpet.108.141291; Ramanathan RK, 2011, CANCER CHEMOTH PHARM, V67, P503, DOI 10.1007/s00280-010-1343-8; Ray S, 2010, MOL ENDOCRINOL, V24, P391, DOI 10.1210/me.2009-0319; Redell MS, 2005, CURR PHARM DESIGN, V11, P2873, DOI 10.2174/1381612054546699; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Singh-Gupta V, 2009, INT J CANCER, V124, P1675, DOI 10.1002/ijc.24015; Su DA, 2011, BIOCHEMISTRY-US, V50, P82, DOI 10.1021/bi101248s; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Wang D, 2004, MOL CANCER THER, V3, P679; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Xie KP, 2006, CYTOKINE GROWTH F R, V17, P147, DOI 10.1016/j.cytogfr.2006.01.002; Yang G, 2009, WORLD J GASTROENTERO, V15, P3757, DOI 10.3748/wjg.15.3757; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	50	70	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47462	10.1371/journal.pone.0047462	http://dx.doi.org/10.1371/journal.pone.0047462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094050	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200024
J	Matthews, PC; Listgarten, J; Carlson, JM; Payne, R; Huang, KHG; Frater, J; Goedhals, D; Steyn, D; van Vuuren, C; Paioni, P; Jooste, P; Ogwu, A; Shapiro, R; Mncube, Z; Ndung'u, T; Walker, BD; Heckerman, D; Goulder, PJR				Matthews, Philippa C.; Listgarten, Jennifer; Carlson, Jonathan M.; Payne, Rebecca; Huang, Kuan-Hsiang Gary; Frater, John; Goedhals, Dominique; Steyn, Dewald; van Vuuren, Cloete; Paioni, Paolo; Jooste, Pieter; Ogwu, Anthony; Shapiro, Roger; Mncube, Zenele; Ndung'u, Thumbi; Walker, Bruce D.; Heckerman, David; Goulder, Philip J. R.			Co-Operative Additive Effects between HLA Alleles in Control of HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; DISEASE PROGRESSION; IMMUNE CONTROL; SELECTION PRESSURE; VIRAL LOAD; NK CELLS; INFECTION; VIREMIA; ASSOCIATION	Background: HLA class I genotype is a major determinant of the outcome of HIV infection, and the impact of certain alleles on HIV disease outcome is well studied. Recent studies have demonstrated that certain HLA class I alleles that are in linkage disequilibrium, such as HLA-A*74 and HLA-B*57, appear to function co-operatively to result in greater immune control of HIV than mediated by either single allele alone. We here investigate the extent to which HLA alleles - irrespective of linkage disequilibrium - function co-operatively. Methodology/Principal Findings: We here refined a computational approach to the analysis of >2000 subjects infected with C-clade HIV first to discern the individual effect of each allele on disease control, and second to identify pairs of alleles that mediate 'co-operative additive' effects, either to improve disease suppression or to contribute to immunological failure. We identified six pairs of HLA class I alleles that have a co-operative additive effect in mediating HIV disease control and four hazardous pairs of alleles that, occurring together, are predictive of worse disease outcomes (q<0.05 in each case). We developed a novel 'sharing score' to quantify the breadth of CD8+ T cell responses made by pairs of HLA alleles across the HIV proteome, and used this to demonstrate that successful viraemic suppression correlates with breadth of unique CD8+ T cell responses (p = 0.03). Conclusions/Significance: These results identify co-operative effects between HLA Class I alleles in the control of HIV-1 in an extended Southern African cohort, and underline complementarity and breadth of the CD8+ T cell targeting as one potential mechanism for this effect.	[Matthews, Philippa C.; Payne, Rebecca; Paioni, Paolo; Goulder, Philip J. R.] Univ Oxford, Dept Paediat, Oxford, England; [Listgarten, Jennifer; Carlson, Jonathan M.; Heckerman, David] Microsoft Res, ESci Grp, Los Angeles, CA USA; [Huang, Kuan-Hsiang Gary; Frater, John] Univ Oxford, Nuffield Dept Med, Oxford, England; [Goedhals, Dominique] Univ Orange Free State, Dept Med Microbiol & Virol, Natl Hlth Lab Serv, Bloemfontein, South Africa; [Steyn, Dewald; van Vuuren, Cloete] Univ Orange Free State, Dept Internal Med, Bloemfontein, South Africa; [Jooste, Pieter] Univ Orange Free State, Kimberley Hosp, Dept Paediat, Kimberley, Northern Cape, South Africa; [Ogwu, Anthony; Shapiro, Roger] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Shapiro, Roger] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Mncube, Zenele; Ndung'u, Thumbi; Walker, Bruce D.; Goulder, Philip J. R.] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Ndung'u, Thumbi; Walker, Bruce D.] Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02114 USA	University of Oxford; Microsoft; University of Oxford; University of the Free State; University of the Free State; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health; University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Matthews, PC (corresponding author), Univ Oxford, Dept Paediat, Oxford, England.	p.matthews@doctors.org.uk	Matthews, Philippa/P-7810-2019; Payne, Rebecca/AAC-4783-2022	Matthews, Philippa/0000-0002-4036-4269; Payne, Rebecca/0000-0002-9037-7367; Frater, John/0000-0001-7163-7277; Paioni, Paolo/0000-0002-3904-1606; Ndung'u, Thumbi/0000-0003-2962-3992; van Vuuren, Cloete/0000-0002-9095-0039	UK Medical Research Council; Oxford Radcliffe Hospitals Medical Research Fund; Wellcome Trust; National Institutes of Health; Bill and Melinda Gates Foundation; South African AIDS Vaccine Initiative; MRC [G108/626] Funding Source: UKRI; Medical Research Council [G108/626] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046995, P30AI060354] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Radcliffe Hospitals Medical Research Fund; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); South African AIDS Vaccine Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	PM was funded by the UK Medical Research Council and Oxford Radcliffe Hospitals Medical Research Fund. PG was funded by Wellcome Trust and is an Elizabeth Glaser Paediatric AIDS Foundation Scientist. TN holds the South African Department of Science and Technology/National Research Foundation Research Chair in Systems Biology of HIV/AIDS. The Durban cohort was funded by grants from the Wellcome Trust, The National Institutes of Health, The Bill and Melinda Gates Foundation and the South African AIDS Vaccine Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x; Alter G, 2009, J VIROL, V83, P6798, DOI 10.1128/JVI.00256-09; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Carlson J.M., 2009, MSRTR200953; Carlson J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000591; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2011, J INFECT DIS, V203, P773, DOI 10.1093/infdis/jiq125; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Honeyborne I, 2010, J VIROL, V84, P11279, DOI 10.1128/JVI.01144-10; Huang KHG, 2009, ANTIVIR THER, V14, P975, DOI 10.3851/IMP1416; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kloverpris HN, 2012, J VIROL, V86, P919, DOI 10.1128/JVI.06150-11; Koehler RN, 2010, J INFECT DIS, V202, P1562, DOI 10.1086/656913; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Listgarten J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000016; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; Ngumbela KC, 2008, AIDS RES HUM RETROV, V24, P72, DOI 10.1089/aid.2007.0124; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Song W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023469; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100	33	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47799	10.1371/journal.pone.0047799	http://dx.doi.org/10.1371/journal.pone.0047799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094091	gold, Green Published, Green Submitted			2022-12-27	WOS:000310050200047
J	Andersson, SEM; Svensson, MND; Erlandsson, MC; Dehlin, M; Andersson, KME; Bokarewa, MI				Andersson, Sofia E. M.; Svensson, Mattias N. D.; Erlandsson, Malin C.; Dehlin, Mats; Andersson, Karin M. E.; Bokarewa, Maria I.			Activation of Fms-Like Tyrosine Kinase 3 Signaling Enhances Survivin Expression in a Mouse Model of Rheumatoid Arthritis	PLOS ONE			English	Article							DENDRITIC CELL-DEVELOPMENT; FLT3 LIGAND; PROGENITOR CELLS; EXTRACELLULAR SURVIVIN; HEMATOPOIETIC STEM; COLORECTAL-CANCER; IN-VIVO; APOPTOSIS; INHIBITOR; RECEPTOR	Survivin is known as an inhibitor of apoptosis and a positive regulator of cell division. We have recently identified survivin as a predictor of joint destruction in patients with rheumatoid arthritis (RA). Flt3 ligand (Flt3L) is expressed in the inflamed joints and has adjuvant properties in arthritis. Studies on 90 RA patients (median age 60.5 years [range, 24-87], disease duration 10.5 years [range, 0-35]) show a strong positive association between the levels of survivin and Flt3L in blood. Here, we present experimental evidence connecting survivin and Flt3L signaling. Treatment of BALB/c mice with Flt3L led to an increase of survivin in the bone marrow and in splenic dendritic cells. Flt3L changed the profile of survivin splice variants, increasing transcription of the short survivin40 in the bone marrow. Treatment with an Flt3 inhibitor reduced total survivin expression in bone marrow and in the dendritic cell population in spleen. Inhibition of survivin transcription in mice, by shRNA lentiviral constructs, reduced the gene expression of Flt3L. We conclude that expression of survivin is a downstream event of Flt3 signaling, which serves as an essential mechanism supporting survival of leukocytes during their differentiation, and maturation of dendritic cells, in RA.	[Andersson, Sofia E. M.; Svensson, Mattias N. D.; Erlandsson, Malin C.; Dehlin, Mats; Andersson, Karin M. E.; Bokarewa, Maria I.] Univ Goteborg, Dept Rheumatol & Inflammat Res, Sahlgrenska Univ Hosp, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg	Andersson, SEM (corresponding author), Univ Goteborg, Dept Rheumatol & Inflammat Res, Sahlgrenska Univ Hosp, Gothenburg, Sweden.	sofia.andersson@rheuma.gu.se	Svensson, Mattias N.D./A-9827-2012; Bokarewa, Maria I/A-8114-2019	Svensson, Mattias N.D./0000-0001-8077-9824; Bokarewa, Maria I/0000-0001-9424-5145; Erlandsson, Malin/0000-0003-1100-7577; Andersson, Sofia/0000-0003-2933-7339; Andersson, Karin/0000-0002-9475-3040	Medical Society of Goteborg; Swedish Association against Rheumatism; King Gustaf V:s 80-year Foundation; Commission of European Union [HEALTH-F2-2010-261460]; Swedish Research Council; IngaBritt and Arne Lundberg Foundation; Professor Nanna Swartz Foundation; Torsten Soderberg Foundation; AME Wolff Foundation; Rune and Ulla Amlovs Trust; Swedish Research Agency for Innovation Systems (VINNOVA); Swedish Foundation for Strategic Research; Pharmacist Hedberg's Foundation; Magnus Bergwall Foundation; University of Goteborg; Family Tholen and Kristlers Foundation; Western Gotaland county council; University of Goteborg (LUA/ALF)	Medical Society of Goteborg; Swedish Association against Rheumatism; King Gustaf V:s 80-year Foundation; Commission of European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); IngaBritt and Arne Lundberg Foundation; Professor Nanna Swartz Foundation; Torsten Soderberg Foundation; AME Wolff Foundation; Rune and Ulla Amlovs Trust; Swedish Research Agency for Innovation Systems (VINNOVA)(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Pharmacist Hedberg's Foundation; Magnus Bergwall Foundation; University of Goteborg; Family Tholen and Kristlers Foundation; Western Gotaland county council; University of Goteborg (LUA/ALF)	This work was funded by grants from the Medical Society of Goteborg, the Swedish Association against Rheumatism, the King Gustaf V:s 80-year Foundation, the Commission of European Union (HEALTH-F2-2010-261460), the Swedish Research Council, IngaBritt and Arne Lundberg Foundation, Professor Nanna Swartz Foundation, Torsten Soderberg Foundation, AME Wolff Foundation, Rune and Ulla Amlovs Trust, the Swedish Research Agency for Innovation Systems (VINNOVA), the Swedish Foundation for Strategic Research, the Pharmacist Hedberg's Foundation, Magnus Bergwall Foundation, the University of Goteborg, the Family Tholen and Kristlers Foundation, the Regional agreement on medical training and clinical research between the Western Gotaland county council and the University of Goteborg (LUA/ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JK, 2010, INFLAMMATION, V33, P381, DOI 10.1007/s10753-010-9196-1; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Altznauer F, 2004, J EXP MED, V199, P1343, DOI 10.1084/jem.20032033; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baran M, 2009, J CELL MOL MED, V13, P3797, DOI 10.1111/j.1582-4934.2009.00721.x; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Bokarewa M, 2005, ARTHRITIS RES THER, V7, pR349, DOI 10.1186/ar1498; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Carter BZ, 2001, BLOOD, V97, P2784, DOI 10.1182/blood.V97.9.2784; Chklovskaia E, 2001, BLOOD, V97, P1027, DOI 10.1182/blood.V97.4.1027; Conway EM, 2000, BLOOD, V95, P1435, DOI 10.1182/blood.V95.4.1435.004k01_1435_1442; Deane KD, 2010, ARTHRITIS RHEUM-US, V62, P3161, DOI 10.1002/art.27638; Dehlin M, 2011, J LEUKOCYTE BIOL, V90, P811, DOI 10.1189/jlb.1110640; Dehlin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003633; Dharmapatni AASSK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2603; Fukuda S, 2001, BLOOD, V98, P2091, DOI 10.1182/blood.V98.7.2091; Fukuda S, 2009, BLOOD, V114, P394, DOI 10.1182/blood-2008-11-188714; Gu LB, 2007, EXP HEMATOL, V35, P957, DOI 10.1016/j.exphem.2007.03.007; Horiuchi K, 2009, J IMMUNOL, V182, P7408, DOI 10.4049/jimmunol.0801931; Isgren A, 2012, SEMIN ARTHRITIS RHEU, V41, P652, DOI 10.1016/j.semarthrit.2011.08.005; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kang BH, 2011, J BIOL CHEM, V286, P16758, DOI 10.1074/jbc.M110.210120; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Kornacker M, 2001, IMMUNOL LETT, V76, P169, DOI 10.1016/S0165-2478(01)00186-9; Kuttler F, 2002, LEUKEMIA, V16, P726, DOI 10.1038/sj.leu.2402427; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Li FZ, 2010, AM J PATHOL, V176, P1629, DOI 10.2353/ajpath.2010.090414; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Mera S, 2008, J LEUKOCYTE BIOL, V83, P149, DOI 10.1189/jlb.0507287; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Noton EA, 2006, J BIOL CHEM, V281, P1286, DOI 10.1074/jbc.M508773200; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Petrarca CR, 2011, CLIN BREAST CANCER, V11, P129, DOI 10.1016/j.clbc.2011.03.002; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; Small Donald, 2006, Hematology Am Soc Hematol Educ Program, P178; Smith MD, 2010, RHEUMATOLOGY, V49, P862, DOI 10.1093/rheumatology/kep467; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Svensson B, 2010, ANN MED, V42, P45, DOI 10.3109/07853890903376280; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Tussiwand R, 2005, J IMMUNOL, V175, P3674, DOI 10.4049/jimmunol.175.6.3674; Williams NS, 2003, CLIN CANCER RES, V9, P931; Xia F, 2006, CANCER RES, V66, P3392, DOI 10.1158/0008-5472.CAN-05-4537; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Zhou JB, 2009, BLOOD, V113, P4052, DOI 10.1182/blood-2008-05-156422	50	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47668	10.1371/journal.pone.0047668	http://dx.doi.org/10.1371/journal.pone.0047668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082191	Green Submitted, gold, Green Published			2022-12-27	WOS:000311146900088
J	Cai, Y; Yi, JY; Zhou, CH; Shen, XZ				Cai, Yu; Yi, JiaYong; Zhou, ChaoHui; Shen, XiZhong			Pharmacogenetic Study of Drug-Metabolising Enzyme Polymorphisms on the Risk of Anti-Tuberculosis Drug-Induced Liver Injury: A Meta-Analysis	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; CYTOCHROME-P450 2E1 GENOTYPE; INDUCED HEPATOTOXICITY; GENETIC POLYMORPHISMS; N-ACETYLTRANSFERASE-2 GENE; NULL MUTATIONS; SUSCEPTIBILITY; CYP2E1; GSTM1; GSTT1	Background: Three first-line antituberculosis drugs, isoniazid, rifampicin and pyrazinamide, may induce liver injury, especially isoniazid. This antituberculosis drug-induced liver injury (ATLI) ranges from a mild to severe form, and the associated mortality cases are not rare. In the past decade, many investigations have focused the association between drug-metabolising enzyme (DME) gene polymorphisms and risk for ATLI; however, these studies have yielded contradictory results. Methods: PubMed, EMBASE, ISI web of science and the Chinese National Knowledge Infrastructure databases were systematically searched to identify relevant studies. A meta-analysis was performed to examine the association between polymorphisms from 4 DME genes (NAT2, CYP2E1, GSTM1 and GSTT1) and susceptibility to ATLI. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Heterogeneity among articles and their publication bias were also tested. Results: 38 studies involving 2,225 patients and 4,906 controls were included. Overall, significantly increased ATLI risk was associated with slow NAT2 genotype and GSTM1 null genotype when all studies were pooled into the meta-analysis. Significantly increased risk was also found for CYP2E1*1A in East Asians when stratified by ethnicity. However, no significant results were observed for GSTT1. Conclusions: Our results demonstrated that slow NAT2 genotype, CYP2E1*1A and GSTM1 null have a modest effect on genetic susceptibility to ATLI.	[Cai, Yu; Zhou, ChaoHui; Shen, XiZhong] Fudan Unvers, Zhongshan Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Yi, JiaYong] Fudan Unvers, Zhongshan Hosp, Dept Orthoped, Shanghai, Peoples R China	Fudan University; Fudan University	Zhou, CH (corresponding author), Fudan Unvers, Zhongshan Hosp, Dept Gastroenterol, Shanghai, Peoples R China.	chaohuizhou001@163.com			Shanghai Natural Science Foundation [12ZR1405300]; Shanghai Science and Technology Commission [10410709400, 10411950100]	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Shanghai Natural Science Foundation (12ZR1405300) and Shanghai Science and Technology Commission (10410709400; 10411950100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HR, 2012, CLIN EXP PHARMACOL P, V39, P535, DOI 10.1111/j.1440-1681.2012.05713.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Ben Mahmoud L, 2012, PATHOL BIOL, V60, P324, DOI 10.1016/j.patbio.2011.07.001; Bose PD, 2011, J GASTROEN HEPATOL, V26, P312, DOI 10.1111/j.1440-1746.2010.06355.x; Bozok Cetintas V, 2008, TUBERK TORAK, V56, P81; Chatterjee S, 2010, J CLIN PHARM THER, V35, P465, DOI 10.1111/j.1365-2710.2009.01101.x; [陈怡 Chen Yi], 2010, [中华传染病杂志, Chinese Journal of Infections Diseases], V28, P748; Cho HJ, 2007, TUBERCULOSIS, V87, P551, DOI 10.1016/j.tube.2007.05.012; Teixeira RLD, 2011, MEM I OSWALDO CRUZ, V106, P716, DOI 10.1590/S0074-02762011000600011; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; [郭梅 GUO Mei], 2010, [中华传染病杂志, Chinese Journal of Infections Diseases], V28, P99; Guo Mingruo, 2009, P1; Higuchi N, 2007, WORLD J GASTROENTERO, V13, P6003, DOI 10.3748/wjg.13.6003; Huang DS, 2011, ZHONGHUA SHENG WU YI, V17, P444; Huang YS, 2007, J HEPATOL, V47, P128, DOI 10.1016/j.jhep.2007.02.009; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; Kim SH, 2010, TUBERCULOSIS, V90, P39, DOI 10.1016/j.tube.2009.12.001; Kim SH, 2009, PHARMACOGENOMICS, V10, P1767, DOI 10.2217/PGS.09.100; LAUTERBURG BH, 1985, J PHARMACOL EXP THER, V235, P566; Lee SW, 2010, INT J TUBERC LUNG D, V14, P622; LEE WM, 1995, NEW ENGL J MED, V333, P1118, DOI 10.1056/NEJM199510263331706; Leiro V, 2008, LIVER INT, V28, P835, DOI 10.1111/j.1478-3231.2008.01700.x; Leiro-Fernandez V, 2011, INT J TUBERC LUNG D, V15, P1403, DOI 10.5588/ijtld.10.0648; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; Naisbitt DJ, 2001, CURR OPIN ALLERGY CL, V1, P317; Ohno M, 2000, INT J TUBERC LUNG D, V4, P256; Possuelo LG, 2008, EUR J CLIN PHARMACOL, V64, P673, DOI 10.1007/s00228-008-0484-8; Rana SV, 2012, HEPATOL INT, V6, P397, DOI 10.1007/s12072-011-9309-4; Roy B, 2006, J GASTROEN HEPATOL, V21, P784, DOI 10.1111/j.1440-1746.2006.04197.x; Roy B, 2001, J GASTROEN HEPATOL, V16, P1033, DOI 10.1046/j.1440-1746.2001.02585.x; RungeMorris M, 1996, DRUG METAB DISPOS, V24, P734; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Shimizu Y, 2006, TUBERCULOSIS, V86, P374, DOI 10.1016/j.tube.2005.09.002; Sistanizad M, 2011, IRAN J PHARM RES, V10, P633; Sotsuka T, 2011, IN VIVO, V25, P803; Strange RC, 2000, TOXICOL LETT, V112, P357, DOI 10.1016/S0378-4274(99)00230-1; Tang KF, 2010, GENOMICS, V95, P224, DOI 10.1016/j.ygeno.2010.01.005; Tang SW, 2012, J CLIN PHARM THER, V37, P588, DOI 10.1111/j.1365-2710.2012.01334.x; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Vuilleumier Nicolas, 2006, Eur J Clin Pharmacol, V62, P423; Wang JH, 2004, ACAD J PLA POSTGRAD, V25, P239; Wang PY, 2009, CHIN J PUBLIC HLTH, V25, P300; Wang T, 2010, J INT MED RES, V38, P977, DOI 10.1177/147323001003800324; Wang Tao, 2009, Zhonghua Jie He He Hu Xi Za Zhi, V32, P585; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Wu Yu-Mei, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P467, DOI 10.3760/cma.j.issn.1007-3418.2010.06.017; Yamada S, 2009, PHARMACOGENOMICS, V10, P1433, DOI [10.2217/pgs.09.66, 10.2217/PGS.09.66]; Yimer G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027810; Zhu Dong-lin, 2011, Zhongguo Kangshengsu Zazhi, V36, P864	51	72	82	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47769	10.1371/journal.pone.0047769	http://dx.doi.org/10.1371/journal.pone.0047769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082213	gold, Green Submitted, Green Published			2022-12-27	WOS:000311146900110
J	Dzunkova, M; D'Auria, G; Perez-Villarroya, D; Moya, A				Dzunkova, Maria; D'Auria, Giuseppe; Perez-Villarroya, David; Moya, Andres			Hybrid Sequencing Approach Applied to Human Fecal Metagenomic Clone Libraries Revealed Clones with Potential Biotechnological Applications	PLOS ONE			English	Article							ARGININE DEIMINASE; PROTEIN FAMILIES; DOMAIN-STRUCTURE; ALGINATE LYASE; PHASE-I; GENE; IDENTIFICATION; DATABASE; THERAPY; HOMOCYSTINURIA	Natural environments represent an incredible source of microbial genetic diversity. Discovery of novel biomolecules involves biotechnological methods that often require the design and implementation of biochemical assays to screen clone libraries. However, when an assay is applied to thousands of clones, one may eventually end up with very few positive clones which, in most of the cases, have to be "domesticated'' for downstream characterization and application, and this makes screening both laborious and expensive. The negative clones, which are not considered by the selected assay, may also have biotechnological potential; however, unfortunately they would remain unexplored. Knowledge of the clone sequences provides important clues about potential biotechnological application of the clones in the library; however, the sequencing of clones one-by-one would be very time-consuming and expensive. In this study, we characterized the first metagenomic clone library from the feces of a healthy human volunteer, using a method based on 454 pyrosequencing coupled with a clone-by-clone Sanger end-sequencing. Instead of whole individual clone sequencing, we sequenced 358 clones in a pool. The medium-large insert (7-15 kb) cloning strategy allowed us to assemble these clones correctly, and to assign the clone ends to maintain the link between the position of a living clone in the library and the annotated contig from the 454 assembly. Finally, we found several open reading frames (ORFs) with previously described potential medical application. The proposed approach allows planning ad-hoc biochemical assays for the clones of interest, and the appropriate sub-cloning strategy for gene expression in suitable vectors/hosts.	[Dzunkova, Maria; D'Auria, Giuseppe; Perez-Villarroya, David; Moya, Andres] Univ Valencia, Joint Unit Res Genom & Hlth, Ctr Publ Hlth Res CSISP, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Dzunkova, Maria; D'Auria, Giuseppe; Moya, Andres] CIBER Epidemiol & Salud Publ CIBEResp, Madrid, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	D'Auria, G (corresponding author), Univ Valencia, Joint Unit Res Genom & Hlth, Ctr Publ Hlth Res CSISP, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain.	dauria_giu@gva.es	Moya, Andrés/A-8190-2008; D'Auria, Giuseppe/E-6583-2010; Dzunkova, Maria/AAE-3093-2022	Moya, Andrés/0000-0002-2867-1119; Dzunkova, Maria/0000-0002-1765-0697; D'Auria, Giuseppe/0000-0003-0672-2541	Miguel Servet, Instituto de Salud Carlos III, Spain [CP09/00049]; Spanish Ministry for Science and Innovation (MCINN) [SAF2009-13032-C02-01, FU2008-04501-E]; Conselleria D'Educacio Generalitat Valenciana, Spain [Prometeo/2009/092]; Spanish Ministry of Education [FPU2010]	Miguel Servet, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Spanish Ministry for Science and Innovation (MCINN); Conselleria D'Educacio Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); Spanish Ministry of Education(Spanish Government)	This work was funded by grant CP09/00049 Miguel Servet, Instituto de Salud Carlos III, Spain to GD; by projects SAF2009-13032-C02-01 from the Spanish Ministry for Science and Innovation (MCINN), FU2008-04501-E from Spanish Ministry for Science and Innovation (MCINN) in the frame of ERA-Net PathoGenoMics and Prometeo/2009/092 from Conselleria D'Educacio Generalitat Valenciana, Spain, to AM. MD is recipient of a fellowship from Spanish Ministry of Education FPU2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; Ausubel F. M., 1992, CURRENT PROTOCOLS MO, P211; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Brady SF, 2009, NAT PROD REP, V26, P1488, DOI 10.1039/b817078a; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Cieslinski H, 2009, POL J MICROBIOL, V58, P199; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; Crystal RG, 1997, HUM GENE THER, V8, P985, DOI 10.1089/hum.1997.8.8-985; DAHER GC, 1990, PHARMACOL THERAPEUT, V48, P189, DOI 10.1016/0163-7258(90)90080-L; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Duan CJ, 2009, J APPL MICROBIOL, V107, P245, DOI 10.1111/j.1365-2672.2009.04202.x; Elend C, 2006, APPL ENVIRON MICROB, V72, P3637, DOI 10.1128/AEM.72.5.3637-3645.2006; Ensor CM, 2002, CANCER RES, V62, P5443; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Greco O, 2001, J CELL PHYSIOL, V187, P22, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1060>3.0.CO;2-H; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Harvey A, 2000, DRUG DISCOV TODAY, V5, P294, DOI 10.1016/S1359-6446(00)01511-7; HEALY FG, 1995, APPL MICROBIOL BIOT, V43, P667, DOI [10.1007/s002530050468, 10.1007/BF00164771]; Heath C, 2009, APPL ENVIRON MICROB, V75, P4657, DOI 10.1128/AEM.02597-08; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Henne A, 2000, APPL ENVIRON MICROB, V66, P3113, DOI 10.1128/AEM.66.7.3113-3116.2000; Hjort K, 2010, FEMS MICROBIOL ECOL, V71, P197, DOI 10.1111/j.1574-6941.2009.00801.x; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Islam MR, 2007, PLANT MOL BIOL, V63, P465, DOI 10.1007/s11103-006-9101-3; Izzo F, 2007, J GASTROEN HEPATOL, V22, P86, DOI 10.1111/j.1440-1746.2006.04463.x; Jukic LV, 2008, J BIOMED SCI, V15, P205, DOI 10.1007/s11373-007-9224-9; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lima T, 2009, NUCLEIC ACIDS RES, V37, pD471, DOI 10.1093/nar/gkn661; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; MUDD SH, 1964, SCIENCE, V143, P1443, DOI 10.1126/science.143.3613.1443; MUDD SH, 1970, J CLIN INVEST, V49, P1762, DOI 10.1172/JCI106394; Ni Y, 2008, CANCER LETT, V261, P1, DOI 10.1016/j.canlet.2007.11.038; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Niethammer AG, 2002, NAT MED, V8, P1369, DOI 10.1038/nm794; Oh HJ, 2004, MOL THER, V9, pS69; Pandha HS, 1999, J CLIN ONCOL, V17, P2180, DOI 10.1200/JCO.1999.17.7.2180; Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024; Pereira DIA, 2002, CRIT REV BIOCHEM MOL, V37, P259, DOI 10.1080/10409230290771519; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Rhee JK, 2005, APPL ENVIRON MICROB, V71, P817, DOI 10.1128/AEM.71.2.817-825.2005; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Scordis P, 1999, BIOINFORMATICS, V15, P799, DOI 10.1093/bioinformatics/15.10.799; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Simon C, 2009, APPL MICROBIOL BIOT, V85, P265, DOI 10.1007/s00253-009-2233-z; Simon C, 2009, APPL ENVIRON MICROB, V75, P2964, DOI 10.1128/AEM.02644-08; SIZEMORE DR, 1995, SCIENCE, V270, P299, DOI 10.1126/science.270.5234.299; Staden R, 2000, Methods Mol Biol, V132, P115; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stein JL, 1996, J BACTERIOL, V178, P591, DOI 10.1128/jb.178.3.591-599.1996; Strohl WR, 2000, DRUG DISCOV TODAY, V5, P39, DOI 10.1016/S1359-6446(99)01443-9; TAKAKU H, 1995, JPN J CANCER RES, V86, P840, DOI 10.1111/j.1349-7006.1995.tb03094.x; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Wang XJ, 2004, J BIOL CHEM, V279, P51370, DOI 10.1074/jbc.M410471200; Waschkowitz T, 2009, APPL ENVIRON MICROB, V75, P2506, DOI 10.1128/AEM.02136-08; Wells J, 2011, ANNU REV FOOD SCI T, V2, P423, DOI 10.1146/annurev-food-022510-133640; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Wu CH, 2003, NUCLEIC ACIDS RES, V31, P345, DOI 10.1093/nar/gkg040; Yu HH, 2008, J NEUROSCI RES, V86, P2963, DOI 10.1002/jnr.21740; Yun J, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-8	72	3	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47654	10.1371/journal.pone.0047654	http://dx.doi.org/10.1371/journal.pone.0047654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082187	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900084
J	Jimenez, E; Sefah, K; Lopez-Colon, D; Van Simaeys, D; Chen, HW; Tockman, MS; Tan, WH				Jimenez, Elizabeth; Sefah, Kwame; Lopez-Colon, Dalia; Van Simaeys, Dimitri; Chen, Hui William; Tockman, Melvyn S.; Tan, Weihong			Generation of Lung Adenocarcinoma DNA Aptamers for Cancer Studies	PLOS ONE			English	Article							CELL; PEGAPTANIB; PROBES	Lung cancer is the most lethal malignancy in the world, and each year thousands of people die from this disease. Early detection has proven to increase the 5-year survival for this cancer in general, independent of the origination site in the lung. To address this challenge, we have used cell-based SELEX (Systematic Evolution of Ligands by Exponential Enrichment) to select a panel of aptamers capable of distinguishing lung adenocarcinoma cells from normal lung epithelial cells. These aptamers bind at physiological and formalin-fixed conditions and display affinity for their targets with apparent K(d')s in the nanomolar range. Our findings suggest that the selected aptamers have the potential to be used in clinical settings, as well as to improve classification of nonsurgical specimens, another current challenge in lung cancer.	[Jimenez, Elizabeth; Sefah, Kwame; Lopez-Colon, Dalia; Van Simaeys, Dimitri; Tan, Weihong] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Chen, Hui William] Univ N Carolina, Dept Chem, Chapel Hill, NC USA; [Tockman, Melvyn S.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Oncol Sci, Tampa, FL 33682 USA	State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Tan, WH (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	tan@chem.ufl.edu	Jimenez, Elizabeth/GQB-5576-2022; Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008	Jimenez, Elizabeth/0000-0001-7798-2194; Tan, Weihong/0000-0002-8066-1524; Van Simaeys, Dimitri/0000-0003-3457-761X	University of Florida Open-Access Publishing Fund; National Institutes of Health, Washington, DC [69953]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	University of Florida Open-Access Publishing Fund; National Institutes of Health, Washington, DC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund and by the National Institutes of Health grant #69953, Washington, DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American cancer Society, 2011, AM CANC SOC, V1, P1; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Chakravarthy U, 2006, OPHTHALMOLOGY, V113, P1508, DOI 10.1016/j.ophtha.2006.02.064; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; FRAIRE AE, 1987, CANCER, V60, P370, DOI 10.1002/1097-0142(19870801)60:3<370::AID-CNCR2820600314>3.0.CO;2-W; Gold L, 2002, CHEM BIOL, V9, P1259, DOI 10.1016/S1074-5521(02)00286-7; Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787; Huang YP, 2011, INT J CANCER, V128, P2261, DOI 10.1002/ijc.25569; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karnezis T, 2012, CANCER CELL, V21, P181, DOI 10.1016/j.ccr.2011.12.026; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Parekh P, 2010, ANAL CHEM, V82, P8642, DOI 10.1021/ac101801j; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rerole AL, 2011, CANCER RES, V71, P484, DOI 10.1158/0008-5472.CAN-10-1443; ROGGLI VL, 1985, HUM PATHOL, V16, P569, DOI 10.1016/S0046-8177(85)80106-4; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Said N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp719; Sefah K, 2010, PLOS ONE, V12; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shi H, 2011, P NATL ACAD SCI USA, V108, P3900, DOI 10.1073/pnas.1016197108; Shi H, 2010, CHEM-ASIAN J, V5, P2209, DOI 10.1002/asia.201000242; Stoltenburg R, 2005, ANAL BIOANAL CHEM, V383, P83, DOI 10.1007/s00216-005-3388-9; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Van Simaeys D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013770; Weiderpass E, 2010, J PREVENTIVE MED PUB, V6, P459; Zeng ZH, 2010, MODERN PATHOL, V23, P1553, DOI 10.1038/modpathol.2010.151; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k	30	20	22	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46222	10.1371/journal.pone.0046222	http://dx.doi.org/10.1371/journal.pone.0046222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082117	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900012
J	Perea, M; Gomez, P				Perea, Manuel; Gomez, Pablo			Subtle Increases in Interletter Spacing Facilitate the Encoding of Words during Normal Reading	PLOS ONE			English	Article							EYE-MOVEMENTS; FIXATION LOCATION; LEXICAL DECISION; MODEL; IDENTIFICATION; NEIGHBORHOOD; INFORMATION	Background: Several recent studies have revealed that words presented with a small increase in interletter spacing are identified faster than words presented with the default interletter spacing (i.e., water faster than water). Modeling work has shown that this advantage occurs at an early encoding level. Given the implications of this finding for the ease of reading in the new digital era, here we examined whether the beneficial effect of small increases in interletter spacing can be generalized to a normal reading situation. Methodology: We conducted an experiment in which the participant's eyes were monitored when reading sentences varying in interletter spacing: i) sentences were presented with the default (0.0) interletter spacing; ii) sentences presented with a +1.0 interletter spacing; and iii) sentences presented with a +1.5 interletter spacing. Principal Findings: Results showed shorter fixation duration times as an inverse function of interletter spacing (i.e., fixation durations were briefest with +1.5 spacing and slowest with the default spacing). Conclusions: Subtle increases in interletter spacing facilitate the encoding of the fixated word during normal reading. Thus, interletter spacing is a parameter that may affect the ease of reading, and it could be adjustable in future implementations of e-book readers.	[Perea, Manuel] Univ Valencia, ERI Lectura, Valencia, Spain; [Perea, Manuel] Univ Valencia, Dept Metodol, Valencia, Spain; [Gomez, Pablo] Depaul Univ, Dept Psychol, Chicago, IL 60604 USA	University of Valencia; University of Valencia; DePaul University	Perea, M (corresponding author), Univ Valencia, ERI Lectura, Valencia, Spain.	mperea@valencia.edu	Gomez, Pablo/ABC-8797-2021; Perea, Manuel/B-3345-2011; GOMEZ, PABLO/A-8157-2012	Perea, Manuel/0000-0002-3291-1365; GOMEZ, PABLO/0000-0003-4180-1560	Spanish Ministry of Science and Innovation [PSI2011-26924]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The research reported in this article has been supported by Grant PSI2011-26924 from the Spanish Ministry of Science and Innovation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung STL, 2002, INVEST OPHTH VIS SCI, V43, P1270; Davis CJ, 2005, BEHAV RES METHODS, V37, P665, DOI 10.3758/BF03192738; Davis CJ, 2010, PSYCHOL REV, V117, P713, DOI 10.1037/a0019738; Dufau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024974; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Gomez P, 2008, PSYCHOL REV, V115, P577, DOI 10.1037/a0012667; Inhoff AW, 2000, J MEM LANG, V42, P23, DOI 10.1006/jmla.1999.2666; Johnson RL, 2007, J EXP PSYCHOL HUMAN, V33, P209, DOI 10.1037/0096-1523.33.1.209; McCandliss BD, 2012, P NATL ACAD SCI USA, V109, P11064, DOI 10.1073/pnas.1209921109; Mcleish E, 2007, BRIT J VISUAL IMPA, V25, P133, DOI 10.1177/0264619607075995; MORRISON RE, 1981, VISIBLE LANG, V15, P129; OREGAN JK, 1984, J EXP PSYCHOL HUMAN, V10, P250, DOI 10.1037/0096-1523.10.2.250; Paterson KB, 2010, MEM COGNITION, V38, P502, DOI 10.3758/MC.38.4.502; Perea M, 2012, LEARN INSTR, V22, P420, DOI 10.1016/j.learninstruc.2012.04.001; Perea M, 2012, PSYCHON B REV, V19, P332, DOI 10.3758/s13423-011-0214-6; Perea M, 2011, ACTA PSYCHOL, V137, P345, DOI 10.1016/j.actpsy.2011.04.003; Perea M, 2009, VISION RES, V49, P1994, DOI 10.1016/j.visres.2009.05.009; POLLATSEK A, 1995, J EXP PSYCHOL LEARN, V21, P785, DOI 10.1037/0278-7393.21.3.785; Ratcliff R, 2004, PSYCHOL REV, V111, P159, DOI 10.1037/0033-295X.111.1.159; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 1996, PERCEPT PSYCHOPHYS, V58, P734, DOI 10.3758/BF03213106; Reichle ED, 1998, PSYCHOL REV, V105, P125, DOI 10.1037/0033-295X.105.1.125; Simola J, 2011, J EXP PSYCHOL-APPL, V17, P174, DOI 10.1037/a0024042; Slattery TJ, 2010, APPL COGNITIVE PSYCH, V24, P1129, DOI 10.1002/acp.1623; Spinelli D, 2002, CORTEX, V38, P179, DOI 10.1016/S0010-9452(08)70649-X; Tinker M.A., 1963, LEGIBILITY PRINT; Vitu F, 2001, VISION RES, V41, P3513, DOI 10.1016/S0042-6989(01)00166-3	29	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47568	10.1371/journal.pone.0047568	http://dx.doi.org/10.1371/journal.pone.0047568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082178	gold, Green Submitted, Green Published			2022-12-27	WOS:000311146900074
J	Sanchez-Quinto, F; Botigue, LR; Civit, S; Arenas, C; Avila-Arcos, MC; Bustamante, CD; Comas, D; Lalueza-Fox, C				Sanchez-Quinto, Federico; Botigue, Laura R.; Civit, Sergi; Arenas, Conxita; Avila-Arcos, Maria C.; Bustamante, Carlos D.; Comas, David; Lalueza-Fox, Carles			North African Populations Carry the Signature of Admixture with Neandertals	PLOS ONE			English	Article							EUROPE; JACKKNIFE; ANCESTRY; ORIGINS; HISTORY; ASIA	One of the main findings derived from the analysis of the Neandertal genome was the evidence for admixture between Neandertals and non-African modern humans. An alternative scenario is that the ancestral population of non-Africans was closer to Neandertals than to Africans because of ancient population substructure. Thus, the study of North African populations is crucial for testing both hypotheses. We analyzed a total of 780,000 SNPs in 125 individuals representing seven different North African locations and searched for their ancestral/derived state in comparison to different human populations and Neandertals. We found that North African populations have a significant excess of derived alleles shared with Neandertals, when compared to sub-Saharan Africans. This excess is similar to that found in non-African humans, a fact that can be interpreted as a sign of Neandertal admixture. Furthermore, the Neandertal's genetic signal is higher in populations with a local, pre-Neolithic North African ancestry. Therefore, the detected ancient admixture is not due to recent Near Eastern or European migrations. Sub-Saharan populations are the only ones not affected by the admixture event with Neandertals.	[Sanchez-Quinto, Federico; Botigue, Laura R.; Comas, David; Lalueza-Fox, Carles] CSIC Univ Pompeu Fabra, Inst Biol Evolut, Barcelona, Spain; [Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Civit, Sergi; Arenas, Conxita] Univ Barcelona, Dept Estadist, Barcelona, Spain; [Avila-Arcos, Maria C.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark	Pompeu Fabra University; Stanford University; University of Barcelona; University of Copenhagen	Lalueza-Fox, C (corresponding author), CSIC Univ Pompeu Fabra, Inst Biol Evolut, Barcelona, Spain.	carles.lalueza@upf.edu	Ávila-Arcos, Maria C./AGZ-3897-2022; Comas, David/D-5382-2014; Botigue, Laura/AAF-8895-2019; Sánchez-Quinto, Federico/AAV-8927-2020; civit-vives, sergi/N-4287-2015; Arenas, Concepcion/H-5579-2015; LALUEZA-FOX, CARLES/AAG-5341-2020	Ávila-Arcos, Maria C./0000-0003-1691-1696; Comas, David/0000-0002-5075-0956; Botigue, Laura/0000-0001-7114-5168; Sánchez-Quinto, Federico/0000-0002-0201-6204; civit-vives, sergi/0000-0002-2511-4579; Arenas, Concepcion/0000-0002-6489-4934; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Bustamante, Carlos D./0000-0002-4187-7920	Ministerio de Ciencia e Innovacion of Spain [BFU2009-06974, CGL2010-14944/BOS]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	FS-Q, SC, CA and CL-F are supported by a grant from the Ministerio de Ciencia e Innovacion of Spain (BFU2009-06974) and CGL2010-14944/BOS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Balter M, 2011, SCIENCE, V331, P20, DOI 10.1126/science.331.6013.20; Barton RNE, 2009, QUATERNARY SCI REV, V28, P1914, DOI 10.1016/j.quascirev.2009.03.010; Bouzouggar A, 2007, P NATL ACAD SCI USA, V104, P9964, DOI 10.1073/pnas.0703877104; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P13956, DOI 10.1073/pnas.1200567109; Garcea E., 2010, S E MED PEOPLES 130, P192; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Harvati K, 2012, MODERN ORIGINS N AFR; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Hublin J-J, 2012, MODERN ORIGINS N AFR; Hunter-Zinck H, 2010, AM J HUM GENET, V87, P17, DOI 10.1016/j.ajhg.2010.05.018; Kuhner MK, 2000, GENETICS, V156, P439; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Meyer M, 2012, SCIENCE         0831; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Osborne AH, 2008, P NATL ACAD SCI USA, V105, P16444, DOI 10.1073/pnas.0804472105; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sankararaman S, 2012, ARXIV12082238V1; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Yang MA, 2012, MOL BIOL EVOL; Yotova V, 2011, MOL BIOL EVOL, V28, P1957, DOI 10.1093/molbev/msr024	32	54	56	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47765	10.1371/journal.pone.0047765	http://dx.doi.org/10.1371/journal.pone.0047765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082212	Green Published, gold			2022-12-27	WOS:000311146900109
J	Sperduti, A; Crivellaro, F; Rossi, PF; Bondioli, L				Sperduti, Alessandra; Crivellaro, Federica; Rossi, Paola Francesca; Bondioli, Luca			"Do Octopuses Have a Brain?" Knowledge, Perceptions and Attitudes towards Neuroscience at School	PLOS ONE			English	Article							SCIENCE; NEUROETHICS; SOCIETY; DECADE; WANT	The present study contributes to the question of school literacy about the brain, with an original survey conducted on Italian students from the 3rd to 10th grades (n = 508). The main goal was to test student's knowledge, attitudes, and interests about neuroscience, to assess needs, prospects, and difficulties in teaching about the brain from elementary to high school. A written questionnaire, maintaining anonymity, asked 12 close-ended multiple choice questions on topics related to human and animal brains, plus one facultative open-ended question about interests and curiosities on brain topics. The results show that respondents have a fragmentary level of basic knowledge about the brain, with aspects related to brain functions and consciousness the most challenging. As expected, degrees of performance improve with school level; elementary school students answered correctly an average number of 5.3 questions, middle school 6.5, and high school 7.4. Overall, students show great interest in the brain, as shown by the large number of questions gathered through the open-ended question (n = 384). Other topics are addressed, mostly related to brain structure/functions and the role of the brain in the everyday life. The survey indicates the need of more thorough school programs on this subject, reinforced by interdisciplinary teaching where comparative anatomy and evolutionary aspects of brain development are covered.	[Sperduti, Alessandra; Crivellaro, Federica; Rossi, Paola Francesca; Bondioli, Luca] Natl Museum Prehist & Ethnog L Pigorini, Sect Anthropol, Rome, Italy		Sperduti, A (corresponding author), Natl Museum Prehist & Ethnog L Pigorini, Sect Anthropol, Rome, Italy.	alesandra.sperduti@beniculturali.it	Sperduti, Alessandra/AAP-8192-2020	Bondlioli, Luca/0000-0002-8511-7667; Sperduti, Alessandra/0000-0001-9338-5891; Crivellaro, Federica/0000-0003-1656-8605	Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR)	Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research was performed with the contribution of the Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR) grant for the Scientific Culture Dissemination (year 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached JM, 2008, EMBO REP, V9, P1158, DOI 10.1038/embor.2008.211; Ausubel D.P., 1968, ED PSYCHOL COGNITIVE; Cameron W, 2003, NAT REV NEUROSCI, V4, P763, DOI 10.1038/nrn1200; Cameron William E, 2006, CBE Life Sci Educ, V5, P91, DOI 10.1187/cbe.06-03-0151; Carlson BA, 2012, ARCH NEUROL-CHICAGO, V69, P987, DOI 10.1001/archneurol.2012.77; Celone K, 2009, AM J BIOETHICS, V9, P28, DOI 10.1080/15265160802617985; Chudler EH, 2010, SCIENCE, V328, P1648, DOI 10.1126/science.1186935; D'Antona M, 2001, DIDATTICA BIOL; Dehaene S., 2005, MONKEY BRAIN HUMAN B; Della Sala S, 1999, MIND MYTHS EXPLORING; Dominici G, 2008, TUTTOSCUOLA, V480, P46; Falchetti E, 2007, PUBLIC UNDERST SCI, V16, P489, DOI 10.1177/0963662505063797; Foy Judith G, 2006, CBE Life Sci Educ, V5, P128, DOI 10.1187/cbe.05-08-0107; Frantz Kyle J, 2006, CBE Life Sci Educ, V5, P175, DOI 10.1187/cbe.05-09-0119; Frazzetto G, 2009, NAT REV NEUROSCI, V10, P815, DOI 10.1038/nrn2736; Herculano-Houzel S, 2003, NAT NEUROSCI, V6, P325, DOI 10.1038/nn0403-325; Herculano-Houzel S, 2002, NEUROSCIENTIST, V8, P98, DOI 10.1177/107385840200800206; Herculano-Houzel S, 2011, ANN NY ACAD SCI, V1225, P191, DOI 10.1111/j.1749-6632.2011.05976.x; Holloway R. L., 2009, ENCY NEUROSCIENCE, P1326; Hughes V, 2010, NATURE, V464, P340, DOI 10.1038/464340a; Illes J, 2005, NAT REV NEUROSCI, V6, P977, DOI 10.1038/nrn1808; Illes J, 2006, TRENDS NEUROSCI, V29, P511, DOI 10.1016/j.tins.2006.07.002; Illes J, 2010, NAT REV NEUROSCI, V11, P61, DOI 10.1038/nrn2773; Jenkins E. W., 2006, STUD SCI EDUC, V42, P49, DOI DOI 10.1080/03057260608560220; Kawade S., 2011, P IEEE GLOB TEL C GL, P1; Labriole M, 2010, CEREBRUM; Liu Dennis, 2006, CBE Life Sci Educ, V5, P94, DOI 10.1187/cbe.06-02-0147; Longo C, 2001, DIDATTICA BIOL; McLennan DA, 2010, EVOLUTION N Y, V3, P548; Miller L, 2002, NEUROSCIENTIST, V8, P16, DOI 10.1177/107385840200800106; Miller Leslie, 2006, CBE Life Sci Educ, V5, P137, DOI 10.1187/cbe.05-08-0115; O'Brien D. T., 2011, EVOLUTION ED OUTREAC, V4, P107, DOI [10.1007/s12052-010-0305-2, DOI 10.1007/S12052-010-0305-2]; O'Connor C, 2012, NEURON, V74, P220, DOI 10.1016/j.neuron.2012.04.004; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramani D, 2009, J CLIN OUTCOMES MANA, P8; Roseman JE, 2010, CEREBRUM; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sperduti A, 2010, MUSEOLOGIA SCI MEMOR, V6, P231; Tanner KD, 2006, CBE-LIFE SCI EDUC, P5; Valente A, 2008, 22 CNR; Wardlaw JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025829; Yandell BS, 1997, PRACTICAL DATA ANAL; Zardetto-Smith AM, 2000, NEUROSCIENTIST, V6, P159, DOI 10.1177/107385840000600307; Zardetto-Smith AM, 2002, NEUROSCIENTIST, V8, P396, DOI 10.1177/107385802236965	44	14	14	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47943	10.1371/journal.pone.0047943	http://dx.doi.org/10.1371/journal.pone.0047943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082231	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900128
J	VerCauteren, KC; Pilon, JL; Nash, PB; Phillips, GE; Fischer, JW				VerCauteren, Kurt C.; Pilon, John L.; Nash, Paul B.; Phillips, Gregory E.; Fischer, Justin W.			Prion Remains Infectious after Passage through Digestive System of American Crows (Corvus brachyrhynchos)	PLOS ONE			English	Article							SCRAPIE AGENT; MULE DEER; PROTEIN; ENCEPHALOPATHY; SHEEP; DISEASE; TRANSPORTATION; TRANSMISSION; INACTIVATION; DEGRADATION	Avian scavengers, such as American crows (Corvus brachyrhynchos), have potential to translocate infectious agents (prions) of transmissible spongiform encephalopathy (TSE) diseases including chronic wasting disease, scrapie, and bovine spongiform encephalopathy. We inoculated mice with fecal extracts obtained from 20 American crows that were force-fed material infected with RML-strain scrapie prions. These mice all evinced severe neurological dysfunction 196-231 d postinoculation ((x) over bar = 198; 95% CI: 210-216) and tested positive for prion disease. Our results suggest a large proportion of crows that consume prion-positive tissue are capable of passing infectious prions in their feces ((p) over cap = 1.0; 95% CI: 0.8-1.0). Therefore, this common, migratory North American scavenger could play a role in the geographic spread of TSE diseases.	[VerCauteren, Kurt C.; Pilon, John L.; Nash, Paul B.; Phillips, Gregory E.; Fischer, Justin W.] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA	United States Department of Agriculture (USDA)	VerCauteren, KC (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA.	kurt.c.vercauteren@aphis.usda.gov		Fischer, Justin/0000-0002-9472-8945	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services (VS)	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services (VS)	Funding was provided by U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services (VS). A representative of VS served on a panel that provided input to the 5-year plan for the Chronic Wasting Disease Project of the National Wildlife Research Center, within which this project was conducted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; [Anonymous], 2006, SAS MIXED MODELS; Appel TR, 2006, J GEN VIROL, V87, P1385, DOI 10.1099/vir.0.81426-0; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Centers for Disease Control and Prevention, 2011, BSE BOV SPONG ENC MA; CHANDLER RL, 1961, LANCET, V1, P1378; Chronic Wasting Disease Alliance, 2011, CHRON WAST DIS N AM; COLLINGE J, 2006, BASIC NEUROCHEMISTRY, P791; Dagleish MP, 2010, J GEN VIROL, V91, P3116, DOI 10.1099/vir.0.025049-0; Duke G.E., 1986, P289; Evans H. E., 2004, HDB BIRD BIOL, P41; Giles K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000206; HUNTER GD, 1967, J COMP PATHOL, V77, P301, DOI 10.1016/0021-9975(67)90039-4; Jackson GS, 2005, J GEN VIROL, V86, P869, DOI 10.1099/vir.0.80484-0; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Jennelle CS, 2009, J WILDLIFE MANAGE, V73, P655, DOI 10.2193/2008-282; KASCSAK RJ, 1985, J GEN VIROL, V66, P1715, DOI 10.1099/0022-1317-66-8-1715; Kruger D, 2009, VET RES, V40, DOI 10.1051/vetres:2008042; Kuczius T, 1999, MOL MED, V5, P406, DOI 10.1007/BF03402129; Langeveld JPM, 2003, J INFECT DIS, V188, P1782, DOI 10.1086/379664; de Motes CM, 2008, VET MICROBIOL, V131, P205, DOI 10.1016/j.vetmic.2008.02.014; Martinsen TC, 2002, SCAND J GASTROENTERO, V37, P497, DOI 10.1080/00365520252903017; Matthews D, 2003, REV SCI TECH OIE, V22, P283, DOI 10.20506/rst.22.1.1393; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Nicholson EM, 2007, LETT APPL MICROBIOL, V44, P631, DOI 10.1111/j.1472-765X.2007.02124.x; Peretz D, 2006, J VIROL, V80, P322, DOI 10.1128/JVI.80.1.322-331.2006; Post K, 1999, LANCET, V354, P1969, DOI 10.1016/S0140-6736(99)00469-9; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Scherbel C, 2006, VET RES, V37, P695, DOI 10.1051/vetres:2006024; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Wisniewski HM, 1996, LANCET, V347, P1114, DOI 10.1016/S0140-6736(96)90310-4; Ziswiler V., 1972, P343; [No title captured]	36	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e45774	10.1371/journal.pone.0045774	http://dx.doi.org/10.1371/journal.pone.0045774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082115	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900010
J	Ong, WD; Voo, LYC; Kumar, VS				Ong, Wen Dee; Voo, Lok-Yung Christopher; Kumar, Vijay Subbiah			De Novo Assembly, Characterization and Functional Annotation of Pineapple Fruit Transcriptome through Massively Parallel Sequencing	PLOS ONE			English	Article							GENES; IDENTIFICATION; FOLATE; BIOCHEMISTRY; GENERATION; HEALTH; ESTS; TAGS	Background: Pineapple (Ananas comosus var. comosus), is an important tropical non-climacteric fruit with high commercial potential. Understanding the mechanism and processes underlying fruit ripening would enable scientists to enhance the improvement of quality traits such as, flavor, texture, appearance and fruit sweetness. Although, the pineapple is an important fruit, there is insufficient transcriptomic or genomic information that is available in public databases. Application of high throughput transcriptome sequencing to profile the pineapple fruit transcripts is therefore needed. Methodology/Principal Findings: To facilitate this, we have performed transcriptome sequencing of ripe yellow pineapple fruit flesh using Illumina technology. About 4.7 millions Illumina paired-end reads were generated and assembled using the Velvet de novo assembler. The assembly produced 28,728 unique transcripts with a mean length of approximately 200 bp. Sequence similarity search against non-redundant NCBI database identified a total of 16,932 unique transcripts (58.93%) with significant hits. Out of these, 15,507 unique transcripts were assigned to gene ontology terms. Functional annotation against Kyoto Encyclopedia of Genes and Genomes pathway database identified 13,598 unique transcripts (47.33%) which were mapped to 126 pathways. The assembly revealed many transcripts that were previously unknown. Conclusions: The unique transcripts derived from this work have rapidly increased of the number of the pineapple fruit mRNA transcripts as it is now available in public databases. This information can be further utilized in gene expression, genomics and other functional genomics studies in pineapple.	[Ong, Wen Dee; Voo, Lok-Yung Christopher; Kumar, Vijay Subbiah] Univ Malaysia Sabah, Biotechnol Res Inst, Kota Kinabalu, Sabah, Malaysia	Universiti Malaysia Sabah	Kumar, VS (corresponding author), Univ Malaysia Sabah, Biotechnol Res Inst, Kota Kinabalu, Sabah, Malaysia.	vijay@ume.edu.my	Kumar, Vijay S./G-4290-2011; Voo, Christopher/I-6880-2016	Kumar, Vijay S./0000-0002-0384-1580; 	Ministry of Science, Technology and Innovation, Malaysia [02-01-10-SF0026]	Ministry of Science, Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This study was supported by the ScienceFund grant (02-01-10-SF0026) from the Ministry of Science, Technology and Innovation, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Bevan M, 2005, GENOME RES, V15, P1632, DOI 10.1101/gr.3723405; Bombarely A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-503; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; Crowhurst RN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-351; de La Garza RID, 2007, P NATL ACAD SCI USA, V104, P4218, DOI 10.1073/pnas.0700409104; Dudareva N, 2004, PLANT PHYSIOL, V135, P1893, DOI 10.1104/pp.104.049981; Dudareva N, 2008, CURR OPIN BIOTECH, V19, P181, DOI 10.1016/j.copbio.2008.02.011; Elss S, 2005, LWT-FOOD SCI TECHNOL, V38, P263, DOI 10.1016/j.lwt.2004.07.014; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Li JH, 2006, BIOTECHNOL LETT, V28, P1193, DOI 10.1007/s10529-006-9074-y; Liu Q, 2009, J EXP BOT, V60, P801, DOI 10.1093/jxb/ern329; Lokanathan Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-76; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moyle R, 2005, J EXP BOT, V56, P101, DOI 10.1093/jxb/eri015; Negri AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-378; Newcomb RD, 2006, PLANT PHYSIOL, V141, P147, DOI 10.1104/pp.105.076208; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Park S, 2006, PLANT PHYSIOL, V141, P811, DOI 10.1104/pp.106.080994; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Quilang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-157; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Smith AG, 2007, CURR OPIN PLANT BIOL, V10, P266, DOI 10.1016/j.pbi.2007.04.009; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Vahteristo L, 1997, FOOD CHEM, V59, P589, DOI 10.1016/S0308-8146(96)00318-4; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou YC, 2003, FOOD CHEM, V80, P565, DOI 10.1016/S0308-8146(02)00375-8	41	36	38	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46937	10.1371/journal.pone.0046937	http://dx.doi.org/10.1371/journal.pone.0046937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091603	gold, Green Submitted, Green Published			2022-12-27	WOS:000310135800018
J	Serranova, T; Jech, R; Marti, MJ; Modreanu, R; Valldeoriola, F; Sieger, T; Ruzicka, E; Valls-Sole, J				Serranova, Tereza; Jech, Robert; Jose Marti, Maria; Modreanu, Raluca; Valldeoriola, Francesc; Sieger, Tomas; Ruzicka, Evzen; Valls-Sole, Josep			A Loud Auditory Stimulus Overcomes Voluntary Movement Limitation in Cervical Dystonia	PLOS ONE			English	Article							SPASMODIC TORTICOLLIS; PARADOXICAL KINESIA; ARM MOVEMENTS; REACTION-TIME; STARTLE; PATHOPHYSIOLOGY; EXCITABILITY; HUMANS; STIMULATION; DISORDERS	Background: Patients with cervical dystonia (CD) present with an impaired performance of voluntary neck movements, which are usually slow and limited. We hypothesized that such abnormality could involve defective preparation for task execution. Therefore, we examined motor preparation in CD patients using the StartReact method. In this test, a startling auditory stimulus (SAS) is delivered unexpectedly at the time of the imperative signal (IS) in a reaction time task to cause a faster execution of the prepared motor programme. We expected that CD patients would show an abnormal StartReact phenomenon. Methods: Fifteen CD patients and 15 age matched control subjects (CS) were asked to perform a rotational movement (RM) to either side as quick as possible immediately after IS perception (a low intensity electrical stimulus to the II finger). In randomly interspersed test trials (25%) a 130 dB SAS was delivered simultaneously with the IS. We recorded RMs in the horizontal plane with a high speed video camera (2.38 ms per frame) in synchronization with the IS. The RM kinematic-parameters (latency, velocity, duration and amplitude) were analyzed using video-editing software and screen protractor. Patients were asked to rate the difficulty of their RMs in a numerical rating scale. Results: In control trials, CD patients executed slower RMs (repeated measures ANOVA, p<0.10(-5)), and reached a smaller final head position angle relative to the midline (p<0.05), than CS. In test trials, SAS improved all RMs in both groups (p<0.10(-14)). In addition, patients were more likely to reach beyond their baseline RM than CS (chi(2), p<0.001) and rated their performance better than in control trials (t-test, p<0.01). Conclusion: We found improvement of kinematic parameters and subjective perception of motor performance in CD patients with StartReact testing. Our results suggest that CD patients reach an adequate level of motor preparation before task execution.	[Serranova, Tereza; Jech, Robert; Sieger, Tomas; Ruzicka, Evzen] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Serranova, Tereza; Jech, Robert; Sieger, Tomas; Ruzicka, Evzen] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Jose Marti, Maria; Modreanu, Raluca; Valldeoriola, Francesc] Univ Barcelona, Hosp Clin, Parkinsons Dis & Movement Disorders Unit,Inst Inv, Ctr Invest Red Enfermedades Neurodegenerat CIBERN, Barcelona, Spain; [Sieger, Tomas] Czech Tech Univ, Fac Elect Engn, Dept Cybernet, CR-16635 Prague, Czech Republic; [Valls-Sole, Josep] Univ Barcelona, Fac Med, Hosp Clin, Dept Neurol,EMG & Motor Control Unit,Inst Invest, Barcelona 7, Spain	Charles University Prague; Charles University Prague; University of Barcelona; Czech Technical University Prague; University of Barcelona	Serranova, T (corresponding author), Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic.	tereza.serranova@gmail.com	Jech, Robert/HHY-7342-2022; Sieger, Tomas/AAD-9342-2019; Serranová, Tereza/AAY-2386-2021	Jech, Robert/0000-0002-9732-8947; Serranová, Tereza/0000-0001-6525-3971; Sieger, Tomas/0000-0003-4960-1934; Ruzicka, Evzen/0000-0002-4893-9661	Czech Ministry of Health [IGA MZ CR NT12282-5/2011]; Czech Ministry of Education [MSM 0021620849]; Charles University in Prague [PRVOUK-P26/LF1/4]; Marato TV3 [PI110930]; European Neurological Society	Czech Ministry of Health(Ministry of Health, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; Marato TV3; European Neurological Society	This work was supported by the Czech Ministry of Health: IGA MZ CR NT12282-5/2011, the Czech Ministry of Education: research project MSM 0021620849, by the Charles University in Prague: research project PRVOUK-P26/LF1/4 and by a grant from Marato TV3 (PI110930) to JVS. TS was supported by Fellowship of the European Neurological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibiglou L, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2011.219592; Anzak A, 2011, EUR J NEUROSCI, V34, P124, DOI 10.1111/j.1460-9568.2011.07735.x; Anzak A, 2011, EXP BRAIN RES, V208, P237, DOI 10.1007/s00221-010-2474-1; Berardelli A, 1996, BRAIN, V119, P661, DOI 10.1093/brain/119.2.661; Berardelli A, 1998, BRAIN, V121, P1195, DOI 10.1093/brain/121.7.1195; Boccagni C, 2008, NEUROL SCI, V29, P375, DOI 10.1007/s10072-008-1033-z; Bonanni L, 2010, MOVEMENT DISORD, V25, P1302, DOI 10.1002/mds.23075; Carboncini MC, 2004, ARCH ITAL BIOL, V142, P113; Carlsen AN, 2004, EXP BRAIN RES, V159, P301, DOI 10.1007/s00221-004-1924-z; CHAN J, 1991, MOVEMENT DISORD, V6, P119, DOI 10.1002/mds.870060206; Comella CL, 1997, MOVEMENT DISORD, V12, P570, DOI 10.1002/mds.870120414; Curra A, 2000, MOVEMENT DISORD, V15, P103, DOI 10.1002/1531-8257(200001)15:1<103::AID-MDS1016>3.0.CO;2-3; Dauer WT, 1998, BRAIN, V121, P547, DOI 10.1093/brain/121.4.547; FAHN S, 1987, CLASSIFICATION INVES, P332; Gregori B, 2008, CLIN NEUROPHYSIOL, V119, P273, DOI 10.1016/j.clinph.2007.10.007; Hallett M, 2006, J NEURAL TRANSM-SUPP, P485; HALLETT M, 1975, J NEUROL NEUROSUR PS, V38, P1154, DOI 10.1136/jnnp.38.12.1154; Hamani C, 2007, CURR OPIN NEUROL, V20, P470, DOI 10.1097/WCO.0b013e32825ea69d; Henderson L, 1998, BRIT J PSYCHOL, V89, P531, DOI 10.1111/j.2044-8295.1998.tb02702.x; MacKinnon CD, 2000, J PHYSIOL-LONDON, V528, P633, DOI 10.1111/j.1469-7793.2000.00633.x; MacKinnon CD, 2004, MOVEMENT DISORD, V19, P273, DOI 10.1002/mds.20017; Muller J, 2003, MOVEMENT DISORD, V18, P1522, DOI 10.1002/mds.10609; Munchau A, 2001, BRAIN, V124, P47, DOI 10.1093/brain/124.1.47; NAKASHIMA K, 1989, NEUROLOGY, V39, P1354, DOI 10.1212/WNL.39.10.1354; NAKASHIMA K, 1989, BRAIN, V112, P681, DOI 10.1093/brain/112.3.681; Queralt A, 2008, J PHYSIOL-LONDON, V586, P4453, DOI 10.1113/jphysiol.2008.156042; Reynolds RF, 2007, J PHYSIOL-LONDON, V583, P1107, DOI 10.1113/jphysiol.2007.136192; Rothwell J C, 1988, Adv Neurol, V50, P133; Sanegre MT, 2004, EXP BRAIN RES, V155, P527, DOI 10.1007/s00221-004-1849-6; Schlesinger I, 2007, MOVEMENT DISORD, V22, P2394, DOI 10.1002/mds.21739; TOLOSA E, 1988, MOVEMENT DISORD, V3, P61, DOI 10.1002/mds.870030108; Valldeoriola F, 1998, NEUROLOGY, V51, P1315, DOI 10.1212/WNL.51.5.1315; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; Valls-Sole Josep, 2004, Suppl Clin Neurophysiol, V57, P554; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; VANDERKAMP W, 1989, J NEUROL NEUROSUR PS, V52, P1043, DOI 10.1136/jnnp.52.9.1043; Vitek JL, 2002, MOVEMENT DISORD, V17, pS49, DOI 10.1002/mds.10142	37	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46586	10.1371/journal.pone.0046586	http://dx.doi.org/10.1371/journal.pone.0046586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091598	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800010
J	Zhou, HC; Dong, XY; Kabarriti, R; Chen, Y; Avsar, Y; Wang, X; Ding, JQ; Liu, LB; Fox, IJ; Roy-Chowdhury, J; Roy-Chowdhury, N; Guha, C				Zhou, Hongchao; Dong, Xinyuan; Kabarriti, Rafi; Chen, Yong; Avsar, Yesim; Wang, Xia; Ding, Jianqiang; Liu, Laibin; Fox, Ira J.; Roy-Chowdhury, Jayanta; Roy-Chowdhury, Namita; Guha, Chandan			Single Liver Lobe Repopulation with Wildtype Hepatocytes Using Regional Hepatic Irradiation Cures Jaundice in Gunn Rats	PLOS ONE			English	Article							EXTERNAL-BEAM RADIOTHERAPY; PREPARATIVE REGIMEN; PARTIAL-HEPATECTOMY; TRANSPLANTATION; RADIATION; DISEASE; MODEL; BILIRUBIN; TYPE-1; VIVO	Background and Aims: Preparative hepatic irradiation (HIR), together with mitotic stimulation of hepatocytes, permits extensive hepatic repopulation by transplanted hepatocytes in rats and mice. However, whole liver HIR is associated with radiation-induced liver disease (RILD), which limits its potential therapeutic application. In clinical experience, restricting HIR to a fraction of the liver reduces the susceptibility to RILD. Here we test the hypothesis that repopulation of selected liver lobes by regional HIR should be sufficient to correct some inherited metabolic disorders. Methods: Hepatocytes (10(7)) isolated from wildtype F344 rats or Wistar-RHA rats were engrafted into the livers of congeneic dipeptidylpeptidase IV deficient (DPPIV-) rats or uridinediphosphoglucuronateglucuronosyltransferase-1A1-deficient jaundiced Gunn rats respectively by intrasplenic injection 24 hr after HIR (50 Gy) targeted to the median lobe, or median plus left liver lobes. An adenovector expressing hepatocyte growth factor (10(11) particles) was injected intravenously 24 hr after transplantation. Results: Three months after hepatocyte transplantation in DPPIV- rats, 30-60% of the recipient hepatocytes were replaced by donor cells in the irradiated lobe, but not in the nonirradiated lobes. In Gunn rats receiving median lobe HIR, serum bilirubin declined from pretreatment levels of 5.17 +/- 0.78 mg/dl to 0.96 +/- 0.30 mg/dl in 8 weeks and remained at this level throughout the 16 week observation period. A similar effect was observed in the group, receiving median plus left lobe irradiation. Conclusions: As little as 20% repopulation of 30% of the liver volume was sufficient to correct hyperbilirubinemia in Gunn rats, highlighting the potential of regiospecific HIR in hepatocyte transplantation-based therapy of inherited metabolic liver diseases.	[Chen, Yong; Avsar, Yesim; Wang, Xia; Ding, Jianqiang; Roy-Chowdhury, Jayanta; Roy-Chowdhury, Namita] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Zhou, Hongchao; Dong, Xinyuan; Kabarriti, Rafi; Liu, Laibin; Guha, Chandan] Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; [Zhou, Hongchao; Dong, Xinyuan; Kabarriti, Rafi; Liu, Laibin; Guha, Chandan] Montefiore Med Ctr, Bronx, NY 10467 USA; [Fox, Ira J.] Univ Pittsburgh, Childrens Hosp Pittsburgh UPMC, Sch Med, Dept Surg, Pittsburgh, PA USA; [Fox, Ira J.] McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Chen, Yong; Avsar, Yesim; Wang, Xia; Ding, Jianqiang; Roy-Chowdhury, Jayanta; Roy-Chowdhury, Namita] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Zhou, Hongchao; Dong, Xinyuan; Kabarriti, Rafi; Liu, Laibin] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Roy-Chowdhury, N (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	Namita.Roychowdhury@Einstein.YU.edu; cguha@montefiore.org		Ding, Jianqiang/0000-0003-1964-1513	National Institutes of Health [RO1 DK 46057, RO1 DK 67440]; NY Stem [CO24346, DK RO1 079017]; Oxalosis and Hyperoxaluria Foundation [R01 DK64670, R21/R33 CA121051]; NATIONAL CANCER INSTITUTE [R21CA121051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064670, R01DK046057, R01DK067440, R01DK079017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NY Stem; Oxalosis and Hyperoxaluria Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grants: RO1 DK 46057 and RO1 DK 67440, NY Stem CO24346 (to JRC); DK RO1 079017 (NRC), Oxalosis and Hyperoxaluria Foundation (to NRC); R01 DK64670 and R21/R33 CA121051 (to CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino G, 2005, CELL TRANSPLANT, V14, P151, DOI 10.3727/000000005783983250; CHOWDHURY J R, 1981, Hepatology, V1, P622; Chowdury NR, 2009, LIVER BIOL PATHOBIOL, P251; Christiansen H, 2006, INT J RADIAT ONCOL, V65, P509, DOI 10.1016/j.ijrobp.2006.01.040; Dawson LA, 2005, SEMIN RADIAT ONCOL, V15, P279, DOI 10.1016/j.semradonc.2005.04.005; Dawson LA, 2002, INT J RADIAT ONCOL, V53, P810, DOI 10.1016/S0360-3016(02)02846-8; Dhawan A, 2006, J INHERIT METAB DIS, V29, P431, DOI 10.1007/s10545-006-0245-8; Dhawan A, 2010, METHODS MOL BIOL, V640, P525, DOI 10.1007/978-1-60761-688-7_29; FEVERY J, 1977, J CLIN INVEST, V60, P970, DOI 10.1172/JCI108877; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Grompe M, 1999, SEMIN LIVER DIS, V19, P7, DOI 10.1055/s-2007-1007093; Guha C, 2005, AM J NEPHROL, V25, P161, DOI 10.1159/000085408; Guha C, 2002, HEPATOLOGY, V36, P354, DOI 10.1053/jhep.2002.34516; Guha C, 2001, INT J RADIAT ONCOL, V49, P451, DOI 10.1016/S0360-3016(00)01495-4; Guha C, 1999, CANCER RES, V59, P5871; Gupta S, 1999, HEPATOLOGY, V29, P509, DOI 10.1002/hep.510290213; Gupta S, 1999, SEMIN LIVER DIS, V19, P15, DOI 10.1055/s-2007-1007094; Horslen SP, 2003, PEDIATRICS, V111, P1262, DOI 10.1542/peds.111.6.1262; Jiang JL, 2008, TRANSPLANTATION, V85, P1253, DOI 10.1097/TP.0b013e31816de49e; Krause P, 2011, INT J RADIAT ONCOL, V80, P1214, DOI 10.1016/j.ijrobp.2011.02.035; Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5; Lake JR, 1998, NEW ENGL J MED, V338, P1463, DOI 10.1056/NEJM199805143382012; Legido-Quigley C, 2009, BIOANALYSIS, V1, P1527, DOI [10.4155/bio.09.112, 10.4155/BIO.09.112]; NEUFELD DS, 1997, ISOLATION RAT HEPATO; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; PIAZZA GA, 1989, BIOCHEM J, V262, P327, DOI 10.1042/bj2620327; Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010; Waelzlein JH, 2009, CURR OPIN NEPHROL HY, V18, P481, DOI 10.1097/MNH.0b013e3283318e1c; Wang Xia, 2009, V481, P117, DOI 10.1007/978-1-59745-201-4_11; Yamanouchi K, 2009, HEPATOLOGY, V49, P258, DOI 10.1002/hep.22573	32	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46775	10.1371/journal.pone.0046775	http://dx.doi.org/10.1371/journal.pone.0046775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091601	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800014
J	Bashir, T; Cloninger, C; Artinian, N; Anderson, L; Bernath, A; Holmes, B; Benavides-Serrato, A; Sabha, N; Nishimura, RN; Guha, A; Gera, J				Bashir, Tariq; Cloninger, Cheri; Artinian, Nicholas; Anderson, Lauren; Bernath, Andrew; Holmes, Brent; Benavides-Serrato, Angelica; Sabha, Nesrin; Nishimura, Robert N.; Guha, Abhijit; Gera, Joseph			Conditional Astroglial Rictor Overexpression Induces Malignant Glioma in Mice	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; CELLULAR COMPOSITION; PTEN LOSS; MTOR; PATHWAY; EXPRESSION; COMPLEX; CANCER	Background: Hyperactivation of the mTORC2 signaling pathway has been shown to contribute to the oncogenic properties of gliomas. Moreover, overexpression of the mTORC2 regulatory subunit Rictor has been associated with increased proliferation and invasive character of these tumor cells. Methodology/Principal Findings: To determine whether Rictor overexpression was sufficient to induce glioma formation in mice, we inserted a Cre-lox-regulated human Rictor transgene into the murine ROSA26 locus. This floxed Rictor strain was crossed with mice expressing the Cre recombinase driven from the glial fibrillary acidic protein (GFAP) promoter whose expression is limited to the glial cell compartment. Double transgenic GFAP-Cre/Rictor(loxP/loxP) mice developed multifocal infiltrating glioma containing elevated mTORC2 activity and typically involved the subventricular zone (SVZ) and lateral ventricle. Analysis of Rictor-dependent signaling in these tumors demonstrated that in addition to elevated mTORC2 activity, an mTORC2-independent marker of cortical actin network function, was also elevated. Upon histological examination of the neoplasms, many displayed oligodendroglioma-like phenotypes and expressed markers associated with oligodendroglial lineage tumors. To determine whether upstream oncogenic EGFRvIII signaling would alter tumor phenotypes observed in the GFAP-Cre/Rictor(loxP/loxP) mice, transgenic GFAP-EGFRvIII; GFAP-Cre/Rictor(loxP/loxP) mice were generated. These mice developed mixed astrocytic-oligodendroglial tumors, however glioma formation was accelerated and correlated with increased mTORC2 activity. Additionally, the subventricular zone within the GFAP-Cre/Rictor(loxP/loxP) mouse brain was markedly expanded, and a further proliferation within this compartment of the brain was observed in transgenic GFAP-EGFRvIII; GFAP-Cre/Rictor(loxP/loxP) mice. Conclusion/Significance: These data collectively establish Rictor as a novel oncoprotein and support the role of dysregulated Rictor expression in gliomagenesis via mTOR-dependent and mTOR-independent mechanisms. Furthermore, oncogenic EGFRvIII signaling appears to potentiate the in vivo proliferative capacity of GFAP-Cre/Rictor(loxP/loxP) gliomas.	[Bashir, Tariq; Cloninger, Cheri; Artinian, Nicholas; Anderson, Lauren; Bernath, Andrew; Holmes, Brent; Benavides-Serrato, Angelica; Nishimura, Robert N.; Gera, Joseph] Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA USA; [Gera, Joseph] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Nishimura, Robert N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Sabha, Nesrin; Guha, Abhijit] Univ Toronto, Hosp Sick Children, Res Inst, Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; [Gera, Joseph] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Gera, Joseph] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gera, J (corresponding author), Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA USA.	jgera@mednet.ucla.edu		Gera, Joseph/0000-0002-2908-6894; Holmes, Brent/0000-0002-2768-2991	National Institutes of Health [R01CA109312]; Veterans Administration; NATIONAL CANCER INSTITUTE [R01CA168700, R01CA109312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by National Institutes of Health grant R01CA109312 and funds from the Veterans Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel TW, 2009, MOL CANCER RES, V7, P645, DOI 10.1158/1541-7786.MCR-08-0477; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bromberg JEC, 2009, ONCOLOGIST, V14, P155, DOI 10.1634/theoncologist.2008-0248; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Dasgupta B, 2005, CANCER RES, V65, P2755, DOI 10.1158/0008-5472.CAN-04-4058; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Ding H, 2003, CANCER RES, V63, P1106; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fortin D, 1999, NEUROSURGERY, V45, P1279, DOI 10.1097/00006123-199912000-00001; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Gibault L, 2012, MODERN PATHOL, V25, P197, DOI 10.1038/modpathol.2011.163; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hagan GN, 2008, MOL CELL BIOL, V28, P4215, DOI 10.1128/MCB.00867-07; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; HURTT MR, 1992, J NEUROPATH EXP NEUR, V51, P84, DOI 10.1097/00005072-199201000-00010; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; JAROS E, 1992, BRIT J CANCER, V66, P373, DOI 10.1038/bjc.1992.273; Johannessen CM, 2008, CURR BIOL, V18, P56, DOI 10.1016/j.cub.2007.11.066; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee DY, 2010, GENE DEV, V24, P2317, DOI 10.1101/gad.1957110; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Martin J, 2008, BIOCHEM BIOPH RES CO, V372, P578, DOI 10.1016/j.bbrc.2008.05.086; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Morri LGT, 2011, P NATL ACAD SCI USA, V108, P19024, DOI 10.1073/pnas.1111963108; Nagy A., 2003, MANIPULATING MOUSE E; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Sabatini D.M., 2012, COLD SPRING HARB PER, V4; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; SCHLEGEL J, 1994, J NEURO-ONCOL, V22, P201, DOI 10.1007/BF01052920; Setoguchi T, 2004, J CELL BIOL, V166, P963, DOI 10.1083/jcb.200404104; Shannon P, 2005, AM J PATHOL, V167, P859, DOI 10.1016/S0002-9440(10)62057-3; Shinojima N, 2003, CANCER RES, V63, P6962; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; SUZUMURA A, 1984, BRAIN RES, V324, P379, DOI 10.1016/0006-8993(84)90054-4; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang F, 2010, CANCER RES, V70, P9360, DOI 10.1158/0008-5472.CAN-10-0207; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	57	40	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47741	10.1371/journal.pone.0047741	http://dx.doi.org/10.1371/journal.pone.0047741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077666	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100158
J	Chaturvedi, P; Khanna, R; Parnaik, VK				Chaturvedi, Pankaj; Khanna, Richa; Parnaik, Veena K.			Ubiquitin ligase RNF123 Mediates Degradation of Heterochromatin Protein 1 alpha and beta in Lamin A/C Knock-Down Cells	PLOS ONE			English	Article							A-TYPE LAMINS; HUTCHINSON-GILFORD-PROGERIA; CHROMATIN ORGANIZATION; NUCLEAR LAMINS; PROTEASOMAL DEGRADATION; RETINOBLASTOMA PROTEIN; REGULATES PROTEOLYSIS; HIGH-MOBILITY; LAMINOPATHIES; EXPRESSION	Background: The nuclear lamina is a key determinant of nuclear architecture, integrity and functionality in metazoan nuclei. Mutations in the human lamin A gene lead to highly debilitating genetic diseases termed as laminopathies. Expression of lamin A mutations or reduction in levels of endogenous A-type lamins leads to nuclear defects such as abnormal nuclear morphology and disorganization of heterochromatin. This is accompanied by increased proteasomal degradation of certain nuclear proteins such as emerin, nesprin-1 alpha, retinoblastoma protein and heterochromatin protein 1 (HP1). However, the pathways of proteasomal degradation have not been well characterized. Methodology/Principal Findings: To investigate the mechanisms underlying the degradation of HP1 proteins upon lamin misexpression, we analyzed the effects of shRNA-mediated knock-down of lamins A and C in HeLa cells. Cells with reduced levels of expression of lamins A and C exhibited proteasomal degradation of HP1 alpha and HP1 beta but not HP1 gamma. Since specific ubiquitin ligases are upregulated in lamin A/C knock-down cells, further studies were carried out with one of these ligases, RNF123, which has a putative HP1-binding motif. Ectopic expression of GFP-tagged RNF123 directly resulted in degradation of HP1 alpha and HP1 beta. Mutational analysis showed that the canonical HP1-binding pentapeptide motif PXVXL in the N-terminus of RNF123 was required for binding to HP1 proteins and targeting them for degradation. The role of endogenous RNF123 in the degradation of HP1 isoforms was confirmed by RNF123 RNAi experiments. Furthermore, FRAP analysis suggested that HP1 beta was displaced from chromatin in laminopathic cells. Conclusions/Significance: Our data support a role for RNF123 ubiquitin ligase in the degradation of HP1 alpha and HP1 beta upon lamin A/C knock-down. Hence lamin misexpression can cause degradation of mislocalized proteins involved in key nuclear processes by induction of specific components of the ubiquitin-proteasome system.	[Chaturvedi, Pankaj; Khanna, Richa; Parnaik, Veena K.] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Parnaik, VK (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	veenap@ccmb.res.in	Chaturvedi, Pankaj/ABC-4658-2020	Chaturvedi, Pankaj/0000-0001-7596-2165; Khanna, Richa/0000-0001-8513-3029	Department of Science and Technology, India; Council of Scientific and Industrial Research; University Grants Commission, India	Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, India(University Grants Commission, India)	VKP is a recipient of the JC Bose national fellowship from the Department of Science and Technology, India. PC and RK were supported by pre-doctoral fellowships from the Council of Scientific and Industrial Research and University Grants Commission, India, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chaturvedi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010620; Columbaro M, 2005, CELL MOL LIFE SCI, V62, P2669, DOI 10.1007/s00018-005-5318-6; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Filesi I, 2005, PHYSIOL GENOMICS, V23, P150, DOI 10.1152/physiolgenomics.00060.2005; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gurudatta BV, 2010, J GENET, V89, P37, DOI 10.1007/s12041-010-0009-y; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Lu BY, 2000, GENETICS, V155, P699; Manju K, 2006, J CELL SCI, V119, P2704, DOI 10.1242/jcs.03009; Mariappan I, 2005, MOL BIOL CELL, V16, P1948, DOI 10.1091/mbc.E04-02-0154; Muchir A, 2006, BIOCHEM BIOPH RES CO, V351, P1011, DOI 10.1016/j.bbrc.2006.10.147; Muralikrishna B, 2012, MOL CELL BIOCHEM, V365, P323, DOI 10.1007/s11010-012-1272-4; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Nitta RT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000963; Parnaik VK, 2008, INT REV CEL MOL BIO, V266, P157, DOI 10.1016/S1937-6448(07)66004-3; Parnaik VK, 2011, J BIOSCIENCES, V36, P471, DOI 10.1007/s12038-011-9085-2; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Tripathi K, 2008, J BIOSCIENCES, V33, P345, DOI 10.1007/s12038-008-0054-3; Vogel MJ, 2006, GENOME RES, V16, P1493, DOI 10.1101/gr.5391806	37	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47558	10.1371/journal.pone.0047558	http://dx.doi.org/10.1371/journal.pone.0047558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077635	gold, Green Published, Green Submitted			2022-12-27	WOS:000309995100130
J	Shaukat, Z; Wong, HWS; Nicolson, S; Saint, RB; Gregory, SL				Shaukat, Zeeshan; Wong, Heidi W. S.; Nicolson, Shannon; Saint, Robert B.; Gregory, Stephen L.			A Screen for Selective Killing of Cells with Chromosomal Instability Induced by a Spindle Checkpoint Defect	PLOS ONE			English	Article							GENOMIC INSTABILITY; ASSEMBLY CHECKPOINT; TARGETING CANCER; DNA BREAKS; DROSOPHILA; ANEUPLOIDY; JNK; P53; MUTATIONS; MAD2	Background: The spindle assembly checkpoint is crucial for the maintenance of a stable chromosome number. Defects in the checkpoint lead to Chromosomal INstability (CIN), which is linked to the progression of tumors with poor clinical outcomes such as drug resistance and metastasis. As CIN is not found in normal cells, it offers a cancer-specific target for therapy, which may be particularly valuable because CIN is common in advanced tumours that are resistant to conventional therapy. Principal Findings: Here we identify genes that are required for the viability of cells with a CIN phenotype. We have used RNAi knockdown of the spindle assembly checkpoint to induce CIN in Drosophila and then screened the set of kinase and phosphatase genes by RNAi knockdown to identify those that induce apoptosis only in the CIN cells. Genes identified include those involved in JNK signaling pathways and mitotic cytoskeletal regulation. Conclusions/Significance: The screen demonstrates that it is feasible to selectively kill cells with CIN induced by spindle checkpoint defects. It has identified candidates that are currently being pursued as cancer therapy targets (e. g. Nek2: NIMA related kinase 2), confirming that the screen is able to identify promising drug targets of clinical significance. In addition, several other candidates were identified that have no previous connection with mitosis or apoptosis. Further screening and detailed characterization of the candidates could potentially lead to the therapies that specifically target advanced cancers that exhibit CIN.	[Shaukat, Zeeshan; Nicolson, Shannon; Gregory, Stephen L.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Wong, Heidi W. S.; Saint, Robert B.] Univ Melbourne, Dept Genet, Melbourne, Vic, Australia	University of Adelaide; University of Melbourne	Gregory, SL (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	stephen.gregory@adelaide.edu.au	Saint, Robert/A-4190-2008; Gregory, Stephen L/B-9918-2008	Saint, Robert/0000-0002-7989-6043; Gregory, Stephen L/0000-0002-0046-5815; Nicolson, Shannon/0000-0001-9580-3460	National Health and Medical Research Council [525477, 1027878]; University of Adelaide; University of Melbourne	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Adelaide; University of Melbourne(University of Melbourne)	This work was funded in part by National Health and Medical Research Council grants 525477 and 1027878 (www.nhmrc.gov.au). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Bloomington and VDRC stock centers for provision of flies. We thank the University of Adelaide and University of Melbourne for providing facilities and student scholarships.	Aihara H, 2004, GENE DEV, V18, P877, DOI 10.1101/gad.1184604; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bogoyevitch MA, 2009, BIOCHIM BIOPHYS ACTA, V1804, P463; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570; Burds AA, 2005, P NATL ACAD SCI USA, V102, P11296, DOI 10.1073/pnas.0505053102; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Crasta K, 2012, NATURE; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Dotiwala F, 2010, CURR BIOL, V20, P328, DOI 10.1016/j.cub.2009.12.033; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Duensing A, 2010, ADV EXP MED BIOL, V676, P93; Fukasawa K, 1997, MOL CELL BIOL, V17, P506, DOI 10.1128/MCB.17.1.506; Furlong F, 2012, J PATHOL, V226, P746, DOI 10.1002/path.3035; Galimberti F, 2011, CLIN CANCER RES, V17, P1218, DOI 10.1158/1078-0432.CCR-10-1178; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Gutierrez GJ, 2010, J BIOL CHEM, V285, P14217, DOI 10.1074/jbc.M110.121848; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Heilig CE, 2010, J CELL MOL MED, V14, P895, DOI 10.1111/j.1582-4934.2009.00905.x; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Kasiappan R, 2009, MOL CANCER RES, V7, P536, DOI 10.1158/1541-7786.MCR-08-0422; Kawajiri S, 2011, TRENDS PHARMACOL SCI, V32, P573, DOI 10.1016/j.tips.2011.06.001; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Lawlor KT, 2011, HUM MOL GENET, V20, P3757, DOI 10.1093/hmg/ddr292; Liu QD, 2010, EXP MOL PATHOL, V88, P225, DOI 10.1016/j.yexmp.2009.12.004; Liu RX, 2010, ENDOCRINE, V38, P38, DOI 10.1007/s12020-010-9324-6; Lunardi A, 2010, P NATL ACAD SCI USA, V107, P6322, DOI 10.1073/pnas.1002447107; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; MacDonald PE, 2011, DIABETOLOGIA, V54, P719, DOI 10.1007/s00125-011-2072-1; Mazzorana M, 2011, CURR CANCER DRUG TAR, V11, P600, DOI 10.2174/156800911795655949; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Menzel N, 2007, MECH DEVELOP, V124, P78, DOI 10.1016/j.mod.2006.09.007; MERTENS F, 1994, GENE CHROMOSOME CANC, V10, P221, DOI 10.1002/gcc.2870100402; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Mitelman F, 1997, CANCER GENET CYTOGEN, V95, P1, DOI 10.1016/S0165-4608(96)00252-X; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Orr B, 2007, MOL BIOL CELL, V18, P850, DOI 10.1091/mbc.E06-07-0587; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pihan GA, 2001, CANCER RES, V61, P2212; Polaski S, 2006, GENETICS, V174, P719, DOI 10.1534/genetics.106.056564; Prencipe M, 2010, CELL CYCLE, V9, P2856, DOI 10.4161/cc.9.14.12362; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Roschke AV, 2005, CELL CYCLE, V4, P679, DOI 10.4161/cc.4.5.1687; Schlafli P, 2009, CELL MOL LIFE SCI, V66, P876, DOI 10.1007/s00018-009-8699-0; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Shiryaev A, 2010, CELL SIGNAL, V22, P1185, DOI 10.1016/j.cellsig.2010.03.002; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Sonn S, 2011, ZYGOTE, V19, P15, DOI 10.1017/S0967199410000183; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Stronach B, 2005, DEV DYNAM, V232, P575, DOI 10.1002/dvdy.20283; Suzuki K, 2010, CANCER SCI, V101, P1163, DOI 10.1111/j.1349-7006.2010.01504.x; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tritarelli A, 2004, MOL BIOL CELL, V15, P3751, DOI 10.1091/mbc.E03-12-0900; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Weaver BAA, 2009, J CELL BIOL, V185, P934, DOI 10.1083/jcb.200905098; WILLIAMS BC, 1994, J CELL SCI, V107, P785; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang JY, 2009, MOL BIOL CELL, V20, P2381, DOI 10.1091/mbc.E08-12-1206	71	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47447	10.1371/journal.pone.0047447	http://dx.doi.org/10.1371/journal.pone.0047447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077619	gold, Green Submitted, Green Published			2022-12-27	WOS:000309995100115
J	Siemer, AB; Huang, KY; McDermott, AE				Siemer, Ansgar B.; Huang, Kuo-Ying; McDermott, Ann E.			Protein Linewidth and Solvent Dynamics in Frozen Solution NMR	PLOS ONE			English	Article							SOLID-STATE NMR; NUCLEAR-MAGNETIC-RESONANCE; GLASS-TRANSITION; CONFORMATIONAL DISTRIBUTIONS; ANTIFREEZE PROTEIN; METHYL-GROUP; T4 LYSOZYME; WATER; SPECTROSCOPY; HYDRATION	Solid-state NMR of proteins in frozen aqueous solution is a potentially powerful technique in structural biology, especially if it is combined with dynamic nuclear polarization signal enhancement strategies. One concern regarding NMR studies of frozen solution protein samples at low temperatures is that they may have poor linewidths, thus preventing high-resolution studies. To learn more about how the solvent shell composition and temperature affects the protein linewidth, we recorded H-1, H-2, and C-13 spectra of ubiquitin in frozen water and frozen glycerol-water solutions at different temperatures. We found that the C-13 protein linewidths generally increase with decreasing temperature. This line broadening was found to be inhomogeneous and independent of proton decoupling. In pure water, we observe an abrupt line broadening with the freezing of the bulk solvent, followed by continuous line broadening at lower temperatures. In frozen glycerol-water, we did not observe an abrupt line broadening and the NMR lines were generally narrower than for pure water at the same temperature. H-1 and H-2 measurements characterizing the dynamics of water that is in exchange with the protein showed that the C-13 line broadening is relatively independent from the arrest of isotropic water motions.	[Siemer, Ansgar B.; Huang, Kuo-Ying; McDermott, Ann E.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Siemer, AB (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	asiemer@usc.edu; aem5@columbia.edu		McDermott, Ann/0000-0002-9249-1649	National Science Foundation (NSF) [mcb 0316248]; National Institutes of Health (NIH) [r01 gm 88724]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088724] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation (NSF) mcb 0316248 and National Institutes of Health (NIH) r01 gm 88724. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Atilgan C, 2008, BIOPHYS J, V94, P79, DOI 10.1529/biophysj.107.116426; Bajaj VS, 2009, J AM CHEM SOC, V131, P118, DOI 10.1021/ja8045926; Barnes AB, 2008, APPL MAGN RESON, V34, P237, DOI 10.1007/s00723-008-0129-1; Bertini I, 2011, P NATL ACAD SCI USA, V108, P10396, DOI 10.1073/pnas.1103854108; BIELECKI A, 1995, J MAGN RESON SER A, V116, P215, DOI 10.1006/jmra.1995.0010; Doster W, 2005, BBA-PROTEINS PROTEOM, V1749, P173, DOI 10.1016/j.bbapap.2005.03.010; Doster W, 2010, BBA-PROTEINS PROTEOM, V1804, P3, DOI 10.1016/j.bbapap.2009.06.019; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gabel F, 2002, Q REV BIOPHYS, V35, P327, DOI 10.1017/S0033583502003840; Georgieva ER, 2012, J MAGN RESON, V216, P69, DOI 10.1016/j.jmr.2012.01.004; Goddard YA, 2009, J MAGN RESON, V199, P68, DOI 10.1016/j.jmr.2009.04.001; Halle B, 2004, PHILOS T R SOC B, V359, P1207, DOI 10.1098/rstb.2004.1499; Havlin RH, 2005, P NATL ACAD SCI USA, V102, P3284, DOI 10.1073/pnas.0406130102; Havlin RH, 2007, BIOCHEMISTRY-US, V46, P3586, DOI 10.1021/bi0622928; Heugen U, 2006, P NATL ACAD SCI USA, V103, P12301, DOI 10.1073/pnas.0604897103; Hu KN, 2010, J AM CHEM SOC, V132, P24, DOI 10.1021/ja908471n; Jansson H, 2005, J PHYS CHEM B, V109, P24134, DOI 10.1021/jp052418v; KENNEDY SD, 1990, BIOPOLYMERS, V29, P1801, DOI 10.1002/bip.360291411; Krushelnitsky A, 2009, J PHYS CHEM B, V113, P10022, DOI 10.1021/jp900337x; Linden AH, 2011, J BIOMOL NMR, V51, P283, DOI 10.1007/s10858-011-9535-z; Long HW, 1998, J AM CHEM SOC, V120, P7039, DOI 10.1021/ja974277j; Maus DC, 1996, J AM CHEM SOC, V118, P5665, DOI 10.1021/ja960248h; Nucci NV, 2011, NAT STRUCT MOL BIOL, V18, P245, DOI 10.1038/nsmb.1955; Ringe D, 2003, BIOPHYS CHEM, V105, P667, DOI 10.1016/S0301-4622(03)00096-6; Sharpe S, 2006, BIOCHEMISTRY-US, V45, P918, DOI 10.1021/bi051766k; Sharpe S, 2004, J AM CHEM SOC, V126, P4979, DOI 10.1021/ja0392162; Shinyashiki N, 2009, J PHYS CHEM B, V113, P14448, DOI 10.1021/jp905511w; Siemer AB, 2010, P NATL ACAD SCI USA, V107, P17580, DOI 10.1073/pnas.1009369107; Siemer AB, 2008, J AM CHEM SOC, V130, P17394, DOI 10.1021/ja8047893; Tompa K, 2009, BIOPHYS J, V96, P2789, DOI 10.1016/j.bpj.2008.11.038; Tournier AL, 2003, BIOPHYS J, V85, P1871, DOI 10.1016/S0006-3495(03)74614-1; Gonzalez JAT, 2011, J CHEM ENG DATA, V56, P1397, DOI 10.1021/je101164q; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; Vogel M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.225701; Vugmeyster L, 2010, J AM CHEM SOC, V132, P4038, DOI 10.1021/ja909599k; Zech SG, 2005, J AM CHEM SOC, V127, P8618, DOI 10.1021/ja0503128	38	51	51	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47242	10.1371/journal.pone.0047242	http://dx.doi.org/10.1371/journal.pone.0047242			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077575	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100079
J	Smith, S; Witkowski, A; Moghul, A; Yoshinaga, Y; Nefedov, M; de Jong, P; Feng, DJ; Fong, LR; Tu, YP; Hu, Y; Young, SG; Pham, T; Cheung, C; Katzman, SM; Brand, MD; Quinlan, CL; Fens, M; Kuypers, F; Misquitta, S; Griffey, SM; Tran, S; Gharib, A; Knudsen, J; Hannibal-Bach, HK; Wang, G; Larkin, S; Thweatt, J; Pasta, S				Smith, Stuart; Witkowski, Andrzej; Moghul, Ayesha; Yoshinaga, Yuko; Nefedov, Michael; de Jong, Pieter; Feng, Dejiang; Fong, Loren; Tu, Yiping; Hu, Yan; Young, Stephen G.; Pham, Thomas; Cheung, Carling; Katzman, Shana M.; Brand, Martin D.; Quinlan, Casey L.; Fens, Marcel; Kuypers, Frans; Misquitta, Stephanie; Griffey, Stephen M.; Tran, Son; Gharib, Afshin; Knudsen, Jens; Hannibal-Bach, Hans Kristian; Wang, Grace; Larkin, Sandra; Thweatt, Jennifer; Pasta, Saloni			Compromised Mitochondrial Fatty Acid Synthesis in Transgenic Mice Results in Defective Protein Lipoylation and Energy Disequilibrium	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; BLOOD-CELLS; LIPOIC ACID; EXPRESSION; SYNTHASE; CLONING; PURIFICATION; ENZYME; DEATH	A mouse model with compromised mitochondrial fatty acid synthesis has been engineered in order to assess the role of this pathway in mitochondrial function and overall health. Reduction in the expression of mitochondrial malonyl CoA-acyl carrier protein transacylase, a key enzyme in the pathway encoded by the nuclear Mcat gene, was achieved to varying extents in all examined tissues employing tamoxifen-inducible Cre-lox technology. Although affected mice consumed more food than control animals, they failed to gain weight, were less physically active, suffered from loss of white adipose tissue, reduced muscle strength, kyphosis, alopecia, hypothermia and shortened lifespan. The Mcat-deficient phenotype is attributed primarily to reduced synthesis, in several tissues, of the octanoyl precursors required for the posttranslational lipoylation of pyruvate and alpha-ketoglutarate dehydrogenase complexes, resulting in diminished capacity of the citric acid cycle and disruption of energy metabolism. The presence of an alternative lipoylation pathway that utilizes exogenous free lipoate appears restricted to liver and alone is insufficient for preservation of normal energy metabolism. Thus, de novo synthesis of precursors for the protein lipoylation pathway plays a vital role in maintenance of mitochondrial function and overall vigor.	[Smith, Stuart; Witkowski, Andrzej; Moghul, Ayesha; Yoshinaga, Yuko; Nefedov, Michael; de Jong, Pieter; Feng, Dejiang; Pham, Thomas; Cheung, Carling; Fens, Marcel; Kuypers, Frans; Misquitta, Stephanie; Tran, Son; Gharib, Afshin; Wang, Grace; Larkin, Sandra; Thweatt, Jennifer; Pasta, Saloni] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Fong, Loren; Tu, Yiping; Hu, Yan; Young, Stephen G.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Katzman, Shana M.; Brand, Martin D.; Quinlan, Casey L.] Buck Inst Res Aging, Novato, CA USA; [Griffey, Stephen M.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Gharib, Afshin] Dominican Univ Calif, San Rafael, CA USA; [Knudsen, Jens; Hannibal-Bach, Hans Kristian] Odense Univ, Dept Biochem & Mol Biol, Odense, Denmark	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Los Angeles; Buck Institute for Research on Aging; University of California System; University of California Davis; University of Southern Denmark	Smith, S (corresponding author), Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.	ssmith@chori.org	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Witkowski, Andrzej/0000-0002-0442-4586; Quinlan, Casey/0000-0002-7808-8271; Young, Stephen/0000-0001-7270-3176	National Institutes of Health [GM069717, AG032118]; United Mitochondrial Disease Foundation; Netherlands Organisation for Scientific Research, The Hague, The Netherlands; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [PL1AG032118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Mitochondrial Disease Foundation; Netherlands Organisation for Scientific Research, The Hague, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant GM069717 and United Mitochondrial Disease Foundation (to SS) and National Institutes of Health Grant AG032118 (to MDB). MF is supported by the Netherlands Organisation for Scientific Research, The Hague, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; BONNEFONT JP, 1992, J PEDIATR-US, V121, P255, DOI 10.1016/S0022-3476(05)81199-0; BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875; Brugnara C, 1998, INT J CLIN LAB RES, V28, P1, DOI 10.1007/s005990050011; Bunkoczi G, 2009, CHEM BIOL, V16, P667, DOI 10.1016/j.chembiol.2009.04.011; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474; Chen ZJ, 2009, FASEB J, V23, P3682, DOI 10.1096/fj.09-133587; Crawley J. N., 2007, WHATS WRONG MY MOUSE; de Jong K, 2001, BLOOD, V98, P1577, DOI 10.1182/blood.V98.5.1577; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; FUJIWARA K, 1994, J BIOL CHEM, V269, P16605; Fujiwara K, 2001, J BIOL CHEM, V276, P28819, DOI 10.1074/jbc.M101748200; Gharid A, 2011, NEURODEGENERATION TH, P63; Gurvitz A, 2008, APPL ENVIRON MICROB, V74, P5078, DOI 10.1128/AEM.00655-08; Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018; Haines DC, 2001, TOXICOL PATHOL, V29, P653, DOI 10.1080/019262301753385988; Jong MC, 1998, J CLIN INVEST, V101, P145, DOI 10.1172/JCI791; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kikuchi G, 2008, P JPN ACAD B-PHYS, V84, P246, DOI [10.2183/pjab.84.246, 10.2183/pjab/84.246]; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Laws N, 2004, J APPL PHYSIOL, V97, P1970, DOI 10.1152/japplphysiol.01357.2003; Ma TH, 2001, AM J PHYSIOL-CELL PH, V280, pC126; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; Naviaux R, 1997, SPECTRUM MITOCHONDRI, P3; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Paul E, 2009, MAMM GENOME, V20, P92, DOI 10.1007/s00335-008-9168-z; Pliss L, 2004, J NEUROCHEM, V91, P1082, DOI 10.1111/j.1471-4159.2004.02790.x; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; SCHNEIDER H, 1980, P NATL ACAD SCI-BIOL, V77, P442, DOI 10.1073/pnas.77.1.442; Schwab MA, 2005, CLIN CHEM, V51, P151, DOI 10.1373/clinchem.2004.033852; Sidhu S, 2008, AM J PHYSIOL-HEART C, V295, pH946, DOI 10.1152/ajpheart.00363.2008; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; Tous M, 2004, METABOLISM, V53, P95, DOI 10.1016/j.metabol.2003.08.012; Treiber N, 2011, AGING CELL, V10, P239, DOI 10.1111/j.1474-9726.2010.00658.x; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; van Ampting MTJ, 2009, DIGEST DIS SCI, V54, P2588, DOI 10.1007/s10620-008-0685-0; Wang JP, 2006, MOL BIOTECHNOL, V32, P43, DOI 10.1385/MB:32:1:043; WILLIAMS JN, 1964, ARCH BIOCHEM BIOPHYS, V107, P537, DOI 10.1016/0003-9861(64)90313-3; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Witkowski A, 2011, J BIOL CHEM, V286, P33729, DOI 10.1074/jbc.M111.291591; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Yiou R, 2001, J ANAT, V199, P599, DOI 10.1046/j.1469-7580.2001.19950599.x; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200	52	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47196	10.1371/journal.pone.0047196	http://dx.doi.org/10.1371/journal.pone.0047196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077570	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100075
J	He, Y; Wang, H; Qian, BD; McConkey, B; DePauw, R				He, Yong; Wang, Hong; Qian, Budong; McConkey, Brian; DePauw, Ron			How Early Can the Seeding Dates of Spring Wheat Be under Current and Future Climate in Saskatchewan, Canada?	PLOS ONE			English	Article							GRAIN-YIELD; CERES-WHEAT; TEMPERATURE; GROWTH; PREDICTION; MODELS; PRECIPITATION; SIMULATION; MANAGEMENT; ALBERTA	Background: Shorter growing season and water stress near wheat maturity are the main factors that presumably limit the yield potential of spring wheat due to late seeding in Saskatchewan, Canada. Advancing seeding dates can be a strategy to help producers mitigate the impact of climate change on spring wheat. It is unknown, however, how early farmers can seed while minimizing the risk of spring frost damage and the soil and machinery constraints. Methodology/principal findings: This paper explores early seeding dates of spring wheat on the Canadian Prairies under current and projected future climate. To achieve this, (i) weather records from 1961 to 1990 were gathered at three sites with different soil and climate conditions in Saskatchewan, Canada; (ii) four climate databases that included a baseline (treated as historic weather climate during the period of 1961-1990) and three climate change scenarios (2040-2069) developed by the Canadian global climate model (GCM) with the forcing of three greenhouse gas (GHG) emission scenarios (A2, A1B and B1); (iii) seeding dates of spring wheat (Triticum aestivum L.) under baseline and projected future climate were predicted. Compared with the historical record of seeding dates, the predicted seeding dates were advanced under baseline climate for all sites using our seeding date model. Driven by the predicted temperature increase of the scenarios compared with baseline climate, all climate change scenarios projected significantly earlier seeding dates than those currently used. Compared to the baseline conditions, there is no reduction in grain yield because precipitation increases during sensitive growth stages of wheat, suggesting that there is potential to shift seeding to an earlier date. The average advancement of seeding dates varied among sites and chosen scenarios. The Swift Current (south-west) site has the highest potential for earlier seeding (7 to 11 days) whereas such advancement was small in the Melfort (north-east, 2 to 4 days) region. Conclusions/significance: The extent of projected climate change in Saskatchewan indicates that growers in this region have the potential of earlier seeding. The results obtained in this study may be used for adaptation assessments of seeding dates under possible climate change to mitigate the impact of potential warming.	[He, Yong; Wang, Hong; McConkey, Brian; DePauw, Ron] Agr & Agri Food Canada, Semiarid Prairie Agr Res Ctr, Swift Current, SK, Canada; [He, Yong] China Agr Univ, Dept Soil & Water Sci, Beijing 100094, Peoples R China; [Qian, Budong] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada	Agriculture & Agri Food Canada; China Agricultural University; Agriculture & Agri Food Canada	Wang, H (corresponding author), Agr & Agri Food Canada, Semiarid Prairie Agr Res Ctr, Swift Current, SK, Canada.	hong.wang@agr.gc.ca		Qian, Budong/0000-0001-5413-3114; He, Yong/0000-0003-4062-9201	Agriculture and Agri-Food Canada [96]; Visiting Fellowships in Canadian Government Laboratories Program	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Visiting Fellowships in Canadian Government Laboratories Program	This study was funded by Agriculture and Agri-Food Canada (Abase project #96). The authors gratefully acknowledge support for this research from the Visiting Fellowships in Canadian Government Laboratories Program, managed by the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov VA, 2000, THEOR APPL CLIMATOL, V67, P45, DOI 10.1007/s007040070015; Anderson WK, 1996, AUST J EXP AGR, V36, P203, DOI 10.1071/EA9960203; [Anonymous], 2000, SPECIAL REPORT EMISS; Bannayan M, 2003, AGRON J, V95, P114, DOI 10.2134/agronj2003.0114; Barklacich M, 1995, SPECIAL PUBLICATION, P147; BOOTSMA A, 1988, CAN J PLANT SCI, V68, P513, DOI 10.4141/cjps88-062; BOOTSMA A, 1986, CAN J PLANT SCI, V66, P789, DOI 10.4141/cjps86-097; BOOTSMA A, 1993, CAN J PLANT SCI, V73, P389, DOI 10.4141/cjps93-058; BOOTSMA A, 1994, CLIMATIC CHANGE, V26, P65, DOI 10.1007/BF01094009; Chipanshi AC, 1999, AGR SYST, V59, P57, DOI 10.1016/S0308-521X(98)00082-1; DEJONG R, 1984, CAN J SOIL SCI, V64, P667, DOI 10.4141/cjss84-067; *ENV CAN, 1993, CAN CLIM NORM; Gan YT, 2000, RES LETT; Hassan AE, 1975, CAN AGR ENG, V17, P124; HUNT LA, 1993, AGRON J, V85, P1090, DOI 10.2134/agronj1993.00021962008500050025x; Jame YW, 2004, AGR FOREST METEOROL, V124, P207, DOI 10.1016/j.agrformet.2004.01.012; Jamieson PD, 1998, FIELD CROP RES, V55, P23, DOI 10.1016/S0378-4290(97)00060-9; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; KERR NJ, 1992, AUST J EXP AGR, V32, P717, DOI 10.1071/EA9920717; Khan M, 1996, WEED SCI, V44, P362, DOI 10.1017/S0043174500094017; Kim SJ, 2003, CLIM DYNAM, V20, P635, DOI 10.1007/s00382-002-0292-2; Kim SJ, 2002, CLIM DYNAM, V19, P515, DOI 10.1007/s00382-002-0243-y; MACDOWALL FD, 1974, CAN J BOT, V52, P151, DOI 10.1139/b74-017; Major DJ, 1996, CAN J PLANT SCI, V76, P59, DOI 10.4141/cjps96-010; McCaig TN, 1997, CAN J PLANT SCI, V77, P215, DOI 10.4141/P96-144; McGinn SM, 1999, OUTLOOK AGR, V28, P19, DOI 10.1177/003072709902800104; MOGENSEN VO, 1985, ACTA AGR SCAND, V35, P353; MOULIN AP, 1993, CAN J PLANT SCI, V73, P713, DOI 10.4141/cjps93-093; Nangia V, 2008, J ENVIRON QUAL, V37, P296, DOI 10.2134/jeq2007.0224; Prasad PVV, 2011, J AGRON CROP SCI, V197, P430, DOI 10.1111/j.1439-037X.2011.00477.x; Qian BD, 2004, CLIM RES, V26, P175, DOI 10.3354/cr026175; Qian BD, 2011, AGR FOREST METEOROL, V151, P1781, DOI 10.1016/j.agrformet.2011.07.016; Quiring SM, 2003, AGR FOREST METEOROL, V118, P49, DOI 10.1016/S0168-1923(03)00072-8; Richards JH, 1969, ATLAS SASKATCHEWAN; SAS Institute Inc, 1999, SAS PRC GUID VERS 8; SIONIT N, 1980, PHYSIOL PLANTARUM, V50, P11, DOI 10.1111/j.1399-3054.1980.tb02675.x; Smith C.W., 1995, CROP PRODUCTION EVOL; Solomon S., 2007, PHYS SCI BASIS WORKI; Thornton PE, 2000, AGR FOREST METEOROL, V104, P255, DOI 10.1016/S0168-1923(00)00170-2; Wang H, 2009, NJAS-WAGEN J LIFE SC, V57, P65, DOI 10.1016/j.njas.2009.07.003; Wang H, 2010, CAN J SOIL SCI, V90, P37, DOI 10.4141/CJSS08084; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Zentner RP, 2003, CAN J PLANT SCI, V83, P667, DOI 10.4141/P02-160	43	21	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e45153	10.1371/journal.pone.0045153	http://dx.doi.org/10.1371/journal.pone.0045153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23094015	gold, Green Published, Green Submitted			2022-12-27	WOS:000312385200006
J	Drott, CJ; Olerud, J; Emanuelsson, H; Christoffersson, G; Carlsson, PO				Drott, Carl Johan; Olerud, Johan; Emanuelsson, Hanna; Christoffersson, Gustav; Carlsson, Per-Ola			Sustained Beta-Cell Dysfunction but Normalized Islet Mass in Aged Thrombospondin-1 Deficient Mice	PLOS ONE			English	Article							MOUSE PANCREATIC-ISLETS; ENDOTHELIAL-CELLS; BLOOD-FLOW; IN-VITRO; REVASCULARIZATION; VASCULARIZATION; HYPERGLYCEMIA; INHIBITION; MATRIX; GROWTH	Pancreatic islet endothelial cells have in recent years been shown to support beta-cell mass and function by paracrine interactions. Recently, we identified an islets endothelial-specific glycoprotein, thrombospondin-1 (TSP-1), that showed to be of importance for islet angiogenesis and beta-cell function in young mice. The present study aimed to investigate long-term consequences for islet morphology and beta-cell function of TSP-1 deficiency. Islet and beta-cell mass were observed increased at 10-12 weeks of age in TSP-1 deficient mice, but were normalized before 16 weeks of age when compared to wild-type controls. Islet vascularity was normal in 10-12 and 16-week-old TSP-1 deficient animals, whereas islets of one-year-old animals lacking TSP-1 were hypervascular. Beta-cell dysfunction in TSP-1 deficient animals was present at similar magnitudes between 10-12 and 52 weeks of age, as evaluated by glucose tolerance tests. The insulin secretion capacity in vivo of islets in one-year-old TSP-1 deficient animals was only similar to 15% of that in wild-type animals. Using a transplantation model, we reconstituted TSP-1 in adult TSP-deficient islets. In contrast to neonatal TSP-1 deficient islets that we previously reported to regain function after TSP-1 reconstitution, adult islets failed to recover. We conclude that TSP-1 deficiency in islets causes changing vascular and endocrine morphological alterations postnatally, but is coupled to a chronic beta-cell dysfunction. The beta-cell dysfunction induced by TSP-1 deficiency is irreversible if not substituted early in life.	[Drott, Carl Johan; Emanuelsson, Hanna; Christoffersson, Gustav; Carlsson, Per-Ola] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Olerud, Johan] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Carlsson, Per-Ola] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Carlsson, PO (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Per-Ola.Carlsson@mcb.uu.se	Christoffersson, Gustaf/ABC-7939-2020	Drott, Carl Johan/0000-0003-2829-8999; Christoffersson, Gustaf/0000-0002-9640-9702	Swedish Research Council; Juvenile Diabetes Research Foundation; European Foundation for the Study of Diabetes/Novo Nordisk Programme; Novo Nordisk Foundation; AFA Insurance; Diabetes Wellness Sweden; Swedish Diabetes Association; Family Ernfors Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Foundation for the Study of Diabetes/Novo Nordisk Programme; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); AFA Insurance; Diabetes Wellness Sweden; Swedish Diabetes Association; Family Ernfors Fund	This work was supported by grants from the Swedish Research Council, the Juvenile Diabetes Research Foundation, the European Foundation for the Study of Diabetes/Novo Nordisk Programme 2010, the Novo Nordisk Foundation, AFA Insurance, Diabetes Wellness Sweden, the Swedish Diabetes Association and the Family Ernfors Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON A, 1978, DIABETOLOGIA, V14, P397, DOI 10.1007/BF01228134; BONNERWEIR S, 1988, DIABETES, V37, P616, DOI 10.2337/diabetes.37.5.616; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Carlsson PO, 2002, J CLIN ENDOCR METAB, V87, P5418, DOI 10.1210/jc.2002-020728; Carlsson PO, 1996, AM J PHYSIOL-ENDOC M, V271, pE990, DOI 10.1152/ajpendo.1996.271.6.E990; Carlsson PO, 1998, AM J PHYSIOL-ENDOC M, V275, pE594, DOI 10.1152/ajpendo.1998.275.4.E594; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; JANSSON L, 1981, ACTA PHYSIOL SCAND, V113, P371, DOI 10.1111/j.1748-1716.1981.tb06909.x; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Johansson A, 2009, DIABETOLOGIA, V52, P2385, DOI 10.1007/s00125-009-1485-6; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Johansson M, 2006, J ANAT, V208, P191, DOI 10.1111/j.1469-7580.2006.00520.x; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kayali AG, 2007, DIABETES, V56, P703, DOI 10.2337/db06-1545; KORSGREN O, 1990, J CLIN INVEST, V86, P2161, DOI 10.1172/JCI114955; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; LEE MS, 1995, AM J PATHOL, V147, P42; Mattsson G, 2002, DIABETES, V51, P1362, DOI 10.2337/diabetes.51.5.1362; Mattsson G, 2002, PANCREATOLOGY, V2, P155, DOI 10.1159/000055906; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287; Olerud J, 2008, DIABETES, V57, P1870, DOI 10.2337/db07-0724; Olerud J, 2011, DIABETES, V60, P1946, DOI 10.2337/db10-0277; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; SJOHOLM A, 1991, AM J PHYSIOL, V260, pC1046, DOI 10.1152/ajpcell.1991.260.5.C1046; Svensson JE, 2010, DIABETOLOGIA, V53, pS197; Weibel E.R, 1979, STEREOLOGICAL METHOD	29	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47451	10.1371/journal.pone.0047451	http://dx.doi.org/10.1371/journal.pone.0047451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094049	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200023
J	Li, NC; Lu, J; Willars, GB				Li, Naichang; Lu, Jing; Willars, Gary B.			Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9-36 Amide at the GLP-1 Receptor	PLOS ONE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; TYPE-2 DIABETES-MELLITUS; SMALL-MOLECULE AGONISTS; HEALTHY-SUBJECTS; IN-VIVO; CELLS; ACTIVATION; DEGRADATION; SECRETION; PATHWAYS	Glucagon-like peptide-1 (GLP-1) released from intestinal L cells in response to nutrients has many physiological effects but particularly enhances glucose-dependent insulin release through the GLP-1 receptor (GLP-1R). GLP-1 7-36 amide, the predominant circulating active form of GLP-1, is rapidly truncated by dipeptidyl peptidase-4 to GLP-1 9-36 amide, which is generally considered inactive. Given its physiological roles, the GLP-1R is targeted for treatment of type 2 diabetes. Recently 'compound 2' has been described as both an agonist and positive allosteric modulator of GLP-1 7-36 amide affinity, but not potency, at the GLP-1R. Importantly, we demonstrated previously that exendin 9-39, generally considered a GLP-1R antagonist, enhances compound 2 efficacy (or vice versa) at the GLP-1R. Given that GLP-1 9-36 amide is the major circulating form of GLP-1 post-prandially and is a low affinity weak partial agonist or antagonist at the GLP-1R, we investigated interaction between this metabolite and compound 2 in a cell line with recombinant expression of the human GLP-1R and the rat insulinoma cell line, INS-1E, with native expression of the GLP-1R. We show compound 2 markedly enhances efficacy and potency of GLP-1 9-36 amide for key cellular responses including AMP generation, Ca2+ signaling and extracellular signal-regulated kinase. Thus, metabolites of peptide hormones including GLP-1 that are often considered inactive may provide a means of manipulating key aspects of receptor function and a novel therapeutic strategy.	[Li, Naichang; Lu, Jing; Willars, Gary B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Li, Naichang] Tianjin Med Univ, Dept Biochem, Tianjin, Peoples R China	University of Leicester; Tianjin Medical University	Willars, GB (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	gbw2@le.ac.uk			University of Leicester	University of Leicester	This work was funded by the University of Leicester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroda VR, 2012, CLIN THER, V34, P1247, DOI 10.1016/j.clinthera.2012.04.013; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bavec A, 2003, REGUL PEPTIDES, V111, P137, DOI 10.1016/S0167-0115(02)00282-3; Bootman MD, 2011, METHODS MOL BIOL, V746, P277, DOI 10.1007/978-1-61779-126-0_15; BROWN BL, 1971, BIOCHEM J, V121, P561, DOI 10.1042/bj1210561; Cheong YH, 2012, BIOCHEM BIOPH RES CO, V417, P558, DOI 10.1016/j.bbrc.2011.12.004; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Coopman K, 2010, J PHARMACOL EXP THER, V334, P795, DOI 10.1124/jpet.110.166009; Deacon CF, 2002, AM J PHYSIOL-ENDOC M, V282, pE873, DOI 10.1152/ajpendo.00452.2001; DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126; DEACON CF, 1995, J CLIN ENDOCR METAB, V80, P952, DOI 10.1210/jc.80.3.952; DIMITRIADIS GD, 1991, BIOCHEM J, V278, P587, DOI 10.1042/bj2780587; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Erdogdu O, 2010, MOL CELL ENDOCRINOL, V325, P26, DOI 10.1016/j.mce.2010.04.022; Flatt PR, 2008, FRONT BIOSCI-LANDMRK, V13, P3648, DOI 10.2741/2956; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Hallbrink M, 2001, BBA-PROTEIN STRUCT M, V1546, P79, DOI 10.1016/S0167-4838(00)00270-3; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; Huang Y, 2010, BRIT J PHARMACOL, V159, P237, DOI 10.1111/j.1476-5381.2009.00517.x; Karagiannis T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1369; Kenakin T, 2010, J RECEPT SIG TRANSD, V30, P313, DOI 10.3109/10799893.2010.503964; Knudsen LB, 1996, EUR J PHARMACOL, V318, P429, DOI 10.1016/S0014-2999(96)00795-9; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Knudsen LB, 2012, REGUL PEPTIDES, V175, P21, DOI 10.1016/j.regpep.2011.12.006; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Kurian N, 2009, J PHARMACOL EXP THER, V330, P502, DOI 10.1124/jpet.109.153619; Meier JJ, 2005, DIABETES-METAB RES, V21, P91, DOI 10.1002/dmrr.538; Meier JJ, 2004, DIABETES, V53, P654, DOI 10.2337/diabetes.53.3.654; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; Montrose-Rafizadeh C, 1999, ENDOCRINOLOGY, V140, P1132, DOI 10.1210/en.140.3.1132; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; ORSKOV C, 1993, DIABETES, V42, P658, DOI 10.2337/diabetes.42.5.658; ORSKOV C, 1994, DIABETES, V43, P535, DOI 10.2337/diabetes.43.4.535; Theander S, 2004, ENDOCRINOLOGY, V145, P667; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Tomas E, 2010, TRENDS ENDOCRIN MET, V21, P59, DOI 10.1016/j.tem.2009.11.007; Willard FS, 2012, EXP DIABETES RES, DOI 10.1155/2012/709893; WILLARS GB, 1995, BRIT J PHARMACOL, V114, P1133, DOI 10.1111/j.1476-5381.1995.tb13325.x; Yamasaki-Mann M, 2009, CELL CALCIUM, V45, P293, DOI 10.1016/j.ceca.2008.11.008; Zhou J, 1999, DIABETES, V48, P2358, DOI 10.2337/diabetes.48.12.2358	43	24	24	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47936	10.1371/journal.pone.0047936	http://dx.doi.org/10.1371/journal.pone.0047936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094100	gold, Green Published, Green Submitted			2022-12-27	WOS:000310050200053
J	Li, YF; Huang, J; Amos, CI				Li, Yafang; Huang, Jian; Amos, Christopher I.			Genetic Association Analysis of Complex Diseases Incorporating Intermediate Phenotype Information	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OBSTRUCTIVE PULMONARY-DISEASE; LUNG-CANCER; SUSCEPTIBILITY LOCUS; CHROMOSOME 3P; TGFB1 GENE; METAANALYSIS; VARIANTS; SMOKING; 15Q25	Genetic researchers often collect disease related quantitative traits in addition to disease status because they are interested in understanding the pathophysiology of disease processes. In genome-wide association (GWA) studies, these quantitative phenotypes may be relevant to disease development and serve as intermediate phenotypes or they could be behavioral or other risk factors that predict disease risk. Statistical tests combining both disease status and quantitative risk factors should be more powerful than case-control studies, as the former incorporates more information about the disease. In this paper, we proposed a modified inverse-variance weighted meta-analysis method to combine disease status and quantitative intermediate phenotype information. The simulation results showed that when an intermediate phenotype was available, the inverse-variance weighted method had more power than did a case-control study of complex diseases, especially in identifying susceptibility loci having minor effects. We further applied this modified meta-analysis to a study of imputed lung cancer genotypes with smoking data in 1154 cases and 1137 matched controls. The most significant SNPs came from the CHRNA3-CHRNA5-CHRNB4 region on chromosome 15q24-25.1, which has been replicated in many other studies. Our results confirm that this CHRNA region is associated with both lung cancer development and smoking behavior. We also detected three significant SNPs-rs1800469, rs1982072, and rs2241714-in the promoter region of the TGFB1 gene on chromosome 19 (p=1.46x10(-5), 1.18x10(-5), and 6.57x10(-5), respectively). The SNP rs1800469 is reported to be associated with chronic obstructive pulmonary disease and lung cancer in cigarette smokers. The present study is the first GWA study to replicate this result. Signals in the 3q26 region were also identified in the meta-analysis. We demonstrate the intermediate phenotype can potentially enhance the power of complex disease association analysis and the modified meta-analysis method is robust to incorporate intermediate phenotype or other quantitative risk factor in the analysis.	[Li, Yafang; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Huang, Jian] Univ Iowa, Dept Stat & Actuarial Sci, Iowa City, IA 52242 USA; [Amos, Christopher I.] Dartmouth Coll, Geisel Coll Med, Dept Community & Family Med, Hanover, NH 03755 USA	University of Texas System; UTMD Anderson Cancer Center; University of Iowa; Dartmouth College	Amos, CI (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	Christopher.I.Amos@Dartmouth.edu		HUANG, Jian/0000-0002-5218-9269	National Institutes of Health [P50CA70907, RO1CA121197, P30CA016772, U19 CA148127]; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA121197, U19CA148127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was partially supported by National Institutes of Health grants P50CA70907, RO1CA121197, P30CA016772 and U19 CA148127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Boyd NF, 2005, LANCET ONCOL, V6, P798, DOI 10.1016/S1470-2045(05)70390-9; Braga E, 2002, INT J CANCER, V100, P534, DOI 10.1002/ijc.10511; Celedon JC, 2004, HUM MOL GENET, V13, P1649, DOI 10.1093/hmg/ddh171; Chan RCK, 2009, SCHIZOPHR B, V36, P1089, DOI [10.1093/schbul/sbp011, DOI 10.1093/SCHBUL/SBP011]; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Dasgupta S, 2003, J CLIN PATHOL-MOL PA, V56, P263, DOI 10.1136/mp.56.5.263; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Greenwood TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029630; Guest editorial, 2008, MOL PSYCHIATR, V13, P233; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Lynch M., 1998, GENETICS ANAL QUANTI; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Munafo MR, 2012, JNCI-J NATL CANCER I, V104, P740, DOI 10.1093/jnci/djs191; Neelam K, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-139; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Park KH, 2006, CANCER GENET CYTOGEN, V169, P39, DOI 10.1016/j.cancergencyto.2006.03.012; Shulman JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011244; Simons CJ, 2012, SCHIZOPHR B; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Spitz MR, 2012, J NATL CANCER I, V104, P720, DOI 10.1093/jnci/djs211; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Timofeeva MN, 2011, CANCER EPIDEM BIOMAR, V20, P2250, DOI 10.1158/1055-9965.EPI-11-0496; VanderWeele TJ, 2012, AM J EPIDEMIOL, V175, P1013, DOI 10.1093/aje/kwr467; Wang JA, 2010, CANCER-AM CANCER SOC, V116, P3458, DOI 10.1002/cncr.25085; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	36	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e46612	10.1371/journal.pone.0046612	http://dx.doi.org/10.1371/journal.pone.0046612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094028	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200012
J	Palagani, V; El Khatib, M; Kossatz, U; Bozko, P; Muller, MR; Manns, MP; Krech, T; Malek, NP; Plentz, RR				Palagani, Vindhya; El Khatib, Mona; Kossatz, Uta; Bozko, Przemyslaw; Mueller, Martin R.; Manns, Michael P.; Krech, Till; Malek, Nisar P.; Plentz, Ruben R.			Epithelial Mesenchymal Transition and Pancreatic Tumor Initiating CD44+/EpCAM+ Cells Are Inhibited by gamma-Secretase Inhibitor IX	PLOS ONE			English	Article							CANCER STEM-CELLS; INTRAEPITHELIAL NEOPLASIA; CADHERIN EXPRESSION; SIGNALING PATHWAY; NOTCH; IDENTIFICATION; GEMCITABINE; PROGRESSION; RESISTANCE; PHENOTYPE	Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a high rate of metastasis. Recent studies have indicated that the Notch signalling pathway is important in PDAC initiation and maintenance, although the specific cell biological roles of the pathway remain to be established. Here we sought to examine this question in established pancreatic cancer cell lines using the gamma-secretase inhibitor IX (GSI IX) to inactivate Notch. Based on the known roles of Notch in development and stem cell biology, we focused on effects on epithelial mesenchymal transition (EMT) and on pancreatic tumor initiating CD44+/EpCAM+ cells. We analyzed the effect of the GSI IX on growth and epithelial plasticity of human pancreatic cancer cell lines, and on the tumorigenicity of pancreatic tumor initiating CD44+/EpCAM+ cells. Notably, apoptosis was induced after GSI IX treatment and EMT markers were selectively targeted. Furthermore, under GSI IX treatment, decline in the growth of pancreatic tumor initiating CD44+/EpCAM+ cells was observed in vitro and in a xenograft mouse model. This study demonstrates a central role of Notch signalling pathway in pancreatic cancer pathogenesis and identifies an effective approach to inhibit selectively EMT and suppress tumorigenesis by eliminating pancreatic tumor initiating CD44+/EpCAM+ cells.	[Palagani, Vindhya; El Khatib, Mona; Kossatz, Uta; Bozko, Przemyslaw; Malek, Nisar P.; Plentz, Ruben R.] Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany; [Mueller, Martin R.] Med Univ Hosp, Dept Internal Med 2, Tubingen, Germany; [Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Krech, Till] Hannover Med Sch, Inst Pathol, D-3000 Hannover, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; Hannover Medical School	Plentz, RR (corresponding author), Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany.	Ruben.Plentz@med.uni-tuebingen.de	Udhane, Vindhya/Z-5947-2019	Kossatz, Uta/0000-0002-9092-7154	Deutsche Forschungsgemeinschaft [DFG PL 468/4-1]; TUI Stiftung [TUI AZ68/09]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TUI Stiftung	The work was supported by Deutsche Forschungsgemeinschaft (DFG PL 468/4-1) and TUI Stiftung (TUI AZ68/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Bednar F, 2011, J GASTROENTEROL; Buchler P, 2005, ANN SURG, V242, P791, DOI 10.1097/01.sla.0000189115.94847.f1; Cano C, 2010, THESCIENTIFICWORLDJO, V10, P1947, DOI 10.1100/tsw.2010.183; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hansel DE, 2003, ANNU REV GENOM HUM G, V4, P237, DOI 10.1146/annurev.genom.4.070802.110341; Hermann PC, 2008, CELL CYCLE, V7, P188, DOI 10.4161/cc.7.2.5326; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hong SM, 2011, MODERN PATHOL, V24, P1237, DOI 10.1038/modpathol.2011.74; Hong SP, 2009, INT J CANCER, V125, P2323, DOI 10.1002/ijc.24573; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; IKEDA Y, 1990, JPN J CANCER RES, V81, P987, DOI 10.1111/j.1349-7006.1990.tb03336.x; Ischehko I, 2009, SURGERY, V146, P430, DOI 10.1016/j.surg.2009.05.003; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; Joo YE, 2002, PANCREATOLOGY, V2, P129, DOI 10.1159/000055903; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Lonardo E, 2010, MOL ONCOL, V4, P431, DOI 10.1016/j.molonc.2010.06.002; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Ni X, 2011, J CELL MOL MED; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Plentz R, 2009, GASTROENTEROLOGY, V136, P1741, DOI 10.1053/j.gastro.2009.01.008; Rachagani S, 2011, BRIT J CANCER, V104, P1038, DOI 10.1038/bjc.2011.31; Rozenblum E, 1997, CANCER RES, V57, P1731; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang YH, 2009, NEOPLASMA, V56, P371, DOI 10.4149/neo_2009_05_371; Wang ZW, 2011, ANTICANCER RES, V31, P1105; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Yin T, 2011, INT J MOL SCI, V12, P1595, DOI 10.3390/ijms12031595	49	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e46514	10.1371/journal.pone.0046514	http://dx.doi.org/10.1371/journal.pone.0046514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094026	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200010
J	Lee, YJ; Johnson, KR; Hallenbeck, JM				Lee, Yang-ja; Johnson, Kory R.; Hallenbeck, John M.			Global Protein Conjugation by Ubiquitin-Like-Modifiers during Ischemic Stress Is Regulated by MicroRNAs and Confers Robust Tolerance to Ischemia	PLOS ONE			English	Article							ARCTIC GROUND-SQUIRRELS; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; DOWN-REGULATION; CELLS; INVASION; SUPPRESSION; TORPOR; SYSTEM; TISSUE	Hibernation torpor provides an excellent model of natural tolerance to ischemia. We have previously shown that massive global SUMOylation occurs during hibernation torpor in ground squirrels. We have also shown that overexpression of Ubc9, SUMO-1, or SUMO-2/3 provides protection against ischemic damage in cell lines and cortical neurons exposed to oxygen/glucose deprivation, and in mice exposed to middle cerebral artery occlusion. We have now extended our study to other Ubiquitin-Like-Modifiers (ULMs), which have multiple cellular functions during stress, in order to assess the possibility that they also have roles in tolerance to ischemia. We found that not only SUMO conjugation, but also global protein conjugation by other ULMs including NEDD8, ISG15, UFM1 and FUB1 were significantly increased in the brains of hibernating ground squirrels during torpor. By means of miRNA microarrays of ground squirrel brain samples (from active and torpor phase) we found that the miR-200 family (miR-200a,b,c/miR-141/miR-429) and the miR-182 family (miR-182/miR-183/miR-96) were among the most consistently depressed miRNAs in the brain during the torpor phase as compared to active animals. In addition, we showed that these miRNAs are involved in the expression of various ULM proteins and their global conjugation to proteins. We observed that inhibition of the miR-200 family and/or miR-182 family miRNA activities in SHSY5Y cells increases global protein conjugation by the above ULMs and makes these cells more tolerant to OGD-induced cell death. This is the first report to describe that the natural tolerance to brain ischemia in hibernators is linked to regulation by microRNAs of a broad range of ubiquitin-like modifiers.	[Lee, Yang-ja; Hallenbeck, John M.] NINDS, Stroke Branch, NIH, Bethesda, MD 20892 USA; [Johnson, Kory R.] NINDS, Bioinformat Sect, Informat Technol & Bioinformat Program, DIR,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Hallenbeck, JM (corresponding author), NINDS, Stroke Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	hallenbj@ninds.nih.gov			National Institute of Neurological Disorders and Stroke/National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002856] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen RX, 2012, MOL MED REP, V5, P800, DOI 10.3892/mmr.2011.695; Dharap A, 2010, J NEUROCHEM, V113, P1685, DOI 10.1111/j.1471-4159.2010.06735.x; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Gravgaard KH, 2012, BREAST CANC RES TREA; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hur K, 2012, GUT; Jeon YJ, 2010, BBA-MOL BASIS DIS, V1802, P485, DOI 10.1016/j.bbadis.2010.02.006; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Lee ST, 2010, STROKE, V41, P1646, DOI 10.1161/STROKEAHA.110.579649; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025852; Lee YJ, 2009, J NEUROCHEM, V109, P257, DOI 10.1111/j.1471-4159.2009.05957.x; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liu S, 2012, ANN SURG ONCOL; Liu YT, 2010, PHYSIOL GENOMICS, V42A, P39, DOI 10.1152/physiolgenomics.00054.2010; Liu Z, 2012, J PATHOL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Morin PJ, 2008, BBA-GENE REGUL MECH, V1779, P628, DOI 10.1016/j.bbagrm.2008.07.011; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Nakamura M, 2006, J BIOL CHEM, V281, P16861, DOI 10.1074/jbc.M509907200; Nakka VP, 2011, J CEREBR BLOOD F MET, V31, P2375, DOI 10.1038/jcbfm.2011.103; Oved S, 2006, J BIOL CHEM, V281, P21640, DOI 10.1074/jbc.M513034200; Shao CX, 2010, MOL CELL PROTEOMICS, V9, P313, DOI 10.1074/mcp.M900260-MCP200; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Suzuki K, 1996, IMMUNOBIOLOGY, V195, P187, DOI 10.1016/S0171-2985(96)80038-6; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Wang J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-227; Yan J, 2006, PHYSIOL GENOMICS, V25, P346, DOI 10.1152/physiolgenomics.00260.2005; Zhang LF, 2011, INT J MOL MED, V28, P381, DOI 10.3892/ijmm.2011.679; Zhu JF, 2012, AM J PATHOL, V180, P2440, DOI 10.1016/j.ajpath.2012.02.023	38	47	50	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47787	10.1371/journal.pone.0047787	http://dx.doi.org/10.1371/journal.pone.0047787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094087	Green Published, gold, Green Submitted			2022-12-27	WOS:000312384500023
J	Oikonomou, G; Machado, VS; Santisteban, C; Schukken, YH; Bicalho, RC				Oikonomou, Georgios; Machado, Vinicius Silva; Santisteban, Carlos; Schukken, Ynte Hein; Bicalho, Rodrigo Carvalho			Microbial Diversity of Bovine Mastitic Milk as Described by Pyrosequencing of Metagenomic 16s rDNA	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; POLYMERASE-CHAIN-REACTION; SUBCLINICAL MASTITIS; HELCOCOCCUS-OVIS; IDENTIFICATION; PATHOGENS; ENDOCARDITIS; SEQUENCES; BACTERIA; CULTURE	Dairy cow mastitis is an important disease in the dairy industry. Different microbial species have been identified as causative agents in mastitis, and are traditionally diagnosed by bacterial culture. The objective of this study was to use metagenomic pyrosequencing of bacterial 16S rRNA genes to investigate bacterial DNA diversity in milk samples of mastitic and healthy dairy cows and compare the results with those obtained by classical bacterial culture. One hundred and thirty-six milk samples were collected from cows showing signs of mastitis and used for microbiological culture. Additionally, 20 milk samples were collected from healthy quarters. Bacterial DNA was isolated from the same milk samples and the 16S rRNA genes were individually amplified and pyrosequenced. Discriminant analysis showed that the groups of samples that were most clearly different from the rest and thus easily discriminated were the normal milk samples from healthy cows and those characterised by culture as Trueperella pyogenes and Streptococcus spp. The mastitis pathogens identified by culture were generally among the most frequent organisms detected by pyrosequencing, and in some cases (Escherichia coli, Klebsiella spp. and Streptococcus uberis mastitis) the single most prevalent microorganism. Trueperella pyogenes sequences were the second most prevalent sequences in mastitis cases diagnosed as Trueperella pyogenes by culture, Streptococcus dysgalactiae sequences were the second most prevalent sequences in mastitis cases diagnosed as Streptococcus dysgalactiae by culture, and Staphyloccocus aureus sequences were the third most prevalent in mastitis cases diagnosed as Staphylococcus aureus by culture. In samples that were aerobic culture negative, pyrosequencing identified DNA of bacteria that are known to cause mastitis, DNA of bacteria that are known pathogens but have so far not been associated with mastitis, and DNA of bacteria that are currently not known to be pathogens. A possible role of anaerobic pathogens in bovine mastitis is also suggested.	[Oikonomou, Georgios; Machado, Vinicius Silva; Santisteban, Carlos; Schukken, Ynte Hein; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Schukken, Ynte H/C-3405-2008; Schukken, Ynte/ABD-3352-2021	Schukken, Ynte H/0000-0002-8250-4194; Schukken, Ynte/0000-0002-8250-4194	United States Department of Agriculture/National Institute of Food and Agriculture Federal Formula Funds [NE-1028]	United States Department of Agriculture/National Institute of Food and Agriculture Federal Formula Funds	Funding was partially provided by the United States Department of Agriculture/National Institute of Food and Agriculture Federal Formula Funds project NE-1028. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bexiga R, 2011, J DAIRY RES, V78, P49, DOI 10.1017/S0022029910000725; Bhatt VD, 2012, J APPL MICROBIOL, V112, P639, DOI 10.1111/j.1365-2672.2012.05244.x; Bicalho ML, 2011, VET MICROBIOL; CANTOR CR, 1966, P NATL ACAD SCI USA, V56, P177, DOI 10.1073/pnas.56.1.177; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins MD, 1999, INT J SYST BACTERIOL, V49, P1429, DOI 10.1099/00207713-49-4-1429; Drummond GB, 2012, J PHYSIOL-LONDON, V590, P1303, DOI 10.1113/jphysiol.2012.229856; Elad D, 2004, EMERG INFECT DIS, V10, P505, DOI 10.3201/eid1003.020592; Fessler AT, 2010, J ANTIMICROB CHEMOTH, V65, P1576, DOI 10.1093/jac/dkq172; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Herrero IA, 2002, J CLIN MICROBIOL, V40, P3848, DOI 10.1128/JCM.40.10.3848-3850.2002; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Kolbert CP, 1999, CURR OPIN MICROBIOL, V2, P299, DOI 10.1016/S1369-5274(99)80052-6; Koskinen MT, 2010, J DAIRY SCI, V93, P5707, DOI 10.3168/jds.2010-3167; Kuang Y, 2009, BIOCHEM ENG J, V45, P76, DOI 10.1016/j.bej.2009.02.010; Kutzer P, 2008, J CLIN MICROBIOL, V46, P3291, DOI 10.1128/JCM.00867-08; Luthje P, 2006, J ANTIMICROB CHEMOTH, V57, P966, DOI 10.1093/jac/dk1061; Nagaraja TG, 2005, ANAEROBE, V11, P239, DOI 10.1016/j.anaerobe.2005.01.007; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; PYORALA S, 1992, BRIT VET J, V148, P54, DOI 10.1016/0007-1935(92)90067-B; Pyorala S, 2009, VET MICROBIOL, V134, P3, DOI 10.1016/j.vetmic.2008.09.015; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos TMA, 2011, J DAIRY SCI, V94, P291, DOI 10.3168/jds.2010-3668; Schaechter M., 2009, ENCY MICROBIOLOGY, P57; Schukken YH, 2009, VET MICROBIOL, V134, P9, DOI 10.1016/j.vetmic.2008.09.014; Schwaiger K, 2012, J DAIRY SCI, V95, P98, DOI 10.3168/jds.2011-4700; Shome BR, 2011, J APPL MICROBIOL, V111, P1349, DOI 10.1111/j.1365-2672.2011.05169.x; Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872; Taponen S, 2009, J DAIRY SCI, V92, P2610, DOI 10.3168/jds.2008-1729; Tsakalidou E, 1998, INT J SYST BACTERIOL, V48, P519, DOI 10.1099/00207713-48-2-519; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	33	110	117	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47671	10.1371/journal.pone.0047671	http://dx.doi.org/10.1371/journal.pone.0047671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082192	gold, Green Published			2022-12-27	WOS:000311146900089
J	Sabag-Daigle, A; Ahmer, BMM				Sabag-Daigle, Anice; Ahmer, Brian M. M.			ExpI and PhzI Are Descendants of the Long Lost Cognate Signal Synthase for SdiA	PLOS ONE			English	Article							FISCHERI LUXR PROTEIN; PSEUDOMONAS-AERUGINOSA; ACYLHOMOSERINE LACTONE; SALMONELLA-ENTERICA; TERMINAL REGION; QUORUM; AUTOINDUCER; REGULATORS; BACTERIA; EXPRESSION	SdiA of E. coli and Salmonella is a LuxR homolog that detects N-acyl homoserine lactones (AHLs). Most LuxR homologs function together with a cognate AHL synthase (a LuxI homolog), but SdiA does not. Instead, SdiA detects AHLs produced by other bacterial species. In this report, we performed a phylogenetic analysis of SdiA. The results suggest that one branch of the Enterobacteriaceae obtained a rhlR/rhlI pair by horizontal transfer. The Erwinia and Pantoea branches still contain the complete pair where it is known as expR/expI and phzR/phzI, respectively. A deletion event removed the luxI homolog from the remainder of the group, leaving just the luxR homolog known as sdiA. Thus ExpR and PhzR are SdiA orthologs and ExpI and PhzI are descendants of the long lost cognate signal synthase of SdiA.	[Sabag-Daigle, Anice; Ahmer, Brian M. M.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Sabag-Daigle, Anice; Ahmer, Brian M. M.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ahmer, BMM (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	ahmer.1@osu.edy	Ahmer, Brian M. M./F-2228-2010	Ahmer, Brian M. M./0000-0002-4267-7322	National Institute of Allergy and Infectious Diseases [R01AI073971, R01AI097116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097116, R01AI073971] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Award Numbers R01AI073971 and R01AI097116 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson S, 2009, J R SOC INTERFACE, V6, P959, DOI 10.1098/rsif.2009.0203; CHOI SH, 1992, J BACTERIOL, V174, P4064, DOI 10.1128/jb.174.12.4064-4069.1992; CHOI SH, 1991, P NATL ACAD SCI USA, V88, P11115, DOI 10.1073/pnas.88.24.11115; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Drummond A., 2011, GENEIOUS V5 5; Dyszel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008946; Dyszel JL, 2010, J BACTERIOL, V192, P29, DOI 10.1128/JB.01139-09; Evans K, 1998, J BACTERIOL, V180, P5443, DOI 10.1128/JB.180.20.5443-5447.1998; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Gray KM, 2001, MICROBIOL-SGM, V147, P2379, DOI 10.1099/00221287-147-8-2379; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HANZELKA BL, 1995, J BACTERIOL, V177, P815, DOI 10.1128/jb.177.3.815-817.1995; Hoang TT, 1999, GENE, V237, P361, DOI 10.1016/S0378-1119(99)00331-5; Hoang TT, 2002, MICROBIOL-SGM, V148, P3849, DOI 10.1099/00221287-148-12-3849; Janssens JCA, 2007, APPL ENVIRON MICROB, V73, P535, DOI 10.1128/AEM.01451-06; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Lerat E, 2004, MOL BIOL EVOL, V21, P903, DOI 10.1093/molbev/msh097; Lindsay A, 2005, J BACTERIOL, V187, P5054, DOI 10.1128/JB.187.14.5054-5058.2005; Michael B, 2001, J BACTERIOL, V183, P5733, DOI 10.1128/JB.183.19.5733-5742.2001; Minagawa S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-70; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; Morohoshi T, 2007, J BACTERIOL, V189, P8333, DOI 10.1128/JB.01054-07; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; Raychaudhuri A, 2005, BIOCHEMISTRY-US, V44, P2974, DOI 10.1021/bi048005m; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Smith JN, 2003, J BACTERIOL, V185, P1357, DOI 10.1128/JB.185.4.1357-1366.2003; Soares JA, 2011, CURR OPIN MICROBIOL, V14, P188, DOI 10.1016/j.mib.2011.01.006; Sperandio V, 2010, GUT MICROBES, V1, P432, DOI 10.4161/gmic.1.6.14177; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Venturi V, 2004, FEMS MICROBIOL LETT, V241, P179, DOI 10.1016/j.femsle.2004.10.015	34	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47720	10.1371/journal.pone.0047720	http://dx.doi.org/10.1371/journal.pone.0047720			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082201	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900098
J	Trancikova, A; Mamais, A; Webber, PJ; Stafa, K; Tsika, E; Glauser, L; West, AB; Bandopadhyay, R; Moore, DJ				Trancikova, Alzbeta; Mamais, Adamantios; Webber, Philip J.; Stafa, Klodjan; Tsika, Elpida; Glauser, Liliane; West, Andrew B.; Bandopadhyay, Rina; Moore, Darren J.			Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic Mutations	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; KINASE-ACTIVITY; PROTEIN-KINASE; GTP-BINDING; DOPAMINERGIC NEURON; ACTIVATION; LINK	Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a common cause of autosomal dominant familial Parkinson's disease (PD). LRRK2 encodes a multi-domain protein containing GTPase and kinase enzymatic domains. Disease-associated mutations in LRRK2 variably influence enzymatic activity with the common G2019S variant leading to enhanced kinase activity. Mutant LRRK2 induces neuronal toxicity through a kinase-dependent mechanism suggesting that kinase activity is important for mediating the pathogenic effects of LRRK2 mutations. A number of LRRK2 kinase substrates have been identified in vitro but whether they represent authentic physiological substrates in mammalian cells or tissues is not yet clear. The eukaryotic initiation factor 4E (eIF4E)-binding protein, 4E-BP1, was recently identified as a potential substrate of LRRK2 kinase activity in vitro and in Drosophila with phosphorylation occurring at Thr37 and Thr46. Here, we explore a potential interaction of LRRK2 and 4E-BP1 in mammalian cells and brain. We find that LRRK2 can weakly phosphorylate 4E-BP1 in vitro but LRRK2 overexpression is not able to alter endogenous 4E-BP1 phosphorylation in mammalian cells. In mammalian neurons LRRK2 and 4E-BP1 display minimal co-localization, whereas the subcellular distribution, protein complex formation and covalent post-translational modification of endogenous 4E-BP1 are not altered in the brains of LRRK2 knockout or mutant LRRK2 transgenic mice. In the brain, the phosphorylation of 4E-BP1 at Thr37 and Thr46 does not change in LRRK2 knockout or mutant LRRK2 transgenic mice, nor is 4E-BP1 phosphorylation altered in idiopathic or G2019S mutant PD brains. Collectively, our results suggest that 4E-BP1 is neither a major nor robust physiological substrate of LRRK2 in mammalian cells or brain.	[Trancikova, Alzbeta; Stafa, Klodjan; Tsika, Elpida; Glauser, Liliane; Moore, Darren J.] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland; [Mamais, Adamantios; Bandopadhyay, Rina] UCL, Inst Neurol, Reta Lila Weston Inst Neurol Dis, London, England; [Webber, Philip J.; West, Andrew B.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of London; University College London; University of Alabama System; University of Alabama Birmingham	Moore, DJ (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland.	darren.moore@epfl.ch	Trancikova, Alzbeta Kralova/X-7402-2018; Bandopadhyay, Rina/C-7926-2009	Trancikova, Alzbeta Kralova/0000-0002-4743-4952; Moore, Darren/0000-0003-2359-5679; West, Andrew/0000-0002-3034-4061; Tsika, Elpida/0000-0003-4189-4234; Mamais, Adamantios/0000-0002-5546-7084	Michael J. Fox Foundation for Parkinson's Research; Swiss National Science Foundation [310030_127478]; Ecole Polytechnique Federale de Lausanne; Reta Lila Weston Trust; National Institutes of Health [R01 NS064934]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064934] Funding Source: NIH RePORTER	Michael J. Fox Foundation for Parkinson's Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne; Reta Lila Weston Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the Michael J. Fox Foundation for Parkinson's Research (DJM), Swiss National Science Foundation (grant no. 310030_127478 to DJM), Ecole Polytechnique Federale de Lausanne (DJM), Reta Lila Weston Trust (RB and AM) and National Institutes of Health grant R01 NS064934 (ABW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasly JO, 2010, MOVEMENT DISORD, V25, P2156, DOI 10.1002/mds.23265; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Biskup S, 2009, BBA-MOL BASIS DIS, V1792, P625, DOI 10.1016/j.bbadis.2008.09.015; Dusonchet J, 2011, J NEUROSCI, V31, P907, DOI 10.1523/JNEUROSCI.5092-10.2011; Gasser T, 2009, BBA-MOL BASIS DIS, V1792, P587, DOI 10.1016/j.bbadis.2008.12.007; Giasson BI, 2006, ANN NEUROL, V59, P315, DOI 10.1002/ana.20791; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Ng Philip, 2002, Methods Mol Med, V69, P389; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Stafa K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002526; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tsika E, 2012, CURR NEUROL NEUROSCI, V12, P251, DOI 10.1007/s11910-012-0265-8; Webber PJ, 2011, J MOL BIOL, V412, P94, DOI 10.1016/j.jmb.2011.07.033; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Xiong YL, 2012, J NEUROSCI, V32, P3877, DOI 10.1523/JNEUROSCI.4566-11.2012; Xiong YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000902; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028; Zhou HS, 2000, VIROLOGY, V275, P348, DOI 10.1006/viro.2000.0515; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	46	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47784	10.1371/journal.pone.0047784	http://dx.doi.org/10.1371/journal.pone.0047784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082216	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900113
J	Xu, Q; Zhang, L; Li, T; Zhang, L; He, L; Dong, K; Liu, NN				Xu, Qiang; Zhang, Lee; Li, Ting; Zhang, Lan; He, Lin; Dong, Ke; Liu, Nannan			Evolutionary Adaptation of the Amino Acid and Codon Usage of the Mosquito Sodium Channel following Insecticide Selection in the Field Mosquitoes	PLOS ONE			English	Article							KNOCKDOWN RESISTANCE KDR; PYRETHROID-RESISTANT; CULEX-QUINQUEFASCIATUS; POINT MUTATIONS; CROSS-RESISTANCE; GENE; IDENTIFICATION; EXPRESSION; DROSOPHILA; SITE	Target site insensitivity resulting from point mutations within the voltage-gated sodium channel of the insect nervous system is known to be of primary importance in the development of resistance to pyrethroid insecticides. This study shifts current research paradigms by conducting, for the first time, a global analysis of all the naturally occurring mutations, both nonsynonymous and synonymous mutations, as well as mutation combinations in the entire mosquito sodium channel of Culex quinquefasciatus and analyzing their evolutionary and heritable feature and roles in insecticide resistance. Through a systematic analysis of comparing nucleotide polymorphisms in the entire sodium channel cDNAs of individuals between susceptible and resistant mosquito strains, between field parental mosquitoes and their permethrin selected offspring, and among different mosquito groups categorized by their levels of tolerance to specific permethrin concentrations within and among the mosquito strains of the field parental strains and their permethrin selected offspring, 3 nonsynonymous (A(109)S, (LF)-F-982, and (WR)-R-1573) and 6 synonymous (L-852, G(891), A(1241), D-1245, P-1249, and G(1733)) mutations were identified. The co-existence of all 9 mutations, both nonsynonymous and synonymous, and their homozygousity were found to be important factors for high levels of resistance. Our study, for the first time, provide a strong case demonstrating the co-existence of both nonsynonymous and synonymous mutations in the sodium channel of resistant mosquitoes in response to insecticide resistance and the inheritance of these mutations in the offspring of field mosquito strains following insecticide selection.	[Xu, Qiang; Li, Ting; Zhang, Lan; He, Lin; Liu, Nannan] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Zhang, Lee] Auburn Univ, Genom Lab, Auburn, AL 36849 USA; [Dong, Ke] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Michigan State University	Liu, NN (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	liunann@auburn.edu	Li, Ting/L-2400-2016; Li, Ting/D-5181-2015; Li, Ting/ABG-2699-2021	Li, Ting/0000-0002-6004-4617; 	National Institute Of Allergy And Infectious Diseases [R21AI090303]; AAES [ALA08-045, ALA015-1-10026]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090303] Funding Source: NIH RePORTER	National Institute Of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AAES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Award Number R21AI090303 from the National Institute Of Allergy And Infectious Diseases, and AAES Hatch/Multistate Grants ALA08-045 and ALA015-1-10026 to N.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Burton MJ, 2011, INSECT BIOCHEM MOLEC, V41, P723, DOI 10.1016/j.ibmb.2011.05.004; Chapman J, 2008, GENET EPIDEMIOL, V32, P560, DOI 10.1002/gepi.20330; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Davies TGE, 2008, PEST MANAG SCI, V64, P1126, DOI 10.1002/ps.1617; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Du Y, 2009, TOXICOL APPL PHARM, V234, P266, DOI 10.1016/j.taap.2008.10.006; Eleftherianos I, 2008, B ENTOMOL RES, V98, P183, DOI 10.1017/S0007485307005524; Goeman JJ, 2006, J ROY STAT SOC B, V68, P477, DOI 10.1111/j.1467-9868.2006.00551.x; Guerrero FD, 1997, INSECT BIOCHEM MOLEC, V27, P745, DOI 10.1016/S0965-1748(97)00057-X; Gupta SK, 2000, BIOCHEM BIOPH RES CO, V269, P692, DOI 10.1006/bbrc.2000.2351; Hanrahan CJ, 2000, GENETICS, V155, P1149; Head DJ, 1998, INSECT MOL BIOL, V7, P191, DOI 10.1046/j.1365-2583.1998.72061.x; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Ingles PJ, 1996, INSECT BIOCHEM MOLEC, V26, P319, DOI 10.1016/0965-1748(95)00093-3; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024323; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Liu HQ, 2004, J MED ENTOMOL, V41, P408, DOI 10.1603/0022-2585-41.3.408; Liu NN, 2007, GENE, V394, P61, DOI 10.1016/j.gene.2007.01.032; Liu NN, 2009, J MED ENTOMOL, V46, P1424, DOI 10.1603/033.046.0625; Liu NN, 2002, INSECT BIOCHEM MOLEC, V32, P755, DOI 10.1016/S0965-1748(01)00158-8; Liu ZQ, 2000, INSECT BIOCHEM MOLEC, V30, P991, DOI 10.1016/S0965-1748(00)00074-6; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5; Miyazaki M, 1996, MOL GEN GENET, V252, P61, DOI 10.1007/BF02173205; MOORMAN JR, 1990, SCIENCE, V250, P688; Morin S, 2002, INSECT BIOCHEM MOLEC, V32, P1781, DOI 10.1016/S0965-1748(02)00137-6; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; Sanchez G, 2012, ASSOTESTER STAT TEST; Soderlund D.M., 2005, P1; Soderlund D. M., 1990, PESTICIDE RESISTANCE, P58; Sonoda S, 2008, ARCH INSECT BIOCHEM, V69, P1, DOI 10.1002/arch.20246; Ting L, 2010, J MED ENTOMOL, V47, P1127; Toda S, 2009, J ECON ENTOMOL, V102, P2296, DOI 10.1603/029.102.0635; Tran HTT, 2005, MOL GENET METAB, V85, P213, DOI 10.1016/j.ymgme.2005.03.006; Tsagkarakou A, 2009, INSECT MOL BIOL, V18, P583, DOI 10.1111/j.1365-2583.2009.00900.x; Usherwood PNR, 2007, FEBS LETT, V581, P5485, DOI 10.1016/j.febslet.2007.10.057; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Wang RW, 2002, J APICULT RES, V41, P17, DOI 10.1080/00218839.2002.11101064; *WHO, 1957, WHO TECH RPT SER; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Xu Q, 2005, PEST MANAG SCI, V61, P1096, DOI 10.1002/ps.1090; Xu QA, 2006, GENE, V379, P62, DOI 10.1016/j.gene.2006.04.013; Xu Q, 2006, BIOCHEM BIOPH RES CO, V345, P774, DOI 10.1016/j.bbrc.2006.04.155; Xu Q, 2011, BIOCHEM BIOPH RES CO, V407, P645, DOI 10.1016/j.bbrc.2011.03.060	46	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47609	10.1371/journal.pone.0047609	http://dx.doi.org/10.1371/journal.pone.0047609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082181	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900077
J	Zhang, WL; Chen, Y; Yang, XM; Fan, JY; Mi, XN; Wang, JZ; Zhang, CN; Hu, FB; Hui, RT				Zhang, Weili; Chen, Yu; Yang, Xiaomin; Fan, Jingyao; Mi, Xuenan; Wang, Jizheng; Zhang, Channa; Hu, Frank B.; Hui, Rutai			Functional Haplotypes of the hTERT Gene, Leukocyte Telomere Length Shortening, and the Risk of Peripheral Arterial Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; ANKLE-BRACHIAL INDEX; COMMON VARIANTS; LOCUS; POLYMORPHISM; MORTALITY; PROMOTER; TERC; ATHEROSCLEROSIS	Background: The development of peripheral arterial disease (PAD) is heterogeneous even in the presence of similar risk factors. Our aim was to determine whether inter-individual differences in leukocyte telomere length contribute to the susceptibility of PAD. Methods: A total of 485 patients with PAD (defined by the ankle-brachial index) and 970 age-and gender-matched controls were recruited from seven rural communities in Henan Province in China. The relative leukocyte telomere length was determined by a quantitative PCR-based method. Two common promoter variants of the hTERT gene were genotyped to assess their effects on telomere length and the risk of PAD. In vivo luciferase assay was performed to study the transcriptional activity. Results: After adjustment for vascular risk factors and genetic variants in the hTERT gene, individuals in the lowest and middle tertiles of telomere length had a significantly higher risk of PAD than did those in the highest tertile (odds ratio [OR] 1.73, 95% confidence interval [CI] 1.29-2.49 in the middle tertile; 3.15, 95%CI 2.31-4.29 in the lowest tertile). Haplotype analysis using the 2 variants (rs2735940 and rs2853669) showed that subjects with the at-risk C-C haplotype had shorter telomere length than those individuals with the T-T haplotype and consistently had 1.30-fold (OR 1.30, 95%CI 1.06-1.58; P = 0.005) increased risk for PAD. The C-C haplotype had 43% lowered transcription activity of hTERT promoter (P<0.001). Conclusion: The associations between the functional haplotype of hTERT gene and telomere length and the risk of atherosclerotic PAD suggested that mean leukocyte telomere length may independently serve as a potential predictor of PAD.	[Zhang, Weili; Chen, Yu; Fan, Jingyao; Mi, Xuenan; Wang, Jizheng; Zhang, Channa; Hui, Rutai] Chinese Acad Med Sci, Sino German Lab Mol Med, State Key Lab Cardiovasc Dis, FuWai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Zhang, Weili; Chen, Yu; Fan, Jingyao; Mi, Xuenan; Wang, Jizheng; Zhang, Channa; Hui, Rutai] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yang, Xiaomin] Baotou Med Coll, Affiliated Hosp 2, Baotou City, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02115 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Baotou Medical College; Harvard University; Harvard T.H. Chan School of Public Health	Zhang, WL (corresponding author), Chinese Acad Med Sci, Sino German Lab Mol Med, State Key Lab Cardiovasc Dis, FuWai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.	zhangwl1747@yahoo.com.cn			Ministry of Science and Technology of China [2011CB503901]; National Natural Science Foundation [81070172]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the grants to Dr. Hui (2011CB503901) from the Ministry of Science and Technology of China and to Dr. Zhang (81070172) from the National Natural Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Belch JJF, 2003, ARCH INTERN MED, V163, P884, DOI 10.1001/archinte.163.8.884; Bischoff C, 2005, TWIN RES HUM GENET, V8, P433, DOI 10.1375/twin.8.5.433; Blackburn EH, 1991, CIRCULATION, V350, P569; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Brevetti G, 2004, ATHEROSCLEROSIS, V175, P131, DOI 10.1016/j.atherosclerosis.2004.03.009; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Ducrest AL, 2002, ONCOGENE, V21, P541, DOI 10.1038/sj.onc.1205081; Fehrer C, 2006, EXP GERONTOL, V41, P648, DOI 10.1016/j.exger.2006.03.016; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Greenland P, 2000, CIRCULATION, V101, P723; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; Hasimu B, 2006, HYPERTENS RES, V29, P23, DOI 10.1291/hypres.29.23; Hayoz D, 2005, J INTERN MED, V258, P238, DOI 10.1111/j.1365-2796.2005.01536.x; Hooi JD, 2004, J CLIN EPIDEMIOL, V57, P294, DOI 10.1016/j.jclinepi.2003.09.003; Horikawa I, 1999, CANCER RES, V59, P826; Hsu CP, 2006, EUR J CANCER, V42, P1466, DOI 10.1016/j.ejca.2006.02.014; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; Knowles JW, 2007, ARTERIOSCL THROM VAS, V27, P2068, DOI 10.1161/01.ATV.0000282199.66398.8c; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Mangino M, 2009, J MED GENET, V46, P451, DOI 10.1136/jmg.2008.064956; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; Matsubara Y, 2006, BIOCHEM BIOPH RES CO, V348, P669, DOI 10.1016/j.bbrc.2006.07.103; McDermott MM, 2009, J AM COLL CARDIOL, V54, P1228, DOI 10.1016/j.jacc.2009.04.081; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Nordfjall K, 2007, BIOCHEM BIOPH RES CO, V358, P215, DOI 10.1016/j.bbrc.2007.04.099; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; Prescott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019635; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Shen Q, 2011, EUR J HUM GENET, V19, P721, DOI 10.1038/ejhg.2011.4; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Soerensen M, 2012, AGING CELL, V11, P223, DOI 10.1111/j.1474-9726.2011.00775.x; Takakura M, 1999, CANCER RES, V59, P551; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Yang XM, 2007, J VASC SURG, V46, P296, DOI 10.1016/j.jvs.2007.03.034; Zee RYL, 2011, CLIN CHIM ACTA, V412, P199, DOI 10.1016/j.cca.2010.10.003; Zheng ZJ, 1997, ATHEROSCLEROSIS, V131, P115, DOI 10.1016/S0021-9150(97)06089-9	46	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47029	10.1371/journal.pone.0047029	http://dx.doi.org/10.1371/journal.pone.0047029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082138	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900033
J	de Boer, BA; van den Berg, G; Soufan, AT; de Boer, PAJ; Hagoort, J; van den Hoff, MJB; Moorman, AFM; Ruijter, JM				de Boer, Bouke A.; van den Berg, Gert; Soufan, Alexandre T.; de Boer, Piet A. J.; Hagoort, Jaco; van den Hoff, Maurice J. B.; Moorman, Antoon F. M.; Ruijter, Jan M.			Measurement and 3D-Visualization of Cell-Cycle Length Using Double Labelling with Two Thymidine Analogues Applied in Early Heart Development	PLOS ONE			English	Article							CHICK-EMBRYO; PROLIFERATION; GROWTH; BROMODEOXYURIDINE; RECONSTRUCTION; TUBE	Organ development is a complex spatial process in which local differences in cell proliferation rate play a key role. Understanding this role requires the measurement of the length of the cell cycle at every position of the three-dimensional (3D) structure. This measurement can be accomplished by exposing the developing embryo to two different thymidine analogues for two different durations immediately followed by tissue fixation. This paper presents a method and a dedicated computer program to measure the resulting labelling indices and subsequently calculate and visualize local cell cycle lengths within the 3D morphological context of a developing organ. By applying this method to the developing heart, we show a large difference in cell cycle lengths between the early heart tube and the adjacent mesenchyme of the pericardial wall. Later in development, a local increase in cell size was found to be associated with a decrease in cell cycle length in the region where the chamber myocardium starts to develop. The combined application of halogenated-thymidine double exposure and image processing enables the automated study of local cell cycle parameters in single specimens in a full 3D context. It can be applied in a wide range of research fields ranging from embryonic development to tissue regeneration and cancer research.	[de Boer, Bouke A.; van den Berg, Gert; Soufan, Alexandre T.; de Boer, Piet A. J.; Hagoort, Jaco; van den Hoff, Maurice J. B.; Moorman, Antoon F. M.; Ruijter, Jan M.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Ruijter, JM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.m.ruijter@amc.uva.nl		van den Hoff, Maurice/0000-0002-3837-8055	EU [Health-F2-2008-223040]; Netherlands Heart foundation [NHS1996M002]	EU(European Commission); Netherlands Heart foundation(Netherlands Heart Foundation)	BAdB was supported by the EU seventh framework program project CHeartED (Health-F2-2008-223040). GvdB was supported by the Netherlands Heart foundation (NHS1996M002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; [Anonymous], 1979, STEREOLOGICAL METHOD; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; Boehm B, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000420; Cai L, 1997, J NEUROSCI, V17, P2079; de Boer BA, 2012, DEV BIOL, V368, P203, DOI 10.1016/j.ydbio.2012.05.001; de Boer BA, 2011, DEVELOPMENT, V138, P159, DOI 10.1242/dev.051086; GERDES J, 1984, J IMMUNOL, V133, P1710; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; MACAULEY A, 1993, DEVELOPMENT, V117, P873; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; SANDERS EJ, 1993, DEVELOPMENT, V118, P389; SHIBUI S, 1989, J HISTOCHEM CYTOCHEM, V37, P1007, DOI 10.1177/37.7.2659659; SISSMAN NJ, 1966, NATURE, V210, P504, DOI 10.1038/210504a0; Soufan AT, 2007, J MICROSC-OXFORD, V225, P269, DOI 10.1111/j.1365-2818.2007.01742.x; Soufan AT, 2006, CIRC RES, V99, P545, DOI 10.1161/01.RES.0000239407.45137.97; Soufan AT, 2003, PHYSIOL GENOMICS, V13, P187, DOI 10.1152/physiolgenomics.00182.2002; STALSBERG H, 1969, DEV BIOL, V20, P18, DOI 10.1016/0012-1606(69)90003-7; van den Berg G, 2009, CIRC RES, V104, P179, DOI 10.1161/CIRCRESAHA.108.185843; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; VOIT EO, 1988, J THEOR BIOL, V131, P435, DOI 10.1016/S0022-5193(88)80039-0; WIMBER DE, 1963, EXP CELL RES, V30, P8, DOI 10.1016/0014-4827(63)90209-X	25	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47719	10.1371/journal.pone.0047719	http://dx.doi.org/10.1371/journal.pone.0047719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091641	Green Published, gold, Green Submitted			2022-12-27	WOS:000310135800067
J	Knox, PC; Amatya, N; Jiang, XY; Gong, Q				Knox, Paul C.; Amatya, Nabin; Jiang, Xiaoyu; Gong, Qyong			Performance Deficits in a Voluntary Saccade Task in Chinese "Express Saccade Makers"	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; SUPERIOR COLLICULUS; ANTISACCADE TASK; PREPARATORY SET; REACTION-TIMES; ANTI-SACCADES; RESEARCH TOOL; EYE-MOVEMENT; REFLEXIVE; MONKEY	Differences in behaviour and cognition have been observed in different human populations. It has been reported that in various types of complex visual task, eye movement patterns differ systematically between Chinese and non-Chinese participants, an observation that has been related to differences in culture between groups. However, we confirm here that, in healthy, naive adult Chinese participants, a far higher proportion (22%) than expected (1-5%) exhibit a pattern of reflexive eye movement behaviour (high numbers of low latency express saccades) in circumstances designed to inhibit such responses (prosaccade overlap tasks). These participants are defined as "express saccade makers'' (ESMs). We then show using the antisaccade paradigm, which requires the inhibition of reflexive responses and the programming and execution of voluntary saccades, that the performance of ESMs is compromised; they have higher antisaccade directional error rates, and the latency distributions of their error saccades again exhibit a higher proportion of low latency express saccade errors consistent with a reduced ability to inhibit reflexive responses. These results are difficult to reconcile with a cultural explanation as they relate to important and specific performance differences within a particular population. They suggest a potential unexpected confound relevant to those studies of Chinese versus other groups which have investigated group differences using oculomotor measures, and explained them in terms of culture. The confirmation of higher numbers of ESMs among Chinese participants provides new opportunities for examining oculomotor control.	[Knox, Paul C.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England; [Amatya, Nabin; Jiang, Xiaoyu; Gong, Qyong] Sichuan Univ, W China Hosp, Ctr Med Imaging, Huaxi MR Res Ctr,Ctr Med Imaging, Chengdu 610064, Peoples R China	University of Liverpool; Sichuan University	Knox, PC (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England.	pcknox@liv.ac.uk	Knox, Paul/Q-1920-2019; Gong, Qiyong/W-3052-2019	Knox, Paul/0000-0002-2578-7335; Gong, Qiyong/0000-0002-5912-4871	National Natural Science Foundation of China [81030027]; UK Royal Society [30711130226]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); UK Royal Society(Royal Society of London)	This study was supported by the National Natural Science Foundation of China (Grant No. 81030027) and a UK Royal Society International Joint Project grant (Grant No. 30711130226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatya N, 2011, EXP BRAIN RES, V210, P117, DOI 10.1007/s00221-011-2609-z; Biscaldi M, 1996, J NEUROPHYSIOL, V76, P199, DOI 10.1152/jn.1996.76.1.199; Bohns VK, 2011, J EXP SOC PSYCHOL, V47, P676, DOI 10.1016/j.jesp.2011.01.001; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Cavegn D, 1996, EXP BRAIN RES, V109, P101; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crawford TJ, 2011, EXP BRAIN RES, V208, P385, DOI 10.1007/s00221-010-2488-8; Cutsuridis V, 2007, NEURAL NETWORKS, V20, P690, DOI 10.1016/j.neunet.2007.01.004; Delinte A, 2002, NEUROSCI RES, V42, P21, DOI 10.1016/S0168-0102(01)00300-5; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dorris MC, 1997, J NEUROSCI, V17, P8566; Edelman JA, 1996, J NEUROPHYSIOL, V76, P908, DOI 10.1152/jn.1996.76.2.908; Evdokimidis I, 2002, EXP BRAIN RES, V147, P45, DOI 10.1007/s00221-002-1208-4; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Everling S, 1999, J NEUROSCI, V19, P2740; Everling S, 1998, J NEUROPHYSIOL, V79, P511, DOI 10.1152/jn.1998.79.2.511; Fischer B, 1997, EXP BRAIN RES, V116, P191, DOI 10.1007/PL00005749; FISCHER B, 1993, EXP BRAIN RES, V92, P528; Fischer B, 1997, BRAIN RES, V754, P285, DOI 10.1016/S0006-8993(97)00094-2; FISCHER B, 1984, EXP BRAIN RES, V57, P191; Goh JO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008238; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Harwood MR, 2008, J NEUROPHYSIOL, V99, P1743, DOI 10.1152/jn.00589.2007; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; Ji LJ, 2000, J PERS SOC PSYCHOL, V78, P943, DOI 10.1037/0022-3514.78.5.943; Kelly DJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00095; KINGSTONE A, 1993, PERCEPT PSYCHOPHYS, V54, P260, DOI 10.3758/BF03211762; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Kobayashi C, 2006, BRAIN LANG, V98, P210, DOI 10.1016/j.bandl.2006.04.013; Koval MJ, 2011, J NEUROSCI, V31, P8659, DOI 10.1523/JNEUROSCI.1258-11.2011; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Massen C, 2004, Q J EXP PSYCHOL-A, V57, P475, DOI 10.1080/02724980343000341; McKone E, 2010, VISION RES, V50, P1540, DOI 10.1016/j.visres.2010.05.010; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Nagel M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-89; Nyffeler T, 2007, EUR J NEUROSCI, V26, P1381, DOI 10.1111/j.1460-9568.2007.05758.x; Ploner CJ, 2005, BIOL PSYCHIAT, V57, P1159, DOI 10.1016/j.biopsych.2005.02.017; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; Trappenberg TP, 2001, J COGNITIVE NEUROSCI, V13, P256, DOI 10.1162/089892901564306; Walker R, 1998, NEUROPSYCHOLOGIA, V36, P1141, DOI 10.1016/S0028-3932(98)00004-9; Wang Q, 2009, COGNITION, V111, P123, DOI 10.1016/j.cognition.2009.01.004; Wegener SP, 2008, EXP BRAIN RES, V190, P463, DOI 10.1007/s00221-008-1488-4; Wu SL, 2007, PSYCHOL SCI, V18, P600, DOI 10.1111/j.1467-9280.2007.01946.x	51	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47688	10.1371/journal.pone.0047688	http://dx.doi.org/10.1371/journal.pone.0047688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	024UX	23091639	Green Published, gold, Green Submitted			2022-12-27	WOS:000310135800064
J	Chauhan, C; Behura, SK; Debruyn, B; Lovin, DD; Harker, BW; Gomez-Machorro, C; Mori, A; Romero-Severson, J; Severson, DW				Chauhan, Chitra; Behura, Susanta K.; Debruyn, Becky; Lovin, Diane D.; Harker, Brent W.; Gomez-Machorro, Consuelo; Mori, Akio; Romero-Severson, Jeanne; Severson, David W.			Comparative Expression Profiles of Midgut Genes in Dengue Virus Refractory and Susceptible Aedes aegypti across Critical Period for Virus Infection	PLOS ONE			English	Article							INNATE IMMUNITY; VECTOR COMPETENCE; RNA INTERFERENCE; MOSQUITO; PATHWAY; DROSOPHILA; GENETICS; PROGRAMS; DEFENSE; DISEASE	Background: Aedes aegypti is the primary mosquito vector for dengue virus (DENV) worldwide. Infectivity of dengue virus varies among natural populations of this mosquito. How A. aegypti responds to DENV infection relative to which genes and associated pathways contribute to its differential susceptibility as a vector is not well defined. Methods/Principal Findings: Here, we used custom cDNA microarrays to identify groups of genes that were differentially expressed in midgut tissues between susceptible and refractory strains in a highly time specific manner. While genes involved in protein processing in the endoplasmic reticulum, mRNA surveillance, and the proteasome were significantly up-regulated in the susceptible strain, several metabolic processes including glycolysis, glycan biosynthesis and Wnt pathway were active in the refractory strain. In addition, several key signaling genes were expressed as common responsive genes in both susceptible and refractory mosquitoes that may be necessary for signal transduction to trigger the appropriate host response to the viral infection. These are coordinately expressed in the form of tight gene networks and expression clusters that may be necessary to differentially contribute to the progression of dengue infection between the two strains. Conclusions: Our data show that highly correlated differential expression of responsive genes throughout the post infection period in A. aegypti midgut tissues is necessary for a coordinated transcriptional response of the mosquito genes to host or defend the viral infection.	[Chauhan, Chitra; Behura, Susanta K.; Debruyn, Becky; Lovin, Diane D.; Harker, Brent W.; Gomez-Machorro, Consuelo; Mori, Akio; Romero-Severson, Jeanne; Severson, David W.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	University of Notre Dame	Severson, DW (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	severson.1@nd.edu	Romero-Severson, Jeanne/B-5259-2011	Romero-Severson, Jeanne/0000-0003-4112-7238; Severson, David/0000-0002-5798-3365; behura, Susanta/0000-0003-1057-2435	National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA [RO1-AI059342]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059342] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by grant RO1-AI059342 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders EM, 2001, INT CONGR SER, V1219, P527, DOI 10.1016/S0531-5131(01)00386-7; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Behura SK, 2012, INFECT GENET EVOL, V12, P1413, DOI 10.1016/j.meegid.2012.04.027; Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385; Bosio CF, 1998, AM J TROP MED HYG, V59, P965, DOI 10.4269/ajtmh.1998.59.965; Brackney DE, 2008, AM J TROP MED HYG, V79, P267, DOI 10.4269/ajtmh.2008.79.267; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; Bubner B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-14; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425; CHEN WJ, 1993, J MED ENTOMOL, V30, P524, DOI 10.1093/jmedent/30.3.524; Christophers, 1960, AEDES AEGYPTI L YELL; Clemons A., 2010, COLD SPRING HARBOR P, V2010; Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189; Gil L, 2004, AM J TROP MED HYG, V71, P652, DOI 10.4269/ajtmh.2004.71.652; Govind S, 2008, INSECT SCI, V15, P29, DOI 10.1111/j.1744-7917.2008.00185.x; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Impoinvil DE, 2007, HEALTH POLICY, V83, P196, DOI 10.1016/j.healthpol.2007.01.009; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; Levy F, 2004, MOL CELL PROTEOMICS, V3, P156, DOI 10.1074/mcp.M300114-MCP200; Linthicum KJ, 1996, MED VET ENTOMOL, V10, P87, DOI 10.1111/j.1365-2915.1996.tb00086.x; Mairuhu ATA, 2004, EUR J CLIN MICROBIOL, V23, P425, DOI 10.1007/s10096-004-1145-1; Medeiros RB, 2004, J VIROL, V78, P4976, DOI 10.1128/JVI.78.10.4976-4982.2004; Molina-Cruz A, 2005, AM J TROP MED HYG, V72, P631, DOI 10.4269/ajtmh.2005.72.631; Morens DM, 2008, JAMA-J AM MED ASSOC, V299, P214, DOI 10.1001/jama.2007.31-a; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Morlais I, 2001, GENETICS, V158, P1125; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; Reich M, 2004, BIOINFORMATICS, V20, P1797, DOI 10.1093/bioinformatics/bth138; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schafer J, 2006, R NEWS, V6, P50; SCHLIESSMANN DJ, 1974, MOSQ NEWS, V34, P1; Schneider JR, 2007, MED VET ENTOMOL, V21, P370, DOI 10.1111/j.1365-2915.2007.00699.x; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Steinert S, 2011, IMMUNOL REV, V240, P129, DOI 10.1111/j.1600-065X.2010.00985.x; Tanji T, 2006, BIOCHEM J, V396, P127, DOI 10.1042/BJ20051921; THATHY V, 1994, J PARASITOL, V80, P705, DOI 10.2307/3283249; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; WHO, 1997, DENG HAEM FEV DIAGN	51	46	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47350	10.1371/journal.pone.0047350	http://dx.doi.org/10.1371/journal.pone.0047350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077596	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100096
J	Kaneko, Y; Tajiri, N; Su, TP; Wang, Y; Borlongan, CV				Kaneko, Yuji; Tajiri, Naoki; Su, Tsung-Ping; Wang, Yun; Borlongan, Cesar V.			Combination Treatment of Hypothermia and Mesenchymal Stromal Cells Amplifies Neuroprotection in Primary Rat Neurons Exposed to Hypoxic-Ischemic-Like Injury In Vitro: Role of the Opioid System	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; BRAIN-INJURY; DELTA; STROKE; HIBERNATION; ENCEPHALOPATHY; NEUROGENESIS; DISORDERS; THERAPY	This study was designed to reveal the therapeutic regimen and mechanism of action underlying hypothermia treatment in combination with stem cell transplantation for ameliorating neonatal hypoxic-ischemic-like injury. Primary rat neurons were exposed to oxygen-glucose deprivation (OGD), which produced hypoxic-ischemic-like injury in vitro, then incubated at 25 degrees C (severe hypothermia), 34 degrees C (moderate hypothermia), and 37 degrees C (normothermia) with or without subsequent co-culture with mesenchymal stromal cells (MSCs). Combination treatment of moderate hypothermia and MSCs significantly improved cell survival and mitochondrial activity after OGD exposure. The exposure of delta opioid human embryonic kidney cells (HEK293) to moderate hypothermia attenuated OGD-mediated cell alterations, which were much more pronounced in HEK293 cells overexpressing the delta opioid receptor. Further, the addition of delta opioid peptide to 34 degrees C hypothermia and stem cell treatment in primary rat neurons showed synergistic neuroprotective effects against OGD which were significantly more robust than the dual combination of moderate hypothermia and MSCs, and were significantly reduced, but not completely abolished, by the opioid receptor antagonist naltrexone altogether implicating a ligand-receptor mechanism of neuroprotection. Further investigations into non-opioid therapeutic signaling pathways revealed growth factor mediation and anti-apoptotic function accompanying the observed therapeutic benefits. These results support combination therapy of hypothermia and stem cells for hypoxic-ischemic-like injury in vitro, which may have a direct impact on current clinical trials using stand-alone hypothermia or stem cells for treating neonatal encephalopathy.	[Kaneko, Yuji; Tajiri, Naoki; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA; [Su, Tsung-Ping; Wang, Yun] NIDA, NIH, Baltimore, MD USA	State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012; Tajiri, Naoki/K-1230-2012	Borlongan, Cesar/0000-0002-2966-9782; Tajiri, Naoki/0000-0003-2189-662X	National Institutes of Health; National Institute of Neurological Disorders and Stroke [1R01NS071956-01]; James and Esther King Foundation for Biomedical Research Program; SanBio Inc.; Celgene Cellular Therapeutics; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000549, ZIADA000206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); James and Esther King Foundation for Biomedical Research Program; SanBio Inc.; Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	CVB is supported by the National Institutes of Health, National Institute of Neurological Disorders and Stroke 1R01NS071956-01, James and Esther King Foundation for Biomedical Research Program, SanBio Inc., Celgene Cellular Therapeutics, KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud O, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003080; Bell E, 2003, DIABETES, V52, P2731, DOI 10.2337/diabetes.52.11.2731; Bolling SF, 2001, J THORAC CARDIOV SUR, V122, P476, DOI 10.1067/mtc.2001.116203; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Borlongan CV, 2011, PROG NEUROBIOL, V95, P213, DOI 10.1016/j.pneurobio.2011.08.005; Borlongan CV, 2011, PEDIATR RES, V70, P3, DOI 10.1203/PDR.0b013e31821d0d00; Borlongan CV, 2010, CELL TRANSPLANT, V19, P507, DOI 10.3727/096368909X480044; Borlongan CV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-31; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Borlongan CV, 2005, BRAIN RES, V1048, P116, DOI 10.1016/j.brainres.2005.04.087; Borlongan CV, 2004, STROKE, V35, P2206, DOI 10.1161/01.STR.0000138954.25825.0b; Borlongan CV, 2004, FRONT BIOSCI-LANDMRK, V9, P3392, DOI 10.2741/1490; Borlongan CV, 2000, NEUROREPORT, V11, P923, DOI 10.1097/00001756-200004070-00005; Borlongan CV, 2001, CELL TRANSPLANT, V10, P53; Boutin H, 1999, STROKE, V30, P1271, DOI 10.1161/01.STR.30.6.1271; De Filippis L, 2011, CELL MOL LIFE SCI, V68, P2831, DOI 10.1007/s00018-011-0723-5; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Eisinger DA, 2002, J NEUROSCI, V22, P10192; Empey PE, 2012, CRIT CARE MED, V40, P1221, DOI 10.1097/CCM.0b013e31823779f9; Fan XY, 2010, CURR NEUROPHARMACOL, V8, P324, DOI 10.2174/157015910793358150; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Glass HC, 2011, J PEDIATR-US, V159, P731, DOI 10.1016/j.jpeds.2011.07.015; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Gunn AJ, 1998, EARLY HUM DEV, V53, P19, DOI 10.1016/S0378-3782(98)00033-4; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Hauser KF, 2000, EUR J NEUROSCI, V12, P1281, DOI 10.1046/j.1460-9568.2000.01015.x; Higgins RD, 2011, J PEDIATR-US, V159, P851, DOI 10.1016/j.jpeds.2011.08.004; Huang YC, 2009, STEM CELL REV REP, V5, P247, DOI 10.1007/s12015-009-9069-x; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Jatana M, 2006, PEDIATR RES, V59, P684, DOI 10.1203/01.pdr.0000215045.91122.44; Jenkins DD, 2009, J CHILD NEUROL, V24, P1212, DOI 10.1177/0883073809338412; Kevelaitis E, 1999, CIRCULATION, V99, P3079, DOI 10.1161/01.CIR.99.23.3079; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Massaro AN, 2011, J PEDIATR-US, V158, P678, DOI 10.1016/j.jpeds.2010.11.060; Matsukawa N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-126; Mortberg E, 2011, RESUSCITATION, V82, P26, DOI 10.1016/j.resuscitation.2010.10.011; Narita M, 2006, J NEUROCHEM, V97, P1494, DOI 10.1111/j.1471-4159.2006.03849.x; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Rodrigues MCO, 2012, NEUROSCI BIOBEHAV R, V36, P177, DOI 10.1016/j.neubiorev.2011.05.010; Ozawa K, 2008, J AUTOIMMUN, V30, P121, DOI 10.1016/j.jaut.2007.12.008; Pacini D, 2012, EUR J CARDIOTHORAC S; Persson AI, 2003, EUR J NEUROSCI, V17, P1159, DOI 10.1046/j.1460-9568.2003.02538.x; Rawls Scott M, 2011, Front Biosci (Schol Ed), V3, P822; Robertson NJ, 2008, LANCET, V372, P801, DOI 10.1016/S0140-6736(08)61329-X; Saller MM, 2012, BIOCHEM BIOPH RES CO, V423, P379, DOI 10.1016/j.bbrc.2012.05.134; Schmitt KRL, 2010, BRAIN PATHOL, V20, P771, DOI 10.1111/j.1750-3639.2009.00358.x; Schwartz CF, 1999, ANN THORAC SURG, V68, P2089, DOI 10.1016/S0003-4975(99)01165-0; Tam EWY, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002884; Tsai SY, 2010, SYNAPSE, V64, P267, DOI 10.1002/syn.20727; Valle-Prieto A, 2010, STEM CELLS DEV, V19, P1885, DOI 10.1089/scd.2010.0093; Yasuhara T, 2010, J CELL MOL MED, V14, P914, DOI 10.1111/j.1582-4934.2008.00671.x; Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011; Yenari M, 2008, STROKE, V39, P2910, DOI 10.1161/STROKEAHA.108.514471; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	56	29	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47583	10.1371/journal.pone.0047583	http://dx.doi.org/10.1371/journal.pone.0047583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077646	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100141
J	Nguyen, KT; Oanh, THK; Ma, S; Pham, DC; Giang, THK; Ruger, JP				Kim Thuy Nguyen; Oanh Thi Hai Khuat; Ma, Shuangge; Duc Cuong Pham; Giang Thi Hong Khuat; Ruger, Jennifer Prah			Effect of Health Expenses on Household Capabilities and Resource Allocation in a Rural Commune in Vietnam	PLOS ONE			English	Article							OUT-OF-POCKET; ILLNESS; CARE; PAYMENTS	Background: Significant health expenses can force households to reduce consumption of items required for daily living and long-term well-being, depriving them of the capability to lead economically stable and healthy lives. Previous studies of out-of-pocket (OOP) and other health expenses have typically characterized them as "catastrophic" in terms of a threshold level or percentage of household income. We aim to re-conceptualize the impact of health expenses on household "flourishing" in terms of "basic capabilities." Methods and Findings: We conducted a 2008 survey covering 697 households, on consumption patterns and health treatments for the previous 12 months. We compare consumption patterns between households with and without inpatient treatment, and between households with different levels of outpatient treatment, for the entire study sample as well as among different income quartiles. We find that compared to households without inpatient treatment and with lower levels of outpatient treatment, households with inpatient treatment and higher levels of outpatient treatment reduced investments in basic capabilities, as evidenced by decreased consumption of food, education and production means. The lowest income quartile showed the most significant decrease. No quartile with inpatient or high-level outpatient treatment was immune to reductions. Conclusions: The effects of health expenses on consumption patterns might well create or exacerbate poverty and poor health, particularly for low income households. We define health expenditures as catastrophic by their reductions of basic capabilities. Health policy should reform the OOP system that causes this economic and social burden.	[Kim Thuy Nguyen; Ma, Shuangge; Ruger, Jennifer Prah] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Oanh Thi Hai Khuat; Duc Cuong Pham; Giang Thi Hong Khuat] Inst Social Dev, Hanoi, Vietnam; [Ma, Shuangge] Yale Univ, Sch Publ Hlth, New Haven, CT USA	Yale University; Yale University	Ruger, JP (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	jennifer.ruger@yale.edu			Downs International Health Fellowship; Whitney and Betty MacMillan Center for International and Area Studies at Yale University; Yale School of Medicine Office of Student Research; Luxembourg Embassy in Hanoi; Luce Foundation; Patrick and Catherine Weldon Donaghue Medical Research Foundation [DF06-112]	Downs International Health Fellowship; Whitney and Betty MacMillan Center for International and Area Studies at Yale University; Yale School of Medicine Office of Student Research; Luxembourg Embassy in Hanoi; Luce Foundation; Patrick and Catherine Weldon Donaghue Medical Research Foundation	This research was supported by the Downs International Health Fellowship and the Whitney and Betty MacMillan Center for International and Area Studies at Yale University, the Yale School of Medicine Office of Student Research, the Luxembourg Embassy in Hanoi, and the Luce Foundation. JPR was supported in part by an Investigator Award from the Patrick and Catherine Weldon Donaghue Medical Research Foundation [grant DF06-112]. The funders had no role in the study design, in the collection, analysis, or interpretation of data, or in the writing of the manuscript and decision to submit it for publication. To the authors' knowledge, the authors are independent from and have no conflict of interest with the funders.	Central Intelligence Agency, 2009, WORLD FACTB 2009; Chaudhuri A, 2008, HEALTH POLICY, V88, P38, DOI 10.1016/j.healthpol.2008.02.014; Chen S.H., 2008, WIDER WORKING PAPER; Dror DM, 2008, INDIAN J MED RES, V127, P347; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; FOSTER AD, 1994, AM ECON REV, V84, P216; Nguyen KT, 2012, SOC SCI MED, V74, P724, DOI 10.1016/j.socscimed.2011.10.027; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; McKenzie JF, 2007, INTRO COMMUNITY HLTH; Ruger JP, 2007, QJM-INT J MED, V100, P53, DOI 10.1093/qjmed/hcl130; Ruger JP, ALTERNATIVE IN PRESS; Segall M, 2002, J EPIDEMIOL COMMUN H, V56, P497, DOI 10.1136/jech.56.7.497; Sepehri A, 2006, HEALTH ECON, V15, P603, DOI 10.1002/hec.1080; Thuan NBT, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-283; Wagstaff A, 2009, HLTH NUTR POPULATION; Wagstaff A, 2007, J HEALTH ECON, V26, P82, DOI 10.1016/j.jhealeco.2006.07.001; Wang H, 2006, HEALTH POLICY, V78, P167, DOI 10.1016/j.healthpol.2005.09.008; WHITE B, 1984, IDS BULL-I DEV STUD, V15, P18, DOI 10.1111/j.1759-5436.1984.mp15001004.x; World Health Organization (WHO), 2007, VIETN NAT EXP HLTH; Xu K, 2007, HEALTH AFFAIR, V26, P1789, DOI 10.1377/hlthaff.26.6.1789-a; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Xu K, 2009, HEALTH POLICY, V91, P297, DOI 10.1016/j.healthpol.2009.01.002	22	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47423	10.1371/journal.pone.0047423	http://dx.doi.org/10.1371/journal.pone.0047423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022WO	23077612	Green Published, gold			2022-12-27	WOS:000309995100108
J	Prusty, BK; Bohme, L; Bergmann, B; Siegl, C; Krause, E; Mehlitz, A; Rudel, T				Prusty, Bhupesh K.; Boehme, Linda; Bergmann, Birgit; Siegl, Christine; Krause, Eva; Mehlitz, Adrian; Rudel, Thomas			Imbalanced Oxidative Stress Causes Chlamydial Persistence during Non-Productive Human Herpes Virus Co-Infection	PLOS ONE			English	Article							IN-VITRO; TRACHOMATIS PERSISTENCE; GLUCOSE-METABOLISM; MIXED INFECTIONS; HUMAN-MONOCYTES; CELL-CULTURE; BLOOD; HUMAN-HERPESVIRUS-6; FAMILY; IDENTIFICATION	Both human herpes viruses and Chlamydia are highly prevalent in the human population and are detected together in different human disorders. Here, we demonstrate that co-infection with human herpes virus 6 (HHV6) interferes with the developmental cycle of C. trachomatis and induces persistence. Induction of chlamydial persistence by HHV6 is independent of productive virus infection, but requires the interaction and uptake of the virus by the host cell. On the other hand, viral uptake is strongly promoted under co-infection conditions. Host cell glutathione reductase activity was suppressed by HHV6 causing NADPH accumulation, decreased formation of reduced glutathione and increased oxidative stress. Prevention of oxidative stress restored infectivity of Chlamydia after HHV6-induced persistence. We show that co-infection with Herpes simplex virus 1 or human Cytomegalovirus also induces chlamydial persistence by a similar mechanism suggesting that Chlamydia -human herpes virus co-infections are evolutionary shaped interactions with a thus far unrecognized broad significance.	[Prusty, Bhupesh K.; Boehme, Linda; Bergmann, Birgit; Siegl, Christine; Mehlitz, Adrian; Rudel, Thomas] Univ Wurzburg, Bioctr, Chair Microbiol, Wurzburg, Germany; [Krause, Eva] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	University of Wurzburg; Heinrich Pette Institute	Rudel, T (corresponding author), Univ Wurzburg, Bioctr, Chair Microbiol, Wurzburg, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de	Prusty, Bhupesh/AAF-4843-2020	Prusty, Bhupesh/0000-0001-7051-4670	German Research Foundation (DFG); University of Wuerzburg; German Federal Ministry of Education and Research [0315834 A, 01GS08200]	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This publication was funded by the German Research Foundation (DFG), the University of Wuerzburg in the funding programme Open Access Publishing, and German Federal Ministry of Education and Research, Grant 0315834 A and 01GS08200 to TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beydemir S, 2002, J ENZYM INHIB MED CH, V17, P271, DOI 10.1080/1475636021000010941; Bohme L, 2010, CELL MICROBIOL, V12, P1340, DOI 10.1111/j.1462-5822.2010.01473.x; Boncompain G, 2010, INFECT IMMUN, V78, P80, DOI 10.1128/IAI.00725-09; Borel N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-201; Carter JD, 2011, ANN MED; Caruso A, 2003, J MED VIROL, V70, P451, DOI 10.1002/jmv.10416; Caselli E, 2002, J CLIN MICROBIOL, V40, P4131, DOI 10.1128/JCM.40.11.4131-4137.2002; Chen FH, 2010, CANCER LETT, V296, P96, DOI 10.1016/j.canlet.2010.04.004; Cirino F, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-23; Dai DF, 2011, AUTOPHAGY, V7, P917, DOI 10.4161/auto.7.8.15813; Dean D, 2001, INFECT IMMUN, V69, P2442, DOI 10.1128/IAI.69.4.2442-2447.2001; Deka S, 2006, CELL MICROBIOL, V8, P149, DOI 10.1111/j.1462-5822.2005.00608.x; Deka S, 2007, CELL MICROBIOL, V9, P725, DOI 10.1111/j.1462-5822.2006.00823.x; Delgado T, 2010, P NATL ACAD SCI USA, V107, P10696, DOI 10.1073/pnas.1004882107; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; HACKSTADT T, 1985, J BACTERIOL, V161, P25, DOI 10.1128/JB.161.1.25-31.1985; HATCH TP, 1986, J BACTERIOL, V165, P379, DOI 10.1128/jb.165.2.379-385.1986; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kahane S, 2001, APPL ENVIRON MICROB, V67, P4789, DOI 10.1128/AEM.67.10.4789-4795.2001; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401; Kuipers JG, 1998, ARTHRITIS RHEUM, V41, P1894, DOI 10.1002/1529-0131(199810)41:10<1894::AID-ART24>3.0.CO;2-E; Lau ATY, 2008, J CELL BIOCHEM, V104, P657, DOI 10.1002/jcb.21655; Lazarev VN, 2010, FREE RADICAL BIO MED, V49, P1947, DOI 10.1016/j.freeradbiomed.2010.09.024; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Luppi M, 1996, HAEMATOLOGICA, V81, P265; Lusso P, 2006, J CLIN VIROL, V37, pS4, DOI 10.1016/S1386-6532(06)70004-X; MANOR E, 1986, INFECT IMMUN, V54, P90, DOI 10.1128/IAI.54.1.90-95.1986; MATSUMOTO A, 1970, J BACTERIOL, V101, P278, DOI 10.1128/JB.101.1.278-285.1970; Mori Y, 2003, J VIROL, V77, P2452, DOI 10.1128/JVI.77.4.2452-2458.2003; Mukhopadhyay S, 2006, MOL CELL PROTEOMICS, V5, P2311, DOI 10.1074/mcp.M600214-MCP200; Nicolson GL, 2003, APMIS, V111, P557, DOI 10.1034/j.1600-0463.2003.1110504.x; Ojcius DM, 1998, J BIOL CHEM, V273, P7052, DOI 10.1074/jbc.273.12.7052; Paavonen J, 1988, Obstet Gynecol Surv, V43, P373, DOI 10.1097/00006254-198807000-00001; Prusty BK, 2008, VIROLOGY, V382, P37, DOI 10.1016/j.virol.2008.09.006; Rotola A, 1998, P NATL ACAD SCI USA, V95, P13911, DOI 10.1073/pnas.95.23.13911; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Sharma M, 2011, CELL MICROBIOL, V13, P1573, DOI 10.1111/j.1462-5822.2011.01642.x; Shima K, 2010, MED MICROBIOL IMMUN, V199, P283, DOI 10.1007/s00430-010-0162-1; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Stuedli A, 2005, VET MICROBIOL, V106, P209, DOI 10.1016/j.vetmic.2004.10.023; Torii S, 2011, CELL DEATH DIFFER, V18, P1711, DOI 10.1038/cdd.2011.47; Vanover J, 2010, MICROBIOLOGY, P1; Vanover J, 2008, MICROBIOL-SGM, V154, P971, DOI 10.1099/mic.0.2007/012161-0; Wang Y, 2006, PROTEIN SCI, V15, P122, DOI 10.1110/ps.051616206; WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6; Wu CA, 1998, J GEN VIROL, V79, P1247, DOI 10.1099/0022-1317-79-5-1247; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394; Yoshikawa T, 2002, J MED VIROL, V66, P497, DOI 10.1002/jmv.2172; Zhan P, 2011, EUR J CANCER, V47, P742, DOI 10.1016/j.ejca.2010.11.003	57	43	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47427	10.1371/journal.pone.0047427	http://dx.doi.org/10.1371/journal.pone.0047427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077614	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100110
J	Torrieri, R; Oliveira, FS; Oliveira, G; Coimbra, RS				Torrieri, Raul; Oliveira, Francislon S.; Oliveira, Guilherme; Coimbra, Roney S.			Automatic Assignment of Prokaryotic Genes to Functional Categories Using Literature Profiling	PLOS ONE			English	Article							ANNOTATION	In the last years, there was an exponential increase in the number of publicly available genomes. Once finished, most genome projects lack financial support to review annotations. A few of these gene annotations are based on a combination of bioinformatics evidence, however, in most cases, annotations are based solely on sequence similarity to a previously known gene, which was most probably annotated in the same way. As a result, a large number of predicted genes remain unassigned to any functional category despite the fact that there is enough evidence in the literature to predict their function. We developed a classifier trained with term-frequency vectors automatically disclosed from text corpora of an ensemble of genes representative of each functional category of the J. Craig Venter Institute Comprehensive Microbial Resource (JCVI-CMR) ontology. The classifier achieved up to 84% precision with 68% recall (for confidence >= 0.4), F-measure 0.76 (recall and precision equally weighted) in an independent set of 2,220 genes, from 13 bacterial species, previously classified by JCVI-CMR into unambiguous categories of its ontology. Finally, the classifier assigned (confidence >= 0.7) to functional categories a total of 5,235 out of the similar to 24 thousand genes previously in categories "Unknown function" or "Unclassified" for which there is literature in MEDLINE. Two biologists reviewed the literature of 100 of these genes, randomly picket, and assigned them to the same functional categories predicted by the automatic classifier. Our results confirmed the hypothesis that it is possible to confidently assign genes of a real world repository to functional categories, based exclusively on the automatic profiling of its associated literature. The LitProf - Gene Classifier web server is accessible at: www.cebio.org/litprofGC.	[Torrieri, Raul; Oliveira, Francislon S.; Oliveira, Guilherme; Coimbra, Roney S.] FIOCRUZ Minas, Ctr Excellence Bioinformat, Belo Horizonte, MG, Brazil; [Oliveira, Guilherme; Coimbra, Roney S.] FIOCRUZ Minas, Genom & Computat Biol Grp, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Coimbra, RS (corresponding author), FIOCRUZ Minas, Ctr Excellence Bioinformat, Belo Horizonte, MG, Brazil.	roney.s.coimbra@cpqrr.fiocruz.br	Coimbra, Roney/ABA-0586-2022; Coimbra, Roney/B-3102-2013; DoenÃas Tropicais, Inct/K-2308-2013; Oliveira, Guilherme/E-2624-2014	Coimbra, Roney/0000-0002-9204-0573; Oliveira, Guilherme/0000-0003-0054-3438	FAPEMIG [TCT 16.028/10]; NIH-FIC [TW007012]; CNPq [564941/2010-7]; FIOCRUZ-Minas; FOGARTY INTERNATIONAL CENTER [D43TW007012] Funding Source: NIH RePORTER	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); NIH-FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ-Minas; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by FAPEMIG (TCT 16.028/10; www.fapemig.br), NIH-FIC (TW007012; http://www.fic.nih.gov/Pages/Default.aspx), CNPq (564941/2010-7; www.cnpq.br), and FIOCRUZ-Minas (www.cpqrr.fiocruz.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaby-Haas CE, 2011, TRENDS BIOTECHNOL, V29, P174, DOI 10.1016/j.tibtech.2011.01.001; Chaussabel D, 2002, GENOME BIOL, V3; Coimbra RS, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-15; Coimbra RS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S3; Hunter L, 2006, MOL CELL, V21, P589, DOI 10.1016/j.molcel.2006.02.012; Lan M, 2009, J BIOMED INFORM, V42, P866, DOI 10.1016/j.jbi.2009.07.004; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Poptsova MS, 2010, MICROBIOL-SGM, V156, P1909, DOI 10.1099/mic.0.033811-0; Raychaudhuri S, 2002, GENOME RES, V12, P203, DOI 10.1101/gr.199701; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Theodosiou T, 2007, INT J MED INFORM, V76, P601, DOI 10.1016/j.ijmedinf.2006.04.011	12	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47436	10.1371/journal.pone.0047436	http://dx.doi.org/10.1371/journal.pone.0047436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077617	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100113
J	Nagpal, P; Plant, PJ; Correa, J; Bain, A; Takeda, M; Kawabe, H; Rotin, D; Bain, JR; Batt, JAE				Nagpal, Preena; Plant, Pamela J.; Correa, Judy; Bain, Alexandra; Takeda, Michiko; Kawabe, Hiroshi; Rotin, Daniela; Bain, James R.; Batt, Jane A. E.			The Ubiquitin Ligase Nedd4-1 Participates in Denervation-Induced Skeletal Muscle Atrophy in Mice	PLOS ONE			English	Article							PROTEASOME PATHWAY; MYOFIBRILLAR PROTEINS; CELL ACTIVATION; NOTCH; DEGRADATION; TARGET; GROWTH; SPECIFICITY; PHOSPHATASE; SARCOPENIA	Skeletal muscle atrophy is a consequence of muscle inactivity resulting from denervation, unloading and immobility. It accompanies many chronic disease states and also occurs as a pathophysiologic consequence of normal aging. In all these conditions, ubiquitin-dependent proteolysis is a key regulator of the loss of muscle mass, and ubiquitin ligases confer specificity to this process by interacting with, and linking ubiquitin moieties to target substrates through protein: protein interaction domains. Our previous work suggested that the ubiquitin-protein ligase Nedd4-1 is a potential mediator of skeletal muscle atrophy associated with inactivity (denervation, unloading and immobility). Here we generated a novel tool, the Nedd4-1 skeletal muscle-specific knockout mouse (myo Cre; Nedd4-1 flox/flox) and subjected it to a well validated model of denervation induced skeletal muscle atrophy. The absence of Nedd4-1 resulted in increased weights and cross-sectional area of type II fast twitch fibres of denervated gastrocnemius muscle compared with wild type littermates controls, at seven and fourteen days following tibial nerve transection. These effects are not mediated by the Nedd4-1 substrates MTMR4, FGFR1 and Notch-1. These results demonstrate that Nedd4-1 plays an important role in mediating denervation-induced skeletal muscle atrophy in vivo.	[Nagpal, Preena; Plant, Pamela J.; Correa, Judy; Batt, Jane A. E.] St Michaels Hosp, Keenan Res Ctr, LiKaShing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Nagpal, Preena; Bain, Alexandra; Batt, Jane A. E.] Univ Toronto, Dept Med, Div Clin Sci, Toronto, ON, Canada; [Takeda, Michiko; Kawabe, Hiroshi] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-3400 Gottingen, Germany; [Rotin, Daniela] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Bain, James R.] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Max Planck Society; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University	Batt, JAE (corresponding author), St Michaels Hosp, Keenan Res Ctr, LiKaShing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	jane.batt@utoronto.ca	Kawabe, Hiroshi/U-7325-2018	Kawabe, Hiroshi/0000-0001-5650-8696	Neuromuscular Research Partnership (Canadian Institutes of Health Research (CIHR)/Amyotrophic Lateral Sclerosis Society of Canada/Muscular Dystrophy Canada) [JNM - 90959]; German Research Foundation [SPP1365/KA3423/1-1]; Fritz Thyssen Foundation; CIHR Clinical Research Initiative - New Investigator Award	Neuromuscular Research Partnership (Canadian Institutes of Health Research (CIHR)/Amyotrophic Lateral Sclerosis Society of Canada/Muscular Dystrophy Canada)(Canadian Institutes of Health Research (CIHR)); German Research Foundation(German Research Foundation (DFG)); Fritz Thyssen Foundation; CIHR Clinical Research Initiative - New Investigator Award(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Neuromuscular Research Partnership (Canadian Institutes of Health Research (CIHR)/Amyotrophic Lateral Sclerosis Society of Canada/Muscular Dystrophy Canada, # JNM - 90959; to JAEB), the German Research Foundation (SPP1365/KA3423/1-1; to HK) and the Fritz Thyssen Foundation (to HK). JAEB was supported by a CIHR Clinical Research Initiative - New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Argiles JM, 2011, SARCOPENIA-AGE-RELATED MUSCLE WASTING AND WEAKNESS: MECHANISMS AND TREATMENTS, P9, DOI 10.1007/978-90-481-9713-2_2; Bain JR, 2001, NEUROSCIENCE, V103, P503, DOI 10.1016/S0306-4522(00)00577-7; Batt J, 2005, FASEB J, V19, P115, DOI 10.1096/fj.04-3640fje; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Buj-Bello A, 2008, HUM MOL GENET, V17, P2132, DOI 10.1093/hmg/ddn112; Cao CH, 2008, MOL BIOL CELL, V19, P3334, DOI 10.1091/mbc.E08-04-0367; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Decramer M, 1997, EUR RESPIR J, V10, P417, DOI 10.1183/09031936.97.10020417; Eash J, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-32; Eddins MJ, 2011, CELL BIOCHEM BIOPHYS, V60, P113, DOI 10.1007/s12013-011-9175-7; Fouladkou F, 2010, J BIOL CHEM, V285, P6770, DOI 10.1074/jbc.M109.082347; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Jejurikar SS, 2002, PLAST RECONSTR SURG, V110, P160, DOI 10.1097/00006534-200207000-00027; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Kuschel R, 1999, J HISTOCHEM CYTOCHEM, V47, P1375, DOI 10.1177/002215549904701104; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu XH, 2011, BIOCHEM BIOPH RES CO, V414, P165, DOI 10.1016/j.bbrc.2011.09.048; Liu Y, 2009, DEV BIOL, V330, P153, DOI 10.1016/j.ydbio.2009.03.023; Luo D, 2005, SEMIN CELL DEV BIOL, V16, P612, DOI 10.1016/j.semcdb.2005.07.002; MCGEACHIE J, 1978, CELL TISSUE RES, V193, P259; Mostert R, 2000, RESP MED, V94, P859, DOI 10.1053/rmed.2000.0829; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; Plant PJ, 2010, AM J RESP CELL MOL, V42, P461, DOI 10.1165/rcmb.2008-0382OC; Plant PJ, 2009, BIOCHEM J, V419, P57, DOI 10.1042/BJ20081866; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Viguie CA, 1997, ANAT REC, V248, P346; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhao RX, 2001, EXP CELL RES, V265, P329, DOI 10.1006/excr.2001.5185	52	49	51	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e46427	10.1371/journal.pone.0046427	http://dx.doi.org/10.1371/journal.pone.0046427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110050	Green Published, Green Submitted, gold			2022-12-27	WOS:000310262500006
J	Sukumar, D; Rengaswamy, M; Chakravarthy, VS				Sukumar, Deepika; Rengaswamy, Maithreye; Chakravarthy, V. Srinivasa			Modeling the Contributions of Basal Ganglia and Hippocampus to Spatial Navigation Using Reinforcement Learning	PLOS ONE			English	Article							MULTIPLE MEMORY-SYSTEMS; CAUDATE-NUCLEUS LESIONS; COMPUTATIONAL MODEL; SYNAPTIC-TRANSMISSION; PARKINSONS-DISEASE; FUNCTIONAL-ANATOMY; PREFRONTAL CORTEX; PATH-INTEGRATION; ACTION SELECTION; DORSAL STRIATUM	A computational neural model that describes the competing roles of Basal Ganglia and Hippocampus in spatial navigation is presented. Model performance is evaluated on a simulated Morris water maze explored by a model rat. Cue-based and place-based navigational strategies, thought to be subserved by the Basal ganglia and Hippocampus respectively, are described. In cue-based navigation, the model rat learns to directly head towards a visible target, while in place-based navigation the target position is represented in terms of spatial context provided by an array of poles placed around the pool. Learning is formulated within the framework of Reinforcement Learning, with the nigrostriatal dopamine signal playing the role of Temporal Difference Error. Navigation inherently involves two apparently contradictory movements: goal oriented movements vs. random, wandering movements. The model hypothesizes that while the goal-directedness is determined by the gradient in Value function, randomness is driven by the complex activity of the SubThalamic Nucleus (STN)-Globus Pallidus externa (GPe) system. Each navigational system is associated with a Critic, prescribing actions that maximize value gradients for the corresponding system. In the integrated system, that incorporates both cue-based and place-based forms of navigation, navigation at a given position is determined by the system whose value function is greater at that position. The proposed model describes the experimental results of [ 1], a lesion-study that investigates the competition between cue-based and place-based navigational systems. The present study also examines impaired navigational performance under Parkinsonian-like conditions. The integrated navigational system, operated under dopamine-deficient conditions, exhibits increased escape latency as was observed in experimental literature describing MPTP model rats navigating a water maze.	[Rengaswamy, Maithreye; Chakravarthy, V. Srinivasa] Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India; [Sukumar, Deepika] Cognizant Technol Solut, Bangalore, Karnataka, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Chakravarthy, VS (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India.	schakra@ee.iitm.ac.in		Chakravarthy, Srinivasa/0000-0002-2453-1637	Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	The research described in this study was funded by the Department of Biotechnology, India (http://dbtindia.nic.in/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1985, J NEUROPHYSIOL, V53, P1417, DOI 10.1152/jn.1985.53.6.1417; Amaral D G, 1993, Curr Opin Neurobiol, V3, P225, DOI 10.1016/0959-4388(93)90214-J; Arleo Angelo, 2007, Journal of Integrative Neuroscience, V6, P327, DOI 10.1142/S0219635207001593; Banquet JP, 2005, NEURAL COMPUT, V17, P1339, DOI 10.1162/0899766053630369; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Bourdaud N, 2008, IEEE T NEUR SYS REH, V16, P549, DOI 10.1109/TNSRE.2008.926712; BURGESS N, 1994, NEURAL NETWORKS, V7, P1065, DOI 10.1016/S0893-6080(05)80159-5; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Chavarriaga R, 2005, NEUROINFORMATICS, V3, P223, DOI 10.1385/NI:3:3:223; Cohen J, 2002, CURR OPIN NEUROBIOL, V12, P223, DOI 10.1016/S0959-4388(02)00314-8; Costa C, 2012, BRAIN, V135, P1884, DOI 10.1093/brain/aws101; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dayan P, 2001, COMPUTATIONAL NEUROS; Devan BD, 1999, J NEUROSCI, V19, P2789; Dolle L, 2010, BIOL CYBERN, V103, P299, DOI 10.1007/s00422-010-0400-z; Doshay LJ, 1960, PARKINSONS DIS ITS M; Dreher JC, 2002, NEURAL NETWORKS, V15, P583, DOI 10.1016/S0893-6080(02)00051-5; Foerde K, 2006, P NATL ACAD SCI USA, V103, P11778, DOI 10.1073/pnas.0602659103; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Fox C, 2009, FRONTIERS NEUROINFOR, V3; Gangadhar G, 2008, NEURAL COMPUT, V20, P2491, DOI 10.1162/neco.2008.03-07-498; GASBARRI A, 1994, BRAIN RES BULL, V33, P445, DOI 10.1016/0361-9230(94)90288-7; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Gurney K, 2001, BIOL CYBERN, V84, P401, DOI 10.1007/PL00007984; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Hasselmo ME, 2005, J COGNITIVE NEUROSCI, V17, P1115, DOI 10.1162/0898929054475190; Hornykiewicz O, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.2_Suppl_2.S2; Hsu KS, 1996, J NEUROPHYSIOL, V76, P1887, DOI 10.1152/jn.1996.76.3.1887; Humphries MD, 2006, J NEUROSCI, V26, P12921, DOI 10.1523/JNEUROSCI.3486-06.2006; JOEL D, 1994, NEUROSCIENCE, V63, P363, DOI 10.1016/0306-4522(94)90536-3; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Joseph D, 2010, NEUROCOMPUTING, V74, P205, DOI 10.1016/j.neucom.2010.03.001; Kalva SK, 2012, NEURAL NETWORKS; Kobayashi K, 2006, EUR J NEUROSCI, V24, P1867, DOI 10.1111/j.1460-9568.2006.05079.x; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Krishnan R, 2011, NEURAL NETWORKS, V24, P801, DOI 10.1016/j.neunet.2011.06.002; Leea AS, 2008, P NATL ACAD SCI USA, V105, P17163, DOI 10.1073/pnas.0807749105; Maaswinkel H, 1999, BEHAV BRAIN RES; Magdoom KN, 2011, NEURAL COMPUT, V23, P477, DOI 10.1162/NECO_a_00073; MANSOUR A, 1992, NEUROSCIENCE, V46, P959, DOI 10.1016/0306-4522(92)90197-A; Martinet LE, 2008, LECT NOTES ARTIF INT, V5248, P39, DOI 10.1007/978-3-540-87601-4_6; Maya MC, 2012, INT J MIND IN PRESS; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Miyoshi E, 2002, BRAIN RES BULL, V58, P41, DOI 10.1016/S0361-9230(02)00754-2; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Niv Y, 2006, ADV NEURAL INF PROCE, V18, P1019; Obeso JA, 2002, NEWS PHYSIOL SCI, V17, P51, DOI 10.1152/rips.01363.2001; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Pearce JM, 1998, NATURE, V396, P75, DOI 10.1038/23941; Pitkanen A, 2002, HIPPOCAMPUS, V12, P186, DOI 10.1002/hipo.1099; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Purzner J, 2007, J NEUROSCI, V27, P6029, DOI 10.1523/JNEUROSCI.5441-06.2007; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Rolls ET, 2005, J NEUROSCI, V25, P6167, DOI 10.1523/JNEUROSCI.1481-05.2005; Sakamoto T, 2001, NEUROBIOL LEARN MEM, V76, P192, DOI 10.1006/nlme.2001.4006; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; SHERRY DF, 1987, PSYCHOL REV, V94, P439, DOI 10.1037/0033-295X.94.4.439; Sridharan D, 2006, INT J NEURAL SYST, V16, P111, DOI 10.1142/S0129065706000548; Standage DI, 2005, NEURAL NETWORKS, V18, P620, DOI 10.1016/j.neunet.2005.06.015; Strosslin T, 2005, NEURAL NETWORKS, V18, P1125, DOI 10.1016/j.neunet.2005.08.012; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Suzuki T, 2001, J NEUROSCI, V21, P6492, DOI 10.1523/JNEUROSCI.21-17-06492.2001; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Trullier O, 1997, PROG NEUROBIOL, V51, P483, DOI 10.1016/S0301-0082(96)00060-3; WHISHAW IQ, 1987, BEHAV BRAIN RES, V24, P125, DOI 10.1016/0166-4328(87)90250-6	73	15	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47467	10.1371/journal.pone.0047467	http://dx.doi.org/10.1371/journal.pone.0047467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110073	Green Published, gold			2022-12-27	WOS:000310262500011
J	Zhuang, WY; Liu, CY				Zhuang, Wen-Ying; Liu, Chao-Yang			What an rRNA Secondary Structure Tells about Phylogeny of Fungi in Ascomycota with Emphasis on Evolution of Major Types of Ascus	PLOS ONE			English	Article							ANCESTRAL STATE RECONSTRUCTION; CHARACTER STATES; MIXED MODELS; ALIGNMENT; CLASSIFICATION; PEZIZOMYCOTINA; SUBSTITUTION; SEQUENCES; ANATOMY; TAXA	Background: RNA secondary structure is highly conserved throughout evolution. The higher order structure is fundamental in establishing important structure-function relationships. Nucleotide sequences from ribosomal RNA (rRNA) genes have made a great contribution to our understanding of Ascomycota phylogeny. However, filling the gaps between molecular phylogeny and morphological assumptions based on ascus dehiscence modes and type of fruitbodies at the higher level classification of the phylum remains an unfulfilled task faced by mycologists. Methodology/Principal Findings: We selected some major groups of Ascomycota to view their phylogenetic relationships based on analyses of rRNA secondary structure. Using rRNA secondary structural information, here, we converted nucleotide sequences into the structure ones over a 20-symbol code. Our structural analyses together with ancestral character state reconstruction produced reasonable phylogenetic position for the class Geoglossomycetes as opposed to the classic nucleotide analyses. Judging from the secondary structure analyses with consideration of mode of ascus dehiscence and the ability of forming fruitbodies, we draw a clear picture of a possible evolutionary route for fungal asci and some major groups of fungi in Ascomycota. The secondary structure trees show a more reasonable phylogenetic position for the class Geoglossomycetes. Conclusions: Our results illustrate that asci lacking of any dehiscence mechanism represent the most primitive type. Passing through the operculate and Orbilia-type asci, bitunicate asci occurred. The evolution came to the most advanced inoperculate type. The ascus-producing fungi might be derived from groups lacking of the capacity to form fruitbodies, and then evolved multiple times. The apothecial type of fruitbodies represents the ancestral state, and the ostiolar type is advanced. The class Geoglossomycetes is closely related to Leotiomycetes and Sordariomycetes having a similar ascus type other than it was originally placed based on nucleotide sequence analyses.	[Zhuang, Wen-Ying] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Liu, Chao-Yang] SW Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Southwest University of Science & Technology - China	Zhuang, WY (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	zhuangwy@im.ac.cn			National Natural Science Foundation of China [31070015]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-6]; State 863 Project [2008AA02Z312]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); State 863 Project(National High Technology Research and Development Program of China)	This study was funded by the National Natural Science Foundation of China (31070015), Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-6), and State 863 Project (2008AA02Z312) to WYZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth GC, 1973, FUNGI ADV TREATISE A, VIV; Alexopoulos C. J., 1996; [Anonymous], 1973, FUNGI ADV TREATISE; BARR ME, 1983, MYCOLOGIA, V75, P1, DOI 10.2307/3792917; Barr ME, 2001, MYCOTA, V7, P161; BENNY GL, 1978, CAN J BOT, V56, P2006, DOI 10.1139/b78-241; Boudier E, 1885, B SOC MYCOL FRANCE, V1, P91; Boudier E, 1904, ICONES MYCOLOGICAE, V1; Brodo I. M., 2001, LICHENS N AM; BUTLER ELLYS T., 1939, MYCOLOGIA, V31, P612; Caetano-Anolles G, 2002, NUCLEIC ACIDS RES, V30, P2575, DOI 10.1093/nar/30.11.2575; Collins LJ, 2000, J MOL EVOL, V51, P194, DOI 10.1007/s002390010081; de Hoog GS, 2005, STUD MYCOL, P33; Ekman S, 2008, SYST BIOL, V57, P141, DOI 10.1080/10635150801910451; Eriksson O.E., 2003, MYCONET, V9, P91; Eriksson OE, 1997, MYCONET, V1, P1; Eriksson Ove E., 1998, Systema Ascomycetum, V16, P83; Fennel D.I., 1973, FUNGI ADV TREATISE A, V4A, P45; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansen PV, 2007, MYCOL RES, V111, P592, DOI 10.1016/j.mycres.2007.02.010; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; HONEGGER R, 1978, LICHENOLOGIST, V10, P47, DOI 10.1017/S0024282978000079; Hudelot C, 2003, MOL PHYLOGENET EVOL, V28, P241, DOI 10.1016/S1055-7903(03)00061-7; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; JOHNSON MS, 1990, J MOL EVOL, V30, P43, DOI 10.1007/BF02102452; Jow H, 2002, MOL BIOL EVOL, V19, P1591, DOI 10.1093/oxfordjournals.molbev.a004221; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kirk PM, 2008, AINSWORTH BISBYS DIC; KJER KM, 1995, MOL PHYLOGENET EVOL, V4, P314, DOI 10.1006/mpev.1995.1028; Landvik S, 2003, MYCOL RES, V107, P1021, DOI 10.1017/S0953756203008219; Landvik Sara, 1993, Systema Ascomycetum, V11, P107; Liu YJ, 2004, P NATL ACAD SCI USA, V101, P4507, DOI 10.1073/pnas.0400938101; LUTTRELL ES, 1955, MYCOLOGIA, V47, P511, DOI 10.2307/3755666; Luttrell ES, 1973, FUNGI ADV TREATISE, P135; MADDISON WP, 2006, MESQUITE MODULAR SYS; Mittl PRE, 2001, CURR OPIN CHEM BIOL, V5, P402, DOI 10.1016/S1367-5931(00)00221-0; Mugridge NB, 2000, MOL BIOL EVOL, V17, P1842, DOI 10.1093/oxfordjournals.molbev.a026285; Muller E, 1973, FUNGI              A, V4A, P87; Nannfeldt JA, 1932, NOVA ACTA REGIAE SOC, V8, P1; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; RICHARDSON D. H. S., 1964, LICHENOLOGIST, V2, P205, DOI 10.1017/S0024282964000251; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schaferhoff B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-352; Schaffer S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-246; Schoch CL, 2009, PERSOONIA, V22, P129, DOI 10.3767/003158509X461486; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Seaver FJ, 1928, N AM CUP FUNGI OPERC; Smith AD, 2004, MOL BIOL EVOL, V21, P419; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Subbotin SA, 2007, MOL PHYLOGENET EVOL, V43, P881, DOI 10.1016/j.ympev.2006.09.019; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TAI F. L., 1931, Sinensia, V1, P147; Telford MJ, 2005, MOL BIOL EVOL, V22, P1129, DOI 10.1093/molbev/msi099; Verkley G.J.M., 1995, ASCUS APICAL APPARAT; Wang Z, 2006, MOL PHYLOGENET EVOL, V41, P295, DOI 10.1016/j.ympev.2006.05.031; Zhuang WY, 2004, CHINESE FUNGUS FLORA, V21	59	6	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47546	10.1371/journal.pone.0047546	http://dx.doi.org/10.1371/journal.pone.0047546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110078	gold, Green Published, Green Submitted			2022-12-27	WOS:000310262500014
J	Chadderdon, GL; Neymotin, SA; Kerr, CC; Lytton, WW				Chadderdon, George L.; Neymotin, Samuel A.; Kerr, Cliff C.; Lytton, William W.			Reinforcement Learning of Targeted Movement in a Spiking Neuronal Model of Motor Cortex	PLOS ONE			English	Article							DOPAMINE DEPLETION; DEPENDENT PLASTICITY; BASAL GANGLIA; REWARD; PERFORMANCE; MODULATION; ACQUISITION; ACTIVATION; ERROR; AREA	Sensorimotor control has traditionally been considered from a control theory perspective, without relation to neurobiology. In contrast, here we utilized a spiking-neuron model of motor cortex and trained it to perform a simple movement task, which consisted of rotating a single-joint "forearm'' to a target. Learning was based on a reinforcement mechanism analogous to that of the dopamine system. This provided a global reward or punishment signal in response to decreasing or increasing distance from hand to target, respectively. Output was partially driven by Poisson motor babbling, creating stochastic movements that could then be shaped by learning. The virtual forearm consisted of a single segment rotated around an elbow joint, controlled by flexor and extensor muscles. The model consisted of 144 excitatory and 64 inhibitory event-based neurons, each with AMPA, NMDA, and GABA synapses. Proprioceptive cell input to this model encoded the 2 muscle lengths. Plasticity was only enabled in feedforward connections between input and output excitatory units, using spike-timing-dependent eligibility traces for synaptic credit or blame assignment. Learning resulted from a global 3-valued signal: reward (+1), no learning (0), or punishment (21), corresponding to phasic increases, lack of change, or phasic decreases of dopaminergic cell firing, respectively. Successful learning only occurred when both reward and punishment were enabled. In this case, 5 target angles were learned successfully within 180 s of simulation time, with a median error of 8 degrees. Motor babbling allowed exploratory learning, but decreased the stability of the learned behavior, since the hand continued moving after reaching the target. Our model demonstrated that a global reinforcement signal, coupled with eligibility traces for synaptic plasticity, can train a spiking sensorimotor network to perform goal-directed motor behavior.	[Chadderdon, George L.; Neymotin, Samuel A.; Kerr, Cliff C.; Lytton, William W.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Neymotin, Samuel A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Kerr, Cliff C.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Lytton, William W.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Lytton, William W.] Kings Cty Hosp, Brooklyn, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Yale University; University of Sydney; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Chadderdon, GL (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.	georgec@neurosim.downstate.edu		Lytton, William/0000-0002-3727-2849; Neymotin, Samuel/0000-0003-3646-5195	Defense Advanced Research Projects Agency (DARPA) [N66001-10-C-2008]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	Research supported by Defense Advanced Research Projects Agency (DARPA) grant N66001-10-C-2008 (http://www.darpa.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almassy N, 1998, CEREB CORTEX, V8, P346, DOI 10.1093/cercor/8.4.346; Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carnevale NT, 2006, NEURON BOOK; Chadderdon G., 2009, THESIS INDIANA U; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Demiris Y., 2005, MOTOR BABBLING HIERA; Der R, 2006, LECT NOTES COMPUT SC, V4095, P406; Edelman GM, 1987, NEURAL DARWINISM THE; Farries MA, 2007, J NEUROPHYSIOL, V98, P3648, DOI 10.1152/jn.00364.2007; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Hecht-Nielsen R., 1992, IEEE T NEURAL NETWOR, p65e93, DOI [10.1016/B978-0-12-741252-8.50010-8, DOI 10.1016/B978-0-12-741252-8.50010-8, 10.1109/IJCNN.1989.118638, DOI 10.1109/IJCNN.1989.118638]; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Luft AR, 2009, INT J DEV NEUROSCI, V27, P415, DOI 10.1016/j.ijdevneu.2009.05.004; Lytton WW, 2008, NEURAL COMPUT, V20, P2745, DOI 10.1162/neco.2008.10-07-622; Lytton WW, 2008, J NEUROSCI METH, V171, P309, DOI 10.1016/j.jneumeth.2008.03.005; Lytton WW, 2007, J CLIN NEUROPHYSIOL, V24, P175, DOI 10.1097/WNP.0b013e3180336fc0; Lytton WW, 2006, NEUROCOMPUTING, V69, P1160, DOI 10.1016/j.neucom.2005.12.066; Lytton WW, 2005, INT J BIOELECTROMAGN, V7, P47; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; MUFSON EJ, 1984, J COMP NEUROL, V225, P31, DOI 10.1002/cne.902250105; Neymotin SA, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00019; O'Neill M, 2007, NEUROBIOL LEARN MEM, V88, P75, DOI 10.1016/j.nlm.2007.03.003; Parkinson JA, 2002, BEHAV BRAIN RES, V137, P149, DOI 10.1016/S0166-4328(02)00291-7; Potjans W, 2009, NEURAL COMPUT, V21, P301, DOI 10.1162/neco.2008.08-07-593; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; ROBBINS TW, 1990, BEHAV BRAIN RES, V38, P243, DOI 10.1016/0166-4328(90)90179-I; Roberts PD, 2002, BIOL CYBERN, V87, P392, DOI 10.1007/s00422-002-0361-y; Rumelhart DE, 1986, PARALLEL DISTRIBUTED; Sanchez JC, 2011, I IEEE EMBS C NEUR E, P525, DOI 10.1109/NER.2011.5910601; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; SINGER W, 2003, HDB BRAIN THEORY NEU, P1136; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; Sober SJ, 2009, NAT NEUROSCI, V12, P927, DOI 10.1038/nn.2336; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sporns O, 2002, NEURAL NETWORKS, V15, P761, DOI 10.1016/S0893-6080(02)00062-X; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TESAURO G, 1995, COMMUN ACM, V38, P58, DOI 10.1145/203330.203343; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Wanjerkhede SM, 2008, PROG BRAIN RES, V168, P193, DOI 10.1016/S0079-6123(07)68016-9	60	25	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47251	10.1371/journal.pone.0047251	http://dx.doi.org/10.1371/journal.pone.0047251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094042	gold, Green Submitted, Green Published			2022-12-27	WOS:000310050200019
J	Ording, AG; Garne, JP; Nystrom, PMW; Cronin-Fenton, D; Tarp, M; Sorensen, HT; Lash, TL				Ording, Anne Gulbech; Garne, Jens Peter; Nystrom, Petra Mariann Witt; Cronin-Fenton, Deirdre; Tarp, Maja; Sorensen, Henrik Toft; Lash, Timothy L.			Hospital Recorded Morbidity and Breast Cancer Incidence: A Nationwide Population-Based Case-Control Study	PLOS ONE			English	Article							CHARLSON COMORBIDITY INDEX; IMMUNE-SYSTEM; CO-MORBIDITY; RISK-FACTORS; REGISTRY; PREVENTION; EPIDEMIOLOGY; ESTROGEN; DISEASE; ISSUES	Introduction: Chronic diseases and their complications may increase breast cancer risk through known or still unknown mechanisms, or by shared causes. The association between morbidities and breast cancer risk has not been studied in depth. Methods: Data on all Danish women aged 45 to 85 years, diagnosed with breast cancer between 1994 and 2008 and data on preceding morbidities were retrieved from nationwide medical registries. Odds ratios (OR) and 95% confidence intervals (CI) were estimated using conditional logistic regression associating the Charlson comorbidity score (measured using both the original and an updated Charlson Comorbidity Index (CCI)) with incident breast cancer. Furthermore, we estimated associations between 202 morbidity categories and incident breast cancer, adjusting for multiple comparisons using empirical Bayes (EB) methods. Results: The study included 46,324 cases and 463,240 population controls. Increasing CCI score, up to a score of six, was associated with slightly increased breast cancer risk. Among the Charlson diseases, preceding moderate to severe renal disease (OR = 1.25, 95% CI: 1.06, 1.48), any tumor (OR = 1.17, 95% CI: 1.10, 1.25), moderate to severe liver disease (OR = 1.86, 95% CI: 1.32, 2.62), and metastatic solid tumors (OR = 1.49, 95% CI: 1.17, 1.89), were most strongly associated with subsequent breast cancer. Preceding myocardial infarction (OR = 0.89, 95% CI: 0.81, 0.99), connective tissue disease (OR = 0.87, 95% CI: 0.80, 0.94), and ulcer disease (OR = 0.91, 95% CI: 0.83, 0.99) were most strongly inversely associated with subsequent breast cancer. A history of breast disorders was associated with breast cancer after EB adjustment. Anemias were inversely associated with breast cancer, but the association was near null after EB adjustment. Conclusions: There was no substantial association between morbidity measured with the CCI and breast cancer risk.	[Ording, Anne Gulbech; Cronin-Fenton, Deirdre; Tarp, Maja; Sorensen, Henrik Toft; Lash, Timothy L.] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Garne, Jens Peter] Aarhus Univ Hosp, Aalborg Hosp, Breast Clin, DK-8000 Aarhus, Denmark; [Nystrom, Petra Mariann Witt] Aarhus Univ Hosp, Aalborg Hosp, Dept Oncol, DK-8000 Aarhus, Denmark; [Nystrom, Petra Mariann Witt] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden; [Lash, Timothy L.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Uppsala University; Uppsala University Hospital; Wake Forest University	Ording, AG (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark.	ao@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040	Clinical Epidemiology Research Foundation; Aarhus University; Karen Elise Jensens Foundation; Arkitekt Holger Hjortenberg og Hustru Dagmar Hjortenbergs Foundation; Inge og Jorgen Larsens Mindelegat Foundation	Clinical Epidemiology Research Foundation; Aarhus University; Karen Elise Jensens Foundation; Arkitekt Holger Hjortenberg og Hustru Dagmar Hjortenbergs Foundation; Inge og Jorgen Larsens Mindelegat Foundation	This study was supported by the Clinical Epidemiology Research Foundation, Aarhus University, Karen Elise Jensens Foundation, Arkitekt Holger Hjortenberg og Hustru Dagmar Hjortenbergs Foundation, and Inge og Jorgen Larsens Mindelegat Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Andersen TF, 1999, DAN MED BULL, V46, P263; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chung SH, 2010, TRENDS ENDOCRIN MET, V21, P504, DOI 10.1016/j.tem.2010.03.005; Cosman F, 1999, ENDOCR REV, V20, P418, DOI 10.1210/er.20.3.418; *DAN NAT BOARD HLT, 1993, CLASS DIS; *DAN NAT BOARD HLT, 1986, CLASS DIS; De Flora S, 2011, CARCINOGENESIS, V32, P787, DOI 10.1093/carcin/bgr054; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Ershler WB, 1997, JNCI-J NATL CANCER I, V89, P1489, DOI 10.1093/jnci/89.20.1489; ERSHLER WB, 1993, J GERONTOL, V48, pB3, DOI 10.1093/geronj/48.1.B3; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Janicki SC, 2010, CURR NEUROL NEUROSCI, V10, P359, DOI 10.1007/s11910-010-0122-6; Januel JM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-194; Jensen AR, 2002, EUR J CANCER PREV, V11, P359, DOI 10.1097/00008469-200208000-00007; Jian JL, 2011, FREE RADICAL BIO MED, V50, P841, DOI 10.1016/j.freeradbiomed.2010.12.028; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kilkkinen A, 2008, INT J CANCER, V123, P2152, DOI 10.1002/ijc.23622; Kintzel PE, 2001, DRUG SAFETY, V24, P19, DOI 10.2165/00002018-200124010-00003; Lansang MC, 2011, CLEV CLIN J MED, V78, P748, DOI 10.3949/ccjm.78a.10180; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Latourelle Jeanne C, 2010, Clin Epidemiol, V2, P153; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Nkondjock A, 2004, CANCER LETT, V205, P1, DOI 10.1016/j.canlet.2003.10.005; Pedersen CB, 2006, DAN MED BULL, V53, P441; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rockhill B, 1998, AM J EPIDEMIOL, V147, P826, DOI 10.1093/oxfordjournals.aje.a009535; Rothman KJ, 2008, MODERN EPIDEMIOLOGY; Sorensen HT, 1998, AM J GASTROENTEROL, V93, P231, DOI 10.1016/S0002-9270(97)00050-6; Steenland K, 2000, CANCER EPIDEM BIOMAR, V9, P895; Storm HH, 1997, DAN MED BULL, V44, P535; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Tinelli A, 2008, ACTA OBSTET GYN SCAN, V87, P1101, DOI 10.1080/00016340802160079; Tirona MT, 2010, CANCER INVEST, V28, P743, DOI 10.3109/07357907.2010.494321; Torti SV, 2011, CANCER RES, V71, P1511, DOI 10.1158/0008-5472.CAN-10-3614; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x	38	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47329	10.1371/journal.pone.0047329	http://dx.doi.org/10.1371/journal.pone.0047329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094045	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200021
J	Brown, ZZ; Akula, K; Arzumanyan, A; Alleva, J; Jackson, M; Bichenkov, E; Sheffield, JB; Feitelson, MA; Schafmeister, CE				Brown, Zachary Z.; Akula, Kavitha; Arzumanyan, Alla; Alleva, Jennifer; Jackson, Marcus; Bichenkov, Eugeney; Sheffield, Joel B.; Feitelson, Mark A.; Schafmeister, Christian E.			A Spiroligomer alpha-Helix Mimic That Binds HDM2, Penetrates Human Cells and Stabilizes HDM2 in Cell Culture	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SECONDARY STRUCTURE; BETA-PEPTIDES; P53 PEPTIDE; MDM2; ACTIVATION; MIMETICS; PATHWAY; CANCER; TRANSACTIVATION	We demonstrate functionalized spiroligomers that mimic the HDM2-bound conformation of the p53 activation domain. Spiroligomers are stereochemically defined, functionalized, spirocyclic monomers coupled through pairs of amide bonds to create spiro-ladder oligomers [1]. Two series of spiroligomers were synthesized, one of structural analogs and one of stereochemical analogs, from which we identified compound 1, that binds HDM2 with a Kd value of 400 nM. The spiroligomer 1 penetrates human liver cancer cells through passive diffusion and in a dose-dependent and time-dependent manner increases the levels of HDM2 more than 30-fold in Huh7 cells in which the p53/HDM2 negative feed-back loop is inoperative. This is a biological effect that is not seen with the HDM2 ligand nutlin-3a. We propose that compound 1 modulates the levels of HDM2 by stabilizing it to proteolysis, allowing it to accumulate in the absence of a p53/HDM2 feedback loop.	[Akula, Kavitha; Jackson, Marcus; Schafmeister, Christian E.] Temple Univ, Dept Chem, Philadelphia, PA 19122 USA; [Brown, Zachary Z.; Alleva, Jennifer] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Arzumanyan, Alla; Bichenkov, Eugeney; Sheffield, Joel B.; Feitelson, Mark A.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Schafmeister, CE (corresponding author), Temple Univ, Dept Chem, Philadelphia, PA 19122 USA.	meister@temple.edu		Feitelson, Mark/0000-0002-4904-0498	NIH/NIGMS [EUREKA-GM094843-01]; Defense Threat Reduction Agency (DOD-DTRA) [HDTRA1-09-1-0009]; National Science Foundation through TeraGrid resources; NICS [TG-CHE100059]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067866, R01GM094843] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Defense Threat Reduction Agency (DOD-DTRA)(United States Department of DefenseDefense Threat Reduction Agency); National Science Foundation through TeraGrid resources(National Science Foundation (NSF)); NICS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funders: NIH/NIGMS (EUREKA-GM094843-01) and the Defense Threat Reduction Agency (DOD-DTRA) (HDTRA1-09-1-0009). This research was supported in part by the National Science Foundation through TeraGrid resources provided by NICS under grant number TG-CHE100059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler MJ, 2011, CURR TOP MICROBIOL, V348, P1, DOI 10.1007/82_2010_91; Appella DH, 1997, NATURE, V387, P381, DOI 10.1038/387381a0; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Brown ZZ, 2008, J AM CHEM SOC, V130, P14382, DOI 10.1021/ja806063k; Brown ZZ, 2011, BIOPOLYMERS, V96, P578, DOI 10.1002/bip.21591; Brown ZZ, 2010, ORG LETT, V12, P1436, DOI 10.1021/ol100048g; Clegg HV, 2008, CELL CYCLE, V7, P287, DOI 10.4161/cc.7.3.5358; Cummings CG, 2010, CURR OPIN CHEM BIOL, V14, P341, DOI 10.1016/j.cbpa.2010.04.001; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Czarna A, 2009, CELL CYCLE, V8, P1176, DOI 10.4161/cc.8.8.8185; Davis JM, 2007, CHEM SOC REV, V36, P326, DOI 10.1039/b608043j; Di Como CJ, 1998, ONCOGENE, V16, P2527; Hailfinger S, 2007, INT J CANCER, V120, P1459, DOI 10.1002/ijc.22519; Hara T, 2006, J AM CHEM SOC, V128, P1995, DOI 10.1021/ja056344c; Harker EA, 2009, BIOORGAN MED CHEM, V17, P2038, DOI 10.1016/j.bmc.2009.01.039; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Kritzer JA, 2005, BIOORGAN MED CHEM, V13, P11, DOI 10.1016/j.bmc.2004.09.009; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Liu J, 2008, J AM CHEM SOC, V130, P4334, DOI 10.1021/ja077704u; Michel J, 2009, J AM CHEM SOC, V131, P6356, DOI 10.1021/ja901478e; Murray JK, 2007, BIOPOLYMERS, V88, P657, DOI 10.1002/bip.20741; Patgiri A, 2008, ACCOUNTS CHEM RES, V41, P1289, DOI 10.1021/ar700264k; Ross NT, 2010, PHILOS T R SOC A, V368, P989, DOI 10.1098/rsta.2009.0210; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Schafmeister CE, 2008, ACCOUNTS CHEM RES, V41, P1387, DOI 10.1021/ar700283y; Scrima M, 2010, EUR J ORG CHEM, V2010, P446, DOI 10.1002/ejoc.200901157; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Yin H, 2005, ANGEW CHEM INT EDIT, V44, P2704, DOI 10.1002/anie.200462316; Zondlo SC, 2006, BIOCHEMISTRY-US, V45, P11945, DOI 10.1021/bi060309g	35	22	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e45948	10.1371/journal.pone.0045948	http://dx.doi.org/10.1371/journal.pone.0045948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094022	Green Published, gold, Green Submitted			2022-12-27	WOS:000312384500002
J	Omoyinmi, E; Forabosco, P; Hamaoui, R; Bryant, A; Hinks, A; Ursu, S; Wedderburn, LR; Thomson, W; Lewis, CM; Woo, P				Omoyinmi, Ebun; Forabosco, Paola; Hamaoui, Raja; Bryant, Annette; Hinks, Anne; Ursu, Simona; Wedderburn, Lucy R.; Thomson, Wendy; Lewis, Cathryn M.; Woo, Patricia		Childhood Arthrit Prospective Stud; BSPAR Study Grp; Childhood Arthrit Response Medicat	Association of the IL-10 Gene Family Locus on Chromosome 1 with Juvenile Idiopathic Arthritis (JIA)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTERLEUKIN-20; IDENTIFICATION; POLYMORPHISM; EXPRESSION; VARIANTS; IL-20; HAPLOTYPES; IL10; SET	Background: The cytokine IL-10 and its family members have been implicated in autoimmune diseases and we have previously reported that genetic variants in IL-10 were associated with a rare group of diseases called juvenile idiopathic arthritis (JIA). The aim of this study was to fine map genetic variants within the IL-10 cytokine family cluster on chromosome 1 using linkage disequilibrium (LD)-tagging single nucleotide polymorphisms (tSNPs) approach with imputation and conditional analysis to test for disease associations. Methodology/Principal Findings: Fifty-three tSNPs were tested for association between Caucasian paediatric cohorts [219 systemic JIA (sJIA), 187 persistent oligoarticular JIA (pOJIA), and 139 extended OJIA (eOJIA) patients], and controls (Wellcome Trust control cohort, WTCCC2). Significant association with sJIA was detected at rs1400986 in the promoter of IL-20 (odds ratio 1.53; 95% CI 1.21-1.93; p = 0.0004), but in no other subtypes. Imputation analysis identified additional associated SNPs for pOJIA at IL-20 and IL-24, including a rare, functional, missense variant at IL-24 with a p = 0.0002. Penalised logistic regression analysis with HyperLasso and conditional analysis identified several further associations with JIA subtypes. In particular, haplotype analysis refined the sJIA association, with a joint effect at rs1400986 and rs4129024 in intron 1 of MAPKAPK2 (p = 3.2E-5). For pOJIA, a 3-SNP haplotype including rs1878672 in intron 3 of IL-10 showed evidence for association (p = 0.0018). In eOJIA, rs10863962 (3'UTR of FCAMR) and rs12409577 (intron of IL-19) haplotype showed some evidence of association (p = 0.0003). Conclusions: This study supports previous association of IL-20 with sJIA. Haplotype analyses provided stronger association signals than single point analyses, while a penalised logistic regression approach also suggested multiple independent association signals. Replication studies are required to confirm or refute these findings. The results indicate that combined effects with unknown/rare variants remain to be characterised in JIA, and represent a possible example of synthetic association in this region.	[Omoyinmi, Ebun; Hamaoui, Raja; Bryant, Annette; Woo, Patricia] UCL, Dept Immunol & Mol Pathol, London, England; [Forabosco, Paola] CNR, Ist Genet Popolaz, Sassari, Italy; [Hinks, Anne; Thomson, Wendy] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Ursu, Simona; Wedderburn, Lucy R.] UCL, Inst Child Hlth, Rheumatol Unit, London, England; [Lewis, Cathryn M.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Lewis, Cathryn M.] Kings Coll London, MRC SGDP Ctr, Inst Psychiat, London WC2R 2LS, England	University of London; University College London; Consiglio Nazionale delle Ricerche (CNR); University of Manchester; University of London; University College London; University of London; King's College London; University of London; King's College London	Omoyinmi, E (corresponding author), UCL, Dept Immunol & Mol Pathol, London, England.	e.omoyinmi@ucl.ac.uk	Hinks, Anne/E-1853-2015; Forabosco, Paola/AAM-5540-2021; Lewis, Cathryn/M-8766-2019; Lewis, Cathryn M/A-5225-2010	Hinks, Anne/0000-0001-8843-3967; Lewis, Cathryn/0000-0002-8249-8476; Lewis, Cathryn M/0000-0002-8249-8476; FORABOSCO, PAOLA/0000-0002-2006-2693; Hyrich, Kimme/0000-0001-8242-9262; Wedderburn, Lucy/0000-0002-7495-1429; Thomson, Wendy/0000-0002-9022-5179	Arthritis Research UK; SPARKS UK [08ICH09, RG/1/010135231]; Great Ormond Street Children's Charity; Wellcome Trust [076113, 085475]; Medical Research Council [G9817803B] Funding Source: researchfish; Versus Arthritis [17287] Funding Source: researchfish; Sparks Charity [08ICH09] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); SPARKS UK; Great Ormond Street Children's Charity; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); Sparks Charity	This work was supported by Arthritis Research UK and by grants from SPARKS UK [08ICH09; the Big Lottery Fund (RG/1/010135231)], and in part by Great Ormond Street Children's Charity. This study makes use of data generated by the Wellcome Trust Case-Control Consortium 2. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113 and 085475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi KR, 2005, NAT GENET, V37, P84, DOI 10.1038/ng1488; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Atan D, 2010, INVEST OPHTH VIS SCI, V51, P4133, DOI 10.1167/iovs.09-4583; Barnes MG, 2009, ARTHRITIS RHEUM-US, V60, P2102, DOI 10.1002/art.24601; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen WY, 2006, ARTERIOSCL THROM VAS, V26, P2090, DOI 10.1161/01.ATV.0000232502.88144.6f; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Crawley E, 2001, RHEUMATOLOGY, V40, P574, DOI 10.1093/rheumatology/40.5.574; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fife MS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2041; Hinks A, 2009, ARTHRITIS RHEUM, V60, P258, DOI 10.1002/art.24179; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Hsieh MY, 2006, GENES IMMUN, V7, P234, DOI 10.1038/sj.gene.6364291; Hsu YH, 2006, ARTHRITIS RHEUM-US, V54, P2722, DOI 10.1002/art.22039; Jones EA, 2005, J IMMUNOL, V175, P7437, DOI 10.4049/jimmunol.175.11.7437; Lard LR, 2003, ARTHRITIS RHEUM-US, V48, P1841, DOI 10.1002/art.11160; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; MALEFYT RD, 1991, J EXP MED, V174, P1209; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P577, DOI 10.1016/j.intimp.2004.01.007; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Otkjaer K, 2007, J INVEST DERMATOL, V127, P1326, DOI 10.1038/sj.jid.5700713; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Petty RE, 2004, J RHEUMATOL, V31, P390; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian Y, 2010, CURR OPIN OPHTHALMOL, V21, P468, DOI 10.1097/ICU.0b013e32833eab83; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Saraiva M, 2005, J IMMUNOL, V175, P1041, DOI 10.4049/jimmunol.175.2.1041; Scherag A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013967; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Vignal CM, 2011, ANN HUM GENET, V75, P655, DOI 10.1111/j.1469-1809.2011.00670.x; Wei CC, 2005, CLIN IMMUNOL, V117, P65, DOI 10.1016/j.clim.2005.06.012; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Woo P, 2009, BEST PRACT RES CL RH, V23, P589, DOI 10.1016/j.berh.2009.08.001	40	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47673	10.1371/journal.pone.0047673	http://dx.doi.org/10.1371/journal.pone.0047673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094074	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000312384500017
J	Chaikeeratisak, V; Somboonwiwat, K; Tassanakajon, A				Chaikeeratisak, Vorrapon; Somboonwiwat, Kunlaya; Tassanakajon, Anchalee			Shrimp Alpha-2-Macroglobulin Prevents the Bacterial Escape by Inhibiting Fibrinolysis of Blood Clots	PLOS ONE			English	Article							BLACK TIGER SHRIMP; DIFFERENTIALLY EXPRESSED PROTEINS; LUMINOUS VIBRIO-HARVEYI; MOLECULAR-CLONING; PENAEUS-MONODON; PROTEOMIC ANALYSIS; CYSTEINE PROTEASE; SERINE PROTEINASE; HORSESHOE-CRAB; LYMPHOID ORGAN	Proteomic analysis of the hemocytic proteins of Penaeus monodon (Pm) has previously shown that alpha-2-macroglobulin (A2M) was among the proteins that showed substantially altered expression levels upon Vibrio harveyi infection. Therefore, in this study its potentially important role in the response of shrimp to bacterial infection was further characterized. The yeast two-hybrid system revealed that the receptor binding domain of PmA2M interacted with the carboxyl-terminus of one or both of the transglutaminase type II isoforms, which are key enzymes involved in the shrimp clotting system. In accord with this, PmA2M was found to be localized on the extracellular blood clots and to colocalize with clottable proteins. RNA interference (RNAi)-mediated knockdown of A2M transcript levels reduced the PmA2M transcript levels (similar to 94%) and significantly reduced the bacterial seizing ability of the clotting system, resulting in an up to 3.3-fold higher number of V. harveyi that systemically disseminated into the circulatory system at 5 min post-infection before subsequent clearance by the immune system. Furthermore, an appearance of PmA2M depleted clots in the presence of V. harveyi strikingly demonstrated fibrinolysis zones surrounding the bacteria. This study provides the first evidence of the vital role of PmA2M in enhancing bacterial sequestration by protecting blood clots against fibrinolysis.	[Chaikeeratisak, Vorrapon; Somboonwiwat, Kunlaya; Tassanakajon, Anchalee] Chulalongkorn Univ, Ctr Excellence Mol Biol & Genom Shrimp, Fac Sci, Dept Biochem, Bangkok, Thailand	Chulalongkorn University	Tassanakajon, A (corresponding author), Chulalongkorn Univ, Ctr Excellence Mol Biol & Genom Shrimp, Fac Sci, Dept Biochem, Bangkok, Thailand.	anchalee.k@chula.ac.th	chaikeeratisak, Vorrapon/AFL-6715-2022; chaikeeratisak, Vorrapon/AAG-6852-2022	chaikeeratisak, vorrapon/0000-0003-2793-5394	Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC); National Research University Project of CHE; Ratchadaphiseksomphot Endowment Fund [FW643A]; Royal Golden Jubilee Ph.D. program under the Thailand Research Fund (TRF); TRF; Office of the Higher Education Commission [MRG5280119]; Faculty of Science, Chulalongkorn University [RESA1B1-11]	Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC); National Research University Project of CHE; Ratchadaphiseksomphot Endowment Fund; Royal Golden Jubilee Ph.D. program under the Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); TRF(Thailand Research Fund (TRF)); Office of the Higher Education Commission; Faculty of Science, Chulalongkorn University(Chulalongkorn University)	This research was financially supported by research grants from the Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC), the National Research University Project of CHE and the Ratchadaphiseksomphot Endowment Fund (FW643A). VC received a student fellowship from the Royal Golden Jubilee Ph.D. program under the Thailand Research Fund (TRF) and KS received additional financial support from the TRF, the Office of the Higher Education Commission (Grant No. MRG5280119) and the Faculty of Science, Chulalongkorn University (Grant No. RESA1B1-11). The exchange of scientists (KS) under the JSPS-NRCT Program is also acknowledged, as is the provision of research equipment from the Thai Government Stimulus Package 2 (TKK2555) under the Project for the Establishment of a Comprehensive Center for Innovative Food, Health Products and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Amparyup P, 2012, J BIOL CHEM, V287, P10060, DOI 10.1074/jbc.M111.294744; Armstrong PB, 2010, ISJ-INVERT SURVIV J, V7, P165; ARMSTRONG PB, 1984, THROMB HAEMOSTASIS, V52, P117; Armstrong PB, 1996, J INSECT PHYSIOL, V42, P53, DOI 10.1016/0022-1910(95)00082-8; ARMSTRONG PB, 1985, BIOCHIM BIOPHYS ACTA, V827, P453, DOI 10.1016/0167-4838(85)90232-8; Armstrong PB, 1999, DEV COMP IMMUNOL, V23, P375, DOI 10.1016/S0145-305X(99)00018-X; Armstrong PB, 2003, BIOL BULL-US, V205, P201, DOI 10.2307/1543252; Armstrong PB, 2001, TRENDS IMMUNOL, V22, P47, DOI 10.1016/S1471-4906(00)01803-2; Armstrong PB, 2006, IMMUNOBIOLOGY, V211, P263, DOI 10.1016/j.imbio.2006.01.002; ASPAN A, 1990, INSECT BIOCHEM, V20, P485, DOI 10.1016/0020-1790(90)90030-X; Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Bidla G, 2005, DEV COMP IMMUNOL, V29, P669, DOI 10.1016/j.dci.2004.11.007; Bourchookarn A, 2008, BBA-PROTEINS PROTEOM, V1784, P504, DOI 10.1016/j.bbapap.2007.12.006; Buresova V, 2009, DEV COMP IMMUNOL, V33, P489, DOI 10.1016/j.dci.2008.09.011; Cerenius L, 2011, J INNATE IMMUN, V3, P3, DOI 10.1159/000322066; Chaikeeratisak V, 2012, MOL BIOL REP, V39, P6367, DOI 10.1007/s11033-012-1458-6; Chen MY, 2005, DEV COMP IMMUNOL, V29, P1003, DOI 10.1016/j.dci.2005.03.012; Chotigeat W, 2007, AQUACULTURE, V271, P112, DOI 10.1016/j.aquaculture.2007.03.019; DORSCH M, 1992, INT J SYST BACTERIOL, V42, P58, DOI 10.1099/00207713-42-1-58; FUKASAWA S, 1988, AGR BIOL CHEM TOKYO, V52, P3009, DOI 10.1080/00021369.1988.10869174; FUKASAWA S, 1988, AGR BIOL CHEM TOKYO, V52, P435; Gollas-Galvan T, 2003, COMP BIOCHEM PHYS C, V134, P431, DOI 10.1016/S1532-0456(03)00002-4; HALL M, 1994, COMP BIOCHEM PHYS B, V108, P65, DOI 10.1016/0305-0491(94)90166-X; Harris LJ, 1999, DIS AQUAT ORGAN, V38, P11, DOI 10.3354/dao038011; Ho PY, 2009, FISH SHELLFISH IMMUN, V26, P459, DOI 10.1016/j.fsi.2009.01.007; Huang CC, 2004, DEV COMP IMMUNOL, V28, P279, DOI 10.1016/j.dci.2003.08.005; Isakova V, 2003, BIOL BULL-US, V205, P203, DOI 10.2307/1543253; Jiravanichpaisal P., 1994, Journal of Aquatic Animal Health, V6, P27, DOI 10.1577/1548-8667(1994)006&lt;0027:HBAPOV&gt;2.3.CO;2; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Lin YC, 2008, DEV COMP IMMUNOL, V32, P317, DOI 10.1016/j.dci.2007.07.002; Lin YC, 2007, MOL IMMUNOL, V44, P1065, DOI 10.1016/j.molimm.2006.08.002; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Liu PC, 1999, LETT APPL MICROBIOL, V28, P428, DOI 10.1046/j.1365-2672.1999.00555.x; Liu PC, 1997, CURR MICROBIOL, V35, P32, DOI 10.1007/s002849900207; Ma HM, 2010, DEV COMP IMMUNOL, V34, P677, DOI 10.1016/j.dci.2010.01.014; MARTIN GG, 1985, J MORPHOL, V185, P339, DOI 10.1002/jmor.1051850306; Montero AB, 1999, J FISH DIS, V22, P377, DOI 10.1046/j.1365-2761.1999.00189.x; Pongsomboon S, 2011, FISH SHELLFISH IMMUN, V30, P439, DOI 10.1016/j.fsi.2010.10.015; Ponprateep S, 2009, AQUACULTURE, V289, P219, DOI 10.1016/j.aquaculture.2009.01.026; Prapavorarat A, 2010, J BIOL CHEM, V285, P21467, DOI 10.1074/jbc.M110.130526; Rattanachai A, 2004, FISH SHELLFISH IMMUN, V16, P599, DOI 10.1016/j.fsi.2003.09.011; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Rojtinnakorn J, 2002, FISH SHELLFISH IMMUN, V13, P69, DOI 10.1006/fsim.2001.0382; Somboonwiwat K, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-39; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Tonganunt M, 2005, J BIOTECHNOL, V120, P135, DOI 10.1016/j.jbiotec.2005.06.006; Vargas-Albores F., 1998, ADV SHRIMP BIOTECHNO, P161; Wang HC, 2007, DEV COMP IMMUNOL, V31, P672, DOI 10.1016/j.dci.2006.11.001; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Yeh MS, 2007, FISH SHELLFISH IMMUN, V23, P272, DOI 10.1016/j.fsi.2006.10.007; Yeh MS, 2006, BBA-PROTEINS PROTEOM, V1764, P1167, DOI 10.1016/j.bbapap.2006.04.005	55	34	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47384	10.1371/journal.pone.0047384	http://dx.doi.org/10.1371/journal.pone.0047384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082160	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900056
J	Chen, YL; Chang, MC; Chen, CA; Lin, HW; Cheng, WF; Chien, CL				Chen, Yu-Li; Chang, Ming-Cheng; Chen, Chi-An; Lin, Han-Wei; Cheng, Wen-Fang; Chien, Chung-Liang			Depletion of Regulatory T Lymphocytes Reverses the Imbalance between Pro- and Anti-Tumor Immunities via Enhancing Antigen-Specific T Cell Immune Responses	PLOS ONE			English	Article							RNA VACCINE POTENCY; OVARIAN-CANCER; IFN-GAMMA; IMMUNOLOGICAL RESPONSES; PROGNOSTIC-SIGNIFICANCE; TGF-BETA; ENHANCEMENT; GENERATION; RESISTANCE; PHENOTYPE	Background: The regulatory T cells (Tregs) can actively suppress the immune responses. However, literature about detailed changes of host effective and suppressive immunities before and after depletion of Tregs in ovarian carcinomas, is rare. Materials and Methods: Ovarian cancer patients and the ascitogenic animal model were employed. Immunologic profiles with flow cytometric analyses, immunohistochemistric staining, RT-PCR, ELISA, and ELISPOT assays were performed. In vivo depletion of Treg cells with the mAb PC61 was also performed in the animal model. Results: The cytokines, including IL-4 (p = 0.017) and TNF-alpha (p = 0.046), significantly decreased while others such as TGF-beta (p = 0.013), IL-6 (p = 0.016), and IL-10 (p = 0.018) were elevated in ascites of ovarian cancer patients, when the disease progressed to advanced stages. The ratio of CD8(+) T cell/Treg cell in ascites was also lower in advanced diseases than in early diseases (advanced 7.37 +/- 0.64 vs. early 14.25 +/- 3.11, p = 0.037). The kinetic low-dose CD25 Ab depletion group had significantly lower intra-peritoneal tumor weight (0.20 +/- 0.03 g) than the sequential high-dose (0.69 +/- 0.06 g) and sequential low-dose (0.67 +/- 0.07 g) CD25 Ab deletion groups (p = 0.001) after 49 days of tumor challenge in the animal. The kinetic low-dose CD25 Ab depletion group generated the highest number of low-dose, mesothelin-specific T lymphocytes compared to the other groups (p < 0.001). Conclusions: The imbalance between effective and suppressive immunities becomes more severe as a tumor progresses. The depletion of Treg cells can correct the imbalance of immunologic profiles and generate potent anti-tumor effects. Targeting Treg cells can be a new strategy for the immunotherapy of ovarian carcinoma.	[Chen, Yu-Li; Chen, Chi-An; Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei 10764, Taiwan; [Chen, Yu-Li; Chien, Chung-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei 10764, Taiwan; [Chen, Yu-Li] Cathay Gen Hosp, Dept Obstet & Gynecol, Gynecol Canc Ctr, Taipei, Taiwan; [Chang, Ming-Cheng; Lin, Han-Wei; Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan; [Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chang, Ming-Cheng] Natl Taiwan Univ, Coll Med, Dept Anesthesiol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; Cathay General Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Cheng, WF (corresponding author), Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei 10764, Taiwan.	wenfangcheng@yahoo.com; chien@ntu.edu.tw		CHIEN, CHUNG-LIANG/0000-0001-9806-486X; CHEN, CHI-AN/0000-0001-6670-7939; CHENG, WEN-FANG/0000-0002-3282-6304	National Science Committee of Taiwan [NSC 98-2628-B-002-083-MY3, 100-2314-B-002-O24]; Department of Medical Research of National Taiwan University Hospital	National Science Committee of Taiwan(Ministry of Science and Technology, Taiwan); Department of Medical Research of National Taiwan University Hospital	The funding for this study was granted by the National Science Committee of Taiwan (NSC 98-2628-B-002-083-MY3 and 100-2314-B-002-O24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the 2nd and 7th core laboratory facility of the Department of Medical Research of National Taiwan University Hospital.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; [Anonymous], 1987, Am J Obstet Gynecol, V156, P263; Baecher-Allan C, 2006, SEMIN CANCER BIOL, V16, P98, DOI 10.1016/j.semcancer.2005.11.003; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Chen CA, 2010, MOL THER, V18, P1233, DOI 10.1038/mt.2010.34; Cheng WF, 2007, CANCER-AM CANCER SOC, V110, P420, DOI 10.1002/cncr.22781; Cheng WF, 2005, IMMUNOLOGY, V115, P136, DOI 10.1111/j.1365-2567.2005.02126.x; Cheng WF, 2001, J IMMUNOL, V166, P6218, DOI 10.4049/jimmunol.166.10.6218; Cheng WF, 2001, HUM GENE THER, V12, P235, DOI 10.1089/10430340150218387; Chu CS, 2008, EXPERT REV ANTICANC, V8, P243, DOI 10.1586/14737140.8.2.243; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; den Boer AT, 2005, CANCER RES, V65, P6984, DOI 10.1158/0008-5472.CAN-04-3344; DiSaia PJ, 2003, GYNECOL ONCOL, V90, pS24, DOI 10.1016/S0090-8258(03)00341-X; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Freeman CM, 2005, J IMMUNOL, V174, P1962, DOI 10.4049/jimmunol.174.4.1962; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; GOLUMBEK PT, 1991, SCIENCE, V254, P713, DOI 10.1126/science.1948050; Gonzalez-Diego P, 2000, EUR J CANCER, V36, P1816, DOI 10.1016/S0959-8049(00)00184-2; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Hallermalm K, 2008, J IMMUNOL, V180, P3766, DOI 10.4049/jimmunol.180.6.3766; Imai H, 2007, CANCER SCI, V98, P416, DOI 10.1111/j.1349-7006.2006.00385.x; IOANNIDES CG, 1991, CANCER RES, V51, P4257; Kryczek I, 2007, CANCER RES, V67, P8900, DOI 10.1158/0008-5472.CAN-07-1866; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Larmonier N, 2007, CANCER IMMUNOL IMMUN, V56, P48, DOI 10.1007/s00262-006-0160-8; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; Lejeune FJ, 2002, J CLIN INVEST, V110, P433, DOI 10.1172/JCI200216493; Li Q, 2003, CANCER RES, V63, P2546; Liao CW, 2005, CANCER RES, V65, P9089, DOI 10.1158/0008-5472.CAN-05-0958; Malmberg KJ, 2002, J CLIN INVEST, V110, P1515, DOI 10.1172/JC1200215564; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; PFLEIDERER A, 1984, J CANCER RES CLIN, V107, P81, DOI 10.1007/BF00399376; Roord STA, 2008, BLOOD, V111, P5233, DOI 10.1182/blood-2007-12-128488; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Tomsova M, 2008, GYNECOL ONCOL, V108, P415, DOI 10.1016/j.ygyno.2007.10.016; Tsuji NM, 2003, INT IMMUNOL, V15, P525, DOI 10.1093/intimm/dxg051; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Workman CJ, 2002, EUR J IMMUNOL, V32, P2255, DOI 10.1002/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A; Wynn TA, 2005, NAT IMMUNOL, V6, P1069, DOI 10.1038/ni1105-1069; Yigit R, 2010, GYNECOL ONCOL, V117, P366, DOI 10.1016/j.ygyno.2010.01.019; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	49	24	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47190	10.1371/journal.pone.0047190	http://dx.doi.org/10.1371/journal.pone.0047190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082146	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900041
J	Schellong, K; Schulz, S; Harder, T; Plagemann, A				Schellong, Karen; Schulz, Sandra; Harder, Thomas; Plagemann, Andreas			Birth Weight and Long-Term Overweight Risk: Systematic Review and a Meta-Analysis Including 643,902 Persons from 66 Studies and 26 Countries Globally	PLOS ONE			English	Article							BODY-MASS INDEX; IMPAIRED GLUCOSE-TOLERANCE; DIABETES-MELLITUS; SUBSEQUENT RISK; SCHOOL-CHILDREN; CHILDHOOD OVERWEIGHT; CARDIOVASCULAR RISK; PRESCHOOL-CHILDREN; ABDOMINAL OBESITY; MATERNAL SMOKING	Background: Overweight is among the major challenging health risk factors. It has been claimed that birth weight, being a critical indicator of prenatal developmental conditions, is related to long-term overweight risk. In order to check this important assumption of developmental and preventive medicine, we performed a systematic review and comprehensive meta-analysis. Methods and Findings: Relevant studies published up to January 2011 that investigated the relation between birth weight and later risk of overweight were identified through literature searches using MEDLINE and EMBASE. For meta-analysis, 66 studies from 26 countries and five continents were identified to be eligible, including 643,902 persons aged 1 to 75 years. We constructed random-effects and fixed-effects models, performed subgroup-analyses, influence-analyses, assessed heterogeneity and publication bias, performed meta-regression analysis as well as analysis of confounder adjusted data. Meta-regression revealed a linear positive relationship between birth weight and later overweight risk (p<0.001). Low birth weight (<2,500 g) was found to be followed by a decreased risk of overweight (odds ratio (OR)=0.67; 95% confidence interval (CI) 0.59-0.76). High birth weight (>4,000 g) was associated with increased risk of overweight (OR=1.66; 95% CI 1.55-1.77). Results did not change significantly by using normal birth weight (2,500-4,000 g) as reference category (OR=0.73, 95% CI 0.63-0.84, and OR=1.60, 95% CI 1.45-1.77, respectively). Subgroup-and influence-analyses revealed no indication for bias/confounding. Adjusted estimates indicate a doubling of long-term overweight risk in high as compared to normal birth weight subjects (OR=1.96, 95% CI 1.43-2.67). Conclusions: Findings demonstrate that low birth weight is followed by a decreased long-term risk of overweight, while high birth weight predisposes for later overweight. Preventing in-utero overnutrition, e. g., by avoiding maternal overnutrition, overweight and/or diabetes during pregnancy, might therefore be a promising strategy of genuine overweight prevention, globally.	[Schellong, Karen; Schulz, Sandra; Harder, Thomas; Plagemann, Andreas] Charite Univ Med Berlin, Campus Virchow Klinikum, Div Expt Obstet, Clin Obstet, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Plagemann, A (corresponding author), Charite Univ Med Berlin, Campus Virchow Klinikum, Div Expt Obstet, Clin Obstet, Berlin, Germany.	andreas.plagemann@charite.de			German Research Foundation (DFG) [GRK 1208, PL 241/5-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by grants of the the German Research Foundation (DFG: GRK 1208; PL 241/5-1) to Dr. Plagemann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarup Mie, 2008, Ugeskr Laeger, V170, P452; Apfelbacher CJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-171; Araujo CL, 2009, EUR J CLIN NUTR, V63, P634, DOI 10.1038/ejcn.2008.20; Armstrong J, 2002, LANCET, V359, P2003, DOI 10.1016/S0140-6736(02)08837-2; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Barros AJD, 2008, CAD SAUDE PUBLICA, V24, pS417, DOI 10.1590/S0102-311X2008001500007; BARTA L, 1965, ACTA PAEDIATR HUNG, V6, P163; Barthel B, 2001, Sante Publique, V13, P7; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; BINKIN NJ, 1988, PEDIATRICS, V82, P828; Boggs DA, 2011, NEW ENGL J MED, V365, P901, DOI 10.1056/NEJMoa1104119; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Bouhours-Nouet N, 2008, DIABETES CARE, V31, P1031, DOI 10.2337/dc07-1647; BROOKS AA, 1995, EARLY HUM DEV, V42, P29, DOI 10.1016/0378-3782(95)01637-I; Burdette HL, 2007, ETHNIC DIS, V17, P467; Cardwell CR, 2009, AM J EPIDEMIOL, V170, P529, DOI 10.1093/aje/kwp189; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Celi F, 2003, EUR J CLIN NUTR, V57, P1045, DOI 10.1038/sj.ejcn.1601640; CHARNEY E, 1976, NEW ENGL J MED, V295, P6, DOI 10.1056/NEJM197607012950102; Chen AM, 2006, INT J EPIDEMIOL, V35, P121, DOI 10.1093/ije/dyi218; COY JF, 1973, MED J AUSTRALIA, V2, P12, DOI 10.5694/j.1326-5377.1973.tb128606.x; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Danielzik S, 2004, INT J OBESITY, V28, P1494, DOI 10.1038/sj.ijo.0802756; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dennison BA, 2006, OBESITY, V14, P491, DOI 10.1038/oby.2006.64; Dieu HTT, 2007, INT J PEDIATR OBES, V2, P40, DOI 10.1080/17477160601103922; DORNER G, 1994, HORM METAB RES, V26, P213, DOI 10.1055/s-2007-1001668; Drachler Maria de Lourdes, 2003, Cad Saude Publica, V19, P1073, DOI 10.1590/S0102-311X2003000400029; Dubois L, 2006, INT J OBESITY, V30, P610, DOI 10.1038/sj.ijo.0803141; Dutra Carmem L., 2006, Cad. Saúde Pública, V22, P151, DOI 10.1590/S0102-311X2006000100016; Eheman C, 2012, CANCER-AM CANCER SOC, V118, P2338, DOI 10.1002/cncr.27514; Eriksson J, 2001, INT J OBESITY, V25, P735, DOI 10.1038/sj.ijo.0801602; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Freinkel N, 1979, CIBA F S, P3; Frye C, 2003, INT J OBESITY, V27, P963, DOI 10.1038/sj.ijo.0802321; Fuiano N, 2008, J ENDOCRINOL INVEST, V31, P979, DOI 10.1007/BF03345635; GALLAHER MM, 1991, AM J DIS CHILD, V145, P1262, DOI 10.1001/archpedi.1991.02160110054019; Gigante DP, 2008, REV SAUDE PUBL, V42, P60, DOI 10.1590/S0034-89102008000900009; Gigante Denise Petrucci, 2003, Cad. Saúde Pública, V19, pS141, DOI 10.1590/S0102-311X2003000700015; Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Guimarães Lenir Vaz, 2006, Rev. Nutr., V19, P5, DOI 10.1590/S1415-52732006000100001; Hack M, 2003, PEDIATRICS, V112, pE30, DOI 10.1542/peds.112.1.e30; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harder T, 2008, AM J EPIDEMIOL, V168, P366, DOI 10.1093/aje/kwn144; Harder T, 2007, LANCET, V369, P1859, DOI 10.1016/S0140-6736(07)60847-2; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Harder T, 2009, AM J EPIDEMIOL, V170, P530, DOI 10.1093/aje/kwp190; Harder T, 2009, AM J EPIDEMIOL, V169, P1428, DOI 10.1093/aje/kwp065; Hawkins SS, 2009, J EPIDEMIOL COMMUN H, V63, P147, DOI 10.1136/jech.2008.077917; He Q, 2000, INT J OBESITY, V24, P1528, DOI 10.1038/sj.ijo.0801394; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirschler V, 2008, ARCH MED RES, V39, P796, DOI 10.1016/j.arcmed.2008.08.003; HOLEMANS K, 1991, DIABETOLOGIA, V34, P81, DOI 10.1007/BF00500377; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hui LL, 2003, INT J OBESITY, V27, P1411, DOI 10.1038/sj.ijo.0802423; Huxley R, 2004, JAMA-J AM MED ASSOC, V292, P2755, DOI 10.1001/jama.292.22.2755; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Jovanovic L, 2001, JAMA-J AM MED ASSOC, V286, P2516, DOI 10.1001/jama.286.20.2516; Kang Hee-Tae, 2006, J Prev Med Public Health, V39, P371; Kersey M, 2005, AMBUL PEDIATR, V5, P355, DOI 10.1367/A04-088R.1; Kilpelaeinen TO, 2011, AM J CLIN NUTR, V93, P851, DOI 10.3945/ajcn.110.000828; King D, 2011, LANCET, V378, P743, DOI 10.1016/S0140-6736(11)61261-0; Kleiser C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-46; Kniazewska Maria, 2006, Przegl Lek, V63 Suppl 3, P118; Koupil I, 2008, INT J OBESITY, V32, P73, DOI 10.1038/sj.ijo.0803681; Kromeyer-Hauschild K, 1999, INT J OBESITY, V23, P1143, DOI 10.1038/sj.ijo.0801044; Laitinen J, 2001, AM J CLIN NUTR, V74, P287; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Leong NM, 2003, INT J CANCER, V103, P789, DOI 10.1002/ijc.10886; Levin BE, 2010, FRONT NEUROENDOCRIN, V31, P270, DOI 10.1016/j.yfrne.2010.02.005; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; LOCARD E, 1992, INT J OBESITY, V16, P721; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Lundgren EM, 2003, PAEDIATR PERINAT EP, V17, P156, DOI 10.1046/j.1365-3016.2003.00489.x; Maddah M, 2009, INT J CARDIOL, V136, P235, DOI 10.1016/j.ijcard.2008.04.046; MAFFEIS C, 1994, INT J OBESITY, V18, P301; Mangrio E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-764; Mardones F, 2008, INT J EPIDEMIOL, V37, P902, DOI 10.1093/ije/dyn133; Mazur A, 2003, PEDIATR POL, V78, P889; Mazur A, 2003, PEDIATR POL, V78, P881; Mazur A, 2008, ANN AGR ENV MED, V15, P281; Meas T, 2008, J CLIN ENDOCR METAB, V93, P3804, DOI 10.1210/jc.2008-0488; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mikulandra F, 2000, COLLEGIUM ANTROPOL, V24, P133; Miletic T, 2004, GYNAECOL PERINATOL, V13, P13; MOGAN J, 1986, INT J NURS STUD, V23, P255, DOI 10.1016/0020-7489(86)90023-4; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Monteiro POA, 2003, INT J OBESITY, V27, P1274, DOI 10.1038/sj.ijo.0802409; Moraes Suzana Alves de, 2006, Cad. Saúde Pública, V22, P1289; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Newby PK, 2005, INT J OBESITY, V29, P1084, DOI 10.1038/sj.ijo.0802996; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; OCallaghan MJ, 1997, J PAEDIATR CHILD H, V33, P311, DOI 10.1111/j.1440-1754.1997.tb01607.x; Ochoa MC, 2007, NUTRITION, V23, P379, DOI 10.1016/j.nut.2007.02.004; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Oldroyd J, 2011, EUR J PEDIATR, V170, P899, DOI 10.1007/s00431-010-1375-4; Olson CM, 2009, MATERN CHILD HLTH J, V13, P839, DOI 10.1007/s10995-008-0413-6; Osler M, 2009, EUR J EPIDEMIOL, V24, P57, DOI 10.1007/s10654-008-9301-z; Padez C, 2005, ACTA PAEDIATR, V94, P1550, DOI 10.1080/08035250510042924; Panagiotakos DB, 2008, PEDIATR INT, V50, P563, DOI 10.1111/j.1442-200X.2008.02612.x; Peter Szabolcs, 2008, Orvosi Hetilap, V149, P407, DOI 10.1556/OH.2008.28251; PETTITT DJ, 1983, NEW ENGL J MED, V308, P242, DOI 10.1056/NEJM198302033080502; Phillips DIW, 2000, INT J OBESITY, V24, P281, DOI 10.1038/sj.ijo.0801125; Pilpel D, 1995, Public Health Rev, V23, P253; Plagemann A, 1997, INT J OBESITY, V21, P451, DOI 10.1038/sj.ijo.0800429; Plagemann A, 2008, J MATERN-FETAL NEO M, V21, P143, DOI 10.1080/14767050801929869; Plagemann A, 2010, NEW ENGL J MED, V362, P1840; Plagemann A, 2009, JAMA-J AM MED ASSOC, V301, P1540, DOI 10.1001/jama.2009.486; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Ribeiro ID, 2003, PUBLIC HEALTH NUTR, V6, P659, DOI 10.1079/PHN2003473; Rose D, 2006, PEDIATRICS, V117, P464, DOI 10.1542/peds.2005-0582; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; Savva SC, 2005, EUR J CLIN NUTR, V59, P1259, DOI 10.1038/sj.ejcn.1602237; Schaefer-Graf UM, 2005, DIABETES CARE, V28, P1745, DOI 10.2337/diacare.28.7.1745; Scully Tony, 2012, Nature, V485, pS2; SEIDMAN DS, 1991, AM J DIS CHILD, V145, P782; Seidman DS, 1998, ACTA OBSTET GYN SCAN, V77, P58, DOI 10.1080/00016349808565813; Serra-Majem L, 2006, BRIT J NUTR, V96, pS67, DOI 10.1079/BJN20061703; Sewell MF, 2006, AM J OBSTET GYNECOL, V195, P1100, DOI 10.1016/j.ajog.2006.06.014; Shehadeh N, 2008, J PEDIATR ENDOCR MET, V21, P9; Silva ID, 2008, PLOS MED, V5, P1372, DOI 10.1371/journal.pmed.0050193; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Sorensen HT, 1997, BRIT MED J, V315, P1137, DOI 10.1136/bmj.315.7116.1137; Stettler N, 2003, AM J CLIN NUTR, V77, P1374, DOI 10.1093/ajcn/77.6.1374; Stettler N, 2002, INT J OBESITY, V26, P214, DOI 10.1038/sj.ijo.0801860; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; Stockard CR, 1921, AM J ANAT, V28, P115, DOI 10.1002/aja.1000280202; Strufaldi MWL, 2009, EUR J PEDIATR, V168, P619, DOI 10.1007/s00431-008-0813-z; Sugihara S, 2008, PEDIATR DIABETES, V9, P285, DOI 10.1111/j.1399-5448.2008.00402.x; Sugimori H, 1997, Environ Health Prev Med, V2, P74, DOI 10.1007/BF02931968; Takahashi E, 1999, PREV MED, V28, P293, DOI 10.1006/pmed.1998.0428; Takatani H, 1967, NIPPON SHONIKA GAKKA, V71, P309; Tene Carlos Enrique, 2003, Gac Med Mex, V139, P15; Terry MB, 2007, AM J EPIDEMIOL, V166, P5, DOI 10.1093/aje/kwm094; Tian JY, 2006, EUR J ENDOCRINOL, V155, P601, DOI 10.1530/eje.1.02265; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Tome FS, 2007, BRAZ J MED BIOL RES, V40, P1221, DOI 10.1590/S0100-879X2006005000163; Toschke AM, 2002, J PEDIATR-US, V141, P764, DOI 10.1067/mpd.2002.128890; Turkkahraman D, 2006, SAUDI MED J, V27, P1028; Tzschentke B, 2006, WORLD POULTRY SCI J, V62, P626, DOI 10.1079/WPS2006117; Van Assche FA, 2010, DIABETOLOGIA, V53, P1243, DOI 10.1007/s00125-010-1712-1; Van Assche FA, 2001, BRIT MED BULL, V60, P173, DOI 10.1093/bmb/60.1.173; VERDY M, 1974, NEW ENGL J MED, V290, P576; Vitolo MR, 2008, J PEDIAT-BRAZIL, V84, P251, DOI [10.2223/JPED.1776, 10.1590/S0021-75572008000300011]; VOHR BR, 1980, J PEDIATR-US, V97, P196, DOI 10.1016/S0022-3476(80)80473-2; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147; Wang Y, 2009, INT J OBESITY, V33, P923, DOI 10.1038/ijo.2009.131; Wei JN, 2007, OBESITY, V15, P1609, DOI 10.1038/oby.2007.190; Weyermann M, 2006, INT J OBESITY, V30, P1281, DOI 10.1038/sj.ijo.0803260; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612; Yu Z, 2008, INT J OBESITY, V32, P55, DOI 10.1038/sj.ijo.0803765; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x; Zhang X, 2009, PREV MED, V49, P172, DOI 10.1016/j.ypmed.2009.07.013	166	233	240	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47776	10.1371/journal.pone.0047776	http://dx.doi.org/10.1371/journal.pone.0047776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082214	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900111
J	Chua, BY; Johnson, D; Tan, A; Earnest-Silveira, L; Sekiya, T; Chin, R; Torresi, J; Jackson, DC				Chua, Brendon Y.; Johnson, Douglas; Tan, Amabel; Earnest-Silveira, Linda; Sekiya, Toshiki; Chin, Ruth; Torresi, Joseph; Jackson, David C.			Hepatitis C VLPs Delivered to Dendritic Cells by a TLR2 Targeting Lipopeptide Results in Enhanced Antibody and Cell-Mediated Responses	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; RESPIRATORY SYNDROME CORONAVIRUS; CD8(+) T-CELL; NEUTRALIZING ANTIBODIES; VACCINE; IMMUNIZATION; INFECTION; BINDING; GLYCOPROTEIN; PROTECTION	Although many studies provide strong evidence supporting the development of HCV virus-like particle (VLP)-based vaccines, the fact that heterologous viral vectors and/or multiple dosing regimes are required to induce protective immunity indicates that it is necessary to improve their immunogenicity. In this study, we have evaluated the use of an anionic self-adjuvanting lipopeptide containing the TLR2 agonist Pam(2)Cys (E(8)Pam(2)Cys) to enhance the immunogenicity of VLPs containing the HCV structural proteins (core, E1 and E2) of genotype 1a. While co-formulation of this lipopeptide with VLPs only resulted in marginal improvements in dendritic cell (DC) uptake, its ability to concomitantly induce DC maturation at very small doses is a feature not observed using VLPs alone or in the presence of an aluminium hydroxide-based adjuvant (Alum). Dramatically improved VLP and E2-specific antibody responses were observed in VLP+E(8)Pam(2)Cys vaccinated mice where up to 3 doses of non-adjuvanted or traditionally alum-adjuvanted VLPs was required to match the antibody titres obtained with a single dose of VLPs formulated with this lipopeptide. This result also correlated with significantly higher numbers of specific antibody secreting cells that was detected in the spleens of VLP+E(8)Pam(2)Cys vaccinated mice and greater ability of sera from these mice to neutralise the binding and uptake of VLPs by Huh7 cells. Moreover, vaccination of HLA-A2 transgenic mice with this formulation also induced better VLP-specific IFN-gamma-mediated responses compared to non-adjuvanted VLPs but comparable levels to that achieved when coadministered with complete freund's adjuvant. These results suggest overall that the immunogenicity of HCV VLPs can be significantly improved by the addition of this novel adjuvant by targeting their delivery to DCs and could therefore constitute a viable vaccine strategy for the treatment of HCV.	[Chua, Brendon Y.; Tan, Amabel; Sekiya, Toshiki; Jackson, David C.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Johnson, Douglas; Torresi, Joseph] Austin Hosp, Dept Infect Dis, Heidelberg, Vic 3084, Australia; [Johnson, Douglas; Earnest-Silveira, Linda; Chin, Ruth; Torresi, Joseph] Univ Melbourne, Austin Hosp, Dept Med, Heidelberg, Vic, Australia	University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Chua, BY (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	bychua@unimelb.edu.au	Chua, Brendon Y/A-9755-2012	Chua, Brendon Y/0000-0001-5654-1293; Jackson, David/0000-0001-7255-270X; Torresi, Joseph/0000-0002-8212-0887	National Health and Medical Research Council of Australia; Australian Centre for HIV and Hepatitis Research; Department of Innovation, Industry, Science and Research, Commonwealth of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Research; Department of Innovation, Industry, Science and Research, Commonwealth of Australia	This work was supported by grants from the National Health and Medical Research Council of Australia, The Australian Centre for HIV and Hepatitis Research and from the Department of Innovation, Industry, Science and Research, Commonwealth of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; Barth H, 2005, BLOOD, V105, P3605, DOI 10.1182/blood-2004-05-1952; Buonaguro L, 2007, VACCINE, V25, P5968, DOI 10.1016/j.vaccine.2007.05.052; Buonaguro L, 2011, EXPERT REV VACCINES, V10, P1569, DOI [10.1586/ERV.11.135, 10.1586/erv.11.135]; Chin R, 2007, J HEPATOL, V47, P325, DOI 10.1016/j.jhep.2007.03.025; CHOO QL, 1994, P NATL ACAD SCI USA, V91, P1294, DOI 10.1073/pnas.91.4.1294; Chua BY, 2008, PEPTIDES, V29, P881, DOI 10.1016/j.peptides.2008.01.025; Chua BY, 2007, VACCINE, V25, P92, DOI 10.1016/j.vaccine.2006.07.012; Chua BY, 2011, J IMMUNOL, V187, P1692, DOI 10.4049/jimmunol.1100486; Deliyannis G, 2006, EUR J IMMUNOL, V36, P770, DOI 10.1002/eji.200535217; Eriksson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023828; Firat H, 1999, EUR J IMMUNOL, V29, P3112, DOI 10.1002/(SICI)1521-4141(199910)29:10<3112::AID-IMMU3112>3.0.CO;2-Q; Garrone P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002330; Grebely J, 2006, HEPATOLOGY, V44, P1139, DOI 10.1002/hep.21376; Grollo L, 2006, ANTIVIR THER, V11, P1005; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Jagu S, 2010, VACCINE, V28, P4478, DOI 10.1016/j.vaccine.2010.04.039; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Lauer GM, 2005, J VIROL, V79, P12979, DOI 10.1128/JVI.79.20.12979-12988.2005; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lechmann M, 2001, HEPATOLOGY, V34, P417, DOI 10.1053/jhep.2001.26523; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Liu YV, 2011, VACCINE, V29, P6606, DOI 10.1016/j.vaccine.2011.06.111; Lu BJ, 2010, IMMUNOLOGY, V130, P254, DOI 10.1111/j.1365-2567.2010.03231.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Middelberg APJ, 2011, VACCINE, V29, P7154, DOI 10.1016/j.vaccine.2011.05.075; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Murata K, 2003, P NATL ACAD SCI USA, V100, P6753, DOI 10.1073/pnas.1131929100; Nattermann J, 2005, J HEPATOL, V42, P499, DOI 10.1016/j.jhep.2004.12.018; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Puig M, 2006, HEPATOLOGY, V44, P736, DOI 10.1002/hep.21319; Raghuraman S, 2012, J INFECT DIS, V205, P763, DOI 10.1093/infdis/jir835; Rosa D, 1996, P NATL ACAD SCI USA, V93, P1759, DOI 10.1073/pnas.93.5.1759; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Schneider-Ohrum K, 2011, VACCINE, V29, P9081, DOI 10.1016/j.vaccine.2011.09.051; Smyk-Pearson S, 2006, J INFECT DIS, V194, P454, DOI 10.1086/505714; Steinmann D, 2004, J VIROL, V78, P9030, DOI 10.1128/JVI.78.17.9030-9040.2004; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Torresi J, 2007, HEPATOLOGY, V45, P911, DOI 10.1002/hep.21538; Torresi J, 2007, IMMUNOL CELL BIOL, V85, P169, DOI 10.1038/sj.icb.7100021; Velasquez LS, 2010, CLIN VACCINE IMMUNOL, V17, P1850, DOI 10.1128/CVI.00230-10; Visciano ML, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-4; Walpita P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018437; Wang BZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013972; Zeng WG, 1996, J PEPT SCI, V2, P66	47	43	43	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47492	10.1371/journal.pone.0047492	http://dx.doi.org/10.1371/journal.pone.0047492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091628	Green Submitted, Green Published, gold			2022-12-27	WOS:000310135800051
J	Mao, DH; Chen, CY				Mao, Donghai; Chen, Caiyan			Colinearity and Similar Expression Pattern of Rice DREB1s Reveal Their Functional Conservation in the Cold-Responsive Pathway	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; FREEZING TOLERANCE; BOOTING STAGE; CBF GENES; NATURAL VARIATION; CANDIDATE GENE; HIGH-SALT; ARABIDOPSIS	The clustered genes C-repeat (CRT) binding factor (CBF)1/dehydration-responsive element binding protein (DREB)1B, CBF2/DREB1C, and CBF3/DREB1A play a central role in cold acclimation and facilitate plant resistance to freezing in Arabidopsis thaliana. Rice (Oryza sativa L.) is very sensitive to low temperatures; enhancing the cold stress tolerance of rice is a key challenge to increasing its yield. In this study, we demonstrate chilling acclimation, a phenomenon similar to Arabidopsis cold acclimation, in rice. To determine whether rice CBF/DREB1 genes participate in this cold-responsive pathway, all putative homologs of Arabidopsis DREB1 genes were filtered from the complete rice genome through a BLASTP search, followed by phylogenetic, colinearity and expression analysis. We thereby identified 10 rice genes as putative DREB1 homologs: nine of these were located in rice genomic regions with some colinearity to the Arabidopsis CBF1-CBF4 region. Expression profiling revealed that six of these genes (Os01g73770, Os02g45450, Os04g48350, Os06g03670, Os09g35010, and Os09g35030) were similarly expressed in response to chilling acclimation and cold stress and were co-expressed with genes involved in cold signalling, suggesting that these DREB1 homologs may be involved in the cold response in rice. The results presented here serve as a prelude towards understanding the function of rice homologs of DREB1 genes in cold-sensitive crops.	[Mao, Donghai; Chen, Caiyan] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Chen, CY (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Peoples R China.	cychen@isa.ac.cn	Chen, Caiyan/ABB-1458-2021; Mao, Donghai/AAB-7444-2020	Mao, Donghai/0000-0002-9850-149X	Chinese Academy of Sciences [KZCX2-YW-T07, KZCX2-YW-JC403]; National Natural Science Foundation of China [31101211]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Chinese Academy of Sciences (http://www.cas.cn. KZCX2-YW-T07, KZCX2-YW-JC403) and the National Natural Science Foundation of China (http://www.nsfc.gov.cn. 31101211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Alonso-Blanco C, 2005, PLANT PHYSIOL, V139, P1304, DOI 10.1104/pp.105.068510; Andaya VC, 2003, J EXP BOT, V54, P2579, DOI 10.1093/jxb/erg243; ANDERSON MD, 1994, PLANT PHYSIOL, V105, P331, DOI 10.1104/pp.105.1.331; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Francia E, 2007, THEOR APPL GENET, V115, P1083, DOI 10.1007/s00122-007-0634-x; Fujino K, 2008, P NATL ACAD SCI USA, V105, P12623, DOI 10.1073/pnas.0805303105; Fursova OV, 2009, GENE, V429, P98, DOI 10.1016/j.gene.2008.10.016; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Han Longzhi, 2007, Journal of Genetics and Genomics, V34, P239, DOI 10.1016/S1673-8527(07)60025-3; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Ji SuLan, 2008, Acta Agronomica Sinica, V34, P551, DOI 10.3724/SP.J.1006.2008.00551; Ji ZJ, 2010, RICE SCI, V17, P282, DOI 10.1016/S1672-6308(09)60028-7; Jiang YH, 2012, PLANT J, V70, P398, DOI 10.1111/j.1365-313X.2011.04877.x; Knox AK, 2008, PLANT MOL BIOL, V67, P257, DOI 10.1007/s11103-008-9316-6; Kuroki M, 2007, THEOR APPL GENET, V115, P593, DOI 10.1007/s00122-007-0589-y; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levitt J., 1980, RESPONSES PLANTS ENV; Lin YH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-111; Liu FX, 2003, CHINESE SCI BULL, V48, P2068, DOI 10.1360/03wc0287; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou QJ, 2007, EUPHYTICA, V158, P87, DOI 10.1007/s10681-007-9431-5; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; McKhann HI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-105; Miller AK, 2006, MOL GENET GENOMICS, V275, P193, DOI 10.1007/s00438-005-0076-6; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Ohno S., 1970, P1; Page RD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0602S01; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Saito K, 2004, THEOR APPL GENET, V109, P515, DOI 10.1007/s00122-004-1667-z; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Vagujfalvi A, 2003, MOL GENET GENOMICS, V269, P60, DOI 10.1007/s00438-003-0806-6; Vandepoele K, 2002, TRENDS GENET, V18, P606, DOI 10.1016/S0168-9525(02)02796-8; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang QY, 2008, PLANT MOL BIOL, V67, P589, DOI 10.1007/s11103-008-9340-6; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-284; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Xia RuiXiang, 2010, Scientia Agricultura Sinica, V43, P443; Xu LM, 2008, PLANT SCI, V174, P340, DOI 10.1016/j.plantsci.2007.12.003; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhang Y, 2009, BMB REP, V42, P486, DOI 10.5483/BMBRep.2009.42.8.486; Zhou L, 2010, THEOR APPL GENET, V121, P895, DOI 10.1007/s00122-010-1358-x; Zhu HY, 2006, GENETICS, V172, P2491, DOI 10.1534/genetics.105.051185	58	63	73	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47275	10.1371/journal.pone.0047275	http://dx.doi.org/10.1371/journal.pone.0047275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077584	gold, Green Submitted, Green Published			2022-12-27	WOS:000310135800037
J	Shi, T; Gao, ZH; Wang, LJ; Zhang, Z; Zhuang, WB; Sun, HL; Zhong, WJ				Shi, Ting; Gao, Zhihong; Wang, Liangju; Zhang, Zhen; Zhuang, Weibing; Sun, Hailong; Zhong, Wenjun			Identification of Differentially-Expressed Genes Associated with Pistil Abortion in Japanese Apricot by Genome-Wide Transcriptional Analysis	PLOS ONE			English	Article							DIRECTED DNA METHYLATION; FLOWERING-LOCUS-C; ARABIDOPSIS-THALIANA; CELL-WALL; RNA-SEQ; GAMETOPHYTE DEVELOPMENT; PRUNUS-MUME; POLLEN; PROTEINS; MUTANT	The phenomenon of pistil abortion widely occurs in Japanese apricot, and imperfect flowers with pistil abortion seriously decrease the yield in production. Although transcriptome analyses have been extensively studied in the past, a systematic study of differential gene expression has not been performed in Japanese apricot. To investigate genes related to the pistil development of Japanese apricot, high-throughput sequencing technology (Illumina) was employed to survey gene expression profiles from perfect and imperfect Japanese apricot flower buds. 3,476,249 and 3,580,677 tags were sequenced from two libraries constructed from perfect and imperfect flower buds of Japanese apricot, respectively. There were 689 significant differentially-expressed genes between the two libraries. GO annotation revealed that highly ranked genes were those implicated in small molecule metabolism, cellular component organisation or biogenesis at the cellular level and fatty acid metabolism. According to the results, we assumed that late embryogenesis abundant protein (LEA), Dicer-like 3 (DCL3) Xyloglucan endotransglucosylase/hydrolase 2 (XTH2), Pectin lyase-like superfamily protein (PPME1), Lipid transfer protein 3 (LTP3), Fatty acid biosynthesis 1 (FAB1) and Fatty acid desaturase 5 (FAD5) might have relationships with the pistil abortion in Japanese apricot. The expression patterns of 36 differentially expressed genes were confirmed by real-time (RT)-PCR. This is the first report of the Illumina RNA-seq technique being used for the analysis of differentially-expressed gene profiles related to pistil abortion that both computationally and experimentally provides valuable information for the further functional characterisation of genes associated with pistil development in woody plants.	[Shi, Ting; Gao, Zhihong; Wang, Liangju; Zhang, Zhen; Zhuang, Weibing; Sun, Hailong; Zhong, Wenjun] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Gao, ZH (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	gaozhihong@njau.edu.cn		Shi, Ting/0000-0002-0955-016X	Specialized Fund for the Basic Research Operating expenses Program of Central College; National Science Foundation of China [31101526]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Specialized Fund for the Basic Research Operating expenses Program of Central College; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Specialized Fund for the Basic Research Operating expenses Program of Central College 2012, the National Science Foundation of China (31101526) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) for funding part of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Arathi HS, 1999, AM J BOT, V86, P659, DOI 10.2307/2656574; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barkan L, 2006, PLANT PHYSIOL, V141, P1012, DOI 10.1104/pp.106.080481; Benjamini Y, 2001, ANN STAT, V29, P1165; Beppu K, 2011, J JPN SOC HORTIC SCI, V80, P1, DOI 10.2503/jjshs1.80.1; Boavida LC, 2009, GENETICS, V181, P1369, DOI 10.1534/genetics.108.090852; Borner GHH, 2002, PLANT PHYSIOL, V129, P486, DOI 10.1104/pp.010884; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Bourc'his D, 2010, SCIENCE, V330, P617, DOI 10.1126/science.1194776; Causier B, 2003, PLANT MOL BIOL, V52, P1051, DOI 10.1023/A:1025426016267; Chen WW, 2010, PLANT PHYSIOL, V154, P810, DOI 10.1104/pp.110.161109; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chinnusamy V, 2009, SCI CHINA SER C, V52, P331, DOI 10.1007/s11427-009-0052-1; Chu M.Y., 1999, CHINA FRUIT RECORDS; Chung T, 2009, PLANT PHYSIOL, V151, P1498, DOI 10.1104/pp.109.141705; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; Gao Z., 2006, JIANGSU AGR SCI, V6, P231; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; Gou MY, 2009, PLANT J, V60, P757, DOI 10.1111/j.1365-313X.2009.03995.x; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Habu T, 2012, J JPN SOC HORTIC SCI, V81, P239, DOI 10.2503/jjshs1.81.239; Hao QN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-525; Heilmann I, 2004, PLANT PHYSIOL, V136, P4237, DOI 10.1104/pp.104.052951; Hou JH, 2011, PLANT MOL BIOL REP, V29, P473, DOI 10.1007/s11105-010-0248-3; Hunt M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-145; Hyodo H, 2003, PLANT MOL BIOL, V52, P473, DOI 10.1023/A:1023904217641; Imoto K, 2005, PLANT MOL BIOL, V58, P177, DOI 10.1007/s11103-005-5344-7; Ji LZ, 2011, PURE APPL MATH Q, V7, P1, DOI 10.1371/journal.pgen.1001358; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kanchiswamy CN, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-97; Kato M, 2004, PLANT PROD SCI, V7, P184, DOI 10.1626/pps.7.184; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Kocsis Marianna, 2008, Acta Biologica Szegediensis, V52, P247; Kokubun M, 2001, CROP SCI, V41, P1517, DOI 10.2135/cropsci2001.4151517x; Kroeger TS, 2009, P NATL ACAD SCI USA, V106, P4537, DOI 10.1073/pnas.0812503106; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Li YJ, 2011, FEBS J, V278, P156, DOI 10.1111/j.1742-4658.2010.07941.x; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Liu HC, 2000, BBA-MOL CELL BIOL L, V1487, P106, DOI 10.1016/S1388-1981(00)00072-X; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Maris A, 2011, J EXP BOT, V62, P261, DOI 10.1093/jxb/erq263; Meier I, 2012, BBA-GENE REGUL MECH, V1819, P531, DOI 10.1016/j.bbagrm.2012.01.006; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Menges M, 2008, NEW PHYTOL, V179, P643, DOI 10.1111/j.1469-8137.2008.02552.x; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; OKAMOTO G, 1991, J JPN SOC HORTIC SCI, V60, P521, DOI 10.2503/jjshs.60.521; Parre E, 2005, PLANTA, V220, P582, DOI 10.1007/s00425-004-1368-5; Peng SM, 2008, BIOL PLANTARUM, V52, P222, DOI 10.1007/s10535-008-0049-9; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rapoport HF, 2012, ENVIRON EXP BOT, V77, P227, DOI 10.1016/j.envexpbot.2011.11.021; Reale L, 2009, SEX PLANT REPROD, V22, P109, DOI 10.1007/s00497-009-0096-1; Rockel N, 2008, PLANT J, V53, P133, DOI 10.1111/j.1365-313X.2007.03325.x; Schmitz RJ, 2007, GENETICS, V176, P1359, DOI 10.1534/genetics.107.070649; Shi T, 2012, J PLANT PHYSIOL, V169, P1301, DOI 10.1016/j.jplph.2012.05.009; Shi Ting, 2011, Journal of Plant Resources and Environment, V20, P35; Sivitz A, 2011, PLANT J; Srinivasan A, 1999, FIELD CROP RES, V60, P209, DOI 10.1016/S0378-4290(98)00126-9; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Wang HC, 2008, PLANT CELL, V20, P602, DOI 10.1105/tpc.108.058032; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang S., 2008, PRELIMINARY STUDIES; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whittle CA, 2009, BOTANY, V87, P650, DOI 10.1139/B09-030; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; Xia DZ, 2011, LWT-FOOD SCI TECHNOL, V44, P347, DOI 10.1016/j.lwt.2010.05.017; Xiao LH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-177; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang HM, 2011, CURR OPIN PLANT BIOL, V14, P142, DOI 10.1016/j.pbi.2011.02.003; Zinn KE, 2010, J EXP BOT, V61, P1959, DOI 10.1093/jxb/erq053	80	38	39	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47810	10.1371/journal.pone.0047810	http://dx.doi.org/10.1371/journal.pone.0047810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091648	Green Submitted, Green Published, gold			2022-12-27	WOS:000310135800074
J	Dongol, S; Thompson, CN; Clare, S; Tran, VTN; Duy, PT; Karkey, A; Arjyal, A; Koirala, S; Khatri, NS; Maskey, P; Poudel, S; Jaiswal, VK; Vaidya, S; Dougan, G; Farrar, JJ; Dolecek, C; Basnyat, B; Baker, S				Dongol, Sabina; Thompson, Corinne N.; Clare, Simon; Tran Vu Thieu Nga; Pham Thanh Duy; Karkey, Abhilasha; Arjyal, Amit; Koirala, Samir; Khatri, Nely Shrestha; Maskey, Pukar; Poudel, Sanjay; Jaiswal, Vijay Kumar; Vaidya, Sujan; Dougan, Gordon; Farrar, Jeremy J.; Dolecek, Christiane; Basnyat, Buddha; Baker, Stephen			The Microbiological and Clinical Characteristics of Invasive Salmonella in Gallbladders from Cholecystectomy Patients in Kathmandu, Nepal	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHI; CARRIERS; BILIARY; FEVER; BLOOD; INFECTIONS; GALLSTONES; PARATYPHI; BACTERIA; BILE	Gallbladder carriage of invasive Salmonella is considered fundamental in sustaining typhoid fever transmission. Bile and tissue was obtained from 1,377 individuals undergoing cholecystectomy in Kathmandu to investigate the prevalence, characteristics and relevance of invasive Salmonella in the gallbladder in an endemic area. Twenty percent of bile samples contained a Gram-negative organism, with Salmonella Typhi and Salmonella Paratyphi A isolated from 24 and 22 individuals, respectively. Gallbladders that contained Salmonella were more likely to show evidence of acute inflammation with extensive neutrophil infiltrate than those without Salmonella, corresponding with higher neutrophil and lower lymphocyte counts in the blood of Salmonella positive individuals. Antimicrobial resistance in the invasive Salmonella isolates was limited, indicating that gallbladder colonization is unlikely to be driven by antimicrobial resistance. The overall role of invasive Salmonella carriage in the gallbladder is not understood; here we show that 3.5% of individuals undergoing cholecystectomy in this setting have a high concentration of antimicrobial sensitive, invasive Salmonella in their bile. We predict that such individuals will become increasingly important if current transmission mechanisms are disturbed; prospectively identifying these individuals is, therefore, paramount for rapid local and regional elimination.	[Thompson, Corinne N.; Tran Vu Thieu Nga; Pham Thanh Duy; Farrar, Jeremy J.; Dolecek, Christiane; Baker, Stephen] Univ Oxford, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Clin Res Unit, Ho Chi Minh City, Vietnam; [Dongol, Sabina; Karkey, Abhilasha; Arjyal, Amit; Koirala, Samir; Khatri, Nely Shrestha; Basnyat, Buddha] Univ Oxford, Clin Res Unit, Patan Acad Hlth Sci, Kathmandu, Nepal; [Thompson, Corinne N.; Farrar, Jeremy J.; Dolecek, Christiane; Baker, Stephen] Univ Oxford, Ctr Trop Med, Oxford, England; [Clare, Simon; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Maskey, Pukar; Poudel, Sanjay; Jaiswal, Vijay Kumar; Vaidya, Sujan] Patan Hosp, Kathmandu, Nepal	University of Oxford; University of Oxford; University of Oxford; Wellcome Trust Sanger Institute	Baker, S (corresponding author), Univ Oxford, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Clin Res Unit, Ho Chi Minh City, Vietnam.	sbaker@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Pham, Thanh Duy/AAX-3845-2020	Pham, Thanh Duy/0000-0001-7029-9210; SHRESTHA KHATRI, NELY/0000-0002-5399-4171; Baker, Stephen/0000-0003-1308-5755; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust of Great Britain; OAK Foundation through Oxford University, UK	Wellcome Trust of Great Britain(Wellcome Trust); OAK Foundation through Oxford University, UK	This work was supported by The Wellcome Trust of Great Britain. SB is funded by an OAK Foundation through Oxford University, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PERF STAND ANT SEN S; Baker S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110008; Baker S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-45; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; BENAVENTE L, 1984, T ROY SOC TROP MED H, V78, P404, DOI 10.1016/0035-9203(84)90134-2; Brooks J, 1996, CAN MED ASSOC J, V154, P915; Capoor MR, 2008, BRAZ J INFECT DIS, V12, P222, DOI 10.1590/S1413-86702008000300012; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Everest P, 2001, TRENDS MICROBIOL, V9, P316, DOI 10.1016/S0966-842X(01)02067-4; GILMAN RH, 1979, LANCET, V1, P795; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; Karkey A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013988; Khatri NS, 2009, ANN INTERN MED, V150, P567, DOI 10.7326/0003-4819-150-8-200904210-00017; LEVINE MM, 1982, J INFECT DIS, V146, P724, DOI 10.1093/infdis/146.6.724; Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168; Parry CM, 2010, ANTIMICROB AGENTS CH, V54, P5201, DOI 10.1128/AAC.00963-10; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; Ristori C, 1982, Bull Pan Am Health Organ, V16, P361; RYAN CA, 1989, REV INFECT DIS, V11, P1; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; SCHIOLER H, 1983, SCAND J INFECT DIS, V15, P17, DOI 10.3109/inf.1983.15.issue-1.04; Tran VTN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-125; Vaishnavi C, 2005, JPN J INFECT DIS, V58, P363; Vaishnavi C, 2005, MICROBIOL IMMUNOL, V49, P107, DOI 10.1111/j.1348-0421.2005.tb03709.x; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998	30	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47342	10.1371/journal.pone.0047342	http://dx.doi.org/10.1371/journal.pone.0047342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077595	Green Published, gold, Green Accepted			2022-12-27	WOS:000309995100095
J	Garcia-Bermudez, M; Lopez-Mejias, R; Gonzalez-Juanatey, C; Corrales, A; Robledo, G; Castaneda, S; Miranda-Filloy, JA; Blanco, R; Fernandez-Gutierrez, B; Balsa, A; Gonzalez-Alvaro, I; Gomez-Vaquero, C; Llorca, J; Martin, J; Gonzalez-Gay, MA				Garcia-Bermudez, Mercedes; Lopez-Mejias, Raquel; Gonzalez-Juanatey, Carlos; Corrales, Alfonso; Robledo, Gema; Castaneda, Santos; Miranda-Filloy, Jose A.; Blanco, Ricardo; Fernandez-Gutierrez, Benjamin; Balsa, Alejandro; Gonzalez-Alvaro, Isidoro; Gomez-Vaquero, Carmen; Llorca, Javier; Martin, Javier; Gonzalez-Gay, Miguel A.			Analysis of the Interferon Gamma (rs2430561,+874T/A) Functional Gene Variant in Relation to the Presence of Cardiovascular Events in Rheumatoid Arthritis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTIMA-MEDIA THICKNESS; ENDOTHELIAL DYSFUNCTION; ATHEROSCLEROTIC DAMAGE; DISEASE; SUSCEPTIBILITY; INFLAMMATION; POLYMORPHISM; MECHANISMS; CONTRIBUTE	Objective: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased cardiovascular (CV) morbidity and mortality. Since interferon-gamma (IFN-gamma) has a direct effect on inflammation, in this study we assessed the potential association of the IFNG functional gene variant rs2430561 with CV disease in patients with RA. Methods: One thousand six hundred and thirty-five patients fulfilling the 1987 American College of Rheumatology classification criteria for RA were genotyped for the IFNG (rs2430561, +874T/A) gene polymorphism using TaqMan genotyping assay. Patients were stratified according to the presence of CV events or not. Logistic regression models to explain the presence of CV disease according to the IFNG rs2430561 allele distribution were performed. The potential influence of this variant in the development of subclinical atherosclerosis was also analyzed in a subgroup of patients with no history of CV events to determine carotid artery intima-media thickness (IMT) (n = 286) and presence of carotid plaques. Levels of the cytokine were determined in a subgroup of patients by ELISA. Results: Adjusted logistic regression model disclosed that presence of the minor allele A was not associated with increased risk of suffering CV events in RA patients. Besides, differences did not achieve statistical significance regarding carotid IMT and presence of carotid plaques in RA patients carrying IFNG rs2430561 variant allele. Levels of IFN-gamma were higher in patients who had suffered CV events compared to patients who did not. Conclusion: Our results do not support a role of IFNG rs2430561 (+874T/A) functional gene variant in the development of CV disease in RA patients.	[Lopez-Mejias, Raquel; Corrales, Alfonso; Blanco, Ricardo; Gonzalez-Gay, Miguel A.] Hosp Univ Marques de Valdecilla, IFIMAV, Dept Rheumatol, Santander, Spain; [Garcia-Bermudez, Mercedes; Robledo, Gema; Martin, Javier] CSIC, IPBLN, Granada, Spain; [Gonzalez-Juanatey, Carlos] Hosp Xeral Calde, Div Cardiol, Lugo, Spain; [Castaneda, Santos; Gonzalez-Alvaro, Isidoro] Hosp Univ La Princesa, IIS Princesa, Dept Rheumatol, Madrid, Spain; [Miranda-Filloy, Jose A.] Hosp Xeral Calde, Dept Rheumatol, Lugo, Spain; [Fernandez-Gutierrez, Benjamin] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain; [Balsa, Alejandro] Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain; [Gomez-Vaquero, Carmen] Hosp Univ Bellvitge, IDIBELL, Dept Rheumatol, Barcelona, Spain; [Llorca, Javier] Univ Cantabria, Dept Epidemiol & Computat Biol, Sch Med, E-39005 Santander, Spain; [Llorca, Javier] IFIMAV, CIBERESP, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo; Hospital Clinico San Carlos; Hospital Universitario La Paz; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Universidad de Cantabria; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Gonzalez-Gay, MA (corresponding author), Hosp Univ Marques de Valdecilla, IFIMAV, Dept Rheumatol, Santander, Spain.	miguelaggay@hotmail.com	Martín, María/HDL-9512-2022; García-Bermúdez, Mercedes/E-7708-2013; González-Gay, Miguel A./B-2306-2008; Martin, Javier/B-8141-2008; Fernandez-Gutierrez, Benjamin/AAM-9063-2020; Balsa, Alejandro/ABF-6456-2020; Martín, Javier/AAV-5209-2021; blanco, ricardo/AAA-1248-2020; Llorca, Javier/F-7371-2011	García-Bermúdez, Mercedes/0000-0002-2643-5956; González-Gay, Miguel A./0000-0002-7924-7406; Martin, Javier/0000-0002-2202-0622; blanco, ricardo/0000-0003-2344-2285; Llorca, Javier/0000-0001-8569-861X; Fernandez-Gutierrez, Benjamin/0000-0002-6126-8786	Fondo de Investigaciones Sanitarias [PI06-0024, PS09/00748]; Instituto de Salud Carlos III (ISCIII), National Health System (Spain) [RD08/0075]; EuropeanIMI BTCure Program; Fundacion Espanola de Reumatologia	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Instituto de Salud Carlos III (ISCIII), National Health System (Spain); EuropeanIMI BTCure Program; Fundacion Espanola de Reumatologia	This work was supported by two grants from Fondo de Investigaciones Sanitarias PI06-0024 and PS09/00748 (Spanish National Health System; Ministry of Science and Innovation, Spain Government) and by RETICS Program, RD08/0075 (RIER) from Instituto de Salud Carlos III (ISCIII), National Health System (Spain) within the VI Programa Nacionalde I+D+i 2008-2011 (FEDER). This work was supported in part by grants from the EuropeanIMI BTCure Program. MGB is a beneficiary of a grant from Fundacion Espanola de Reumatologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos S, 2011, CYTOKINE, V54, P68, DOI 10.1016/j.cyto.2011.01.004; Amezcua-Guerra LM, 2008, J RHEUMATOL, V35, P2071; Aravena O, 2011, IMMUNOBIOLOGY, V216, P1256, DOI 10.1016/j.imbio.2011.07.006; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x; Bartoloni E, 2011, ARTHRIT CARE RES, V63, P178, DOI 10.1002/acr.20322; Carmona L, 2002, RHEUMATOLOGY, V41, P88, DOI 10.1093/rheumatology/41.1.88; Constantin A, 2001, LANCET, V358, P2051, DOI 10.1016/S0140-6736(01)07143-4; Dessein PH, 2005, J RHEUMATOL, V32, P435; Dhawan SS, 2008, CURR ATHEROSCLER REP, V10, P128, DOI 10.1007/s11883-008-0019-x; Firestein GS, 2005, JCR-J CLIN RHEUMATOL, V11, pS39, DOI 10.1097/01.rhu.0000166673.34461.33; Full LE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2631; Gerli R, 2004, CIRCULATION, V109, P2744, DOI 10.1161/01.CIR.0000131450.66017.B3; Gonzalez-Gay MA, 2005, SEMIN ARTHRITIS RHEU, V35, P8, DOI 10.1016/j.semarthrit.2005.03.004; Gonzalez-Gay MA, 2008, SEMIN ARTHRITIS RHEU, V38, P67, DOI 10.1016/j.semarthrit.2008.02.001; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Gonzalez-Juanatey C, 2003, AM J MED, V114, P647, DOI 10.1016/S0002-9343(03)00133-5; Gonzalez-Juanatey C, 2009, SEMIN ARTHRITIS RHEU, V38, P366, DOI 10.1016/j.semarthrit.2008.01.012; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Harvey EJ, 2005, CARDIOVASC RES, V67, P11, DOI 10.1016/j.cardiores.2005.04.019; Kerekes G, 2008, J RHEUMATOL, V35, P398; Khani-Hanjani A, 2000, LANCET, V356, P820, DOI 10.1016/S0140-6736(00)02657-X; Kim K, 2010, ANN RHEUM DIS, V69, P1247, DOI 10.1136/ard.2009.117572; Libby P, 2008, AM J MED, V121, P21, DOI 10.1016/j.amjmed.2008.06.014; Lopez-Mejias R, 2012, ATHEROSCLEROSIS; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Mattey DL, 2007, ARTHRITIS RHEUM-US, V56, P1408, DOI 10.1002/art.22527; Palomino-Morales R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2989; Patel S, 2008, INT J BIOCHEM CELL B, V40, P576, DOI 10.1016/j.biocel.2007.11.017; Pokorny V, 2001, LANCET, V358, P122, DOI 10.1016/S0140-6736(01)05342-9; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Rodriguez-Rodriguez L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3444; Rodriguez-Rodriguez L, 2011, ATHEROSCLEROSIS, V216, P125, DOI 10.1016/j.atherosclerosis.2010.10.052; Schroecksnadel Katharina, 2006, Current Vascular Pharmacology, V4, P205, DOI 10.2174/157016106777698379; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Vandenbroeck K, 2003, ARTHRITIS RHEUM-US, V48, P2773, DOI 10.1002/art.11236	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47166	10.1371/journal.pone.0047166	http://dx.doi.org/10.1371/journal.pone.0047166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077565	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100071
J	Juvet, SC; Han, M; Vanama, R; Joe, B; Kim, EY; Zhao, FLD; Jeon, C; Adeyi, O; Zhang, L				Juvet, Stephen C.; Han, Mei; Vanama, Ramesh; Joe, Betty; Kim, Edward Y.; Zhao, Fei Linda; Jeon, Caroline; Adeyi, Oyedele; Zhang, Li			Autocrine IFN gamma Controls the Regulatory Function of Lymphoproliferative Double Negative T Cells	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; INTERFERON-GAMMA; DENDRITIC CELLS; SURFACE EXPRESSION; APOPTOTIC CELLS; HELPER-CELLS; FAS LIGAND; INHIBITION; ACTIVATION; PATHWAY	TCR alpha beta(+) CD4(-)CD8(-)NK(-) double negative T cells (DN T cells) can act as regulatory T cells to inhibit allograft rejection and autoimmunity. Their role in graft-versus-host disease and mechanisms of suppression remain elusive. In this study, we demonstrate that DN T cells can inhibit CD4(+) T cell-mediated GVHD in a semi-allogeneic model of bone marrow transplantation. Furthermore, we present evidence of a novel autocrine IFN gamma signaling pathway in Fas-deficient C57BL/6.lpr (B6.lpr) DN T cells. B6.lpr DN T cells lacking IFN gamma or its receptor were impaired in their ability to suppress syngeneic CD4(+) T cells responding to alloantigen stimulation both in vitro and in vivo. Autocrine IFN gamma signaling was required for sustained B6.lpr DN T cell IFN gamma secretion in vivo and for upregulation of surface Fas ligand expression during TCR stimulation. Fas ligand (FasL) expression by B6.lpr DN T cells permitted lysis of activated CD4(+) T cells and was required for suppression of GVHD. Collectively, our data indicate that DN T cells can inhibit GVHD and that IFN gamma plays a critical autocrine role in controlling the regulatory function of B6.lpr DN T cells.	[Juvet, Stephen C.; Zhang, Li] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Juvet, Stephen C.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto Lung Transplant Program, Toronto, ON, Canada; [Juvet, Stephen C.] Univ Toronto, Div Respirol, Toronto, ON, Canada; [Juvet, Stephen C.] Univ Toronto, Dept Med, Clinician Scientist Training Program, Toronto, ON, Canada; [Han, Mei; Vanama, Ramesh; Joe, Betty; Kim, Edward Y.; Adeyi, Oyedele; Zhang, Li] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Zhao, Fei Linda; Jeon, Caroline; Zhang, Li] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Juvet, Stephen C.; Han, Mei; Vanama, Ramesh; Joe, Betty; Kim, Edward Y.; Zhao, Fei Linda; Jeon, Caroline; Adeyi, Oyedele; Zhang, Li] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Zhang, L (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.	lzhang@uhnres.utoronto.ca		Adeyi, Oyedele/0000-0003-4272-1095; Juvet, Stephen/0000-0002-7243-556X	Canadian Institutes of Health Research [14431]; Canadian Cancer Society [020516]; Terry Fox Foundation/National Cancer Institute of Canada [18014]; Department of Medicine, University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation/National Cancer Institute of Canada; Department of Medicine, University of Toronto(University of Toronto)	This work was supported by Canadian Institutes of Health Research (http://cihr-irsc.gc.ca/) Grant # 14431 and Canadian Cancer Society (http://www.cancer.ca/Research.aspx) Grant # 020516 to LZ. SCJ received salary support from a Terry Fox Foundation/National Cancer Institute of Canada (http://www.cancer.ca/Research.aspx) Clinical Research Fellowship # 18014 and the Clinician-Scientist Training Program, Department of Medicine, University of Toronto (http://www.deptmedicine.utoronto.ca/edustudies/CSTProgram.htm). LZ is the Maria H. Bacardi Chair in Transplantation at the University Health Network (www.uhn.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Blazar BR, 1997, TRANSPLANTATION, V64, P571, DOI 10.1097/00007890-199708270-00004; Boselli D, 2007, EUR J IMMUNOL, V37, P2196, DOI 10.1002/eji.200636541; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; BRADLEY LM, 1991, J EXP MED, V174, P547, DOI 10.1084/jem.174.3.547; Chen WH, 2003, J IMMUNOL, V170, P1846, DOI 10.4049/jimmunol.170.4.1846; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Ford MS, 2007, EUR J IMMUNOL, V37, P2234, DOI 10.1002/eji.200636991; Ford MS, 2002, J EXP MED, V196, P261, DOI 10.1084/jem.20020029; GIESE T, 1994, J IMMUNOL, V152, P2000; Haas C, 1997, J IMMUNOL, V158, P5484; Hamad ARA, 2003, J IMMUNOL, V171, P2421, DOI 10.4049/jimmunol.171.5.2421; Hill M, 2011, AM J TRANSPLANT, V11, P2036, DOI 10.1111/j.1600-6143.2011.03651.x; Hillhouse EE, 2010, IMMUNOL CELL BIOL, V88, P771, DOI 10.1038/icb.2010.84; JEVNIKAR AM, 1994, J EXP MED, V179, P1137, DOI 10.1084/jem.179.4.1137; Jung ID, 2007, FEBS LETT, V581, P1449, DOI 10.1016/j.febslet.2007.02.073; KELLEY VE, 1985, CLIN IMMUNOL IMMUNOP, V37, P220, DOI 10.1016/0090-1229(85)90153-9; Kim S, 2000, J IMMUNOL, V164, P2931, DOI 10.4049/jimmunol.164.6.2931; Kyttaris VC, 2010, J IMMUNOL, V184, P4605, DOI 10.4049/jimmunol.0903595; Lee BPL, 2005, J IMMUNOL, V174, P4535, DOI 10.4049/jimmunol.174.8.4535; Li XJ, 2007, J IMMUNOL, V179, P939, DOI 10.4049/jimmunol.179.2.939; Ma L, 2005, EUR J IMMUNOL, V35, P3364, DOI 10.1002/eji.200535192; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; McIver Z, 2008, BRIT J HAEMATOL, V141, P170, DOI 10.1111/j.1365-2141.2008.07021.x; MURRAY L, 1989, EUR J IMMUNOL, V19, P563, DOI 10.1002/eji.1830190325; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Ren GW, 2008, J IMMUNOL, V181, P3277, DOI 10.4049/jimmunol.181.5.3277; Sawitzki B, 2005, J EXP MED, V201, P1925, DOI 10.1084/jem.20050419; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; SHIVAKUMAR S, 1989, J IMMUNOL, V143, P103; SYKES M, 1995, BLOOD, V86, P2429, DOI 10.1182/blood.V86.6.2429.bloodjournal8662429; Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817; Voelkl S, 2011, EUR J IMMUNOL, V41, P739, DOI 10.1002/eji.201040982; Wang ZJ, 2006, J CLIN INVEST, V116, P2434, DOI 10.1172/JCI25826; Wei B, 2010, AM J TRANSPLANT, V10, P69, DOI 10.1111/j.1600-6143.2009.02858.x; Yang YG, 1998, J CLIN INVEST, V102, P2126, DOI 10.1172/JCI4992; Young KJ, 2003, J IMMUNOL, V171, P134, DOI 10.4049/jimmunol.171.1.134; Young KJ, 2002, BLOOD, V100, P3408, DOI 10.1182/blood-2002-01-0235; Zhang D, 2007, BLOOD, V109, P4071, DOI 10.1182/blood-2006-10-050625; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513	44	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47732	10.1371/journal.pone.0047732	http://dx.doi.org/10.1371/journal.pone.0047732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077665	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100157
J	Karimi, K; Kandiah, N; Chau, J; Bienenstock, J; Forsythe, P				Karimi, Khalil; Kandiah, Nalaayini; Chau, Jessie; Bienenstock, John; Forsythe, Paul			A Lactobacillus rhamnosus Strain Induces a Heme Oxygenase Dependent Increase in Foxp3+Regulatory T Cells	PLOS ONE			English	Article							DENDRITIC CELLS; THERAPEUTIC TARGET; ORAL TOLERANCE; EXPRESSION; MATURATION; INDUCTION; COMMENSAL; DIFFERENTIATION; INTERLEUKIN-10; INFLAMMATION	We investigated the consequences of feeding with a Lactobacillus species on the immune environment in GALT, and the role of dendritic cells and heme oxygenase-1 in mediating these responses. Feeding with a specific strain of Lactobacillus rhamnosus induced a significant increase in CD4+CD25+Foxp3+ functional regulatory T cells in GALT. This increase was greatest in the mesenteric lymph nodes and associated with a marked decrease in TNF and IFN gamma production. Dendritic cell regulatory function and HO-1 expression was also increased. The increase in Foxp3+ T cells could be prevented by treatment with a heme oxygenase inhibitor. However, neither inhibition of heme oxygenase nor blockade of IL-10 and TGF beta prevented the inhibition of inflammatory cytokine production. In conclusion Lactobacillus feeding induced a tolerogenic environment in GALT. HO-1 was critical to the enhancement of Foxp3+ regulatory T cells while additional, as yet unknown, pathways were involved in the down-regulation of inflammatory cytokine production by T cells.	[Karimi, Khalil; Kandiah, Nalaayini; Chau, Jessie; Bienenstock, John; Forsythe, Paul] McMaster Univ, Brain Body Inst, Hamilton, ON, Canada; [Forsythe, Paul] McMaster Univ, Firestone Inst Resp Hlth, Hamilton, ON, Canada; [Karimi, Khalil; Chau, Jessie; Forsythe, Paul] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Bienenstock, John] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Karimi, K (corresponding author), McMaster Univ, Brain Body Inst, Hamilton, ON, Canada.	karimik@mcmaster.ca; forsytp@mcmaster.ca	Karimi, Khalil/ABA-4735-2020	Karimi, Khalil/0000-0002-7245-5851	AllerGen NCE [09-B6]	AllerGen NCE	Funded in part by a grant from AllerGen NCE (http://www.allergen-nce.ca/index.html) Grant 09-B6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton SD, 1999, DRUG METAB DISPOS, V27, P1214; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Berberat PO, 2005, INFLAMM BOWEL DIS, V11, P350, DOI 10.1097/01.MIB.0000164017.06538.8a; Biburger M, 2010, J LEUKOCYTE BIOL, V87, P192, DOI 10.1189/jlb.0508280; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brusko TM, 2005, J IMMUNOL, V174, P5181, DOI 10.4049/jimmunol.174.9.5181; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Choi BM, 2005, BIOCHEM BIOPH RES CO, V327, P1066, DOI 10.1016/j.bbrc.2004.12.106; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Commeren DL, 2003, IMMUNOLOGY, V110, P188, DOI 10.1046/j.1365-2567.2003.01730.x; Dubois B, 2005, CELL MOL LIFE SCI, V62, P1322, DOI 10.1007/s00018-005-5036-0; Dubois B, 2009, GASTROENTEROLOGY, V137, P1019, DOI 10.1053/j.gastro.2009.03.055; El Andaloussi A, 2007, J NEURO-ONCOL, V83, P145, DOI 10.1007/s11060-006-9314-y; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Forsythe P, 2007, AM J RESP CRIT CARE, V175, P561, DOI 10.1164/rccm.200606-821OC; Forsythe P, 2010, IMMUNOL INVEST, V39, P429, DOI 10.3109/08820131003667978; George JF, 2008, AM J PATHOL, V173, P154, DOI 10.2353/ajpath.2008.070963; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Giris M, 2007, INT J COLORECTAL DIS, V22, P591, DOI 10.1007/s00384-006-0238-y; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Hoarau C, 2006, J ALLERGY CLIN IMMUN, V117, P696, DOI 10.1016/j.jaci.2005.10.043; Kalliomaki M, 2003, CURR OPIN ALLERGY CL, V3, P15, DOI [10.1097/00130832-200302000-00003, 10.1097/01.all.0000053262.39029.a1]; Karimi K, 2008, MOL THER, V16, P411, DOI 10.1038/sj.mt.6300347; Karimi K, 2010, BRAIN BEHAV IMMUN, V24, P316, DOI 10.1016/j.bbi.2009.10.016; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Listopad J, 2007, EXP DERMATOL, V16, P661, DOI 10.1111/j.1600-0625.2007.00581.x; Lyons A, 2010, CLIN EXP ALLERGY, V40, P811, DOI 10.1111/j.1365-2222.2009.03437.x; Ma DL, 2004, INFECT IMMUN, V72, P5308, DOI 10.1128/IAI.72.9.5308-5314.2004; Maassen CBM, 2000, VACCINE, V18, P2613, DOI 10.1016/S0264-410X(99)00378-3; MacPherson AJ, 2004, ANN NY ACAD SCI, V1029, P36, DOI 10.1196/annals.1309.005; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2006, J EXP MED, V203, P497, DOI 10.1084/jem.20060227; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Moreau A, 2009, FASEB J, V23, P3070, DOI 10.1096/fj.08-128173; Mougiakakos D, 2011, BLOOD, V117, P4826, DOI 10.1182/blood-2010-12-324038; Naito Y, 2004, ALIMENT PHARM THERAP, V20, P177, DOI 10.1111/j.1365-2036.2004.01992.x; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Park DJ, 2010, AM J PATHOL, V176, P2831, DOI 10.2353/ajpath.2010.090845; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Raval CM, 2010, CURR DRUG TARGETS, V11, P1532; Reid G, 2005, CAN FAM PHYSICIAN, V51, P1487; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Sturm A, 2005, INFECT IMMUN, V73, P1452, DOI 10.1128/IAI.73.3.1452-1465.2005; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sun LA, 2011, J SURG RES, V166, pE187, DOI 10.1016/j.jss.2010.11.917; Trampuz A, 2006, J MED MICROBIOL, V55, P1271, DOI 10.1099/jmm.0.46488-0; Ueckert JE, 1997, LETT APPL MICROBIOL, V25, P295, DOI 10.1046/j.1472-765X.1997.00225.x; Vancanneyt M, 2006, APPL ENVIRON MICROB, V72, P5376, DOI 10.1128/AEM.00091-06; Vijayan V, 2010, WORLD J GASTROENTERO, V16, P3112, DOI 10.3748/wjg.v16.i25.3112; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Wunder C, 2002, J PHYSIOL-LONDON, V540, P1013, DOI 10.1113/physiol.2001.015446; Xia ZW, 2007, AM J PATHOL, V171, P1904, DOI 10.2353/ajpath.2007.070096; Xia ZW, 2006, J IMMUNOL, V177, P5936, DOI 10.4049/jimmunol.177.9.5936; Zelenay S, 2007, INT IMMUNOL, V19, P11, DOI 10.1093/intimm/dxl116	61	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47556	10.1371/journal.pone.0047556	http://dx.doi.org/10.1371/journal.pone.0047556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077634	gold, Green Published, Green Submitted			2022-12-27	WOS:000309995100129
J	Preta, G; Fadeel, B				Preta, Giulio; Fadeel, Bengt			AIF and Scythe (Bat3) Regulate Phosphatidylserine Exposure and Macrophage Clearance of Cells Undergoing Fas (APO-1)-Mediated Apoptosis	PLOS ONE			English	Article							BASIC BIOLOGICAL PHENOMENON; WIDE-RANGING IMPLICATIONS; MEDIATED APOPTOSIS; LIPID RAFTS; AMINOPHOSPHOLIPID TRANSLOCASE; PHOSPHOLIPID SCRAMBLASE-1; AUTOIMMUNE-DISEASE; FLIP-FLOP; EXTERNALIZATION; CLEAVAGE	Phosphatidylserine (PS) exposure on the cell surface has been considered a characteristic feature of apoptosis and serves as a molecular cue for engulfment of dying cells by phagocytes. However, the mechanism of PS exposure is still not fully elucidated. Here we show that the cytosolic release from mitochondria of apoptosis-inducing factor (AIF) is required for PS exposure during death receptor-induced apoptosis and for efficient clearance of cell corpses by primary human macrophages. Fas-triggered PS exposure was significantly reduced upon siRNA-mediated silencing of AIF expression and by inhibition of the cytosolic translocation of AIF. In addition, AIF localizes to the plasma membrane upon Fas ligation and promotes activation of phospholipid scrambling activity. Finally, cytosolic stabilization of AIF through interaction with Scythe is shown to be involved in apoptotic PS exposure. Taken together, our results suggest an essential role for AIF and its binding partner Scythe in the pathway leading to apoptotic corpse clearance.	[Preta, Giulio; Fadeel, Bengt] Karolinska Inst, Div Mol Toxicol, Inst Environm Med, Stockholm, Sweden	Karolinska Institutet	Fadeel, B (corresponding author), Karolinska Inst, Div Mol Toxicol, Inst Environm Med, Stockholm, Sweden.	bengt.fadeel@ki.se	Preta, Giulio/N-7141-2016; Preta, Giulio/AAW-6182-2021	Preta, Giulio/0000-0002-8318-4698; 	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The authors received support from the Swedish Research Council (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo A, 2002, J BIOL CHEM, V277, P49965, DOI 10.1074/jbc.M204513200; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Borisenko GG, 2003, ARCH BIOCHEM BIOPHYS, V413, P41, DOI 10.1016/S0003-9861(03)00083-3; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Eramo A, 2004, EUR J IMMUNOL, V34, P1930, DOI 10.1002/eji.200324786; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Frasch SC, 2004, J BIOL CHEM, V279, P17625, DOI 10.1074/jbc.M313414200; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Jitkaew S, 2009, J BIOL CHEM, V284, P27827, DOI 10.1074/jbc.M109.027912; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Marchetti P, 1996, J IMMUNOL, V157, P4830; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Martin SJ, 1996, J BIOL CHEM, V271, P28753, DOI 10.1074/jbc.271.46.28753; Norberg E, 2010, EMBO J, V29, P3869, DOI 10.1038/emboj.2010.253; Preta G, 2012, FEBS LETT, V586, P747, DOI 10.1016/j.febslet.2012.01.034; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; Sun Y, 2005, BLOOD, V105, P4070, DOI 10.1182/blood-2004-10-4075; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Tyurina YY, 2007, J BIOL CHEM, V282, P8498, DOI 10.1074/jbc.M606950200; Uthaisang W, 2003, FEBS LETT, V545, P110, DOI 10.1016/S0014-5793(03)00508-8; van Delft MF, 2010, CELL DEATH DIFFER, V17, P821, DOI 10.1038/cdd.2009.166; Vanags DM, 1996, J BIOL CHEM, V271, P31075, DOI 10.1074/jbc.271.49.31075; Wang XC, 2007, NAT CELL BIOL, V9, P541, DOI 10.1038/ncb1574; Witasp Erika, 2008, Current Immunology Reviews, V4, P53, DOI 10.2174/157339508784325064; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200; Zhuang JG, 1998, J BIOL CHEM, V273, P15628, DOI 10.1074/jbc.273.25.15628	44	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47328	10.1371/journal.pone.0047328	http://dx.doi.org/10.1371/journal.pone.0047328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077592	Green Submitted, gold, Green Published			2022-12-27	WOS:000309995100092
J	Rueppell, O; Meier, S; Deutsch, R				Rueppell, Olav; Meier, Stephen; Deutsch, Roland			Multiple Mating But Not Recombination Causes Quantitative Increase in Offspring Genetic Diversity for Varying Genetic Architectures	PLOS ONE			English	Article							HONEY-BEE; APIS-MELLIFERA; SOCIAL EVOLUTION; SCIENTIFIC NOTE; LINKAGE MAP; COLONIES; POLYANDRY; FREQUENCY; QTL; SEX	Explaining the evolution of sex and recombination is particularly intriguing for some species of eusocial insects because they display exceptionally high mating frequencies and genomic recombination rates. Explanations for both phenomena are based on the notion that both increase colony genetic diversity, with demonstrated benefits for colony disease resistance and division of labor. However, the relative contributions of mating number and recombination rate to colony genetic diversity have never been simultaneously assessed. Our study simulates colonies, assuming different mating numbers, recombination rates, and genetic architectures, to assess their worker genotypic diversity. The number of loci has a strong negative effect on genotypic diversity when the allelic effects are inversely scaled to locus number. In contrast, dominance, epistasis, lethal effects, or limiting the allelic diversity at each locus does not significantly affect the model outcomes. Mating number increases colony genotypic variance and lowers variation among colonies with quickly diminishing returns. Genomic recombination rate does not affect intra-and inter-colonial genotypic variance, regardless of mating frequency and genetic architecture. Recombination slightly increases the genotypic range of colonies and more strongly the number of workers with unique allele combinations across all loci. Overall, our study contradicts the argument that the exceptionally high recombination rates cause a quantitative increase in offspring genotypic diversity across one generation. Alternative explanations for the evolution of high recombination rates in social insects are therefore needed. Short-term benefits are central to most explanations of the evolution of multiple mating and high recombination rates in social insects but our results also apply to other species.	[Rueppell, Olav] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Meier, Stephen] Univ N Carolina, Dept Phys & Astron, Greensboro, NC 27412 USA; [Deutsch, Roland] Univ N Carolina, Dept Math & Stat, Greensboro, NC 27412 USA	University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Greensboro	Rueppell, O (corresponding author), Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA.	olav_rueppell@uncg.edu	Rueppell, Olav/G-2679-2010	Rueppell, Olav/0000-0001-5370-4229; Deutsch, Roland/0000-0002-5938-0330	UNCG; National Evolutionary Synthesis Center (NESCent); NSF [EF-0423641, 0926288, 0850465]; National Institutes of Health [R15GM102753]; United States Department of Agriculture [2010-65104-20533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM102753] Funding Source: NIH RePORTER	UNCG; National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSF(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by UNCG, the National Evolutionary Synthesis Center (NESCent), NSF #EF-0423641, two undergraduate training grants of the National Science Foundation (#0926288 and #0850465), and OR was additionally supported by a National Institutes of Health grant (R15GM102753) and the United States Department of Agriculture (2010-65104-20533). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer B, 1999, NATURE, V397, P151, DOI 10.1038/16451; BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Becks L, 2011, J EVOLUTION BIOL, V24, P656, DOI 10.1111/j.1420-9101.2010.02199.x; Becks L, 2010, NATURE, V468, P89, DOI 10.1038/nature09449; Behrens D, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.17; Bell G, 1982, MASTERPIECE NATURE E; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Boomsma Jacobus J., 2009, P3; Brown MJF, 2003, EVOLUTION, V57, P2067, DOI 10.1111/j.0014-3820.2003.tb00386.x; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Crozier RH, 2001, ANN ZOOL FENN, V38, P267; CROZIER RH, 1985, BEHAV ECOL SOCIOBIOL, V18, P105, DOI 10.1007/BF00299039; Fuchs S, 1999, BEHAV ECOL SOCIOBIOL, V45, P269, DOI 10.1007/s002650050561; Gadau J, 2000, NATURWISSENSCHAFTEN, V87, P87, DOI 10.1007/s001140050016; Gempe T, 2011, BIOESSAYS, V33, P52, DOI 10.1002/bies.201000043; Gove R, 2009, INSECT SOC, V56, P319, DOI 10.1007/s00040-009-0028-y; Graham AM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-95; Haberl M, 1998, BEHAV ECOL SOCIOBIOL, V42, P247, DOI 10.1007/s002650050436; Hansen TF, 2006, ANNU REV ECOL EVOL S, V37, P123, DOI 10.1146/annurev.ecolsys.37.091305.110224; Hughes WOH, 2008, J EVOLUTION BIOL, V21, P1090, DOI 10.1111/j.1420-9101.2008.01532.x; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; HUNT GJ, 1995, GENETICS, V139, P1371; Hunt GJ, 2007, NATURWISSENSCHAFTEN, V94, P247, DOI 10.1007/s00114-006-0183-1; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Kallenberg O., 1997, FDN MODERN PROBABILI; KELLER L, 1995, TRENDS ECOL EVOL, V10, P355, DOI 10.1016/S0169-5347(00)89133-8; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Lohaus R, 2010, J HERED, V101, pS142, DOI 10.1093/jhered/esq013; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Mattila HR, 2008, P ROY SOC B-BIOL SCI, V275, P809, DOI 10.1098/rspb.2007.1620; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Meznar ER, 2010, J HERED, V101, pS118, DOI 10.1093/jhered/esq002; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; Oxley PR, 2010, MOL ECOL, V19, P1452, DOI 10.1111/j.1365-294X.2010.04569.x; Palmer KA, 2000, APIDOLOGIE, V31, P235, DOI 10.1051/apido:2000119; Rueppell O, 2008, BIOL LETTERS, V4, P270, DOI 10.1098/rsbl.2008.0065; Rueppell O, 2009, BEHAV GENET, V39, P541, DOI 10.1007/s10519-009-9278-8; Ruppell O, 2003, MOL ECOL, V12, P795, DOI 10.1046/j.1365-294X.2003.01769.x; Ruppell O, 2004, J HERED, V95, P481, DOI 10.1093/jhered/esh072; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; SHERMAN PW, 1979, AM NAT, V113, P925, DOI 10.1086/283445; Sirvio A, 2006, J EVOLUTION BIOL, V19, P1475, DOI 10.1111/j.1420-9101.2006.01131.x; Sirvio A, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-95; Sirvio A, 2011, EVOLUTION, V65, P869, DOI 10.1111/j.1558-5646.2010.01170.x; SMITH JM, 1976, J THEOR BIOL, V63, P245, DOI 10.1016/0022-5193(76)90033-3; Solignac M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r66; Song YX, 2011, J THEOR BIOL, V273, P55, DOI 10.1016/j.jtbi.2010.12.020; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; Team RDC, 2005, R LANG ENV STAT COMP; TEMPLETON AR, 1979, AM NAT, V113, P937, DOI 10.1086/283446; Waibel M, 2006, P ROY SOC B-BIOL SCI, V273, P1815, DOI 10.1098/rspb.2006.3513; Wattanachaiyingcharoen W, 2003, APIDOLOGIE, V34, P85, DOI 10.1051/apido:2002044; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wiernasz DC, 2008, MOL ECOL, V17, P1137, DOI 10.1111/j.1365-294X.2007.03646.x; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950; ZHAO HY, 1995, GENETICS, V139, P1057	59	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47220	10.1371/journal.pone.0047220	http://dx.doi.org/10.1371/journal.pone.0047220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077571	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100076
J	Shiner, T; Seymour, B; Symmonds, M; Dayan, P; Bhatia, KP; Dolan, RJ				Shiner, Tamara; Seymour, Ben; Symmonds, Mkael; Dayan, Peter; Bhatia, Kailash P.; Dolan, Raymond J.			The Effect of Motivation on Movement: A Study of Bradykinesia in Parkinson's Disease	PLOS ONE			English	Article							DECISION-MAKING; STRIDE LENGTH; EXTERNAL CUES; REWARD; GAIT; VARIABILITY; DOPAMINE; REINFORCEMENT; POTENTIALS; NUCLEUS	Background: Bradykinesia is a cardinal feature of Parkinson's disease (PD). Despite its disabling impact, the precise cause of this symptom remains elusive. Recent thinking suggests that bradykinesia may be more than simply a manifestation of motor slowness, and may in part reflect a specific deficit in the operation of motivational vigour in the striatum. In this paper we test the hypothesis that movement time in PD can be modulated by the specific nature of the motivational salience of possible action-outcomes. Methodology/Principal Findings: We developed a novel movement time paradigm involving winnable rewards and avoidable painful electrical stimuli. The faster the subjects performed an action the more likely they were to win money (in appetitive blocks) or to avoid a painful shock (in aversive blocks). We compared PD patients when OFF dopaminergic medication with controls. Our key finding is that PD patients OFF dopaminergic medication move faster to avoid aversive outcomes (painful electric shocks) than to reap rewarding outcomes (winning money) and, unlike controls, do not speed up in the current trial having failed to win money in the previous one. We also demonstrate that sensitivity to distracting stimuli is valence specific. Conclusions/Significance: We suggest this pattern of results can be explained in terms of low dopamine levels in the Parkinsonian state leading to an insensitivity to appetitive outcomes, and thus an inability to modulate movement speed in the face of rewards. By comparison, sensitivity to aversive stimuli is relatively spared. Our findings point to a rarely described property of bradykinesia in PD, namely its selective regulation by everyday outcomes.	[Shiner, Tamara; Seymour, Ben; Symmonds, Mkael; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Seymour, Ben] Univ Cambridge, Dept Clin Neurol, Cambridge, England; [Dayan, Peter] UCL, Gatsby Computat Neurosci Unit, London, England; [Bhatia, Kailash P.] UCL, Sobell Dept Motor Neurosci & Movement Disorders, London, England	University of London; University College London; University of Cambridge; University of London; University College London; University of London; University College London	Shiner, T (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	tamarashiner@gmail.com	Shiner, Tamara/AAT-7920-2020	Dayan, Peter/0000-0003-3476-1839; Seymour, Ben/0000-0003-1724-5832; Dolan, Ray/0000-0001-9356-761X; Bhatia, Kailash/0000-0001-8185-286X	MRC; Wellcome Trust; GlaxoSmithKline; Orion Corporation; Ipsen; Merz Pharmaceuticals, LLC; MRC [G0700531] Funding Source: UKRI; Medical Research Council [G0700531] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Orion Corporation; Ipsen(Ipsen); Merz Pharmaceuticals, LLC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The funders for this study are the MRC who support Tamara Shiner with a clinical research training fellowship grant and the Wellcome trust who support RD with a Wellcome Trust Programme Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interests: KP Bhatia received funding for travel from GlaxoSmithKline, Orion Corporation, Ipsen, and Merz Pharmaceuticals, LLC; serves on the editorial boards of Movement Disorders and Therapeutic Advances in Neurological Disorders; receives royalties from the publication of Oxford Specialist Handbook of Parkinson's Disease and Other Movement Disorders (Oxford University Press, 2008); received speaker honoraria from GlaxoSmithKline, Ipsen, Merz Pharmaceuticals, LLC, and Sun Pharmaceutical Industries Ltd.; personal compensation for scientific advisory board for GSK and Boehringer Ingelheim; received research support from Ipsen. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Baker K, 2007, ARCH PHYS MED REHAB, V88, P1593, DOI 10.1016/j.apmr.2007.07.026; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BERARDELLI A, 1986, J NEUROL NEUROSUR PS, V49, P1273, DOI 10.1136/jnnp.49.11.1273; BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; BROWN RG, 1988, BRAIN, V111, P323, DOI 10.1093/brain/111.2.323; Cools R, 2010, BRAIN, V133, P225, DOI 10.1093/brain/awp301; Critchley M, 1929, BRAIN, V52, P23, DOI 10.1093/brain/52.1.23; Crofts HS, 2001, CEREB CORTEX, V11, P1015, DOI 10.1093/cercor/11.11.1015; CUNNINGTON R, 1995, BRAIN, V118, P935, DOI 10.1093/brain/118.4.935; Czernecki V, 2002, NEUROPSYCHOLOGIA, V40, P2257, DOI 10.1016/S0028-3932(02)00108-2; Edwards MJ, 2008, PARKINSONS DIS OTHER; Fahn S., 1987, UNIFIED PARKINSONS D; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Graef S, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00169; HALLETT M, 1980, BRAIN, V103, P301, DOI 10.1093/brain/103.2.301; Hausdorff JM, 2003, J GERIATR PSYCH NEUR, V16, P53, DOI 10.1177/0891988702250580; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Lewis GN, 2000, BRAIN, V123, P2077, DOI 10.1093/brain/123.10.2077; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; Monchi O, 2007, BRAIN, V130, P233, DOI 10.1093/brain/awl326; MONTGOMERY EB, 1990, NEUROLOGY, V40, P269, DOI 10.1212/WNL.40.2.269; Moustafa AA, 2008, J NEUROSCI, V28, P12294, DOI 10.1523/JNEUROSCI.3116-08.2008; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Niva Y, 2007, ANN NY ACAD SCI, V1104, P357, DOI 10.1196/annals.1390.018; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Praamstra P, 1998, BRAIN, V121, P167, DOI 10.1093/brain/121.1.167; Rahman S, 2008, BEHAV NEUROL, V19, P127, DOI 10.1155/2008/456298; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Samuel M, 1997, BRAIN, V120, P963, DOI 10.1093/brain/120.6.963; Seymour B, 2012, J NEUROSCI, V32, P5833, DOI 10.1523/JNEUROSCI.0053-12.2012; SHERIDAN MR, 1990, BRAIN, V113, P1149, DOI 10.1093/brain/113.4.1149; SHERIDAN MR, 1987, BRAIN, V110, P1247, DOI 10.1093/brain/110.5.1247; TEASDALE N, 1990, J NEUROL NEUROSUR PS, V53, P862, DOI 10.1136/jnnp.53.10.862; Uc EY, 2006, NEUROLOGY, V67, P1774, DOI 10.1212/01.wnl.0000245086.32787.61; Weintraub D, 2009, MOVEMENT DISORD, V24, P1461, DOI 10.1002/mds.22571	38	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47138	10.1371/journal.pone.0047138	http://dx.doi.org/10.1371/journal.pone.0047138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077557	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100066
J	Umbers, KDL; Osborne, L; Keogh, JS				Umbers, Kate D. L.; Osborne, Louise; Keogh, J. Scott			The Effects of Residency and Body Size on Contest Initiation and Outcome in the Territorial Dragon, Ctenophorus decresii	PLOS ONE			English	Article							AGONISTIC DISPLAYS; FIDDLER-CRAB; MALE COMBAT; LIZARD; EVOLUTION; AGGRESSION; SIGNALS; INFORMATION; COMPETITION; ENCOUNTERS	Empirical studies of the determinants of contests have been attempting to unravel the complexity of animal contest behaviour for decades. This complexity requires that experiments incorporate multiple determinants into studies to tease apart their relative effects. In this study we examined the complex contest behaviour of the tawny dragon (Ctenophorus decresii), a territorial agamid lizard, with the specific aim of defining the factors that determine contest outcome. We manipulated the relative size and residency status of lizards in contests to weight their importance in determining contest outcome. We found that size, residency and initiating a fight were all important in determining outcomes of fights. We also tested whether residency or size was important in predicting the status of lizard that initiated a fight. We found that residency was the most important factor in predicting fight initiation. We discuss the effects of size and residency status in context of previous studies on contests in tawny dragons and other animals. Our study provides manipulative behavioural data in support of the overriding effects of residency on initiation fights and winning them.	[Umbers, Kate D. L.; Osborne, Louise; Keogh, J. Scott] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Australian National University	Keogh, JS (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	scott.keogh@anu.edu.au	Keogh, Scott/C-8441-2009; Umbers, Kate/D-3566-2011	Keogh, Scott/0000-0002-1373-6186; Umbers, Kate/0000-0002-9375-4527	Australian Research Council; School of Botany and Zoology; ANU	Australian Research Council(Australian Research Council); School of Botany and Zoology; ANU(Australian National University)	This study was funded by the Australian Research Council (www.arc.gov.au), the School of Botany and Zoology, and ANU (www.anu.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J, 1996, ECOL ENTOMOL, V21, P309, DOI 10.1046/j.1365-2311.1996.00007.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARYL PG, 1979, BEHAVIOUR, V68, P136, DOI 10.1163/156853979X00287; Cook JM, 2006, ANIM BEHAV, V71, P1095, DOI 10.1016/j.anbehav.2005.07.027; DAVIES NB, 1978, ANIM BEHAV, V26, P138, DOI 10.1016/0003-3472(78)90013-1; DECOURCY KR, 1994, ANIM BEHAV, V47, P251, DOI 10.1006/anbe.1994.1037; ENGLUND G, 1990, ANIM BEHAV, V39, P55, DOI 10.1016/S0003-3472(05)80725-0; ENQUIST M, 1990, ANIM BEHAV, V39, P1, DOI 10.1016/S0003-3472(05)80721-3; FOX SF, 1992, ANIM BEHAV, V44, P780, DOI 10.1016/S0003-3472(05)80306-9; Gibbons J. R., 1977, COMP ECOLOGY BEHAV L; GIBBONS JRH, 1979, COPEIA, P29; GRAFEN A, 1987, ANIM BEHAV, V35, P462, DOI 10.1016/S0003-3472(87)80271-3; Hardy ICW, 1998, TRENDS ECOL EVOL, V13, P385, DOI 10.1016/S0169-5347(98)01430-X; Hardy ICW, 2001, TRENDS ECOL EVOL, V16, P174, DOI 10.1016/S0169-5347(01)02119-X; Hoefler CD, 2002, J INSECT BEHAV, V15, P779, DOI 10.1023/A:1021123523307; Hofmann HA, 2001, ANIM BEHAV, V62, P337, DOI 10.1006/anbe.2001.1746; Huntingford F.A., 1987, ANIMAL CONFLICT; Huntingford FA, 1995, J EXP MAR BIOL ECOL, V193, P21, DOI 10.1016/0022-0981(95)00108-5; Jaroensutasinee M, 2002, CRUSTACEANA, V75, P1107, DOI 10.1163/156854002763270509; Jennions MD, 1996, BIOL J LINN SOC, V57, P293, DOI 10.1111/j.1095-8312.1996.tb01851.x; JENSSEN TA, 1977, AM ZOOL, V17, P203; Kratochvil L, 2002, BIOL J LINN SOC, V76, P303, DOI 10.1046/j.1095-8312.2002.00064.x; Lappin AK, 2006, AM NAT, V168, P100, DOI 10.1086/505161; LEIMAR O, 1991, EVOLUTION, V45, P862, DOI 10.1111/j.1558-5646.1991.tb04355.x; LIGON JD, 1990, ANIM BEHAV, V40, P367, DOI 10.1016/S0003-3472(05)80932-7; LINDSTROM K, 1992, BEHAV ECOL SOCIOBIOL, V30, P53; MCMANN S, 1993, ANIM BEHAV, V46, P657, DOI 10.1006/anbe.1993.1242; Nijman V, 2000, BEHAV PROCESS, V49, P77, DOI 10.1016/S0376-6357(00)00078-4; OLSSON M, 1992, ANIM BEHAV, V44, P386, DOI 10.1016/0003-3472(92)90046-C; Olsson M, 2000, BEHAV ECOL, V11, P587, DOI 10.1093/beheco/11.6.587; Osborne L, 2005, ACTA ETHOLOG, V8, P45, DOI 10.1007/s10211-005-0108-6; Osborne L, 2005, J ETHOL, V23, P189, DOI 10.1007/s10164-005-0151-9; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Peters RA, 2003, AUSTRAL ECOL, V28, P499, DOI 10.1046/j.1442-9993.2003.01306.x; R Core Team, 2018, R LANG ENV STAT COMP; Radder RS, 2006, J ETHOL, V24, P275, DOI 10.1007/s10164-006-0192-8; RAND WM, 1976, Z TIERPSYCHOL, V40, P279; ROWLAND WJ, 1989, ANIM BEHAV, V37, P282, DOI 10.1016/0003-3472(89)90117-6; Sacchi R, 2009, AGGRESSIVE BEHAV, V35, P274, DOI 10.1002/ab.20305; SMITH IP, 1994, ANIM BEHAV, V47, P885, DOI 10.1006/anbe.1994.1120; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Stapley J, 2006, BIOL LETTERS, V2, P169, DOI 10.1098/rsbl.2005.0419; Stokkebo S, 2000, ANIM BEHAV, V59, P1111, DOI 10.1006/anbe.2000.1407; Stuart-Fox DM, 2003, ANIM BEHAV, V66, P541, DOI 10.1006/anbe.2003.2235; Wenseleers T, 2002, J INSECT BEHAV, V15, P85, DOI 10.1023/A:1014484229639; Whiting MJ, 2006, ANIM BEHAV, V72, P353, DOI 10.1016/j.anbehav.2005.10.018; Whiting MJ, 1999, BEHAV ECOL SOCIOBIOL, V46, P210, DOI 10.1007/s002650050611	47	24	24	19	218	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47143	10.1371/journal.pone.0047143	http://dx.doi.org/10.1371/journal.pone.0047143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077558	Green Published, gold			2022-12-27	WOS:000309995100067
J	Melzer, N; Hicking, G; Gobel, K; Wiendl, H				Melzer, Nico; Hicking, Gordon; Goebel, Kerstin; Wiendl, Heinz			TRPM2 Cation Channels Modulate T Cell Effector Functions and Contribute to Autoimmune CNS Inflammation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT STRIATAL NEURONS; ADP-RIBOSE; HYDROGEN-PEROXIDE; CALCIUM INFLUX; IMMUNE-SYSTEM; ACTIVATION; ACID; LTRPC2; LYMPHOCYTES	TRPM2, a highly Ca2+-permeable member of the transient receptor potential melastatin-related (TRPM) family of cation channels, is expressed in cells of the immune system. We demonstrate firstly that TRPM2 cation channels on T cells critically influence T cell proliferation and proinflammatory cytokine secretion following polyclonal T cell receptor stimulation. Consistently, trpm2-deficient mice exhibited an attenuated clincal phenotype of experimental autoimmune encephalomyelitis (EAE) with reduced inflammatory and demyelinating spinal cord lesions. Importantly, trmp2-deficient T cells were as susceptible as wildtype T cells to oxidative stress-induced cell death as it occurs in inflammatory CNS lesions. This supports the notion that the attenuated EAE phenotype is mainly due to reduced T cell effector functions but unaffected by potential modulation of T cell survival at the site of inflammation. Our findings suggest TRPM2 cation channels as a potential target for treating autoimmune CNS inflammation.	[Melzer, Nico; Hicking, Gordon; Goebel, Kerstin; Wiendl, Heinz] Univ Munster, Dept Neurol Inflammatory Disorders Nervous Syst &, Munster, Germany	University of Munster	Melzer, N (corresponding author), Univ Munster, Dept Neurol Inflammatory Disorders Nervous Syst &, Munster, Germany.	nico.melzer@ukmuenster.de	Wiendl, Heinz/AAX-6041-2021; Melzer, Nico/HGE-2991-2022	Melzer, Nico/0000-0002-2420-701X; Wiendl, Heinz/0000-0003-4310-3432	University of Munster (IMF) [ME121010]	University of Munster (IMF)	This study was supported by an intramural grant of the University of Munster (IMF - ME121010) to NM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari MR, 2009, J CELL MOL MED, V13, P3260, DOI 10.1111/j.1582-4934.2009.00737.x; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Bittner S, 2009, BRAIN, V132, P2501, DOI 10.1093/brain/awp163; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Harteneck C, 2005, N-S ARCH PHARMACOL, V371, P307, DOI 10.1007/s00210-005-1034-x; Hill K, 2006, NEUROPHARMACOLOGY, V50, P89, DOI 10.1016/j.neuropharm.2005.08.021; Inada H, 2006, BIOCHEM BIOPH RES CO, V350, P762, DOI 10.1016/j.bbrc.2006.09.111; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Kraft R, 2006, BRIT J PHARMACOL, V148, P264, DOI 10.1038/sj.bjp.0706739; Lipski J, 2006, BRAIN RES, V1077, P187, DOI 10.1016/j.brainres.2006.01.016; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Malavasi F, 2006, MOL MED, V12, P334, DOI 10.2119/2006-00094.Malavasi; Melzer N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003149; Meuth SG, 2008, J BIOL CHEM, V283, P14559, DOI 10.1074/jbc.M800637200; Olah ME, 2009, J PHYSIOL-LONDON, V587, P965, DOI 10.1113/jphysiol.2008.162289; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schuhmann MK, 2010, J IMMUNOL, V184, P1536, DOI 10.4049/jimmunol.0902161; Smith MA, 2003, J PHYSIOL-LONDON, V547, P417, DOI 10.1113/jphysiol.2002.034561; Sumoza-Toledo A, 2011, FASEB J, V25, P3529, DOI 10.1096/fj.10-178483; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758	27	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47617	10.1371/journal.pone.0047617	http://dx.doi.org/10.1371/journal.pone.0047617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077651	gold, Green Submitted, Green Published			2022-12-27	WOS:000309809500053
J	Li, Q; Zhang, CJ; Li, J; Wang, L; Ren, ZH				Li, Qiang; Zhang, Cunjia; Li, Jing; Wang, Lina; Ren, Zhonghai			Genome-Wide Identification and Characterization of R2R3MYB Family in Cucumis sativus	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SUPERFAMILY; GAMYB-LIKE GENES; MYB GENES; PHYLOGENETIC ANALYSIS; EXPRESSION ANALYSIS; ARABIDOPSIS; EVOLUTION; CELL; DUPLICATION; R2R3-MYB	Background: The R2R3MYB proteins comprise one of the largest families of transcription factors in plants. Although genome-wide analysis of this family has been carried out in some species, little is known about R2R3MYB genes in cucumber (Cucumis sativus L.). Principal Findings: This study has identified 55 R2R3MYB genes in the latest cucumber genome and the CsR2R3MYB family contained the smallest number of identified genes compared to other species that have been studied due to the absence of recent gene duplication events. These results were also supported by genome distribution and gene duplication analysis. Phylogenetic analysis showed that they could be classified into 11 subgroups. The evolutionary relationships and the intron - exon organizations that showed similarities with Arabidopsis, Vitis and Glycine R2R3MYB proteins were also analyzed and suggested strong gene conservation but also the expansions of particular functional genes during the evolution of the plant species. In addition, we found that 8 out of 55 (similar to 14.54%) cucumber R2R3MYB genes underwent alternative splicing events, producing a variety of transcripts from a single gene, which illustrated the extremely high complexity of transcriptome regulation. Tissue-specific expression profiles showed that 50 cucumber R2R3MYB genes were expressed in at least one of the tissues and the other 5 genes showed very low expression in all tissues tested, which suggested that cucumber R2R3MYB genes took part in many cellular processes. The transcript abundance level analysis during abiotic conditions (NaCl, ABA and low temperature treatments) identified a group of R2R3MYB genes that responded to one or more treatments. Conclusions: This study has produced a comparative genomics analysis of the cucumber R2R3MYB gene family and has provided the first steps towards the selection of CsR2R3MYB genes for cloning and functional dissection that can be used in further studies to uncover their roles in cucumber growth and development.	[Li, Qiang; Zhang, Cunjia; Li, Jing; Wang, Lina; Ren, Zhonghai] Shandong Agr Univ, Coll Hort Sci & Engn, Minist Agr,State Key Lab Crop Biol, Key Lab Biol & Genet Improvement Hort Crops Huang, Tai An, Shandong, Peoples R China	Ministry of Agriculture & Rural Affairs; Shandong Agricultural University	Ren, ZH (corresponding author), Shandong Agr Univ, Coll Hort Sci & Engn, Minist Agr,State Key Lab Crop Biol, Key Lab Biol & Genet Improvement Hort Crops Huang, Tai An, Shandong, Peoples R China.	zhren@sdau.edu.cn	Ren, Zhonghai/N-6944-2019	Ren, Zhonghai/0000-0002-0759-3668	National Natural Science Foundation of China [31171977]; Foundation for "Taishan Scholar" from the People's Government of Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for "Taishan Scholar" from the People's Government of Shandong Province	This study was funded by grant 31171977 from National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Foundation for "Taishan Scholar" from the People's Government of Shandong Province (http://www.sd.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Araki S, 2004, J BIOL CHEM, V279, P32979, DOI 10.1074/jbc.M403171200; Bailey-Serres J, 1999, TRENDS PLANT SCI, V4, P142, DOI 10.1016/S1360-1385(99)01386-2; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Brownfield L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000430; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daniel X, 1999, PLANT J, V20, P57, DOI 10.1046/j.1365-313X.1999.00578.x; Dias AP, 2003, PLANT PHYSIOL, V131, P610, DOI 10.1104/pp.012047; Du H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-106; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Glover BJ, 1998, DEVELOPMENT, V125, P3497; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Gonzalez A, 2009, DEV BIOL, V325, P412, DOI 10.1016/j.ydbio.2008.10.005; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; He HS, 2012, PLANT CELL REP, V31, P1199, DOI 10.1007/s00299-012-1241-0; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hu LF, 2012, GENOME, V55, P245, DOI [10.1139/G2012-009, 10.1139/g2012-009]; Hu LF, 2011, GENET MOL BIOL, V34, P624, DOI 10.1590/S1415-47572011005000054; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Ito M, 2001, PLANT CELL, V13, P1891, DOI 10.1105/tpc.13.8.1891; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; JANOUDI AK, 1993, J AM SOC HORTIC SCI, V118, P366, DOI 10.21273/JASHS.118.3.366; Jiang CZ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r46; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kazan K, 2003, TRENDS PLANT SCI, V8, P468, DOI 10.1016/j.tplants.2003.09.001; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Klobus G, 2004, PHYSIOL PLANTARUM, V121, P84, DOI 10.1111/j.0031-9317.2004.00306.x; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Larsen LK, 2002, BIOCHEM J, V366, P767, DOI 10.1042/BJ20011821; Lee MM, 2001, DEVELOPMENT, V128, P1539; Lee SH, 2004, J EXP BOT, V55, P1733, DOI 10.1093/jxb/erh189; Lee SH, 2004, PHYSIOL PLANTARUM, V120, P413, DOI 10.1111/j.0031-9317.2004.00248.x; Lee TH, 2000, BIOCHEM BIOPH RES CO, V270, P356, DOI 10.1006/bbrc.2000.2430; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li JG, 2006, J EXP BOT, V57, P1263, DOI 10.1093/jxb/erj094; Li Q, 2012, MOL BIOL REP, V39, P4283, DOI 10.1007/s11033-011-1215-2; Li SF, 2009, PLANT CELL, V21, P72, DOI 10.1105/tpc.108.063503; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Liu SQ, 2011, GENET MOL RES, V10, P2613, DOI 10.4238/2011.October.25.9; Liu SQ, 2008, THEOR APPL GENET, V117, P927, DOI 10.1007/s00122-008-0832-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locatelli F, 2002, PLANT MOL BIOL, V48, P309, DOI 10.1023/A:1013340004348; Lorkovic ZJ, 2000, TRENDS PLANT SCI, V5, P160, DOI 10.1016/S1360-1385(00)01595-8; Mandaokar A, 2009, PLANT PHYSIOL, V149, P851, DOI 10.1104/pp.108.132597; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Mehan Michael R., 2004, Human Genomics, V1, P335; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Muller D, 2006, PLANT CELL, V18, P586, DOI 10.1105/tpc.105.038745; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P20421, DOI 10.1073/pnas.0709956104; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Payne T, 1999, DEVELOPMENT, V126, P671; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Schauser L, 2005, J MOL EVOL, V60, P229, DOI 10.1007/s00239-004-0144-2; Serna L, 2006, TRENDS PLANT SCI, V11, P274, DOI 10.1016/j.tplants.2006.04.008; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Shi QH, 2007, PLANT PHYSIOL BIOCH, V45, P542, DOI 10.1016/j.plaphy.2007.05.005; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; Urao T, 1996, PLANT J, V10, P1145, DOI 10.1046/j.1365-313X.1996.10061145.x; Wang LJ, 1998, PLANT CELL, V10, P1733, DOI 10.1105/tpc.10.10.1733; Wiese A, 2004, PLANT CELL, V16, P1717, DOI 10.1105/tpc.019349; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Yang CX, 2011, P NATL ACAD SCI USA, V108, P11836, DOI 10.1073/pnas.1100532108; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102	85	46	50	8	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47576	10.1371/journal.pone.0047576	http://dx.doi.org/10.1371/journal.pone.0047576			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110079	Green Published, gold, Green Submitted			2022-12-27	WOS:000310193600016
J	Schwarz, J; Tome, D; Baars, A; Hooiveld, GJEJ; Muller, M				Schwarz, Jessica; Tome, Daniel; Baars, Annemarie; Hooiveld, Guido J. E. J.; Mueller, Michael			Dietary Protein Affects Gene Expression and Prevents Lipid Accumulation in the Liver in Mice	PLOS ONE			English	Article							HIGH-FAT DIET; INSULIN-RESISTANCE; HEPATIC STEATOSIS; PHYSICAL-ACTIVITY; ADIPOSE-TISSUE; BODY-WEIGHT; LIFE-STYLE; METABOLISM; DISEASE; RATS	Background and Aims: High protein (HP) diets are suggested to positively modulate obesity and associated increased prevalence of non-alcoholic fatty liver (NAFLD) disease in humans and rodents. The aim of our study was to detect mechanisms by which a HP diet affects hepatic lipid accumulation. Methods: To investigate the acute and long term effect of high protein ingestion on hepatic lipid accumulation under both low and high fat (HF) conditions, mice were fed combinations of high (35 energy%) or low (10 energy%) fat and high (50 energy%) or normal (15 energy%) protein diets for 1 or 12 weeks. Effects on body composition, liver fat, VLDL production rate and the hepatic transcriptome were investigated. Results: Mice fed the HP diets displayed a lower body weight, developed less adiposity and decreased hepatic lipid accumulation, which could be attributed to a combination of several processes. Next to an increased hepatic VLDL production rate, increased energy utilisation due to enhanced protein catabolic processes, such as transamination, TCA cycle and oxidative phosphorylation was found upon high protein ingestion. Conclusion: Feeding a HP diet prevented the development of NAFLD by enhancing lipid secretion into VLDL particles and a less efficient use of ingested calories.	[Schwarz, Jessica; Tome, Daniel; Baars, Annemarie; Hooiveld, Guido J. E. J.; Mueller, Michael] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Schwarz, Jessica; Hooiveld, Guido J. E. J.; Mueller, Michael] Netherlands Nutrigenom Ctr, Wageningen, Netherlands; [Tome, Daniel] AgroParisTech, INRA, Nutr Physiol & Ingest Behav UMR914, Paris, France	Wageningen University & Research; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Schwarz, J (corresponding author), Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands.	jessica.schwarz@wur.nl	Muller, Michael/B-5795-2008; Hooiveld, Guido JEJ/F-4912-2010; Muller, Michael/M-5724-2019; Schwarz, Jessica/J-3374-2012	Muller, Michael/0000-0002-5930-9905; Hooiveld, Guido JEJ/0000-0003-1954-3542; Muller, Michael/0000-0002-5930-9905; Schwarz, Jessica/0000-0002-2594-2200	Marie Curie European Reintegration Grant within the 7th European Community Framework Programme; Dutch Dairy Organisation (NZO)	Marie Curie European Reintegration Grant within the 7th European Community Framework Programme; Dutch Dairy Organisation (NZO)	This research was supported by a Marie Curie European Reintegration Grant within the 7th European Community Framework Programme and by the Dutch Dairy Organisation (NZO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Abete I, 2009, INT J FOOD SCI NUTR, V60, P1, DOI 10.1080/09637480802232625; Aragno M, 2009, FREE RADICAL BIO MED, V47, P1067, DOI 10.1016/j.freeradbiomed.2009.07.016; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Beymer C, 2003, ARCH SURG-CHICAGO, V138, P1240, DOI 10.1001/archsurg.138.11.1240; Bortolotti M., 2010, e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, V5, pe191; Bortolotti M, 2009, AM J CLIN NUTR, V90, P1002, DOI 10.3945/ajcn.2008.27296; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Chevalier L, 2010, AM J PHYSIOL-REG I, V299, pR1720, DOI 10.1152/ajpregu.00497.2010; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Wit NJW, 2012, J HEPATOL, V57, P1370, DOI 10.1016/j.jhep.2012.07.003; Do GM, 2011, MOL NUTR FOOD RES, V55, pS173, DOI 10.1002/mnfr.201100064; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; EISENSTEIN RS, 1991, J NUTR, V121, P1581, DOI 10.1093/jn/121.10.1581; Evangelista LS, 2009, J CARDIOVASC NURS, V24, P207, DOI 10.1097/JCN.0b013e31819846b9; Frank JW, 2006, AM J PHYSIOL-ENDOC M, V290, pE225, DOI 10.1152/ajpendo.00351.2005; Fromentin C, 2011, AMINO ACIDS, V40, P1461, DOI 10.1007/s00726-010-0756-3; Gholam PM, 2007, AM J GASTROENTEROL, V102, P399, DOI 10.1111/j.1572-0241.2006.01041.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jean C, 2001, J NUTR, V131, P91, DOI 10.1093/jn/131.1.91; Kantartzis K, 2009, GUT, V58, P1281, DOI 10.1136/gut.2008.151977; Kawasaki T, 2009, J NUTR, V139, P2067, DOI 10.3945/jn.109.105858; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Krasnoff JB, 2008, HEPATOLOGY, V47, P1158, DOI 10.1002/hep.22137; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Morenga LAT, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-40; Muller M, 2010, GENES NUTR, V5, P297, DOI 10.1007/s12263-010-0168-8; Noguchi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012057; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Peter A, 2011, INT J OBES LOND; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Scorletti E, 2011, ENDOCRINE, V40, P332, DOI 10.1007/s12020-011-9530-x; Shertzer HG, 2011, J NUTR, V141, P582, DOI 10.3945/jn.110.133736; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stepien M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014664; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki A, 2005, J HEPATOL, V43, P1060, DOI 10.1016/j.jhep.2005.06.008; Uebanso T, 2009, AM J PHYSIOL-ENDOC M, V297, pE76, DOI 10.1152/ajpendo.00014.2009; Westerbacka J, 2005, J CLIN ENDOCR METAB, V90, P2804, DOI 10.1210/jc.2004-1983; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yki-Jarvinen H, 2010, CURR OPIN CLIN NUTR, V13, P709, DOI 10.1097/MCO.0b013e32833f4b34; Zelber-Sagi S, 2011, WORLD J GASTROENTERO, V17, P3377, DOI 10.3748/wjg.v17.i29.3377	48	50	61	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47303	10.1371/journal.pone.0047303	http://dx.doi.org/10.1371/journal.pone.0047303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110065	Green Published, Green Submitted, gold			2022-12-27	WOS:000310193600012
J	Ahamed, M; Chan, B; Jensen, P; Todd, MH				Ahamed, Muneer; Chan, Bun; Jensen, Paul; Todd, Matthew H.			The Outcome of the Oxidations of Unusual Enediamide Motifs Is Governed by the Stabilities of the Intermediate Iminium Ions	PLOS ONE			English	Article							SINGLET OXYGEN; ACID; DELTA(5)-2-OXOPIPERAZINES; CYCLIZATIONS; DERIVATIVES; PRODUCTS; ENAMIDES	We compare the results from the oxidation of two unusual "enediamide'' motifs (3,4-dihydropyrazin-2(1H)-ones), where a double bond is flanked by two amides. In one case the oxidation led to a ring-opened product arising from the cleavage of the double bond, and in the other a rare cis-dioxygenated compound was obtained. Both products have been characterized by X-ray crystallography. The outcomes of the key reactions are rationalized based on calculated free energies of intermediates.	[Ahamed, Muneer; Chan, Bun; Jensen, Paul; Todd, Matthew H.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Chan, Bun] ARC Ctr Excellence Free Rad Chem & Biotechnol, Melbourne, Vic, Australia	University of Sydney	Todd, MH (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	matthew.todd@sydney.edu.au	Todd, Matthew/S-2678-2018	Todd, Matthew/0000-0001-7096-4751; Ahamed, Muneer/0000-0002-8204-6875; Ahamed, Muneer/0000-0002-6834-4585; Chan, Bun/0000-0002-0082-5497	University of Sydney; School of Chemistry at The University of Sydney; Wellcome Trust	University of Sydney(University of Sydney); School of Chemistry at The University of Sydney(University of Sydney); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank the University of Sydney for a University of Sydney International Fee Scholarship and the School of Chemistry at The University of Sydney for a Lamberton Scholarship (to MA) and the Wellcome Trust for a postdoctoral fellowship (to MHT, 1999-2000, when compound 3 was isolated). The authors thank Professor Leo Radom (The University of Sydney) for a fellowship (to BC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aciro C, 2008, TETRAHEDRON, V64, P9320, DOI 10.1016/j.tet.2008.07.012; Adam W, 2004, J ORG CHEM, V69, P1704, DOI 10.1021/jo035745c; ADAM W, 1995, J AM CHEM SOC, V117, P9690, DOI 10.1021/ja00143a011; BATTISTINI C, 1974, J CHEM SOC CHEM COMM, P712, DOI 10.1039/c39740000712; Cheng JF, 2002, TETRAHEDRON LETT, V43, P6293, DOI 10.1016/S0040-4039(02)01403-X; Frauenrath H, 2001, ANGEW CHEM INT EDIT, V40, P177, DOI 10.1002/1521-3773(20010105)40:1<177::AID-ANIE177>3.0.CO;2-X; Frisch G. W., 2013, GAUSSIAN 09; Girard AL, 2011, CHEM-ASIAN J, V6, P1321, DOI 10.1002/asia.201100209; HARAYAMA T, 1986, CHEM PHARM BULL, V34, P2354; HARAYAMA T, 1985, TETRAHEDRON LETT, V26, P3587, DOI 10.1016/S0040-4039(00)89197-2; KIECKONONOWICZ K, 1989, ARCH PHARM, V322, P795, DOI 10.1002/ardp.19893221104; Lee SC, 2007, J COMB CHEM, V9, P828, DOI 10.1021/cc0700492; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Matsumoto K, 2007, SYNLETT, P3137, DOI 10.1055/s-2007-990911; Merrick JP, 2007, J PHYS CHEM A, V111, P11683, DOI 10.1021/jp073974n; MOLTKELETH C, 1993, ACTA CHEM SCAND, V47, P1117, DOI 10.3891/acta.chem.scand.47-1117; Orsini F, 2004, TETRAHEDRON LETT, V45, P9253, DOI 10.1016/j.tetlet.2004.10.072; RYANG HS, 1978, J AM CHEM SOC, V100, P1302, DOI 10.1021/ja00472a051; SCHREIBER SL, 1984, J AM CHEM SOC, V106, P4186, DOI 10.1021/ja00327a020; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Todd MH, 2002, J ORG CHEM, V67, P3985, DOI 10.1021/jo010990m; Wai JS, 2007, BIOORG MED CHEM LETT, V17, P5595, DOI 10.1016/j.bmcl.2007.07.092; Wang W, 2011, J ORG CHEM, V76, P637, DOI 10.1021/jo102058s; Woelfle M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001260; Xiong H, 2002, TETRAHEDRON LETT, V43, P4449, DOI 10.1016/S0040-4039(02)00849-3; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	26	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47224	10.1371/journal.pone.0047224	http://dx.doi.org/10.1371/journal.pone.0047224			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094038	Green Submitted, gold, Green Published			2022-12-27	WOS:000310050200017
J	Giang, T; Bell, R; Buchner, A				Giang, Trang; Bell, Raoul; Buchner, Axel			Does Facial Resemblance Enhance Cooperation?	PLOS ONE			English	Article							HUMAN KIN RECOGNITION; SOURCE MEMORY; SAME-SEX; FACES; SIMILARITY; EVOLUTION; NONPATERNITY; ALTRUISM; KINSHIP; HUMANS	Facial self-resemblance has been proposed to serve as a kinship cue that facilitates cooperation between kin. In the present study, facial resemblance was manipulated by morphing stimulus faces with the participants' own faces or control faces (resulting in self-resemblant or other-resemblant composite faces). A norming study showed that the perceived degree of kinship was higher for the participants and the self-resemblant composite faces than for actual first-degree relatives. Effects of facial self-resemblance on trust and cooperation were tested in a paradigm that has proven to be sensitive to facial trustworthiness, facial likability, and facial expression. First, participants played a cooperation game in which the composite faces were shown. Then, likability ratings were assessed. In a source memory test, participants were required to identify old and new faces, and were asked to remember whether the faces belonged to cooperators or cheaters in the cooperation game. Old-new recognition was enhanced for self-resemblant faces in comparison to other-resemblant faces. However, facial self-resemblance had no effects on the degree of cooperation in the cooperation game, on the emotional evaluation of the faces as reflected in the likability judgments, and on the expectation that a face belonged to a cooperator rather than to a cheater. Therefore, the present results are clearly inconsistent with the assumption of an evolved kin recognition module built into the human face recognition system.	[Giang, Trang; Bell, Raoul; Buchner, Axel] Univ Dusseldorf, Dept Expt Psychol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Giang, T (corresponding author), Univ Dusseldorf, Dept Expt Psychol, D-40225 Dusseldorf, Germany.	Trang.Giang@hhu.de; Raoul.Bell@hhu.de		Bell, Raoul/0000-0002-0592-0362	Deutsche Forschungsgemeinschaft [BE 4311/1-1]; John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development	The research reported in this article was supported by a grant from the Deutsche Forschungsgemeinschaft (BE 4311/1-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Trang Giang, Department of Experimental Psychology, Heinrich Heine University Dusseldorf, Dusseldorf, Germany, Raoul Bell, Department of Experimental Psychology, Heinrich Heine University Dusseldorf, Dusseldorf, Germany and Axel Buchner, Department of Experimental Psychology, Heinrich Heine University Dusseldorf, Dusseldorf, Germany. We declare that no competing interests existed. We thank Lara Schlunder and Marie-Luisa Schaper for their help with stimulus generation and data collection. We thank Daniel Steinmann for allowing us to use his photo for an illustration of the morphing method. Development of the MacBrain Face Stimulus Set was overseen by Nim Tottenham and supported by the John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development. Please contact Nim Tottenham at tott0006@tc.umn.edu for more information concerning the stimulus set.	Alvergne A, 2009, J VISION, V9, DOI 10.1167/9.6.23; Anastasi J.S., 2006, N AM J PSYCHOL, V8, P237; Bailenson JN, 2006, POLIT PSYCHOL, V27, P373, DOI 10.1111/j.1467-9221.2006.00505.x; Bailenson JN, 2008, PUBLIC OPIN QUART, V72, P935, DOI 10.1093/poq/nfn064; Barclay P, 2006, HUM NATURE-INT BIOS, V17, P98, DOI 10.1007/s12110-006-1022-y; Bayen UJ, 1996, J EXP PSYCHOL LEARN, V22, P197, DOI 10.1037/0278-7393.22.1.197; Bayen UJ, 2011, J MEM LANG, V64, P1, DOI 10.1016/j.jml.2010.09.001; Bell R, J EXPT PSYC IN PRESS; Bell R, 2012, J EXP PSYCHOL LEARN, V38, P457, DOI 10.1037/a0026017; Bell R, 2011, EMOTION, V11, P249, DOI 10.1037/a0022597; Bell R, 2010, COGNITION, V117, P261, DOI 10.1016/j.cognition.2010.08.020; Berenson KR, 2006, PERS SOC PSYCHOL B, V32, P1509, DOI 10.1177/0146167206291671; Bressan P, 2009, ARCH SEX BEHAV, V38, P657, DOI 10.1007/s10508-008-9350-0; Buchner A, 2009, EVOL HUM BEHAV, V30, P212, DOI 10.1016/j.evolhumbehav.2009.01.004; BURNSTEIN E, 1994, J PERS SOC PSYCHOL, V67, P773, DOI 10.1037/0022-3514.67.5.773; Cohen J.E., 1988, STAT POWER ANAL BEHA; DeBruine LM, 2011, P NATL ACAD SCI USA, V108, P11710, DOI 10.1073/pnas.1105919108; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; DeBruine LM, 2004, P ROY SOC B-BIOL SCI, V271, P2085, DOI 10.1098/rspb.2004.2824; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Erdfelder E, 2009, Z PSYCHOL, V217, P108, DOI 10.1027/0044-3409.217.3.108; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fraley RC, 2010, PERS SOC PSYCHOL B, V36, P1202, DOI 10.1177/0146167210377180; Fu Yun, 2011, 22 INT JOINT C ART I, DOI DOI 10.5591/978-1-57735-516-8/IJCAI11-422; Greeff JM, 2012, EVOL HUM BEHAV, V33, P268, DOI 10.1016/j.evolhumbehav.2011.10.004; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Havlicek J, 2009, PSYCHONEUROENDOCRINO, V34, P497, DOI 10.1016/j.psyneuen.2008.10.007; Jackson MC, 2008, J EXP PSYCHOL HUMAN, V34, P556, DOI 10.1037/0096-1523.34.3.556; Kaminski G, 2010, PERCEPTION, V39, P807, DOI 10.1068/p6372; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; KLATZKY RL, 1984, MEM COGNITION, V12, P60, DOI 10.3758/BF03196998; Kraus MW, 2010, PSYCHOL SCI, V21, P518, DOI 10.1177/0956797610364949; Kroneisen M, MEMORY IN PRESS; Krupp DB, 2012, J EVOLUTION BIOL, V25, P1472, DOI 10.1111/j.1420-9101.2012.02553.x; Krupp DB, 2008, EVOL HUM BEHAV, V29, P49, DOI 10.1016/j.evolhumbehav.2007.08.002; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lass-Hennemann J, 2011, ARCH SEX BEHAV, V40, P1007, DOI 10.1007/s10508-010-9662-8; Lieberman D, 2007, NATURE, V445, P727, DOI 10.1038/nature05510; Lieberman D, 2012, EVOL HUM BEHAV, V33, P26, DOI 10.1016/j.evolhumbehav.2011.05.002; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; Maloney LT, 2006, J VISION, V6, P1047, DOI 10.1167/6.10.4; Mehl B, 2008, EVOL HUM BEHAV, V29, P35, DOI 10.1016/j.evolhumbehav.2007.08.001; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Nash RA, 2010, MEMORY, V18, P451, DOI 10.1080/09658211003742706; Park JH, 2008, REV GEN PSYCHOL, V12, P215, DOI 10.1037/1089-2680.12.3.215; Pause BM, 2006, P ROY SOC B-BIOL SCI, V273, P471, DOI 10.1098/rspb.2005.3342; Platek SM, 2003, EVOL HUM BEHAV, V24, P81, DOI 10.1016/S1090-5138(02)00117-4; Platek SM, 2002, EVOL HUM BEHAV, V23, P159, DOI 10.1016/S1090-5138(01)00094-0; PORTER RH, 1981, PHYSIOL BEHAV, V27, P493, DOI 10.1016/0031-9384(81)90337-1; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Sporer SL, 2001, PSYCHOL PUBLIC POL L, V7, P36, DOI 10.1038//1076-8971.7.1.36; Todorov A, 2008, ANN NY ACAD SCI, V1124, P208, DOI 10.1196/annals.1440.012; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; Wolf M, 2012, HUM NATURE-INT BIOS, V23, P208, DOI 10.1007/s12110-012-9143-y; Wright DB, 2003, ACTA PSYCHOL, V114, P101, DOI 10.1016/S0001-6918(03)00052-0; Xia S, 2012, IEEE T MULTIMEDIA T	59	19	20	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47809	10.1371/journal.pone.0047809	http://dx.doi.org/10.1371/journal.pone.0047809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	023QT	23094095	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200050
J	Li, X; Cai, Y; Wang, YS; Shi, YY; Hou, W; Xu, CS; Wang, HY; Ye, Z; Yao, LB; Zhang, J				Li, Xia; Cai, Yan; Wang, Yu-Sheng; Shi, Yuan-Yuan; Hou, Wei; Xu, Chun-Sheng; Wang, Hai-Yan; Ye, Zi; Yao, Li-Bo; Zhang, Jian			Hyperglycaemia Exacerbates Choroidal Neovascularisation in Mice via the Oxidative Stress-Induced Activation of STAT3 Signalling in RPE Cells	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; AGE-RELATED MACULOPATHY; N-ACETYL-CYSTEINE; MACULAR DEGENERATION; RISK-FACTORS; VEGF EXPRESSION; PATHOGENESIS; COMPLICATIONS; EXPOSURE; MODEL	Choroidal neovascularisation (CNV) that occurs as a result of age-related macular degeneration (AMD) causes severe vision loss among elderly patients. The relationship between diabetes and CNV remains controversial. However, oxidative stress plays a critical role in the pathogenesis of both AMD and diabetes. In the present study, we investigated the influence of diabetes on experimentally induced CNV and on the underlying molecular mechanisms of CNV. CNV was induced via photocoagulation in the ocular fundi of mice with streptozotocin-induced diabetes. The effect of diabetes on the severity of CNV was measured. An immunofluorescence technique was used to determine the levels of oxidative DNA damage by anti-8- hydroxy-2-deoxyguanosine (8-OHdG) antibody, the protein expression of phosphorylated signal transducer and activator of transcription 3 (p-STAT3) and vascular endothelial growth factor (VEGF), in mice with CNV. The production of reactive oxygen species (ROS) in retinal pigment epithelial (RPE) cells that had been cultured under high glucose was quantitated using the 2',7'-dichlorofluorescein diacetate (DCFH-DA) method. p-STAT3 expression was examined using Western blot analysis. RT-PCR and ELISA processes were used to detect VEGF expression. Hyperglycaemia exacerbated the development of CNV in mice. Oxidative stress levels and the expression of p-STAT3 and VEGF were highly elevated both in mice and in cultured RPE cells. Treatment with the antioxidant compound N-acetyl-cysteine (NAC) rescued the severity of CNV in diabetic mice. NAC also inhibited the overexpression of p-STAT3 and VEGF in CNV and in RPE cells. The JAK-2/STAT3 pathway inhibitor AG490 blocked VEGF expression but had no effect on the production of ROS in vitro. These results suggest that hyperglycaemia promotes the development of CNV by inducing oxidative stress, which in turn activates STAT3 signalling in RPE cells. Antioxidant supplementation helped attenuate the development of CNV. Thus, our results reveal a potential strategy for the treatment and prevention of diseases involving CNV.	[Li, Xia; Cai, Yan; Wang, Yu-Sheng; Shi, Yuan-Yuan; Wang, Hai-Yan; Ye, Zi] Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Xian 710032, Shaanxi Provinc, Peoples R China; [Yao, Li-Bo; Zhang, Jian] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Shaanxi Provinc, Peoples R China; [Hou, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Shaanxi Provinc, Peoples R China; [Xu, Chun-Sheng] Fourth Mil Med Univ, Xijing Hosp, Dept Gastrointestinal Surg, State Key Lab Canc Biol, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wang, YS (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Xian 710032, Shaanxi Provinc, Peoples R China.	wangys003@126.com; biozhangj@yahoo.com.cn			National Natural Science Foundation of China [30872818, 81070748]; National Basic Research Program of China (973 Program) [2011CB510200]; Alexander Von Humboldt Foundation in Germany [V8151/02085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Alexander Von Humboldt Foundation in Germany(Alexander von Humboldt Foundation)	This work was supported by grants from the National Natural Science Foundation of China (No. 30872818, 81070748) and National Basic Research Program of China (973 Program/No. 2011CB510200). The project was sponsored partly by the equipment donation from the Alexander Von Humboldt Foundation in Germany (to Y.S.W., V8151/02085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktunc E, 2010, CLIN EXP DERMATOL, V35, P902, DOI 10.1111/j.1365-2230.2010.03823.x; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3231, DOI 10.1167/iovs.08-1754; Awad N, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.030; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bertram KM, 2009, AM J PHYSIOL-CELL PH, V297, pC1200, DOI 10.1152/ajpcell.00126.2009; Borrone R, 2008, EUR J OPHTHALMOL, V18, P949, DOI 10.1177/112067210801800615; Brezniceanu ML, 2010, J AM SOC NEPHROL, V21, P943, DOI 10.1681/ASN.2009030242; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Calabrese A, 2011, INVEST OPHTH VIS SCI, V52, P2417, DOI 10.1167/iovs.09-5056; Campa C, 2011, CURR DRUG TARGETS, V12, P173, DOI 10.2174/138945011794182674; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Choi JK, 2011, ARCH OPHTHALMOL-CHIC, V129, P196, DOI 10.1001/archophthalmol.2010.355; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Duan YK, 2007, OPHTHALMOLOGY, V114, P732, DOI 10.1016/j.ophtha.2006.07.045; Fraser-Bell S, 2008, AM J OPHTHALMOL, V145, P308, DOI 10.1016/j.ajo.2007.10.007; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Guymer RH, 2006, MED J AUSTRALIA, V184, P455, DOI 10.5694/j.1326-5377.2006.tb00318.x; Hara R, 2010, CURR EYE RES, V35, P1012, DOI 10.3109/02713683.2010.500112; HIDAYAT AA, 1985, OPHTHALMOLOGY, V92, P512; Hou HY, 2008, EXP EYE RES, V86, P983, DOI 10.1016/j.exer.2008.03.018; Hou HY, 2010, MOL THER, V18, P1837, DOI 10.1038/mt.2010.144; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; KLEIN R, 1992, OPHTHALMOLOGY, V99, P1527; Klein R, 2007, AM J OPHTHALMOL, V143, P473, DOI 10.1016/j.ajo.2006.11.058; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; Li QH, 2008, MOL THER, V16, P1688, DOI 10.1038/mt.2008.164; Lyzogubov VV, 2010, INVEST OPHTH VIS SCI, V51; MILLER H, 1990, INVEST OPHTH VIS SCI, V31, P899; Motyl K, 2009, BIOL PROCED ONLINE, V11, P296, DOI 10.1007/s12575-009-9000-5; Pop-Busui R, 2006, DIABETES-METAB RES, V22, P257, DOI 10.1002/dmrr.625; Proctor B, 2007, INVEST OPHTHALMOL VI, V48, P2149; Ryan CM, 2006, DIABETES CARE, V29, P345, DOI 10.2337/diacare.29.02.06.dc05-1626; Sakurai E, 2008, INVEST OPHTH VIS SCI, V49, P540; Shi Y, 2011, INT J INF TECH DECIS, V10, P1, DOI 10.1142/S0219622011004294; Strunnikova N, 2004, INVEST OPHTH VIS SCI, V45, P3767, DOI 10.1167/iovs.04-0311; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; Topouzis F, 2009, BRIT J OPHTHALMOL, V93, P1037, DOI 10.1136/bjo.2008.146316; Wei Michael, 2003, Heart Lung Circ, V12, P44, DOI 10.1046/j.1444-2892.2003.00160.x; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yan ML, 2011, CARDIOVASC DRUG THER, V25, P451, DOI 10.1007/s10557-011-6342-4; Yildirim Z, 2011, CLINICS, V66, P743, DOI 10.1590/S1807-59322011000500006; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhang FJ, 2011, TOXICOL SCI, V120, P87, DOI 10.1093/toxsci/kfq364; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275; Zhu J, 2009, EXP EYE RES, V88, P910, DOI 10.1016/j.exer.2008.11.034	49	42	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47600	10.1371/journal.pone.0047600	http://dx.doi.org/10.1371/journal.pone.0047600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094067	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200034
J	Limame, R; Wouters, A; Pauwels, B; Fransen, E; Peeters, M; Lardon, F; De Wever, O; Pauwels, P				Limame, Ridha; Wouters, An; Pauwels, Bea; Fransen, Erik; Peeters, Marc; Lardon, Filip; De Wever, Olivier; Pauwels, Patrick			Comparative Analysis of Dynamic Cell Viability, Migration and Invasion Assessments by Novel Real-Time Technology and Classic Endpoint Assays	PLOS ONE			English	Article								Background: Cell viability and motility comprise ubiquitous mechanisms involved in a variety of (patho)biological processes including cancer. We report a technical comparative analysis of the novel impedance-based xCELLigence Real-Time Cell Analysis detection platform, with conventional label-based endpoint methods, hereby indicating performance characteristics and correlating dynamic observations of cell proliferation, cytotoxicity, migration and invasion on cancer cells in highly standardized experimental conditions. Methodology/Principal Findings: Dynamic high-resolution assessments of proliferation, cytotoxicity and migration were performed using xCELLigence technology on the MDA-MB-231 (breast cancer) and A549 (lung cancer) cell lines. Proliferation kinetics were compared with the Sulforhodamine B (SRB) assay in a series of four cell concentrations, yielding fair to good correlations (Spearman's Rho 0.688 to 0.964). Cytotoxic action by paclitaxel (0-100 nM) correlated well with SRB (Rho>0.95) with similar IC50 values. Reference cell migration experiments were performed using Transwell plates and correlated by pixel area calculation of crystal violet-stained membranes (Rho 0.90) and optical density (OD) measurement of extracted dye (Rho. 0.95). Invasion was observed on MDA-MB-231 cells alone using Matrigel-coated Transwells as standard reference method and correlated by OD reading for two Matrigel densities (Rho>0.95). Variance component analysis revealed increased variances associated with impedance-based detection of migration and invasion, potentially caused by the sensitive nature of this method. Conclusions/Significance: The xCELLigence RTCA technology provides an accurate platform for non-invasive detection of cell viability and motility. The strong correlations with conventional methods imply a similar observation of cell behavior and interchangeability with other systems, illustrated by the highly correlating kinetic invasion profiles on different platforms applying only adapted matrix surface densities. The increased sensitivity however implies standardized experimental conditions to minimize technical-induced variance.	[Limame, Ridha; Wouters, An; Pauwels, Bea; Peeters, Marc; Lardon, Filip; Pauwels, Patrick] Univ Antwerp, Ctr Oncol Res CORE, B-2020 Antwerp, Belgium; [Fransen, Erik] Univ Antwerp, StatUA Ctr Stat, B-2020 Antwerp, Belgium; [Peeters, Marc] Univ Antwerp Hosp, Dept Oncol, Antwerp, Belgium; [De Wever, Olivier] Ghent Univ Hosp, Dept Radiotherapy & Nucl Med, Lab Expt Canc Res, Ghent, Belgium; [Pauwels, Patrick] Univ Antwerp Hosp, Pathol Lab, Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; Ghent University; Ghent University Hospital; University of Antwerp	Limame, R (corresponding author), Univ Antwerp, Ctr Oncol Res CORE, B-2020 Antwerp, Belgium.	ridha.limame@ua.ac.be	Lardon, Filip/A-3559-2010; Fransen, Erik/C-4102-2015; de wever, olivier/J-3094-2013; Wouters, An/B-5384-2017; Peeters, Marc/C-5525-2013	Lardon, Filip/0000-0001-7174-4144; Fransen, Erik/0000-0001-7785-4790; de wever, olivier/0000-0002-5453-760X; Wouters, An/0000-0001-7771-1239; Peeters, Marc/0000-0003-4969-2303				Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Atienza JM, 2006, ASSAY DRUG DEV TECHN, V4, P597, DOI 10.1089/adt.2006.4.597; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; De Wever O, 2010, INT J DEV BIOL, V54, P887, DOI 10.1387/ijdb.092948ow; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang J, 2005, MOL BIOL CELL, V16, P4982, DOI 10.1091/mbc.E05-03-0258; Hulkower Keren I, 2011, Pharmaceutics, V3, P107, DOI 10.3390/pharmaceutics3010107; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Pauwels B, 2003, EUR J CANCER, V39, P838, DOI 10.1016/S0959-8049(03)00002-9; Pauwels B, 2003, CANCER CHEMOTH PHARM, V51, P221, DOI 10.1007/s00280-002-0557-9; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Zhang DW, 2009, CLIN CANCER RES, V15, P6639, DOI 10.1158/1078-0432.CCR-09-0951	17	208	210	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e46536	10.1371/journal.pone.0046536	http://dx.doi.org/10.1371/journal.pone.0046536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094027	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200011
J	Schwaiger, CS; Borjesson, SI; Hess, B; Wallner, B; Elinder, F; Lindahl, E				Schwaiger, Christine S.; Borjesson, Sara I.; Hess, Berk; Wallner, Bjorn; Elinder, Fredrik; Lindahl, Erik			The Free Energy Barrier for Arginine Gating Charge Translation Is Altered by Mutations in the Voltage Sensor Domain	PLOS ONE			English	Article							SHAKER K+ CHANNEL; NUCLEAR MAGNETIC-RESONANCE; POTASSIUM CHANNEL; SOLID-STATE; SODIUM-CHANNELS; RESTING STATE; SIDE-CHAINS; S4 SEGMENT; DYNAMICS; PROTEIN	The gating of voltage-gated ion channels is controlled by the arginine-rich S4 helix of the voltage-sensor domain moving in response to an external potential. Recent studies have suggested that S4 moves in three to four steps to open the conducting pore, thus visiting several intermediate conformations during gating. However, the exact conformational changes are not known in detail. For instance, it has been suggested that there is a local rotation in the helix corresponding to short segments of a 3(10)-helix moving along S4 during opening and closing. Here, we have explored the energetics of the transition between the fully open state (based on the X-ray structure) and the first intermediate state towards channel closing (C-1), modeled from experimental constraints. We show that conformations within 3 angstrom of the X-ray structure are obtained in simulations starting from the C-1 model, and directly observe the previously suggested sliding 3(10)-helix region in S4. Through systematic free energy calculations, we show that the C-1 state is a stable intermediate conformation and determine free energy profiles for moving between the states without constraints. Mutations indicate several residues in a narrow hydrophobic band in the voltage sensor contribute to the barrier between the open and C-1 states, with F233 in the S2 helix having the largest influence. Substitution for smaller amino acids reduces the transition cost, while introduction of a larger ring increases it, largely confirming experimental activation shift results. There is a systematic correlation between the local aromatic ring rotation, the arginine barrier crossing, and the corresponding relative free energy. In particular, it appears to be more advantageous for the F233 side chain to rotate towards the extracellular side when arginines cross the hydrophobic region.	[Schwaiger, Christine S.; Hess, Berk; Lindahl, Erik] Sci Life Lab, Solna, Sweden; [Schwaiger, Christine S.; Hess, Berk; Lindahl, Erik] Royal Inst Technol, Dept Theoret Phys, S-10044 Stockholm, Sweden; [Borjesson, Sara I.; Elinder, Fredrik] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden; [Wallner, Bjorn] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Wallner, Bjorn] Linkoping Univ, Swedish Esci Res Ctr, Linkoping, Sweden; [Lindahl, Erik] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden	Royal Institute of Technology; Linkoping University; Linkoping University; Linkoping University; Swedish e-Science Research Centre (SeRC); Stockholm University	Lindahl, E (corresponding author), Sci Life Lab, Solna, Sweden.	erik@kth.se	Liin, Sara/I-2941-2012; Wallner, Björn/R-1030-2018; Lindahl, Erik/D-4590-2013	Wallner, Björn/0000-0002-3772-8279; Lindahl, Erik/0000-0002-2734-2794; Hess, Berk/0000-0002-7498-7763; Liin, Sara/0000-0001-8493-0114; Elinder, Fredrik/0000-0001-9125-5583	European Research Council [209825]; Vetenskapsradet [2010-5107]; Swedish Foundation for Strategic Research; Swedish e-Science Research Center	European Research Council(European Research Council (ERC)European Commission); Vetenskapsradet(Swedish Research Council); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish e-Science Research Center	This work was supported by grants from the European Research Council (209825), Vetenskapsradet (2010-5107), the Swedish Foundation for Strategic Research and the Swedish e-Science Research Center. Computing resources were provided by the Swedish National Infrastructure for Computing (SNIC 014/10-31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bjelkmar P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000289; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Cohen BE, 2003, NEURON, V39, P395, DOI 10.1016/S0896-6273(03)00472-0; French RJ, 1996, NEURON, V16, P407, DOI 10.1016/S0896-6273(00)80058-6; FREY MH, 1985, J AM CHEM SOC, V107, P7311, DOI 10.1021/ja00311a016; GALL CM, 1982, P NATL ACAD SCI-BIOL, V79, P101, DOI 10.1073/pnas.79.1.101; Henrion U, 2012, P NATL ACAD SCI US, DOI 101073/pnas1116938109; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hiraoki T, 1998, J MOL STRUCT, V441, P243, DOI 10.1016/S0022-2860(97)00257-3; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; KINSEY RA, 1981, J BIOL CHEM, V256, P9028; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lacroix JJ, 2011, P NATL ACAD SCI USA, V108, P6444, DOI 10.1073/pnas.1103397108; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LEVY RM, 1983, BIOPHYS J, V41, P217, DOI 10.1016/S0006-3495(83)84422-1; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Lin MCA, 2011, J GEN PHYSIOL, V138, P155, DOI 10.1085/jgp.201110642; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Pless SA, 2011, NAT CHEM BIOL, V7, P617, DOI [10.1038/nchembio.622, 10.1038/NCHEMBIO.622]; SAITO H, 1990, MACROMOLECULES, V23, P83, DOI 10.1021/ma00203a016; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Schrodinger LLC, 2010, PYM MOL GRAPH SYST V; Schwaiger CS, 2011, BIOPHYS J, V100, P1446, DOI 10.1016/j.bpj.2011.02.003; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Shafrir Y, 2008, BIOPHYS J, V95, P3663, DOI 10.1529/biophysj.108.135335; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Upadhyay SK, 2009, J PHYSIOL-LONDON, V587, P3851, DOI 10.1113/jphysiol.2009.174730; Vargas E, 2011, NEURON, V72, P713, DOI 10.1016/j.neuron.2011.09.024; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	49	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e45880	10.1371/journal.pone.0045880	http://dx.doi.org/10.1371/journal.pone.0045880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094020	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200005
J	Zhou, K; Michiels, CW; Aertsen, A				Zhou, Kai; Michiels, Chris W.; Aertsen, Abram			Variation of Intragenic Tandem Repeat Tract of tolA Modulates Escherichia coli Stress Tolerance	PLOS ONE			English	Article							FILAMENTOUS PHAGE INFECTION; C-TERMINAL DOMAIN; MICROSATELLITE INSTABILITY; CELL-DIVISION; MUTATIONS; MEMBRANE; COMPLEX; CHROMOSOME; CORECEPTOR; MECHANISMS	In recent work we discovered that the intragenic tandem repeat (TR) region of the tolA gene is highly variable among different Escherichia coli strains. The aim of this study was therefore to investigate the biological function and dynamics of TR variation in E. coli tolA. The biological impact of TR variation was examined by comparing the ability of a set of synthetic tolA variants with in frame repeat copies varying from 2 to 39 to rescue the altered susceptibility of an E. coli Delta tolA mutant to deoxycholic acid, sodium dodecyl sulfate, hyperosmolarity, and infection with filamentous bacteriophage. Interestingly, although each of the TolA variants was able to at least partly rescue the Delta tolA mutant, the extent was clearly dependent on both the repeat number and the type of stress imposed, indicating the existence of opposing selective forces with regard to the optimal TR copy number. Subsequently, TR dynamics in a clonal population were assayed, and we could demonstrate that TR contractions are RecA dependent and enhanced in a DNA repair deficient uvrD background, and can occur at a frequency of 6.9x10(-5).	[Aertsen, Abram] Katholieke Univ Leuven, Fac Biosci Engn, Dept Microbial & Mol Syst M2S, Food Microbiol Lab, Louvain, Belgium; Katholieke Univ Leuven, Fac Biosci Engn, Dept Microbial & Mol Syst M2S, Leuven Food Sci & Nutr Res Ctr LFoRCe, Louvain, Belgium	KU Leuven; KU Leuven	Aertsen, A (corresponding author), Katholieke Univ Leuven, Fac Biosci Engn, Dept Microbial & Mol Syst M2S, Food Microbiol Lab, Louvain, Belgium.	abram.aertsen@biw.kuleuven.be	Michiels, Chris/I-6847-2013	Michiels, Chris/0000-0002-7710-6802; Aertsen, Abram/0000-0002-1897-2305	Research Foundation Flanders [G.0289.06N]	Research Foundation Flanders(FWO)	This work was financially supported by a grant from the Research Foundation Flanders (G.0289.06N); http://www.fwo.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bichara M, 2006, MUTAT RES-FUND MOL M, V598, P144, DOI 10.1016/j.mrfmmm.2006.01.020; Bierne H, 1997, MOL MICROBIOL, V26, P557, DOI 10.1046/j.1365-2958.1997.6011973.x; Bouveret E, 1998, MOL MICROBIOL, V27, P143, DOI 10.1046/j.1365-2958.1998.00667.x; Callewaert L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000019; Cooley MB, 2010, APPL ENVIRON MICROB, V76, P3398, DOI 10.1128/AEM.02373-09; Croes E, 2009, J AGR FOOD CHEM, V57, P1029, DOI 10.1021/jf802638n; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dawid S, 1999, P NATL ACAD SCI USA, V96, P1077, DOI 10.1073/pnas.96.3.1077; De Paepe M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002107; DEROUICHE R, 1995, J BIOL CHEM, V270, P11078, DOI 10.1074/jbc.270.19.11078; Deszo EL, 2005, P NATL ACAD SCI USA, V102, P5564, DOI 10.1073/pnas.0407428102; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Hashem VI, 2004, MUTAT RES-FUND MOL M, V554, P95, DOI 10.1016/j.mrfmmm.2004.03.012; Heermann R, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-14; Hernandez SB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002459; Hill TM, 1997, J BACTERIOL, V179, P1931, DOI 10.1128/jb.179.6.1931-1939.1997; Karlsson F, 2003, J BACTERIOL, V185, P2628, DOI 10.1128/JB.185.8.2628-2634.2003; Krachler AM, 2010, J MOL BIOL, V403, P270, DOI 10.1016/j.jmb.2010.08.050; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; LEVENGOOD SK, 1991, P NATL ACAD SCI USA, V88, P5939, DOI 10.1073/pnas.88.14.5939; LEVENGOODFREYERMUTH SK, 1993, J BACTERIOL, V175, P222, DOI 10.1128/JB.175.1.222-228.1993; Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6; Luria SE, 1943, GENETICS, V28, P491; Madoff LC, 1996, P NATL ACAD SCI USA, V93, P4131, DOI 10.1073/pnas.93.9.4131; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; MARVIN DA, 1969, BACTERIOL REV, V33, P172, DOI 10.1007/BF02702778; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Meury J, 1999, BIOL CELL, V91, P67, DOI 10.1016/S0248-4900(99)80032-X; Morel P, 1998, P NATL ACAD SCI USA, V95, P10003, DOI 10.1073/pnas.95.17.10003; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Raggett EM, 1998, MOL MICROBIOL, V28, P1335, DOI 10.1046/j.1365-2958.1998.00899.x; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; Ritz D, 2001, SCIENCE, V294, P158, DOI 10.1126/science.1063143; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schendel SL, 1997, J BACTERIOL, V179, P3683, DOI 10.1128/jb.179.11.3683-3690.1997; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Shaver AC, 2003, J BACTERIOL, V185, P6076, DOI 10.1128/JB.185.20.6076-6082.2003; Sheets AJ, 2011, J BACTERIOL, V193, P329, DOI 10.1128/JB.00933-10; VANHAM SM, 1993, CELL, V73, P1187, DOI 10.1016/0092-8674(93)90647-9; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Vines ED, 2005, J BACTERIOL, V187, P3359, DOI 10.1128/JB.187.10.3359-3368.2005; Vogler AJ, 2006, J BACTERIOL, V188, P4253, DOI 10.1128/JB.00001-06; Wagner J, 2000, J BACTERIOL, V182, P4587, DOI 10.1128/JB.182.16.4587-4595.2000; Zhou K, 2012, RES MICROBIOL, V163, P316, DOI 10.1016/j.resmic.2012.05.003	48	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47766	10.1371/journal.pone.0047766	http://dx.doi.org/10.1371/journal.pone.0047766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094082	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200043
J	Clark, D; Tuor, UI; Thompson, R; Institoris, A; Kulynych, A; Zhang, X; Kinniburgh, DW; Bari, F; Busija, DW; Barber, PA				Clark, Darren; Tuor, Ursula I.; Thompson, Roger; Institoris, Adam; Kulynych, Angela; Zhang, Xu; Kinniburgh, David W.; Bari, Ferenc; Busija, David W.; Barber, Philip A.			Protection against Recurrent Stroke with Resveratrol: Endothelial Protection	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ISCHEMIA-REPERFUSION; TRANS-RESVERATROL; OXIDATIVE STRESS; RAT-BRAIN; INJURY; CELLS; MODEL; EXPRESSION; DISEASES	Despite increased risk of a recurrent stroke following a minor stroke, information is minimal regarding the interaction between injurious mild cerebral ischemic episodes and the possible treatments which might be effective. The aim of the current study was to investigate recurrent ischemic stroke and whether resveratrol, a nutritive polyphenol with promising cardio-and neuro-protective properties, could ameliorate the associated brain damage. Experiments in adult rats demonstrated that a mild ischemic stroke followed by a second mild cerebral ischemia exacerbated brain damage, and, daily oral resveratrol treatment after the first ischemic insult reduced ischemic cell death with the recurrent insult (P<0.002). Further investigation demonstrated reduction of both inflammatory changes and markers of oxidative stress in resveratrol treated animals. The protection observed with resveratrol treatment could not be explained by systemic effects of resveratrol treatment including effects either on blood pressure or body temperature measured telemetrically. Investigation of resveratrol effects on the blood-brain barrier in vivo demonstrated that resveratrol treatment reduced blood-brain barrier disruption and edema following recurrent stroke without affecting regional cerebral blood flow. Investigation of the mechanism in primary cell culture studies demonstrated that resveratrol treatment significantly protected endothelial cells against an in vitro 'ischemia' resulting in improved viability against oxygen and glucose deprivation (39.6 +/- 6.6% and 81.3 +/- 9.5% in vehicle and resveratrol treated cells, respectively). An inhibition of nitric oxide synthesis did not prevent the improved cell viability following oxygen glucose deprivation but SIRT-1 inhibition with sirtinol partially blocked the protection (P<0.001) suggesting endothelial protection is to some extent SIRT-1 dependent. Collectively, the results support that oral resveratrol treatment provides a low risk strategy to protect the brain from enhanced damage produced by recurrent stroke which is mediated in part by a protective effect of resveratrol on the endothelium of the cerebrovasculature.	[Clark, Darren; Tuor, Ursula I.; Thompson, Roger; Kulynych, Angela; Barber, Philip A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Clark, Darren; Tuor, Ursula I.; Thompson, Roger; Kulynych, Angela; Barber, Philip A.] Univ Calgary, Fac Med, Calgary, AB, Canada; [Clark, Darren; Tuor, Ursula I.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Clark, Darren; Tuor, Ursula I.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Clark, Darren; Tuor, Ursula I.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Clark, Darren; Bari, Ferenc] Univ Szeged, Dept Med Phys & Informat, Szeged, Hungary; [Institoris, Adam] Univ Szeged, Dept Physiol, Szeged, Hungary; [Busija, David W.] Tulane Univ, Dept Pharmacol, New Orleans, LA 70118 USA; [Zhang, Xu; Kinniburgh, David W.] Univ Calgary, Alberta Ctr Toxicol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; Szeged University; Szeged University; Tulane University; University of Calgary	Tuor, UI (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	utuor@ucalgary.ca	Barber, Philip A/C-7108-2016	Clark, Darren/0000-0002-9152-6539	Canadian Institutes for Health Research [172805, 231136]; Heart and Stroke Foundation; Eli Lilly; OTKA [K81266]; HURO-TRANSMED	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Eli Lilly(Eli Lilly); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); HURO-TRANSMED	This work was supported by the Canadian Institutes for Health Research (Grants 172805 and 231136) and a fellowship to DC from the Heart and Stroke Foundation and Eli Lilly. Studies conducted in Hungary were supported by OTKA (K81266) and HURO-TRANSMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida L, 2009, MOL NUTR FOOD RES, V53, pS7, DOI 10.1002/mnfr.200800177; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Boocock DJ, 2007, J CHROMATOGR B, V848, P182, DOI 10.1016/j.jchromb.2006.10.017; Borriello A, 2010, NUTR METAB CARDIOVAS, V20, P618, DOI 10.1016/j.numecd.2010.07.004; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Chan V, 2011, CURR PHARM BIOTECHNO, V12, P429, DOI 10.2174/138920111794480552; Chang HC, 2010, J CEREB BLOOD FLOW M; Cheng G, 2009, NEUROSCI LETT, V451, P105, DOI 10.1016/j.neulet.2008.12.045; Dal-Pan Alexandre, 2010, BMC Physiology, V10, P11, DOI 10.1186/1472-6793-10-11; del Zoppo GJ, 2010, ANN NY ACAD SCI, V1207, P46, DOI 10.1111/j.1749-6632.2010.05760.x; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Domoki F, 2008, AM J PHYSIOL-REG I, V295, pR1099, DOI 10.1152/ajpregu.90430.2008; Dong WP, 2008, J VASC SURG, V48, P709, DOI 10.1016/j.jvs.2008.04.007; Gao DK, 2006, LIFE SCI, V78, P2564, DOI 10.1016/j.lfs.2005.10.030; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Kaur J, 2011, J CEREB BLOOD FLOW M; Kis B, 2002, J NEUROENDOCRINOL, V14, P283, DOI 10.1046/j.1365-2826.2002.00778.x; Kiziltepe U, 2004, J VASC SURG, V40, P138, DOI 10.1016/j.jvs.2004.03.032; Kleindorfer D, 2005, STROKE, V36, P720, DOI 10.1161/01.STR.0000158917.59233.b7; Lin YL, 2010, J NUTR, V140, P2187, DOI 10.3945/jn.110.123505; Mayers JR, 2009, FASEB J, V23, P1032, DOI 10.1096/fj.08-115923; Morris KC, 2011, J CEREBR BLOOD F MET, V31, P1003, DOI 10.1038/jcbfm.2010.229; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Qiao M, 2009, J NEUROSCI METH, V184, P244, DOI 10.1016/j.jneumeth.2009.08.010; Qiao M, 2009, INT J DEV NEUROSCI, V27, P691, DOI 10.1016/j.ijdevneu.2009.07.004; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Schmitt CA, 2010, BIOFACTORS, V36, P342, DOI 10.1002/biof.109; Shin JA, 2010, J NEUROIMMUNOL; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Thandapilly SJ, 2010, AM J HYPERTENS, V23, P192, DOI 10.1038/ajh.2009.228; Tsai SK, 2007, J VASC SURG, V46, P346, DOI 10.1016/j.jvs.2007.04.044; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, pH1876, DOI 10.1152/ajpheart.00375.2009; Wang CX, 2009, INT J STROKE, V4, P274, DOI 10.1111/j.1747-4949.2009.00317.x; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yenari MA, 2010, STROKE, V41, pS72, DOI 10.1161/STROKEAHA.110.595371	39	61	64	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47792	10.1371/journal.pone.0047792	http://dx.doi.org/10.1371/journal.pone.0047792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082218	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000311146900115
J	Golden, CD; Rasolofoniaina, BJR; Benjamin, R; Young, SL				Golden, Christopher D.; Rasolofoniaina, B. J. Rodolph; Benjamin, Rakoto; Young, Sera L.			Pica and Amylophagy Are Common among Malagasy Men, Women and Children	PLOS ONE			English	Article							PREGNANT-WOMEN; GEOPHAGY; IRON; SCHOOLCHILDREN; NUTRITION; ANEMIA; ASSOCIATION; INFECTION; TANZANIA	Pica, the craving and purposive consumption of non-food substances, is of public health concern for its potential deleterious and salubrious health consequences. However, neither its prevalence nor demographic correlates have been well characterized. Therefore, we conducted the first population-based study of pica and amylophagy in Madagascar. From February to December 2009, we surveyed pica and amylophagy behaviors in a random sample of 760 individuals >5 years in 167 households among two ethnic groups in 16 villages in the Makira Protected Area of Madagascar. Of the 760 individuals interviewed, 62.5% were children (5-11 years), 5.4% were adolescents (12-16 years), and 35.1% were adults (>= 17 years). Thirteen non-food items were reported being consumed. Across the entire population in the prior year, the prevalence of geophagy was 53.4%, of amylophagy, 85.2%, and of other pica substances (e.g. charcoal, chalk) was 19.0%. The prevalence of these behaviors was not higher during pregnancy. These findings differ from previous studies in terms of the higher overall prevalence of these behaviors, the high prevalence among men, and the absence of any peak in behaviors during pregnancy. However, there are two categories of substances that elevate our estimates but fall outside the strict definition of pica as a craving: 1) substances consumed for self-medication and 2) substances viewed as food, such as all amylophagic substances in this case. Our results suggest that population-based studies of pica should include males of all ages. Further, the prevalence of the behavior underscores the importance of understanding the etiology and health consequences of these ingestive behaviors (Abstract S1).	[Golden, Christopher D.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Golden, Christopher D.; Rasolofoniaina, B. J. Rodolph] Madagascar Hlth & Environm Res MAHERY, Maroantsetra, Madagascar; [Benjamin, Rakoto] Univ Antananarivo, Ecole Super Sci Agron, Dept Agr, Antananarivo, Madagascar; [Young, Sera L.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Harvard University; University Antananarivo; Cornell University	Golden, CD (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	cgolden@fas.harvard.edu		Young, Sera/0000-0002-1763-1218; Golden, Christopher/0000-0002-2258-7493; Golden, Christopher/0000-0002-0358-4625	Margot Marsh Biodiversity Fund [023815]; National Geographic Society Conservation Trust [C135-08]; National Science Foundation Doctoral Dissertation Improvement Grant [DEB- 1011714]	Margot Marsh Biodiversity Fund; National Geographic Society Conservation Trust(National Geographic Society); National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF))	This study was supported by the Margot Marsh Biodiversity Fund #023815, the National Geographic Society Conservation Trust #C135-08, and the National Science Foundation Doctoral Dissertation Improvement Grant- DEB- 1011714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anell B, 1958, STUD ETHNOGR, V17, P1; BRUHN CM, 1971, J AM DIET ASSOC, V58, P417; Corbett Robin Webb, 2003, MCN Am J Matern Child Nurs, V28, P183; CROSBY WH, 1971, ARCH INTERN MED, V127, P960; DANFORD DE, 1982, ANNU REV NUTR, V2, P303, DOI 10.1146/annurev.nu.02.070182.001511; de Flacourt, 1658, HIST GRANDE ISLE MAD, P209; Diouf S, 2000, Dakar Med, V45, P48; FERGUSON JAMES H., 1950, NEW ORLEANS MED AND SURG JOUR, V103, P81; Furuseth O, 1973, GEOPHAGY E N CAROLIN; Geissler PW, 1998, T ROY SOC TROP MED H, V92, P7, DOI 10.1016/S0035-9203(98)90934-8; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Heusinger K, 1852, SOGENANNTE GEOPHAGIE; Hooper D, 1906, MEM ASIATIC SOC BENG, V1, P249; Kawai K, 2009, AM J TROP MED HYG, V80, P36, DOI 10.4269/ajtmh.2009.80.36; KEITH L, 1969, Chicago Medical School Quarterly, V28, P109; KEITH LG, 1969, J AMER MED ASSOC, V208, P535, DOI 10.1001/jama.1969.03160030109024; Laufer B, 1930, FIELD MUSEUM NATURAL, P99; Lopez LB, 2007, INT J GYNECOL OBSTET, V98, P151, DOI 10.1016/j.ijgo.2007.03.038; Luoba AI, 2005, TROP MED INT HEALTH, V10, P220, DOI 10.1111/j.1365-3156.2004.01380.x; MARCHI M, 1990, J AM ACAD CHILD PSY, V29, P112, DOI 10.1097/00004583-199001000-00017; Nchito M, 2004, T ROY SOC TROP MED H, V98, P218, DOI 10.1016/S0035-9203(03)00045-2; Ngudi DD, 2003, FOOD CHEM TOXICOL, V41, P1193, DOI 10.1016/S0278-6915(03)00111-X; Nyaruhucha C N M, 2009, Tanzan J Health Res, V11, P29; Rainville AJ, 1998, J AM DIET ASSOC, V98, P293, DOI 10.1016/S0002-8223(98)00069-8; Saathoff E, 2002, T ROY SOC TROP MED H, V96, P485, DOI 10.1016/S0035-9203(02)90413-X; SAYERS G, 1974, S AFR MED J, V48, P1655; Simpson E, 2000, WESTERN J MED, V173, P20, DOI 10.1136/ewjm.173.1.20; Sule S, 2001, Niger J Med, V10, P25; Tayie FAK., 1999, GHANA MED J, V33, P67; Thompson C.J.S., 1914, P 17 INT C MED, P433; WALKER ARP, 1985, BRIT J OBSTET GYNAEC, V92, P484, DOI 10.1111/j.1471-0528.1985.tb01353.x; Young SL, 2011, Q REV BIOL, V86, P97, DOI 10.1086/659884; Young SL, 2010, ANNU REV NUTR, V30, P403, DOI 10.1146/annurev.nutr.012809.104713; Young SL, 2010, AM J TROP MED HYG, V83, P144, DOI 10.4269/ajtmh.2010.09-0442; Young SL, 2010, J CHEM ECOL, V36, P129, DOI 10.1007/s10886-009-9729-y; Young SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003147	37	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47129	10.1371/journal.pone.0047129	http://dx.doi.org/10.1371/journal.pone.0047129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082143	Green Submitted, gold, Green Published			2022-12-27	WOS:000311146900038
J	Majdandzic, J; Bauer, H; Windischberger, C; Moser, E; Engl, E; Lamm, C				Majdandzic, Jasminka; Bauer, Herbert; Windischberger, Christian; Moser, Ewald; Engl, Elisabeth; Lamm, Claus			The Human Factor: Behavioral and Neural Correlates of Humanized Perception in Moral Decision Making	PLOS ONE			English	Article							PREFRONTAL CORTEX; PERSPECTIVE-TAKING; COGNITIVE CONTROL; PERSONAL/IMPERSONAL DISTINCTION; ORBITOFRONTAL CORTEX; NEGATIVE AFFECT; FUNCTIONAL MRI; EMPATHY; JUDGMENT; PAIN	The extent to which people regard others as full-blown individuals with mental states ("humanization'') seems crucial for their prosocial motivation towards them. Previous research has shown that decisions about moral dilemmas in which one person can be sacrificed to save multiple others do not consistently follow utilitarian principles. We hypothesized that this behavior can be explained by the potential victim's perceived humanness and an ensuing increase in vicarious emotions and emotional conflict during decision making. Using fMRI, we assessed neural activity underlying moral decisions that affected fictitious persons that had or had not been experimentally humanized. In implicit priming trials, participants either engaged in mentalizing about these persons (HUMANIZED condition) or not (NEUTRAL condition). In subsequent moral dilemmas, participants had to decide about sacrificing these persons' lives in order to save the lives of numerous others. Humanized persons were sacrificed less often, and the activation pattern during decisions about them indicated increased negative affect, emotional conflict, vicarious emotions, and behavioral control (pgACC/mOFC, anterior insula/IFG, aMCC and precuneus/PCC). Besides, we found enhanced effective connectivity between aMCC and anterior insula, which suggests increased emotion regulation during decisions affecting humanized victims. These findings highlight the importance of others' perceived humanness for prosocial behavior - with aversive affect and other-related concern when imagining harming more "human-like'' persons acting against purely utilitarian decisions.	[Majdandzic, Jasminka; Bauer, Herbert; Engl, Elisabeth; Lamm, Claus] Univ Vienna, Social Cognit & Affect Neurosci Unit, Fac Psychol, Vienna, Austria; [Majdandzic, Jasminka; Windischberger, Christian; Moser, Ewald] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria	University of Vienna; Medical University of Vienna	Majdandzic, J (corresponding author), Univ Vienna, Social Cognit & Affect Neurosci Unit, Fac Psychol, Vienna, Austria.	jasminka.majdandzic@univie.ac.at; claus.lamm@univie.ac.at	Moser, Ewald/B-3666-2013; Lamm, Claus/B-3357-2014	Moser, Ewald/0000-0001-8278-9583; Engl, Elisabeth/0000-0002-1400-7858; Lamm, Claus/0000-0002-5422-0653; Windischberger, Christian/0000-0002-9944-0190	Austrian Federal Ministry of Defence and Sports, Vienna, Austria	Austrian Federal Ministry of Defence and Sports, Vienna, Austria	This work was supported by a grant from the Austrian Federal Ministry of Defence and Sports, Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichhorn M, 2009, J COGNITIVE NEUROSCI, V21, P1179, DOI 10.1162/jocn.2009.21082; Allport G. W., 1954, NATURE PREJUDICE; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; BATSON CD, 1995, J PERS SOC PSYCHOL, V68, P1042, DOI 10.1037/0022-3514.68.6.1042; BATSON CD, 1987, J PERS, V55, P19, DOI 10.1111/j.1467-6494.1987.tb00426.x; Batson CD, 1997, PERS SOC PSYCHOL B, V23, P751, DOI 10.1177/0146167297237008; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chang LJ, 2008, ADV HEALTH ECON HEAL, V20, P31, DOI 10.1016/S0731-2199(08)20002-6; Cheetham M, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.029.2009; CIALDINI RB, 1987, J PERS SOC PSYCHOL, V52, P749, DOI 10.1037/0022-3514.52.4.749; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Cikara M, 2010, SOC COGN AFFECT NEUR, V5, P404, DOI 10.1093/scan/nsq011; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Decety J., 2005, OTHER MINDS HUMANS B, P143; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Farrow TFD, 2001, NEUROREPORT, V12, P2433, DOI 10.1097/00001756-200108080-00029; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Foot, 1967, OXFORD REV, V5, P5, DOI DOI 10.1093/0199252866.003.0002; Friston K. J., 1994, Human Brain Mapping, V2, P189, DOI 10.1002/hbm.460020402; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2009, J EXP SOC PSYCHOL, V45, P581, DOI 10.1016/j.jesp.2009.01.003; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Harcourt AH., 1992, COALITIONS ALLIANCES; Harenski CL, 2008, SOC COGN AFFECT NEUR, V3, P313, DOI 10.1093/scan/nsn026; Harenski CL, 2006, NEUROIMAGE, V30, P313, DOI 10.1016/j.neuroimage.2005.09.034; Harris LT, 2006, PSYCHOL SCI, V17, P847, DOI 10.1111/j.1467-9280.2006.01793.x; Haslam N, 2006, PERS SOC PSYCHOL REV, V10, P252, DOI 10.1207/s15327957pspr1003_4; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jahoda G., 1999, IMAGES SAVAGES ANCIE; Klein C, 2011, NEUROETHICS-NETH, V4, P143, DOI 10.1007/s12152-010-9077-1; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lamm C, 2008, CEREB CORTEX, V18, P2369, DOI 10.1093/cercor/bhn006; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lamm C, 2010, BRAIN STRUCT FUNCT, V214, P579, DOI 10.1007/s00429-010-0251-3; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Leyens JP, 2000, PERS SOC PSYCHOL REV, V4, P186, DOI 10.1207/S15327957PSPR0402_06; Maner JK, 2002, PERS SOC PSYCHOL B, V28, P1601, DOI 10.1177/014616702237586; McGuire J, 2009, J EXP SOC PSYCHOL, V45, P577, DOI 10.1016/j.jesp.2009.01.002; Mercadillo RE, 2011, BRAIN COGNITION, V76, P5, DOI 10.1016/j.bandc.2011.03.019; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Moll J, 2001, ARQ NEURO-PSIQUIAT, V59, P657, DOI 10.1590/S0004-282X2001000500001; Moore AB, 2008, PSYCHOL SCI, V19, P549, DOI 10.1111/j.1467-9280.2008.02122.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Robertson D, 2006, NEUROPSYCHOLOGIA; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shenhav A, 2010, NEURON, V67, P667, DOI 10.1016/j.neuron.2010.07.020; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sladky R, 2011, NEUROIMAGE, V58, P588, DOI 10.1016/j.neuroimage.2011.06.078; Thomson Judith J, 1976, Monist, V59, P204; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Ugazio G, 2012, EMOTION, V12, P579, DOI 10.1037/a0024611; Valentini E, 2010, J NEUROPHYSIOL, V104, P584, DOI 10.1152/jn.00487.2010; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Wager TD, 2004, AFFECT CONTROL FUNCT; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Waytz A, 2010, J PERS SOC PSYCHOL, V99, P410, DOI 10.1037/a0020240; Wrangham Richard, 1996, DEMONIC MALES APES O; Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104; Young L, 2009, J COGNITIVE NEUROSCI, V21, P1396, DOI 10.1162/jocn.2009.21137	92	30	30	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47698	10.1371/journal.pone.0047698	http://dx.doi.org/10.1371/journal.pone.0047698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082194	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900091
J	Marutani-Hert, M; Bowman, KD; McCollum, GT; Mirkov, TE; Evens, TJ; Niedz, RP				Marutani-Hert, Mizuri; Bowman, Kim D.; McCollum, Greg T.; Mirkov, T. Erik; Evens, Terence J.; Niedz, Randall P.			A Dark Incubation Period Is Important for Agrobacterium-Mediated Transformation of Mature Internode Explants of Sweet Orange, Grapefruit, Citron, and a Citrange Rootstock	PLOS ONE			English	Article							GENETIC-TRANSFORMATION; SHOOT REGENERATION; PLANT-REGENERATION; STEM SEGMENTS; SINENSIS; GROWTH; TUMEFACIENS; RESISTANCE; CULTURE; TISSUE	Background: Citrus has an extended juvenile phase and trees can take 2-20 years to transition to the adult reproductive phase and produce fruit. For citrus variety development this substantially prolongs the time before adult traits, such as fruit yield and quality, can be evaluated. Methods to transform tissue from mature citrus trees would shorten the evaluation period via the direct production of adult phase transgenic citrus trees. Methodology/Principal Findings: Factors important for promoting shoot regeneration from internode explants from adult phase citrus trees were identified and included a dark incubation period and the use of the cytokinin zeatin riboside. Transgenic trees were produced from four citrus types including sweet orange, citron, grapefruit, and a trifoliate hybrid using the identified factors and factor settings. Significance: The critical importance of a dark incubation period for shoot regeneration was established. These results confirm previous reports on the feasibility of transforming mature tissue from sweet orange and are the first to document the transformation of mature tissue from grapefruit, citron, and a trifoliate hybrid.	[Marutani-Hert, Mizuri; Bowman, Kim D.; McCollum, Greg T.; Evens, Terence J.; Niedz, Randall P.] ARS, US Hort Res Lab, USDA, Ft Pierce, FL USA; [Mirkov, T. Erik] Texas A&M Univ, Texas AgriLIFE Res, Dept Plant Pathol & Microbiol, Weslaco, TX USA	United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University Kingsville	Niedz, RP (corresponding author), ARS, US Hort Res Lab, USDA, Ft Pierce, FL USA.	randall.niedz@ars.usda.gov			Citrus Research and Development Foundation [144]	Citrus Research and Development Foundation	Research funded by the Citrus Research and Development Foundation (http://www.citrusrdf.org/blog/) under project #144 - Agrobacterium-mediated Genetic Transformation of Mature Citrus Tissue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida WAB, 2003, PLANT SCI, V164, P203, DOI 10.1016/S0168-9452(02)00401-6; Ananthakrishnan G, 2007, IN VITRO CELL DEV-PL, V43, P593, DOI 10.1007/s11627-007-9059-0; Bassan MM, 2011, PESQUI AGROPECU BRAS, V46, P672, DOI 10.1590/S0100-204X2011000600015; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bowman KD, 2006, HORTSCIENCE, V41, P832, DOI 10.21273/HORTSCI.41.3.832; Cervera M, 1998, TRANSGENIC RES, V7, P51, DOI 10.1023/A:1008855922283; Cervera M, 2008, TREE PHYSIOL, V28, P55, DOI 10.1093/treephys/28.1.55; Curtis IS, 2012, PLANT CELL TISS ORG, V108, P345, DOI 10.1007/s11240-011-0037-1; de Carvalho MHC, 2000, PLANT SCI, V159, P223, DOI 10.1016/S0168-9452(00)00346-0; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; DURANVILA N, 1992, PLANT CELL TISS ORG, V29, P11, DOI 10.1007/BF00036140; Dutt M, 2011, PLANT CELL TISS ORG, V107, P79, DOI 10.1007/s11240-011-9959-x; Enrique R, 2011, PLANT BIOTECHNOL J, V9, P394, DOI 10.1111/j.1467-7652.2010.00555.x; Franche C, 1997, PLANT J, V11, P897, DOI 10.1046/j.1365-313X.1997.11040897.x; Fu XZ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-55; Geekiyanage S, 2006, PLANT BIOTECHNOL, V23, P431, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.23.431; Ghorbel R, 2001, PHYSIOL MOL PLANT P, V58, P103, DOI 10.1006/pmpp.2000.0318; He YR, 2011, SCI HORTIC-AMSTERDAM, V128, P99, DOI 10.1016/j.scienta.2011.01.002; HIDAKA T, 1990, JPN J BREED, V40, P199; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; JEFFERSON RA, 1987, EMBO J, V6, P3901; KANEYOSHI J, 1994, PLANT CELL REP, V13, P541, DOI 10.1007/BF00234507; Khawale RN, 2006, CURR SCI INDIA, V91, P1700; Kobayashi AK, 2003, PLANT CELL TISS ORG, V74, P99, DOI 10.1023/A:1023375526781; Loeza-Kuk E, 2011, AGROCIENCIA-MEXICO, V45, P55; Marutani-Hert M, 2011, PLANT CELL TISS ORG, V106, P81, DOI 10.1007/s11240-010-9896-0; Molinari HBC, 2004, SCI HORTIC-AMSTERDAM, V99, P379, DOI 10.1016/S0304-4238(03)00111-0; MOORE GA, 1992, PLANT CELL REP, V11, P238, DOI 10.1007/BF00235073; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Naik SK, 2003, J PLANT PHYSIOL, V160, P423, DOI 10.1078/0176-1617-00949; Niedz RP, 2011, IN VITRO CELL DEV-PL, V47, P682, DOI 10.1007/s11627-011-9381-4; de Oliveira MLP, 2010, PESQUI AGROPECU BRAS, V45, P654, DOI 10.1590/S0100-204X2010000700004; Pena L, 1997, PLANT CELL REP, V16, P731, DOI 10.1007/s002990050311; PENA L, 1995, PLANT SCI, V104, P183, DOI 10.1016/0168-9452(94)04021-8; Perez-Tornero O, 2010, PLANT CELL TISS ORG, V100, P263, DOI 10.1007/s11240-009-9643-6; Rodriguez A, 2008, PLANT CELL TISS ORG, V93, P97, DOI 10.1007/s11240-008-9347-3; Saini HK, 2010, INDIAN J BIOTECHNOL, V9, P419; Uliaie E D, 2008, Pak J Biol Sci, V11, P2040, DOI 10.3923/pjbs.2008.2040.2043; United States Department of Agriculture, 2010, NOT FRUIT GROW NURS; VANCANNEYT G, 1990, MOL GEN GENET, V220, P245, DOI 10.1007/BF00260489; Xu SX, 2011, PLANT CELL TISS ORG, V104, P199, DOI 10.1007/s11240-010-9819-0; Yang L, 2011, PLANT MOL BIOL, V75, P11, DOI 10.1007/s11103-010-9699-z; Yang ZN, 2000, PLANT CELL REP, V19, P1203, DOI 10.1007/s002990000257	45	20	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47426	10.1371/journal.pone.0047426	http://dx.doi.org/10.1371/journal.pone.0047426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082165	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900061
J	Mccoy, MW; Touchon, JC; Landberg, T; Warkentin, KM; Vonesh, JR				McCoy, Michael W.; Touchon, Justin C.; Landberg, Tobias; Warkentin, Karen M.; Vonesh, James R.			Prey Responses to Predator Chemical Cues: Disentangling the Importance of the Number and Biomass of Prey Consumed	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; PHENOTYPIC PLASTICITY; CONSPECIFIC DENSITY; TEMPORAL VARIATION; DOSAGE RESPONSE; OPPOSITE SHIFTS; INDUCED DEFENSE; ALARM CUES; RISK; SIZE	To effectively balance investment in predator defenses versus other traits, organisms must accurately assess predation risk. Chemical cues caused by predation events are indicators of risk for prey in a wide variety of systems, but the relationship between how prey perceive risk in relation to the amount of prey consumed by predators is poorly understood. While per capita predation rate is often used as the metric of relative risk, studies aimed at quantifying predator-induced defenses commonly control biomass of prey consumed as the metric of risk. However, biomass consumed can change by altering either the number or size of prey consumed. In this study we determine whether phenotypic plasticity to predator chemical cues depends upon prey biomass consumed, prey number consumed, or both. We examine the growth response of red-eyed treefrog tadpoles (Agalychnis callidryas) to cues from a larval dragonfly (Anax amazili). Biomass consumed was manipulated by either increasing the number of prey while holding individual prey size constant, or by holding the number of prey constant and varying individual prey size. We address two questions. (i) Do prey reduce growth rate in response to chemical cues in a dose dependent manner? (ii) Does the magnitude of the response depend on whether prey consumption increases via number or size of prey? We find that the phenotypic response of prey is an asymptotic function of prey biomass consumed. However, the asymptotic response is higher when more prey are consumed. Our findings have important implications for evaluating past studies and how future experiments should be designed. A stronger response to predation cues generated by more individual prey deaths is consistent with models that predict prey sensitivity to per capita risk, providing a more direct link between empirical and theoretical studies which are often focused on changes in population sizes not individual biomass.	[McCoy, Michael W.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [McCoy, Michael W.; Vonesh, James R.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Touchon, Justin C.; Warkentin, Karen M.] Smithsonian Trop Res Inst, Balboa, Panama; [Touchon, Justin C.; Landberg, Tobias; Warkentin, Karen M.] Boston Univ, Dept Biol, Boston, MA 02215 USA	University of North Carolina; East Carolina University; Virginia Commonwealth University; Smithsonian Institution; Smithsonian Tropical Research Institute; Boston University	Mccoy, MW (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	mccoym@ecu.edu	; Vonesh, James/I-1573-2013	McCoy, Michael/0000-0002-7993-6236; Vonesh, James/0000-0003-2481-9988; Warkentin, Karen/0000-0002-7804-800X	U.S. National Science Foundation [DEB-0717220, DEB-0716923]; Office Of Internatl Science &Engineering [1064566] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the U.S. National Science Foundation (DEB-0717220 to JRV and DEB-0716923 to KMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Abrams Peter A., 1996, P371; Altwegg R, 2003, EVOLUTION, V57, P872; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; Bolker B, 2003, ECOLOGY, V84, P1101, DOI 10.1890/0012-9658(2003)084[1101:CTAESO]2.0.CO;2; Bolker B., 2012, BBMLE TOOLS GEN MAXI; Brown GE, 1997, ENVIRON BIOL FISH, V49, P89, DOI 10.1023/A:1007302614292; Brown J., 2000, SCALING BIOL; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Dicke M, 2001, ANNU REV ECOL SYST, V32, P1, DOI 10.1146/annurev.ecolsys.32.081501.113951; Fraker ME, 2009, HORM BEHAV, V55, P520, DOI 10.1016/j.yhbeh.2009.01.007; Iyengar EV, 2002, MAR ECOL PROG SER, V225, P205, DOI 10.3354/meps225205; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Laurila A, 1997, BEHAV ECOL SOCIOBIOL, V40, P329, DOI 10.1007/s002650050349; Laurila A, 2004, OIKOS, V107, P90, DOI 10.1111/j.0030-1299.2004.13126.x; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1998, ADV STUD BEHAV, V27, P215; Mccoy MW, 2008, J ANIM ECOL, V77, P478, DOI 10.1111/j.1365-2656.2008.01372.x; Mccoy MW, 2007, OECOLOGIA, V153, P871, DOI 10.1007/s00442-007-0795-y; McCoy MW, 2011, AM NAT, V177, P752, DOI 10.1086/659950; MITTELBACH GG, 1981, ECOLOGY, V62, P1370, DOI 10.2307/1937300; Orrock JL, 2004, BEHAV ECOL, V15, P433, DOI 10.1093/beheco/arh031; Pangle KL, 2006, FRESHWATER BIOL, V51, P1070, DOI 10.1111/j.1365-2427.2006.01555.x; Peacor SD, 2004, ISR J ZOOL, V50, P139, DOI 10.1560/KPRR-X1C3-5NHE-QV2N; Peacor SD, 2003, OIKOS, V100, P409, DOI 10.1034/j.1600-0706.2003.12043.x; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; R Development Core Team, 2006, R LANG ENV STAT COMP; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Relyea RA, 2003, ECOLOGY, V84, P1827, DOI 10.1890/0012-9658(2003)084[1827:HPRTCP]2.0.CO;2; Relyea RA, 2003, ECOLOGY, V84, P1840, DOI 10.1890/0012-9658(2003)084[1840:PCAPGT]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P541, DOI 10.1890/0012-9658(2001)082[0541:TRBPRA]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; RIESSEN HP, 1992, AM NAT, V140, P349, DOI 10.1086/285416; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schmidt KA, 2006, OIKOS, V113, P82; Schoeppner NM, 2009, FUNCT ECOL, V23, P1114, DOI 10.1111/j.1365-2435.2009.01578.x; Schoeppner NM, 2005, ECOL LETT, V8, P505, DOI 10.1111/j.1461-0248.2005.00744.x; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; Storm JJ, 2008, CAN J ZOOL, V86, P1259, DOI 10.1139/Z08-114; Teplitsky C, 2005, OECOLOGIA, V145, P364, DOI 10.1007/s00442-005-0132-2; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Touchon JC, 2008, OIKOS, V117, P634, DOI 10.1111/j.0030-1299.2008.16354.x; Touchon JC, ECOLOGY IN PRESS; Turner AM, 2004, OIKOS, V104, P561, DOI 10.1111/j.0030-1299.2004.12615.x; Van Buskirk J, 2002, ECOLOGY, V83, P1580, DOI 10.2307/3071977; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Vonesh JR, 2006, ECOLOGY, V87, P556, DOI 10.1890/05-0930; Warkentin Karen M., 2009, P177; Warkentin KM, 2005, ANIM BEHAV, V70, P59, DOI 10.1016/j.anbehav.2004.09.019; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Wiackowski K, 1999, FUNCT ECOL, V13, P59, DOI 10.1046/j.1365-2435.1999.00282.x	54	32	32	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47495	10.1371/journal.pone.0047495	http://dx.doi.org/10.1371/journal.pone.0047495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082171	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900067
J	Rueegg, CS; Michel, G; Wengenroth, L; von der Weid, NX; Bergstraesser, E; Kuehni, CE				Rueegg, Corina S.; Michel, Gisela; Wengenroth, Laura; von der Weid, Nicolas X.; Bergstraesser, Eva; Kuehni, Claudia E.		SPOG	Physical Performance Limitations in Adolescent and Adult Survivors of Childhood Cancer and Their Siblings	PLOS ONE			English	Article							QUALITY-OF-LIFE; LONG-TERM SURVIVORS; HEMATOPOIETIC GROWTH-FACTORS; RANDOMIZED CONTROLLED-TRIAL; COST-EFFECTIVENESS; HEALTH-STATUS; EXERCISE; FITNESS; DESIGN; RETINOBLASTOMA	Purpose: This study investigates physical performance limitations for sports and daily activities in recently diagnosed childhood cancer survivors and siblings. Methods: The Swiss Childhood Cancer Survivor Study sent a questionnaire to all survivors (>= 16 years) registered in the Swiss Childhood Cancer Registry, who survived >5 years and were diagnosed 1976-2003 aged <16 years. Siblings received similar questionnaires. We assessed two types of physical performance limitations: 1) limitations in sports; 2) limitations in daily activities (using SF-36 physical function score). We compared results between survivors diagnosed before and after 1990 and determined predictors for both types of limitations by multivariable logistic regression. Results: The sample included 1038 survivors and 534 siblings. Overall, 96 survivors (9.5%) and 7 siblings (1.1%) reported a limitation in sports (Odds ratio 5.5, 95% CI 2.9-10.4, p<0.001), mainly caused by musculoskeletal and neurological problems. Findings were even more pronounced for children diagnosed more recently (OR 4.8, CI 2.4-9.6 and 8.3, CI 3.7-18.8 for those diagnosed <1990 and >= 1990, respectively; p = 0.025). Mean physical function score for limitations in daily activities was 49.6 (CI 48.9-50.4) in survivors and 53.1 (CI 52.5-53.7) in siblings (p<0.001). Again, differences tended to be larger in children diagnosed more recently. Survivors of bone tumors, CNS tumors and retinoblastoma and children treated with radiotherapy were most strongly affected. Conclusion: Survivors of childhood cancer, even those diagnosed recently and treated with modern protocols, remain at high risk for physical performance limitations. Treatment and follow-up care should include tailored interventions to mitigate these late effects in high-risk patients.	[Rueegg, Corina S.; Michel, Gisela; Wengenroth, Laura; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland; [von der Weid, Nicolas X.] CHU Vaudois, Paediat Hematol Oncol Unit, Lausanne, Switzerland; [Bergstraesser, Eva] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland	University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University Children's Hospital Zurich	Kuehni, CE (corresponding author), Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland.	kuehni@ispm.unibe.ch	Rueegg, Corina Silvia/H-7128-2019; Michel, Gisela/G-1081-2018	Rueegg, Corina Silvia/0000-0003-3720-4659; Michel, Gisela/0000-0002-9589-0928; Kuehni, Claudia E./0000-0001-8957-2002; Bergstrasser, Eva/0000-0002-0340-1868; Leibundgut, Kurt/0000-0003-2514-6041	Cancer League Zurich; Swiss Bridge; Stiftung zur Krebsbekaempfung; Swiss National Science Foundation [PZ00P3_121682/1, PZ00P3_141722, 3233-069348]; Swiss Paediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur krebskranke Kinder Regio Basiliensis; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Novartis Oncology Switzerland; Interpharma; Axa Wintherthur; Glaxo Smithkline; Amgen; Bristol Myers Squibb; Swiss Cancer League [KLS-01605-10-2004, KLS-2215-02-2008, KLS-02783-02-2011]; Cancer League Aargau	Cancer League Zurich; Swiss Bridge; Stiftung zur Krebsbekaempfung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Paediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur krebskranke Kinder Regio Basiliensis; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Novartis Oncology Switzerland; Interpharma; Axa Wintherthur; Glaxo Smithkline(GlaxoSmithKline); Amgen(Amgen); Bristol Myers Squibb(Bristol-Myers Squibb); Swiss Cancer League; Cancer League Aargau	This study was supported by the Swiss Cancer League (Grant No KLS-01605-10-2004, KLS-2215-02-2008, KLS-02783-02-2011; www.krebsliga.ch), Cancer League Aargau (www.krebsliga-aargau.ch), Cancer League Zurich (www.krebsliga-zh.ch), Swiss Bridge (www.swissbridge.ch) and Stiftung zur Krebsbekaempfung (www.krebsbekaempfung.ch). GM and CEK were funded by the Swiss National Science Foundation (GM: Ambizione Fellowship grant PZ00P3_121682/1 and PZ00P3_141722; CEK:PROSPER grant 3233-069348; www.snf.ch). The work of the Swiss Childhood Cancer Registry is supported by the Swiss Paediatric Oncology Group (www.spog.ch), Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch), Stiftung fur krebskranke Kinder Regio Basiliensis (www.krebskrankekinder.ch), Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren (GDK; www.gdk-cds.ch), Novartis Oncology Switzerland (www.novartisoncology.ch), Interpharma (www.interpharma.ch), Axa Wintherthur (www.axa-winterthur.ch), Glaxo Smithkline (www.glaxosmithkline.ch), Amgen (www.amgen.ch) and Bristol Myers Squibb (www.bms.ch). The funders of the Swiss Childhood Cancer Registry support the daily running of the registry and have no role in the scientific projects. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JA, 2007, CURR OPIN PEDIATR, V19, P23, DOI 10.1097/MOP.0b013e328013c89e; Badr H, 2011, J AM DIET ASSOC, V111, P1917, DOI 10.1016/j.jada.2011.09.004; Bekkering WP, 2012, PEDIATR BLOOD CANCER, V58, P978, DOI 10.1002/pbc.23328; Braam KI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-624; Drabko K, 2012, BONE MARROW TRANSPLA; Ellert U, 1999, Gesundheitswesen, V61 Spec No, pS184; Gatta G, 2009, EUR J CANCER, V45, P992, DOI 10.1016/j.ejca.2008.11.042; Germann U, 2005, EIDGENOSSISCHE VOLKS; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; Heuser M, 2011, CANCER TREAT RES, V157, P339, DOI 10.1007/978-1-4419-7073-2_19; Huang TT, 2011, INT J PEDIAT, V2011, DOI 10.1155/2011/461512; Hudson MM, 2003, JAMA-J AM MED ASSOC, V290, P1583, DOI 10.1001/jama.290.12.1583; Jarvela LS, 2012, PEDIATR BLOOD CANCER, V59, P155, DOI 10.1002/pbc.24049; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaneko A, 2003, JPN J CLIN ONCOL, V33, P601, DOI 10.1093/jjco/hyg113; Kelly AKW, 2011, CURR SPORT MED REP, V10, P352, DOI 10.1249/JSR.0b013e318237be40; Kuehni CE, 2011, INT J EPIDEMIOL, DOI [10.1093/ije/dyr1142, DOI 10.1093/IJE/DYR1142]; Kuehni CE, 2012, CANCER-AM CANCER SOC, V118, P1439, DOI 10.1002/cncr.26418; Kunin-Batson A, 2011, PEDIATR BLOOD CANCER, V57, P1197, DOI 10.1002/pbc.22982; Liebherr R, 2010, NEUCHATEL BUNDESAMT; Meadows AT, 2006, J CLIN ONCOL, V24, P5160, DOI 10.1200/JCO.2006.07.3114; Michel G, 2007, SWISS MED WKLY, V137, P502; Moyer-Mileur LJ, 2009, J PEDIAT HEMATOL ONC, V31, P259, DOI 10.1097/MPH.0b013e3181978fd4; Nagarajan R, 2004, BRIT J CANCER, V91, P1858, DOI 10.1038/sj.bjc.6602220; Ness KK, 2008, ARCH PHYS MED REHAB, V89, P128, DOI 10.1016/j.apmr.2007.08.123; Ness KK, 2010, CANCER-AM CANCER SOC, V116, P3034, DOI 10.1002/cncr.25051; Ness KK, 2009, J CLIN ONCOL, V27, P2382, DOI 10.1200/JCO.2008.21.1482; Ness KK, 2005, ANN INTERN MED, V143, P639, DOI 10.7326/0003-4819-143-9-200511010-00007; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Puhalla S, 2012, MOL ONCOL, V6, P237, DOI 10.1016/j.molonc.2012.03.001; Reulen RC, 2007, INT J CANCER, V121, P633, DOI 10.1002/ijc.22658; Reulen RC, 2006, HEALTH QUAL LIFE OUT, P4; Robert RS, 2010, PEDIATR BLOOD CANCER, V54, P990, DOI 10.1002/pbc.22419; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Rueegg CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034930; Juan AFS, 2011, RECENT RESULTS CANC, V186, P319, DOI 10.1007/978-3-642-04231-7_14; Sheppard L, 2005, CHILD CARE HLTH DEV, V31, P137, DOI 10.1111/j.1365-2214.2005.00498.x; Shields CL, 2010, CURR OPIN OPHTHALMOL, V21, P203, DOI 10.1097/ICU.0b013e328338676a; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Szymlek-Gay EA, 2011, NEW ZEAL MED J, V124, P77; van Waart H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-673; Velthuis MJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-272; von Hoff K, 2012, CURR TREAT OPTION NE, V14, P416, DOI 10.1007/s11940-012-0183-8; Ware J, 2000, SCORE VERSION 2 SF36; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Winter C, 2010, PEDIATR BLOOD CANCER, V54, P501, DOI 10.1002/pbc.22271; Zeltzer LK, 2008, CANCER EPIDEM BIOMAR, V17, P435, DOI 10.1158/1055-9965.EPI-07-2541	47	38	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47944	10.1371/journal.pone.0047944	http://dx.doi.org/10.1371/journal.pone.0047944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082232	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000311146900129
J	Tabarean, IV				Tabarean, Iustin V.			Persistent Histamine Excitation of Glutamatergic Preoptic Neurons	PLOS ONE			English	Article							CENTRAL NEURAL PATHWAYS; OPERATED CALCIUM-ENTRY; CATION CHANNEL; TRPC CHANNELS; FLUFENAMIC ACID; NERVOUS-SYSTEM; CA2+ RELEASE; RAT-BRAIN; RECEPTOR; ACTIVATION	Thermoregulatory neurons of the median preoptic nucleus (MnPO) represent a target at which histamine modulates body temperature. The mechanism by which histamine excites a population of MnPO neurons is not known. In this study it was found that histamine activated a cationic inward current and increased the intracellular Ca2+ concentration, actions that had a transient component as well as a sustained one that lasted for tens of minutes after removal of the agonist. The sustained component was blocked by TRPC channel blockers. Single-cell reverse transcription-PCR analysis revealed expression of TRPC1, TRPC5 and TRPC7 subunits in neurons excited by histamine. These studies also established the presence of transcripts for the glutamatergic marker Vglut2 and for the H1 histamine receptor in neurons excited by histamine. Intracellular application of antibodies directed against cytoplasmic sites of the TRPC1 or TRPC5 channel subunits decreased the histamine-induced inward current. The persistent inward current and elevation in intracellular Ca2+ concentration could be reversed by activating the PKA pathway. This data reveal a novel mechanism by which histamine induces persistent excitation and sustained intracellular Ca2+ elevation in glutamatergic MnPO neurons.	Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA	Scripps Research Institute	Tabarean, IV (corresponding author), Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA.	tabarean@scripps.edu			National Institutes of Health [NS060799]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS060799 (IVT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert AP, 2006, J PHYSIOL-LONDON, V571, P361, DOI 10.1113/jphysiol.2005.102780; Ariano P, 2011, CELL CALCIUM, V49, P387, DOI 10.1016/j.ceca.2011.03.007; Ben-Mabrouk F, 2010, EUR J NEUROSCI, V31, P1219, DOI 10.1111/j.1460-9568.2010.07156.x; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Chen S, 2011, CELL CALCIUM, V50, P523, DOI 10.1016/j.ceca.2011.08.008; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; COLBOC O, 1982, NEUROPHARMACOLOGY, V21, P45, DOI 10.1016/0028-3908(82)90209-X; Cui NR, 2011, J NEUROPHYSIOL, V105, P2791, DOI 10.1152/jn.00759.2010; Cvetkovic-Lopes V, 2011, PLOS ONE, V5; Dimitrov E., 2011, J NEUROSCI, V518, P4375; DISMUKES K, 1974, BRAIN RES, V78, P467, DOI 10.1016/0006-8993(74)90929-9; Foster RR, 2009, CELL CALCIUM, V45, P384, DOI 10.1016/j.ceca.2009.01.003; Gorelova N, 1996, J NEUROPHYSIOL, V75, P707, DOI 10.1152/jn.1996.75.2.707; GREEN MD, 1976, NEUROPHARMACOLOGY, V15, P321, DOI 10.1016/0028-3908(76)90136-2; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Harper MT, 2011, CELL CALCIUM, V50, P351, DOI 10.1016/j.ceca.2011.06.005; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; Hill K, 2004, NEUROPHARMACOLOGY, V47, P450, DOI 10.1016/j.neuropharm.2004.04.014; Horinouchi T, 2012, J PHARMACOL EXP THER, V340, P143, DOI 10.1124/jpet.111.187500; HOUGH LB, 1984, BRAIN RES, V291, P103, DOI 10.1016/0006-8993(84)90655-3; Ishikawa J, 2003, J IMMUNOL, V170, P4441, DOI 10.4049/jimmunol.170.9.4441; Ju M, 2010, J PHYSIOL-LONDON, V588, P1419, DOI 10.1113/jphysiol.2009.185256; Kim EY, 2012, AM J PHYSIOL-RENAL, V302, pF298, DOI 10.1152/ajprenal.00423.2011; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kinoshita H, 2010, CIRC RES, V106, P1849, DOI 10.1161/CIRCRESAHA.109.208314; Lundius EG, 2010, J NEUROSCI, V30, P4369, DOI 10.1523/JNEUROSCI.0378-10.2010; Malarkey EB, 2008, GLIA, V56, P821, DOI 10.1002/glia.20656; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; MCCORMICK DA, 1991, J NEUROSCI, V11, P3188; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Morrison SF, 2011, J APPL PHYSIOL, V110, P1137, DOI 10.1152/japplphysiol.01227.2010; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; MUNAKATA M, 1994, J PHYSIOL-LONDON, V480, P233, DOI 10.1113/jphysiol.1994.sp020356; NORIS G, 1995, ENDOCRINOLOGY, V136, P2967, DOI 10.1210/en.136.7.2967; Olah T, 2011, CELL CALCIUM, V49, P415, DOI 10.1016/j.ceca.2011.03.012; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PORONNIK P, 1992, FEBS LETT, V296, P245, DOI 10.1016/0014-5793(92)80296-S; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; REINER PB, 1994, NEUROSCIENCE, V59, P579, DOI 10.1016/0306-4522(94)90178-3; Riccio A, 2002, J BIOL CHEM, V277, P12302, DOI 10.1074/jbc.M112313200; Saada R, 2009, CURR BIOL, V19, P479, DOI 10.1016/j.cub.2009.01.060; Sergeeva OA, 2003, J NEUROCHEM, V85, P1547, DOI 10.1046/j.1471-4159.2003.01806.x; Sethi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029134; Smith BN, 1996, J PHYSIOL-LONDON, V495, P465, DOI 10.1113/jphysiol.1996.sp021607; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sung TS, 2011, AM J PHYSIOL-CELL PH, V301, pC823, DOI 10.1152/ajpcell.00351.2010; Tabarean IV, 2012, NEUROPHARMA IN PRESS; Tupone D, 2011, J NEUROSCI, V31, P15944, DOI 10.1523/JNEUROSCI.3909-11.2011; WADA H, 1992, FOLIA PHARMACOL JPN, V99, P63, DOI 10.1254/fpj.99.63; Whyment AD, 2006, J NEUROPHYSIOL, V95, P2492, DOI 10.1152/jn.01135.2004; Williams KW, 2011, J NEUROSCI, V31, P13147, DOI 10.1523/JNEUROSCI.2602-11.2011; Zhou FW, 2008, J NEUROSCI, V28, P473, DOI 10.1523/JNEUROSCI.3978-07.2008; Zhou FW, 2006, J NEUROPHYSIOL, V96, P1581, DOI 10.1152/jn.00148.2006; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	57	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47700	10.1371/journal.pone.0047700	http://dx.doi.org/10.1371/journal.pone.0047700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082195	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900092
J	Rohacek, M; Szucs-Farkas, Z; Pfortmuller, CA; Zimmermann, H; Exadaktylos, A				Rohacek, Martin; Szucs-Farkas, Zsolt; Pfortmueller, Carmen A.; Zimmermann, Heinz; Exadaktylos, Aristomenis			Acute Cardiac Disorder or Pneumonia and Concomitant Presence of Pulmonary Embolism	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; D-DIMER; RISK; PROBABILITY; ANGIOGRAPHY; OUTCOMES	Purpose: To determine the frequency of apparent acute pulmonary embolism (PE) and of concomitant disease in computed tomography pulmonary angiography (CTPA); to compare the frequency of PE in patients with pneumonia or acute cardiac disorder (acute coronary syndrome, tachyarrhythmia, acute left ventricular heart failure or cardiogenic shock), with the frequency of PE in patients with none of these alternative chest pathologies (comparison group). Methods: Retrospective analysis of all patients who received a CTPA at the emergency department (ED) within a period of four years and 5 months. Results: Of 1275 patients with CTPA, 28 (2.2%) had PE and concomitant radiologic evidence of another chest disease; 3 more (0.2%) had PE and an acute cardiac disorder without radiological evidence of heart failure. PE was found in 11 of 113 patients (10%) with pneumonia, in 5 of 154 patients (3.3%) with an acute cardiac disorder and in 186 of 1008 patients (18%) in the comparison group. After adjustment for risk factors for thromboembolism and for other relevant patient's characteristics, the proportion of CTPAs with evidence of PE in patients with an acute cardiac disorder or pneumonia was significantly lower than in the comparison group (OR 0.13, 95% CI 0.05-0.33, p < 0.001 for patients with an acute cardiac disorder, and OR 0.45, 95% CI 0.23-0.89, p = 0.021 for patients with pneumonia). Conclusion: The frequency of PE and a concomitant disease that can mimic PE was low. The presence of an acute cardiac disorder or pneumonia was associated with decreased odds of PE.	[Rohacek, Martin; Zimmermann, Heinz; Exadaktylos, Aristomenis] Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland; [Szucs-Farkas, Zsolt] Univ Hosp Bern, Inselspital, Dept Diagnost Intervent & Pediat Radiol, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.] Univ Hosp Bern, Inselspital, Dept Internal Med, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Rohacek, M (corresponding author), Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland.	martin.rohacek@gmail.com		Pfortmueller, Carmen/0000-0003-0326-2770				Beemath A, 2006, AM J CARDIOL, V98, P793, DOI 10.1016/j.amjcard.2006.03.064; Carrier M, 2009, THROMB HAEMOSTASIS, V101, P886, DOI 10.1160/TH-08-10-0689; Clayton TC, 2011, INT J EPIDEMIOL, V40, P819, DOI 10.1093/ije/dyr012; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Kelly J, 2002, ARCH INTERN MED, V162, P747, DOI 10.1001/archinte.162.7.747; Klok FA, 2008, ARCH INTERN MED, V168, P2131, DOI 10.1001/archinte.168.19.2131; Matos MF, 2011, THROMB RES, V128, P216, DOI 10.1016/j.thromres.2011.04.016; Miniati M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030891; Moores LK, 2004, ANN INTERN MED, V141, P866, DOI 10.7326/0003-4819-141-11-200412070-00011; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Rohacek M, 2012, INTENS CARE MED, V38, P1345, DOI 10.1007/s00134-012-2595-z; Schmidt M, 2012, J INTERN MED, V271, P608, DOI 10.1111/j.1365-2796.2011.02473.x; Spencer FA, 2006, J GEN INTERN MED, V21, P722, DOI 10.1111/j.1525-1497.2006.00458.x; van Beek EJR, 2001, CLIN RADIOL, V56, P838, DOI 10.1053/crad.2001.0778; Venkatesh AK, 2012, ARCH INTERN MED, P1; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Zoller B, 2012, LANCET, V379, P244, DOI 10.1016/S0140-6736(11)61306-8	18	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47418	10.1371/journal.pone.0047418	http://dx.doi.org/10.1371/journal.pone.0047418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091623	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800046
J	Sikand, K; Singh, J; Ebron, JS; Shukla, GC				Sikand, Kavleen; Singh, Jagjit; Ebron, Jey Sabith; Shukla, Girish C.			Housekeeping Gene Selection Advisory: Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and beta-Actin Are Targets of miR-644a	PLOS ONE			English	Article							URACIL DNA-GLYCOSYLASE; MESSENGER-RNA LEVELS; CELL-LINES; REAL-TIME; ALZHEIMERS-DISEASE; BREAST-CANCER; RT-PCR; EXPRESSION; MICRORNAS; PROTEIN	Results of overexpression or downregulation of a microRNA (miRNA) on its target mRNA expression are often validated by reverse-transcription and quantitative PCR analysis using an appropriate housekeeping gene as an internal control. The possible direct or indirect effects of a miRNA on the expression of housekeeping genes are often overlooked. Among many housekeeping genes, expressions of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and beta-actin have been used extensively for normalization of gene expression data. Here, we show that GAPDH and beta-actin are direct targets of miR-644a. Our data demonstrate the unsuitability of GAPDH and beta-actin as internal controls in miR-644a functional studies and emphasize the need to carefully consider the choice of a reference gene in miRNA experiments.	[Sikand, Kavleen; Singh, Jagjit; Ebron, Jey Sabith; Shukla, Girish C.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Shukla, Girish C.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Shukla, GC (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA.	g.shukla@csuohio.edu		Ebron, Jey Sabith/0000-0002-5820-4175; Sikand, Kavleen/0000-0003-0170-2613; Shukla, Girish/0000-0003-1982-2218	National Science Foundation (NSF) [0842606]; DoD Prostate Cancer Research Program; DoD-USAMRAA [W81XWH-11-1-0204]	National Science Foundation (NSF)(National Science Foundation (NSF)); DoD Prostate Cancer Research Program; DoD-USAMRAA(United States Department of Defense)	Research in GCS laboratory is supported by grants from National Science Foundation (NSF) and DoD Prostate Cancer Research Program. JS was supported by NSF grant 0842606 and JSE was supported by DoD-USAMRAA grant W81XWH-11-1-0204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Barroso I, 1999, EUR J ENDOCRINOL, V141, P169, DOI 10.1530/eje.0.1410169; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; BAXI MD, 1995, BIOCHEMISTRY-US, V34, P9700, DOI 10.1021/bi00030a007; BLOMBERG J, 1987, BRIT J HAEMATOL, V65, P83, DOI 10.1111/j.1365-2141.1987.tb06139.x; Cheng C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-431; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Corbin IR, 2002, CELL PROLIFERAT, V35, P173; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; DESPREZ PY, 1992, CANCER LETT, V64, P219, DOI 10.1016/0304-3835(92)90046-X; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Ferreira E, 2012, MOL BIOTECHNOL, V50, P121, DOI 10.1007/s12033-011-9425-3; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; Gutala RV, 2004, J NEUROSCI METH, V132, P101, DOI 10.1016/j.jneumeth.2003.09.005; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; HUITOREL P, 1985, EUR J BIOCHEM, V150, P265, DOI 10.1111/j.1432-1033.1985.tb09016.x; Ishitani R, 1996, P NATL ACAD SCI USA, V93, P9937, DOI 10.1073/pnas.93.18.9937; JABBOUR W, 1992, J NEUROIMMUNOL, V38, P199, DOI 10.1016/0165-5728(92)90013-B; Le PU, 1998, CANCER RES, V58, P1631; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lupberger J, 2002, MOL CELL PROBE, V16, P25, DOI 10.1006/mcpr.2001.0392; MATRISIAN LM, 1985, NUCLEIC ACIDS RES, V13, P711, DOI 10.1093/nar/13.3.711; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; MORGENEGG G, 1986, J NEUROCHEM, V47, P54; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Nowak D, 2005, ACTA BIOCHIM POL, V52, P461; Ostling P, 2011, CANCER RES, V71, P1956, DOI 10.1158/0008-5472.CAN-10-2421; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; ROBBINS AR, 1995, J CELL BIOL, V130, P1093, DOI 10.1083/jcb.130.5.1093; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; SCHEK N, 1988, CANCER RES, V48, P6354; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Sikand K, 2011, INT J CANCER, V129, P810, DOI 10.1002/ijc.25753; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Thorrez L, 2011, GENOME RES, V21, P95, DOI 10.1101/gr.109173.110; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; Valenti MT, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-49; Xu YZ, 2010, MOL BIOL CELL, V21, P811, DOI 10.1091/mbc.E09-06-0534; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	46	56	60	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47510	10.1371/journal.pone.0047510	http://dx.doi.org/10.1371/journal.pone.0047510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091630	Green Submitted, gold, Green Published			2022-12-27	WOS:000310135800053
J	Combes, A; Ndoye, I; Bance, C; Bruzaud, J; Djediat, C; Dupont, J; Nay, B; Prado, S				Combes, Audrey; Ndoye, Idrissa; Bance, Caroline; Bruzaud, Jerome; Djediat, Chakib; Dupont, Joelle; Nay, Bastien; Prado, Soizic			Chemical Communication between the Endophytic Fungus Paraconiothyrium Variabile and the Phytopathogen Fusarium oxysporum	PLOS ONE			English	Article							MASS-SPECTROMETRY; BIOSYNTHESIS; OXYLIPINS; TETRALONE; WOOD	Paraconiothyrium variabile, one of the specific endophytic fungi isolated from the host plant Cephalotaxus harringtonia, possesses the faculty to inhibit the growth of common phytopathogens, thus suggesting a role in its host protection. A strong antagonism between the endophyte P. variabile and Fusarium oxysporum was observed and studied using optic and electronic microscopies. A disorganization of the mycelium of F. oxysporum was thus noticed. Interestingly, the biological effect of the main secondary metabolites isolated from P. variabile against F. oxysporum did not account for this strong antagonism. However, a metabolomic approach of pure fungal strains and confrontation zones using the data analysis tool XCMS were analyzed and pointed out a competition-induced metabolite production by the endophyte in the presence of the phytopathogen. Subsequent MS/MS fragmentations permitted to identify one of the induced metabolites as 13-oxo-9,11-octadecadienoic acid and highlighted a negative modulation of the biosynthesis of beauvericin, one of the most potent mycotoxin of F. oxysporum, during the competition with the endophyte.	[Combes, Audrey; Ndoye, Idrissa; Bance, Caroline; Bruzaud, Jerome; Nay, Bastien; Prado, Soizic] Museum Natl Hist Nat, MCAM, MNHN CNRS, UMR 7245, F-75231 Paris, France; [Dupont, Joelle] Museum Natl Hist Nat, OSEB, MNHN CNRS, UMR 7205, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Prado, S (corresponding author), Museum Natl Hist Nat, MCAM, MNHN CNRS, UMR 7245, F-75231 Paris, France.	sprado@mnhn.fr	Nay, Bastien/E-7483-2011	Nay, Bastien/0000-0002-1209-1830; Audrey, combes/0000-0003-3318-7230	Fondation pour la Recherche sur la Biodiversite; Action Transversale du Museum "Biodiversite des microorganismes dans les ecosystemes actuels et passe's" from the Museum National d'Histoire Naturelle; Consortium National de Recherche en Ge'nomique; "service de systematique moleculaire" of the Museum National d'Histoire Naturelle [IFR 101]	Fondation pour la Recherche sur la Biodiversite; Action Transversale du Museum "Biodiversite des microorganismes dans les ecosystemes actuels et passe's" from the Museum National d'Histoire Naturelle; Consortium National de Recherche en Ge'nomique; "service de systematique moleculaire" of the Museum National d'Histoire Naturelle(Centre National de la Recherche Scientifique (CNRS))	The French Ambassy at Dakar, Senegal and Cheikh Anta Diop University at Dakar are acknowledged providing a research fellowship to IN. This project was supported by the following grants: "Projets Innovants FRB 2009" from the Fondation pour la Recherche sur la Biodiversite (AAP-IN-2009-026), the Action Transversale du Museum "Biodiversite des microorganismes dans les ecosystemes actuels et passe's" from the Museum National d'Histoire Naturelle, by the "Consortium National de Recherche en Ge'nomique", and the "service de systematique moleculaire" of the Museum National d'Histoire Naturelle (IFR 101). It is part of the agreement no 2005/67 between the Genoscope and the Museum National d'Histoire Naturelle on the project "Macrophylogeny of life" directed by Guillaume Lecointre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript can be added to the manuscript.	Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; BALLIO A, 1966, TETRAHEDRON LETT, P3723; Bocar M, 2003, J NAT PROD, V66, P152, DOI 10.1021/np0203178; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; Dong JY, 2008, J NAT PROD, V71, P952, DOI 10.1021/np800034g; Dufour C, 2005, CHEM PHYS LIPIDS, V138, P60, DOI 10.1016/j.chemphyslip.2005.08.003; Estrada AER, 2011, FUNGAL GENET BIOL, V48, P874, DOI 10.1016/j.fgb.2011.06.006; Evanno L, 2008, PLANTA MED, V74, P870, DOI 10.1055/s-2008-1074546; Evidente A, 2011, EUR J ORG CHEM, V2011, P5564, DOI 10.1002/ejoc.201100941; Feng SB, 2007, J AGR FOOD CHEM, V55, P8589, DOI 10.1021/jf0716735; Fox EM, 2008, CURR OPIN MICROBIOL, V11, P481, DOI 10.1016/j.mib.2008.10.007; Fujimoto H, 1998, CHEM PHARM BULL, V46, P423; Gimenez C, 2007, CURR ORG CHEM, V11, P707, DOI 10.2174/138527207780598765; Glauser G, 2009, J AGR FOOD CHEM, V57, P1127, DOI 10.1021/jf8033539; Heilmann-Clausen J, 2005, MICROB ECOL, V49, P399, DOI 10.1007/s00248-004-0240-2; IWASAKI S, 1973, TETRAHEDRON LETT, P3537; KNIGHT DW, 1977, TETRAHEDRON LETT, P4543; Kokubun T, 2003, PHYTOCHEMISTRY, V62, P779, DOI 10.1016/S0031-9422(02)00606-4; Langenfeld A, 2012, FUNGAL BIOL IN PRESS; Laurent D, 2002, TETRAHEDRON, V58, P9163, DOI 10.1016/S0040-4020(02)01222-X; Leao PN, 2010, P NATL ACAD SCI USA, V107, P11183, DOI 10.1073/pnas.0914343107; Liu L, 2010, EUR J ORG CHEM, V2010, P3302, DOI 10.1002/ejoc.201000284; Macias-Rubalcava ML, 2010, J CHEM ECOL, V36, P1122, DOI 10.1007/s10886-010-9848-5; Morita M, 1996, CHEM PHARM BULL, V44, P1603, DOI 10.1248/cpb.44.1603; Oh DC, 2005, BIOORGAN MED CHEM, V13, P5267, DOI 10.1016/j.bmc.2005.05.068; Oh DC, 2007, J NAT PROD, V70, P515, DOI 10.1021/np060381f; Park HB, 2009, J NAT PROD, V72, P248, DOI 10.1021/np800606e; POWELL R G, 1970, Tetrahedron Letters, V11, P815, DOI 10.1016/S0040-4039(01)97839-6; Prado S, 2011, STUDIES NATURAL PROD; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Reverberi M, 2010, APPL MICROBIOL BIOT, V87, P899, DOI 10.1007/s00253-010-2657-5; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Schulz B, 1999, MYCOL RES, V103, P1275, DOI 10.1017/S0953756299008540; Shiono Y, 2011, PHYTOCHEMISTRY, V72, P1400, DOI 10.1016/j.phytochem.2011.04.016; Singh SK, 2011, MICROB ECOL, V61, P729, DOI 10.1007/s00248-011-9818-7; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Soliman SSM, 2011, J NAT PROD, V74, P2497, DOI 10.1021/np200303v; Song HH, 2009, FOOD ADDIT CONTAM A, V26, P518, DOI 10.1080/02652030802562904; Tsitsigiannis DI, 2006, MOL MICROBIOL, V59, P882, DOI 10.1111/j.1365-2958.2005.05000.x; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Wicklow DT, 2005, MYCOL RES, V109, P610, DOI 10.1017/S0953756205002820; Young CA, 2005, MOL GENET GENOMICS, V274, P13, DOI 10.1007/s00438-005-1130-0; Zhang CL, 2008, APPL MICROBIOL BIOT, V78, P833, DOI 10.1007/s00253-008-1371-z	44	61	64	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47313	10.1371/journal.pone.0047313	http://dx.doi.org/10.1371/journal.pone.0047313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077591	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100091
J	Hasselrot, K; Cheruiyot, J; Kimani, J; Ball, TB; Kaul, R; Hirbod, T				Hasselrot, Klara; Cheruiyot, Juliana; Kimani, Joshua; Ball, Terry B.; Kaul, Rupert; Hirbod, Taha			Feasibility and Safety of Cervical Biopsy Sampling for Mucosal Immune Studies in Female Sex Workers from Nairobi, Kenya	PLOS ONE			English	Article							HIV-1 INFECTION; TRANSMISSION; PROSTITUTES; EXPRESSION; RECEPTORS; TISSUE; WOMEN; RISK	Background: There is an urgent need to improve our understanding of the mucosal immuno-pathogenesis of HIV acquisition in the female genital tract, particularly in high-risk women such as female sex workers (FSWs). Cervical biopsy samples offer technical advantages over cytobrush sampling, but there are concerns that this might increase HIV acquisition, particularly if healing is slow and/or women do not abstain from sex during healing. Methodology/Principal Findings: Cervical biopsy samples and cervico-vaginal swabs for co-infection diagnostics, prostate specific antigen (PSA) and immune studies were collected from 59 women, including HIV seropositive and HIV-exposed seronegative (HESN) FSWs as well as lower risk women from Nairobi, Kenya. A clinical-demographic questionnaire was administered and women were instructed to avoid sexual intercourse, douching and the insertion of tampons for 14 days. All participants underwent a repeat exam to assess healing within the 14 days, and had HIV diagnostics at six months. Cervical sampling was well tolerated, and 82% of participants had healed macroscopically by 5 days. Both self-report and PSA screening suggested high levels of compliance with pre- and post-procedure abstinence. Delayed healing was associated with vulvovaginal candidiasis (VVC) and HESN status. At six-month follow up all low-risk and HESN participants remained HIV seronegative. Conclusion: Cervical biopsy sampling is a safe and well-tolerated method to obtain cervical biopsies in this context, particularly if participants with VVC are excluded. As healing could be delayed up to 11 days, it is important to support (both financially and with rigorous counseling) a period of post-procedure abstinence to minimize HIV risk.	[Hasselrot, Klara; Hirbod, Taha] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Dept Med,Unit Infect Dis, Stockholm, Sweden; [Cheruiyot, Juliana; Kimani, Joshua; Kaul, Rupert] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Ball, Terry B.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Ball, Terry B.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Ball, Terry B.] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada; [Kaul, Rupert; Hirbod, Taha] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Kaul, Rupert; Hirbod, Taha] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada	Karolinska Institutet; Karolinska University Hospital; University of Nairobi; University of Manitoba; University of Manitoba; Public Health Agency of Canada; University of Toronto; University of Toronto	Hirbod, T (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Dept Med,Unit Infect Dis, Stockholm, Sweden.	taha.hirbod@ki.se		Kaul, Rupert/0000-0002-1586-4093	SIDA; Swedish Research Council; Eric and Edith Fernstrom Foundation; Canadian Institutes of Health Research; Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative	SIDA; Swedish Research Council(Swedish Research CouncilEuropean Commission); Eric and Edith Fernstrom Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative(Bill & Melinda Gates Foundation)	This study was supported by grants from SIDA, the Swedish Research Council, Eric and Edith Fernstrom Foundation and the Canadian Institutes of Health Research and the Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Embree JE, 2000, AIDS, V14, P2535, DOI 10.1097/00002030-200011100-00016; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Hirbod T, 2009, JAIDS-J ACQ IMM DEF, V51, P239, DOI 10.1097/QAI.0b013e3181a74f89; Hobbs MM, 2010, CONTRACEPTION, V82, P291, DOI 10.1016/j.contraception.2010.02.022; Horton RE, 2010, J INFECT DIS, V202, pS377, DOI 10.1086/655971; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; Kaul R, 2011, SEX TRANSM INFECT, V87, P125, DOI 10.1136/sti.2009.040931; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Lajoie J, 2012, MUCOSAL IMMUNOL, V5, P277, DOI 10.1038/mi.2012.7; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; Saba E, 2010, MUCOSAL IMMUNOL, V3, P280, DOI 10.1038/mi.2010.2; Songok EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030048; Wendel SB, 2010, INT J ONCOL, V37, P1565, DOI 10.3892/ijo_00000810; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	17	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47570	10.1371/journal.pone.0047570	http://dx.doi.org/10.1371/journal.pone.0047570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077640	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100135
J	Jagdeo, JR; Adams, LE; Brody, NI; Siegel, DM				Jagdeo, Jared R.; Adams, Lauren E.; Brody, Neil I.; Siegel, Daniel M.			Transcranial Red and Near Infrared Light Transmission in a Cadaveric Model	PLOS ONE			English	Article							LASER THERAPY; IRRADIATION; RADIATION; STROKE; SAFETY	Background and Objective: Low level light therapy has garnered significant interest within the past decade. The exact molecular mechanisms of how red and near infrared light result in physiologic modulation are not fully understood. Heme moieties and copper within cells are red and near infrared light photoreceptors that induce the mitochondrial respiratory chain component cytochrome C oxidase, resulting in a cascade linked to cytoprotection and cellular metabolism. The copper centers in cytochrome C oxidase have a broad absorption range that peaks around 830 nm. Several in vitro and in vivo animal and human models exist that have demonstrated the benefits of red light and near infrared light for various conditions. Clinical applications for low level light therapy are varied. One study in particular demonstrated improved durable functional outcomes status post-stroke in patients treated with near infrared low level light therapy compared to sham treatment [1]. Despite previous data suggesting the beneficial effect in treating multiple conditions, including stroke, with low level light therapy, limited data exists that measures transmission in a human model. Study Design/Materials and Methods: To investigate this idea, we measured the transmission of near infrared light energy, using red light for purposes of comparison, through intact cadaver soft tissue, skull bones, and brain using a commercially available LED device at 830 nm and 633 nm. Results: Our results demonstrate that near infrared measurably penetrates soft tissue, bone and brain parenchyma in the formalin preserved cadaveric model, in comparison to negligible red light transmission in the same conditions. Conclusion: These findings indicate that near infrared light can penetrate formalin fixed soft tissue, bone and brain and implicate that benefits observed in clinical studies are potentially related to direct action of near infrared light on neural tissue.	[Jagdeo, Jared R.; Adams, Lauren E.; Brody, Neil I.; Siegel, Daniel M.] Suny Downstate Med Ctr, Dept Dermatol, Brooklyn, NY 11203 USA; [Jagdeo, Jared R.] Sacramento Vet Affairs Med Ctr, Dermatol Serv, Mather, CA USA; [Jagdeo, Jared R.] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA; [Siegel, Daniel M.] Brooklyn Vet Affairs Med Ctr, Dermatol Serv, Brooklyn, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of California System; University of California Davis	Jagdeo, JR (corresponding author), Suny Downstate Med Ctr, Dept Dermatol, Brooklyn, NY 11203 USA.	jrjagdeo@gmail.com						Bachelard HS, 1975, BRAIN WORK, P79; BEAUVOIT B, 1994, BIOPHYS J, V67, P2501, DOI 10.1016/S0006-3495(94)80740-4; Berrocal E, 2009, OPT EXPRESS, V17, P13792, DOI 10.1364/OE.17.013792; Chiappelli J, 2008, J ENVIRON HEALTH, V71, P24; Danno K, 2001, PHOTODERMATOL PHOTO, V17, P261, DOI 10.1034/j.1600-0781.2001.170603.x; GARN SM, 1954, AMA ARCH DERM SYPH, V70, P601, DOI 10.1001/archderm.1954.01540230051006; Giuliani A, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-8; Goldberg David J, 2006, J Drugs Dermatol, V5, P748; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Hirsch R, 2007, DERMATOLOGY, P2145; James Byrnes, 2009, NATO SCI PEACE SECUR, P21; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Leonard DR, 2004, DIABETES CARE, V27, P168, DOI 10.2337/diacare.27.1.168; Levy M, 2004, PHYSIOLOGY, P265; Minatel DG, 2009, LASER SURG MED, V41, P433, DOI 10.1002/lsm.20789; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Pandian PS, 2009, MED BIOL ENG COMPUT, V47, P1197, DOI 10.1007/s11517-009-0531-3; Rojas JC, 2008, J NEUROSCI, V28, P13511, DOI 10.1523/JNEUROSCI.3457-08.2008; Samoilova K I, 2003, Tsitologiia, V45, P596; Samoilova KA, 2004, PHOTOCH PHOTOBIO SCI, V3, P96, DOI 10.1039/b305738k; Schubert V, 2001, PHOTODERMATOL PHOTO, V17, P32, DOI 10.1034/j.1600-0781.2001.017001032.x; Waiz Makram, 2006, J Cosmet Laser Ther, V8, P27, DOI 10.1080/14764170600607368; WAN S, 1981, PHOTOCHEM PHOTOBIOL, V34, P679, DOI 10.1111/j.1751-1097.1981.tb09424.x; Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Yamazaki M, 2003, INT J DERMATOL, V42, P738, DOI 10.1046/j.1365-4362.2003.01968.x; Yokoyama K, RHEUMATOID ARTHRITIS; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707; Zhang YO, 2003, J INVEST DERMATOL, V120, P849, DOI 10.1046/j.1523-1747.2003.12133.x; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	32	91	96	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47460	10.1371/journal.pone.0047460	http://dx.doi.org/10.1371/journal.pone.0047460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077622	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100118
J	Ott, M; Litzenburger, UM; Sahm, F; Rauschenbach, KJ; Tudoran, R; Hartmann, C; Marquez, VE; von Deimling, A; Wick, W; Platten, M				Ott, Martina; Litzenburger, Ulrike M.; Sahm, Felix; Rauschenbach, Katharina J.; Tudoran, Ruxandra; Hartmann, Christian; Marquez, Victor E.; von Deimling, Andreas; Wick, Wolfgang; Platten, Michael			Promotion of Glioblastoma Cell Motility by Enhancer of Zeste Homolog 2 (EZH2) Is Mediated by AXL Receptor Kinase	PLOS ONE			English	Article							POLYCOMB-REPRESSIVE COMPLEX-2; METHYLTRANSFERASE GENE EZH2; ACUTE-LEUKEMIA CELLS; GROUP PROTEIN EZH2; TYROSINE KINASE; BREAST-CANCER; TRANSCRIPTIONAL REPRESSION; COORDINATED REGULATION; THERAPEUTIC TARGET; PROLONGS SURVIVAL	Enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of the Polycomb-repressive complex 2 (PRC2) that epigenetically silences gene transcription through histone H3 lysine trimethylation (H3K27me3). EZH2 has been implicated in stem cell maintenance and is overexpressed in hematological and solid malignancie's including malignant glioma. EZH2 is thought to promote tumor progression by silencing tumor suppressor genes. Hence pharmacological disruption of the PRC2 is an attractive therapeutic strategy for cancer treatment. Here we show that EZH2 is expressed in human glioma and correlates with malignancy. Silencing of EZH2 reduced glioma cell proliferation and invasiveness. While we did not observe induction of cell cycle-associated tumor suppressor genes by silencing or pharmacological inhibition of EZH2, microarray analyses demonstrated a strong transcriptional reduction of the AXL receptor kinase. Neither histone nor DNA methylation appeared to be involved in the positive regulation of AXL by EZH2. Silencing AXL mimicked the antiinvasive effects of EZH2 knockdown. Finally, AXL expression is found in human gliomas with high EZH2 expression. Collectively these data suggest that EZH2 drives glioma invasiveness via transcriptional control of AXL independent of histone or DNA methylation.	[Ott, Martina; Litzenburger, Ulrike M.; Rauschenbach, Katharina J.; Tudoran, Ruxandra; Wick, Wolfgang; Platten, Michael] Univ Heidelberg Hosp, Dept Neurooncol, Heidelberg, Germany; [Sahm, Felix; Hartmann, Christian; von Deimling, Andreas] Univ Heidelberg Hosp, Inst Neuropathol, Heidelberg, Germany; [Ott, Martina; Litzenburger, Ulrike M.; Rauschenbach, Katharina J.; Tudoran, Ruxandra; Platten, Michael] German Canc Res Ctr, Clin Cooperat Unit, D-6900 Heidelberg, Germany; [Ott, Martina; Litzenburger, Ulrike M.; Rauschenbach, Katharina J.; Tudoran, Ruxandra; Platten, Michael] German Canc Res Ctr, Helmholtz Grp Expt Neuroimmunol, D-6900 Heidelberg, Germany; [Wick, Wolfgang] German Canc Res Ctr, Dept Neurooncol, D-6900 Heidelberg, Germany; [Sahm, Felix; Hartmann, Christian; von Deimling, Andreas] German Canc Res Ctr, Dept Neuropathol, D-6900 Heidelberg, Germany; [Hartmann, Christian] Hannover Med Sch, Inst Pathol, Dept Neuropathol, D-3000 Hannover, Germany; [Marquez, Victor E.] NCI, Biol Chem Lab, Frederick, MD 21701 USA	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Platten, M (corresponding author), Univ Heidelberg Hosp, Dept Neurooncol, Heidelberg, Germany.	michael.platten@med.uni-heidelberg.de	Marquez, Victor/AAP-3549-2021; Wick, Wolfgang/AAA-2545-2020; Platten, Michael/F-2902-2013; Sahm, Felix/GQY-8202-2022; von Deimling, Andreas/F-7774-2013; Hartmann, Christian/D-1882-2010	Wick, Wolfgang/0000-0002-6171-634X; Platten, Michael/0000-0002-4746-887X; Sahm, Felix/0000-0001-5441-1962; von Deimling, Andreas/0000-0002-5863-540X; 	Helmholtz Association [VH-NG-306]; Hertie Foundation; Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research	Helmholtz Association(Helmholtz Association); Hertie Foundation; Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Helmholtz Association (VH-NG-306) to MP and the Hertie Foundation to WW and by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research to VM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Au SLK, 2012, HEPATOLOGY, V56, P622, DOI 10.1002/hep.25679; Avilla E, 2011, CANCER RES, V71, P1792, DOI 10.1158/0008-5472.CAN-10-2186; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bommi PV, 2010, CELL CYCLE, V9, P2663, DOI 10.4161/cc.9.13.12147; Breton CV, 2011, EPIGENETICS, V6; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Capper D, 2009, ACTA NEUROPATHOL; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; de Haan G, 2007, ANN NY ACAD SCI, V1106, P233, DOI 10.1196/annals.1392.008; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; Fiskus W, 2009, CANCER BIOL THER, V8, P939, DOI 10.4161/cbt.8.10.8213; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; GLAZER RI, 1986, BIOCHEM PHARMACOL, V35, P4523, DOI 10.1016/0006-2952(86)90774-4; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Jung JW, 2010, CELL MOL LIFE SCI, V67, P1165, DOI 10.1007/s00018-009-0242-9; Keating AK, 2010, MOL CANCER THER, V9, P1298, DOI 10.1158/1535-7163.MCT-09-0707; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee WP, 2002, ONCOGENE, V21, P329, DOI 10.1038/sj.onc.1205066; Lemke D, 2012, CLIN CANCER RES, V18, P105, DOI 10.1158/1078-0432.CCR-11-0880; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Liu R, 2010, BLOOD, V116, P297, DOI 10.1182/blood-2009-12-257154; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Lu CH, 2007, CANCER RES, V67, P1757, DOI 10.1158/0008-5472.CAN-06-3700; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Mudduluru G, 2008, BIOSCIENCE REP, V28, P161, DOI 10.1042/BSR20080046; Mudduluru G, 2011, BIOL CELL, V103, P21, DOI 10.1042/BC20100094; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Orzan F, 2011, NEUROPATH APPL NEURO, V37, P381, DOI 10.1111/j.1365-2990.2010.01132.x; Ou WB, 2011, ONCOGENE, V30, P1643, DOI 10.1038/onc.2010.555; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Prezioso C, 2011, FEBS LETT, V585, P2067, DOI 10.1016/j.febslet.2011.04.062; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Schmitt M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp581; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Smits M, 2010, ONCOTARGET, V1, P710, DOI 10.18632/oncotarget.205; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Staflin K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-206; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tsang DPF, 2011, J GASTROEN HEPATOL, V26, P19, DOI 10.1111/j.1440-1746.2010.06447.x; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wagener N, 2008, INT J CANCER, V123, P1545, DOI 10.1002/ijc.23683; Wick W, 2011, NEURO-ONCOLOGY, V13, P566, DOI 10.1093/neuonc/nor039; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661; Zheng SC, 2011, NEURO-ONCOLOGY, V13, P280, DOI 10.1093/neuonc/noq190	66	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47663	10.1371/journal.pone.0047663	http://dx.doi.org/10.1371/journal.pone.0047663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077658	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100151
J	Petersen, HI; Lindstrom, S				Petersen, Henrik I.; Lindstrom, Sofie			Synchronous Wildfire Activity Rise and Mire Deforestation at the Triassic-Jurassic Boundary	PLOS ONE			English	Article							ATLANTIC MAGMATIC PROVINCE; TRIASSIC/JURASSIC BOUNDARY; MASS-EXTINCTION; CHARCOAL; TERRESTRIAL; BORNHOLM; REFLECTANCE; TEMPERATURE; SUCCESSION; GREENLAND	The end-Triassic mass extinction event (similar to 201.4 million years ago) caused major faunal and floral turnovers in both the marine and terrestrial realms. The biotic changes have been attributed to extreme greenhouse warming across the Triassic-Jurassic (T-J) boundary caused by massive release of carbon dioxide and/or methane related to extensive volcanism in the Central Atlantic Magmatic Province (CAMP), resulting in a more humid climate with increased storminess and lightning activity. Lightning strikes are considered the primary source of wildfires, producing charcoal, microscopically recognized as inertinite macerals. The presence of polycyclic aromatic hydrocarbons (PAHs) of pyrolytic origin and allochthonous charcoal in siliciclastic T-J boundary strata has suggested widespread wildfire activity at the time. We have investigated largely autochthonous coal and coaly beds across the T-J boundary in Sweden and Denmark. These beds consist of predominantly organic material from the in situ vegetation in the mires, and as the coaly beds represent a substantial period of time they are excellent environmental archives. We document a remarkable increase in inertinite content in the coal and coaly beds across the T-J boundary. We show estimated burning temperatures derived from inertinite reflectance measurements coupled with palynological data and conclude that pre-boundary late Rhaetian mire wildfires included high-temperature crown fires, whereas latest Rhaetian-Sinemurian mire wildfires were more frequent but dominated by lower temperature surface fires. Our results suggest a major change in the mire ecosystems across the T-J boundary from forested, conifer dominated mires to mires with a predominantly herbaceous and shrubby vegetation. Contrary to the overall regional vegetation for which onset of recovery commenced in the early Hettangian, the sensitive mire ecosystem remained affected during the Hettangian and did not start to recover until around the Hettangian-Sinemurian boundary. Decreasing inertinite content through the Lower Jurassic suggests that fire activity gradually resumed to considerable lower levels.	[Petersen, Henrik I.] Geol Survey Denmark & Greenland GEUS, Dept Reservoir Geol, Copenhagen, Denmark; [Lindstrom, Sofie] Geol Survey Denmark & Greenland GEUS, Dept Stratig, Copenhagen, Denmark	Geological Survey Of Denmark & Greenland; Geological Survey Of Denmark & Greenland	Petersen, HI (corresponding author), Geol Survey Denmark & Greenland GEUS, Dept Reservoir Geol, Copenhagen, Denmark.	hip@geus.dk	Lindström, Sofie/G-5481-2018; Petersen, Henrik/ABB-4663-2020	Lindström, Sofie/0000-0001-8278-1055; Petersen, Henrik/0000-0001-6606-7062				Ahlberg A, 2003, SEDIMENT GEOL, V161, P15, DOI 10.1016/S0037-0738(02)00381-0; Ahlberg A, 2002, TERRA NOVA, V14, P241, DOI 10.1046/j.1365-3121.2002.00416.x; Ahlberg A, 1994, LUND PUBLICATIONS GE, V123; ARNDORFF L, 1993, PALAEOGEOGR PALAEOCL, V100, P235, DOI 10.1016/0031-0182(93)90056-O; BALME BE, 1995, REV PALAEOBOT PALYNO, V87, P85; Belcher CM, 2010, NAT GEOSCI, V3, P426, DOI 10.1038/NGEO871; Berner RA, 2007, PALAEOGEOGR PALAEOCL, V244, P368, DOI 10.1016/j.palaeo.2006.06.039; Bojesen-Koefoed JA, 1997, INT J COAL GEOL, V34, P345, DOI 10.1016/S0166-5162(97)00030-X; Bonis NR, 2009, REV PALAEOBOT PALYNO, V156, P376, DOI 10.1016/j.revpalbo.2009.04.003; Bonis NR, 2010, J GEOL SOC LONDON, V167, P877, DOI 10.1144/0016-76492009-141; BUSH MB, 1995, AM NAT, V145, P594, DOI 10.1086/285757; Bush MB, 2001, GLOBAL ECOL BIOGEOGR, V10, P359, DOI 10.1046/j.1466-822X.2001.00247.x; Diesscl C.F.K, 1992, COAL BEARING DEPOSIT; Dybkjaer K, 1991, DANMARKS GEOLOGISK A, V30; Gravesen P, 1982, DANMARKS GEOLOGISK B, V7; GRY H, 1969, MEDDELELSER DANSK GE, V19, P69; Hallam A, 1999, EARTH-SCI REV, V48, P217, DOI 10.1016/S0012-8252(99)00055-0; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Int Comm Coal Organic Petrology, 2001, FUEL, V80, P459, DOI 10.1016/s0016-2361(00)00102-2; Jones T.P., 1997, MEDED NED INST TOEG, V58, P93; JONES TP, 1991, B SOC GEOL FR, V162, P193; Konijnenburg-Van Cittert JHAV, 2002, REV PALAEOBOT PALYNO, V119, P113; Kuerschner WM, 2007, PALAEOGEOGR PALAEOCL, V244, P257, DOI 10.1016/j.palaeo.2006.06.031; Larsen G, 1968, PALAEOGEOGR PALAEOCL, V106, P91; Lindstrom S, 2006, PALAEOGEOGR PALAEOCL, V241, P339, DOI 10.1016/j.palaeo.2006.04.006; Lindstrom S, 2002, REV PALAEOBOT PALYNO, V120, P247, DOI 10.1016/S0034-6667(02)00079-9; Lindstrom S, 2012, GEOLOGY, V40, P531, DOI 10.1130/G32928.1; Mander L, 2012, INT J PLANT SCI, V173, P429, DOI 10.1086/664715; Marynowski L, 2009, PALAIOS, V24, P785, DOI 10.2110/palo.2009.p09-044r; Marzoli A, 2004, GEOLOGY, V32, P973, DOI 10.1130/G20652.1; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McElwain JC, 2007, PALEOBIOLOGY, V33, P547, DOI 10.1666/06026.1; Moore P. D., 1987, GEOL SOC SPEC PUBL, V32, P7, DOI DOI 10.1144/GSL.SP.1987.032.01.02; Nichols GJ, 2000, PALAEOGEOGR PALAEOCL, V164, P43, DOI 10.1016/S0031-0182(00)00174-7; Nielsen L.H., 2003, JURASSIC DENMARK GRE, V1, P459, DOI [10.34194/geusb.v1.4681, DOI 10.34194/GEUSB.V1.4681]; Nielsen LH, 2010, PALAEOGEOGR PALAEOCL, V292, P103, DOI 10.1016/j.palaeo.2010.03.032; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; Petersen HI, 2011, INT J COAL GEOL, V87, P2, DOI 10.1016/j.coal.2011.04.004; Petersen H. I., 2003, JURASSIC DENMARK GRE, V1; PETERSEN HI, 1993, INT J COAL GEOL, V22, P189, DOI 10.1016/0166-5162(93)90026-7; PETERSEN HI, 1995, INT J COAL GEOL, V27, P99, DOI 10.1016/0166-5162(94)00020-Z; Petersen HI, 1994, DANMARKS GEOLOGISK A, V55, P1; PIENKOWSKI G, 1991, SEDIMENTOLOGY, V38, P503, DOI 10.1111/j.1365-3091.1991.tb00364.x; Pott C, 2011, PALAEONTOLOGY, V54, P1025, DOI 10.1111/j.1475-4983.2011.01090.x; Poulsen NE, 2003, CONTRIBUTION SERIES, V31; Poulsen Niels E., 2003, Geological Survey of Denmark and Greenland Bulletin, V1, P115; Preto N, 2010, PALAEOGEOGR PALAEOCL, V290, P1, DOI 10.1016/j.palaeo.2010.03.015; Reeve N, 1999, Q J ROY METEOR SOC, V125, P893, DOI 10.1002/qj.49712555507; REIN G., 2009, INT REV CHEM ENG, V1, P3; Ruhl M, 2011, GEOLOGY, V39, P431, DOI 10.1130/G31680.1; Ruhl M, 2011, SCIENCE, V333, P430, DOI 10.1126/science.1204255; Schoene B, 2010, GEOLOGY, V38, P387, DOI 10.1130/G30683.1; Scott AC, 2005, GEOLOGY, V33, P589, DOI 10.1130/G21474.1; SCOTT AC, 1989, INT J COAL GEOL, V12, P443, DOI 10.1016/0166-5162(89)90061-X; Scott AC, 2000, PALAEOGEOGR PALAEOCL, V164, P281, DOI 10.1016/S0031-0182(00)00192-9; Scott AC, 1994, NATURE INFLUENCE FIR; Scott AC, 2007, INT J COAL GEOL, V70, P53, DOI 10.1016/j.coal.2006.02.009; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; Steinthorsdottir M, 2012, GEOLOGY, V40, P815, DOI 10.1130/G33334.1; Steinthorsdottir M, 2011, PALAEOGEOGR PALAEOCL, V308, P418, DOI 10.1016/j.palaeo.2011.05.050; SURLYK F, 1995, SEDIMENTOLOGY, V42, P323, DOI 10.1111/j.1365-3091.1995.tb02105.x; Sykorova I, 2005, INT J COAL GEOL, V62, P85, DOI 10.1016/j.coal.2004.06.006; Taylor G. H., 1998, ORGANIC PETROLOGY NE; Therkelsen J, 1992, THESIS U AARHUS; Troedsson G, 1951, LUNDS U ARSSKRIFT NY; van de Schootbrugge B, 2007, PALAEOGEOGR PALAEOCL, V244, P126, DOI 10.1016/j.palaeo.2006.06.026; van de Schootbrugge B, 2009, NAT GEOSCI, V2, P589, DOI 10.1038/NGEO577; VAUGHAN A, 1995, J SEDIMENT RES A, V65, P129; Whiteside JH, 2007, PALAEOGEOGR PALAEOCL, V244, P345, DOI 10.1016/j.palaeo.2006.06.035	69	59	68	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47236	10.1371/journal.pone.0047236	http://dx.doi.org/10.1371/journal.pone.0047236			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077574	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100078
J	Franke, EI; Vanderbrink, BA; Hile, KL; Zhang, HJ; Cain, A; Matsui, F; Meldrum, KK				Franke, Ethan I.; Vanderbrink, Brian A.; Hile, Karen L.; Zhang, Hongji; Cain, Alexandra; Matsui, Futoshi; Meldrum, Kirstan K.			Renal IL-18 Production Is Macrophage Independent During Obstructive Injury	PLOS ONE			English	Article							GAMMA-INDUCING FACTOR; UP-REGULATION; INTERLEUKIN-18; KIDNEY; TGF-BETA-1; ACTIVATION; CYTOKINE; CELLS; MICE	Background: Interleukin 18 (IL-18) is a pro-inflammatory cytokine that mediates fibrotic renal injury during obstruction. Macrophages are a well-known source of IL-18; however, renal tubular epithelial cells are also a potential source of this cytokine. We hypothesized that IL-18 is predominantly a renal tubular cell product and is produced during renal obstruction independent of macrophage infiltration. Methods: To study this, male C57BL6 mice were subjected to unilateral ureteral obstruction (UUO) vs. sham operation in the presence or absence of macrophage depletion (liposomal clodronate (1 ml/100 g body weight i.v.)). The animals were sacrificed 1 week after surgery and renal cortical tissue harvested. Tissue levels of active IL-18 (ELISA), IL-18 receptor mRNA expression (real time PCR), and active caspase-1 expression (western blot) were measured. The cellular localization of IL-18 and IL-18R was assessed using dual labeling immunofluorescent staining (IFS). Results: Immunohistochemical staining of renal tissue sections confirmed macrophage depletion by liposomal clodronate. IL-18 production, IL-18R expression, and active caspase 1 expression were elevated in response to renal obstruction and did not decline to a significant degree in the presence of macrophage depletion. Obstruction-induced IL-18 and IL-18R production localized predominantly to tubular epithelial cells (TEC) during obstruction despite macrophage depletion. Conclusion: These results demonstrate that renal tubular epithelial cells are the primary source of IL-18 production during obstructive injury, and that tubular cell production of IL-18 occurs independent of macrophage infiltration.	[Meldrum, Kirstan K.] Univ Florida, Dept Urol, Gainesville, FL 32611 USA; [Franke, Ethan I.; Vanderbrink, Brian A.; Hile, Karen L.; Zhang, Hongji; Cain, Alexandra; Matsui, Futoshi] Indiana Univ Sch Med, Dept Urol, Indianapolis, IN USA	State University System of Florida; University of Florida; Indiana University System; Indiana University Bloomington	Meldrum, KK (corresponding author), Univ Florida, Dept Urol, Gainesville, FL 32611 USA.	Kirstan.Meldrum@urology.ufl.edu			United States National Institutes of Health grant [DK08165]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081695, F32DK008165] Funding Source: NIH RePORTER	United States National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by United States National Institutes of Health grant DK08165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bani-Hani AH, 2009, KIDNEY INT, V76, P500, DOI 10.1038/ki.2009.216; Daemen MARC, 1999, J IMMUNOL, V162, P5506; DIAMOND JR, 1994, AM J PHYSIOL, V266, pF926, DOI 10.1152/ajprenal.1994.266.6.F926; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Faust J, 2002, ARTHRITIS RHEUM-US, V46, P3083, DOI 10.1002/art.10563; Fortin CF, 2009, FASEB J, V23, P194, DOI 10.1096/fj.08-110213; Gauer S, 2007, KIDNEY INT, V72, P1081, DOI 10.1038/sj.ki.5002473; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; He ZB, 2009, AM J PHYSIOL-RENAL, V296, pF535, DOI 10.1152/ajprenal.90634.2008; KANETO H, 1993, KIDNEY INT, V44, P313, DOI 10.1038/ki.1993.246; Leslie JA, 2008, J SURG RES, V145, P170, DOI 10.1016/j.jss.2007.03.037; Liang D, 2007, NEPHROLOGY, V12, P53, DOI 10.1111/j.1440-1797.2006.00737.x; Striz I, 2005, IMMUNOL LETT, V99, P30, DOI 10.1016/j.imlet.2005.01.010; VanderBrink BA, 2011, J UROLOGY, V186, P1502, DOI 10.1016/j.juro.2011.05.046; Zhang HJ, 2011, AM J PHYSIOL-RENAL, V301, pF171, DOI 10.1152/ajprenal.00339.2010	17	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47417	10.1371/journal.pone.0047417	http://dx.doi.org/10.1371/journal.pone.0047417			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077611	Green Published, Green Submitted, gold			2022-12-27	WOS:000309809500048
J	Theodoric, N; Bechberger, JF; Naus, CC; Sin, WC				Theodoric, Nicolas; Bechberger, John F.; Naus, Christian C.; Sin, Wun-Chey			Role of Gap Junction Protein Connexin43 in Astrogliosis Induced by Brain Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT SPINAL-CORD; FIBRILLARY ACIDIC PROTEIN; FOCAL CEREBRAL-ISCHEMIA; REACTIVE ASTROCYTES; GLIAL SCAR; NESTIN EXPRESSION; CX43 EXPRESSION; UP-REGULATION; STAB WOUNDS	Astrogliosis is a process that involves morphological and biochemical changes associated with astrocyte activation in response to cell damage in the brain. The upregulation of intermediate filament proteins including glial fibrillary acidic protein (GFAP), nestin and vimentin are often used as indicators for astrogliosis. Although connexin43 (Cx43), a channel protein widely expressed in adult astrocytes, exhibits enhanced immunoreactivity in the peri-lesion region, its role in astrogliosis is still unclear. Here, we correlated the temporal and spatial expression of Cx43 to the activation of astrocytes and microglia in response to an acute needle stab wound in vivo. We found large numbers of microglia devoid of Cx43 in the needle wound at 3 days post injury (dpi) while reactive astrocytes expressing Cx43 were present in the peripheral zone surrounding the injury site. A redistribution of Cx43 to the needle site, corresponding to the increased presence of GFAP-positive reactive astrocytes in the region, was only apparent from 6 dpi and sustained until at least 15 dpi. Interestingly, the extent of microglial activation and subsequent astrogliosis in the brain of Cx43 knockout mice was significantly larger than those of wild type, suggesting that Cx43 expression limits the degree of microgliosis. Although Cx43 is not essential for astrogliosis and microglial activation induced by a needle injury, our results demonstrate that Cx43 is a useful marker for injury induced astrogliosis due to its enhanced expression specifically within a small region of the lesion for an extended period. As a channel protein, Cx43 is a potential in vivo diagnostic tool of asymptomatic brain injury.	[Theodoric, Nicolas; Bechberger, John F.; Naus, Christian C.; Sin, Wun-Chey] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Sin, WC (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	wcsin@mail.ubc.ca			Heart & Stroke Foundation of Canada [20R63496]; Canada Research Chair	Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This study was supported by a grant from the Heart & Stroke Foundation of Canada (Project grant number: 20R63496) to C.C.N. C.C.N. also holds a Canada Research Chair. The funders have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; Baklaushev VP, 2011, DRUG DELIV, V18, P331, DOI 10.3109/10717544.2010.549527; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; CAVANAGH JB, 1970, J ANAT, V106, P471; Cerutti SM, 2000, CELL BIOL INT, V24, P35, DOI 10.1006/cbir.1999.0451; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Cronin M, 2008, MOL CELL NEUROSCI, V39, P152, DOI 10.1016/j.mcn.2008.06.005; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DERMIETZEL R, 1993, TRENDS NEUROSCI, V16, P186, DOI 10.1016/0166-2236(93)90151-B; Dobrenis K, 2005, J NEUROSCI RES, V82, P306, DOI 10.1002/jnr.20650; Duffy HS, 2000, J NEUROSCI, V20; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Ezan P, 2012, J CEREB BLOOD FLOW M; Faustmann PM, 2003, GLIA, V42, P101, DOI 10.1002/glia.10141; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fonseca CG, 2002, BRAIN RES, V929, P105, DOI 10.1016/S0006-8993(01)03289-9; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Froger N, 2010, MOL CELL NEUROSCI, V45, P37, DOI 10.1016/j.mcn.2010.05.007; Garg S, 2005, J NEUROCHEM, V95, P475, DOI 10.1111/j.1471-4159.2005.03384.x; Giaume C, 1996, TRENDS NEUROSCI, V19, P319, DOI 10.1016/0166-2236(96)10046-1; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Haupt C, 2007, MOL CELL NEUROSCI, V35, P89, DOI 10.1016/j.mcn.2007.02.005; Hinkerohe D, 2005, GLIA, V52, P85, DOI 10.1002/glia.20223; HOLNESS CL, 1993, BLOOD, V81, P1607; HOSSAIN MZ, 1994, BRAIN RES, V652, P311, DOI 10.1016/0006-8993(94)90242-9; HOSSAIN MZ, 1994, GLIA, V10, P250, DOI 10.1002/glia.440100404; Huang CL, 2012, J NEUROSCI, V32, P3333, DOI 10.1523/JNEUROSCI.1216-11.2012; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Kielian T, 2008, J NEUROCHEM, V106, P1000, DOI 10.1111/j.1471-4159.2008.05405.x; Kozoriz MG, 2010, J NEUROPATH EXP NEUR, V69, P196, DOI 10.1097/NEN.0b013e3181cd44df; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kronenberg G, 2005, J CEREBR BLOOD F MET, V25, P1613, DOI 10.1038/sj.jcbfm.9600156; Kunzelmann P, 1999, GLIA, V25, P111, DOI 10.1002/(SICI)1098-1136(19990115)25:2<111::AID-GLIA2>3.0.CO;2-I; Lee IH, 2005, J COMP NEUROL, V489, P1, DOI 10.1002/cne.20567; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Li WEI, 1998, EUR J NEUROSCI, V10, P2444, DOI 10.1046/j.1460-9568.1998.00253.x; LIN RCS, 1995, NEUROBIOL DIS, V2, P79, DOI 10.1006/nbdi.1995.0008; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Martinez AD, 2002, BRAIN RES, V943, P191, DOI 10.1016/S0006-8993(02)02621-5; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Meme W, 2006, FASEB J, V20, P494, DOI 10.1096/fj.05-4297fje; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Nakase T, 2004, BBA-BIOMEMBRANES, V1662, P149, DOI 10.1016/j.bbamem.2004.01.009; Nakase T, 2003, STROKE, V34, P1987, DOI 10.1161/01.STR.0000079814.72027.34; Nakase T, 2006, GLIA, V54, P369, DOI 10.1002/glia.20399; Naus CCG, 2001, CELL COMMUN ADHES, V8, P325, DOI 10.3109/15419060109080747; OCHALSKI PAY, 1995, GLIA, V14, P279, DOI 10.1002/glia.440140405; Oki K, 2010, NEUROSCI RES, V66, P390, DOI 10.1016/j.neures.2009.12.013; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rouach N, 2002, BIOL CELL, V94, P457, DOI 10.1016/S0248-4900(02)00016-3; Rozental R, 2000, BRAIN RES REV, V32, P11, DOI 10.1016/S0165-0173(99)00095-8; Sheng JS, 2004, EUR J NEUROSCI, V20, P873, DOI 10.1111/j.1460-9568.2004.03567.x; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; Siushansian R, 2001, J COMP NEUROL, V440, P387, DOI 10.1002/cne.1392; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tamagno I, 2006, J NEURO-ONCOL, V80, P227, DOI 10.1007/s11060-006-9181-6; Tatsumi K, 2008, J NEUROSCI RES, V86, P3494, DOI 10.1002/jnr.21862; Theis M, 2001, CELL COMMUN ADHES, V8, P383, DOI 10.3109/15419060109080758; Theriault E, 1997, J COMP NEUROL, V382, P199; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	80	49	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47311	10.1371/journal.pone.0047311	http://dx.doi.org/10.1371/journal.pone.0047311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110066	Green Published, gold, Green Submitted			2022-12-27	WOS:000310193600013
J	Bae, JC; Suh, S; Park, SE; Rhee, EJ; Park, CY; Oh, KW; Park, SW; Kim, SW; Hur, KY; Kim, JH; Lee, MS; Lee, MK; Kim, KW; Lee, WY				Bae, Ji Cheol; Suh, Sunghwan; Park, Se Eun; Rhee, Eun Jung; Park, Cheol Young; Oh, Ki Won; Park, Sung Woo; Kim, Sun Woo; Hur, Kyu Yeon; Kim, Jae Hyeon; Lee, Myung-Shik; Lee, Moon Kyu; Kim, Kwang-Won; Lee, Won-Young			Regular Exercise Is Associated with a Reduction in the Risk of NAFLD and Decreased Liver Enzymes in Individuals with NAFLD Independent of Obesity in Korean Adults	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; WEIGHT-LOSS; CARDIORESPIRATORY FITNESS; NONDIABETIC SUBJECTS; METABOLIC SYNDROME; BODY-COMPOSITION; DISEASE; LIFE	Background: We evaluated the association of regular physical exercise with the presence of non-alcoholic fatty liver disease (NAFLD) and liver enzymes in relation to obesity and insulin resistance. Methodology/Principal Findings: A cross-sectional analysis was conducted in 72,359 healthy Korean adults without diabetes who participated in a comprehensive health check-up. Subjects who have been exercising regularly (more than 3 times per week, at least for 30 minutes each time and for consecutive 3 month) were categorized into exercise group. All subjects were categorized into deciles based on their body mass index (BMI) and we estimated the odds ratios (ORs) for having NAFLD according to exercise regularity in each decile. The diagnosis of NAFLD was based on ultrasonography findings. Individuals with NAFLD (n = 19,921) were analyzed separately to evaluate ORs for having elevated liver enzymes based on regularity of exercise. The risk for NAFLD was significantly reduced in exercise group with age- and sex-adjusted ORs of 0.53-0.72 for all BMI deciles except at BMI categories of < 19.6 and 20.7-21.6 kg/m(2). While no difference was seen in BMI between subjects in exercise and non-exercise group across the BMI deciles, the values of body fat percentage and metabolic risk factors differed. Among NAFLD patients, subjects in exercise group had a lower risk for having elevated liver enzymes with multivariable adjusted OR of 0.85 (95% CI 0.74-0.99, for AST) and 0.74 (95% CI 0.67-0.81, for ALT) than did subjects in non-exercise group. Conclusions/Significance: Regular exercise was associated with a reduced risk for having NAFLD and decreased liver enzymes in patients with NAFLD, and this relationship was also independent of obesity.	[Park, Se Eun; Rhee, Eun Jung; Park, Cheol Young; Oh, Ki Won; Park, Sung Woo; Kim, Sun Woo; Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea; [Bae, Ji Cheol; Suh, Sunghwan; Hur, Kyu Yeon; Kim, Jae Hyeon; Lee, Myung-Shik; Lee, Moon Kyu; Kim, Kwang-Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea.	drlwy@hanmail.net	Lee, Myung Shik/C-9606-2011; Rhee, Eun-Jung/M-9294-2015; LEE, WON-YOUNG/C-7249-2018; Park, Cheol-Young/C-6690-2018	Rhee, Eun-Jung/0000-0002-6108-7758; LEE, WON-YOUNG/0000-0002-1082-7592; Suh, Sunghwan/0000-0001-6865-966X; Park, Cheol-Young/0000-0002-9415-9965				Bae JC, 2011, DIABETES CARE, V34, P727, DOI 10.2337/dc10-1991; Bae JC, 2010, AM J GASTROENTEROL, V105, P2389, DOI 10.1038/ajg.2010.275; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bell LM, 2007, J CLIN ENDOCR METAB, V92, P4230, DOI 10.1210/jc.2007-0779; BLAIR SN, 1993, ANN INTERN MED, V119, P702, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00015; BODEN G, 1993, DIABETES CARE, V16, P728, DOI 10.2337/diacare.16.5.728; Booth FW, 2008, EUR J APPL PHYSIOL, V102, P381, DOI 10.1007/s00421-007-0606-5; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Brodney S, 2001, MED SCI SPORT EXER, V33, P459, DOI 10.1097/00005768-200103000-00020; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Hallsworth K, 2011, GUT, V60, P1278, DOI 10.1136/gut.2011.242073; Harrison SA, 2007, GUT, V56, P1760, DOI 10.1136/gut.2006.112094; Hickman IJ, 2004, GUT, V53, P413, DOI 10.1136/gut.2003.027581; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Johnson NA, 2010, HEPATOLOGY, V52, P370, DOI 10.1002/hep.23711; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Kantartzis K, 2009, GUT, V58, P1281, DOI 10.1136/gut.2008.151977; Keating SE, 2012, J HEPATOL, V57, P157, DOI 10.1016/j.jhep.2012.02.023; Kistler KD, 2011, AM J GASTROENTEROL, V106, P460, DOI 10.1038/ajg.2010.488; Longo DL, 2011, HARRISONS PRINCIPLES, V2, P3588; Malavolti M, 2003, ANN HUM BIOL, V30, P380, DOI 10.1080/0301446031000095211; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Sullivan S, 2012, HEPATOLOGY, V55, P1738, DOI 10.1002/hep.25548; Thoma C, 2012, J HEPATOL, V56, P255, DOI 10.1016/j.jhep.2011.06.010; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Ueno T, 1997, J HEPATOL, V27, P103, DOI 10.1016/S0168-8278(97)80287-5; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Wei YZ, 2008, WORLD J GASTROENTERO, V14, P193, DOI 10.3748/wjg.14.193; Westerbacka J, 2005, J CLIN ENDOCR METAB, V90, P2804, DOI 10.1210/jc.2004-1983; Wong SL, 2004, MED SCI SPORT EXER, V36, P286, DOI 10.1249/01.MSS.0000113665.40775.35; World Health Organization Regional Office for the Western Pacific (WPRO) International Association for the Study of Obesity International Obesity Task Force, 2000, AS PAC PERS RED OB I; Zelber-Sagi S, 2008, HEPATOLOGY, V48, P1791, DOI 10.1002/hep.22525; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	38	67	70	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e46819	10.1371/journal.pone.0046819	http://dx.doi.org/10.1371/journal.pone.0046819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110056	gold, Green Published, Green Submitted			2022-12-27	WOS:000310193400006
J	D'Orazio, M; Pacello, F; Battistoni, A				D'Orazio, Melania; Pacello, Francesca; Battistoni, Andrea			Extracellular Glutathione Decreases the Ability of Burkholderia cenocepacia to Penetrate into Epithelial Cells and to Induce an Inflammatory Response	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; REDUCED GLUTATHIONE; N-ACETYLCYSTEINE; CFTR MUTATION; CEPACIA; INVASION; THIOLS; IMPROVEMENT; SALMONELLA; VIRUS	Background: The airway surface liquid (ASL) of Cystic Fibrosis (CF) patients contains a lower concentration of reduced glutathione (GSH) with respect to healthy people. It is not known whether this defect may favor lung colonization by opportunistic pathogens. Principal Findings: We have analyzed the effects of extracellular GSH on the ability of Burkholderia cenocepacia to penetrate and multiply in epithelial respiratory cells. Extracellular GSH proved to be able to drastically reduce the pathogen ability to adhere and invade airway epithelial cells. This effect is correlated to a GSH-dependent increase in the number of free thiols on the surface of epithelial cells, suggestive of a change in the oxidoreductive status of membrane proteins involved in B. cenocepacia recognition. Moreover, treatments with GSH led to a consistent reduction of the expression of IL-8, TNF-alpha and IL-1 beta in response to B. cenocepacia infection. Conclusions and Significance: Extracellular GSH modulates the interaction between B. cenocepacia and epithelial respiratory cells and inhibits the bacterial invasion into these cells. This suggests that therapies aimed at restoring normal levels of GSH in the ASL might be beneficial to control CF lung infections.	[Pacello, Francesca; Battistoni, Andrea] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [D'Orazio, Melania] Ist Ricovero & Cura Carattere Sci San Raffaele Pi, Rome, Italy	University of Rome Tor Vergata	Battistoni, A (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	andrea.battistoni@uniroma2.it	Battistoni, Andrea/A-4778-2016	Battistoni, Andrea/0000-0003-4085-7917	Italian Cystic Fibrosis Research Foundation [11/2008, 15/2010]; Studio Palladio	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Studio Palladio	This work was supported by the Italian Cystic Fibrosis Research Foundation (Grant FFC# 11/2008 and 15#/2010). Following selection, these projects were "adopted" by Studio Palladio 2000, Sandrigo (VI) and of Delegazione FFC Roma 2, respectively, as a form of support to FFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly supported by Studio Palladio 2000. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bishop C, 2005, CHEST, V127, P308, DOI 10.1378/chest.127.1.308; Buhler T, 1998, J APPL MICROBIOL, V85, P457, DOI 10.1046/j.1365-2672.1998.853501.x; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; Dauletbaev N, 2009, EUR J MED RES, V14, P352; Duff C, 2006, MICROB PATHOGENESIS, V41, P183, DOI 10.1016/j.micpath.2006.07.005; ERNST RK, 1990, INFECT IMMUN, V58, P2014, DOI 10.1128/IAI.58.6.2014-2016.1990; Filomeni G, 2002, BIOCHEM PHARMACOL, V64, P1057, DOI 10.1016/S0006-2952(02)01176-0; Ghezzi P, 2011, INT J GEN MED, V4, P105, DOI 10.2147/IJGM.S15618; Gould NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-119; Greunert DC, 1988, P NATL ACAD SCI USA, V85, P5951; Griese M, 2004, AM J RESP CRIT CARE, V169, P822, DOI 10.1164/rccm.200308-1104OC; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Hudson VM, 2001, FREE RADICAL BIO MED, V30, P1440, DOI 10.1016/S0891-5849(01)00530-5; Imhoff BR, 2009, BIOCHEM J, V424, P491, DOI 10.1042/BJ20091286; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; Muller M, 2011, FREE RADICAL BIO MED, V50, P971, DOI 10.1016/j.freeradbiomed.2011.01.012; Nash EF, 2009, COCHRANE DB SYST REV, V21; Nencioni L, 2003, FASEB J, V17, P758, DOI 10.1096/fj.02-0508fje; Nicolis E, 2008, INT IMMUNOPHARMACOL, V8, P1672, DOI 10.1016/j.intimp.2008.08.001; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Petrucca A, 2003, RES MICROBIOL, V154, P491, DOI 10.1016/S0923-2508(03)00145-1; Pirone L, 2008, ENVIRON MICROBIOL, V10, P2773, DOI 10.1111/j.1462-2920.2008.01697.x; Rada B, 2011, MUCOSAL IMMUNOL, V4, P158, DOI 10.1038/mi.2010.62; Roum JH, 1999, J APPL PHYSIOL, V87, P438, DOI 10.1152/jappl.1999.87.1.438; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Sajjan U, 2004, INFECT IMMUN, V72, P4188, DOI 10.1128/IAI.72.7.4188-4199.2004; Sajjan U, 2001, J MED MICROBIOL, V50, P535, DOI 10.1099/0022-1317-50-6-535; Sajjan US, 2008, CELL MICROBIOL, V10, P188, DOI 10.1111/j.1462-5822.2007.01029.x; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Skalska J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008115; Sokol PA, 1999, INFECT IMMUN, V67, P4443, DOI 10.1128/IAI.67.9.4443-4455.1999; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Tipper JL, 1998, CLIN MICROBIOL INFEC, V8, P450; Tirouvanziam R, 2006, P NATL ACAD SCI USA, V103, P4628, DOI 10.1073/pnas.0511304103; Vasu VT, 2011, FREE RADICAL RES, V45, P165, DOI 10.3109/10715762.2010.521154; Velsor LW, 2001, AM J PHYSIOL-LUNG C, V281, pL31, DOI 10.1152/ajplung.2001.281.1.L31; Venketaraman V, 2008, MICROB PATHOGENESIS, V44, P255, DOI 10.1016/j.micpath.2007.09.002; Visca A, 2008, J CYST FIBROS, V7, P433, DOI 10.1016/j.jcf.2008.03.006	42	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47550	10.1371/journal.pone.0047550	http://dx.doi.org/10.1371/journal.pone.0047550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094061	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200029
J	Katsura, Y; Satta, Y				Katsura, Yukako; Satta, Yoko			No Evidence for a Second Evolutionary Stratum during the Early Evolution of Mammalian Sex Chromosomes	PLOS ONE			English	Article							Y-CHROMOSOME; DNA-SEQUENCE; GENE; PLATYPUS; PROTEIN; ORIGIN; MODEL; DEGENERATION; DISTANCE; REGION	Mammalian sex chromosomes originated from a pair of autosomes, and homologous genes on the sex chromosomes (gametologs) differentiated through recombination arrest between the chromosomes. It was hypothesized that this differentiation in eutherians took place in a stepwise fashion and left a footprint on the X chromosome termed "evolutionary strata.'' The evolutionary stratum hypothesis claims that strata 1 and 2 (which correspond to the first two steps of chromosomal differentiation) were generated in the stem lineage of Theria or before the divergence between eutherians and marsupials. However, this prediction relied solely on the molecular clock hypothesis between pairs of human gametologs, and molecular evolution of marsupial sex chromosomal genes has not yet been investigated. In this study, we analyzed the following 7 pairs of marsupial gametologs, together with their eutherian orthologs that reside in stratum 1 or 2: SOX3/SRY, RBMX/Y, RPS4X/Y, HSFX/Y, XKRX/Y, SMCX/Y (KDM5C/D, JARID1C/D), and UBE1X/Y (UBA1/UBA1Y). Phylogenetic analyses and estimated divergence time of these gametologs reveal that they all differentiated at the same time in the therian ancestor. We have also provided strong evidence for gene conversion that occurred in the 39 region of the eutherian stratum 2 genes (SMCX/Y and UBE1X/Y). The results of the present study show that (1) there is no compelling evidence for the second stratum in the stem lineage of Theria; (2) gene conversion, which may have occurred between SMCX/Y and UBE1X/Y in the eutherian lineage, potentially accounts for their apparently lower degree of overall divergence.	[Katsura, Yukako; Satta, Yoko] Grad Univ Adv Studies Sokendai, Dept Evolutionary Study Biosyst, Hayama, Kanagawa, Japan	Graduate University for Advanced Studies - Japan	Satta, Y (corresponding author), Grad Univ Adv Studies Sokendai, Dept Evolutionary Study Biosyst, Hayama, Kanagawa, Japan.	satta@soken.ac.jp	Katsura, Yukako/V-1413-2018	Satta, Yoko/0000-0002-5305-493X	Graduate University for Advanced Studies;  [17018032]	Graduate University for Advanced Studies; 	This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas (17018032; http://www.mext.go.jp/english/index.htm) and The Graduate University for Advanced Studies (http://www.soken.ac.jp/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhowmick BK, 2007, GENOME RES, V17, P441, DOI 10.1101/gr.5734907; Calenda G, 2006, GENE, V370, P6, DOI 10.1016/j.gene.2005.10.037; Carvalho-Silva DR, 2004, CHROMOSOME RES, V12, P795, DOI 10.1007/s10577-005-5376-5; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Deakin JE, 2008, CHROMOSOME RES, V16, P1159, DOI 10.1007/s10577-008-1266-y; Elango N, 2009, BIOL LETTERS, V5, P405, DOI 10.1098/rsbl.2008.0712; FOSTER JW, 1992, NATURE, V359, P531, DOI 10.1038/359531a0; Goodstadt L, 2007, GENOME RES, V17, P969, DOI 10.1101/gr.6093907; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Iwase M, 2003, P NATL ACAD SCI USA, V100, P5258, DOI 10.1073/pnas.0635848100; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; JUKES T H, 1969, P21; Katsura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020365; KIMURA M, 1972, J MOL EVOL, V2, P87, DOI 10.1007/BF01653945; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Makova KD, 2004, GENOME RES, V14, P567, DOI 10.1101/gr.1971104; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Matsunaga S, 2006, GENES GENET SYST, V81, P219, DOI 10.1266/ggs.81.219; Mitchell MJ, 1998, HUM MOL GENET, V7, P429, DOI 10.1093/hmg/7.3.429; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; Muller H. J., 1914, Science New York N S, V39, DOI 10.1126/science.39.1016.906-a; Murtagh VJ, 2012, GENOME RES, V22, P498, DOI 10.1101/gr.120790.111; NEI M, 1969, GENETICS, V63, P669; OHNO S, 1967, SEX CHROMOSOME SEX L; Omoe K, 1996, GENOMICS, V31, P44, DOI 10.1006/geno.1996.0007; Painter TS, 1923, SCIENCE, V58, P247, DOI 10.1126/science.58.1500.247; Pask A, 2000, P NATL ACAD SCI USA, V97, P13198, DOI 10.1073/pnas.230424497; Rens W, 2004, P NATL ACAD SCI USA, V101, P16257, DOI 10.1073/pnas.0405702101; Ross JA, 2008, GENETICS, V179, P2173, DOI 10.1534/genetics.108.088559; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandstedt SA, 2004, GENOME RES, V14, P267, DOI 10.1101/gr.1796204; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SOURDIS J, 1988, MOL BIOL EVOL, V5, P298; TAKAHATA N, 1991, MOL BIOL EVOL, V8, P494; TAKAHATA N, 1994, IMMUNOGENETICS, V39, P146, DOI 10.1007/BF00188618; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Rheede T, 2006, MOL BIOL EVOL, V23, P587, DOI 10.1093/molbev/msj064; Veyrunes F, 2008, GENOME RES, V18, P965, DOI 10.1101/gr.7101908; Wallis MC, 2007, CHROMOSOME RES, V15, P949, DOI 10.1007/s10577-007-1185-3; Wilkerson AJP, 2008, GENOMICS, V92, P329, DOI 10.1016/j.ygeno.2008.06.012; Wilson MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000568; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1	54	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e45488	10.1371/journal.pone.0045488	http://dx.doi.org/10.1371/journal.pone.0045488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094017	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200002
J	Lori, F; De Forni, D; Katabira, E; Baev, D; Maserati, R; Calarota, SA; Cahn, P; Testori, M; Rakhmanova, A; Stevens, MR				Lori, Franco; De Forni, Davide; Katabira, Elly; Baev, Denis; Maserati, Renato; Calarota, Sandra A.; Cahn, Pedro; Testori, Marco; Rakhmanova, Aza; Stevens, Michael R.			VS411 Reduced Immune Activation and HIV-1 RNA Levels in 28 Days: Randomized Proof-of-Concept Study for AntiViral-HyperActivation Limiting Therapeutics	PLOS ONE			English	Article							T-CELL-ACTIVATION; POTENT ANTIRETROVIRAL THERAPY; VIRUS TYPE-1 REPLICATION; PLACEBO-CONTROLLED TRIAL; CLINICAL-TRIAL; HIV-1-INFECTED INDIVIDUALS; INFECTED PATIENTS; HYDROXYUREA; DIDANOSINE; COMBINATION	Background: A new class of antiretrovirals, AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs), has been proposed as a disease-modifying therapy to both reduce Human Immunodeficiency Virus Type 1 (HIV-1) RNA levels and the excessive immune activation now recognized as the major driver of not only the continual loss of CD4(+) T cells and progression to Acquired Immunodeficiency Syndrome (AIDS), but also of the emergence of both AIDS-defining and non-AIDS events that negatively impact upon morbidity and mortality despite successful (ie, fully suppressive) therapy. VS411, the first-in-class AV-HALT, combined low-dose, slow-release didanosine with low-dose hydroxycarbamide to accomplish both objectives with a favorable toxicity profile during short-term administration. Five dose combinations were administered as VS411 to test the AV-HALT Proof-of-Concept in HIV-1-infected subjects. Methods: Multinational, double-blind, 28-day Phase 2a dose-ranging Proof-of-Concept study of antiviral activity, immunological parameters, safety, and genotypic resistance in 58 evaluable antiretroviral-naive HIV-1-infected adults. Randomization and allocation to study arms were carried out by a central computer system. Results were analyzed by ANOVA, Kruskal-Wallis, ANCOVA, and two-tailed paired t tests. Results: VS411 was well-tolerated, produced significant reductions of HIV-1 RNA levels, increased CD4(+) T cell counts, and led to significant, rapid, unprecedented reductions of immune activation markers after 28 days despite incomplete viral suppression and without inhibiting HIV-1-specific immune responses. The didanosine 200 mg/HC 900 mg once-daily formulation demonstrated the greatest antiviral efficacy (HIV-1 RNA: -1.47 log(10) copies/mL; CD4(+) T cell count: + 135 cells/mm 3) and fewest adverse events. Conclusions: VS411 successfully established the Proof-of-Concept that AV-HALTs can combine antiviral efficacy with rapid, potentially beneficial reductions in the excessive immune system activation associated with HIV-1 disease. Rapid reductions in markers of immune system hyperactivation and cellular proliferation were obtained despite the fact that VS411 did not attain maximal suppression of HIV RNA, suggesting this effect was due to the HALT component.	[Lori, Franco; De Forni, Davide; Baev, Denis; Calarota, Sandra A.; Testori, Marco] ViroStatics Srl, Alghero, Italy; [Katabira, Elly] Makerere Med Sch, Kampala, Uganda; [Maserati, Renato] Carattere Sci Policlin San Matteo, Fdn Ist Ricovero & Cura, Infect Dis Unit, Pavia, Italy; [Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Rakhmanova, Aza] St Petersburg Hlth Dept, Dept Infect Dis, St Petersburg, Russia; [Stevens, Michael R.] ViroStatics Srl, Princeton, NJ USA	Makerere University; IRCCS Fondazione San Matteo	Lori, F (corresponding author), ViroStatics Srl, Alghero, Italy.	info@virostatics.it			ViroStatics srl	ViroStatics srl	The study was sponsored by commercial funder ViroStatics srl; FL, DDF and MRS are currently consultants to, employees of and/or hold shares or options in ViroStatics srl. FL is the CEO and President of the Board of ViroStatics srl. Although VS411 is not being commercially developed, there are several patents to protect the VS411 combination product and technology in which FL is an inventor, as follows: "Method of Inhibiting Human Immunodeficiency Virus by combined use of Hydroxyurea, a nucleoside analog, and a protease inhibitor", USSN 08/812,515 filed Mar 7, 1997. Issued as USPN 6,114,312 on Sep 5, 2000. HU + ddI + protease inhibitor ("Triple Combination Continuation") Inventors: Julianna Lisziewicz; FL. USSN 09/048,886, WO/1999/048504 filed Mar 26, 1998. Issued as USPN 6,251,874 on June 26, 2001: "Method of Inhibiting Human Immunodeficiency Virus using Hydroxyurea and a Reverse Transcriptase Inhibitor in vivo". Issued. Method, HU+ddI+Indinavir OR HU + ddI, depending on viral load ("Double or Triple") Inventors: Julianna Lisziewicz; FL. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Biron F, 1996, ANTIVIR RES, V29, P111, DOI 10.1016/0166-3542(95)00931-0; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cauley JA, 2007, J BONE MINER RES, V22, P1088, DOI 10.1359/JBMR.070409; De Forni D, 2010, BRIT J PHARMACOL, V161, P830, DOI 10.1111/j.1476-5381.2010.00940.x; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; DONEHOWER RC, 1992, SEMIN ONCOL, V19, P11; Douek Daniel C., 2003, AIDS Reviews, V5, P172; Evans TG, 1998, ANTIVIR RES, V39, P163, DOI 10.1016/S0166-3542(98)00035-7; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Foli A, 2001, AIDS, V15, P1687, DOI 10.1097/00002030-200109070-00012; Foli A, 1997, Antivir Ther, V2, P31; Frank I, 2004, AIDS RES HUM RETROV, V20, P916, DOI 10.1089/aid.2004.20.916; Ganesan A, 2011, J INFECT DIS, V203, P756, DOI 10.1093/infdis/jiq115; GAO WY, 1993, P NATL ACAD SCI USA, V90, P8925, DOI 10.1073/pnas.90.19.8925; Giguere JF, 2004, J VIROL, V78, P12062, DOI 10.1128/JVI.78.21.12062-12065.2004; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Grossman Z, 2000, NAT MED, V6, P976, DOI 10.1038/79667; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; Heredia A, 2003, P NATL ACAD SCI USA, V100, P4179, DOI 10.1073/pnas.0630584100; Ho JE, 2010, AIDS, V24, P1897, DOI 10.1097/QAD.0b013e32833bee44; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Lesho Emil, 2006, Expert Rev Anti Infect Ther, V4, P469, DOI 10.1586/14787210.4.3.469; Lisziewicz J, 2003, DRUG SAFETY, V26, P605, DOI 10.2165/00002018-200326090-00002; Lori F, 2005, AIDS, V19, P1173, DOI 10.1097/01.aids.0000176217.02743.d1; Lori F, 1997, AIDS RES HUM RETROV, V13, P1403, DOI 10.1089/aid.1997.13.1403; Lori F, 1997, AIDS RES HUM RETROV, V13, P1083, DOI 10.1089/aid.1997.13.1083; LORI F, 1994, SCIENCE, V266, P801, DOI 10.1126/science.7973634; Lubinski C, 2009, CLIN INFECT DIS, V48, P1335, DOI 10.1086/598169; MAHALINGAM M, 1993, CLIN EXP IMMUNOL, V93, P337, DOI 10.1111/j.1365-2249.1993.tb08182.x; MALLEY SD, 1994, P NATL ACAD SCI USA, V91, P11017, DOI 10.1073/pnas.91.23.11017; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Mitsuyasu Ronald T, 2008, Top HIV Med, V16, P117; Moncunill G, 2005, AIDS, V19, P1697, DOI 10.1097/01.aids.0000183517.60384.db; Montaner JSG, 1997, J INFECT DIS, V175, P801, DOI 10.1086/513974; Montoya CJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-41; Murray SM, 2010, J VIROL, V84, P12082, DOI 10.1128/JVI.01466-10; Navarra P, 1999, CRIT REV ONCOL HEMAT, V29, P249, DOI 10.1016/S1040-8428(98)00032-8; Palmer S, 1999, ANTIMICROB AGENTS CH, V43, P2046, DOI 10.1128/AAC.43.8.2046; Piconi S., 2011, BLOOD; Ravot E, 1999, DRUGS, V58, P953, DOI 10.2165/00003495-199958060-00001; Read SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011937; Rutschmann OT, 1998, AIDS, V12, pF71, DOI 10.1097/00002030-199808000-00003; Silvestri G, 2005, J VIROL, V79, P4043, DOI 10.1128/JVI.79.7.4043-4054.2005; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Vila J, 1997, LANCET, V350, P635, DOI 10.1016/S0140-6736(97)24035-3; YARBRO JW, 1992, SEMIN ONCOL, V19, P1	50	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47485	10.1371/journal.pone.0047485	http://dx.doi.org/10.1371/journal.pone.0047485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094055	Green Published, gold			2022-12-27	WOS:000310050200027
J	Grellet-Tinner, G; Murelaga, X; Larrasoana, JC; Silveira, LF; Olivares, M; Ortega, LA; Trimby, PW; Pascual, A				Grellet-Tinner, Gerald; Murelaga, Xabier; Larrasoana, Juan C.; Silveira, Luis F.; Olivares, Maitane; Ortega, Luis A.; Trimby, Patrick W.; Pascual, Ana			The First Occurrence in the Fossil Record of an Aquatic Avian Twig-Nest with Phoenicopteriformes Eggs: Evolutionary Implications	PLOS ONE			English	Article							EBRO BASIN; LOWER MIOCENE; AVES; DIFFRACTION; PHYLOGENY; BIRDS	Background: We describe the first occurrence in the fossil record of an aquatic avian twig-nest with five eggs in situ (Early Miocene Tudela Formation, Ebro Basin, Spain). Extensive outcrops of this formation reveal autochthonous avian osteological and oological fossils that represent a single taxon identified as a basal phoenicopterid. Although the eggshell structure is definitively phoenicopterid, the characteristics of both the nest and the eggs are similar to those of modern grebes. These observations allow us to address the origin of the disparities between the sister taxa Podicipedidae and Phoenicopteridae crown clades, and traces the evolution of the nesting and reproductive environments for phoenicopteriforms. Methodology/Principal Findings: Multi-disciplinary analyses performed on fossilized vegetation and eggshells from the eggs in the nest and its embedding sediments indicate that this new phoenicopterid thrived under a semi-arid climate in an oligohaline (seasonally mesohaline) shallow endorheic lacustine environment. High-end microcharacterizations including SEM, TEM, and EBSD techniques were pivotal to identifying these phoenicopterid eggshells. Anatomical comparisons of the fossil bones with those of Phoenicopteriformes and Podicipediformes crown clades and extinct palaelodids confirm that this avian fossil assemblage belongs to a new and basal phoenicopterid. Conclusions/Significance: Although the Podicipediformes-Phoenicopteriformes sister group relationship is now well supported, flamingos and grebes exhibit feeding, reproductive, and nesting strategies that diverge significantly. Our multi-disciplinary study is the first to reveal that the phoenicopteriform reproductive behaviour, nesting ecology and nest characteristics derived from grebe-like type strategies to reach the extremely specialized conditions observed in modern flamingo crown groups. Furthermore, our study enables us to map ecological and reproductive characters on the Phoenicopteriformes evolutionary lineage. Our results demonstrate that the nesting paleoenvironments of flamingos were closely linked to the unique ecology of this locality, which is a direct result of special climatic (high evaporitic regime) and geological (fault system) conditions.	[Grellet-Tinner, Gerald] CRILAR, CONICET, Anillaco, Argentina; [Grellet-Tinner, Gerald] Field Museum, Chicago, IL USA; [Grellet-Tinner, Gerald] Journey Museum, Rapid City, SD USA; [Murelaga, Xabier; Olivares, Maitane; Ortega, Luis A.; Pascual, Ana] Euskal Herriko Unibertsitatea, Fac Ciencia & Tecnol, Dept Estratig & Paleontol, Bilbao, Spain; [Larrasoana, Juan C.] Inst Geol & Minero Espana, Zaragoza, Spain; [Silveira, Luis F.] Univ Sao Paulo, Secao Aves, Museu Zool, Sao Paulo, Brazil; [Trimby, Patrick W.] Univ Sydney, Australian Ctr Microscopy & Microanal, Sydney, NSW 2006, Australia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Field Museum of Natural History (Chicago); University of Basque Country; Universidade de Sao Paulo; University of Sydney	Grellet-Tinner, G (corresponding author), CRILAR, CONICET, Anillaco, Argentina.	locarnolugano@gmail.com	Olivares, Maitane/C-4044-2017; Larrasoana, Juan C./O-1350-2013; Silveira, Luis Fabio/F-8337-2012; Murelaga, Xabier/O-2262-2019; Olivares, Maitane/AAY-7123-2021; Silveira, Luis/V-6161-2019; Pascual, Ana/F-8753-2016; Ortega, Luis Angel/K-8453-2014	Olivares, Maitane/0000-0001-7047-3055; Silveira, Luis Fabio/0000-0003-2576-7657; Murelaga, Xabier/0000-0001-8049-4917; Silveira, Luis/0000-0003-2576-7657; Pascual, Ana/0000-0001-9822-6478; Ortega, Luis Angel/0000-0002-8929-0328; Larrasoana, Juan Cruz/0000-0003-4568-631X	Australian Microscopy and Microanalysis Research Facility TAP GRANT [1016]; REMOSS 3D-4D [CGL2007-66431-C02-02/BTE]; FAPESP (Fundacao de Amparo a Pesquisa no Estado de Sao Paulo) [2007/56378-0]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [313818/2009-6]	Australian Microscopy and Microanalysis Research Facility TAP GRANT; REMOSS 3D-4D; FAPESP (Fundacao de Amparo a Pesquisa no Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for eggshell microcharacterization came from the Australian Microscopy and Microanalysis Research Facility TAP GRANT# 1016 (to GGT). Fieldwork was supported by project REMOSS 3D-4D CGL2007-66431-C02-02/BTE (to XM and JCL) and some laboratory analyses were funded by the FAPESP (Fundacao de Amparo a Pesquisa no Estado de Sao Paulo, grant 2007/56378-0) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant 313818/2009-6) (to LFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Zarza A.M., 2002, GEOLOGY SPAIN, DOI [10.1144/gospp.13, DOI 10.1144/GOSPP.13]; ALVARENGA H M F, 1990, Anais da Academia Brasileira de Ciencias, V62, P335; Arenas C, 1999, PALAEOGEOGR PALAEOCL, V151, P127, DOI 10.1016/S0031-0182(99)00025-5; Bohme M, 2003, PALAEOGEOGR PALAEOCL, V195, P389, DOI 10.1016/S0031-0182(03)00367-5; Boles WE, 1991, ACT 20 C INT ORN; Bonaparte CL, 1838, GEOGRAPHICAL COMP LI; Caziani Sandra M., 2000, Waterbirds, V23, P121, DOI 10.2307/1522157; CHENEVAL J, 1983, GEOBIOS-LYON, V16, P179, DOI 10.1016/S0016-6995(83)80018-7; DINGLEY DJ, 1984, SCAN ELECTRON MICROS, P569; Feduccia A, 1999, P NATL ACAD SCI USA, V96, P4740, DOI 10.1073/pnas.96.9.4740; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Garces M, 2009, GEOPH RES ABSTR, V11, P4594; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; Grellet-Tinner G, 2006, ALCHERINGA, V30, P141, DOI 10.1080/03115510608619350; Grellet-Tinner G, 2000, 1 INT S DIN EGGS BAB, P61; Grellet-Tinner G, 2011, GONDWANA RES, V20, P621, DOI 10.1016/j.gr.2011.02.007; HARTMANN G, 1974, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V70, P7; Hilgen FJ, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P923, DOI 10.1016/B978-0-444-59425-9.00029-9; Horne DJ, 2002, GEOPH MONOG SERIES, V131, P5; Johnsgard PA, 2009, BIRDS GREAT PLAINS; Kempf EK, 1997, INDEX BIBLIO NONMARI; Kempf EK, 1980, INDEX BIBLIO NONMARI; Kohring R, 1999, STRUKTUREN BIOSTRATI; Larrasoana JC, 2006, EARTH PLANET SC LETT, V243, P409, DOI 10.1016/j.epsl.2006.01.034; Llimona F., 1992, P174; Luzon A, 2002, J PALEOLIMNOL, V28, P441, DOI 10.1023/A:1021675227754; Mayr G, 2005, BIOL REV, V80, P515, DOI 10.1017/S1464793105006779; Mayr G, 2004, ZOOL J LINN SOC-LOND, V140, P157, DOI 10.1111/j.1096-3642.2003.00094.x; Mayr G., 2006, SPECIES PHYLOGENY EV, V1, P59; Mayr Gerald, 2002, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V72, P139; Mayr Gerald, 2011, Palaeobiodiversity Palaeoenvironments, V91, P325, DOI 10.1007/s12549-011-0062-4; Meisch C, 2000, SUSSWASSERFAUNA MITT, V8, P522; Murelaga X, 2002, GEOBIOS-LYON, V35, P347, DOI 10.1016/S0016-6995(02)00031-1; Murelaga X., 2006, Munibe (Ciencias Naturales - Natur Zientziak), V55, P7; MURELAGA X., 2004, GEOGACETA, V36, P179; Murelaga X, 2000, ESTUDIO FAUNAS VERTE; Olivares M, 2011, J CHROMATOGR A, V1218, P1656, DOI 10.1016/j.chroma.2010.11.034; Olson S.L., 1985, Avian Biology, V8, P79; Olson S.L., 1980, Smithsonian Contributions to Zoology, P1; Olson Storrs L., 1995, Courier Forschungsinstitut Senckenberg, V181, P131; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Peters K.E., 2005, BIOMARKER GUIDE; Pipik R, 2007, ACTA PALAEONTOL POL, V52, P351; Polhill R. M., 1981, Advances in legume systematics. Part 1 [Polhill, R.M.; Raven, P.H. (Editors)]., P1; Prior DJ, 1999, AM MINERAL, V84, P1741; Rasmussen DT, 1987, FOSSIL BIRDS OLIGOCE; RICH P V, 1987, Memoirs of the Queensland Museum, V25, P207; Ruiz-Sanchez FJ, 2012, ACTA PALAEONTOL POL, V57, P225, DOI 10.4202/app.2010.0081; SALVANY JM, 1994, J SEDIMENT RES A, V64, P190; Salvany JM, 2007, SEDIMENTOLOGY, V54, P443, DOI 10.1111/j.1365-3091.2006.00844.x; Sangster G, 2005, IBIS, V147, P612, DOI 10.1111/j.1474-919x.2005.00432.x; Schwartz A. J., 2009, ELECT BACKSCATTER DI; Soto R, 2009, J STRUCT GEOL, V31, P512, DOI 10.1016/j.jsg.2009.03.006; Svec P., 1982, Casopis pro Mineralogii a Geologii, V27, P243; Svec P, 1984, CASOPIS PRO MINERALO, V29, P167; Trimby P, 2011, HIDDEN SECRETS DINOS, V24, P4; Van Tuinen M, 2001, P ROY SOC B-BIOL SCI, V268, P1345; VANBERGEN PF, 1994, GEOCHIM COSMOCHIM AC, V58, P231, DOI 10.1016/0016-7037(94)90460-X; Vanden Berge James C., 1993, Publications of the Nuttall Ornithological Club, V23, P189; Worthy TH, 2010, REC AUST MUS, V62, P77, DOI 10.3853/j.0067-1975.62.2010.1545	60	22	22	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46972	10.1371/journal.pone.0046972	http://dx.doi.org/10.1371/journal.pone.0046972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082136	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900031
J	Dworeck, T; Zimmermann, M				Dworeck, Tamara; Zimmermann, Martin			Site Directed Mutagenesis of Schizosaccharomyces pombe Glutathione Synthetase Produces an Enzyme with Homoglutathione Synthetase Activity	PLOS ONE			English	Article							RAT-KIDNEY; GENE; BIOSYNTHESIS	Three different His-tagged, mutant forms of the fission yeast glutathione synthetase (GSH2) were derived by site-directed mutagenesis. The mutant and wild-type enzymes were expressed in E. coli DH5 alpha and affinity purified in a two-step procedure. Analysis of enzyme activity showed that it was possible to shift the substrate specificity of GSH2 from Gly (k(m) 0,19; wild-type) to beta-Ala or Ser. One mutation (substitution of Ile471, Cy472 to Met and Val and Ala 485 and Thr486 to Leu and Pro) increased the affinity of GSH2 for beta-Ala (k(m) 0,07) and lowered the affinity for Gly (k(m) 0,83), which is a characteristic of the enzyme homoglutathione synthetase found in plants. Substitution of Ala485 and Thr486 to Leu and Pro only, increased instead the affinity of GSH2 for Ser (k(m) 0,23) as a substrate, while affinity to Gly was preserved (k(m) 0,12). This provides a new biosynthetic pathway for hydroxymethyl glutathione, which is known to be synthesized from glutathione and Ser in a reaction catalysed by carboxypeptidase Y. The reported findings provide further insight into how specific amino acids positioned in the GSH2 active site facilitate the recognition of different amino acid substrates, furthermore they support the evolutionary theory that homoglutathione synthetase evolved from glutathione synthetase by a single gene duplication event.	[Zimmermann, Martin] Rhein Westfal TH Aachen, Inst Biol Appl Microbiol 4, Aachen, Germany; [Dworeck, Tamara] Rhein Westfal TH Aachen, Dept Biol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University	Zimmermann, M (corresponding author), Rhein Westfal TH Aachen, Inst Biol Appl Microbiol 4, Aachen, Germany.	Martin.Zimmermann@rwth-aachen.de	Dworeck, Tamara/G-3429-2012	Dworeck, Tamara/0000-0002-8975-7776	RWTH Aachen University	RWTH Aachen University	This work was funded by RWTH Aachen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Al-Lahham A, 1999, YEAST, V15, P385, DOI 10.1002/(SICI)1097-0061(19990330)15:5<385::AID-YEA382>3.0.CO;2-6; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; Bernhard W R, 1987, Experientia Suppl, V52, P309; Frendo P, 2001, PLANT PHYSIOL, V126, P1706, DOI 10.1104/pp.126.4.1706; HUANG CS, 1995, P NATL ACAD SCI USA, V92, P1232, DOI 10.1073/pnas.92.4.1232; KLAPHECK S, 1992, BOT ACTA, V105, P174, DOI 10.1111/j.1438-8677.1992.tb00284.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACNICOL PK, 1987, PLANT SCI, V53, P229, DOI 10.1016/0168-9452(87)90159-2; MACNICOL PK, 1984, PLANT SCI LETT, V36, P219, DOI 10.1016/0304-4211(84)90172-X; MEISTER A, 1985, METHOD ENZYMOL, V113, P393; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Okumura R, 2003, BIOSCI BIOTECH BIOCH, V67, P434, DOI 10.1271/bbb.67.434; Penninckx M, 2000, ENZYME MICROB TECH, V26, P737, DOI 10.1016/S0141-0229(00)00165-4; Phlippen N, 2003, J BIOL CHEM, V278, P40152, DOI 10.1074/jbc.M303102200; Polekhina G, 1999, EMBO J, V18, P3204, DOI 10.1093/emboj/18.12.3204; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Skipsey M, 2005, BIOCHEM J, V391, P567, DOI 10.1042/BJ20050718; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	21	0	0	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46580	10.1371/journal.pone.0046580	http://dx.doi.org/10.1371/journal.pone.0046580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091597	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800009
J	Nicastro, KR; Zardi, GI; McQuaid, CD; Pearson, GA; Serrao, EA				Nicastro, Katy R.; Zardi, Gerardo I.; McQuaid, Christopher D.; Pearson, Gareth A.; Serrao, Ester A.			Love Thy Neighbour: Group Properties of Gaping Behaviour in Mussel Aggregations	PLOS ONE			English	Article							INDIGENOUS PERNA-PERNA; INVASIVE MYTILUS-GALLOPROVINCIALIS; ROCKY INTERTIDAL ZONE; CLIMATE-CHANGE; BODY-TEMPERATURE; WAVE EXPOSURE; SOUTH-AFRICA; ATTACHMENT STRENGTH; SEASONAL-VARIATION; OXYGEN-TENSION	By associating closely with others to form a group, an animal can benefit from a number of advantages including reduced risk of predation, amelioration of environmental conditions, and increased reproductive success, but at the price of reduced resources. Although made up of individual members, an aggregation often displays novel effects that do not manifest at the level of the individual organism. Here we show that very simple behaviour in intertidal mussels shows new effects in dense aggregations but not in isolated individuals. Perna perna and Mytilus galloprovincialis are gaping (periodic valve movement during emersion) and non-gaping mussels respectively. P. perna gaping behaviour had no effect on body temperatures of isolated individuals, while it led to increased humidity and decreased temperatures in dense groups (beds). Gaping resulted in cooler body temperatures for P. perna than M. galloprovincialis when in aggregations, while solitary individuals exhibited the highest temperatures. Gradients of increasing body temperature were detected from the center to edges of beds, but M. galloprovincialis at the edge had the same temperature as isolated individuals. Furthermore, a field study showed that during periods of severe heat stress, mortality rates of mussels within beds of the gaping P. perna were lower than those of isolated individuals or within beds of M. galloprovincialis, highlighting the determinant role of gaping on fitness and group functioning. We demonstrate that new effects of very simple individual behaviour lead to amelioration of abiotic conditions at the aggregation level and that these effects increase mussel resistance to thermal stress.	[Nicastro, Katy R.; Zardi, Gerardo I.; Pearson, Gareth A.; Serrao, Ester A.] Univ Algarve, CCMAR CIMAR Lab Associado, Faro, Portugal; [McQuaid, Christopher D.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Universidade do Algarve; Rhodes University	Zardi, GI (corresponding author), Univ Algarve, CCMAR CIMAR Lab Associado, Faro, Portugal.	zardi73@yahoo.it	Pearson, Gareth/J-3911-2013; Zardi, Gerardo/M-4026-2013; McQuaid, Christopher/AAT-3725-2020; Nicastro, Katy R/ABI-1531-2020; Serrao, Ester A/C-6686-2012; Nicastro, Katy/AAY-3692-2021; Nicastro, Katy/D-2259-2012	Pearson, Gareth/0000-0002-0768-464X; Zardi, Gerardo/0000-0001-8798-5794; McQuaid, Christopher/0000-0002-3473-8308; Nicastro, Katy R/0000-0002-7071-141X; Serrao, Ester A/0000-0003-1316-658X; Nicastro, Katy/0000-0002-7071-141X	FCT, Portugal; FCT [PTDC/BIA-BEC/103916/2008]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BEC/103916/2008] Funding Source: FCT	FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Fundação para a Ciência e a Tecnologia	This research was supported by post-doctoral fellowships from FCT, Portugal (to GIZ) and funded by project PTDC/BIA-BEC/103916/2008 from FCT (to GIZ). This work is based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, BIOPHYSICAL PLANT PH; BAYNE BL, 1976, OECOLOGIA, V22, P229, DOI 10.1007/BF00344794; Bownes SJ, 2006, J EXP MAR BIOL ECOL, V338, P140, DOI 10.1016/j.jembe.2006.07.006; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bryant SR, 2000, OECOLOGIA, V122, P1, DOI 10.1007/PL00008825; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Bulleri F, 2008, PLOS BIOL, V6, P1136, DOI 10.1371/journal.pbio.0060162; Bulleri F, 2009, J ECOL, V97, P1121, DOI 10.1111/j.1365-2745.2009.01567.x; Carrington E, 2002, LIMNOL OCEANOGR, V47, P1723, DOI 10.4319/lo.2002.47.6.1723; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Connell J.H., 1972, Annual Rev Ecol Syst, V3, P169, DOI 10.1146/annurev.es.03.110172.001125; Cote IM, 1999, J EXP MAR BIOL ECOL, V235, P201, DOI 10.1016/S0022-0981(98)00155-5; Davenport J, 2005, MAR ECOL PROG SER, V292, P41, DOI 10.3354/meps292041; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; FAMME P, 1980, COMP BIOCHEM PHYS A, V66, P161, DOI 10.1016/0300-9629(80)90147-4; FIELDS PA, 1993, TRENDS ECOL EVOL, V8, P361, DOI 10.1016/0169-5347(93)90220-J; Fitzhenry T, 2004, MAR BIOL, V145, P339, DOI 10.1007/s00227-004-1318-6; Gautier P, 2006, BEHAV ECOL SOCIOBIOL, V59, P836, DOI 10.1007/s00265-005-0130-8; Gerlach JD, 2003, ECOL APPL, V13, P167, DOI 10.1890/1051-0761(2003)013[0167:TLHCOI]2.0.CO;2; Gilman SE, 2006, P NATL ACAD SCI USA, V103, P9560, DOI 10.1073/pnas.0510992103; Guinez R, 1999, AM NAT, V154, P341, DOI 10.1086/303234; Guiñez Ricardo, 2005, Rev. biol. mar. oceanogr., V40, P1; Hamner WM, 1997, IS SUM PARTS EQUAL W, P163; HEINRICH B, 1981, SCIENCE, V212, P565, DOI 10.1126/science.212.4494.563; Helmuth B, 2003, LIMNOL OCEANOGR, V48, P1338, DOI 10.4319/lo.2003.48.3.1338; Helmuth B, 2006, ECOL MONOGR, V76, P461, DOI 10.1890/0012-9615(2006)076[0461:MPOTSI]2.0.CO;2; Helmuth BST, 2001, BIOL BULL-US, V201, P374, DOI 10.2307/1543615; Helmuth BST, 1998, ECOL MONOGR, V68, P51, DOI 10.1890/0012-9615(1998)068[0051:IMMPTB]2.0.CO;2; HU SXS, 1995, ECOLOGY, V76, P2278, DOI 10.2307/1941702; Jost J, 2007, BIOL BULL-US, V213, P141, DOI 10.2307/25066630; Krause J, 2002, LIVING GROUPS; Leicht-Young SA, 2007, OECOLOGIA, V154, P273, DOI 10.1007/s00442-007-0839-3; LENT CM, 1969, AM ZOOL, V9, P283; Lourenco Carla R., 2012, Marine Biodiversity Records, V5, pe39, DOI 10.1017/S1755267212000280; Marsden ID, 1998, J EXP MAR BIOL ECOL, V230, P15, DOI 10.1016/S0022-0981(98)00067-7; McKechnie AE, 2001, PHYSIOL BIOCHEM ZOOL, V74, P238, DOI 10.1086/319669; MCMAHON RF, 1983, AM ZOOL, V23, P938; MCQUAID CD, 1979, J THERM BIOL, V4, P47, DOI 10.1016/0306-4565(79)90045-7; Miller LP, 2009, FUNCT ECOL, V23, P756, DOI 10.1111/j.1365-2435.2009.01567.x; Moeser GM, 2006, J EXP BIOL, V209, P1996, DOI 10.1242/jeb.02234; MOON T W, 1970, Journal of Experimental Marine Biology and Ecology, V5, P35, DOI 10.1016/0022-0981(70)90027-4; Nicastro KR, 2007, MAR ECOL PROG SER, V336, P169, DOI 10.3354/meps336169; Nicastro KR, 2010, BIOL INVASIONS, V12, P2165, DOI 10.1007/s10530-009-9619-9; Nicastro KR, 2008, MAR ECOL PROG SER, V372, P119, DOI 10.3354/meps07671; Nicastro Katy R., 2010, BMC Ecology, V10, P17, DOI 10.1186/1472-6785-10-17; Paine R. T., 1994, MARINE ROCKY SHORES; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Rius M, 2006, MAR BIOL, V150, P69, DOI 10.1007/s00227-006-0322-4; Robinson TB, 2005, AFR J MAR SCI, V27, P297, DOI 10.2989/18142320509504088; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Stamp NE, 1993, CATERPILLARS ECOLOGI, P5; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; Underwood A.J., 2002, GMAV 5 WINDOWS ANAL; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952; Wethey DS, 2008, HYDROBIOLOGIA, V606, P139, DOI 10.1007/s10750-008-9338-8; WIDDOWS J, 1979, COMP BIOCHEM PHYS A, V62, P301, DOI 10.1016/0300-9629(79)90060-4; Zardi G, 2011, OECOLOGIA, P1; Zardi GI, 2008, MAR BIOL, V153, P853, DOI 10.1007/s00227-007-0857-z; Zardi GI, 2006, MAR BIOL, V150, P79, DOI 10.1007/s00227-006-0328-y	60	44	44	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47382	10.1371/journal.pone.0047382	http://dx.doi.org/10.1371/journal.pone.0047382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091620	Green Submitted, gold, Green Published			2022-12-27	WOS:000310135800043
J	Westengen, OT; Berg, PR; Kent, MP; Brysting, AK				Westengen, Ola T.; Berg, Paul R.; Kent, Matthew P.; Brysting, Anne K.			Spatial Structure and Climatic Adaptation in African Maize Revealed by Surveying SNP Diversity in Relation to Global Breeding and Landrace Panels	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; GENETIC DIVERSITY; DNA MICROSATELLITES; SOUTHERN AFRICA; FLOWERING TIME; INBRED LINES; MAYS L.; ASSOCIATION	Background: Climate change threatens maize productivity in sub-Saharan Africa. To ensure food security, access to locally adapted genetic resources and varieties is an important adaptation measure. Most of the maize grown in Africa is a genetic mix of varieties introduced at different historic times following the birth of the trans-Atlantic economy, and knowledge about geographic structure and local adaptations is limited. Methodology: A panel of 48 accessions of maize representing various introduction routes and sources of historic and recent germplasm introductions in Africa was genotyped with the MaizeSNP50 array. Spatial genetic structure and genetic relationships in the African panel were analysed separately and in the context of a panel of 265 inbred lines representing global breeding material (based on 26,900 SNPs) and a panel of 1127 landraces from the Americas (270 SNPs). Environmental association analysis was used to detect SNPs associated with three climatic variables based on the full 43,963 SNP dataset. Conclusions: The genetic structure is consistent between subsets of the data and the markers are well suited for resolving relationships and admixture among the accessions. The African accessions are structured in three clusters reflecting historical and current patterns of gene flow from the New World and within Africa. The Sahelian cluster reflects original introductions of Meso-American landraces via Europe and a modern introduction of temperate breeding material. The Western cluster reflects introduction of Coastal Brazilian landraces, as well as a Northeast-West spread of maize through Arabic trade routes across the continent. The Eastern cluster most strongly reflects gene flow from modern introduced tropical varieties. Controlling for population history in a linear model, we identify 79 SNPs associated with maximum temperature during the growing season. The associations located in genes of known importance for abiotic stress tolerance are interesting candidates for local adaptations.	[Westengen, Ola T.] Univ Oslo, Ctr Dev & Environm SUM, Oslo, Norway; [Westengen, Ola T.] Nord Genet Resource Ctr, Alnarp, Sweden; [Westengen, Ola T.; Kent, Matthew P.] Univ Oslo, Dept Biol, CEES, Oslo, Norway; [Kent, Matthew P.] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, As, Norway	University of Oslo; University of Oslo; Norwegian University of Life Sciences	Westengen, OT (corresponding author), Univ Oslo, Ctr Dev & Environm SUM, Oslo, Norway.	ola.westengen@sum.uio.no	Berg, Paul/A-3648-2011; Brysting, Anne Krag/G-5032-2017; Berg, Paul Ragnar/Q-1584-2019	Berg, Paul/0000-0002-4974-8509; Brysting, Anne Krag/0000-0003-0388-4406; Berg, Paul Ragnar/0000-0002-4974-8509	Centre for Development and the Environment, University of Oslo	Centre for Development and the Environment, University of Oslo	This research was supported by the Centre for Development and the Environment, University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banziger M, 2006, AGR WATER MANAGE, V80, P212, DOI 10.1016/j.agwat.2005.07.014; Bellon MR, 2011, P NATL ACAD SCI USA, V108, P13432, DOI 10.1073/pnas.1103373108; Bellon MR, 2001, WORLD DEV, V29, P799, DOI 10.1016/S0305-750X(01)00013-4; Bitocchi E, 2009, MOL ECOL, V18, P603, DOI 10.1111/j.1365-294X.2008.04064.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Burke MB, 2009, GLOBAL ENVIRON CHANG, V19, P317, DOI 10.1016/j.gloenvcha.2009.04.003; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; DeVries J, 2001, SECURING HARVEST BIO; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Endresen DTF, 2011, CROP SCI, V51, P2036, DOI 10.2135/cropsci2010.12.0717; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gibson RW, 2005, ANN APPL BIOL, V147, P153, DOI 10.1111/j.1744-7348.2005.00021.x; Global Crop Diversity Trust (GCDT), 2007, GLOB STRAT EXS CONS; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hao ZF, 2011, J INTEGR PLANT BIOL, V53, P641, DOI 10.1111/j.1744-7909.2011.01051.x; Harlan JR, 1992, CROPS MAN, V2nd; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; JEFFREYS MDW, 1953, NATURE, V172, P965, DOI 10.1038/172965a0; Jones ES, 2007, THEOR APPL GENET, V115, P361, DOI 10.1007/s00122-007-0570-9; Krill AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009958; Langyintuo AS, 2010, FOOD POLICY, V35, P323, DOI 10.1016/j.foodpol.2010.01.005; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu KJ, 2003, GENETICS, V165, P2117; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; McCann JC, 2005, MAIZE GRACE AFRICAS; McCouch SR, 2012, AM J BOT, V99, P407, DOI 10.3732/ajb.1100385; Mirzaei M, 2012, PROTEOMICS, V12, P864, DOI 10.1002/pmic.201100389; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Porteres R, 1959, J AGR TROPICALE BOT, V2, P221; Pressoir G, 2004, HEREDITY, V92, P88, DOI 10.1038/sj.hdy.6800387; Pressoir G, 2004, HEREDITY, V92, P95, DOI 10.1038/sj.hdy.6800388; Pritchard JK, 2000, GENETICS, V155, P945; Reif JC, 2004, CROP SCI, V44, P326, DOI 10.2135/cropsci2004.0326; Revilla P, 2003, MAYDICA, V48, P141; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Setter TL, 2011, J EXP BOT, V62, P701, DOI 10.1093/jxb/erq308; Smale M., 2003, MAIZE E SO AFRICA SE; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tenaillon MI, 2011, CR BIOL, V334, P221, DOI 10.1016/j.crvi.2010.12.015; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; van Heerwaarden J, 2010, HEREDITY, V104, P28, DOI 10.1038/hdy.2009.110; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Warburton ML, 2008, CROP SCI, V48, P617, DOI 10.2135/cropsci2007.02.0103; Warburton ML, 2011, GENET RESOUR CROP EV, V58, P1243, DOI 10.1007/s10722-010-9658-1; Weir BS., 1996, GENETIC DATA ANAL; WILLETT F, 1962, AFRICA, V32, P1, DOI 10.2307/1157291; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	63	14	14	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47832	10.1371/journal.pone.0047832	http://dx.doi.org/10.1371/journal.pone.0047832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091649	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000310135800075
J	Bai, F; Groth, HL; Kawai, M				Bai, Fan; Groth, Heather L.; Kawai, Masataka			DCM-Related Tropomyosin Mutants E40K/E54K Over-Inhibit the Actomyosin Interaction and Lead to a Decrease in the Number of Cycling Cross-Bridges	PLOS ONE			English	Article							FAMILIAL DILATED CARDIOMYOPATHY; RABBIT PSOAS FIBERS; SKINNED VENTRICULAR MUSCLE; DIASTOLIC HEART-FAILURE; ALPHA-TROPOMYOSIN; THIN FILAMENT; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC-MUSCLE; BOVINE MYOCARDIUM; ISOMETRIC TENSION	Two DCM mutants (E40K and E54K) of tropomyosin (Tm) were examined using the thin-filament extraction/reconstitu-tion technique. The effects of the Ca2+, ATP, phos-phate (Pi), and ADP concentrations on isometric tension and its transients were studied at 25 degrees C, and the results were com-pared to those for the WT protein. Our results indicate that both E40K and E54K have a significantly lower T-HC (high Ca2+ ten-sion at pCa 4.66) (E40K: 1.21+/-0.06 T-a, +/-SEM, N = 34; E54K: 1.24+/-0.07 T-a, N = 28), a significantly lower T-LC (low-Ca2+ tension at pCa 7.0) (E40K: 0.07+/-0.02 T-a, N = 34; E54K: 0.06+/-0.02 T-a, N = 28), and a significantly lower T-act (Ca2+ activatable tension) (T-act = T-HC-T-LC, E40K: 1.15+/-0.08 T-a, N = 34; E54K: 1.18+/-0.06 T-a, N = 28) than WT (T-HC = 1.53+/-0.07 T-a, T-LC = 0.12+/-0.01 T-a, T-act = 1.40+/-0.07 T-a, N = 25). All tensions were normalized to T-a (= 13.9+/-0.8 kPa, N = 57), the ten-sion of actin-filament reconstituted cardiac fibers (myocardium) under the standard activating conditions. The Ca2+ sensitivity (pCa(50)) of E40K (5.23+/-0.02, N = 34) and E54K (5.24+/-0.03, N = 28) was similar to that of the WT protein (5.26+/-0.03, N = 25). The cooper-a-tivity increased significantly in E54K (3.73+/-0.25, N = 28) compared to WT (2.80+/-0.17, N = 25). Seven kinetic constants were deduced using sinusoidal analysis at pCa 4.66. These results enabled us to calculate the cross-bridge distribution in the strongly attached states, and thereby deduce the force/cross-bridge. The results indicate that the force/cross-bridge is similar to 15% less in E54K than WT, but remains similar to that of the WT protein in the case of E40K. We conclude that over-inhibition of the actomyosin interaction by E40K and E54K Tm mutants leads to a decreased force-generating ability at systole, which is the main mechanism underlying the early pathogenesis of DCM.	[Kawai, Masataka] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Kawai, M (corresponding author), Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA.	masataka-kawai@uiowa.edu	Bai, Fan/I-8572-2012	Kawai, Masataka/0000-0002-3219-3527	National Institute of Health [HL70041]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070041] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was in part supported by a grant National Institute of Health HL70041. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham TP, 2009, CARDIOVASC RES, V82, P84, DOI 10.1093/cvr/cvp016; Bai F, 2011, BIOPHYS J, V100, P1014, DOI 10.1016/j.bpj.2011.01.001; Borovikov YS, 2011, BIOCHEM BIOPH RES CO, V411, P496, DOI 10.1016/j.bbrc.2011.06.138; BRANDT PW, 1982, J GEN PHYSIOL, V79, P997, DOI 10.1085/jgp.79.6.997; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Chang AN, 2005, J BIOL CHEM, V280, P34343, DOI 10.1074/jbc.M505014200; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Davis JP, 2008, CARDIOVASC RES, V77, P619, DOI 10.1093/cvr/cvm098; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Dweck D, 2010, J BIOL CHEM, V285, P17371, DOI 10.1074/jbc.M109.064105; Fozzard HA, 1992, HEART CARDIOVASCULAR; Fujita H, 2004, J PHYSIOL-LONDON, V556, P637, DOI 10.1113/jphysiol.2003.059956; Fujita H, 2002, BIOPHYS J, V82, P915, DOI 10.1016/S0006-3495(02)75453-2; Fujita H, 2002, J PHYSIOL-LONDON, V539, P267, DOI 10.1113/jphysiol.2001.013220; Fujita H, 1996, BIOPHYS J, V71, P2307, DOI 10.1016/S0006-3495(96)79465-1; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; GILLUM RF, 1986, AM HEART J, V111, P752, DOI 10.1016/0002-8703(86)90111-0; GODT RE, 1988, AM J PHYSIOL, V254, pC591, DOI 10.1152/ajpcell.1988.254.5.C591; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Hamdani N, 2008, CARDIOVASC RES, V77, P649, DOI 10.1093/cvr/cvm079; Hanft LM, 2008, CARDIOVASC RES, V77, P627, DOI 10.1093/cvr/cvm099; HARRISON SM, 1989, J GEN PHYSIOL, V93, P411, DOI 10.1085/jgp.93.3.411; Hershberger RE, 2011, J AM COLL CARDIOL, V57, P1641, DOI 10.1016/j.jacc.2011.01.015; Hershberger RE, 2009, J CARD FAIL, V15, P83, DOI 10.1016/j.cardfail.2009.01.006; HIBBERD MG, 1985, SCIENCE, V228, P1317, DOI 10.1126/science.3159090; Hitchcock-DeGregori SE, 2010, J STRUCT BIOL, V170, P319, DOI 10.1016/j.jsb.2009.12.013; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Holthauzen LMF, 2004, J BIOL CHEM, V279, P15204, DOI 10.1074/jbc.M308904200; James J, 2000, CIRC RES, V87, P805, DOI 10.1161/01.RES.87.9.805; JULIAN FJ, 1981, J PHYSIOL-LONDON, V311, P179, DOI 10.1113/jphysiol.1981.sp013580; KAWAI M, 1981, BIOPHYS J, V35, P375, DOI 10.1016/S0006-3495(81)84796-0; KAWAI M, 1991, BIOPHYS J, V59, P329, DOI 10.1016/S0006-3495(91)82227-5; Kawai M, 1980, J Muscle Res Cell Motil, V1, P279, DOI 10.1007/BF00711932; KAWAI M, 1993, CIRC RES, V73, P35, DOI 10.1161/01.RES.73.1.35; KAWAI M, 1990, J MUSCLE RES CELL M, V11, P392, DOI 10.1007/BF01739760; KAWAI M, 2009, J BIOPHYS, P1; Kawai M, 2006, J MUSCLE RES CELL M, V27, P455, DOI 10.1007/s10974-006-9075-4; KENTISH JC, 1986, J PHYSIOL-LONDON, V370, P585, DOI 10.1113/jphysiol.1986.sp015952; KENTISH JC, 1984, J PHYSIOL-LONDON, V352, P353, DOI 10.1113/jphysiol.1984.sp015296; KENTISH JC, 1986, CIRC RES, V58, P755, DOI 10.1161/01.RES.58.6.755; Lakdawala NK, 2010, J AM COLL CARDIOL, V55, P320, DOI 10.1016/j.jacc.2009.11.017; Lee S, 2010, CLIN EXP PHARMACOL P, V37, P1134, DOI 10.1111/j.1440-1681.2010.05443.x; Li XC, 2012, BIOCHEM BIOPH RES CO, V424, P493, DOI 10.1016/j.bbrc.2012.06.141; Lu XY, 2006, BIOPHYS J, V91, P4230, DOI 10.1529/biophysj.106.084608; Lu XY, 2010, J MUSCLE RES CELL M, V31, P93, DOI 10.1007/s10974-010-9213-x; Lu XY, 2003, J PHYSIOL-LONDON, V553, P457, DOI 10.1113/jphysiol.2003.053694; Mandinov L, 2000, CARDIOVASC RES, V45, P813, DOI 10.1016/S0008-6363(99)00399-5; Marian AJ, 1999, J CLIN INVEST, V104, P1683, DOI 10.1172/JCI7956; Martyn DA, 2002, BIOPHYS J, V83, P3425, DOI 10.1016/S0006-3495(02)75342-3; McConnell BK, 1999, J CLIN INVEST, V104, P1771, DOI 10.1172/JCI7377C1; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Mirza M, 2007, J BIOL CHEM, V282, P13487, DOI 10.1074/jbc.M701071200; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Olson TM, 2001, J MOL CELL CARDIOL, V33, P723, DOI 10.1006/jmcc.2000.1339; OPIE LH, 1971, BIOCHEM J, V124, P475, DOI 10.1042/bj1240475; PINAMONTI B, 1993, J AM COLL CARDIOL, V22, P808, DOI 10.1016/0735-1097(93)90195-7; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Ranatunga KW, 1999, J MUSCLE RES CELL M, V20, P489, DOI 10.1023/A:1005509731881; ROTH K, 1989, J MAGN RESON, V81, P299, DOI 10.1016/0022-2364(89)90062-0; SAEKI Y, 1991, CIRC RES, V68, P772, DOI 10.1161/01.RES.68.3.772; Sagawa K., 1988, CARDIAC CONTRACTION; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154; Smille LB, 1999, GUIDEBOOK EXTRACELLU, P159; Solaro RJ, 2008, CARDIOVASC RES, V77, P616, DOI 10.1093/cvr/cvn004; Solaro RJ, 1999, ADV PHYSIOL EDUC, V22, pS155, DOI 10.1152/advances.1999.277.6.S155; Solaro RJ, 2002, MOL CONTROL MECH STR, P291; Solaro RJ, 1980, EUR HEART J SUPPL, P21; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Strang KT, 1994, CIRC RES, V74, P524; Wang G, 1999, BIOPHYS J, V76, P978, DOI 10.1016/S0006-3495(99)77261-9; WANG JX, 1994, AM J PHYSIOL, V267, pH918, DOI 10.1152/ajpheart.1994.267.3.H918; Wannenburg T, 2000, AM J PHYSIOL-HEART C, V279, pH779, DOI 10.1152/ajpheart.2000.279.2.H779; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Wisloff U, 2002, CARDIOVASC RES, V54, P162, DOI 10.1016/S0008-6363(01)00565-X; Wolff MR, 1996, J CLIN INVEST, V98, P167, DOI 10.1172/JCI118762; Zhao Y, 1996, BIOPHYS J, V71, P2759, DOI 10.1016/S0006-3495(96)79469-9; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290	84	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47471	10.1371/journal.pone.0047471	http://dx.doi.org/10.1371/journal.pone.0047471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077624	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100120
J	Zhou, ZH; Rajabi, M; Chen, T; Karnaukhova, E; Kozlowski, S				Zhou, Zhao-Hua; Rajabi, Mohsen; Chen, Trina; Karnaukhova, Elena; Kozlowski, Steven			Oversulfated Chondroitin Sulfate Inhibits the Complement Classical Pathway by Potentiating C1 Inhibitor	PLOS ONE			English	Article							ADVERSE CLINICAL EVENTS; POLYSULFATED GLYCOSAMINOGLYCAN; CONTAMINATED HEPARIN; ACTIVATION; SYSTEM; MECHANISM; C3; PATHOGENESIS; POPULATION; INFECTION	Oversulfated chondroitin sulfate (OSCS) has become the subject of multidisciplinary investigation as a non-traditional contaminant in the heparin therapeutic preparations that were linked to severe adverse events. In this study, it was found that OSCS inhibited complement fixation on bacteria and bacterial lysis mediated by the complement classical pathway. The inhibition of complement by OSCS is not due to interference with antibody/antigen interaction or due to consumption of C3 associated with FXII-dependent contact system activation. However, OSCS complement inhibition is dependent on C1 inhibitor (C1inh) since the depletion of C1inh from either normal or FXII-deficient complement plasma prevents OSCS inhibition of complement activity. Surface plasmon resonance measurements revealed that immobilized C1inhibitor bound greater than 5-fold more C1s in the presence of OSCS than in presence of heparin. Although heparin can also inhibit complement, OSCS and OSCS contaminated heparin are more potent inhibitors of complement. Furthermore, polysulfated glycosaminoglycan (PSGAG), an anti-inflammatory veterinary medicine with a similar structure to OSCS, also inhibited complement in the plasma of dogs and farm animals. This study provides a new insight that in addition to the FXII-dependent activation of contact system, oversulfated and polysulfated chondroitin-sulfate can inhibit complement activity by potentiating the classical complement pathway regulator C1inh. This effect on C1inh may play a role in inhibiting inflammation as well as impacting bacterial clearance.	[Zhou, Zhao-Hua; Chen, Trina; Kozlowski, Steven] US FDA, Div Monoclonal Antibodies, Off Biotechnol Prod, Off Pharmaceut Sci,Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Rajabi, Mohsen; Karnaukhova, Elena] US FDA, Div Hematol, Ctr Biol Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Kozlowski, S (corresponding author), US FDA, Div Monoclonal Antibodies, Off Biotechnol Prod, Off Pharmaceut Sci,Ctr Drug Evaluat & Res, Silver Spring, MD USA.	Steven.Kozlowski@fda.hhs.gov	Zhou, Zhaohua/AGR-4892-2022		US Food and Drug Administration and Food and Drug Administration/Center for Drug Evaluation and Research	US Food and Drug Administration and Food and Drug Administration/Center for Drug Evaluation and Research	This research was supported by the Intramural Research Program of the US Food and Drug Administration and Food and Drug Administration/Center for Drug Evaluation and Research, Critical Path Funds. The views expressed in this manuscript represent the opinions of the authors, and do not necessarily represent the official views of the FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2010, BIOMATERIALS, V31, P5741, DOI 10.1016/j.biomaterials.2010.03.074; Beinrohr L, 2007, J BIOL CHEM, V282, P21100, DOI 10.1074/jbc.M700841200; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; Bohlson SS, 2001, INFECT IMMUN, V69, P7729, DOI 10.1128/IAI.69.12.7729-7735.2001; CAUGHMAN GB, 1982, MOL IMMUNOL, V19, P287, DOI 10.1016/0161-5890(82)90342-X; CHESNE S, 1982, BIOCHEM J, V201, P61, DOI 10.1042/bj2010061; DEMESSIAS IT, 1994, J INVEST ALLERG CLIN, V4, P172; Engstrom G, 2005, DIABETES, V54, P570, DOI 10.2337/diabetes.54.2.570; Girardi G, 2004, NAT MED, V10, P1222, DOI 10.1038/nm1121; GUSTAFSON SB, 1989, AM J VET RES, V50, P2014; GUSTAFSON SB, 1989, AM J VET RES, V50, P2018; HIRSH J, 1992, CHEST, V102, pS337, DOI 10.1378/chest.102.4.337S; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Jaskowski TD, 1999, CLIN DIAGN LAB IMMUN, V6, P137, DOI 10.1128/CDLI.6.1.137-139.1999; Jiang HX, 2001, J EXP MED, V194, P1609, DOI 10.1084/jem.194.11.1609; King CS, 2007, CHEST, V131, P507, DOI 10.1378/chest.06-1861; Kirschfink M, 2003, CLIN DIAGN LAB IMMUN, V10, P982, DOI 10.1128/CDLI.10.6.982-989.2003; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Li BZ, 2009, BIOCHEM PHARMACOL, V78, P292, DOI 10.1016/j.bcp.2009.04.012; MAILLET F, 1988, MOL IMMUNOL, V25, P917, DOI 10.1016/0161-5890(88)90130-7; Makrides SC, 1998, PHARMACOL REV, V50, P59; Martinez-Barricarte R, 2010, J CLIN INVEST, V120, P3702, DOI 10.1172/JCI43343; Matsushita M, 2010, J INNATE IMMUN, V2, P24, DOI 10.1159/000228160; MULLEREBERHARD HJ, 1975, ANNU REV BIOCHEM, V44, P697, DOI 10.1146/annurev.bi.44.070175.003405; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546; PANGBURN MK, 1983, ANN NY ACAD SCI, V421, P291, DOI 10.1111/j.1749-6632.1983.tb18116.x; Rajabi M, 2012, BBA-GEN SUBJECTS, V1820, P56, DOI 10.1016/j.bbagen.2011.10.008; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Tami C, 2008, BIOMATERIALS, V29, P4808, DOI 10.1016/j.biomaterials.2008.08.024; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Wuillemin WA, 1997, J IMMUNOL, V159, P1953; Zhang ZQ, 2008, J MED CHEM, V51, P5498, DOI 10.1021/jm800785t; Zhou ZH, 2007, CELL HOST MICROBE, V1, P51, DOI 10.1016/j.chom.2007.01.002; Zhou ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034978	35	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47296	10.1371/journal.pone.0047296	http://dx.doi.org/10.1371/journal.pone.0047296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077587	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100088
J	Fang, Y; Xun, F; Bai, WM; Zhang, WH; Li, LH				Fang, Ying; Xun, Fen; Bai, Wenming; Zhang, Wenhao; Li, Linghao			Long-Term Nitrogen Addition Leads to Loss of Species Richness Due to Litter Accumulation and Soil Acidification in a Temperate Steppe	PLOS ONE			English	Article							FINE-ROOT PRODUCTION; COMMUNITY STRUCTURE; ELEVATED CO2; DEPOSITION; GRASSLAND; WATER; ECOSYSTEMS; LIMITATION; DIVERSITY; CLIMATE	Background: Although community structure and species richness are known to respond to nitrogen fertilization dramatically, little is known about the mechanisms underlying specific species replacement and richness loss. In an experiment in semiarid temperate steppe of China, manipulative N addition with five treatments was conducted to evaluate the effect of N addition on the community structure and species richness. Methodology/Principal Findings: Species richness and biomass of community in each plot were investigated in a randomly selected quadrat. Root element, available and total phosphorus (AP, TP) in rhizospheric soil, and soil moisture, pH, AP, TP and inorganic N in the soil were measured. The relationship between species richness and the measured factors was analyzed using bivariate correlations and stepwise multiple linear regressions. The two dominant species, a shrub Artemisia frigida and a grass Stipa krylovii, responded differently to N addition such that the former was gradually replaced by the latter. S. krylovii and A. frigida had highly-branched fibrous and un-branched tap root systems, respectively. S. krylovii had higher height than A. frigida in both control and N added plots. These differences may contribute to the observed species replacement. In addition, the analysis on root element and AP contents in rhizospheric soil suggests that different calcium acquisition strategies, and phosphorus and sodium responses of the two species may account for the replacement. Species richness was significantly reduced along the five N addition levels. Our results revealed a significant relationship between species richness and soil pH, litter amount, soil moisture, AP concentration and inorganic N concentration. Conclusions/Significance: Our results indicate that litter accumulation and soil acidification accounted for 52.3% and 43.3% of the variation in species richness, respectively. These findings would advance our knowledge on the changes in species richness in semiarid temperate steppe of northern China under N deposition scenario.	[Fang, Ying; Xun, Fen; Bai, Wenming; Zhang, Wenhao; Li, Linghao] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Fang, Ying; Xun, Fen] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, WM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	bwming@ibcas.ac.cn	Zhang, Wen-Hao/B-5805-2009	Zhang, Wen-Hao/0000-0003-2708-2221	National Natural Science Foundation of China [31070432]; Beijing Institutes of Life Science, Chinese Academy of Sciences [2010-Biols-CAS-0101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Institutes of Life Science, Chinese Academy of Sciences	This research was supported by the National Natural Science Foundation of China (31070432) and Beijing Institutes of Life Science, Chinese Academy of Sciences (2010-Biols-CAS-0101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Berendse F, 1999, TRENDS ECOL EVOL, V14, P4, DOI 10.1016/S0169-5347(98)01451-7; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; Bowman WD, 2008, NAT GEOSCI, V1, P767, DOI 10.1038/ngeo339; Carroll JA, 2003, ENVIRON POLLUT, V121, P363, DOI 10.1016/S0269-7491(02)00241-5; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Craine JM, 2002, FUNCT ECOL, V16, P563, DOI 10.1046/j.1365-2435.2002.00660.x; Deutsch ES, 2010, AGR ECOSYST ENVIRON, V135, P1, DOI 10.1016/j.agee.2009.08.002; Dupre C, 2010, GLOBAL CHANGE BIOL, V16, P344, DOI 10.1111/j.1365-2486.2009.01982.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Emery NC, 2001, ECOLOGY, V82, P2471, DOI 10.1890/0012-9658(2001)082[2471:CASMPZ]2.0.CO;2; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Frink CR, 1999, P NATL ACAD SCI USA, V96, P1175, DOI 10.1073/pnas.96.4.1175; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gilliam FS, 2006, J ECOL, V94, P1176, DOI 10.1111/j.1365-2745.2006.01155.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; He Bin, 2007, Journal of Northeast Forestry University, V35, P35; Huang JY, 2008, PLANT SOIL, V306, P149, DOI 10.1007/s11104-008-9565-9; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Jackson M.L., 1979, SOIL CHEM ANAL ADV C; Jones MLM, 2000, CRITICAL LOADS NITRO; Khan MA, 2000, J ARID ENVIRON, V45, P73, DOI 10.1006/jare.1999.0617; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lee KH, 2003, FOREST ECOL MANAG, V185, P263, DOI 10.1016/S0378-1127(03)00164-6; Likens GE, 1996, SCIENCE, V272, P244, DOI 10.1126/science.272.5259.244; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Magill AH, 2004, FOREST ECOL MANAG, V196, P7, DOI 10.1016/j.foreco.2004.03.033; Martinelli LA, 2006, BIOGEOCHEMISTRY, V79, P3, DOI 10.1007/s10533-006-9000-3; Maskell LC, 2010, GLOBAL CHANGE BIOL, V16, P671, DOI 10.1111/j.1365-2486.2009.02022.x; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1007/BF01007574; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Mulvaney RL, 1996, METHODS SOIL ANAL, P1123, DOI DOI 10.2136/SSSAB00KSER5.3.C38; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Perakis S, 2006, ECOSYSTEMS, V9, P63, DOI 10.1007/s10021-004-0039-5; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; SCHULZE ED, 1989, SCIENCE, V244, P776, DOI 10.1126/science.244.4906.776; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Sullivan PF, 2007, OECOLOGIA, V153, P643, DOI 10.1007/s00442-007-0753-8; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vojtech E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000499; Wu FZ, 2009, J ARID ENVIRON, V73, P1067, DOI 10.1016/j.jaridenv.2009.06.007; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Yang Y.S., 1998, ACTA ECOL SIN, V18, P198; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100; Zhang JL, 2010, PLANT SOIL, V326, P45, DOI 10.1007/s11104-009-0076-0	56	44	65	13	204	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47369	10.1371/journal.pone.0047369	http://dx.doi.org/10.1371/journal.pone.0047369			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077603	Green Submitted, gold, Green Published			2022-12-27	WOS:000309809500045
J	Sun, F; Wang, XM; Mao, XO; Xie, L; Jin, KL				Sun, Fen; Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Jin, Kunlin			Ablation of Neurogenesis Attenuates Recovery of Motor Function after Focal Cerebral Ischemia in Middle-Aged Mice	PLOS ONE			English	Article							STROKE-INDUCED NEUROGENESIS; SUBVENTRICULAR ZONE; NEUROBLAST MIGRATION; DENTATE GYRUS; ADULT BRAIN; STEM-CELLS; RAT-BRAIN; PROLIFERATION; ANGIOGENESIS; REPLACEMENT	Depletion of neurogenesis worsens functional outcome in young-adult mice after focal cerebral ischemia, but whether a similar effect occurs in older mice is unknown. Using middle-aged (12-month-old) transgenic (DCX-TK(+)) mice that express herpes simplex virus thymidine kinase (HSV-TK) under control of the doublecortin (DCX) promoter, we conditionally depleted DCX-positive cells in the subventricular zone (SVZ) and hippocampus by treatment with ganciclovir (GCV) for 14 days. Focal cerebral ischemia was induced by permanent occlusion of the middle cerebral artery (MCAO) or occlusion of the distal segment of middle cerebral artery (dMCAO) on day 14 of vehicle or GCV treatment and mice were killed 24 hr or 12 weeks later. Increased infarct volume or brain atrophy was found in GCV-compared to vehicle-treated middle-aged DCX-TK(+) mice, both 24 hr after MCAO and 12 weeks after dMCAO. More severe motor deficits were also observed in GCV-treated, middle-aged DCX-TK(+) transgenic mice at both time points. Our results indicate that ischemia-induced newborn neurons contribute to anatomical and functional outcome after experimental stroke in middle-aged mice.	[Sun, Fen; Jin, Kunlin] Univ N Texas, Dept Pharmacol & Neurosci, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA; [Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA	University of North Texas System; University of North Texas Health Science Center; Buck Institute for Research on Aging	Jin, KL (corresponding author), Univ N Texas, Dept Pharmacol & Neurosci, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA.	kunlin.jin@UNTHSC.edu		SUN, FEN/0000-0003-2094-9494	US Public Health Service [NS57186, AG21980]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021980] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by US Public Health Service Grants NS57186 and AG21980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn MY, 1999, BRAIN RES, V837, P169, DOI 10.1016/S0006-8993(99)01645-5; Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Andersen MB, 1999, PHARMACOL BIOCHEM BE, V62, P673, DOI 10.1016/S0091-3057(98)00204-4; ARNOLD KG, 1981, AGE AGEING, V10, P5, DOI 10.1093/ageing/10.1.5; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Buga AM, 2011, AGING DIS, V2, P64; Burns TC, 2011, EXPERT OPIN BIOL TH, V11, P447, DOI 10.1517/14712598.2011.552883; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; DAVIS M, 1995, STROKE, V26, P1072, DOI 10.1161/01.STR.26.6.1072; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; HOYER S, 1987, GERONTOLOGY, V33, P203, DOI 10.1159/000212877; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2004, AGING CELL, V3, P373, DOI 10.1111/j.1474-9728.2004.00131.x; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING DIS, V1, P72; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Liu JL, 1998, J NEUROSCI, V18, P7768; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Nagayama M, 1999, J CEREBR BLOOD F MET, V19, P661, DOI 10.1097/00004647-199906000-00009; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Ooboshi H, 2000, BRAIN RES, V884, P23, DOI 10.1016/S0006-8993(00)02861-4; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Popa-Wagner A, 1998, STROKE, V29, P2196, DOI 10.1161/01.STR.29.10.2196; Popa-Wagner A, 2010, STROKE, V41, P1027, DOI 10.1161/STROKEAHA.109.575621; Ramirez-Lassepas M, 1998, GERIATRICS-US, V53, pS44; Sugiura S, 2005, STROKE, V36, P859, DOI 10.1161/01.STR.0000158905.22871.95; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takagi Y, 1999, BRAIN RES, V831, P283, DOI 10.1016/S0006-8993(99)01411-0; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tropepe V, 1997, J NEUROSCI, V17, P7850; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; YAO H, 1991, STROKE, V22, P1414, DOI 10.1161/01.STR.22.11.1414; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009	38	51	52	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e46326	10.1371/journal.pone.0046326	http://dx.doi.org/10.1371/journal.pone.0046326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110048	Green Published, Green Submitted, gold			2022-12-27	WOS:000310262500004
J	Yang, JM; Feng, XG; Fu, ZQ; Yuan, CX; Hong, Y; Shi, YJ; Zhang, M; Liu, JM; Li, H; Lu, K; Lin, JJ				Yang, Jianmei; Feng, Xingang; Fu, Zhiqiang; Yuan, Chunxiu; Hong, Yang; Shi, Yaojun; Zhang, Min; Liu, Jinming; Li, Hao; Lu, Ke; Lin, Jiaojiao			Ultrastructural Observation and Gene Expression Profiling of Schistosoma japonicum Derived from Two Natural Reservoir Hosts, Water Buffalo and Yellow Cattle	PLOS ONE			English	Article							PARASITE RELATIONSHIPS; VISUALIZATION; FAMILY; TOOL; EGG	Water buffalo and yellow cattle are the two of the most important natural reservoir hosts for Schistosoma japonicum in endemic areas of China, although their susceptibility differs, with water buffalo being less conducive to the growth and development of S. japonicum. Results from the current study show that the general morphology and ultrastructure of adult schistosomes derived from the two hosts also differed. Using high-throughput microarray technology, we also compared the gene expression profiles of adult schistosomes derived from the two hosts. We identified genes that were differentially expressed in worms from the two natural hosts. Further analysis revealed that genes associated with protein kinase and phosphatase, the stimulus response, and lipid and nucleotide metabolism were overexpressed, whereas genes associated with reproduction, anatomical structure morphogenesis and multifunctional motif were underexpressed in schistosomes from water buffalo. These differentially expressed genes were mainly involved in nucleotide, energy, lipid metabolism, energy metabolism, transcription, transport and signaling pathway. This suggests that they are key molecules affecting the survival and development of schistosomes in different natural host species. The results of this study add to current understanding of the interplay between parasites and their natural hosts, and provide valuable information for the screening of vaccine candidates or new drug targets against schistosomiasis in the natural reservoir hosts in endemic areas.	[Yang, Jianmei; Feng, Xingang; Fu, Zhiqiang; Yuan, Chunxiu; Hong, Yang; Shi, Yaojun; Zhang, Min; Liu, Jinming; Li, Hao; Lu, Ke; Lin, Jiaojiao] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr China, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Lin, JJ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr China, Shanghai, Peoples R China.	qqyangjianmei@163.com			National Science and Technology Major Project [2012ZX10004220-008, 2008ZX10004-011]; National Basic Research Program [2007CB513108]; Special Fund for Agro-scientific Research in the Public Interest [200903036]	National Science and Technology Major Project; National Basic Research Program(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest	The authors acknowledge financial support of the National Science and Technology Major Project (No.2012ZX10004220-008, No.2008ZX10004-011), the National Basic Research Program (No.2007CB513108), and Special Fund for Agro-scientific Research in the Public Interest (No. 200903036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton PD, 2001, PARASITOLOGY, V122, P329, DOI 10.1017/S0031182001007351; Brouwers JFHM, 1997, MOL BIOCHEM PARASIT, V88, P175, DOI 10.1016/S0166-6851(97)00091-1; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Da'Dara AA, 2008, VACCINE, V26, P3617, DOI 10.1016/j.vaccine.2008.04.080; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Freitas TC, 2007, PLOS PATHOG, V3, P489, DOI 10.1371/journal.ppat.0030052; Gentleman R, 1997, R LANGUAGE; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; Grossel MJ, 2006, CELL CYCLE, V5, P266, DOI 10.4161/cc.5.3.2385; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; He Yi-Xun, 1992, Acta Zoologica Sinica, V38, P266; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hong Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006098; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Krejcova R, 1997, CHEM LISTY, V91, P466; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Lei Zheng-long, 2011, Zhongguo Xuexichongbing Fangzhi Zazhi, V23, P599; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Liu SX, 1997, VET PARASITOL, V69, P39, DOI 10.1016/S0304-4017(96)01092-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockyer AE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-634; LUO XF, 1988, CHIN J VET SCI TECHN, V8, P42; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; McGarvey ST, 1999, PARASITOL TODAY, V15, P214, DOI 10.1016/S0169-4758(99)01409-X; McManus DP, 2005, PARASITE IMMUNOL, V27, P297, DOI 10.1111/j.1365-3024.2005.00784.x; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; Norberg S, 1998, PEDIATR RES, V44, P233, DOI 10.1203/00006450-199808000-00016; Osman A, 2006, PLOS PATHOG, V2, P536, DOI 10.1371/journal.ppat.0020054; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Parisi M, 2000, CURR BIOL, V10, pR81, DOI 10.1016/S0960-9822(00)00283-9; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Peng JB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-155; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Shen W., 1992, CHIN J SCHISTOSOMIAS, V4, P82; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wang XZ, 2009, MOL BIOCHEM PARASIT, V166, P62, DOI 10.1016/j.molbiopara.2009.02.016; World Health Organization, 2002, TDR TDR STRAT DIR SC; Yang JM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-25; Zheng Jiang, 2000, Chinese Journal of Zoonoses, V16, P87; Zheng Jiang, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P291; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	49	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47660	10.1371/journal.pone.0047660	http://dx.doi.org/10.1371/journal.pone.0047660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110087	Green Published, gold, Green Submitted			2022-12-27	WOS:000310262500017
J	Yurovsky, D; Hidaka, S; Wu, R				Yurovsky, Daniel; Hidaka, Shohei; Wu, Rachel			Quantitative Linking Hypotheses for Infant Eye Movements	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; MODEL; 6-MONTH-OLD; PERCEPTION; PREFERENCE; PATTERNS; HABITUATION; FAMILIARITY; ATTENTION; INFERENCE	The study of cognitive development hinges, largely, on the analysis of infant looking. But analyses of eye gaze data require the adoption of linking hypotheses: assumptions about the relationship between observed eye movements and underlying cognitive processes. We develop a general framework for constructing, testing, and comparing these hypotheses, and thus for producing new insights into early cognitive development. We first introduce the general framework - applicable to any infant gaze experiment - and then demonstrate its utility by analyzing data from a set of experiments investigating the role of attentional cues in infant learning. The new analysis uncovers significantly more structure in these data, finding evidence of learning that was not found in standard analyses and showing an unexpected relationship between cue use and learning rate. Finally, we discuss general implications for the construction and testing of quantitative linking hypotheses. MATLAB code for sample linking hypotheses can be found on the first author's website.	[Yurovsky, Daniel] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Hidaka, Shohei] Japan Adv Inst Sci & Technol, Sch Knowledge Sci, Nomi, Ishikawa, Japan; [Wu, Rachel] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA	Stanford University; Japan Advanced Institute of Science & Technology (JAIST); University of Rochester	Yurovsky, D (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	yurovsky@stanford.edu		Wu, Rachel/0000-0002-7486-697X; Lauwereyns, Jan/0000-0003-0551-2550	National Science Foundation (NSF); NSF East Asia Pacific Summer Institute Fellowship; BPS Postgraduate Study Visits Awards;  [23300099]; Grants-in-Aid for Scientific Research [23300099] Funding Source: KAKEN	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF East Asia Pacific Summer Institute Fellowship; BPS Postgraduate Study Visits Awards; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a National Science Foundation (NSF) Graduate Research Fellowship and NSF East Asia Pacific Summer Institute Fellowship to DY, two BPS Postgraduate Study Visits Awards to RW, and Grant-in-Aid for Scientific Research B No. 23300099 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous D.J., 1985, LECT NOTES MATH, V1117, P1, DOI DOI 10.1007/BFB0099421; Anderson B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00246; Anderson JR, 1998, J MEM LANG, V38, P341, DOI 10.1006/jmla.1997.2553; Aslin RN, 2000, INFANCY, V1, P463, DOI 10.1207/S15327078IN0104_6; Aslin RN, 2007, DEVELOPMENTAL SCI, V10, P48, DOI 10.1111/j.1467-7687.2007.00563.x; BAILLARGEON R, 1986, COGNITION, V23, P21, DOI 10.1016/0010-0277(86)90052-1; Barr DJ, 2008, J MEM LANG, V59, P457, DOI 10.1016/j.jml.2007.09.002; Brannon EM, 2004, COGNITION, V93, pB59, DOI 10.1016/j.cognition.2004.01.004; Cashon CH, 2000, INFANCY, V1, P429, DOI 10.1207/S15327078IN0104_4; Castelhano MS, 2009, J VISION, V9, DOI 10.1167/9.3.6; Cha SH, 2002, PATTERN RECOGN, V35, P1355, DOI 10.1016/S0031-3203(01)00118-2; Cohen LB, 2004, INFANT CHILD DEV, V13, P349, DOI 10.1002/icd.355; Donkin C, 2012, PSYCHOL SCI, V23, P625, DOI 10.1177/0956797611430961; EDWARDS W, 1963, PSYCHOL REV, V70, P193, DOI 10.1037/h0044139; ESTES WK, 1956, PSYCHOL BULL, V53, P134, DOI 10.1037/h0045156; ESTES WK, 1957, AM PSYCHOL, V12, P609, DOI 10.1037/h0046778; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Figuerido MAT, 2002, ADV NEURAL INFORM PR, V14, P722; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Gilmore RO, 2002, INFANT BEHAV DEV, V25, P399, DOI 10.1016/S0163-6383(02)00142-X; Glymour C, 1998, PHILOS SCI, V65, P1, DOI 10.1086/392624; GOLINKOFF RM, 1987, J CHILD LANG, V14, P23, DOI 10.1017/S030500090001271X; Griffiths TL, 2010, TRENDS COGN SCI, V14, P357, DOI 10.1016/j.tics.2010.05.004; Halberda J, 2003, COGNITION, V87, pB23, DOI 10.1016/S0010-0277(02)00186-5; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Hunter M.A., 1988, ADV INFANCY RES, VVol. 5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jackson I, 2009, DEVELOPMENTAL SCI, V12, P670, DOI 10.1111/j.1467-7687.2008.00805.x; Jones M, 2011, BEHAV BRAIN SCI, V34, P215, DOI [10.1017/S0140525X10003134, 10.1017/S0140525X11001439]; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; Kidd C, 2011, DEVELOPMENTAL SCI, V14, P925, DOI 10.1111/j.1467-7687.2011.01049.x; Kobayashi T, 2005, DEVELOPMENTAL SCI, V8, P409, DOI 10.1111/j.1467-7687.2005.00429.x; Kruschke JK, 2011, PERSPECT PSYCHOL SCI, V6, P299, DOI 10.1177/1745691611406925; Kruschke JK, 2010, TRENDS COGN SCI, V14, P293, DOI 10.1016/j.tics.2010.05.001; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Lee MD, 2010, COGNITIVE SCI, V34, P51, DOI 10.1111/j.1551-6709.2009.01063.x; Marchman VA, 2008, DEVELOPMENTAL SCI, V11, pF9, DOI 10.1111/j.1467-7687.2008.00671.x; Mather E, 2010, J EXP CHILD PSYCHOL, V105, P232, DOI 10.1016/j.jecp.2009.11.004; McClelland JL, 2010, TRENDS COGN SCI, V14, P348, DOI 10.1016/j.tics.2010.06.002; McClelland JL, 2009, TOP COGN SCI, V1, P11, DOI 10.1111/j.1756-8765.2008.01003.x; Miller GA, 2003, TRENDS COGN SCI, V7, P141, DOI 10.1016/S1364-6613(03)00029-9; Mix KS, 2002, PSYCHOL BULL, V128, P278, DOI 10.1037//0033-2909.128.2.278; Munakata Y, 2000, INFANCY, V1, P471, DOI 10.1207/S15327078IN0104_7; Navarro DJ, 2006, J MATH PSYCHOL, V50, P101, DOI 10.1016/j.jmp.2005.11.006; Newell A., 1973, YOU CANT PLAY 20 QUE, DOI 10.1016/B978-0-12-170150-5.50012-3; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Rasmussen CE, 2000, ADV NEUR IN, V12, P554; Roder BJ, 2000, INFANCY, V1, P491, DOI 10.1207/S15327078IN0104_9; Schoner G, 2006, PSYCHOL REV, V113, P273, DOI 10.1037/0033-295X.113.2.273; Shiffrin RM, 2010, TOP COGN SCI, V2, P736, DOI 10.1111/j.1756-8765.2010.01092.x; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SIEGLER RS, 1987, J EXP PSYCHOL GEN, V116, P250; Sirois S, 2004, J COGNITIVE NEUROSCI, V16, P1352, DOI 10.1162/0898929042304778; Smith L, 2008, COGNITION, V106, P1558, DOI 10.1016/j.cognition.2007.06.010; Spelke ES, 1998, INFANT BEHAV DEV, V21, P181, DOI 10.1016/S0163-6383(98)90002-9; Stager CL, 1997, NATURE, V388, P381, DOI 10.1038/41102; TELLER DY, 1984, VISION RES, V24, P1233, DOI 10.1016/0042-6989(84)90178-0; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Waxman SR, 1995, COGNITIVE PSYCHOL, V29, P257, DOI 10.1006/cogp.1995.1016; Werker JF, 1998, DEV PSYCHOL, V34, P1289, DOI 10.1037/0012-1649.34.6.1289; Wu R, 2010, J EXP CHILD PSYCHOL, V107, P118, DOI 10.1016/j.jecp.2010.04.014; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; YOUNGER BA, 1986, CHILD DEV, V57, P803, DOI 10.2307/1130356; Yu C, 2012, INFANCY, V17, P33, DOI 10.1111/j.1532-7078.2011.00095.x; Yu C, 2011, DEVELOPMENTAL SCI, V14, P165, DOI 10.1111/j.1467-7687.2010.00958.x	67	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47419	10.1371/journal.pone.0047419	http://dx.doi.org/10.1371/journal.pone.0047419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	026GL	23110071	gold, Green Submitted, Green Published			2022-12-27	WOS:000310262500010
J	Bashiri, G; Perkowski, EF; Turner, AP; Feltcher, ME; Braunstein, M; Baker, EN				Bashiri, Ghader; Perkowski, Ellen F.; Turner, Adrian P.; Feltcher, Meghan E.; Braunstein, Miriam; Baker, Edward N.			Tat-Dependent Translocation of an F-420-Binding Protein of Mycobacterium tuberculosis	PLOS ONE			English	Article							F-420-DEPENDENT GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; SIGNAL PEPTIDES; DRUG CANDIDATE; SIGMA-FACTOR; IDENTIFICATION; COENZYME; PATHWAY; SMEGMATIS; EXPORT; PURIFICATION	F-420 is a unique cofactor present in a restricted range of microorganisms, including mycobacteria. It has been proposed that F-420 has an important role in the oxidoreductive reactions of Mycobacterium tuberculosis, possibly associated with anaerobic survival and persistence. The protein encoded by Rv0132c has a predicted N-terminal signal sequence and is annotated as an F-420-dependent glucose-6-phosphate dehydrogenase. Here we show that Rv0132c protein does not have the annotated activity. It does, however, co-purify with F-420 during expression experiments in M. smegmatis. We also show that the Rv0132c-F-420 complex is a substrate for the Tat pathway, which mediates translocation of the complex across the cytoplasmic membrane, where Rv0132c is anchored to the cell envelope. This is the first report of any F-420-binding protein being a substrate for the Tat pathway and of the presence of F-420 outside of the cytosol in any F-420-producing microorganism. The Rv0132c protein and its Tat export sequence are essentially invariant in the Mycobacterium tuberculosis complex. Taken together, these results show that current understanding of F-420 biology in mycobacteria should be expanded to include activities occurring in the extra-cytoplasmic cell envelope.	[Bashiri, Ghader; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; [Perkowski, Ellen F.; Feltcher, Meghan E.; Braunstein, Miriam] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Turner, Adrian P.] Univ Auckland, Sch Biol Sci, Microscopy & Graph Unit, Auckland 1, New Zealand	University of Auckland; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Auckland	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand.	en.baker@auckland.ac.nz	; Bashiri, Ghader/R-4957-2017	Baker, Edward/0000-0003-2456-7661; Bashiri, Ghader/0000-0002-5092-3749; Turner, Adrian/0000-0001-5098-398X	Health Research Council of New Zealand; Foundation for Research, Science and Technology of New Zealand; United States National Institutes of Health [RO1 AI054540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054540] Funding Source: NIH RePORTER	Health Research Council of New Zealand(Health Research Council of New Zealand); Foundation for Research, Science and Technology of New Zealand(New Zealand Foundation for Research, Science and Technology); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Health Research Council of New Zealand, the Foundation for Research, Science and Technology of New Zealand and the United States National Institutes of Health (grant RO1 AI054540). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Bashiri G, 2008, J BIOL CHEM, V283, P17531, DOI 10.1074/jbc.M801854200; Bashiri G, 2007, PROTEIN EXPRES PURIF, V54, P38, DOI 10.1016/j.pep.2007.01.014; Bashiri G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015803; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 2000, BBA-BIOENERGETICS, V1459, P325, DOI 10.1016/S0005-2728(00)00168-7; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Braunstein M, 2002, METHOD ENZYMOL, V358, P67; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; D'Orazio M, 2001, BIOCHEM J, V359, P17, DOI 10.1042/0264-6021:3590017; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; DeMaio J, 1996, P NATL ACAD SCI USA, V93, P2790, DOI 10.1073/pnas.93.7.2790; Dogra M, 2010, BR J PHARM; Duncan K, 2004, CURR OPIN MICROBIOL, V7, P460, DOI 10.1016/j.mib.2004.08.011; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; Geiman DE, 2004, INFECT IMMUN, V72, P1733, DOI 10.1128/IAI.72.3.1733-1745.2004; Gibbons HS, 2007, J BACTERIOL, V189, P5090, DOI 10.1128/JB.00163-07; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Gurumurthy M, 2012, FEBS J, V279, P113, DOI 10.1111/j.1742-4658.2011.08404.x; Isabelle D, 2002, APPL ENVIRON MICROB, V68, P5750, DOI 10.1128/AEM.68.11.5750-5755.2002; JACOBSON FS, 1982, J BIOL CHEM, V257, P3385; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Marrichi M, 2008, J BIOL CHEM, V283, P35223, DOI 10.1074/jbc.M802660200; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; McDonough JA, 2008, J BACTERIOL, V190, P6428, DOI 10.1128/JB.00749-08; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Purwantini E, 1996, J BACTERIOL, V178, P2861, DOI 10.1128/jb.178.10.2861-2866.1996; Purwantini E, 2009, P NATL ACAD SCI USA, V106, P6333, DOI 10.1073/pnas.0812883106; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Stephenson K, 2005, MOL MEMBR BIOL, V22, P17, DOI 10.1080/09687860500063308; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Sutcliffe IC, 2004, FEMS MICROBIOL REV, V28, P645, DOI 10.1016/j.femsre.2004.06.002; Taylor MC, 2010, MOL MICROBIOL, V78, P561, DOI 10.1111/j.1365-2958.2010.07356.x; THOMPSON BJ, 2010, MOL MICROBIOL; Tullman-Ercek D, 2007, J BIOL CHEM, V282, P8309, DOI 10.1074/jbc.M610507200; Valente FMA, 2007, FEBS LETT, V581, P3341, DOI 10.1016/j.febslet.2007.06.020; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Widdick DA, 2011, MOL MICROBIOL, V80, P1395, DOI 10.1111/j.1365-2958.2011.07656.x; World Health Organization, 2010, GLOB TUB CONTR	44	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e45003	10.1371/journal.pone.0045003	http://dx.doi.org/10.1371/journal.pone.0045003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110042	Green Submitted, Green Published, gold			2022-12-27	WOS:000310193400002
J	Garcia-Gamez, E; Gutierrez-Gil, B; Sahana, G; Sanchez, JP; Bayon, Y; Arranz, JJ				Garcia-Gamez, Elsa; Gutierrez-Gil, Beatriz; Sahana, Goutam; Sanchez, Juan-Pablo; Bayon, Yolanda; Arranz, Juan-Jose			GWA Analysis for Milk Production Traits in Dairy Sheep and Genetic Support for a QTN Influencing Milk Protein Percentage in the LALBA Gene	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SOMATIC-CELL SCORE; ALPHA-LACTALBUMIN; LINKAGE DISEQUILIBRIUM; MISSENSE MUTATION; FERTILITY TRAITS; LOCI; NUCLEOTIDE; CATTLE; YIELD	In this study, we used the Illumina OvineSNP50 BeadChip to conduct a genome-wide association (GWA) analysis for milk production traits in dairy sheep by analyzing a commercial population of Spanish Churra sheep. The studied population consisted of a total of 1,681 Churra ewes belonging to 16 half-sib families with available records for milk yield (MY), milk protein and fat yields (PY and FY) and milk protein and fat contents (PP and FP). The most significant association identified reached experiment-wise significance for PP and FP and was located on chromosome 3 (OAR3). These results confirm the population-level segregation of a previously reported QTL affecting PP and suggest that this QTL has a significant pleiotropic effect on FP. Further associations were detected at the chromosome-wise significance level on 14 other chromosomal regions. The marker on OAR3 showing the highest significant association was located at the third intron of the alpha-lactalbumin (LALBA) gene, which is a functional and positional candidate underlying this association. Sequencing this gene in the 16 Churra rams of the studied resource population identified additional polymorphisms. One out of the 31 polymorphisms identified was located within the coding gene sequence (LALBA_g.242T>C) and was predicted to cause an amino acid change in the protein (Val27Ala). Different approaches, including GWA analysis, a combined linkage and linkage disequilibrium study and a concordance test with the QTL segregating status of the sires, were utilized to assess the role of this mutation as a putative QTN for the genetic effects detected on OAR3. Our results strongly support the polymorphism LALBA_g.242T>C as the most likely causal mutation of the studied OAR3 QTL affecting PP and FP, although we cannot rule out the possibility that this SNP is in perfect linkage disequilibrium with the true causal polymorphism.	[Garcia-Gamez, Elsa; Gutierrez-Gil, Beatriz; Bayon, Yolanda; Arranz, Juan-Jose] Univ Leon, Dept Anim Prod, E-24071 Leon, Spain; [Sahana, Goutam] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Sanchez, Juan-Pablo] IRTA, Lleida, Spain	Universidad de Leon; Aarhus University; IRTA	Arranz, JJ (corresponding author), Univ Leon, Dept Anim Prod, E-24071 Leon, Spain.	jjarrs@unileon.es	Sahana, Goutam/K-7613-2014; Sanchez, Juan Pablo/D-8133-2013; Sahana, Goutam/AAI-7579-2021; Arranz, Juan-Jose/H-1225-2015; Gutierrez, Beatriz/AAU-1711-2021	Sahana, Goutam/0000-0001-7608-7577; Sanchez, Juan Pablo/0000-0001-8639-6146; Sahana, Goutam/0000-0001-7608-7577; Arranz, Juan-Jose/0000-0001-9058-131X; Gutierrez-Gil, Beatriz/0000-0001-7990-5723	Spanish Ministry of Education; Foundation of Supercomputing Center of Castile and Leon (FCSCL); Spanish Ministry of Science [AGL2009-07000]; European Commission	Spanish Ministry of Education(Spanish Government); Foundation of Supercomputing Center of Castile and Leon (FCSCL); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	Elsa Garcia-Gamez has an FPU contract from the Spanish Ministry of Education. The support and availability to the computing facilities of the Foundation of Supercomputing Center of Castile and Leon (FCSCL) (http://www.fcsc.es) is greatly acknowledged.; This work was supported by the Spanish Ministry of Science (Project AGL2009-07000) and by the European Commission by 3SR Project (Sustainable Solutions for Small Ruminants; http://www.3srbreeding.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barillet Francis, 2005, Genet Sel Evol, V37 Suppl 1, pS109, DOI 10.1051/gse:2004033; Becker D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008689; Blott S, 2003, GENETICS, V163, P253; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Boston WS, 2001, J DAIRY SCI, V84, P620, DOI 10.3168/jds.S0022-0302(01)74516-X; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Daetwyler HD, 2008, J DAIRY SCI, V91, P3225, DOI 10.3168/jds.2007-0333; Diez-Tascon C, 2001, J DAIRY RES, V68, P389, DOI 10.1017/S0022029901004988; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Filangi O, 2010, P 9 WORLD C GEN APPL; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Garcia-Fernandez M, 2011, ANIM GENET, V42, P415, DOI 10.1111/j.1365-2052.2010.02162.x; Garcia-Fernandez M, 2009, MOL CELL PROBE, V23, P107, DOI 10.1016/j.mcp.2009.01.001; Garcia-Gamez E, 2012, ANIM GENET, V43, P636, DOI 10.1111/j.1365-2052.2011.02294.x; Garcia-Gamez E, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-43; Garcia-Gamez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021158; GAYE P, 1987, BIOCHIMIE, V69, P601, DOI 10.1016/0300-9084(87)90179-9; Gonda Y, 2007, GENE EXPR PATTERNS, V7, P431, DOI 10.1016/j.modgep.2006.11.005; Green P, 1990, DOCUMENTATION CRI MA; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Gutierrez-Gil B, 2012, ANIM GENET, V43, P654, DOI 10.1111/j.1365-2052.2012.02322.x; Gutierrez-Gil B, 2009, ANIM GENET, V40, P423, DOI 10.1111/j.1365-2052.2009.01856.x; Gutierrez-Gil B, 2007, J DAIRY SCI, V90, P422, DOI 10.3168/jds.S0022-0302(07)72643-7; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Howard B, 2006, PLOS GENET, V2, P1121, DOI 10.1371/journal.pgen.0020112; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Legarra A, 2001, ANIM SCI, V73, P407, DOI 10.1017/S1357729800058379; Legarra A, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-43; Lunden A, 1998, P 6 WORLD C GEN APPL, V25; Mai MD, 2010, J ANIM SCI, V88, P3522, DOI 10.2527/jas.2009-2713; Mateescu RG, 2010, ANIM GENET, V41, P460, DOI 10.1111/j.1365-2052.2010.02045.x; Moioli B, 2007, SMALL RUMINANT RES, V68, P179, DOI 10.1016/j.smallrumres.2006.09.008; Mullen Michael Paul, 2011, Frontiers in Genetics, V2, P3, DOI 10.3389/fgene.2011.00003; Olsen HG, 2011, ANIM GENET, V42, P466, DOI 10.1111/j.1365-2052.2011.02179.x; Olsen HG, 2010, ANIM GENET, V41, P273, DOI 10.1111/j.1365-2052.2009.01998.x; Olsen HG, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-32; Othmane MH, 2002, GENET SEL EVOL, V34, P581, DOI [10.1051/gse:2002024, 10.1186/1297-9686-34-5-581]; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Plante Y, 2001, J DAIRY SCI, V84, P1516, DOI 10.3168/jds.S0022-0302(01)70185-3; Raadsma HW, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-45; Ron M, 2007, ANIM GENET, V38, P429, DOI 10.1111/j.1365-2052.2007.01640.x; Sahana G, 2011, J DAIRY SCI, V94, P479, DOI 10.3168/jds.2010-3381; Sahana G, 2010, ANIM GENET, V41, P579, DOI 10.1111/j.1365-2052.2010.02064.x; Schopen GCB, 2011, J DAIRY SCI, V94, P3148, DOI 10.3168/jds.2010-4030; Schulman NF, 2011, ANIM GENET, V42, P263, DOI 10.1111/j.1365-2052.2010.02149.x; Seaton G, 2006, P 8 WORLD C GEN APPL; Seroussi E, 2009, ANIM GENET, V40, P230, DOI 10.1111/j.1365-2052.2008.01809.x; Sharif S, 1998, ANIM GENET, V29, P185, DOI 10.1111/j.1365-2052.1998.00318.x; STINNAKRE MG, 1994, P NATL ACAD SCI USA, V91, P6544, DOI 10.1073/pnas.91.14.6544; Taylor J, 2012, 20 PLANT AN GEN C SA; VANRADEN PM, 1991, J DAIRY SCI, V74, P2737, DOI 10.3168/jds.S0022-0302(91)78453-1; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021739	53	56	59	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47782	10.1371/journal.pone.0047782	http://dx.doi.org/10.1371/journal.pone.0047782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094085	Green Published, Green Submitted, gold			2022-12-27	WOS:000312384500022
J	Rausch, F; Schicht, M; Paulsen, F; Ngueya, I; Brauer, L; Brandt, W				Rausch, Felix; Schicht, Martin; Paulsen, Friedrich; Ngueya, Ivan; Braeuer, Lars; Brandt, Wolfgang			"SP-G", a Putative New Surfactant Protein - Tissue Localization and 3D Structure	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; LINEAR CONSTRAINT SOLVER; PARTICLE MESH EWALD; PULMONARY SURFACTANT; FORCE-FIELD; NASAL EPITHELIUM; EUSTACHIAN-TUBE; HOST-DEFENSE; I-TASSER; SP-B	Surfactant proteins (SP) are well known from human lung. These proteins assist the formation of a monolayer of surface-active phospholipids at the liquid-air interface of the alveolar lining, play a major role in lowering the surface tension of interfaces, and have functions in innate and adaptive immune defense. During recent years it became obvious that SPs are also part of other tissues and fluids such as tear fluid, gingiva, saliva, the nasolacrimal system, and kidney. Recently, a putative new surfactant protein (SFTA2 or SP-G) was identified, which has no sequence or structural identity to the already know surfactant proteins. In this work, computational chemistry and molecular-biological methods were combined to localize and characterize SP-G. With the help of a protein structure model, specific antibodies were obtained which allowed the detection of SP-G not only on mRNA but also on protein level. The localization of this protein in different human tissues, sequence based prediction tools for posttranslational modifications and molecular dynamic simulations reveal that SP-G has physicochemical properties similar to the already known surfactant proteins B and C. This includes also the possibility of interactions with lipid systems and with that, a potential surface-regulatory feature of SP-G. In conclusion, the results indicate SP-G as a new surfactant protein which represents an until now unknown surfactant protein class.	[Rausch, Felix; Brandt, Wolfgang] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Germany; [Schicht, Martin; Paulsen, Friedrich; Ngueya, Ivan; Braeuer, Lars] Univ Erlangen Nurnberg, Inst Anat, Dept 2, D-91054 Erlangen, Germany	Leibniz Institut fur Pflanzenbiochemie; University of Erlangen Nuremberg	Brandt, W (corresponding author), Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Germany.	wbrandt@ipb-halle.de		Paulsen, Friedrich/0000-0002-0527-0953; Schicht, Martin/0000-0001-5155-5477	Deutsche Forschungsgemeinschaft (DFG) [BR 1329/12-1, BR 3681/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/index.jsp) given to W.B. (grant: BR 1329/12-1) and L.B. (grant BR 3681/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2004, BIOPHYS J, V87, P4188, DOI 10.1529/biophysj.104.051201; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Baoukina S, 2011, BIOPHYS J, V100, P1678, DOI 10.1016/j.bpj.2011.02.019; Bartlett J, 2011, BIOCHEM SOC T, V39, P1012, DOI 10.1042/BST0391012; Beck DC, 2000, J BIOL CHEM, V275, P3365, DOI 10.1074/jbc.275.5.3365; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Bernhard W, 1997, AM J RESP CELL MOL, V17, P41, DOI 10.1165/ajrcmb.17.1.2594; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bourbon JR, 2001, COMP BIOCHEM PHYS A, V129, P151, DOI 10.1016/S1095-6433(01)00312-9; Brauer L, 2007, CURR EYE RES, V32, P931, DOI 10.1080/02713680701694369; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Brauer L, 2012, BIOMED ENG-BIOMED TE, V57, P59, DOI 10.1515/bmt-2011-0031; Brauer L, 2009, HISTOCHEM CELL BIOL, V132, P331, DOI 10.1007/s00418-009-0609-x; Brauer L, 2008, J EPITHEL BIOL PHARM, V1, P62; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; CURSTEDT T, 1988, EUR J BIOCHEM, V172, P521, DOI 10.1111/j.1432-1033.1988.tb13918.x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duncan SL, 2010, BBA-BIOMEMBRANES, V1798, P1632, DOI 10.1016/j.bbamem.2010.04.006; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferguson JS, 1999, J IMMUNOL, V163, P312; GLASSER SW, 1988, J BIOL CHEM, V263, P9; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Gustafsson M, 2000, BBA-BIOMEMBRANES, V1466, P169, DOI 10.1016/S0005-2736(00)00198-X; Guttentag S, 2003, AM J RESP CELL MOL, V28, P69, DOI 10.1165/rcmb.2002-0111OC; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kaleem A, 2011, J CELL BIOCHEM, V112, P138, DOI 10.1002/jcb.22909; Kandasamy SK, 2005, BIOPHYS J, V88, P1577, DOI 10.1529/biophysj.104.038430; Kankavi O, 2003, ACTA BIOCHIM POL, V50, P1057; Kaznessis YN, 2002, J MOL BIOL, V322, P569, DOI 10.1016/S0022-2836(02)00774-X; KHOOR A, 1994, J HISTOCHEM CYTOCHEM, V42, P1187, DOI 10.1177/42.9.8064126; Kiemer L, 2005, BIOINFORMATICS, V21, P1269, DOI 10.1093/bioinformatics/bti130; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim JK, 2007, AM J PHYSIOL-LUNG C, V292, pL879, DOI 10.1152/ajplung.00156.2006; KING RJ, 1973, AM J PHYSIOL, V224, P788, DOI 10.1152/ajplegacy.1973.224.4.788; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kukol A, 2009, J CHEM THEORY COMPUT, V5, P615, DOI 10.1021/ct8003468; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeClair EE, 2001, BIOCHEM BIOPH RES CO, V284, P792, DOI 10.1006/bbrc.2001.5024; Mancia A, 2012, COMP BIOCHEM PHYS C, V155, P136, DOI 10.1016/j.cbpc.2011.04.002; Mittal RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040011; Nakai K, 2000, ADV PROTEIN CHEM, V54, P277, DOI 10.1016/S0065-3233(00)54009-1; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; NOTTER RH, 1987, CHEM PHYS LIPIDS, V44, P1, DOI 10.1016/0009-3084(87)90002-8; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Paananen R, 2001, AM J PHYSIOL-LUNG C, V280, pL214, DOI 10.1152/ajplung.2001.280.2.L214; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schicht M, 2010, KLIN MONATSBL AUGENH, V227, P864, DOI 10.1055/s-0029-1245609; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Smith GR, 2002, GROMACS USER CONTRIB; Sommer B, 2011, J CHEM INF MODEL, V51, P1165, DOI 10.1021/ci1003619; Ten Brinke A, 2002, BIOCHEM J, V361, P663, DOI 10.1042/0264-6021:3610663; Vallat BK, 2008, PROTEINS, V72, P910, DOI 10.1002/prot.21976; Vallat BK, 2009, PROTEINS, V76, P930, DOI 10.1002/prot.22401; van de Wetering JK, 2004, EUR J BIOCHEM, V271, P1229, DOI 10.1111/j.1432-1033.2004.04040.x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; VOORHOUT WF, 1992, AM J PHYSIOL, V263, pL479, DOI 10.1152/ajplung.1992.263.4.L479; Vorbroker DK, 1995, AM J PHYSIOL-LUNG C, V269, pL727, DOI 10.1152/ajplung.1995.269.6.L727; Weaver TE, 1998, BBA-MOL BASIS DIS, V1408, P173, DOI 10.1016/S0925-4439(98)00066-0; Weston WM, 1999, J BIOL CHEM, V274, P13698, DOI 10.1074/jbc.274.19.13698; WHITSETT JA, 1986, PEDIATR RES, V20, P744, DOI 10.1203/00006450-198608000-00009; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; YU SH, 1987, BIOCHIM BIOPHYS ACTA, V921, P437; YU SH, 1990, BIOCHIM BIOPHYS ACTA, V1046, P233, DOI 10.1016/0005-2760(90)90236-Q; Yu SH, 2003, J LIPID RES, V44, P621, DOI 10.1194/jlr.M200380-JLR200; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504	82	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47789	10.1371/journal.pone.0047789	http://dx.doi.org/10.1371/journal.pone.0047789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094088	gold, Green Published, Green Submitted			2022-12-27	WOS:000312384500024
J	Verkade, E; Bergmans, AMC; Budding, AE; van Belkum, A; Savelkoul, P; Buiting, AG; Kluytmans, J				Verkade, Erwin; Bergmans, Anneke M. C.; Budding, Andries E.; van Belkum, Alex; Savelkoul, Paul; Buiting, Anton G.; Kluytmans, Jan			Recent Emergence of Staphylococcus aureus Clonal Complex 398 in Human Blood Cultures	PLOS ONE			English	Article							METHICILLIN-RESISTANT; ST398; AMPLIFICATION; INFECTIONS	Background: Recently, a clone of MRSA with clonal complex 398 (CC398) has emerged that is related to an extensive reservoir in animals, especially pigs and veal calves. It has been reported previously that methicillin-susceptible variants of CC398 circulate among humans at low frequency, and these have been isolated in a few cases of bloodstream infections (BSI). The purpose of this study was to determine the prevalence of S. aureus CC398 in blood cultures taken from patients in a geographic area with a high density of pigs. Methodology/Principal Findings: In total, 612 consecutive episodes of S. aureus BSI diagnosed before and during the emergence of CC398 were included. Three strains (2 MSSA and 1 MRSA) that were isolated from bacteremic patients between 2010-2011 were positive in a CC398 specific PCR. There was a marked increase in prevalence of S. aureus CC398 BSI isolated between 2010-2011 compared to the combined collections that were isolated between 1996-1998 and 2002-2005 (3/157, 1.9% vs. 0/455, 0.0%; p = 0.017). Conclusions/Significance: In conclusion, in an area with a relative high density of pigs, S. aureus CC398 was found as a cause of BSI in humans only recently. This indicates that S. aureus CC398 is able to cause invasive infections in humans and that the prevalence is rising. Careful monitoring of the evolution and epidemiology of S. aureus CC398 in animals and humans is therefore important.	[Verkade, Erwin; Bergmans, Anneke M. C.; Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Verkade, Erwin; Buiting, Anton G.; Kluytmans, Jan] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Bergmans, Anneke M. C.] Franciscus Hosp, Microbiol Lab, Roosendaal, Netherlands; [Budding, Andries E.; Savelkoul, Paul; Kluytmans, Jan] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [van Belkum, Alex] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [van Belkum, Alex] BioMerieux, Microbiol R&D, La Balme Les Grottes, France	Amphia Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; bioMerieux	Verkade, E (corresponding author), Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.	everkade@amphia.nl		Budding, Andries/0000-0001-5128-5411				Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bhat M, 2009, EMERG INFECT DIS, V15, P285, DOI 10.3201/eid1502.080609; Budding AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013671; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Diederen BMW, 2006, J INFECTION, V52, P157, DOI 10.1016/j.jinf.2005.09.001; DOLZANI L, 1994, FEMS MICROBIOL LETT, V119, P167, DOI 10.1016/0378-1097(94)90409-X; Ekkelenkamp M B, 2006, Ned Tijdschr Geneeskd, V150, P2442; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Melles DC, 2007, J MICROBIOL METH, V69, P371, DOI 10.1016/j.mimet.2007.01.013; Jimenez JN, 2011, EMERG INFECT DIS, V17, P1970, DOI 10.3201/eid1710.110638; National Committee for Clinical Laboratory Standards, 2006, M100S16 NAT COMM CLI; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rasigade JP, 2010, EMERG INFECT DIS, V16, P1330, DOI 10.3201/eid1608.100317; Schmitz FJ, 1998, J MED MICROBIOL, V47, P341, DOI 10.1099/00222615-47-4-341; Schmitz FJ, 1997, ZBL HYG UMWELTMED, V200, P172; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; van Wamel WJB, 2010, EUR J CLIN MICROBIOL, V29, P119, DOI 10.1007/s10096-009-0816-3; Vandenbroucke-Grauls C M J E, 2006, Ned Tijdschr Geneeskd, V150, P1710; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x	29	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e41855	10.1371/journal.pone.0041855	http://dx.doi.org/10.1371/journal.pone.0041855			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094014	gold, Green Published, Green Submitted			2022-12-27	WOS:000312384500001
J	Zhai, K; Hubert, F; Nicolas, V; Ji, GJ; Fischmeister, R; Leblais, V				Zhai, Kui; Hubert, Fabien; Nicolas, Valerie; Ji, Guangju; Fischmeister, Rodolphe; Leblais, Veronique			beta-Adrenergic cAMP Signals Are Predominantly Regulated by Phosphodiesterase Type 4 in Cultured Adult Rat Aortic Smooth Muscle Cells	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; SELECTIVE INHIBITOR; ADENYLYL-CYCLASE; NITRIC-OXIDE; EXPRESSION; CGMP; RELAXATION; RECEPTORS; PATHWAYS	Background: We investigated the role of cyclic nucleotide phosphodiesterases (PDEs) in the spatiotemporal control of intracellular cAMP concentrations in rat aortic smooth muscle cells (RASMCs). Methodology/Principal Findings: The rank order of PDE families contributing to global cAMP-PDE activity was PDE4> PDE3 = PDE1. PDE7 mRNA expression but not activity was confirmed. The Fluorescence Resonance Energy Transfer (FRET)-based cAMP sensor, Epac1-camps, was used to monitor the time course of cytosolic cAMP changes. A pulse application of the beta-adrenoceptor (beta-AR) agonist isoproterenol (Iso) induced a transient FRET signal. Both beta(1)- and beta(2)-AR antagonists decreased the signal amplitude without affecting its kinetics. The non-selective PDE inhibitor (IBMX) dramatically increased the amplitude and delayed the recovery phase of Iso response, in agreement with a role of PDEs in degrading cAMP produced by Iso. Whereas PDE1, PDE3 and PDE7 blockades [with MIMX, cilostamide (Cil) and BRL 50481 (BRL), respectively] had no or minor effect on Iso response, PDE4 inhibition [with Ro-20-1724 (Ro)] strongly increased its amplitude and delayed its recovery. When Ro was applied concomitantly with MIMX or Cil (but not with BRL), the Iso response was drastically further prolonged. PDE4 inhibition similarly prolonged both beta(1)- and beta(2)-AR-mediated responses. When a membrane-targeted FRET sensor was used, PDE3 and PDE4 acted in a synergistic manner to hydrolyze the submembrane cAMP produced either at baseline or after beta-AR stimulation. Conclusion/Significance: Our study underlines the importance of cAMP-PDEs in the dynamic control of intracellular cAMP signals in RASMCs, and demonstrates the prominent role of PDE4 in limiting beta-AR responses. PDE4 inhibition unmasks an effect of PDE1 and PDE3 on cytosolic cAMP hydrolyzis, and acts synergistically with PDE3 inhibition at the submembrane compartment. This suggests that mixed PDE4/PDE1 or PDE4/PDE3 inhibitors would be attractive to potentiate cAMP-related functions in vascular cells.	[Zhai, Kui; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Zhai, Kui; Hubert, Fabien; Fischmeister, Rodolphe; Leblais, Veronique] LabEx LERMIT, Inserm UMR S 769, Chatenay Malabry, France; [Zhai, Kui; Hubert, Fabien; Nicolas, Valerie; Fischmeister, Rodolphe; Leblais, Veronique] Univ Paris 11, Fac Pharm, F-92290 Chatenay Malabry, France; [Nicolas, Valerie] IPSIT IFR141, F-92290 Chatenay Malabry, France	Chinese Academy of Sciences; Institute of Biophysics, CAS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Ji, GJ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	gj28@ibp.ac.cn; veronique.leblais@u-psud.fr	LEBLAIS, Véronique/Q-3845-2018; Fischmeister, Rodolphe/L-6061-2018; Hubert, Fabien/ABE-6866-2021	LEBLAIS, Véronique/0000-0001-9934-8944; Fischmeister, Rodolphe/0000-0003-2086-9865; Hubert, Fabien/0000-0003-1360-4092; Zhai, Kui/0000-0003-4725-190X	University Paris-Sud; "Region Ile de France" (SETCI); National Basic Research Program of China [2011CB8091004, 2009CB918701]	University Paris-Sud; "Region Ile de France" (SETCI)(Region Ile-de-France); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from "University Paris-Sud" (Bonus Attractivite Paris-Sud 2009-2012; http://www.u-psud.fr/fr/la_recherche/les_appels_a_projet.html), "Region Ile de France" (SETCI; http://www.iledefrance.fr/appels-a-projets/recherche-enseignement-sup/clos/cotutelle-internationale/) and "National Basic Research Program of China" (2011CB8091004 and 2009CB918701; http://www.973.gov.cn/English/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boess FG, 2004, NEUROPHARMACOLOGY, V47, P1081, DOI 10.1016/j.neuropharm.2004.07.040; Brawley L, 2000, BRIT J PHARMACOL, V129, P637, DOI 10.1038/sj.bjp.0703091; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; Degerman E, 1997, J BIOL CHEM, V272, P6823, DOI 10.1074/jbc.272.11.6823; Delpy E, 1996, BRIT J PHARMACOL, V119, P471, DOI 10.1111/j.1476-5381.1996.tb15696.x; Dunkerley HA, 2002, MOL PHARMACOL, V61, P1033, DOI 10.1124/mol.61.5.1033; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Goncalves RL, 2009, EUR J PHARMACOL, V620, P78, DOI 10.1016/j.ejphar.2009.08.008; Guimaraes S, 2001, PHARMACOL REV, V53, P319; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Koyama H, 2001, J CELL PHYSIOL, V186, P1; Leblais V, 2008, CARDIOVASC RES, V77, P202, DOI 10.1093/cvr/cvm008; Leroy J, 2008, CIRC RES, V102, P1091, DOI 10.1161/CIRCRESAHA.107.167817; Liu HG, 2000, J BIOL CHEM, V275, P26615, DOI 10.1074/jbc.M001634200; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; MCDANIEL NL, 1994, CAN J PHYSIOL PHARM, V72, P1380, DOI 10.1139/y94-199; Mika D, 2012, J MOL CELL CARDIOL, V52, P323, DOI 10.1016/j.yjmcc.2011.08.016; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nikolaev VO, 2006, PHYSIOLOGY, V21, P86, DOI 10.1152/physiol.00057.2005; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Orallo F, 2004, N-S ARCH PHARMACOL, V370, P452, DOI 10.1007/s00210-004-0994-6; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Palmer D, 2000, MOL PHARMACOL, V58, P247, DOI 10.1124/mol.58.2.247; Phillips PG, 2005, AM J PHYSIOL-LUNG C, V288, pL103, DOI 10.1152/ajplung.00095.2004; Piggott LA, 2006, J GEN PHYSIOL, V128, P3, DOI 10.1085/jgp.200509403; Rautureau Y, 2002, BRIT J PHARMACOL, V137, P153, DOI 10.1038/sj.bjp.0704867; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Rose RJ, 1997, BRIT J PHARMACOL, V122, P233, DOI 10.1038/sj.bjp.0701376; ROVNER AS, 1986, J BIOL CHEM, V261, P4740; Rybalkin SD, 1997, J CLIN INVEST, V100, P2611, DOI 10.1172/JCI119805; Sassi Y, 2008, J CLIN INVEST, V118, P2747, DOI 10.1172/JCI35067; Saucerman JJ, 2006, ANN NY ACAD SCI, V1080, P348, DOI 10.1196/annals.1380.026; Smith SJ, 2004, MOL PHARMACOL, V66, P1679, DOI 10.1124/mol.104.002246; Sudo T, 2000, BIOCHEM PHARMACOL, V59, P347, DOI 10.1016/S0006-2952(99)00346-9; THOMPSON WJ, 1971, J BIOL CHEM, V246, P3145; THYBERG J, 1990, ARTERIOSCLEROSIS, V10, P966, DOI 10.1161/01.ATV.10.6.966; Trochu JN, 1999, BRIT J PHARMACOL, V128, P69, DOI 10.1038/sj.bjp.0702797; Vallot O, 2000, ARTERIOSCL THROM VAS, V20, P1225, DOI 10.1161/01.ATV.20.5.1225; von Hayn K, 2010, AM J PHYSIOL-CELL PH, V298, pC324, DOI 10.1152/ajpcell.00197.2009; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; WELLS JN, 1988, METHOD ENZYMOL, V159, P489; Xiang YK, 2011, CIRC RES, V109, P231, DOI 10.1161/CIRCRESAHA.110.231340	46	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47826	10.1371/journal.pone.0047826	http://dx.doi.org/10.1371/journal.pone.0047826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094097	Green Submitted, Green Published, gold			2022-12-27	WOS:000312384500028
J	Karduna, AR; Sainburg, RL				Karduna, Andrew R.; Sainburg, Robert L.			Similarities in the Neural Control of the Shoulder and Elbow Joints Belie Their Structural Differences	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; REACHING MOVEMENTS; INTERNAL-MODEL; INTERJOINT COORDINATION; ONLINE CONTROL; ARM MOVEMENTS; DYNAMICS; ACCURACY; PROPRIOCEPTION; POSITION	Movement of the hand in three dimensional space is primarily controlled by the orientation of the shoulder and elbow complexes. Due to discrepancies in proprioceptive acuity, overlap in motor cortex representation and grossly different anatomies between these joints, we hypothesized that there would be differences in the accuracy of aimed movements between the two joints. Fifteen healthy young adults were tested under four conditions - shoulder motion with the elbow constrained and unconstrained, and elbow motion with the shoulder constrained and unconstrained. End point target locations for each joint were set to coincide with joint excursions of 10, 20 or 30 degrees of either the shoulder or elbow joint. Targets were presented in a virtual reality environment. For the constrained condition, there were no significant differences in angular errors between the two joints, suggesting that the central nervous system represents linked segment models of the limb in planning and controlling movements. For the unconstrained condition, although angle errors were higher, hand position errors remained the same as those of the constrained trials. These results support the idea that the CNS utilizes abundant degrees of freedom to compensate for the potentially different contributions to end-point errors introduced by each joint.	[Karduna, Andrew R.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [Sainburg, Robert L.] Penn State Univ, Dept Kinesiol & Neurol, University Pk, PA 16802 USA	University of Oregon; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Karduna, AR (corresponding author), Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA.	karduna@uoregon.edu	Karduna, Andrew/ABA-7373-2021	Sainburg, Robert/0000-0003-2627-1258; Karduna, Andrew/0000-0003-4859-4330	National Institutes of Health (NICHD) [R01HD39311, R01HD059783]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059783] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039311] Funding Source: NIH RePORTER	National Institutes of Health (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (NICHD) grants R01HD39311 and R01HD059783 to Robert Sainburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 1999, EXP BRAIN RES, V125, P200, DOI 10.1007/s002210050674; Arce F, 2010, J NEUROSCI, V30, P5415, DOI 10.1523/JNEUROSCI.0076-10.2010; ATKESON CG, 1989, ANNU REV NEUROSCI, V12, P157, DOI 10.1146/annurev.neuro.12.1.157; BUNEO CA, 1995, EXP BRAIN RES, V104, P467; CLARK FJ, 1995, EXP BRAIN RES, V107, P73; Debicki DB, 2005, EXP BRAIN RES, V163, P252, DOI 10.1007/s00221-005-2229-6; Ebner TJ, 2011, CEREBELLUM, V10, P683, DOI 10.1007/s12311-010-0243-0; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; Galloway JC, 2002, EXP BRAIN RES, V142, P163, DOI 10.1007/s002210100882; GEORGOPOULOS AP, 1991, ANNU REV NEUROSCI, V14, P361, DOI 10.1146/annurev.ne.14.030191.002045; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; GHEZ C, 1995, CAN J PHYSIOL PHARM, V73, P273, DOI 10.1139/y95-038; Goble JA, 2007, J NEUROPHYSIOL, V98, P1240, DOI 10.1152/jn.00582.2007; Goldscheider A., 1889, ARCHIV F R PHYSIOLOG, V3, P369; Graham KM, 2003, J NEUROPHYSIOL, V89, P2667, DOI 10.1152/jn.00742.2002; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; Gritsenko V, 2007, J NEUROPHYSIOL, V98, P1140, DOI 10.1152/jn.00162.2007; Gritsenko V, 2009, J NEUROPHYSIOL, V102, P914, DOI 10.1152/jn.91324.2008; Gritsenko V, 2011, J NEUROSCI, V31, P11968, DOI 10.1523/JNEUROSCI.0132-11.2011; HALL LA, 1983, J PHYSIOL-LONDON, V335, P519, DOI 10.1113/jphysiol.1983.sp014548; HANCOCK GR, 1995, J MOTOR BEHAV, V27, P241, DOI 10.1080/00222895.1995.9941714; Herter TM, 2007, J NEUROPHYSIOL, V97, P2887, DOI 10.1152/jn.00757.2006; Holzbaur KRS, 2005, ANN BIOMED ENG, V33, P829, DOI 10.1007/s10439-005-3320-7; Imamizu H, 1998, J EXP PSYCHOL HUMAN, V24, P812, DOI 10.1037/0096-1523.24.3.812; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; Kocak M, 2009, RADIOLOGY, V251, P485, DOI 10.1148/radiol.2512080231; Kwok JC, 2010, ARCH PHYS MED REHAB, V91, P149, DOI 10.1016/j.apmr.2009.07.018; Lackner JR, 1998, J NEUROPHYSIOL, V80, P546, DOI 10.1152/jn.1998.80.2.546; Li Y, 2005, J NEUROPHYSIOL, V94, P2139, DOI 10.1152/jn.00312.2005; MARTIN JH, 1993, EXP BRAIN RES, V94, P429; Melgari JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003069; Messier J, 2003, EXP BRAIN RES, V150, P399, DOI 10.1007/s00221-003-1413-9; Milner TE, 2004, EXP BRAIN RES, V159, P172, DOI 10.1007/s00221-004-1944-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penfield W., 1952, CEREBRAL CORTEX MAN; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Sainburg RL, 2004, J NEUROPHYSIOL, V92, P1374, DOI 10.1152/jn.00181.2004; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; Sainburg RL, 2003, J NEUROPHYSIOL, V89, P401, DOI 10.1152/jn.00243.2002; SAINBURG RL, 1993, J NEUROPHYSIOL, V70, P2136, DOI 10.1152/jn.1993.70.5.2136; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; Sarlegna F, 2003, EXP BRAIN RES, V151, P524, DOI 10.1007/s00221-003-1504-7; Sarlegna FR, 2010, J VISION, V10, DOI 10.1167/10.5.24; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; SCOTT SH, 1994, J NEUROSCI, V14, P7529; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Sturnieks DL, 2007, J PHYSIOL-LONDON, V585, P833, DOI 10.1113/jphysiol.2007.139089; Tomlinson T, 2012, J MOTOR BEHAV, V44, P13, DOI 10.1080/00222895.2011.636398; Tripp BL, 2006, CLIN BIOMECH, V21, P466, DOI 10.1016/j.clinbiomech.2005.12.015; Wang JS, 2007, EXP BRAIN RES, V178, P565, DOI 10.1007/s00221-007-0936-x; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yao J, 2009, NEUROIMAGE, V45, P490, DOI 10.1016/j.neuroimage.2008.12.002	56	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e45837	10.1371/journal.pone.0045837	http://dx.doi.org/10.1371/journal.pone.0045837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082116	Green Published, Green Submitted, gold			2022-12-27	WOS:000311146900011
J	Kultima, JR; Sunagawa, S; Li, JH; Chen, WN; Chen, H; Mende, DR; Arumugam, M; Pan, Q; Liu, BH; Qin, JJ; Wang, J; Bork, P				Kultima, Jens Roat; Sunagawa, Shinichi; Li, Junhua; Chen, Weineng; Chen, Hua; Mende, Daniel R.; Arumugam, Manimozhiyan; Pan, Qi; Liu, Binghang; Qin, Junjie; Wang, Jun; Bork, Peer			MOCAT: A Metagenomics Assembly and Gene Prediction Toolkit	PLOS ONE			English	Article							SHORT READ ALIGNMENT; SEQUENCES; RESOURCE; LIFE	MOCAT is a highly configurable, modular pipeline for fast, standardized processing of single or paired-end sequencing data generated by the Illumina platform. The pipeline uses state-of-the-art programs to quality control, map, and assemble reads from metagenomic samples sequenced at a depth of several billion base pairs, and predict protein-coding genes on assembled metagenomes. Mapping against reference databases allows for read extraction or removal, as well as abundance calculations. Relevant statistics for each processing step can be summarized into multi-sheet Excel documents and queryable SQL databases. MOCAT runs on UNIX machines and integrates seamlessly with the SGE and PBS queuing systems, commonly used to process large datasets. The open source code and modular architecture allow users to modify or exchange the programs that are utilized in the various processing steps. Individual processing steps and parameters were benchmarked and tested on artificial, real, and simulated metagenomes resulting in an improvement of selected quality metrics. MOCAT can be freely downloaded at http://www.bork.embl.de/mocat/.	[Kultima, Jens Roat; Sunagawa, Shinichi; Mende, Daniel R.; Arumugam, Manimozhiyan; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Li, Junhua; Chen, Weineng; Chen, Hua; Pan, Qi; Liu, Binghang; Qin, Junjie; Wang, Jun] BGI Shenzhen, Dept Sci & Technol, Shenzhen, Guangdong, Peoples R China; [Li, Junhua] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany	European Molecular Biology Laboratory (EMBL); Beijing Genomics Institute (BGI); South China University of Technology; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	bork@embl.de	Mende, Daniel R/I-3662-2019; Li, Junhua/AAG-3919-2019; Arumugam, Manimozhiyan/E-1211-2011; Arumugam, Manimozhiyan/AAJ-2394-2020; Sunagawa, Shinichi/Q-5950-2019; Wang, Jun/A-7261-2013; Bork, Peer/F-1813-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Mende, Daniel R/0000-0001-6831-4557; Li, Junhua/0000-0001-6784-1873; Arumugam, Manimozhiyan/0000-0002-0886-9101; Arumugam, Manimozhiyan/0000-0002-0886-9101; Sunagawa, Shinichi/0000-0003-3065-0314; Bork, Peer/0000-0002-2627-833X; liu, bh/0000-0002-4948-2835; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	European Community [HEALTH-F4-2007-201052]; International Human Microbiome Standards (IHMS) [HEALTH-F4-2010-261376]; Cancerbiome (ERC Advanced Grant) [268985]	European Community(European Commission); International Human Microbiome Standards (IHMS); Cancerbiome (ERC Advanced Grant)	This work was funded by EMBL, the European Community's Seventh Framework Programme via the MetaHIT (HEALTH-F4-2007-201052), International Human Microbiome Standards (IHMS) (HEALTH-F4-2010-261376), and Cancerbiome (ERC Advanced Grant 268985) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Edgar CRC, 2012, INFECT DIS SOC AM, V54, DOI [10.1093/cid/cir977, DOI 10.1093/CID/CIR977]; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gonzalez A, 2012, CURR OPIN BIOTECH, V23, P64, DOI 10.1016/j.copbio.2011.11.028; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Mende DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031386; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schwartz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016685; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	26	121	127	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47656	10.1371/journal.pone.0047656	http://dx.doi.org/10.1371/journal.pone.0047656			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082188	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900085
J	Lewis, SEM; Rapino, C; Di Tommaso, M; Pucci, M; Battista, N; Paro, R; Simon, L; Lutton, D; Maccarrone, M				Lewis, Sheena E. M.; Rapino, Cinzia; Di Tommaso, Monia; Pucci, Mariangela; Battista, Natalia; Paro, Rita; Simon, Luke; Lutton, Deborah; Maccarrone, Mauro			Differences in the Endocannabinoid System of Sperm from Fertile and Infertile Men	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; FOLLICLE-STIMULATING-HORMONE; TYPE-1 CANNABINOID RECEPTOR; ACROSOME REACTION; MOLECULAR CHARACTERIZATION; MALE REPRODUCTION; SERTOLI-CELLS; CB2 RECEPTORS; SEA-URCHINS; IN-VIVO	Male infertility is a major cause of problems for many couples in conceiving a child. Recently, lifestyle pastimes such as alcohol, tobacco and marijuana have been shown to have further negative effects on male reproduction. The endocannabinoid system (ECS), mainly through the action of anandamide (AEA) and 2-arachidonoylglycerol (2-AG) at cannabinoid (CB1, CB2) and vanilloid (TRPV1) receptors, plays a crucial role in controlling functionality of sperm, with a clear impact on male reproductive potential. Here, sperm from fertile and infertile men were used to investigate content (through LC-ESI-MS), mRNA (through quantitative RT-PCR), protein (through Western Blotting and ELISA) expression, and functionality (through activity and binding assays) of the main metabolic enzymes of AEA and 2-AG (NAPE-PLD and FAAH, for AEA; DAGL and MAGL for 2-AG), as well as of their binding receptors CB1, CB2 and TRPV1. Our findings show a marked reduction of AEA and 2-AG content in infertile seminal plasma, paralleled by increased degradation: biosynthesis ratios of both substances in sperm from infertile versus fertile men. In addition, TRPV1 binding was detected in fertile sperm but was undetectable in infertile sperm, whereas that of CB1 and CB2 receptors was not statistically different in the two groups. In conclusion, this study identified unprecedented alterations of the ECS in infertile sperm, that might impact on capacitation and acrosome reaction, and hence fertilization outcomes. These alterations might also point to new biomarkers to determine male reproductive defects, and identify distinct ECS elements as novel targets for therapeutic exploitation of ECS-oriented drugs to treat male fertility problems.	[Rapino, Cinzia; Di Tommaso, Monia; Pucci, Mariangela; Battista, Natalia; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, Teramo, Italy; [Lewis, Sheena E. M.; Paro, Rita; Simon, Luke] Queens Univ Belfast, Sch Med, Ctr Publ Hlth, Inst Clin Sci, Belfast, Antrim, North Ireland; [Lutton, Deborah] Royal Jubilee Matern Serv, Reg Fertil Ctr, Belfast, Antrim, North Ireland; [Maccarrone, Mauro] IRCCS Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy	University of Teramo; Queens University Belfast; IRCCS Santa Lucia	Maccarrone, M (corresponding author), Univ Teramo, Dept Biomed Sci, Teramo, Italy.	mmaccarrone@unite.it	Maccarrone, Mauro/K-5398-2012; Lewis, Sheena E M/ABI-8338-2020; Battista, Natalia/AAC-2529-2019; Pucci, Mariangela/K-6379-2016	Maccarrone, Mauro/0000-0002-3990-2963; Pucci, Mariangela/0000-0003-4657-6075; Battista, Natalia/0000-0002-1936-6710	Ulster Garden Villages, Northern Ireland; Organon Laboratories; Fondazione TERCAS	Ulster Garden Villages, Northern Ireland; Organon Laboratories; Fondazione TERCAS	This investigation was supported by Ulster Garden Villages, Northern Ireland, and Organon Laboratories (to SEML), and by Fondazione TERCAS (grant 2009-2012 to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Bari M, 2006, MINI-REV MED CHEM, V6, P257, DOI 10.2174/138955706776073466; Bari M, 2011, FRONT BIOSCI-LANDMRK, V16, P498, DOI 10.2741/3701; Bari M, 2011, STEM CELLS DEV, V20, P139, DOI 10.1089/scd.2009.0515; Barratt CLR, 2010, HUM REPROD, V25, P824, DOI 10.1093/humrep/dep465; Battista N, 2008, J NEUROENDOCRINOL, V20, P82, DOI 10.1111/j.1365-2826.2008.01684.x; Battista N, 2012, MOL CELL ENDOCRINOL, V355, P1, DOI 10.1016/j.mce.2012.01.014; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Buffone MG, 2012, MOL REPROD DEV, V79, P4, DOI 10.1002/mrd.21393; Cacciola G, 2008, BIOL REPROD, V79, P758, DOI 10.1095/biolreprod.108.070128; Cacciola G, 2008, MOL CELL ENDOCRINOL, V286, pS24, DOI 10.1016/j.mce.2008.01.004; Catanzaro G, 2011, MOL CELL ENDOCRINOL, V343, P88, DOI 10.1016/j.mce.2011.01.022; CHANG MC, 1993, MOL REPROD DEV, V36, P507, DOI 10.1002/mrd.1080360416; Cobellis G, 2006, BIOL REPROD, V75, P82, DOI 10.1095/biolreprod.106.051730; Cobellis G, 2010, BIOL REPROD, V82, P451, DOI 10.1095/biolreprod.109.079210; Colombo G, 2009, J MOL NEUROSCI, V37, P111, DOI 10.1007/s12031-008-9114-2; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Di Marzo V, 2010, CURR MED CHEM, V17, P1430; Dinh TP, 2002, CHEM PHYS LIPIDS, V121, P149, DOI 10.1016/S0009-3084(02)00150-0; El-Talatini MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004579; Fasano S, 2009, ANN NY ACAD SCI, V1163, P112, DOI 10.1111/j.1749-6632.2009.04437.x; Fezza F, 2005, ANAL BIOCHEM, V339, P113, DOI 10.1016/j.ab.2004.12.005; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; Gasperi V, 2007, CELL MOL LIFE SCI, V64, P219, DOI 10.1007/s00018-006-6445-4; Giuffrida A, 2000, EUR J PHARMACOL, V408, P161, DOI 10.1016/S0014-2999(00)00786-X; Giwercman A, 2010, INT J ANDROL, V33, pE221, DOI 10.1111/j.1365-2605.2009.00995.x; Glanemann C, 2003, APPL MICROBIOL BIOT, V61, P61, DOI 10.1007/s00253-002-1191-5; Gervasi MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016993; Gervasi MG, 2009, REPRODUCTION, V137, P403, DOI 10.1530/REP-08-0204; Grimaldi P, 2009, P NATL ACAD SCI USA, V106, P11131, DOI 10.1073/pnas.0812789106; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Gye MC, 2005, ARCH ANDROLOGY, V51, P247, DOI 10.1080/014850190898845; Habayeb OMH, 2008, JAMA-J AM MED ASSOC, V299, P1135, DOI 10.1001/jama.299.10.1135; Hall W, 1998, LANCET, V352, P1611, DOI 10.1016/S0140-6736(98)05021-1; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; KRUGER TF, 1987, UROLOGY, V30, P248, DOI 10.1016/0090-4295(87)90246-9; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Lefievre L, 2007, REPRODUCTION, V133, P675, DOI 10.1530/REP-06-0332; Lewis SEM, 2012, INT J ANDROL, V35, P731, DOI 10.1111/j.1365-2605.2012.01259.x; Lewis SE, 2009, PHARMACOL RES, V60, P126, DOI 10.1016/j.phrs.2009.02.009; Lewis SEM, 2007, REPRODUCTION, V134, P31, DOI 10.1530/REP-07-0152; LINDEMANN CB, 1989, ARCH ANDROLOGY, V23, P1, DOI 10.3109/01485018908986783; LIST A, 1977, DRUG METAB DISPOS, V5, P268; Maccarrone M, 2008, BRIT J PHARMACOL, V153, P189, DOI 10.1038/sj.bjp.0707444; Maccarrone M, 2005, J CELL SCI, V118, P4393, DOI 10.1242/jcs.02536; Maccarrone M, 2003, ENDOCRINOLOGY, V144, P20, DOI 10.1210/en.2002-220544; Maccarrone M, 2002, PROSTAG LEUKOTR ESS, V66, P309, DOI 10.1054/plef.2001.0354; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Matias I, 2006, INT J OBESITY, V30, pS7, DOI 10.1038/sj.ijo.0803271; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Moriconi A, 2010, CURR MED CHEM, V17, P1411, DOI 10.2174/092986710790980069; Muccioli GG, 2010, DRUG DISCOV TODAY, V15, P474, DOI 10.1016/j.drudis.2010.03.007; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Pasquariello N, 2009, J BIOL CHEM, V284, P29413, DOI 10.1074/jbc.M109.044412; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Pierantoni R, 2009, VITAM HORM, V81, P367, DOI 10.1016/S0083-6729(09)81014-5; Ricci G, 2007, GEN COMP ENDOCR, V153, P320, DOI 10.1016/j.ygcen.2007.02.003; Rossato M, 2005, J CLIN ENDOCR METAB, V90, P984, DOI 10.1210/jc.2004-1287; Rossato M, 2008, MOL CELL ENDOCRINOL, V286, pS31, DOI 10.1016/j.mce.2008.02.013; Rossi G, 2007, ENDOCRINOLOGY, V148, P1431, DOI 10.1210/en.2006-0969; Sadeu JC, 2010, CRIT REV TOXICOL, V40, P633, DOI 10.3109/10408444.2010.493552; Schuel H, 2005, BIOL REPROD, V73, P1078, DOI 10.1095/biolreprod.105.043273; Schuel H, 2002, CHEM PHYS LIPIDS, V121, P211, DOI 10.1016/S0009-3084(02)00158-5; SCHUEL H, 1994, P NATL ACAD SCI USA, V91, P7678, DOI 10.1073/pnas.91.16.7678; Schuel H, 2002, MOL REPROD DEV, V63, P376, DOI 10.1002/mrd.90021; SCHUEL H, 1991, PHARMACOL BIOCHEM BE, V40, P609, DOI 10.1016/0091-3057(91)90371-8; Shukla KK, 2012, J ANDROL, V33, P777, DOI 10.2164/jandrol.111.015552; Tambaro S, 2005, EUR J PHARMACOL, V525, P150, DOI 10.1016/j.ejphar.2005.09.058; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Wang HB, 2006, ENDOCR REV, V27, P427, DOI 10.1210/er.2006-0006; Wenger T, 2001, BIOCHEM BIOPH RES CO, V284, P363, DOI 10.1006/bbrc.2001.4977; Whan LB, 2006, FERTIL STERIL, V85, P653, DOI 10.1016/j.fertnstert.2005.08.027; World Health Organization, 2010, WHO LAB MAN EX HUM S; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Yanagimachi R, 1988, PHYSL REPROD, V1; Yates ML, 2009, VITAM HORM, V81, P25, DOI 10.1016/S0083-6729(09)81002-9	81	58	60	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47704	10.1371/journal.pone.0047704	http://dx.doi.org/10.1371/journal.pone.0047704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082196	gold, Green Published			2022-12-27	WOS:000311146900093
J	Randhawa, V; Thakkar, M; Wei, LP				Randhawa, Varunpreet; Thakkar, Megha; Wei, Liping			Applicability of Hydrogen Peroxide in Brown Tide Control - Culture and Microcosm Studies	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; AUREOCOCCUS-ANOPHAGEFFERENS; MICROCYSTIN-LR; PHOTOCATALYTIC OXIDATION; TEMPORAL VARIABILITY; NORTH-CAROLINA; KINETIC-MODEL; COASTAL BAYS; PHYTOPLANKTON; TOXICITY	Brown tide algal blooms, caused by the excessive growth of Aureococcus anophagefferens, recur in several northeastern US coastal bays. Direct bloom control could alleviate the ecological and economic damage associated with bloom outbreak. This paper explored the effectiveness and safety of natural chemical biocide hydrogen peroxide (H2O2) for brown tide bloom control. Culture studies showed that H2O2 at 1.6 mg L-1 effectively eradicated high density A. anophagefferens within 24-hr, but caused no significant growth inhibition in the diatoms, prymnesiophytes, green algae and dinoflagellates of >2-3 mu m cell sizes among 12 phytoplankton species tested over 1-week observation. When applied to brown tide bloom prone natural seawater in a microcosm study, this treatment effectively removed the developing brown tide bloom, while the rest of phytoplankton assemblage (quantified via HPLC based marker pigment analyses), particularly the diatoms and green algae, experienced only transient suppression then recovered with total chlorophyll a exceeding that in the controls within 72-hr; cyanobacteria was not eradicated but was still reduced about 50% at 72-hr, as compared to the controls. The action of H2O2 against phytoplankton as a function of cell size and cell wall structure, and a realistic scenario of H2O2 application were discussed.	[Randhawa, Varunpreet; Thakkar, Megha; Wei, Liping] New Jersey Inst Technol, Dept Chem & Environm Sci, Newark, NJ 07102 USA	New Jersey Institute of Technology	Wei, LP (corresponding author), New Jersey Inst Technol, Dept Chem & Environm Sci, Newark, NJ 07102 USA.	liping.wei@njit.edu	Thakkar, Megha/X-3006-2019; wei, li/GSD-3630-2022; Randhawa, Varunpreet/AAA-4303-2020; 黎, 伟/GXM-4040-2022	Thakkar, Megha/0000-0002-9094-5723; 				Ahner BA, 2002, MAR ECOL PROG SER, V232, P93, DOI 10.3354/meps232093; Andersen RA, 1996, DEEP-SEA RES PT II, V43, P517, DOI 10.1016/0967-0645(95)00095-X; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Anderson DM, 2009, OCEAN COAST MANAGE, V52, P342, DOI 10.1016/j.ocecoaman.2009.04.006; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Avery GB, 2005, MAR CHEM, V97, P236, DOI 10.1016/j.marchem.2005.03.006; BALDRY MGC, 1983, J APPL BACTERIOL, V54, P417, DOI 10.1111/j.1365-2672.1983.tb02637.x; Bandala ER, 2004, TOXICON, V43, P829, DOI 10.1016/j.toxicon.2004.03.013; Barrington DJ, 2011, J ENVIRON ENG, V137, P952, DOI 10.1061/(ASCE)EE.1943-7870.0000401; Barrington DJ, 2008, ENVIRON SCI TECHNOL, V42, P8916, DOI 10.1021/es801717y; BARROIN G, 1986, WATER RES, V20, P619, DOI 10.1016/0043-1354(86)90026-6; Boesch DF, 1997, DICISION ANAL SERIES, V10, P1; Boettcher AA, 1997, AQUACULTURE, V148, P247, DOI 10.1016/S0044-8486(96)01421-4; Breuer E, 1999, ESTUARIES, V22, P603, DOI 10.2307/1353048; Bricelj VM, 1997, LIMNOL OCEANOGR, V42, P1023, DOI 10.4319/lo.1997.42.5_part_2.1023; Busenberg E, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003312; Clark CD, 2010, WATER RES, V44, P2203, DOI 10.1016/j.watres.2009.12.044; COOPER WJ, 1994, ADV CHEM SER, V237, P391; Cornish BJPA, 2000, APPL CATAL B-ENVIRON, V25, P59, DOI 10.1016/S0926-3373(99)00121-6; Crittenden JC, 1999, WATER RES, V33, P2315, DOI 10.1016/S0043-1354(98)00448-5; DeLuca MJ, 2003, WATER RESOURCES DATA; Drabkova M, 2007, PHOTOSYNTHETICA, V45, P363, DOI 10.1007/s11099-007-0062-9; Drabkova M, 2007, ENVIRON SCI TECHNOL, V41, P309, DOI 10.1021/es060746i; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; Gaikowski MP, 1999, AQUACULTURE, V178, P191, DOI 10.1016/S0044-8486(99)00123-4; GARCIAMENDOZA A, 1993, MICROB ECOL HEALTH D, V6, P17, DOI 10.3109/08910609309141557; GARCIAPICHEL F, 1993, APPL ENVIRON MICROB, V59, P163, DOI 10.1128/AEM.59.1.163-169.1993; Gastrich MD, 2004, HARMFUL ALGAE, V3, P305, DOI 10.1016/j.hal.2004.06.003; Gelabert A, 2004, GEOCHIM COSMOCHIM AC, V68, P4039, DOI 10.1016/j.gca.2004.01.011; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; Gobler CJ, 2005, ESTUARIES, V28, P726, DOI 10.1007/BF02732911; Gobler CJ, 2002, MAR CHEM, V77, P71, DOI 10.1016/S0304-4203(01)00076-7; Hakkinen PJ, 2004, CAN J FISH AQUAT SCI, V61, P1520, DOI 10.1139/F04-098; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P1285; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Jeong HJ, 2002, PHYCOLOGIA, V41, P643, DOI 10.2216/i0031-8884-41-6-643.1; KAY SH, 1984, J AQUAT PLANT MANAGE, V22, P25; Levy JL, 2007, SCI TOTAL ENVIRON, V387, P141, DOI 10.1016/j.scitotenv.2007.07.016; Liu CP, 2001, BOT BULL ACAD SINICA, V42, P207; Liu I, 2003, ENVIRON SCI TECHNOL, V37, P3214, DOI 10.1021/es0201855; Lu CP, 2011, J AGR FOOD CHEM, V59, P11403, DOI 10.1021/jf202874r; Matthijs HCP, 2012, WATER RES, V46, P1460, DOI 10.1016/j.watres.2011.11.016; Meinertz JR, 2008, SCI TOTAL ENVIRON, V392, P225, DOI 10.1016/j.scitotenv.2007.12.015; MILLER WL, 1995, MAR CHEM, V50, P63, DOI 10.1016/0304-4203(95)00027-O; MOFFETT JW, 1990, LIMNOL OCEANOGR, V35, P1221, DOI 10.4319/lo.1990.35.6.1221; MSDEP, 2010, HYDR PER PER AC SOD; Mullaugh KM, 2011, ENVIRON SCI TECHNOL, V45, P9538, DOI 10.1021/es202634s; Neale PJ, 1998, J PHYCOL, V34, P928, DOI 10.1046/j.1529-8817.1998.340928.x; Nicholson RS, 2003, REV SELECTED REFEREN; Noctor G, 2000, PHILOS T R SOC B, V355, P1465, DOI 10.1098/rstb.2000.0707; NYSDEC, 2005, SYN REV TECHN INF RE; O'Sullivan DW, 2005, MAR CHEM, V97, P14, DOI 10.1016/j.marchem.2005.04.003; Olsen PS, 2001, J COASTAL RES, V32, P115; PALENIK B, 1988, LIMNOL OCEANOGR, V33, P1606, DOI 10.4319/lo.1988.33.6_part_2.1606; Pan G, 2006, ENVIRON POLLUT, V141, P206, DOI 10.1016/j.envpol.2005.08.047; Penna TCV, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-16; Petasne RG, 1997, MAR CHEM, V56, P215, DOI 10.1016/S0304-4203(96)00072-2; PRICE N M, 1988, Biological Oceanography, V6, P443; RAVIKUMAR JX, 1994, ENVIRON SCI TECHNOL, V28, P394, DOI 10.1021/es00052a009; Schmidt L.J., 2006, ENV ASSESSMENT USE H; Schrader KK, 1998, AQUACULTURE, V163, P85, DOI 10.1016/S0044-8486(98)00223-3; Sengco MR, 2004, J EUKARYOT MICROBIOL, V51, P169, DOI 10.1111/j.1550-7408.2004.tb00541.x; Shaked Y, 2005, LIMNOL OCEANOGR, V50, P872, DOI 10.4319/lo.2005.50.3.0872; SIEBURTH JM, 1988, J PHYCOL, V24, P416, DOI 10.1111/j.1529-8817.1988.tb00192.x; Srisapoom S, 1999, ACUTE TOXICITY HYDRO, P107; Steigenberger S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032555; Sym Stuart D., 1993, Progress in Phycological Research, V9, P281; TESTER PA, 1995, MAR ECOL PROG SER, V124, P237, DOI 10.3354/meps124237; Tomas CR, 1997, IDENTIFYING MARINE P; Trice TM, 2004, HARMFUL ALGAE, V3, P295, DOI 10.1016/j.hal.2004.06.010; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; Weinbauer MG, 1999, AQUAT MICROB ECOL, V18, P217, DOI 10.3354/ame018217; WOLFE RL, 1989, APPL ENVIRON MICROB, V55, P2230, DOI 10.1128/AEM.55.9.2230-2241.1989; Wolfe-Simon F, 2005, J PHYCOL, V41, P453, DOI 10.1111/j.1529-8817.2005.00086.x; WU JF, 1995, MAR CHEM, V50, P159, DOI 10.1016/0304-4203(95)00033-N; Xenopoulos MA, 1997, PHOTOCHEM PHOTOBIOL, V66, P471, DOI 10.1111/j.1751-1097.1997.tb03175.x; Yuan JC, 2001, DEEP-SEA RES PT II, V48, P2947, DOI 10.1016/S0967-0645(01)00026-1; Zhang XJ, 2008, CHIN J OCEANOL LIMN, V26, P238, DOI 10.1007/s00343-008-0238-6; Zhu CJ, 1997, J APPL PHYCOL, V9, P189, DOI 10.1023/A:1007914806640	82	15	19	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47844	10.1371/journal.pone.0047844	http://dx.doi.org/10.1371/journal.pone.0047844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082223	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900120
J	Whiteside, MD; Garcia, MO; Treseder, KK				Whiteside, Matthew D.; Garcia, Maria O.; Treseder, Kathleen K.			Amino Acid Uptake in Arbuscular Mycorrhizal Plants	PLOS ONE			English	Article							ORGANIC NITROGEN; FUNGI; TRANSPORT; HYPHAE; SOIL; DECOMPOSITION; ASSOCIATIONS; DEPLETION; NITRATE	We examined the extent to which arbuscular mycorrhizal (AM) fungi root improved the acquisition of simple organic nitrogen (ON) compounds by their host plants. In a greenhouse-based study, we used quantum dots (fluorescent nanoparticles) to assess uptake of each of the 20 proteinaceous amino acids by AM-colonized versus uncolonized plants. We found that AM colonization increased uptake of phenylalanine, lysine, asparagine, arginine, histidine, methionine, tryptophan, and cysteine; and reduced uptake of aspartic acid. Arbuscular mycorrhizal colonization had the greatest effect on uptake of amino acids that are relatively rare in proteins. In addition, AM fungi facilitated uptake of neutral and positively-charged amino acids more than negatively-charged amino acids. Overall, the AM fungi used in this study appeared to improve access by plants to a number of amino acids, but not necessarily those that are common or negatively-charged.	[Treseder, Kathleen K.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Garcia, Maria O.] Oregon State Univ, Corvallis, OR 97331 USA; [Whiteside, Matthew D.] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada; [Whiteside, Matthew D.] Univ British Columbia Okanagan, Inst Species Risk & Habitat Studies, Kelowna, BC, Canada	University of California System; University of California Irvine; Oregon State University; University of British Columbia; University of British Columbia Okanagan; University of British Columbia; University of British Columbia Okanagan	Treseder, KK (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	Treseder@uci.edu	Treseder, Kathleen K/E-5148-2011	Treseder, Kathleen K/0000-0003-2847-6935	National Science Foundation Ecosystems Panel [DEB 1144888]	National Science Foundation Ecosystems Panel	This study was funded by the National Science Foundation Ecosystems Panel (DEB 1144888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan N, 2009, MOL PLANT MICROBE IN, V22, P1484, DOI 10.1094/MPMI-22-12-1484; AMES RN, 1983, NEW PHYTOL, V95, P381, DOI 10.1111/j.1469-8137.1983.tb03506.x; Bago B, 1996, NEW PHYTOL, V133, P273, DOI 10.1111/j.1469-8137.1996.tb01894.x; Cappellazzo G, 2008, PLANT PHYSIOL, V147, P429, DOI 10.1104/pp.108.117820; Govindarajulu M, 2005, NATURE, V435, P819, DOI 10.1038/nature03610; Hawkins HJ, 2000, PLANT SOIL, V226, P275, DOI 10.1023/A:1026500810385; HEGGO A, 1990, SOIL BIOL BIOCHEM, V22, P865, DOI 10.1016/0038-0717(90)90169-Z; Hodge A, 2001, NEW PHYTOL, V151, P725, DOI 10.1046/j.0028-646x.2001.00200.x; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; JONES DL, 1994, PLANT SOIL, V163, P1; Leigh J, 2009, NEW PHYTOL, V181, P199, DOI 10.1111/j.1469-8137.2008.02630.x; LI XL, 1991, NEW PHYTOL, V119, P397, DOI 10.1111/j.1469-8137.1991.tb00039.x; Meharg AA, 2003, MYCOL RES, V107, P1253, DOI 10.1017/S0953756203008608; MOSSE B, 1971, J GEN MICROBIOL, V69, P157, DOI 10.1099/00221287-69-2-157; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Paterson E, 2009, NEW PHYTOL, V184, P19, DOI 10.1111/j.1469-8137.2009.03001.x; Paungfoo-Lonhienne C, 2008, P NATL ACAD SCI USA, V105, P4524, DOI 10.1073/pnas.0712078105; Requena N, 2007, PHYTOCHEMISTRY, V68, P33, DOI 10.1016/j.phytochem.2006.09.036; Rufyikiri G, 2003, NEW PHYTOL, V158, P391, DOI 10.1046/j.1469-8137.2003.00747.x; Schnitzer M, 1986, T 13 C INT SOIL SCI, V3, P473; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Talbot JM, 2010, PEDOBIOLOGIA, V53, P169, DOI 10.1016/j.pedobi.2009.12.001; Tanaka Y, 2005, PLANT CELL ENVIRON, V28, P1247, DOI 10.1111/j.1365-3040.2005.01360.x; TOBAR R, 1994, NEW PHYTOL, V126, P119, DOI 10.1111/j.1469-8137.1994.tb07536.x; Webb MR, 2003, STRUCTURE, V11, P736, DOI 10.1016/S0969-2126(03)00129-1; Whiteside MD, 2012, SOIL BIOL BIOCHEM, V55, P7, DOI 10.1016/j.soilbio.2012.06.001; Whiteside MD, 2009, ECOLOGY, V90, P100, DOI 10.1890/07-2115.1	30	63	67	0	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47643	10.1371/journal.pone.0047643	http://dx.doi.org/10.1371/journal.pone.0047643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23094070	Green Published, gold			2022-12-27	WOS:000311146900082
J	Xia, HY; Cao, Y; Dai, XM; Marelja, Z; Zhou, D; Mo, R; Al-Mahdawi, S; Pook, MA; Leimkuehler, S; Rouault, TA; Li, KY				Xia, Haiyan; Cao, Yun; Dai, Xiaoman; Marelja, Zvonimir; Zhou, Di; Mo, Ran; Al-Mahdawi, Sahar; Pook, Mark A.; Leimkuehler, Silke; Rouault, Tracey A.; Li, Kuanyu			Novel Frataxin Isoforms May Contribute to the Pathological Mechanism of Friedreich Ataxia	PLOS ONE			English	Article							IN-VIVO; EXTRAMITOCHONDRIAL FRATAXIN; CLUSTER BIOGENESIS; REPEAT EXPANSION; IRON HOMEOSTASIS; SCAFFOLD PROTEIN; MOUSE MODEL; CELLS; COMPLEX; GENE	Friedreich ataxia (FRDA) is an inherited neurodegenerative disease caused by frataxin (FXN) deficiency. The nervous system and heart are the most severely affected tissues. However, highly mitochondria-dependent tissues, such as kidney and liver, are not obviously affected, although the abundance of FXN is normally high in these tissues. In this study we have revealed two novel FXN isoforms (II and III), which are specifically expressed in affected cerebellum and heart tissues, respectively, and are functional in vitro and in vivo. Increasing the abundance of the heart-specific isoform III significantly increased the mitochondrial aconitase activity, while over-expression of the cerebellum-specific isoform II protected against oxidative damage of Fe-S cluster-containing aconitase. Further, we observed that the protein level of isoform III decreased in FRDA patient heart, while the mRNA level of isoform II decreased more in FRDA patient cerebellum compared to total FXN mRNA. Our novel findings are highly relevant to understanding the mechanism of tissue-specific pathology in FRDA.	[Xia, Haiyan; Cao, Yun; Dai, Xiaoman; Zhou, Di; Mo, Ran; Li, Kuanyu] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China; [Xia, Haiyan; Li, Kuanyu] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Marelja, Zvonimir; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Al-Mahdawi, Sahar; Pook, Mark A.] Brunel Univ, Sch Hlth Sci & Social Care, Div Biosci, Uxbridge UB8 3PH, Middx, England; [Rouault, Tracey A.] NICHHD, Program Mol Med, Bethesda, MD 20892 USA	Nanjing University; Nanjing University; University of Potsdam; Brunel University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Li, KY (corresponding author), Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China.	likuanyu@nju.edu.cn	Marelja, Zvonimir/AAL-3557-2020; Li, Kuanyu/AAL-2051-2020	Leimkuhler, Silke/0000-0003-3238-2122; Marelja, Zvonimir/0000-0002-3702-7528	National Institute of Child Health and Human Development, National Institutes of Health; Friedreich ataxia research association; National Nature Science Foundation of China (NSFC) [31071085]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; State Key Laboratory of Pharmaceutical Biotechnology [ZZYJ-SN-201006]; Studienstiftung des Deutschen Volkes; Deutscher Akademischer Austauschdienst scholarship; Deutsche Forschungsgemeinschaft [SL1171/5-3]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008814] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Friedreich ataxia research association; National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Key Laboratory of Pharmaceutical Biotechnology; Studienstiftung des Deutschen Volkes; Deutscher Akademischer Austauschdienst scholarship(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the intramural program of the National Institute of Child Health and Human Development, National Institutes of Health, and in part by Friedreich ataxia research association; by the National Nature Science Foundation of China (NSFC) (No. 31071085), by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, and by State Key Laboratory of Pharmaceutical Biotechnology (No. ZZYJ-SN-201006). Zvonimir Marelja was supported by a grant from the Studienstiftung des Deutschen Volkes and by Deutscher Akademischer Austauschdienst scholarship. Additional support was obtained from the Deutsche Forschungsgemeinschaft Grant SL1171/5-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva F, 2005, J CELL SCI, V118, P3917, DOI 10.1242/jcs.02516; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Boehm T, 2011, NEUROL SCI, V32, P327, DOI 10.1007/s10072-010-0326-1; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Condo I, 2006, J BIOL CHEM, V281, P16750, DOI 10.1074/jbc.M511960200; Condo I, 2010, HUM MOL GENET, V19, P1221, DOI 10.1093/hmg/ddp592; Coppola G, 2011, ANN NEUROL, V70, P790, DOI 10.1002/ana.22526; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Huang J, 2008, J BIOL INORG CHEM, V13, P825, DOI 10.1007/s00775-008-0369-4; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Kumari D, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-2; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Li KY, 2006, J BIOL CHEM, V281, P12344, DOI 10.1074/jbc.M600582200; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Marobbio CMT, 2012, MITOCHONDRION, V12, P156, DOI 10.1016/j.mito.2011.07.001; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Michael S, 2006, CEREBELLUM, V5, P257, DOI 10.1080/14734220600913246; Nachbauer W, 2011, MOVEMENT DISORD, V26, P1935, DOI 10.1002/mds.23789; Navarro JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021017; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Pennell DJ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-45; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Selak MA, 2011, MITOCHONDRION, V11, P342, DOI 10.1016/j.mito.2010.12.003; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Velasco-Sanchez D, 2011, CEREBELLUM, V10, P1, DOI 10.1007/s12311-010-0212-7; Yoon T, 2007, J BIOL INORG CHEM, V12, P535, DOI 10.1007/s00775-007-0205-2	44	34	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47847	10.1371/journal.pone.0047847	http://dx.doi.org/10.1371/journal.pone.0047847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082224	gold, Green Submitted, Green Published			2022-12-27	WOS:000311146900121
J	Hoffmann, J; Fiser, K; Weaver, J; Dimmick, I; Loeher, M; Pircher, H; Martin-Ruiz, C; Veerasamy, M; Keavney, B; von Zglinicki, T; Spyridopoulos, I				Hoffmann, Jedrzej; Fiser, Karel; Weaver, Jolanta; Dimmick, Ian; Loeher, Monika; Pircher, Hanspeter; Martin-Ruiz, Carmen; Veerasamy, Murugapathy; Keavney, Bernard; von Zglinicki, Thomas; Spyridopoulos, Ioakim			High-Throughput 13-Parameter Immunophenotyping Identifies Shifts in the Circulating T-Cell Compartment Following Reperfusion in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							ST-SEGMENT ELEVATION; POLYCHROMATIC FLOW-CYTOMETRY; PRIMARY ANGIOPLASTY; RECEPTOR ACTIVATION; LYMPHOCYTES; INJURY; EXPRESSION; MEMORY; ASSOCIATION; POPULATIONS	Rationale: With the advent of primary PCI (PPCI), reperfusion is achieved in almost all patients presenting with acute myocardial infarction. However, despite multiple trials, reperfusion injury has not been successfully dealt with so far. In mouse models, CD4(+) T lymphocytes (T cells) have been shown to be crucial instigators of reperfusion injury. Objective: Our goal was to investigate the role of CD4(+) T cells during myocardial reperfusion following PPCI by developing a protocol for high-throughput multiplexed flow cytometric analysis and multivariate flow clustering. Methods and Results: 13-parameter immunophenotyping and hierarchical cluster analysis (HCA) identified a unique CD4(+)CD57(+) T-cell population in PPCI patients that reflected acute proliferation in the CD4(+) T-cell compartment. CD4(+)CCR7(+) T cells were specifically depleted from peripheral blood during the first 30 min of myocardial reperfusion after PPCI, suggesting a potential role for the chemokine receptor CCR7 in T-cell redistribution to either peripheral tissues or migration to the infarcted heart during ischemia/reperfusion following PPCI. Conclusions: High-throughput polychromatic flow cytometry and HCA are capable of objective, time and cost efficient assessment of the individual T-cell immune profile in different stages of coronary heart disease and have broad applications in clinical trials.	[Hoffmann, Jedrzej; Dimmick, Ian; Loeher, Monika; Veerasamy, Murugapathy; Keavney, Bernard; Spyridopoulos, Ioakim] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Martin-Ruiz, Carmen; von Zglinicki, Thomas] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Weaver, Jolanta] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Pircher, Hanspeter] Univ Freiburg, Dept Immunol, Inst Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Fiser, Karel] Charles Univ Prague, Med Sch 2, Dept Paediat Haematol & Oncol, CLIP, Prague, Czech Republic	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Freiburg; Charles University Prague	Spyridopoulos, I (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	ioakim.spyridopoulos@newcastle.ac.uk	Fišer, Karel/W-6465-2019	Fišer, Karel/0000-0002-7265-3268; Keavney, Bernard/0000-0001-9573-0812; Hoffmann, Jedrzej/0000-0003-0487-4373; Martin-Ruiz, Carmen/0000-0002-3361-6974; Spyridopoulos, Ioakim/0000-0002-2750-2444; von Zglinicki, Thomas/0000-0002-5939-0248	UK NIHR Biomedical Research Centre; Newcastle Healthcare Charity; Newcastle Upon Tyne Hospitals NHS Charity; MRC [G0601333] Funding Source: UKRI; British Heart Foundation [FS/12/55/29695, RG/08/012/25941] Funding Source: researchfish; Medical Research Council [G0601333] Funding Source: researchfish	UK NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Newcastle Healthcare Charity; Newcastle Upon Tyne Hospitals NHS Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK NIHR Biomedical Research Centre award to the Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Healthcare Charity and Newcastle Upon Tyne Hospitals NHS Charity (all to IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeja BG, 2002, CIRCULATION, V105, P282, DOI 10.1161/hc0302.103588; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Burchfield JS, 2008, CIRC RES, V103, P203, DOI 10.1161/CIRCRESAHA.108.178475; Burman A, 2005, J IMMUNOL, V174, P1693, DOI 10.4049/jimmunol.174.3.1693; Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; Cho KH, 2011, AM J CARDIOL, V107, P849, DOI 10.1016/j.amjcard.2010.10.067; Claeys MJ, 1999, CIRCULATION, V99, P1972, DOI 10.1161/01.CIR.99.15.1972; Damas JK, 2007, ARTERIOSCL THROM VAS, V27, P614, DOI 10.1161/01.ATV.0000255581.38523.7c; Desmet W, 2011, EUR HEART J, V32, P867, DOI 10.1093/eurheartj/ehq492; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Fiser K, 2012, CYTOM PART A, V81A, P25, DOI 10.1002/cyto.a.21148; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Husser O, 2011, INFLAMMATION, V34, P73, DOI 10.1007/s10753-010-9209-0; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; Kruk M, 2008, CIRC J, V72, P205, DOI 10.1253/circj.72.205; Luchtefeld M, 2010, CIRCULATION, V122, P1621, DOI 10.1161/CIRCULATIONAHA.110.956730; Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; Nunez J, 2010, CORONARY ARTERY DIS, V21, P1, DOI 10.1097/MCA.0b013e328332ee15; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sharma AK, 2010, J THORAC CARDIOV SUR, V139, P474, DOI 10.1016/j.jtcvs.2009.08.033; van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765; Yang Z, 2009, J THORAC CARDIOVASC, V137, P702; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244; Yang ZQ, 2009, J THORAC CARDIOV SUR, V137, P695, DOI 10.1016/j.jtcvs.2008.10.044; Yang ZQ, 2005, CIRCULATION, V111, P2190, DOI 10.1161/01.CIR.0000163586.62253.A5; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yokota N, 2003, AM J PHYSIOL-RENAL, V285, pF319, DOI 10.1152/ajprenal.00432.2002	33	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47155	10.1371/journal.pone.0047155	http://dx.doi.org/10.1371/journal.pone.0047155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077561	Green Published, Green Submitted, gold			2022-12-27	WOS:000310135800029
J	Garcia-Orti, L; Cristobal, I; Cirauqui, C; Guruceaga, E; Marcotegui, N; Calasanz, MJ; Castello-Cros, R; Odero, MD				Garcia-Orti, Laura; Cristobal, Ion; Cirauqui, Cristina; Guruceaga, Elisabet; Marcotegui, Nerea; Calasanz, Maria J.; Castello-Cros, Remedios; Odero, Maria D.			Integration of SNP and mRNA Arrays with MicroRNA Profiling Reveals That MiR-370 Is Upregulated and Targets NF1 in Acute Myeloid Leukemia	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; EXPRESSION; NEUROFIBROMATOSIS; RECOGNITION; PATTERNS; DELETION; TYPE-1; CANCER; ALLELE	Background: Deregulated miRNA expression plays a crucial role in carcinogenesis. Recent studies show different mechanisms leading to miRNA deregulation in cancer; however, alterations affecting miRNAs by DNA copy number variations (CNV) remain poorly studied. Results: Our integrative analysis including data from high resolution SNPs arrays, mRNA expression arrays, and miRNAs expression profiles in 16 myeloid cell lines highlights that CNV are alternative mechanisms to deregulate the expression of miRNAs in acute myeloid leukemia (AML), and represent a novel approach to identify novel candidate genes involved in AML. We found association between the expression levels of 19 miRNAs and CNVs affecting their loci. Functional analysis showed that NF1 is a direct target of miR-370, and that overexpression of miR-370 has similar effects that NF1 inactivation, increasing proliferation and colony formation in AML cells. Moreover, real time RT-PCR showed that NF1 downregulation is a recurrent event in AML (30.8%), and western blot analysis confirmed this result. MiR-370 overexpression and deletions affecting the NF1 locus were identified as alternative mechanisms to downregulate NF1. Conclusions: NF1 downregulation is a common event in AML, and both deletions in the NF1 locus and overexpression of miR-370 are alternative mechanisms to downregulate NF1 in this disease. Our results suggest a leukemogenic role of miR-370 through NF1 downregulation in AML cells. Since NF1 deficiency leads to RAS activation, patients with AML and overexpression of miR-370 may potentially benefit from additional treatment with either RAS or mTOR inhibitors.	[Garcia-Orti, Laura; Cristobal, Ion; Cirauqui, Cristina; Marcotegui, Nerea; Castello-Cros, Remedios; Odero, Maria D.] Univ Navarra, Div Oncol, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Cristobal, Ion; Calasanz, Maria J.; Odero, Maria D.] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain; [Guruceaga, Elisabet] Univ Navarra, Unit Prote Genom & Bioinformat, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra	Odero, MD (corresponding author), Univ Navarra, Div Oncol, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain.	modero@unav.es	Calasanz, MJ/R-5813-2016; Odero/ABG-9860-2020; Guruceaga, Elizabeth/B-1796-2008	Calasanz, MJ/0000-0002-0374-3008; Odero/0000-0002-8858-2054; Cirauqui, Cristina/0000-0002-4064-6485; Guruceaga, Elizabeth/0000-0003-0547-681X	Ministerio Educacion y Ciencia [AP2006-03038]; Ministerio Ciencia e Innovacion [PI081687]; Instituto de Salud Carlos III-Red Tematica de investigacion Cooperativa en Cancer (ISCIII-RTICC) [RD06/0020/0078]; Fundacion para la Investigacion Medica Aplicada Union (FIMA)(Spain)	Ministerio Educacion y Ciencia(Spanish Government); Ministerio Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III-Red Tematica de investigacion Cooperativa en Cancer (ISCIII-RTICC); Fundacion para la Investigacion Medica Aplicada Union (FIMA)(Spain)	This work was supported by Ministerio Educacion y Ciencia [AP2006-03038], Ministerio Ciencia e Innovacion [PI081687], Instituto de Salud Carlos III-Red Tematica de investigacion Cooperativa en Cancer (ISCIII-RTICC)[RD06/0020/0078], and Fundacion para la Investigacion Medica Aplicada Union (FIMA)(Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babashah S, 2009, EUR J HAEMATOL, V83, P261, DOI 10.1111/j.1600-0609.2009.01264.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Brems H, 2009, LANCET ONCOL, V10, P508, DOI 10.1016/S1470-2045(09)70033-6; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haferlach C, 2012, LEUKEMIA, V26, P834, DOI 10.1038/leu.2011.296; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo SS, 2012, ONCOGENE, V31, P226, DOI 10.1038/onc.2011.226; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Marcucci Guido, 2009, Curr Hematol Malig Rep, V4, P83, DOI 10.1007/s11899-009-0012-7; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; Parkin B, 2010, CLIN CANCER RES, V16, P4135, DOI 10.1158/1078-0432.CCR-09-2639; Schiffman JD, 2009, CANCER GENET CYTOGEN, V193, P9, DOI 10.1016/j.cancergencyto.2009.03.005; Schwind S, 2010, J CLIN ONCOL, V28, P5257, DOI 10.1200/JCO.2010.29.2953; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Starczynowski DT, 2011, BLOOD, V117, P595, DOI 10.1182/blood-2010-03-277012; Waldman SA, 2009, FEBS J, V276, P2157, DOI 10.1111/j.1742-4658.2009.06934.x; Weksberg R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-180	28	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47717	10.1371/journal.pone.0047717	http://dx.doi.org/10.1371/journal.pone.0047717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077663	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100155
J	Kim, HK; Prokunina-Olsson, L; Chanock, SJ				Kim, Hye Kyung; Prokunina-Olsson, Ludmila; Chanock, Stephen J.			Common Genetic Variants in miR-1206 (8q24.2) and miR-612 (11q13.3) Affect Biogenesis of Mature miRNA Forms	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROSTATE-CANCER SUSCEPTIBILITY; MICRORNA-RELATED GENES; RENAL-CELL CARCINOMA; COLORECTAL-CANCER; CHROMOSOME 8Q24; BLADDER-CANCER; CERVICAL-CANCER; FRAGILE SITES; MULTIPLE LOCI	Cancer genome-wide association studies (GWAS) have identified many common genetic markers located in non-coding regions of the genome. Two notable examples are the multi-cancer susceptibility regions, 8q24.2 and 11q13.3. Since these GWAS signals localize to gene-poor regions, we investigated genetic variants within pre-microRNA (pre-miRNA) transcripts as a possible link between the GWAS findings and the associated molecular phenotypes. Across the two regions, which contain 37 miRNAs genes, we explored genetic variants by surveying public databases and conducting targeted resequencing. Specifically, we investigated one common single nucleotide polymorphism (SNP) within miR-1206 on 8q24.2 and two SNPs within miR-612 on 11q13.3. Though these variants are not correlated with known GWAS signals, we conjectured that they might be important for function of corresponding miRNAs. To test the functional significance of these genetic variants, we cloned both allelic forms of miR-1206 and miR-612 pre-miRNA into expression vectors and assessed biogenesis of mature miRNA-forms. The two SNPs within miR-612 significantly affected expression of mature miR-612 in a cell-type specific manner; enhancement in prostate cancer cell lines, reduction in colon cancer cells, and no effect in breast cancer cell lines. The SNP within miR-1206 also affected expression of mature miR-1206, but not in a cell-type specific manner. Future studies should identify targets of miR-1206 and miR-612 and help understand the biological roles of these miRNAs and their possible role in carcinogenesis.	[Kim, Hye Kyung; Prokunina-Olsson, Ludmila; Chanock, Stephen J.] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chanock, SJ (corresponding author), NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov	Prokunina-Olsson, Ludmila/A-8240-2019; Prokunina-Olsson, Ludmila/V-7960-2019	Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Prokunina-Olsson, Ludmila/0000-0002-9622-2091	National Institutes of Health, National Cancer Institute (NCI); NCI	National Institutes of Health, National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the intramural research program of the National Institutes of Health, National Cancer Institute (NCI) and the NCI Director's Innovation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Balaguer F, 2011, CLIN CANCER RES, V17, P6239, DOI 10.1158/1078-0432.CCR-11-1424; Barsotti AM, 2012, J BIOL CHEM, V287, P2509, DOI 10.1074/jbc.M111.322875; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; Davis-Dusenbery Brandi N, 2010, Genes Cancer, V1, P1100, DOI 10.1177/1947601910396213; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Reshmi G, 2011, GENOMICS, V97, P333, DOI 10.1016/j.ygeno.2011.02.010; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schodel J, 2012, NAT GENET; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Slaby O, 2012, J CELL MOL MED, V16, P8, DOI 10.1111/j.1582-4934.2011.01359.x; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Yamashita Y, 2005, WORLD J GASTROENTERO, V11, P5129; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Yue C, 2011, GYNECOL ONCOL, V122, P33, DOI 10.1016/j.ygyno.2011.03.032; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhou B, 2011, MOL CARCINOGEN, V50, P499, DOI 10.1002/mc.20740	53	26	26	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47454	10.1371/journal.pone.0047454	http://dx.doi.org/10.1371/journal.pone.0047454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077621	Green Submitted, gold, Green Published			2022-12-27	WOS:000309995100117
J	Maisel, T; Joseph, S; Mielke, T; Burger, J; Schwarzinger, S; Meyer, O				Maisel, Tobias; Joseph, Stephanie; Mielke, Thorsten; Buerger, Joerg; Schwarzinger, Stephan; Meyer, Ortwin			The CoxD Protein, a Novel AAA plus ATPase Involved in Metal Cluster Assembly: Hydrolysis of Nucleotide-Triphosphates and Oligomerization	PLOS ONE			English	Article							CARBON-MONOXIDE DEHYDROGENASE; OLIGOTROPHA CARBOXIDOVORANS; MAGNESIUM CHELATASE; MEGAPLASMID PHCG3; GENE-CLUSTER; ACTIVE-SITE; SEQUENCE; VISUALIZATION; BIOGENESIS; MICROSCOPY	CoxD of the alpha-proteobacterium Oligotropha carboxidovorans is a membrane protein which is involved in the posttranslational biosynthesis of the [CuSMoO2] cluster in the active site of the enzyme CO dehydrogenase. The bacteria synthesize CoxD only in the presence of CO. Recombinant CoxD produced in E. coli K38 pGP1-2/pETMW2 appeared in inclusion bodies from where it was solubilized by urea and refolded by stepwise dilution. Circular dichroism spectroscopy revealed the presence of secondary structural elements in refolded CoxD. CoxD is a P-loop ATPase of the AAA-protein family. Refolded CoxD catalyzed the hydrolysis of MgATP yielding MgADP and inorganic phosphate at a 1:1:1 molar ratio. The reaction was inhibited by the slow hydrolysable MgATP-gamma-S. GTPase activity of CoxD did not exceed 2% of the ATPase activity. Employing different methods (non linear regression, Hanes and Woolf, Lineweaver-Burk), preparations of CoxD revealed a mean K-M value of 0.69+/-0.14 mM ATP and an apparent V-max value of 19.3+/-2.3 nmol ATP hydrolyzed min(-1) mg(-1). Sucrose density gradient centrifugation and gel filtration showed that refolded CoxD can exist in various multimeric states (2-mer, 4-mer or 6-mer), preferentially as hexamer or dimer. Within weeks the hexamer dissociates into the dimer, a process which can be reversed by MgATP or MgATP-gamma-S within hours. Only the hexamers and the dimers exhibited MgATPase activity. Transmission electron microscopy of negatively stained CoxD preparations revealed distinct particles within a size range of 10-16 nm, which further corroborates the oligomeric organization. The 3D structure of CoxD was modeled with the 3D structure of BchI from Rhodobacter capsulatus as template. It has the key elements of an AAA+ domain in the same arrangement and at same positions as in BchI and displays the characteristic inserts of the PS-II-insert clade. Possible functions of CoxD in [CuSMoO2] cluster assembly are discussed.	[Maisel, Tobias; Joseph, Stephanie; Meyer, Ortwin] Univ Bayreuth, Chair Microbiol, Bayreuth, Germany; [Mielke, Thorsten; Buerger, Joerg] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Mielke, Thorsten; Buerger, Joerg] Charite, Inst Med Phys & Biophys, D-13353 Berlin, Germany; [Schwarzinger, Stephan] Univ Bayreuth, Chair Biopolymers, Bayreuth, Germany; [Schwarzinger, Stephan; Meyer, Ortwin] Bayreuth Res Ctr Biomacromol, Bayreuth, Germany	University of Bayreuth; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bayreuth	Meyer, O (corresponding author), Univ Bayreuth, Chair Microbiol, Bayreuth, Germany.	Ortwin.Meyer@uni-bayreuth.de	Schwarzinger, Stephan/GWV-5819-2022; Schwarzinger, Stephan/O-4318-2014	Burger, Jorg/0000-0002-4326-5047; Schwarzinger, Stephan/0000-0002-0894-5290	Deutsche Forschungsgemeinschaft [Me 732/11-1, SFB 740 TPZ1, Schw 901/3-1]; European Union; Senatsverwaltung fur Wissenschaft, Forschung und Kultur, Berlin, Germany (UltraStructureNetwork, Anwenderzentrum)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Senatsverwaltung fur Wissenschaft, Forschung und Kultur, Berlin, Germany (UltraStructureNetwork, Anwenderzentrum)	The authors acknowledge financial support from the Deutsche Forschungsgemeinschaft (Me 732/11-1 to OM, SFB 740 TPZ1 to TM and Schw 901/3-1 to STS) and the European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur, Berlin, Germany (UltraStructureNetwork, Anwenderzentrum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; BEISENHERZ G, 1953, Z NATURFORSCH B, V8, P555; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Dobbek H, 2002, P NATL ACAD SCI USA, V99, P15971, DOI 10.1073/pnas.212640899; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fuhrmann S, 2003, GENE, V322, P67, DOI 10.1016/j.gene.2003.08.027; FUTO S, 1986, ARCH MICROBIOL, V145, P358, DOI 10.1007/BF00470871; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; Gnida M, 2003, BIOCHEMISTRY-US, V42, P222, DOI 10.1021/bi026514n; Goc A, 2010, J MOL BIOL, V401, P363, DOI 10.1016/j.jmb.2010.06.044; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Harrison MD, 1999, J BIOL INORG CHEM, V4, P145, DOI 10.1007/s007750050297; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Ikegami A, 2007, J BIOL CHEM, V282, P19282, DOI 10.1074/jbc.M703324200; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Joly N, 2006, J BIOL CHEM, V281, P34997, DOI 10.1074/jbc.M606628200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Lundqvist J, 2010, STRUCTURE, V18, P354, DOI 10.1016/j.str.2010.01.001; MEYER O, 1983, ANNU REV MICROBIOL, V37, P277, DOI 10.1146/annurev.mi.37.100183.001425; MEYER O, 1979, J BACTERIOL, V137, P811, DOI 10.1128/JB.137.2.811-817.1979; Meyer OO, 2005, BERGEYS MANUAL SYSTE, V2, P468; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Neuwald AF, 1999, GENOME RES, V9, P27; PARK K, 1993, PROTEIN SCI, V2, P325; Paul D, 2008, J BACTERIOL, V190, P5531, DOI 10.1128/JB.00614-08; Pelzmann A, 2009, J BIOL CHEM, V284, P9578, DOI 10.1074/jbc.M805354200; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Resch M, 2005, J BIOL INORG CHEM, V10, P518, DOI 10.1007/s00775-005-0006-4; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santiago B, 1999, GENE, V236, P115, DOI 10.1016/S0378-1119(99)00245-0; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schachman H.K., 1959, ULTRACENTRIFUGATION; SCHUBEL U, 1995, J BACTERIOL, V177, P2197, DOI 10.1128/jb.177.8.2197-2203.1995; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Walker CJ, 1997, BIOCHEM J, V327, P321; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Willows RD, 2004, J STRUCT BIOL, V146, P227, DOI 10.1016/j.jsb.2003.11.019; Willows RD, 2003, NAT PROD REP, V20, P327, DOI 10.1039/b110549n	52	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47424	10.1371/journal.pone.0047424	http://dx.doi.org/10.1371/journal.pone.0047424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077613	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100109
J	Prangkio, P; Yusko, EC; Sept, D; Yang, J; Mayer, M				Prangkio, Panchika; Yusko, Erik C.; Sept, David; Yang, Jerry; Mayer, Michael			Multivariate Analyses of Amyloid-Beta Oligomer Populations Indicate a Connection between Pore Formation and Cytotoxicity	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; ALZHEIMERS-DISEASE; ION CHANNELS; PROTEIN OLIGOMERIZATION; SYNAPTIC PLASTICITY; SECONDARY STRUCTURE; PRECURSOR PROTEIN; IN-VITRO; MEMBRANE; PEPTIDE	Aggregates of amyloid-beta (A beta) peptides are thought to be involved in the development of Alzheimer's disease because they can change synaptic plasticity and induce neuronal cell death by inflammation, oxidative damage, and transmembrane pore formation. Exactly which oligomeric species underlie these cytotoxic effects remains unclear. The work presented here established well-controlled aggregation conditions of A beta(1-40) or A beta(1-42) peptides over a 20-day period and characterized these preparations with regard to their beta-sheet content, degree of fibril formation, relative abundance of various oligomer sizes, and propensity to induce membrane pore formation and cytotoxicity. Using this multivariate data set, a systematic and inherently unbiased partial least squares (PLS) approach showed that for both peptides the abundance of oligomers in the tetramer to 13-mer range contributed positively to both pore formation and cytotoxicity, while monomers, dimers, trimers, and the largest oligomers (>210 kDa) were negatively correlated to both phenomena. Multivariate PLS analysis is ideally suited to handle complex data sets and interdependent variables such as relative oligomer concentrations, making it possible to elucidate structure function relationships in complex mixtures. This approach, therefore, introduces an enabling tool to the field of amyloid research, in which it is often difficult to interpret the activity of individual species within a complex mixture of bioactive species.	[Prangkio, Panchika; Yusko, Erik C.; Sept, David; Mayer, Michael] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Sept, David] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Yang, Jerry] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Mayer, Michael] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of Michigan System; University of Michigan	Mayer, M (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	mimayer@umich.edu	Mayer, Michael/AAS-1777-2020; Taylor, Graham/A-4027-2012; Mayer, Michael/C-1299-2010; Yusko, Erik/E-7179-2010	Mayer, Michael/0000-0002-6148-5756; Yusko, Erik/0000-0003-3559-8375; Sept, David/0000-0003-3719-2483; Prangkio, Panchika/0000-0002-6376-7116	Wallace H. Coulter Foundation; Alzheimer's Association [NIRG-08-01651]; NSF [CHE-0847530]; government of Thailand	Wallace H. Coulter Foundation; Alzheimer's Association(Alzheimer's Association); NSF(National Science Foundation (NSF)); government of Thailand	This work was supported by the Wallace H. Coulter Foundation (M. M.). J.Y. acknowledges support from the Alzheimer's Association (NIRG-08-01651) and an NSF CAREER Award to J.Y. (CHE-0847530). P. P. is supported by government of Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APELL HJ, 1979, BIOCHIM BIOPHYS ACTA, V552, P369, DOI 10.1016/0005-2736(79)90181-0; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; Arispe NJ, 2007, BIOPHYS J, p612A; Baruch-Suchodolsky R, 2009, BIOCHEMISTRY-US, V48, P4354, DOI 10.1021/bi802361k; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bhatia R, 2000, FASEB J, V14, P1233, DOI 10.1096/fasebj.14.9.1233; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen QS, 2000, J NEUROSCI RES, V60, P65, DOI 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q; Connelly L, 2012, J PHYS CHEM B, V116, P1728, DOI 10.1021/jp2108126; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Demuro A, 2011, J CELL BIOL, V195, P515, DOI 10.1083/jcb.201104133; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Diaz JC, 2009, P NATL ACAD SCI USA, V106, P3348, DOI 10.1073/pnas.0813355106; Ding H, 2009, BIOPHYS J, V97, P912, DOI 10.1016/j.bpj.2009.05.035; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Habib LK, 2010, J BIOL CHEM, V285, P38933, DOI 10.1074/jbc.M110.132860; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirakura Y, 1999, J NEUROSCI RES, V57, P458, DOI 10.1002/(SICI)1097-4547(19990815)57:4<458::AID-JNR5>3.0.CO;2-4; HOLTZMAN DM, 2011, SCI TRANSLATIONAL ME, V3; Jang HB, 2008, TRENDS BIOCHEM SCI, V33, P91, DOI 10.1016/j.tibs.2007.10.007; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Jang H, 2010, J MOL BIOL, V404, P917, DOI 10.1016/j.jmb.2010.10.025; Jang H, 2009, BIOPHYS J, V97, P3029, DOI 10.1016/j.bpj.2009.09.014; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Johnson RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023970; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kagan BL, 2012, PROG MOL BIOL TRANSL, V107, P295, DOI [10.1016/B978-0-12-385883-2.00001-1, 10.1016/B978-0-12-385883-2.00009-6]; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; Kawahara M, 1997, BIOPHYS J, V73, P67, DOI 10.1016/S0006-3495(97)78048-2; Kawahara M, 2010, CURR PHARM DESIGN, V16, P2779, DOI 10.2174/138161210793176545; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; KHACHATURIAN ZS, 1987, NEUROBIOL AGING, V8, P345, DOI 10.1016/0197-4580(87)90073-X; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Kourie JI, 2001, CELL MOL NEUROBIOL, V21, P255, DOI 10.1023/A:1010995121153; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kurganov B, 2004, PEPTIDES, V25, P217, DOI 10.1016/j.peptides.2004.01.001; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lal R, 2007, BBA-BIOMEMBRANES, V1768, P1966, DOI 10.1016/j.bbamem.2007.04.021; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lin MCA, 2002, PEPTIDES, V23, P1215, DOI 10.1016/S0196-9781(02)00057-8; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Majd S, 2010, CURR OPIN BIOTECH, V21, P439, DOI 10.1016/j.copbio.2010.05.002; Marx J, 2007, SCIENCE, V318, P384, DOI 10.1126/science.318.5849.384; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mayer M, 2008, J AM CHEM SOC, V130, P1453, DOI 10.1021/ja077555f; Micelli S, 2004, BIOPHYS J, V86, P2231, DOI 10.1016/S0006-3495(04)74281-2; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Pan JX, 2012, BIOCHEMISTRY-US, V51, P3694, DOI 10.1021/bi3002049; Parihar MS, 2004, J CLIN NEUROSCI, V11, P456, DOI 10.1016/j.jocn.2003.12.007; PIKE CJ, 1993, J NEUROSCI, V13, P1676; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Puzzo Daniela, 2006, Current Alzheimer Research, V3, P179, DOI 10.2174/156720506777632871; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rajalahti T, 2011, INT J PHARMACEUT, V417, P280, DOI 10.1016/j.ijpharm.2011.02.019; Rangachari V, 2006, BIOCHEMISTRY-US, V45, P8639, DOI 10.1021/bi060323t; Ryan DA, 2010, J NEUROSCI METH, V190, P171, DOI 10.1016/j.jneumeth.2010.05.001; Sanchez L, 2011, J AM CHEM SOC, V133, P6505, DOI 10.1021/ja1117123; Schauerte JA, 2010, BIOCHEMISTRY-US, V49, P3031, DOI 10.1021/bi901444w; Schnabel J, 2011, NATURE, V475, pS12, DOI 10.1038/475S12a; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shafrir Y, 2010, PROTEINS, V78, P3473, DOI 10.1002/prot.22853; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021; Shao J., 2012, JACKKNIFE BOOTSTRAP; SIMMONS LK, 1994, MOL PHARMACOL, V45, P373; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Strodel B, 2010, J AM CHEM SOC, V132, P13300, DOI 10.1021/ja103725c; Stroud JC, 2012, P NATL ACAD SCI US; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729; Wong PT, 2009, J MOL BIOL, V386, P81, DOI 10.1016/j.jmb.2008.11.060	113	60	63	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47261	10.1371/journal.pone.0047261	http://dx.doi.org/10.1371/journal.pone.0047261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077580	Green Published, gold, Green Submitted			2022-12-27	WOS:000309995100083
J	Zhou, XM; Xie, GL; Wang, SB; Wang, YG; Zhang, KJ; Zheng, S; Chu, L; Xiao, LL; Yu, YM; Zhang, Y; Liu, XY				Zhou, Xiumei; Xie, Guoliang; Wang, Shibing; Wang, Yigang; Zhang, Kangjian; Zheng, Shu; Chu, Liang; Xiao, Lianli; Yu, Yuemei; Zhang, Yue; Liu, Xinyuan			Potent and Specific Antitumor Effect for Colorectal Cancer by CEA and Rb Double Regulated Oncolytic Adenovirus Harboring ST13 Gene	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; CARCINOEMBRYONIC ANTIGEN; VIRO-THERAPY; TRAIL; VIROTHERAPY; CARCINOMA; SURVIVAL; PROTEIN; VECTOR	Cancer Targeting Gene-Viro-Therapy (CTGVT) is constructed by inserting an antitumor gene into an oncolytic virus (OV). It is actually an OV-gene therapy, which has much better antitumor effect than either gene therapy alone or virotherapy alone in our previously published papers. This study is a modification of CTGVT by inserting a colorectal cancer (CRC) specific suppressor gene, ST13, into a CRC specific oncolytic virus, the Ad.CEA.E1A(Delta 24), to construct the Ad.(ST13).CEA.E1A(Delta 24) for increasing the targeting tropism to colorectal cancer and it was briefly named as CTGVT-CRC. Although many studies on CEA promoter and ST13 gene were reported but no construct has been performed to combine both of them as a new strategy for colorectal cancer (CRC) specific therapy. In addition to the CRC specificity, the antitumor effect of Ad.(ST13).CEA.E1A(Delta 24) was also excellent and got nearly complete inhibition (not eradication) of CRC xenograft since ST13 was an effective antitumor gene with less toxicity, and a Chinese patent (No. 201110319434.4) was available for this study. Ad.(ST13).CEA.E1A(Delta 24) caused cell apoptosis through P38 MAPK (i.e. P38) which upregulated CHOP and ATF2 expression. The mitochondrial medicated apoptosis pathway was activated by the increase of caspase 9 and caspase 3 expression.	[Zhou, Xiumei; Wang, Shibing; Wang, Yigang; Xiao, Lianli; Yu, Yuemei; Zhang, Yue; Liu, Xinyuan] Zhejiang Sci Tech Univ, Coll Life Sci, Xinyuan Inst Med & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Kangjian; Chu, Liang; Liu, Xinyuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Xie, Guoliang] Zhejiang Univ, Affiliated Hosp 1, Dept Lab Med, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Shu] Zhejiang Univ, Affiliated Hosp 2, Inst Canc, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Sci-Tech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang University; Zhejiang University	Liu, XY (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Xinyuan Inst Med & Biotechnol, Hangzhou, Zhejiang, Peoples R China.	xyliu@sibs.ac.cn	xie, guoliang/T-3191-2017; Liu, Xinyuan/HDM-5505-2022		Science Foundation of Zhejiang Sci-Tech University (ZSTU) [1016834-Y]; National Basic Research Program of China (973 Program) [2010CB529901, 2011CB510104]; National Natural Science Foundation of China [81172449]; Important National Science AMP; Technology Specific Project of Hepatitis and Hepatoma Related Program [2008ZX10002-023]; New Innovation Program [2009-ZX-09102-246]	Science Foundation of Zhejiang Sci-Tech University (ZSTU)(Zhejiang Sci-Tech University); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important National Science AMP; Technology Specific Project of Hepatitis and Hepatoma Related Program; New Innovation Program	This work was supported by the Science Foundation of Zhejiang Sci-Tech University (ZSTU) under Grant No. 1016834-Y, the National Basic Research Program of China (973 Program) (No. 2010CB529901, No. 2011CB510104), the National Natural Science Foundation of China (81172449), the Important National Science & Technology Specific Project of Hepatitis and Hepatoma Related Program (2008ZX10002-023), and the New Innovation Program (2009-ZX-09102-246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; Breitbach CJ, 2011, NATURE, V477, P99, DOI 10.1038/nature10358; Cao X, 2011, GENE THER, V18, P765, DOI 10.1038/gt.2011.16; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chu L, 2006, CANCER BIOL THER, V5, P615, DOI 10.4161/cbt.5.6.2662; Chung-Faye GA, 2000, MOL MED TODAY, V6, P82, DOI 10.1016/S1357-4310(99)01598-1; DIMAIO JM, 1994, SURGERY, V116, P205; Ding M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035153; Evans J, 2011, NAT MED, V17, P268, DOI 10.1038/nm0311-268b; Horndasch M, 2006, ONCOGENE, V25, P3397, DOI 10.1038/sj.onc.1209380; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Liu XY, 2006, CELL RES, V16, P879, DOI 10.1038/sj.cr.7310108; Liu XY, 2005, MOL THER, V11, P531, DOI 10.1016/j.ymthe.2004.12.003; Liu XY, 2001, CHIN J CANC BIOTHER, V8, P1; Liu XY, 2012, RECENT ADV IN PRESS; Liu XY, 2012, CURR PHARM BIOTECHNO; Mo Y, 1996, Zhonghua Zhong Liu Za Zhi, V18, P241; Mo YQ, 1997, AIZHENG, V16, P12; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pei ZF, 2004, HEPATOLOGY, V39, P1371, DOI 10.1002/hep.20203; Sagawa T, 2004, MOL THER, V10, P1043, DOI 10.1016/j.ymthe.2004.08.023; SCHREWE H, 1990, MOL CELL BIOL, V10, P2738, DOI 10.1128/MCB.10.6.2738; Shi Zheng-Zheng, 2007, Journal of Zhejiang University-Science B, V8, P170, DOI 10.1631/jzus.2007.B0170; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wei RC, 2011, HUM GENE THER, V22, P1109, DOI 10.1089/hum.2010.219; Xu HN, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-133; Yang M, 2008, HUM GENE THER, V19, P343, DOI 10.1089/hum.2007.0137; Yu DB, 2009, CANCER SCI, V100, P678, DOI 10.1111/j.1349-7006.2009.01110.x; Zhang Q, 2004, CANCER RES, V64, P5390, DOI 10.1158/0008-5472.CAN-04-1229; Zhang YH, 2006, CANCER RES, V66, P4291, DOI 10.1158/0008-5472.CAN-05-1834; Zhang ZW, 2009, CLIN CANCER RES, V15, P5154, DOI 10.1158/1078-0432.CCR-09-0025; Zhang ZL, 2003, CELL RES, V13, P481, DOI 10.1038/sj.cr.7290191; Zhao L, 2006, CANCER GENE THER, V13, P1011, DOI 10.1038/sj.cgt.7700969; Zheng S, 1997, CHINESE MED J-PEKING, V110, P543; Zheng S, 1997, Zhonghua Yi Xue Za Zhi, V77, P256; Zheng S, 2005, CHIN GERMAN J CLIN O, V4, P2; Zheng S, 1998, INT J MODERN CANC TH, V1, P3; Zheng S, 2001, B CHINESE CANC, V10, P136	38	15	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47566	10.1371/journal.pone.0047566	http://dx.doi.org/10.1371/journal.pone.0047566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077639	Green Submitted, Green Published, gold			2022-12-27	WOS:000309995100134
J	Peyton, CC; Burmeister, D; Petersen, B; Andersson, KE; Christ, G				Peyton, Charles C.; Burmeister, David; Petersen, Bryon; Andersson, Karl-Erik; Christ, George			Characterization of the Early Proliferative Response of the Rodent Bladder to Subtotal Cystectomy: A Unique Model of Mammalian Organ Regeneration	PLOS ONE			English	Article							MESENCHYMAL-EPITHELIAL INTERACTIONS; RAT URINARY-BLADDER; LIVER-REGENERATION; SMOOTH-MUSCLE; CELL-PROLIFERATION; STEM-CELLS; INTERSTITIAL-CELLS; ACELLULAR MATRIX; RABBIT BLADDER; GROWTH-FACTORS	Subtotal cystectomy (STC; surgical removal of similar to 75% of the rat urinary bladder) elicits a robust proliferative response resulting in complete structural and functional bladder regeneration within 8-weeks. The goal of these studies was to characterize the early cellular response that mediates this regenerative phenomenon, which is unique among mammalian organ systems. STC was performed on eighteen 12-week-old female Fischer F344 rats. At 1, 3, 5 and 7-days post-STC, the bladder was harvested 2-hours after intraperitoneal injection of bromodeoxyuridine (BrdU). Fluorescent BrdU labeling was quantified in cells within the urothelium, lamina propria (LP), muscularis propria (MP) and serosa. Cell location was confirmed with fluorescently co-labeled cytokeratin, vimentin or smooth muscle actin (SMA), to identify urothelial, interstitial and smooth muscle cells, respectively. Expression of sonic hedgehog (Shh), Gli-1 and bone morphogenic factor-4 (BMP-4) were evaluated with immunochemistry. Three non-operated rats injected with BrdU served as controls. Less than 1% of cells in the bladder wall were labeled with BrdU in control bladders, but this percentage significantly increased by 5-8-fold at all time points post-STC. The spatiotemporal characteristics of the proliferative response were defined by a significantly higher percentage of BrdU-labeled cells within the urothelium at 1-day than in the MP and LP. A time-dependent shift at 3 and 5-days post-STC revealed significantly fewer BrdU-labeled cells in the MP than LP or urothelium. By 7-days the percentage of BrdU-labeled cells was similar among urothelium, LP and MP. STC also caused an increase in immunostaining for Shh, Gli-1 and BMP-4. In summary, the early stages of functional bladder regeneration are characterized by time-dependent changes in the location of the proliferating cell population, and expression of several evolutionarily conserved developmental signaling proteins. This report extends previous observations and further establishes the rodent bladder as an excellent model for studying novel aspects of mammalian organ regeneration.	[Burmeister, David; Petersen, Bryon; Andersson, Karl-Erik; Christ, George] Wake Forest Univ, Inst Regenerat Med, Winston Salem, NC 27109 USA; [Peyton, Charles C.] Wake Forest Baptist Med Ctr, Dept Urol, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center	Christ, G (corresponding author), Wake Forest Univ, Inst Regenerat Med, Winston Salem, NC 27109 USA.	gchrist@wakehealth.edu			United States National Institutes of Health R21 grant [DK081832]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK081832] Funding Source: NIH RePORTER	United States National Institutes of Health R21 grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was supported in part by United States National Institutes of Health R21 grant DK081832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study	Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003; Baskin L, 2001, J UROLOGY, V165, P1283, DOI 10.1016/S0022-5347(05)66514-7; Baskin LS, 1996, J UROLOGY, V156, P1820, DOI 10.1016/S0022-5347(01)65545-9; Baskin LS, 1997, J UROLOGY, V157, P2388, DOI 10.1016/S0022-5347(01)64786-4; BOHNE AW, 1957, J UROLOGY, V77, P725, DOI 10.1016/S0022-5347(17)66624-2; BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5; Burmeister D, 2010, TISSUE ENG PT A, V16, P2541, DOI 10.1089/ten.TEA.2009.0697; Cao M, 2010, DIFFERENTIATION, V79, P244, DOI 10.1016/j.diff.2010.02.002; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Columbano A, 1996, FASEB J, V10, P1118, DOI 10.1096/fasebj.10.10.8751714; DEBOER WI, 1994, AM J PATHOL, V145, P1199; Dekaney CM, 2007, AM J PHYSIOL-GASTR L, V293, pG1013, DOI 10.1152/ajpgi.00218.2007; Faggian L, 1998, HISTOCHEM CELL BIOL, V109, P25; Frederiksen H, 2004, NEUROUROL URODYNAM, V23, P159, DOI 10.1002/nau.10159; Frederiksen H, 2008, SCAND J UROL NEPHROL, V42, P205, DOI 10.1080/00365590701871641; Freeman MR, 1997, J CLIN INVEST, V99, P1028, DOI 10.1172/JCI119230; GRISHAM JW, 1962, CANCER RES, V22, P842; Gunin AG, 1999, J GASTROENTEROL, V34, P661, DOI 10.1007/s005350050316; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hyun JS, 2012, PLAST RECONSTR SURG, V129, P1097, DOI 10.1097/PRS.0b013e31824a2c49; Jayo MJ, 2008, J UROLOGY, V180, P392, DOI 10.1016/j.juro.2008.02.039; Jin YR, 2012, PHARM BIOL, V50, P523, DOI 10.3109/13880209.2011.611143; Johnston L, 2012, J CELL MOL MED, V16, P1533, DOI 10.1111/j.1582-4934.2011.01410.x; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; Krishna-Subramanian S, 2012, INT J CANCER, V130, P2771, DOI 10.1002/ijc.26336; Kurzrock EA, 2008, AM J PHYSIOL-RENAL, V294, pF1415, DOI 10.1152/ajprenal.00533.2007; LIANG DS, 1963, J UROLOGY, V89, P427, DOI 10.1016/S0022-5347(17)64568-3; LIANG DS, 1963, J UROLOGY, V90, P187, DOI 10.1016/S0022-5347(17)64386-6; Master VA, 2003, J UROLOGY, V170, P1628, DOI 10.1097/01.ju.0000084407.24615.f8; McCloskey KD, 2011, J UROLOGY, V185, P1562, DOI 10.1016/j.juro.2011.02.2587; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819; Miya M, 2012, AM J PHYSIOL-RENAL, V302, pF694, DOI 10.1152/ajprenal.00249.2011; Mysorekar IU, 2009, CELL HOST MICROBE, V5, P463, DOI 10.1016/j.chom.2009.04.005; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pampinella F, 1996, EXP CELL RES, V223, P327, DOI 10.1006/excr.1996.0088; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Sisk V, 1939, T AM ASS GENITOURINA, V32, P197; STEER CJ, 1995, FASEB J, V9, P1396, DOI 10.1096/fasebj.9.14.7589980; Stocum DL, 2011, DEV DYNAM, V240, P943, DOI 10.1002/dvdy.22553; Syn WK, 2009, GASTROENTEROLOGY, V137, P1478, DOI 10.1053/j.gastro.2009.06.051; Takahashi N, 2011, TOXICOL PATHOL, V39, P1107, DOI 10.1177/0192623311422076; Tasian G, 2010, DIFFERENTIATION, V80, P106, DOI 10.1016/j.diff.2010.05.004; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tsonis PA, 2002, DIFFERENTIATION, V70, P397, DOI 10.1046/j.1432-0436.2002.700802.x; Varley C, 2005, EXP CELL RES, V306, P216, DOI 10.1016/j.yexcr.2005.02.004; Wu YJ, 2007, WOUND REPAIR REGEN, V15, pS18, DOI 10.1111/j.1524-475X.2007.00221.x; Zhang H, 2011, UROLOGY; Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835	53	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47414	10.1371/journal.pone.0047414	http://dx.doi.org/10.1371/journal.pone.0047414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077610	gold, Green Published, Green Submitted			2022-12-27	WOS:000309809500047
J	Gros, SJ; Kurschat, N; Drenckhan, A; Dohrmann, T; Forberich, E; Effenberger, K; Reichelt, U; Hoffman, RM; Pantel, K; Kaifi, JT; Izbicki, JR				Gros, Stephanie J.; Kurschat, Nina; Drenckhan, Astrid; Dohrmann, Thorsten; Forberich, Evelyn; Effenberger, Katharina; Reichelt, Uta; Hoffman, Robert M.; Pantel, Klaus; Kaifi, Jussuf T.; Izbicki, Jakob R.			Involvement of CXCR4 Chemokine Receptor in Metastastic HER2-Positive Esophageal Cancer	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; C-ERBB-2 ONCOPROTEIN; BARRETTS-ESOPHAGUS; ANTICANCER THERAPY; PROTEIN EXPRESSION; TUMOR-METASTASIS; MESSENGER-RNA; NEU ONCOGENE; OVEREXPRESSION; ADENOCARCINOMA	A functional linkage of the structurally unrelated receptors HER2 and CXCR4 has been suggested for breast cancer but has not been evaluated for esophageal carcinoma. The inhibition of HER2 leads to a reduction of primary tumor growth and metastases in an orthotopic model of esophageal carcinoma. The chemokine receptor CXCR4 has been implicated in metastatic dissemination of various tumors and correlates with poor survival in esophageal carcinoma. The aim of this study was to investigate a correlation between the expression levels of HER2 and CXCR4 and to evaluate the involvemnent of CXCR4-expression in HER2-positive esophageal carcinoma. The effects of HER2-inhibition with trastuzumab and of CXCR4-inhibition with AMD3100 on primary tumor growth, metastatic homing, and receptor expression were evaluated in vitro and in an orthotopic model of metastatic esophageal carcinoma using MRI for imaging. The clinical relevance of HER2- and CXCR4-expression was examined in esophageal carcinoma patients. A significant correlation of HER2- and CXCR4-expression in primary tumor and metastases exists in the orthotopic model. Trastuzumab and AMD3100 treatment led to a significant reduction of primary tumor growth, metastases and micrometastases. HER2-expression was significantly elevated under AMD3100 treatment in the primary tumor and particularly in the metastases. The positive correlation between HER2- and CXCR4-expression was validated in esophageal cancer patients. The correlation of CXCR4- and HER2-expression and the elevation of HER2-expression and reduction of metastases through CXCR4-inhibition suggest a possible functional linkage and a role in tumor dissemination in HER2-positive esophageal carcinoma.	[Gros, Stephanie J.; Kurschat, Nina; Drenckhan, Astrid; Dohrmann, Thorsten; Effenberger, Katharina; Kaifi, Jussuf T.; Izbicki, Jakob R.] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Forberich, Evelyn] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Hamburg, Germany; [Effenberger, Katharina; Pantel, Klaus] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany; [Reichelt, Uta] Charite, Dept Pathol, Berlin, Germany; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Anti Cancer Inc; University of California System; University of California San Diego	Gros, SJ (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany.	sgros@uke.de			Deutsche Forschungsgemeinschaft (DFG) [GR 3484/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work has been supported by grant GR 3484/1-1 of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu M, 2003, INT J RADIAT ONCOL, V57, P1323, DOI 10.1016/S0360-3016(03)00782-X; ALKASSPOOLES M, 1993, INT J CANCER, V54, P213, DOI 10.1002/ijc.2910540209; Baselga J, 2001, EUR J CANCER, V37, pS16; Bernards R, 2003, NATURE, V425, P247, DOI 10.1038/425247a; Effenberger KE, 2012, INT J CANCER, V131, pE475, DOI 10.1002/ijc.26439; Friess H, 1999, WORLD J SURG, V23, P1010, DOI 10.1007/s002689900616; Gros SJ, 2010, ANTICANCER RES, V30, P3933; Gros SJ, 2010, MOL CANCER THER, V9, P2037, DOI 10.1158/1535-7163.MCT-10-0209; Gros SJ, 2010, INT J CANCER, V126, P2671, DOI 10.1002/ijc.24980; HARDWICK RH, 1994, GUT, V35, P764, DOI 10.1136/gut.35.6.764; Izbicki JR, 2002, SURGERY, V131, P1, DOI 10.1067/msy.2002.114649; Izbicki JR, 1996, J THORAC CARDIOV SUR, V112, P623, DOI 10.1016/S0022-5223(96)70044-2; JANKOWSKI J, 1992, GUT, V33, P1033, DOI 10.1136/gut.33.8.1033; Kaifi JT, 2005, J NATL CANCER I, V97, P1840, DOI 10.1093/jnci/dji431; Koenig AM, 2009, ANN SURG ONCOL, V16, P454, DOI 10.1245/s10434-008-0169-7; Kollmannsberger C, 1999, ANN ONCOL, V10, P1393, DOI 10.1023/A:1008365216323; Lam KY, 1998, EUR J SURG ONCOL, V24, P431, DOI 10.1016/S0748-7983(98)92403-9; Leyland-Jones B, 2002, LANCET ONCOL, V3, P137, DOI 10.1016/S1470-2045(02)00676-9; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liotta LA, 2001, NATURE, V410, P24, DOI 10.1038/35065180; Locati LD, 2005, ORAL ONCOL, V41, P97, DOI 10.1016/j.oraloncology.2004.03.002; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakagawa T, 2005, J UROLOGY, V173, P1767, DOI 10.1097/01.ju.0000154632.11824.4d; NAKAMURA T, 1994, CANCER-AM CANCER SOC, V73, P1785, DOI 10.1002/1097-0142(19940401)73:7<1785::AID-CNCR2820730703>3.0.CO;2-0; Pantel K, 1996, CURR TOP MICROBIOL, V213, P1; Pantel K, 2005, BBA-REV CANCER, V1756, P53, DOI 10.1016/j.bbcan.2005.07.002; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Reichelt U, 2007, MODERN PATHOL, V20, P120, DOI 10.1038/modpathol.3800712; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sobin, 2005, TNM ATLAS ILLUSTRATE; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; SUWANAGOOL P, 1993, ASIAN PAC J ALLERGY, V11, P119; Tan M, 1997, CANCER RES, V57, P1199; Tripathy D, 2004, J CLIN ONCOL, V22, P1063, DOI 10.1200/JCO.2004.06.557; Tuma RS, 2005, J NATL CANCER I, V97, P870, DOI 10.1093/jnci/97.12.870; Walch A, 2001, LAB INVEST, V81, P791, DOI 10.1038/labinvest.3780289; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YEATMAN TJ, 1993, SEMIN SURG ONCOL, V9, P256; YU DH, 1991, ONCOGENE, V6, P1991; Yu DH, 1996, ONCOGENE, V13, P1359; Yu DH, 2000, BIOESSAYS, V22, P673, DOI 10.1002/1521-1878(200007)22:7<673::AID-BIES10>3.0.CO;2-A; Zhang DH, 2003, HUM PATHOL, V34, P362, DOI 10.1053/hupa.2003.60	46	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47287	10.1371/journal.pone.0047287	http://dx.doi.org/10.1371/journal.pone.0047287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082154	Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900050
J	Markowitz, N; Lopardo, G; Wentworth, D; Gey, D; Babiker, A; Fox, L; Tavel, J				Markowitz, Norman; Lopardo, Gustavo; Wentworth, Deborah; Gey, Daniela; Babiker, Abdel; Fox, Lawrence; Tavel, Jorge		STALWART Study Grp	Long-Term Effects of Intermittent IL-2 in HIV Infection: Extended Follow-Up of the INSIGHT STALWART Study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INTERLEUKIN-2 THERAPY; RANDOMIZED-TRIAL; CELL COUNT; CD4(+); EXPANSION; SURVIVAL; PLASMA; IMPACT	Background: The Study of Aldesleukin with and without Antiretroviral Therapy (STALWART) was designed to evaluate whether intermittent IL-2 alone or with peri-cycle ART increased CD4+ cell counts (and so delayed initiation of ART) in HIV infected individuals having >= 300 CD4+ cells/mm(3) compared to untreated controls. When the results of two large clinical trials, ESPRIT and SILCAAT, showed no clinical benefit from IL-2 therapy, IL-2 administration was halted in STALWART. Because IL-2 recipients in STALWART experienced a greater number of opportunistic disease (OD) or death and adverse events (AEs), participants were asked to consent to an extended follow-up phase in order to assess persistence of IL-2 effects. Methodology: Participants in this study were followed for clinical events and AEs every 4 months for 24 months. Unadjusted Cox proportional hazards models were used to summarize death, death or first OD event, and first grade 3 or 4 AE. Principal Findings: A total of 267 persons were enrolled in STALWART (176 randomized to the IL-2 arms and 91 to the no therapy arm); 142 individuals in the IL-2 group and 80 controls agreed to enter the extended follow-up study. Initiation of continuous ART was delayed in the IL-2 groups, but once started, resulted in similar CD4+ cell and viral load responses compared to controls. The hazard ratios (95% CI) for IL-2 versus control during the extension phase for death or OD, grade 3 or 4 AE, and grade 4 AE were 1.45 (0.38, 5.45), 0.43 (0.24, 1.63) and 0.20 (0.04, 1.03), respectively. The hazard ratios for the AE outcomes were significantly lower during the extension than during the main study. Conclusions: Adverse events associated with IL-2 cycling did not persist upon discontinuation of IL-2. The use of IL-2 did not impact the subsequent response to initiation of cART.	[Markowitz, Norman] Henry Ford Hosp, Detroit, MI 48202 USA; [Lopardo, Gustavo] Fdn Ctr Estudios Infectol, Buenos Aires, DF, Argentina; [Wentworth, Deborah] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Gey, Daniela] Univ Copenhagen, Copenhagen HIV Programme, Copenhagen, Denmark; [Babiker, Abdel] MRC, London, England; [Fox, Lawrence; Tavel, Jorge] NIAID, Bethesda, MD 20892 USA	Henry Ford Health System; Henry Ford Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Markowitz, N (corresponding author), Henry Ford Hosp, Detroit, MI 48202 USA.	nmarkow1@hfhs.org			National Institutes of Health (NIH) [U01-AI068641, U01-AI46957]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068641, U01AI046957] Funding Source: NIH RePORTER; Medical Research Council [MC_U122886352] Funding Source: researchfish; MRC [MC_U122886352] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by National Institutes of Health (NIH) grants U01-AI068641 and U01-AI46957. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Barbai VH, 2010, CLIN EXP IMMUNOL, V161, P134, DOI 10.1111/j.1365-2249.2010.04145.x; Beq S, 2004, EUR CYTOKINE NETW, V15, P279; Connors M, 1997, NAT MED, V3, P533, DOI 10.1038/nm0597-533; Fontas E, 2010, J ANTIMICROB CHEMOTH, V65, P2215, DOI 10.1093/jac/dkq296; Herzmann C, 2008, J ANTIMICROB CHEMOTH, V62, P583, DOI 10.1093/jac/dkn238; Kovacs JA, 2005, J CLIN INVEST, V115, P2139, DOI 10.1172/JCI23196; Kovacs JA, 2000, J INFECT DIS, V182, P1063, DOI 10.1086/315821; Lafeuillade A, 2001, HIV Med, V2, P189, DOI 10.1046/j.1468-1293.2001.00065.x; Lempicki RA, 2000, P NATL ACAD SCI USA, V97, P13778, DOI 10.1073/pnas.250472097; Molina JM, 2009, J INFECT DIS, V200, P206, DOI 10.1086/599989; Musselwhite LW, 2011, AIDS, V25, P787, DOI 10.1097/QAD.0b013e3283453fcb; Porter BO, 2009, AIDS, V23, P2015, DOI 10.1097/QAD.0b013e32832d72c6; Read SW, 2008, J INFECT DIS, V198, P843, DOI 10.1086/591250; Read SW, 2011, JAIDS-J ACQ IMM DEF, V56, P340, DOI 10.1097/QAI.0b013e31820bf84c; Sabbatini F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014119; Sereti I, 2004, BLOOD, V104, P775, DOI 10.1182/blood-2003-12-4355; Sereti I, 2005, J CLIN INVEST, V115, P1839, DOI 10.1172/JCI24307; Sereti I, 2002, BLOOD, V100, P2159, DOI 10.1182/blood.V100.6.2159.h81802002159_2159_2167; Sereti I, 2007, J INFECT DIS, V196, P677, DOI 10.1086/520087; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; Tavel JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009334; Youle M, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010003; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157	24	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47506	10.1371/journal.pone.0047506	http://dx.doi.org/10.1371/journal.pone.0047506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082173	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000311146900069
J	Nieva, C; Marro, M; Santana-Codina, N; Rao, S; Petrov, D; Sierra, A				Nieva, Claudia; Marro, Monica; Santana-Codina, Naiara; Rao, Satish; Petrov, Dmitri; Sierra, Angels			The Lipid Phenotype of Breast Cancer Cells Characterized by Raman Microspectroscopy: Towards a Stratification of Malignancy	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; MESENCHYMAL TRANSITION; IN-SITU; SPECTROSCOPY; CHOLESTEROL; OVEREXPRESSION; METASTASIS; METABOLISM; EXPRESSION; MIGRATION	Although molecular classification brings interesting insights into breast cancer taxonomy, its implementation in daily clinical care is questionable because of its expense and the information supplied in a single sample allocation is not sufficiently reliable. New approaches, based on a panel of small molecules derived from the global or targeted analysis of metabolic profiles of cells, have found a correlation between activation of de novo lipogenesis and poorer prognosis and shorter disease-free survival for many tumors. We hypothesized that the lipid content of breast cancer cells might be a useful indirect measure of a variety of functions coupled to breast cancer progression. Raman microspectroscopy was used to characterize metabolism of breast cancer cells with different degrees of malignancy. Raman spectra from MDA-MB-435, MDA-MB-468, MDA-MB-231, SKBR3, MCF7 and MCF10A cells were acquired with an InVia Raman microscope (Renishaw) with a backscattered configuration. We used Principal Component Analysis and Partial Least Squares Discriminant Analyses to assess the different profiling of the lipid composition of breast cancer cells. Characteristic bands related to lipid content were found at 3014, 2935, 2890 and 2845 cm 21, and related to lipid and protein content at 2940 cm(-1). A classificatory model was generated which segregated metastatic cells and non-metastatic cells without basal-like phenotype with a sensitivity of 90% and a specificity of 82.1%. Moreover, expression of SREBP-1c and ABCA1 genes validated the assignation of the lipid phenotype of breast cancer cells. Indeed, changes in fatty acid unsaturation were related with the epithelial-to-mesenchymal transition phenotype. Raman microspectroscopy is a promising technique for characterizing and classifying the malignant phenotype of breast cancer cells on the basis of their lipid profiling. The algorithm for the discrimination of metastatic ability is a first step towards stratifying breast cancer cells using this rapid and reagent-free tool.	[Nieva, Claudia; Santana-Codina, Naiara; Sierra, Angels] IDIBELL Inst Invest Biomed Bellvitge, Barcelona, Spain; [Nieva, Claudia; Marro, Monica; Petrov, Dmitri] ICFO Inst Ciencies Foton, Barcelona, Spain; [Santana-Codina, Naiara] UAB Univ Autonoma Barcelona, Barcelona, Spain; [Rao, Satish] Mt Sinai Sch Med, New York, NY USA; [Petrov, Dmitri] ICREA Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Icahn School of Medicine at Mount Sinai; ICREA	Sierra, A (corresponding author), IDIBELL Inst Invest Biomed Bellvitge, Barcelona, Spain.	asierra@idibell.cat	santana, naiara/AAV-3984-2021; Marro, Monica/AAV-1362-2021; Santana-Codina, Naiara/K-5705-2019; Marro, Monica/E-4159-2016	Marro, Monica/0000-0003-4031-4605; Santana-Codina, Naiara/0000-0002-8250-4530; Marro, Monica/0000-0003-4031-4605; Sierra, Angels/0000-0003-1023-3492	Spanish Ministry of Health and Consumer Affairs [FIS-PI10/00057]; Generalitat de Catalunya [MIIN FIS2008-00114, 2009-SGR-159]; Fundacio Privada Cellex Barcelona; ICREA Funding Source: Custom	Spanish Ministry of Health and Consumer Affairs(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacio Privada Cellex Barcelona(Foundation CELLEX); ICREA(ICREA)	This study was supported by grants from the Spanish Ministry of Health and Consumer Affairs FIS-PI10/00057 and by grants from MIIN FIS2008-00114, 2009-SGR-159 from the Generalitat de Catalunya and Fundacio Privada Cellex Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-78; American Cancer Society, 2010, CANC FACTS FIG 2010; [Anonymous], 2003, WHO CLASSIFICATION T; Antalis CJ, 2011, CLIN EXP METASTAS, V28, P733, DOI 10.1007/s10585-011-9405-9; Antalis CJ, 2010, BREAST CANCER RES TR, V122, P661, DOI 10.1007/s10549-009-0594-8; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Bhalla K, 2011, CANCER RES, V71, P6888, DOI 10.1158/0008-5472.CAN-11-1011; Bocklitz T, 2011, ANAL CHIM ACTA, V704, P47, DOI 10.1016/j.aca.2011.06.043; Brough R, 2011, FUNCTIONAL VIABILITY, V1, P261; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Diaz G, 2008, MICRON, V39, P819, DOI 10.1016/j.micron.2008.01.001; Fenn Michael B., 2011, Advances in Optical Technologies, DOI 10.1155/2011/213783; Ferlay J, 2010, IARC CANCERBASE; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Garcia-Flores AF, 2011, THEOR CHEM ACC, V130, P1231, DOI 10.1007/s00214-011-0925-9; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Guo DL, 2011, CANCER DISCOV, V1, P442, DOI 10.1158/2159-8290.CD-11-0102; Hartsuiker L, 2010, ANALYST, V135, P3220, DOI 10.1039/c0an00524j; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Hu H, 2011, EXPERT REV PROTEOMIC, V8, P505, DOI 10.1586/EPR.11.31; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kasaian K, 2011, FUTURE ONCOL, V7, P873, DOI [10.2217/FON.11.63, 10.2217/fon.11.63]; Knowles LM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-168; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lieber CA, 2010, BIOMED OPT EXPRESS, V1, P975, DOI 10.1364/BOE.1.000975; Mikhailyuk IK, 2003, INSTRUM EXP TECH+, V46, P765, DOI 10.1023/B:INET.0000008930.87741.b9; Min W, 2011, ANNU REV PHYS CHEM, V62, P507, DOI 10.1146/annurev.physchem.012809.103512; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Pichardo-Molina JL, 2007, LASER MED SCI, V22, P229, DOI 10.1007/s10103-006-0432-8; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Popp J, 2011, OPT PHOTONIK, V6, P24, DOI 10.1002/opph.201190383; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Raniero L, 2011, THEOR CHEM ACC, V130, P1239, DOI 10.1007/s00214-011-1027-4; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Rehman S, 2007, J RAMAN SPECTROSC, V38, P1345, DOI 10.1002/jrs.1774; Rodenhiser DI, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2791; Rudolph MC, 2010, AM J PHYSIOL-ENDOC M, V299, pE918, DOI 10.1152/ajpendo.00376.2010; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Simpson NE, 2012, BREAST CANCER RES TR, V133, P959, DOI 10.1007/s10549-011-1871-x; Sleeman J, 2010, EUR J CANCER, V46, P1177, DOI 10.1016/j.ejca.2010.02.039; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Van de Sande T, 2002, CANCER RES, V62, P642; Vazquez-Martin A, 2008, CELL PROLIFERAT, V41, P59, DOI 10.1111/j.1365-2184.2007.00498.x; Vedin LL, 2009, CARCINOGENESIS, V30, P575, DOI 10.1093/carcin/bgp029; Voss MJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-158; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	54	89	90	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46456	10.1371/journal.pone.0046456	http://dx.doi.org/10.1371/journal.pone.0046456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082122	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900017
J	Sousa, M; Servidoni, MF; Vinagre, AM; Ramalho, AS; Bonadia, LC; Felicio, V; Ribeiro, MA; Uliyakina, I; Marson, FA; Kmit, A; Cardoso, SR; Ribeiro, JD; Bertuzzo, CS; Sousa, L; Kunzelmann, K; Ribeiro, AF; Amaral, MD				Sousa, Marisa; Servidoni, Maria F.; Vinagre, Adriana M.; Ramalho, Anabela S.; Bonadia, Luciana C.; Felicio, Veronica; Ribeiro, Maria A.; Uliyakina, Inna; Marson, Fernando A.; Kmit, Arthur; Cardoso, Silvia R.; Ribeiro, Jose D.; Bertuzzo, Carmen S.; Sousa, Lisete; Kunzelmann, Karl; Ribeiro, Antonio F.; Amaral, Margarida D.			Measurements of CFTR-Mediated Cl- Secretion in Human Rectal Biopsies Constitute a Robust Biomarker for Cystic Fibrosis Diagnosis and Prognosis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NASAL POTENTIAL DIFFERENCE; AIRWAY ION-TRANSPORT; PULMONARY-DISEASE; LUNG-FUNCTION; MUTATION; IDENTIFICATION; CONSENSUS; GENOTYPE; GENE	Background: Cystic Fibrosis (CF) is caused by similar to 1,900 mutations in the CF transmembrane conductance regulator (CFTR) gene encoding for a cAMP-regulated chloride (Cl-) channel expressed in several epithelia. Clinical features are dominated by respiratory symptoms, but there is variable organ involvement thus causing diagnostic dilemmas, especially for non-classic cases. Methodology/Principal Findings: To further establish measurement of CFTR function as a sensitive and robust biomarker for diagnosis and prognosis of CF, we herein assessed cholinergic and cAMP-CFTR-mediated Cl- secretion in 524 freshly excised rectal biopsies from 118 individuals, including patients with confirmed CF clinical diagnosis (n = 51), individuals with clinical CF suspicion (n = 49) and age-matched non-CF controls (n = 18). Conclusive measurements were obtained for 96% of cases. Patients with "Classic CF'', presenting earlier onset of symptoms, pancreatic insufficiency, severe lung disease and low Shwachman-Kulczycki scores were found to lack CFTR-mediated Cl- secretion (<5%). Individuals with milder CF disease presented residual CFTR-mediated Cl- secretion (10-57%) and non-CF controls show CFTR-mediated Cl- secretion >= 30-35% and data evidenced good correlations with various clinical parameters. Finally, comparison of these values with those in "CF suspicion'' individuals allowed to confirm CF in 16/49 individuals (33%) and exclude it in 28/49 (57%). Statistical discriminant analyses showed that colonic measurements of CFTR-mediated Cl- secretion are the best discriminator among Classic/Non-Classic CF and non-CF groups. Conclusions/Significance: Determination of CFTR-mediated Cl- secretion in rectal biopsies is demonstrated here to be a sensitive, reproducible and robust predictive biomarker for the diagnosis and prognosis of CF. The method also has very high potential for (pre-) clinical trials of CFTR-modulator therapies.	[Sousa, Marisa; Ramalho, Anabela S.; Felicio, Veronica; Uliyakina, Inna; Amaral, Margarida D.] Univ Lisbon, BioFIG Ctr Biodivers Funct & Integrat Genom, Fac Sci, P-1699 Lisbon, Portugal; [Sousa, Marisa; Ramalho, Anabela S.; Uliyakina, Inna; Amaral, Margarida D.] Natl Inst Hlth, Dept Genet, Lisbon, Portugal; [Servidoni, Maria F.] Univ Estadual Campinas, Gastroctr, Endoscopy Unit, Campinas, SP, Brazil; [Servidoni, Maria F.; Cardoso, Silvia R.; Ribeiro, Jose D.; Ribeiro, Antonio F.] Univ Estadual Campinas, Dept Pediat, Campinas, SP, Brazil; [Vinagre, Adriana M.; Bonadia, Luciana C.; Marson, Fernando A.; Kmit, Arthur; Ribeiro, Jose D.; Bertuzzo, Carmen S.; Ribeiro, Antonio F.] Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil; [Ribeiro, Maria A.; Ribeiro, Jose D.; Ribeiro, Antonio F.] Univ Estadual Campinas, CIPED Res Ctr Pediat, Campinas, SP, Brazil; [Cardoso, Silvia R.] Univ Hosp Campinas, Endoscopy Unit, Campinas, SP, Brazil; [Sousa, Lisete] Univ Lisbon, CEAUL Ctr Stat & Applicat, P-1699 Lisbon, Portugal; [Sousa, Lisete] Univ Lisbon, Fac Sci, Dept Stat & Operat Res, P-1699 Lisbon, Portugal; [Kunzelmann, Karl] Univ Regensburg, Inst Physiol, Regensburg, Germany	Universidade de Lisboa; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Lisboa; Universidade de Lisboa; University of Regensburg	Amaral, MD (corresponding author), Univ Lisbon, BioFIG Ctr Biodivers Funct & Integrat Genom, Fac Sci, P-1699 Lisbon, Portugal.	mdamaral@fc.ul.pt	Marson, Fernando Augusto Lima/H-1641-2012; Ribeiro, Jose Dirceu D/I-7308-2012; RIBEIRO, ANTONIO FERNANDO AF/F-2786-2014; Kmit, Arthur Henrique Pezzo/E-2296-2018; Amaral, Margarida D/E-5748-2012; Marson, Fernando/AAP-1589-2021; Sousa, Lisete M R/M-1842-2015; Ramalho, Anabela/AAY-4037-2020; Servidoni, Maria de Fátima Correa Pimenta/ABC-6857-2021	Marson, Fernando Augusto Lima/0000-0003-4955-4234; Ribeiro, Jose Dirceu D/0000-0002-3387-5642; Kmit, Arthur Henrique Pezzo/0000-0002-3744-7741; Amaral, Margarida D/0000-0002-0828-8630; Marson, Fernando/0000-0003-4955-4234; Sousa, Lisete M R/0000-0002-2114-720X; Ramalho, Anabela/0000-0002-6480-8725; Felicio, Veronica/0000-0001-6753-323X; SOUSA, MARISA/0000-0003-2305-4813; Kunzelmann, Karl/0000-0002-4583-7037; Uliyakina, Inna/0000-0002-7091-2123; Bertuzzo, Carmen Silvia/0000-0002-2813-2887	TargetScreen2 [EU/FP6/LSH/2005/037365, PIC/IC/83103/2007]; FCT (Portugal) [PEstOE/BIA/UI4046/2011, PEstOE/MAT/UI0006/2011, SFRH/BD/35936/2007, SFRH/BD/69180/2010]; FAPESP (SPRF, Brazil); CNPq, (Brazil) [40.8924/2006/3]; Mukoviszidose e.V. (Germany) [S02/10];  [PTDC/MAT/118335/2010]	TargetScreen2; FCT (Portugal)(Portuguese Foundation for Science and TechnologyEuropean Commission); FAPESP (SPRF, Brazil); CNPq, (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Mukoviszidose e.V. (Germany); 	This work was supported by grants TargetScreen2 (EU/FP6/LSH/2005/037365), PIC/IC/83103/2007; PTDC/MAT/118335/2010; PEstOE/BIA/UI4046/2011 (to BioFIG) and PEstOE/MAT/UI0006/2011 (to CEAUL) from FCT (Portugal); and FAPESP (SPRF, Brazil), CNPq (40.8924/2006/3, Brazil) and Mukoviszidose e.V. S02/10 (Germany). MS and IU are recipients of SFRH/BD/35936/2007 and SFRH/BD/69180/2010 PhD fellowships (FCT, Portugal), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Amaral MD, 2005, PEDIATR PULM, V39, P479, DOI 10.1002/ppul.20168; Amaral MD, 2001, J MED GENET, V38, P777, DOI 10.1136/jmg.38.11.777; Beck S, 1999, HUM MUTAT, V14, P133, DOI 10.1002/(SICI)1098-1004(1999)14:2<133::AID-HUMU5>3.0.CO;2-T; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Bombieri C, 2011, J CYST FIBROS, V10, pS86, DOI 10.1016/S1569-1993(11)60014-3; Bonadia L, 2011, CORRELACAO ENTRE ASP; Boyle MP, 2003, CURR OPIN PULM MED, V9, P498, DOI 10.1097/00063198-200311000-00009; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cleveland RH, 2009, RADIOLOGY, V253, P813, DOI 10.1148/radiol.2533090418; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Correia C, 2005, PREVALENCIA SEIS MUT; De Boeck K, 2006, THORAX, V61, P627, DOI 10.1136/thx.2005.043539; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; Derichs N, 2010, THORAX, V65, P594, DOI 10.1136/thx.2009.125088; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Felicio V, 2011, ESTUDO CARACTERIZACA; Gavin JR, 1999, DIABETES CARE, V22, pS5; Hirtz S, 2004, GASTROENTEROLOGY, V127, P1085, DOI 10.1053/j.gastro.2004.07.006; Ho LP, 1997, EUR RESPIR J, V10, P2018, DOI 10.1183/09031936.97.10092018; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P192, DOI 10.1007/s001980050281; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; Mall M, 2004, GASTROENTEROLOGY, V126, P32, DOI 10.1053/j.gastro.2003.10.049; Mall M, 2000, AM J PHYSIOL-GASTR L, V278, pG617, DOI 10.1152/ajpgi.2000.278.4.G617; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Mall M, 1998, AM J PHYSIOL-GASTR L, V275, pG1274, DOI 10.1152/ajpgi.1998.275.6.G1274; Mall Marcus, 2004, J Cyst Fibros, V3 Suppl 2, P165, DOI 10.1016/j.jcf.2004.05.035; Noone PG, 2001, RESP RES, V2, P328, DOI 10.1186/rr82; Parad RB, 2005, J PEDIATR-US, V147, pS78, DOI 10.1016/j.jpeds.2005.08.017; Paranjape SM, 2008, CLIN REV ALLERG IMMU, V35, P116, DOI 10.1007/s12016-008-8083-0; Pratha VS, 2000, GASTROENTEROLOGY, V118, P1051, DOI 10.1016/S0016-5085(00)70358-1; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Roth EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024445; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Schaedel C, 2002, PEDIATR PULM, V33, P483, DOI 10.1002/ppul.10100; Sermet-Gaudelus I, 2010, THORAX, V65, P539, DOI 10.1136/thx.2009.123422; Shah S, 2011, THORAX, V66, P984, DOI DOI 10.1136/THX.2011.159491; Standaert TA, 2004, PEDIATR PULM, V37, P385, DOI 10.1002/ppul.10448; Taylor CJ, 2009, PAEDIATR RESPIR REV, V10, P220, DOI 10.1016/j.prrv.2009.05.002; van Barneveld A, 2006, BBA-MOL BASIS DIS, V1762, P393, DOI 10.1016/j.bbadis.2006.01.007; van Barneveld A, 2010, BBA-MOL BASIS DIS, V1802, P1062, DOI 10.1016/j.bbadis.2010.08.001; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Walker LC, 1997, AM J RESP CRIT CARE, V155, P1684, DOI 10.1164/ajrccm.155.5.9154877; Wallace HL, 2003, AM J RESP CRIT CARE, V168, P594, DOI 10.1164/rccm.200211-1302OC; Yu H, 2012, J CYST FIBROS	52	46	46	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47708	10.1371/journal.pone.0047708	http://dx.doi.org/10.1371/journal.pone.0047708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082198	Green Published, gold			2022-12-27	WOS:000311146900095
J	van Zanten, GC; Knudsen, A; Roytio, H; Forssten, S; Lawther, M; Blennow, A; Lahtinen, SJ; Jakobsen, M; Svensson, B; Jespersen, L				van Zanten, Gabriella C.; Knudsen, Anne; Roytio, Henna; Forssten, Sofia; Lawther, Mark; Blennow, Andreas; Lahtinen, Sampo J.; Jakobsen, Mogens; Svensson, Birte; Jespersen, Lene			The Effect of Selected Synbiotics on Microbial Composition and Short-Chain Fatty Acid Production in a Model System of the Human Colon	PLOS ONE			English	Article							LACTOBACILLUS-ACIDOPHILUS NCFM; IN-VITRO FERMENTATION; BIFIDOBACTERIUM-LACTIS; GUT MICROBIOTA; DOUBLE-BLIND; FECAL MICROBIOTA; XYLO-OLIGOSACCHARIDES; CONTINUOUS-CULTURE; INFECTION-RATES; BACTERIA	Background: Prebiotics, probiotics and synbiotics can be used to modulate both the composition and activity of the gut microbiota and thereby potentially affecting host health beneficially. The aim of this study was to investigate the effects of eight synbiotic combinations on the composition and activity of human fecal microbiota using a four-stage semicontinuous model system of the human colon. Methods and Findings: Carbohydrates were selected by their ability to enhance growth of the probiotic bacteria Lactobacillus acidophilus NCFM (NCFM) and Bifidobacterium animalis subsp. lactis Bl0-04 (Bl-04) under laboratory conditions. The most effective carbohydrates for each probiotic were further investigated, using the colonic model, for the ability to support growth of the probiotic bacteria, influence the composition of the microbiota and stimulate formation of short-chain fatty acids (SCFA). The following combinations were studied: NCFM with isomaltulose, cellobiose, raffinose and an oat beta-glucan hydrolysate (OBGH) and Bl-04 with melibiose, xylobiose, raffinose and maltotriose. All carbohydrates showed capable of increasing levels of NCFM and Bl-04 during fermentations in the colonic model by 10(3)-10(4) fold and 10-10(2) fold, respectively. Also the synbiotic combinations decreased the modified ratio of Bacteroidetes/Firmicutes (calculated using qPCR results for Bacteroides-Prevotella-Porphyromonas group, Clostridium perfringens cluster I, Clostridium coccoides Eubacterium rectale group and Clostridial cluster XIV) as well as significantly increasing SCFA levels, especially acetic and butyric acid, by three to eight fold, as compared to the controls. The decreases in the modified ratio of Bacteroidetes/Firmicutes were found to be correlated to increases in acetic and butyric acid (p = 0.04 and p = 0.03, respectively). Conclusions: The results of this study show that all synbiotic combinations investigated are able to shift the predominant bacteria and the production of SCFA of fecal microbiota in a model system of the human colon, thereby potentially being able to manipulate the microbiota in a way connected to human health.	[van Zanten, Gabriella C.; Jakobsen, Mogens; Jespersen, Lene] Univ Copenhagen, Fac Life Sci, Dept Food Sci, Frederiksberg, Denmark; [van Zanten, Gabriella C.; Knudsen, Anne; Svensson, Birte] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Knudsen, Anne; Blennow, Andreas] Univ Copenhagen, Fac Life Sci, Dept Plant Biol & Biotechnol, Frederiksberg, Denmark; [Roytio, Henna; Forssten, Sofia; Lahtinen, Sampo J.] DuPont Nutr & Hlth, Kantvik, Finland; [Lawther, Mark] Biovelop AS, Kvistgard, Denmark	University of Copenhagen; Technical University of Denmark; University of Copenhagen	van Zanten, GC (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Food Sci, Frederiksberg, Denmark.	gcz@life.ku.dk	Jespersen, Lene/AAA-4230-2021; van Zanten, Gabriella/M-6000-2014; Forssten, Sofia/AAD-1805-2022; Jespersen, Lene/E-1717-2015; Blennow, Andreas/F-7451-2014	Jespersen, Lene/0000-0002-2555-5948; van Zanten, Gabriella/0000-0002-7793-8465; Jespersen, Lene/0000-0002-2555-5948; Blennow, Andreas/0000-0001-6476-9546; Svensson, Birte/0000-0002-2993-8196	Danish Strategic Research Council's Program Committee on Health, Food and Welfare (FoSu)	Danish Strategic Research Council's Program Committee on Health, Food and Welfare (FoSu)	This project was funded by the Danish Strategic Research Council's Program Committee on Health, Food and Welfare (FoSu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SA, 2007, J PEDIATR-US, V151, P293, DOI 10.1016/j.jpeds.2007.03.043; Andreasen AS, 2010, BRIT J NUTR, V104, P1831, DOI 10.1017/S0007114510002874; Apajalahti JHA, 2002, APPL ENVIRON MICROB, V68, P4986, DOI 10.1128/AEM.68.10.4986-4995.2002; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bartosch S, 2005, CLIN INFECT DIS, V40, P28, DOI 10.1086/426027; Beards E, 2010, BRIT J NUTR, V104, P701, DOI 10.1017/S0007114510001078; Benjamin JL, 2011, GUT, V60, P923, DOI 10.1136/gut.2010.232025; Bjorklund M, 2012, AGE, V34, P987, DOI 10.1007/s11357-011-9294-5; Bolognani F, 2001, EUR J NUTR, V40, P293, DOI 10.1007/s394-001-8359-7; Bouhnik Y, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-8; Brighenti F, 1999, EUR J CLIN NUTR, V53, P726, DOI 10.1038/sj.ejcn.1600841; Collado MC, 2009, CURR DRUG METAB, V10, P68, DOI 10.2174/138920009787048437; De Preter V, 2010, MOL NUTR FOOD RES, V54, P1791, DOI 10.1002/mnfr.201000136; Dinoto A, 2006, APPL ENVIRON MICROB, V72, P784, DOI 10.1128/AEM.72.1.784-792.2006; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Engelbrektson A, 2009, J MED MICROBIOL, V58, P663, DOI 10.1099/jmm.0.47615-0; Francavilla R, 2010, PEDIATRICS, V126, pE1445, DOI 10.1542/peds.2010-0467; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; GAMET L, 1992, INT J CANCER, V52, P286, DOI 10.1002/ijc.2910520222; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gobel R., 2010, International Journal of Probiotics and Prebiotics, V5, P53; Griffin IJ, 2002, BRIT J NUTR, V87, pS187, DOI [10.1079/BJN2001503, 10.1079/BJN/2002536]; Hansen MR, 2008, FOOD HYDROCOLLOID, V22, P1551, DOI 10.1016/j.foodhyd.2007.10.010; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Hernandez-Hernandez O, 2011, J AGR FOOD CHEM, V59, P10901, DOI 10.1021/jf202466s; Holben WE, 2002, MICROB ECOL, V44, P175, DOI 10.1007/s00248-002-1011-6; Hughes R, 2000, Curr Issues Intest Microbiol, V1, P51; Hughes R, 2001, CARCINOGENESIS, V22, P43, DOI 10.1093/carcin/22.1.43; Hughes SA, 2008, FEMS MICROBIOL ECOL, V64, P482, DOI 10.1111/j.1574-6941.2008.00478.x; HUNGATE RE, 1950, BACTERIOL REV, V14, P1; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kukkonen K, 2008, PEDIATRICS, V122, P8, DOI 10.1542/peds.2007-1192; Kvist S, Soluble dietary fibre from oat and barley grains, method for producing a fraction rich in &UBeta;-glucan and use of the fraction in foods, pharmaceuticals and cosmetics: Patent Num, Patent No. [WO2005048735-A1, 2005048735]; Larsen N, 2011, FEMS MICROBIOL ECOL, V75, P482, DOI 10.1111/j.1574-6941.2010.01024.x; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Luoto R, 2010, INT J OBESITY, V34, P1531, DOI 10.1038/ijo.2010.50; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Mai V, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-49; Makelainen H., 2010, International Journal of Probiotics and Prebiotics, V5, P203; Makelainen H, 2010, BENEF MICROBES, V1, P139, DOI 10.3920/BM2009.0029; Makelainen H, 2010, BENEF MICROBES, V1, P81, DOI 10.3920/BM2009.0025; Makelainen H, 2009, LETT APPL MICROBIOL, V49, P666, DOI 10.1111/j.1472-765X.2009.02698.x; Makelainen H, 2009, INT DAIRY J, V19, P675, DOI 10.1016/j.idairyj.2009.06.005; Makelainen HS, 2007, J FOOD SCI, V72, pM153, DOI 10.1111/j.1750-3841.2007.00350.x; Makivuokko H, 2005, NUTR CANCER, V52, P94, DOI 10.1207/s15327914nc5201_12; Makivuokko H, 2010, BENEF MICROBES, V1, P131, DOI 10.3920/BM2009.0033; MARSH PD, 1995, J CHEM TECHNOL BIOT, V64, P1, DOI 10.1002/jctb.280640102; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Ouwehand AC, 2009, BRIT J NUTR, V101, P367, DOI 10.1017/S0007114508003097; Paineau D, 2008, FEMS IMMUNOL MED MIC, V53, P107, DOI 10.1111/j.1574-695X.2008.00413.x; Payne AN, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.8; Quigley EMM, 2010, PHARMACOL RES, V61, P213, DOI 10.1016/j.phrs.2010.01.004; Rafter J, 2007, AM J CLIN NUTR, V85, P488, DOI 10.1093/ajcn/85.2.488; Rayes N, 2007, ANN SURG, V246, P36, DOI 10.1097/01.sla.0000259442.78947.19; Ringel-Kulka T, 2011, J CLIN GASTROENTEROL, V45, P518, DOI 10.1097/MCG.0b013e31820ca4d6; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Riordan Stephen M., 2007, Microbial Ecology in Health and Disease, V19, P7, DOI 10.1080/08910600601178709; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Rosenfeldt V, 2002, PEDIATR INFECT DIS J, V21, P417, DOI 10.1097/00006454-200205000-00013; Rosenfeldt V, 2003, J ALLERGY CLIN IMMUN, V111, P389, DOI 10.1067/mai.2003.389; Roy MJ, 2009, NUTRITION, V25, P1193, DOI 10.1016/j.nut.2009.04.008; Sannasiddappa TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023227; Sanz ML, 2006, FEMS MICROBIOL ECOL, V56, P383, DOI 10.1111/j.1574-6941.2006.00075.x; Sanz ML, 2005, J AGR FOOD CHEM, V53, P5192, DOI 10.1021/jf050276w; SCHEPPACH W, 1995, EUR J CANCER, V31A, P1077, DOI 10.1016/0959-8049(95)00165-F; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Silk DBA, 2009, ALIMENT PHARM THER, V29, P508, DOI 10.1111/j.1365-2036.2008.03911.x; Snart J, 2006, APPL ENVIRON MICROB, V72, P1925, DOI 10.1128/AEM.72.3.1925-1931.2006; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; van den Heuvel EGHM, 2009, NUTR RES, V29, P229, DOI 10.1016/j.nutres.2009.03.005; Ventura M, 2001, APPL ENVIRON MICROB, V67, P2760, DOI 10.1128/AEM.67.6.2760-2765.2001; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Walton GE, 2012, BRIT J NUTR, V107, P1466, DOI 10.1017/S0007114511004697; Welters CFM, 2002, DIS COLON RECTUM, V45, P621, DOI 10.1007/s10350-004-6257-2; Wickens K, 2008, J ALLERGY CLIN IMMUN, V122, P788, DOI 10.1016/j.jaci.2008.07.011	77	74	75	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47212	10.1371/journal.pone.0047212	http://dx.doi.org/10.1371/journal.pone.0047212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082149	Green Submitted, Green Published, gold			2022-12-27	WOS:000311146900045
J	Gross, EL; Beall, CJ; Kutsch, SR; Firestone, ND; Leys, EJ; Griffen, AL				Gross, Erin L.; Beall, Clifford J.; Kutsch, Stacey R.; Firestone, Noah D.; Leys, Eugene J.; Griffen, Ann L.			Beyond Streptococcus mutans: Dental Caries Onset Linked to Multiple Species by 16S rRNA Community Analysis	PLOS ONE			English	Article							EARLY-CHILDHOOD CARIES; HUMAN CLINICAL SPECIMENS; SALIVARIUS TOVE-R; IN-VITRO; ORAL BACTERIA; MOLECULAR ANALYSIS; VEILLONELLA-ALCALESCENS; ARGININE DEIMINASE; GENUS VEILLONELLA; GNOTOBIOTIC-RATS	Dental caries in very young children may be severe, result in serious infection, and require general anesthesia for treatment. Dental caries results from a shift within the biofilm community specific to the tooth surface, and acidogenic species are responsible for caries. Streptococcus mutans, the most common acid producer in caries, is not always present and occurs as part of a complex microbial community. Understanding the degree to which multiple acidogenic species provide functional redundancy and resilience to caries-associated communities will be important for developing biologic interventions. In addition, microbial community interactions in health and caries pathogenesis are not well understood. The purpose of this study was to investigate bacterial community profiles associated with the onset of caries in the primary dentition. In a combination cross-sectional and longitudinal design, bacterial community profiles at progressive stages of caries and over time were examined and compared to those of health. 16S rRNA gene sequencing was used for bacterial community analysis. Streptococcus mutans was the dominant species in many, but not all, subjects with caries. Elevated levels of S. salivarius, S. sobrinus, and S. parasanguinis were also associated with caries, especially in subjects with no or low levels of S. mutans, suggesting these species are alternative pathogens, and that multiple species may need to be targeted for interventions. Veillonella, which metabolizes lactate, was associated with caries and was highly correlated with total acid producing species. Among children without previous history of caries, Veillonella, but not S. mutans or other acid-producing species, predicted future caries. Bacterial community diversity was reduced in caries as compared to health, as many species appeared to occur at lower levels or be lost as caries advanced, including the Streptococcus mitis group, Neisseria, and Streptococcus sanguinis. This may have implications for bacterial community resilience and the restoration of oral health.	[Kutsch, Stacey R.; Griffen, Ann L.] Ohio State Univ, Coll Dent, Div Pediat Dent & Community Oral Hlth, Columbus, OH 43210 USA; [Gross, Erin L.; Beall, Clifford J.; Firestone, Noah D.; Leys, Eugene J.] Ohio State Univ, Coll Dent, Div Oral Biol, Columbus, OH 43210 USA; [Kutsch, Stacey R.; Griffen, Ann L.] Nationwide Childrens Hosp, Dept Dent, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Griffen, AL (corresponding author), Ohio State Univ, Coll Dent, Div Pediat Dent & Community Oral Hlth, Columbus, OH 43210 USA.	griffen.1@osu.edu	Griffen, Ann/AAC-5999-2019; Beall, Clifford/D-1035-2012	Beall, Clifford/0000-0002-2198-9124	National Institute of Dental and Craniofacial Research, National Institutes of Health [R01DE016125, T32DE14320, F30DE019339]; OMNII Research Fellowship from the American Academy of Pediatric Dentistry; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016125, F30DE019339] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OMNII Research Fellowship from the American Academy of Pediatric Dentistry; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants R01DE016125, T32DE14320, and F30DE019339 from the National Institute of Dental and Craniofacial Research, National Institutes of Health (www.nidcr.nih.gov), and the OMNII Research Fellowship from the American Academy of Pediatric Dentistry (www.aapd.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Al-Shalan Thakib A., 1997, Pediatric Dentistry, V19, P37; Alm A, 2007, CARIES RES, V41, P392, DOI 10.1159/000104798; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arif N, 2008, J DENT RES, V87, P278, DOI 10.1177/154405910808700308; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Beighton D, 2005, COMMUNITY DENT ORAL, V33, P248, DOI 10.1111/j.1600-0528.2005.00232.x; Bergey DH., 2001, BERGEYS MANUAL SYSTE; Bradshaw DJ, 1996, J APPL BACTERIOL, V80, P124, DOI 10.1111/j.1365-2672.1996.tb03199.x; BRADSHAW DJ, 1989, J DENT RES, V68, P1298, DOI 10.1177/00220345890680090101; Bradshaw DJ, 1998, CARIES RES, V32, P456, DOI 10.1159/000016487; Burne RA, 1998, J DENT RES, V77, P445, DOI 10.1177/00220345980770030301; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Casamassimo PS, 2009, J AM DENT ASSOC, V140, P650, DOI 10.14219/jada.archive.2009.0250; Chen YYM, 1996, FEMS MICROBIOL LETT, V135, P223, DOI 10.1016/0378-1097(95)00454-8; CHESTNUTT IG, 1994, ARCH ORAL BIOL, V39, P589, DOI 10.1016/0003-9969(94)90134-1; Chhour KL, 2005, J CLIN MICROBIOL, V43, P843, DOI 10.1128/JCM.43.2.843-849.2005; Choi EJ, 2009, INT J PAEDIATR DENT, V19, P141, DOI 10.1111/j.1365-263X.2008.00942.x; Corby PM, 2007, TWIN RES HUM GENET, V10, P821, DOI 10.1375/twin.10.6.821; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Dong YQ, 2002, APPL ENVIRON MICROB, V68, P5549, DOI 10.1128/AEM.68.11.5549-5553.2002; DRUCKER DB, 1984, ARCH ORAL BIOL, V29, P437, DOI 10.1016/0003-9969(84)90024-4; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; HIROSE H, 1993, CARIES RES, V27, P292, DOI 10.1159/000261553; HORTON WA, 1985, ARCH ORAL BIOL, V30, P777, DOI 10.1016/0003-9969(85)90131-1; HOWELL A, 1961, BACTERIOL REV, V25, P162, DOI 10.1128/MMBR.25.2.162-171.1961; Hughes CV, 2012, PEDIAT DENT, V34, P16; Jiang W, 2011, MICROB ECOL, V61, P342, DOI 10.1007/s00248-010-9753-z; Kanasi E, 2010, J DENT RES, V89, P378, DOI 10.1177/0022034509360010; Kanellis MJ, 2000, J PUBLIC HEALTH DENT, V60, P28; Kawamura Y, 1998, INT J SYST BACTERIOL, V48, P921, DOI 10.1099/00207713-48-3-921; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; KIKUCHI K, 1995, J CLIN MICROBIOL, V33, P1215, DOI 10.1128/JCM.33.5.1215-1222.1995; Kleinberg I, 2002, CRIT REV ORAL BIOL M, V13, P108, DOI 10.1177/154411130201300202; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Kuramitsu Howard K, 2006, BMC Oral Health, V6 Suppl 1, pS11; LEYS EJ, 1994, J CLIN MICROBIOL, V32, P1288, DOI 10.1128/JCM.32.5.1288-1294.1994; Li Y, 2007, J CLIN MICROBIOL, V45, P81, DOI 10.1128/JCM.01622-06; Lima KC, 2011, CARIES RES, V45, P21, DOI 10.1159/000322299; Lin X, 2008, J BACTERIOL, V190, P4367, DOI 10.1128/JB.01898-07; Liu JM, 2011, MICROBIOL-SGM, V157, P2433, DOI 10.1099/mic.0.048314-0; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; LOESCHE WJ, 1973, CARIES RES, V7, P201, DOI 10.1159/000259844; Loyola-Rodriguez Juan Pablo, 2008, J Clin Pediatr Dent, V32, P121; Marchandin H, 2003, MICROBIOL-SGM, V149, P1493, DOI 10.1099/mic.0.26132-0; Marchant S, 2001, CARIES RES, V35, P397, DOI 10.1159/000047482; MARGOLIS HC, 1985, J DENT RES, V64, P786, DOI 10.1177/00220345850640050101; Margolis HC, 1999, J DENT RES, V78, P1326, DOI 10.1177/00220345990780070701; Marsh P D, 1994, Adv Dent Res, V8, P263; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Mattila ML, 2005, CARIES RES, V39, P85, DOI 10.1159/000083152; MCDERMID AS, 1986, J GEN MICROBIOL, V132, P1205; MIKX FHM, 1975, ARCH ORAL BIOL, V20, P407, DOI 10.1016/0003-9969(75)90224-1; MOORE LVH, 1987, INT J SYST BACTERIOL, V37, P271, DOI 10.1099/00207713-37-3-271; NOORDA WD, 1988, CARIES RES, V22, P342, DOI 10.1159/000261134; Okada M, 2005, J MED MICROBIOL, V54, P661, DOI 10.1099/jmm.0.46069-0; Oksanen J., 2011, COMMUNITY ECOLOGY; Paddick JS, 2005, APPL ENVIRON MICROB, V71, P2467, DOI 10.1128/AEM.71.5.2467-2472.2005; Palmer CA, 2010, J DENT RES, V89, P1224, DOI 10.1177/0022034510376543; Peretz Benjamin, 2003, Pediatr Dent, V25, P114; Preza D, 2008, J CLIN MICROBIOL, V46, P2015, DOI 10.1128/JCM.02411-07; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROGOSA M, 1964, J BACTERIOL, V87, P162, DOI 10.1128/JB.87.1.162-170.1964; Seki M, 2006, ORAL MICROBIOL IMMUN, V21, P47, DOI 10.1111/j.1399-302X.2005.00253.x; Tanner ACR, 2011, J CLIN MICROBIOL, V49, P1464, DOI 10.1128/JCM.02427-10; Tanzer J M, 2001, J Dent Educ, V65, P1028; TANZER JM, 1985, INFECT IMMUN, V48, P44, DOI 10.1128/IAI.48.1.44-50.1985; TANZER JM, 1985, INFECT IMMUN, V49, P76, DOI 10.1128/IAI.49.1.76-83.1985; Toro E, 2010, ARCH ORAL BIOL, V55, P249, DOI 10.1016/j.archoralbio.2009.12.007; US Department of Health and Human Services, 2000, OR HLTH AM REP SURG; VANHOUTE J, 1994, J DENT RES, V73, P672, DOI 10.1177/00220345940730031301; Wang BY, 2005, APPL ENVIRON MICROB, V71, P354, DOI 10.1128/AEM.71.1.354-362.2005; WHILEY RA, 1990, FEMS MICROBIOL LETT, V68, P115, DOI 10.1111/j.1574-6968.1990.tb04133.x; WILLCOX MDP, 1988, ARCH ORAL BIOL, V33, P109, DOI 10.1016/0003-9969(88)90053-2; WILLCOX MDP, 1991, ARCH ORAL BIOL, V36, P327, DOI 10.1016/0003-9969(91)90001-B	77	280	294	7	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47722	10.1371/journal.pone.0047722	http://dx.doi.org/10.1371/journal.pone.0047722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091642	gold, Green Submitted, Green Published			2022-12-27	WOS:000310135800068
J	Mapanga, RF; Rajamani, U; Dlamini, N; Zungu-Edmondson, M; Kelly-Laubscher, R; Shafiullah, M; Wahab, A; Hasan, MY; Fahim, MA; Rondeau, P; Bourdon, E; Essop, MF				Mapanga, Rudo F.; Rajamani, Uthra; Dlamini, Nonkululeko; Zungu-Edmondson, Makhosazane; Kelly-Laubscher, Roisin; Shafiullah, Mohammed; Wahab, Athiq; Hasan, Mohamed Y.; Fahim, Mohamed A.; Rondeau, Philippe; Bourdon, Emmanuel; Essop, M. Faadiel			Oleanolic Acid: A Novel Cardioprotective Agent That Blunts Hyperglycemia-Induced Contractile Dysfunction	PLOS ONE			English	Article							NF-KAPPA-B; HEXOSAMINE BIOSYNTHETIC-PATHWAY; ISCHEMIA-REPERFUSION INJURY; ACUTE MYOCARDIAL-INFARCTION; INDUCED DIABETIC-RATS; NITRIC-OXIDE; OXIDATIVE STRESS; IN-VITRO; MITOCHONDRIAL RESPIRATION; CORONARY-ARTERIOGRAPHY	Diabetes constitutes a major health challenge. Since cardiovascular complications are common in diabetic patients this will further increase the overall burden of disease. Furthermore, stress-induced hyperglycemia in non-diabetic patients with acute myocardial infarction is associated with higher in-hospital mortality. Previous studies implicate oxidative stress, excessive flux through the hexosamine biosynthetic pathway (HBP) and a dysfunctional ubiquitin-proteasome system (UPS) as potential mediators of this process. Since oleanolic acid (OA; a clove extract) possesses antioxidant properties, we hypothesized that it attenuates acute and chronic hyperglycemia-mediated pathophysiologic molecular events (oxidative stress, apoptosis, HBP, UPS) and thereby improves contractile function in response to ischemia-reperfusion. We employed several experimental systems: 1) H9c2 cardiac myoblasts were exposed to 33 mM glucose for 48 hr vs. controls (5 mM glucose); and subsequently treated with two OA doses (20 and 50 mu M) for 6 and 24 hr, respectively; 2) Isolated rat hearts were perfused ex vivo with Krebs-Henseleit buffer containing 33 mM glucose vs. controls (11 mM glucose) for 60 min, followed by 20 min global ischemia and 60 min reperfusion +/- OA treatment; 3) In vivo coronary ligations were performed on streptozotocin treated rats +/- OA administration during reperfusion; and 4) Effects of long-term OA treatment (2 weeks) on heart function was assessed in streptozotocin-treated rats. Our data demonstrate that OA treatment blunted high glucose-induced oxidative stress and apoptosis in heart cells. OA therapy also resulted in cardioprotection, i.e. for ex vivo and in vivo rat hearts exposed to ischemia-reperfusion under hyperglycemic conditions. In parallel, we found decreased oxidative stress, apoptosis, HBP flux and proteasomal activity following ischemia-reperfusion. Long-term OA treatment also improved heart function in streptozotocin-diabetic rats. These findings are promising since it may eventually result in novel therapeutic interventions to treat acute hyperglycemia (in non-diabetic patients) and diabetic patients with associated cardiovascular complications.	[Mapanga, Rudo F.; Rajamani, Uthra; Essop, M. Faadiel] Univ Stellenbosch, Dept Physiol Sci, CMRG, ZA-7600 Stellenbosch, South Africa; [Dlamini, Nonkululeko; Zungu-Edmondson, Makhosazane] Univ KwaZulu Natal, Sch Med Sci, Discipline Physiol, Durban, South Africa; [Kelly-Laubscher, Roisin] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Observatory, South Africa; [Shafiullah, Mohammed; Wahab, Athiq; Hasan, Mohamed Y.; Fahim, Mohamed A.] United Arab Emirates Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Rondeau, Philippe; Bourdon, Emmanuel] Univ Reunion, GEICO, St Denis De La Reunion, France	Stellenbosch University; University of Kwazulu Natal; University of Cape Town; United Arab Emirates University; University of La Reunion	Essop, MF (corresponding author), Univ Stellenbosch, Dept Physiol Sci, CMRG, ZA-7600 Stellenbosch, South Africa.	mfessop@sun.ac.za	Bourdon, Emmanuel/P-8455-2019; rondeau, philippe/F-6755-2015; rondeau, philippe/Q-1967-2019; Kelly-Laubscher, Roisin F/AAC-6012-2019	rondeau, philippe/0000-0002-4652-1376; Kelly-Laubscher, Roisin F/0000-0002-6379-9943; Bourdon, Emmanuel/0000-0003-3731-150X; Essop, Faadiel/0000-0002-8434-4294	South African National Research Foundation; Stellenbosch University; Ministere de l'Enseignement Superieur et de la Recherche; Universite de La Reunion; Conseil Regional de La Reunion; l'Europe	South African National Research Foundation(National Research Foundation - South Africa); Stellenbosch University; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Universite de La Reunion; Conseil Regional de La Reunion; l'Europe	This work was supported by the South African National Research Foundation and Stellenbosch University (to MFE). Experimental work conducted at Universite de La Reunion was supported by the Ministere de l'Enseignement Superieur et de la Recherche and the Universite de La Reunion and the Conseil Regional de La Reunion and l'Europe (to EB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2002, PHYTOCHEMISTRY, V60, P295, DOI 10.1016/S0031-9422(02)00104-8; Arstall MA, 1999, CIRC RES, V85, P829, DOI 10.1161/01.RES.85.9.829; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Bradshaw D, 2007, SAMJ S AFR MED J, V97, P700; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Cai L, 2002, DIABETES, V51, P1938, DOI 10.2337/diabetes.51.6.1938; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Carvalho G, 2011, J CLIN ENDOCR METAB, V96, P1469, DOI 10.1210/jc.2010-1934; Ceriello A, 2000, METABOLISM, V49, P27, DOI 10.1016/S0026-0495(00)80082-7; Ceriello A, 2002, DIABETES, V51, P1076, DOI 10.2337/diabetes.51.4.1076; Choi CY, 2001, BIOCHEM BIOPH RES CO, V288, P49, DOI 10.1006/bbrc.2001.5727; CROSS HR, 1995, J MOL CELL CARDIOL, V27, P1369, DOI 10.1006/jmcc.1995.0130; D'Amico M, 2001, DIABETOLOGIA, V44, P464, DOI 10.1007/s001250051644; Deuchar GA, 2007, LIFE SCI, V80, P1686, DOI 10.1016/j.lfs.2007.01.040; Du Y, 2006, PLANTA MED, V72, P222, DOI 10.1055/s-2005-916197; Du Y, 2006, MOL CELL BIOCHEM, V288, P135, DOI [10.1007/s11010-006-9129-3, 10.1016/j.molcel.2005.11.014]; EYER KM, 1973, AM HEART J, V86, P428, DOI 10.1016/0002-8703(73)90057-4; Friguet B, 2002, METHOD ENZYMOL, V353, P253; Ge F, 2010, J MED MICROBIOL, V59, P567, DOI 10.1099/jmm.0.014837-0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GOKHROO R, 1989, INT J CARDIOL, V22, P267, DOI 10.1016/0167-5273(89)90078-8; Gurib-Fakim Ameenah, 2006, Molecular Aspects of Medicine, V27, P1, DOI 10.1016/j.mam.2005.07.008; Han SK, 1997, LIPIDS, V32, P769, DOI 10.1007/s11745-997-0098-9; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Hostettmann K, 1995, CHEM PHARM NATURAL P; Howarth F C, 2001, Arch Physiol Biochem, V109, P200, DOI 10.1076/apab.109.3.200.11598; Ichikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008391; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jonassen AK, 2001, CIRC RES, V89, P1191, DOI 10.1161/hh2401.101385; Kaiserova K, 2006, J BIOL CHEM, V281, P15110, DOI 10.1074/jbc.M600837200; Kelly RF, 2010, BASIC RES CARDIOL, V105, P763, DOI 10.1007/s00395-010-0125-0; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Mapanga RF, 2009, RENAL FAILURE, V31, P481, DOI 10.1080/08860220902963558; Marfella R, 2009, CARDIOVASC PATHOL, V18, P332, DOI 10.1016/j.carpath.2008.09.008; Marfella R, 2009, J AM COLL CARDIOL, V53, P1425, DOI 10.1016/j.jacc.2009.01.041; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437; Musabayane CT, 2010, RENAL FAILURE, V32, P832, DOI 10.3109/0886022X.2010.494802; OSWALD GA, 1986, BMJ-BRIT MED J, V293, P917, DOI 10.1136/bmj.293.6552.917; Powell SR, 2008, J MOL CELL CARDIOL, V44, P618, DOI 10.1016/j.yjmcc.2007.12.009; Pye J, 2003, AM J PHYSIOL-HEART C, V284, pH919, DOI 10.1152/ajpheart.00851.2002; Rajamani U, 2011, ACTA PHYSIOL, V202, P151, DOI 10.1111/j.1748-1716.2011.02275.x; Rajamani U, 2010, AM J PHYSIOL-CELL PH, V299, pC139, DOI 10.1152/ajpcell.00020.2010; Requena JR, 2003, AMINO ACIDS, V25, P221, DOI 10.1007/s00726-003-0012-1; Rong ZT, 2011, PHARM BIOL, V49, P78, DOI 10.3109/13880209.2010.499130; Sack MN, 2003, J AM COLL CARDIOL, V41, P1404, DOI 10.1016/S0735-1097(03)00164-5; Senthil S, 2007, TOXICOL PATHOL, V35, P418, DOI 10.1080/01926230701230312; Somova LI, 2003, J ETHNOPHARMACOL, V84, P299, DOI 10.1016/S0378-8741(02)00332-X; Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Tang WH, 2010, AM J PHYSIOL-CELL PH, V299, pC643, DOI 10.1152/ajpcell.00137.2010; Van den Berghe G, 2011, J CLIN ENDOCR METAB, V96, P1272, DOI 10.1210/jc.2011-0683; WALKER WJ, 1973, NEW ENGL J MED, V288, P826, DOI 10.1056/NEJM197304192881607; Wang X, 2011, PHYTOTHER RES, V25, P1031, DOI 10.1002/ptr.3385; Wang X, 2010, CHEM-BIOL INTERACT, V184, P328, DOI 10.1016/j.cbi.2010.01.034; Wang XJ, 2011, AM J PHYSIOL-HEART C, V301, pH2207, DOI 10.1152/ajpheart.00714.2011; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xie YW, 1996, CIRCULATION, V94, P2580, DOI 10.1161/01.CIR.94.10.2580; Yu XC, 2010, CARDIOVASC RES, V85, P312, DOI 10.1093/cvr/cvp309	63	38	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47322	10.1371/journal.pone.0047322	http://dx.doi.org/10.1371/journal.pone.0047322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091615	Green Published, gold			2022-12-27	WOS:000310135800038
J	Slack, C; Foley, A; Partridge, L				Slack, Cathy; Foley, Andrea; Partridge, Linda			Activation of AMPK by the Putative Dietary Restriction Mimetic Metformin Is Insufficient to Extend Lifespan in Drosophila	PLOS ONE			English	Article							HER-2/NEU TRANSGENIC MICE; FEMALE SHR MICE; CALORIC RESTRICTION; PROTEIN-KINASE; C-ELEGANS; SKELETAL-MUSCLE; MAMMARY-TUMORS; PATHWAYS; HUMANS; IDENTIFICATION	The biguanide drug, metformin, commonly used to treat type-2 diabetes, has been shown to extend lifespan and reduce fecundity in C. elegans through a dietary restriction-like mechanism via the AMP-activated protein kinase (AMPK) and the AMPK-activating kinase, LKB1. We have investigated whether the longevity-promoting effects of metformin are evolutionarily conserved using the fruit fly, Drosophila melanogaster. We show here that while feeding metformin to adult Drosophila resulted in a robust activation of AMPK and reduced lipid stores, it did not increase lifespan in either male or female flies. In fact, we found that when administered at high concentrations, metformin is toxic to flies. Furthermore, no decreases in female fecundity were observed except at the most toxic dose. Analysis of intestinal physiology after metformin treatment suggests that these deleterious effects may result from disruptions to intestinal fluid homeostasis. Thus, metformin appears to have evolutionarily conserved effects on metabolism but not on fecundity or lifespan.	[Slack, Cathy; Foley, Andrea; Partridge, Linda] UCL, Dept Genet Evolut & Environm, Inst Hlth Ageing, London, England; [Partridge, Linda] ZMMK Forshungsgebaude, Max Planck Inst Biol Ageing, Cologne, Germany	University of London; University College London; Max Planck Society	Partridge, L (corresponding author), UCL, Dept Genet Evolut & Environm, Inst Hlth Ageing, London, England.	l.partridge@ucl.ac.uk	Partridge, Linda/E-7342-2015; Partridge, Linda/A-5501-2010	Slack, Cathy/0000-0002-7949-4079; Partridge, Linda/0000-0001-9615-0094	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Anisimov VN, 2011, AGING-US, V3, P148, DOI 10.18632/aging.100273; Anisimov VN, 2010, AGING-US, V2, P945, DOI 10.18632/aging.100245; Anisimov VN, 2010, CELL CYCLE, V9, P188, DOI 10.4161/cc.9.1.10407; Anisimov VN, 2005, B EXP BIOL MED+, V139, P721, DOI 10.1007/s10517-005-0389-9; Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Bhalla K, 2012, CANCER PREV RES, V5, P544, DOI 10.1158/1940-6207.CAPR-11-0228; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Collier CA, 2006, AM J PHYSIOL-ENDOC M, V291, pE182, DOI 10.1152/ajpendo.00272.2005; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cusi K, 1996, J CLIN ENDOCR METAB, V81, P4059, DOI 10.1210/jc.81.11.4059; Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005; Dirkswager E., 2002, TEACHERS OWNERS KEY; Drenos F, 2005, MECH AGEING DEV, V126, P99, DOI 10.1016/j.mad.2004.09.026; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Funakoshi M, 2011, BIOCHEM BIOPH RES CO, V405, P667, DOI 10.1016/j.bbrc.2011.01.090; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Holloszy JO, 2007, EXP GERONTOL, V42, P709, DOI 10.1016/j.exger.2007.03.009; Jafari M, 2007, BIOGERONTOLOGY, V8, P639, DOI 10.1007/s10522-007-9105-7; Johnson EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012799; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Klachko D, 2011, CARDIORENAL MED, V1, P87, DOI 10.1159/000327151; KLIP A, 1990, DIABETES CARE, V13, P696, DOI 10.2337/diacare.13.6.696; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Redman LM, 2008, PHYSIOL BEHAV, V94, P643, DOI 10.1016/j.physbeh.2008.04.017; Ruiter R, 2012, DIABETES CARE, V35, P119, DOI 10.2337/dc11-0857; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Smith DL, 2010, J GERONTOL A-BIOL, V65, P468, DOI 10.1093/gerona/glq033; Spindler SR, 2012, AGE, V34, P111, DOI 10.1007/s11357-011-9224-6; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; vanHerrewege J, 1997, ECOSCIENCE, V4, P151, DOI 10.1080/11956860.1997.11682389; VERMA S, 1994, AM J PHYSIOL-HEART C, V267, pH1250, DOI 10.1152/ajpheart.1994.267.4.H1250; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	49	125	128	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47699	10.1371/journal.pone.0047699	http://dx.doi.org/10.1371/journal.pone.0047699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077661	gold, Green Published, Green Accepted			2022-12-27	WOS:000310135800065
J	Wong, EB; Omar, T; Setlhako, GJ; Osih, R; Feldman, C; Murdoch, DM; Martinson, NA; Bangsberg, DR; Venter, WDF				Wong, Emily B.; Omar, Tanvier; Setlhako, Gosetsemang J.; Osih, Regina; Feldman, Charles; Murdoch, David M.; Martinson, Neil A.; Bangsberg, David R.; Venter, W. D. F.			Causes of Death on Antiretroviral Therapy: A Post-Mortem Study from South Africa	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; HIV-POSITIVE PATIENTS; SUB-SAHARAN AFRICA; EARLY MORTALITY; AUTOPSY; TUBERCULOSIS; DISEASE; ADULTS; PATHOLOGY; COHORT	Background: Mortality in the first months of antiretroviral therapy (ART) is a significant clinical problem in sub-Saharan Africa. To date, no post-mortem study has investigated the causes of mortality in these patients. Methods: HIV-positive adults who died as in-patients at a Johannesburg academic hospital underwent chart-review and ultrasound-guided needle autopsy for histological and microbiological examination of lung, liver, spleen, kidney, bone marrow, lymph node, skin and cerebrospinal fluid. A clinico-pathologic committee considered all available data and adjudicated immediate and contributing causes of death. Results: Thirty-nine adults were enrolled: 1 14 pre-ART, 15 early-ART (7-90 days), and 10 late-ART (>90 days). Needle sampling yielded adequate specimen in 100% of kidney, skin, heart and cerebrospinal fluid samples, 97% of livers and lungs, 92% of bone marrows, 87% of spleens and 68% of lymph nodes. Mycobacterial infections were implicated in 69% of deaths (26 of 27 of these due to M. tuberculosis), bacterial infections in 33%, fungal infections in 21%, neoplasm in 26%, and non-infectious organ failure in 26%. Immune reconstitution inflammatory syndrome (IRIS) was implicated in 73% of early-ART deaths. Post-mortem investigations revealed previously undiagnosed causes of death in 49% of cases. Multiple pathologies were common with 62% of subjects with mycobacterial infection also having at least one other infectious or neoplastic cause of death. Conclusions: Needle biopsy was efficient and yielded excellent pathology. The large majority of deaths in all three groups were caused by M. tuberculosis suggesting an urgent need for improved diagnosis and expedited treatment prior to and throughout the course of antiretroviral therapy. Complex, unrecognized co-morbidities pose an additional challenge.	[Wong, Emily B.; Setlhako, Gosetsemang J.; Osih, Regina; Venter, W. D. F.] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Wong, Emily B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Wong, Emily B.] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Omar, Tanvier] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Setlhako, Gosetsemang J.; Feldman, Charles] Univ Witwatersrand, Charlotte Maxeke Johannesburg Acad Hosp, Dept Internal Med, Johannesburg, South Africa; [Murdoch, David M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Martinson, Neil A.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Bangsberg, David R.] Harvard Univ, Sch Med, Ragon Inst MGH MIT & Harvard, Massachusetts Gen Hosp,Ctr Global Hlth, Boston, MA 02115 USA	University of Witwatersrand; Harvard University; Massachusetts General Hospital; University of Kwazulu Natal; University of Witwatersrand; University of Witwatersrand; Duke University; University of Witwatersrand; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Wong, EB (corresponding author), Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa.	emily.wong@k-rith.org	Feldman, Charles/ABF-3315-2020	Feldman, Charles/0000-0002-6881-8314; Venter, Willem/0000-0002-4157-732X	Fogarty International Center at the National Institutes of Health [R24TW007988, RTW007373/0, D43TW000010-21S1]; President's Emergency Plan for AIDS Relief [674-A-00-08-00005-00]; National Research Foundation of South Africa; FOGARTY INTERNATIONAL CENTER [K01TW008005, U2RTW007373, D43TW000010, R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, T32AI007387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227] Funding Source: NIH RePORTER	Fogarty International Center at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Research Foundation of South Africa(National Research Foundation - South Africa); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Fogarty International Center at the National Institutes of Health (www.fic.nih.gov, R24TW007988 supported and provided research training to E. B. W. and G.J.S.; RTW007373/0 supported N.M. and provided research training to W. D. F. V.; and D43TW000010-21S1 provided research training to T.O.), the President's Emergency Plan for AIDS Relief (www.pepfar.gov, 674-A-00-08-00005-00 supported R.O., G.J.S, W. D. F. V.), and the National Research Foundation of South Africa (www.nrf.ac.za, supported C. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; BAUMGART KW, 1994, PATHOLOGY, V26, P141, DOI 10.1080/00313029400169381; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Chakraborty R, 2002, ANN TROP PAEDIATR, V22, P125, DOI 10.1179/027249302125000841; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Cox JA, 2010, AIDS REV, V12, P183; Cury PM, 2003, PATHOL RES PRACT, V199, P811, DOI 10.1078/0344-0338-00500; de Cherif TKS, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-205; Domoua K, 1995, Med Trop (Mars), V55, P252; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Gous N, 2012, J CLIN MICROBIOL, V50, P2100, DOI 10.1128/JCM.00252-12; GREENBERG AE, 1995, AIDS, V9, P1251, DOI 10.1097/00002030-199511000-00006; Guerra I, 2001, PATHOL RES PRACT, V197, P165, DOI 10.1078/0344-0338-00028; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Hanzlick R, 1996, ARCH INTERN MED, V156, P25, DOI 10.1001/archinte.156.1.25; Huston BM, 1996, MODERN PATHOL, V9, P1101; Karstaedt A, 2009, CAUSES DEATH PATIENT; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; Lanjewar DN, 2011, PATHOLOG RES INT, V2011; Lawn SD, 2005, AIDS, V19, P2050, DOI 10.1097/01.aids.0000191232.16111.f9; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2008, CURR OPIN HIV AIDS, V3, P425, DOI 10.1097/COH.0b013e3282fe99dc; Lawn SD, 2009, AIDS, V23, P143, DOI 10.1097/QAD.0b013e32831d2a98; Leng K, 2008, INT J STD AIDS, V19, P642, DOI 10.1258/ijsa.2008.008062; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Lucas S, 2012, CURR OPIN INFECT DIS, V25, P36, DOI 10.1097/QCO.0b013e32834ef5c4; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Makadzange AT, 2010, CLIN INFECT DIS, V50, P1532, DOI 10.1086/652652; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Meintjes G, 2009, CLIN INFECT DIS, V48, P667, DOI 10.1086/596764; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; MOHAR A, 1992, AIDS, V6, P467, DOI 10.1097/00002030-199205000-00005; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Murray J, 2007, AIDS, V21, pS97, DOI 10.1097/01.aids.0000299416.61808.24; Nojilana B, 2009, SAMJ S AFR MED J, V99, P648; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Satyanarayana S, 2003, Indian J Pathol Microbiol, V46, P416; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Soeiro AD, 2008, CLINICS, V63, P497, DOI 10.1590/S1807-59322008000400014; Wester CW, 2007, JAIDS-J ACQ IMM DEF, V46, P318, DOI 10.1097/QAI.0b013e3181568e3f	42	104	105	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47542	10.1371/journal.pone.0047542	http://dx.doi.org/10.1371/journal.pone.0047542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23094059	gold, Green Published			2022-12-27	WOS:000310135800054
J	Eckers, E; Deponte, M				Eckers, Elisabeth; Deponte, Marcel			No Need for Labels: The Autofluorescence of Leishmania tarentolae Mitochondria and the Necessity of Negative Controls	PLOS ONE			English	Article							FLUORESCENCE; LIGHT	Background: Fluorescence microscopy is a powerful tool to study the morphology and function of subcellular compartments or to determine the localization of proteins. The method is also regularly used for the analysis of parasitic protists including kinetoplastida. Results: Here, we report a significant autofluorescence of Leishmania tarentolae mitochondria. The autofluorescence, presumably caused by flavoproteins, was detectable using a variety of cell fixation protocols and had a maximum emission at approximately 538 nm. Stable signals were obtained with xenon lamps as a light source and filter sets that are commonly used for the detection of green fluorescent protein. Conclusions: On the one hand, we present a methodological approach to examine mitochondrial morphology or to study the colocalization of mitochondrial proteins without additional staining or labeling procedures. On the other hand, under certain experimental conditions, mitochondrial autofluorescence can result in false positive signals, demonstrating the necessity to analyze unlabeled cells as negative controls.	[Eckers, Elisabeth; Deponte, Marcel] Heidelberg Univ, Dept Parasitol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Deponte, M (corresponding author), Heidelberg Univ, Dept Parasitol, Heidelberg, Germany.	marcel.deponte@gmx.de		Deponte, Marcel/0000-0003-2141-917X	Deutsche Forschungsgemeinschaft [DE 1431/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (grant DE 1431/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 1998, J MICROSC-OXFORD, V191, P1; AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; BENSON RC, 1979, J HISTOCHEM CYTOCHEM, V27, P44, DOI 10.1177/27.1.438504; Chorvat D, 2004, LASER PHYS, V14, P220; Davis RW, 2010, MICROSC MICROANAL, V16, P478, DOI 10.1017/S1431927610000322; Deponte M, 2008, BBA-MOL CELL RES, V1783, P1396, DOI 10.1016/j.bbamcr.2008.01.018; Deponte M, 2012, CELL MOL LIFE SCI, V69, P1025, DOI 10.1007/s00018-012-0932-6; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Eckers E, 2012, BIOL CHEM, V393, P513, DOI 10.1515/hsz-2011-0255; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; KUNZ WS, 1986, FEBS LETT, V195, P92, DOI 10.1016/0014-5793(86)80137-5; KUNZ WS, 1985, BIOCHIM BIOPHYS ACTA, V841, P237, DOI 10.1016/0304-4165(85)90064-9; Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Romashko DN, 1998, P NATL ACAD SCI USA, V95, P1618, DOI 10.1073/pnas.95.4.1618; Simpson L, 1996, Methods Enzymol, V264, P99, DOI 10.1016/S0076-6879(96)64012-9; Simpson L, 1997, MOL BIOCHEM PARASIT, V87, P71, DOI 10.1016/S0166-6851(97)00044-3; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200	21	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47641	10.1371/journal.pone.0047641	http://dx.doi.org/10.1371/journal.pone.0047641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077654	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100148
J	Gatfield, J; Grandjean, CM; Sasse, T; Clozel, M; Nayler, O				Gatfield, John; Grandjean, Celia Mueller; Sasse, Thomas; Clozel, Martine; Nayler, Oliver			Slow Receptor Dissociation Kinetics Differentiate Macitentan from Other Endothelin Receptor Antagonists in Pulmonary Arterial Smooth Muscle Cells	PLOS ONE			English	Article							SHEAR-STRESS; HYPERTENSION; CALCIUM; MECHANISMS; EXPRESSION; GENE; PROLIFERATION; DEGRADATION; PATHWAYS; CA2+	Two endothelin receptor antagonists (ERAs), bosentan and ambrisentan, are currently approved for the treatment of pulmonary arterial hypertension (PAH), a devastating disease involving an activated endothelin system and aberrant contraction and proliferation of pulmonary arterial smooth muscle cells (PASMC). The novel ERA macitentan has recently concluded testing in a Phase III morbidity/mortality clinical trial in PAH patients. Since the association and dissociation rates of G protein-coupled receptor antagonists can influence their pharmacological activity in vivo, we used human PASMC to characterize inhibitory potency and receptor inhibition kinetics of macitentan, ambrisentan and bosentan using calcium release and inositol-1-phosphate (IP1) assays. In calcium release assays macitentan, ambrisentan and bosentan were highly potent ERAs with K-b values of 0.14 nM, 0.12 nM and 1.1 nM, respectively. Macitentan, but not ambrisentan and bosentan, displayed slow apparent receptor association kinetics as evidenced by increased antagonistic potency upon prolongation of antagonist pre-incubation times. In compound washout experiments, macitentan displayed a significantly lower receptor dissociation rate and longer receptor occupancy half-life (ROt(1/2)) compared to bosentan and ambrisentan (ROt(1/2): 17 minutes versus 70 seconds and 40 seconds, respectively). Because of its lower dissociation rate macitentan behaved as an insurmountable antagonist in calcium release and IP1 assays, and unlike bosentan and ambrisentan it blocked endothelin receptor activation across a wide range of endothelin-1 (ET-1) concentrations. However, prolongation of the ET-1 stimulation time beyond ROt(1/2) rendered macitentan a surmountable antagonist, revealing its competitive binding mode. Bosentan and ambrisentan behaved as surmountable antagonists irrespective of the assay duration and they lacked inhibitory activity at high ET-1 concentrations. Thus, macitentan is a competitive ERA with significantly slower receptor dissociation kinetics than the currently approved ERAs. Slow dissociation caused insurmountable antagonism in functional PASMC-based assays and this could contribute to an enhanced pharmacological activity of macitentan in ET-1-dependent pathologies.	[Gatfield, John; Grandjean, Celia Mueller; Sasse, Thomas; Clozel, Martine; Nayler, Oliver] Actel Pharmaceut Ltd, Allschwil, Switzerland	Actelion Pharmaceuticals Ltd	Gatfield, J (corresponding author), Actel Pharmaceut Ltd, Allschwil, Switzerland.	john.gatfield@actelion.com						Anthes JC, 2002, EUR J PHARMACOL, V449, P229, DOI 10.1016/S0014-2999(02)02049-6; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; BATTISTINI B, 1995, BIOCHEM BIOPH RES CO, V207, P675, DOI 10.1006/bbrc.1995.1240; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; Casarosa P, 2011, J PHARMACOL EXP THER, V337, P600, DOI 10.1124/jpet.111.179259; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Davie N, 2002, AM J RESP CRIT CARE, V165, P398, DOI 10.1164/ajrccm.165.3.2104059; De Mey JGR, 2011, TRENDS PHARMACOL SCI, V32, P345, DOI 10.1016/j.tips.2011.02.018; DICKINSON KEJ, 1991, BIOCHEM BIOPH RES CO, V176, P423, DOI 10.1016/0006-291X(91)90941-Y; EDANO T, 1994, BIOL PHARM BULL, V17, P379; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Golovina VA, 2001, AM J PHYSIOL-HEART C, V280, pH746, DOI 10.1152/ajpheart.2001.280.2.H746; Gradman AH, 2002, J HUM HYPERTENS, V16, pS9, DOI 10.1038/sj.jhh.1001434; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Haynes WG, 1998, J HYPERTENS, V16, P1081, DOI 10.1097/00004872-199816080-00001; Herbert Jean-Marc, 2003, Semin Vasc Med, V3, P113; HOSODA K, 1991, FEBS LETT, V287, P23, DOI 10.1016/0014-5793(91)80007-P; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Iglarz M, 2008, J PHARMACOL EXP THER, V327, P736, DOI 10.1124/jpet.108.142976; Iglarz M, 2007, J CARDIOVASC PHARM, V50, P621, DOI 10.1097/FJC.0b013e31813c6cc3; JANAKIDEVI K, 1992, AM J PHYSIOL, V263, pC1295, DOI 10.1152/ajpcell.1992.263.6.C1295; KANSE SM, 1991, EUR J PHARMACOL, V199, P99, DOI 10.1016/0014-2999(91)90641-3; Kenakin T, 2006, J PHARMACOL EXP THER, V319, P710, DOI 10.1124/jpet.106.107375; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; Kuhr FK, 2012, AM J PHYSIOL-HEART C, V302, pH1546, DOI 10.1152/ajpheart.00944.2011; Le MT, 2007, BRIT J PHARMACOL, V151, P952, DOI 10.1038/sj.bjp.0707323; Leask A, 2011, PHARMACOL RES, V63, P502, DOI 10.1016/j.phrs.2011.01.011; MALEK AM, 1993, P NATL ACAD SCI USA, V90, P5999, DOI 10.1073/pnas.90.13.5999; Malek AM, 1999, J MOL CELL CARDIOL, V31, P387, DOI 10.1006/jmcc.1998.0873; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; OGAWA Y, 1991, BIOCHEM BIOPH RES CO, V178, P248, DOI 10.1016/0006-291X(91)91806-N; PEREZVIZCAINO F, 1995, BRIT J PHARMACOL, V114, P867, DOI 10.1111/j.1476-5381.1995.tb13284.x; Platoshyn O, 2000, AM J PHYSIOL-CELL PH, V279, pC1540, DOI 10.1152/ajpcell.2000.279.5.C1540; POLLOCK DM, 1995, FASEB J, V9, P1196, DOI 10.1096/fasebj.9.12.7672512; Price LC, 2008, AM J CARDIOVASC DRUG, V8, P171, DOI 10.2165/00129784-200808030-00004; Rodriguez-Pascual F, 2004, J CARDIOVASC PHARM, V44, pS39, DOI 10.1097/01.fjc.0000166216.27544.22; Russell FD, 1999, BRIT J PHARMACOL, V126, P391, DOI 10.1038/sj.bjp.0702315; Russell FD, 1998, J CARDIOVASC PHARM, V31, P424, DOI 10.1097/00005344-199803000-00014; Salani D, 2000, AM J PATHOL, V157, P1703, DOI 10.1016/S0002-9440(10)64807-9; Schiffrin EL, 1998, J CARDIOVASC PHARM, V32, pS2; Schroeder AC, 2000, HYPERTENSION, V35, P280, DOI 10.1161/01.HYP.35.1.280; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Shimoda LA, 2000, AM J PHYSIOL-LUNG C, V278, pL157, DOI 10.1152/ajplung.2000.278.1.L157; Swinney DC, 2006, CURR TOP MED CHEM, V6, P461, DOI 10.2174/156802606776743093; Tajsic T, 2011, COMPR PHYSIOL, V1, P295, DOI 10.1002/cphy.c100026; Tuder RM, 2001, CLIN CHEST MED, V22, P405, DOI 10.1016/S0272-5231(05)70280-X; Vauquelin G, 2010, BRIT J PHARMACOL, V161, P488, DOI 10.1111/j.1476-5381.2010.00936.x; WAGNER OF, 1992, J BIOL CHEM, V267, P16066; Woods M, 1999, MOL PHARMACOL, V55, P902; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yuan JXJ, 1998, CIRCULATION, V98, P1400, DOI 10.1161/01.CIR.98.14.1400	53	127	136	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47662	10.1371/journal.pone.0047662	http://dx.doi.org/10.1371/journal.pone.0047662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077657	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100150
J	Hou, J; Liu, Y; Liu, Y; Shao, YM				Hou, Jue; Liu, Yong; Liu, Ying; Shao, Yiming			The MSHA Strain of Pseudomonas Aeruginosa Activated TLR Pathway and Enhanced HIV-1 DNA Vaccine Immunoreactivity	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-5; BACTERIAL FLAGELLIN; DENDRITIC CELLS; AVIDITY MATURATION; IMMUNE-RESPONSES; CPG MOTIFS; ADJUVANT; ENVELOPE; ANTIGEN; MICE	The mannose-sensitive hemagglutination pilus strain of Pseudomonas aeruginosa (PA-MSHA) has been shown to trigger naive immune responses through the activation of monocytes, macrophages, natural killer cells (NK cells) and antigen presenting cells (APCs). Based on the hypothesis that PA-MSHA activates natural immunity through the Toll-like receptor (TLR) pathway, we scanned several critical TLR pathway molecules in mouse splenocytes using high-throughput real-time QRT-PCR and co-stimulatory molecule in bone marrow-derived dendritic cells (BMDCs) following in vitro stimulation by PA-MSHA. PA-MSHA enabled activation of the TLR pathway mediated by NF-kappa B and JNK signaling in splenocytes, and the costimulatory molecule CD86 was up-regulated in BMDCs. We then assessed the adjuvant effect of PA-MSHA for HIV-1 DNA vaccines. In comparison to DNA inoculation alone, co-inoculation with low dosage of PA-MSHA enhanced specific immunoreactivity against HIV-1 Env in both cellular and humoral responses, and promoted antibody avidity maturation. However, high doses of adjuvant resulted in an immunosuppressive effect; a two-or three-inoculation regimen yielded low antibody responses and the two-inoculation regimen exhibited only a slight cellular immunity response. To our knowledge, this is the first report demonstrating the utility of PA-MSHA as an adjuvant to a DNA vaccine. Further research is needed to investigate the exact mechanisms through which PA-MSHA achieves its adjuvant effects on innate immune responses, especially on dendritic cells.	[Hou, Jue; Liu, Yong; Liu, Ying; Shao, Yiming] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	yshao08@gmail.com	Hou, Jue/S-8184-2017	Hou, Jue/0000-0001-9913-8365	National Major projects for Infectious Diseases Control and Prevention [2012ZX10001008]; National Natural Science Foundation of China [81020108030]; State Key Laboratory for Infectious Disease Prevention and Control (SKLID) [2008SKLID101]; Ministry of Science and Technology of China [2009DFB30420]	National Major projects for Infectious Diseases Control and Prevention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Infectious Disease Prevention and Control (SKLID); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	National Major projects for Infectious Diseases Control and Prevention (2012ZX10001008) http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohkjjys/s8543/index.htm; National Natural Science Foundation of China (81020108030) http://159.226.244.22/portal/proj_search.asp; State Key Laboratory for Infectious Disease Prevention and Control (SKLID) Development grant (2008SKLID101); International Cooperative Grant from the Ministry of Science and Technology of China (2009DFB30420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge JR, 2000, VACCINE, V18, P2416, DOI 10.1016/S0264-410X(99)00572-1; Bates JT, 2008, MECH AGEING DEV, V129, P271, DOI 10.1016/j.mad.2008.01.009; Bower JF, 2005, CURR HIV RES, V3, P191, DOI 10.2174/1570162053506937; Braga CJM, 2010, VACCINE, V28, P1373, DOI 10.1016/j.vaccine.2009.11.003; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Davis HL, 1998, J IMMUNOL, V160, P870; Deml L, 1999, CLIN CHEM LAB MED, V37, P199, DOI 10.1515/CCLM.1999.037; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Evans TG, 2001, VACCINE, V19, P2080, DOI 10.1016/S0264-410X(00)00415-1; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hertz CJ, 2001, J IMMUNOL, V166, P2444, DOI 10.4049/jimmunol.166.4.2444; Inaba Kayo, 2009, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0307s86; Jorgensen JB, 2003, J VIROL, V77, P11471, DOI 10.1128/JVI.77.21.11471-11479.2003; Klinman DM, 1999, VACCINE, V17, P19, DOI 10.1016/S0264-410X(98)00151-0; Kruisbeek Ada M, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0314s24; Letran SE, 2011, EUR J IMMUNOL, V41, P29, DOI 10.1002/eji.201040717; Liu ZB, 2010, ONCOGENE, V29, P2996, DOI 10.1038/onc.2010.70; Liu ZB, 2009, J CELL BIOCHEM, V108, P195, DOI 10.1002/jcb.22241; MATHE G, 1977, BIOMED EXPRESS, V27, P368; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Montgomery CP, 2009, INFECT IMMUN, V77, P2159, DOI 10.1128/IAI.00021-09; Reeves J P, 2001, Curr Protoc Immunol, VChapter 1, DOI 10.1002/0471142735.im0110s02; Ross TM, 2000, NAT IMMUNOL, V1, P127, DOI 10.1038/77802; Ross TM, 2001, AIDS RES HUM RETROV, V17, P829, DOI 10.1089/088922201750252025; Smith NJ, 2011, J UROLOGY, V186, P1084, DOI 10.1016/j.juro.2011.04.112; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Stacey KJ, 1999, INFECT IMMUN, V67, P3719, DOI 10.1128/IAI.67.8.3719-3726.1999; Tengvall S, 2005, J REPROD IMMUNOL, V68, P53, DOI 10.1016/j.jri.2005.06.010; Tsujimoto H, 2005, J LEUKOCYTE BIOL, V78, P888, DOI 10.1189/jlb.0105051; Vicente-Suarez I, 2009, IMMUNOL LETT, V125, P114, DOI 10.1016/j.imlet.2009.06.007; Wang XJ, 2008, VACCINE, V26, P1893, DOI 10.1016/j.vaccine.2008.01.043; XY M, 1986, J MICROBIOL, V26, P176; Yang SC, 2010, VIRUS RES, V151, P162, DOI 10.1016/j.virusres.2010.04.011	36	15	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47724	10.1371/journal.pone.0047724	http://dx.doi.org/10.1371/journal.pone.0047724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077664	Green Submitted, gold, Green Published			2022-12-27	WOS:000309995100156
J	Li, YQ; Fang, JW				Li, Yunqi; Fang, Jianwen			PROTS-RF: A Robust Model for Predicting Mutation-Induced Protein Stability Changes	PLOS ONE			English	Article							RATIONAL DESIGN; POINT MUTATIONS; RANDOM FOREST; THERMOSTABILITY; SEQUENCE; PERFORMANCE; SELECTION; SOLUBILITY; RESIDUES; ENZYMES	The ability to improve protein thermostability via protein engineering is of great scientific interest and also has significant practical value. In this report we present PROTS-RF, a robust model based on the Random Forest algorithm capable of predicting thermostability changes induced by not only single-, but also double-or multiple-point mutations. The model is built using 41 features including evolutionary information, secondary structure, solvent accessibility and a set of fragment-based features. It achieves accuracies of 0.799,0.782, 0.787, and areas under receiver operating characteristic (ROC) curves of 0.873, 0.868 and 0.862 for single-, double-and multiple-point mutation datasets, respectively. Contrary to previous suggestions, our results clearly demonstrate that a robust predictive model trained for predicting single point mutation induced thermostability changes can be capable of predicting double and multiple point mutations. It also shows high levels of robustness in the tests using hypothetical reverse mutations. We demonstrate that testing datasets created based on physical principles can be highly useful for testing the robustness of predictive models.	[Li, Yunqi; Fang, Jianwen] Univ Kansas, Appl Bioinformat Lab, Lawrence, KS 66045 USA	University of Kansas	Fang, JW (corresponding author), Univ Kansas, Appl Bioinformat Lab, Lawrence, KS 66045 USA.	jwfang@ku.edu						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Chan CH, 2004, PROTEINS, V57, P684, DOI 10.1002/prot.20263; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Dahiyat BI, 1999, CURR OPIN BIOTECH, V10, P387, DOI 10.1016/S0958-1669(99)80070-6; England JL, 2003, P NATL ACAD SCI USA, V100, P8727, DOI 10.1073/pnas.1530713100; Fang Jianwen, 2008, Journal of Bioinformatics and Computational Biology, V6, P223, DOI 10.1142/S0219720008003345; Fang Jianwen, 2009, BMC Chemical Biology, V9, P5, DOI 10.1186/1472-6769-9-5; Frenz CM, 2005, PROTEINS, V59, P147, DOI 10.1002/prot.20400; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Galzitskaya OV, 2008, PROTEINS, V70, P329, DOI 10.1002/prot.21619; Glyakina AV, 2007, BIOINFORMATICS, V23, P2231, DOI 10.1093/bioinformatics/btm345; Glyakina AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028464; Gromiha MM, 1999, BIOPHYS CHEM, V82, P51, DOI 10.1016/S0301-4622(99)00103-9; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hand DJ, 2009, MACH LEARN, V77, P103, DOI 10.1007/s10994-009-5119-5; Hirano S, 2005, PROTEINS, V58, P271, DOI 10.1002/prot.20333; Huang LT, 2009, BIOINFORMATICS, V25, P2181, DOI 10.1093/bioinformatics/btp370; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Lazar GA, 2003, CURR OPIN STRUC BIOL, V13, P513, DOI 10.1016/S0959-440X(03)00104-0; Li YQ, 2012, PROTEINS, V80, P81, DOI 10.1002/prot.23163; Li YQ, 2011, BIOINFORMATICS, V27, P3379, DOI 10.1093/bioinformatics/btr579; Li YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-62; Lippow SM, 2007, CURR OPIN BIOTECH, V18, P305, DOI 10.1016/j.copbio.2007.04.009; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Masso M, 2008, BIOINFORMATICS, V24, P2002, DOI 10.1093/bioinformatics/btn353; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Montanucci L, 2008, BIOINFORMATICS, V24, pI190, DOI 10.1093/bioinformatics/btn166; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Sanchez IE, 2006, J MOL BIOL, V363, P422, DOI 10.1016/j.jmb.2006.08.020; Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237; Schweiker Katrina L., 2009, V490, P261, DOI 10.1007/978-1-59745-367-7_11; Schweiker KL, 2009, METHOD ENZYMOL, V454, P175, DOI 10.1016/S0076-6879(08)03807-X; Shakhnovich BE, 2005, GENOME RES, V15, P385, DOI 10.1101/gr.3133605; Sikic M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000278; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Unsworth LD, 2007, FEBS J, V274, P4044, DOI 10.1111/j.1742-4658.2007.05954.x; Wang L, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-220, 10.1186/1471-2164-10-S1-S1]; Wu LC, 2009, EXPERT SYST APPL, V36, P9007, DOI 10.1016/j.eswa.2008.12.020; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	52	34	37	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47247	10.1371/journal.pone.0047247	http://dx.doi.org/10.1371/journal.pone.0047247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077576	gold, Green Published, Green Submitted			2022-12-27	WOS:000309995100080
J	Schneider, JC; Trinh, NHT; Selleck, E; Fregni, F; Salles, SS; Ryan, CM; Stein, J				Schneider, Jeffrey C.; Trinh, Nhi-Ha T.; Selleck, Elizabeth; Fregni, Felipe; Salles, Sara S.; Ryan, Colleen M.; Stein, Joel			The Long-Term Impact of Physical and Emotional Trauma: The Station Nightclub Fire	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HEALTH-STATUS; EVENT SCALE; VERSION; WORK; AFGHANISTAN; POPULATION; PREVALENCE; PREDICTORS; DEPRESSION	Background: Survivors of physical and emotional trauma experience enduring occupational, psychological and quality of life impairments. Examining survivors from a large fire provides a unique opportunity to distinguish the impact of physical and emotional trauma on long-term outcomes. The objective is to detail the multi-dimensional long-term effects of a large fire on its survivor population and assess differences in outcomes between survivors with and without physical injury. Methods and Findings: This is a survey-based cross-sectional study of survivors of The Station fire on February 20, 2003. The relationships between functional outcomes and physical injury were evaluated with multivariate regression models adjusted for pre-injury characteristics and post-injury outcomes. Outcome measures include quality of life (Burn Specific Health Scale-Brief), employment (time off work), post-traumatic stress symptoms (Impact of Event Scale-Revised) and depression symptoms (Beck Depression Inventory). 104 fire survivors completed the survey; 47% experienced a burn injury. There was a 42% to 72% response rate range. Although depression and quality of life were associated with burn injury in univariate analyses (p<0.05), adjusted analyses showed no significant relationship between burn injury and these outcomes (p = 0.91; p = .51). Post-traumatic stress symptoms were not associated with burn injury in the univariate (p = 0.13) or adjusted analyses (p = 0.79). Time off work was the only outcome in which physical injury remained significant in the multivariate analysis (p = 0.03). Conclusions: Survivors of this large fire experienced significant life disruption, including occupational, psychological and quality of life sequelae. The findings suggest that quality of life, depression and post-traumatic stress outcomes are related to emotional trauma, not physical injury. However, physical injury is correlated with employment outcomes. The long-term impact of this traumatic event underscores the importance of longitudinal and mental health care for trauma survivors, with attention to those with and without physical injuries.	[Schneider, Jeffrey C.; Fregni, Felipe] Harvard Univ, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Sch Med, Boston, MA 02115 USA; [Trinh, Nhi-Ha T.] Massachusetts Gen Hosp, Dept Psychiat, Depress & Clin Res Program, Boston, MA 02114 USA; [Fregni, Felipe] Harvard Univ, Lab Neuromodulat, Spaulding Rehabil Hosp, Sch Med, Boston, MA USA; [Salles, Sara S.] Univ Kentucky, Dept Phys Med & Rehabil, Lexington, KY USA; [Ryan, Colleen M.] Massachusetts Gen Hosp, Dept Surg, Sumner Redstone Burn Ctr, Boston, MA 02114 USA; [Ryan, Colleen M.] Shriners Hosp Children Boston, Boston, MA USA; [Stein, Joel] New York Presbyterian Hosp, New York, NY USA; [Stein, Joel] Weill Cornell Med Coll, Div Rehabil Med, New York, NY USA; [Stein, Joel] Columbia Univ, Dept Rehabil & Regenerat Med, Med Ctr, New York, NY USA	Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; University of Kentucky; Harvard University; Massachusetts General Hospital; NewYork-Presbyterian Hospital; Cornell University; Columbia University	Schneider, JC (corresponding author), Harvard Univ, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Sch Med, Boston, MA 02115 USA.	jcschneider@partners.org	Schneider, Jeffrey/AAO-2126-2020; Trinh, Nhi-Ha/AAH-7836-2019	Stein, Joel/0000-0001-5527-025X; Fregni, Felipe/0000-0001-9359-8643; Ryan, Colleen/0000-0002-6455-936X	International Association of Fire Fighters	International Association of Fire Fighters	This project was supported by a pilot grant from the International Association of Fire Fighters. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, TASK FORC DSM 4 DIAG; [Anonymous], 2003, PROVIDENCE J    1005; [Anonymous], 2009, STAND DEF FIN DISP C; Ayuso-Mateos JL, 1999, ACTA PSYCHIAT SCAND, V99, P26, DOI 10.1111/j.1600-0447.1999.tb05381.x; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bland SH, 1996, PSYCHOSOM MED, V58, P18, DOI 10.1097/00006842-199601000-00004; Brych SB, 2001, J BURN CARE REHABIL, V22, P401, DOI 10.1097/00004630-200111000-00010; Corrigan M., 2009, PUBLIC HLTH S3, V99, P702; Dacey MJ, 2003, NEW ENGL J MED, V349, P1990, DOI 10.1056/NEJMp038179; Esselman PC, 2007, ARCH PHYS MED REHAB, V88, pS50, DOI 10.1016/j.apmr.2007.09.009; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holavanahalli RK, 2010, J BURN CARE RES, V31, P631, DOI 10.1097/BCR.0b013e3181e4ca62; Hyre AD, 2007, AM J KIDNEY DIS, V50, P585, DOI 10.1053/j.ajkd.2007.07.013; Jaycox LH, 2004, PSYCHIAT SERV, V55, P415, DOI 10.1176/appi.ps.55.4.415; Kildal M, 2002, BURNS, V28, P639, DOI 10.1016/S0305-4179(02)00111-0; Kildal M, 2001, J TRAUMA, V51, P740, DOI 10.1097/00005373-200110000-00020; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kvannli L, 2011, BURNS, V37, P54, DOI 10.1016/j.burns.2010.07.010; Lasa L, 2000, J AFFECT DISORDERS, V57, P261, DOI 10.1016/S0165-0327(99)00088-9; Lundin T, 2007, NORD J PSYCHIAT, V61, P479, DOI 10.1080/08039480701773329; Marmar CR, 1999, J NERV MENT DIS, V187, P15, DOI 10.1097/00005053-199901000-00004; McKibben JBA, 2008, J BURN CARE RES, V29, P22, DOI 10.1097/BCR.0b013e31815f59c4; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Parker PE, 2007, PROVIDENCE J; Patterson DR, 2000, J BURN CARE REHABIL, V21, P490, DOI 10.1097/00004630-200021060-00004; Phillips CJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-52; Resnick SG, 2008, J REHABIL RES DEV, V45, P427, DOI 10.1682/JRRD.2007.06.0093; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schneider JC, 2010, DELISAS PHYS MED REH, P1125; Schneider JC, 2009, J BURN CARE RES, V30, P294, DOI 10.1097/BCR.0b013e318198a2c2; Silove D, 2007, SOC PSYCH PSYCH EPID, V42, P467, DOI 10.1007/s00127-007-0194-z; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Szklo M, 1998, EPIDEMIOL REV, V20, P81, DOI 10.1093/oxfordjournals.epirev.a017974; Van Loey NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041532; Van Loon AJM, 2003, ANN EPIDEMIOL, V13, P105, DOI 10.1016/S1047-2797(02)00257-0; Weiss D, 1999, ASSESSING PSYCHOL TR, P399; Wiechman SA, 2001, J BURN CARE REHABIL, V22, P417, DOI 10.1097/00004630-200111000-00012; Wu KK, 2003, SOC PSYCH PSYCH EPID, V38, P94, DOI 10.1007/s00127-003-0611-x; Yzermans CJ, 2003, PUBLIC HLTH EUROPE 1, P317	41	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47339	10.1371/journal.pone.0047339	http://dx.doi.org/10.1371/journal.pone.0047339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022WO	23077593	Green Submitted, gold, Green Published			2022-12-27	WOS:000309995100093
J	Abushahba, W; Olabisi, OO; Jeong, BS; Boregowda, RK; Wen, Y; Liu, F; Goydos, JS; Lasfar, A; Cohen-Solal, KA				Abushahba, Walid; Olabisi, Oyenike O.; Jeong, Byeong-Seon; Boregowda, Rajeev K.; Wen, Yu; Liu, Fang; Goydos, James S.; Lasfar, Ahmed; Cohen-Solal, Karine A.			Non-Canonical Smads Phosphorylation Induced by the Glutamate Release Inhibitor, Riluzole, through GSK3 Activation in Melanoma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GLYCOGEN-SYNTHASE KINASE-3; CYCLIN-DEPENDENT KINASES; TGF-BETA; PLASMINOGEN-ACTIVATOR; ACTIVIN-A; IN-VIVO; MALIGNANT-MELANOMA; LINKER PHOSPHORYLATION; ESOPHAGEAL-CARCINOMA	Riluzole, an inhibitor of glutamate release, has shown the ability to inhibit melanoma cell xenograft growth. A phase 0 clinical trial of riluzole as a single agent in patients with melanoma resulted in involution of tumors associated with inhibition of both the mitogen-activated protein kinase (MAPK) and phophoinositide-3-kinase/AKT (PI3K/AKT) pathways in 34% of patients. In the present study, we demonstrate that riluzole inhibits AKT-mediated glycogen synthase kinase 3 (GSK3) phosphorylation in melanoma cell lines. Because we have demonstrated that GSK3 is involved in the phosphorylation of two downstream effectors of transforming growth factor beta (TGF beta), Smad2 and Smad3, at their linker domain, our aim was to determine whether riluzole could induce GSK3 beta-mediated linker phosphorylation of Smad2 and Smad3. We present evidence that riluzole increases Smad2 and Smad3 linker phosphorylation at the cluster of serines 245/250/255 and serine 204 respectively. Using GSK3 inhibitors and siRNA knock-down, we demonstrate that the mechanism of riluzole-induced Smad phosphorylation involved GSK3 beta. In addition, GSK3 beta could phosphorylate the same linker sites in vitro. The riluzole-induced Smad linker phosphorylation is mechanistically different from the Smad linker phosphorylation induced by TGF beta. We also demonstrate that riluzole-induced Smad linker phosphorylation is independent of the expression of the metabotropic glutamate receptor 1 (GRM1), which is one of the glutamate receptors whose involvement in human melanoma has been documented. We further show that riluzole upregulates the expression of INHBB and PLAU, two genes associated with the TGFb signaling pathway. The non-canonical increase in Smad linker phosphorylation induced by riluzole could contribute to the modulation of the pro-oncogenic functions of Smads in late stage melanomas.	[Abushahba, Walid; Olabisi, Oyenike O.; Boregowda, Rajeev K.; Cohen-Solal, Karine A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Div Med Oncol,Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Jeong, Byeong-Seon; Wen, Yu; Goydos, James S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, Canc Inst New Jersey,Div Surg Oncol, New Brunswick, NJ 08903 USA; [Liu, Fang] Rutgers State Univ, Ctr Adv Biotechnol & Med, Susan Lehman Cullman Lab Canc Res, Ernest Mario Sch Pharm,Dept Chem Biol, Piscataway, NJ 08854 USA; [Lasfar, Ahmed] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Cohen-Solal, KA (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Div Med Oncol,Canc Inst New Jersey, New Brunswick, NJ 08903 USA.	cohenska@umdnj.edu	Goydos, James/AAR-8990-2020	Goydos, James/0000-0001-9811-939X	Research Development Award from the New Jersey Commission on Cancer Research [09-1143-CCR-EO]; Research Development Award from the Cancer Center Support Grant [CCSG P30CA072720]; Research Scholar Grant from the American Cancer Society [116683-RSG-09-087-01-TBE]; National Cancer Institute [1RO1CA149627-01]; Biomedical Science Education Postdoctoral Training Program from the National Institute of Health [K12 GM093854-01]; NATIONAL CANCER INSTITUTE [R01CA149627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093854] Funding Source: NIH RePORTER	Research Development Award from the New Jersey Commission on Cancer Research; Research Development Award from the Cancer Center Support Grant; Research Scholar Grant from the American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biomedical Science Education Postdoctoral Training Program from the National Institute of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Research Development Award from the New Jersey Commission on Cancer Research 09-1143-CCR-EO, a Research Development Award from the Cancer Center Support Grant CCSG P30CA072720, a Research Scholar Grant from the American Cancer Society 116683-RSG-09-087-01-TBE (K.C.S.) and a grant from the National Cancer Institute 1RO1CA149627-01 (J. Goydos). Dr. Olabisi was supported by a Biomedical Science Education Postdoctoral Training Program from the National Institute of Health K12 GM093854-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bellingham MC, 2011, CNS NEUROSCI THER, V17, P4, DOI 10.1111/j.1755-5949.2009.00116.x; Biechele TL, 2010, CHEM BIOL, V17, P1177, DOI 10.1016/j.chembiol.2010.08.012; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Carlson BA, 1996, CANCER RES, V56, P2973; Chen DH, 2009, PIGM CELL MELANOMA R, V22, P761, DOI 10.1111/j.1755-148X.2009.00603.x; Choi KY, 2011, P NATL ACAD SCI USA, V108, P15219, DOI 10.1073/pnas.1107304108; Chu XJ, 2006, J MED CHEM, V49, P6549, DOI 10.1021/jm0606138; Cohen-Solal KA, 2011, PIGM CELL MELANOMA R, V24, P512, DOI 10.1111/j.1755-148X.2011.00858.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DePinto W, 2006, MOL CANCER THER, V5, P2644, DOI 10.1158/1535-7163.MCT-06-0355; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Gutierrez LS, 2000, CANCER RES, V60, P5839; Javelaud D, 2008, PIGM CELL MELANOMA R, V21, P123, DOI 10.1111/j.1755-148X.2008.00450.x; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Khan AJ, 2011, CLIN CANCER RES, V17, P1807, DOI 10.1158/1078-0432.CCR-10-1276; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Lasfar A, 2010, CARCINOGENESIS, V31, P1710, DOI 10.1093/carcin/bgq155; Le MN, 2010, J INVEST DERMATOL, V130, P2240, DOI 10.1038/jid.2010.126; Lee HJ, 2011, CLIN CANCER RES, V17, P7080, DOI 10.1158/1078-0432.CCR-11-0098; Liu F, 2006, CYTOKINE GROWTH F R, V17, P9, DOI 10.1016/j.cytogfr.2005.09.010; Madhunapantula SV, 2009, PIGM CELL MELANOMA R, V22, P400, DOI 10.1111/j.1755-148X.2009.00585.x; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; McDowall A, 2008, CYTOKINE GROWTH F R, V19, P415, DOI [10.1016/j.cytogfr.2009.08.005, 10.1016/j.cytogfr.2008.08.005]; Mehnert JM, 2011, 2011 ANN M ASCO AM S; Millet C, 2009, J BIOL CHEM, V284, P19808, DOI 10.1074/jbc.M109.016667; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Ohtani Y, 2008, ONCOGENE, V27, P7162, DOI 10.1038/onc.2008.329; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Rizzolio F, 2010, CURR DRUG TARGETS, V11, P279, DOI 10.2174/138945010790711978; Satyamoorthy K, 2003, CANCER RES, V63, P756; Sedlacek HH, 2001, CRIT REV ONCOL HEMAT, V38, P139, DOI 10.1016/S1040-8428(00)00124-4; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shapiro RL, 1996, CANCER RES, V56, P3597; Shin SS, 2008, NEUROPHARMACOLOGY, V55, P396, DOI 10.1016/j.neuropharm.2008.04.021; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Stove C, 2004, ONCOGENE, V23, P5330, DOI 10.1038/sj.onc.1207699; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Wildi S, 2001, GUT, V49, P409, DOI 10.1136/gut.49.3.409; Yip D, 2009, CLIN CANCER RES, V15, P3896, DOI 10.1158/1078-0432.CCR-08-3303; Yoshinaga K, 2004, CLIN CANCER RES, V10, P5702, DOI 10.1158/1078-0432.CCR-03-0262; Yoshinaga K, 2003, INT J ONCOL, V22, P75; Yoshinaga K, 2008, ANN SURG ONCOL, V15, P96, DOI 10.1245/s10434-007-9631-1; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang DF, 2010, J INT MED RES, V38, P1343, DOI 10.1177/147323001003800416	61	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47312	10.1371/journal.pone.0047312	http://dx.doi.org/10.1371/journal.pone.0047312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077590	Green Published, Green Submitted, gold			2022-12-27	WOS:000309809500042
J	Sacks-Davis, R; Daraganova, G; Aitken, C; Higgs, P; Tracy, L; Bowden, S; Jenkinson, R; Rolls, D; Pattison, P; Robins, G; Grebely, J; Barry, A; Hellard, M				Sacks-Davis, Rachel; Daraganova, Galina; Aitken, Campbell; Higgs, Peter; Tracy, Lilly; Bowden, Scott; Jenkinson, Rebecca; Rolls, David; Pattison, Philippa; Robins, Garry; Grebely, Jason; Barry, Alyssa; Hellard, Margaret			Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GLOBAL EPIDEMIOLOGY; USERS; INCARCERATION; HIV; TRANSMISSION; INFECTION; GENOTYPES	It is hypothesized that social networks facilitate transmission of the hepatitis C virus (HCV). We tested for association between HCV phylogeny and reported injecting relationships using longitudinal data from a social network design study. People who inject drugs were recruited from street drug markets in Melbourne, Australia. Interviews and blood tests took place three monthly (during 2005-2008), with participants asked to nominate up to five injecting partners at each interview. The HCV core region of individual isolates was then sequenced and phylogenetic trees were constructed. Genetic clusters were identified using bootstrapping (cut-off: 70%). An adjusted Jaccard similarity coefficient was used to measure the association between the reported injecting relationships and relationships defined by clustering in the phylogenetic analysis (statistical significance assessed using the quadratic assignment procedure). 402 participants consented to participate; 244 HCV infections were observed in 238 individuals. 26 genetic clusters were identified, with 2-7 infections per cluster. Newly acquired infection (AOR = 2.03, 95% CI: 1.04-3.96, p = 0.037, and HCV genotype 3 (vs. genotype 1, AOR = 2.72, 95% CI: 1.48-4.99) were independent predictors of being in a cluster. 54% of participants whose infections were part of a cluster in the phylogenetic analysis reported injecting with at least one other participant in that cluster during the study. Overall, 16% of participants who were infected at study entry and 40% of participants with newly acquired infections had molecular evidence of related infections with at least one injecting partner. Likely transmission clusters identified in phylogenetic analysis correlated with reported injecting relationships (adjusted Jaccard coefficient: 0.300; p<0.001). This is the first study to show that HCV phylogeny is associated with the injecting network, highlighting the importance of the injecting network in HCV transmission.	[Sacks-Davis, Rachel; Aitken, Campbell; Higgs, Peter; Jenkinson, Rebecca; Hellard, Margaret] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Sacks-Davis, Rachel; Aitken, Campbell; Higgs, Peter; Hellard, Margaret] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Sacks-Davis, Rachel; Aitken, Campbell; Higgs, Peter; Jenkinson, Rebecca; Hellard, Margaret] Burnet Inst, Ctr Res Excellence Injecting Drug Use, Melbourne, Vic, Australia; [Grebely, Jason] Univ New S Wales, Kirby Inst Infect & Immun Soc, Darlinghurst, NSW, Australia; [Tracy, Lilly; Bowden, Scott] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Barry, Alyssa] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic, Australia; [Barry, Alyssa] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Burnet Institute; Monash University; Burnet Institute; University of New South Wales Sydney; Kirby Institute; Victorian Infectious Diseases Reference Laboratory; Walter & Eliza Hall Institute; University of Melbourne	Sacks-Davis, R (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia.	rachelsd@burnet.edu.au	Rolls, David/C-2886-2012; Higgs, Peter/P-7816-2019; Sacks-Davis, Rachel/H-3277-2019; Higgs, Peter G/L-5939-2013	Rolls, David/0000-0003-0397-9923; Higgs, Peter/0000-0002-5587-5379; Higgs, Peter G/0000-0002-5587-5379; Aitken, Campbell/0000-0002-0923-4837; Pattison, Philippa/0000-0001-9626-2897; Barry, Alyssa/0000-0002-1189-2310; Robins, Garry/0000-0001-7538-5804; Sacks-Davis, Rachel/0000-0003-0860-2762	Australia's National Health and Medical Research Council [331312]; Victorian Department of Health; Australian Centre for HIV and Hepatitis Virology Research [ACH2]; Victorian Operational Infrastructure Support Program; Burnet Institute; Centre for Research Excellence into Injecting Drug Use; Australian Research Council [0987730]	Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Department of Health; Australian Centre for HIV and Hepatitis Virology Research; Victorian Operational Infrastructure Support Program; Burnet Institute; Centre for Research Excellence into Injecting Drug Use; Australian Research Council(Australian Research Council)	This work was supported by Australia's National Health and Medical Research Council [project grant 331312, postgraduate scholarship to RSD, training fellowship to PH, Senior Research Fellowship to MH, http://www.nhmrc.gov.au/]; the Victorian Department of Health [public health research grant 2008-09, http://www.health.vic.gov.au/]; the Australian Centre for HIV and Hepatitis Virology Research [ACH2, http://www.hiv.edu.au/]; the Victorian Operational Infrastructure Support Program [http://www.business.vic.gov.au/BUSVIC/STANDARD/PC_60698.html]; the Burnet Institute [http://www.burnet.edu.au]; the Centre for Research Excellence into Injecting Drug Use [top-up postgraduate scholarship to RSD, http://www.creidu.edu.au]; and the Australian Research Council [Discovery project grant 0987730, http://www.arc.gov.au/ncgp/dp/dp_default.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Aitken CK, 2009, HEPAT MON, V9, P17; Aitken CK, 2008, HEPATOLOGY, V48, P1746, DOI 10.1002/hep.22534; Aitken CK, 2004, J INFECT DIS, V190, P1586, DOI 10.1086/424678; Bernard EJ, 2007, HIV MED, V8, P382, DOI 10.1111/j.1468-1293.2007.00486.x; Borgatti S., 2002, UCINET WINDOWS SOFTW; Borgatti S.P., 2002, NETDRAW GRAPH VISUAL; Brewer DD, 2006, J INFECT DIS, V194, P764, DOI 10.1086/505585; De P, 2007, ADDICTION, V102, P1730, DOI 10.1111/j.1360-0443.2007.01936.x; Dev AT, 2002, HEPATOLOGY, V36, P1259, DOI 10.1053/jhep.2002.36781; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Friedman SR, 2001, J URBAN HEALTH, V78, P411, DOI 10.1093/jurban/78.3.411; Hahn JA, 2009, EPIDEMICS-NETH, V1, P47, DOI 10.1016/j.epidem.2008.10.002; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Jurgens R, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-26; Kuiken C, 2006, HEPATOLOGY, V44, P1355, DOI 10.1002/hep.21377; Latkin C, 2011, DRUG ALCOHOL DEPEN, V117, P50, DOI 10.1016/j.drugalcdep.2011.01.005; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; McCaw R, 1997, J VIRAL HEPATITIS, V4, P351, DOI 10.1046/j.1365-2893.1997.00060.x; Miller ER, 2009, J INFECTION, V58, P375, DOI 10.1016/j.jinf.2009.02.014; Morgenstern B, 2003, BIOINFORMATICS, V19, P425, DOI 10.1093/bioinformatics/btf882; Nei M., 2000, MOL EVOLUTION PHYLOG; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Pham ST, 2010, HEPATOLOGY, V52, P1564, DOI 10.1002/hep.23885; Pilon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022245; Pollini RA, 2009, DRUG ALCOHOL DEPEN, V103, P52, DOI 10.1016/j.drugalcdep.2009.03.005; Rolls DA, 2012, J THEOR BIOL, V297, P73, DOI 10.1016/j.jtbi.2011.12.008; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011170; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Simpson W, 2001, STATA US 1 N AM M BO; Smith DB, 1997, J GASTROEN HEPATOL, V12, P522, DOI 10.1111/j.1440-1746.1997.tb00477.x; Stumpf MPH, 2002, FEMS MICROBIOL LETT, V214, P143, DOI 10.1111/j.1574-6968.2002.tb11338.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valente TW, 2001, AM J PUBLIC HEALTH, V91, P406, DOI 10.2105/AJPH.91.3.406; Volz E, 2007, P ROY SOC B-BIOL SCI, V274, P2925, DOI 10.1098/rspb.2007.1159; Wood E, 2005, PUBLIC HEALTH REP, V120, P150, DOI 10.1177/003335490512000208; Wylie JL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-229; Wylie JL, 2007, HEALTH PLACE, V13, P617, DOI 10.1016/j.healthplace.2006.09.002	43	56	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47335	10.1371/journal.pone.0047335	http://dx.doi.org/10.1371/journal.pone.0047335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110068	gold, Green Published, Green Submitted			2022-12-27	WOS:000310262500009
J	Interlandi, G; Ling, MH; Tu, AY; Chung, DW; Thomas, WE				Interlandi, Gianluca; Ling, Minhua; Tu, An Yue; Chung, Dominic W.; Thomas, Wendy E.			Structural Basis of Type 2A von Willebrand Disease Investigated by Molecular Dynamics Simulations and Experiments	PLOS ONE			English	Article							FACTOR A2 DOMAIN; ANKYRIN REPEAT PROTEINS; BINDING-SITE; VONWILLEBRAND DISEASE; SPACER DOMAIN; ADAMTS13; CLEAVAGE; MUTATIONS; IIA; FORCE	The hemostatic function of von Willebrand factor is downregulated by the metalloprotease ADAMTS13, which cleaves at a unique site normally buried in the A2 domain. Exposure of the proteolytic site is induced in the wild-type by shear stress as von Willebrand factor circulates in blood. Mutations in the A2 domain, which increase its susceptibility to cleavage, cause type 2A von Willebrand disease. In this study, molecular dynamics simulations suggest that the A2 domain unfolds under tensile force progressively through a series of steps. The simulation results also indicated that three type 2A mutations in the C-terminal half of the A2 domain, L1657I, I1628T and E1638K, destabilize the native state fold of the protein. Furthermore, all three type 2A mutations lowered in silico the tensile force necessary to undock the C-terminal helix alpha 6 from the rest of the A2 domain, the first event in the unfolding pathway. The mutations F1520A, I1651A and A1661G were also predicted by simulations to destabilize the A2 domain and facilitate exposure of the cleavage site. Recombinant A2 domain proteins were expressed and cleavage assays were performed with the wild-type and single-point mutants. All three type 2A and two of the three predicted mutations exhibited increased rate of cleavage by ADAMTS13. These results confirm that destabilization of the helix alpha 6 in the A2 domain facilitates exposure of the cleavage site and increases the rate of cleavage by ADAMTS13.	[Interlandi, Gianluca; Tu, An Yue; Thomas, Wendy E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Ling, Minhua; Chung, Dominic W.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Interlandi, G (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	gianluca@u.washington.edu	Sessum, Rachel/F-7312-2015	Sessum, Rachel/0000-0002-2444-7056; Thomas, Wendy/0000-0001-8602-0819	American Heart Association [0820107Z, AHA09GRNT2230070]; National Institutes of Health research grant [1R01-HL106074]; National Scientist Development grant from the American Heart Association [0735337N]; National Science Foundation through TeraGrid resources [TG-MCB060069N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106074] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Scientist Development grant from the American Heart Association; National Science Foundation through TeraGrid resources(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was financially supported by a postdoctoral fellowship from the American Heart Association number 0820107Z to GI, a National Institutes of Health research grant number 1R01-HL106074 to WET, a National Scientist Development grant from the American Heart Association number 0735337N to WET and a grant from the American Heart Association number AHA09GRNT2230070 to DWC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Jim Pfaendtner for helpful and interesting discussions. The computations were performed on the Abe supercomputer at the National Center for Supercomputing Applications supported by the National Science Foundation and made available to GI and WT through TeraGrid resources under grant number TG-MCB060069N. We would like to specifically thank Susan John for assistance with the allocation and technical help.	Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen JM, 2010, BLOOD, V115, P706, DOI 10.1182/blood-2009-03-213967; Chen W, 2009, CELL MOL BIOENG, V2, P75, DOI 10.1007/s12195-009-0051-0; CHRISTOPHE O, 1994, BLOOD, V83, P3553; Crawley JTB, 2011, BLOOD, V118, P3212, DOI 10.1182/blood-2011-02-306597; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Groot R, 2009, BLOOD, V113, P5609, DOI 10.1182/blood-2008-11-187914; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; Di Stasio E, 2010, BIOPHYS CHEM, V153, P1, DOI 10.1016/j.bpc.2010.07.002; Drews RE, 2010, ANN INTERN MED, V152, P655, DOI 10.7326/0003-4819-152-10-201005180-00244; Enayat MS, 2000, THROMB HAEMOSTASIS, V84, P369; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Franchini M, 2006, ANN HEMATOL, V85, P415, DOI 10.1007/s00277-006-0085-5; Gao WQ, 2008, BLOOD, V112, P1713, DOI 10.1182/blood-2008-04-148759; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Hassenpflug WA, 2006, BLOOD, V107, P2339, DOI 10.1182/blood-2005-04-1758; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IANNUZZI MC, 1991, AM J HUM GENET, V48, P757; Interlandi G, 2008, J MOL BIOL, V375, P837, DOI 10.1016/j.jmb.2007.09.042; Interlandi G, 2010, PROTEINS, V78, P2506, DOI 10.1002/prot.22759; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Jin SY, 2010, BLOOD, V115, P2300, DOI 10.1182/blood-2009-07-235101; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kramer MA, 2010, J MOL BIOL, V404, P381, DOI 10.1016/j.jmb.2010.09.023; Lenting PJ, 2010, THROMB HAEMOSTASIS, V104, P449, DOI 10.1160/TH09-11-0777; Luken BM, 2010, BLOOD, V115, P4910, DOI 10.1182/blood-2009-12-257949; LYONS SE, 1994, BLOOD, V83, P1551; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Matthew Auton MAC, 2007, J MOL BIOL, V366, P966; Mize GJ, 2008, PROTEIN EXPRES PURIF, V57, P280, DOI 10.1016/j.pep.2007.09.018; Nishida H, 2006, BLOOD COAGUL FIBRIN, V17, P203, DOI 10.1097/01.mbc.0000220242.22714.b3; Pos W, 2010, BLOOD, V115, P1640, DOI 10.1182/blood-2009-06-229203; RIBBA AS, 1992, J BIOL CHEM, V267, P23209; Ruggeri Z M, 2004, Hamostaseologie, V24, P1; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Sousa SF, 2010, COMB CHEM HIGH T SCR, V13, P442; Sutherland JJ, 2004, J MOL MODEL, V10, P259, DOI 10.1007/s00894-004-0194-9; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Willis B.T.M., 1975, THERMAL VIBRATIONS C; Wu JJ, 2006, P NATL ACAD SCI USA, V103, P18470, DOI 10.1073/pnas.0609190103; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Xu AJ, 2012, P NATL ACAD SCI USA, V109, P3742, DOI 10.1073/pnas.1121261109; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Zanardelli S, 2009, BLOOD, V114, P2819, DOI 10.1182/blood-2009-05-224915; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zhou MY, 2011, BLOOD, V117, P4623, DOI 10.1182/blood-2010-11-321596	50	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e45207	10.1371/journal.pone.0045207	http://dx.doi.org/10.1371/journal.pone.0045207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110044	Green Submitted, Green Published, gold			2022-12-27	WOS:000310193600002
J	Nurmatov, U; Buckingham, S; Kendall, M; Murray, SA; White, P; Sheikh, A; Pinnock, H				Nurmatov, Ulugbek; Buckingham, Susan; Kendall, Marilyn; Murray, Scott A.; White, Patrick; Sheikh, Aziz; Pinnock, Hilary			Effectiveness of Holistic Interventions for People with Severe Chronic Obstructive Pulmonary Disease: Systematic Review of Controlled Clinical Trials	PLOS ONE			English	Article							QUALITY-OF-LIFE; END-STAGE COPD; PALLIATIVE CARE; CASE-MANAGEMENT; ACUTE EXACERBATION; CHRONIC ILLNESS; OLDER-PEOPLE; RISK-FACTORS; PROGRAM; PREVALENCE	Background: Despite a well-recognised burden of disabling physical symptoms compounded by co-morbidities, psychological distress and social isolation, the needs of people with severe chronic obstructive pulmonary disease (COPD) are typically poorly addressed. Aim: To assess the effectiveness of interventions designed to deliver holistic care for people with severe COPD. Methods: We searched 11 biomedical databases, three trial repositories (January 1990-March 2012; no language restrictions) and contacted international experts to locate published, unpublished and in-progress randomised controlled trials (RCTs), quasi-RCTs and controlled clinical trials (CCTs) that investigated holistic interventions to support patients with severe COPD in any healthcare context. The primary outcome was health-related quality of life (HRQoL). Quality assessment and data extraction followed Cochrane Collaboration methodology. We used a piloted data extraction sheet and undertook narrative synthesis. Results: From 2,866 potentially relevant papers, we identified three trials: two RCTs (from United States and Australia), and one CCT (from Thailand): total 216 patients. Risk of bias was assessed as moderate in two studies and high in the third. All the interventions were led by nurses acting in a co-ordinating role (e.g. facilitating community support in Thailand, providing case-management in the USA, or co-ordinating inpatient care in Australia). HRQoL improved significantly in the Thai CCT compared to the (very limited) usual care (p < 0.001), in two sub-domains in the American trial, but showed no significant changes in the Australian trial. Exercise tolerance, dyspnoea, and satisfaction with care also improved in the Thai trial. Conclusions: Some 15 years after reports first highlighted the unmet needs of people with severe COPD, we have been unable to find robust trial evidence about interventions that can address those needs. There is an urgent need to develop and evaluate holistic care interventions designed improve HRQoL for people with severe COPD.	[Nurmatov, Ulugbek; Buckingham, Susan; Sheikh, Aziz; Pinnock, Hilary] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland; [Kendall, Marilyn; Murray, Scott A.] Univ Edinburgh, Ctr Populat Hlth Sci, Primary Palliat Care Res Grp, Edinburgh, Midlothian, Scotland; [White, Patrick] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England	University of Edinburgh; University of Edinburgh; University of London; King's College London	Pinnock, H (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland.	hilary.pinnock@ed.ac.uk	Sheikh, Aziz/D-2818-2009; White, Patrick/AAN-7799-2020	Sheikh, Aziz/0000-0001-7022-3056; White, Patrick/0000-0002-2047-8787	Dunhill Medical Trust Grant [R210 071]; Primary Care Research Career Award from the Chief Scientist Office of the Scottish Government; The Dunhill Medical Trust [R210/0711] Funding Source: researchfish; Chief Scientist Office [CZH/4/320, PCRCA/08/01] Funding Source: researchfish	Dunhill Medical Trust Grant(Dunhill Medical Trust); Primary Care Research Career Award from the Chief Scientist Office of the Scottish Government; The Dunhill Medical Trust(Dunhill Medical Trust); Chief Scientist Office	This work was supported by Dunhill Medical Trust Grant R210 071 (http://www.dunhillmedical.org.uk). HP is supported by a Primary Care Research Career Award from the Chief Scientist Office of the Scottish Government (http://www.cso.scot.nhs.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken LS, 2006, J PALLIAT MED, V9, P111, DOI 10.1089/jpm.2006.9.111; Almagro P, 2002, CHEST, V121, P1441, DOI 10.1378/chest.121.5.1441; BELMAN MJ, 1993, THORAX, V48, P936, DOI 10.1136/thx.48.9.936; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; British Lung Foundation, 2012, BREATH EAS; Brumley Richard D, 2003, J Palliat Med, V6, P715, DOI 10.1089/109662103322515220; Casas A, 2006, EUR RESPIR J, V28, P123, DOI 10.1183/09031936.06.00063205; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Clavarino AM, 1997, DYING FROM EXPERIENC; Cochrane Eff ective Practice and Organisation of Care Group, RISK BIAS EPOC SPEC; Communities and local government, 2012, BUILD BIG SOC; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Craig P., 2008, DEV EVALUATING COMPL; Davies E, 2004, SOLID FACTS PALLIATI; Department of Health, 2004, PALL CAR; Dewan NA, 2011, COPD, V8, P153, DOI 10.3109/15412555.2011.560129; Egan Elizabeth, 2002, Lippincotts Case Manag, V7, P170, DOI 10.1097/00129234-200209000-00002; Elofsson LC, 2004, PALLIATIVE MED, V18, P611, DOI 10.1191/0269216304pm922oa; Exley C, 2005, PALLIATIVE MED, V19, P76, DOI 10.1191/0269216305pm973oa; Garcia-Ayrnerich J, 2007, RESP MED, V101, P1462, DOI 10.1016/j.rmed.2007.01.012; Gore JM, 2000, THORAX, V55, P1000, DOI 10.1136/thorax.55.12.1000; Gravelle H, 2007, BMJ-BRIT MED J, V334, P31, DOI 10.1136/bmj.39020.413310.55; Habraken JM, 2007, PATIENT EDUC COUNS, V68, P121, DOI 10.1016/j.pec.2007.05.011; Habraken JM, 2008, BRIT J GEN PRACT, V58, P844, DOI 10.3399/bjgp08X376186; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lockhart Carol A, 2003, J Palliat Med, V6, P1001, DOI 10.1089/109662103322654929; Lynn J, 2000, J AM GERIATR SOC, V48, pS91, DOI 10.1111/j.1532-5415.2000.tb03147.x; Lynn J, 2003, LIVING WELL END LIFE; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Markle-Reid M, 2013, J EVAL CLIN PRACT, V19, P118, DOI 10.1111/j.1365-2753.2011.01782.x; Meier Diane E, 2004, J Palliat Med, V7, P119, DOI 10.1089/109662104322737395; Melis RJF, 2008, J GERONTOL A-BIOL, V63, P283, DOI 10.1093/gerona/63.3.283; Murray SA, 2005, BRIT MED J, V330, P611, DOI 10.1136/bmj.330.7492.611; Neuman B., 1995, NEUMAN SYSTEMS MODEL; NHS End of Life Care Programme, 2012, GOLD STAND FRAM; Noonill NSS., 2007, THAI J NURSING RES, V11, P118; Oeseburg B, 2009, NURS RES, V58, P201, DOI 10.1097/NNR.0b013e3181a30941; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Pinnock H, 2012, HELPING OLDER PEOPLE; Pinnock H, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d142; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; Rocker GM, 2007, J PALLIAT MED, V10, P783, DOI 10.1089/jpm.2007.9951; Seamark DA, 2007, J ROY SOC MED, V100, P225, DOI 10.1258/jrsm.100.5.225; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Sindhu SAR, 2004, THAI J NURSING COUNC, V19, P1; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Sridhar M, 2008, THORAX, V63, P194, DOI 10.1136/thx.2007.077578; US Department of Health and Human Services, 2008, US DEP HLTH HUM SERV; Ware J., 1993, SF 36 HLTH SURVEY MA; White P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X578043	54	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e46433	10.1371/journal.pone.0046433	http://dx.doi.org/10.1371/journal.pone.0046433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025MO	23110052	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000310193600004
J	Molina-Montenegro, MA; Naya, DE				Molina-Montenegro, Marco A.; Naya, Daniel E.			Latitudinal Patterns in Phenotypic Plasticity and Fitness-Related Traits: Assessing the Climatic Variability Hypothesis (CVH) with an Invasive Plant Species	PLOS ONE			English	Article							DANDELIONS TARAXACUM-OFFICINALE; THERMAL TOLERANCE; GEOGRAPHICAL RANGE; LOCAL ADAPTATION; MOUNTAIN PASSES; EVOLUTION; PERFORMANCE; FLEXIBILITY; POPULATIONS; LIMITS	Phenotypic plasticity has been suggested as the main mechanism for species persistence under a global change scenario, and also as one of the main mechanisms that alien species use to tolerate and invade broad geographic areas. However, contrasting with this central role of phenotypic plasticity, standard models aimed to predict the effect of climatic change on species distributions do not allow for the inclusion of differences in plastic responses among populations. In this context, the climatic variability hypothesis (CVH), which states that higher thermal variability at higher latitudes should determine an increase in phenotypic plasticity with latitude, could be considered a timely and promising hypothesis. Accordingly, in this study we evaluated, for the first time in a plant species (Taraxacum officinale), the prediction of the CVH. Specifically, we measured plastic responses at different environmental temperatures (5 and 20 degrees C), in several ecophysiological and fitness-related traits for five populations distributed along a broad latitudinal gradient. Overall, phenotypic plasticity increased with latitude for all six traits analyzed, and mean trait values increased with latitude at both experimental temperatures, the change was noticeably greater at 20 degrees than at 5 degrees C. Our results suggest that the positive relationship found between phenotypic plasticity and geographic latitude could have very deep implications on future species persistence and invasion processes under a scenario of climate change.	[Molina-Montenegro, Marco A.] Univ Catolica Norte, Fac Ciencias Mar, Ctr Estudios Avanzados Zonas Aridas, Coquimbo, Chile; [Naya, Daniel E.] Univ Republica, Fac Ciencias, Dept Ecol & Evolut, Montevideo, Uruguay; [Naya, Daniel E.] Univ Republica, Ctr Univ Reg Este, Montevideo, Uruguay	Universidad Catolica del Norte; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Molina-Montenegro, MA (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, Ctr Estudios Avanzados Zonas Aridas, Coquimbo, Chile.	marco.molina@ceaza.cl		Molina-Montenegro, Marco/0000-0001-6801-8942				Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Arroyo Mary T. Kalin, 2000, P385; BRATTSTROM BH, 1968, COMP BIOCHEM PHYSIOL, V24, P93, DOI 10.1016/0010-406X(68)90961-4; BROWN JH, 1971, EVOLUTION, V25, P390, DOI 10.1111/j.1558-5646.1971.tb01893.x; Calosi P, 2008, BIOL LETTERS, V4, P99, DOI 10.1098/rsbl.2007.0408; Chown SL, 2004, FUNCT ECOL, V18, P159, DOI 10.1111/j.0269-8463.2004.00825.x; COUNTS RL, 1993, CAN J BOT, V71, P145, DOI 10.1139/b93-016; Darlington C. D., 1937, RECENT ADV CYTOLOGY; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; di Castri F., 1989, SCOPE, V37, P1; Duncan RP, 2009, P ROY SOC B-BIOL SCI, V276, P1449, DOI 10.1098/rspb.2008.1801; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Fernandez MH, 2005, J BIOGEOGR, V32, P903, DOI 10.1111/j.1365-2699.2004.01188.x; FRANCE R, 1992, AM NAT, V139, P342, DOI 10.1086/285330; Fuller A, 2010, PHYSIOL BIOCHEM ZOOL, V83, P713, DOI 10.1086/652242; Gaston Kevin J., 2004, BIODIVERSITY INTRO; Gaston KJ, 1999, OIKOS, V84, P309, DOI 10.2307/3546727; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Gianoli E, 2004, INT J PLANT SCI, V165, P825, DOI 10.1086/422050; Gianoli E, 2012, BIOL J LINN SOC, V105, P1, DOI 10.1111/j.1095-8312.2011.01793.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Holm L, 1997, NATURAL HIST DISTRIB; HUEY RB, 1978, AM NAT, V112, P225, DOI 10.1086/283262; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jonas CS, 1999, AM J BOT, V86, P333, DOI 10.2307/2656755; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; LETCHER AJ, 1994, AM NAT, V144, P30, DOI 10.1086/285659; Maldonado K, 2012, ZOOLOGY, V115, P128, DOI 10.1016/j.zool.2011.09.005; Maldonado K, 2011, PHYSIOL BIOCHEM ZOOL, V84, P377, DOI 10.1086/660970; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; Mitchell KA, 2011, FUNCT ECOL, V25, P661, DOI 10.1111/j.1365-2435.2010.01821.x; Molina-Montenegro MA, 2012, BIOL INVASIONS, V14, P21, DOI 10.1007/s10530-011-0055-2; Molina-Montenegro MA, 2012, PLANT ECOL, V213, P133, DOI 10.1007/s11258-011-9964-5; Molina-Montenegro MA, 2010, BIOL INVASIONS, V12, P2277, DOI 10.1007/s10530-009-9638-6; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Mou P, 2013, PLANT SOIL, V364, P373, DOI 10.1007/s11104-012-1336-y; Naya DE, 2008, AM NAT, V172, pE122, DOI 10.1086/590957; Naya DE, 2012, AM NAT, V179, pE172, DOI 10.1086/665646; Naya DE, 2011, EVOL ECOL RES, V13, P647; Neuffer B, 1999, MOL ECOL, V8, P1667, DOI 10.1046/j.1365-294x.1999.00752.x; NOVAK SJ, 1991, AM J BOT, V78, P1150, DOI 10.2307/2444902; Overgaard J, 2011, AM NAT, V178, pS80, DOI 10.1086/661780; PAGEL MD, 1991, AM NAT, V137, P791, DOI 10.1086/285194; Pichancourt JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032323; PLATENKAMP GAJ, 1990, J ECOL, V78, P772, DOI 10.2307/2260898; Quiroz CL, 2009, ECOL RES, V24, P175, DOI 10.1007/s11284-008-0498-9; Rezende EL, 2004, EVOLUTION, V58, P1361; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Santamaria L, 2003, ECOLOGY, V84, P2454, DOI 10.1890/02-0431; SCHLICHTING CD, 1995, INT J PLANT SCI, V156, P542, DOI 10.1086/297277; Sexton JP, 2002, ECOL APPL, V12, P1652, DOI 10.1890/1051-0761(2002)012[1652:PAGDMA]2.0.CO;2; SNYDER GK, 1975, AM NAT, V109, P93, DOI 10.1086/282976; Speakman JR, 2000, ADV ECOL RES, V30, P177; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; van Baarlen P, 2000, GENOME, V43, P827, DOI 10.1139/gen-43-5-827; van Dijk PJ, 2004, GENETICS, V166, P483, DOI 10.1534/genetics.166.1.483; VANBERKUM FH, 1988, AM NAT, V132, P327, DOI 10.1086/284856; Vasut RJ, 2003, PRESLIA, V75, P311	64	88	88	4	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47620	10.1371/journal.pone.0047620	http://dx.doi.org/10.1371/journal.pone.0047620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110083	gold, Green Submitted, Green Published			2022-12-27	WOS:000310193400013
J	Alam, MS; Getz, M; Safeukui, I; Yi, S; Tamez, P; Shin, J; Velazquez, P; Haldar, K				Alam, Md Suhail; Getz, Michelle; Safeukui, Innocent; Yi, Sue; Tamez, Pamela; Shin, Jenny; Velazquez, Peter; Haldar, Kasturi			Genomic Expression Analyses Reveal Lysosomal, Innate Immunity Proteins, as Disease Correlates in Murine Models of a Lysosomal Storage Disorder	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; C DISEASE; MOUSE MODEL; CHOLESTEROL ACCUMULATION; MEMBRANE CHOLESTEROL; PROTEOMIC ANALYSIS; NPC1 DEFICIENCY; PLASMA-MEMBRANE; HOST-DEFENSE; IFN-GAMMA	Niemann-Pick Type C (NPC) disease is a rare, genetic, lysosomal disorder with progressive neurodegeneration. Poor understanding of the pathophysiology and a lack of blood-based diagnostic markers are major hurdles in the treatment and management of NPC and several additional, neurological lysosomal disorders. To identify disease severity correlates, we undertook whole genome expression profiling of sentinel organs, brain, liver, and spleen of Balb/c Npc1(-/-) mice relative to Npc1(+/-) at an asymptomatic stage, as well as early- and late-symptomatic stages. Unexpectedly, we found prominent up regulation of innate immunity genes with age-dependent change in their expression, in all three organs. We shortlisted a set of 12 secretory genes whose expression steadily increased with age in both brain and liver, as potential plasma correlates of neurological and/or liver disease. Ten were innate immune genes with eight ascribed to lysosomes. Several are known to be elevated in diseased organs of murine models of other lysosomal diseases including Gaucher's disease, Sandhoff disease and MPSIIIB. We validated the top candidate lysozyme, in the plasma of Npc1(-/-) as well as Balb/c Npc1(nmf164) mice (bearing a point mutation closer to human disease mutants) and show its reduction in response to an emerging therapeutic. We further established elevation of innate immunity in Npc1(-/-) mice through multiple functional assays including inhibition of bacterial infection as well as cellular analysis and immunohistochemistry. These data revealed neutrophil elevation in the Npc1(-/-) spleen and liver (where large foci were detected proximal to damaged tissue). Together our results yield a set of lysosomal, secretory innate immunity genes that have potential to be developed as pan or specific plasma markers for neurological diseases associated with lysosomal storage and where diagnosis is a major problem. Further, the accumulation of neutrophils in diseased organs (hitherto not associated with NPC) suggests their role in pathophysiology and disease exacerbation.	[Alam, Md Suhail; Getz, Michelle; Safeukui, Innocent; Yi, Sue; Tamez, Pamela; Shin, Jenny; Velazquez, Peter; Haldar, Kasturi] Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Alam, Md Suhail; Getz, Michelle; Safeukui, Innocent; Yi, Sue; Tamez, Pamela; Shin, Jenny; Haldar, Kasturi] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Velazquez, Peter] Indiana Univ Sch Med, Dept Microbiol & Immunol, South Bend, IN USA	University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University South Bend	Haldar, K (corresponding author), Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA.	khaldar@nd.edu	Haldar, Kasturi/C-6685-2014	Tamez, Pamela/0000-0001-9005-4560; Shin, Jenny/0000-0002-5650-8044	University of Notre Dame, IN, USA; National Institutes of Health [P01HL078826]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078826] Funding Source: NIH RePORTER	University of Notre Dame, IN, USA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the University of Notre Dame, IN, USA and the National Institutes of Health (P01HL078826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2004, EUR J IMMUNOL, V34, P2907, DOI 10.1002/eji.200425071; Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Beltroy EP, 2005, HEPATOLOGY, V42, P886, DOI 10.1002/hep.20868; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; De Windt A, 2007, DNA CELL BIOL, V26, P665, DOI 10.1089/dna.2006.0570; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; El Kebir D, 2010, THESCIENTIFICWORLDJO, V10, P1731, DOI 10.1100/tsw.2010.169; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hofmann E, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-61; Jethwaney D, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-12; Jiang Q, 2005, GENE THER, V12, P1761, DOI 10.1038/sj.gt.3302558; Kasten KR, 2010, INFECT IMMUN, V78, P4714, DOI 10.1128/IAI.00456-10; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Lee KH, 2000, J IMMUNOL, V165, P4970, DOI 10.4049/jimmunol.165.9.4970; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Liao GH, 2010, BRAIN RES, V1325, P128, DOI 10.1016/j.brainres.2010.02.019; Liao GH, 2009, BRAIN RES, V1270, P140, DOI 10.1016/j.brainres.2009.03.027; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; Lopez ME, 2012, HUM MOL GENET, DOI 101093/hmg/dds126; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Maue RA, 2012, HUM MOL GENET, V21, P730, DOI 10.1093/hmg/ddr505; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Myerowitz R, 2002, HUM MOL GENET, V11, P1343, DOI 10.1093/hmg/11.11.1343; Nakatsuji T, 2011, J INVEST DERMATOL; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; Parikh SS, 2003, INFECT IMMUN, V71, P6582, DOI 10.1128/IAI.71.11.6582-6590.2003; Parra J, 2011, BIOCHEM BIOPH RES CO, V413, P400, DOI 10.1016/j.bbrc.2011.08.096; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Pressey SNR, 2012, NEUROBIOL DIS, V45, P1086, DOI 10.1016/j.nbd.2011.12.027; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Rimkunas VM, 2008, HEPATOLOGY, V47, P1504, DOI 10.1002/hep.22327; Rimkunas VM, 2009, J LIPID RES, V50, P327, DOI 10.1194/jlr.M800415-JLR200; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Sagiv Y, 2006, J IMMUNOL, V177, P26, DOI 10.4049/jimmunol.177.1.26; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; Sayre NL, 2010, J LIPID RES, V51, P2372, DOI 10.1194/jlr.M007211; Schrantz N, 2007, J EXP MED, V204, P841, DOI 10.1084/jem.20061562; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Silva MT, 2011, J LEUKOCYTE BIOL, V89, P675, DOI 10.1189/jlb.0910536; SILVERSTEIN E, 1977, CLIN CHIM ACTA, V74, P21, DOI 10.1016/0009-8981(77)90382-5; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Trexler AJ, 2007, CURR PROTEIN PEPT SC, V8, P537, DOI 10.2174/138920307783018659; Tsolis RM, 1999, ADV EXP MED BIOL, V473, P261; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Vazquez MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028777; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Vitner EB, 2010, HUM MOL GENET, V19, P3583, DOI 10.1093/hmg/ddq273; Voikar V, 2002, BEHAV BRAIN RES, V132, P1, DOI 10.1016/S0166-4328(01)00380-1; Watarai M, 2002, INFECT IMMUN, V70, P4818, DOI 10.1128/IAI.70.9.4818-4825.2002; Wraith JE, 2009, MOL GENET METAB, V98, P152, DOI 10.1016/j.ymgme.2009.06.008; Xie XF, 2011, P NATL ACAD SCI USA, V108, P15330, DOI 10.1073/pnas.1112751108; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969	67	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e48273	10.1371/journal.pone.0048273	http://dx.doi.org/10.1371/journal.pone.0048273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094108	Green Published, Green Submitted, gold			2022-12-27	WOS:000310050200060
J	Olbrich, M; Rieger, M; Reinert, S; Alexander, D				Olbrich, Marcus; Rieger, Melanie; Reinert, Siegmar; Alexander, Dorothea			Isolation of Osteoprogenitors from Human Jaw Periosteal Cells: A Comparison of Two Magnetic Separation Methods	PLOS ONE			English	Article							PROGENITOR CELLS; STEM-CELLS; BONE; DIFFERENTIATION; ANGIOGENESIS; OSTEOGENESIS; REGULATOR; MINERALIZATION; OSTEOBLAST; INHIBITOR	Human jaw periosteum tissue contains osteoprogenitors that have potential for tissue engineering applications in oral and maxillofacial surgeries. To isolate osteoprogenitor cells from heterogeneous cell populations, we used the specific mesenchymal stem cell antigen-1 (MSCA-1) antibody and compared two magnetic separation methods. We analyzed the obtained MSCA-1(+) and MSCA-1(-) fractions in terms of purity, yield of positive/negative cells and proliferative and mineralization potentials. The analysis of cell viability after separation revealed that the EasySep method yielded higher viability rates, whereas the flow cytometry results showed a higher purity for the MACS-separated cell fractions. The mineralization capacity of the osteogenic induced MSCA-1(+) cells compared with the MSCA-1(-) controls using MACS was 5-fold higher, whereas the same comparison after EasySep showed no significant differences between both fractions. By analyzing cell proliferation, we detected a significant difference between the proliferative potential of the osteogenic cells versus untreated cells after the MACS and EasySep separations. The differentiated cells after MACS separation adjusted their proliferative capacity, whereas the EasySep-separated cells failed to do so. The protein expression analysis showed small differences between the two separation methods. Our findings suggest that MACS is a more suitable separation method to isolate osteoprogenitors from the entire jaw periosteal cell population.	[Olbrich, Marcus; Rieger, Melanie; Reinert, Siegmar; Alexander, Dorothea] Univ Tubingen Hosp, Dept Oral & Maxillofacial Surg, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Alexander, D (corresponding author), Univ Tubingen Hosp, Dept Oral & Maxillofacial Surg, Tubingen, Germany.	dorothea.alexander@med.uni-tuebingen.de			Bundesministerium fur Bildung und Forschung (BMBF) [FKZO1KQ0902A]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was partially sponsored by Bundesministerium fur Bildung und Forschung (BMBF) (funder's website: www.bmbf.de) in the framework of REGiNA (grant number: FKZO1KQ0902A). MR was financed by BMBF. No additional external funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D, 2011, CELL BIOL INT, V35, P973, DOI 10.1042/CBI20100836; Alexander D, 2010, CELL PHYSIOL BIOCHEM, V26, P1073, DOI 10.1159/000323985; Alexander D, 2009, CELL PHYSIOL BIOCHEM, V24, P283, DOI 10.1159/000233253; Alipoor FJ, 2009, J ASSIST REPROD GEN, V26, P143, DOI 10.1007/s10815-009-9298-6; Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Buhring HJ, 2007, ANN NY ACAD SCI, V1106, P262, DOI 10.1196/annals.1392.000; Chen DY, 2011, INT J MOL MED, V27, P707, DOI 10.3892/ijmm.2011.634; Choi YS, 2008, BIOTECHNOL LETT, V30, P593, DOI 10.1007/s10529-007-9584-2; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753; Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Handgretinger R, 2003, ANN NY ACAD SCI, V996, P141, DOI 10.1111/j.1749-6632.2003.tb03242.x; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Hutmacher DW, 2003, TISSUE ENG, V9, pS45, DOI 10.1089/10763270360696978; Kawase T, 2009, J TISSUE ENG REGEN M, V3, P218, DOI 10.1002/term.156; Kim Y, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2751414; Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376; Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109; Melendez-Zajgla J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-85; Mucci I, 2009, BIOLOGICALS, V37, P288, DOI 10.1016/j.biologicals.2009.05.004; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Olsen HS, 1996, P NATL ACAD SCI USA, V93, P1792, DOI 10.1073/pnas.93.5.1792; Pafumi C, 2002, PEDIATR HEMAT ONCOL, V19, P239, DOI 10.1080/08880010252899406; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Sobiesiak M, 2010, STEM CELLS DEV, V19, P669, DOI 10.1089/scd.2009.0290; SQUIER CA, 1990, J ANAT, V171, P233; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Torroni A, 2009, J ORAL MAXIL SURG, V67, P1121, DOI 10.1016/j.joms.2008.11.020; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Yoshiko Y, 2002, J HISTOCHEM CYTOCHEM, V50, P483, DOI 10.1177/002215540205000405	34	21	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47176	10.1371/journal.pone.0047176	http://dx.doi.org/10.1371/journal.pone.0047176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094035	Green Published, gold, Green Submitted			2022-12-27	WOS:000310050200016
J	Mitchell, MD; Cowman, PF; McCormick, MI				Mitchell, Matthew D.; Cowman, Peter F.; McCormick, Mark I.			Chemical Alarm Cues Are Conserved within the Coral Reef Fish Family Pomacentridae	PLOS ONE			English	Article							BEHAVIORAL-RESPONSES; HABITAT UTILIZATION; PREDATOR AVOIDANCE; SKIN EXTRACT; RISK; CONSPECIFICS; RECOGNITION; ENCOUNTERS; SURVIVAL; SIGNALS	Fishes are known to use chemical alarm cues from both conspecifics and heterospecifics to assess local predation risks and enhance predator detection. Yet it is unknown how recognition of heterospecific cues arises for coral reef fishes. Here, we test if naive juvenile fish have an innate recognition of heterospecific alarm cues. We also examine if there is a relationship between the intensity of the antipredator response to these cues and the degree to which species are related to each other. Naive juvenile anemone fish, Amphiprion percula, were tested to see if they displayed antipredator responses to chemical alarm cues from four closely related heterospecific species (family Pomacentridae), a distantly related sympatric species (Asterropteryx semipunctatus) and a saltwater (control). Juveniles displayed significant reductions in foraging rate when exposed to all four confamilial heterospecific species but they did not respond to the distantly related sympatric species or the saltwater control. There was also a strong relationship between the intensity of the antipredator response and the extent to which species were related, with responses weakening as species became more distantly related. These findings demonstrate that chemical alarm cues are conserved within the pomacentrid family, providing juveniles with an innate recognition of heterospecific alarm cues as predicted by the phylogenetic relatedness hypothesis.	[Mitchell, Matthew D.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Mitchell, MD (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	matthew.mitchell1@my.jcu.edu.au	Cowman, Peter Francis/G-9998-2017; McCormick, Mark I/J-8301-2014	Cowman, Peter Francis/0000-0001-5977-5327; McCormick, Mark I/0000-0001-9289-1645	Australian Research Council; ARC Centre of Excellence for Coral Reef Studies [CE0561432]	Australian Research Council(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	Funding was provided by the Australian Research Council (MIM) and the ARC Centre of Excellence for Coral Reef Studies (Grant No. CE0561432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Berejikian BA, 2003, ENVIRON BIOL FISH, V67, P241, DOI 10.1023/A:1025887015436; BROWN GE, 1995, J FISH BIOL, V47, P387; Brown GE, 2000, J CHEM ECOL, V26, P139, DOI 10.1023/A:1005445629144; Brown Grant E., 2005, P34; Chivers DP, 2007, P ROY SOC B-BIOL SCI, V274, P2611, DOI 10.1098/rspb.2007.0709; CHIVERS DP, 1994, J CHEM ECOL, V20, P1517, DOI 10.1007/BF02059877; Chivers DP, 2002, BEHAVIOUR, V139, P929, DOI 10.1163/156853902320387909; Chivers DP, 2001, CHEM SIGNAL, V9, P277; Commens AM, 1999, J FISH BIOL, V55, P1359, DOI 10.1006/jfbi.1999.1132; Commens-Carson AM, 2007, COPEIA, P838, DOI 10.1643/0045-8511(2007)7[838:ROTDSG]2.0.CO;2; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Dalesman S, 2007, ECOLOGY, V88, P2462, DOI 10.1890/07-0403.1; Dalesman S, 2010, ANIM BEHAV, V79, P173, DOI 10.1016/j.anbehav.2009.10.024; Depczynski M, 2004, MAR BIOL, V145, P455, DOI 10.1007/s002270004-1342-6; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; ELLIOTT JK, 1995, MAR BIOL, V122, P377, DOI 10.1007/BF00350870; Elliott JK, 2001, MAR BIOL, V138, P23, DOI 10.1007/s002270000441; Fallow PM, 2011, BEHAV ECOL, V22, P401, DOI 10.1093/beheco/arq221; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Goldman B, 1976, P125; Golub JL, 2005, J FISH BIOL, V66, P1073, DOI 10.1111/j.0022-1112.2005.00658.x; Golub JL, 2003, BEHAV ECOL SOCIOBIOL, V54, P113, DOI 10.1007/s00265-003-0629-9; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Halbgewachs CF, 2009, BIOL J LINN SOC, V98, P891, DOI 10.1111/j.1095-8312.2009.01328.x; Haney DC, 2001, J FISH BIOL, V59, P810, DOI 10.1006/jfbi.2001.1690; Hartman EJ, 2000, P ROY SOC B-BIOL SCI, V267, P571, DOI 10.1098/rspb.2000.1039; Hazlett BA, 2005, J CHEM ECOL, V31, P671, DOI 10.1007/s10886-005-2054-1; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Huryn AD, 1999, J CHEM ECOL, V25, P2729, DOI 10.1023/A:1020851524335; Karplus I, 2006, MAR ECOL PROG SER, V319, P215, DOI 10.3354/meps319215; Leahy SM, 2011, BIOL LETTERS, V7, P811, DOI 10.1098/rsbl.2011.0645; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516; Mariscal R. N., 1970, Univ. Calif. Publs Zool., V91, P1; MATHIS A, 1993, BEHAV ECOL, V4, P260, DOI 10.1093/beheco/4.3.260; McCormick MI, 2006, J FISH BIOL, V68, P969, DOI 10.1111/j.1095-8649.2006.00982.x; MILICICH MJ, 1994, MAR ECOL PROG SER, V110, P121, DOI 10.3354/meps110121; Mirza RS, 2003, BEHAVIOUR, V140, P1359, DOI 10.1163/156853903771980620; Mirza RS, 2001, ETHOLOGY, V107, P989, DOI 10.1046/j.1439-0310.2001.00729.x; Mirza RS, 2001, J CHEM ECOL, V27, P1641, DOI 10.1023/A:1010414426082; Mirza RS, 2001, CHEM SIGNALS VERTEBR, V9; Mitchell MD, 2011, ANIM COGN, V14, P707, DOI 10.1007/s10071-011-0405-6; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; Schoeppner NM, 2009, COPEIA, P190, DOI 10.1643/CE-08-041; Schoeppner NM, 2005, ECOL LETT, V8, P505, DOI 10.1111/j.1461-0248.2005.00744.x; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Shriner WM, 1998, ANIM BEHAV, V55, P529, DOI 10.1006/anbe.1997.0623; SMITH RJF, 1991, J CHEM ECOL, V17, P2253, DOI 10.1007/BF00988005; St John J., 1995, THESIS J COOK U N QU; Sullivan AM, 2003, BEHAVIOUR, V140, P553, DOI 10.1163/156853903322127977; THRESHER RE, 1985, ECOLOGY, V66, P1139, DOI 10.2307/1939166; Vadas RL, 2003, MAR ECOL, V24, P100; Vail AL, 2011, BIOL LETTERS, V7, P921, DOI 10.1098/rsbl.2011.0380; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x	56	42	42	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47428	10.1371/journal.pone.0047428	http://dx.doi.org/10.1371/journal.pone.0047428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094047	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000312384500009
J	Rangrez, AY; M'Baya-Moutoula, E; Metzinger-Le Meuth, V; Henaut, L; Djelouat, MSE; Benchitrit, J; Massy, ZA; Metzinger, L				Rangrez, Ashraf Yusuf; M'Baya-Moutoula, Eleonore; Metzinger-Le Meuth, Valerie; Henaut, Lucie; Djelouat, Mohamed Seif el Islam; Benchitrit, Joyce; Massy, Ziad A.; Metzinger, Laurent			Inorganic Phosphate Accelerates the Migration of Vascular Smooth Muscle Cells: Evidence for the Involvement of miR-223	PLOS ONE			English	Article							GENE-EXPRESSION; CALCIFICATION; MICRORNA-223; METABOLISM; PHENOTYPE; MIR-145; GROWTH; MICE	Backgound: An elevated serum inorganic phosphate (Pi) level is a major risk factor for kidney disease and downstream vascular complications. We focused on the effect of Pi levels on human aortic vascular smooth muscle cells (VSMCs), with an emphasis on the role of microRNAs (miRNAs). Methodology/Principal Findings: Exposure of human primary VSMCs in vitro to pathological levels of Pi increased calcification, migration rate and concomitantly reduced cell proliferation and the amount of the actin cytoskeleton. These changes were evidenced by significant downregulation of miRNA-143 (miR-143) and miR-145 and concomitant upregulation of their targets and key markers in synthetic VSMCs, such as Kruppel-like factors -4 and -5 and versican. Interestingly, we also found that miR-223 (a marker of muscle damage and a key factor in osteoclast differentiation) is expressed in VSMCs and is significantly upregulated in Pi-treated cells. Over-expressing miR-223 in VSMCs increased proliferation and markedly enhanced VSMC migration. Additionally, we found that the expression of two of the known miR-223 targets, Mef2c and RhoB, was highly reduced in Pi treated as well as miR-223 over-expressing VSMCs. To complement these in vitro findings, we also observed significant downregulation of miR-143 and miR-145 and upregulation of miR-223 in aorta samples collected from ApoE knock-out mice, which display vascular calcification. Conclusions/Significance: Our results suggest that (i) high levels of Pi increase VSMC migration and calcification, (ii) altered expression levels of miR-223 could play a part in this process and (iii) miR-223 is a potential new biomarker of VSMC damage.	[Rangrez, Ashraf Yusuf; M'Baya-Moutoula, Eleonore; Metzinger-Le Meuth, Valerie; Henaut, Lucie; Djelouat, Mohamed Seif el Islam; Benchitrit, Joyce; Massy, Ziad A.; Metzinger, Laurent] INSERM, U1088, Amiens, France; [Rangrez, Ashraf Yusuf; M'Baya-Moutoula, Eleonore; Henaut, Lucie; Djelouat, Mohamed Seif el Islam; Benchitrit, Joyce; Massy, Ziad A.; Metzinger, Laurent] Jules Verne Univ Picardie, Fac Pharm & Med, Amiens, France; [Massy, Ziad A.] Amiens Univ Hosp, Div Pharmacol Nephrol, Amiens, France; [Metzinger-Le Meuth, Valerie] Univ Paris 13, UFR SMBH, Bobigny, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite Paris 13	Metzinger, L (corresponding author), INSERM, U1088, Amiens, France.	laurent.metzinger@u-picardie.fr	Meuth, Valérie Metzinger-Le/H-6338-2016; Rangrez, Ashraf/H-4988-2016; Hénaut, Lucie/AAN-6974-2020; metzinger, laurent/AAY-4634-2021; Metzinger, Laurent/B-1426-2016	Meuth, Valérie Metzinger-Le/0000-0003-1718-5083; Rangrez, Ashraf/0000-0003-2630-9754; metzinger, laurent/0000-0002-7636-8480; Metzinger, Laurent/0000-0002-7636-8480	Region Picardie, France	Region Picardie, France(Region Hauts-de-France)	This work was supported by grants from Region Picardie, France ("MARNO-MPCC" and "Modulation des calcifications cardiovasculaires"), including post-doctoral fellowships for AYR and EMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Eyholzer M, 2010, LEUKEMIA RES, V34, P672, DOI 10.1016/j.leukres.2009.11.019; FATIGATI V, 1984, J BIOL CHEM, V259, P4383; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Goettsch C, 2011, AM J PATHOL, V179, P1594, DOI 10.1016/j.ajpath.2011.06.016; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Ivanovski O, 2009, ATHEROSCLEROSIS, V205, P55, DOI 10.1016/j.atherosclerosis.2008.10.043; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Liu QF, 2011, INT J CANCER, V129, P2662, DOI 10.1002/ijc.25921; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Maizel J, 2009, CIRCULATION, V119, P306, DOI 10.1161/CIRCULATIONAHA.108.797407; Massy ZA, 2005, J AM SOC NEPHROL, V16, P109, DOI 10.1681/ASN.2004060495; Mozar A, 2008, J CELL PHYSIOL, V215, P47, DOI 10.1002/jcp.21283; Mune S, 2009, CLIN EXP NEPHROL, V13, P571, DOI 10.1007/s10157-009-0208-0; Nagai R, 2005, J THROMB HAEMOST, V3, P1569, DOI 10.1111/j.1538-7836.2005.01366.x; Neven E, 2011, CIRC RES, V108, P249, DOI 10.1161/CIRCRESAHA.110.225904; Pagiatakis C, 2012, J BIOL CHEM, V287, P8361, DOI 10.1074/jbc.M111.286203; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335; Sun G, NUCL ACIDS RES, V38, P239; Tang JR, 2002, BIOCHEM BIOPH RES CO, V290, P1255, DOI 10.1006/bbrc.2002.6336; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Wang X, J BIOL CHEM, V285, P23241; Wojciak-Stothard B, 2012, CIRC RES, V110, P1423, DOI 10.1161/CIRCRESAHA.112.264473; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x	37	90	96	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47807	10.1371/journal.pone.0047807	http://dx.doi.org/10.1371/journal.pone.0047807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094093	Green Published, gold, Green Submitted			2022-12-27	WOS:000312384500026
J	Lindqvist, D; Kaufman, E; Brundin, L; Hall, S; Surova, Y; Hansson, O				Lindqvist, Daniel; Kaufman, Eli; Brundin, Lena; Hall, Sara; Surova, Yulia; Hansson, Oskar			Non-Motor Symptoms in Patients with Parkinson's Disease - Correlations with Inflammatory Cytokines in Serum	PLOS ONE			English	Article							MAJOR DEPRESSION; CEREBROSPINAL-FLUID; DOUBLE-BLIND; TNF-ALPHA; INTERLEUKIN-2; CELECOXIB; METAANALYSIS; ASSOCIATION; DISORDERS; RECEPTOR	Background: Parkinson's Disease (PD) is the second most common neurodegenerative disorder of the central nervous system. Motor symptoms are the focus of pharmacotherapy, yet non-motor features of the disease (e. g. fatigue, mood disturbances, sleep disturbances and symptoms of anxiety) are both common and disabling for the patient. The pathophysiological mechanisms behind the non-motor symptoms in PD are yet to be untangled. The main objective of this study was to investigate associations between pro-inflammatory substances and non-motor symptoms in patients with PD. Methods and Materials: We measured C-reactive protein, interleukin (IL)-6, soluble IL-2 receptor (sIL-2R) and tumor necrosis factor-alpha (TNF-alpha) in blood samples from PD patients (n = 86) and healthy controls (n = 40). Symptoms of fatigue, depression, anxiety and sleeping difficulties were assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT), the Hospital Anxiety and Depression Scale (HAD), and the Scales for Outcome in PD-Sleep Scale respectively. Results: IL-6 was significantly higher in PD patients than in healthy controls. Compared to healthy controls, PD patients displayed significantly higher mean scores on HAD and lower scores on FACIT, thus indicating more severe symptoms as measured with these scales. Within the PD sample, high levels of both sIL-2R and TNF-alpha were significantly associated with more severe symptoms assessed by means of FACIT and HAD (depression and anxiety subscales). SIL-2-R levels were able to significantly predict FACIT and HAD scores after the effects of age, gender, anti-parkinsonian medications, and severity of motor symptoms were controlled for. Discussion: We suggest that non-motor symptoms in PD patients, such as fatigue and depressive symptoms, might be generated via inflammatory mechanisms. This knowledge might contribute to the development of novel treatment options in PD, specifically targeting non-motor symptoms.	[Lindqvist, Daniel; Kaufman, Eli; Brundin, Lena] Lund Univ, Dept Clin Sci, Sect Psychiat, Lund, Sweden; [Lindqvist, Daniel] Psychiat Skane, Lund, Sweden; [Brundin, Lena] Michigan State Univ, Dept Translat Sci & Mol Med, Grand Rapids, MI USA; [Hall, Sara; Surova, Yulia; Hansson, Oskar] Skane Univ Hosp, Dept Neurol, Lund, Sweden; [Hansson, Oskar] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Malmo, Sweden	Lund University; Michigan State University; Lund University; Skane University Hospital; Lund University	Lindqvist, D (corresponding author), Lund Univ, Dept Clin Sci, Sect Psychiat, Lund, Sweden.	Daniel.Lindqvist@med.lu.se	Lindenmayer, David B/P-7183-2017; Hansson, Oskar/A-7134-2013	Lindenmayer, David B/0000-0002-4766-4088; Hansson, Oskar/0000-0001-8467-7286; Brundin, Lena/0000-0002-8327-6242	Swedish Research Council; Sjobring Foundation; OM Persson Foundation; province of Scania state grants (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Sjobring Foundation; OM Persson Foundation; province of Scania state grants (ALF)	This study was performed with the support of the Swedish Research Council grants, the Sjobring Foundation, OM Persson Foundation and the province of Scania state grants (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2009, MOVEMENT DISORD, V24, P2175, DOI 10.1002/mds.22589; Akhondzadeh S, 2009, DEPRESS ANXIETY, V26, P607, DOI 10.1002/da.20589; Barnum CJ, 2008, NEUROSCIENCE, V156, P30, DOI 10.1016/j.neuroscience.2008.07.016; Barnum CJ, 2012, CURR NEUROL IN PRESS; Bjorklund A, 2010, PROG BRAIN RES, V184, P113, DOI 10.1016/S0079-6123(10)84006-3; BlumDegen D, 1995, NEUROSCI LETT, V202, P17, DOI 10.1016/0304-3940(95)12192-7; CARUSO C, 1993, MEDIAT INFLAMM, V2, P3, DOI 10.1155/S0962935193000018; Cella D, 1997, MANUAL FUNCTIONAL AS; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dinh W, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-58; Dobbs RJ, 1999, ACTA NEUROL SCAND, V100, P34, DOI 10.1111/j.1600-0404.1999.tb00721.x; Findley L, 2003, MOVEMENT DISORD, V18, P1139, DOI 10.1002/mds.10507; Gagne JJ, 2010, NEUROLOGY, V74, P995, DOI 10.1212/WNL.0b013e3181d5a4a3; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Hagell P, 2009, J NEUROL NEUROSUR PS, V80, P489, DOI 10.1136/jnnp.2008.159772; Hou RH, 2012, HUM PSYCHOPHARM CLIN, V27, P6, DOI 10.1002/hup.1259; Jacob EL, 2010, PARKINSONISM RELAT D, V16, P576, DOI 10.1016/j.parkreldis.2010.06.014; KLUTER H, 1995, J NEUROL SCI, V133, P134, DOI 10.1016/0022-510X(95)00180-A; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Liu Y., 2011, JFSP RES PROJECT REP, P1; Marinus J, 2003, SLEEP, V26, P1049, DOI 10.1093/sleep/26.8.1049; McKinlay A, 2008, PARKINSONISM RELAT D, V14, P37, DOI 10.1016/j.parkreldis.2007.05.009; Menza M, 2010, PSYCHOSOMATICS, V51, P474, DOI 10.1176/appi.psy.51.6.474; Menza M, 2010, MOVEMENT DISORD, V25, pS117, DOI 10.1002/mds.22788; Muller N, 2006, MOL PSYCHIATR, V11, P680, DOI 10.1038/sj.mp.4001805; Muller T, 1998, ACTA NEUROL SCAND, V98, P142; Nilsson FM, 2002, ACTA PSYCHIAT SCAND, V106, P202, DOI 10.1034/j.1600-0447.2002.02229.x; Ouchi Y, 2009, PARKINSONISM RELAT D, V15, pS200, DOI 10.1016/S1353-8020(09)70814-4; Palhagen S, 2010, J NEUROL, V257, P524, DOI 10.1007/s00415-009-5353-6; Raison CL, 2009, BRAIN BEHAV IMMUN, V23, P327, DOI 10.1016/j.bbi.2008.11.005; Reale M, 2009, BRAIN BEHAV IMMUN, V23, P55, DOI 10.1016/j.bbi.2008.07.003; Rees K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008454.pub2; RUBIN LA, 1990, ANN INTERN MED, V113, P619, DOI 10.7326/0003-4819-113-8-619; Sairam K, 2003, BRAIN RES, V966, P245, DOI 10.1016/S0006-8993(02)04174-4; Scalzo P, 2010, NEUROSCI LETT, V468, P56, DOI 10.1016/j.neulet.2009.10.062; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; Teismann P, 2001, SYNAPSE, V39, P167, DOI 10.1002/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Weintraub D, 2005, MOVEMENT DISORD, V20, P1161, DOI 10.1002/mds.20555; Weintraub D, 2004, J AM GERIATR SOC, V52, P784, DOI 10.1111/j.1532-5415.2004.52219.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	44	170	177	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47387	10.1371/journal.pone.0047387	http://dx.doi.org/10.1371/journal.pone.0047387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082161	gold, Green Published, Green Submitted			2022-12-27	WOS:000311146900057
J	Lopez-Rodriguez, A; Holmgren, M				Lopez-Rodriguez, Angelica; Holmgren, Miguel			Restoration of Proper Trafficking to the Cell Surface for Membrane Proteins Harboring Cysteine Mutations	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNELS; SHAKER K+ CHANNEL; RENAL TUBULAR-ACIDOSIS; ION CHANNELS; FUNCTIONAL EXPRESSION; CHEMICAL CHAPERONES; POTASSIUM CHANNEL; COMPLEMENTARY-DNA; GAUCHER-DISEASE; CNGA3 MUTATIONS	A common phenotype for many genetic diseases is that the cell is unable to deliver full-length membrane proteins to the cell surface. For some forms of autism, hereditary spherocytosis and color blindness, the culprits are single point mutations to cysteine. We have studied two inheritable cysteine mutants of cyclic nucleotide-gated channels that produce achromatopsia, a common form of severe color blindness. By taking advantage of the reactivity of cysteine's sulfhydryl group, we modified these mutants with chemical reagents that attach moieties with similar chemistries to the wild-type amino acids' side chains. We show that these modifications restored proper delivery to the cell membrane. Once there, the channels exhibited normal functional properties. This strategy might provide a unique opportunity to assess the chemical nature of membrane protein traffic problems.	[Lopez-Rodriguez, Angelica; Holmgren, Miguel] NINDS, Neurophysiol Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Holmgren, M (corresponding author), NINDS, Neurophysiol Sect, Porter Neurosci Res Ctr, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	holmgren@ninds.nih.gov		Lopez-Rodriguez, Angelica/0000-0003-4411-8441	National Institutes of Health, National Institute Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002993] Funding Source: NIH RePORTER	National Institutes of Health, National Institute Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Bartoli M, 2008, HUM MOL GENET, V17, P1214, DOI 10.1093/hmg/ddn029; BONIGK W, 1993, NEURON, V10, P865, DOI 10.1016/0896-6273(93)90202-3; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Dhermy D, 1999, MOL MEMBR BIOL, V16, P305, DOI 10.1080/096876899294526; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Duricka DL, 2012, BIOCHEM J, V441, P685, DOI 10.1042/BJ20111004; Faillace MP, 2004, J BIOL CHEM, V279, P22643, DOI 10.1074/jbc.M400035200; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Koeppen K, 2008, EUR J NEUROSCI, V27, P2391, DOI 10.1111/j.1460-9568.2008.06195.x; Liu CM, 2005, AM J PHYSIOL-CELL PH, V289, pC187, DOI 10.1152/ajpcell.00490.2004; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Pages F, 2000, BIOPHYS J, V78, P1227, DOI 10.1016/S0006-3495(00)76680-X; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Patel KA, 2005, INVEST OPHTH VIS SCI, V46, P2282, DOI 10.1167/iovs.05-0179; Peng CH, 2004, NEURON, V42, P401, DOI 10.1016/S0896-6273(04)00225-9; Peng CH, 2003, J BIOL CHEM, V278, P34533, DOI 10.1074/jbc.M305102200; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; Reuter P, 2008, HUM MUTAT, V29, P1228, DOI 10.1002/humu.20790; Rungroj N, 2004, J BIOL CHEM, V279, P13833, DOI 10.1074/jbc.M400188200; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; STRYER L, 1988, COLD SPRING HARB SYM, V53, P283, DOI 10.1101/SQB.1988.053.01.035; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Toye AM, 2006, AM J PHYSIOL-CELL PH, V291, pC788, DOI 10.1152/ajpcell.00094.2006; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Yu ZQ, 2007, FEBS J, V274, P4944, DOI 10.1111/j.1742-4658.2007.06042.x; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	43	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47693	10.1371/journal.pone.0047693	http://dx.doi.org/10.1371/journal.pone.0047693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082193	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900090
J	van der Donk, CFM; van de Bovenkamp, JHB; De Brauwer, EIGB; De Mol, P; Feldhoff, KH; Kalka-Moll, WM; Nys, S; Thoelen, I; Trienekens, TAM; Stobberingh, EE				van der Donk, Christina F. M.; van de Bovenkamp, Jeroen H. B.; De Brauwer, Els I. G. B.; De Mol, Patrick; Feldhoff, Karl-Heinz; Kalka-Moll, Wiltrud M.; Nys, Sita; Thoelen, Inge; Trienekens, Thera A. M.; Stobberingh, Ellen E.			Antimicrobial Resistance and Spread of Multi Drug Resistant Escherichia coli Isolates Collected from Nine Urology Services in the Euregion Meuse-Rhine	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; URINARY-TRACT-INFECTIONS; BETA-LACTAMASE GENES; ANTIBIOTIC SUSCEPTIBILITY; SPECTRUM; ENTEROBACTERIACEAE; SURVEILLANCE; CYSTITIS; EUROPE; TRENDS	We determined the prevalence and spread of antibiotic resistance and the characteristics of ESBL producing and/or multi drug resistant (MDR) Escherichia coli isolates collected from urine samples from urology services in the Euregio Meuse-Rhine, the border region of the Netherlands (n = 176), Belgium (n = 126) and Germay (n = 119). Significant differences in resistance between the three regions were observed. Amoxicillin-clavulanic acid resistance ranged from 24% in the Netherlands to 39% in Belgium (p = 0.018), from 20% to 40% (p<0.004) for the fluoroquinolones and from 20% to 40% (p = 0.018) for the folate antagonists. Resistance to nitrofurantoin was less than 5%. The prevalence of ESBL producing isolates varied from 2% among the Dutch isolates to 8% among the German ones (p = 0.012) and were mainly CTX-M 15. The prevalence of MDR isolates among the Dutch, German and Belgian isolates was 11%, 17% and 27%, respectively (p<=0.001 for the Belgian compared with the Dutch isolates). The majority of the MDR and ESBL producing isolates belonged to ST131. This study indicates that most antibiotics used as first choice oral empiric treatment for UTIs (amoxicillin-clavulanic acid, fluoroquinolones and folate antagonists) are not appropriate for this purpose and that MDR strains such as CTX-M producing ST131 have spread in the entire Euregion. Our data stress the importance of ward specific surveillance to optimize empiric treatment. Also, prudent use of antibiotics and further research to alternative agents are warranted.	[van der Donk, Christina F. M.; Stobberingh, Ellen E.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands; [van der Donk, Christina F. M.; Stobberingh, Ellen E.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [van de Bovenkamp, Jeroen H. B.] PAMM, Lab Med Microbiol, Veldhoven, Netherlands; [De Brauwer, Els I. G. B.] Atrium Med Ctr, Dept Med Microbiol, Heerlen, Netherlands; [De Mol, Patrick] Ctr Hosp Univ Liege, Microbiol Lab, Liege, Belgium; [Feldhoff, Karl-Heinz] Gesundheitsamt Kreises Heinsberg, Heinsberg, Germany; [Kalka-Moll, Wiltrud M.] Med Care Ctr Dr Stein & Colleagues, Monchengladbach, Germany; [Nys, Sita] Jessa Hosp, Dept Biol Clin, Hasselt, Belgium; [Thoelen, Inge] Gen Hosp Vesalius, Dept Biol Clin, Tongeren, Belgium; [Trienekens, Thera A. M.] VieCuri Med Ctr, Dept Med Microbiol, Venlo, Netherlands	Maastricht University; Maastricht University; Atrium Medical Center; University of Liege; VieCuri Medical Center	Stobberingh, EE (corresponding author), Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands.	e.stobberingh@mumc.nl			Provincie Limburg - the Netherlands; Ministerium fur Wirtschaft; Energie; Bauen; Wohnen und Verkehr des Landes Nordrhein-Westfalen - Germany; Ministerium der Deutschsprachige Gemeinschaft Belgiens - Belgium; Provincie Limburg - Belgium; Wallonie - Belgium; Rheinland-Westfalen - Germany; Interreg; Euregio Meuse-Rhine; European fund for regional development (EFRO)	Provincie Limburg - the Netherlands; Ministerium fur Wirtschaft; Energie; Bauen; Wohnen und Verkehr des Landes Nordrhein-Westfalen - Germany; Ministerium der Deutschsprachige Gemeinschaft Belgiens - Belgium; Provincie Limburg - Belgium; Wallonie - Belgium; Rheinland-Westfalen - Germany; Interreg; Euregio Meuse-Rhine; European fund for regional development (EFRO)(European Commission)	This project was financially supported by Provincie Limburg - the Netherlands, Ministerium fur Wirtschaft, Energie, Bauen, Wohnen und Verkehr des Landes Nordrhein-Westfalen - Germany, Ministerium der Deutschsprachige Gemeinschaft Belgiens - Belgium, Provincie Limburg - Belgium, Wallonie - Belgium, Rheinland-Westfalen - Germany, Interreg, the Euregio Meuse-Rhine and the European fund for regional development (EFRO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charalabopoulos K, 2003, CHEMOTHERAPY, V49, P269, DOI 10.1159/000074526; Colodner R, 2008, INFECTION, V36, P41, DOI 10.1007/s15010-007-7083-y; Coque T M, 2008, Euro Surveill, V13; Cullen IM, 2011, BJU INT, P1999; De Backer D, 2008, J ANTIMICROB CHEMOTH, V62, P364, DOI 10.1093/jac/dkn197; den Heijer CDJ, 2010, J ANTIMICROB CHEMOTH, V65, P2128, DOI 10.1093/jac/dkq286; ECDC, 2020, ANN REPORT EUROPEAN; EIS, 2006, EUR MEUSE RHIN FIG; EUCAST, 2011, EUCAST BREAKP TABL I; Gibreel TM, 2012, J ANTIMICROB CHEMOTH, V67, P346, DOI 10.1093/jac/dkr451; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Jans B, 2009, SURVEILLANCE MULTIRE; Lee SS, 2011, J INFECTION, V62, P159, DOI 10.1016/j.jinf.2010.10.009; Naber KG, 2008, EUR UROL, V54, P1164, DOI 10.1016/j.eururo.2008.05.010; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; NVMM, 2008, ENT; Nys S, 2008, J ANTIMICROB CHEMOTH, V62, P126, DOI 10.1093/jac/dkn151; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Pallecchi L, 2004, ANTIMICROB AGENTS CH, V48, P4556, DOI 10.1128/AAC.48.12.4556-4561.2004; Pitout JDD, 2009, ANTIMICROB AGENTS CH, V53, P2846, DOI 10.1128/AAC.00247-09; Raz R, 2012, CLIN MICROBIOL INFEC, V18, P4, DOI 10.1111/j.1469-0691.2011.03636.x; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rodriguez-Villalobos H, 2011, J ANTIMICROB CHEMOTH, V66, P37, DOI 10.1093/jac/dkq388; Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1016/S0378-1097(02)00484-6; SWAB, 2011, NETHM 2011 CONS ANT; SWAB, 2006, RICHTL ANT THER BIJ; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; van der Donk CFM, 2011, J ANTIMICROB CHEMOTH, V66, P855, DOI 10.1093/jac/dkq538; Wagenlehner FME, 2008, INT J ANTIMICROB AG, V31, pS25, DOI 10.1016/j.ijantimicag.2007.07.029; Yagupsky P, 2006, PEDIATR INFECT DIS J, V25, P974, DOI 10.1097/01.inf.0000239270.33190.71	31	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47707	10.1371/journal.pone.0047707	http://dx.doi.org/10.1371/journal.pone.0047707			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082197	Green Published, gold, Green Submitted			2022-12-27	WOS:000311146900094
J	Yin, LY; Colman, BP; McGill, BM; Wright, JP; Bernhardt, ES				Yin, Liyan; Colman, Benjamin P.; McGill, Bonnie M.; Wright, Justin P.; Bernhardt, Emily S.			Effects of Silver Nanoparticle Exposure on Germination and Early Growth of Eleven Wetland Plants	PLOS ONE			English	Article							DEPENDENT TOXICITY; PHYTOTOXICITY; NANOSILVER; IMPACTS; STRESS; OXYGEN	The increasing commercial production of engineered nanoparticles (ENPs) has led to concerns over the potential adverse impacts of these ENPs on biota in natural environments. Silver nanoparticles (AgNPs) are one of the most widely used ENPs and are expected to enter natural ecosystems. Here we examined the effects of AgNPs on germination and growth of eleven species of common wetland plants. We examined plant responses to AgNP exposure in simple pure culture experiments (direct exposure) and for seeds planted in homogenized field soils in a greenhouse experiment (soil exposure). We compared the effects of two AgNPs-20-nm polyvinylpyrrolidine-coated silver nanoparticles (PVP-AgNPs) and 6-nm gum arabic coated silver nanoparticles (GA-AgNPs)-to the effects of AgNO3 exposure added at equivalent Ag concentrations (1, 10 or 40 mg Ag L-1). In the direct exposure experiments, PVP-AgNP had no effect on germination while 40 mg Ag L-1 GA-AgNP exposure significantly reduced the germination rate of three species and enhanced the germination rate of one species. In contrast, 40 mg Ag L-1 AgNO3 enhanced the germination rate of five species. In general root growth was much more affected by Ag exposure than was leaf growth. The magnitude of inhibition was always greater for GA-AgNPs than for AgNO3 and PVP-AgNPs. In the soil exposure experiment, germination effects were less pronounced. The plant growth response differed by taxa with Lolium multiflorum growing more rapidly under both AgNO3 and GA-AgNP exposures and all other taxa having significantly reduced growth under GA-AgNP exposure. AgNO3 did not reduce the growth of any species while PVP-AgNPs significantly inhibited the growth of only one species. Our findings suggest important new avenues of research for understanding the fate and transport of NPs in natural media, the interactions between NPs and plants, and indirect and direct effects of NPs in mixed plant communities.	[Yin, Liyan] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China; [Yin, Liyan; Colman, Benjamin P.; Bernhardt, Emily S.] Duke Univ, Ctr Environm Implicat Nanotechnol, Durham, NC USA; [Yin, Liyan; Colman, Benjamin P.; McGill, Bonnie M.; Wright, Justin P.; Bernhardt, Emily S.] Duke Univ, Dept Biol, Durham, NC USA	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Duke University; Duke University	Yin, LY (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China.	lyyin@163.com	Wright, Justin/AAG-6461-2019; Colman, Benjamin/B-5704-2009; Colman, Benjamin P./AGJ-4864-2022; Bernhardt, Emily S/D-9940-2011; Bernhardt, Emily/B-4541-2010; McGill, Bonnie/AAT-7426-2020	Wright, Justin/0000-0002-9102-5347; Colman, Benjamin/0000-0001-6290-3705; Colman, Benjamin P./0000-0001-6290-3705; Bernhardt, Emily S/0000-0003-3031-621X; McGill, Bonnie/0000-0002-5417-3519; Hu, Mengjun/0000-0003-1567-0843	Chinese Academy of Sciences; National Natural Science Foundation of China [31170481]; National Science Foundation (NSF) [29970065]; Environmental Protection Agency (EPA) under NSF, Center for the Environmental Implications of NanoTechnology(CEINT) [EF-0830093]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation (NSF)(National Science Foundation (NSF)); Environmental Protection Agency (EPA) under NSF, Center for the Environmental Implications of NanoTechnology(CEINT)(United States Environmental Protection Agency)	During this work, L.Y. was supported as a visiting scholar at Duke University by a fellowship from the Chinese Academy of Sciences and the National Natural Science Foundation of China (31170481). This material is based upon work supported by the National Science Foundation (NSF)(29970065), and the Environmental Protection Agency (EPA) under NSF Cooperative Agreement EF-0830093, Center for the Environmental Implications of NanoTechnology(CEINT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaout CL, 2012, ENVIRON SCI TECHNOL, V46, P5387, DOI 10.1021/es204540z; Asharani PV, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255102; Bailey-Serres J, 2010, CURR OPIN PLANT BIOL, V13, P489, DOI 10.1016/j.pbi.2010.08.002; Benn TM, 2008, ENVIRON SCI TECHNOL, V42, P4133, DOI 10.1021/es7032718; Bernhardt ES, 2010, J ENVIRON QUAL, V39, P1954, DOI 10.2134/jeq2009.0479; Blaser SA, 2008, SCI TOTAL ENVIRON, V390, P396, DOI 10.1016/j.scitotenv.2007.10.010; Bradford A, 2009, ENVIRON SCI TECHNOL, V43, P4530, DOI 10.1021/es9001949; Calabrese EJ, 2000, HUM EXP TOXICOL, V19, P2, DOI 10.1191/096032700678815585; CARPITA N, 1979, SCIENCE, V205, P1144, DOI 10.1126/science.205.4411.1144; Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h; Colman BP, 2012, ECOTOXICOLOGY, V21, P1867, DOI 10.1007/s10646-012-0920-5; Dietz KJ, 2011, TRENDS PLANT SCI, V16, P582, DOI 10.1016/j.tplants.2011.08.003; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6; Geisler-Lee J, 2013, NANOTOXICOLOGY, V7, P323, DOI 10.3109/17435390.2012.658094; Glover RD, 2011, ACS NANO, V5, P8950, DOI 10.1021/nn2031319; Gubbins EJ, 2011, ENVIRON POLLUT, V159, P1551, DOI 10.1016/j.envpol.2011.03.002; Jiang HS, 2012, ENVIRON TOXICOL CHEM, V31, P1880, DOI 10.1002/etc.1899; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Kim J, 2011, NANOTOXICOLOGY, V5, P208, DOI 10.3109/17435390.2010.508137; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; Kumari M, 2009, SCI TOTAL ENVIRON, V407, P5243, DOI 10.1016/j.scitotenv.2009.06.024; Lin DH, 2007, ENVIRON POLLUT, V150, P243, DOI 10.1016/j.envpol.2007.01.016; Ma JW, 2011, J BIOMED NANOTECHNOL, V7, P263, DOI 10.1166/jbn.2011.1286; Meyer JN, 2010, AQUAT TOXICOL, V100, P140, DOI 10.1016/j.aquatox.2010.07.016; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Neal AL, 2008, ECOTOXICOLOGY, V17, P362, DOI 10.1007/s10646-008-0217-x; Reinsch BC, 2012, ENVIRON SCI TECHNOL, V46, P6992, DOI 10.1021/es203732x; Ruffini Castiglione M, 2009, CARYOLOGIA, V62, P161, DOI 10.1080/00087114.2004.10589681; Sresty TVS, 1999, ENVIRON EXP BOT, V41, P3, DOI 10.1016/S0098-8472(98)00034-3; Stampoulis D, 2009, ENVIRON SCI TECHNOL, V43, P9473, DOI 10.1021/es901695c; van der Zande M, 2011, TOXICOL LETT, V205, pS289, DOI 10.1016/j.toxlet.2011.05.979; Wierzbicka M, 1998, PLANT SCI, V137, P155, DOI 10.1016/S0168-9452(98)00138-1; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Xiu ZM, 2011, ENVIRON SCI TECHNOL, V45, P9003, DOI 10.1021/es201918f; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Yin LY, 2011, ENVIRON SCI TECHNOL, V45, P2360, DOI 10.1021/es103995x	39	204	213	5	204	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47674	10.1371/journal.pone.0047674	http://dx.doi.org/10.1371/journal.pone.0047674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091638	gold, Green Published, Green Submitted			2022-12-27	WOS:000310135800063
J	Artunc, F; Mueller, C; Breidthardt, T; Twerenbold, R; Peter, A; Thamer, C; Weyrich, P; Haering, HU; Friedrich, B				Artunc, Ferruh; Mueller, Christian; Breidthardt, Tobias; Twerenbold, Raphael; Peter, Andreas; Thamer, Claus; Weyrich, Peter; Haering, Hans-Ulrich; Friedrich, Bjoern			Sensitive Troponins - Which Suits Better for Hemodialysis Patients? Associated Factors and Prediction of Mortality	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR MASS; CARDIAC TROPONIN; MYOCARDIAL-INFARCTION; ASYMPTOMATIC PATIENTS; HEART-FAILURE; I ASSAYS; RELEASE; DEATH	Background: In hemodialysis patients, elevated plasma troponin concentrations are a common finding that has even increased with the advent of newly developed sensitive assays. However, the interpretation and relevance of this is still under debate. Methods: In this cross-sectional study, we analyzed plasma concentrations of sensitive troponin I (TnI) and troponin T (TnT) in stable ambulatory hemodialysis patients (n = 239) and investigated their associations with clinical factors and mortality. Results: In all of the enrolled patients, plasma TnI or TnT was detectable at a median concentration of 14 pg/ml (interquartile range: 7-29) using the Siemens TnI ultra assay and 49 pg/ml (31-74) using the Roche Elecsys high sensitive TnT assay. Markedly more patients exceeded the 99th percentile for TnT than for TnI (95% vs. 14%, p<0.0001). In a multivariate linear regression model, TnT was independently associated with age, gender, systolic dysfunction, time on dialysis, residual diuresis and systolic blood pressure, whereas TnI was independently associated with age, systolic dysfunction, pulse pressure, time on dialysis and duration of a HD session. During a follow-up period of nearly two years, TnT concentration above 38 pg/mL was associated with a 5-fold risk of death, whereas elevation of TnI had a gradual association to mortality. Conclusion: In hemodialysis patients, elevations of plasma troponin concentrations are explained by cardiac function and dialysis-related parameters, which contribute to cardiac strain. Both are highly predictive of increased risk of death.	[Artunc, Ferruh; Peter, Andreas; Thamer, Claus; Weyrich, Peter; Haering, Hans-Ulrich; Friedrich, Bjoern] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, D-72074 Tubingen, Germany; [Mueller, Christian; Breidthardt, Tobias; Twerenbold, Raphael] Univ Basel, Div Cardiol, Dept Internal Med, Basel, Switzerland; [Friedrich, Bjoern] Dialysis Ctr, Leonberg, Germany	Eberhard Karls University of Tubingen; University of Basel	Artunc, F (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, D-72074 Tubingen, Germany.	ferruh.artunc@med.uni-tuebingen.de	Müller, Christian/AAB-4783-2022; Twerenbold, Raphael/H-3533-2018	Müller, Christian/0000-0002-1120-6405; Twerenbold, Raphael/0000-0003-3814-6542; Breidthardt, Tobias/0000-0003-2671-6456				Apple FS, 2009, CLIN CHEM, V55, P1303, DOI 10.1373/clinchem.2009.128363; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Artunc Ferruh, 2010, Dtsch Med Wochenschr, V135, P240, DOI 10.1055/s-0030-1247609; Bodor GS, 1997, CLIN CHEM, V43, P476; Breidthardt T, 2011, REV CARDIOVASC MED, V12, P13, DOI 10.3909/ricm0585; deFilippi C, 2003, JAMA-J AM MED ASSOC, V290, P353, DOI 10.1001/jama.290.3.353; Dierkes J, 2000, CIRCULATION, V102, P1964, DOI 10.1161/01.CIR.102.16.1964; Diris JHC, 2004, CIRCULATION, V109, P23, DOI 10.1161/01.CIR.0000109483.45211.8F; Ellis K, 2001, SOUTHERN MED J, V94, P993; EVRIN PE, 1972, SCAND J CLIN LAB INV, V29, P69, DOI 10.3109/00365517209081057; Fernandez-Reyes MJ, 2004, J NEPHROL, V17, P721; Freda BJ, 2002, J AM COLL CARDIOL, V40, P2065, DOI 10.1016/S0735-1097(02)02608-6; Giannitsis E, 2004, CIRCULATION, V110, pE25, DOI 10.1161/01.CIR.0000135543.93270.D2; Hayashi T, 2008, NEPHROL DIAL TRANSPL, V23, P2936, DOI 10.1093/ndt/gfn181; Hickman PE, 2007, ANN CLIN BIOCHEM, V44, P285, DOI 10.1258/000456307780480855; Horwich TB, 2003, CIRCULATION, V108, P833, DOI 10.1161/01.CIR.0000084543.79097.34; Jacobs LH, 2009, ANN CLIN BIOCHEM, V46, P283, DOI 10.1258/acb.2009.008197; Jung HH, 2004, NEPHROL DIAL TRANSPL, V19, P3117, DOI 10.1093/ndt/gfh488; Kalantar-Zadeh K, 2009, CIRCULATION, V119, P671, DOI 10.1161/CIRCULATIONAHA.108.807362; Kanderian AS, 2006, KIDNEY INT, V69, P1112, DOI 10.1038/sj.ki.5000174; KATUS HA, 1995, CLIN CHEM, V41, P1201; Keller T, 2011, CIRCULATION, V123, P1361, DOI 10.1161/CIRCULATIONAHA.111.023200; Khan NA, 2005, CIRCULATION, V112, P3088, DOI 10.1161/CIRCULATIONAHA.105.560128; Kumar N, 2011, NEPHROL DIAL TRANSPL, V26, P665, DOI 10.1093/ndt/gfq442; London GM, 2002, NEPHROL DIAL TRANSPL, V17, P29, DOI 10.1093/ndt/17.suppl_1.29; Mallamaci F, 2002, AM J KIDNEY DIS, V40, P68, DOI 10.1053/ajkd.2002.33914; Mallamaci F, 2002, KIDNEY INT, V62, P1884, DOI 10.1046/j.1523-1755.2002.00641.x; McGill D, 2010, CLIN CHIM ACTA, V411, P936, DOI 10.1016/j.cca.2010.03.004; Noordzij M, 2011, NEPHROL DIAL TRANSPL; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Porter GA, 1998, EUR HEART J, V19, pN34; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Stolear JC, 1999, NEPHROL DIAL TRANSPL, V14, P1961, DOI 10.1093/ndt/14.8.1961; Termorshuizen F, 2004, J AM SOC NEPHROL, V15, P1061, DOI 10.1097/01.ASN.0000117976.29592.93; Thygesen K, 2007, EUR HEART J, V28, P2525; Wang AYM, 2008, J AM SOC NEPHROL, V19, P1643, DOI 10.1681/ASN.2008010012; Wu AHB, 1999, CLIN CHIM ACTA, V284, P161, DOI 10.1016/S0009-8981(99)00078-9; Zumrutdal AO, 2000, NEPHRON, V86, P522, DOI 10.1159/000045852	38	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47610	10.1371/journal.pone.0047610	http://dx.doi.org/10.1371/journal.pone.0047610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077650	Green Published, Green Submitted, gold			2022-12-27	WOS:000309995100145
J	Hua, R; Adamczyk, A; Robbins, C; Ray, G; Rose, RA				Hua, Rui; Adamczyk, Andrew; Robbins, Courtney; Ray, Gibanananda; Rose, Robert A.			Distinct Patterns of Constitutive Phosphodiesterase Activity in Mouse Sinoatrial Node and Atrial Myocardium	PLOS ONE			English	Article							RECTIFIER K+ CURRENT; CALCIUM-CHANNELS; ELECTRICAL-CONDUCTION; NATRIURETIC PEPTIDE; PACEMAKER ACTIVITY; FUNCTIONAL ROLES; IONIC CURRENTS; CA2+ CURRENT; HEART-RATE; CGMP	Phosphodiesterases (PDEs) are critical regulators of cyclic nucleotides in the heart. In ventricular myocytes, the L-type Ca2+ current (I-Ca,I-L) is a major target of regulation by PDEs, particularly members of the PDE2, PDE3 and PDE4 families. Conversely, much less is known about the roles of PDE2, PDE3 and PDE4 in the regulation of action potential (AP) properties and I-Ca,I-L in the sinoatrial node (SAN) and the atrial myocardium, especially in mice. Thus, the purpose of our study was to measure the effects of global PDE inhibition with Isobutyl-1-methylxanthine (IBMX) and selective inhibitors of PDE2, PDE3 and PDE4 on AP properties in isolated mouse SAN and right atrial myocytes. We also measured the effects of these inhibitors on I-Ca,I-L in SAN and atrial myocytes in comparison to ventricular myocytes. Our data demonstrate that IBMX markedly increases spontaneous AP frequency in SAN myocytes and AP duration in atrial myocytes. Spontaneous AP firing in SAN myocytes was also increased by the PDE2 inhibitor erythro-9-[2-hydroxy-3-nonyl] adenine (EHNA), the PDE3 inhibitor milrinone (Mil) and the PDE4 inhibitor rolipram (Rol). In contrast, atrial AP duration was increased by EHNA and Rol, but not by Mil. IBMX also potently, and similarly, increased I-Ca,I-L in SAN, atrial and ventricular myocytes; however, important differences emerged in terms of which inhibitors could modulate I-Ca,I-L in each myocyte type. Consistent with our AP measurements, EHNA, Mil and Rol each increased I-Ca,I-L in SAN myocytes. Also, EHNA and Rol, but not Mil, increased atrial I-Ca,I-L. In complete contrast, no selective PDE inhibitors increased I-Ca,I-L in ventricular myocytes when given alone. Thus, our data show that the effects of selective PDE2, PDE3 and PDE4 inhibitors are distinct in the different regions of the myocardium indicating important differences in how each PDE family constitutively regulates ion channel function in the SAN, atrial and ventricular myocardium.	[Hua, Rui; Adamczyk, Andrew; Robbins, Courtney; Ray, Gibanananda; Rose, Robert A.] Dalhousie Univ, Fac Med, Dept Physiol & Biophys, Halifax, NS B3H 4H7, Canada	Dalhousie University	Rose, RA (corresponding author), Dalhousie Univ, Fac Med, Dept Physiol & Biophys, Halifax, NS B3H 4H7, Canada.	robert.rose@dal.ca		Rose, Robert/0000-0001-9880-3482; Adamczyk, Andrew/0000-0001-7417-1505	Canadian Institutes of Health Research [MOP 93718]; Heart and Stroke Foundation of Nova Scotia; Canada Foundation for Innovation; Dalhousie Medical Research Foundation; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Nova Scotia; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Dalhousie Medical Research Foundation; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by grants from the Canadian Institutes of Health Research (MOP 93718; http://www.cihr-irsc.gc.ca/e/193.html), the Heart and Stroke Foundation of Nova Scotia (http://www.hsf.ca/research/en/home), The Canada Foundation for Innovation (http://www.innovation.ca/en) and the Dalhousie Medical Research Foundation (http://www.dmrf.ca/en/home/default.aspx) to RAR who is a CIHR New Investigator. RH is supported by a postdoctoral fellowship from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BASIC RES CARDIOLOGY; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; Beca S, 2011, CURR OPIN PHARMACOL, V11, P714, DOI 10.1016/j.coph.2011.10.017; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bers DR, 1999, CARDIOVASC RES, V42, P339, DOI 10.1016/S0008-6363(99)00038-3; Cifelli C, 2008, CIRC RES, V103, P527, DOI 10.1161/CIRCRESAHA.108.180984; Clark RB, 2004, AM J PHYSIOL-HEART C, V286, pH1757, DOI 10.1152/ajpheart.00753.2003; DIFRANCESCO D, 1988, J PHYSIOL-LONDON, V405, P493, DOI 10.1113/jphysiol.1988.sp017344; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Ertel SI, 1997, CARDIOVASC DRUG THER, V11, P723, DOI 10.1023/A:1007706022381; FISCHMEISTER R, 1991, LIFE SCI, V48, P2365, DOI 10.1016/0024-3205(91)90369-M; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; Hata T, 1998, HEART VESSELS, V13, P114, DOI 10.1007/BF01747828; HESS P, 1988, CAN J PHYSIOL PHARM, V66, P1218, DOI 10.1139/y88-201; HIRANO Y, 1989, AM J PHYSIOL, V256, pH1478, DOI 10.1152/ajpheart.1989.256.5.H1478; IRISAWA H, 1993, PHYSIOL REV, V73, P197, DOI 10.1152/physrev.1993.73.1.197; Kaumann AJ, 2011, TRENDS PHARMACOL SCI, V32, P377, DOI 10.1016/j.tips.2011.03.003; Kerfant BG, 2007, CIRC RES, V101, P400, DOI 10.1161/CIRCRESAHA.107.156422; Kerfant EG, 2006, TRENDS CARDIOVAS MED, V16, P250, DOI 10.1016/j.tcm.2006.04.006; KIRSTEIN M, 1995, J CLIN INVEST, V95, P794, DOI 10.1172/JCI117729; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; MERY PF, 1995, MOL PHARMACOL, V48, P121; Molina CE, 2012, J AM COLL CARDIOL, V59, P2182, DOI 10.1016/j.jacc.2012.01.060; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Orito K, 1996, JPN J PHARMACOL, V72, P79, DOI 10.1254/jjp.72.79; Patrucco E, 2010, J MOL CELL CARDIOL, V49, P330, DOI 10.1016/j.yjmcc.2010.03.016; Richter W, 2011, BASIC RES CARDIOL, V106, P249, DOI 10.1007/s00395-010-0138-8; RivetBastide M, 1997, J CLIN INVEST, V99, P2710, DOI 10.1172/JCI119460; Rose RA, 2004, AM J PHYSIOL-HEART C, V286, pH1970, DOI 10.1152/ajpheart.00893.2003; Rose RA, 2011, CIRC-ARRHYTHMIA ELEC, V4, P733, DOI 10.1161/CIRCEP.110.960401; Shimizu K, 2002, BRIT J PHARMACOL, V137, P127, DOI 10.1038/sj.bjp.0704843; Springer J, 2012, J MOL CELL CARDIOL, V52, P1122, DOI 10.1016/j.yjmcc.2012.01.018; Vandecasteele G, 2001, J PHYSIOL-LONDON, V533, P329, DOI 10.1111/j.1469-7793.2001.0329a.x; Vandeput F, 2007, J BIOL CHEM, V282, P32749, DOI 10.1074/jbc.M703173200; Verde I, 1999, BRIT J PHARMACOL, V127, P65, DOI 10.1038/sj.bjp.0702506; Vinogradova TM, 2008, CIRC RES, V102, P761, DOI 10.1161/CIRCRESAHA.107.161679; Zaccolo M, 2011, CURR OPIN PHARMACOL, V11, P649, DOI 10.1016/j.coph.2011.09.014; Zhang ML, 2011, TRENDS PHARMACOL SCI, V32, P360, DOI 10.1016/j.tips.2011.02.019; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070; Zhang Z, 2002, CIRC RES, V90, P981, DOI 10.1161/01.RES.0000018003.14304.E2	50	49	49	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47652	10.1371/journal.pone.0047652	http://dx.doi.org/10.1371/journal.pone.0047652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077656	gold, Green Published, Green Submitted			2022-12-27	WOS:000309995100149
J	Wang, HS; Chen, ZJ; Zhang, G; Ou, XL; Yang, XL; Wong, CKC; Giesy, JP; Du, J; Chen, SY				Wang, Hong-Sheng; Chen, Zhuo-Jia; Zhang, Ge; Ou, Xue-Ling; Yang, Xiang-Ling; Wong, Chris K. C.; Giesy, John P.; Du, Jun; Chen, Shou-Yi			A Novel Micro-Linear Vector for In Vitro and In Vivo Gene Delivery and Its Application for EBV Positive Tumors	PLOS ONE			English	Article							AMPLIFIED DNA FRAGMENTS; TRANSGENE EXPRESSION; MINICIRCLE DNA; PLASMID DNA; IMMUNE-RESPONSES; THERAPY; CELLS; METHYLATION; ACTIVATION; PERSISTENT	Background: The gene delivery vector for DNA-based therapy should ensure its transfection efficiency and safety for clinical application. The Micro-Linear vector (MiLV) was developed to improve the limitations of traditional vectors such as viral vectors and plasmids. Methods: The MiLV which contained only the gene expression cassette was amplified by polymerase chain reaction (PCR). Its cytotoxicity, transfection efficiency in vitro and in vivo, duration of expression, pro-inflammatory responses and potential application for Epstein-Barr virus (EBV) positive tumors were evaluated. Results: Transfection efficiency for exogenous genes transferred by MiLV was at least comparable with or even greater than their corresponding plasmids in eukaryotic cell lines. MiLV elevated the expression and prolonged the duration of genes in vitro and in vivo when compared with that of the plasmid. The in vivo pro-inflammatory response of MiLV group was lower than that of the plasmid group. The MEKK1 gene transferred by MiLV significantly elevated the sensitivity of B95-8 cells and transplanted tumor to the treatment of Ganciclovir (GCV) and sodium butyrate (NaB). Conclusions: The present study provides a safer, more efficient and stable MiLV gene delivery vector than plasmid. These advantages encourage further development and the preferential use of this novel vector type for clinical gene therapy studies.	[Wang, Hong-Sheng; Zhang, Ge; Yang, Xiang-Ling; Du, Jun] Sun Yat Sen Univ, Dept Microbial & Biochem Pharm, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Zhuo-Jia] Sun Yat Sen Univ, Inst Clin Pharmacol, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Ou, Xue-Ling] Sun Yat Sen Univ, Dept Forens Med, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Wong, Chris K. C.] Hong Kong Baptist Univ, Dept Biol, Kowloon, Hong Kong, Peoples R China; [Giesy, John P.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK S7N 0W0, Canada; [Giesy, John P.] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK S7N 0W0, Canada; [Chen, Shou-Yi] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Hong Kong Baptist University; University of Saskatchewan; University of Saskatchewan	Wang, HS (corresponding author), Sun Yat Sen Univ, Dept Microbial & Biochem Pharm, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	hswang2000@gmail.com; dujun@mail.sysu.edu.cn	wong, chris/GSN-0962-2022; Wang, Hongsheng/N-1940-2019; Ou, Xueling/W-9964-2019	Wang, Hongsheng/0000-0002-0054-4820; Ou, Xueling/0000-0003-2345-4980; Giesy, John/0000-0003-1931-9962; Yang, Xiangling/0000-0002-5881-4299	National Natural Science Foundation of China [31101071, 30873032, 81071712]; National Basic Research Program of China (973 Program) [2011CB9358003]; National Science and Engineering Research Council of Canada [326415-07]; Department of Biology and Chemistry and State Key Laboratory in Marine Pollution, City University of Hong Kong; Chinese Academy of Sciences; King Saud University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Biology and Chemistry and State Key Laboratory in Marine Pollution, City University of Hong Kong(City University of Hong Kong); Chinese Academy of Sciences(Chinese Academy of Sciences); King Saud University(King Saud University)	This work was supported by Supported by the National Natural Science Foundation of China (Grant No. 31101071), National Basic Research Program of China (973 Program, No. 2011CB9358003), and National Natural Science Foundation of China (No. 30873032and 81071712). The research was supported, in part, by a Discovery Grant from the National Science and Engineering Research Council of Canada (Project # 326415-07). JPG was supported by the Canada Research Chair program, an at large Chair Professorship at the Department of Biology and Chemistry and State Key Laboratory in Marine Pollution, City University of Hong Kong, The Einstein Professor Program of the Chinese Academy of Sciences and the Visiting Professor Program of King Saud University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Chang CW, 2008, J CONTROL RELEASE, V125, P155, DOI 10.1016/j.jconrel.2007.10.014; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Chen ZY, 2001, MOL THER, V3, P403, DOI 10.1006/mthe.2001.0278; Coban C, 2005, J LEUKOCYTE BIOL, V78, P647, DOI 10.1189/jlb.1104627; Darquet AM, 1999, GENE THER, V6, P209, DOI 10.1038/sj.gt.3300816; de Wolf HK, 2008, PHARM RES-DORDR, V25, P1654, DOI 10.1007/s11095-008-9558-7; Esin S, 1996, CLIN EXP IMMUNOL, V104, P419, DOI 10.1046/j.1365-2249.1996.d01-691.x; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hagstrom JE, 1997, J CELL SCI, V110, P2323; He YW, 2008, VIRUS RES, V135, P175, DOI 10.1016/j.virusres.2008.03.012; Hirata K, 2007, J PHARM SCI-US, V96, P2251, DOI 10.1002/jps.20879; Hofman CR, 2001, GENE THER, V8, P71, DOI 10.1038/sj.gt.3301373; Johansson P, 2002, VACCINE, V20, P3379, DOI 10.1016/S0264-410X(02)00265-7; Kako K, 2008, J PHARM SCI-US, V97, P3074, DOI 10.1002/jps.21254; Kameda S, 2003, BIOCHEM BIOPH RES CO, V309, P929, DOI 10.1016/j.bbrc.2003.08.087; Li HP, 2005, CELL RES, V15, P262, DOI 10.1038/sj.cr.7290295; Lopez-Fuertes L, 2002, VACCINE, V21, P247, DOI 10.1016/S0264-410X(02)00450-4; Ludtke JJ, 1999, J CELL SCI, V112, P2033; Machelska H, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-72; Mitsui M, 2009, J GENE MED, V11, P435, DOI 10.1002/jgm.1317; Nakai H, 2003, MOL THER, V7, P101, DOI 10.1016/S1525-0016(02)00023-0; Nishikawa M, 2002, BIOL PHARM BULL, V25, P275, DOI 10.1248/bpb.25.275; Reyes-Sandoval A, 2004, MOL THER, V9, P249, DOI 10.1016/j.ymthe.2003.11.008; Schakowski F, 2001, MOL THER, V3, P793, DOI 10.1006/mthe.2001.0322; Schakowski F, 2007, IN VIVO, V21, P17; Schmidt-Wolf GD, 2003, TRENDS MOL MED, V9, P67, DOI 10.1016/S1471-4914(03)00005-4; Tan YD, 1999, HUM GENE THER, V10, P2153, DOI 10.1089/10430349950017149; Wilson KD, 2009, ADV DRUG DELIVER REV, V61, P233, DOI 10.1016/j.addr.2008.12.014; Xu XY, 2010, MOL THER, V18, P835, DOI 10.1038/mt.2010.3; Yasuda K, 2005, J LEUKOCYTE BIOL, V77, P71, DOI 10.1189/0204089; Yoshida H, 2008, J PHARM SCI-US, V97, P4575, DOI 10.1002/jps.21302; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang XC, 2008, HUM GENE THER, V19, P820, DOI 10.1089/hum.2007.141; Zheng C, 2006, VACCINE, V24, P4625, DOI 10.1016/j.vaccine.2005.08.046	37	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47159	10.1371/journal.pone.0047159	http://dx.doi.org/10.1371/journal.pone.0047159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077563	gold, Green Published, Green Submitted			2022-12-27	WOS:000309995100069
J	You, JS; Frey, JW; Hornberger, TA				You, Jae Sung; Frey, John W.; Hornberger, Troy A.			Mechanical Stimulation Induces mTOR Signaling via an ERK-Independent Mechanism: Implications for a Direct Activation of mTOR by Phosphatidic Acid	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; MAMMALIAN TARGET; S6 KINASE; TUBEROUS SCLEROSIS; PHOSPHOLIPASE-D; PHOSPHOINOSITIDE 3-KINASE; PHOSPHORYLATION; BINDING; INHIBITOR; COMPLEX	Signaling by mTOR is a well-recognized component of the pathway through which mechanical signals regulate protein synthesis and muscle mass. However, the mechanisms involved in the mechanical regulation of mTOR signaling have not been defined. Nevertheless, recent studies suggest that a mechanically-induced increase in phosphatidic acid (PA) may be involved. There is also evidence which suggests that mechanical stimuli, and PA, utilize ERK to induce mTOR signaling. Hence, we reasoned that a mechanically-induced increase in PA might promote mTOR signaling via an ERK-dependent mechanism. To test this, we subjected mouse skeletal muscles to mechanical stimulation in the presence or absence of a MEK/ERK inhibitor, and then measured several commonly used markers of mTOR signaling. Transgenic mice expressing a rapamycin-resistant mutant of mTOR were also used to confirm the validity of these markers. The results demonstrated that mechanically-induced increases in p70(s6k) T389 and 4E-BP1 S64 phosphorylation, and unexpectedly, a loss in total 4E-BP1, were fully mTOR-dependent signaling events. Furthermore, we determined that mechanical stimulation induced these mTOR-dependent events, and protein synthesis, through an ERK-independent mechanism. Similar to mechanical stimulation, exogenous PA also induced mTOR-dependent signaling via an ERK-independent mechanism. Moreover, PA was able to directly activate mTOR signaling in vitro. Combined, these results demonstrate that mechanical stimulation induces mTOR signaling, and protein synthesis, via an ERK-independent mechanism that potentially involves a direct interaction of PA with mTOR. Furthermore, it appears that a decrease in total 4E-BP1 may be part of the mTOR-dependent mechanism through which mechanical stimuli activate protein synthesis.	[You, Jae Sung; Hornberger, Troy A.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [You, Jae Sung; Frey, John W.; Hornberger, Troy A.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hornberger, TA (corresponding author), Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA.	thornb1@svm.vetmed.wisc.edu	You, Jae-Sung/ABF-6763-2020	You, Jae-Sung/0000-0001-7791-8563; Hornberger, Troy/0000-0002-2349-1899	National Institutes of Health [AR057347]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grant AR057347 to TAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Avila G, 2003, J BIOL CHEM, V278, P22600, DOI 10.1074/jbc.M205866200; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Drummond MJ, 2009, J PHYSIOL-LONDON, V587, P1535, DOI 10.1113/jphysiol.2008.163816; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; FERRARI S, 1991, J BIOL CHEM, V266, P22770; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; GOLDBERG AL, 1975, MED SCI SPORT EXER, V7, P185; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Hornberger TA, 2006, J CELL BIOCHEM, V97, P1207, DOI 10.1002/jcb.20671; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Hornberger TA, 2011, INT J BIOCHEM CELL B, V43, P1267, DOI 10.1016/j.biocel.2011.05.007; Hou JQ, 2012, ONCOTARGET, V3, P118; Ikenoue T, 2009, METHOD ENZYMOL, V452, P165, DOI 10.1016/S0076-6879(08)03611-2; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; Karim MM, 2001, J BIOL CHEM, V276, P20750, DOI 10.1074/jbc.M011068200; Kubica N, 2005, J BIOL CHEM, V280, P7570, DOI 10.1074/jbc.M413732200; LORENZ MC, 1995, J BIOL CHEM, V270, P27531, DOI 10.1074/jbc.270.46.27531; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; Miyazaki M, 2011, J PHYSIOL-LONDON, V589, P1831, DOI 10.1113/jphysiol.2011.205658; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; Osman B, 2009, CELL SIGNAL, V21, P1806, DOI 10.1016/j.cellsig.2009.07.016; Pahor M, 1998, J Nutr Health Aging, V2, P97; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Proctor DN, 1998, J NUTR, V128, p351S, DOI 10.1093/jn/128.2.351S; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Spangenburg EE, 2006, J APPL PHYSIOL, V100, P129, DOI 10.1152/japplphysiol.00619.2005; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; VANDENBURGH HH, 1990, AM J PHYSIOL, V259, pC232, DOI 10.1152/ajpcell.1990.259.2.C232; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Wang TW, 2004, FRONT BIOSCI-LANDMRK, V9, P619, DOI 10.2741/1095; Winter JN, 2010, AM J PHYSIOL-CELL PH, V299, pC335, DOI 10.1152/ajpcell.00039.2010; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yonezawa K, 2003, CURR TOP MICROBIOL, V279, P271; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	65	60	62	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47258	10.1371/journal.pone.0047258	http://dx.doi.org/10.1371/journal.pone.0047258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077579	gold, Green Published, Green Submitted			2022-12-27	WOS:000309995100082
J	Park, YS; Jeon, YJ; Kim, HS; Chae, KY; Oh, SH; Han, IB; Kim, HS; Kim, WC; Kim, OJ; Kim, TG; Choi, JU; Kim, DS; Kim, NK				Park, Young Seok; Jeon, Young Joo; Kim, Hyun Seok; Chae, Kyu Young; Oh, Seung-Hun; Han, In Bo; Kim, Hyun Sook; Kim, Won-Chan; Kim, Ok-Joon; Kim, Tae Gon; Choi, Joong-Uhn; Kim, Dong-Seok; Kim, Nam Keun			The Role of VEGF and KDR Polymorphisms in Moyamoya Disease and Collateral Revascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MIDDLE CEREBRAL-ARTERY; FACTOR GENE; FACTOR EXPRESSION; CHROMOSOME 17Q25; ISCHEMIC-STROKE; MESSENGER-RNA; RAT-BRAIN; HYPOXIA; RECEPTORS	We conducted a case-control study to investigate whether vascular endothelial growth factor (VEGF 22578, 21154, 2634, and 936) and kinase insert domain containing receptor (KDR -2604, 1192, and 1719) polymorphisms are associated with moyamoya disease. Korean patients with moyamoya disease (n = 107, mean age, 20.9 +/- 15.9 years; 66.4% female) and 243 healthy control subjects (mean age, 23.0 +/- 16.1 years; 56.8% female) were included. The subjects were divided into pediatric and adult groups. Among the 64 surgical patients, we evaluated collateral vessel formation after 2 years and divided patients into good (collateral grade A) or poor (collateral grade B and C) groups. The frequencies and distributions of four VEGF (-2578, -1154, -634, and 936) and KDR (-604, 1192, and 1719) polymorphisms were assessed from patients with moyamoya disease and compared to the control group. No differences were observed in VEGF -2578, -1154, -634, and 936 or KDR -604, 1192, and 1719 polymorphisms between the control group and moyamoya disease group. However, we found the -634CC genotype occurred less frequently in the pediatric moyamoya group (p = 0.040) whereas the KDR -604C/1192A/1719T haplotype increased the risk of pediatric moyamoya (p = 0.024). Patients with the CC genotype of VEGF -634 had better collateral vessel formation after surgery. Our results suggest that the VEGF -634G allele is associated with pediatric moyamoya disease and poor collateral vessel formation.	[Kim, Dong-Seok] Yonsei Univ, Brain Res Inst, Brain Korea Project Med Sci 21, Dept Pediat Neurosurg,Severance Hosp,Coll Med, Seoul, South Korea; [Oh, Seung-Hun; Kim, Hyun Sook; Kim, Won-Chan; Kim, Ok-Joon] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurol, Songnam, South Korea; [Chae, Kyu Young; Kim, Nam Keun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Pediat, Songnam, South Korea; [Jeon, Young Joo; Kim, Hyun Seok] CHA Univ, Sch Med, CHA Bundang Med Ctr, Inst Clin Res, Songnam, South Korea; [Park, Young Seok; Han, In Bo; Kim, Tae Gon; Choi, Joong-Uhn] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurosurg, Songnam, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University; Pochon Cha University; Pochon Cha University; Pochon Cha University	Kim, DS (corresponding author), Yonsei Univ, Brain Res Inst, Brain Korea Project Med Sci 21, Dept Pediat Neurosurg,Severance Hosp,Coll Med, Seoul, South Korea.	dskim33@yuhs.ac; nkkim@cha.ac.kr	KIM, WON CHAN/AAJ-4506-2020	Kim, Nam Keun/0000-0003-0541-3528	National Research Foundation of Korea [2010-0023851]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (2010-0023851). The funders had no role in the study design or decision to publish.	Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Brogan IJ, 1999, HUM IMMUNOL, V60, P1245, DOI 10.1016/S0198-8859(99)00132-9; Cao YH, 2005, CARDIOVASC RES, V65, P639, DOI 10.1016/j.cardiores.2004.11.020; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fabian E, 2011, WIEN KLIN WOCHENSCHR, V123, P496, DOI 10.1007/s00508-011-0002-3; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fukui M, 1997, SURG NEUROL, V47, P138, DOI 10.1016/S0090-3019(96)00358-8; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Han H, 2003, J KOREAN MED SCI, V18, P876, DOI 10.3346/jkms.2003.18.6.876; Harry Lorraine E., 2003, Birth Defects Research, V69, P363, DOI 10.1002/bdrc.10024; Hayashi T, 1997, STROKE, V28, P2039, DOI 10.1161/01.STR.28.10.2039; HEDRICK PW, 1987, GENETICS, V117, P331; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Ikeda H, 1999, AM J HUM GENET, V64, P533, DOI 10.1086/302243; Inoue TK, 2000, J CHILD NEUROL, V15, P179, DOI 10.1177/088307380001500307; Issa R, 1999, LAB INVEST, V79, P417; Jin KL, 2000, NEUROSCIENCE, V99, P577, DOI 10.1016/S0306-4522(00)00207-4; Kang HS, 2006, NEUROSURGERY, V58, P1074, DOI 10.1227/01.NEU.0000215854.66011.4F; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Kuo NT, 1999, J APPL PHYSIOL, V86, P260, DOI 10.1152/jappl.1999.86.1.260; Kuroda S, 2007, STROKE, V38, P1430, DOI 10.1161/STROKEAHA.106.478297; La Rosa S, 2003, HUM PATHOL, V34, P18, DOI 10.1053/hupa.2003.56; Lennmyr F, 1998, J NEUROPATH EXP NEUR, V57, P874, DOI 10.1097/00005072-199809000-00009; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liu Wanyang, 2010, Environmental Health and Preventive Medicine, V15, P94, DOI 10.1007/s12199-009-0116-7; Marchand GS, 2002, AM J PHYSIOL-HEART C, V282, pH194, DOI 10.1152/ajpheart.2002.282.1.H194; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; MATSUSHIMA T, 1992, NEUROSURGERY, V31, P401, DOI 10.1227/00006123-199209000-00003; Mineharu Y, 2008, NEUROLOGY, V70, P2357, DOI 10.1212/01.wnl.0000291012.49986.f9; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Nanba R, 2005, CHILD NERV SYST, V21, P62, DOI 10.1007/s00381-004-1005-4; Oh SH, 2011, J NEUROL SCI, V308, P62, DOI 10.1016/j.jns.2011.06.012; Okuda Y, 1998, LIFE SCI, V63, P477, DOI 10.1016/S0024-3205(98)00296-3; Park YS, 2011, CHILD NERV SYST, V27, P1919, DOI 10.1007/s00381-011-1504-z; Petrovic D, 2007, CARDIOLOGY, V107, P291, DOI 10.1159/000099064; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Sakamoto S, 2008, NEUROSURG REV, V31, P77, DOI 10.1007/s10143-007-0102-8; Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6; Schneider BP, 2008, J CLIN ONCOL, V26, P4672, DOI 10.1200/JCO.2008.16.1612; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Takekawa Y, 2004, NEUROPATHOLOGY, V24, P236, DOI 10.1111/j.1440-1789.2004.00550.x; Thomas KA, 1996, J BIOL CHEM, V271, P603, DOI 10.1074/jbc.271.2.603; Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang Y, 2007, J AM COLL CARDIOL, V50, P760, DOI 10.1016/j.jacc.2007.04.074; Yamauchi T, 2000, STROKE, V31, P930, DOI 10.1161/01.STR.31.4.930	51	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47158	10.1371/journal.pone.0047158	http://dx.doi.org/10.1371/journal.pone.0047158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077562	Green Published, Green Submitted, gold			2022-12-27	WOS:000309809500033
J	Ma, JM; Xu, JQ; Anderson, RN; Jemal, A				Ma, Jiemin; Xu, Jiaquan; Anderson, Robert N.; Jemal, Ahmedin			Widening Educational Disparities in Premature Death Rates in Twenty Six States in the United States, 1993-2007	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; SOCIOECONOMIC-STATUS; ALL-CAUSE; INEQUALITIES; ADULTS; TRENDS; NORWAY; GAP	Background: Eliminating socioeconomic disparities in health is an overarching goal of the U.S. Healthy People decennial initiatives. We present recent trends in mortality by education among working-aged populations. Methods and Findings: Age-standardized death rates and their average annual percent change for all-cause and five major causes (cancer, heart disease, stroke, diabetes, and accidents) were calculated from 1993 through 2007 for individuals aged 25-64 years by educational attainment as a marker of socioeconomic status, using national vital registration data for 26 states with consistent educational information on the death certificates. Rate ratios and rate differences were used to assess disparities (<= 12 versus >= 16 years of education) for 1993 through 2007. From 1993 through 2007, relative educational disparities in all-cause mortality continued to increase among working-aged men and women in the U. S., due to larger decreases of mortality rates among the most educated coupled with smaller decreases or even worsening trends in the less educated. For example, the rate ratios of all-cause mortality increased from 2.5 (95% confidence interval (CI), 2.4-2.6) in 1993 to 3.6 (95% CI, 3.5-3.7) in 2007 in men and from 1.9 (95% CI, 1.8-2.0) to 3.0 (95% CI, 2.9-3.1) in women. Generally, the rate differences (per 100,000 persons) of all-cause mortality increased from 415.5 (95% CI, 399.1-431.9) in 1993 to 472.7 (95% CI, 460.2-485.2) in 2007 in men and from 165.4 (95% CI, 154.5-176.2) to 256.2 (95% CI, 248.3-264.2) in women. Disparity patterns varied largely across the five specific causes considered in this study, with the largest increases of relative disparities for accidents, especially in women. Conclusions: Relative educational differentials in mortality continued to widen among men and women despite emphasis on reducing disparities in the U. S. Healthy People decennial initiatives.	[Ma, Jiemin; Jemal, Ahmedin] Amer Canc Soc, Surveillance Res Program, Atlanta, GA 30329 USA; [Xu, Jiaquan; Anderson, Robert N.] Ctr Dis Control & Prevent, Mortal Stat Branch, Natl Ctr Hlth Stat, Hyattsville, MD USA	American Cancer Society; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Ma, JM (corresponding author), Amer Canc Soc, Surveillance Res Program, Atlanta, GA 30329 USA.	jiemin.ma@cancer.org	shen, Guanxin/F-7441-2011	Liu, Hongbo/0000-0002-7187-8115	American Cancer Society and the Centers for Disease Control and Prevention	American Cancer Society and the Centers for Disease Control and Prevention	The American Cancer Society and the Centers for Disease Control and Prevention funded the analysis, interpretation, and compilation of surveillance data. No staff at either agency, other than the authors, was involved in the conduct of the study; collection, management, analysis, and interpretation of the data; or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2010, 2010 NAT HEALTHC DIS; Ahluwalia IB, 2008, J COMMUN HEALTH, V33, P293, DOI 10.1007/s10900-008-9106-8; Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Berkman L F, 1997, IARC Sci Publ, P51; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; FELDMAN JJ, 1989, AM J EPIDEMIOL, V129, P919, DOI 10.1093/oxfordjournals.aje.a115225; Hadden WC, 2008, INT J HEALTH SERV, V38, P47, DOI 10.2190/HS.38.1.c; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; Jemal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002181; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kominski R., 1994, ED ATTAINMENT US MAR, P20; Korhonen N, 2011, INJURY, V42, P885, DOI 10.1016/j.injury.2010.08.033; Krieger N, 2008, PLOS MED, V5, P227, DOI 10.1371/journal.pmed.0050046; Mackenbach JP, 2010, SOC SCI MED, V71, P1249, DOI 10.1016/j.socscimed.2010.07.014; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Minino A., 2007, NATL VITAL STAT REP, V55, P1; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Paulozzi L., 2007, Morbidity and Mortality Weekly Report, V56, P93; Rim Sun Hee, 2011, Morbidity and Mortality Weekly Report, V60, P42; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Rostron BL, 2010, ED REP CLASS DEATH C, Viii; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schalick LM, 2000, INT J HEALTH SERV, V30, P13, DOI 10.2190/8QMH-4FAB-XAWP-VU95; Schwartz CR, 2005, DEMOGRAPHY, V42, P621, DOI 10.1353/dem.2005.0036; Shkolnikov VM, 2012, J EPIDEMIOL COMMUN H, V66, P372, DOI 10.1136/jech.2009.104786; Sorlie PD, 1996, EPIDEMIOLOGY, V7, P437, DOI 10.1097/00001648-199607000-00017; Steenland K, 2004, AM J PUBLIC HEALTH, V94, P1037, DOI 10.2105/AJPH.94.6.1037; Steenland K, 2002, AM J EPIDEMIOL, V156, P11, DOI 10.1093/aje/kwf001; Strand BH, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c654; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; U.S. Department of Health and Human Services, 2010, HLTH PEOPL 2020; U.S. Department of Health and Human Services, 2007, HLTH PEOPL 2010 MIDC; WHO, 2018, INT STAT CLASS DIS R; World Health Organization, 1977, INT STAT CLASS DIS R	37	76	81	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41560	10.1371/journal.pone.0041560	http://dx.doi.org/10.1371/journal.pone.0041560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977GL	23094023	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600087
J	Zhao, XW; Zhang, WY; Xu, X; Ma, ZQ; Yin, MH				Zhao, Xiaowei; Zhang, Wenyi; Xu, Xin; Ma, Zhiqiang; Yin, Minghao			Prediction of Protein Phosphorylation Sites by Using the Composition of k-Spaced Amino Acid Pairs	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; INTRINSIC DISORDER; P38 MAPK; SEQUENCE; DATABASE; UBIQUITYLATION; GLYCOSYLATION; LOCALIZATION; SERVER; TOOL	As one of the most widespread protein post-translational modifications, phosphorylation is involved in many biological processes such as cell cycle, apoptosis. Identification of phosphorylated substrates and their corresponding sites will facilitate the understanding of the molecular mechanism of phosphorylation. Comparing with the labor-intensive and time-consuming experiment approaches, computational prediction of phosphorylation sites is much desirable due to their convenience and fast speed. In this paper, a new bioinformatics tool named CKSAAP_PhSite was developed that ignored the kinase information and only used the primary sequence information to predict protein phosphorylation sites. The highlight of CKSAAP_PhSite was to utilize the composition of k-spaced amino acid pairs as the encoding scheme, and then the support vector machine was used as the predictor. The performance of CKSAAP_PhSite was measured with a sensitivity of 84.81%, a specificity of 86.07% and an accuracy of 85.43% for serine, a sensitivity of 78.59%, a specificity of 82.26% and an accuracy of 80.31% for threonine as well as a sensitivity of 74.44%, a specificity of 78.03% and an accuracy of 76.21% for tyrosine. Experimental results obtained from cross validation and independent benchmark suggested that our method was very promising to predict phosphorylation sites and can be served as a useful supplement tool to the community. For public access, CKSAAP_PhSite is available at http://59.73.198.144/cksaap_phsite/.	[Zhao, Xiaowei; Zhang, Wenyi; Xu, Xin; Ma, Zhiqiang; Yin, Minghao] NE Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China	Northeast Normal University - China	Ma, ZQ (corresponding author), NE Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China.	zhiqiang.ma967@gmail.com; minghao.yin197@gmail.com	Grosso Jasuktar, Hilary/AGX-7358-2022; Yin, Minghao/E-9611-2015; Yin, Minghao/A-4031-2013	Grosso Jasuktar, Hilary/0000-0002-1441-2191; Yin, Minghao/0000-0002-6226-2394; Mouradian, M. Maral/0000-0002-9937-412X; Ichijo, Hidenori/0000-0002-5005-6438	National Natural Science Foundation of China [60803102, 61070084]; Natural Science Foundation of Jilin Province [20101506, 20110104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	This research is partially supported by the National Natural Science Foundation of China under Grant Nos. 60803102, 61070084, and also funded by the Natural Science Foundation of Jilin Province (Nos. 20101506 and 20110104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas AK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-273; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boersema PJ, 2009, J MASS SPECTROM, V44, P861, DOI 10.1002/jms.1599; Bu YH, 2010, J ENDOCRINOL, V206, P271, DOI 10.1677/JOE-10-0064; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-25; Chen K, 2007, BIOCHEM BIOPH RES CO, V355, P764, DOI 10.1016/j.bbrc.2007.02.040; Chen K, 2009, J COMPUT CHEM, V30, P163, DOI 10.1002/jcc.21053; Chen YZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-101; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hu LL, 2011, BIOPOLYMERS, V95, P763, DOI 10.1002/bip.21645; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Huang JH, 2012, BIOCHIMIE, V94, P1697, DOI 10.1016/j.biochi.2012.03.022; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jensen ON, 2004, CURR OPIN CHEM BIOL, V8, P33, DOI 10.1016/j.cbpa.2003.12.009; Kim SH, 2011, EUR J IMMUNOL, V41, P461, DOI 10.1002/eji.201040668; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Plewczynski D, 2005, BIOINFORMATICS, V21, P2525, DOI 10.1093/bioinformatics/bti333; Ressurreicao M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-6; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Uddin S, 2003, BIOCHEM BIOPH RES CO, V308, P325, DOI 10.1016/S0006-291X(03)01382-2; Uversky VN, 2008, SCIENCE, V322, P1340, DOI 10.1126/science.1167453; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Wang XB, 2009, PROTEIN ENG DES SEL, V22, P707, DOI 10.1093/protein/gzp055; Wang YY, 2010, ACTA PHARMACOL SIN, V31, P160, DOI 10.1038/aps.2009.201; Wood CD, 2009, INT J BIOL SCI, V5, P428; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Xue Y, 2010, CURR PROTEIN PEPT SC, V11, P485, DOI 10.2174/138920310791824138; Xue Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011290; Zhao XW, 2011, INT J MOL SCI, V12, P8347, DOI 10.3390/ijms12128347	48	101	108	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e46302	10.1371/journal.pone.0046302	http://dx.doi.org/10.1371/journal.pone.0046302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	22253830	Green Submitted, Green Published, gold			2022-12-27	WOS:000310193400004
J	Villani, A; Frigessi, A; Liljeros, F; Nordvik, MK; de Blasio, BF				Villani, Antonella; Frigessi, Arnoldo; Liljeros, Fredrik; Nordvik, Monica K.; de Blasio, Birgitte Freiesleben			A Characterization of Internet Dating Network Structures among Nordic Men Who Have Sex with Men	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; PARTNERS; ONLINE; RISK; PREFERENCES	Background: The Internet has become an important venue for seeking sexual partners and may facilitate transmission of sexually transmitted infections. Methods: We examined a 64-day data log of flirt messages expressing sexual interest among MSM within the Qruiser. com community. We used logistic regression to analyze characteristics of MSM sending and receiving flirt messages and negative binomial regression to examine individual activity and popularity. The structural properties, including the core structure of the flirt network, were analyzed. Results: The MSM population consisted of approximately 40% homosexuals and 37% bisexuals, while the remaining 23% included men who identified as heterosexual but searched for sex with men and "experimental". MSM were more likely to send flirt messages if they were homosexual and aged 40+ years; young people aged, 30 years were more likely to receive a flirt. Possession of a webcam was strongly associated with both sending flirt messages and being a flirt target. The distributions of flirts sent (max k(out) = 2162) and received (max k(in) = 84) were highly heterogeneous. Members in central cores were more likely homosexuals, singles, and aged 31-40 years. The probability of a matched flirt (flirt returned from target) increased from 1% in the outer core to 18% in the central core (core size = 4). Discussion: The flirt network showed high degree heterogeneity similar to the structural properties of real sexual contact networks with a single central core. Further studies are needed to explore use of webcam for Internet dating.	[Villani, Antonella] Univ Aquila, Dept Math, I-67100 Laquila, Italy; [Frigessi, Arnoldo; de Blasio, Birgitte Freiesleben] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Liljeros, Fredrik; Nordvik, Monica K.] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden; [Liljeros, Fredrik] Inst Future Studies, Stockholm, Sweden; [Nordvik, Monica K.] Mid Sweden Univ, Dept Social Work, Ostersund, Sweden; [de Blasio, Birgitte Freiesleben] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Div Infect Dis Control, Oslo, Norway	University of L'Aquila; University of Oslo; Stockholm University; Institute for Futures Studies; Mid-Sweden University; Norwegian Institute of Public Health (NIPH)	Villani, A (corresponding author), Univ Aquila, Dept Math, I-67100 Laquila, Italy.	birgitte.deblasio@basalmed.uio.no	Liljeros, Fredrik G I/I-2667-2018	Liljeros, Fredrik G I/0000-0001-8642-6624; Frigessi, Arnoldo/0000-0001-7103-7589; Norkko, Joanna/0000-0001-9885-8408; Villnas, Anna/0000-0003-3077-929X	Norwegian Research Council [166056/V50]; Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation)	Norwegian Research Council(Research Council of NorwayEuropean Commission); Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation)	Birgitte Freiesleben de Blasio was supported by the Norwegian Research Council (Projects 166056/V50). Fredrik Liljeros was supported by Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no external funding sources for this study.	Al-Tayyib AA, 2009, SEX TRANSM INFECT, V85, P216, DOI 10.1136/sti.2008.032631; Benotsch EG, 2002, ARCH SEX BEHAV, V31, P177, DOI 10.1023/A:1014739203657; Bull SS, 2000, SEX TRANSM DIS, V27, P545, DOI 10.1097/00007435-200010000-00008; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Daneback K, 2005, ARCH SEX BEHAV, V34, P321, DOI 10.1007/s10508-005-3120-z; Daneback K, 2007, CYBERPSYCHOL BEHAV, V10, P100, DOI 10.1089/cpb.2006.9986; de Nooy W, 2005, EXPLORATIVE SOCIAL N; Ellison N, 2006, J COMPUT-MEDIAT COMM, V11; Fiore ART, 2004, THESIS MIT; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Gobrogge KL, 2007, ARCH SEX BEHAV, V36, P717, DOI 10.1007/s10508-007-9216-x; Kim AA, 2001, J ACQ IMMUN DEF SYND, V28, P89; Klausner JD, 2000, JAMA-J AM MED ASSOC, V284, P447, DOI 10.1001/jama.284.4.447; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; McFarlane M, 2000, JAMA-J AM MED ASSOC, V284, P443, DOI 10.1001/jama.284.4.443; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mustanski BS, 2007, AIDS CARE, V19, P822, DOI 10.1080/09540120701237244; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ross MW, 2005, CYBERPSYCHOL BEHAV, V8, P131, DOI 10.1089/cpb.2005.8.131; Sautter JM, 2010, SOC SCI QUART, V91, P554, DOI 10.1111/j.1540-6237.2010.00707.x; Silverthorne ZA, 2000, ARCH SEX BEHAV, V29, P67, DOI 10.1023/A:1001886521449; Suler J, 2004, CYBERPSYCHOL BEHAV, V7, P321, DOI 10.1089/1094931041291295	22	34	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39717	10.1371/journal.pone.0039717	http://dx.doi.org/10.1371/journal.pone.0039717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974CF	22808052	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700011
J	Lee, KW; Zhao, X; Im, JY; Grosso, H; Jang, WH; Chan, TW; Sonsalla, PK; German, DC; Ichijo, H; Junn, E; Mouradian, MM				Lee, Kang-Woo; Zhao, Xin; Im, Joo-Young; Grosso, Hilary; Jang, Won Hee; Chan, Teresa W.; Sonsalla, Patricia K.; German, Dwight C.; Ichijo, Hidenori; Junn, Eunsung; Mouradian, M. Mara			Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; OXIDATIVE STRESS; SUBSTANTIA-NIGRA; DOPAMINERGIC NEURODEGENERATION; MOUSE MODEL; CELL-DEATH; ASK1; DEGENERATION; CYCLOOXYGENASE-2; NEURONS	Apoptosis signal-regulating kinase 1 ASIK1) member of the mitogen-activated protein kinase 3 family, is activated by oxidative stress. The death-signaling pathway mediated by ASK1 is inhibited by DJ 1, which is linked to recessively inherited Parkinson's disease (PD). Considering that DJ-1 deficiency exacerbates the toxicity of the mitochondrial complex I inhibitor 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), we sought to investigate the direct role and mechanism of ASK1 in MPTP-induced dopamine neuron toxicity. In the present study, we found that MPTP administration to wild-type mice activates ASK1 in the midbrain. In ASK1 null mice, MPTP-induced motor impairment was less profound, and striatal dopamine content and nigral dopamine neuron counts were relatively preserved compared to wild type littermates. Further, microglia and astrocyte activation seen in wild-type mice challenged with MPTP was markedly attenuated in,ASK1(-/-) mice. These data suggest that ASK1 is a key player in MPTP-induced glial activation linking oxidative stress with neuroinflammation, two well recognized pathogenetic factors in PD. These findings demonstrate that ASK1 is an important effector of MPTP-induced toxicity and suggest that inhibiting this kinase is a plausible therapeutic strategy for protecting dopamine neurons in PD.	[Lee, Kang-Woo; Zhao, Xin; Im, Joo-Young; Grosso, Hilary; Chan, Teresa W.; Sonsalla, Patricia K.; Junn, Eunsung; Mouradian, M. Mara] UMDNJ Robert Wood Johnson Med Sch, Dept Neurol, Ctr Neurodegenerat & Neuroimmunol Dis, Piscataway, NJ 08854 USA; [Jang, Won Hee] Inje Univ, Coll Med, Dept Biochem, Pusan, South Korea; [German, Dwight C.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Inje University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tokyo	Lee, KW (corresponding author), UMDNJ Robert Wood Johnson Med Sch, Dept Neurol, Ctr Neurodegenerat & Neuroimmunol Dis, Piscataway, NJ 08854 USA.	Mouradian@umdnj.edu	Grosso Jasuktar, Hilary/AGX-7358-2022; Yin, Minghao/E-9611-2015; Yin, Minghao/A-4031-2013	Grosso Jasuktar, Hilary/0000-0002-1441-2191; Yin, Minghao/0000-0002-6226-2394; Mouradian, M. Maral/0000-0002-9937-412X; Ichijo, Hidenori/0000-0002-5005-6438	NINDS/NIH [NS059869, NS53517]; American Parkinson Disease Association; Foundation of UMDNJ	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Parkinson Disease Association; Foundation of UMDNJ	This work was supported by NINDS/NIH grants NS059869 and NS53517 to M.M.M. and by grants from the American Parkinson Disease Association and the Foundation of UMDNJ to E.J. M.M.M. is the William Dow Lovett Professor of Neurology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfinito PD, 2003, J NEUROSCI, V23, P10982; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Gao HM, 2003, J NEUROSCI, V23, P6181; Guo XL, 2010, EMBO MOL MED, V2, P504, DOI 10.1002/emmm.201000103; Hu XM, 2011, J NEUROSCI, V31, P247, DOI 10.1523/JNEUROSCI.4589-10.2011; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kandil S, 2010, FASEB J, V56, P611; Karunakaran S, 2008, J NEUROSCI, V28, P12500, DOI 10.1523/JNEUROSCI.4511-08.2008; Kim YS, 2007, FASEB J, V21, P179, DOI 10.1096/fj.06-5865com; Kumakura K, 2010, NEUROSCI RES, V66, P313, DOI 10.1016/j.neures.2009.12.003; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Saeed U, 2009, NEUROTOX RES, V16, P116, DOI 10.1007/s12640-009-9058-5; Sager TN, 2010, BEHAV BRAIN RES, V208, P444, DOI 10.1016/j.bbr.2009.12.014; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sedelis M, 2000, BEHAV GENET, V30, P171, DOI 10.1023/A:1001958023096; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; SONSALLA PK, 1991, J PHARMACOL EXP THER, V256, P506; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Sugama S, 2003, BRAIN RES, V964, P288, DOI 10.1016/S0006-8993(02)04085-4; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; UPCHURCH M, 1983, BEHAV NEURAL BIOL, V39, P221, DOI 10.1016/S0163-1047(83)90876-2; Vijitruth R, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-6; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Zeevalk GD, 2007, EXP NEUROL, V203, P512, DOI 10.1016/j.expneurol.2006.09.004; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	45	101	108	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					242	249	e29935	10.1371/journal.pone.0029935	http://dx.doi.org/10.1371/journal.pone.0029935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253830	Green Published, Green Submitted, gold			2022-12-27	WOS:000301353900026
J	Ma, JW; Huang, CM; Yao, XX; Shi, C; Sun, LF; Yuan, L; Lei, P; Zhu, HF; Liu, HB; Wu, XW; Ning, Q; Zhou, C; Shen, GX				Ma, Jingwei; Huang, Chunmei; Yao, Xinxin; Shi, Chuan; Sun, Lifang; Yuan, Lu; Lei, Ping; Zhu, Huifen; Liu, Hongbo; Wu, Xiongwen; Ning, Qin; Zhou, Chun; Shen, Guanxin			Inhibition of Hepatitis B Virus and Induction of Hepatoma Cell Apoptosis by ASGPR-Directed Delivery of shRNAs	PLOS ONE			English	Article							SMALL INTERFERING RNAS; ASIALOGLYCOPROTEIN RECEPTOR; INCREASES MIGRATION; NATURAL-HISTORY; PROTEIN-X; SURVIVIN; GENE; EXPRESSION; LIVER; SIRNA	Hepatitis B virus (HBV) infection is a worldwide liver disease and nearly 25% of chronic HBV infections terminate in hepatocellular carcinoma (HCC). Currently, there is no effective therapy to inhibit HBV replication and to eliminate hepatoma cells, making it highly desired to develop novel therapies for these two stages of the HBV-caused detrimental disease. Recently, short hairpin RNA (shRNA) has emerged as a potential therapy for virus-infected disease and cancer. Here, we have generated a shRNA, pGenesil-siHBV4, which effectively inhibits HBV replication in the human hepatoma cell line HepG2.2.15. The inhibitory effects of pGenesil-siHBV4 are manifested by the decrease of both the HBV mRNA level and the protein levels of the secreted HBV surface antigen (HBsAg) and HBV e antigen (HBeAg), and by the reduction of secreted HBV DNA. Using mouse hydrodynamic tail vein injection, we demonstrate that pGenesil-siHBV4 is effective in inhibiting HBV replication in vivo. Because survivin plays a key role in cancer cell escape from apoptosis, we further generated pGenesil-siSurvivin, a survivin-silencing shRNA, and showed its effect of triggering apoptosis of HBV-containing hepatoma cells. To develop targeted shRNA therapy, we have identified that as a specific binder of the asialoglycoprotein receptor (ASGPR), jetPEI-Hepatocyte delivers pGenesil-siHBV4 and pGenesil-siSurvivin specifically to hepatocytes, not other types of cells. Finally, co-transfection of pGenesil-siHBV4 and pGenesil-siSurvivin exerts synergistic effects in inducing hepatoma cell apoptosis, a novel approach to eliminate hepatoma by downregulating survivin via multiple mechanisms. The application of these novel shRNAs with the jetPEI-Hepatocyte targeting strategy demonstrates the proof-of-principle for a promising approach to inhibit HBV replication and eliminate hepatoma cells with high specificity.	[Zhou, Chun] Columbia Univ, Dept Environm Hlth Sci, New York, NY 10027 USA; [Ma, Jingwei; Huang, Chunmei; Yao, Xinxin; Shi, Chuan; Sun, Lifang; Yuan, Lu; Lei, Ping; Zhu, Huifen; Liu, Hongbo; Wu, Xiongwen; Shen, Guanxin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China; [Ning, Qin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China	Columbia University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhou, C (corresponding author), Columbia Univ, Dept Environm Hlth Sci, New York, NY 10027 USA.	cz2132@columbia.edu; guanxin_shen@yahoo.com.cn	shen, Guanxin/F-7441-2011	Liu, Hongbo/0000-0002-7187-8115	Program for Changjiang Scholars and Innovative Research Team in University [IRT1131]; State Project on Major Infectious Diseases Prevention [2012ZX10002006-003]; International Science & Technology Cooperation Program of China [2011DFA31030]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); State Project on Major Infectious Diseases Prevention; International Science & Technology Cooperation Program of China	This research work was supported by Program for Changjiang Scholars and Innovative Research Team in University (Grant, No: IRT1131), State Project on Major Infectious Diseases Prevention (Grant 2012ZX10002006-003), and the International Science & Technology Cooperation Program of China (2011DFA31030). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Budker VG, 2006, J GENE MED, V8, P874, DOI 10.1002/jgm.920; But DYK, 2008, WORLD J GASTROENTERO, V14, P1652, DOI 10.3748/wjg.14.1652; Chen Y, 2004, WORLD J GASTROENTERO, V10, P82; De Paula D, 2007, RNA, V13, P431, DOI 10.1261/rna.459807; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; Gong Q, 2011, DNA CELL BIOL, V30, P347, DOI 10.1089/dna.2010.1172; Guan SH, 2007, WORLD J GASTROENTERO, V13, P228, DOI 10.3748/wjg.v13.i2.228; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Ikeguchi M, 2002, DIAGN MOL PATHOL, V11, P33, DOI 10.1097/00019606-200203000-00007; KANEKO S, 1988, J VIROL, V62, P3979, DOI 10.1128/JVI.62.11.3979-3984.1988; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim EM, 2005, J CONTROL RELEASE, V108, P557, DOI 10.1016/j.jconrel.2005.09.001; Kim SI, 2007, MOL THER, V15, P1145, DOI 10.1038/sj.mt.6300168; Kumar R, 2003, GENOME RES, V13, P2333, DOI 10.1101/gr.1575003; Kuo TC, 2010, BIOCHEM PHARMACOL, V80, P1093, DOI 10.1016/j.bcp.2010.06.003; Li Donghua, 2003, J Huazhong Univ Sci Technolog Med Sci, V23, P383; Li L, 2009, MOL BIOSYST, V5, P1361, DOI 10.1039/b903428e; Liu FJ, 2007, WORLD J GASTROENTERO, V13, P5324, DOI 10.3748/wjg.v13.i40.5324; Liu HY, 2007, CANCER BIOL THER, V6, P697; Liu YQ, 2009, MOL THER, V17, P269, DOI 10.1038/mt.2008.266; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Masiero M, 2007, MOL ASPECTS MED, V28, P143, DOI 10.1016/j.mam.2006.12.004; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Nguyen DH, 2008, J CELL PHYSIOL, V216, P289, DOI 10.1002/jcp.21416; NISHIKAWA M, 1995, AM J PHYSIOL-GASTR L, V268, pG849, DOI 10.1152/ajpgi.1995.268.5.G849; O'Driscoll L, 2003, CURR CANCER DRUG TAR, V3, P131, DOI 10.2174/1568009033482038; Pan XF, 2011, MOL IMMUNOL, V48, P1573, DOI 10.1016/j.molimm.2011.03.012; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Shu Y, 2011, MOL THER, V19, P1304, DOI 10.1038/mt.2011.23; Shu Y, 2011, METHODS, V54, P204, DOI 10.1016/j.ymeth.2011.01.008; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Xia LM, 2009, VIROLOGY, V385, P335, DOI 10.1016/j.virol.2008.11.042; Zhang R, 2010, CANCER GENE THER, V17, P275, DOI 10.1038/cgt.2009.68; Zhang XD, 2005, J MED VIROL, V77, P374, DOI 10.1002/jmv.20466; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031458; Zhou Y, 2010, J BIOL CHEM, V285, P12159, DOI 10.1074/jbc.M109.067629	50	76	81	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e46096	10.1371/journal.pone.0046096	http://dx.doi.org/10.1371/journal.pone.0046096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094023	gold, Green Published, Green Submitted			2022-12-27	WOS:000310050200007
J	Xie, T; d' Ario, G; Lamb, JR; Martin, E; Wang, K; Tejpar, S; Delorenzi, M; Bosman, FT; Roth, AD; Yan, P; Bougel, S; Di Narzo, AF; Popovici, V; Budinska, E; Mao, M; Weinrich, SL; Rejto, PA; Hodgson, JG				Xie, Tao; d' Ario, Giovanni; Lamb, John R.; Martin, Eric; Wang, Kai; Tejpar, Sabine; Delorenzi, Mauro; Bosman, Fred T.; Roth, Arnaud D.; Yan, Pu; Bougel, Stephanie; Di Narzo, Antonio Fabio; Popovici, Vlad; Budinska, Eva; Mao, Mao; Weinrich, Scott L.; Rejto, Paul A.; Hodgson, J. Graeme			A Comprehensive Characterization of Genome-Wide Copy Number Aberrations in Colorectal Cancer Reveals Novel Oncogenes and Patterns of Alterations	PLOS ONE			English	Article							ELONGATION-FACTOR EEF1A2; COLON-CANCER; OVARIAN-CANCER; BREAST-CANCER; CELL-LINES; DNA; GENES; HYBRIDIZATION; PROTEIN; TUMORS	To develop a comprehensive overview of copy number aberrations (CNAs) in stage-II/III colorectal cancer (CRC), we characterized 302 tumors from the PETACC-3 clinical trial. Microsatellite-stable (MSS) samples (n = 269) had 66 minimal common CNA regions, with frequent gains on 20 q (72.5%), 7 (41.8%), 8 q (33.1%) and 13 q (51.0%) and losses on 18 (58.6%), 4 q (26%) and 21 q (21.6%). MSS tumors have significantly more CNAs than microsatellite-instable (MSI) tumors: within the MSI tumors a novel deletion of the tumor suppressor WWOX at 16 q23.1 was identified (p<0.01). Focal aberrations identified by the GISTIC method confirmed amplifications of oncogenes including EGFR, ERBB2, CCND1, MET, and MYC, and deletions of tumor suppressors including TP53, APC, and SMAD4, and gene expression was highly concordant with copy number aberration for these genes. Novel amplicons included putative oncogenes such as WNK1 and HNF4A, which also showed high concordance between copy number and expression. Survival analysis associated a specific patient segment featured by chromosome 20 q gains to an improved overall survival, which might be due to higher expression of genes such as EEF1B2 and PTK6. The CNA clustering also grouped tumors characterized by a poor prognosis BRAF-mutant-like signature derived from mRNA data from this cohort. We further revealed non-random correlation between CNAs among unlinked loci, including positive correlation between 20 q gain and 8 q gain, and 20 q gain and chromosome 18 loss, consistent with co-selection of these CNAs. These results reinforce the non-random nature of somatic CNAs in stage-II/III CRC and highlight loci and genes that may play an important role in driving the development and outcome of this disease.	[Xie, Tao; Lamb, John R.; Martin, Eric; Wang, Kai; Mao, Mao; Weinrich, Scott L.; Rejto, Paul A.; Hodgson, J. Graeme] Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA USA; [d' Ario, Giovanni; Delorenzi, Mauro; Di Narzo, Antonio Fabio; Popovici, Vlad; Budinska, Eva] Swiss Inst Bioinformat, Lausanne, Switzerland; [Tejpar, Sabine] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Louvain, Belgium; [Delorenzi, Mauro; Bosman, Fred T.; Yan, Pu; Bougel, Stephanie] Univ Lausanne, Med Ctr, Lausanne, Switzerland; [Roth, Arnaud D.] Univ Hosp Geneva, Geneva, Switzerland	Pfizer; Swiss Institute of Bioinformatics; KU Leuven; University Hospital Leuven; University of Lausanne; University of Geneva	Xie, T (corresponding author), Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA USA.	tao.xie@pfizer.com; hodgson.graeme@gmail.com	Whitehall, Vicki L/B-6262-2013; Budinska, Eva/F-2698-2011; Leggett, Barbara A/D-3579-2011; Young, Joanne P/H-7774-2014; Pandeya, Nirmala/F-8054-2010; Young, Joanne P/B-9981-2011; Whitehall, Vicki/E-5414-2019; Rejto, Paul/M-4782-2019; Popovici, Vlad C./C-2039-2008	Whitehall, Vicki L/0000-0002-8285-2391; Budinska, Eva/0000-0002-9004-9187; Pandeya, Nirmala/0000-0003-1462-4968; Popovici, Vlad C./0000-0002-1311-9188; Wang, Kai/0000-0003-0567-3004; /0000-0003-3281-8643	Swiss National Science Foundation [SNF 320030_135421]; Foundation Medic; Krebsforschung Schweiz [KFS 02697-08-2010]; Belgian Federation Against Cancer; Belgian National Cancer Plan	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Medic; Krebsforschung Schweiz; Belgian Federation Against Cancer; Belgian National Cancer Plan	This work was supported in part by a grant from the Swiss National Science Foundation (SNF 320030_135421) and Foundation Medic and a grant of the Krebsforschung Schweiz (KFS 02697-08-2010) to AR and MD. ST is a senior clinical investigator of the Fund for Scientific Research Flanders and has received research grants from the Belgian Federation Against Cancer and from the Belgian National Cancer Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; Andersen CL, 2010, INT J CANC; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Aubele M, 2007, BRIT J CANCER, V96, P801, DOI 10.1038/sj.bjc.6603613; Aust DE, 2004, SCAND J GASTROENTERO, V39, P766, DOI 10.1080/00365520410003191; Bartos JD, 2007, MUTAT RES-FUND MOL M, V615, P1, DOI 10.1016/j.mrfmmm.2006.09.006; Bouteille N, 2009, ONCOGENE, V28, P2569, DOI 10.1038/onc.2009.120; Brosens RPM, 2010, J PATHOL, V221, P411, DOI 10.1002/path.2724; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; Camps J, 2009, GENE CHROMOSOME CANC, V48, P1002, DOI 10.1002/gcc.20699; Darsigny M, 2010, CANCER RES, V70, P9423, DOI 10.1158/0008-5472.CAN-10-1697; Diep CB, 2006, GENE CHROMOSOME CANC, V45, P31, DOI 10.1002/gcc.20261; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Hodgson JG, 2003, BREAST CANCER RES TR, V78, P337, DOI 10.1023/A:1023085825042; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ji HL, 2006, CANCER RES, V66, P7910, DOI 10.1158/0008-5472.CAN-06-0595; Kazuo M, 2008, ANN SURG ONCOL, V15, P1530, DOI 10.1245/s10434-007-9746-4; Kulkarni G, 2007, BREAST CANCER RES TR, V102, P31, DOI 10.1007/s10549-006-9315-8; Kurashina K, 2008, CANCER SCI, V99, P1835, DOI 10.1111/j.1349-7006.2008.00881.x; Lamb JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020090; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Sayagues JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013752; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Nakao K, 2004, CARCINOGENESIS, V25, P1345, DOI 10.1093/carcin/bgh134; Nakao M, 2009, CANCER GENET CYTOGEN, V188, P70, DOI 10.1016/j.cancergencyto.2008.09.013; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pinke DE, 2008, GYNECOL ONCOL, V108, P561, DOI 10.1016/j.ygyno.2007.11.019; Platzer P, 2002, CANCER RES, V62, P1134; Popovici V, 2012, J CONTRACEPT FERTIL; Postma C, 2009, ANN ONCOL, V20, P1048, DOI 10.1093/annonc/mdn738; Poulogiannis G, 2010, J PATHOL, V220, P338, DOI 10.1002/path.2640; Reid JF, 2009, GENE CHROMOSOME CANC, V48, P953, DOI 10.1002/gcc.20697; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Sabbah M, 2011, MOL CELL BIOL, V31, P1459, DOI 10.1128/MCB.01316-10; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Speleman F, 2008, CYTOGENET GENOME RES, V123, P176, DOI 10.1159/000184706; Van Cutsem E, 2009, J CLIN ONCOL, V27, P3117, DOI 10.1200/JCO.2008.21.6663; Venkatachalam R, 2008, CYTOGENET GENOME RES, V123, P188, DOI 10.1159/000184708; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wierzbicki PM, 2009, J PHYSIOL PHARMACOL, V60, P63; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xie T, 2010, OMICS, V14, P91, DOI 10.1089/omi.2009.0114	46	83	87	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42001	10.1371/journal.pone.0042001	http://dx.doi.org/10.1371/journal.pone.0042001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	23094064	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600049
J	Zhao, JP; Diao, S; Zhang, BY; Niu, BQ; Wang, QL; Wan, XC; Luo, YQ				Zhao, Jia-Ping; Diao, Shu; Zhang, Bing-Yu; Niu, Bao-Qing; Wang, Qing-Ling; Wan, Xian-Chong; Luo, You-Qing			Phylogenetic Analysis and Molecular Evolution Patterns in the MIR482-MIR1448 Polycistron of Populus L	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; STRESS-RESPONSIVE MICRORNAS; COMPENSATORY MUTATIONS; TARGET SEQUENCES; SALICACEAE; CONSERVATION; DUPLICATION; BIOGENESIS; PREDICTION; DIVERSE	The microRNAs (miRNAs) miR482 and miR1448 are disease resistance-related miRNAs; the former is ubiquitously distributed in seed plants whereas the latter has only been reported in Populus trichocarpa. The precursor and mature sequences of poplar miR1448 are highly homologous to those of poplar miR482, and these two miRNAs are located in one transcript as a polycistron. Therefore, we hypothesized that the MIR1448 gene may have evolved from the MIR482 gene in poplar. However, the molecular evolution patterns of this process remain unclear. In this study, utilizing cloning and Blast analysis in NCBI ESTs and whole-genome shotgun contigs (WGS) dataset, we determined that the MIR482-MIR1448 polycistron is a family-specific clustered miRNA in Salicaceae. Moreover, phylogenetic analysis illustrated that MIR1448 is the product of a tandem duplication event from MIR482. Nucleotide substitution analysis revealed that both MIR482 and MIR1448 have more rapid evolution ratios than ribosomal DNA (rDNA) genes, and that compensatory mutations that occurred in the stem region of the secondary structure were the main mechanisms that drove the evolution of these MIRNA genes. Furthermore, by comparing the substitution patterns in the miRNA-target complexes of miR482 and miR1448, we inferred that co-evolution between miRNAs and their targets was the major force that drove the "duplicated MIR482" evolve to MIR1448. We propose a novel miRNA-target pairing pattern called the "frameshift targeted mechanism" to explain the gain of target genes by miR1448. The results also imply that the major role of miR482 was in resistance to disease or other stresses via NBS-LRR proteins, whereas the biological functions of miR1448 are more diverse.	[Zhao, Jia-Ping; Wan, Xian-Chong] Chinese Acad Forestry, Inst New Forestry Technol, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Zhao, Jia-Ping; Luo, You-Qing] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China; [Diao, Shu; Zhang, Bing-Yu] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Niu, Bao-Qing; Wang, Qing-Ling] Agr Univ Hebei, Baoding, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry New Technology, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Beijing Forestry University; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Hebei Agricultural University	Zhao, JP (corresponding author), Chinese Acad Forestry, Inst New Forestry Technol, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	zhaojiaping@gmail.com; yqluo@bjfu.edu.cn		Yan, Xiaodong/0000-0002-0774-9140; Jia, Gensuo/0000-0001-5950-9555	National Program on Key Basic Research Project of China (973 Program) [2009CB119107]; National Natural Science Foundation of China [30872048]; Chinese Postdoctoral Funding [20110490302]; National Science & Technology Basic Program of China [2009FY210100]	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Funding; National Science & Technology Basic Program of China	This work was financially supported by National Program on Key Basic Research Project of China (973 Program) (No. 2009CB119107), National Natural Science Foundation of China (No. 30872048), Chinese Postdoctoral Funding (No. 20110490302) and National Science & Technology Basic Program of China (No. 2009FY210100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Chakraborty S, 2012, RNA, V18, P1014, DOI 10.1261/rna.031039.111; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; COLLINSON ME, 1992, P ROY SOC EDINB B, V98, P155, DOI 10.1017/S0269727000007521; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; DIXON MT, 1993, MOL BIOL EVOL, V10, P256; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Gazzani S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-62; Guo XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-454; Hamzeh M, 2004, AM J BOT, V91, P1398, DOI 10.3732/ajb.91.9.1398; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393; Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620; Kim VN, 2008, CELL, V133, P25, DOI 10.1016/j.cell.2008.03.015; Laubinger S, 2010, P NATL ACAD SCI USA, V107, P17466, DOI 10.1073/pnas.1012891107; Leskinen E, 1999, PLANT SYST EVOL, V215, P209, DOI 10.1007/BF00984656; Li AL, 2007, CELL RES, V17, P212, DOI 10.1038/sj.cr.7310113; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Merchan F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r136; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81	41	20	23	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47811	10.1371/journal.pone.0047811	http://dx.doi.org/10.1371/journal.pone.0047811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23144853	gold, Green Published, Green Submitted			2022-12-27	WOS:000312384500027
J	Pratheeshkumar, P; Budhraja, A; Son, YO; Wang, X; Zhang, Z; Ding, SZ; Wang, L; Hitron, A; Lee, JC; Xu, M; Chen, G; Luo, J; Shi, XL				Pratheeshkumar, Poyil; Budhraja, Amit; Son, Young-Ok; Wang, Xin; Zhang, Zhuo; Ding, Songze; Wang, Lei; Hitron, Andrew; Lee, Jeong-Chae; Xu, Mei; Chen, Gang; Luo, Jia; Shi, Xianglin			Quercetin Inhibits Angiogenesis Mediated Human Prostate Tumor Growth by Targeting VEGFR-2 Regulated AKT/mTOR/P70S6K Signaling Pathways	PLOS ONE			English	Article							CANCER PREVENTION; ACTIVATION; APOPTOSIS; INVASION; BIOLOGY; CELLS; MTOR	Angiogenesis is a crucial step in the growth and metastasis of cancers, since it enables the growing tumor to receive oxygen and nutrients. Cancer prevention using natural products has become an integral part of cancer control. We studied the antiangiogenic activity of quercetin using ex vivo, in vivo and in vitro models. Rat aortic ring assay showed that quercetin at non-toxic concentrations significantly inhibited microvessel sprouting and exhibited a significant inhibition in the proliferation, migration, invasion and tube formation of endothelial cells, which are key events in the process of angiogenesis. Most importantly, quercetin treatment inhibited ex vivo angiogenesis as revealed by chicken egg chorioallantoic membrane assay (CAM) and matrigel plug assay. Western blot analysis showed that quercetin suppressed VEGF induced phosphorylation of VEGF receptor 2 and their downstream protein kinases AKT, mTOR, and ribosomal protein S6 kinase in HUVECs. Quercetin (20 mg/kg/d) significantly reduced the volume and the weight of solid tumors in prostate xenograft mouse model, indicating that quercetin inhibited tumorigenesis by targeting angiogenesis. Furthermore, quercetin reduced the cell viability and induced apoptosis in prostate cancer cells, which were correlated with the downregulation of AKT, mTOR and P70S6K expressions. Collectively the findings in the present study suggest that quercetin inhibits tumor growth and angiogenesis by targeting VEGF-R2 regulated AKT/mTOR/P70S6K signaling pathway, and could be used as a potential drug candidate for cancer therapy.	[Pratheeshkumar, Poyil; Budhraja, Amit; Son, Young-Ok; Wang, Xin; Zhang, Zhuo; Ding, Songze; Wang, Lei; Hitron, Andrew; Lee, Jeong-Chae; Shi, Xianglin] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Xu, Mei; Chen, Gang; Luo, Jia] Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY USA	University of Kentucky; University of Kentucky	Shi, XL (corresponding author), Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA.	xshi5@email.uky.edu	Luo, Jia/E-4674-2012; Wang, Lei/E-3063-2012; Son, Youngok/AAB-1380-2021; Zhang, Zhuo/B-8601-2012; Son, Young-Ok/P-3675-2015	Luo, Jia/0000-0002-6968-3618; Budhraja, Amit/0000-0002-4216-8608; Son, Youngok/0000-0003-0154-4061	National Institutes of Health [1R01ES020870, 5R21ES019249]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020870, R21ES019249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants: 1R01ES020870 (Shi), and 5R21ES019249 (Shi and Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER NA, 1985, BIOCHEMISTRY-US, V24, P4352, DOI 10.1021/bi00337a015; Berger NA, 2010, POLY ADP RIBOSE CELL; Bhat TA, 2008, FOOD CHEM TOXICOL, V46, P1334, DOI 10.1016/j.fct.2007.08.032; Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8; Budhraja A, 2012, MOL CANCER THER, V11, P132, DOI 10.1158/1535-7163.MCT-11-0343; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Chen J, 2002, BIOCHEM PHARMACOL, V64, P1071, DOI 10.1016/S0006-2952(02)01263-7; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Fasolo A, 2008, MTOR INHIBITORS TREA; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Kuttan G, 2011, PHARM BIOL, V49, P995, DOI 10.3109/13880209.2011.559476; Li W, 2008, ONCOL REP, V20, P713, DOI 10.3892/or_00000064; Liu LZ, 2008, CANCER RES, V68, P8183, DOI 10.1158/0008-5472.CAN-08-0819; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020858; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Murakami A, 2008, CANCER LETT, V269, P315, DOI 10.1016/j.canlet.2008.03.046; Nicholson DW, 1995, IDENTIFICATION INHIB; Pang XF, 2009, CANCER RES, V69, P5893, DOI 10.1158/0008-5472.CAN-09-0755; Patan S, 2004, CANC TREAT, V117, P3; Pratheeshkumar P, 2011, J ENVIRON PATHOL TOX, V30, P33, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i1.40; Pratheeshkumar P, 2012, ANTICANCER AGENTS ME; Pratheeshkumar P, 2011, EUROPEAN J PHARM; Pratheeshkumar P, 2011, DRUG CHEM TOXICOL, V34, P261, DOI 10.3109/01480545.2010.520017; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roberts WG, 1997, CANCER RES, V57, P765; Seeliger H, 2007, CANCER METAST REV, V26, P611, DOI 10.1007/s10555-007-9077-8; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tie Jeanne, 2012, Critical Reviews in Oncogenesis, V17, P51; Tufan AC, 2005, CURR CANCER DRUG TAR, V5, P249, DOI 10.2174/1568009054064624; Wang SP, 2011, BOUND VALUE PROBL, DOI 10.1155/2011/901796; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yao H, 2011, J ENVIRON SCI HEAL C, V29, P1, DOI 10.1080/10590501.2011.551317; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yi TF, 2008, MOL CANCER THER, V7, P1789, DOI 10.1158/1535-7163.MCT-08-0124	40	186	200	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47516	10.1371/journal.pone.0047516	http://dx.doi.org/10.1371/journal.pone.0047516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23300633	Green Published, Green Submitted, gold			2022-12-27	WOS:000312384500013
J	Wang, XM; Zhu, CF; Bao, WG; Zhao, K; Niu, JQ; Yu, XF; Zhang, WY				Wang, Xiaomei; Zhu, Chunfeng; Bao, Wanguo; Zhao, Ke; Niu, Junqi; Yu, Xiao-Fang; Zhang, Wenyan			Characterization of Full-Length Enterovirus 71 Strains from Severe and Mild Disease Patients in Northeastern China	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; FOOT; HAND; TAIWAN; RECOMBINATION; INFECTION; EVOLUTION; OUTBREAK	Human enterovirus 71 (EV71)-associated hand, foot, and mouth disease (HFMD) has been a leading cause of childhood infection in China since 2008. Epidemic and molecular characteristics of HFMD have been examined in many areas of China, including the central and southern regions. However, clinical and genetic characterization of EV71 in the northeastern region of China is scarce. In this study, a series of analyses were performed on seven full-length EV71 sequences from HFMD patients who had either severe or mild disease. We have determined that these seven circulating EV71 viruses from Changchun, China are actually complex recombinant viruses involving multiple type A human enterovirus (HEV). Classified as EV71 subtype C4 (EV71 C4), these Changchun EV71 viruses contain genetic recombination events between the CA4, CA5, EV71B4 and EV71C1 strains. Most of the structural protein region (P1) of these viruses resembled that of the prototype EV71 C1 strains. The non-structural protein domains (P2 and P3) showed a high degree of similarity with CA4, CA5 and EV71 B4 in different regions. The 5'UTR had unclassified recombination, while partial 3D region of these viruses showed a high degree of similarity to CA16. Phylogenetic analysis of full-length or partial sequences of isolates from severe or mild disease patients in Changchun always formed a single cluster in various phylogenetic analyses of different genomic regions, suggesting that all seven strains originated from one single common ancestor. There was no correlation between viral genomic sequence and virulence. Thus, we found that circulating recombinant forms of EV71 are prevalent among HFMD patients in Northeastern China. The existence of a unique cluster of EV71 related viruses in Northeast China has important implications for vaccine development that would address the increasing prevalence of HFMD.	[Wang, Xiaomei; Zhu, Chunfeng; Zhao, Ke; Yu, Xiao-Fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China; [Wang, Xiaomei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin Province, Peoples R China; [Bao, Wanguo] Jilin Univ, Hosp 1, Dept Infect Dis, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, XM (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China.	junqiniu@yahoo.com.cn; xfyu@jhsph.edu; zhangwenyan@jlu.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	Specialized Research Fund for the Doctoral Program of Higher Education; Jilin University [200903258]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jilin University(Jilin University); Key Laboratory of Molecular Virology, Jilin Province, China; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by funding from the Specialized Research Fund for the Doctoral Program of Higher Education and Jilin University (No200903258) to Wenyan Zhang, and a grant from the Key Laboratory of Molecular Virology, Jilin Province (20102209), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026237; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shi XD, 2011, CENT EUR J MED, V6, P220, DOI 10.2478/s11536-010-0075-9; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	22	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32405	10.1371/journal.pone.0050575	http://dx.doi.org/10.1371/journal.pone.0050575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22558416	gold, Green Submitted, Green Published			2022-12-27	WOS:000304523400005
J	Wang, XX; Huang, M; Wang, YZ				Wang, Xinxia; Huang, Ming; Wang, Yizhen			The Effect of Insulin, TNF alpha and DHA on the Proliferation, Differentiation and Lipolysis of Preadipocytes Isolated from Large Yellow Croaker (Pseudosciaena Crocea R.)	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TROUT ONCORHYNCHUS-MYKISS; FATTY-ACID SYNTHASE; INHIBITS ADIPOCYTE DIFFERENTIATION; ADIPOSE TRIGLYCERIDE LIPASE; ACTIVATED RECEPTORS ALPHA; SIGNAL-RELATED KINASE; LPL GENE-EXPRESSION; RAINBOW-TROUT; LIPOPROTEIN-LIPASE	Fish final product can be affected by excessive lipid accumulation. Therefore, it is important to develop strategies to control obesity in cultivated fish to strengthen the sustainability of the aquaculture industry. As in mammals, the development of adiposity in fish depends on hormonal, cytokine and dietary factors. In this study, we investigated the proliferation and differentiation of preadipocytes isolated from the large yellow croaker and examined the effects of critical factors such as insulin, TNF alpha and DHA on the proliferation, differentiation and lipolysis of adipocytes. Preadipocytes were isolated by collagenase digestion, after which their proliferation was evaluated. The differentiation process was optimized by assaying glycerol-3-phosphate dehydrogenase (GPDH) activity. Oil red O staining and electron microscopy were performed to visualize the accumulated triacylglycerol. Gene transcript levels were measured using SYBR green quantitative real-time PCR. Insulin promoted preadipocytes proliferation, stimulated cell differentiation and decreased lipolysis of mature adipocytes. TNF alpha and DHA inhibited cell proliferation and differentiation. While TNF alpha stimulated mature adipocyte lipolysis, DHA showed no lipolytic effect on adipocytes. The expressions of adipose triglyceride lipase (ATGL), fatty acid synthase (FAS), lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor alpha, gamma (PPAR alpha, PPAR gamma) were quantified during preadipocytes differentiation and adipocytes lipolysis to partly explain the regulation mechanisms. In summary, the results of this study indicated that although preadipocytes proliferation and the differentiation process in large yellow croaker are similar to these processes in mammals, the effects of critical factors such as insulin, TNF alpha and DHA on fish adipocytes development are not exactly the same. Our findings fill in the gaps in the basic data regarding the effects of critical factors on adiposity development in fish and will facilitate the further study of molecular mechanism by which these factors act in fish and the application of this knowledge to eventually control obesity in cultured species.	[Wang, Xinxia; Huang, Ming; Wang, Yizhen] Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, YZ (corresponding author), Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yzwang@zju.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	NSFC (National Natural Science Foundation of China) [30901104]; China Postdoctoral Science Foundation [2009046138]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by grants from the NSFC (National Natural Science Foundation of China, grant # 30901104), and the China Postdoctoral Science Foundation (grant # 2009046138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2007, COMP BIOCHEM PHYS B, V148, P151, DOI 10.1016/j.cbpb.2007.05.004; Albalat A, 2005, COMP BIOCHEM PHYS A, V142, P347, DOI 10.1016/j.cbpa.2005.08.006; Albalat A, 2005, AM J PHYSIOL-REG I, V289, pR259, DOI 10.1152/ajpregu.00574.2004; Albalat A, 2005, J ENDOCRINOL, V184, P527, DOI 10.1677/joe.1.05940; Albalat A, 2006, GEN COMP ENDOCR, V146, P226, DOI 10.1016/j.ygcen.2005.11.011; [Anonymous], 2011, CHIN FISH STAT YB; Awad AB, 2000, J NUTR BIOCHEM, V11, P153, DOI 10.1016/S0955-2863(99)00087-X; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Boone C, 2000, REPROD NUTR DEV, V40, P325, DOI 10.1051/rnd:2000103; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; Bouraoui L, 2012, COMP BIOCHEM PHYS A, V161, P83, DOI 10.1016/j.cbpa.2011.09.008; Bouraoui L, 2010, AM J PHYSIOL-REG I, V299, pR33, DOI 10.1152/ajpregu.00457.2009; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Capilla E, 2011, GEN COMP ENDOCR, V172, P107, DOI 10.1016/j.ygcen.2011.03.020; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cersosimo E, 2012, AM J PHYSIOL-CELL PH, V302, pC652, DOI 10.1152/ajpcell.00022.2011; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Claycombe KJ, 1998, AM J PHYSIOL-REG I, V274, pR1253, DOI 10.1152/ajpregu.1998.274.5.R1253; CORNELIUS P, 1990, J BIOL CHEM, V265, P20506; DANI C, 1990, J CELL BIOCHEM, V43, P103, DOI 10.1002/jcb.240430202; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; Deiuliis JA, 2008, LIPIDS, V43, P215, DOI 10.1007/s11745-007-3146-1; DOERRLER W, 1994, CYTOKINE, V6, P478, DOI 10.1016/1043-4666(94)90074-4; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FRANSEN L, 1986, CELL IMMUNOL, V100, P260, DOI 10.1016/0008-8749(86)90025-0; Garcia-Castillo J, 2004, CELL MOL LIFE SCI, V61, P1331, DOI 10.1007/s00018-004-4068-1; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Glosli H, 2005, BBA-MOL CELL BIOL L, V1734, P235, DOI 10.1016/j.bbalip.2005.02.011; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grohmann M, 2005, J LIPID RES, V46, P93, DOI 10.1194/jlr.M400295-JLR200; GRUNFELD C, 1988, J LIPID RES, V29, P1327; Hansen JO, 2008, AQUACULTURE, V284, P159, DOI 10.1016/j.aquaculture.2008.07.043; HARMON JS, 1992, GEN COMP ENDOCR, V87, P214, DOI 10.1016/0016-6480(92)90025-F; Hensler M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-128; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Khan S, 2002, J LIPID RES, V43, P979; Kim HK, 2006, J NUTR, V136, P409, DOI 10.1093/jn/136.2.409; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Kras KM, 2000, OBES RES, V8, P186, DOI 10.1038/oby.2000.20; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezSoriano J, 1997, MOL CELL ENDOCRINOL, V132, P93, DOI 10.1016/S0303-7207(97)00125-1; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Montserrat N, 2007, GEN COMP ENDOCR, V150, P462, DOI 10.1016/j.ygcen.2006.11.009; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Niemela SM, 2007, J CRANIOFAC SURG, V18, P325, DOI 10.1097/scs.0b013e3180333b6a; Oku H, 2006, COMP BIOCHEM PHYS B, V144, P326, DOI 10.1016/j.cbpb.2006.03.008; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; PALOMBELLA VJ, 1989, J BIOL CHEM, V264, P18128; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ramsay TG, 2003, COMP BIOCHEM PHYS B, V136, P245, DOI 10.1016/S1096-4959(02)00261-0; Rieusset J, 1999, DIABETES, V48, P699, DOI 10.2337/diabetes.48.4.699; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; SMITH RA, 1986, J BIOL CHEM, V261, P4871; Sottile V, 2001, ANAL BIOCHEM, V293, P124, DOI 10.1006/abio.2001.5121; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Sun C, 2011, MOL BIOL REP, V38, P731, DOI 10.1007/s11033-010-0160-9; Suryawan A, 1997, J ANIM SCI, V75, P105; Todorcevic M, 2008, BBA-MOL CELL BIOL L, V1781, P326, DOI 10.1016/j.bbalip.2008.04.014; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Vegusdal A, 2003, LIPIDS, V38, P289, DOI 10.1007/s11745-003-1063-3; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wang XX, 2012, AQUAC RES, V43, P281, DOI 10.1111/j.1365-2109.2011.02826.x; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhang F, 2004, DRUG NEWS PERSPECT, V17, P661, DOI 10.1358/dnp.2004.17.10.873918; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhao ZY, 2008, J FOOD LIPIDS, V15, P534, DOI 10.1111/j.1745-4522.2008.00138.x; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	87	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48069	10.1371/journal.pone.0048069	http://dx.doi.org/10.1371/journal.pone.0048069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	22558416	Green Published, gold, Green Submitted			2022-12-27	WOS:000310262500033
J	Wang, XG; Comita, LS; Hao, ZQ; Davies, SJ; Ye, J; Lin, F; Yuan, ZQ				Wang, Xugao; Comita, Liza S.; Hao, Zhanqing; Davies, Stuart J.; Ye, Ji; Lin, Fei; Yuan, Zuoqiang			Local-Scale Drivers of Tree Survival in a Temperate Forest	PLOS ONE			English	Article							TROPICAL TREE; DENSITY-DEPENDENCE; HABITAT ASSOCIATIONS; SHADE TOLERANCE; SPATIAL DISTRIBUTIONS; SIZE DISTRIBUTIONS; SOIL INTERACTIONS; INDIVIDUAL TREES; LONG-TERM; GROWTH	Tree survival plays a central role in forest ecosystems. Although many factors such as tree size, abiotic and biotic neighborhoods have been proposed as being important in explaining patterns of tree survival, their contributions are still subject to debate. We used generalized linear mixed models to examine the relative importance of tree size, local abiotic conditions and the density and identity of neighbors on tree survival in an old-growth temperate forest in northeastern China at three levels (community, guild and species). Tree size and both abiotic and biotic neighborhood variables influenced tree survival under current forest conditions, but their relative importance varied dramatically within and among the community, guild and species levels. Of the variables tested, tree size was typically the most important predictor of tree survival, followed by biotic and then abiotic variables. The effect of tree size on survival varied from strongly positive for small trees (1-20 cm dbh) and medium trees (20-40 cm dbh), to slightly negative for large trees (>40 cm dbh). Among the biotic factors, we found strong evidence for negative density and frequency dependence in this temperate forest, as indicated by negative effects of both total basal area of neighbors and the frequency of conspecific neighbors. Among the abiotic factors tested, soil nutrients tended to be more important in affecting tree survival than topographic variables. Abiotic factors generally influenced survival for species with relatively high abundance, for individuals in smaller size classes and for shade-tolerant species. Our study demonstrates that the relative importance of variables driving patterns of tree survival differs greatly among size classes, species guilds and abundance classes in temperate forest, which can further understanding of forest dynamics and offer important insights into forest management.	[Wang, Xugao; Hao, Zhanqing; Ye, Ji; Lin, Fei; Yuan, Zuoqiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China; [Comita, Liza S.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Comita, Liza S.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Davies, Stuart J.] Harvard Univ, Ctr Trop Forest Sci, Boston, MA 02115 USA; [Davies, Stuart J.] Smithsonian Trop Res Inst, Boston, MA USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Smithsonian Institution; Smithsonian Tropical Research Institute	Wang, XG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China.	hzq@iae.ac.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	Chinese Academy of Sciences [KSCX2-EW-Z-5, KZCX2-YW-QN402]; National Natural Science Foundation of China [40971286, 31011120470, 31061160188]; Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF [EF-0553768]; University of California, Santa Barbara; State of California; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This study was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-5 and KZCX2-YW-QN402) and the National Natural Science Foundation of China (40971286, 31011120470 and 31061160188). XW acknowledges the support of a fellowship from the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute and the HSBC Climate Partnership. LSC acknowledges the support of a fellowship from the National Center for Ecological Analysis and Synthesis, a center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2009, LME4 LINEAR MIXED EF; Blundell AG, 2001, J ECOL, V89, P608, DOI 10.1046/j.0022-0477.2001.00581.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Castagneri D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009111; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONNELL J H, 1971, P298; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; FILIP GM, 1982, PLANT DIS, V66, P240, DOI 10.1094/PD-66-240; Finzi AC, 1998, ECOL APPL, V8, P447, DOI 10.2307/2641084; Finzi AC, 1998, ECOL APPL, V8, P440, DOI 10.2307/2641083; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Gelman A, DATA ANAL USING REGR; [郝占庆 HAO ZhanQing], 2008, [植物生态学报, Acta Phytoecologica Sinica], V32, P238; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harrell FE, 2001, REGRESSION MODELING; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; HIBBS DE, 1983, ECOLOGY, V64, P1394, DOI 10.2307/1937493; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Imaji A, 2010, OECOLOGIA, V162, P273, DOI 10.1007/s00442-009-1453-3; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Keane RE, 2001, CLIMATIC CHANGE, V51, P509, DOI 10.1023/A:1012539409854; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; Maloney PE, 2008, CAN J FOREST RES, V38, P3011, DOI 10.1139/X08-141; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; NORBERG RA, 1988, AM NAT, V131, P220, DOI 10.1086/284787; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Packer A, 2003, ECOLOGY, V84, P108, DOI 10.1890/0012-9658(2003)084[0108:SPAPSS]2.0.CO;2; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; R Core Team, 2020, R LANG ENV STAT COMP; Reinhart KO, 2009, ECOLOGY, V90, P2984, DOI 10.1890/08-1380.1; Runkle JR, 2000, ECOLOGY, V81, P554, DOI 10.1890/0012-9658(2000)081[0554:CTTIOG]2.0.CO;2; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Shibata M, 2010, ECOSCIENCE, V17, P137, DOI 10.2980/17-2-3163; Slik JW, 2001, OECOLOGIA, V141, P114; SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wang LiWei, 2011, Biodiversity Science, V19, P260, DOI 10.3724/SP.J.1003.2011.11279; Wang XG, 2008, ACTA OECOL, V33, P345, DOI 10.1016/j.actao.2008.01.005; Wang XG, 2010, CAN J FOREST RES, V40, P1011, DOI 10.1139/X10-056; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; Woods KD, 2000, ECOLOGY, V81, P110, DOI 10.2307/177138; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yao XH, 2001, CAN J FOREST RES, V31, P283, DOI 10.1139/cjfr-31-2-283; Zhang J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008086; Zhao DH, 2006, ECOL MODEL, V196, P90, DOI 10.1016/j.ecolmodel.2006.02.002; Zuur Alain F., 2009, P1	83	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e29469	10.1371/journal.pone.0029469	http://dx.doi.org/10.1371/journal.pone.0029469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22558416	gold, Green Published, Green Submitted			2022-12-27	WOS:000302733900002
J	Wang, XM; Yang, R; Feng, SF; Hou, XQ; Zhang, YQ; Li, Y; Ren, Y				Wang, Xumei; Yang, Rui; Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Li, Yan; Ren, Yi			Genetic Variation in Rheum palmatum and Rheum tanguticum (Polygonaceae), Two Medicinally and Endemic Species in China Using ISSR Markers	PLOS ONE			English	Article							CHLOROPLAST DNA; DIVERSITY; SEQUENCE; EVOLUTION; RHUBARB; DIFFERENTIATION; POPULATIONS; RADIATION; PLATEAU; NUMBER	Aims: Both Rheum palmatum and R. tanguticum are important but endangered medicinal plants endemic to China. In this study, we aimed to (i) investigate the level and pattern of genetic variability within/among populations of those species; (ii) evaluate genetic differentiation between both species and its relationships and ascertain whether both species are consistent with their current taxonomical treatment as separate species; and (iii) discuss the implications for the effective conservation of two species. Methods: Total 574 individuals from 30 populations of R. palmatum and R. tanguticum were collected, covering the entire distribution range of two species in China. The genetic variation within and among 30 populations was evaluated using inter-simple sequence repeat (ISSR) markers. Important Findings: Twelve selected ISSR primers generated a total of 175 fragments, 173 (98.86%) of which were polymorphic. The Nei's gene diversity (H) and Shannon's index (I) of both species were high at species level (H = 0.3107, I = 0.4677 for R. palmatum; H = 0.2848, I = 0.4333 for R. tanguticum). But for both species, the genetic diversity was low at population level, and average within-population diversity of R. palmatum was H = 0.1438, I = 0.2151, and that of R. tanguticum was H = 0.1415, I = 0.2126. The hierarchical AMOVA revealed high levels of among-population genetic differentiation in both species, in line with the gene differentiation coefficient and the limited among-population gene flow (R. palmatum: Phi(st) = 0.592, G(st) = 0.537, N-m = 0.432; R. tanguticum: Phi(st) = 0.567, G(st) = 0.497, N-m = 0.507). By contrast, only 6.52% of the total genetic variance was partitioned between R. palmatum and R. tanguticum. Bayesian analysis, UPGMA cluster analysis, and PCoA analysis all demonstrated the similar results. A significant isolation-by-distance pattern was revealed in R. palmatum (r = 0.547, P = 0.010), but not in R. tanguticum (r = 0.241, P = 0.100). Based on these results, effective conservation strategies were proposed for these two species. The small molecular variance between R. palmatum and R. tanguticum revealed that they had a common ancestor, and we considered that these two species might not be good species.	[Wang, Xumei; Yang, Rui; Li, Yan] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China; [Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Ren, Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Shaanxi Normal University	Wang, XM (corresponding author), Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China.	wangxumei@mail.xjtu.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	National Nature Science Foundation of China [81001602]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Nature Science Foundation of China (No. 81001602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amel SH, 2004, GENET RESOUR CROP EV, V51, P269, DOI 10.1023/B:GRES.0000024012.59828.6b; [Anonymous], 1984, GARTENFLORA, V23, P305; Bao BJ., 2003, FLORA CHINA, V5, P341; BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Chen Da-Xia, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2309; Chen FJ, 2009, BIOCHEM SYST ECOL, V37, P613, DOI 10.1016/j.bse.2009.08.004; Chennaoui-Kourda H, 2007, BIOCHEM SYST ECOL, V35, P682, DOI 10.1016/j.bse.2007.05.005; Chinese Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, P22; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Doyle J. J., 1987, PHYTOCHEM B, P11; Esselman EJ, 1999, MOL ECOL, V8, P443, DOI 10.1046/j.1365-294X.1999.00585.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Freeland J. R., 2011, MOL ECOLOGY; Ge XJ, 2005, BIODIVERS CONSERV, V14, P849, DOI 10.1007/s10531-004-0655-6; Ge XJ, 1999, MOL ECOL, V8, P2061, DOI 10.1046/j.1365-294x.1999.00821.x; Goropashnaya AV, 2001, MOL ECOL, V10, P2807, DOI 10.1046/j.1365-294X.2001.t01-1-01410.x; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hogbin PM, 1999, CONSERV BIOL, V13, P514, DOI 10.1046/j.1523-1739.1999.98182.x; Hu YP, 2010, BIOCHEM SYST ECOL, V38, P264, DOI 10.1016/j.bse.2010.01.006; KARRON JD, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P87; Knuth P, 1906, HDB FLOWER POLLINATI, V3; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li EX, 2008, MOL PHYLOGENET EVOL, V49, P702, DOI 10.1016/j.ympev.2008.09.012; Li JM, 2007, PLANT SCI, V172, P1048, DOI 10.1016/j.plantsci.2007.02.009; Li PQ, 2010, LIAONING J TRAD CHIN, V37, P136; Lu Jian-ying, 2008, Xibei Shifan Daxue Xuebao (Ziran Kexue Ban), V44, P66; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Miller MP, 1997, TOOLS POPULATION GEN; Moreira RG, 2010, CONSERV GENET, V11, P1247, DOI 10.1007/s10592-009-9953-6; Moreno S, 1998, EUPHYTICA, V101, P117, DOI 10.1023/A:1018379805873; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; NEI M, 1974, GENETICS, V76, P379; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rajesh PN, 2003, EUPHYTICA, V129, P15, DOI 10.1023/A:1021567821141; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Song ZQ, 2010, GENETICA, V138, P241, DOI 10.1007/s10709-009-9416-5; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Suo FengMei, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P292; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang A. T., 2009, THESIS LANZHOU U; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang XM, 2012, INT J MOL SCI, V13, P3900, DOI 10.3390/ijms13033900; Wang XM, 2010, J MED PLANTS RES, V4, P1865; Wang XM, 2010, J MED PLANTS RES, V4, P904; Wright S, 1931, GENETICS, V16, P0097; Wu JK, 1992, ACTA BOT BOREALI-OCC, V12, P309; Xia T, 2005, BIOCHEM GENET, V43, P87, DOI 10.1007/s10528-005-1502-5; Xiao Su-ping, 2007, Zhongguo Zhong Yao Za Zhi, V32, P195; Yang DY, 2004, BIOL PHARM BULL, V27, P375, DOI 10.1248/bpb.27.375; Yeh F.C., 1997, POPGENE VERSION 1 31	55	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51667	10.1371/journal.pone.0051667	http://dx.doi.org/10.1371/journal.pone.0051667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	22558416	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300022
J	Wang, XH; Fiorini, Z; Smith, C; Zhang, YN; Li, J; Watkins, LR; Yin, H				Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Zhang, Yingning; Li, Jing; Watkins, Linda R.; Yin, Hang			Repositioning Antimicrobial Agent Pentamidine as a Disruptor of the Lateral Interactions of Transmembrane Domain 5 of EBV Latent Membrane Protein 1	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN CYCLIN A(2); ENDOTHELIAL-CELLS; P-GLYCOPROTEIN; EXPRESSION; BRAIN; ACTIVATION; RESISTANCE; STABILITY; APOPTOSIS	The lateral transmembrane protein-protein interactions (PPI) have been regarded as "undruggable" despite their importance in many essential biological processes. The homo-trimerization of transmembrane domain 5 (TMD-5) of latent membrane protein 1 (LMP-1) is critical for the constitutive oncogenic activation of the Epstein-Barr virus (EBV). Herein we repurpose the antimicrobial agent pentamidine as a regulator of LMP-1 TMD-5 lateral interactions. The results of ToxR assay, tryptophan fluorescence assay, courmarin fluorescence dequenching assay, and Bis-Tris sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) consistently show pentamidine disrupts LMP-1 TMD-5 lateral interactions. Furthermore, pentamidine inhibits LMP-1 signaling, inducing cellular apoptosis and suppressing cell proliferation in the EBV infected B cells. In contrast, EBV negative cells are less susceptible to pentamidine. This study provides a novel non-peptide small molecule agent for regulating LMP-1 TMD-5 lateral interactions.	[Li, Jing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Li, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China.	lijing6515@pumch.cn; hubert.yin@colorado.edu	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	National Institutes of Health [R21CA138373, DA024044]; Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research [SKF-08-101]; Stand Up to Cancer Innovative Research Award [SU2C]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research; Stand Up to Cancer Innovative Research Award; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank the National Institutes of Health (R21CA138373, DA024044), Cancer League of Colorado for financial supports of this work. H.Y. is also grateful for the 2009 Elion Award from the American Association of Cancer Research, a Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research (SKF-08-101) and a Stand Up to Cancer (SU2C) Innovative Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1988, CANCER RES, V48, P589; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Beaulieu E, 1997, BIOCHEM J, V326, P539, DOI 10.1042/bj3260539; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Grigoriev MY, 2002, CELL CYCLE, V1, P337, DOI 10.4161/cc.1.5.152; Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10; Joce C, 2011, JOVE-J VIS EXP, DOI 10.3791/2721; Joce C, 2011, BBA-BIOMEMBRANES, V1808, P2948, DOI 10.1016/j.bbamem.2011.07.008; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Long HM, 2011, CURR OPIN IMMUNOL, V23, P258, DOI 10.1016/j.coi.2010.12.014; Maeda E, 2009, JPN J RADIOL, V27, P4, DOI 10.1007/s11604-008-0291-2; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Quintana FJ, 2007, BIOCHEMISTRY-US, V46, P2317, DOI 10.1021/bi061849g; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sackett DL, 2009, NAT CHEM, V1, P596, DOI 10.1038/nchem.427; Sammond DW, 2011, BIOPOLYMERS, V95, P772, DOI 10.1002/bip.21672; Sheikh MS, 2003, CELL CYCLE, V2, P550, DOI 10.4161/cc.2.6.566; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sun BH, 2000, WORLD J GASTROENTERO, V6, P356; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Vereide D, 2009, SEMIN CANCER BIOL, V19, P389, DOI 10.1016/j.semcancer.2009.07.006; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XH, 2008, J PHYS CHEM B, V112, P8346, DOI 10.1021/jp712026m; Wang X, 2007, PROTEIN EXPRES PURIF, V56, P27, DOI 10.1016/j.pep.2007.05.011; Wang XH, 2012, BBA-BIOMEMBRANES, V1818, P2282, DOI 10.1016/j.bbamem.2012.05.013; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006665; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Yin H, 2008, ANGEW CHEM INT EDIT, V47, P2744, DOI 10.1002/anie.200704780; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zhao TX, 2010, CURR PHARM DESIGN, V16, P1055, DOI 10.2174/138161210790963878	38	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47703	10.1371/journal.pone.0047703	http://dx.doi.org/10.1371/journal.pone.0047703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	22558416	Green Submitted, gold, Green Published			2022-12-27	WOS:000310050200040
